Cytogenetic location	Genomic coordinates (From NCBI/GRCh38)	Gene/Locus	Gene/Locus name	Gene/Locus MIM number	Approved Symbol	Entrez Gene ID	Ensembl Gene ID	Comments	Phenotype	Phenotype MIM number	Inheritance	Pheno map key	Mouse Gene (from MGI)
1p36	1:1-27600000	ALPQTL2	Alkaline phosphatase, plasma level of, QTL 2	612367		100196914		linkage with rs1780324	{Alkaline phosphatase, plasma level of, QTL 2}	612367		2	
1p	1:1-123400001	ANON1	Anorexia nervosa, susceptibility to, 1	606788		171514			{Anorexia nervosa, susceptibility to, 1}	606788		2	
1p36	1:1-27600000	BCC1	Basal cell carcinoma, susceptibility to, 1	605462		100307118		associated with rs7538876	{Basal cell carcinoma, susceptibility to, 1}	605462		2	
1p36	1:1-27600000	BMND3	Bone mineral density QTL 3	606928		246259		?another locus at 3p21	[Bone mineral density QTL 3]	606928		2	
1p36.33	1:1-2300000	C1DUPp36.33, DUP1p36.33	Chromosome 1p36.33 duplication syndrome, ATAD3 gene cluster	618815					Chromosome 1p36.33 duplication syndrome, ATAD3 gene cluster	618815	AD	4	
1p36	1:1-27600000	CMM, MLM, DNS	Cutaneous malignant melanoma/dysplastic nevus	155600		1243		some linkage studies negative; see 9p	{Melanoma, cutaneous malignant, 1}	155600	AD	2	
1pter-p36.13	1:1-20100000	CTRCT8, CCV	Cataract, congenital, Volkmann type	115665		7792		linked to Rh in Scottish family	Cataract 8, multiple types	115665	AD	2	
1p36	1:1-27600000	DEL1p36, C1DELp36	Chromosome 1p36 deletion syndrome, distal	607872				contiguous gene deletion syndrome	Chromosome 1p36 deletion syndrome, distal	607872	IC	4	
1p36	1:1-27600000	DEL1p36, C1DELp36	Chromosome 1p36 deletion syndrome, proximal	619343					Chromosome 1p36 deletion syndrome, proximal	619343	AD	4	
1p36-p34	1:1-46300000	DYX8	Dyslexia, susceptibility to, 8	608995		406874		between D1S552 and D1S1622	{Dyslexia, susceptibility to, 8}	608995	AD, Mu	2	
1p36	1:1-27600000	IBD7	Inflammatory bowel disease 7	605225		57042		associated with rs6426833	{Inflammatory bowel disease 7}	605225		2	
1p36	1:1-27600000	MS4	Multiple sclerosis, susceptibility to, 4	612596		100271696		associated with rs10492972	{Multiple sclerosis, susceptibility to, 4}	612596		2	
1p36	1:1-27600000	MYP14	Myopia 14	610320		100359407		between D1S552 and D1S1622	Myopia 14	610320	AD	2	
1p	1:1-123400001	PSORS7	Psoriasis susceptibility 7	605606					{Psoriasis susceptibility 7}	605606		2	
1p36.33	1:1013497-1014540	ISG15, G1P2, IFI15, IMD38	ISG15 ubiquitin-like modifier	147571	ISG15	9636	ENSG00000187608,ENST00000649529;;;ENST00000649529		Immunodeficiency 38	616126	AR	3	Isg15
1p36.33	1:1020120-1056116	AGRN, CMS8	Agrin	103320	AGRN	375790	ENSG00000188157,ENST00000379370;;;ENST00000379370		Myasthenic syndrome, congenital, 8, with pre- and postsynaptic defects	615120	AR	3	Agrn
1p36.33	1:1211340-1214153	TNFRSF4, TXGP1L, OX40, ACT35, IMD16	Tumor necrosis factor receptor superfamily, member 4	600315	TNFRSF4	7293	ENSG00000186827,ENST00000379236;;;ENST00000379236	mutation identified in 1 IMD16 family	?Immunodeficiency 16	615593	AR	3	Tnfrsf4
1p36.33	1:1232237-1235041	B3GALT6, SEMDJL1, EDSSPD2, ALGAZ	UDP-Gal:beta-Gal beta-1,3-galactosyltransferase polypeptide 6	615291	B3GALT6	126792	ENSG00000176022,ENST00000379198;;;ENST00000379198		Al-Gazali syndrome	609465	AR	3	B3galt6
1p36.33	1:1232237-1235041	B3GALT6, SEMDJL1, EDSSPD2, ALGAZ	UDP-Gal:beta-Gal beta-1,3-galactosyltransferase polypeptide 6	615291	B3GALT6	126792	ENSG00000176022,ENST00000379198;;;ENST00000379198		Ehlers-Danlos syndrome, spondylodysplastic type, 2	615349	AR	3	B3galt6
1p36.33	1:1232237-1235041	B3GALT6, SEMDJL1, EDSSPD2, ALGAZ	UDP-Gal:beta-Gal beta-1,3-galactosyltransferase polypeptide 6	615291	B3GALT6	126792	ENSG00000176022,ENST00000379198;;;ENST00000379198		Spondyloepimetaphyseal dysplasia with joint laxity, type 1, with or without fractures	271640	AR	3	B3galt6
1p36.33	1:1311600-1324660	INTS11, PSF3L, RC68, NEDMLOB	Integrator complex subunit 11	611354	INTS11	54973	ENSG00000127054,ENST00000435064;;;ENST00000435064		Neurodevelopmental disorder with motor and language delay, ocular defects, and brain abnormalities	620428	AR	3	Ints11
1p36.33	1:1335278-1349418	DVL1, DRS2	Dishevelled segment polarity protein 1	601365	DVL1	1855	ENSG00000107404,ENST00000378888;;;ENST00000378888		Robinow syndrome, autosomal dominant 2	616331	AD	3	Dvl1
1p36.33	1:1435690-1442882	VWA1, WARP, HMNR7	von Willebrand factor A domain-containing protein 1	611901	VWA1	64856	ENSG00000179403,ENST00000476993;;;ENST00000476993		Neuronopathy, distal hereditary motor, autosomal recessive 7	619216	AR	3	Vwa1
1p36.33	1:1512162-1534685	ATAD3A, HAYOS, PHRINL	ATPase family, AAA domain-containing, member 3A	612316	ATAD3A	55210	ENSG00000197785,ENST00000378756;;;ENST00000378756		Harel-Yoon syndrome	617183	AD, AR	3	Atad3a
1p36.33	1:1512162-1534685	ATAD3A, HAYOS, PHRINL	ATPase family, AAA domain-containing, member 3A	612316	ATAD3A	55210	ENSG00000197785,ENST00000378756;;;ENST00000378756		Pontocerebellar hypoplasia, hypotonia, and respiratory insufficiency syndrome, neonatal lethal	618810	AR	3	Atad3a
1p36.33	1:1534778-1540624	TMEM240, C1orf70, SCA21	Transmembrane protein 240	616101	TMEM240	339453	ENSG00000205090,ENST00000378733;;;ENST00000378733		Spinocerebellar ataxia 21	607454	AD	3	Tmem240
1p36.33	1:1785286-1891087	GNB1, MRD42, MDS	Guanine nucleotide-binding protein, beta polypeptide-1	139380	GNB1	2782	ENSG00000078369,ENST00000378609;;;ENST00000378609		Intellectual developmental disorder, autosomal dominant 42	616973	AD	3	Gnb1
1p36.33	1:1785286-1891087	GNB1, MRD42, MDS	Guanine nucleotide-binding protein, beta polypeptide-1	139380	GNB1	2782	ENSG00000078369,ENST00000378609;;;ENST00000378609		Leukemia, acute lymphoblastic, somatic	613065		3	Gnb1
1p36.33	1:1785286-1891087	GNB1, MRD42, MDS	Guanine nucleotide-binding protein, beta polypeptide-1	139380	GNB1	2782	ENSG00000078369,ENST00000378609;;;ENST00000378609		Myelodysplastic syndrome, somatic	614286		3	Gnb1
1p36.33	1:1921957-2003786	CFAP74, KIAA1751, C1orf222, CILD49	Cilia- and flagella-associated protein 74	620187	CFAP74	85452	ENSG00000142609,ENST00000682832;;;ENST00000682832		Ciliary dyskinesia, primary, 49, without situs inversus	620197	AR	3	Cfap74
1p36.33	1:2019345-2030758	GABRD, GEFSP5	Gamma-aminobutyric acid (GABA) A receptor, delta	137163	GABRD	2563	ENSG00000187730,ENST00000378585;;;ENST00000378585	mutation identified in 1 GEFSP5 family	{?Generalized epilepsy with febrile seizures plus, type 5, susceptibility to}	613060	AD	3	Gabrd
1p36.33-p36.32	1:2228319-2310213	SKI, SGS	SKI protooncogene	164780	SKI	6497	ENSG00000157933,ENST00000378536;;;ENST00000378536	formerly mapped to 1q22-q24	Shprintzen-Goldberg syndrome	182212	AD	3	Ski
1p36.32-p36.13	1:2300001-20100000	DYT13	Dystonia 13, torsion	607671		93983			Dystonia 13, torsion	607671	AD	2	
1p36.32-p35.3	1:2300001-29900000	KONDS	Kondoh syndrome	606242		100653373		linked to rs966321 and rs1441834	Kondoh syndrome	606242	AR	2	
1p36.32	1:2403974-2413827	PEX10, NALD, PBD6A, PBD6B	Peroxisome biogenesis factor 10	602859	PEX10	5192	ENSG00000157911,ENST00000447513;;;ENST00000447513		Peroxisome biogenesis disorder 6A (Zellweger)	614870	AR	3	Pex10
1p36.32	1:2403974-2413827	PEX10, NALD, PBD6A, PBD6B	Peroxisome biogenesis factor 10	602859	PEX10	5192	ENSG00000157911,ENST00000447513;;;ENST00000447513		Peroxisome biogenesis disorder 6B	614871	AR	3	Pex10
1p36.32	1:2508537-2526596	PANK4, CTRCT49	Pantothenate kinase 4	606162	PANK4	55229	ENSG00000157881,ENST00000378466;;;ENST00000378466	mutation identified in 1 CTRCT49 family	?Cataract 49	619593	AD	3	Pank4
1p36.32	1:3069203-3438621	PRDM16, MEL1, LVNC8, CMD1LL	PR domain-containing protein 16	605557	PRDM16	63976	ENSG00000142611,ENST00000270722;;;ENST00000270722		Cardiomyopathy, dilated, 1LL	615373	AD	3	Prdm16
1p36.32	1:3069203-3438621	PRDM16, MEL1, LVNC8, CMD1LL	PR domain-containing protein 16	605557	PRDM16	63976	ENSG00000142611,ENST00000270722;;;ENST00000270722		Left ventricular noncompaction 8	615373	AD	3	Prdm16
1p36.32	1:3652516-3736201	TP73, CILD47	p53-related protein	601990	TP73	7161	ENSG00000078900,ENST00000378295;;;ENST00000378295	imprinted	Ciliary dyskinesia, primary, 47, and lissencephaly	619466	AR	3	Trp73
1p36.32	1:3772749-3775956	SMIM1, VEL	Small integral membrane protein 1	615242	SMIM1	388588	ENSG00000235169,ENST00000642557;;;ENST00000642557		[Blood group, Vel system]	615264	AR	3	Smim1
1p36.32	1:3812086-3857211	CEP104, GLYBP, KIAA0562, JBTS25, MRT77	Centrosomal protein, 104kD	616690	CEP104	9731	ENSG00000116198,ENST00000378230;;;ENST00000378230		Intellectual developmental disorder, autosomal recessive 77	619988	AR	3	Cep104
1p36.32	1:3812086-3857211	CEP104, GLYBP, KIAA0562, JBTS25, MRT77	Centrosomal protein, 104kD	616690	CEP104	9731	ENSG00000116198,ENST00000378230;;;ENST00000378230		Joubert syndrome 25	616781	AR	3	Cep104
1p36.31-p36.13	1:5300001-20100000	DFNB96	Deafness, autosomal recessive 96	614414		100861440		between rs3817914 and rs477558	Deafness, autosomal recessive 96	614414	AR	2	
1p36.31	1:5862811-5992425	NPHP4, SLSN4	Nephrocystin 4	607215	NPHP4	261734	ENSG00000131697,ENST00000378156;;;ENST00000378156		Nephronophthisis 4	606966	AR	3	Nphp4
1p36.31	1:5862811-5992425	NPHP4, SLSN4	Nephrocystin 4	607215	NPHP4	261734	ENSG00000131697,ENST00000378156;;;ENST00000378156		Senior-Loken syndrome 4	606996	AR	3	Nphp4
1p36.31	1:6101787-6180321	CHD5, PMNDS	Chromodomain helicase DNA-binding protein 5	610771	CHD5	26038	ENSG00000116254,ENST00000262450;;;ENST00000262450		Parenti-Mignot neurodevelopmental syndrome	619873	AD	3	Chd5
1p36.31	1:6424776-6461370	ESPN, USH1M	Espin	606351	ESPN	83715	ENSG00000187017,ENST00000645284;;;ENST00000645284	mutation identified in 1 USH1M family	?Usher syndrome, type 1M	618632	AR	3	Espn
1p36.31	1:6424776-6461370	ESPN, USH1M	Espin	606351	ESPN	83715	ENSG00000187017,ENST00000645284;;;ENST00000645284	mutation identified in 1 USH1M family	Deafness, autosomal recessive 36	609006	AR	3	Espn
1p36.31	1:6424776-6461370	ESPN, USH1M	Espin	606351	ESPN	83715	ENSG00000187017,ENST00000645284;;;ENST00000645284	mutation identified in 1 USH1M family	Deafness, neurosensory, without vestibular involvement, autosomal dominant	609006	AR	3	Espn
1p36.31	1:6467122-6520092	PLEKHG5, KIAA0720, HMNR4, CMTRIC	Pleckstrin homology domain- and RhoGEF domain-containing protein G5	611101	PLEKHG5	57449	ENSG00000171680,ENST00000377728;;;ENST00000377728		Charcot-Marie-Tooth disease, recessive intermediate C	615376	AR	3	Plekhg5
1p36.31	1:6467122-6520092	PLEKHG5, KIAA0720, HMNR4, CMTRIC	Pleckstrin homology domain- and RhoGEF domain-containing protein G5	611101	PLEKHG5	57449	ENSG00000171680,ENST00000377728;;;ENST00000377728		Neuronopathy, distal hereditary motor, autosomal recessive 4	611067	AR	3	Plekhg5
1p36.31-p36.23	1:6785454-7769706	CAMTA1, KIAA0833, CECBA	Calmodulin-binding transcription activator 1	611501	CAMTA1	23261	ENSG00000171735,ENST00000303635;;;ENST00000303635		Cerebellar dysfunction with variable cognitive and behavioral abnormalities	614756	AD	3	Camta1
1p36.2-p36.1	1:7100001-27600000	GLC3B	Glaucoma 3, primary infantile, B	600975		2728			Glaucoma 3, primary infantile, B	600975	AR	2	
1p36.2	1:7100001-15900000	SCZD12	Schizophrenia 12	608543		619488		max lod at D1S1612	{Schizophrenia 12}	181500	AD	2	
1p36.23	1:7784291-7845177	PER3, FASPS3	Period circadian regulator 3	603427	PER3	8863	ENSG00000049246,ENST00000377532;;;ENST00000377532	mutation identified in 1 FASPS3 family	?Advanced sleep phase syndrome, familial, 3	616882	AD	3	Per3
1p36.23	1:7915871-7940839	TNFRSF9, ILA, CD137, IMD109	Tumor necrosis factor receptor superfamily, member 9 (interleukin-activated receptor; Ly63, mouse, homolog of)	602250	TNFRSF9	3604	ENSG00000049249,ENST00000377507;;;ENST00000377507		Immunodeficiency 109 with lymphoproliferation	620282	AR	3	Tnfrsf9
1p36.23	1:7961711-7985505	DJ1, PARK7	Oncogene DJ-1	602533	PARK7	11315	ENSG00000116288,ENST00000338639;;;ENST00000338639		Parkinson disease 7, autosomal recessive early-onset	606324	AR	3	Park7
1p36.23	1:8318114-8344165	SLC45A1, DNB5, IDDNPF	Solute carrier family 45, member 1	605763	SLC45A1	50651	ENSG00000162426,ENST00000471889;;;ENST00000471889		Intellectual developmental disorder with neuropsychiatric features	617532	AR	3	Slc45a1
1p36.23	1:8352404-8817640	RERE, NEDBEH	Arginine-glutamic acid dipeptide repeats	605226	RERE	473	ENSG00000142599,ENST00000400908;;;ENST00000400908		Neurodevelopmental disorder with or without anomalies of the brain, eye, or heart	616975	AD	3	Rere
1p36.22	1:9234774-9271337	H6PD, GDH, G6PDH, CORTRD1	Hexose-6-phosphate dehydrogenase	138090	H6PD	9563	ENSG00000049239,ENST00000377403;;;ENST00000377403	digenic triallelic mutations with HSD11B1	Cortisone reductase deficiency 1	604931	AR	3	H6pd
1p36.22	1:9627258-9729114	PIK3CD, APDS, IMD14A, IMD14B, ROCHIS	Phosphatidylinositol 3-kinase, catalytic, 110kD, delta	602839	PIK3CD	5293	ENSG00000171608,ENST00000377346;;;ENST00000377346	mutation identified in 1 ROCHIS family	?Roifman-Chitayat syndrome, digenic	613328	DR	3	Pik3cd
1p36.22	1:9627258-9729114	PIK3CD, APDS, IMD14A, IMD14B, ROCHIS	Phosphatidylinositol 3-kinase, catalytic, 110kD, delta	602839	PIK3CD	5293	ENSG00000171608,ENST00000377346;;;ENST00000377346	mutation identified in 1 ROCHIS family	Immunodeficiency 14A, autosomal dominant	615513	AD	3	Pik3cd
1p36.22	1:9627258-9729114	PIK3CD, APDS, IMD14A, IMD14B, ROCHIS	Phosphatidylinositol 3-kinase, catalytic, 110kD, delta	602839	PIK3CD	5293	ENSG00000171608,ENST00000377346;;;ENST00000377346	mutation identified in 1 ROCHIS family	Immunodeficiency 14B, autosomal recessive	619281	AR	3	Pik3cd
1p36.22	1:9942923-9996892	NMNAT1, NMNAT, PNAT1, LCA9, SHILCA	Nicotinamide nucleotide adenylyltransferase 1	608700	NMNAT1	64802	ENSG00000173614,ENST00000377205;;;ENST00000377205		Leber congenital amaurosis 9	608553	AR	3	Nmnat1
1p36.22	1:9942923-9996892	NMNAT1, NMNAT, PNAT1, LCA9, SHILCA	Nicotinamide nucleotide adenylyltransferase 1	608700	NMNAT1	64802	ENSG00000173614,ENST00000377205;;;ENST00000377205		Spondyloepiphyseal dysplasia, sensorineural hearing loss, intellectual developmental disorder, and Leber congenital amaurosis	619260	AR	3	Nmnat1
1p36.22	1:10210570-10381603	KIF1B, CMT2A, CMT2A1, NBLST1	Kinesin family member 1B	605995	KIF1B	23095	ENSG00000054523,ENST00000676179;;;ENST00000676179		{Neuroblastoma, susceptibility to, 1}	256700	AD, SMu	3	Kif1b
1p36.22	1:10210570-10381603	KIF1B, CMT2A, CMT2A1, NBLST1	Kinesin family member 1B	605995	KIF1B	23095	ENSG00000054523,ENST00000676179;;;ENST00000676179		Charcot-Marie-Tooth disease, type 2A1	118210	AD	3	Kif1b
1p36.22	1:10474950-10630758	PEX14, PBD13A	Peroxisome biogenesis factor 14	601791	PEX14	5195	ENSG00000142655,ENST00000356607;;;ENST00000356607		Peroxisome biogenesis disorder 13A (Zellweger)	614887	AR	3	Pex14
1p36.22	1:10946475-10982076	CIROZ, C1orf127, CIROZ, HTX14	Ciliated left-right organizer protein containing ZP-N domains	619700	CIROZ	148345	ENSG00000175262,ENST00000377004;;;ENST00000377004		Heterotaxy, visceral, 14, autosomal	621080	AR	3	Ciroz
1p36.22	1:11012654-11030528	TARDBP, TDP43, ALS10	TAR DNA-binding protein	605078	TARDBP	23435	ENSG00000120948,ENST00000240185;;;ENST00000240185	pseudogenes on 2, 6, 8, 13, 20	Amyotrophic lateral sclerosis 10, with or without FTD	612069	AD	3	Tardbp
1p36.22	1:11012654-11030528	TARDBP, TDP43, ALS10	TAR DNA-binding protein	605078	TARDBP	23435	ENSG00000120948,ENST00000240185;;;ENST00000240185	pseudogenes on 2, 6, 8, 13, 20	Frontotemporal lobar degeneration, TARDBP-related	612069	AD	3	Tardbp
1p36.22	1:11026523-11047239	MASP2	Mannan-binding lectin serine protease 2	605102	MASP2	10747	ENSG00000009724,ENST00000400897;;;ENST00000400897		MASP2 deficiency	613791	AR	3	Masp2
1p36.22	1:11106535-11262551	MTOR, FRAP1, SKS	Mechanistic target of rapamycin	601231	MTOR	2475	ENSG00000198793,ENST00000361445;;;ENST00000361445		Focal cortical dysplasia, type II, somatic	607341		3	Mtor
1p36.22	1:11106535-11262551	MTOR, FRAP1, SKS	Mechanistic target of rapamycin	601231	MTOR	2475	ENSG00000198793,ENST00000361445;;;ENST00000361445		Smith-Kingsmore syndrome	616638	AD	3	Mtor
1p36.22	1:11273198-11299574	UBIAD1, TERE1, SCCD	UbiA prenyltransferase domain-containing protein 1	611632	UBIAD1	29914	ENSG00000120942,ENST00000376810;;;ENST00000376810		Corneal dystrophy, Schnyder type	121800	AD	3	Ubiad1
1p36.22	1:11674480-11691830	MAD2L2, MAD2B, FANCV	Mitotic arrest-deficient 2 like 2	604094	MAD2L2	10459	ENSG00000116670,ENST00000376692;;;ENST00000376692	mutation identified in 1 FANCV patient; pseudogene on 14q21-q23	?Fanconi anemia, complementation group V	617243	AR	3	Mad2l2
1p36.22	1:11785723-11805964	MTHFR	Methylenetetrahydrofolate reductase	607093	MTHFR	4524	ENSG00000177000,ENST00000376590;;;ENST00000376590		{Neural tube defects, susceptibility to}	601634	AR	3	Mthfr
1p36.22	1:11785723-11805964	MTHFR	Methylenetetrahydrofolate reductase	607093	MTHFR	4524	ENSG00000177000,ENST00000376590;;;ENST00000376590		{Schizophrenia, susceptibility to}	181500	AD	3	Mthfr
1p36.22	1:11785723-11805964	MTHFR	Methylenetetrahydrofolate reductase	607093	MTHFR	4524	ENSG00000177000,ENST00000376590;;;ENST00000376590		{Thromboembolism, susceptibility to}	188050	AD	3	Mthfr
1p36.22	1:11785723-11805964	MTHFR	Methylenetetrahydrofolate reductase	607093	MTHFR	4524	ENSG00000177000,ENST00000376590;;;ENST00000376590		{Vascular disease, susceptibility to}			3	Mthfr
1p36.22	1:11785723-11805964	MTHFR	Methylenetetrahydrofolate reductase	607093	MTHFR	4524	ENSG00000177000,ENST00000376590;;;ENST00000376590		Homocystinuria due to MTHFR deficiency	236250	AR	3	Mthfr
1p36.22	1:11806191-11843130	CLCN6, CLCN6	Chloride channel 6	602726	CLCN6	1185	ENSG00000011021,ENST00000346436;;;ENST00000346436		Ceroid lipofuscinosis, neuronal, 15	619173	AD	3	Clcn6
1p36.22	1:11845709-11847783	NPPA, PND, ANP, ATFB6, ATRST2	Natriuretic peptide precursor A	108780	NPPA	4878	ENSG00000175206,ENST00000376480;;;ENST00000376480		Atrial fibrillation, familial, 6	612201	AD	3	Nppa
1p36.22	1:11845709-11847783	NPPA, PND, ANP, ATFB6, ATRST2	Natriuretic peptide precursor A	108780	NPPA	4878	ENSG00000175206,ENST00000376480;;;ENST00000376480		Atrial standstill 2	615745	AR	3	Nppa
1p36.22	1:11934717-11975537	PLOD1, LH1, LLH, EDSKCL1	Procollagen-lysine, 2-oxoglutarate 5-dioxygenase (lysine hydroxylase)	153454	PLOD1	5351	ENSG00000083444,ENST00000196061;;;ENST00000196061		Ehlers-Danlos syndrome, kyphoscoliotic type, 1	225400	AR	3	Plod1
1p36.22	1:11980444-12013508	MFN2, KIAA0214, CMT2A2A, HMSN6A, CMT2A2B, MSL	Mitofusin 2	608507	MFN2	9927	ENSG00000116688,ENST00000235329;;;ENST00000235329		Charcot-Marie-Tooth disease, axonal, type 2A2A	609260	AD	3	Mfn2
1p36.22	1:11980444-12013508	MFN2, KIAA0214, CMT2A2A, HMSN6A, CMT2A2B, MSL	Mitofusin 2	608507	MFN2	9927	ENSG00000116688,ENST00000235329;;;ENST00000235329		Charcot-Marie-Tooth disease, axonal, type 2A2B	617087	AR	3	Mfn2
1p36.22	1:11980444-12013508	MFN2, KIAA0214, CMT2A2A, HMSN6A, CMT2A2B, MSL	Mitofusin 2	608507	MFN2	9927	ENSG00000116688,ENST00000235329;;;ENST00000235329		Hereditary motor and sensory neuropathy VIA	601152	AD	3	Mfn2
1p36.22	1:11980444-12013508	MFN2, KIAA0214, CMT2A2A, HMSN6A, CMT2A2B, MSL	Mitofusin 2	608507	MFN2	9927	ENSG00000116688,ENST00000235329;;;ENST00000235329		Lipomatosis, multiple symmetric, with or without peripheral neuropathy	151800	AR	3	Mfn2
1p36.22-p36.21	1:12230030-12512047	VPS13D, SCAR4	Vacuolar protein sorting 13 homolog D	608877	VPS13D	55187	ENSG00000048707,ENST00000620676;;;ENST00000620676		Spinocerebellar ataxia, autosomal recessive 4	607317	AR	3	Vps13d
1p36.21	1:12500001-15900000	GBD2	Gallbladder disease 2	609918		100048905		between D1S1597 and D1S47	Gallbladder disease 2	609918		2	
1p36.21	1:15438443-15449242	CTRC, CLCR	Chymotrypsin	601405	CTRC	11330	ENSG00000162438,ENST00000375949;;;ENST00000375949		{Pancreatitis, chronic, susceptibility to}	167800	AD	3	Ctrc
1p36.21	1:15456732-15472091	CELA2A, ELA2A, AOMS4	Chymotrypsin-like elastase family, member 2A	609443	CELA2A	63036	ENSG00000142615,ENST00000359621;;;ENST00000359621		Abdominal obesity-metabolic syndrome 4	618620	AD	3	Cela2a
1p36.21-p36.13	1:15847707-15940456	SPEN, MINT, SHARP, HIAA0929, RATARS	Spen family transcriptional repressor	613484	SPEN	23013	ENSG00000065526,ENST00000375759;;;ENST00000375759		Radio-Tartaglia syndrome	619312	AD	3	Spen
1p36.13-p34.3	1:15900001-39600000	ANIB3	Aneurysm, intracranial berry, 3	609122		497657			Aneurysm, intracranial berry, 3	609122	AD	2	
1p36.13-p34.3	1:15900001-39600000	EA8	Episodic ataxia, type 8	616055		104326187		between rs2743201 and rs215791	Episodic ataxia, type 8	616055	AD	2	
1p36.13	1:16022036-16034050	CLCNKA	Chloride channel, kidney, A	602024	CLCNKA	1187	ENSG00000186510,ENST00000331433;;;ENST00000331433	11kb from CLCNKB; simultaneous mutation in CLCNKA and CLCNKB	Bartter syndrome, type 4b, digenic	613090	DR	3	Clcnka,Clcnkb
1p36.13	1:16043782-16057326	CLCNKB	Chloride channel, kidney, B	602023	CLCNKB	1188	ENSG00000184908,ENST00000375679;;;ENST00000375679	unequal crossingover with CLCNKA	Bartter syndrome, type 3	607364	AR	3	Clcnka,Clcnkb
1p36.13	1:16043782-16057326	CLCNKB	Chloride channel, kidney, B	602023	CLCNKB	1188	ENSG00000184908,ENST00000375679;;;ENST00000375679	unequal crossingover with CLCNKA	Bartter syndrome, type 4b, digenic	613090	DR	3	Clcnka,Clcnkb
1p36.13	1:16124337-16156069	EPHA2, ECK, CTPP1, CTPA, ARCC2, CTRCT6	Ephrin receptor EphA2	176946	EPHA2	1969	ENSG00000142627,ENST00000358432;;;ENST00000358432		Cataract 6, multiple types	116600	AD	3	Epha2
1p36.13	1:16985958-17011928	ATP13A2, PARK9, KRPPD, SPG78	ATPase 13A2	610513	ATP13A2	23400	ENSG00000159363,ENST00000326735;;;ENST00000326735	mutation identified in 1 family with CLN12	Kufor-Rakeb syndrome	606693	AR	3	Atp13a2
1p36.13	1:16985958-17011928	ATP13A2, PARK9, KRPPD, SPG78	ATPase 13A2	610513	ATP13A2	23400	ENSG00000159363,ENST00000326735;;;ENST00000326735	mutation identified in 1 family with CLN12	Spastic paraplegia 78, autosomal recessive	617225	AR	3	Atp13a2
1p36.13	1:17018722-17054032	SDHB, SDH2, SDHIP, PPGL4, MC2DN4	Succinate dehydrogenase complex, iron-sulfur subunit B	185470	SDHB	6390	ENSG00000117118,ENST00000375499;;;ENST00000375499	1 of 2 polypeptides	Gastrointestinal stromal tumor	606764	AD, IC	3	Sdhb
1p36.13	1:17018722-17054032	SDHB, SDH2, SDHIP, PPGL4, MC2DN4	Succinate dehydrogenase complex, iron-sulfur subunit B	185470	SDHB	6390	ENSG00000117118,ENST00000375499;;;ENST00000375499	1 of 2 polypeptides	Mitochondrial complex II deficiency, nuclear type 4	619224	AR	3	Sdhb
1p36.13	1:17018722-17054032	SDHB, SDH2, SDHIP, PPGL4, MC2DN4	Succinate dehydrogenase complex, iron-sulfur subunit B	185470	SDHB	6390	ENSG00000117118,ENST00000375499;;;ENST00000375499	1 of 2 polypeptides	Paraganglioma and gastric stromal sarcoma	606864		3	Sdhb
1p36.13	1:17018722-17054032	SDHB, SDH2, SDHIP, PPGL4, MC2DN4	Succinate dehydrogenase complex, iron-sulfur subunit B	185470	SDHB	6390	ENSG00000117118,ENST00000375499;;;ENST00000375499	1 of 2 polypeptides	Pheochromocytoma/paraganglioma syndrome 4	115310	AD	3	Sdhb
1p36.13	1:17249098-17284233	PADI3, UHS1	Peptidylarginine deiminase, type III	606755	PADI3	51702	ENSG00000142619,ENST00000375460;;;ENST00000375460		Uncombable hair syndrome	191480	AR	3	Padi3
1p36.13	1:17372196-17401699	PADI6, OZEMA16	Peptidylarginine deiminase, type VI	610363	PADI6	353238	ENSG00000276747,ENST00000619609;;;ENST00000619609		Oocyte/zygote/embryo maturation arrest 16	617234	AR	3	Padi6
1p36.13	1:18630846-18748866	PAX7, RMS2, CMYO19	Paired box gene 7	167410	PAX7	5081	ENSG00000009709,ENST00000420770;;;ENST00000420770	fused with FKHR in rhabdomyosarcoma	Congenital myopathy 19	618578	AR	3	Pax7
1p36.13	1:18630846-18748866	PAX7, RMS2, CMYO19	Paired box gene 7	167410	PAX7	5081	ENSG00000009709,ENST00000420770;;;ENST00000420770	fused with FKHR in rhabdomyosarcoma	Rhabdomyosarcoma 2, alveolar	268220	SMu	3	Pax7
1p36.13	1:18871430-18902555	ALDH4A1, ALDH4, P5CDH	Aldehyde dehydrogenase 4 family, member A1 (delta-1-pyrroline 5-carboxylate dehydrogenase)	606811	ALDH4A1	8659	ENSG00000159423,ENST00000375341;;;ENST00000375341		Hyperprolinemia, type II	239510	AR	3	Aldh4a1
1p36.13	1:19215660-19251524	EMC1, KIAA0090, CAVIPMR	Endoplasmic reticulum membrane protein complex, subunit 1	616846	EMC1	23065	ENSG00000127463,ENST00000477853;;;ENST00000477853		Cerebellar atrophy, visual impairment, and psychomotor retardation	616875	AR	3	Emc1
1p36.13	1:19975431-19980434	PLA2G2A, PLA2B, PLA2L, MOM1	Phospholipase A2, group IIA, platelets, synovial fluid	172411	PLA2G2A	5320	ENSG00000188257,ENST00000482011;;;ENST00000482011	germline mutation identified in 1 CRC patient	{?Colorectal cancer, susceptibility to}	114500	AD, SMu	3	Pla2g2a
1p36.13	1:20028408-20091911	PLA2G5, FRFB	Phospholipase A2, group V	601192	PLA2G5	5322	ENSG00000127472,ENST00000375108;;;ENST00000375108		[Fleck retina, familial benign]	228980	AR	3	Pla2g5
1p36.12	1:20100001-23600000	B6QTL1	Vitamin B6 plasma level QTL 1	612957		100302718		associated with rs4654748	{Vitamin B6 plasma level QTL 1}	612957		2	
1p36.12-p35.1	1:20100001-34300000	BFIS4, BFIC4	Seizures, benign familial infantile, 4	612627		100271922		between D1S2864 and D1S2830	Seizures, benign familial infantile, 4	612627		2	
1p36.12	1:20633458-20651511	PINK1, PARK6	PTEN-induced putative kinase 1	608309	PINK1	65018	ENSG00000158828,ENST00000321556;;;ENST00000321556		Parkinson disease 6, early onset	605909	AR	3	Pink1
1p36.12	1:20651777-20661369	DDOST, OST, OST48, CDG1R	Dolichyl-diphosphooligosaccharide-protein glycosyltransferase	602202	DDOST	1650	ENSG00000244038,ENST00000602624;;;ENST00000602624		Congenital disorder of glycosylation, type Ir	614507	AR	3	Ddost
1p36.12	1:21217250-21345504	ECE1	Endothelin converting enzyme 1	600423	ECE1	1889	ENSG00000117298,ENST00000374893;;;ENST00000374893	mutation identified in 1 HCAD patient	?Hirschsprung disease, cardiac defects, and autonomic dysfunction	613870	AD	3	Ece1
1p36.12	1:21217250-21345504	ECE1	Endothelin converting enzyme 1	600423	ECE1	1889	ENSG00000117298,ENST00000374893;;;ENST00000374893	mutation identified in 1 HCAD patient	{Hypertension, essential, susceptibility to}	145500	Mu	3	Ece1
1p36.12	1:21508984-21578410	ALPL, HOPS, TNSALP, HPPA, HPPO, HPPI, HPPC	Alkaline phosphatase, liver/bone/kidney	171760	ALPL	249	ENSG00000162551,ENST00000374840;;;ENST00000374840		Hypophosphatasia, adult	146300	AD, AR	3	Alpl
1p36.12	1:21508984-21578410	ALPL, HOPS, TNSALP, HPPA, HPPO, HPPI, HPPC	Alkaline phosphatase, liver/bone/kidney	171760	ALPL	249	ENSG00000162551,ENST00000374840;;;ENST00000374840		Hypophosphatasia, childhood	241510	AR	3	Alpl
1p36.12	1:21508984-21578410	ALPL, HOPS, TNSALP, HPPA, HPPO, HPPI, HPPC	Alkaline phosphatase, liver/bone/kidney	171760	ALPL	249	ENSG00000162551,ENST00000374840;;;ENST00000374840		Hypophosphatasia, infantile	241500	AR	3	Alpl
1p36.12	1:21508984-21578410	ALPL, HOPS, TNSALP, HPPA, HPPO, HPPI, HPPC	Alkaline phosphatase, liver/bone/kidney	171760	ALPL	249	ENSG00000162551,ENST00000374840;;;ENST00000374840		Odontohypophosphatasia	146300	AD, AR	3	Alpl
1p36.12	1:21678298-21783149	USP48, USP31, DFNA85	Ubiquitin-specific peptidase 48	617445	USP48	84196	ENSG00000090686,ENST00000308271;;;ENST00000308271		Deafness, autosomal dominant 85	620227	AD	3	Usp48
1p36.12	1:21822244-21937310	HSPG2, PLC, SJS, SJA, SJS1	Heparan sulfate proteoglycan of basement membrane (perlecan)	142461	HSPG2	3339	ENSG00000142798,ENST00000374695;;;ENST00000374695		Dyssegmental dysplasia, Silverman-Handmaker type	224410	AR	3	Hspg2
1p36.12	1:21822244-21937310	HSPG2, PLC, SJS, SJA, SJS1	Heparan sulfate proteoglycan of basement membrane (perlecan)	142461	HSPG2	3339	ENSG00000142798,ENST00000374695;;;ENST00000374695		Schwartz-Jampel syndrome, type 1	255800	AR	3	Hspg2
1p36.12	1:22052709-22101360	CDC42, TKS	Cell division cycle 42 (GTP-binding protein, 25kD)	116952	CDC42	998	ENSG00000070831,ENST00000656825;;;ENST00000656825		Takenouchi-Kosaki syndrome	616737	AD	3	Cdc42
1p36.12	1:22117313-22143097	WNT4, SERKAL	Wingless-type MMTV integration site family, member 4	603490	WNT4	54361	ENSG00000162552,ENST00000290167;;;ENST00000290167		Mullerian aplasia and hyperandrogenism	158330	AD	3	Wnt4
1p36.12	1:22117313-22143097	WNT4, SERKAL	Wingless-type MMTV integration site family, member 4	603490	WNT4	54361	ENSG00000162552,ENST00000290167;;;ENST00000290167		SERKAL syndrome	611812	AR	3	Wnt4
1p36.12	1:22636463-22639678	C1QA, C1QD1	Complement component 1, q subcomponent, A chain	120550	C1QA	712	ENSG00000173372,ENST00000374642;;;ENST00000374642		C1q deficiency 1	613652	AR	3	C1qa
1p36.12	1:22643633-22648108	C1QC, C1QG, C1QD3	Complement component 1, q subcomponent, C chain	120575	C1QC	714	ENSG00000159189,ENST00000374640;;;ENST00000374640		C1q deficiency 3	620322	AR	3	C1qc
1p36.12	1:22653236-22661637	C1QB, C1QD2	Complement component 1, q subcomponent, B chain	120570	C1QB	713	ENSG00000173369,ENST00000509305;;;ENST00000509305		C1q deficiency 2	620321	AR	3	C1qb
1p36.12	1:22710838-22921500	EPHB2, EPHT3, DRT, ERK, PCBC, CAPB, BDPLT22	eph tyrosine kinase 3 (ephrin receptor EphB2)	600997	EPHB2	2048	ENSG00000133216,ENST00000374630;;;ENST00000374630	mutation identified in 1 BDPLT22 family	?Bleeding disorder, platelet-type, 22	618462	AR	3	Ephb2
1p36.12	1:22710838-22921500	EPHB2, EPHT3, DRT, ERK, PCBC, CAPB, BDPLT22	eph tyrosine kinase 3 (ephrin receptor EphB2)	600997	EPHB2	2048	ENSG00000133216,ENST00000374630;;;ENST00000374630	mutation identified in 1 BDPLT22 family	{Prostate cancer/brain cancer susceptibility, somatic}	603688		3	Ephb2
1p36.12	1:23019468-23083689	KDM1A, LSD1, AOF2, BHC110, KIAA0601, CPRF, AIMAH3	Lysine demethylase 1A	609132	KDM1A	23028	ENSG00000004487,ENST00000400181;;;ENST00000400181		{ACTH-independent macronodular adrenal hyperplasia 3}	620990	AD	3	Kdm1a
1p36.12	1:23019468-23083689	KDM1A, LSD1, AOF2, BHC110, KIAA0601, CPRF, AIMAH3	Lysine demethylase 1A	609132	KDM1A	23028	ENSG00000004487,ENST00000400181;;;ENST00000400181		Cleft palate, psychomotor retardation, and distinctive facial features	616728	AD	3	Kdm1a
1p36.12	1:23304688-23344284	HNRPR, HNRNPR, NEDDFSB	Heterogeneous nuclear ribonucleoprotein R	607201	HNRNPR	10236	ENSG00000125944,ENST00000302271;;;ENST00000302271		Neurodevelopmental disorder with dysmorphic facies and skeletal and brain abnormalities	620073	AD	3	Hnrnpr
1p36.11	1:23691779-23696835	RPL11, DBA7	Ribosomal protein L11	604175	RPL11	6135	ENSG00000142676,ENST00000643754;;;ENST00000643754		Diamond-Blackfan anemia 7	612562	AD	3	Rpl11
1p36.11	1:23795599-23800754	GALE, THC13	UDP galactose-4-epimerase	606953	GALE	2582	ENSG00000117308,ENST00000617979;;;ENST00000617979		Galactose epimerase deficiency	230350	AR	3	Gale
1p36.11	1:23795599-23800754	GALE, THC13	UDP galactose-4-epimerase	606953	GALE	2582	ENSG00000117308,ENST00000617979;;;ENST00000617979		Thrombocytopenia 13, syndromic	620776	AR	3	Gale
1p36.11	1:23801885-23825429	HMGCL	3-hydroxy-3-methylglutaryl-Coenzyme A lyase	613898	HMGCL	3155	ENSG00000117305,ENST00000374490;;;ENST00000374490		HMG-CoA lyase deficiency	246450	AR	3	Hmgcl
1p36.11	1:23845077-23868290	FUCA1	Fucosidase, alpha-L- 1, tissue	612280	FUCA1	2517	ENSG00000179163,ENST00000374479;;;ENST00000374479	8cM distal to RH; pseudogene on 2q31-q32	Fucosidosis	230000	AR	3	Fuca1
1p36.11	1:24319357-24364482	GRHL3, SOM, TFCP2L4, VWS2	Grainyhead-like 3	608317	GRHL3	57822	ENSG00000158055,ENST00000361548;;;ENST00000361548		van der Woude syndrome 2	606713	AD	3	Grhl3
1p36.11	1:25272486-25330445	RHD, HDFNRH	Rhesus system D polypeptide	111680	RHD	6007	ENSG00000187010,ENST00000328664;;;ENST00000328664		[Blood group, RH system]	111690		3	Rhd
1p36.11	1:25272486-25330445	RHD, HDFNRH	Rhesus system D polypeptide	111680	RHD	6007	ENSG00000187010,ENST00000328664;;;ENST00000328664		{Hemolytic disease of fetus and newborn, RH-induced}	619462	IC	3	Rhd
1p36.11	1:25362249-25430203	RHCE, RHNA	Rhesus system C and E polypeptides	111700	RHCE	6006	ENSG00000188672,ENST00000294413;;;ENST00000294413		Rh-null disease, amorph type	617970	AR	3	Rhd
1p36.11	1:25543606-25590400	LDLRAP1, ARH, FHCB2, FHCB1, FHCL4	Low density lipoprotein receptor adaptor protein 1	605747	LDLRAP1	26119	ENSG00000157978,ENST00000374338;;;ENST00000374338		Hypercholesterolemia, familial, 4	603813	AR	3	Ldlrap1
1p36.11	1:25800193-25818221	SELENON, SEPN1, SELN, CMYO3	Selenoprotein N	606210	SELENON	57190	ENSG00000162430,ENST00000361547		Congenital myopathy 3 with rigid spine	602771	AR	3	Selenon
1p36.11	1:26037252-26046118	SLC30A2, ZNT2, TNZD	Solute carrier family 30 (zinc transporter), member 2	609617	SLC30A2	7780	ENSG00000158014,ENST00000374276;;;ENST00000374276		Zinc deficiency, transient neonatal	608118	AD	3	Slc30a2
1p36.11	1:26051301-26067630	TRIM63, RNF28, SMRZ, MURF1, CMH31	Tripartite motif containing 63	606131	TRIM63	84676	ENSG00000158022,ENST00000374272;;;ENST00000374272		Cardiomyopathy, familial hypertrophic, 31	621270	AR	3	Trim63
1p36.11	1:26432321-26471306	DHDDS, HDS, RP59, DEDSM	Dehydrodolichyl diphosphate synthase	608172	DHDDS	79947	ENSG00000117682,ENST00000236342;;;ENST00000236342	mutation identified in 1 CDG1BB patient	?Congenital disorder of glycosylation, type 1bb	613861	AR	3	Dhdds
1p36.11	1:26432321-26471306	DHDDS, HDS, RP59, DEDSM	Dehydrodolichyl diphosphate synthase	608172	DHDDS	79947	ENSG00000117682,ENST00000236342;;;ENST00000236342	mutation identified in 1 CDG1BB patient	Developmental delay and seizures with or without movement abnormalities	617836	AD	3	Dhdds
1p36.11	1:26432321-26471306	DHDDS, HDS, RP59, DEDSM	Dehydrodolichyl diphosphate synthase	608172	DHDDS	79947	ENSG00000117682,ENST00000236342;;;ENST00000236342	mutation identified in 1 CDG1BB patient	Retinitis pigmentosa 59	613861	AR	3	Dhdds
1p36.11	1:26696015-26782104	ARID1A, C1orf4, B120, SMARCF1, MRD14, CSS2	AT rich interactive domain 1A, SWI-like	603024	ARID1A	8289	ENSG00000117713,ENST00000324856;;;ENST00000324856		Coffin-Siris syndrome 2	614607	AD	3	Arid1a
1p36.11	1:26787054-26800659	PIGV, HPMRS1	Phosphatidylinositol glycan, class V	610274	PIGV	55650	ENSG00000060642,ENST00000674202;;;ENST00000674202		Hyperphosphatasia with impaired intellectual development syndrome 1	239300	AR	3	Pigv
1p36.11	1:26911489-26913975	NR0B2, SHP	Nuclear receptor subfamily 0, group B, member 2	604630	NR0B2	8431	ENSG00000131910,ENST00000254227;;;ENST00000254227		Obesity, mild, early-onset	601665	AD, AR, Mu	3	Nr0b2
1p36.11	1:26949562-26960468	KDF1, C1orf172, ECTD12	Keratinocyte differentiation factor 1	616758	KDF1	126695	ENSG00000175707,ENST00000320567;;;ENST00000320567	mutation identified in 1 ECTD12 family	?Ectodermal dysplasia 12, hypohidrotic/hair/tooth/nail type	617337	AD	3	Kdf1
1p36.11	1:27098809-27155125	SLC9A1, NHE1, APNH, LIKNS	Solute carrier family 9 (sodium/hydrogen exchanger), member 1 (antiporter, Na+/H+, amiloride sensitive)	107310	SLC9A1	6548	ENSG00000090020,ENST00000263980;;;ENST00000263980		Lichtenstein-Knorr syndrome	616291	AR	3	Slc9a1
1p36.11	1:27322163-27336400	TMEM222, C1orf160, NEDMOSBA	Transmembrane protein 222	619469	TMEM222	84065	ENSG00000186501,ENST00000374076;;;ENST00000374076		Neurodevelopmental disorder with motor and speech delay and behavioral abnormalities	619470	AR	3	Tmem222
1p36.11	1:27369110-27374824	FCN3, HAKA1	Ficolin 3	604973	FCN3	8547	ENSG00000142748,ENST00000270879;;;ENST00000270879		Immunodeficiency due to ficolin 3 deficiency	613860	AR	3	
1p36.11-p35.3	1:27534245-27604227	AHDC1, XIGIS, MRD25	AT-hook DNA-binding motif-containing protein 1	615790	AHDC1	27245	ENSG00000126705,ENST00000673934;;;ENST00000673934		Xia-Gibbs syndrome	615829	AD	3	Ahdc1
1p35	1:27600001-34300000	C1DELp35, DEL1p35	Chromosome 1p35 deletion syndrome	617930				SRO 1.03 Mb containing 23 genes	Chromosome 1p35 deletion syndrome	617930	AD	4	
1p35.3	1:28506043-28538989	CHC1, RCC1, IIAAN	Regulator of chromosome condensation	179710	RCC1	1104	ENSG00000180198,ENST00000683442;;;ENST00000683442		Infection-induced acute-onset axonal neuropathy	621333	AR	3	Rcc1
1p35.3	1:28887100-29120041	EPB41, EL1	Erythrocyte surface protein band 4.1	130500	EPB41	2035	ENSG00000159023,ENST00000343067;;;ENST00000343067		Elliptocytosis-1	611804	AD, AR	3	Epb41
1p35.3	1:29167696-29230934	MECR, NRBF1, DYTOABG, OPA16	Mitochondrial trans-2-enoyl-CoA reductase	608205	MECR	51102	ENSG00000116353,ENST00000263702;;;ENST00000263702	mutation identified in 1 OPA16 family	Dystonia, childhood-onset, with optic atrophy and basal ganglia abnormalities	617282	AR	3	Mecr
1p35.3	1:29167696-29230934	MECR, NRBF1, DYTOABG, OPA16	Mitochondrial trans-2-enoyl-CoA reductase	608205	MECR	51102	ENSG00000116353,ENST00000263702;;;ENST00000263702	mutation identified in 1 OPA16 family	Optic atrophy 16	620629	AR	3	Mecr
1p35.2	1:30869466-30909735	SDC3, SYND3, SDCN	Syndecan 3	186357	SDC3	9672	ENSG00000162512,ENST00000339394;;;ENST00000339394		{Obesity, association with}	601665	AD, AR, Mu	3	Sdc3
1p35.2	1:30931506-31065717	PUM1, KIAA0099, NEDMSF	Pumilio RNA binding family member 1	607204	PUM1	9698	ENSG00000134644,ENST00000426105;;;ENST00000426105		Neurodevelopmental disorder with motor abnormalities, and facial dysmorphism	620719	AD	3	Pum1
1p35.2	1:32196011-32205387	CCDC28B, MGC1203	Coiled-coil domain-containing protein 28B	610162	CCDC28B	79140	ENSG00000160050,ENST00000373602;;;ENST00000373602		{Bardet-Biedl syndrome 1, modifier of}	209900	AR, DR	3	Ccdc28b
1p35.2	1:32251265-32286165	LCK, IMD22	Lymphocyte-specific protein tyrosine kinase	153390	LCK	3932	ENSG00000182866,ENST00000336890;;;ENST00000336890	LCK/TCRB fusion in leukemia	Immunodeficiency 22	615758	AR	3	Lck
1p35.1	1:32775239-32817358	YARS1, YARS, CMTDIC, TYRRS, YTS, YRS, IMNEPD2	Tyrosyl-tRNA synthetase 1	603623	YARS1	8565	ENSG00000134684,ENST00000373477;;;ENST00000373477		Charcot-Marie-Tooth disease, dominant intermediate C	608323	AD	3	Yars1
1p35.1	1:32775239-32817358	YARS1, YARS, CMTDIC, TYRRS, YTS, YRS, IMNEPD2	Tyrosyl-tRNA synthetase 1	603623	YARS1	8565	ENSG00000134684,ENST00000373477;;;ENST00000373477		Infantile-onset multisystem neurologic, endocrine, and pancreatic disease 2	619418	AR	3	Yars1
1p35.1	1:32885996-32894646	HPCA, DYT2	Hippocalcin, 23kD, Ca2+-binding protein	142622	HPCA	3208	ENSG00000121905,ENST00000373467;;;ENST00000373467		Dystonia 2, torsion, autosomal recessive	224500	AR	3	Hpca
1p35.1	1:33007940-33036883	AK2	Adenylate kinase-2, mitochondrial	103020	AK2	204	ENSG00000004455,ENST00000672715;;;ENST00000672715		Reticular dysgenesis	267500	AR	3	Ak2
1p34.3	1:34300001-39600000	GBD3	Gallbladder disease 3	609919		100048906		new D2S255	Gallbladder disease 3	609919		2	
1p34-p32	1:34300001-60800000	MACST	Macrostomia	613545		100529231		max lod at D1S2797	Macrostomia	613545		2	
1p34.3	1:34759740-34762327	GJB4, CX30.3, EKVP2	Gap junction protein, beta-4	605425	GJB4	127534	ENSG00000189433,ENST00000339480;;;ENST00000339480		Erythrokeratodermia variabilis et progressiva 2	617524	AD	3	Gjb4
1p34.3	1:34781214-34786364	GJB3, CX31, DFNA2B, EKVP1	Gap junction protein, beta-3	603324	GJB3	2707	ENSG00000188910,ENST00000373366;;;ENST00000373366	same YAC as GJA4	Deafness, autosomal dominant 2B, with or without peripheral neuropathy	612644	AD	3	Gjb3
1p34.3	1:34781214-34786364	GJB3, CX31, DFNA2B, EKVP1	Gap junction protein, beta-3	603324	GJB3	2707	ENSG00000188910,ENST00000373366;;;ENST00000373366	same YAC as GJA4	Deafness, digenic, GJB2/GJB3	220290	AR, DD	3	Gjb3
1p34.3	1:34781214-34786364	GJB3, CX31, DFNA2B, EKVP1	Gap junction protein, beta-3	603324	GJB3	2707	ENSG00000188910,ENST00000373366;;;ENST00000373366	same YAC as GJA4	Erythrokeratodermia variabilis et progressiva 1	133200	AD, AR	3	Gjb3
1p34.3	1:35557799-35566779	NCDN, KIAA0607, NEDIES	Neurochondrin	608458	NCDN	23154	ENSG00000020129,ENST00000373243;;;ENST00000373243		Neurodevelopmental disorder with infantile epileptic spasms	619373	AD	3	Ncdn
1p34.3	1:35869761-35930532	AGO1, EIF2C1, GERP95, EIF2C, NEDLBAS	Argonaute RISC component 1	606228	AGO1	26523	ENSG00000092847,ENST00000373204;;;ENST00000373204		Neurodevelopmental disorder with language delay and behavioral abnormalities, with or without seizures	620292	AD	3	Ago1
1p34.3	1:36088892-36093932	ADPRS, ADPRHL2, ARH3, CONDSIAS	ADP-ribosylserine hydrolase	610624	ADPRS	54936	ENSG00000116863,ENST00000373178;;;ENST00000373178		Neurodegeneration, childhood-onset, stress-induced, with variable ataxia and seizures	618170	AR	3	Adprs
1p34.3	1:36095239-36125222	COL8A2, FECD1, PPCD2	Collagen VIII, alpha-2 polypeptide	120252	COL8A2	1296	ENSG00000171812,ENST00000397799;;;ENST00000397799		Corneal dystrophy, Fuchs endothelial, 1	136800	AD	3	Col8a2
1p34.3	1:36095239-36125222	COL8A2, FECD1, PPCD2	Collagen VIII, alpha-2 polypeptide	120252	COL8A2	1296	ENSG00000171812,ENST00000397799;;;ENST00000397799		Corneal dystrophy, posterior polymorphous 2	609140	AD	3	Col8a2
1p34.3	1:36466043-36483314	CSF3R, GCSFR, SCN7	Colony-stimulating factor-3 receptor (granulocyte)	138971	CSF3R	1441	ENSG00000119535,ENST00000373106;;;ENST00000373106	mutation identified in 1 HNTP family	?Neutrophilia, hereditary	162830	AD	3	Csf3r
1p34.3	1:36466043-36483314	CSF3R, GCSFR, SCN7	Colony-stimulating factor-3 receptor (granulocyte)	138971	CSF3R	1441	ENSG00000119535,ENST00000373106;;;ENST00000373106	mutation identified in 1 HNTP family	Neutropenia, severe congenital, 7, autosomal recessive	617014	AR	3	Csf3r
1p34.3	1:37534449-37554293	SNIP1, NEDHCS	SMAD nuclear interacting protein 1	608241	SNIP1	79753	ENSG00000163877,ENST00000296215;;;ENST00000296215		Neurodevelopmental disorder with hypotonia, craniofacial abnormalities, and seizures	614501	AR	3	Snip1
1p34.3	1:37556940-37566857	DNALI1, P28, SPGF83	Dynein, axonemal, light intermediate polypeptide 1	602135	DNALI1	7802	ENSG00000163879,ENST00000652629;;;ENST00000652629		Spermatogenic failure 83	620354	AR	3	Dnali1
1p34.3	1:37611350-37634892	RSPO1, FLJ40906	R-spondin 1	609595	RSPO1	284654	ENSG00000169218,ENST00000356545;;;ENST00000356545		Palmoplantar hyperkeratosis and true hermaphroditism	610644	AR	3	Rspo1
1p34.3	1:37611350-37634892	RSPO1, FLJ40906	R-spondin 1	609595	RSPO1	284654	ENSG00000169218,ENST00000356545;;;ENST00000356545		Palmoplantar hyperkeratosis with squamous cell carcinoma of skin and sex reversal	610644	AR	3	Rspo1
1p34.3	1:37713880-37765120	EPHA10, DFNA88	Ephrin receptor EphA10	611123	EPHA10	284656	ENSG00000183317,ENST00000373048;;;ENST00000373048	mutation identified in 1 DFNA88 family	?Deafness, autosomal dominant 88	620283	AD	3	Epha10
1p34.3	1:37802945-37808208	YRDC, IRIP, GAMOS10	YRDC domain-containing protein	612276	YRDC	79693	ENSG00000196449,ENST00000373044;;;ENST00000373044		Galloway-Mowat syndrome 10	619609	AR	3	Yrdc
1p34.3	1:38838198-38859772	RRAGC, RAGC, LNGODS	RAS-related GTP-binding protein C	608267	RRAGC	64121	ENSG00000116954,ENST00000373001;;;ENST00000373001		Long-Olsen-Distelmaier syndrome	620609	AD	3	Rragc
1p34.3	1:39084167-39487138	MACF1, ACF7, KIAA1251, LIS9	Microtubule-actin cross-linking factor 1	608271	MACF1	23499	ENSG00000127603,ENST00000564288;;;ENST00000564288		Lissencephaly 9 with complex brainstem malformation	618325	AD	3	Macf1
1p34.2	1:39838110-39883511	TRIT1, IPT, COXPD35	tRNA isopentenyltransferase 1	617840	TRIT1	54802	ENSG00000043514,ENST00000316891;;;ENST00000316891		Combined oxidative phosphorylation deficiency 35	617873	AR	3	Trit1
1p34.2	1:39955145-39969956	MFSD2A, NEDMISBA	Major facilitator superfamily domain-containing protein 2A	614397	MFSD2A	84879	ENSG00000168389,ENST00000372811;;;ENST00000372811		Neurodevelopmental disorder with progressive microcephaly, spasticity, and brain abnormalities	616486	AR	3	Mfsd2a
1p34.2	1:40071461-40097252	PPT1, CLN1	Palmitoyl-protein thioesterase 1	600722	PPT1	5538	ENSG00000131238,ENST00000642050;;;ENST00000642050		Ceroid lipofuscinosis, neuronal, 1	256730	AR	3	Ppt1
1p34.2	1:40258236-40294180	ZMPSTE24, FACE1, STE24, MADB, RSDM1	Zinc metalloproteinase STE24	606480	ZMPSTE24	10269	ENSG00000084073,ENST00000372759;;;ENST00000372759		Mandibuloacral dysplasia with type B lipodystrophy	608612	AR	3	Zmpste24
1p34.2	1:40258236-40294180	ZMPSTE24, FACE1, STE24, MADB, RSDM1	Zinc metalloproteinase STE24	606480	ZMPSTE24	10269	ENSG00000084073,ENST00000372759;;;ENST00000372759		Restrictive dermopathy 1	275210	AR	3	Zmpste24
1p34.2	1:40300489-40317286	COL9A2, EDM2, STL5	Collagen IX, alpha-2 polypeptide	120260	COL9A2	1298	ENSG00000049089,ENST00000372748;;;ENST00000372748	mutation identified in1 STL5 family	?Stickler syndrome, type V	614284	AR	3	Col9a2
1p34.2	1:40300489-40317286	COL9A2, EDM2, STL5	Collagen IX, alpha-2 polypeptide	120260	COL9A2	1298	ENSG00000049089,ENST00000372748;;;ENST00000372748	mutation identified in1 STL5 family	Epiphyseal dysplasia, multiple, 2	600204	AD	3	Col9a2
1p34.2	1:40783787-40840452	KCNQ4, DFNA2A	Potassium voltage-gated channel, KQT-like subfamily, member 4	603537	KCNQ4	9132	ENSG00000117013,ENST00000347132;;;ENST00000347132		Deafness, autosomal dominant 2A	600101	AD	3	Kcnq4
1p34.2	1:40979696-41012565	CTPS1, CTPS, IMD24	Cytidine 5'-triphosphate synthetase 1	123860	CTPS1	1503	ENSG00000171793,ENST00000650070;;;ENST00000650070		Immunodeficiency 24	615897	AR	3	Ctps1
1p34.2	1:42456341-42473417	PPCS, CMD2C	Phosphopantothenoylcysteine synthetase	609853	PPCS	79717	ENSG00000127125,ENST00000372561;;;ENST00000372561		Cardiomyopathy, dilated, 2C	618189	AR	3	Ppcs
1p34.2	1:42733093-42740236	CLDN19, HOMG5	Claudin 19	610036	CLDN19	149461	ENSG00000164007,ENST00000296387;;;ENST00000296387		Hypomagnesemia 5, renal, with ocular involvement	248190	AR	3	Cldn19
1p34.2	1:42746374-42767028	P3H1, LEPRE1, GROS1, OI8	Prolyl 3-hydroxylase 1	610339	P3H1	64175	ENSG00000117385,ENST00000296388;;;ENST00000296388		Osteogenesis imperfecta, type VIII	610915	AR	3	P3h1
1p34.2	1:42807052-42817397	SVBP, CCDC23, NEDAHM	Small vasohibin-binding protein	617853	SVBP	374969	ENSG00000177868,ENST00000372521;;;ENST00000372521		Neurodevelopmental disorder with ataxia, hypotonia, and microcephaly	618569	AR	3	Svbp
1p34.2	1:42817122-42844991	ERMAP, SC, RD	Erythroblast membrane-associated protein	609017	ERMAP	114625	ENSG00000164010,ENST00000372517;;;ENST00000372517		[Blood group, Radin]	111620		3	Ermap
1p34.2	1:42817122-42844991	ERMAP, SC, RD	Erythroblast membrane-associated protein	609017	ERMAP	114625	ENSG00000164010,ENST00000372517;;;ENST00000372517		[Blood group, Scianna system]	111750		3	Ermap
1p34.2	1:42925353-42958868	SLC2A1, GLUT1, HTLVR, DYT18, PED, GLUT1DS, EIG12, DYT9, SDCHCN	Solute carrier family 2 (facilitated glucose transporter), member 1	138140	SLC2A1	6513	ENSG00000117394,ENST00000426263;;;ENST00000426263	probably in 1p33	{Epilepsy, idiopathic generalized, susceptibility to, 12}	614847	AD	3	Slc2a1
1p34.2	1:42925353-42958868	SLC2A1, GLUT1, HTLVR, DYT18, PED, GLUT1DS, EIG12, DYT9, SDCHCN	Solute carrier family 2 (facilitated glucose transporter), member 1	138140	SLC2A1	6513	ENSG00000117394,ENST00000426263;;;ENST00000426263	probably in 1p33	Dystonia 9	601042	AD	3	Slc2a1
1p34.2	1:42925353-42958868	SLC2A1, GLUT1, HTLVR, DYT18, PED, GLUT1DS, EIG12, DYT9, SDCHCN	Solute carrier family 2 (facilitated glucose transporter), member 1	138140	SLC2A1	6513	ENSG00000117394,ENST00000426263;;;ENST00000426263	probably in 1p33	GLUT1 deficiency syndrome 1, infantile onset, severe	606777	AD, AR	3	Slc2a1
1p34.2	1:42925353-42958868	SLC2A1, GLUT1, HTLVR, DYT18, PED, GLUT1DS, EIG12, DYT9, SDCHCN	Solute carrier family 2 (facilitated glucose transporter), member 1	138140	SLC2A1	6513	ENSG00000117394,ENST00000426263;;;ENST00000426263	probably in 1p33	GLUT1 deficiency syndrome 2, childhood onset	612126	AD	3	Slc2a1
1p34.2	1:42925353-42958868	SLC2A1, GLUT1, HTLVR, DYT18, PED, GLUT1DS, EIG12, DYT9, SDCHCN	Solute carrier family 2 (facilitated glucose transporter), member 1	138140	SLC2A1	6513	ENSG00000117394,ENST00000426263;;;ENST00000426263	probably in 1p33	Stomatin-deficient cryohydrocytosis with neurologic defects	608885	AD	3	Slc2a1
1p34.2	1:43172330-43254358	CFAP57, WDR65, SPGF95	Cilia- and flagella-associated protein 57	614259	CFAP57	149465	ENSG00000243710,ENST00000372492;;;ENST00000372492		Spermatogenic failure 95	620917	AR	3	Cfap57
1p34.2	1:43300982-43323108	TIE, JTK14, TIE1, LMPHM11	Tyrosine kinase with immunoglobulin and epidermal growth factor homology domains	600222	TIE1	7075	ENSG00000066056,ENST00000372476;;;ENST00000372476		Lymphatic malformation 11	619401	AD	3	Tie1
1p34.2	1:43337818-43354466	MPL, TPOR, MPLV, THCYT2	MPL protooncogene, thrombopoietin receptor	159530	MPL	4352	ENSG00000117400,ENST00000372470;;;ENST00000372470		Amegakaryocytic thrombocytopenia, congenital, 1	604498	AR	3	Mpl
1p34.2	1:43337818-43354466	MPL, TPOR, MPLV, THCYT2	MPL protooncogene, thrombopoietin receptor	159530	MPL	4352	ENSG00000117400,ENST00000372470;;;ENST00000372470		Myelofibrosis with myeloid metaplasia, somatic	254450		3	Mpl
1p34.2	1:43337818-43354466	MPL, TPOR, MPLV, THCYT2	MPL protooncogene, thrombopoietin receptor	159530	MPL	4352	ENSG00000117400,ENST00000372470;;;ENST00000372470		Thrombocythemia 2	601977	AD, SMu	3	Mpl
1p34.2	1:43358981-43363203	CDC20, OZEMA14	Cell division cycle 20	603618	CDC20	991	ENSG00000117399,ENST00000310955;;;ENST00000310955	pseudogene on 9q13-q21	Oocyte/zygote/embryo maturation arrest 14	620276	AR	3	Cdc20
1p34.2	1:43363401-43368011	ELOVL1, SSC1, IKSHD	Elongation of very long chain fatty acids-like 1	611813	ELOVL1	64834	ENSG00000066322,ENST00000372458;;;ENST00000372458		Ichthyotic keratoderma, spasticity, hypomyelination, and dysmorphic facies	618527	AD, AR	3	Elovl1
1p34.2	1:43389899-43454247	SZT2, KIAA0467, DEE18	SZT2 subunit of KICSTOR complex	615463	SZT2	23334	ENSG00000198198,ENST00000634258;;;ENST00000634258		Developmental and epileptic encephalopathy 18	615476	AR	3	Szt2
1p34.2	1:43522051-43623666	PTPRF, LAR, BNAH2	Protein tyrosine phosphatase, receptor type, f polypeptide	179590	PTPRF	5792	ENSG00000142949,ENST00000359947;;;ENST00000359947	mutation identified in 1 BNAH2 family	?Breasts and/or nipples, aplasia or hypoplasia of, 2	616001	AR	3	Ptprf
1p34.1-p32	1:43700001-60800000	PTOS1	Ptosis, congenital 1, autosomal dominant	178300		5765			Ptosis, hereditary congenital, 1	178300	AD	2	
1p34.1	1:43707536-43931159	ST3GAL3, SIAT6, ST3GALII, MRT12, DEE15	ST3 beta-galactoside alpha-2,3-sialyltransferase 3	606494	ST3GAL3	6487	ENSG00000126091,ENST00000347631;;;ENST00000347631		Developmental and epileptic encephalopathy 15	615006	AR	3	St3gal3
1p34.1	1:43707536-43931159	ST3GAL3, SIAT6, ST3GALII, MRT12, DEE15	ST3 beta-galactoside alpha-2,3-sialyltransferase 3	606494	ST3GAL3	6487	ENSG00000126091,ENST00000347631;;;ENST00000347631		Intellectual developmental disorder, autosomal recessive 12	611090	AR	3	St3gal3
1p34.1	1:43970010-43973369	DPH2, DPH2L2, DEDSSH2	Diphthamide biosynthesis protein 2	603456	DPH2	1802	ENSG00000132768,ENST00000255108;;;ENST00000255108		Developmental delay with short stature, dysmorphic facial features, and sparse hair 2	620062	AR	3	Dph2
1p34.1	1:43996483-44031462	SLC6A9, GLYT1, GCENSG	Solute carrier family 6 (neurotransmitter transporter, glycine), member 9	601019	SLC6A9	6536	ENSG00000196517,ENST00000372310;;;ENST00000372310		Glycine encephalopathy with normal serum glycine	617301	AR	3	Slc6a9
1p34.1	1:44404783-44651724	RNF220, HLD23	RING finger protein 220	616136	RNF220	55182	ENSG00000187147,ENST00000361799;;;ENST00000361799		Leukodystrophy, hypomyelinating, 23, with ataxia, deafness, liver dysfunction, and dilated cardiomyopathy	619688	AR	3	Rnf220
1p34.1	1:44653247-44674481	TMEM53, NET4, CTDI	Transmembrane protein 53	619722	TMEM53	79639	ENSG00000126106,ENST00000372237;;;ENST00000372237		Craniotubular dysplasia, Ikegawa type	619727	AR	3	Tmem53
1p34.1	1:44819845-44843253	PTCH2	Patched 2	603673	PTCH2	8643	ENSG00000117425,ENST00000372192;;;ENST00000372192		Basal cell carcinoma, somatic	605462		3	Ptch2
1p34.1	1:44819845-44843253	PTCH2	Patched 2	603673	PTCH2	8643	ENSG00000117425,ENST00000372192;;;ENST00000372192		Medulloblastoma, somatic	155255		3	Ptch2
1p34.1	1:44850522-44986595	EIF2B3, VWM3	Eukaryotic translation initiation factor 2B, subunit 3	606273	EIF2B3	8891	ENSG00000070785,ENST00000360403;;;ENST00000360403		Leukoencephalopathy with vanishing white matter 3, with or without ovarian failure	620313	AR	3	Eif2b3
1p34.1	1:45012254-45015575	UROD	Uroporphyrinogen decarboxylase	613521	UROD	7389	ENSG00000126088,ENST00000246337;;;ENST00000246337		Porphyria cutanea tarda	176100	AD, AR	3	Urod
1p34.1	1:45012254-45015575	UROD	Uroporphyrinogen decarboxylase	613521	UROD	7389	ENSG00000126088,ENST00000246337;;;ENST00000246337		Porphyria, hepatoerythropoietic	176100	AD, AR	3	Urod
1p34.1	1:45326895-45328710	HPDL, NEDSWMA, SPG83	4-hydroxyphenylpyruvate dioxygenase-like	618994	HPDL	84842	ENSG00000186603,ENST00000334815;;;ENST00000334815		Neurodevelopmental disorder with progressive spasticity and brain white matter abnormalities	619026	AR	3	Hpdl
1p34.1	1:45326895-45328710	HPDL, NEDSWMA, SPG83	4-hydroxyphenylpyruvate dioxygenase-like	618994	HPDL	84842	ENSG00000186603,ENST00000334815;;;ENST00000334815		Spastic paraplegia 83, autosomal recessive	619027	AR	3	Hpdl
1p34.1	1:45329242-45340440	MUTYH, MYH	mutY DNA glycosylase	604933	MUTYH	4595	ENSG00000132781,ENST00000456914;;;ENST00000456914		Adenomas, multiple colorectal	608456	AR	3	Mutyh
1p34.1	1:45329242-45340440	MUTYH, MYH	mutY DNA glycosylase	604933	MUTYH	4595	ENSG00000132781,ENST00000456914;;;ENST00000456914		Gastric cancer, somatic	613659		3	Mutyh
1p34.1	1:45340170-45343973	TOE1, PCH7	Target of EGR1	613931	TOE1	114034	ENSG00000132773,ENST00000372090;;;ENST00000372090		Pontocerebellar hypoplasia, type 7	614969	AR	3	Toe1
1p34.1	1:45500300-45513382	MMACHC	Metabolism of cobalamin associated C	609831	MMACHC	25974	ENSG00000132763,ENST00000401061;;;ENST00000401061		Methylmalonic aciduria and homocystinuria, cblC type	277400	AR	3	Mmachc
1p34.1	1:45511051-45522890	PRDX1, PRXI, PAGA, NKEFA	Peroxiredoxin 1	176763	PRDX1	5052	ENSG00000117450,ENST00000319248;;;ENST00000319248	pseudogene PAGB on 9p22	Methylmalonic aciduria and homocystinuria, cblC type, digenic	277400	AR	3	Prdx1
1p34.1	1:46188683-46220305	POMGNT1, MEB, MDDGA3, MDDGB3, MDDGC3, RP76, LGMDR15	Protein 0-mannose beta-1,2-N-acetylglucosaminyltransferase	606822	POMGNT1	55624	ENSG00000085998,ENST00000371984;;;ENST00000371984		Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 3	253280	AR	3	Pomgnt1
1p34.1	1:46188683-46220305	POMGNT1, MEB, MDDGA3, MDDGB3, MDDGC3, RP76, LGMDR15	Protein 0-mannose beta-1,2-N-acetylglucosaminyltransferase	606822	POMGNT1	55624	ENSG00000085998,ENST00000371984;;;ENST00000371984		Muscular dystrophy-dystroglycanopathy (congenital with impaired intellectual development), type B, 3	613151	AR	3	Pomgnt1
1p34.1	1:46188683-46220305	POMGNT1, MEB, MDDGA3, MDDGB3, MDDGC3, RP76, LGMDR15	Protein 0-mannose beta-1,2-N-acetylglucosaminyltransferase	606822	POMGNT1	55624	ENSG00000085998,ENST00000371984;;;ENST00000371984		Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 3	613157	AR	3	Pomgnt1
1p34.1	1:46188683-46220305	POMGNT1, MEB, MDDGA3, MDDGB3, MDDGC3, RP76, LGMDR15	Protein 0-mannose beta-1,2-N-acetylglucosaminyltransferase	606822	POMGNT1	55624	ENSG00000085998,ENST00000371984;;;ENST00000371984		Retinitis pigmentosa 76	617123	AR	3	Pomgnt1
1p34.1	1:46247688-46278473	RAD54L, HR54, HRAD54	RAD54 like	603615	RAD54L	8438	ENSG00000085999,ENST00000371975;;;ENST00000371975		{Breast cancer, invasive ductal}	114480	AD, SMu	3	Rad54l
1p34.1	1:46247688-46278473	RAD54L, HR54, HRAD54	RAD54 like	603615	RAD54L	8438	ENSG00000085999,ENST00000371975;;;ENST00000371975		Adenocarcinoma, colonic, somatic			3	Rad54l
1p34.1	1:46247688-46278473	RAD54L, HR54, HRAD54	RAD54 like	603615	RAD54L	8438	ENSG00000085999,ENST00000371975;;;ENST00000371975		Lymphoma, non-Hodgkin, somatic	605027		3	Rad54l
1p33-p32	1:46300001-60800000	BMND14	Bone mineral density quantitative trait locus 14	612728		100294718		associated with rs17131547	[Bone mineral density QTL 14]	612728		2	
1p33-p31.1	1:46300001-84400000	FWS	Forsythe-Wakeling syndrome	613606		100529224		between rs2354462 and rs718883	Forsythe-Wakeling syndrome	613606	AR	2	
1p33	1:46300001-50200000	OFC13	Orofacial cleft 13	613857		100653367		associated with rs3827730	Orofacial cleft 13	613857	AD	2	
1p33	1:46300001-50200000	PAINQTL1	Pain sensitivity quantitative trait locus 1	618377				deletion identified in 1 PAINQTL1 family	?Pain sensitivity QTL1	618377	AD	4	
1p33	1:46303698-46316776	UQCRH, MC3DN11	Ubiquinol-cytochrome c reductase hinge protein	613844	UQCRH	7388	ENSG00000173660,ENST00000311672;;;ENST00000311672	mutation identified in 1 MC3DN11 family	?Mitochondrial complex III deficiency, nuclear type 11	620137	AR	3	Uqcrh
1p33	1:46394317-46413845	FAAH	Fatty acid amide hydrolase	602935	FAAH	2166	ENSG00000117480,ENST00000243167;;;ENST00000243167		{Drug addiction, susceptibility to}	606581		3	Faah
1p33	1:47216290-47232335	TAL1, TCL5, SCL	T-cell acute lymphocytic leukemia-1	187040	TAL1	6886	ENSG00000162367,ENST00000691006;;;ENST00000691006	proximal to MYCL1	Leukemia, T-cell acute lymphocytic, somatic	613065		3	Tal1
1p33	1:47250139-47314896	STIL, SIL, MCPH7	SCL/TAL1-interrupting locus	181590	STIL	6491	ENSG00000123473,ENST00000371877;;;ENST00000371877	within about 250kb of SCL	Microcephaly 7, primary, autosomal recessive	612703	AR	3	Stil
1p33	1:47416285-47418052	FOXE3, FKHL12, ASMD, CTRCT34, ASGD2, AAT11	Forkhead box E3	601094	FOXE3	2301	ENSG00000186790,ENST00000335071;;;ENST00000335071		{Aortic aneurysm, familial thoracic 11, susceptibility to}	617349	AD	3	Foxe3
1p33	1:47416285-47418052	FOXE3, FKHL12, ASMD, CTRCT34, ASGD2, AAT11	Forkhead box E3	601094	FOXE3	2301	ENSG00000186790,ENST00000335071;;;ENST00000335071		Anterior segment dysgenesis 2, multiple subtypes	610256	AR	3	Foxe3
1p33	1:47416285-47418052	FOXE3, FKHL12, ASMD, CTRCT34, ASGD2, AAT11	Forkhead box E3	601094	FOXE3	2301	ENSG00000186790,ENST00000335071;;;ENST00000335071		Cataract 34, multiple types	612968	AR	3	Foxe3
1p32	1:50200001-60800000	PARK10, AAOPD	Parkinson disease 10	606852		170534		max lod at D1S2652; ?associated with CDCP2	{Parkinson disease 10}	606852		2	
1p32	1:50200001-60800000	STQTL23	Stature quantitative trait locus 23	613548		100529222		linked to rs628667	{Stature QTL 23}	613548		2	
1p32.3	1:52372829-52409503	ORC1, ORC1L	Origin recognition complex, subunit 1	601902	ORC1	4998	ENSG00000085840,ENST00000371568;;;ENST00000371568		Meier-Gorlin syndrome 1	224690	AR	3	Orc1
1p32.3	1:52684449-52698347	COA7, RESA1, SELRC1, C1orf163, SCAN3	Cytochrome C oxidase assembly factor	615623	COA7	65260	ENSG00000162377,ENST00000371538;;;ENST00000371538		Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 3	618387	AR	3	Coa7
1p32.3	1:52927276-53051698	SCP2	Sterol carrier protein-2	184755	SCP2	6342	ENSG00000116171,ENST00000371514;;;ENST00000371514	mutation identified in 1 LKDMN patient	?Leukoencephalopathy with dystonia and motor neuropathy	613724	AR	3	Scp2
1p32.3	1:53196824-53214197	CPT2, IIAE4	Carnitine palmitoyltransferase II	600650	CPT2	1376	ENSG00000157184,ENST00000371486;;;ENST00000371486	formerly at 1p13	{Encephalopathy, acute, infection-induced, 4, susceptibility to}	614212	AD, AR	3	Cpt2
1p32.3	1:53196824-53214197	CPT2, IIAE4	Carnitine palmitoyltransferase II	600650	CPT2	1376	ENSG00000157184,ENST00000371486;;;ENST00000371486	formerly at 1p13	CPT II deficiency, infantile	600649	AR	3	Cpt2
1p32.3	1:53196824-53214197	CPT2, IIAE4	Carnitine palmitoyltransferase II	600650	CPT2	1376	ENSG00000157184,ENST00000371486;;;ENST00000371486	formerly at 1p13	CPT II deficiency, lethal neonatal	608836	AR	3	Cpt2
1p32.3	1:53196824-53214197	CPT2, IIAE4	Carnitine palmitoyltransferase II	600650	CPT2	1376	ENSG00000157184,ENST00000371486;;;ENST00000371486	formerly at 1p13	CPT II deficiency, myopathic, stress-induced	255110	AD, AR	3	Cpt2
1p32.3	1:53242364-53328070	LRP8, APOER2, MCI1	Low density lipoprotein receptor-related protein 8 (Apolipoprotein E receptor 2)	602600	LRP8	7804	ENSG00000157193,ENST00000306052;;;ENST00000306052		{Myocardial infarction, susceptibility to}	608446		3	Lrp8
1p32.3	1:53765478-53838296	NDC1, TMEM48, NEDAPA	NDC1 transmembrane nucleoporin	610115	NDC1	55706	ENSG00000058804,ENST00000371429;;;ENST00000371429		Neurodevelopmental disorder with achalasia, polyneuropathy, and alacrima	621328	AR	3	Ndc1
1p32.3	1:53894187-53911086	DIO1, TXDI1, THMA2	Deiodinase, iodothyronine, type I	147892	DIO1	1733	ENSG00000211452,ENST00000361921;;;ENST00000361921		Thyroid hormone metabolism, abnormal, 2	619855	AD	3	Dio1
1p32.3	1:54756898-54764523	PARS2, DEE75	Prolyl-tRNA synthetase 2	612036	PARS2	25973	ENSG00000162396,ENST00000371279;;;ENST00000371279		Developmental and epileptic encephalopathy 75	618437	AR	3	Pars2
1p32.3	1:54849627-54887195	DHCR24, KIAA0018	24-dehydrocholesterol reductase	606418	DHCR24	1718	ENSG00000116133,ENST00000371269;;;ENST00000371269		Desmosterolosis	602398	AR	3	Dhcr24
1p32.3	1:54998933-55017172	BSND	Barttin	606412	BSND	7809	ENSG00000162399,ENST00000651561;;;ENST00000651561		Bartter syndrome, type 4a	602522	AR	3	Bsnd
1p32.3	1:54998933-55017172	BSND	Barttin	606412	BSND	7809	ENSG00000162399,ENST00000651561;;;ENST00000651561		Sensorineural deafness with mild renal dysfunction	602522	AR	3	Bsnd
1p32.3	1:55039548-55064852	PCSK9, NARC1, HCHOLA3, FH3, LDLCQ1, FHCL3	Proprotein convertase, subtilisin/kexin-type, 9	607786	PCSK9	255738	ENSG00000169174,ENST00000302118;;;ENST00000302118		{Low density lipoprotein cholesterol level QTL 1}	603776	AD	3	Pcsk9
1p32.3	1:55039548-55064852	PCSK9, NARC1, HCHOLA3, FH3, LDLCQ1, FHCL3	Proprotein convertase, subtilisin/kexin-type, 9	607786	PCSK9	255738	ENSG00000169174,ENST00000302118;;;ENST00000302118		Hypercholesterolemia, familial, 3	603776	AD	3	Pcsk9
1p32.2	1:56854797-56918223	C8A	Complement component-8, alpha polypeptide	120950	C8A	731	ENSG00000157131,ENST00000361249;;;ENST00000361249		C8 deficiency, type I	613790	AR	3	C8a
1p32.2	1:56929207-56966015	C8B	Complement component-8, beta polypeptide	120960	C8B	732	ENSG00000021852,ENST00000371237;;;ENST00000371237		C8 deficiency, type II	613789	AR	3	C8b
1p32.2-p32.1	1:56994778-58546726	DAB1, SCA37	DAB adaptor protein 1	603448	DAB1	1600	ENSG00000173406,ENST00000371236;;;ENST00000371236		Spinocerebellar ataxia 37	615945	AD	3	Dab1
1p32.1	1:58575433-58577252	TACSTD2, TROP2, M1S1	Tumor-associated calcium signal transducer 2	137290	TACSTD2	4070	ENSG00000184292,ENST00000371225;;;ENST00000371225		Corneal dystrophy, gelatinous drop-like	204870	AR	3	Tacstd2
1p32.1	1:58654743-58700062	MYSM1, 2ADUB, KIAA1915, BMFS4	MYB-like, SWIRM, and MPN domains-containing protein 1	612176	MYSM1	114803	ENSG00000162601,ENST00000472487;;;ENST00000472487		Bone marrow failure syndrome 4	618116	AR	3	Mysm1
1p31	1:60800001-84400000	AIR	Acute insulin response	601676		7808			Acute insulin response	601676		2	
1p31	1:60800001-84400000	ASRT4	Asthma-related traits, susceptibility to, 4	610906		100188823		max lod at D1S2890	{Asthma-related traits, susceptibility to, 4}	610906		2	
1p31-p21	1:60800001-106700000	AVSD1, AVCD	Atrioventricular septal defect, susceptibility to, 1	606215		7446			{Atrioventricular septal defect, susceptibility to, 1}	606215		2	
1p31	1:60800001-84400000	OFC14	Orofacial cleft 14	615892		103581096			Orofacial cleft 14	615892	AR	2	
1p31.3	1:60800001-68500000	OPHLC, C1DUPp31.3, DUP1p31.3	Omphalocele due to duplication of 1p31.3	164750				duplication of 710kb at 1p31.3	Omphalocele due to duplication of 1p31.3	164750	IC	4	
1p31	1:60800001-84400000	PAOD1	Peripheral arterial occlusive disease 1	606787		171513			Peripheral arterial occlusive disease 1	606787		2	
1p31.3-p31.1	1:60800001-84400000	POROK5, DSAP3	Porokeratosis 5, disseminated superficial actinic	612293		100190982		between D1S438 and D1S464	Porokeratosis 5, disseminated superficial actinic	612293		2	
1p31.3	1:61077227-61462788	NFIA, BRMUTD	Nuclear factor I/A	600727	NFIA	4774	ENSG00000162599,ENST00000403491;;;ENST00000403491		Brain malformations with or without urinary tract defects	613735	AD	3	Nfia
1p31.3	1:62454726-62688386	DOCK7, KIAA1771, DEE23	Dedicator of cytokinesis 7	615730	DOCK7	85440	ENSG00000116641,ENST00000635253;;;ENST00000635253		Developmental and epileptic encephalopathy 23	615859	AR	3	Dock7
1p31.3	1:62597520-62606313	ANGPTL3, ANGPT5, FHBL2	Angiopoietin-like 3	604774	ANGPTL3	27329	ENSG00000132855,ENST00000371129;;;ENST00000371129		Hypobetalipoproteinemia, familial, 2	605019	AR	3	Angptl3
1p31.3	1:63322567-63325128	FOXD3, AIS1, VAMAS2	Forkhead box D3	611539	FOXD3	27022	ENSG00000187140,ENST00000371116;;;ENST00000371116		{Autoimmune disease, susceptibility to, 1}	607836	AD	3	Foxd3
1p31.3	1:63367627-63438553	ALG6, CDG1C	ALG6 alpha-1,3-glucosyltransferase	604566	ALG6	29929	ENSG00000088035,ENST00000263440;;;ENST00000263440		Congenital disorder of glycosylation, type Ic	603147	AR	3	Alg6
1p31.3	1:63593411-63660245	PGM1, GSD14, CDG1T	Phosphoglucomutase-1	171900	PGM1	5236	ENSG00000079739,ENST00000371084;;;ENST00000371084	distal to ACADM; formerly 1p22.1	Congenital disorder of glycosylation, type It	614921	AR	3	Pgm1
1p31.3	1:63774017-64181498	ROR1, NTRKR1	Receptor tyrosine kinase-like orphan receptor 1	602336	ROR1	4919	ENSG00000185483,ENST00000371079;;;ENST00000371079	mutation identified in 1 DFNB108 family	?Deafness, autosomal recessive 108	617654	AR	3	Ror1
1p31.3	1:64833229-65067746	JAK1, AIIDE	Janus kinase 1 (a protein-tyrosine kinase)	147795	JAK1	3716	ENSG00000162434,ENST00000342505;;;ENST00000342505	related gene on 9p24	Autoinflammation, immune dysregulation, and eosinophilia	618999	AD	3	Jak1
1p31.3	1:65264749-65415871	DNAJC6, DJC6, KIAA0473, PARK19	DNAJ heat shock protein family (Hsp40) member C6	608375	DNAJC6	9829	ENSG00000116675,ENST00000371069;;;ENST00000371069		Parkinson disease 19a, juvenile-onset	615528	AR	3	Dnajc6
1p31.3	1:65264749-65415871	DNAJC6, DJC6, KIAA0473, PARK19	DNAJ heat shock protein family (Hsp40) member C6	608375	DNAJC6	9829	ENSG00000116675,ENST00000371069;;;ENST00000371069		Parkinson disease 19b, early-onset	615528	AR	3	Dnajc6
1p31.3	1:65420652-65641559	LEPR, OBR, LEPRD	Leptin receptor	601007	LEPR	3953	ENSG00000116678,ENST00000349533;;;ENST00000349533		Obesity, morbid, due to leptin receptor deficiency	614963	AR	3	Lepr
1p31.3	1:66972976-67054148	SLC35D1, UGTREL7, KIAA0260, SHNKND	Solute carrier family 35 (UDP-glucuronic acid/UDP-N-acetylgalactosamine dual transporter), member D1	610804	SLC35D1	23169	ENSG00000116704,ENST00000235345;;;ENST00000235345		Schneckenbecken dysplasia	269250	AR	3	Slc35d1
1p31.3	1:67138637-67265903	IL23R, IBD17	Interleukin 23 receptor	607562	IL23R	149233	ENSG00000162594,ENST00000347310;;;ENST00000347310		{Inflammatory bowel disease 17, protection against}	612261		3	Il23r
1p31.3	1:67138637-67265903	IL23R, IBD17	Interleukin 23 receptor	607562	IL23R	149233	ENSG00000162594,ENST00000347310;;;ENST00000347310		{Psoriasis, protection against}	605606		3	Il23r
1p31.3	1:68098459-68232546	WLS, GPR177, EVI, ZKS	WNT ligand secretion mediator	611514	WLS	79971	ENSG00000116729,ENST00000262348;;;ENST00000262348		Zaki syndrome	619648	AR	3	Wls
1p31.3	1:68428822-68449954	RPE65, RP20, LCA2	RPE65 retinoid isomerohydrolase	180069	RPE65	6121	ENSG00000116745,ENST00000262340;;;ENST00000262340		Leber congenital amaurosis 2	204100	AR	3	Rpe65
1p31.3	1:68428822-68449954	RPE65, RP20, LCA2	RPE65 retinoid isomerohydrolase	180069	RPE65	6121	ENSG00000116745,ENST00000262340;;;ENST00000262340		Retinitis pigmentosa 20	613794	AR	3	Rpe65
1p31.3	1:68428822-68449954	RPE65, RP20, LCA2	RPE65 retinoid isomerohydrolase	180069	RPE65	6121	ENSG00000116745,ENST00000262340;;;ENST00000262340		Retinitis pigmentosa 87 with choroidal involvement	618697	AD	3	Rpe65
1p31.2	1:68500001-69300000	PBC3	Biliary cirrhosis, primary, 3	613008		100303717		associated with rs3790567	{Biliary cirrhosis, primary, 3}	613008		2	
1p31.1-p21.1	1:69300001-106700000	SPG29	Spastic paraplegia 29, autosomal dominant	609727		619379		max lod at D1S2865	Spastic paraplegia 29, autosomal dominant	609727	AD	2	
1p31.1	1:70411268-70439851	CTH	Cystathionine gamma-lyase	607657	CTH	1491	ENSG00000116761,ENST00000370938;;;ENST00000370938	previously assigned to chr.16	Cystathioninuria	219500	AR	3	Cth
1p31.1	1:74235387-74544428	TNNI3K, CCDD	TNNI3-interacting kinase	613932	TNNI3K	51086	ENSG00000116783,ENST00000326637;;;ENST00000326637		Cardiac conduction disease with or without dilated cardiomyopathy	616117	AD	3	Tnni3k
1p31.1	1:75724709-75763679	ACADM, MCAD	Acyl-Coenzyme A dehydrogenase, C-4 to C-12 straight chain	607008	ACADM	34	ENSG00000117054,ENST00000370841;;;ENST00000370841		Acyl-CoA dehydrogenase, medium chain, deficiency of	201450	AR	3	Acadm
1p31.1	1:75796882-75913242	MSH4, POF20, SPGF2	mutS homolog 4	602105	MSH4	4438	ENSG00000057468,ENST00000263187;;;ENST00000263187		Premature ovarian failure 20	619938	AR	3	Msh4
1p31.1	1:75796882-75913242	MSH4, POF20, SPGF2	mutS homolog 4	602105	MSH4	4438	ENSG00000057468,ENST00000263187;;;ENST00000263187		Spermatogenic failure 2	108420	AR	3	Msh4
1p31.1	1:77088989-77219430	PIGK, GPI8, NEDHCAS	Phosphatidylinositol glycan, class K	605087	PIGK	10026	ENSG00000142892,ENST00000370812;;;ENST00000370812		Neurodevelopmental disorder with hypotonia and cerebellar atrophy, with or without seizures	618879	AR	3	Pigk
1p31.1	1:77888624-77943895	NEXN, NELIN, CMD1CC, CMH20, CDM2M	Nexilin F-actin binding protein	613121	NEXN	91624	ENSG00000162614,ENST00000334785;;;ENST00000334785		Cardiomyopathy, dilated, 1CC	613122	AD	3	Nexn
1p31.1	1:77888624-77943895	NEXN, NELIN, CMD1CC, CMH20, CDM2M	Nexilin F-actin binding protein	613121	NEXN	91624	ENSG00000162614,ENST00000334785;;;ENST00000334785		Cardiomyopathy, dilated, 2M, autosomal recessive	621261	AR	3	Nexn
1p31.1	1:77888624-77943895	NEXN, NELIN, CMD1CC, CMH20, CDM2M	Nexilin F-actin binding protein	613121	NEXN	91624	ENSG00000162614,ENST00000334785;;;ENST00000334785		Cardiomyopathy, hypertrophic, 20	613876	AD	3	Nexn
1p31.1	1:77979175-78017964	DNAJB4, HLJ1, CMYO21	DNAJ/HSP40 homolog, subfamily B, member 4	611327	DNAJB4	11080	ENSG00000162616,ENST00000370763;;;ENST00000370763		Congenital myopathy 21 with early respiratory failure	620326	AR	3	Dnajb4
1p31.1	1:84078079-84238498	PRKACB, CAFD2	Protein kinase, cAMP-dependent, catalytic, beta	176892	PRKACB	5567	ENSG00000142875,ENST00000370685;;;ENST00000370685		Cardioacrofacial dysplasia 2	619143	AD, SMo	3	Prkacb
1p22	1:84400001-94300000	CMM4	Melanoma, cutaneous malignant, 4	608035		474388		between D1S430 and D1S2664	{Melanoma, cutaneous malignant, 4}	608035	AD	2	
1p22	1:84400001-94300000	KAZA2	Kala-azar, susceptibility to, 2	611381		101241898			{Kala-azar, susceptibility to, 2}	611381		2	
1p22	1:84400001-94300000	UOX	Urate oxidase, pseudogene	191540	UOX	391051		nonsense mutations responsible for absence of enzyme in man and hominoid primates	[Urate oxidase deficiency]			1	
1p22.3	1:85265776-85276632	BCL10, IMD37	BCL10 immune signaling adaptor	603517	BCL10	8915	ENSG00000142867,ENST00000648566;;;ENST00000648566	mutation identified in 1 IMD37 patient	?Immunodeficiency 37	616098	AR	3	Bcl10
1p22.3	1:85265776-85276632	BCL10, IMD37	BCL10 immune signaling adaptor	603517	BCL10	8915	ENSG00000142867,ENST00000648566;;;ENST00000648566	mutation identified in 1 IMD37 patient	{Lymphoma, follicular, somatic}	605027		3	Bcl10
1p22.3	1:85265776-85276632	BCL10, IMD37	BCL10 immune signaling adaptor	603517	BCL10	8915	ENSG00000142867,ENST00000648566;;;ENST00000648566	mutation identified in 1 IMD37 patient	{Male germ cell tumor, somatic}	273300		3	Bcl10
1p22.3	1:85265776-85276632	BCL10, IMD37	BCL10 immune signaling adaptor	603517	BCL10	8915	ENSG00000142867,ENST00000648566;;;ENST00000648566	mutation identified in 1 IMD37 patient	{Mesothelioma, somatic}	156240		3	Bcl10
1p22.3	1:85265776-85276632	BCL10, IMD37	BCL10 immune signaling adaptor	603517	BCL10	8915	ENSG00000142867,ENST00000648566;;;ENST00000648566	mutation identified in 1 IMD37 patient	{Sezary syndrome, somatic}			3	Bcl10
1p22.3	1:85265776-85276632	BCL10, IMD37	BCL10 immune signaling adaptor	603517	BCL10	8915	ENSG00000142867,ENST00000648566;;;ENST00000648566	mutation identified in 1 IMD37 patient	Lymphoma, MALT, somatic	137245		3	Bcl10
1p22.3	1:86914635-87109982	HS2ST1, NFSRA	Heparan sulfate 2-O-sulfotransferase 1	604844	HS2ST1	9653	ENSG00000153936,ENST00000370550;;;ENST00000370550		Neurofacioskeletal syndrome with or without renal agenesis	619194	AR	3	Hs2st1
1p22.2	1:89615824-89719533	LRRC8C, FAD158, AD158, TIMES	Leucine-rich repeat-containing protein 8C	612889	LRRC8C	84230	ENSG00000171488,ENST00000370454;;;ENST00000370454		TIMES syndrome	621056	AD	3	Lrrc8c
1p22.2	1:90915304-91022035	ZNF644, MYP21	Zinc finger protein 644	614159	ZNF644	84146	ENSG00000122482,ENST00000337393;;;ENST00000337393		Myopia 21, autosomal dominant	614167	AD	3	Zfp644
1p22.2	1:91260766-91408007	HFM1, MER3, POF9	Helicase for meiosis 1	615684	HFM1	164045	ENSG00000162669,ENST00000370425;;;ENST00000370425		Premature ovarian failure 9	615724	AR	3	Hfm1
1p22.1	1:91949371-92014428	BRDT, SPGF21	Bromodomain, testis-specific	602144	BRDT	676	ENSG00000137948,ENST00000399546;;;ENST00000399546	mutation identified in 1 SPGF21 patient	?Spermatogenic failure 21	617644	AR	3	Brdt
1p22.1	1:92246402-92370844	GLMN, GVM, VMGLOM	Glomulin	601749	GLMN	11146	ENSG00000174842,ENST00000370360;;;ENST00000370360		Glomuvenous malformations	138000	AD	3	Glmn
1p22.1	1:92473043-92486925	GFI1, ZNF163, SCN2	Growth factor independent 1	600871	GFI1	2672	ENSG00000162676,ENST00000294702;;;ENST00000294702	mutation identified in 1 NICINA patient	?Neutropenia, nonimmune chronic idiopathic, of adults	607847	AD	3	Gfi1
1p22.1	1:92473043-92486925	GFI1, ZNF163, SCN2	Growth factor independent 1	600871	GFI1	2672	ENSG00000162676,ENST00000294702;;;ENST00000294702	mutation identified in 1 NICINA patient	Neutropenia, severe congenital 2, autosomal dominant	613107	AD	3	Gfi1
1p22.1	1:92831986-92841924	RPL5, DBA6	Ribosomal protein L5	603634	RPL5	6125	ENSG00000122406,ENST00000370321;;;ENST00000370321		Diamond-Blackfan anemia 6	612561	AD	3	Rpl5
1p22.1	1:93885199-93909430	GCLM, GLCLR	Glutamate-cysteine ligase, modifier subunit	601176	GCLM	2730	ENSG00000023909,ENST00000370238;;;ENST00000370238		{Myocardial infarction, susceptibility to}	608446		3	Gclm
1p22.1	1:93992834-94121148	ABCA4, ABCR, STGD1, FFM, RP19, CORD3, ARMD2	ATP-binding transporter, retina-specific	601691	ABCA4	24	ENSG00000198691,ENST00000370225;;;ENST00000370225		{Macular degeneration, age-related, 2}	153800	AD	3	Abca4
1p22.1	1:93992834-94121148	ABCA4, ABCR, STGD1, FFM, RP19, CORD3, ARMD2	ATP-binding transporter, retina-specific	601691	ABCA4	24	ENSG00000198691,ENST00000370225;;;ENST00000370225		Cone-rod dystrophy 3	604116	AR	3	Abca4
1p22.1	1:93992834-94121148	ABCA4, ABCR, STGD1, FFM, RP19, CORD3, ARMD2	ATP-binding transporter, retina-specific	601691	ABCA4	24	ENSG00000198691,ENST00000370225;;;ENST00000370225		Fundus flavimaculatus	248200	AR	3	Abca4
1p22.1	1:93992834-94121148	ABCA4, ABCR, STGD1, FFM, RP19, CORD3, ARMD2	ATP-binding transporter, retina-specific	601691	ABCA4	24	ENSG00000198691,ENST00000370225;;;ENST00000370225		Retinal dystrophy, early-onset severe	248200	AR	3	Abca4
1p22.1	1:93992834-94121148	ABCA4, ABCR, STGD1, FFM, RP19, CORD3, ARMD2	ATP-binding transporter, retina-specific	601691	ABCA4	24	ENSG00000198691,ENST00000370225;;;ENST00000370225		Retinitis pigmentosa 19	601718	AR	3	Abca4
1p22.1	1:93992834-94121148	ABCA4, ABCR, STGD1, FFM, RP19, CORD3, ARMD2	ATP-binding transporter, retina-specific	601691	ABCA4	24	ENSG00000198691,ENST00000370225;;;ENST00000370225		Stargardt disease 1	248200	AR	3	Abca4
1p21	1:94300001-106700000	STQTL7	Stature quantitative trait locus 7	609822		100037265		max lod at D1S1631	{Stature QTL 7}	609822		2	
1p21-p13.3	1:94300001-111200000	WS2B	Waardenburg syndrome, type 2B	600193		7488			Waardenburg syndrome, type 2B	600193	AD	2	
1p21.3	1:94385131-94518663	ABCD3, PXMP1, PMP70, CBAS5	ATP-binding cassette, subfamily D, member 3 (peroxisomal membrane protein 1, 70kD)	170995	ABCD3	5825	ENSG00000117528,ENST00000370214;;;ENST00000370214	mutation identified in 1 CBAS5 family	?Bile acid synthesis defect, congenital, 5	616278	AR	3	Abcd3
1p21.3	1:94974405-95072951	ALG14, CMS15, IDDEBF, MEPCA	ALG14 UDP-N-acetylglucosaminyltransferase subunit	612866	ALG14	199857	ENSG00000172339,ENST00000370205;;;ENST00000370205	mutation identified in 1 CMSWTA family	?Myasthenic syndrome, congenital, 15, without tubular aggregates	616227	AR	3	Alg14
1p21.3	1:94974405-95072951	ALG14, CMS15, IDDEBF, MEPCA	ALG14 UDP-N-acetylglucosaminyltransferase subunit	612866	ALG14	199857	ENSG00000172339,ENST00000370205;;;ENST00000370205	mutation identified in 1 CMSWTA family	Intellectual developmental disorder with epilepsy, behavioral abnormalities, and coarse facies	619031	AR	3	Alg14
1p21.3	1:94974405-95072951	ALG14, CMS15, IDDEBF, MEPCA	ALG14 UDP-N-acetylglucosaminyltransferase subunit	612866	ALG14	199857	ENSG00000172339,ENST00000370205;;;ENST00000370205	mutation identified in 1 CMSWTA family	Myopathy, epilepsy, and progressive cerebral atrophy	619036	AR	3	Alg14
1p21.3	1:97077743-97921059	DPYD, DPD	Dihydropyrimidine dehydrogenase	612779	DPYD	1806	ENSG00000188641,ENST00000370192;;;ENST00000370192		5-fluorouracil toxicity	274270	AR	3	Dpyd
1p21.3	1:97077743-97921059	DPYD, DPD	Dihydropyrimidine dehydrogenase	612779	DPYD	1806	ENSG00000188641,ENST00000370192;;;ENST00000370192		Dihydropyrimidine dehydrogenase deficiency	274270	AR	3	Dpyd
1p21.2	1:99849258-99924023	AGL, GDE	Amylo-1,6-glucosidase, 4-alpha-glucanotransferase (glycogen debranching enzyme)	610860	AGL	178	ENSG00000162688,ENST00000361915;;;ENST00000361915		Glycogen storage disease IIIa	232400	AR	3	Agl
1p21.2	1:99849258-99924023	AGL, GDE	Amylo-1,6-glucosidase, 4-alpha-glucanotransferase (glycogen debranching enzyme)	610860	AGL	178	ENSG00000162688,ENST00000361915;;;ENST00000361915		Glycogen storage disease IIIb	232400	AR	3	Agl
1p21.2	1:99969996-100035634	SLC35A3, AMRS	Solute carrier family 35 (UDP-GlcNAc transporter), member 3	605632	SLC35A3	23443	ENSG00000117620,ENST00000533028;;;ENST00000533028		Arthrogryposis, impaired intellectual development, and seizures	615553	AR	3	Slc35a3
1p21.2	1:100083570-100132930	SASS6, SAS6, MCPH14	SAS-6 centriolar assembly protein	609321	SASS6	163786	ENSG00000156876,ENST00000287482;;;ENST00000287482		Microcephaly 14, primary, autosomal recessive	616402	AR	3	Sass6
1p21.2	1:100186919-100249834	DBT, BCATE2, MSUD2	Dihydrolipoamide branched chain transacylase (E2 component of branched chain keto acid dehydrogenase complex)	248610	DBT	1629	ENSG00000137992,ENST00000370132;;;ENST00000370132	pseudogene on 3q24	Maple syrup urine disease, type II	620699	AR	3	Dbt
1p21.2	1:100345001-100520277	CDC14A, DFNB32	Cell division cycle 14A	603504	CDC14A	8556	ENSG00000079335,ENST00000336454;;;ENST00000336454		Deafness, autosomal recessive 32, with or without immotile sperm	608653	AR	3	Cdc14a
1p21.2	1:100538139-100542021	GPR88, STRG, COCPMR	G protein-coupled receptor 88	607468	GPR88	54112	ENSG00000181656,ENST00000315033;;;ENST00000315033	mutation identified in 1 COCPMR family	?Chorea, childhood-onset, with psychomotor retardation	616939	AR	3	Gpr88
1p21.2	1:100896090-100996078	SLC30A7, ZNT7, ZHS	Solute carrier family 30 (zinc transporter), member 7	611149	SLC30A7	148867	ENSG00000162695,ENST00000357650;;;ENST00000357650		Ziegler-Huang syndrome	620501	AR	3	Slc30a7
1p21.2	1:100989623-101025784	DPH5, HSPC143, NEDSFF	Diphthamide biosynthesis protein 5	611075	DPH5	51611	ENSG00000117543,ENST00000370109;;;ENST00000370109		Neurodevelopmental disorder with short stature, prominent forehead, and feeding difficulties	620070	AR	3	Dph5
1p21.1-p13.3	1:101800001-111200000	MRT4	Intellectual developmental disorder, autosomal recessive 4	611107		100009675		between D2S429 and D1S187	Intellectual developmental disorder, autosomal recessive 4	611107	AR	2	
1p21.1	1:102876473-103108522	COL11A1, STL2, DFNA37	Collagen XI, alpha-1 polypeptide	120280	COL11A1	1301	ENSG00000060718,ENST00000370096;;;ENST00000370096		{Lumbar disc herniation, susceptibility to}	603932		3	Col11a1
1p21.1	1:102876473-103108522	COL11A1, STL2, DFNA37	Collagen XI, alpha-1 polypeptide	120280	COL11A1	1301	ENSG00000060718,ENST00000370096;;;ENST00000370096		Deafness, autosomal dominant 37	618533	AD	3	Col11a1
1p21.1	1:102876473-103108522	COL11A1, STL2, DFNA37	Collagen XI, alpha-1 polypeptide	120280	COL11A1	1301	ENSG00000060718,ENST00000370096;;;ENST00000370096		Fibrochondrogenesis 1	228520	AR	3	Col11a1
1p21.1	1:102876473-103108522	COL11A1, STL2, DFNA37	Collagen XI, alpha-1 polypeptide	120280	COL11A1	1301	ENSG00000060718,ENST00000370096;;;ENST00000370096		Marshall syndrome	154780	AD	3	Col11a1
1p21.1	1:102876473-103108522	COL11A1, STL2, DFNA37	Collagen XI, alpha-1 polypeptide	120280	COL11A1	1301	ENSG00000060718,ENST00000370096;;;ENST00000370096		Stickler syndrome, type II	604841	AD	3	Col11a1
1p21.1	1:103525699-103555239	RNPC3, SNRNP65, KIAA1839, CPHD7	RNA-binding region-containing protein 3	618016	RNPC3	55599	ENSG00000185946,ENST00000423855;;;ENST00000423855		Pituitary hormone deficiency, combined or isolated, 7	618160	AR	3	Rnpc3
1p13	1:106700001-117200000	VUR1	Vesicoureteral reflux	193000		54113			Vesicoureteral reflux 1	193000	AD	2	
1p13.3	1:108134043-108200343	SLC25A24, SCAMC1	Solute carrier family 25 (mitochondrial carrier, phosphate carrier), member 24	608744	SLC25A24	29957	ENSG00000085491,ENST00000565488;;;ENST00000565488		Fontaine progeroid syndrome	612289	AD	3	Slc25a24
1p13.3	1:108876985-108934545	GPSM2, LGN, PINS, DFNB82, CMCS	G-protein signaling modulator 2	609245	GPSM2	29899	ENSG00000121957,ENST00000264126;;;ENST00000264126		Chudley-McCullough syndrome	604213	AR	3	Gpsm2
1p13.3	1:108929505-108963484	CLCC1, MCLC, RP32	Chloride channel CLIC-like 1	617539	CLCC1	23155	ENSG00000121940,ENST00000369969;;;ENST00000369969		Retinitis pigmentosa 32	609913	AR	3	Clcc1
1p13.3	1:109064140-109076003	TAF13, TAF2K, MRT60	TAF13 RNA polymerase II, TATA box-binding protein-associated factor, 18kD	600774	TAF13	6884	ENSG00000197780,ENST00000338366;;;ENST00000338366		Intellectual developmental disorder, autosomal recessive 60	617432	AR	3	Taf13
1p13.3	1:109213893-109238182	SARS1, SARS, SERS, NEDMAS	Seryl-tRNA synthetase 1	607529	SARS1	6301	ENSG00000031698,ENST00000234677;;;ENST00000234677		Neurodevelopmental disorder with microcephaly, ataxia, and seizures	617709	AR	3	Sars1
1p13.3	1:109309575-109397918	SORT1, NT3, LDLCQ6	Sortilin	602458	SORT1	6272	ENSG00000134243,ENST00000256637;;;ENST00000256637		[Low density lipoprotein cholesterol level QTL6]	613589	AD	3	Sort1
1p13.3	1:109548615-109600195	GNAI3, ARCND1	Guanine nucleotide-binding protein (G-protein), alpha-inhibiting activity polypeptide-3	139370	GNAI3	2773	ENSG00000065135,ENST00000369851;;;ENST00000369851		Auriculocondylar syndrome 1	602483	AD	3	Gnai3
1p13.3	1:109603091-109619616	GNAT2, ACHM4	Guanine nucleotide-binding protein (G-protein), alpha-transducing (transducin) activity polypeptide-2	139340	GNAT2	2780	ENSG00000134183,ENST00000679935;;;ENST00000679935		Achromatopsia 4	613856		3	Gnat2
1p13.3	1:109619837-109632055	AMPD2, SPG63, PCH9	Adenosine monophosphate deaminase-2, isoform L	102771	AMPD2	271	ENSG00000116337,ENST00000528667;;;ENST00000528667	mutation identified in 1 SPG63 family	?Spastic paraplegia 63, autosomal recessive	615686	AR	3	Ampd2
1p13.3	1:109619837-109632055	AMPD2, SPG63, PCH9	Adenosine monophosphate deaminase-2, isoform L	102771	AMPD2	271	ENSG00000116337,ENST00000528667;;;ENST00000528667	mutation identified in 1 SPG63 family	Pontocerebellar hypoplasia, type 9	615809	AR	3	Ampd2
1p13.3	1:109750080-109763923	EPS8L3, EPS8R3, HYPT5	EPS8-like protein 3	614989	EPS8L3	79574	ENSG00000198758,ENST00000361965;;;ENST00000361965	mutation identified in 1 HYPT5 family	?Hypotrichosis 5	612841	AD	3	Eps8l3
1p13.3	1:110059870-110070672	ALX3, FND1	Aristaless-like homeobox 3	606014	ALX3	257	ENSG00000156150,ENST00000647563;;;ENST00000647563		Frontonasal dysplasia 1	136760	AR	3	Alx3
1p13.3	1:110150494-110202202	SLC6A17, NTT4, MRT48	Solute carrier family 6 (neurotransmitter transporter), member 17	610299	SLC6A17	388662	ENSG00000197106,ENST00000331565;;;ENST00000331565		Intellectual developmental disorder, autosomal recessive 48	616269	AR	3	Slc6a17
1p13.3	1:110593580-110631440	KCNA2, DEE32	Potassium channel, voltage-gated, Shaker-related subfamily, member 2	176262	KCNA2	3737	ENSG00000177301,ENST00000316361;;;ENST00000316361		Developmental and epileptic encephalopathy 32	616366	AD	3	Kcna2
1p13.3	1:110874957-110963922	LRIF1, RIF1, FSHD3	Ligand-dependent nuclear receptor-interacting factor 1	615354	LRIF1	55791	ENSG00000121931,ENST00000369763;;;ENST00000369763	mutation identified in 1 FSHD3 patient	?Facioscapulohumeral muscular dystrophy 3, digenic	619477	DR	3	Lrif1
1p13.3	1:111117163-111140093	DRAM2, TMEM77, CORD21	Damage-regulated autophagy modulator 2	613360	DRAM2	128338	ENSG00000156171,ENST00000484310;;;ENST00000484310		Cone-rod dystrophy 21	616502	AR	3	Dram2
1p13.2	1:111770662-111989668	KCND3, KCND3S, KCND3L, SCA19, SCA22, BRGDA9	Potassium voltage-gated channel, Shal-related subfamily, member 3	605411	KCND3	3752	ENSG00000171385,ENST00000302127;;;ENST00000302127		Brugada syndrome 9	616399	AD	3	Kcnd3
1p13.2	1:111770662-111989668	KCND3, KCND3S, KCND3L, SCA19, SCA22, BRGDA9	Potassium voltage-gated channel, Shal-related subfamily, member 3	605411	KCND3	3752	ENSG00000171385,ENST00000302127;;;ENST00000302127		Spinocerebellar ataxia 19	607346	AD	3	Kcnd3
1p13.2	1:112466541-112530165	WNT2B, WNT13, XWNT2	Wingless-type MMTV integration site family, member 2B	601968	WNT2B	7482	ENSG00000134245,ENST00000369684;;;ENST00000369684		Diarrhea 9	618168	AR	3	Wnt2b
1p13.2	1:112911847-112956196	SLC16A1, MCT1, HHF7, MCT1D	Solute carrier family 16 (monocarboxylic acid transporters), member 1	600682	SLC16A1	6566	ENSG00000155380,ENST00000369626;;;ENST00000369626		Erythrocyte lactate transporter defect	245340	AD	3	Slc16a1
1p13.2	1:112911847-112956196	SLC16A1, MCT1, HHF7, MCT1D	Solute carrier family 16 (monocarboxylic acid transporters), member 1	600682	SLC16A1	6566	ENSG00000155380,ENST00000369626;;;ENST00000369626		Hyperinsulinemic hypoglycemia, familial, 7	610021	AD	3	Slc16a1
1p13.2	1:112911847-112956196	SLC16A1, MCT1, HHF7, MCT1D	Solute carrier family 16 (monocarboxylic acid transporters), member 1	600682	SLC16A1	6566	ENSG00000155380,ENST00000369626;;;ENST00000369626		Monocarboxylate transporter 1 deficiency	616095	AD, AR	3	Slc16a1
1p13.2	1:113073198-113132260	LRIG2, LIG2, KIAA0806, UFS2	Leucine-rich repeats- and immunoglobulin-like domains-containing protein 2	608869	LRIG2	9860	ENSG00000198799,ENST00000361127;;;ENST00000361127		Urofacial syndrome 2	615112	AR	3	Lrig2
1p13.2	1:113894194-113905028	AP4B1, SPG47, CPSQ5	Adaptor-related protein complex 4, beta-1 subunit	607245	AP4B1	10717	ENSG00000134262,ENST00000369569;;;ENST00000369569		Spastic paraplegia 47, autosomal recessive	614066	AR	3	Ap4b1
1p13.2	1:113904619-113914086	DCLRE1B, SNM1B, APOLLO, DKCB8	DNA cross-link repair protein 1B	609683	DCLRE1B	64858	ENSG00000118655,ENST00000650450;;;ENST00000650450		Dyskeratosis congenita, autosomal recessive 8	620133	AR	3	Dclre1b
1p13.2	1:114392790-114511203	TRIM33, TIF1G, RFG7, PTC7, DDH4	Tripartite motif-containing protein 33	605769	TRIM33	51592	ENSG00000197323,ENST00000358465;;;ENST00000358465	fused with RET to form PTC7	?Developmental dysplasia of the hip 4	621311	AR	3	Trim33
1p13.2	1:114673098-114695546	AMPD1, MMDD	Adenosine monophosphate deaminase-1, muscle	102770	AMPD1	270	ENSG00000116748,ENST00000520113;;;ENST00000520113		Myopathy due to myoadenylate deaminase deficiency	615511	AR	3	Ampd1
1p13.2	1:114704469-114716771	NRAS, ALPS4, NS6, CMNS, NCMS	NRAS protooncogene, GTPase	164790	NRAS	4893	ENSG00000213281,ENST00000369535;;;ENST00000369535	cen-CD2-NGFB-NRAS	?RAS-associated autoimmune lymphoproliferative syndrome type IV, somatic	614470		3	Nras
1p13.2	1:114704469-114716771	NRAS, ALPS4, NS6, CMNS, NCMS	NRAS protooncogene, GTPase	164790	NRAS	4893	ENSG00000213281,ENST00000369535;;;ENST00000369535	cen-CD2-NGFB-NRAS	Colorectal cancer, somatic	114500		3	Nras
1p13.2	1:114704469-114716771	NRAS, ALPS4, NS6, CMNS, NCMS	NRAS protooncogene, GTPase	164790	NRAS	4893	ENSG00000213281,ENST00000369535;;;ENST00000369535	cen-CD2-NGFB-NRAS	Epidermal nevus, somatic	162900		3	Nras
1p13.2	1:114704469-114716771	NRAS, ALPS4, NS6, CMNS, NCMS	NRAS protooncogene, GTPase	164790	NRAS	4893	ENSG00000213281,ENST00000369535;;;ENST00000369535	cen-CD2-NGFB-NRAS	Melanocytic nevus syndrome, congenital, somatic	137550		3	Nras
1p13.2	1:114704469-114716771	NRAS, ALPS4, NS6, CMNS, NCMS	NRAS protooncogene, GTPase	164790	NRAS	4893	ENSG00000213281,ENST00000369535;;;ENST00000369535	cen-CD2-NGFB-NRAS	Neurocutaneous melanosis, somatic	249400		3	Nras
1p13.2	1:114704469-114716771	NRAS, ALPS4, NS6, CMNS, NCMS	NRAS protooncogene, GTPase	164790	NRAS	4893	ENSG00000213281,ENST00000369535;;;ENST00000369535	cen-CD2-NGFB-NRAS	Noonan syndrome 6	613224	AD	3	Nras
1p13.2	1:114704469-114716771	NRAS, ALPS4, NS6, CMNS, NCMS	NRAS protooncogene, GTPase	164790	NRAS	4893	ENSG00000213281,ENST00000369535;;;ENST00000369535	cen-CD2-NGFB-NRAS	Schimmelpenning-Feuerstein-Mims syndrome, somatic mosaic	163200		3	Nras
1p13.2	1:114704469-114716771	NRAS, ALPS4, NS6, CMNS, NCMS	NRAS protooncogene, GTPase	164790	NRAS	4893	ENSG00000213281,ENST00000369535;;;ENST00000369535	cen-CD2-NGFB-NRAS	Thyroid carcinoma, follicular, somatic	188470		3	Nras
1p13.2	1:115029826-115034309	TSHB, CHNG4	Thyroid-stimulating hormone, beta polypeptide	188540	TSHB	7252	ENSG00000134200,ENST00000256592;;;ENST00000256592	centromeric to NGFB	Hypothyroidism, congenital, nongoitrous 4	275100	AR	3	Tshb
1p13.2	1:115285917-115338249	NGF, NGFB, HSAN5	Nerve growth factor, beta	162030	NGF	4803	ENSG00000134259,ENST00000369512;;;ENST00000369512	same 310kb fragment as TSHB; order: cen-CD2-CD58-ATP1A1-NGF-TSHB-NRAS-tel	Neuropathy, hereditary sensory and autonomic, type V	608654	AR	3	Ngf
1p13.1	1:115641970-115698221	VANGL1, STBM2	Vang-like 1	610132	VANGL1	81839	ENSG00000173218,ENST00000355485;;;ENST00000355485		{Neural tube defects, susceptibility to}	182940	AD	3	Vangl1
1p13.1	1:115641970-115698221	VANGL1, STBM2	Vang-like 1	610132	VANGL1	81839	ENSG00000173218,ENST00000355485;;;ENST00000355485		Caudal regression syndrome	600145	AD	3	Vangl1
1p13.1	1:115700021-115768714	CASQ2	Calsequestrin, fast-twitch, skeletal muscle-2	114251	CASQ2	845	ENSG00000118729,ENST00000261448;;;ENST00000261448		Ventricular tachycardia, catecholaminergic polymorphic, 2	611938	AR	3	Casq2
1p13.1	1:115831344-115841126	NHLH2, HEN2, HH27	Nescient helix loop helix 2	162361	NHLH2	4808	ENSG00000177551,ENST00000320238;;;ENST00000320238	mutation identified in 1 HH27 patient	?Hypogonadotropic hypogonadism 27 without anosmia	619755	AR	3	Nhlh2
1p13.1	1:116373244-116404774	ATP1A1, CMT2DD, HOMGSMR2	ATPase, Na+K+ transporting, alpha-1 polypeptide	182310	ATP1A1	476	ENSG00000163399,ENST00000295598;;;ENST00000295598		Charcot-Marie-Tooth disease, axonal, type 2DD	618036	AD	3	Atp1a1
1p13.1	1:116373244-116404774	ATP1A1, CMT2DD, HOMGSMR2	ATPase, Na+K+ transporting, alpha-1 polypeptide	182310	ATP1A1	476	ENSG00000163399,ENST00000295598;;;ENST00000295598		Hypomagnesemia, seizures, and impaired intellectual development 2	618314	AD	3	Atp1a1
1p13.1	1:116574398-116667755	IGSF3, LCDD	Immunoglobulin superfamily, member 3	603491	IGSF3	3321	ENSG00000143061,ENST00000369486;;;ENST00000369486	mutation identified in 1 LCDD family	?Lacrimal duct defect	149700	AR	3	Igsf3
1p12	1:117863485-117929621	GDAP2, SCAR27	Ganglioside-induced differentiation-associated protein 2	618128	GDAP2	54834	ENSG00000196505,ENST00000369443;;;ENST00000369443		Spinocerebellar ataxia, autosomal recessive 27	618369	AR	3	Gdap2
1p12	1:117953590-118185228	SPAG17, PF6, SPGF55	Sperm-associated antigen 17	616554	SPAG17	200162	ENSG00000155761,ENST00000336338;;;ENST00000336338	mutation identified in 1 SPGF55 family	?Spermatogenic failure 55	619380	AR	3	Spag17
1p12	1:118883047-118989510	TBX15	T-box 15	604127	TBX15	6913	ENSG00000092607,ENST00000369429;;;ENST00000369429		Cousin syndrome	260660	AR	3	Tbx15
1p12	1:119031216-119140672	WARS2, NEMMLAS, PKDYS3	Tryptophanyl-tRNA synthetase 2	604733	WARS2	10352	ENSG00000116874,ENST00000235521;;;ENST00000235521		Neurodevelopmental disorder, mitochondrial, with abnormal movements and lactic acidosis, with or without seizures	617710	AR	3	Wars2
1p12	1:119031216-119140672	WARS2, NEMMLAS, PKDYS3	Tryptophanyl-tRNA synthetase 2	604733	WARS2	10352	ENSG00000116874,ENST00000235521;;;ENST00000235521		Parkinsonism-dystonia 3, childhood-onset	619738	AR	3	Wars2
1p12	1:119414931-119423034	HSD3B2	Hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase, type 2 (adrenal, gonadal)	613890	HSD3B2	3284	ENSG00000203859,ENST00000369416;;;ENST00000369416		Adrenal hyperplasia, congenital, due to 3-beta-hydroxysteroid dehydrogenase 2 deficiency	201810	AR	3	Hsd3b1,Hsd3b2,Hsd3b3,Hsd3b4,Hsd3b5,Hsd3b6,Hsd3b8,Hsd3b9
1p12	1:119711934-119744215	PHGDH, NLS1, PHGDHD	Phosphoglycerate dehydrogenase	606879	PHGDH	26227	ENSG00000092621,ENST00000641023;;;ENST00000641023		Neu-Laxova syndrome 1	256520	AR	3	Phgdh
1p12	1:119711934-119744215	PHGDH, NLS1, PHGDHD	Phosphoglycerate dehydrogenase	606879	PHGDH	26227	ENSG00000092621,ENST00000641023;;;ENST00000641023		Phosphoglycerate dehydrogenase deficiency	601815	AR	3	Phgdh
1p12	1:119747996-119768932	HMGCS2	3-hydroxy-3-methylglutaryl-Coenzyme A synthase 2, mitochondrial	600234	HMGCS2	3158	ENSG00000134240,ENST00000369406;;;ENST00000369406		HMG-CoA synthase-2 deficiency	605911	AR	3	Hmgcs2
1p12	1:119911553-120069662	NOTCH2, AGS2, HJCYS	Notch receptor 2	600275	NOTCH2	4853	ENSG00000134250,ENST00000256646;;;ENST00000256646		Alagille syndrome 2	610205	AD	3	Notch2
1p12	1:119911553-120069662	NOTCH2, AGS2, HJCYS	Notch receptor 2	600275	NOTCH2	4853	ENSG00000134250,ENST00000256646;;;ENST00000256646		Hajdu-Cheney syndrome	102500	AD	3	Notch2
1p11	1:120400001-123400000	MNRI	Meningioma, radiation-induced	606190		117192			Meningioma, radiation-induced	606190		2	
1q12-q24	1:125100001-173000000	CORD8	Cone-rod dystrophy 8	605549		54109			Cone-rod dystrophy 8	605549	AR	2	
1q21	1:143200001-155100000	AD13	Alzheimer disease-13	611152		100188837		max lod D1S498	{Alzheimer disease-13}	611152		2	
1q21-q22	1:143200001-156600000	ASPG3	Asperger syndrome, susceptibility to, 3	608781		449015		max lod at D1S484	{Asperger syndrome susceptibility 3}	608781		2	
1q21-q23	1:143200001-165500000	BMND2	Bone mineral density QTL 2	605833		338027			[Bone mineral density QTL 2]	605833		2	
1q21.1	1:143200001-147500000	DEL1q21, C1DELq21	Chromosome 1q21.1 deletion syndrome	612474				contiguous gene deletion syndrome	Chromosome 1q21.1 deletion syndrome	612474	AD, IC	4	
1q21-q23	1:143200001-165500000	DFNA49	Deafness, autosomal dominant 49	608372		317664		max lod at D1S3784 and D1S3786	Deafness, autosomal dominant 49	608372	AD	2	
1q21.1	1:143200001-147500000	DUP1q21, C1DUPq21	Chromosome 1q21.1 duplication syndrome	612475				contiguous gene duplication syndrome	Chromosome 1q21.1 duplication syndrome	612475	AD, IC	4	
1q21.1	1:143200001-147500000	NBLST6	Neuroblastoma, susceptibility to, 6	613017		100306939		?contiguous gene deletion or duplication disease	{Neuroblastoma, susceptibility to, 6}	613017		2	
1q21	1:143200001-155100000	PSORS4	Psoriasis susceptibility 4	603935		10547			{Psoriasis susceptibility 4}	603935		2	
1q21	1:143200001-155100000	PTCPRN, PRN1	Papillary thyroid carcinoma with papillary renal neoplasia	605642		79052			Thyroid carcinoma, papillary, with papillary renal neoplasia	605642		2	
1q21	1:143200001-155100000	RFH1, AORF	Renal failure, progressive, with hypertension	161900		59331			Nephropathy-hypertension	161900	AD	2	
1q21-q23	1:143200001-165500000	SLEB14	Systemic lupus erythematosus, susceptibility to, 14	613145		100322878		associated with rs3093061	{Systemic lupus erythematosus, susceptibility to, 14}	613145	AD	2	
1q21.1	1:143200001-147500000	UAQTL6	Uric acid concentration, serum, quantitative trait locus 6	614747		100996935		associated with C/T variant at chr1_142697422	[Uric acid concentration, serum, QTL6]	614747		2	
1q21.1	1:145911348-145918717	PEX11B, PEX14B	Peroxisome biogenesis 11B	603867	PEX11B	8799	ENSG00000131779,ENST00000369306;;;ENST00000369306		Peroxisome biogenesis disorder 14B	614920	AR	3	Pex11b
1q21.1	1:145921556-145927484	RBM8A, RBM8B, TAR, C1DELq21.1, DEL1q21.1	RNA-binding motif protein 8A	605313	RBM8A	9939	ENSG00000265241,ENST00000583313;;;ENST00000583313	pseudogene on chr.14	Thrombocytopenia-absent radius syndrome	274000	AR	3	Rbm8a
1q21.1	1:145964690-145978848	POLR3GL, SOFM	Polymerase III, RNA, subunit G-like	617457	POLR3GL	84265	ENSG00000121851,ENST00000369314;;;ENST00000369314		Short stature, oligodontia, dysmorphic facies, and motor delay	619234	AR	3	Polr3gl
1q21.1	1:146017470-146021735	HJV, HFE2A	Hemojuvelin	608374	HJV	148738	ENSG00000168509,ENST00000336751;;;ENST00000336751	between D1S442 and D1S2347	Hemochromatosis, type 2A	602390	AR	3	Hjv
1q21.2	1:147756199-147773351	GJA5, CX40, ATFB11	Gap junction protein, alpha-5, 40kD (connexin 40)	121013	GJA5	2702	ENSG00000265107,ENST00000579774;;;ENST00000579774		Atrial fibrillation, familial, 11	614049	AD	3	Gja5
1q21.2	1:147756199-147773351	GJA5, CX40, ATFB11	Gap junction protein, alpha-5, 40kD (connexin 40)	121013	GJA5	2702	ENSG00000265107,ENST00000579774;;;ENST00000579774		Atrial standstill, digenic (GJA5/SCN5A)	108770	AD	3	Gja5
1q21.2	1:147902795-147914486	GJA8, CX50, CTRCT1, CZP1, CAE1	Gap junction membrane channel protein alpha-8 (connexin 50)	600897	GJA8	2703	ENSG00000121634,ENST00000369235;;;ENST00000369235		Cataract 1, multiple types	116200	AD	3	Gja8
1q21.2	1:149390621-149471833	NOTCH2NLC, NIID, ETM6, OPDM3	NOTCH2 N-terminal-like protein C	618025	NOTCH2NLC	100996717	ENSG00000286219,ENST00000650865;;;ENST00000650865		Neuronal intranuclear inclusion disease	603472	AD	3	
1q21.2	1:149390621-149471833	NOTCH2NLC, NIID, ETM6, OPDM3	NOTCH2 N-terminal-like protein C	618025	NOTCH2NLC	100996717	ENSG00000286219,ENST00000650865;;;ENST00000650865		Oculopharyngodistal myopathy 3	619473	AD	3	
1q21.2	1:149390621-149471833	NOTCH2NLC, NIID, ETM6, OPDM3	NOTCH2 N-terminal-like protein C	618025	NOTCH2NLC	100996717	ENSG00000286219,ENST00000650865;;;ENST00000650865		Tremor, hereditary essential, 6	618866	AD	3	
1q21.2	1:149782694-149800609	FCGR1A, IGFR1, CD64	Fc fragment of IgG receptor Ia	146760	FCGR1A	2209	ENSG00000150337,ENST00000369168;;;ENST00000369168		[IgG receptor I, phagocytic, familial deficiency of]			3	Fcgr1
1q21.2	1:149903318-149917844	SV2A, SV2, DEE113	Synaptic vesicle glycoprotein 2A	185860	SV2A	9900	ENSG00000159164,ENST00000369146;;;ENST00000369146		Developmental and epileptic encephalopathy 113	620772	AR	3	Sv2a
1q21.2	1:149923317-149927803	SF3B4, SF3B49, SAP49, AFD1	Splicing factor 3B, subunit 4	605593	SF3B4	10262	ENSG00000143368,ENST00000271628;;;ENST00000271628		Acrofacial dysostosis 1, Nager type	154400	AD	3	Sf3b4
1q21.2	1:150067382-150145329	VPS45, VPS45A, SCN5	Vacuolar protein sorting 45 homolog	610035	VPS45	11311	ENSG00000136631,ENST00000644510;;;ENST00000644510		Neutropenia, severe congenital, 5, autosomal recessive	615285	AR	3	Vps45
1q21.2	1:150321468-150353233	PRPF3, HPRP3, RP18	Pre-mRNA processing factor 3	607301	PRPF3	9129	ENSG00000117360,ENST00000324862;;;ENST00000324862		Retinitis pigmentosa 18	601414	AD	3	Prpf3
1q21.2	1:150487419-150507602	TARS2, COXPD21	Threonyl-tRNA synthetase 2	612805	TARS2	80222	ENSG00000143374,ENST00000369064;;;ENST00000369064		Combined oxidative phosphorylation deficiency 21	615918	AR	3	Tars2
1q21.2	1:150508109-150513789	ECM1, URBWD	Extracellular matrix protein-1	602201	ECM1	1893	ENSG00000143369,ENST00000369047;;;ENST00000369047		Urbach-Wiethe disease	247100	AR	3	Ecm1
1q21.2	1:150549408-150560937	ADAMTSL4, TSRC1, ECTOL2	ADAMTS-like 4	610113	ADAMTSL4	54507	ENSG00000143382,ENST00000271643;;;ENST00000271643		Ectopia lentis et pupillae	225200	AR	3	Adamtsl4
1q21.2	1:150549408-150560937	ADAMTSL4, TSRC1, ECTOL2	ADAMTS-like 4	610113	ADAMTSL4	54507	ENSG00000143382,ENST00000271643;;;ENST00000271643		Ectopia lentis, isolated, autosomal recessive	225100	AR	3	Adamtsl4
1q21.3	1:150600001-155100000	HRM2	Hair morphology 2 (curly hair)	139450		100379199		associated with rs11803731	Hair, curly	139450	AD	2	
1q21.3	1:150796208-150808260	CTSK	Cathepsin K	601105	CTSK	1513	ENSG00000143387,ENST00000271651;;;ENST00000271651		Pycnodysostosis	265800	AR	3	Ctsk
1q21.3	1:151008449-151035713	PRUNE1, DRES17, NMIHBA	Prune exopolyphosphatase 1	617413	PRUNE1	58497	ENSG00000143363,ENST00000271620;;;ENST00000271620		Neurodevelopmental disorder with microcephaly, hypotonia, and variable brain anomalies	617481	AR	3	Prune1
1q21.3	1:151166144-151170296	SCNM1, MGC3180, OFD19	Sodium channel modifier 1	608095	SCNM1	79005	ENSG00000163156,ENST00000368905;;;ENST00000368905		Orofaciodigital syndrome XIX	620107	AR	3	Scnm1
1q21.3	1:151281522-151292176	ZNF687, KIAA1441, PDB6	Zinc finger protein 687	610568	ZNF687	57592	ENSG00000143373,ENST00000336715;;;ENST00000336715	fused with AML1 in t(1;21)	Paget disease of bone 6	616833	AD	3	Zfp687
1q21.3	1:151291797-151327715	PI4KB, PIK4CB, DFNA87	Phosphatidylinositol 4-kinase, beta	602758	PI4KB	5298	ENSG00000143393,ENST00000368873;;;ENST00000368873		Deafness, autosomal dominant 87	620281	AD	3	Pi4kb
1q21.3	1:151340640-151347252	RFX5, MHC2D3, MHC2D5	Regulatory factor X, 5 (influences HLA class II expression)	601863	RFX5	5993	ENSG00000143390,ENST00000452671;;;ENST00000452671	mutation identified in 1 MHC2D5 family	?MHC class II deficiency 5	620818	AR	3	Rfx5
1q21.3	1:151340640-151347252	RFX5, MHC2D3, MHC2D5	Regulatory factor X, 5 (influences HLA class II expression)	601863	RFX5	5993	ENSG00000143390,ENST00000452671;;;ENST00000452671	mutation identified in 1 MHC2D5 family	MHC class II deficiency 3	620816	AR	3	Rfx5
1q21.3	1:151364304-151372705	SELENBP1, SP56, EHMTO	Selenium-binding protein 1	604188	SELENBP1	8991	ENSG00000143416,ENST00000368868;;;ENST00000368868		Extraoral halitosis due to MTO deficiency	618148	AR	3	Selenbp1,Selenbp2
1q21.3	1:151399573-151401937	PSMB4, PRAAS3	Proteasome subunit, beta type, 4	602177	PSMB4	5692	ENSG00000159377,ENST00000290541;;;ENST00000290541	mutation identified in 1 PRAAS3 patient and 1 digenic family	?Proteasome-associated autoinflammatory syndrome 3 and digenic forms	617591	AR	3	Psmb4
1q21.3	1:151402724-151459494	POGZ, KIAA0461, MRD37, WHSUS	POGO transposable-element derived protein with ZNF domain	614787	POGZ	23126	ENSG00000143442,ENST00000271715;;;ENST00000271715		White-Sutton syndrome	616364	AD	3	Pogz
1q21.3	1:151540309-151583583	TUFT1, WHSF	Tuftelin 1	600087	TUFT1	7286	ENSG00000143367,ENST00000368849;;;ENST00000368849		Woolly hair-skin fragility syndrome	620415	AR	3	Tuft1
1q21.3	1:151806071-151831802	RORC, RORG, RZRG, IMD42	RAR-related orphan receptor C	602943	RORC	6097	ENSG00000143365,ENST00000318247;;;ENST00000318247		Immunodeficiency 42	616622	AR	3	Rorc
1q21.3	1:152106317-152115444	TCHH, THH, THL, TRHY, UHS3	Trichohyalin	190370	TCHH	7062	ENSG00000159450,ENST00000614923;;;ENST00000614923	mutation identified in 1 UHS3 patient	?Uncombable hair syndrome 3	617252	AR	3	Tchh
1q21.3	1:152302165-152325239	FLG, ATOD2	Filaggrin	135940	FLG	2312	ENSG00000143631,ENST00000368799;;;ENST00000368799		{Dermatitis, atopic, susceptibility to, 2}	605803	AD	3	
1q21.3	1:152302165-152325239	FLG, ATOD2	Filaggrin	135940	FLG	2312	ENSG00000143631,ENST00000368799;;;ENST00000368799		Ichthyosis vulgaris	146700	AD, AR	3	
1q21.3	1:152348735-152360006	FLG2, IFPS, PSS6	Filaggrin family, member 2	616284	FLG2	388698	ENSG00000143520,ENST00000388718;;;ENST00000388718		Peeling skin syndrome 6	618084	AR	3	Flg2
1q21.3	1:153259687-153262124	LORICRIN, LOR	Loricrin cornified envelope precursor protein	152445	LORICRIN	4014	ENSG00000203782,ENST00000368742;;;ENST00000368742		Vohwinkel syndrome with ichthyosis	604117	AD	3	Loricrin
1q21.3	1:153658654-153661852	SNAPIN, SNAPAP, BLOC1S7, BLOS7, NEDBAC	SNAP-associated protein	607007	SNAPIN	23557	ENSG00000143553,ENST00000368685;;;ENST00000368685		Neurodevelopmental disorder with structural brain abnormalities and craniofacial abnormalities	621393	AR	3	Snapin
1q21.3	1:153804725-153922972	GATAD2B, KIAA1150, p68, GANDS	GATA zinc finger domain-containing protein 2B	614998	GATAD2B	57459	ENSG00000143614,ENST00000368655;;;ENST00000368655		GAND syndrome	615074	AD	3	Gatad2b
1q21.3	1:153990762-153992155	RPS27, MPS1, DBA17	Ribosomal protein S27	603702	RPS27	6232	ENSG00000177954,ENST00000651669;;;ENST00000651669	mutation identified in 1 DBA17 patient	?Diamond-Blackfan anemia 17	617409	AD	3	Rps27,Rps27rt
1q21.3	1:153992690-154155116	NUP210L, SPGF97	NUP210-like protein	621033	NUP210L	91181	ENSG00000143552,ENST00000368559;;;ENST00000368559	mutation identified in 1 SPGF97 patient	?Spermatogenic failure 97	621057	AR	3	Nup210l
1q21.3	1:154155308-154192100	TPM3, NEM1, CMYO4A, CMYO4B	Tropomyosin 3	191030	TPM3	7170	ENSG00000143549,ENST00000651641;;;ENST00000651641		Congenital myopathy 4A, autosomal dominant	255310	AD	3	Tpm3
1q21.3	1:154155308-154192100	TPM3, NEM1, CMYO4A, CMYO4B	Tropomyosin 3	191030	TPM3	7170	ENSG00000143549,ENST00000651641;;;ENST00000651641		Congenital myopathy 4B, autosomal recessive	609284	AR	3	Tpm3
1q21.3	1:154220172-154271510	UBAP2L, NICE4, NEDLBF	Ubiquitin-associated protein 2-like	616472	UBAP2L	9898	ENSG00000143569,ENST00000428931;;;ENST00000428931		Neurodevelopmental disorder with impaired language, behavioral abnormalities, and dysmorphic facies	620494	AD	3	Ubap2l
1q21.3	1:154272629-154275875	HAX1, SCN3	HCLS1-associated protein X1	605998	HAX1	10456	ENSG00000143575,ENST00000328703;;;ENST00000328703		Neutropenia, severe congenital 3, autosomal recessive	610738	AR	3	Hax1
1q21.3	1:154405343-154469450	IL6R, IL6RQ, IL6QTL, HIES5	Interleukin-6 receptor	147880	IL6R	3570	ENSG00000160712,ENST00000368485;;;ENST00000368485	IL6R-like gene on chr.9	[Interleukin 6, serum level of, QTL]	614752		3	Il6ra
1q21.3	1:154405343-154469450	IL6R, IL6RQ, IL6QTL, HIES5	Interleukin-6 receptor	147880	IL6R	3570	ENSG00000160712,ENST00000368485;;;ENST00000368485	IL6R-like gene on chr.9	[Interleukin-6 receptor, soluble, serum level of, QTL]	614689		3	Il6ra
1q21.3	1:154405343-154469450	IL6R, IL6RQ, IL6QTL, HIES5	Interleukin-6 receptor	147880	IL6R	3570	ENSG00000160712,ENST00000368485;;;ENST00000368485	IL6R-like gene on chr.9	Hyper-IgE syndrome 5, autosomal recessive, with recurrent infections	618944	AR	3	Il6ra
1q21.3	1:154567778-154580013	CHRNB2, EFNL3	Cholinergic receptor, nicotinic, beta polypeptide-2	118507	CHRNB2	1141	ENSG00000160716,ENST00000368476;;;ENST00000368476	linked to AMY in mouse	Epilepsy, nocturnal frontal lobe, 3	605375		3	Chrnb2
1q21.3	1:154582057-154627997	ADAR, DRADA, DSH, DSRAD, IFI4, G1P1, AGS6	Adenosine deaminase, RNA-specific	146920	ADAR	103	ENSG00000160710,ENST00000368474;;;ENST00000368474		Aicardi-Goutieres syndrome 6	615010	AR	3	Adar
1q21.3	1:154582057-154627997	ADAR, DRADA, DSH, DSRAD, IFI4, G1P1, AGS6	Adenosine deaminase, RNA-specific	146920	ADAR	103	ENSG00000160710,ENST00000368474;;;ENST00000368474		Dyschromatosis symmetrica hereditaria	127400	AD	3	Adar
1q21.3	1:154697455-154870281	KCNN3, SK3, SKCA3, ZLS3	Potassium channel, calcium-activated, intermediate/small conductance, subfamily N, member 3	602983	KCNN3	3782	ENSG00000143603,ENST00000271915;;;ENST00000271915		Zimmermann-Laband syndrome 3	618658	AD	3	Kcnn3
1q21.3	1:154924740-154942658	PMVK, PMK, POROK1	Phosphomevalonate kinase	607622	PMVK	10654	ENSG00000163344,ENST00000368467;;;ENST00000368467		Porokeratosis 1, multiple types	175800	AD	3	Pmvk
1q21.3	1:154983344-154993111	FLAD1, FADS, LSMFLAD	Flavin adenine dinucleotide synthetase 1	610595	FLAD1	80308	ENSG00000160688,ENST00000292180;;;ENST00000292180		Lipid storage myopathy due to flavin adenine dinucleotide synthetase deficiency	255100	AR	3	Flad1
1q22	1:155139891-155140531	DPM3, MDDGC15, MDDGB15	Dolichyl-phosphate mannosyltransferase 3	605951	DPM3	54344	ENSG00000179085,ENST00000368400;;;ENST00000368400	mutation identified in 1 MDDGB15 patient	?Muscular dystrophy-dystroglycanopathy (congenital with impaired intellectual development), type B, 15	618992	AR	3	Dpm3
1q22	1:155139891-155140531	DPM3, MDDGC15, MDDGB15	Dolichyl-phosphate mannosyltransferase 3	605951	DPM3	54344	ENSG00000179085,ENST00000368400;;;ENST00000368400	mutation identified in 1 MDDGB15 patient	Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 15	612937	AR	3	Dpm3
1q22	1:155185824-155192915	MUC1, PUM, ADTKD2	Mucin 1, cell surface associated	158340	MUC1	4582	ENSG00000185499,ENST00000368392	5cM proximal to SPTA1	Tubulointerstitial kidney disease, autosomal dominant, 2	174000	AD	3	Muc1
1q22	1:155234452-155244627	GBA1	Glucosylceramidase beta 1	606463	GBA1	2629	ENSG00000177628,ENST00000368373;;;ENST00000368373	pseudogene GBAP ~16kb 3' to GBA	{Lewy body dementia, susceptibility to}	127750	AD	3	Gba1
1q22	1:155234452-155244627	GBA1	Glucosylceramidase beta 1	606463	GBA1	2629	ENSG00000177628,ENST00000368373;;;ENST00000368373	pseudogene GBAP ~16kb 3' to GBA	{Parkinson disease, late-onset, susceptibility to}	168600	AD, Mu	3	Gba1
1q22	1:155234452-155244627	GBA1	Glucosylceramidase beta 1	606463	GBA1	2629	ENSG00000177628,ENST00000368373;;;ENST00000368373	pseudogene GBAP ~16kb 3' to GBA	Gaucher disease, perinatal lethal	608013	AR	3	Gba1
1q22	1:155234452-155244627	GBA1	Glucosylceramidase beta 1	606463	GBA1	2629	ENSG00000177628,ENST00000368373;;;ENST00000368373	pseudogene GBAP ~16kb 3' to GBA	Gaucher disease, type I	230800	AR	3	Gba1
1q22	1:155234452-155244627	GBA1	Glucosylceramidase beta 1	606463	GBA1	2629	ENSG00000177628,ENST00000368373;;;ENST00000368373	pseudogene GBAP ~16kb 3' to GBA	Gaucher disease, type II	230900	AR	3	Gba1
1q22	1:155234452-155244627	GBA1	Glucosylceramidase beta 1	606463	GBA1	2629	ENSG00000177628,ENST00000368373;;;ENST00000368373	pseudogene GBAP ~16kb 3' to GBA	Gaucher disease, type III	231000	AR	3	Gba1
1q22	1:155234452-155244627	GBA1	Glucosylceramidase beta 1	606463	GBA1	2629	ENSG00000177628,ENST00000368373;;;ENST00000368373	pseudogene GBAP ~16kb 3' to GBA	Gaucher disease, type IIIC	231005	AR	3	Gba1
1q22	1:155289293-155308654	PKLR, PK1, CNSHA2	Pyruvate kinase, liver and RBC type	609712	PKLR	5313	ENSG00000143627,ENST00000342741;;;ENST00000342741		[Adenosine triphosphate, elevated, of erythrocytes]	102900	AD	3	Pklr
1q22	1:155289293-155308654	PKLR, PK1, CNSHA2	Pyruvate kinase, liver and RBC type	609712	PKLR	5313	ENSG00000143627,ENST00000342741;;;ENST00000342741		Anemia, congenital, nonspherocytic hemolytic, 2, pyruvate kinase deficient	266200	AR	3	Pklr
1q22	1:155308866-155320665	FDPS, FPS, POROK9	Farnesyl diphosphate synthase	134629	FDPS	2224	ENSG00000160752,ENST00000368356;;;ENST00000368356		Porokeratosis 9, multiple types	616631	AD	3	Fdps
1q22	1:155335268-155563202	ASH1L, KIAA1420, ASH1, MRD52	ASH1-like histone lysine methyltransferase	607999	ASH1L	55870	ENSG00000116539,ENST00000392403;;;ENST00000392403		Intellectual developmental disorder, autosomal dominant 52	617796	AD	3	Ash1l
1q22	1:155563246-155614967	MSTO1, MMYAT	Misato 1, mitochondrial distribution and morphology regulator	617619	MSTO1	55154	ENSG00000125459,ENST00000245564;;;ENST00000245564		Myopathy, mitochondrial, and ataxia	617675	AD, AR	3	Msto1
1q22	1:155659442-155688996	YY1AP1, YAP, HCCA2, GRNG	YY1 associated protein 1	607860	YY1AP1	55249	ENSG00000163374,ENST00000355499;;;ENST00000355499		Grange syndrome	602531	AR	3	Gon4l
1q22	1:155687948-155739010	DAP3, PRLTS7	Death associated protein 3	602074	DAP3	7818	ENSG00000132676,ENST00000368336;;;ENST00000368336		Perrault syndrome 7	621101	AR	3	Dap3
1q22	1:155745112-155859431	GON4L, KIAA1606, LTMS	GON4-like protein	610393	GON4L	54856	ENSG00000116580,ENST00000368331;;;ENST00000368331		Li-Takada-Miyake syndrome	621212	AR	3	Gon4l
1q22	1:155897808-155911349	RIT1, RIT, ROC1, NS8	Ric-like protein without CAAX motif 1	609591	RIT1	6016	ENSG00000143622,ENST00000368323;;;ENST00000368323		Noonan syndrome 8	615355	AD	3	Rit1
1q22	1:155946854-155979617	ARHGEF2, GEFH1, KIAA0651, NEDMHM	RHO guanine nucleotide exchange factor 2	607560	ARHGEF2	9181	ENSG00000116584,ENST00000361247;;;ENST00000361247	mutation identified in 1 NEDMHM family	?Neurodevelopmental disorder with midbrain and hindbrain malformations	617523	AR	3	Arhgef2
1q22	1:156054782-156058506	LAMTOR2, MAPBPIP, p14,	Late endosomal/lysosomal adaptor, MAPK and MTOR activator 2	610389	LAMTOR2	28956	ENSG00000116586,ENST00000368305;;;ENST00000368305	mutation identified in 1 family	Immunodeficiency due to defect in MAPBP-interacting protein	610798	AR	3	Lamtor2
1q22	1:156082573-156140081	LMNA, LMN1, EMD2, FPLD2, CMD1A, HGPS	Lamin A/C	150330	LMNA	4000	ENSG00000160789,ENST00000368300;;;ENST00000368300		Cardiomyopathy, dilated, 1A	115200	AD	3	Lmna
1q22	1:156082573-156140081	LMNA, LMN1, EMD2, FPLD2, CMD1A, HGPS	Lamin A/C	150330	LMNA	4000	ENSG00000160789,ENST00000368300;;;ENST00000368300		Charcot-Marie-Tooth disease, type 2B1	605588	AR	3	Lmna
1q22	1:156082573-156140081	LMNA, LMN1, EMD2, FPLD2, CMD1A, HGPS	Lamin A/C	150330	LMNA	4000	ENSG00000160789,ENST00000368300;;;ENST00000368300		Emery-Dreifuss muscular dystrophy 2, autosomal dominant	181350	AD	3	Lmna
1q22	1:156082573-156140081	LMNA, LMN1, EMD2, FPLD2, CMD1A, HGPS	Lamin A/C	150330	LMNA	4000	ENSG00000160789,ENST00000368300;;;ENST00000368300		Emery-Dreifuss muscular dystrophy 3, autosomal recessive	616516	AR	3	Lmna
1q22	1:156082573-156140081	LMNA, LMN1, EMD2, FPLD2, CMD1A, HGPS	Lamin A/C	150330	LMNA	4000	ENSG00000160789,ENST00000368300;;;ENST00000368300		Heart-hand syndrome, Slovenian type	610140	AD	3	Lmna
1q22	1:156082573-156140081	LMNA, LMN1, EMD2, FPLD2, CMD1A, HGPS	Lamin A/C	150330	LMNA	4000	ENSG00000160789,ENST00000368300;;;ENST00000368300		Hutchinson-Gilford progeria	176670	AD	3	Lmna
1q22	1:156082573-156140081	LMNA, LMN1, EMD2, FPLD2, CMD1A, HGPS	Lamin A/C	150330	LMNA	4000	ENSG00000160789,ENST00000368300;;;ENST00000368300		Lipodystrophy, familial partial, type 2	151660	AD	3	Lmna
1q22	1:156082573-156140081	LMNA, LMN1, EMD2, FPLD2, CMD1A, HGPS	Lamin A/C	150330	LMNA	4000	ENSG00000160789,ENST00000368300;;;ENST00000368300		Malouf syndrome	212112	AD	3	Lmna
1q22	1:156082573-156140081	LMNA, LMN1, EMD2, FPLD2, CMD1A, HGPS	Lamin A/C	150330	LMNA	4000	ENSG00000160789,ENST00000368300;;;ENST00000368300		Mandibuloacral dysplasia	248370	AR	3	Lmna
1q22	1:156082573-156140081	LMNA, LMN1, EMD2, FPLD2, CMD1A, HGPS	Lamin A/C	150330	LMNA	4000	ENSG00000160789,ENST00000368300;;;ENST00000368300		Muscular dystrophy, congenital	613205	AD	3	Lmna
1q22	1:156082573-156140081	LMNA, LMN1, EMD2, FPLD2, CMD1A, HGPS	Lamin A/C	150330	LMNA	4000	ENSG00000160789,ENST00000368300;;;ENST00000368300		Restrictive dermopathy 2	619793	AD	3	Lmna
1q22	1:156147373-156177744	SEMA4A, SEMB, RP35, CORD10	Semaphorin 4A	607292	SEMA4A	64218	ENSG00000196189,ENST00000368285;;;ENST00000368285		Cone-rod dystrophy 10	610283	AR	3	Sema4a
1q22	1:156147373-156177744	SEMA4A, SEMB, RP35, CORD10	Semaphorin 4A	607292	SEMA4A	64218	ENSG00000196189,ENST00000368285;;;ENST00000368285		Retinitis pigmentosa 35	610282	AR	3	Sema4a
1q22	1:156308968-156338292	CCT3, TRIC5, NEDSVH	Chaperonin-containing TCP1, subunit 3, gamma (TCP1 (t-complex-1) ring complex, polypeptide 5)	600114	CCT3	7203	ENSG00000163468,ENST00000295688;;;ENST00000295688		Neurodevelopmental disorder with speech or visual impairment and brain hypomyelination	621034	AD	3	Cct3
1q22	1:156591776-156594299	NAXE, APOA1BP, AIBP, PEBEL	NAD(P)HX epimerase	608862	NAXE	128240	ENSG00000163382,ENST00000368235;;;ENST00000368235		Encephalopathy, progressive, early-onset, with brain edema and/or leukoencephalopathy	617186	AR	3	Naxe
1q23	1:156600001-165500000	BDET	Bleeding disorder, east Texas type	605913		85504			Bleeding disorder, east Texas type	605913		2	
1q23.1	1:156767535-156800815	PRCC, RCCP1	Proline-rich mitotic checkpoint control factor	179755	PRCC	5546	ENSG00000143294,ENST00000271526;;;ENST00000271526	t(X;1)(p11;q21); fuses with TFE3 in RCCP	Renal cell carcinoma, papillary	605074		3	Prcc
1q23.1	1:156815750-156881850	NTRK1, TRKA	Neurotrophic tyrosine kinase, receptor, type 1	191315	NTRK1	4914	ENSG00000198400,ENST00000524377;;;ENST00000524377	TRK = chimera of TPM3 and NTRK1	Insensitivity to pain, congenital, with anhidrosis	256800	AR	3	Ntrk1
1q23.1	1:157993645-158100262	KIRREL1, NEPH1, NPHS23	Kirre-like nephrin family adhesion molecule 1	607428	KIRREL1	55243	ENSG00000183853,ENST00000359209;;;ENST00000359209		Nephrotic syndrome, type 23	619201	AR	3	Kirrel1
1q23.1	1:158610704-158686715	SPTA1, EL2, SPH3, HS3, HPP	Spectrin, alpha, erythrocytic-1	182860	SPTA1	6708	ENSG00000163554,ENST00000643759;;;ENST00000643759	17cM proximal to FY	Elliptocytosis-2	130600	AD	3	Spta1
1q23.1	1:158610704-158686715	SPTA1, EL2, SPH3, HS3, HPP	Spectrin, alpha, erythrocytic-1	182860	SPTA1	6708	ENSG00000163554,ENST00000643759;;;ENST00000643759	17cM proximal to FY	Pyropoikilocytosis	266140	AR	3	Spta1
1q23.1	1:158610704-158686715	SPTA1, EL2, SPH3, HS3, HPP	Spectrin, alpha, erythrocytic-1	182860	SPTA1	6708	ENSG00000163554,ENST00000643759;;;ENST00000643759	17cM proximal to FY	Spherocytosis, type 3	270970	AR	3	Spta1
1q23.2	1:159171615-159203313	CADM3, IGSF4B, TSLL1, NECL1, SYNCAM3, CMT2FF	Cell adhesion molecule 3	609743	CADM3	57863	ENSG00000162706,ENST00000368125;;;ENST00000368125		Charcot-Marie-Tooth disease, axonal, type 2FF	619519	AD	3	Cadm3
1q23.2	1:159204875-159206500	ACKR1, DARC, FY, GPD, WBCQ1	Atypical chemokine receptor 1 (Duffy antigen receptor for chemokines)	613665	ACKR1	2532	ENSG00000213088,ENST00000368122;;;ENST00000368122	by A, 1q22-q23	[Blood group, Duffy system]	110700	AD, AR	3	Ackr1
1q23.2	1:159204875-159206500	ACKR1, DARC, FY, GPD, WBCQ1	Atypical chemokine receptor 1 (Duffy antigen receptor for chemokines)	613665	ACKR1	2532	ENSG00000213088,ENST00000368122;;;ENST00000368122	by A, 1q22-q23	[White blood cell count QTL]	611862	AR	3	Ackr1
1q23.2	1:159204875-159206500	ACKR1, DARC, FY, GPD, WBCQ1	Atypical chemokine receptor 1 (Duffy antigen receptor for chemokines)	613665	ACKR1	2532	ENSG00000213088,ENST00000368122;;;ENST00000368122	by A, 1q22-q23	{Malaria, vivax, protection against}	611162		3	Ackr1
1q23.2	1:159872364-159900165	CFAP45, CCDC19, NESG1, HTX11	Cilia- and flagella-associated protein 45	605152	CFAP45	25790	ENSG00000213085,ENST00000368099;;;ENST00000368099		Heterotaxy, visceral, 11, autosomal, with male infertility	619608	AR	3	Cfap45
1q23.2	1:160024953-160031990	PIGM	Phosphatidylinositol glycan, class M	610273	PIGM	93183	ENSG00000143315,ENST00000368090;;;ENST00000368090		Glycosylphosphatidylinositol deficiency	610293	AR	3	Pigm
1q23.2	1:160037467-160070160	KCNJ10, SESAME	Potassium inwardly-rectifying channel, subfamily J, member 10	602208	KCNJ10	3766	ENSG00000177807,ENST00000644903;;;ENST00000644903		Enlarged vestibular aqueduct, digenic	600791	AR	3	Kcnj10
1q23.2	1:160037467-160070160	KCNJ10, SESAME	Potassium inwardly-rectifying channel, subfamily J, member 10	602208	KCNJ10	3766	ENSG00000177807,ENST00000644903;;;ENST00000644903		SESAME syndrome	612780	AR	3	Kcnj10
1q23.2	1:160115759-160143591	ATP1A2, FHM2, MHP2, FARIMPD, DEE98	ATPase, Na+K+ transporting, alpha-2 polypeptide	182340	ATP1A2	477	ENSG00000018625,ENST00000361216;;;ENST00000361216		Alternating hemiplegia of childhood 1	104290	AD	3	Atp1a2
1q23.2	1:160115759-160143591	ATP1A2, FHM2, MHP2, FARIMPD, DEE98	ATPase, Na+K+ transporting, alpha-2 polypeptide	182340	ATP1A2	477	ENSG00000018625,ENST00000361216;;;ENST00000361216		Developmental and epileptic encephalopathy 98	619605	AD	3	Atp1a2
1q23.2	1:160115759-160143591	ATP1A2, FHM2, MHP2, FARIMPD, DEE98	ATPase, Na+K+ transporting, alpha-2 polypeptide	182340	ATP1A2	477	ENSG00000018625,ENST00000361216;;;ENST00000361216		Fetal akinesia, respiratory insufficiency, microcephaly, polymicrogyria, and dysmorphic facies	619602	AR	3	Atp1a2
1q23.2	1:160115759-160143591	ATP1A2, FHM2, MHP2, FARIMPD, DEE98	ATPase, Na+K+ transporting, alpha-2 polypeptide	182340	ATP1A2	477	ENSG00000018625,ENST00000361216;;;ENST00000361216		Migraine, familial basilar	602481	AD	3	Atp1a2
1q23.2	1:160115759-160143591	ATP1A2, FHM2, MHP2, FARIMPD, DEE98	ATPase, Na+K+ transporting, alpha-2 polypeptide	182340	ATP1A2	477	ENSG00000018625,ENST00000361216;;;ENST00000361216		Migraine, familial hemiplegic, 2	602481	AD	3	Atp1a2
1q23.2	1:160190575-160201886	CASQ1, VMCQA	Calsequestrin, fast-twitch, skeletal muscle-1	114250	CASQ1	844	ENSG00000143318,ENST00000368078;;;ENST00000368078		Myopathy, vacuolar, with CASQ1 aggregates	616231	AD	3	Casq1
1q23.2	1:160215720-160262549	DCAF8, WDR42A, GAN2	DDB1- and CUL4-associated factor 8	615820	DCAF8	50717	ENSG00000132716,ENST00000368074;;;ENST00000368074	mutation identified in 1 GAN2 family	?Giant axonal neuropathy 2, autosomal dominant	610100	AD	3	Dcaf8
1q23.2	1:160276807-160285151	PEX19, PXF, HK33, D1S2223E, PBD12A	Peroxisome biogenesis factor 19 (peroxisomal farnesylated protein)	600279	PEX19	5824	ENSG00000162735,ENST00000368072;;;ENST00000368072		Peroxisome biogenesis disorder 12A (Zellweger)	614886	AR	3	Pex19
1q23.2	1:160288594-160343250	COPA, AIAISD	Coatomer protein complex, subunit alpha	601924	COPA	1314	ENSG00000122218,ENST00000241704;;;ENST00000241704		{Autoinflammation and autoimmunity, systemic, with immune dysregulation}	616414	AD	3	Copa
1q23.2	1:160343383-160358949	NCSTN	Nicastrin	605254	NCSTN	23385	ENSG00000162736,ENST00000294785;;;ENST00000294785		Acne inversa, familial, 1	142690	AD	3	Ncstn
1q23.2	1:160400564-160428670	VANGL2, LTAP	VANGL planar cell polarity protein 2	600533	VANGL2	57216	ENSG00000162738,ENST00000368061;;;ENST00000368061		Neural tube defects	182940	AD	3	Vangl2
1q23.3	1:160500001-165500000	QTV	QT interval, variation in	610141		100379215		associated with rs12143842	[QT interval, variation in]	610141		2	
1q23.3	1:160830160-160862887	CD244, NAIL, NKR2B4, SLAMF4	CD244 antigen	605554	CD244	51744	ENSG00000122223,ENST00000368034;;;ENST00000368034		{Rheumatoid arthritis, susceptibility to}	180300		3	Cd244a
1q23.3	1:161039251-161045977	USF1, HYPLIP1	Upstream transcription factor 1	191523	USF1	7391	ENSG00000158773,ENST00000368021;;;ENST00000368021		{Hyperlipidemia, familial combined, susceptibility to}	602491		3	Usf1
1q23.3	1:161070998-161089558	NECTIN4, PVRL4, PRR4, EDSS1	Nectin 4	609607	NECTIN4	81607	ENSG00000143217,ENST00000368012;;;ENST00000368012		Ectodermal dysplasia-syndactyly syndrome 1	613573	AR	3	Nectin4
1q23.3	1:161118105-161125445	NIT1, BSVD4	Nitrilase 1	604618	NIT1	4817	ENSG00000158793,ENST00000368009;;;ENST00000368009		Brain small vessel disease 4	621313	AR	3	Nit1
1q23.3	1:161153978-161158856	UFC1, NEDSG	Ubiquitin-fold modifier-conjugating enzyme 1	610554	UFC1	51506	ENSG00000143222,ENST00000368003;;;ENST00000368003		Neurodevelopmental disorder with spasticity and poor growth	618076	AR	3	Ufc1
1q23.3	1:161165728-161178013	PPOX, VP, VPCO	Protoporphyrinogen oxidase	600923	PPOX	5498	ENSG00000143224,ENST00000367999;;;ENST00000367999		Variegate porphyria	176200	AD	3	Ppox
1q23.3	1:161165728-161178013	PPOX, VP, VPCO	Protoporphyrinogen oxidase	600923	PPOX	5498	ENSG00000143224,ENST00000367999;;;ENST00000367999		Variegate porphyria, childhood-onset	620483	AR	3	Ppox
1q23.3	1:161197417-161214395	NDUFS2, MC1DN6, LHONAR2	NADH-ubiquinone oxidoreductase core subunit S2	602985	NDUFS2	4720	ENSG00000158864,ENST00000676972;;;ENST00000676972	mutation identified in 1 LHONAR2 family	?Leber-like hereditary optic neuropathy, autosomal recessive 2	620569	AR	3	Ndufs2
1q23.3	1:161197417-161214395	NDUFS2, MC1DN6, LHONAR2	NADH-ubiquinone oxidoreductase core subunit S2	602985	NDUFS2	4720	ENSG00000158864,ENST00000676972;;;ENST00000676972	mutation identified in 1 LHONAR2 family	Mitochondrial complex I deficiency, nuclear type 6	618228	AR	3	Ndufs2
1q23.3	1:161222292-161223628	APOA2	Apolipoprotein A-II	107670	APOA2	336	ENSG00000158874,ENST00000367990;;;ENST00000367990		{Hypercholesterolemia, familial, modifier of}	143890	AD, AR	3	Apoa2
1q23.3	1:161222292-161223628	APOA2	Apolipoprotein A-II	107670	APOA2	336	ENSG00000158874,ENST00000367990;;;ENST00000367990		Apolipoprotein A-II deficiency			3	Apoa2
1q23.3	1:161303600-161309968	MPZ, CMT1B, CMTDID, DSS, CHN2	Myelin protein zero	159440	MPZ	4359	ENSG00000158887,ENST00000533357;;;ENST00000533357		Charcot-Marie-Tooth disease, dominant intermediate D	607791	AD	3	Mpz
1q23.3	1:161303600-161309968	MPZ, CMT1B, CMTDID, DSS, CHN2	Myelin protein zero	159440	MPZ	4359	ENSG00000158887,ENST00000533357;;;ENST00000533357		Charcot-Marie-Tooth disease, type 1B	118200	AD	3	Mpz
1q23.3	1:161303600-161309968	MPZ, CMT1B, CMTDID, DSS, CHN2	Myelin protein zero	159440	MPZ	4359	ENSG00000158887,ENST00000533357;;;ENST00000533357		Charcot-Marie-Tooth disease, type 2I	607677	AD	3	Mpz
1q23.3	1:161303600-161309968	MPZ, CMT1B, CMTDID, DSS, CHN2	Myelin protein zero	159440	MPZ	4359	ENSG00000158887,ENST00000533357;;;ENST00000533357		Charcot-Marie-Tooth disease, type 2J	607736	AD	3	Mpz
1q23.3	1:161303600-161309968	MPZ, CMT1B, CMTDID, DSS, CHN2	Myelin protein zero	159440	MPZ	4359	ENSG00000158887,ENST00000533357;;;ENST00000533357		Dejerine-Sottas disease	145900	AD, AR	3	Mpz
1q23.3	1:161303600-161309968	MPZ, CMT1B, CMTDID, DSS, CHN2	Myelin protein zero	159440	MPZ	4359	ENSG00000158887,ENST00000533357;;;ENST00000533357		Hypomyelinating neuropathy, congenital, 2	618184	AD	3	Mpz
1q23.3	1:161303600-161309968	MPZ, CMT1B, CMTDID, DSS, CHN2	Myelin protein zero	159440	MPZ	4359	ENSG00000158887,ENST00000533357;;;ENST00000533357		Roussy-Levy syndrome	180800	AD	3	Mpz
1q23.3	1:161314381-161363206	SDHC, PPGL3	Succinate dehydrogenase complex, subunit C	602413	SDHC	6391	ENSG00000143252,ENST00000367975;;;ENST00000367975		Gastrointestinal stromal tumor	606764	AD, IC	3	Sdhc
1q23.3	1:161314381-161363206	SDHC, PPGL3	Succinate dehydrogenase complex, subunit C	602413	SDHC	6391	ENSG00000143252,ENST00000367975;;;ENST00000367975		Paraganglioma and gastric stromal sarcoma	606864		3	Sdhc
1q23.3	1:161314381-161363206	SDHC, PPGL3	Succinate dehydrogenase complex, subunit C	602413	SDHC	6391	ENSG00000143252,ENST00000367975;;;ENST00000367975		Pheochromocytoma/paraganglioma syndrome 3	605373	AD	3	Sdhc
1q23.3	1:161505457-161524048	FCGR2A, IGFR2, CD32	Fc fragment of IgG receptor IIa	146790	FCGR2A	2212	ENSG00000143226,ENST00000271450;;;ENST00000271450	FCG2 and FCG3 within 250kb	{Lupus nephritis, susceptibility to}	152700	AD	3	Fcgr2b,Fcgr3
1q23.3	1:161505457-161524048	FCGR2A, IGFR2, CD32	Fc fragment of IgG receptor IIa	146790	FCGR2A	2212	ENSG00000143226,ENST00000271450;;;ENST00000271450	FCG2 and FCG3 within 250kb	{Malaria, severe, susceptibility to}	611162		3	Fcgr2b,Fcgr3
1q23.3	1:161505457-161524048	FCGR2A, IGFR2, CD32	Fc fragment of IgG receptor IIa	146790	FCGR2A	2212	ENSG00000143226,ENST00000271450;;;ENST00000271450	FCG2 and FCG3 within 250kb	{Pseudomonas aeruginosa, susceptibility to chronic infection by, in cystic fibrosis}	219700	AR	3	Fcgr2b,Fcgr3
1q23.3	1:161541759-161550737	FCGR3A, CD16, IGFR3, IMD20	Fc fragment of IgG receptor IIIa	146740	FCGR3A	2214	ENSG00000203747,ENST00000443193;;;ENST00000443193	FCGR2A and FCGR3A within 250kb antigen	Immunodeficiency 20	615707	AR	3	Fcgr4
1q23.3	1:161647243-161678654	FCGR2B, CD32	Fc fragment of IgG receptor Ia	604590	FCGR2B	2213	ENSG00000072694,ENST00000358671;;;ENST00000358671		{Malaria, resistance to}	611162		3	Fcgr2b
1q23.3	1:161647243-161678654	FCGR2B, CD32	Fc fragment of IgG receptor Ia	604590	FCGR2B	2213	ENSG00000072694,ENST00000358671;;;ENST00000358671		{Systemic lupus erythematosus, susceptibility to}	152700	AD	3	Fcgr2b
1q23.3	1:161766320-161964070	ATF6, ACHM7	Activating transcription factor-6	605537	ATF6	22926	ENSG00000118217,ENST00000367942;;;ENST00000367942		Achromatopsia 7	616517	AR	3	Atf6
1q23.3	1:162069691-162370475	NOS1AP, CAPON, KIAA0464, NPHS22	Nitric oxide synthase 1 (neuronal) adaptor protein	605551	NOS1AP	9722	ENSG00000198929,ENST00000361897;;;ENST00000361897		Nephrotic syndrome, type 22	619155	AR	3	Nos1ap
1q23.3	1:162630863-162787405	DDR2, NTRKR3, TKT, WRCN	Discoidin domain receptor family, member 2	191311	DDR2	4921	ENSG00000162733,ENST00000367921;;;ENST00000367921		Spondylometaepiphyseal dysplasia, short limb-hand type	271665	AR	3	Ddr2
1q23.3	1:162630863-162787405	DDR2, NTRKR3, TKT, WRCN	Discoidin domain receptor family, member 2	191311	DDR2	4921	ENSG00000162733,ENST00000367921;;;ENST00000367921		Warburg-Cinotti syndrome	618175	AD	3	Ddr2
1q23.3	1:163142299-163321735	RGS5	Regulator of G protein signaling-5	603276	RGS5	8490	ENSG00000143248,ENST00000313961;;;ENST00000313961		[Blood pressure regulation QTL]	145500	Mu	2	Rgs5
1q23.3	1:164559184-164886047	PBX1, CAKUHED	Pre-B cell leukemia transcription factor-1	176310	PBX1	5087	ENSG00000185630,ENST00000420696;;;ENST00000420696	pseudogene PBXP1 on chr.3	Congenital anomalies of kidney and urinary tract syndrome with or without hearing loss, abnormal ears, or developmental delay	617641	AD	3	Pbx1
1q23.3	1:165201867-165356715	LMX1A, LMX1, DFNA7	LIM homeobox transcription factor-1, alpha	600298	LMX1A	4009	ENSG00000162761,ENST00000342310;;;ENST00000342310		Deafness, autosomal dominant 7	601412	AD	3	Lmx1a
1q24.1	1:165724291-165768922	TMCO1, CFSMR1	Transmembrane and coiled-coil domains protein 1	614123	TMCO1	54499	ENSG00000143183,ENST00000367881;;;ENST00000367881		Craniofacial dysmorphism, skeletal anomalies, and impaired intellectual development 1	213980	AR	3	Tmco1
1q24.2	1:167430640-167518529	CD247, CD3Z, TCRZ, IMD25	CD247 antigen	186780	CD247	919	ENSG00000198821,ENST00000362089;;;ENST00000362089	mutation identified in one IMD25 patient	?Immunodeficiency 25	610163	AR	3	Cd247
1q24.2	1:167809386-167914134	ADCY10, SAC, HCA2	Adenylyl cyclase 10, soluble	605205	ADCY10	55811	ENSG00000143199,ENST00000367851;;;ENST00000367851		{Hypercalciuria, absorptive, susceptibility to}	143870	AD	3	Adcy10
1q24.2	1:168079542-168137667	GPR161	G protein-coupled receptor 161	612250	GPR161	23432	ENSG00000143147,ENST00000682931;;;ENST00000682931		{Medulloblastoma predisposition syndrome}	155255	AD, AR, SMu	3	Gpr161
1q24.2	1:168280877-168314426	TBX19	T-box 19	604614	TBX19	9095	ENSG00000143178,ENST00000367821;;;ENST00000367821		Adrenocorticotropic hormone deficiency	201400	AR	3	Tbx19
1q24.2	1:169106690-169132719	ATP1B1	ATPase, Na+K+ transporting, beta-1 polypeptide	182330	ATP1B1	481	ENSG00000143153,ENST00000367815;;;ENST00000367815		[Blood pressure regulation QTL]	145500	Mu	2	Atp1b1
1q24.2	1:169463909-169485970	SLC19A2, THTR1, TRMA, THMD1	Solute carrier family 19 (thiamine transporter), member 2	603941	SLC19A2	10560	ENSG00000117479,ENST00000236137;;;ENST00000236137		Thiamine-responsive megaloblastic anemia syndrome	249270	AR	3	Slc19a2
1q24.2	1:169511951-169586481	F5, THPH2, RPRGL1	Coagulation factor V (proaccelerin, labile factor)	612309	F5	2153	ENSG00000198734,ENST00000367797;;;ENST00000367797	Order: F5-GRMP-LYAM1-ELAM1 in 300kb segment	{Budd-Chiari syndrome}	600880	AR	3	F5
1q24.2	1:169511951-169586481	F5, THPH2, RPRGL1	Coagulation factor V (proaccelerin, labile factor)	612309	F5	2153	ENSG00000198734,ENST00000367797;;;ENST00000367797	Order: F5-GRMP-LYAM1-ELAM1 in 300kb segment	{Pregnancy loss, recurrent, susceptibility to, 1}	614389	AD	3	F5
1q24.2	1:169511951-169586481	F5, THPH2, RPRGL1	Coagulation factor V (proaccelerin, labile factor)	612309	F5	2153	ENSG00000198734,ENST00000367797;;;ENST00000367797	Order: F5-GRMP-LYAM1-ELAM1 in 300kb segment	{Stroke, ischemic, susceptibility to}	601367	Mu	3	F5
1q24.2	1:169511951-169586481	F5, THPH2, RPRGL1	Coagulation factor V (proaccelerin, labile factor)	612309	F5	2153	ENSG00000198734,ENST00000367797;;;ENST00000367797	Order: F5-GRMP-LYAM1-ELAM1 in 300kb segment	{Thrombophilia, susceptibility to, due to factor V Leiden}	188055	AD	3	F5
1q24.2	1:169511951-169586481	F5, THPH2, RPRGL1	Coagulation factor V (proaccelerin, labile factor)	612309	F5	2153	ENSG00000198734,ENST00000367797;;;ENST00000367797	Order: F5-GRMP-LYAM1-ELAM1 in 300kb segment	Factor V deficiency	227400	AR	3	F5
1q24.2	1:169511951-169586481	F5, THPH2, RPRGL1	Coagulation factor V (proaccelerin, labile factor)	612309	F5	2153	ENSG00000198734,ENST00000367797;;;ENST00000367797	Order: F5-GRMP-LYAM1-ELAM1 in 300kb segment	Thrombophilia 2 due to activated protein C resistance	188055	AD	3	F5
1q24.2	1:170532166-170553834	GORAB, SCYL1BP1, NTKLBP1, GO	Golgin, RAB6-interacting	607983	GORAB	92344	ENSG00000120370,ENST00000367763;;;ENST00000367763		Geroderma osteodysplasticum	231070	AR	3	Gorab
1q24.2	1:170662768-170739421	PRRX1, PMX1, PHOX1, AGOTC	Paired-related homeobox gene 1	167420	PRRX1	5396	ENSG00000116132,ENST00000239461;;;ENST00000239461		Agnathia-otocephaly complex	202650	AD, AR	3	Prrx1
1q24.3	1:171090905-171117819	FMO3, TMAU	Flavin-containing monooxygenase 3	136132	FMO3	2328	ENSG00000007933,ENST00000367755;;;ENST00000367755		Trimethylaminuria	602079	AR	3	Fmo3
1q24.3	1:171635417-171652688	MYOC, TIGR, GLC1A, JOAG, GPOA	Myocilin (trabecular meshwork-induced glucocorticoid response protein)	601652	MYOC	4653	ENSG00000034971,ENST00000037502;;;ENST00000037502		Glaucoma 1A, primary open angle	137750	AD	3	Myoc
1q24.3	1:171781660-171797716	EEF1AKNMT, METTL13, FEAT, KIAA0859, DFNB26M	EEF1A lysine and N-terminal methyltransferase	617987	METTL13	51603	ENSG00000010165,ENST00000361735;;;ENST00000361735	mutation identified in 1 family	{?Deafness, autosomal recessive 26, modifier of}	605429	AD	3	Mettl13
1q24.3	1:172441457-172444069	PIGC, GPI2, GPIBD16, MRT62	Phosphatidylinositol glycan, class C	601730	PIGC	5279	ENSG00000135845,ENST00000344529;;;ENST00000344529		Glycosylphosphatidylinositol biosynthesis defect 16	617816	AR	3	Pigc
1q24.3	1:172659103-172666876	FASLG, TNFSF6, APT1LG1, FASL, ALPS1B	Fas ligand (TNF superfamily, member 6)	134638	FASLG	356	ENSG00000117560,ENST00000367721;;;ENST00000367721		{Lung cancer, susceptibility to}	211980	AD, SMu	3	Fasl
1q24.3	1:172659103-172666876	FASLG, TNFSF6, APT1LG1, FASL, ALPS1B	Fas ligand (TNF superfamily, member 6)	134638	FASLG	356	ENSG00000117560,ENST00000367721;;;ENST00000367721		Autoimmune lymphoproliferative syndrome, type IB	601859	AD	3	Fasl
1q25	1:173000001-185800000	AD14	Alzheimer disease 14	611154		100188754		max lod at D1S218	{Alzheimer disease-14}	611154		2	
1q25	1:173000001-185800000	PDON2	Periodontitis, aggressive, 2	608526		406237		between D1S196 and D1S533	Periodontitis, aggressive, 2	608526		2	
1q25.1	1:173172870-173450733	TNFSF4, GP34, OX4OL	Tumor necrosis factor ligand superfamily, member 4	603594	TNFSF4	7292	ENSG00000117586,ENST00000281834;;;ENST00000281834		{Myocardial infarction, susceptibility to}	608446		3	Tnfsf4
1q25.1	1:173714981-173786692	KLHL20, KLEIP, KLHLX, NEDSZFB	Kelch-like 20	617679	KLHL20	27252	ENSG00000076321,ENST00000209884;;;ENST00000209884		Neurodevelopmental disorder with early-onset seizures, facial dysmorphism, and behavioral abnormalities	621390		3	Klhl20
1q25.1	1:173824673-173858546	DARS2, ASPRS. LBSL	Aspartyl-tRNA synthetase 2	610956	DARS2	55157	ENSG00000117593,ENST00000649689;;;ENST00000649689		Leukoencephalopathy with brain stem and spinal cord involvement and lactate elevation	611105	AR	3	Dars2
1q25.1	1:173903800-173917327	SERPINC1, AT3, AT3D, THPH7	Antithrombin III	107300	SERPINC1	462	ENSG00000117601,ENST00000367698;;;ENST00000367698	~17cM distal to FY	Thrombophilia 7 due to antithrombin III deficiency	613118	AD, AR	3	Serpinc1
1q25.1	1:173931084-174022357	RC3H1, KIAA2025, IMDSHY	Roquin	609424	RC3H1	149041	ENSG00000135870,ENST00000367696;;;ENST00000367696	mutation identified in 1 IMDSHY patient	?Immune dysregulation and systemic hyperinflammation syndrome	618998	AR	3	Rc3h1
1q25.1	1:175012958-175023425	MRPS14, COXPD38	Mitochondrial ribosomal protein S14	611978	MRPS14	63931	ENSG00000120333,ENST00000476371;;;ENST00000476371	mutation identified in 1 COXPD38 patient	?Combined oxidative phosphorylation deficiency 38	618378	AR	3	Mrps14
1q25.1	1:175315194-175743595	TNR, NEDSTO	Tenascin R (restrictin, janusin)	601995	TNR	7143	ENSG00000116147,ENST00000367674;;;ENST00000367674		Neurodevelopmental disorder, nonprogressive, with spasticity and transient opisthotonus	619653	AR	3	Tnr
1q25.2	1:176463175-176845601	PAPPA2, PAPPE, SSDA	Pappalysin 2	619485	PAPPA2	60676	ENSG00000116183,ENST00000367662;;;ENST00000367662		Short stature, Dauber-Argente type	619489	AR	3	Pappa2
1q25.2	1:179550539-179575948	PDCN, NPHS2, SRN1	Podocin	604766	NPHS2	7827	ENSG00000116218,ENST00000367615;;;ENST00000367615	modifies phenotype of NPHS1 mutations to FSGS	Nephrotic syndrome, type 2	600995	AR	3	Nphs2
1q25.2	1:179882285-179920076	TOR1AIP1, LAP1, LAP1B, LGMD2Y	Torsin 1A-interacting protein 1	614512	TOR1AIP1	26092	ENSG00000143337,ENST00000606911;;;ENST00000606911	mutation identified in 1 MRRSDC family	?Muscular dystrophy, autosomal recessive, with rigid spine and distal joint contractures	617072	AR	3	Tor1aip1
1q25.2	1:180228375-180278984	LHX4, CPHD4	LIM homeobox gene 4	602146	LHX4	89884	ENSG00000121454,ENST00000263726;;;ENST00000263726	fused to IGH in ALL	Pituitary hormone deficiency, combined, 4	262700	AD	3	Lhx4
1q25.2-q25.3	1:180269653-180502577	ACBD6, NEDPM	Acyl-CoA-binding domain-containing protein 6	616352	ACBD6	84320	ENSG00000230124,ENST00000367595;;;ENST00000367595		Neurodevelopmental disorder with progressive movement abnormalities	620785	AR	3	Acbd6
1q25.3	1:180632022-180890279	XPR1, SYG1, IBGC6	Xenotropic and polytropic retrovirus receptor	605237	XPR1	9213	ENSG00000143324,ENST00000367590;;;ENST00000367590		Basal ganglia calcification, idiopathic, 6	616413	AD	3	Xpr1
1q25.3	1:181317699-181808084	CACNA1E, CACNL1A6, DEE69	Calcium channel, voltage-dependent, alpha 1E subunit	601013	CACNA1E	777	ENSG00000198216,ENST00000367573;;;ENST00000367573		Developmental and epileptic encephalopathy 69	618285	AD	3	Cacna1e
1q25.3	1:182378098-182391790	GLUL, GLNS, DEE116	Glutamate-ammonia ligase (glutamine synthase)	138290	GLUL	2752	ENSG00000135821,ENST00000331872;;;ENST00000331872	pseudogene on chr.9	Developmental and epileptic encephalopathy 116	620806	AD	3	Glul
1q25.3	1:182378098-182391790	GLUL, GLNS, DEE116	Glutamate-ammonia ligase (glutamine synthase)	138290	GLUL	2752	ENSG00000135821,ENST00000331872;;;ENST00000331872	pseudogene on chr.9	Glutamine deficiency, congenital	610015	AR	3	Glul
1q25.3	1:182573634-182589256	RNASEL, RNS4, PRCA1, HPC1	Ribonuclease L (2',5'-oligoisoadenylate synthetase-dependent)	180435	RNASEL	6041	ENSG00000135828,ENST00000367559;;;ENST00000367559		Prostate cancer 1	601518	AD	3	Rnasel
1q25.3	1:182839347-182887982	DHX9, DDX9, NDHII, MRD75	DExH-box helicase 9	603115	DHX9	1660	ENSG00000135829,ENST00000367549;;;ENST00000367549		Intellectual developmental disorder, autosomal dominant 75	620988	AD	3	Dhx9
1q25.3	1:183186264-183258968	LAMC2, LAMNB2, LAMB2T, JEB3A, JEB3B	Laminin, gamma-2 (nicein, 100kD; kalinin, 105kD; BM600, 100kD)	150292	LAMC2	3918	ENSG00000058085,ENST00000264144;;;ENST00000264144		Epidermolysis bullosa, junctional 3A, intermediate	619785	AR	3	Lamc2
1q25.3	1:183186264-183258968	LAMC2, LAMNB2, LAMB2T, JEB3A, JEB3B	Laminin, gamma-2 (nicein, 100kD; kalinin, 105kD; BM600, 100kD)	150292	LAMC2	3918	ENSG00000058085,ENST00000264144;;;ENST00000264144		Epidermolysis bullosa, junctional 3B, severe	619786	AR	3	Lamc2
1q25.3	1:183555562-183601849	NCF2	Neutrophil cytosolic factor-2, 65kD	608515	NCF2	4688	ENSG00000116701,ENST00000367535;;;ENST00000367535		Chronic granulomatous disease 2, autosomal recessive	233710	AR	3	Ncf2
1q25.3	1:183620846-183635783	ARPC5, ARC16, IMD113	Actin-related protein 2/3 complex, subunit 5	604227	ARPC5	10092	ENSG00000162704,ENST00000359856;;;ENST00000359856		Immunodeficiency 113 with autoimmunity and autoinflammation	620565	AR	3	Arpc5
1q25.3	1:184051730-184097485	TSEN15, SEN15, C1orf19, PCH2F	tRNA splicing endonuclease, subunit 15	608756	TSEN15	116461	ENSG00000198860,ENST00000645668;;;ENST00000645668		Pontocerebellar hypoplasia, type 2F	617026	AR	3	Tsen15
1q25.3	1:184690237-184754858	EDEM3, C1orf22, CDG2V	Endoplasmic reticulum degradation-enhancing alpha-mannosidase-like protein 3	610214	EDEM3	80267	ENSG00000116406,ENST00000318130;;;ENST00000318130		Congenital disorder of glycosylation, type IIv	619493	AR	3	Edem3
1q25.3	1:185045558-185102603	RNF2, RING2, RING1B, HIPI3, DING, BAP1, LUSYAM	RING finger protein 2	608985	RNF2	6045	ENSG00000121481,ENST00000367510;;;ENST00000367510		Luo-Schoch-Yamamoto syndrome	619460	AD	3	Rnf2
1q25.3	1:185296388-185317243	IVNS1ABP, NS1BP, ND1, IMD70	Influenza virus NS1A protein-binding protein	609209	IVNS1ABP	10625	ENSG00000116679,ENST00000367498;;;ENST00000367498		Immunodeficiency 70	618969	AD	3	Ivns1abp
1q25.3-q31.1	1:185734391-186190949	HMCN1, FBLN6, FIBL6, ARMD1	Hemicentin (fibulin 6)	608548	HMCN1	83872	ENSG00000143341,ENST00000271588;;;ENST00000271588		{Macular degeneration, age-related, 1}	603075	AD	3	Hmcn1
1q31	1:185800001-198700000	BOS2	Branchiootic syndrome 2	120502		64585			Branchiootic syndrome 2	120502	AD	2	
1q31	1:185800001-198700000	CELIAC7	Celiac disease, susceptibility to, 7	612005		100301522		associated with rs2816316	{Celiac disease, susceptibility to, 7}	612005		2	
1q31	1:185800001-198700000	MGR6, FHM3	Migraine, several forms	607516		317773			{Migraine with or without aura, susceptibility to, 6}	607516	AD	2	
1q31	1:185800001-198700000	MGR6, FHM3	Migraine, several forms	607516		317773			{Migraine, familial hemiplegic, 4}	607516	AD	2	
1q31-q42	1:185800001-236400000	PHA2A, PHA2	Pseudohypoaldosteronism type IIA	145260		7830			Pseudohypoaldosteronism, type IIA	145260	AD	2	
1q31.1	1:185800001-190800000	PSNP2	Supranuclear palsy, progressive, 2	609454		619408		between D1S238 and D1S2823	Supranuclear palsy, progressive, 2	609454	AD	2	
1q31	1:185800001-198700000	PVOP1	Pelvic organ prolapse, susceptibility to, 1	176780		100312952		associated with rs10911193	{Pelvic organ prolapse, susceptibility to, 1}	176780	AD	2	
1q31.1	1:186296273-186314567	PRG4, CACP, MSF, SZP, HAPO	Proteoglycan 4 (megakaryocyte stimulating factor; hemangiopoietin)	604283	PRG4	10216	ENSG00000116690,ENST00000445192;;;ENST00000445192		Camptodactyly-arthropathy-coxa vara-pericarditis syndrome	208250	AR	3	Prg4
1q31.1	1:186311652-186375253	TPR, MRT79	Tumor potentiating region (translocated promoter region)	189940	TPR	7175	ENSG00000047410,ENST00000367478;;;ENST00000367478	mutation identified in 1 MRT79 family	?Intellectual developmental disorder, autosomal recessive 79	620393	AR	3	Tpr
1q31.1	1:186828949-186988981	PLA2G4A, PLA2G4, GURDP	Phospholipase A2, group IVA, cytosolic	600522	PLA2G4A	5321	ENSG00000116711,ENST00000367466;;;ENST00000367466		Gastrointestinal ulceration, recurrent, with dysfunctional platelets	618372	AR	3	Pla2g4a
1q31.2	1:193122031-193254815	CDC73, HRPT2, C1orf28	Cell division cycle 73	607393	CDC73	79577	ENSG00000134371,ENST00000367435;;;ENST00000367435		Hyperparathyroidism-jaw tumor syndrome	145001	AD	3	Cdc73
1q31.2	1:193122031-193254815	CDC73, HRPT2, C1orf28	Cell division cycle 73	607393	CDC73	79577	ENSG00000134371,ENST00000367435;;;ENST00000367435		Hyperparathyroidism, familial primary	145000	AD	3	Cdc73
1q31.2	1:193122031-193254815	CDC73, HRPT2, C1orf28	Cell division cycle 73	607393	CDC73	79577	ENSG00000134371,ENST00000367435;;;ENST00000367435		Parathyroid adenoma with cystic changes	145001	AD	3	Cdc73
1q31.2	1:193122031-193254815	CDC73, HRPT2, C1orf28	Cell division cycle 73	607393	CDC73	79577	ENSG00000134371,ENST00000367435;;;ENST00000367435		Parathyroid carcinoma	608266		3	Cdc73
1q31.3	1:196225779-196608440	KCNT2, SLICK, DEE57	Potassium channel, subfamily T, member 2	610044	KCNT2	343450	ENSG00000162687,ENST00000294725;;;ENST00000294725		Developmental and epileptic encephalopathy 57	617771	AD	3	Kcnt2
1q31.3	1:196652043-196747504	CFH, HF1, HUS, ARMD4, AHUS1	Complement factor H	134370	CFH	3075	ENSG00000000971,ENST00000367429;;;ENST00000367429		{Hemolytic uremic syndrome, atypical, susceptibility to, 1}	235400	AD, AR	3	Cfh,Cfhr4
1q31.3	1:196652043-196747504	CFH, HF1, HUS, ARMD4, AHUS1	Complement factor H	134370	CFH	3075	ENSG00000000971,ENST00000367429;;;ENST00000367429		{Macular degeneration, age-related, 4}	610698	AD	3	Cfh,Cfhr4
1q31.3	1:196652043-196747504	CFH, HF1, HUS, ARMD4, AHUS1	Complement factor H	134370	CFH	3075	ENSG00000000971,ENST00000367429;;;ENST00000367429		Basal laminar drusen	126700	AD	3	Cfh,Cfhr4
1q31.3	1:196652043-196747504	CFH, HF1, HUS, ARMD4, AHUS1	Complement factor H	134370	CFH	3075	ENSG00000000971,ENST00000367429;;;ENST00000367429		Complement factor H deficiency	609814	AD, AR	3	Cfh,Cfhr4
1q31.3	1:196774840-196795407	CFHR3, FHR3, HLF4, CFHL3	Complement factor H-related 3	605336	CFHR3	10878	ENSG00000116785,ENST00000367425;;;ENST00000367425		{Hemolytic uremic syndrome, atypical, susceptibility to}	235400	AD, AR	3	Cfhr2
1q31.3	1:196774840-196795407	CFHR3, FHR3, HLF4, CFHL3	Complement factor H-related 3	605336	CFHR3	10878	ENSG00000116785,ENST00000367425;;;ENST00000367425		{Macular degeneration, age-related, reduced risk of}	603075	AD	3	Cfhr2
1q31.3	1:196819731-196832189	CFHR1, FHR1, HFL1, CFHL1	Complement factor H-related 1	134371	CFHR1	3078	ENSG00000244414,ENST00000320493;;;ENST00000320493		{Hemolytic uremic syndrome, atypical, susceptibility to}	235400	AD, AR	3	Cfhr1
1q31.3	1:196819731-196832189	CFHR1, FHR1, HFL1, CFHL1	Complement factor H-related 1	134371	CFHR1	3078	ENSG00000244414,ENST00000320493;;;ENST00000320493		{Macular degeneration, age-related, reduced risk of}	603075	AD	3	Cfhr1
1q31.3	1:196975034-197009678	CFHR5, CFHL5, FHR5, CFHR5D	Complement factor H-related 5	608593	CFHR5	81494	ENSG00000134389,ENST00000256785;;;ENST00000256785		Nephropathy due to CFHR5 deficiency	614809	AD	3	
1q31.3	1:197038741-197067260	F13B	Coagulation factor XIII, B polypeptide	134580	F13B	2165	ENSG00000143278,ENST00000367412;;;ENST00000367412		Factor XIIIB deficiency	613235	AR	3	F13b
1q31.3	1:197084127-197146669	ASPM, MCPH5	Abnormal spindle-like, microcephaly-associated	605481	ASPM	259266	ENSG00000066279,ENST00000367409;;;ENST00000367409		Microcephaly 5, primary, autosomal recessive	608716	AR	3	Aspm
1q31.3	1:197201504-197478455	CRB1, RP12, LCA8	Crumbs cell polarity complex component 1	604210	CRB1	23418	ENSG00000134376,ENST00000367400;;;ENST00000367400		Leber congenital amaurosis 8	613835	AR	3	Crb1
1q31.3	1:197201504-197478455	CRB1, RP12, LCA8	Crumbs cell polarity complex component 1	604210	CRB1	23418	ENSG00000134376,ENST00000367400;;;ENST00000367400		Pigmented paravenous chorioretinal atrophy	172870	AD	3	Crb1
1q31.3	1:197201504-197478455	CRB1, RP12, LCA8	Crumbs cell polarity complex component 1	604210	CRB1	23418	ENSG00000134376,ENST00000367400;;;ENST00000367400		Retinitis pigmentosa-12	600105	AR	3	Crb1
1q31.3-q32.1	1:198638713-198757476	PTPRC, CD45, LCA, IMD105	Protein tyrosine phosphatase, receptor type, c polypeptide	151460	PTPRC	5788	ENSG00000081237,ENST00000442510;;;ENST00000442510		Immunodeficiency 105, severe combined	619924	AR	3	Ptprc
1q32	1:198700001-214400000	GFND1	Glomerulopathy with fibronectin deposits 1	137950		100689213		max lod at D1S2782	Glomerulopathy with fibronectin deposits 1	137950	AD	2	
1q32.1	1:198700001-207100000	IBD23	Inflammatory bowel disease 23	612381		100240733		associated with rs3024505	{Inflammatory bowel disease 23}	612381		2	
1q32	1:198700001-214400000	NYS7	Nystagmus 7, congenital, autosomal dominant	614826				disruption of TADs on 1q32	Nystagmus 7, congenital, autosomal dominant	614826	AD	4	
1q32	1:198700001-214400000	PARK16	Parkinson disease 16	613164		100359403		associated with rs823128	{Parkinson disease 16}	613164		2	
1q32	1:198700001-214400000	PFHB2	Progressive familial heart block, type II	140400		105463127		between D1S70 and D1S505	Progressive familial heart block, type II	140400	AD	2	
1q32.1	1:200551497-200620751	KIF14, KIAA0042, MKS12, MCPH20	Kinesin family member 14	611279	KIF14	9928	ENSG00000118193,ENST00000367350;;;ENST00000367350	mutation identified in 1 MKS12 family	?Meckel syndrome 12	616258	AR	3	Kif14
1q32.1	1:200551497-200620751	KIF14, KIAA0042, MKS12, MCPH20	Kinesin family member 14	611279	KIF14	9928	ENSG00000118193,ENST00000367350;;;ENST00000367350	mutation identified in 1 MKS12 family	Microcephaly 20, primary, autosomal recessive	617914	AR	3	Kif14
1q32.1	1:200640805-200669907	DDX59, OFD5	DEAD-box helicase 59	615464	DDX59	83479	ENSG00000118197,ENST00000331314;;;ENST00000331314		Orofaciodigital syndrome V	174300	AR	3	Ddx59
1q32.1	1:200891531-200915742	INAVA, C1orf106, IBD29	Innate immunity activator	618051	INAVA	55765	ENSG00000163362,ENST00000413687;;;ENST00000413687		{Inflammatory bowel disease 29}	618077	AD	3	Inava
1q32.1	1:201039512-201112426	CACNA1S, CACNL1A3, CCHL1A3, TTPP1, HOKPP1, MHS5, CMYO18	Calcium channel, voltage-dependent, L type, alpha 1S subunit	114208	CACNA1S	779	ENSG00000081248,ENST00000362061;;;ENST00000362061		{Malignant hyperthermia susceptibility 5}	601887	AD	3	Cacna1s
1q32.1	1:201039512-201112426	CACNA1S, CACNL1A3, CCHL1A3, TTPP1, HOKPP1, MHS5, CMYO18	Calcium channel, voltage-dependent, L type, alpha 1S subunit	114208	CACNA1S	779	ENSG00000081248,ENST00000362061;;;ENST00000362061		{Thyrotoxic periodic paralysis, susceptibility to, 1}	188580	AD	3	Cacna1s
1q32.1	1:201039512-201112426	CACNA1S, CACNL1A3, CCHL1A3, TTPP1, HOKPP1, MHS5, CMYO18	Calcium channel, voltage-dependent, L type, alpha 1S subunit	114208	CACNA1S	779	ENSG00000081248,ENST00000362061;;;ENST00000362061		Congenital myopathy 18 due to dihydropyridine receptor defect	620246	AD, AR	3	Cacna1s
1q32.1	1:201039512-201112426	CACNA1S, CACNL1A3, CCHL1A3, TTPP1, HOKPP1, MHS5, CMYO18	Calcium channel, voltage-dependent, L type, alpha 1S subunit	114208	CACNA1S	779	ENSG00000081248,ENST00000362061;;;ENST00000362061		Hypokalemic periodic paralysis, type 1	170400	AD	3	Cacna1s
1q32.1	1:201283506-201332989	PKP1, EDSFS	Plakophilin-1	601975	PKP1	5317	ENSG00000081277,ENST00000367324;;;ENST00000367324		Ectodermal dysplasia/skin fragility syndrome	604536	AR	3	Pkp1
1q32.1	1:201359014-201377680	TNNT2, CMH2, CMD1D, RCM3, LVNC6	Troponin-T2, cardiac	191045	TNNT2	7139	ENSG00000118194,ENST00000656932;;;ENST00000656932		Cardiomyopathy, dilated, 1D	601494	AD	3	Tnnt2
1q32.1	1:201359014-201377680	TNNT2, CMH2, CMD1D, RCM3, LVNC6	Troponin-T2, cardiac	191045	TNNT2	7139	ENSG00000118194,ENST00000656932;;;ENST00000656932		Cardiomyopathy, familial restrictive, 3	612422	AD	3	Tnnt2
1q32.1	1:201359014-201377680	TNNT2, CMH2, CMD1D, RCM3, LVNC6	Troponin-T2, cardiac	191045	TNNT2	7139	ENSG00000118194,ENST00000656932;;;ENST00000656932		Cardiomyopathy, hypertrophic, 2	115195	AD	3	Tnnt2
1q32.1	1:201359014-201377680	TNNT2, CMH2, CMD1D, RCM3, LVNC6	Troponin-T2, cardiac	191045	TNNT2	7139	ENSG00000118194,ENST00000656932;;;ENST00000656932		Left ventricular noncompaction 6	601494	AD	3	Tnnt2
1q32.1	1:201896456-201946548	LMOD1, SMLMOD, 1D, MMIHS3	Leiomodin 1	602715	LMOD1	25802	ENSG00000163431,ENST00000367288;;;ENST00000367288	mutation identified in 1 MMIHD3 patient	?Megacystis-microcolon-intestinal hypoperistalsis syndrome 3	619362	AR	3	Lmod1
1q32.1	1:202331657-202341936	UBE2T, HSPC150, FANCT	Ubiquitin-conjugating enzyme E2 T	610538	UBE2T	29089	ENSG00000077152,ENST00000646651;;;ENST00000646651		Fanconi anemia, complementation group T	616435	AR	3	Ube2t
1q32.1	1:202590596-202710454	SYT2, CMS7A, MYSPC, CMS7B	Synaptotagmin-2	600104	SYT2	127833	ENSG00000143858,ENST00000367268;;;ENST00000367268		Myasthenic syndrome, congenital, 7A, presynaptic, and distal motor neuropathy, autosomal dominant	616040	AD	3	Syt2
1q32.1	1:202590596-202710454	SYT2, CMS7A, MYSPC, CMS7B	Synaptotagmin-2	600104	SYT2	127833	ENSG00000143858,ENST00000367268;;;ENST00000367268		Myasthenic syndrome, congenital, 7B, presynaptic, autosomal recessive	619461	AR	3	Syt2
1q32.1	1:202724495-202808421	KDM5B, JARID1B, PUT1, PLU1, RBBP2H1A, MRT65	Lysine-specific demethylase 5B	605393	KDM5B	10765	ENSG00000117139,ENST00000367265;;;ENST00000367265		Intellectual developmental disorder, autosomal recessive 65	618109	AR	3	Kdm5b
1q32.1	1:203178931-203186704	CHI3L1, GP39, YKL40, ASRT7	Chitinase 3-like 1 (cartilage glycoprotein-39)	601525	CHI3L1	1116	ENSG00000133048,ENST00000255409;;;ENST00000255409		{Asthma-related traits, susceptibility to, 7}	611960		3	Chi3l1
1q32.1	1:203178931-203186704	CHI3L1, GP39, YKL40, ASRT7	Chitinase 3-like 1 (cartilage glycoprotein-39)	601525	CHI3L1	1116	ENSG00000133048,ENST00000255409;;;ENST00000255409		{Schizophrenia, susceptibility to}	181500	AD	3	Chi3l1
1q32.1	1:203216079-203230099	CHIT1, CHIT, CHITD	Chitinase 1	600031	CHIT1	1118	ENSG00000133063,ENST00000367229;;;ENST00000367229		[Chitotriosidase deficiency]	614122	AR	3	Chit1
1q32.1	1:203861599-203871152	SNRPE, HYPT11	Small nuclear ribonucleoprotein polypeptide E	128260	SNRPE	6635	ENSG00000182004,ENST00000414487;;;ENST00000414487		Hypotrichosis 11	615059	AD	3	Snrpe
1q32.1	1:204154819-204166337	REN, RTD, ADTKD4	Renin	179820	REN	5972	ENSG00000143839,ENST00000272190;;;ENST00000272190	~24cM distal to AT3	[Hyperproreninemia]			3	Ren1,Ren2
1q32.1	1:204154819-204166337	REN, RTD, ADTKD4	Renin	179820	REN	5972	ENSG00000143839,ENST00000272190;;;ENST00000272190	~24cM distal to AT3	Renal tubular dysgenesis	267430	AR	3	Ren1,Ren2
1q32.1	1:204154819-204166337	REN, RTD, ADTKD4	Renin	179820	REN	5972	ENSG00000143839,ENST00000272190;;;ENST00000272190	~24cM distal to AT3	Tubulointerstitial kidney disease, autosomal dominant, 4	613092	AD	3	Ren1,Ren2
1q32.1	1:204190341-204196491	KISS1, HH13	KISS1 metastasis suppressor	603286	KISS1	3814	ENSG00000170498,ENST00000367194;;;ENST00000367194	mutation identified in 1 HH13 family	?Hypogonadotropic hypogonadism 13 with or without anosmia	614842	AR	3	Kiss1
1q32.1	1:204395826-204411817	PPP1R15B, CREP, MSSGM2	Protein phosphatase 1, regulatory subunit 15B	613257	PPP1R15B	84919	ENSG00000158615,ENST00000367188;;;ENST00000367188		Microcephaly, short stature, and impaired glucose metabolism 2	616817	AR	3	Ppp1r15b
1q32.1	1:204516406-204558120	MDM4, BMFS6	MDM4 regulator of p53	602704	MDM4	4194	ENSG00000198625,ENST00000367182;;;ENST00000367182	mutation identified in 1 BMFS6 family	?Bone marrow failure syndrome 6	618849	AD	3	Mdm4
1q32.1	1:204828652-205022822	NFASC, KIAA0756, NEDCPMD	Neurofascin	609145	NFASC	23114	ENSG00000163531,ENST00000339876;;;ENST00000339876		Neurodevelopmental disorder with central and peripheral motor dysfunction	618356	AR	3	Nfasc
1q32.1	1:205042949-205078289	CNTN2, TAX, TAX1, EPEO5	Contactin 2 (transiently-expressed axonal glycoprotein)	190197	CNTN2	6900	ENSG00000184144,ENST00000331830;;;ENST00000331830	1 family identified with mutation	Epilepsy, early-onset, 5, with or without developmental delay	615400	AR	3	Cntn2
1q32.1	1:205142505-205211702	DSTYK, KIAA0472, RIP5, DUSTYPK, CAKUT1, SPG23	Dual serine/threonine and tyrosine protein kinase	612666	DSTYK	25778	ENSG00000133059,ENST00000367162;;;ENST00000367162		Congenital anomalies of kidney and urinary tract 1	610805	AD	3	Dstyk
1q32.1	1:205142505-205211702	DSTYK, KIAA0472, RIP5, DUSTYPK, CAKUT1, SPG23	Dual serine/threonine and tyrosine protein kinase	612666	DSTYK	25778	ENSG00000133059,ENST00000367162;;;ENST00000367162		Spastic paraplegia 23, autosomal recessive	270750	AR	3	Dstyk
1q32.1	1:205302063-205321745	NUAK2, SNARK, ANPH2	NUAK family, SNF1-like kinase, 2	608131	NUAK2	81788	ENSG00000163545,ENST00000367157;;;ENST00000367157	mutation identified in 1 ANPH2 family	?Anencephaly 2	619452	AR	3	Nuak2
1q32.1	1:205789095-205813198	SLC41A1, NPHPL2	Solute carrier family 41, member 1	610801	SLC41A1	254428	ENSG00000133065,ENST00000367137;;;ENST00000367137	mutation identified in 1 NPHPL2 family	?Nephronophthisis-like nephropathy 2	619468	AR	3	Slc41a1
1q32.1	1:206767602-206772494	IL10, CSIF, GVHDS	Interleukin-10	124092	IL10	3586	ENSG00000136634,ENST00000423557;;;ENST00000423557		{Graft-versus-host disease, protection against}	614395		3	Il10
1q32.1	1:206767602-206772494	IL10, CSIF, GVHDS	Interleukin-10	124092	IL10	3586	ENSG00000136634,ENST00000423557;;;ENST00000423557		{HIV-1, susceptibility to}	609423		3	Il10
1q32.1	1:206767602-206772494	IL10, CSIF, GVHDS	Interleukin-10	124092	IL10	3586	ENSG00000136634,ENST00000423557;;;ENST00000423557		{Rheumatoid arthritis, progression of}	180300		3	Il10
1q32.2	1:207321678-207360966	CD55, DAF, CROM, CHAPLE	CD55 antigen (blood group Cromer)	125240	CD55	1604	ENSG00000196352,ENST00000367064;;;ENST00000367064		[Blood group Cromer]	613793	AR	3	Cd55,Cd55b
1q32.2	1:207321678-207360966	CD55, DAF, CROM, CHAPLE	CD55 antigen (blood group Cromer)	125240	CD55	1604	ENSG00000196352,ENST00000367064;;;ENST00000367064		Complement hyperactivation, angiopathic thrombosis, and protein-losing enteropathy	226300	AR	3	Cd55,Cd55b
1q32.2	1:207454328-207489892	CR2, C3DR, SLEB9, CVID7	Complement component (3d/Epstein-Barr virus) receptor-2	120650	CR2	1380	ENSG00000117322,ENST00000367057;;;ENST00000367057	mutation identified in CVID7 patient	?Immunodeficiency, common variable, 7	614699	AR	3	Cr2
1q32.2	1:207454328-207489892	CR2, C3DR, SLEB9, CVID7	Complement component (3d/Epstein-Barr virus) receptor-2	120650	CR2	1380	ENSG00000117322,ENST00000367057;;;ENST00000367057	mutation identified in CVID7 patient	{Systemic lupus erythematosus, susceptibility to, 9}	610927	AD	3	Cr2
1q32.2	1:207496157-207641765	CR1, C3BR	Complement component (3b/4b) receptor-1	120620	CR1	1378	ENSG00000203710,ENST00000367049;;;ENST00000367049		[Blood group, Knops system]	607486		3	Cr1l
1q32.2	1:207496157-207641765	CR1, C3BR	Complement component (3b/4b) receptor-1	120620	CR1	1378	ENSG00000203710,ENST00000367049;;;ENST00000367049		{Malaria, severe, resistance to}	611162		3	Cr1l
1q32.2	1:207752038-207795516	MCP, CD46, AHUS2	Membrane cofactor protein (CD46, trophoblast-lymphocyte cross-reactive antigen)	120920	CD46	4179	ENSG00000117335,ENST00000367042;;;ENST00000367042		{Hemolytic uremic syndrome, atypical, susceptibility to, 2}	612922	AD, AR	3	Cd46
1q32.2	1:209614870-209652425	LAMB3, AI1A, JEB1B, JEB1A	Laminin, beta-3 (nicein, 125kD; kalinin, 140kD; BM600, 125kD)	150310	LAMB3	3914	ENSG00000196878,ENST00000356082;;;ENST00000356082		Amelogenesis imperfecta, type IA	104530	AD	3	Lamb3
1q32.2	1:209614870-209652425	LAMB3, AI1A, JEB1B, JEB1A	Laminin, beta-3 (nicein, 125kD; kalinin, 140kD; BM600, 125kD)	150310	LAMB3	3914	ENSG00000196878,ENST00000356082;;;ENST00000356082		Epidermolysis bullosa, junctional 1A, intermediate	226650	AR	3	Lamb3
1q32.2	1:209614870-209652425	LAMB3, AI1A, JEB1B, JEB1A	Laminin, beta-3 (nicein, 125kD; kalinin, 140kD; BM600, 125kD)	150310	LAMB3	3914	ENSG00000196878,ENST00000356082;;;ENST00000356082		Epidermolysis bullosa, junctional 1B, severe	226700	AR	3	Lamb3
1q32.2	1:209686179-209734929	HSD11B1, HSD11, HSD11L, CORTRD2	Hydroxysteroid, 11-beta, dehydrogenase 1	600713	HSD11B1	3290	ENSG00000117594,ENST00000367027;;;ENST00000367027	digenic triallelic mutations with H6PD	Cortisone reductase deficiency 2	614662	AD	3	Hsd11b1
1q32.2	1:209785617-209806142	IRF6, VWS1, LPS, PIT, PPS1, OFC6	Interferon regulatory factor 6	607199	IRF6	3664	ENSG00000117595,ENST00000367021;;;ENST00000367021	OFC6 in enhancer 5' of IRF6	{Orofacial cleft 6}	608864	AD	3	Irf6
1q32.2	1:209785617-209806142	IRF6, VWS1, LPS, PIT, PPS1, OFC6	Interferon regulatory factor 6	607199	IRF6	3664	ENSG00000117595,ENST00000367021;;;ENST00000367021	OFC6 in enhancer 5' of IRF6	Popliteal pterygium syndrome 1	119500	AD	3	Irf6
1q32.2	1:209785617-209806142	IRF6, VWS1, LPS, PIT, PPS1, OFC6	Interferon regulatory factor 6	607199	IRF6	3664	ENSG00000117595,ENST00000367021;;;ENST00000367021	OFC6 in enhancer 5' of IRF6	van der Woude syndrome 1	119300	AD	3	Irf6
1q32.2	1:209938217-210171389	SYT14, SCAR11	Synaptotagmin 14	610949	SYT14	255928	ENSG00000143469,ENST00000367019;;;ENST00000367019	mutation identified in 1 SCAR11 family	?Spinocerebellar ataxia, autosomal recessive 11	614229	AR	3	Syt14
1q32.2	1:210327328-210676290	HHAT, MART2, SKI1, NNMS	Hedgehog acyltransferase	605743	HHAT	55733	ENSG00000054392,ENST00000261458;;;ENST00000261458		Nivelon-Nivelon-Mabille syndrome	600092	AR	3	Hhat
1q32.2	1:210678314-211134148	KCNH1, EAG, TMBTS, ZLS1	Potassium voltage-gated channel, subfamily H, member 1 (ether-a-go-go, drosophila, homolog of)	603305	KCNH1	3756	ENSG00000143473,ENST00000271751;;;ENST00000271751		Temple-Baraitser syndrome	611816	AD	3	Kcnh1
1q32.2	1:210678314-211134148	KCNH1, EAG, TMBTS, ZLS1	Potassium voltage-gated channel, subfamily H, member 1 (ether-a-go-go, drosophila, homolog of)	603305	KCNH1	3756	ENSG00000143473,ENST00000271751;;;ENST00000271751		Zimmermann-Laband syndrome 1	135500	AD	3	Kcnh1
1q32.3	1:211476522-211492162	RD3, LCA12, C1orf36	RD3 regulator of GUCY2D	180040	RD3	343035	ENSG00000198570,ENST00000680073;;;ENST00000680073		Leber congenital amaurosis 12	610612	AR	3	Rd3
1q32.3	1:211658256-211675621	NEK2, RP67	NIMA-related kinase 2	604043	NEK2	4751	ENSG00000117650,ENST00000366999;;;ENST00000366999	pseudogenes on chr. 2, 14, and 22; mutation identified in 1 family	?Retinitis pigmentosa 67	615565	AR	3	Nek2
1q32.3	1:212858275-212899363	FLVCR1, AXPC1, PCARP, NEDMISH, RETSNS	FLVCR heme transporter 1	609144	FLVCR1	28982	ENSG00000162769,ENST00000366971;;;ENST00000366971		Neurodevelopmental disorder with microcephaly, absent speech, and hypotonia	621060	AR	3	Flvcr1
1q32.3	1:212858275-212899363	FLVCR1, AXPC1, PCARP, NEDMISH, RETSNS	FLVCR heme transporter 1	609144	FLVCR1	28982	ENSG00000162769,ENST00000366971;;;ENST00000366971		Retinopathy-sensory neuropathy syndrome	609033	AR	3	Flvcr1
1q32.3-q41	1:214348700-214551602	PTPN14, PEZ, CATLPH	Protein tyrosine phosphatase, nonreceptor-type, 14	603155	PTPN14	5784	ENSG00000152104,ENST00000366956;;;ENST00000366956		Choanal atresia and lymphedema	613611	AR	3	Ptpn14
1q41-q42	1:214400001-236400000	AUTS11	Autism, susceptibility to, 11	610836		100188820		associated with rs12740310, rs3737296, and rs12310279	{Autism susceptibility 11}	610836		2	
1q41-q42	1:214400001-236400000	DEL1q41q42, C1DELq41q42	Chromosome 1q41-q42 deletion syndrome	612530				contiguous gene deletion of 1.7Mb	Chromosome 1q41-q42 deletion syndrome	612530	IC	4	
1q41-q44	1:214400001-248956422	OTSC10	Otosclerosis 10	615589		102723100			Otosclerosis 10	615589	AD	2	
1q41	1:214400001-223900000	RMD1	Rippling muscle disease 1	600332		6022			Rippling muscle disease-1	600332	AD	2	
1q41	1:214603195-214664571	CENPF, CILD31, STROMS	Centromere autoantigen F, 400kD	600236	CENPF	1063	ENSG00000117724,ENST00000366955;;;ENST00000366955		Stromme syndrome	243605	AR	3	Cenpf
1q41	1:215622891-216423448	USH2A, RP39	Usherin	608400	USH2A	7399	ENSG00000042781,ENST00000307340;;;ENST00000307340		Retinitis pigmentosa 39	613809	AR	3	Ush2a
1q41	1:215622891-216423448	USH2A, RP39	Usherin	608400	USH2A	7399	ENSG00000042781,ENST00000307340;;;ENST00000307340		Usher syndrome, type 2A	276901	AR	3	Ush2a
1q41	1:218345336-218444619	TGFB2, LDS4, CAEND2	Transforming growth factor, beta-2	190220	TGFB2	7042	ENSG00000092969,ENST00000366930;;;ENST00000366930		Camurati-Engelmann disease 2	606631	AD	3	Tgfb2
1q41	1:218345336-218444619	TGFB2, LDS4, CAEND2	Transforming growth factor, beta-2	190220	TGFB2	7042	ENSG00000092969,ENST00000366930;;;ENST00000366930		Loeys-Dietz syndrome 4	614816	AD	3	Tgfb2
1q41	1:219910445-219959098	SLC30A10, ZNT10, HMNDYT1	Solute carrier family 30 (zinc transporter), member 10	611146	SLC30A10	55532	ENSG00000196660,ENST00000366926;;;ENST00000366926		Hypermanganesemia with dystonia 1	613280	AR	3	Slc30a10
1q41	1:219968600-220046505	EPRS1, PARS, HLD15	Glutamyl-prolyl-tRNA synthetase 1	138295	EPRS1	2058	ENSG00000136628,ENST00000366923;;;ENST00000366923		Leukodystrophy, hypomyelinating, 15	617951	AR	3	Eprs1
1q41	1:220094132-220148041	IARS2, CAGSSS	Isoleucyl-tRNA synthetase 2	612801	IARS2	55699	ENSG00000067704,ENST00000366922;;;ENST00000366922		Cataracts, growth hormone deficiency, sensory neuropathy, sensorineural hearing loss, and skeletal dysplasia	616007	AR	3	Iars2
1q41	1:220148293-220272453	RAB3GAP2, RAB3GAP150, p150, KIAA0839, WARBM2, MARTS1	RAB3 GTPase-activating protein (noncatalytic) subunit 2	609275	RAB3GAP2	25782	ENSG00000118873,ENST00000358951;;;ENST00000358951		Martsolf syndrome 1	212720	AR	3	Rab3gap2
1q41	1:220148293-220272453	RAB3GAP2, RAB3GAP150, p150, KIAA0839, WARBM2, MARTS1	RAB3 GTPase-activating protein (noncatalytic) subunit 2	609275	RAB3GAP2	25782	ENSG00000118873,ENST00000358951;;;ENST00000358951		Warburg micro syndrome 2	614225	AR	3	Rab3gap2
1q41	1:222618097-222668007	MIA3, TANGO1, TANGO, KIAA0268, ODCD2	MIA SH3 domain ER export factor 3	613455	MIA3	375056	ENSG00000154305,ENST00000344922;;;ENST00000344922	mutation identified in 1 ODCD2 family	?Ondontochondrodysplasia 2 with hearing loss and diabetes	619269	AR	3	Mia3
1q41	1:222815039-223005995	DISP1, DISPA, HPE10	Dispatched RND transporter family, member 1	607502	DISP1	84976	ENSG00000154309,ENST00000675850;;;ENST00000675850		Holoprosencephaly 10	621143	AD, AR	3	Disp1
1q41	1:223109404-223143248	TLR5, TIL3, SLEB1, MELIOS	Toll-like receptor-5	603031	TLR5	7100	ENSG00000187554,ENST00000642603;;;ENST00000642603		{Legionnaire disease, susceptibility to}	608556		3	Tlr5
1q41	1:223109404-223143248	TLR5, TIL3, SLEB1, MELIOS	Toll-like receptor-5	603031	TLR5	7100	ENSG00000187554,ENST00000642603;;;ENST00000642603		{Melioidosis, susceptibility to}	615557	AD	3	Tlr5
1q41	1:223109404-223143248	TLR5, TIL3, SLEB1, MELIOS	Toll-like receptor-5	603031	TLR5	7100	ENSG00000187554,ENST00000642603;;;ENST00000642603		{Systemic lupus erythematosus, resistance to}	601744	AD	3	Tlr5
1q41	1:223109404-223143248	TLR5, TIL3, SLEB1, MELIOS	Toll-like receptor-5	603031	TLR5	7100	ENSG00000187554,ENST00000642603;;;ENST00000642603		{Systemic lupus erythematosus, susceptibility to, 1}	601744	AD	3	Tlr5
1q42	1:223900001-236400000	BCC2	Basal cell carcinoma, susceptibility to, 2	613058		100307119		associated with rs801114	{Basal cell carcinoma, susceptibility to, 2}	613058		2	
1q42	1:223900001-236400000	EA3	Episodic ataxia, type 3	606554		780905		max lod at D1S235	Episodic ataxia, type 3	606554	AD	2	
1q42	1:223900001-236400000	MDC1B	Muscular dystrophy, congenital, 1B	604801		53368			Muscular dystrophy, congenital, 1B	604801	AR	2	
1q42.11	1:224114111-224162047	FBXO28, FBX28, KIAA0483, DEE100	F-box protein 28	609100	FBXO28	23219	ENSG00000143756,ENST00000366862;;;ENST00000366862		Developmental and epileptic encephalopathy 100	619777	AD	3	Fbxo28
1q42.11	1:224183240-224193441	DEGS1, DES1, MLD, HLD18	Delta(4)-desaturase, sphingolipid, 1	615843	DEGS1	8560	ENSG00000143753,ENST00000323699;;;ENST00000323699		Leukodystrophy, hypomyelinating, 18	618404	AR	3	Degs1,Degs1l
1q42.11-q42.12	1:224385146-224434797	WDR26, SKDEAS	WD repeat-containing protein 26	617424	WDR26	80232	ENSG00000162923,ENST00000414423;;;ENST00000414423		Skraban-Deardorff syndrome	617616	AD	3	Wdr26
1q42.12	1:225401502-225428821	LBR, PHA, PHASK	Lamin B receptor	600024	LBR	3930	ENSG00000143815,ENST00000272163;;;ENST00000272163		?Reynolds syndrome	613471	AD	3	Lbr
1q42.12	1:225401502-225428821	LBR, PHA, PHASK	Lamin B receptor	600024	LBR	3930	ENSG00000143815,ENST00000272163;;;ENST00000272163		Greenberg skeletal dysplasia	215140	AR	3	Lbr
1q42.12	1:225401502-225428821	LBR, PHA, PHASK	Lamin B receptor	600024	LBR	3930	ENSG00000143815,ENST00000272163;;;ENST00000272163		Pelger-Huet anomaly	169400	AD	3	Lbr
1q42.12	1:225401502-225428821	LBR, PHA, PHASK	Lamin B receptor	600024	LBR	3930	ENSG00000143815,ENST00000272163;;;ENST00000272163		Rhizomelic skeletal dysplasia with or without Pelger-Huet anomaly	618019	AR	3	Lbr
1q42.12	1:225840556-225882380	TMEM63A, KIAA0792, HLD19	Transmembrane protein 63A	618685	TMEM63A	9725	ENSG00000196187,ENST00000366835;;;ENST00000366835		Leukodystrophy, hypomyelinating, 19, transient infantile	618688	AD	3	Tmem63a
1q42.12	1:225919878-225924250	PYCR2, HLD10	Pyrroline-5-carboxylate reductase 2	616406	PYCR2	29920	ENSG00000143811,ENST00000343818;;;ENST00000343818		Leukodystrophy, hypomyelinating, 10	616420	AR	3	Pycr2
1q42.12	1:226061831-226072019	H3-3A, H3F3A, H3F3, BRYLIB1	H3.3 histone A	601128	H3-3A	3020	ENSG00000163041,ENST00000366815;;;ENST00000366815		Bryant-Li-Bhoj neurodevelopmental syndrome 1	619720	AD	3	H3f3a
1q42.13	1:226870616-226903668	PSEN2, AD4, STM2, CMD1V	Presenilin 2	600759	PSEN2	5664	ENSG00000143801,ENST00000366783;;;ENST00000366783		Alzheimer disease-4	606889	AD	3	Psen2
1q42.13	1:226870616-226903668	PSEN2, AD4, STM2, CMD1V	Presenilin 2	600759	PSEN2	5664	ENSG00000143801,ENST00000366783;;;ENST00000366783		Cardiomyopathy, dilated, 1V	613697	AD	3	Psen2
1q42.13	1:226940294-226987544	COQ8A, ADCK3, CABC1, SCAR9, ARCA2, COQ10D4	Coenzyme Q8A	606980	COQ8A	56997	ENSG00000163050,ENST00000366777;;;ENST00000366777		Coenzyme Q10 deficiency, primary, 4	612016	AR	3	Coq8a
1q42.13	1:228082708-228099212	ARF1, PVNH8	ADP-ribosylation factor-1	103180	ARF1	375	ENSG00000143761,ENST00000272102;;;ENST00000272102		Periventricular nodular heterotopia 8	618185	AD	3	Arf1
1q42.13	1:228140084-228148955	GUK1, MTDPS21	Guanylate kinase-1	139270	GUK1	2987	ENSG00000143774,ENST00000453943;;;ENST00000453943		Mitochondrial DNA depletion syndrome 21	621071	AR	3	Guk1
1q42.13	1:228149930-228159826	GJC2, GJA12, CX47, PMLDAR, HLD2, SPG44, LMPHM3	Gap junction protein, gamma-2 (47kD)	608803	GJC2	57165	ENSG00000198835,ENST00000366714;;;ENST00000366714	mutation identified in 1 SPG44 family	?Spastic paraplegia 44, autosomal recessive	613206	AR	3	Gjc2
1q42.13	1:228149930-228159826	GJC2, GJA12, CX47, PMLDAR, HLD2, SPG44, LMPHM3	Gap junction protein, gamma-2 (47kD)	608803	GJC2	57165	ENSG00000198835,ENST00000366714;;;ENST00000366714	mutation identified in 1 SPG44 family	Leukodystrophy, hypomyelinating, 2	608804	AR	3	Gjc2
1q42.13	1:228149930-228159826	GJC2, GJA12, CX47, PMLDAR, HLD2, SPG44, LMPHM3	Gap junction protein, gamma-2 (47kD)	608803	GJC2	57165	ENSG00000198835,ENST00000366714;;;ENST00000366714	mutation identified in 1 SPG44 family	Lymphatic malformation 3	613480	AD	3	Gjc2
1q42.13	1:228165804-228182257	IBA57, C1orf69, MMDS3, SPG74	Iron-sulfur cluster assembly factor IBA57	615316	IBA57	200205	ENSG00000181873,ENST00000366711;;;ENST00000366711		?Spastic paraplegia 74, autosomal recessive	616451	AR	3	Iba57
1q42.13	1:228165804-228182257	IBA57, C1orf69, MMDS3, SPG74	Iron-sulfur cluster assembly factor IBA57	615316	IBA57	200205	ENSG00000181873,ENST00000366711;;;ENST00000366711		Multiple mitochondrial dysfunctions syndrome 3	615330	AR	3	Iba57
1q42.13	1:228208044-228378876	OBSCN, KIAA1556, KIAA1639, RHABDO1	Obscurin	608616	OBSCN	84033	ENSG00000154358,ENST00000680850;;;ENST00000680850		{Rhabdomyolysis, susceptibility to, 1}	620235	AR	3	Obscn
1q42.13	1:229431245-229434094	ACTA1, ASMA, NEM3, CMYO2A, CMYO2B, SHPM, CMYO2C	Actin, alpha-1, skeletal muscle	102610	ACTA1	58	ENSG00000143632,ENST00000366684;;;ENST00000366684	mutation identified in 1 SHPM family	?Myopathy, scapulohumeroperoneal	616852	AD	3	Acta1
1q42.13	1:229431245-229434094	ACTA1, ASMA, NEM3, CMYO2A, CMYO2B, SHPM, CMYO2C	Actin, alpha-1, skeletal muscle	102610	ACTA1	58	ENSG00000143632,ENST00000366684;;;ENST00000366684	mutation identified in 1 SHPM family	Congenital myopathy 2A, typical, autosomal dominant	161800	AD	3	Acta1
1q42.13	1:229431245-229434094	ACTA1, ASMA, NEM3, CMYO2A, CMYO2B, SHPM, CMYO2C	Actin, alpha-1, skeletal muscle	102610	ACTA1	58	ENSG00000143632,ENST00000366684;;;ENST00000366684	mutation identified in 1 SHPM family	Congenital myopathy 2B, severe infantile, autosomal recessive	620265	AR	3	Acta1
1q42.13	1:229431245-229434094	ACTA1, ASMA, NEM3, CMYO2A, CMYO2B, SHPM, CMYO2C	Actin, alpha-1, skeletal muscle	102610	ACTA1	58	ENSG00000143632,ENST00000366684;;;ENST00000366684	mutation identified in 1 SHPM family	Congenital myopathy 2C, severe infantile, autosomal dominant	620278	AD	3	Acta1
1q42.13	1:229440259-229508341	NUP133, NPHS18, GAMOS8	Nucleoporin, 133kD	607613	NUP133	55746	ENSG00000069248,ENST00000261396;;;ENST00000261396	mutation identified in 1 GAMOS8 family	?Galloway-Mowat syndrome 8	618349	AR	3	Nup133
1q42.13	1:229440259-229508341	NUP133, NPHS18, GAMOS8	Nucleoporin, 133kD	607613	NUP133	55746	ENSG00000069248,ENST00000261396;;;ENST00000261396	mutation identified in 1 GAMOS8 family	Nephrotic syndrome, type 18	618177	AR	3	Nup133
1q42.13	1:230057789-230282122	GALNT2, CDG2T	UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 2	602274	GALNT2	2590	ENSG00000143641,ENST00000366672;;;ENST00000366672		Congenital disorder of glycosylation, type IIt	618885	AR	3	Galnt2
1q42.2-q43	1:230500001-243500000	PCAP	Predisposing for prostate cancer	602759		7834			{Prostate cancer, susceptibility to}	602759		2	
1q42.2-q43	1:230500001-243500000	SHFL1, SHFLD	Split-hand/foot malformation with long bone deficiency 1	119100		791121		between rs1124110 and rs535043	Split-hand/foot malformation with long bone deficiency 1	119100	AD	2	
1q42.2	1:230642481-230693982	COG2, LDLC, CDG2Q	Component of oligomeric golgi complex 2	606974	COG2	22796	ENSG00000135775,ENST00000366669;;;ENST00000366669	mutation identified in 1 CDG2Q patient	?Congenital disorder of glycosylation, type IIq	617395	AR	3	Cog2
1q42.2	1:230702523-230745583	AGT, SERPINA8	Angiotensinogen	106150	AGT	183	ENSG00000135744,ENST00000366667;;;ENST00000366667		Renal tubular dysgenesis	267430	AR	3	Agt
1q42.2	1:230979094-231000733	ARV1, DEE38	ARV1 homolog, fatty acid homeostasis modulator	611647	ARV1	64801	ENSG00000173409,ENST00000310256;;;ENST00000310256		Developmental and epileptic encephalopathy 38	617020	AR	3	Arv1
1q42.2	1:231241212-231277973	GNPAT, DHAPAT, RCDP2	Glyceronephosphate O-acyltransferase	602744	GNPAT	8443	ENSG00000116906,ENST00000366647;;;ENST00000366647		Rhizomelic chondrodysplasia punctata, type 2	222765	AR	3	Gnpat
1q42.2	1:231332753-231337852	EXOC8, EXO84, SEC84, NEDMISB	Exocyst complex component 8	615283	EXOC8	149371	ENSG00000116903,ENST00000366645;;;ENST00000366645	mutation identified in 1 NEDMISB family	?Neurodevelopmental disorder with microcephaly, seizures, and brain atrophy	619076	AR	3	Exoc8
1q42.2	1:231338293-231355023	SPRTN, DVC1, C1orf124, RJALS	SprT-like N-terminal domain protein	616086	SPRTN	83932	ENSG00000010072,ENST00000295050;;;ENST00000295050		Ruijs-Aalfs syndrome	616200	AR	3	Sprtn
1q42.2	1:231363756-231422287	EGLN1, PHD2, HIFPH2, C1orf12, ZMYND6, SM20, ECYT3, HALAH	egl-9 family hypoxia inducible factor 1	606425	EGLN1	54583	ENSG00000135766,ENST00000366641;;;ENST00000366641		[Hemoglobin, high altitude adaptation]	609070	AD	3	Egln1
1q42.2	1:231363756-231422287	EGLN1, PHD2, HIFPH2, C1orf12, ZMYND6, SM20, ECYT3, HALAH	egl-9 family hypoxia inducible factor 1	606425	EGLN1	54583	ENSG00000135766,ENST00000366641;;;ENST00000366641		Erythrocytosis, familial, 3	609820	AD	3	Egln1
1q42.2	1:231626790-232041272	DISC1, SCZD9	Disrupted in schizophrenia 1	605210	DISC1	27185	ENSG00000162946,ENST00000439617;;;ENST00000439617		{Schizophrenia 9, susceptibility to}	604906		3	Disc1
1q42.2	1:231814626-231818517	DISC2	Disrupted in schizophrenia 2	606271	DISC2	27184		noncoding antisense RAN	Schizophrenia	181500	AD	2	
1q42.2	1:234373456-234385080	COA6, C1orf31, MC4DN13	Cytochrome c oxidase assembly factor 6	614772	COA6	388753	ENSG00000168275,ENST00000366615;;;ENST00000366615		Mitochondrial complex IV deficiency, nuclear type 13	616501	AR	3	Coa6
1q42.3	1:234604269-234610178	IRF2BP2, CVID14	Interferon regulatory factor 2-binding protein 2	615332	IRF2BP2	359948	ENSG00000168264,ENST00000366609;;;ENST00000366609	mutation identified in 1 CVID14 family	?Immunodeficiency, common variable, 14	617765	AD	3	Irf2bp2
1q42.3	1:235327216-235344532	GGPS1, GGPPS1, MDHLO	Geranylgeranyl diphosphate synthase 1	606982	GGPS1	9453	ENSG00000152904,ENST00000282841;;;ENST00000282841		Muscular dystrophy, congenital hearing loss, and ovarian insufficiency syndrome	619518	AR	3	Ggps1
1q42.3	1:235367427-235452443	TBCE, KCS, KCS1, HRD, PEAMO	Tubulin-specific chaperone E	604934	TBCE	6905	ENSG00000284770,ENST00000642610;;;ENST00000642610		Encephalopathy, progressive, with amyotrophy and optic atrophy	617207	AR	3	Tbce
1q42.3	1:235367427-235452443	TBCE, KCS, KCS1, HRD, PEAMO	Tubulin-specific chaperone E	604934	TBCE	6905	ENSG00000284770,ENST00000642610;;;ENST00000642610		Hypoparathyroidism-retardation-dysmorphism syndrome	241410	AR	3	Tbce
1q42.3	1:235367427-235452443	TBCE, KCS, KCS1, HRD, PEAMO	Tubulin-specific chaperone E	604934	TBCE	6905	ENSG00000284770,ENST00000642610;;;ENST00000642610		Kenny-Caffey syndrome, type 1	244460	AR	3	Tbce
1q42.3	1:235439796-235504452	B3GALNT2, MGC39558, MDDGA11	Beta-1,3-N-acetylgalactosaminyltransferase 2	610194	B3GALNT2	148789	ENSG00000162885,ENST00000366600;;;ENST00000366600		Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 11	615181	AR	3	B3galnt2
1q42.3	1:235661031-235883713	LYST, CHS1	Lysosomal trafficking regulator	606897	LYST	1130	ENSG00000143669,ENST00000389793;;;ENST00000389793		Chediak-Higashi syndrome	214500	AR	3	Lyst
1q42.3-q43	1:236348259-236484930	EDARADD, ED3, EDA3, ECTD11B, ECTD11A	EDAR-associated death domain	606603	EDARADD	128178	ENSG00000186197,ENST00000334232;;;ENST00000334232		Ectodermal dysplasia 11A, hypohidrotic/hair/tooth type, autosomal dominant	614940	AD	3	Edaradd
1q42.3-q43	1:236348259-236484930	EDARADD, ED3, EDA3, ECTD11B, ECTD11A	EDAR-associated death domain	606603	EDARADD	128178	ENSG00000186197,ENST00000334232;;;ENST00000334232		Ectodermal dysplasia 11B, hypohidrotic/hair/tooth type, autosomal recessive	614941	AR	3	Edaradd
1q43-q44	1:236400001-248956422	DFNB45	Deafness, autosomal recessive 45	612433		449483		between D1S547 and D1S2836	Deafness, autosomal recessive 45	612433	AR	2	
1q43	1:236686499-236764631	ACTN2, CMD1AA, CMH23, CMYO8, MPD6	Actinin, alpha-2	102573	ACTN2	88	ENSG00000077522,ENST00000366578;;;ENST00000366578		Cardiomyopathy, dilated, 1AA, with or without LVNC	612158	AD	3	Actn2
1q43	1:236686499-236764631	ACTN2, CMD1AA, CMH23, CMYO8, MPD6	Actinin, alpha-2	102573	ACTN2	88	ENSG00000077522,ENST00000366578;;;ENST00000366578		Cardiomyopathy, hypertrophic, 23, with or without LVNC	612158	AD	3	Actn2
1q43	1:236686499-236764631	ACTN2, CMD1AA, CMH23, CMYO8, MPD6	Actinin, alpha-2	102573	ACTN2	88	ENSG00000077522,ENST00000366578;;;ENST00000366578		Congenital myopathy 8	618654	AD	3	Actn2
1q43	1:236686499-236764631	ACTN2, CMD1AA, CMH23, CMYO8, MPD6	Actinin, alpha-2	102573	ACTN2	88	ENSG00000077522,ENST00000366578;;;ENST00000366578		Myopathy, distal, 6, adult onset	618655	AD	3	Actn2
1q43	1:236795281-236903981	MTR, HMAG	5-methyltetrahydrofolate-homocysteine methyltransferase 1	156570	MTR	4548	ENSG00000116984,ENST00000366577;;;ENST00000366577		{Neural tube defects, folate-sensitive, susceptibility to}	601634	AR	3	Mtr
1q43	1:236795281-236903981	MTR, HMAG	5-methyltetrahydrofolate-homocysteine methyltransferase 1	156570	MTR	4548	ENSG00000116984,ENST00000366577;;;ENST00000366577		Homocystinuria-megaloblastic anemia, cblG complementation type	250940	AR	3	Mtr
1q43	1:237042184-237833988	RYR2, VTSIP, ARVC2, VACRDS	Ryanodine receptor-2 (cardiac)	180902	RYR2	6262	ENSG00000198626,ENST00000366574;;;ENST00000366574		Ventricular arrhythmias due to cardiac ryanodine receptor calcium release deficiency syndrome	115000	AD	3	Ryr2
1q43	1:237042184-237833988	RYR2, VTSIP, ARVC2, VACRDS	Ryanodine receptor-2 (cardiac)	180902	RYR2	6262	ENSG00000198626,ENST00000366574;;;ENST00000366574		Ventricular tachycardia, catecholaminergic polymorphic, 1	604772	AD	3	Ryr2
1q43	1:239386568-239915450	CHRM3, PBS, EGBRS	Cholinergic receptor, muscarinic, 3	118494	CHRM3	1131	ENSG00000133019,ENST00000676153;;;ENST00000676153		Prune belly syndrome	100100	AR	3	Chrm3
1q43	1:240091883-240475187	FMN2, MRT47	Formin 2	606373	FMN2	56776	ENSG00000155816,ENST00000319653;;;ENST00000319653		Intellectual developmental disorder, autosomal recessive 47	616193	AR	3	Fmn2
1q43	1:240489573-240612155	GREM2, PRDC, STHAG9	Gremlin 2, DAN family BMP antagonist	608832	GREM2	64388	ENSG00000180875,ENST00000318160;;;ENST00000318160		Tooth agenesis, selective, 9	617275	AD	3	Grem2
1q43	1:241497603-241519755	FH, HLRCC, MCUL1, FMRD	Fumarate hydratase	136850	FH	2271	ENSG00000091483,ENST00000366560;;;ENST00000366560		Fumarase deficiency	606812	AR	3	Fh1
1q43	1:241497603-241519755	FH, HLRCC, MCUL1, FMRD	Fumarate hydratase	136850	FH	2271	ENSG00000091483,ENST00000366560;;;ENST00000366560		Leiomyomatosis and renal cell cancer	150800	AD	3	Fh1
1q43-q44	1:243256041-243500091	SDCCAG8, CCCAP, SLSN7, BBS16	SHH signaling and ciliogenesis regulator SDCCAG8	613524	SDCCAG8	10806	ENSG00000054282,ENST00000366541;;;ENST00000366541		Bardet-Biedl syndrome 16	615993	AR	3	Sdccag8
1q43-q44	1:243256041-243500091	SDCCAG8, CCCAP, SLSN7, BBS16	SHH signaling and ciliogenesis regulator SDCCAG8	613524	SDCCAG8	10806	ENSG00000054282,ENST00000366541;;;ENST00000366541		Senior-Loken syndrome 7	613615	AR	3	Sdccag8
1q43-q44	1:243488233-243851079	AKT3, PKBG, MPPH2	AKT serine/threonine kinase 3	611223	AKT3	10000	ENSG00000117020,ENST00000673466;;;ENST00000673466		Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 2	615937	AD	3	Akt3
1q44	1:244048491-244057476	ZBTB18, ZNF238, RP58, MRD22	Zinc finger and BTB domain containing 18	608433	ZBTB18	10472	ENSG00000179456,ENST00000358704;;;ENST00000358704		Intellectual developmental disorder, autosomal dominant 22	612337	AD	3	Zbtb18
1q44	1:244835306-244845063	COX20, FAM36A, MC4DN11	Cytochrome c oxidase assembly factor COX20	614698	COX20	116228	ENSG00000203667,ENST00000411948;;;ENST00000411948		Mitochondrial complex IV deficiency, nuclear type 11	619054	AR	3	Cox20
1q44	1:244850297-244864543	HNRNPU, HNRPU, SAFA, DEE54	Heterogeneous nuclear ribonucleoprotein U	602869	HNRNPU	3192	ENSG00000153187,ENST00000640218;;;ENST00000640218		Developmental and epileptic encephalopathy 54	617391	AD	3	Hnrnpu
1q44	1:247416077-247448817	NLRP3, CIAS1, FCU, FCAS1, NALP3, PYPAF1, DFNA34, KEFH	NLR family, pyrin domain containing 3	606416	NLRP3	114548	ENSG00000162711,ENST00000336119;;;ENST00000336119		CINCA syndrome	607115	AD	3	Nlrp3
1q44	1:247416077-247448817	NLRP3, CIAS1, FCU, FCAS1, NALP3, PYPAF1, DFNA34, KEFH	NLR family, pyrin domain containing 3	606416	NLRP3	114548	ENSG00000162711,ENST00000336119;;;ENST00000336119		Deafness, autosomal dominant 34, with or without inflammation	617772	AD	3	Nlrp3
1q44	1:247416077-247448817	NLRP3, CIAS1, FCU, FCAS1, NALP3, PYPAF1, DFNA34, KEFH	NLR family, pyrin domain containing 3	606416	NLRP3	114548	ENSG00000162711,ENST00000336119;;;ENST00000336119		Familial cold inflammatory syndrome 1	120100	AD	3	Nlrp3
1q44	1:247416077-247448817	NLRP3, CIAS1, FCU, FCAS1, NALP3, PYPAF1, DFNA34, KEFH	NLR family, pyrin domain containing 3	606416	NLRP3	114548	ENSG00000162711,ENST00000336119;;;ENST00000336119		Keratoendothelitis fugax hereditaria	148200	AD	3	Nlrp3
1q44	1:247416077-247448817	NLRP3, CIAS1, FCU, FCAS1, NALP3, PYPAF1, DFNA34, KEFH	NLR family, pyrin domain containing 3	606416	NLRP3	114548	ENSG00000162711,ENST00000336119;;;ENST00000336119		Muckle-Wells syndrome	191900	AD	3	Nlrp3
2pter-p24	2:1-23800000	CTRCT29	Cataract 29, coralliform	115800		101867602		between D2S297 and D2S2269	Cataract 29, coralliform	115800	AD	2	
2p25-p22	2:1-41500000	ETM2, ETM	Tremor, hereditary essential, 2	602134		2112		max lod at D2S272	Essential tremor, hereditary, 2	602134	AD	2	
2p25-p24	2:1-23800000	HYT3	Hypertension, essential, susceptibility to, 3	607329		387575			{Hypertension, essential, susceptibility to, 3}	145500	Mu	2	
2p25	2:1-12000000	PEE2	Preeclampsia/eclampsia 2	609402		780908			Preeclampsia/eclampsia 2	609402		2	
2p25-p12	2:1-83100000	PPKP3	Keratoderma, palmoplantar, punctate type III	101850				max lod at ACP1 and IGKC	?Keratoderma, palmoplantar, punctate type 3	101850	AD	2	
2p25.3	2:1374047-1543673	TPO, TPX, TDH2A	Thyroid peroxidase	606765	TPO	7173	ENSG00000115705,ENST00000329066;;;ENST00000329066		Thyroid dyshormonogenesis 2A	274500	AR	3	Tpo
2p25.3	2:1631887-1744901	PXDN, D2S448E, KIAA0230, PRG2, PXN, COPOA, ASGD7	Peroxidasin	605158	PXDN	7837	ENSG00000130508,ENST00000252804;;;ENST00000252804		Anterior segment dysgenesis 7, with sclerocornea	269400	AR	3	Pxdn
2p25.3	2:1789113-2331275	MYT1L, KIAA1106, MRD39	Myelin transcription factor 1-like	613084	MYT1L	23040	ENSG00000186487,ENST00000647738;;;ENST00000647738		Intellectual developmental disorder, autosomal dominant 39	616521	AD	3	Myt1l
2p25.3	2:3379694-3479565	TRAPPC12, TTC15, PEBAS	Trafficking protein particle complex, subunit 12	614139	TRAPPC12	51112	ENSG00000171853,ENST00000324266;;;ENST00000324266		Encephalopathy, progressive, early-onset, with brain atrophy and spasticity	617669	AR	3	Trappc12
2p25.3	2:3531813-3558333	RNASEH1, PEOB2	Ribonuclease H1	604123	RNASEH1	246243	ENSG00000171865,ENST00000315212;;;ENST00000315212	pseudogenes on chr. 17 and chr.1	Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 2	616479	AR	3	Rnaseh1
2p25.3	2:3575260-3580920	RPS7, DBA8	Ribosomal protein S7	603658	RPS7	6201	ENSG00000171863,ENST00000645674;;;ENST00000645674		Diamond-Blackfan anemia 8	612563	AD	3	Rps7
2p25.3	2:3595112-3644644	COLEC11, CLK1, 3MC2	Collectin 11	612502	COLEC11	78989	ENSG00000118004,ENST00000349077;;;ENST00000349077		3MC syndrome 2	265050	AR	3	Colec11
2p25.2	2:5692384-5701385	SOX11, MRD27, IDDMOH	SRY-box 11	600898	SOX11	6664	ENSG00000176887,ENST00000322002;;;ENST00000322002		Intellectual developmental disorder with microcephaly and with or without ocular malformations or hypogonadotropic hypogonadism	615866	AD	3	Sox11
2p25.2	2:6840553-6866635	CMPK2, IBGC10	Cytidine monophosphate (UMP-CMP) kinase 2, mitochondrial	611787	CMPK2	129607	ENSG00000134326,ENST00000256722;;;ENST00000256722		Basal ganglia calcification, idiopathic, 10, autosomal recessive	621018	AR	3	Cmpk2
2p25.1-p24.3	2:6900001-16500000	DFNB47	Deafness, neurosensory, autosomal recessive 47	609946		449489		max lod at D2S1400 and D2S262	Deafness, neurosensory, autosomal recessive 47	609946	AR	2	
2p25.1	2:8721081-8837613	KIDINS220, ARMS, SINO, VENARG	Kinase D-interacting substrate, 220kD	615759	KIDINS220	57498	ENSG00000134313,ENST00000256707;;;ENST00000256707		Spastic paraplegia, intellectual disability, nystagmus, and obesity	617296	AD	3	Kidins220
2p25.1	2:8721081-8837613	KIDINS220, ARMS, SINO, VENARG	Kinase D-interacting substrate, 220kD	615759	KIDINS220	57498	ENSG00000134313,ENST00000256707;;;ENST00000256707		Ventriculomegaly and arthrogryposis	619501	AR	3	Kidins220
2p25.1	2:9423654-9473101	CPSF3, CPSF73, NEDMHSN	Cleavage and polyadenylation specificity factor 3	606029	CPSF3	51692	ENSG00000119203,ENST00000238112;;;ENST00000238112		Neurodevelopmental disorder with microcephaly, hypotonia, nystagmus, and seizures	619876	AR	3	Cpsf3
2p25.1	2:9488486-9555830	ADAM17, TACE, NISBD1	ADAM metallopeptidase domain 17	603639	ADAM17	6868	ENSG00000151694,ENST00000310823;;;ENST00000310823	mutation identified in 1 NISBD1 family	?Inflammatory skin and bowel disease, neonatal, 1	614328	AR	3	Adam17
2p25.1	2:10043550-10054836	KLF11, TIEG2, FKLF1, FKLF, MODY7	Kruppel-like factor 11	603301	KLF11	8462	ENSG00000172059,ENST00000305883;;;ENST00000305883		Maturity-onset diabetes of the young, type VII	610508		3	Klf11
2p25.1	2:10439968-10448327	ODC1, BABS	Ornithine decarboxylase-1	165640	ODC1	4953	ENSG00000115758,ENST00000234111;;;ENST00000234111	pseudogene ODCP on 7q31-qter	Bachmann-Bupp syndrome	619075	AD	3	Odc1
2p25.1	2:11677544-11827409	LPIN1	Lipin 1	605518	LPIN1	23175	ENSG00000134324,ENST00000674199;;;ENST00000674199	related to LSL	Myoglobinuria, acute recurrent, autosomal recessive	268200	AR	3	Lpin1
2p24-p22	2:12000001-41500000	CLQTL2	Cholesterol level quantitative trait locus 2	610760		100188817		max lod at D2S1360	[Cholesterol level QTL 2]	610760		2	
2p24	2:12000001-23800000	GEFSP4	Generalized epilepsy with febrile seizures plus, type 4	609800		100188796		max lod at D2S305	Generalized epilepsy with febrile seizures plus, type 4	609800	AD	2	
2p24	2:12000001-23800000	KTCN4	Keratoconus 4	609271		550624		between D2S305 and D2S2373	Keratoconus 4	609271		2	
2p24.3	2:14778909-15561334	NBAS, NAG, SOPH, ILFS2	NBAS subunit of NRZ tethering complex	608025	NBAS	51594	ENSG00000151779,ENST00000281513;;;ENST00000281513		Infantile liver failure syndrome 2	616483	AR	3	Nbas
2p24.3	2:14778909-15561334	NBAS, NAG, SOPH, ILFS2	NBAS subunit of NRZ tethering complex	608025	NBAS	51594	ENSG00000151779,ENST00000281513;;;ENST00000281513		Short stature, optic nerve atrophy, and Pelger-Huet anomaly	614800	AR	3	Nbas
2p24.3	2:15940550-15947004	MYCN, NMYC, FGLDS1, MPAPA	Oncogene NMYC	164840	MYCN	4613	ENSG00000134323,ENST00000281043;;;ENST00000281043	proximal to APOB	Feingold syndrome 1	164280	AD	3	Mycn,Mycs
2p24.3	2:15940550-15947004	MYCN, NMYC, FGLDS1, MPAPA	Oncogene NMYC	164840	MYCN	4613	ENSG00000134323,ENST00000281043;;;ENST00000281043	proximal to APOB	Megalencephaly-polydactyly syndrome	620748	AD	3	Mycn,Mycs
2p24.1	2:19910263-19990105	WDR35, NAOFEN, KIAA1336, CED2, SRTD7	WD repeat-containing protein 35	613602	WDR35	57539	ENSG00000118965,ENST00000281405;;;ENST00000281405		Cranioectodermal dysplasia 2	613610	AR	3	Wdr35
2p24.1	2:19910263-19990105	WDR35, NAOFEN, KIAA1336, CED2, SRTD7	WD repeat-containing protein 35	613602	WDR35	57539	ENSG00000118965,ENST00000281405;;;ENST00000281405		Short-rib thoracic dysplasia 7 with or without polydactyly	614091	AR	3	Wdr35
2p24.1	2:19992052-20012668	MATN3, EDM5, HOA, OS2, SEMDBCD	Matrilin 3	602109	MATN3	4148	ENSG00000132031,ENST00000407540;;;ENST00000407540		{Osteoarthritis susceptibility 2}	140600	AD	3	Matn3
2p24.1	2:19992052-20012668	MATN3, EDM5, HOA, OS2, SEMDBCD	Matrilin 3	602109	MATN3	4148	ENSG00000132031,ENST00000407540;;;ENST00000407540		Epiphyseal dysplasia, multiple, 5	607078	AD	3	Matn3
2p24.1	2:19992052-20012668	MATN3, EDM5, HOA, OS2, SEMDBCD	Matrilin 3	602109	MATN3	4148	ENSG00000132031,ENST00000407540;;;ENST00000407540		Spondyloepimetaphyseal dysplasia, Borochowitz-Cormier-Daire type	608728	AR	3	Matn3
2p24.1	2:21001429-21044073	APOB, FLDB, LDLCQ4, FCHL2	Apolipoprotein B (including Ag(x) antigen)	107730	APOB	338	ENSG00000084674,ENST00000233242;;;ENST00000233242	1 gene for liver apo-B100 and gut apo-B48; Ag linked	Hypercholesterolemia, familial, 2	144010	AD	3	Apob
2p24.1	2:21001429-21044073	APOB, FLDB, LDLCQ4, FCHL2	Apolipoprotein B (including Ag(x) antigen)	107730	APOB	338	ENSG00000084674,ENST00000233242;;;ENST00000233242	1 gene for liver apo-B100 and gut apo-B48; Ag linked	Hypobetalipoproteinemia	615558	AR	3	Apob
2p23.3-p22.3	2:23800001-36300000	GINGF3, HGF3, GGF3	Fibromatosis, gingival, 3	609955		780916		between D2S2221 and D2S1788	Fibromatosis, gingival, 3	609955	AD	2	
2p23.3	2:24789728-24793391	PTRHD1, C2orf79, NEDPBA	Peptidyl-tRNA hydrolase domain-containing 1	617342	PTRHD1	391356	ENSG00000184924,ENST00000328379;;;ENST00000328379		Neurodevelopmental disorder with early-onset parkinsonism and behavioral abnormalities	620747	AR	3	Ptrhd1
2p23.3	2:24819169-24920237	ADCY3, BMIQ19	Adenylate cyclase-3	600291	ADCY3	109	ENSG00000138031,ENST00000679454;;;ENST00000679454		{Obesity, susceptibility to, BMIQ19}	617885	AR	3	Adcy3
2p23.3	2:25160860-25168580	POMC, OBAIRH	Proopiomelanocortin (adrenocorticotropin/beta-lipotropin)	176830	POMC	5443	ENSG00000115138,ENST00000395826;;;ENST00000395826		{Obesity, early-onset, susceptibility to}	601665	AD, AR, Mu	3	Pomc
2p23.3	2:25160860-25168580	POMC, OBAIRH	Proopiomelanocortin (adrenocorticotropin/beta-lipotropin)	176830	POMC	5443	ENSG00000115138,ENST00000395826;;;ENST00000395826		Obesity, adrenal insufficiency, and red hair due to POMC deficiency	609734	AR	3	Pomc
2p23.3	2:25227874-25342590	DNMT3A, TBRS, HESJAS	DNA methyltransferase 3A	602769	DNMT3A	1788	ENSG00000119772,ENST00000321117;;;ENST00000321117		Acute myeloid leukemia, somatic	601626		3	Dnmt3a
2p23.3	2:25227874-25342590	DNMT3A, TBRS, HESJAS	DNA methyltransferase 3A	602769	DNMT3A	1788	ENSG00000119772,ENST00000321117;;;ENST00000321117		Heyn-Sproul-Jackson syndrome	618724	AD	3	Dnmt3a
2p23.3	2:25227874-25342590	DNMT3A, TBRS, HESJAS	DNA methyltransferase 3A	602769	DNMT3A	1788	ENSG00000119772,ENST00000321117;;;ENST00000321117		Tatton-Brown-Rahman syndrome	615879	AD	3	Dnmt3a
2p23.3	2:25733753-25878487	ASXL2, KIAA1685, SHAPNS	ASXL transcriptional regulator 2	612991	ASXL2	55252	ENSG00000143970,ENST00000435504;;;ENST00000435504		Shashi-Pena syndrome	617190	AD	3	Asxl2
2p23.3	2:26190635-26244632	HADHA, MTPA	Hydroxyacyl-Coenzyme A dehydrogenase/3-ketoacyl-Coenzyme A thiolase/ enoyl-Coenzyme A hydratase (trifunctional protein), alpha subunit	600890	HADHA	3030	ENSG00000084754,ENST00000380649;;;ENST00000380649		Fatty liver, acute, of pregnancy	609016	AR	3	Hadha
2p23.3	2:26190635-26244632	HADHA, MTPA	Hydroxyacyl-Coenzyme A dehydrogenase/3-ketoacyl-Coenzyme A thiolase/ enoyl-Coenzyme A hydratase (trifunctional protein), alpha subunit	600890	HADHA	3030	ENSG00000084754,ENST00000380649;;;ENST00000380649		HELLP syndrome, maternal, of pregnancy	609016	AR	3	Hadha
2p23.3	2:26190635-26244632	HADHA, MTPA	Hydroxyacyl-Coenzyme A dehydrogenase/3-ketoacyl-Coenzyme A thiolase/ enoyl-Coenzyme A hydratase (trifunctional protein), alpha subunit	600890	HADHA	3030	ENSG00000084754,ENST00000380649;;;ENST00000380649		LCHAD deficiency	609016	AR	3	Hadha
2p23.3	2:26190635-26244632	HADHA, MTPA	Hydroxyacyl-Coenzyme A dehydrogenase/3-ketoacyl-Coenzyme A thiolase/ enoyl-Coenzyme A hydratase (trifunctional protein), alpha subunit	600890	HADHA	3030	ENSG00000084754,ENST00000380649;;;ENST00000380649		Mitochondrial trifunctional protein deficiency 1	609015	AR	3	Hadha
2p23.3	2:26244939-26290465	HADHB, MTPD2	Hydroxyacyl-Coenzyme A dehydrogenase/3-ketoacyl-Coenzyme A thiolase /enoyl-Coenzyme A hydratase (trifunctional protein), beta subunit	143450	HADHB	3032	ENSG00000138029,ENST00000317799;;;ENST00000317799		Mitochondrial trifunctional protein deficiency 2	620300	AR	3	Hadhb
2p23.3	2:26346143-26395885	SELENOI, SELI, SPG81	Selenoprotein I	607915	SELENOI	85465	ENSG00000138018,ENST00000260585;;;ENST00000260585		Spastic paraplegia 81, autosomal recessive	618768	AR	3	Selenoi
2p23.3	2:26401920-26456711	DRC1, CCDC164, C2orf39, CILD21, SPGF80	Dynein regulatory complex, subunit 1	615288	DRC1	92749	ENSG00000157856,ENST00000288710;;;ENST00000288710		Ciliary dyskinesia, primary, 21	615294	AR	3	Drc1
2p23.3	2:26401920-26456711	DRC1, CCDC164, C2orf39, CILD21, SPGF80	Dynein regulatory complex, subunit 1	615288	DRC1	92749	ENSG00000157856,ENST00000288710;;;ENST00000288710		Spermatogenic failure 80	620222	AR	3	Drc1
2p23.3	2:26457203-26558756	OTOF, DFNB9, NSRD9, AUNB1	Otoferlin	603681	OTOF	9381	ENSG00000115155,ENST00000272371;;;ENST00000272371	symbolized DFNB6 by authors	Auditory neuropathy, autosomal recessive, 1	601071	AR	3	Otof
2p23.3	2:26457203-26558756	OTOF, DFNB9, NSRD9, AUNB1	Otoferlin	603681	OTOF	9381	ENSG00000115155,ENST00000272371;;;ENST00000272371	symbolized DFNB6 by authors	Deafness, autosomal recessive 9	601071	AR	3	Otof
2p23.3	2:26692722-26733420	KCNK3, TASK, PPH4, DDSA	Potassium channel, subfamily K, member 3	603220	KCNK3	3777	ENSG00000171303,ENST00000302909;;;ENST00000302909		Developmental delay with sleep apnea	621402	AD	3	Kcnk3
2p23.3	2:26692722-26733420	KCNK3, TASK, PPH4, DDSA	Potassium channel, subfamily K, member 3	603220	KCNK3	3777	ENSG00000171303,ENST00000302909;;;ENST00000302909		Pulmonary hypertension, primary, 4	615344	AD	3	Kcnk3
2p23.3	2:26847995-26950351	DPYSL5, CRMP5, CRAM, RTSC4	Dihydropyrimidinase-like 5	608383	DPYSL5	56896	ENSG00000157851,ENST00000288699;;;ENST00000288699		Ritscher-Schinzel syndrome 4	619435	AD	3	Dpysl5
2p23.3	2:27050364-27070618	AGBL5, CCP5, RP75	AATP/GTP-binding protein-like 5	615900	AGBL5	60509	ENSG00000084693,ENST00000360131;;;ENST00000360131		Retinitis pigmentosa 75	617023	AR	3	Agbl5
2p23.3	2:27078615-27086403	EMILIN1, EMILIN, HMND10, ATBFS	Elastin microfibril interfacer 1	130660	EMILIN1	11117	ENSG00000138080,ENST00000380320;;;ENST00000380320		Arterial tortuosity-bone fragility syndrome	620908	AR	3	Emilin1
2p23.3	2:27078615-27086403	EMILIN1, EMILIN, HMND10, ATBFS	Elastin microfibril interfacer 1	130660	EMILIN1	11117	ENSG00000138080,ENST00000380320;;;ENST00000380320		Neuronopathy, distal hereditary motor, autosomal dominant 10	620080	AD	3	Emilin1
2p23.3	2:27086772-27100762	KHK, FRUCTU	Ketohexokinase (fructokinase)	614058	KHK	3795	ENSG00000138030,ENST00000260598;;;ENST00000260598	mutation identified in 1 FRUCTU family	?[Fructosuria, essential]	229800	AR	3	Khk
2p23.3	2:27199587-27212787	SLC5A6, SMVT, NERIB, SMVTD, COMNB	Solute carrier family 5 (sodium dependent vitamin transporter), member 6	604024	SLC5A6	8884	ENSG00000138074,ENST00000310574;;;ENST00000310574		Peripheral motor neuropathy, childhood-onset, biotin-responsive	619903	AR	3	Slc5a6
2p23.3	2:27199587-27212787	SLC5A6, SMVT, NERIB, SMVTD, COMNB	Solute carrier family 5 (sodium dependent vitamin transporter), member 6	604024	SLC5A6	8884	ENSG00000138074,ENST00000310574;;;ENST00000310574		Sodium-dependent multivitamin transporter deficiency	618973	AR	3	Slc5a6
2p23.3	2:27217369-27243943	CAD, CDG1Z, DEE50	CAD trifunctional protein of pyrimidine biosynthesis	114010	CAD	790	ENSG00000084774,ENST00000264705;;;ENST00000264705		Developmental and epileptic encephalopathy 50	616457	AR	3	Cad
2p23.3	2:27309492-27323097	MPV17, MTDPS6, CMT2EE	Mitochondrial inner membrane protein MPV17	137960	MPV17	4358	ENSG00000115204,ENST00000380044;;;ENST00000380044		Charcot-Marie-Tooth disease, axonal, type 2EE	618400	AR	3	Mpv17
2p23.3	2:27309492-27323097	MPV17, MTDPS6, CMT2EE	Mitochondrial inner membrane protein MPV17	137960	MPV17	4358	ENSG00000115204,ENST00000380044;;;ENST00000380044		Mitochondrial DNA depletion syndrome 6 (hepatocerebral type)	256810	AR	3	Mpv17
2p23.3	2:27364352-27370338	EIF2B4, VWM4	Eukaryotic translation initiation factor 2B, subunit 4	606687	EIF2B4	8890	ENSG00000115211,ENST00000347454;;;ENST00000347454		Leukoencephalopathy with vanishing white matter 4, with or without ovarian failure	620314	AR	3	Eif2b4
2p23.3	2:27377235-27380734	ZNF513, RP58	Zinc finger protein 513	613598	ZNF513	130557	ENSG00000163795,ENST00000323703;;;ENST00000323703	mutation identified in 1 RP58 family	?Retinitis pigmentosa 58	613617	AR	3	Zfp513
2p23.3	2:27444377-27489743	IFT172, SLB, KIAA1179, SRTD10, RP71, BBS20	Intraflagellar transport 172	607386	IFT172	26160	ENSG00000138002,ENST00000260570;;;ENST00000260570		Bardet-Biedl syndrome 20	619471	AR	3	Ift172
2p23.3	2:27444377-27489743	IFT172, SLB, KIAA1179, SRTD10, RP71, BBS20	Intraflagellar transport 172	607386	IFT172	26160	ENSG00000138002,ENST00000260570;;;ENST00000260570		Retinitis pigmentosa 71	616394	AR	3	Ift172
2p23.3	2:27444377-27489743	IFT172, SLB, KIAA1179, SRTD10, RP71, BBS20	Intraflagellar transport 172	607386	IFT172	26160	ENSG00000138002,ENST00000260570;;;ENST00000260570		Short-rib thoracic dysplasia 10 with or without polydactyly	615630	AR	3	Ift172
2p23.3	2:27496839-27523684	GCKR, GKRP, FGQTL5	Glucokinase (hexokinase 4) regulatory protein	600842	GCKR	2646	ENSG00000084734,ENST00000264717;;;ENST00000264717		[Fasting plasma glucose level QTL 5]	613463		3	Gckr
2p23.3	2:27642568-27663614	SUPT7L, SUPT7H, SPT7l, KIAA0764, STAF65G, FZPS	SPTY7-like, STAGA complex subunit gamma	612762	SUPT7L	9913	ENSG00000119760,ENST00000337768;;;ENST00000337768		Fischer-Zirnsak progeroid syndrome	621130	AR	3	Supt7l
2p23.2	2:28392858-28417317	FOSL2, ACED	FOS-like 2, AP-1 transcription factor subunit	601575	FOSL2	2355	ENSG00000075426,ENST00000264716;;;ENST00000264716		Aplasia cutis-enamel dysplasia syndrome	620789	AD	3	Fosl2
2p23.2	2:28751604-28802940	PPP1CB, NSLH2	Protein phosphatase-1, catalytic subunit, beta isoform	600590	PPP1CB	5500	ENSG00000213639,ENST00000395366;;;ENST00000395366		Noonan syndrome-like disorder with loose anagen hair 2	617506	AD	3	Ppp1cb
2p23.2	2:29061695-29074523	PCARE, C2orf71, RP54	Photoreceptor cilium actin regulator	613425	PCARE	388939	ENSG00000179270,ENST00000331664;;;ENST00000331664		Retinitis pigmentosa 54	613428	AR	3	Pcare
2p23.2-p23.1	2:29192774-29921586	ALK, NBLST3	ALK receptor tyrosine kinase	105590	ALK	238	ENSG00000171094,ENST00000389048;;;ENST00000389048		{Neuroblastoma, susceptibility to, 3}	613014		3	Alk
2p23.1	2:31334321-31414742	XDH, XAN1	Xanthine dehydrogenase (xanthine oxidase)	607633	XDH	7498	ENSG00000158125,ENST00000379416;;;ENST00000379416		Xanthinuria, type I	278300	AR	3	Xdh
2p23.1	2:31522480-31663009	SRD5A2	Steroid-5-alpha-reductase, alpha polypeptide-2 (3-oxo-5 alpha-steroid delta 4-dehydrogenase alpha-2)	607306	SRD5A2	6716	ENSG00000277893,ENST00000622030;;;ENST00000622030		Pseudovaginal perineoscrotal hypospadias	264600	AR	3	Srd5a2
2p22.3-p21	2:31800001-47500000	CANDF1, CMCT	Candidiasis, familial, 1	114580		117084		between D2S367 and D2S2240	Candidiasis, familial, 1, autosomal dominant	114580	AD	2	
2p22.3	2:32063556-32157637	SPAST, SPG4	Spastin	604277	SPAST	6683	ENSG00000021574,ENST00000315285;;;ENST00000315285		Spastic paraplegia 4, autosomal dominant	182601	AD	3	Spast
2p22.3	2:32224449-32265743	NLRC4, CARD12, CLAN, IPAF, AIFEC, FCAS4	NLR family, caspase recruitment domain-containing 4	606831	NLRC4	58484	ENSG00000091106,ENST00000402280;;;ENST00000402280	mutation identified in 1 FCAS4 family	?Familial cold autoinflammatory syndrome 4	616115	AD	3	Nlrc4
2p22.3	2:32224449-32265743	NLRC4, CARD12, CLAN, IPAF, AIFEC, FCAS4	NLR family, caspase recruitment domain-containing 4	606831	NLRC4	58484	ENSG00000091106,ENST00000402280;;;ENST00000402280	mutation identified in 1 FCAS4 family	Autoinflammation with infantile enterocolitis	616050	AD	3	Nlrc4
2p22.3	2:32946953-33399509	LTBP1, ARCL2E	Latent transforming growth factor beta binding protein 1	150390	LTBP1	4052	ENSG00000049323,ENST00000404816;;;ENST00000404816		Cutis laxa, autosomal recessive, type IIE	619451	AR	3	Ltbp1
2p22.2	2:36300001-38300000	MACOM	Macrophthalmia, colobomatous, with microcornea	602499					Macrophthalmia, colobomatous, with microcornea	602499	AD	4	
2p22.2	2:37099210-37156980	EIF2AK2, PRKR, LEUDEN, DYT33	Eurkaryotic translation initiation factor 2-alpha kinase 2	176871	EIF2AK2	5610	ENSG00000055332,ENST00000233057;;;ENST00000233057	mutation identified in 1 DYT33 patient	Dystonia 33	619687	AD, AR	3	Eif2ak2
2p22.2	2:37099210-37156980	EIF2AK2, PRKR, LEUDEN, DYT33	Eurkaryotic translation initiation factor 2-alpha kinase 2	176871	EIF2AK2	5610	ENSG00000055332,ENST00000233057;;;ENST00000233057	mutation identified in 1 DYT33 patient	Leukoencephalopathy, developmental delay, and episodic neurologic regression syndrome	618877	AD	3	Eif2ak2
2p22.2	2:38067509-38076151	CYP1B1, GLC3A, ASGD6	Cytochrome P450, subfamily I, dioxin-inducible, polypeptide 1	601771	CYP1B1	1545	ENSG00000138061,ENST00000610745;;;ENST00000610745		Anterior segment dysgenesis 6, multiple subtypes	617315	AR	3	Cyp1b1
2p22.2	2:38067509-38076151	CYP1B1, GLC3A, ASGD6	Cytochrome P450, subfamily I, dioxin-inducible, polypeptide 1	601771	CYP1B1	1545	ENSG00000138061,ENST00000610745;;;ENST00000610745		Glaucoma 3A, primary open angle, congenital, juvenile, or adult onset	231300	AR	3	Cyp1b1
2p22.1-p21	2:38300001-47500000	HNFJ3	Hyperuricemic nephropathy, familial juvenile, 3	614227		100689490		between rs372139 and rs896986	Hyperuricemic nephropathy, familial juvenile, 3	614227	AD	2	
2p22.1	2:38666114-38734765	GALM, GLAT, GALAC4	Galactose mutarotase	137030	GALM	130589	ENSG00000143891,ENST00000272252;;;ENST00000272252		Galactosemia IV	618881	AR	3	Galm
2p22.1	2:38981549-39124868	SOS1, GINGF, GF1, HGF, NS4	SOS Ras/Rac guanine nucleotide exchange factor 1	182530	SOS1	6654	ENSG00000115904,ENST00000402219;;;ENST00000402219		Fibromatosis, gingival, 1	135300	AD	3	Sos1
2p22.1	2:38981549-39124868	SOS1, GINGF, GF1, HGF, NS4	SOS Ras/Rac guanine nucleotide exchange factor 1	182530	SOS1	6654	ENSG00000115904,ENST00000402219;;;ENST00000402219		Noonan syndrome 4	610733	AD	3	Sos1
2p21	2:41500001-47500000	DEL2p21, C2DELp21	Homozygous 2p21 deletion syndrome	606407				contiguous gene syndrome disrupting SLC3A1 and PREPL genes	Hypotonia-cystinuria syndrome	606407	AR	4	
2p21-p12	2:41500001-83100000	DFNA58	Deafness, autosomal dominant 58	615654				duplication of 200kb	Deafness, autosomal dominant 58	615654	AD	4	
2p21	2:41500001-47500000	LEPQTL1, LSL	Leptin serum levels quantitative trait locus 1	601694		7839			[Leptin serum levels QTL1]	601694		2	
2p21	2:42048021-42058517	PKDCC, VLK, SGK493, RLSDF	Protein kinase domain-containing, cytoplasmic	614150	PKDCC	91461	ENSG00000162878,ENST00000294964;;;ENST00000294964		Rhizomelic limb shortening with dysmorphic features	618821	AR	3	Pkdcc
2p21	2:42767089-42792583	HAAO, VCRL1	3-hydroxyanthranilate 3,4-dioxygenase	604521	HAAO	23498	ENSG00000162882,ENST00000294973;;;ENST00000294973		Vertebral, cardiac, renal, and limb defects syndrome 1	617660	AR	3	Haao
2p21	2:43222402-43226606	ZFP36L2, ERF2, TIS11D, OZEMA13	Zinc finger protein 36-like 2	612053	ZFP36L2	678	ENSG00000152518,ENST00000282388;;;ENST00000282388		Oocyte/zygote/embryo maturation arrest 13	620154	AR	3	Zfp36l2
2p21	2:43774039-43828347	DYNC2LI1, D2LIC, LIC3, SRTD15	Dynein, cytoplasmic 2, light intermediate chain 1	617083	DYNC2LI1	51626	ENSG00000138036,ENST00000260605;;;ENST00000260605		Short-rib thoracic dysplasia 15 with polydactyly	617088	AR	3	Dync2li1
2p21	2:43806211-43839231	ABCG5, STSL2	ATP-binding cassette, subfamily G, member 5	605459	ABCG5	64240	ENSG00000138075,ENST00000405322;;;ENST00000405322		Sitosterolemia 2	618666	AR	3	Abcg5
2p21	2:43838971-43882988	ABCG8, GBD4, STSL1	ATP-binding cassette, subfamily G, member 8	605460	ABCG8	64241	ENSG00000143921,ENST00000272286;;;ENST00000272286		{Gallbladder disease 4}	611465		3	Abcg8
2p21	2:43838971-43882988	ABCG8, GBD4, STSL1	ATP-binding cassette, subfamily G, member 8	605460	ABCG8	64241	ENSG00000143921,ENST00000272286;;;ENST00000272286		Sitosterolemia 1	210250	AR	3	Abcg8
2p21	2:43886224-43996265	LRPPRC, LRP130, LSFC, MC4DN5	Leucine-rich PPR motif-containing protein	607544	LRPPRC	10128	ENSG00000138095,ENST00000260665;;;ENST00000260665		Mitochondrial complex IV deficiency, nuclear type 5, (French-Canadian)	220111	AR	3	Lrpprc
2p21	2:44275480-44322437	SLC3A1, ATR1, D2H, NBAT	Solute carrier family 3 (cystine, dibasic and neutral amino acid transporters), member 1	104614	SLC3A1	6519	ENSG00000138079,ENST00000260649;;;ENST00000260649		Cystinuria	220100	AD, AR	3	Slc3a1
2p21	2:44317607-44361862	PREPL, KIAA0436, CMS22	Prolyl endopeptidase-like	609557	PREPL	9581	ENSG00000138078,ENST00000409411;;;ENST00000409411		Myasthenic syndrome, congenital, 22	616224	AR	3	Prepl
2p21	2:44941702-44946071	SIX3, HPE2	SIX homeobox 3	603714	SIX3	6496	ENSG00000138083,ENST00000260653;;;ENST00000260653		Holoprosencephaly 2	157170	AD	3	Six3
2p21	2:44941702-44946071	SIX3, HPE2	SIX homeobox 3	603714	SIX3	6496	ENSG00000138083,ENST00000260653;;;ENST00000260653		Schizencephaly	269160		3	Six3
2p21	2:46297407-46386697	EPAS1, MOP2, HIF2A, ECYT4	Endothelial PAS domain protein 1	603349	EPAS1	2034	ENSG00000116016,ENST00000263734;;;ENST00000263734		Erythrocytosis, familial, 4	611783	AD	3	Epas1
2p21	2:46580937-46617041	PIGF, OORS	Phosphatidylinositol glycan, class F	600153	PIGF	5281	ENSG00000151665,ENST00000281382;;;ENST00000281382	pseudogene on 5	Onychodystrophy, osteodystrophy, impaired intellectual development, and seizures syndrome	619356	AR	3	Pigf
2p21	2:46617215-46630176	CRIPT, RTS3	Cystine-rich PDZ binding protein	604594	CRIPT	9419	ENSG00000119878,ENST00000238892;;;ENST00000238892		Rothmund-Thomson syndrome, type 3	615789	AR	3	Cript
2p21	2:46901870-46941855	MCFD2, F5F8D2	Multiple coagulation factor deficiency protein 2	607788	MCFD2	90411	ENSG00000180398,ENST00000319466;;;ENST00000319466		Factor V and factor VIII, combined deficiency of	613625		3	Mcfd2
2p21	2:46915866-47076123	TTC7A, TTC7, KIAA1140, MINAT, GIDID	Tetratricopeptide repeat domain 7A	609332	TTC7A	57217	ENSG00000068724,ENST00000319190;;;ENST00000319190		Gastrointestinal defects and immunodeficiency syndrome	243150	AR	3	Ttc7
2p21	2:47160082-47176936	CALM2, LQT15	Calmodulin-2	114182	CALM2	805	ENSG00000143933,ENST00000272298;;;ENST00000272298		Long QT syndrome 15	616249	AD	3	Calm2
2p21	2:47369311-47387020	EPCAM, ACSTD1, TROP1, M4S1, MIC18, DIAR5, LYNCH8	Epithelial cellular adhesion molecule	185535	EPCAM	4072	ENSG00000119888,ENST00000263735;;;ENST00000263735	previously assigned to 4q	Diarrhea 5, with tufting enteropathy, congenital	613217	AR	3	Epcam
2p21	2:47369311-47387020	EPCAM, ACSTD1, TROP1, M4S1, MIC18, DIAR5, LYNCH8	Epithelial cellular adhesion molecule	185535	EPCAM	4072	ENSG00000119888,ENST00000263735;;;ENST00000263735	previously assigned to 4q	Lynch syndrome 8	613244	AD	3	Epcam
2p21-p16.3	2:47403067-47709830	MSH2, COCA1, FCC1, LYNCH1, MMRCS2	mutS homolog 2	609309	MSH2	4436	ENSG00000095002,ENST00000233146;;;ENST00000233146		Lynch syndrome 1	120435	AD	3	Msh2
2p21-p16.3	2:47403067-47709830	MSH2, COCA1, FCC1, LYNCH1, MMRCS2	mutS homolog 2	609309	MSH2	4436	ENSG00000095002,ENST00000233146;;;ENST00000233146		Mismatch repair cancer syndrome 2	619096	AR	3	Msh2
2p21-p16.3	2:47403067-47709830	MSH2, COCA1, FCC1, LYNCH1, MMRCS2	mutS homolog 2	609309	MSH2	4436	ENSG00000095002,ENST00000233146;;;ENST00000233146		Muir-Torre syndrome	158320	AD	3	Msh2
2p16	2:47500001-61000000	ASRT3	Asthma-related traits, susceptibility to, 3	609958		100188801		max lod at rs2063871	{Asthma-related traits, susceptibility to, 3}	609958		2	
2p16	2:47500001-61000000	CNC2	Carney complex, type II	605244		1257			Carney complex, type II	605244		2	
2p16.3	2:47500001-52600000	DEL2p16.3, C2DELp16.3	Chromosome 2p16.3 deletion syndrome	614332					Chromosome 2p16.3 deletion syndrome	614332		4	
2p16-p15	2:47500001-63900000	DYX3	Dyslexia, susceptibility to, 3	604254		11192			{Dyslexia, susceptibility to, 3}	604254		2	
2p16	2:47500001-61000000	STQTL24	Stature quantitative trait locus 24	613549		100529223		linked to rs1520446	{Stature QTL 24}	613549		2	
2p16.3	2:47783145-47810101	MSH6, GTBP, LYNCH5, MMRCS3	mutS homolog 6	600678	MSH6	2956	ENSG00000116062,ENST00000234420;;;ENST00000234420	0.5 Mb from MSH2	{Endometrial cancer, familial}	608089	AD, SMu	3	Msh6
2p16.3	2:47783145-47810101	MSH6, GTBP, LYNCH5, MMRCS3	mutS homolog 6	600678	MSH6	2956	ENSG00000116062,ENST00000234420;;;ENST00000234420	0.5 Mb from MSH2	Lynch syndrome 5	614350	AD	3	Msh6
2p16.3	2:47783145-47810101	MSH6, GTBP, LYNCH5, MMRCS3	mutS homolog 6	600678	MSH6	2956	ENSG00000116062,ENST00000234420;;;ENST00000234420	0.5 Mb from MSH2	Mismatch repair cancer syndrome 3	619097	AR	3	Msh6
2p16.3	2:47806920-47906498	FBXO11, FBX11, VIT1, PRMT9, IDDFBA	F-box only protein 11	607871	FBXO11	80204	ENSG00000138081,ENST00000403359;;;ENST00000403359	?2p16	Intellectual developmental disorder with dysmorphic facies and behavioral abnormalities	618089	AD	3	Fbxo11
2p16.3	2:48440766-48515386	PPP1R21, CCDC128, KLRAQ1, NEDHFBA	Protein phosphatase 1, regulatory subunit 21	618159	PPP1R21	129285	ENSG00000162869,ENST00000294952;;;ENST00000294952		Neurodevelopmental disorder with hypotonia, facial dysmorphism, and brain abnormalities	619383	AR	3	Ppp1r21
2p16.3	2:48686774-48755724	LHCGR, LHR, LCGR	Luteinizing hormone/choriogonadotropin receptor	152790	LHCGR	3973	ENSG00000138039,ENST00000294954;;;ENST00000294954		Leydig cell adenoma, somatic, with precocious puberty	176410		3	Lhcgr
2p16.3	2:48686774-48755724	LHCGR, LHR, LCGR	Luteinizing hormone/choriogonadotropin receptor	152790	LHCGR	3973	ENSG00000138039,ENST00000294954;;;ENST00000294954		Leydig cell hypoplasia with hypergonadotropic hypogonadism	238320	AR	3	Lhcgr
2p16.3	2:48686774-48755724	LHCGR, LHR, LCGR	Luteinizing hormone/choriogonadotropin receptor	152790	LHCGR	3973	ENSG00000138039,ENST00000294954;;;ENST00000294954		Leydig cell hypoplasia with pseudohermaphroditism	238320	AR	3	Lhcgr
2p16.3	2:48686774-48755724	LHCGR, LHR, LCGR	Luteinizing hormone/choriogonadotropin receptor	152790	LHCGR	3973	ENSG00000138039,ENST00000294954;;;ENST00000294954		Luteinizing hormone resistance, female	238320	AR	3	Lhcgr
2p16.3	2:48686774-48755724	LHCGR, LHR, LCGR	Luteinizing hormone/choriogonadotropin receptor	152790	LHCGR	3973	ENSG00000138039,ENST00000294954;;;ENST00000294954		Precocious puberty, male	176410	AD	3	Lhcgr
2p16.3	2:48962157-49154515	FSHR, ODG1	Follicle stimulating hormone receptor	136435	FSHR	2492	ENSG00000170820,ENST00000406846;;;ENST00000406846		Ovarian dysgenesis 1	233300	AR	3	Fshr
2p16.3	2:48962157-49154515	FSHR, ODG1	Follicle stimulating hormone receptor	136435	FSHR	2492	ENSG00000170820,ENST00000406846;;;ENST00000406846		Ovarian hyperstimulation syndrome	608115	AD	3	Fshr
2p16.3	2:49918503-51032132	NRXN1, PTHSL2, SCZD17	Neurexin 1	600565	NRXN1	9378	ENSG00000179915,ENST00000401669;;;ENST00000401669	mutation identified in 1 SCZD17 patient	{Schizophrenia, susceptibility to, 17}	621407		3	Nrxn1
2p16.3	2:49918503-51032132	NRXN1, PTHSL2, SCZD17	Neurexin 1	600565	NRXN1	9378	ENSG00000179915,ENST00000401669;;;ENST00000401669	mutation identified in 1 SCZD17 patient	Pitt-Hopkins-like syndrome 2	614325	AR	3	Nrxn1
2p16.2	2:54456327-54671446	SPTBN1, DDISBA	Spectrin, beta, nonerythrocytic-1 (beta-fodrin)	182790	SPTBN1	6711	ENSG00000115306,ENST00000356805;;;ENST00000356805		Developmental delay, impaired speech, and behavioral abnormalities	619475	AD	3	Sptbn1
2p16.1-p15	2:54700001-63900000	DEL2p16.1-p15, C2DELp161-p15	Chromosome 2p16.1-p15 deletion syndrome	612513				contiguous gene deletion syndrome	Chromosome 2p16.1-p15 deletion syndrome	612513	IC	4	
2p16.1	2:54700001-61000000	HBFQTL5	Fetal hemoglobin quantitative trait locus 5	142335		3247		associated with rs11886868	[Fetal hemoglobin QTL5]	142335	AD	2	
2p16.1	2:55287842-55419856	CCDC88A, KIAA1212, HKRP1, GIRDIN, APE, GIV, PEHOL	Coiled-coil domain-containing protein 88A	609736	CCDC88A	55704	ENSG00000115355,ENST00000436346;;;ENST00000436346		PEHO syndrome-like	617507	AR	3	Ccdc88a
2p16.1	2:55634061-55693844	PNPT1, OLD35, COXPD13, DFNB70, SCA25	Polyribonucleotide nucleotidyltransferase 1	610316	PNPT1	87178	ENSG00000138035,ENST00000447944;;;ENST00000447944		Combined oxidative phosphorylation deficiency 13	614932	AR	3	Pnpt1
2p16.1	2:55634061-55693844	PNPT1, OLD35, COXPD13, DFNB70, SCA25	Polyribonucleotide nucleotidyltransferase 1	610316	PNPT1	87178	ENSG00000138035,ENST00000447944;;;ENST00000447944		Deafness, autosomal recessive 70, with or without adult-onset neurodegeneration	614934	AR	3	Pnpt1
2p16.1	2:55634061-55693844	PNPT1, OLD35, COXPD13, DFNB70, SCA25	Polyribonucleotide nucleotidyltransferase 1	610316	PNPT1	87178	ENSG00000138035,ENST00000447944;;;ENST00000447944		Spinocerebellar ataxia 25	608703	AD	3	Pnpt1
2p16.1	2:55865967-55923782	EFEMP1, FBNL, DHRD, GLC1H, ARCL1D	EGF-containing fibulin-like extracellular matrix protein 1 (fibrillin-like)	601548	EFEMP1	2202	ENSG00000115380,ENST00000355426;;;ENST00000355426		Cutis laxa, autosomal recessive, type ID	620780	AR	3	Efemp1
2p16.1	2:55865967-55923782	EFEMP1, FBNL, DHRD, GLC1H, ARCL1D	EGF-containing fibulin-like extracellular matrix protein 1 (fibrillin-like)	601548	EFEMP1	2202	ENSG00000115380,ENST00000355426;;;ENST00000355426		Doyne honeycomb degeneration of retina	126600	AD	3	Efemp1
2p16.1	2:55865967-55923782	EFEMP1, FBNL, DHRD, GLC1H, ARCL1D	EGF-containing fibulin-like extracellular matrix protein 1 (fibrillin-like)	601548	EFEMP1	2202	ENSG00000115380,ENST00000355426;;;ENST00000355426		Glaucoma 1, open angle, H	611276	AD	3	Efemp1
2p16.1	2:58159243-58241380	PHF9, FANCL	PHD finger protein 9	608111	FANCL	55120	ENSG00000115392,ENST00000233741;;;ENST00000233741		Fanconi anemia, complementation group L	614083	AR	3	Fancl
2p16.1	2:60450520-60553924	BCL11A, CTIP1, EVI9, KIAA1809, DILOS	BCL11 transcription factor A	606557	BCL11A	53335	ENSG00000119866,ENST00000642384;;;ENST00000642384		Dias-Logan syndrome	617101	AD	3	Bcl11a
2p16.1	2:60881574-60931612	REL, IMD92	REL protooncogene, NF-kappa-B subunit	164910	REL	5966	ENSG00000162924,ENST00000394479;;;ENST00000394479		Immunodeficiency 92	619652	AR	3	Rel
2p15	2:61017720-61051990	PEX13, ZWS, NALD, PBD11A, PBD11B	Peroxisome biogenesis factor 13 (peroxin 13)	601789	PEX13	5194	ENSG00000162928,ENST00000295030;;;ENST00000295030		Peroxisome biogenesis disorder 11A (Zellweger)	614883	AR	3	Pex13
2p15	2:61017720-61051990	PEX13, ZWS, NALD, PBD11A, PBD11B	Peroxisome biogenesis factor 13 (peroxin 13)	601789	PEX13	5194	ENSG00000162928,ENST00000295030;;;ENST00000295030		Peroxisome biogenesis disorder 11B	614885	AR	3	Pex13
2p15	2:61800240-61854060	FAM161A, RP28	Family with sequence similarity 161, member A	613596	FAM161A	84140	ENSG00000170264,ENST00000404929;;;ENST00000404929		Retinitis pigmentosa 28	606068	AR	3	Fam161a
2p15	2:62673878-63046487	EHBP1, KIAA0903, HPC12	EH domain-binding protein 1	609922	EHBP1	23301	ENSG00000115504,ENST00000431489;;;ENST00000431489		{Prostate cancer, hereditary, 12}	611868		3	Ehbp1
2p15	2:63119559-63840826	WDPCP, C2orf86, BBS15, CHDTHP	WD repeat-containing planar cell polarity effector	613580	WDPCP	51057	ENSG00000143951,ENST00000272321;;;ENST00000272321		Bardet-Biedl syndrome 15	615992	AR	3	Wdpcp
2p15	2:63119559-63840826	WDPCP, C2orf86, BBS15, CHDTHP	WD repeat-containing planar cell polarity effector	613580	WDPCP	51057	ENSG00000143951,ENST00000272321;;;ENST00000272321		Congenital heart defects, hamartomas of tongue, and polysyndactyly	217085	AR	3	Wdpcp
2p15	2:63588963-63607197	MDH1, DEE88, KAR	Malate dehydrogenase 1	154200	MDH1	4190	ENSG00000014641,ENST00000233114;;;ENST00000233114	proximal to APOB; mutation identified in 1 DEE88 family	?Developmental and epileptic encephalopathy 88	618959	AR	3	Mdh1
2p15	2:63840969-63891560	UGP2, UGPP2, DEE83	Uridyl diphosphate glucose pyrophosphorylase-2	191760	UGP2	7360	ENSG00000169764,ENST00000337130;;;ENST00000337130		Developmental and epileptic encephalopathy 83	618744	AR	3	Ugp2
2p14-p13.3	2:63900001-71300000	HRPT3	Hyperparathyroidism 3	610071		780919		between D2S2368 and D2S358	Hyperparathyroidism 3	610071		2	
2p14-p13	2:63900001-74800000	RLS7	Restless legs syndrome, susceptibility to, 7	612853		100302561		associated with rs2300478	{Restless legs syndrome 7}	612853		2	
2p14	2:64988479-65023865	SLC1A4, SATT, ASCT1, SPATCCM	Solute carrier family 1 (glutamate/neutral amino acid transporter), member 4	600229	SLC1A4	6509	ENSG00000115902,ENST00000234256;;;ENST00000234256		Spastic tetraplegia, thin corpus callosum, and progressive microcephaly	616657	AR	3	Slc1a4
2p14	2:65307175-65432599	SPRED2, NS14	Sprouty-related EVH1 domain-containing protein 2	609292	SPRED2	200734	ENSG00000198369,ENST00000356388;;;ENST00000356388		Noonan syndrome 14	619745	AR	3	Spred2
2p13	2:68400001-74800000	OFC2	Orofacial cleft 2	602966		4964		?relation to TGFA	Orofacial cleft 2	602966	AD	2	
2p13	2:68400001-74800000	PARK3	Parkinson disease 3	602404		5072			{Parkinson disease 3}	602404		2	
2p13	2:68400001-74800000	PEE1, PREG1	Preeclampsia/eclampsia 1	189800		5177		?distinct loci at 2p25 and 9p13	Preeclampsia/eclampsia 1	189800	AD	2	
2p13.3	2:69013144-69249327	ANTXR1, TEM8, ATR, GAPO	Anthrax toxin receptor 1	606410	ANTXR1	84168	ENSG00000169604,ENST00000303714;;;ENST00000303714	mutation identified in 1 HCI patient	{?Hemangioma, capillary infantile, susceptibility to}	602089	AD	3	Antxr1
2p13.3	2:69013144-69249327	ANTXR1, TEM8, ATR, GAPO	Anthrax toxin receptor 1	606410	ANTXR1	84168	ENSG00000169604,ENST00000303714;;;ENST00000303714	mutation identified in 1 HCI patient	GAPO syndrome	230740	AR	3	Antxr1
2p13.3	2:69319780-69387227	GFPT1, GFAT1, GFPT1L, MSLG, CMS12, CMSTA1	Glutamine-fructose-6-phosphate transaminase	138292	GFPT1	2673	ENSG00000198380,ENST00000357308;;;ENST00000357308		Myasthenia, congenital, 12, with tubular aggregates	610542	AR	3	Gfpt1
2p13.3	2:69395750-69439567	NFU1, HIRIP, MMDS1, SPG93	NFU1 iron-sulfur cluster scaffold	608100	NFU1	27247	ENSG00000169599,ENST00000410022;;;ENST00000410022		Multiple mitochondrial dysfunctions syndrome 1	605711	AR	3	Nfu1
2p13.3	2:69395750-69439567	NFU1, HIRIP, MMDS1, SPG93	NFU1 iron-sulfur cluster scaffold	608100	NFU1	27247	ENSG00000169599,ENST00000410022;;;ENST00000410022		Spastic paraplegia 93, autosomal recessive	620938	AR	3	Nfu1
2p13.3	2:69932717-70087375	ASPRV1, SASP, TAPS, MUNO, ADLI	Aspartic peptidase, retroviral-like 1	611765	ASPRV1	151516	ENSG00000293615,ENST00000682294		Ichthyosis, lamellar, autosomal dominant	146750	AD	3	Asprv1
2p13.3	2:70209444-70248793	TIA1, WDM, ALS26	TIA1 cytotoxic granule-associated RNA-binding protein	603518	TIA1	7072	ENSG00000116001,ENST00000433529;;;ENST00000433529		Amyotrophic lateral sclerosis 26 with or without frontotemporal dementia	619133	AD	3	Tia1
2p13.3	2:70209444-70248793	TIA1, WDM, ALS26	TIA1 cytotoxic granule-associated RNA-binding protein	603518	TIA1	7072	ENSG00000116001,ENST00000433529;;;ENST00000433529		Welander distal myopathy	604454	AD, AR	3	Tia1
2p13.3	2:70777310-70790643	FIGLA, POF6	Folliculogenesis specific bHLH transcription factor	608697	FIGLA	344018	ENSG00000183733,ENST00000332372;;;ENST00000332372		Premature ovarian failure 6	612310	AD, AR	3	Figla
2p13.3	2:70824130-70835816	CD207, LANGERIN, CLEC4K	CD207 antigen	604862	CD207	50489	ENSG00000116031,ENST00000410009;;;ENST00000410009	mutation identified in 1 patient	[?Birbeck granule deficiency]	613393		3	Cd207
2p13.3	2:70935900-70965431	ATP6V1B1, ATP6B1, VPP3, DRTA2	ATPase, H+ transporting, V1 subunit B1	192132	ATP6V1B1	525	ENSG00000116039,ENST00000234396;;;ENST00000234396		Distal renal tubular acidosis 2 with progressive sensorineural hearing loss	267300	AR	3	Atp6v1b1
2p13.3	2:71109687-71130229	MCEE	Methylmalonyl-CoA epimerase	608419	MCEE	84693	ENSG00000124370,ENST00000244217;;;ENST00000244217		Methylmalonyl-CoA epimerase deficiency	251120	AR	3	Mcee
2p13.2	2:71453561-71686763	DYSF, LGMDR2, MMD1	Dysferlin	603009	DYSF	8291	ENSG00000135636,ENST00000410020;;;ENST00000410020		Miyoshi muscular dystrophy 1	254130	AR	3	Dysf
2p13.2	2:71453561-71686763	DYSF, LGMDR2, MMD1	Dysferlin	603009	DYSF	8291	ENSG00000135636,ENST00000410020;;;ENST00000410020		Muscular dystrophy, limb-girdle, autosomal recessive 2	253601	AR	3	Dysf
2p13.2	2:71453561-71686763	DYSF, LGMDR2, MMD1	Dysferlin	603009	DYSF	8291	ENSG00000135636,ENST00000410020;;;ENST00000410020		Myopathy, distal, with anterior tibial onset	606768	AR	3	Dysf
2p13.2	2:72129238-72147862	CYP26B1, CYP26A2, P450RAI2, RHFCA	Cytochrome P450, subfamily XXVIB, polypeptide 1	605207	CYP26B1	56603	ENSG00000003137,ENST00000001146;;;ENST00000001146		Craniosynostosis with radiohumeral fusions and other skeletal and craniofacial anomalies	614416		3	Cyp26b1
2p13.2	2:72175984-72826033	EXOC6B, SEC15B, KIAA0919, SEMDJL3	Exocyst complex component 6B	607880	EXOC6B	23233	ENSG00000144036,ENST00000272427;;;ENST00000272427		Spondyloepimetaphyseal dysplasia with joint laxity, type 3	618395	AR	3	Exoc6b
2p13.2	2:72887408-72892158	SPR	Sepiapterin reductase	182125	SPR	6697	ENSG00000116096,ENST00000234454;;;ENST00000234454		Dystonia, dopa-responsive, due to sepiapterin reductase deficiency	612716	?AD, AR	3	Spr
2p13.1	2:73385758-73609919	ALMS1, ALSS, KIAA0328	ALMS1 centrosome and basal body associated protein	606844	ALMS1	7840	ENSG00000116127,ENST00000613296;;;ENST00000613296		Alstrom syndrome	203800	AR	3	Alms1
2p13.1	2:73729873-73737345	TPRKB, GAMOS5	TP53RK-binding protein	608680	TPRKB	51002	ENSG00000144034,ENST00000272424;;;ENST00000272424		Galloway-Mowat syndrome 5	617731	AR	3	Tprkb
2p13.1	2:73828961-73873656	STAMBP, AMSH, MICCAP	STAM binding protein	606247	STAMBP	10617	ENSG00000124356,ENST00000394070;;;ENST00000394070		Microcephaly-capillary malformation syndrome	614261	AR	3	Stambp
2p13.1	2:73893008-73919865	ACTG2, ACTA3, VSCM1, MMIHS5	Actin, gamma-2, smooth muscle, enteric	102545	ACTG2	72	ENSG00000163017,ENST00000345517;;;ENST00000345517		Megacystis-microcolon-intestinal hypoperistalsis syndrome 5	619431	AD	3	Actg2
2p13.1	2:73893008-73919865	ACTG2, ACTA3, VSCM1, MMIHS5	Actin, gamma-2, smooth muscle, enteric	102545	ACTG2	72	ENSG00000163017,ENST00000345517;;;ENST00000345517		Visceral myopathy 1	155310	AD	3	Actg2
2p13.1	2:73926880-73958946	DGUOK, DGK, MTDPS3, PEOB4, NCPH1	Deoxyguanosine kinase, mitochondrial	601465	DGUOK	1716	ENSG00000114956,ENST00000264093;;;ENST00000264093		Mitochondrial DNA depletion syndrome 3 (hepatocerebral type)	251880	AR	3	Dguok
2p13.1	2:73926880-73958946	DGUOK, DGK, MTDPS3, PEOB4, NCPH1	Deoxyguanosine kinase, mitochondrial	601465	DGUOK	1716	ENSG00000114956,ENST00000264093;;;ENST00000264093		Portal hypertension, noncirrhotic, 1	617068	AR	3	Dguok
2p13.1	2:73926880-73958946	DGUOK, DGK, MTDPS3, PEOB4, NCPH1	Deoxyguanosine kinase, mitochondrial	601465	DGUOK	1716	ENSG00000114956,ENST00000264093;;;ENST00000264093		Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 4	617070	AR	3	Dguok
2p13.1	2:73983631-74135498	TET3, KIAA0401, BEFAHRS	tet methylcytosine dioxygenase 3	613555	TET3	200424	ENSG00000187605,ENST00000409262;;;ENST00000409262		Beck-Fahrner syndrome	618798	AD, AR	3	Tet3
2p13.1	2:74135400-74147912	BOLA3, MMDS2	bolA family member 3	613183	BOLA3	388962	ENSG00000163170,ENST00000327428;;;ENST00000327428		Multiple mitochondrial dysfunctions syndrome 2 with hyperglycinemia	614299	AR	3	Bola3
2p13.1	2:74361155-74391866	DCTN1, HMND14	Dynactin 1	601143	DCTN1	1639	ENSG00000204843,ENST00000628224;;;ENST00000628224		{Amyotrophic lateral sclerosis, susceptibility to}	105400	AD, AR	3	Dctn1
2p13.1	2:74361155-74391866	DCTN1, HMND14	Dynactin 1	601143	DCTN1	1639	ENSG00000204843,ENST00000628224;;;ENST00000628224		Neuronopathy, distal hereditary motor, autosomal dominant 14	607641	AD	3	Dctn1
2p13.1	2:74361155-74391866	DCTN1, HMND14	Dynactin 1	601143	DCTN1	1639	ENSG00000204843,ENST00000628224;;;ENST00000628224		Perry syndrome	168605	AD	3	Dctn1
2p13.1	2:74461057-74465382	MOGS, GCS1, CDG2B	Mannosyl-oligosaccharide glucosidase	601336	MOGS	7841	ENSG00000115275,ENST00000448666;;;ENST00000448666		Congenital disorder of glycosylation, type IIb	606056	AR	3	Mogs
2p13.1	2:74529405-74533556	HTRA2, OMI, PARK13, PRSS25, MGCA8	HTRA serine peptidase 2	606441	HTRA2	27429	ENSG00000115317,ENST00000258080;;;ENST00000258080		{Parkinson disease 13}	610297		3	Htra2
2p13.1	2:74529405-74533556	HTRA2, OMI, PARK13, PRSS25, MGCA8	HTRA serine peptidase 2	606441	HTRA2	27429	ENSG00000115317,ENST00000258080;;;ENST00000258080		3-methylglutaconic aciduria, type VIII	617248	AR	3	Htra2
2p13.1	2:74532258-74555702	LOXL3, MYP28	Lysyl oxidase-like 3	607163	LOXL3	84695	ENSG00000115318,ENST00000264094;;;ENST00000264094		Myopia 28, autosomal recessive	619781	AR	3	Loxl3
2p13.1	2:74557883-74648330	M1AP, SPATA37, C2orf65, SPGF48	Meiosis 1-associated protein	619098	M1AP	130951	ENSG00000159374,ENST00000421985;;;ENST00000421985		Spermatogenic failure 48	619108	AR	3	M1ap
2p12	2:74800001-83100000	CTRCT27, CCNP	Cataract 27, nuclear progressive	607304		266979		near D2S2333	Cataract 27, nuclear progressive	607304		2	
2p12-p11.2	2:74800001-91800000	DEL2p12p11.2, C2DELp12p11.2	Chromosome 2p12-p11.2 deletion syndrome	613564				contiguous gene deletion syndrome	Chromosome 2p12-p11.2 deletion syndrome	613564	IC	4	
2p12	2:74800001-83100000	DFNA43	Deafness, autosomal dominant 43	608394		192676		max lod at D2S139	Deafness, autosomal dominant 43	608394	AD	2	
2p12-q22	2:74800001-147900000	HSR	Hand skill, relative	139900		338386			[Handedness]	139900	AD	2	
2p12	2:79185377-80648780	CTNNA2, CAPR, CTNR, CDCBM9	Catenin, alpha-2 (cadherin-associated protein, related)	114025	CTNNA2	1496	ENSG00000066032,ENST00000402739;;;ENST00000402739		Cortical dysplasia, complex, with other brain malformations 9	618174	AR	3	Ctnna2
2p11.2	2:84423528-84459280	SUCLG1, SUCLA1, MTDPS9	Succinate-CoA ligase, GDP/ADP-forming, subunit alpha	611224	SUCLG1	8802	ENSG00000163541,ENST00000393868;;;ENST00000393868		Mitochondrial DNA depletion syndrome 9 (encephalomyopathic type with methylmalonic aciduria)	245400	AR	3	Suclg1
2p11.2	2:85354769-85391748	ELMOD3, RBED1, DFNB88, DFNA81	ELMO/CED12 domain-containing protein 3	615427	ELMOD3	84173	ENSG00000115459,ENST00000409013;;;ENST00000409013	mutation identified in 1 DFNB88 and 1 DFNA81 family	?Deafness, autosomal dominant 81	619500	AD	3	Elmod3
2p11.2	2:85354769-85391748	ELMOD3, RBED1, DFNB88, DFNA81	ELMO/CED12 domain-containing protein 3	615427	ELMOD3	84173	ENSG00000115459,ENST00000409013;;;ENST00000409013	mutation identified in 1 DFNB88 and 1 DFNA81 family	?Deafness, autosomal recessive 88	615429	AR	3	Elmod3
2p11.2	2:85544720-85561493	GGCX, VKCFD1	Gamma-glutamyl carboxylase	137167	GGCX	2677	ENSG00000115486,ENST00000233838;;;ENST00000233838		Pseudoxanthoma elasticum-like disorder with multiple coagulation factor deficiency	610842		3	Ggcx
2p11.2	2:85544720-85561493	GGCX, VKCFD1	Gamma-glutamyl carboxylase	137167	GGCX	2677	ENSG00000115486,ENST00000233838;;;ENST00000233838		Vitamin K-dependent clotting factors, combined deficiency of, 1	277450	AR	3	Ggcx
2p11.2	2:85657307-85668741	SFTPB, SFTB3, SMDP1	Pulmonary surfactant-associated protein B, 18kD	178640	SFTPB	6439	ENSG00000168878,ENST00000519937;;;ENST00000519937		Surfactant metabolism dysfunction, pulmonary, 1	265120	AR	3	Sftpb
2p11.2	2:85837120-85889034	SIAT9, ST3GALV, SPDRS	Sialyltransferase 9	604402	ST3GAL5	8869	ENSG00000115525,ENST00000638572;;;ENST00000638572		Salt and pepper developmental regression syndrome	609056	AR	3	St3gal5
2p11.2	2:86020216-86105886	POLR1A, RPA194, AFDCIN, HLD27	Polymerase I, RNA, subunit A	616404	POLR1A	25885	ENSG00000068654,ENST00000263857;;;ENST00000263857		Acrofacial dysostosis, Cincinnati type	616462	AD	3	Polr1a
2p11.2	2:86020216-86105886	POLR1A, RPA194, AFDCIN, HLD27	Polymerase I, RNA, subunit A	616404	POLR1A	25885	ENSG00000068654,ENST00000263857;;;ENST00000263857		Leukodystrophy, hypomyelinating, 27	620675	AR	3	Polr1a
2p11.2	2:86106235-86142157	PTCD3, COXPD51	Pentatricopeptide repeat domain-containing protein 3	614918	PTCD3	55037	ENSG00000132300,ENST00000254630;;;ENST00000254630		Combined oxidative phosphorylation deficiency 51	619057	AR	3	Ptcd3
2p11.2	2:86213993-86338083	REEP1, C2orf23, SPG31, HMND12, HMNR6	Receptor expression-enhancing protein 1	609139	REEP1	65055	ENSG00000068615,ENST00000538924;;;ENST00000538924	mutation identified in 1 HMND12 family	?Neuronopathy, distal hereditary motor, autosomal dominant 12	614751	AD	3	Reep1
2p11.2	2:86213993-86338083	REEP1, C2orf23, SPG31, HMND12, HMNR6	Receptor expression-enhancing protein 1	609139	REEP1	65055	ENSG00000068615,ENST00000538924;;;ENST00000538924	mutation identified in 1 HMND12 family	Neuronopathy, distal hereditary motor, autosomal recessive 6	620011	AR	3	Reep1
2p11.2	2:86213993-86338083	REEP1, C2orf23, SPG31, HMND12, HMNR6	Receptor expression-enhancing protein 1	609139	REEP1	65055	ENSG00000068615,ENST00000538924;;;ENST00000538924	mutation identified in 1 HMND12 family	Spastic paraplegia 31, autosomal dominant	610250	AD	3	Reep1
2p11.2	2:86784605-86808396	CD8A, IMD116	CD8 antigen, alpha polypeptide  (p32)	186910	CD8A	925	ENSG00000153563,ENST00000283635;;;ENST00000283635	distal to IGK	Immunodeficiency 116	608957	AR	3	Cd8a
2p11.2	2:88446787-88452693	FOXI3, CFM2	Forkhead box I3	612351	FOXI3	344167	ENSG00000214336,ENST00000428390;;;ENST00000428390		Craniofacial microsomia 2	620444	AD, AR	3	Foxi3
2p11.2	2:88556741-88628145	EIF2AK3, PEK, PERK, WRS	Eukaryotic translation initiation factor 2-alpha kinase 3	604032	EIF2AK3	9451	ENSG00000172071,ENST00000303236;;;ENST00000303236		Wolcott-Rallison syndrome	226980	AR	3	Eif2ak3
2p11.2	2:88691673-88750929	RPIA, RPI, RPIAD	Ribose 5-phosphate isomerase A	180430	RPIA	22934	ENSG00000153574,ENST00000283646;;;ENST00000283646		Ribose 5-phosphate isomerase deficiency	608611	AR	3	Rpia
2p11.2	2:88857361-88857683	IGKC, IGKCD	Immunoglobulin kappa constant region	147200		3514	ENSG00000211592,-		Kappa light chain deficiency	614102	AR	3	Igkc
2q11-q12	2:93900001-108700000	CELIAC8	Celiac disease, susceptibility to, 8	612006		100188870		associated with rs917997 and rs13015714	{Celiac disease, susceptibility to, 8}	612006		2	
2q	2:93900001-242193529	COPD	Pulmonary disease, chronic obstructive, severe early-onset	606963		260431		?SERPINE2	Pulmonary disease, chronic obstructive, severe early-onset	606963		2	
2cen-q13	2:93900001-112200000	GLC1B	Glaucoma 1, open angle, B (adult-onset)	606689		2722			Glaucoma 1B, primary open angle, adult onset	606689		2	
2q11-q14	2:93900001-129100000	NNO3	Nanophthalmos 3	611897		100187717		max lod at D2S2265	Nanophthalmos 3	611897	AD	2	
2q11.1	2:95025708-95053992	MAL, HLD28	T-lymphocyte maturation-associated protein	188860	MAL	4118	ENSG00000172005,ENST00000309988;;;ENST00000309988	mutation identified in 1 HLD28 family	?Leukodystrophy, hypomyelinating, 28	620978	AR	3	Mal
2q11.2	2:96122818-96138564	ASTL, OZEMA11	Astacin-like metalloendopeptidase	608860	ASTL	431705	ENSG00000188886,ENST00000342380;;;ENST00000342380	mutation identified in 1 OZEMA11 family	?Oocyte/zygote/embryo maturation arrest 11	619643	AR	3	Astl
2q11.2	2:96184859-96208827	STARD7, GTT1, FAME2	START domain-containing protein 4	616712	STARD7	56910	ENSG00000084090,ENST00000337288;;;ENST00000337288		Epilepsy, familial adult myoclonic, 2	607876	AD	3	Stard7
2q11.2	2:96248514-96265997	TMEM127	Transmembrane protein 127	613403	TMEM127	55654	ENSG00000135956,ENST00000258439;;;ENST00000258439		{Pheochromocytoma, susceptibility to}	171300	AD	3	Tmem127
2q11.2	2:96266225-96274173	CIAO1, WDR39, MMDS10	WD repeat-containing protein CIAO1	604333	CIAO1	9391	ENSG00000144021,ENST00000488633;;;ENST00000488633		Multiple mitochondrial dysfunctions syndrome 10	620960	AR	3	Ciao1
2q11.2	2:96274338-96305546	SNRNP200, ASCC3L1, KIAA0788, RP33	Small nuclear ribonucleoprotein 200kD (U5)	601664	SNRNP200	23020	ENSG00000144028,ENST00000323853;;;ENST00000323853		Retinitis pigmentosa 33	610359	AD	3	Snrnp200
2q11.2	2:96335766-96377091	NCAPH, CAPH, BRRN1, MCPH23	Non-SMC condensin I complex subunit H	602332	NCAPH	23397	ENSG00000121152,ENST00000240423;;;ENST00000240423	mutation identified in 1 MCPH23 patient	?Microcephaly 23, primary, autosomal recessive	617985	AR	3	Ncaph
2q11.2	2:96705929-96740064	LMAN2L, VIPL, MRT52, MRD69	Lectin, mannose binding 2-like	609552	LMAN2L	81562	ENSG00000114988,ENST00000264963;;;ENST00000264963	mutation identified in 1 MRT52 family and in 1 MRD69 family	?Intellectual developmental disorder, autosomal dominant 69	617863	AD	3	Lman2l
2q11.2	2:96705929-96740064	LMAN2L, VIPL, MRT52, MRD69	Lectin, mannose binding 2-like	609552	LMAN2L	81562	ENSG00000114988,ENST00000264963;;;ENST00000264963	mutation identified in 1 MRT52 family and in 1 MRD69 family	?Intellectual developmental disorder, autosomal recessive 52	616887	AR	3	Lman2l
2q11.2	2:96760902-96811874	CNNM4, ACDP4	Cyclin M4	607805	CNNM4	26504	ENSG00000158158,ENST00000377075;;;ENST00000377075		Jalili syndrome	217080	AR	3	Cnnm4
2q11.2	2:97713576-97756364	ZAP70, SRK, ADMIO2, IMD48	Zeta-chain associated protein kinase, 70kD (syk-related tyrosine kinase)	176947	ZAP70	7535	ENSG00000115085,ENST00000264972;;;ENST00000264972		Autoimmune disease, multisystem, infantile-onset, 2	617006	AR	3	Zap70
2q11.2	2:97713576-97756364	ZAP70, SRK, ADMIO2, IMD48	Zeta-chain associated protein kinase, 70kD (syk-related tyrosine kinase)	176947	ZAP70	7535	ENSG00000115085,ENST00000264972;;;ENST00000264972		Immunodeficiency 48	269840	AR	3	Zap70
2q11.2	2:98087167-98330616	VWA3B, SCAR22	von Willebrand factor A domain-containing protein 3B	614884	VWA3B	200403	ENSG00000168658,ENST00000477737;;;ENST00000477737	mutation identified in 1 SCAR22 family	?Spinocerebellar ataxia, autosomal recessive 22	616948	AR	3	Vwa3b
2q11.2	2:98346456-98398601	CNGA3, CNG3, ACHM2	Cyclic nucleotide-gated channel, alpha-3	600053	CNGA3	1261	ENSG00000144191,ENST00000272602;;;ENST00000272602		Achromatopsia 2	216900	AR	3	Cnga3
2q11.2	2:98444587-98594392	INPP4A, INPP4, NEDGQS	Inositol polyphosphate-4-phosphatase, type I, 107kD	600916	INPP4A	3631	ENSG00000040933,ENST00000409851;;;ENST00000409851		Neurodevelopmental disorder with growth impairment, quadriparesis, and poor or absent speech	621354	AR	3	Inpp4a
2q11.2	2:98599314-98608512	COA5, C2orf64, PET191, MC4DN9	Cytochrome c oxidase assembly factor 5	613920	COA5	493753	ENSG00000183513,ENST00000328709;;;ENST00000328709	mutation identified in 1 MC4DN9 family	?Mitochondrial complex IV, deficiency, nuclear type 9	616500	AR	3	Coa5
2q11.2	2:98997261-99154966	TSGA10, SPGF26	Testis-specific protein 10	607166	TSGA10	80705	ENSG00000135951,ENST00000393483;;;ENST00000393483	mutation identified in 1 SPGF26	?Spermatogenic failure 26	617961	AR	3	Tsga10
2q11.2	2:99154967-99163137	LIPT1, LIPT1D	Lipoyltransferase 1	610284	LIPT1	51601	ENSG00000144182,ENST00000651691;;;ENST00000651691		Lipoyltransferase 1 deficiency	616299	AR	3	Lipt1
2q11.2	2:99545419-100142590	AFF3, LAF4, KINS	AF4/FMR2 family, member 3	601464	AFF3	3899	ENSG00000144218,ENST00000672756;;;ENST00000672756		KINSSHIP syndrome	619297	AD	3	Aff3
2q11.2-q12.1	2:102070390-102179874	IL1R1, IL1RA, CRMO3	Interleukin-1 receptor, type I	147810	IL1R1	3554	ENSG00000115594,ENST00000410023;;;ENST00000410023	mutation identified in 1 CRMO3 patient	?Chronic recurrent multifocal osteomyelitis 3	259680	AD	3	Il1r1
2q12.1	2:104853276-104927773	POU3F3, SNIBFIS	POU domain, class 3, transcription factor-3	602480	POU3F3	5455	ENSG00000198914,ENST00000361360;;;ENST00000361360		Snijders Blok-Fisher syndrome	618604	AD	3	Pou3f3
2q12.3	2:107986524-108013994	SLC5A7, CHT1, HMND7, CMS20	Solute carrier family 5 (choline transporter), member 7	608761	SLC5A7	60482	ENSG00000115665,ENST00000264047;;;ENST00000264047		Myasthenic syndrome, congenital, 20, presynaptic	617143	AR	3	Slc5a7
2q12.3	2:107986524-108013994	SLC5A7, CHT1, HMND7, CMS20	Solute carrier family 5 (choline transporter), member 7	608761	SLC5A7	60482	ENSG00000115665,ENST00000264047;;;ENST00000264047		Neuronopathy, distal hereditary motor, autosomal dominant 7	158580	AD	3	Slc5a7
2q13	2:108700001-112200000	COMA	Cogan-type congenital oculomotor apraxia	257550		266710		independent gene or feature of nephronophthisis	Oculomotor apraxia, congenital, Cogan-type	257550	AR	2	
2q13	2:108719482-109842301	RANBP2, NUP358, ANE1, IIAE3	RAN-binding protein 2	601181	RANBP2	5903	ENSG00000153201,ENST00000283195;;;ENST00000283195		{Encephalopathy, acute, infection-induced, 3, susceptibility to}	608033	AD	3	Ranbp2
2q13	2:108894471-108989220	EDAR, DL, ED3, EDA3, HRM1, ECTD10A, ECTD10B	Ectodysplasin 1, anhidrotic receptor (downless, mouse, homolog of)	604095	EDAR	10913	ENSG00000135960,ENST00000258443;;;ENST00000258443		[Hair morphology 1, hair thickness]	612630		3	Edar
2q13	2:108894471-108989220	EDAR, DL, ED3, EDA3, HRM1, ECTD10A, ECTD10B	Ectodysplasin 1, anhidrotic receptor (downless, mouse, homolog of)	604095	EDAR	10913	ENSG00000135960,ENST00000258443;;;ENST00000258443		Ectodermal dysplasia 10A, hypohidrotic/hair/nail type, autosomal dominant	129490	AD	3	Edar
2q13	2:108894471-108989220	EDAR, DL, ED3, EDA3, HRM1, ECTD10A, ECTD10B	Ectodysplasin 1, anhidrotic receptor (downless, mouse, homolog of)	604095	EDAR	10913	ENSG00000135960,ENST00000258443;;;ENST00000258443		Ectodermal dysplasia 10B, hypohidrotic/hair/tooth type, autosomal recessive	224900	AR	3	Edar
2q13	2:110123348-110205013	NPHP1, NPH1, SLSN1, JBTS4	Nephrocystin	607100	NPHP1	4867	ENSG00000144061,ENST00000445609;;;ENST00000445609		Joubert syndrome 4	609583	AR	3	Nphp1
2q13	2:110123348-110205013	NPHP1, NPH1, SLSN1, JBTS4	Nephrocystin	607100	NPHP1	4867	ENSG00000144061,ENST00000445609;;;ENST00000445609		Nephronophthisis 1, juvenile	256100	AR	3	Nphp1
2q13	2:110123348-110205013	NPHP1, NPH1, SLSN1, JBTS4	Nephrocystin	607100	NPHP1	4867	ENSG00000144061,ENST00000445609;;;ENST00000445609		Senior-Loken syndrome-1	266900	AR	3	Nphp1
2q13	2:110637528-110678063	BUB1, MCPH30	BUB1 mitotic checkpoint serine/threonine kinase	602452	BUB1	699	ENSG00000169679,ENST00000302759;;;ENST00000302759		Colorectal cancer with chromosomal instability, somatic	114500		3	Bub1
2q13	2:110637528-110678063	BUB1, MCPH30	BUB1 mitotic checkpoint serine/threonine kinase	602452	BUB1	699	ENSG00000169679,ENST00000302759;;;ENST00000302759		Microcephaly 30, primary, autosomal recessive	620183	AR	3	Bub1
2q13	2:111766231-111884193	ANAPC1, APC1	Anaphase-promoting complex, subunit 1	608473	ANAPC1	64682	ENSG00000153107,ENST00000341068;;;ENST00000341068		Rothmund-Thomson syndrome, type 1	618625	AR	3	Anapc1
2q13	2:111898607-112029561	MERTK, RP38	Mer tyrosine kinase protooncogene	604705	MERTK	10461	ENSG00000153208,ENST00000295408;;;ENST00000295408		Retinitis pigmentosa 38	613862	AR	3	Mertk
2q14.1	2:112200001-118100000	BMIQ13	Body mass index quantitative trait locus 13	612459		100233157		associated with rs7566605	[Body mass index QTL13]	612459		2	
2q14-q22	2:112200001-147900000	CMD1H	Cardiomyopathy, dilated, 1H	604288		23459			Cardiomyopathy, dilated, 1H	604288		2	
2q14	2:112200001-129100000	ENDOVESL	ENDOVE syndrome, limb-only type	619217					ENDOVE syndrome, limb-only type	619217	AR	4	
2q14.1	2:112542036-112579818	POLR1B, TCS4	Polymerase I, RNA, subunit B	602000	POLR1B	84172	ENSG00000125630,ENST00000263331;;;ENST00000263331		Treacher-Collins syndrome 4	618939	AD	3	Polr1b
2q14.1	2:112736349-112764609	CKAP2L, RADMIS	Cytoskeleton-associated protein 2-like	616174	CKAP2L	150468	ENSG00000169607,ENST00000302450;;;ENST00000302450		Filippi syndrome	272440	AR	3	Ckap2l
2q14.1	2:112829751-112836779	IL1B	Interleukin-1, beta	147720	IL1B	3553	ENSG00000125538,ENST00000263341;;;ENST00000263341	within 430kb of IL1RN, IL1A	{Gastric cancer risk after H. pylori infection}	613659		3	Il1b
2q14.1	2:112911165-112918882	IL37, IL1F7, FIL1Z, IL1H4, IL1RP1, IBD31	Interleukin 37	605510	IL37	27178	ENSG00000125571,ENST00000263326;;;ENST00000263326	mutation identified in 1 IBD31 patient	?Inflammatory bowel disease (infantile ulcerative colitis) 31	619398	AR	3	
2q14.1	2:113058638-113064744	IL36RN, IL1F5, FIL1D, IL1HY1, IL1RP3, PSORP, PSORS14	Interleukin 36 receptor antagonist	605507	IL36RN	26525	ENSG00000136695,ENST00000393200;;;ENST00000393200		Psoriasis 14, pustular	614204	AR	3	Il36rn
2q14.1	2:113099360-113134014	IL1RN, MVCD4, DIRA, CRMO2	Interleukin-1 receptor antagonist	147679	IL1RN	3557	ENSG00000136689,ENST00000409930;;;ENST00000409930		{Gastric cancer risk after H. pylori infection}	613659		3	Il1rn
2q14.1	2:113099360-113134014	IL1RN, MVCD4, DIRA, CRMO2	Interleukin-1 receptor antagonist	147679	IL1RN	3557	ENSG00000136689,ENST00000409930;;;ENST00000409930		{Microvascular complications of diabetes 4}	612628		3	Il1rn
2q14.1	2:113099360-113134014	IL1RN, MVCD4, DIRA, CRMO2	Interleukin-1 receptor antagonist	147679	IL1RN	3557	ENSG00000136689,ENST00000409930;;;ENST00000409930		Chronic recurrent multifocal osteomyelitis 2, with periostitis and pustulosis	612852	AR	3	Il1rn
2q14.1	2:113099360-113134014	IL1RN, MVCD4, DIRA, CRMO2	Interleukin-1 receptor antagonist	147679	IL1RN	3557	ENSG00000136689,ENST00000409930;;;ENST00000409930		Interleukin 1 receptor antagonist deficiency	612852	AR	3	Il1rn
2q14.1	2:113215997-113278921	PAX8	Paired box homeotic gene-8	167415	PAX8	7849	ENSG00000125618,ENST00000429538;;;ENST00000429538		Hypothyroidism, congenital, due to thyroid dysgenesis or hypoplasia	218700	AD	3	Pax8
2q14.2	2:118842171-118847648	EN1, ENDOVESLB	Engrailed-1	131290	EN1	2019	ENSG00000163064,ENST00000295206;;;ENST00000295206	mutation identified in 1 ENDOVESLB patient	?ENDOVE syndrome, limb-brain type	619218	AR	3	En1
2q14.2	2:119223834-119265652	STEAP3, TSAP6, AHMIO2	STEAP3 metalloreductase	609671	STEAP3	55240	ENSG00000115107,ENST00000393110;;;ENST00000393110	mutation identified in 1 AHMIO2 family	?Anemia, hypochromic microcytic, with iron overload 2	615234	AD	3	Steap3
2q14.2	2:119544449-119660323	CFAP221, PCDP1, CILD55	Cilia- and flagella-associated protein 221	618704	CFAP221	200373	ENSG00000163075,ENST00000413369;;;ENST00000413369		Ciliary dyskinesia, primary, 55	279000	AR	3	Cfap221
2q14.2	2:120735868-120992653	GLI2, HPE9, CJS	GLI-Kruppel family member GLI2 (oncogene GLI2)	165230	GLI2	2736	ENSG00000074047,ENST00000361492;;;ENST00000361492		Culler-Jones syndrome	615849	AD	3	Gli2
2q14.2	2:120735868-120992653	GLI2, HPE9, CJS	GLI-Kruppel family member GLI2 (oncogene GLI2)	165230	GLI2	2736	ENSG00000074047,ENST00000361492;;;ENST00000361492		Holoprosencephaly 9	610829	AD	3	Gli2
2q14.2	2:121530880-121531009	RNU4ATAC, U4ATAC, MOPD1, TALS, RFMN, LWS	RNA, U4ATAC small nuclear	601428	RNU4ATAC	100151683	ENSG00000264229,ENST00000580972;;;ENST00000580972		Lowry-Wood syndrome	226960	AR	3	
2q14.2	2:121530880-121531009	RNU4ATAC, U4ATAC, MOPD1, TALS, RFMN, LWS	RNA, U4ATAC small nuclear	601428	RNU4ATAC	100151683	ENSG00000264229,ENST00000580972;;;ENST00000580972		Microcephalic osteodysplastic primordial dwarfism, type I	210710	AR	3	
2q14.2	2:121530880-121531009	RNU4ATAC, U4ATAC, MOPD1, TALS, RFMN, LWS	RNA, U4ATAC small nuclear	601428	RNU4ATAC	100151683	ENSG00000264229,ENST00000580972;;;ENST00000580972		Roifman syndrome	616651	AR	3	
2q14.3-q21.3	2:121600001-136100000	DYT21	Dystonia 21	614588		100885773			Dystonia 21	614588	AD	2	
2q14.3	2:126656158-126696667	GYPC, GE, GPC	Glycophorin C	110750	GYPC	2995	ENSG00000136732,ENST00000259254;;;ENST00000259254		[Blood group, Gerbich]	616089		3	Gypc
2q14.3	2:126656158-126696667	GYPC, GE, GPC	Glycophorin C	110750	GYPC	2995	ENSG00000136732,ENST00000259254;;;ENST00000259254		{Malaria, resistance to}	611162		3	Gypc
2q14.3	2:127048023-127107154	BIN1, AMPHL, CNM2	Box-dependent MYC-interacting protein-1 (amphiphysin-like)	601248	BIN1	274	ENSG00000136717,ENST00000316724;;;ENST00000316724		Centronuclear myopathy 2	255200	AR	3	Bin1
2q14.3	2:127257290-127294144	ERCC3, XPB, TTD2	ERCC excision repair 3, TFIIH core complex helicase subunit	133510	ERCC3	2071	ENSG00000163161,ENST00000285398;;;ENST00000285398		Trichothiodystrophy 2, photosensitive	616390	AR	3	Ercc3
2q14.3	2:127257290-127294144	ERCC3, XPB, TTD2	ERCC excision repair 3, TFIIH core complex helicase subunit	133510	ERCC3	2071	ENSG00000163161,ENST00000285398;;;ENST00000285398		Xeroderma pigmentosum, group B	610651	AR	3	Ercc3
2q14.3	2:127418427-127429242	PROC, PC, THPH3, THPH4	Protein C (inactivator of coagulation factors Va and VIIIa)	612283	PROC	5624	ENSG00000115718,ENST00000234071;;;ENST00000234071		Thrombophilia 3 due to protein C deficiency, autosomal dominant	176860	AD	3	Proc
2q14.3	2:127418427-127429242	PROC, PC, THPH3, THPH4	Protein C (inactivator of coagulation factors Va and VIIIa)	612283	PROC	5624	ENSG00000115718,ENST00000234071;;;ENST00000234071		Thrombophilia 3 due to protein C deficiency, autosomal recessive	612304	AR	3	Proc
2q14.3	2:127638426-127681786	LIMS2, PINCH2, MDRCMTT	LIM zinc finger domain-containing protein 2	607908	LIMS2	55679	ENSG00000072163,ENST00000355119;;;ENST00000355119	mutation identified in 1 LGMD2W family	?Muscular dystrophy, autosomal recessive, with cardiomyopathy and triangular tongue	616827	AR	3	Lims2
2q14.3	2:128091200-128195677	UGGT1, HUGT1, CDG2CC	UDP-glucose glycoprotein glucosyltransferase 1	605897	UGGT1	56886	ENSG00000136731,ENST00000259253;;;ENST00000259253		Congenital disorder of glycosylation, type IICC	621381	AR	3	Uggt1
2q14.3	2:128265480-128318868	HS6ST1, HS6ST, HH15	Heparan sulfate 6-O-sulfotransferase 1	604846	HS6ST1	9394	ENSG00000136720,ENST00000259241;;;ENST00000259241		{Hypogonadotropic hypogonadism 15 with or without anosmia}	614880	AD	3	Hs6st1
2q21.1	2:129100001-131700000	ADHD5	Attention deficit-hyperactivity disorder, susceptibility to, 5	612311		100190790		max lod at rs985162	{Attention deficit-hyperactivity disorder, susceptibility to, 5}	612311		2	
2q21.1-q22	2:129100001-147900000	CHDS2	Coronary heart disease, susceptibility to, 2	608316		387584			{Coronary heart disease, susceptibility to, 2}	608316		2	
2q21	2:129100001-136100000	NMTC3	Nonmedullary thyroid carcinoma 3	606240		114568			{Thyroid carcinoma, nonmedullary, 3}	606240	AD	2	
2q21.1	2:130151392-130181757	SMPD4, NSMASE3, KIAA1418, NEDMABA	Sphingomyelin phosphodiesterase 4, neutral membrane	610457	SMPD4	55627	ENSG00000136699,ENST00000680298;;;ENST00000680298		Neurodevelopmental disorder with microcephaly, arthrogryposis, and structural brain anomalies	618622	AR	3	Smpd4
2q21.1	2:130337933-130342681	CCDC115, CCP1, CDG2O	Coiled-coil domain-containing protein 115	613734	VMA22	84317	ENSG00000136710,ENST00000259229;;;ENST00000259229		Congenital disorder of glycosylation, type IIo	616828	AR	3	Ccdc115
2q21.1	2:130592165-130599575	CFC1, CRYPTIC, HTX2	Cryptic protein	605194	CFC1	55997	ENSG00000136698,ENST00000259216;;;ENST00000259216		Heterotaxy, visceral, 2, autosomal	605376	AD	3	Cfc1
2q21.1	2:131476119-131482934	TUBA3D, KTCN9	Tubulin, alpha-3D	617878	TUBA3D	113457	ENSG00000075886,ENST00000321253;;;ENST00000321253		Keratoconus 9	617928	AD	3	Tuba3a,Tuba3b
2q21.3	2:134455759-134719000	TMEM163, SV31, HLD25	Transmembrane protein 163	618978	TMEM163	81615	ENSG00000152128,ENST00000281924;;;ENST00000281924	REc	Leukodystrophy, hypomyelinating, 25	620243	AD	3	Tmem163
2q21.3	2:135052292-135176396	RAB3GAP1, WARBM1, P130, MARTS2	RAB3 GTPase-activating protein, catalytic subunit	602536	RAB3GAP1	22930	ENSG00000115839,ENST00000264158;;;ENST00000264158		Martsolf syndrome 2	619420	AR	3	Rab3gap1
2q21.3	2:135052292-135176396	RAB3GAP1, WARBM1, P130, MARTS2	RAB3 GTPase-activating protein, catalytic subunit	602536	RAB3GAP1	22930	ENSG00000115839,ENST00000264158;;;ENST00000264158		Warburg micro syndrome 1	600118	AR	3	Rab3gap1
2q21.3	2:135787850-135837184	LCT, LAC, LPH	Lactase (lactase-phlorizin hydrolase)	603202	LCT	3938	ENSG00000115850,ENST00000264162;;;ENST00000264162		Lactase deficiency, congenital	223000	AR	3	Lct
2q21.3	2:135839626-135876443	MCM6	Minichromosome maintenance complex component 6	601806	MCM6	4175	ENSG00000076003,ENST00000264156;;;ENST00000264156	mutations in introns 9 and 13	Lactase persistence/nonpersistence	223100	AD	3	Mcm6
2q21.3	2:135905881-135985684	DARS1, DARS, HBSL	Aspartyl tRNA synthetase 1	603084	DARS1	1615	ENSG00000115866,ENST00000264161;;;ENST00000264161		Hypomyelination with brainstem and spinal cord involvement and leg spasticity	615281	AR	3	Dars1
2q22-q24	2:136100001-168900000	MAFD5	Major affective disorder 5	611535		100188843			{Major affective disorder 5}	611535		2	
2q22.1	2:136114349-136118149	CXCR4, D2S201E, NPY3R, WHIMS1	Chemokine (C-X-C motif) receptor 4 (neuropeptide Y receptor Y3)	162643	CXCR4	7852	ENSG00000121966,ENST00000241393;;;ENST00000241393		Myelokathexis, isolated	193670	AD	3	Cxcr4
2q22.1	2:136114349-136118149	CXCR4, D2S201E, NPY3R, WHIMS1	Chemokine (C-X-C motif) receptor 4 (neuropeptide Y receptor Y3)	162643	CXCR4	7852	ENSG00000121966,ENST00000241393;;;ENST00000241393		WHIM syndrome 1	193670	AD	3	Cxcr4
2q22.1	2:137964473-138016364	HNMT, MRT51	Histamine N-methyltransferase	605238	HNMT	3176	ENSG00000150540,ENST00000280097;;;ENST00000280097		{Asthma, susceptibility to}	600807	AD	3	Hnmt
2q22.1	2:137964473-138016364	HNMT, MRT51	Histamine N-methyltransferase	605238	HNMT	3176	ENSG00000150540,ENST00000280097;;;ENST00000280097		Intellectual developmental disorder, autosomal recessive 51	616739	AR	3	Hnmt
2q22.2	2:142877664-143055833	KYNU, KYNUU, VCRL2	Kynureninase	605197	KYNU	8942	ENSG00000115919,ENST00000264170;;;ENST00000264170	mutation identified in 1 KYNUU family	?Hydroxykynureninuria	236800	AR	3	Kynu
2q22.2	2:142877664-143055833	KYNU, KYNUU, VCRL2	Kynureninase	605197	KYNU	8942	ENSG00000115919,ENST00000264170;;;ENST00000264170	mutation identified in 1 KYNUU family	Vertebral, cardiac, renal, and limb defects syndrome 2	617661	AR	3	Kynu
2q22.3	2:144384081-144520119	ZEB2, ZFHX1B, SMADIP1, SIP1	Zinc finger E box-binding homeobox 2	605802	ZEB2	9839	ENSG00000169554,ENST00000627532;;;ENST00000627532		Mowat-Wilson syndrome	235730	AD	3	Zeb2
2q23-q24.3	2:147900001-168900000	DFNA16	Deafness, autosomal dominant 16	603964		1694			Deafness, autosomal dominant 16	603964	AD	2	
2q23-q31	2:147900001-182100000	DFNB27	Deafness, autosomal recessive 27	605818		23713			Deafness, autosomal recessive 27	605818	AR	2	
2q23-q24	2:147900001-168900000	GEFSP7, FEB3B	Generalized epilepsy with febrile seizures plus, type 7	613863		120325367		max lod at D2S2330	Generalized epilepsy with febrile seizures plus, type 7	613863	AD	2	
2q23.1	2:147930396-148021551	ORC4, ORC4L	Origin recognition complex, subunit 4	603056	ORC4	5000	ENSG00000115947,ENST00000392857;;;ENST00000392857		Meier-Gorlin syndrome 2	613800	AR	3	Orc4
2q23.1	2:148020927-148516971	MBD5, KIAA1461, MRD1	Methyl-CpG-binding domain protein 5	611472	MBD5	55777	ENSG00000204406,ENST00000642680;;;ENST00000642680		Intellectual developmental disorder, autosomal dominant 1	156200	AD	3	Mbd5
2q23.1-q23.2	2:148875227-149026759	KIF5C, NKHC2, CDCBM2	Kinesin family member 5C	604593	KIF5C	3800	ENSG00000168280,ENST00000435030;;;ENST00000435030		Cortical dysplasia, complex, with other brain malformations 2	615282	AD	3	Kif5c
2q23.2	2:149569637-149587775	MMADHC, C2orf25, MAHCD, MACD, HMAD	Metabolism of cobalamin associated D	611935	MMADHC	27249	ENSG00000168288,ENST00000303319;;;ENST00000303319		Homocystinuria-megaloblastic anemia, cblD type	620952	AR	3	Mmadhc
2q23.2	2:149569637-149587775	MMADHC, C2orf25, MAHCD, MACD, HMAD	Metabolism of cobalamin associated D	611935	MMADHC	27249	ENSG00000168288,ENST00000303319;;;ENST00000303319		Methylmalonic aciduria and homocystinuria, cblD type	277410	AR	3	Mmadhc
2q23.2	2:149569637-149587775	MMADHC, C2orf25, MAHCD, MACD, HMAD	Metabolism of cobalamin associated D	611935	MMADHC	27249	ENSG00000168288,ENST00000303319;;;ENST00000303319		Methylmalonic aciduria, cblD type	620953	AR	3	Mmadhc
2q23.3	2:151485339-151734476	NEB, NEM2, AMC6	Nebulin	161650	NEB	4703	ENSG00000183091,ENST00000397345;;;ENST00000397345		Arthrogryposis multiplex congenita 6	619334	AR	3	Neb
2q23.3	2:151485339-151734476	NEB, NEM2, AMC6	Nebulin	161650	NEB	4703	ENSG00000183091,ENST00000397345;;;ENST00000397345		Nemaline myopathy 2, autosomal recessive	256030	AR	3	Neb
2q23.3	2:151832771-152099167	CACNB4, EJM6, EA5, EIG9	Calcium channel, voltage-dependent, beta 4 subunit	601949	CACNB4	785	ENSG00000182389,ENST00000539935;;;ENST00000539935	mutation identified in 1 EA5 family	?Episodic ataxia, type 5	613855	AD	3	Cacnb4
2q23.3	2:151832771-152099167	CACNB4, EJM6, EA5, EIG9	Calcium channel, voltage-dependent, beta 4 subunit	601949	CACNB4	785	ENSG00000182389,ENST00000539935;;;ENST00000539935	mutation identified in 1 EA5 family	{Epilepsy, idiopathic generalized, susceptibility to, 9}	607682	AD	3	Cacnb4
2q23.3	2:151832771-152099167	CACNB4, EJM6, EA5, EIG9	Calcium channel, voltage-dependent, beta 4 subunit	601949	CACNB4	785	ENSG00000182389,ENST00000539935;;;ENST00000539935	mutation identified in 1 EA5 family	{Epilepsy, juvenile myoclonic, susceptibility to, 6}	607682	AD	3	Cacnb4
2q24-q32	2:154000001-196600000	FGQTL1	Fasting plasma glucose level QTL 1	612108		100499165		associated with rs560887	[Fasting plasma glucose level QTL 1]	612108		2	
2q24.1-q31.1	2:154000001-177100000	INTLQ2	Intelligence quantitative trait locus 3	610295		100462723			{Intelligence QTL3}	610295		2	
2q24-q32	2:154000001-196600000	MMDK, MDK	Mesomelic dysplasia, Kantaputra type	156232				caused by disruption of the HOXD gene cluster	Mesomelic dysplasia, Kantaputra type	156232	AD	4	
2q24.1	2:154000001-158900000	SYNSTH	Synesthesia	612759		100301527		max lod at D2S142	Synesthesia	612759		2	
2q24.1	2:156324437-156332721	NR4A2, NURR1, NOT, TINUR, IDLDP	Nuclear receptor subfamily 4, group A, member 2	601828	NR4A2	4929	ENSG00000153234,ENST00000339562;;;ENST00000339562		Intellectual developmental disorder with language impairment and early-onset DOPA-responsive dystonia-parkinsonism	619911	AD	3	Nr4a2
2q24.1	2:156400281-156586403	GPD2	Glycerol-3-phosphate dehydrogenase 2 (mitochondrial)	138430	GPD2	2820	ENSG00000115159,ENST00000438166;;;ENST00000438166	pseudogene on 19	{Type 2 diabetes mellitus, susceptibility to}	125853	AD	3	Gpd2
2q24.1	2:157736446-157876330	ACVR1, ACVRLK2, ALK2, FOP	Activin A receptor, type I	102576	ACVR1	90	ENSG00000115170,ENST00000434821;;;ENST00000434821		Fibrodysplasia ossificans progressiva	135100	AD	3	Acvr1
2q24.2	2:160099671-160200272	ITGB6, AI1H	Integrin, beta-6	147558	ITGB6	3694	ENSG00000115221,ENST00000283249;;;ENST00000283249		Amelogenesis imperfecta, type IH	616221	AR	3	Itgb6
2q24.2	2:161416297-161425870	TBR1, IDDAS	T-box, brain, 1	604616	TBR1	10716	ENSG00000136535,ENST00000389554;;;ENST00000389554		Intellectual developmental disorder with autism and speech delay	606053	AD	3	Tbr1
2q24.2	2:161624416-161985270	SLC4A10, 620746	Solute carrier family 4 (sodium bicarbonate cotransporter-like), member 10	605556	SLC4A10	57282	ENSG00000144290,ENST00000446997;;;ENST00000446997		Neurodevelopmental disorder with hypotonia and characteristic brain abnormalities	620746	AR	3	Slc4a10
2q24.2	2:162267074-162318684	IFIH1, MDA5, AGS7, SGMRT1, IMD95	Interferon induced with helicase C domain 1	606951	IFIH1	64135	ENSG00000115267,ENST00000649979;;;ENST00000649979		Aicardi-Goutieres syndrome 7	615846	AD	3	Ifih1
2q24.2	2:162267074-162318684	IFIH1, MDA5, AGS7, SGMRT1, IMD95	Interferon induced with helicase C domain 1	606951	IFIH1	64135	ENSG00000115267,ENST00000649979;;;ENST00000649979		Immunodeficiency 95	619773	AR	3	Ifih1
2q24.2	2:162267074-162318684	IFIH1, MDA5, AGS7, SGMRT1, IMD95	Interferon induced with helicase C domain 1	606951	IFIH1	64135	ENSG00000115267,ENST00000649979;;;ENST00000649979		Singleton-Merten syndrome 1	182250	AD	3	Ifih1
2q24.3	2:162900001-168900000	IDDM19	Diabetes mellitus, insulin-dependent, 19	610155				associated with rs1990760	{Diabetes mellitus, insulin-dependent, 19}	610155		2	
2q24.3	2:165087526-165204050	SCN3A, FFEVF4, DEE62	Sodium voltage-gated channel, alpha subunit 3	182391	SCN3A	6328	ENSG00000153253,ENST00000283254;;;ENST00000283254		Developmental and epileptic encephalopathy 62	617938	AD	3	Scn3a
2q24.3	2:165087526-165204050	SCN3A, FFEVF4, DEE62	Sodium voltage-gated channel, alpha subunit 3	182391	SCN3A	6328	ENSG00000153253,ENST00000283254;;;ENST00000283254		Epilepsy, familial focal, with variable foci 4	617935	AD	3	Scn3a
2q24.3	2:165239414-165392304	SCN2A, SCN2A1, BFIC3, DEE11, BFIS3, BFNIS, EA9	Sodium voltage-gated channel, alpha subunit 2	182390	SCN2A	6326	ENSG00000136531,ENST00000375437;;;ENST00000375437	4 related genes on chr.2	Developmental and epileptic encephalopathy 11	613721	AD	3	Scn2a
2q24.3	2:165239414-165392304	SCN2A, SCN2A1, BFIC3, DEE11, BFIS3, BFNIS, EA9	Sodium voltage-gated channel, alpha subunit 2	182390	SCN2A	6326	ENSG00000136531,ENST00000375437;;;ENST00000375437	4 related genes on chr.2	Episodic ataxia, type 9	618924	AD	3	Scn2a
2q24.3	2:165239414-165392304	SCN2A, SCN2A1, BFIC3, DEE11, BFIS3, BFNIS, EA9	Sodium voltage-gated channel, alpha subunit 2	182390	SCN2A	6326	ENSG00000136531,ENST00000375437;;;ENST00000375437	4 related genes on chr.2	Seizures, benign familial infantile, 3	607745	AD	3	Scn2a
2q24.3	2:165747588-165794692	GALNT3, HHS, HFTC1	UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 3	601756	GALNT3	2591	ENSG00000115339,ENST00000392701;;;ENST00000392701		Tumoral calcinosis, hyperphosphatemic, familial, 1	211900	AR	3	Galnt3
2q24.3	2:165873362-165953776	TTC21B, THM1, NPHP12, SRTD4, ATD4	Tetratricopeptide repeat domain 21B	612014	TTC21B	79809	ENSG00000123607,ENST00000243344;;;ENST00000243344		Nephronophthisis 12	613820	AD, AR	3	Ttc21b
2q24.3	2:165873362-165953776	TTC21B, THM1, NPHP12, SRTD4, ATD4	Tetratricopeptide repeat domain 21B	612014	TTC21B	79809	ENSG00000123607,ENST00000243344;;;ENST00000243344		Short-rib thoracic dysplasia 4 with or without polydactyly	613819	AR	3	Ttc21b
2q24.3	2:165984641-166149161	SCN1A, GEFSP2, SMEI, FEB3A, DEE6A, DRVT, FHM3, DEE6B	Sodium voltage-gated channel, alpha subunit 1	182389	SCN1A	6323	ENSG00000144285,ENST00000674923;;;ENST00000674923		Developmental and epileptic encephalopathy 6B, non-Dravet	619317	AD	3	Scn1a
2q24.3	2:165984641-166149161	SCN1A, GEFSP2, SMEI, FEB3A, DEE6A, DRVT, FHM3, DEE6B	Sodium voltage-gated channel, alpha subunit 1	182389	SCN1A	6323	ENSG00000144285,ENST00000674923;;;ENST00000674923		Dravet syndrome	607208	AD	3	Scn1a
2q24.3	2:165984641-166149161	SCN1A, GEFSP2, SMEI, FEB3A, DEE6A, DRVT, FHM3, DEE6B	Sodium voltage-gated channel, alpha subunit 1	182389	SCN1A	6323	ENSG00000144285,ENST00000674923;;;ENST00000674923		Febrile seizures, familial, 3A	604403	AD	3	Scn1a
2q24.3	2:165984641-166149161	SCN1A, GEFSP2, SMEI, FEB3A, DEE6A, DRVT, FHM3, DEE6B	Sodium voltage-gated channel, alpha subunit 1	182389	SCN1A	6323	ENSG00000144285,ENST00000674923;;;ENST00000674923		Generalized epilepsy with febrile seizures plus, type 2	604403	AD	3	Scn1a
2q24.3	2:165984641-166149161	SCN1A, GEFSP2, SMEI, FEB3A, DEE6A, DRVT, FHM3, DEE6B	Sodium voltage-gated channel, alpha subunit 1	182389	SCN1A	6323	ENSG00000144285,ENST00000674923;;;ENST00000674923		Migraine, familial hemiplegic, 3	609634	AD	3	Scn1a
2q24.3	2:166195185-166375987	SCN9A, NENA, PN1, SFNP, HSAN2D	Sodium voltage-gated channel, alpha subunit 9	603415	SCN9A	6335	ENSG00000169432,ENST00000642356;;;ENST00000642356		Erythermalgia, primary	133020	AD	3	Scn9a
2q24.3	2:166195185-166375987	SCN9A, NENA, PN1, SFNP, HSAN2D	Sodium voltage-gated channel, alpha subunit 9	603415	SCN9A	6335	ENSG00000169432,ENST00000642356;;;ENST00000642356		Insensitivity to pain, congenital	243000	AR	3	Scn9a
2q24.3	2:166195185-166375987	SCN9A, NENA, PN1, SFNP, HSAN2D	Sodium voltage-gated channel, alpha subunit 9	603415	SCN9A	6335	ENSG00000169432,ENST00000642356;;;ENST00000642356		Neuropathy, hereditary sensory and autonomic, type IID	243000	AR	3	Scn9a
2q24.3	2:166195185-166375987	SCN9A, NENA, PN1, SFNP, HSAN2D	Sodium voltage-gated channel, alpha subunit 9	603415	SCN9A	6335	ENSG00000169432,ENST00000642356;;;ENST00000642356		Paroxysmal extreme pain disorder	167400	AD	3	Scn9a
2q24.3	2:166195185-166375987	SCN9A, NENA, PN1, SFNP, HSAN2D	Sodium voltage-gated channel, alpha subunit 9	603415	SCN9A	6335	ENSG00000169432,ENST00000642356;;;ENST00000642356		Small fiber neuropathy	133020	AD	3	Scn9a
2q31.1	2:168900001-177100000	DUP2q31.1, C2DUPq31.1	Chromosome 2q31.1 duplication syndrome	613681				duplication of 9 HOXD genes and MTX2	Chromosome 2q31.1 duplication syndrome	613681	AD	4	
2q31	2:168900001-182100000	IDDM7	Insulin-dependent diabetes mellitus-7	600321		3406			{Diabetes mellitus, insulin-dependent, 7}	600321		2	
2q31	2:168900001-182100000	PNKD2	Paroxysmal nonkinesigenic dyskinesia 2	611147		100188328		between D2S2188 and D2S364	Paroxysmal nonkinesigenic dyskinesia 2	611147	AD	2	
2q31	2:168900001-182100000	SHFM5	Split-hand/foot malformation 5	606708		171157		between EVX2 and D2S294	Split-hand/foot malformation 5	606708		2	
2q31.1	2:168915390-169031324	ABCB11, BSEP, SPGP, PFIC2, BRIC2	ATP-binding cassette, subfamily B, member 11 (bile salt export pump)	603201	ABCB11	8647	ENSG00000073734,ENST00000650372;;;ENST00000650372		Cholestasis, benign recurrent intrahepatic, 2	605479	AR	3	Abcb11
2q31.1	2:168915390-169031324	ABCB11, BSEP, SPGP, PFIC2, BRIC2	ATP-binding cassette, subfamily B, member 11 (bile salt export pump)	603201	ABCB11	8647	ENSG00000073734,ENST00000650372;;;ENST00000650372		Cholestasis, progressive familial intrahepatic 2	601847	AR	3	Abcb11
2q31.1	2:169127109-169362534	LRP2, DBS	Low density lipoprotein-related protein 2	600073	LRP2	4036	ENSG00000081479,ENST00000649046;;;ENST00000649046		Donnai-Barrow syndrome	222448	AR	3	Lrp2
2q31.1	2:169479494-169506655	BBS5	BBS gene 5	603650	BBS5	129880	ENSG00000163093,ENST00000295240;;;ENST00000295240		Bardet-Biedl syndrome 5	615983	AR	3	Bbs5
2q31.1	2:169509702-169526258	KLHL41, KBTBD10, SARCOSIN, NEM9	Kelch-like family member 41	607701	KLHL41	10324	ENSG00000239474,ENST00000284669;;;ENST00000284669		Nemaline myopathy 9	615731	AR	3	Klhl41
2q31.1	2:169811757-169824905	METTL5, HSPC133, MRT72	Methyltransferase 5, N6-adenosine	618628	METTL5	29081	ENSG00000138382,ENST00000260953;;;ENST00000260953		Intellectual developmental disorder, autosomal recessive 72	618665	AR	3	Mettl5
2q31.1	2:170813210-170861151	GAD1, SCP, DEE89	Glutamate decarboxylase-1, brain, 67kD	605363	GAD1	2571	ENSG00000128683,ENST00000358196;;;ENST00000358196		Developmental and epileptic encephalopathy 89	619124	AR	3	Gad1
2q31.1	2:171434226-171485052	DCAF17, C20orf37	DDB1- and CUL4-associated factor 17	612515	DCAF17	80067	ENSG00000115827,ENST00000375255;;;ENST00000375255		Woodhouse-Sakati syndrome	241080	AR	3	Dcaf17
2q31.1	2:171687469-171750158	DYNC1I2, DNCI2, IC2, NEDMIBA	Dynein, cytoplasmic-1, intermediate chain-2	603331	DYNC1I2	1781	ENSG00000077380,ENST00000397119;;;ENST00000397119		Neurodevelopmental disorder with microcephaly and structural brain anomalies	618492	AR	3	Dync1i2
2q31.1	2:171783405-171894244	SLC25A12, ARALAR, DEE39	Solute carrier family 25 (mitochondrial carrier, Aralar), member 12	603667	SLC25A12	8604	ENSG00000115840,ENST00000422440;;;ENST00000422440		Developmental and epileptic encephalopathy 39	612949	AR	3	Slc25a12
2q31.1	2:172427336-172506459	ITGA6, JEB6	Integrin, alpha-6	147556	ITGA6	3655	ENSG00000091409,ENST00000684293;;;ENST00000684293		Epidermolysis bullosa, junctional 6, with pyloric atresia	619817	AR	3	Itga6
2q31.1	2:173075517-173268015	MAP3K20, ZAK, MLTK, MRK, SFMMP, CNM6	Mitogen-activated protein kinase kinase kinase 20	609479	MAP3K20	51776	ENSG00000091436,ENST00000375213;;;ENST00000375213		Centronuclear myopathy 6 with fiber-type disproportion	617760	AR	3	Map3k20
2q31.1	2:173075517-173268015	MAP3K20, ZAK, MLTK, MRK, SFMMP, CNM6	Mitogen-activated protein kinase kinase kinase 20	609479	MAP3K20	51776	ENSG00000091436,ENST00000375213;;;ENST00000375213		Split-foot malformation with mesoaxial polydactyly	616890	AR	3	Map3k20
2q31.1	2:173354872-173368997	CDCA7, JPO1, ICF3	Cell division cycle-associated 7	609937	CDCA7	83879	ENSG00000144354,ENST00000306721;;;ENST00000306721		Immunodeficiency-centromeric instability-facial anomalies syndrome 3	616910	AR	3	Cdca7
2q31.1	2:174559574-174682913	WIPF1, WASPIP, WIP, WAS2	WAS/WASL-interacting protein family, member 1	602357	WIPF1	7456	ENSG00000115935,ENST00000679041;;;ENST00000679041		Wiskott-Aldrich syndrome 2	614493	AR	3	Wipf1
2q31.1	2:174747592-174764472	CHRNA1, ACHRD, CMS1B, CMS1A	Cholinergic receptor, nicotinic, alpha polypeptide-1, muscle	100690	CHRNA1	1134	ENSG00000138435,ENST00000348749;;;ENST00000348749		Multiple pterygium syndrome, lethal type	253290	AR	3	Chrna1
2q31.1	2:174747592-174764472	CHRNA1, ACHRD, CMS1B, CMS1A	Cholinergic receptor, nicotinic, alpha polypeptide-1, muscle	100690	CHRNA1	1134	ENSG00000138435,ENST00000348749;;;ENST00000348749		Myasthenic syndrome, congenital, 1A, slow-channel	601462	AD	3	Chrna1
2q31.1	2:174747592-174764472	CHRNA1, ACHRD, CMS1B, CMS1A	Cholinergic receptor, nicotinic, alpha polypeptide-1, muscle	100690	CHRNA1	1134	ENSG00000138435,ENST00000348749;;;ENST00000348749		Myasthenic syndrome, congenital, 1B, fast-channel	608930	AD, AR	3	Chrna1
2q31.1	2:174798809-175005381	CHN1, CHN, ARHGAP2, RHOGAP2, DURS2	Chimerin 1 (GTPase-activating protein, rho, 2)	118423	CHN1	1123	ENSG00000128656,ENST00000409900;;;ENST00000409900		Duane retraction syndrome 2	604356	AD	3	Chn1
2q31.1	2:175176258-175181710	ATP5MC3, ATP5G3, DYTSPG	ATP synthase membrane subunit c locus 3	602736	ATP5MC3	518	ENSG00000154518,ENST00000284727;;;ENST00000284727		Dystonia, early-onset, and/or spastic paraplegia	619681	AD	3	Atp5mc3
2q31.1	2:175923882-176002820	LNPK, KIAA1715, NEDEHCC	Lunapark	610236	LNPK	80856	ENSG00000144320,ENST00000272748;;;ENST00000272748		Neurodevelopmental disorder with epilepsy and hypoplasia of the corpus callosum	618090	AR	3	Lnpk
2q31.1	2:176087487-176095944	HOXD13, HOX4I, SPD1, BDSD	Homeobox D13	142989	HOXD13	3239	ENSG00000128714,ENST00000392539;;;ENST00000392539	mutation identified in 1 BDSD family	?Brachydactyly-syndactyly syndrome	610713		3	Hoxd13
2q31.1	2:176087487-176095944	HOXD13, HOX4I, SPD1, BDSD	Homeobox D13	142989	HOXD13	3239	ENSG00000128714,ENST00000392539;;;ENST00000392539	mutation identified in 1 BDSD family	Brachydactyly, type D	113200	AD	3	Hoxd13
2q31.1	2:176087487-176095944	HOXD13, HOX4I, SPD1, BDSD	Homeobox D13	142989	HOXD13	3239	ENSG00000128714,ENST00000392539;;;ENST00000392539	mutation identified in 1 BDSD family	Brachydactyly, type E	113300	AD	3	Hoxd13
2q31.1	2:176087487-176095944	HOXD13, HOX4I, SPD1, BDSD	Homeobox D13	142989	HOXD13	3239	ENSG00000128714,ENST00000392539;;;ENST00000392539	mutation identified in 1 BDSD family	Syndactyly, type V	186300	AD	3	Hoxd13
2q31.1	2:176087487-176095944	HOXD13, HOX4I, SPD1, BDSD	Homeobox D13	142989	HOXD13	3239	ENSG00000128714,ENST00000392539;;;ENST00000392539	mutation identified in 1 BDSD family	Synpolydactyly 1	186000	AD	3	Hoxd13
2q31.1	2:176116778-176119937	HOXD10, HOX4D	Homeobox D10	142984	HOXD10	3236	ENSG00000128710,ENST00000249501;;;ENST00000249501		Charcot-Marie-Tooth disease, foot deformity of	192950	AD	3	Hoxd10
2q31.1	2:176116778-176119937	HOXD10, HOX4D	Homeobox D10	142984	HOXD10	3236	ENSG00000128710,ENST00000249501;;;ENST00000249501		Vertical talus, congenital	192950	AD	3	Hoxd10
2q31.1	2:176269442-176338025	MTX2, MDPS	Metaxin 2	608555	MTX2	10651	ENSG00000128654,ENST00000249442;;;ENST00000249442		Mandibuloacral dysplasia progeroid syndrome	619127	AR	3	Mtx2
2q31.2	2:177100001-179700000	DEL2q31	Chromosome 2q31.2 deletion syndrome	612345				contiguous gene deletion syndrome	Chromosome 2q31.2 deletion syndrome	612345		4	
2q31.2	2:177230303-177264727	NFE2L2, NRF2, IMDDHH	Nuclear factor, erythroid-derived 2-like 2	600492	NFE2L2	4780	ENSG00000116044,ENST00000397062;;;ENST00000397062		Immunodeficiency, developmental delay, and hypohomocysteinemia	617744	AD	3	Nfe2l2
2q31.2	2:177392773-177543834	AGPS, ADHAPS, RCDP3	Alkylglycerone-phosphate synthase	603051	AGPS	8540	ENSG00000018510,ENST00000264167;;;ENST00000264167		Rhizomelic chondrodysplasia punctata, type 3	600121	AR	3	Agps
2q31.2	2:177623244-178108339	PDE11A, PDE11A1, PDE11A2, PDE11A3, PPNAD2	Phosphodiesterase 11A	604961	PDE11A	50940	ENSG00000128655,ENST00000286063;;;ENST00000286063		Pigmented nodular adrenocortical disease, primary, 2	610475	AD	3	Pde11a
2q31.2	2:178431414-178451175	PRKRA, PACT, RAX, DYT16	Protein kinase, interferon-inducible double-stranded RNA-dependent activator	603424	PRKRA	8575	ENSG00000180228,ENST00000325748;;;ENST00000325748		Dystonia 16	612067	AR	3	Prkra
2q31.2	2:178451378-178462102	PJVK, DFNB59	Pejvakin	610219	PJVK	494513	ENSG00000204311,ENST00000644580;;;ENST00000644580		Deafness, autosomal recessive 59	610220	AR	3	Pjvk
2q31.2	2:178525989-178807423	TTN, CMD1G, TMD, LGMDR10, MPRM, HMERF, CMYO5	Titin	188840	TTN	7273	ENSG00000155657,ENST00000589042;;;ENST00000589042	mutation identified in 1 CMH9 patient	?Cardiomyopathy, familial hypertrophic, 9	613765	AD	3	Ttn
2q31.2	2:178525989-178807423	TTN, CMD1G, TMD, LGMDR10, MPRM, HMERF, CMYO5	Titin	188840	TTN	7273	ENSG00000155657,ENST00000589042;;;ENST00000589042	mutation identified in 1 CMH9 patient	Cardiomyopathy, dilated, 1G	604145	AD	3	Ttn
2q31.2	2:178525989-178807423	TTN, CMD1G, TMD, LGMDR10, MPRM, HMERF, CMYO5	Titin	188840	TTN	7273	ENSG00000155657,ENST00000589042;;;ENST00000589042	mutation identified in 1 CMH9 patient	Congenital myopathy 5 with cardiomyopathy	611705	AR	3	Ttn
2q31.2	2:178525989-178807423	TTN, CMD1G, TMD, LGMDR10, MPRM, HMERF, CMYO5	Titin	188840	TTN	7273	ENSG00000155657,ENST00000589042;;;ENST00000589042	mutation identified in 1 CMH9 patient	Muscular dystrophy, limb-girdle, autosomal recessive 10	608807	AR	3	Ttn
2q31.2	2:178525989-178807423	TTN, CMD1G, TMD, LGMDR10, MPRM, HMERF, CMYO5	Titin	188840	TTN	7273	ENSG00000155657,ENST00000589042;;;ENST00000589042	mutation identified in 1 CMH9 patient	Myopathy myofibrillar, 9, with early respiratory failure	603689	AD	3	Ttn
2q31.2	2:178525989-178807423	TTN, CMD1G, TMD, LGMDR10, MPRM, HMERF, CMYO5	Titin	188840	TTN	7273	ENSG00000155657,ENST00000589042;;;ENST00000589042	mutation identified in 1 CMH9 patient	Tibial muscular dystrophy, tardive	600334	AD	3	Ttn
2q31.3-q32.1	2:179700001-188500000	DA10	Arthrogryposis, distal, type 10	187370				max lod at D2S364	Arthrogryposis, distal, type 10	187370	AD	2	
2q31.3	2:181536672-181657105	CERKL, RP26	Ceramide kinase-like	608381	CERKL	375298	ENSG00000188452,ENST00000410087;;;ENST00000410087		Retinitis pigmentosa 26	608380	AR	3	Cerkl
2q31.3	2:181668295-181680517	NEUROD1, T2D	Neurogenic differentiation 1	601724	NEUROD1	4760	ENSG00000162992,ENST00000295108;;;ENST00000295108		{Type 2 diabetes mellitus, susceptibility to}	125853	AD	3	Neurod1
2q31.3	2:181668295-181680517	NEUROD1, T2D	Neurogenic differentiation 1	601724	NEUROD1	4760	ENSG00000162992,ENST00000295108;;;ENST00000295108		Maturity-onset diabetes of the young 6	606394		3	Neurod1
2q32.1-q32.3	2:182100001-196600000	ARVD4	Arrhythmogenic right ventricular dysplasia 4	602087		425			Arrhythmogenic right ventricular dysplasia 4	602087	AD	2	
2q32.1	2:182100001-188500000	SCZD14	Schizophrenia 14	612361		100196913		associated with rs1344706	{Schizophrenia, susceptibility to, 14}	612361		2	
2q32.1	2:182833275-182866637	FRZB, FRZB1, SRFP3, OS1	Frizzled-related protein	605083	FRZB	2487	ENSG00000162998,ENST00000295113;;;ENST00000295113		{Osteoarthritis susceptibility 1}	165720	Mu	3	Frzb
2q32.1	2:185737134-185833290	FSIP2, SPGF34	Fibrous sheath-interacting protein 2	615796	FSIP2	401024	ENSG00000188738,ENST00000424728;;;ENST00000424728		Spermatogenic failure 34	618153	AR	3	Fsip2
2q32.1	2:186590056-186680901	ITGAV, VNRA, IDNDC	Integrin, alpha-V (vitronectin receptor, alpha polypeptide)	193210	ITGAV	3685	ENSG00000138448,ENST00000261023;;;ENST00000261023		Immune dysregulation, neurodevelopmental defects, and colitis	621375	AR	3	Itgav
2q32.1	2:187341964-187448252	CALCRL, CGRPR, CRLR, LMPHM8	Calcitonin receptor-like	114190	CALCRL	10203	ENSG00000064989,ENST00000392370;;;ENST00000392370	mutation identified in 1 LMPHM8 family	?Lymphatic malformation 8	618773	AR	3	Calcrl
2q32.2	2:188974373-189012746	COL3A1, EDSVASC, PMGEDSV	Collagen III, alpha-1 polypeptide	120180	COL3A1	1281	ENSG00000168542,ENST00000304636;;;ENST00000304636	in same 35kb segment as COL5A2	Ehlers-Danlos syndrome, vascular type	130050	AD	3	Col3a1
2q32.2	2:188974373-189012746	COL3A1, EDSVASC, PMGEDSV	Collagen III, alpha-1 polypeptide	120180	COL3A1	1281	ENSG00000168542,ENST00000304636;;;ENST00000304636	in same 35kb segment as COL5A2	Polymicrogyria with or without vascular-type EDS	618343	AR	3	Col3a1
2q32.2	2:189031898-189441111	COL5A2, EDSCL2	Collagen V, alpha-2 polypeptide	120190	COL5A2	1290	ENSG00000204262,ENST00000374866;;;ENST00000374866	very close to COL3A1	Ehlers-Danlos syndrome, classic type, 2	130010	AD	3	Col5a2
2q32.2	2:189560590-189580786	SLC40A1, SLC11A3, FPN1, IREG1, HFE4	Solute carrier family 40 (iron-regulated transporter), member 1	604653	SLC40A1	30061	ENSG00000138449,ENST00000261024;;;ENST00000261024		Hemochromatosis, type 4	606069	AD	3	Slc40a1
2q32.2	2:190055700-190062729	MSTN, GDF8, MSLHP	Myostatin	601788	MSTN	2660	ENSG00000138379,ENST00000260950;;;ENST00000260950	mutation identified in 1 MSLHP patient	?Muscle hypertrophy	614160	AR	3	Mstn
2q32.2	2:190189735-190319826	HIBCH	3-hydroxyisobutyryl-CoA hydrolase	610690	HIBCH	26275	ENSG00000198130,ENST00000359678;;;ENST00000359678		3-hydroxyisobutryl-CoA hydrolase deficiency	250620	AR	3	Hibch
2q32.2	2:190880821-190965552	GLS, GLS1, DEE71, CASGID, GDPAG	Glutaminase	138280	GLS	2744	ENSG00000115419,ENST00000320717;;;ENST00000320717		CASGID syndrome	618339	AD	3	Gls
2q32.2	2:190880821-190965552	GLS, GLS1, DEE71, CASGID, GDPAG	Glutaminase	138280	GLS	2744	ENSG00000115419,ENST00000320717;;;ENST00000320717		Developmental and epileptic encephalopathy 71	618328	AR	3	Gls
2q32.2	2:190880821-190965552	GLS, GLS1, DEE71, CASGID, GDPAG	Glutaminase	138280	GLS	2744	ENSG00000115419,ENST00000320717;;;ENST00000320717		Global developmental delay, progressive ataxia, and elevated glutamine	618412	AR	3	Gls
2q32.2	2:190969149-191014171	STAT1, CANDF7, IMD31A, IMD31B, IMD31C	Signal transducer and activator of transcription-1	600555	STAT1	6772	ENSG00000115415,ENST00000361099;;;ENST00000361099		Immunodeficiency 31A, mycobacteriosis, autosomal dominant	614892	AD	3	Stat1
2q32.2	2:190969149-191014171	STAT1, CANDF7, IMD31A, IMD31B, IMD31C	Signal transducer and activator of transcription-1	600555	STAT1	6772	ENSG00000115415,ENST00000361099;;;ENST00000361099		Immunodeficiency 31B, mycobacterial and viral infections, autosomal recessive	613796	AR	3	Stat1
2q32.2	2:190969149-191014171	STAT1, CANDF7, IMD31A, IMD31B, IMD31C	Signal transducer and activator of transcription-1	600555	STAT1	6772	ENSG00000115415,ENST00000361099;;;ENST00000361099		Immunodeficiency 31C, chronic mucocutaneous candidiasis, autosomal dominant	614162	AD	3	Stat1
2q32.2-q32.3	2:191029576-191151596	STAT4, SLEB11, DPMC	Signal transducer and activator of transcription-4	600558	STAT4	6775	ENSG00000138378,ENST00000392320;;;ENST00000392320		{Systemic lupus erythematosus, susceptibility to, 11}	612253	AD	3	Stat4
2q32.2-q32.3	2:191029576-191151596	STAT4, SLEB11, DPMC	Signal transducer and activator of transcription-4	600558	STAT4	6775	ENSG00000138378,ENST00000392320;;;ENST00000392320		Disabling pansclerotic morphea of childhood	620443	AD	3	Stat4
2q32.3	2:195737703-196068837	DNAH7, KIAA0944, CILD50	Dynein, axonemal, heavy chain 7	610061	DNAH7	56171	ENSG00000118997,ENST00000312428;;;ENST00000312428		Ciliary dyskinesia, primary, 50	620356	AR	3	Dnah7a,Dnah7b,Dnah7c
2q32.3	2:196194072-196593554	HECW2, NEDL2, KIAA1301, NDHSAL	HECT, C2, and WW domains-containing E3 ubiquitin-protein ligase 2	617245	HECW2	57520	ENSG00000138411,ENST00000644978;;;ENST00000644978		Neurodevelopmental disorder with hypotonia, seizures, and absent language	617268	AD	3	Hecw2
2q33.1	2:196600001-202500000	ANIB9	Aneurysm, intracranial berry, 9	612586		100271688		associated with rs700651	{Aneurysm, intracranial berry, 9}	612586		2	
2q33	2:196600001-208200000	CELIAC3	Celiac disease, susceptibility to, 3	609755					Celiac disease, susceptibility to, 3	609755		2	
2q33-q36	2:196600001-230100000	EJM9	Epilepsy, juvenile myoclonic, susceptibility to, 9	614280		100750238		max lod at D2S2248	{Epilepsy, juvenile myoclonic, susceptibility to, 9}	614280	AD	2	
2q33	2:196600001-208200000	RLS4	Restless legs syndrome, susceptibility to, 4	610439		100188813		between D2S311 and D2S317	{Restless legs syndrome 4}	610439		2	
2q33	2:196600001-208200000	T1D12, IDDM12	Type 1 diabetes mellitus 12	601388					Type 1 diabetes mellitus 12	601388		2	
2q33.1	2:196763035-196799683	GTF3C3, TFIIIC102, NEDFBS	General transcription factor 3C, polypeptide 3	604888	GTF3C3	9330	ENSG00000119041,ENST00000263956;;;ENST00000263956		Neurodevelopmental disorder with dysmorphic facies, brain anomalies, and seizures	621201	AR	3	Gtf3c3
2q33.1	2:196833004-196926707	PGAP1, NEDDSBA	Post-GPI attachment to proteins 1	611655	PGAP1	80055	ENSG00000197121,ENST00000354764;;;ENST00000354764		Neurodevelopmental disorder with dysmorphic features, spasticity, and brain abnormalities	615802	AR	3	Pgap1
2q33.1	2:197389784-197435093	SF3B1, SF3B155, SAP155, MDS	Splicing factor 3B, subunit 1	605590	SF3B1	23451	ENSG00000115524,ENST00000335508;;;ENST00000335508		Myelodysplastic syndrome, somatic	614286		3	Sf3b1
2q33.1	2:197486584-197500274	HSPD1, SPG13, HSP60, HLD4	Heat-shock 60kD protein 1	118190	HSPD1	3329	ENSG00000144381,ENST00000388968;;;ENST00000388968		Leukodystrophy, hypomyelinating, 4	612233	AR	3	Hspd1
2q33.1	2:197486584-197500274	HSPD1, SPG13, HSP60, HLD4	Heat-shock 60kD protein 1	118190	HSPD1	3329	ENSG00000144381,ENST00000388968;;;ENST00000388968		Spastic paraplegia 13, autosomal dominant	605280	AD	3	Hspd1
2q33.1	2:197705369-197708395	MARS2, SPAX3, COXPD25	Methionyl-tRNA synthetase 2	609728	MARS2	92935	ENSG00000247626,ENST00000282276;;;ENST00000282276	mutation identified in 1 COXPD25 family	?Combined oxidative phosphorylation deficiency 25	616430	AR	3	Mars2
2q33.1	2:197705369-197708395	MARS2, SPAX3, COXPD25	Methionyl-tRNA synthetase 2	609728	MARS2	92935	ENSG00000247626,ENST00000282276;;;ENST00000282276	mutation identified in 1 COXPD25 family	Spastic ataxia 3, autosomal recessive	611390	AR	3	Mars2
2q33.1	2:199269500-199471266	SATB2, KIAA1034, GLSS	Special AT-rich sequence-binding protein 2	608148	SATB2	23314	ENSG00000119042,ENST00000417098;;;ENST00000417098		Glass syndrome	612313	AD	3	Satb2
2q33.1	2:199911293-199928273	C2orf69, COXPD53	Chromosome 2 open reading frame 69	619219	C2orf69	205327	ENSG00000178074,ENST00000319974;;;ENST00000319974		Combined oxidative phosphorylation deficiency 53	619423	AR	3	1700066M21Rik
2q33.1	2:201072001-201085750	NDUFB3, MC1DN25	NADH-ubiquinone oxidoreductase subunit B3	603839	NDUFB3	4709	ENSG00000119013,ENST00000237889;;;ENST00000237889	pseudogenes on chr. 1, 9, and 14	Mitochondrial complex I deficiency, nuclear type 25	618246	AR	3	Ndufb3
2q33.1	2:201183141-201229406	CASP10, MCH4, ALPS2	Caspase 10, apoptosis-related cysteine protease	601762	CASP10	843	ENSG00000003400,ENST00000286186;;;ENST00000286186		Autoimmune lymphoproliferative syndrome, type II	603909	AD	3	
2q33.1	2:201183141-201229406	CASP10, MCH4, ALPS2	Caspase 10, apoptosis-related cysteine protease	601762	CASP10	843	ENSG00000003400,ENST00000286186;;;ENST00000286186		Gastric cancer, somatic	613659		3	
2q33.1	2:201183141-201229406	CASP10, MCH4, ALPS2	Caspase 10, apoptosis-related cysteine protease	601762	CASP10	843	ENSG00000003400,ENST00000286186;;;ENST00000286186		Lymphoma, non-Hodgkin, somatic	605027		3	
2q33.1	2:201233463-201287711	CASP8, MCH5, ALPS2B	Caspase 8, apoptosis-related cysteine protease	601763	CASP8	841	ENSG00000064012,ENST00000673742;;;ENST00000673742	mutation identified in 1 CEDS family	?Caspase 8 lymphadenopathy syndrome	607271	AR	3	Casp8
2q33.1	2:201233463-201287711	CASP8, MCH5, ALPS2B	Caspase 8, apoptosis-related cysteine protease	601763	CASP8	841	ENSG00000064012,ENST00000673742;;;ENST00000673742	mutation identified in 1 CEDS family	{Breast cancer, protection against}	114480	AD, SMu	3	Casp8
2q33.1	2:201233463-201287711	CASP8, MCH5, ALPS2B	Caspase 8, apoptosis-related cysteine protease	601763	CASP8	841	ENSG00000064012,ENST00000673742;;;ENST00000673742	mutation identified in 1 CEDS family	{Lung cancer, protection against}	211980	AD, SMu	3	Casp8
2q33.1	2:201233463-201287711	CASP8, MCH5, ALPS2B	Caspase 8, apoptosis-related cysteine protease	601763	CASP8	841	ENSG00000064012,ENST00000673742;;;ENST00000673742	mutation identified in 1 CEDS family	Hepatocellular carcinoma, somatic	114550		3	Casp8
2q33.1	2:201487421-201619178	C2CD6, ALS2CR11, SPGF68	C2 calcium-dependent domain-containing protein 6	619776	CATSPERT	151254	ENSG00000155754,ENST00000439140;;;ENST00000439140	mutation identified in 1 SPGF68 patient	?Spermatogenic failure 68	619805	AR	3	C2cd6
2q33.1	2:201620186-201643503	TMEM237, ALS2CR4, JBTS14	Transmembrane protein 237	614423	TMEM237	65062	ENSG00000155755,ENST00000409883;;;ENST00000409883		Joubert syndrome 14	614424	AR	3	Tmem237
2q33.1	2:201700267-201780933	ALS2, ALSJ, PLSJ, IAHSP	Alsin Rho guanine nucleotide exchange factor ALS2	606352	ALS2	57679	ENSG00000003393,ENST00000264276;;;ENST00000264276		Amyotrophic lateral sclerosis 2, juvenile	205100	AR	3	Als2
2q33.1	2:201700267-201780933	ALS2, ALSJ, PLSJ, IAHSP	Alsin Rho guanine nucleotide exchange factor ALS2	606352	ALS2	57679	ENSG00000003393,ENST00000264276;;;ENST00000264276		Primary lateral sclerosis, juvenile	606353	AR	3	Als2
2q33.1	2:201700267-201780933	ALS2, ALSJ, PLSJ, IAHSP	Alsin Rho guanine nucleotide exchange factor ALS2	606352	ALS2	57679	ENSG00000003393,ENST00000264276;;;ENST00000264276		Spastic paralysis, infantile onset ascending	607225	AR	3	Als2
2q33.1	2:202206171-202238597	SUMO1, UBL1, SMT3, OFC10	Small ubiquitin-like modifier 1	601912	SUMO1	7341	ENSG00000116030,ENST00000392246;;;ENST00000392246	mutation identified in 1 OFC10 patient	?Orofacial cleft 10	613705	IC	3	Sumo1
2q33.1-q33.2	2:202376327-202567749	BMPR2, PPH1, POVD1	Bone morphogenetic receptor, type II	600799	BMPR2	659	ENSG00000204217,ENST00000374580;;;ENST00000374580		Pulmonary hypertension, familial primary, 1, with or without HHT	178600	AD	3	Bmpr2
2q33.1-q33.2	2:202376327-202567749	BMPR2, PPH1, POVD1	Bone morphogenetic receptor, type II	600799	BMPR2	659	ENSG00000204217,ENST00000374580;;;ENST00000374580		Pulmonary hypertension, primary, fenfluramine or dexfenfluramine-associated	178600	AD	3	Bmpr2
2q33.1-q33.2	2:202376327-202567749	BMPR2, PPH1, POVD1	Bone morphogenetic receptor, type II	600799	BMPR2	659	ENSG00000204217,ENST00000374580;;;ENST00000374580		Pulmonary venoocclusive disease 1	265450	AD	3	Bmpr2
2q33.2	2:203706482-203738912	CD28, IMD123	CD28 antigen (Tp44)	186760	CD28	940	ENSG00000178562,ENST00000324106;;;ENST00000324106	mutation identified in 1 IMD123 family	?Immunodeficiency 123 with HPV-related verrucosis	620901	AR	3	Cd28
2q33.2	2:203867771-203873965	CTLA4, ALPS5	Cytotoxic T-lymphocyte-associated serine esterase-4	123890	CTLA4	1493	ENSG00000163599,ENST00000648405;;;ENST00000648405		Immune dysregulation with autoimmunity, immunodeficiency, and lymphoproliferation	616100	AD	3	Ctla4
2q33.2	2:203936763-203961577	ICOS, AILIM, CVID1	Inducible costimulator	604558	ICOS	29851	ENSG00000163600,ENST00000316386;;;ENST00000316386		Immunodeficiency, common variable, 1	607594	AR	3	Icos
2q33.3	2:204100001-208200000	OS4, GOA1	Osteoarthritis susceptibility 4	610839		100188821		max lod at D2S2358	{Osteoarthritis susceptibility 4}	610839		2	
2q33.3	2:206114817-206159444	NDUFS1, MC1DN5	NADH-ubiquinone oxidoreductase core subunit S1	157655	NDUFS1	4719	ENSG00000023228,ENST00000233190;;;ENST00000233190		Mitochondrial complex I deficiency, nuclear type 5	618226	AR	3	Ndufs1
2q33.3	2:206765606-206796189	FASTKD2, KIAA0971, COXPD44	FAST kinase domains 2	612322	FASTKD2	22868	ENSG00000118246,ENST00000402774;;;ENST00000402774		Combined oxidative phosphorylation deficiency 44	618855	AR	3	Fastkd2
2q33.3	2:207529962-207605988	CREB1	cAMP-response element-binding protein-1	123810	CREB1	1385	ENSG00000118260,ENST00000353267;;;ENST00000353267	fusion gene with EWSR1	Histiocytoma, angiomatoid fibrous, somatic	612160		3	Creb1
2q33.3	2:207762598-207769906	FZD5, MCOPCB11	Frizzled class receptor 5	601723	FZD5	7855	ENSG00000163251,ENST00000295417;;;ENST00000295417		Microphthalmia/coloboma 11	620731	AD	3	Fzd5
2q33.3	2:208121607-208124524	CRYGD, CRYG4, CTRCT4, CACA, CCA3, PCC	Crystallin, gamma D	123690	CRYGD	1421	ENSG00000118231,ENST00000264376;;;ENST00000264376		Cataract 4, multiple types	115700	AD	3	Crygd,Cryge,Crygf
2q33.3	2:208128137-208129828	CRYGC, CRYG3, CTRCT2, CCL	Crystallin, gamma C	123680	CRYGC	1420	ENSG00000163254,ENST00000282141;;;ENST00000282141		Cataract 2, multiple types	604307	AD	3	Crygc
2q33.3	2:208142573-208146158	CRYGB, CRYG2, CTRCT39	Crystallin, gamma B	123670	CRYGB	1419	ENSG00000182187,ENST00000260988;;;ENST00000260988		Cataract 39, multiple types, autosomal dominant	615188	AD	3	Crygb
2q34-q36	2:208200001-230100000	DUP2q35, C2DUPq35, SDTY1, SD1	Chromosome 2q35 duplication syndrome (syndactyly, type I)	185900				phenotypes due to different-sized duplications of 2q35	Craniosynostosis, Philadelphia type, with syndactyly	185900	AD	4	
2q34-q36	2:208200001-230100000	DUP2q35, C2DUPq35, SDTY1, SD1	Chromosome 2q35 duplication syndrome (syndactyly, type I)	185900				phenotypes due to different-sized duplications of 2q35	Syndactyly, type 1	185900	AD	4	
2q34	2:208200001-214500000	IDDM13	Insulin-dependent diabetes mellitus-13	601318		3412			{Diabetes mellitus, insulin-dependent, 13}	601318		2	
2q34-q35	2:208200001-220700000	SLEN2	Systemic lupus erythematosus with nephritis, susceptibility to, 2	607966		192679			{Systemic lupus erythematosus with nephritis, susceptibility to, 2}	607966		2	
2q34	2:208200001-214500000	TCL4	T-cell leukemia/lymphoma-4	186860		6946			Leukemia/lymphoma, T-cell	186860		2	
2q34	2:208236227-208255071	IDH1	Isocitrate dehydrogenase (NADP+) 1	147700	IDH1	3417	ENSG00000138413,ENST00000345146;;;ENST00000345146		{Glioma, susceptibility to, somatic}	137800		3	Idh1
2q34	2:208266056-208358746	PIKFYVE, PIP5K3	Phosphatidylinositol kinase, FYVE-finger containing	609414	PIKFYVE	200576	ENSG00000115020,ENST00000264380;;;ENST00000264380		Corneal fleck dystrophy	121850	AD	3	Pikfyve
2q34	2:209771832-209999296	UNC80, C2orf21, KIAA1843	Unc-80 homolog, NALCN channel complex subunit	612636	UNC80	285175	ENSG00000144406,ENST00000673920;;;ENST00000673920		Hypotonia, infantile, with psychomotor retardation and characteristic facies 2	616801	AR	3	Unc80
2q34	2:210290150-210315174	MYL1, CMYO14	Myosin, light polypeptide-1, alkali, skeletal, fast	160780	MYL1	4632	ENSG00000168530,ENST00000352451;;;ENST00000352451		Congenital myopathy 14	618414	AR	3	Myl1
2q34	2:210477685-210679107	CPS1, CPS1D	Carbamoyl-phosphate synthetase 1, mitochondrial	608307	CPS1	1373	ENSG00000021826,ENST00000233072;;;ENST00000233072	urea cycle enzyme	Carbamoylphosphate synthetase I deficiency	237300	AR	3	Cps1
2q34	2:211375717-212538802	ERBB4, HER4, ALS19	Avian erythroblastic leukemia viral (v-erb-b2) oncogene homolog 4	600543	ERBB4	2066	ENSG00000178568,ENST00000342788;;;ENST00000342788		Amyotrophic lateral sclerosis 19	615515	AD	3	Erbb4
2q34	2:212999698-213152456	IKZF2, ANF1A2, HELIOS, IMDIA, ICHAD	Ikaros family zinc finger 2	606234	IKZF2	22807	ENSG00000030419,ENST00000434687;;;ENST00000434687		Immunodysregulation with variable immunodeficiency and autoimmunity	621233	AD, AR	3	Ikzf2
2q34	2:212999698-213152456	IKZF2, ANF1A2, HELIOS, IMDIA, ICHAD	Ikaros family zinc finger 2	606234	IKZF2	22807	ENSG00000030419,ENST00000434687;;;ENST00000434687		Immunodysregulation, craniofacial anomalies, hearing impairment, athelia, and developmental delay	621234	AD	3	Ikzf2
2q35	2:214500001-220700000	MTBS1	Mycobacterium tuberculosis, susceptibility to infection by	607949		404716			{Tuberculosis, susceptibility to}	607949		2	
2q35	2:214500001-220700000	NBLST5	Neuroblastoma, susceptibility to, 5	613016		100306938		associated with rs6435862, rs3768716	{Neuroblastoma, susceptibility to, 5}	613016		2	
2q35	2:214500001-220700000	PHN	Pulmonary hypertension, neonatal, susceptibility to	615371					{Pulmonary hypertension, neonatal, susceptibility to}	615371		2	
2q35	2:214725646-214809683	BARD1	BRCA1-associated RING domain 1	601593	BARD1	580	ENSG00000138376,ENST00000260947;;;ENST00000260947		{Breast cancer, susceptibility to}	114480	AD, SMu	3	Bard1
2q35	2:214931542-215138626	ABCA12, ARCI4A, ARCI4B, ICR2B, LI2	ATP-binding cassette, subfamily A, member 12	607800	ABCA12	26154	ENSG00000144452,ENST00000272895;;;ENST00000272895		Ichthyosis, congenital, autosomal recessive 4A	601277	AR	3	Abca12
2q35	2:214931542-215138626	ABCA12, ARCI4A, ARCI4B, ICR2B, LI2	ATP-binding cassette, subfamily A, member 12	607800	ABCA12	26154	ENSG00000144452,ENST00000272895;;;ENST00000272895		Ichthyosis, congenital, autosomal recessive 4B (harlequin)	242500	AR	3	Abca12
2q35	2:215312059-215368592	ATIC, PURH, AICAR	5-aminoimidazole-4-carboxyamide ribonucleotide formyltransferase/IMP cyclohydrolase	601731	ATIC	471	ENSG00000138363,ENST00000236959;;;ENST00000236959		AICA-ribosiduria due to ATIC deficiency	608688	AR	3	Atic
2q35	2:215360865-215436068	FN1, FN, LETS, FNZ, GFND2, SMDCF	Fibronectin-1	135600	FN1	2335	ENSG00000115414,ENST00000354785;;;ENST00000354785		Glomerulopathy with fibronectin deposits 2	601894	AD	3	Fn1
2q35	2:215360865-215436068	FN1, FN, LETS, FNZ, GFND2, SMDCF	Fibronectin-1	135600	FN1	2335	ENSG00000115414,ENST00000354785;;;ENST00000354785		Spondylometaphyseal dysplasia, corner fracture type	184255	AD	3	Fn1
2q35	2:216412484-216483053	SMARCAL1, HARP, SIOD	SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily A-like	606622	SMARCAL1	50485	ENSG00000138375,ENST00000357276;;;ENST00000357276		Schimke immunoosseous dysplasia	242900	AR	3	Smarcal1
2q35	2:218125294-218137251	CXCR2, IL8RB, IL8R2, WHIMS2	Chemokine, CXC motif, receptor 2	146928	CXCR2	3579	ENSG00000180871,ENST00000318507;;;ENST00000318507	mutation identified in 1 WHIMS2 family	?WHIM syndrome 2	619407	AR	3	Cxcr2
2q35	2:218162841-218166962	CXCR1, IL8RA	Chemokine, CXC motif, receptor 1	146929	CXCR1	3577	ENSG00000163464,ENST00000295683;;;ENST00000295683		{AIDS, slow progression to}	609423		3	Cxcr1
2q35	2:218270519-218346793	PNKD, R1, TAHCCP2, KIPP1184, BRP17, FPD1, PDC, DYT8	PNKD metallo-beta-lactamase domain-containing protein	609023	PNKD	25953	ENSG00000127838,ENST00000273077;;;ENST00000273077		Paroxysmal nonkinesigenic dyskinesia 1	118800	AD	3	Pnkd
2q35	2:218356857-218368094	CATIP, C2orf62	Ciliogenesis-associated TTC17-interacting protein	619387	CATIP	375307	ENSG00000158428,ENST00000289388;;;ENST00000289388	mutation identifed in 1 SPGF54 family	?Spermatogenic failure 54	619379	AR	3	Catip
2q35	2:218382273-218396894	NRAMP1, NRAMP, SLC11A1	Solute carrier family 11 (proton-coupled divalent metal ion transporter), member 1	600266	SLC11A1	6556	ENSG00000018280,ENST00000233202;;;ENST00000233202	within 220 kb of VIL1	{Buruli ulcer, susceptibility to}	610446		3	Slc11a1
2q35	2:218382273-218396894	NRAMP1, NRAMP, SLC11A1	Solute carrier family 11 (proton-coupled divalent metal ion transporter), member 1	600266	SLC11A1	6556	ENSG00000018280,ENST00000233202;;;ENST00000233202	within 220 kb of VIL1	{Mycobacterium tuberculosis, susceptibility to infection by}	607948		3	Slc11a1
2q35	2:218633329-218659623	ZNF142, NEDISHM	Zinc finger protein-142	604083	ZNF142	7701	ENSG00000115568,ENST00000411696;;;ENST00000411696		Neurodevelopmental disorder with impaired speech and hyperkinetic movements	618425	AR	3	Zfp142
2q35	2:218658743-218663443	BCS1L, FLNMS, GRACILE, BJS, PTD, MC3DN1	BCS1 ubiquinol-cytochrome c reductase complex chaperone	603647	BCS1L	617	ENSG00000074582,ENST00000359273;;;ENST00000359273		Bjornstad syndrome	262000	AR	3	Bcs1l
2q35	2:218658743-218663443	BCS1L, FLNMS, GRACILE, BJS, PTD, MC3DN1	BCS1 ubiquinol-cytochrome c reductase complex chaperone	603647	BCS1L	617	ENSG00000074582,ENST00000359273;;;ENST00000359273		GRACILE syndrome	603358	AR	3	Bcs1l
2q35	2:218658743-218663443	BCS1L, FLNMS, GRACILE, BJS, PTD, MC3DN1	BCS1 ubiquinol-cytochrome c reductase complex chaperone	603647	BCS1L	617	ENSG00000074582,ENST00000359273;;;ENST00000359273		Mitochondrial complex III deficiency, nuclear type 1	124000	AR	3	Bcs1l
2q35	2:218672086-218702717	STK36, FU, KIAA1278, CILD46	Serine/threonine protein kinase 36	607652	STK36	27148	ENSG00000163482,ENST00000295709;;;ENST00000295709	mutation identified in 1 CILD46 patient	?Ciliary dyskinesia, primary, 46	619436	AR	3	Stk36
2q35	2:218782147-218815293	CYP27A1, CYP27, CTX	Cytochrome P450, subfamily XXVIIA, polypeptide 1 (sterol 27-hydroxylase)	606530	CYP27A1	1593	ENSG00000135929,ENST00000258415;;;ENST00000258415		Cerebrotendinous xanthomatosis	213700	AR	3	Cyp27a1
2q35	2:218822308-218831803	PRKAG3, SMGMQTL	Protein kinase, AMP-activated, noncatalytic, gamma 3	604976	PRKAG3	53632	ENSG00000115592,ENST00000439262;;;ENST00000439262		[Skeletal muscle glycogen content and metabolism QTL]	619030	AR	3	Prkag3
2q35	2:218874116-218893928	WNT10A, SSPS, STHAG4, ECTD16, OODD	Wingless-type MMTV integration site family, member 10A	606268	WNT10A	80326	ENSG00000135925,ENST00000258411;;;ENST00000258411		Ectodermal dysplasia 16 (odontoonychodermal dysplasia)	257980	AR	3	Wnt10a
2q35	2:218874116-218893928	WNT10A, SSPS, STHAG4, ECTD16, OODD	Wingless-type MMTV integration site family, member 10A	606268	WNT10A	80326	ENSG00000135925,ENST00000258411;;;ENST00000258411		Schopf-Schulz-Passarge syndrome	224750	AR	3	Wnt10a
2q35	2:218874116-218893928	WNT10A, SSPS, STHAG4, ECTD16, OODD	Wingless-type MMTV integration site family, member 10A	606268	WNT10A	80326	ENSG00000135925,ENST00000258411;;;ENST00000258411		Tooth agenesis, selective, 4	150400	AD, AR	3	Wnt10a
2q35	2:218990190-218993422	CRYBA2, CTRCT42	Crystallin, beta A2	600836	CRYBA2	1412	ENSG00000163499,ENST00000295728;;;ENST00000295728	mutation identified in 1 CTRCT42 family	?Cataract 42	115900	AD	3	Cryba2
2q35	2:219002846-219041551	CFAP65, CCDC108, SPGF40	Cilia- and flagella-associated protein 65	614270	CFAP65	255101	ENSG00000181378,ENST00000341552;;;ENST00000341552		Spermatogenic failure 40	618664	AR	3	Cfap65
2q35	2:219054424-219060921	IHH, BDA1	Indian hedgehog	600726	IHH	3549	ENSG00000163501,ENST00000295731;;;ENST00000295731		Acrocapitofemoral dysplasia	607778	AR	3	Ihh
2q35	2:219054424-219060921	IHH, BDA1	Indian hedgehog	600726	IHH	3549	ENSG00000163501,ENST00000295731;;;ENST00000295731		Brachydactyly, type A1	112500	AD	3	Ihh
2q35	2:219069357-219160815	NHEJ1, XLF, IMD124, MCOPCB13	Nonhomologous end-joining factor 1	611290	NHEJ1	79840	ENSG00000187736,ENST00000356853;;;ENST00000356853		Immunodeficiency 124, severe combined	611291	AR	3	Nhej1
2q35	2:219069357-219160815	NHEJ1, XLF, IMD124, MCOPCB13	Nonhomologous end-joining factor 1	611290	NHEJ1	79840	ENSG00000187736,ENST00000356853;;;ENST00000356853		Microphthalmia/coloboma 13	620968	AR	3	Nhej1
2q35	2:219209772-219218958	ABCB6, MTABC3, MCOPCB7, LAN, DUH3, PSHK2	ATP-binding cassette, subfamily B, member 6	605452	ABCB6	10058	ENSG00000115657,ENST00000265316;;;ENST00000265316		[Blood group, Langereis system]	111600		3	Abcb6
2q35	2:219209772-219218958	ABCB6, MTABC3, MCOPCB7, LAN, DUH3, PSHK2	ATP-binding cassette, subfamily B, member 6	605452	ABCB6	10058	ENSG00000115657,ENST00000265316;;;ENST00000265316		Dyschromatosis universalis hereditaria 3	615402	AD	3	Abcb6
2q35	2:219209772-219218958	ABCB6, MTABC3, MCOPCB7, LAN, DUH3, PSHK2	ATP-binding cassette, subfamily B, member 6	605452	ABCB6	10058	ENSG00000115657,ENST00000265316;;;ENST00000265316		Microphthalmia/coloboma 7	614497	AD	3	Abcb6
2q35	2:219209772-219218958	ABCB6, MTABC3, MCOPCB7, LAN, DUH3, PSHK2	ATP-binding cassette, subfamily B, member 6	605452	ABCB6	10058	ENSG00000115657,ENST00000265316;;;ENST00000265316		Pseudohyperkalemia, familial, 2, due to red cell leak	609153	AD	3	Abcb6
2q35	2:219249710-219254740	TUBA4A, TUBA1, OZEMA23, FTDALS9, CMYO26, SPAX11	Tubulin, alpha-4A	191110	TUBA4A	7277	ENSG00000127824,ENST00000248437;;;ENST00000248437		Congenital myopathy 26	621225	AD	3	Tuba4a
2q35	2:219249710-219254740	TUBA4A, TUBA1, OZEMA23, FTDALS9, CMYO26, SPAX11	Tubulin, alpha-4A	191110	TUBA4A	7277	ENSG00000127824,ENST00000248437;;;ENST00000248437		Frontotemporal dementia and/or amyotrophic lateral sclerosis 9	616208	AD	3	Tuba4a
2q35	2:219249710-219254740	TUBA4A, TUBA1, OZEMA23, FTDALS9, CMYO26, SPAX11	Tubulin, alpha-4A	191110	TUBA4A	7277	ENSG00000127824,ENST00000248437;;;ENST00000248437		Oocyte/zygote/embryo maturation arrest 23	621231	AD, AR	3	Tuba4a
2q35	2:219249710-219254740	TUBA4A, TUBA1, OZEMA23, FTDALS9, CMYO26, SPAX11	Tubulin, alpha-4A	191110	TUBA4A	7277	ENSG00000127824,ENST00000248437;;;ENST00000248437		Spastic ataxia 11, autosomal dominant	621226	AD	3	Tuba4a
2q35	2:219279366-219286895	DNAJB2, HSJ1, HSPF3, HMNR5	DNAJ/HSP40 homolog, subfamily B, member 2	604139	DNAJB2	3300	ENSG00000135924,ENST00000336576;;;ENST00000336576		Neuronopathy, distal hereditary motor, autosomal recessive 5	614881	AR	3	Dnajb2
2q35	2:219418377-219426734	DES, CMD1I, MFM1, SCPNK	Desmin	125660	DES	1674	ENSG00000175084,ENST00000373960;;;ENST00000373960		Cardiomyopathy, dilated, 1I	604765	AD	3	Des
2q35	2:219418377-219426734	DES, CMD1I, MFM1, SCPNK	Desmin	125660	DES	1674	ENSG00000175084,ENST00000373960;;;ENST00000373960		Myopathy, myofibrillar, 1	601419	AD, AR	3	Des
2q35	2:219418377-219426734	DES, CMD1I, MFM1, SCPNK	Desmin	125660	DES	1674	ENSG00000175084,ENST00000373960;;;ENST00000373960		Scapuloperoneal syndrome, neurogenic, Kaeser type	181400	AD	3	Des
2q35	2:219434843-219493629	SPEG, APEG1, CNM5	SPEG complex locus	615950	SPEG	10290	ENSG00000072195,ENST00000312358;;;ENST00000312358		Centronuclear myopathy 5	615959	AR	3	Speg
2q35	2:219498891-219506989	GMPPA, AAMR	GDP-mannose pyrophosphorylase A	615495	GMPPA	29926	ENSG00000144591,ENST00000313597;;;ENST00000313597		Alacrima, achalasia, and impaired intellectual development syndrome	615510	AR	3	Gmppa
2q35	2:219547206-219571539	OBSL1, KIAA0657, 3M2	Obscurin-like 1	610991	OBSL1	23363	ENSG00000124006,ENST00000404537;;;ENST00000404537		3-M syndrome 2	612921	AR	3	Obsl1
2q35	2:219627630-219641971	SLC4A3, SLC2C, AE3, SQT7	Solute carrier family 4 (anion exchanger), member 3	106195	SLC4A3	6508	ENSG00000114923,ENST00000358055;;;ENST00000358055		Short QT syndrome 7	620231	AD	3	Slc4a3
2q36	2:220700001-230100000	ACRPV	Acropectorovertebral dysplasia (F syndrome)	102510		414058			Acropectorovertebral dysplasia	102510	AD	2	
2q36	2:220700001-230100000	IGAN2	IgA nephropathy, susceptibility to, 2	613944		100653384		between D2S1323 and D2S362	{IgA nephropathy, susceptibility to, 2}	613944	?AD	2	
2q36.1-q36.3	2:220700001-230100000	SPDA3	Spondyloarthropathy, susceptibility to, 3	613238		100379218		max lod at D2S2228	{Spondyloarthropathy, susceptibility to, 3}	613238		2	
2q36.1	2:222199887-222298998	PAX3, WS1, HUP2, CDHS, WS3	Paired box homeotic gene-3	606597	PAX3	5077	ENSG00000135903,ENST00000392070;;;ENST00000392070		Craniofacial-deafness-hand syndrome	122880	AD	3	Pax3
2q36.1	2:222199887-222298998	PAX3, WS1, HUP2, CDHS, WS3	Paired box homeotic gene-3	606597	PAX3	5077	ENSG00000135903,ENST00000392070;;;ENST00000392070		Rhabdomyosarcoma 2, alveolar	268220	SMu	3	Pax3
2q36.1	2:222199887-222298998	PAX3, WS1, HUP2, CDHS, WS3	Paired box homeotic gene-3	606597	PAX3	5077	ENSG00000135903,ENST00000392070;;;ENST00000392070		Waardenburg syndrome, type 1	193500	AD	3	Pax3
2q36.1	2:222199887-222298998	PAX3, WS1, HUP2, CDHS, WS3	Paired box homeotic gene-3	606597	PAX3	5077	ENSG00000135903,ENST00000392070;;;ENST00000392070		Waardenburg syndrome, type 3	148820	AD, AR	3	Pax3
2q36.1	2:222566899-222656092	FARSB, FARSLB, RILDBC1	Phenylalanine-tRNA synthetase-like, beta subunit	609690	FARSB	10056	ENSG00000116120,ENST00000281828;;;ENST00000281828		Rajab interstitial lung disease with brain calcifications 1	613658	AR	3	Farsb
2q36.1	2:223755326-223837582	AP1S3, PSORS15	Adaptor-related protein complex 1, sigma-3 subunit	615781	AP1S3	130340	ENSG00000152056,ENST00000396654;;;ENST00000396654		{Psoriasis 15, pustular, susceptibility to}	616106	AD	3	Ap1s3
2q36.1	2:223950854-223967714	MRPL44, COXPD16	Mitochondrial ribosomal protein L44	611849	MRPL44	65080	ENSG00000135900,ENST00000258383;;;ENST00000258383		Combined oxidative phosphorylation deficiency 16	615395	AR	3	Mrpl44
2q36.2	2:224470150-224585363	CUL3, PHA2E, NEDAUS	Cullin 3	603136	CUL3	8452	ENSG00000036257,ENST00000264414;;;ENST00000264414		Neurodevelopmental disorder with or without autism or seizures	619239	AD	3	Cul3
2q36.2	2:224470150-224585363	CUL3, PHA2E, NEDAUS	Cullin 3	603136	CUL3	8452	ENSG00000036257,ENST00000264414;;;ENST00000264414		Pseudohypoaldosteronism, type IIE	614496	AD	3	Cul3
2q36.3	2:226731312-226799820	IRS1	Insulin receptor substrate-1	147545	IRS1	3667	ENSG00000169047,ENST00000305123;;;ENST00000305123		{Type 2 diabetes mellitus, susceptibility to}	125853	AD	3	Irs1
2q36.3	2:226967360-227164488	COL4A4, ATS2, BFH1	Collagen IV, alpha-4 polypeptide	120131	COL4A4	1286	ENSG00000081052,ENST00000396625;;;ENST00000396625	head-to-head with COL4A4 in same YAC	Alport syndrome 2, autosomal recessive	203780	AR	3	Col4a4
2q36.3	2:226967360-227164488	COL4A4, ATS2, BFH1	Collagen IV, alpha-4 polypeptide	120131	COL4A4	1286	ENSG00000081052,ENST00000396625;;;ENST00000396625	head-to-head with COL4A4 in same YAC	Hematuria, familial benign, 1	141200	AD	3	Col4a4
2q36.3	2:227164624-227314792	COL4A3, ATS3A, ATS3B, BFH2	Collagen IV, alpha-3 polypeptide (Goodpasture antigen)	120070	COL4A3	1285	ENSG00000169031,ENST00000396578;;;ENST00000396578	noncollagenous domain = Goodpasture antigen	Alport syndrome 3A, autosomal dominant	104200	AD	3	Col4a3
2q36.3	2:227164624-227314792	COL4A3, ATS3A, ATS3B, BFH2	Collagen IV, alpha-3 polypeptide (Goodpasture antigen)	120070	COL4A3	1285	ENSG00000169031,ENST00000396578;;;ENST00000396578	noncollagenous domain = Goodpasture antigen	Alport syndrome 3B, autosomal recessive	620536	AR	3	Col4a3
2q36.3	2:227164624-227314792	COL4A3, ATS3A, ATS3B, BFH2	Collagen IV, alpha-3 polypeptide (Goodpasture antigen)	120070	COL4A3	1285	ENSG00000169031,ENST00000396578;;;ENST00000396578	noncollagenous domain = Goodpasture antigen	Hematuria, benign familial, 2	620320	AD	3	Col4a3
2q36.3	2:227325251-227357836	MFF, C2orf33, EMPF2	Mitochondrial fission factor	614785	MFF	56947	ENSG00000168958,ENST00000304593;;;ENST00000304593		Encephalopathy due to defective mitochondrial and peroxisomal fission 2	617086	AR	3	Mff
2q36.3	2:227362038-227381647	TM4SF20, SLI5	Transmembrane 4 L6 family, member 20	615404	TM4SF20	79853	ENSG00000168955,ENST00000304568;;;ENST00000304568		{Specific language impairment 5}	615432	AD	3	Tm4sf20
2q36.3	2:227683763-227718028	SLC19A3, THMD2, BBGD	Solute carrier family 19 (folate transporter), member 3	606152	SLC19A3	80704	ENSG00000135917,ENST00000644224;;;ENST00000644224		Thiamine metabolism dysfunction syndrome 2 (biotin/thiamine-responsive basal ganglia disease type)	607483	AR	3	Slc19a3
2q36.3	2:227871631-227924344	DAW1, WDR69, ODA16, CILD52	Dynein assembly factor with WD repeats 1	620279	DAW1	164781	ENSG00000123977,ENST00000309931;;;ENST00000309931		Ciliary dyskinesia, primary, 52	620570	AR	3	Daw1
2q36.3	2:229763837-229923186	TRIP12, MRD49	Thyroid hormone receptor interactor 12	604506	TRIP12	9320	ENSG00000153827,ENST00000675903;;;ENST00000675903		Intellectual developmental disorder, autosomal dominant 49	617752	AD	3	Trip12
2q37	2:230100001-242193529	BDMR, C2DELq37, DEL2q37	Chromosome 2q37 deletion syndrome	600430					Chromosome 2q37 deletion syndrome	600430	AD	4	
2q37.1-q37.3	2:230100001-242193529	HPE6	Holoprosencephaly 6	605934		117190			Holoprosencephaly 6	605934		2	
2q37.1	2:230100001-234700000	MYP12	Myopia 12	609995		664780		max lod at D2S2344	Myopia 12	609995		2	
2q37.1	2:230100001-234700000	STQTL21	Stature quantitative trait locus 21	613440		100502568		associated with rs6717918	{Stature QTL 21}	613440		2	
2q37.1	2:230165186-230225636	SP110, IFI41, IFI75, VODI	SP110 nuclear body protein (interferon-induced protein 41, 30kD; interferon-induced protein 75, 52kD)	604457	SP110	3431	ENSG00000135899,ENST00000258381;;;ENST00000258381		{Mycobacterium tuberculosis, susceptibility to}	607948		3	Sp110
2q37.1	2:230165186-230225636	SP110, IFI41, IFI75, VODI	SP110 nuclear body protein (interferon-induced protein 41, 30kD; interferon-induced protein 75, 52kD)	604457	SP110	3431	ENSG00000135899,ENST00000258381;;;ENST00000258381		Hepatic venoocclusive disease with immunodeficiency	235550	AR	3	Sp110
2q37.1	2:231198631-231376848	ARMC9, KIAA1868, JBTS30	Armadillo repeat-containing protein 9	617612	ARMC9	80210	ENSG00000135931,ENST00000611582;;;ENST00000611582		Joubert syndrome 30	617622	AR	3	Armc9
2q37.1	2:231732433-231781282	PDE6D, JBTS22	Phosphodiesterase 6D	602676	PDE6D	5147	ENSG00000156973,ENST00000287600;;;ENST00000287600		Joubert syndrome 22	615665	AR	3	Pde6d
2q37.1	2:231961713-232344350	DIS3L2, PRLMNS	DIS3 like exosome 3'-5' exoribonuclease 2	614184	DIS3L2	129563	ENSG00000144535,ENST00000325385;;;ENST00000325385		Perlman syndrome	267000	AR	3	Dis3l2
2q37.1	2:232479827-232487834	ECEL1, XCE, DA5D	Endothelin-converting enzyme-like 1	605896	ECEL1	9427	ENSG00000171551,ENST00000304546;;;ENST00000304546		Arthrogryposis, distal, type 5D	615065	AR	3	Ecel1
2q37.1	2:232520388-232525716	PRSS56, MCOP6	Protease, serine, 56	613858	PRSS56	646960	ENSG00000237412,ENST00000617714;;;ENST00000617714		Microphthalmia, isolated 6	613517	AR	3	Prss56
2q37.1	2:232526160-232536664	CHRND, ACHRD, SCCMS, CMS3A, CMS3B, CMS3C	Cholinergic receptor, nicotinic, delta polypeptide	100720	CHRND	1144	ENSG00000135902,ENST00000258385;;;ENST00000258385	mutation identified in 1 CMS3A patient and 1 CMS3C family	?Myasthenic syndrome, congenital, 3A, slow-channel	616321	AD	3	Chrnd
2q37.1	2:232526160-232536664	CHRND, ACHRD, SCCMS, CMS3A, CMS3B, CMS3C	Cholinergic receptor, nicotinic, delta polypeptide	100720	CHRND	1144	ENSG00000135902,ENST00000258385;;;ENST00000258385	mutation identified in 1 CMS3A patient and 1 CMS3C family	?Myasthenic syndrome, congenital, 3C, associated with acetylcholine receptor deficiency	616323	AR	3	Chrnd
2q37.1	2:232526160-232536664	CHRND, ACHRD, SCCMS, CMS3A, CMS3B, CMS3C	Cholinergic receptor, nicotinic, delta polypeptide	100720	CHRND	1144	ENSG00000135902,ENST00000258385;;;ENST00000258385	mutation identified in 1 CMS3A patient and 1 CMS3C family	Multiple pterygium syndrome, lethal type	253290	AR	3	Chrnd
2q37.1	2:232526160-232536664	CHRND, ACHRD, SCCMS, CMS3A, CMS3B, CMS3C	Cholinergic receptor, nicotinic, delta polypeptide	100720	CHRND	1144	ENSG00000135902,ENST00000258385;;;ENST00000258385	mutation identified in 1 CMS3A patient and 1 CMS3C family	Myasthenic syndrome, congenital, 3B, fast-channel	616322	AR	3	Chrnd
2q37.1	2:232539692-232548115	CHRNG, ACHRG	Cholinergic receptor, nicotinic, gamma polypeptide	100730	CHRNG	1146	ENSG00000196811,ENST00000651502;;;ENST00000651502	tightly linked to CHRND by RE	Escobar syndrome	265000	AR	3	Chrng
2q37.1	2:232539692-232548115	CHRNG, ACHRG	Cholinergic receptor, nicotinic, gamma polypeptide	100730	CHRNG	1146	ENSG00000196811,ENST00000651502;;;ENST00000651502	tightly linked to CHRND by RE	Multiple pterygium syndrome, lethal type	253290	AR	3	Chrng
2q37.1	2:232697331-232860605	GIGYF2, KIAA0642, PARK11	GRB10-interacting GYF protein 2	612003	GIGYF2	26058	ENSG00000204120,ENST00000373563;;;ENST00000373563		{Parkinson disease 11}	607688		3	Gigyf2
2q37.1	2:232765802-232776565	KCNJ13, SVD, LCA16	Potassium inwardly-rectifying channel, subfamily J, member 13	603208	KCNJ13	3769	ENSG00000115474,ENST00000233826;;;ENST00000233826		Leber congenital amaurosis 16	614186	AR	3	Kcnj13
2q37.1	2:232765802-232776565	KCNJ13, SVD, LCA16	Potassium inwardly-rectifying channel, subfamily J, member 13	603208	KCNJ13	3769	ENSG00000115474,ENST00000233826;;;ENST00000233826		Snowflake vitreoretinal degeneration	193230	AD	3	Kcnj13
2q37.1	2:233251673-233295669	ATG16L1, APG16L, IBD10	Autophagy related 16 like 1	610767	ATG16L1	55054	ENSG00000085978,ENST00000392017;;;ENST00000392017		{Inflammatory bowel disease (Crohn disease) 10}	611081		3	Atg16l1
2q37.1	2:233307816-233347055	SAG, RP47, RP96	S-antigen; retina and pineal gland (arrestin)	181031	SAG	6295	ENSG00000130561,ENST00000409110;;;ENST00000409110		Oguchi disease-1	258100	AR	3	Sag
2q37.1	2:233307816-233347055	SAG, RP47, RP96	S-antigen; retina and pineal gland (arrestin)	181031	SAG	6295	ENSG00000130561,ENST00000409110;;;ENST00000409110		Retinitis pigmentosa 47, autosomal recessive	613758	AR	3	Sag
2q37.1	2:233307816-233347055	SAG, RP47, RP96	S-antigen; retina and pineal gland (arrestin)	181031	SAG	6295	ENSG00000130561,ENST00000409110;;;ENST00000409110		Retinitis pigmentosa 96, autosomal dominant	620228	AD	3	Sag
2q37.1	2:233760270-233773300	UGT1A1, UGT1, GNT1, BILIQTL1	UDP glycosyltransferase 1 family, polypeptide A1	191740	UGT1A1	54658	ENSG00000241635,ENST00000305208;;;ENST00000305208		[Bilirubin, serum level of, QTL1]	601816		3	Ugt1a1
2q37.1	2:233760270-233773300	UGT1A1, UGT1, GNT1, BILIQTL1	UDP glycosyltransferase 1 family, polypeptide A1	191740	UGT1A1	54658	ENSG00000241635,ENST00000305208;;;ENST00000305208		[Gilbert syndrome]	143500	AR	3	Ugt1a1
2q37.1	2:233760270-233773300	UGT1A1, UGT1, GNT1, BILIQTL1	UDP glycosyltransferase 1 family, polypeptide A1	191740	UGT1A1	54658	ENSG00000241635,ENST00000305208;;;ENST00000305208		Crigler-Najjar syndrome, type I	218800	AR	3	Ugt1a1
2q37.1	2:233760270-233773300	UGT1A1, UGT1, GNT1, BILIQTL1	UDP glycosyltransferase 1 family, polypeptide A1	191740	UGT1A1	54658	ENSG00000241635,ENST00000305208;;;ENST00000305208		Crigler-Najjar syndrome, type II	606785	AR	3	Ugt1a1
2q37.1	2:233760270-233773300	UGT1A1, UGT1, GNT1, BILIQTL1	UDP glycosyltransferase 1 family, polypeptide A1	191740	UGT1A1	54658	ENSG00000241635,ENST00000305208;;;ENST00000305208		Hyperbilirubinemia, familial transient neonatal	237900	AD, AR	3	Ugt1a1
2q37.3	2:236400001-242193529	SLEB2	Systemic lupus erythematosus, susceptibility to, 2	605218					{Systemic lupus erythematosus, susceptibility to, 2}	605218	AD	2	
2q37.3	2:236537122-236582354	ACKR3, CXCR7, CMKOR1, GPR159, RDC1	Atypical chemokine receptor 3	610376	ACKR3	57007	ENSG00000144476,ENST00000272928;;;ENST00000272928	mutation identified in 1 OCABSN family	?Oculomotor-abducens synkinesis	619215	AR	3	Ackr3
2q37.3	2:237324018-237414164	COL6A3, DYT27, BTHLM1C, UCMD1C	Collagen VI, alpha-3 polypeptide	120250	COL6A3	1293	ENSG00000163359,ENST00000295550;;;ENST00000295550	close to CRBP1	Bethlem myopathy 1C	620726	AD, AR	3	Col6a3
2q37.3	2:237324018-237414164	COL6A3, DYT27, BTHLM1C, UCMD1C	Collagen VI, alpha-3 polypeptide	120250	COL6A3	1293	ENSG00000163359,ENST00000295550;;;ENST00000295550	close to CRBP1	Dystonia 27	616411	AR	3	Col6a3
2q37.3	2:237324018-237414164	COL6A3, DYT27, BTHLM1C, UCMD1C	Collagen VI, alpha-3 polypeptide	120250	COL6A3	1293	ENSG00000163359,ENST00000295550;;;ENST00000295550	close to CRBP1	Ullrich congenital muscular dystrophy 1C	620728	AD, AR	3	Col6a3
2q37.3	2:237486410-237555322	MLPH	Melanophilin	606526	MLPH	79083	ENSG00000115648,ENST00000264605;;;ENST00000264605		Griscelli syndrome, type 3	609227	AR	3	Mlph
2q37.3	2:238244044-238300065	PER2, FASPS1, KIAA0347	Period circadian regulator 2	603426	PER2	8864	ENSG00000132326,ENST00000254657;;;ENST00000254657	mutation identified in 1 FASPS1 family	?Advanced sleep phase syndrome, familial, 1	604348	AD	3	Per2
2q37.3	2:238320518-238400900	TRAF3IP1, MIPT3, SLSN9	TNF receptor-associated factor 3-interacting protein 1	607380	TRAF3IP1	26146	ENSG00000204104,ENST00000373327;;;ENST00000373327		Senior-Loken syndrome 9	616629	AR	3	Traf3ip1
2q37.3	2:238848085-238910534	TWIST2, DERMO1, SETLSS, FFDD3, BBRSAY, AMS	Twist family bHLH transcription factor 2	607556	TWIST2	117581	ENSG00000233608,ENST00000612363;;;ENST00000612363		Ablepharon-macrostomia syndrome	200110	AD	3	Twist2
2q37.3	2:238848085-238910534	TWIST2, DERMO1, SETLSS, FFDD3, BBRSAY, AMS	Twist family bHLH transcription factor 2	607556	TWIST2	117581	ENSG00000233608,ENST00000612363;;;ENST00000612363		Barber-Say syndrome	209885	AD	3	Twist2
2q37.3	2:238848085-238910534	TWIST2, DERMO1, SETLSS, FFDD3, BBRSAY, AMS	Twist family bHLH transcription factor 2	607556	TWIST2	117581	ENSG00000233608,ENST00000612363;;;ENST00000612363		Focal facial dermal dysplasia 3, Setleis type	227260	AR	3	Twist2
2q37.3	2:239048168-239401649	HDAC4, HDACA, NEDCHF	Histone deacetylase 4	605314	HDAC4	9759	ENSG00000068024,ENST00000543185;;;ENST00000543185		Neurodevelopmental disorder with central hypotonia and dysmorphic facies	619797	AD	3	Hdac4
2q37.3	2:239892442-240025342	NDUFA10, MC1DN22	NADH-ubiquinone oxidoreductase subunit A10	603835	NDUFA10	4705	ENSG00000130414,ENST00000252711;;;ENST00000252711		Mitochondrial complex I deficiency, nuclear type 22	618243	AR	3	Ndufa10
2q37.3	2:240586734-240599104	CAPN10, NIDDM1	Calpain-10	605286	CAPN10	11132	ENSG00000142330,ENST00000391984;;;ENST00000391984		{Diabetes mellitus, noninsulin-dependent 1}	601283		3	Capn10
2q37.3	2:240713767-240821403	KIF1A, ATSV, UNC104, SPG30A, SPG30B, HSN2C, MRD9	Kinesin family member 1A	601255	KIF1A	547	ENSG00000130294,ENST00000498729;;;ENST00000498729	incorrectly assigned to chr.9	NESCAV syndrome	614255	AD	3	Kif1a
2q37.3	2:240713767-240821403	KIF1A, ATSV, UNC104, SPG30A, SPG30B, HSN2C, MRD9	Kinesin family member 1A	601255	KIF1A	547	ENSG00000130294,ENST00000498729;;;ENST00000498729	incorrectly assigned to chr.9	Neuropathy, hereditary sensory, type IIC	614213	AR	3	Kif1a
2q37.3	2:240713767-240821403	KIF1A, ATSV, UNC104, SPG30A, SPG30B, HSN2C, MRD9	Kinesin family member 1A	601255	KIF1A	547	ENSG00000130294,ENST00000498729;;;ENST00000498729	incorrectly assigned to chr.9	Spastic paraplegia 30, autosomal dominant	610357	AD	3	Kif1a
2q37.3	2:240713767-240821403	KIF1A, ATSV, UNC104, SPG30A, SPG30B, HSN2C, MRD9	Kinesin family member 1A	601255	KIF1A	547	ENSG00000130294,ENST00000498729;;;ENST00000498729	incorrectly assigned to chr.9	Spastic paraplegia 30, autosomal recessive	620607	AR	3	Kif1a
2q37.3	2:240868824-240880500	AGXT, SPAT	Alanine-glyoxylate aminotransferase, liver-specific peroxisomal	604285	AGXT	189	ENSG00000172482,ENST00000307503;;;ENST00000307503		Hyperoxaluria, primary, type 1	259900	AR	3	Agxt
2q37.3	2:241675747-241686815	DTYMK, TYMK, CDC8, CONPM	Deoxythymidylate kinase	188345	DTYMK	1841	ENSG00000168393,ENST00000305784;;;ENST00000305784		Neurodegeneration, childhood-onset, with progressive microcephaly	619847	AR	3	Dtymk
2q37.3	2:241734630-241768811	D2HGDH, D2HGD	D-2-hydroxyglutarate dehydrogenase	609186	D2HGDH	728294	ENSG00000180902,ENST00000321264;;;ENST00000321264		D-2-hydroxyglutaric aciduria	600721	AR	3	D2hgdh
2q37.3	2:241849884-241858894	PDCD1, ADMIO4	Programmed cell death 1	600244	PDCD1	5133	ENSG00000188389,ENST00000334409;;;ENST00000334409	mutation identified in 1 ADMIO4 patient	?Autoimmune disease, multisystem, infantile-onset, 4	621004	AR	3	Pdcd1
3p	3:1-90900001	CRCL	Creatinine clearance QTL	607135		261727		in African Americans	Creatinine clearance QTL	607135		2	
3pter-p25	3:1-16300000	DEL3pterp25, C3DELpterp25	3p- syndrome (chromosome 3pter-p25 deletion syndrome)	613792				contiguous gene deletion syndrome	3p- syndrome	613792	AD	4	
3p26	3:1-8100000	HPC5	Prostate cancer, hereditary, 5	609299		619402		between D3S1270 and D3S4559	{Prostate cancer, hereditary, 5}	609299		2	
3p26	3:1-8100000	IBD9	Inflammatory bowel disease 9	608448		317669			{Inflammatory bowel disease 9}	608448		2	
3p26-p24.2	3:1-26300000	MYMY1, MYMY	Moyamoya disease	252350		50960		max lod at D3S3050	Moyamoya disease	252350	AR	2	
3p26	3:1-8100000	STQTL5	Stature quantitative trait locus 5	608982		619479		max lod between D3S1297 and D3S1304	{Stature QTL 5}	608982		2	
3p26.2	3:3126940-3153435	TRNT1, SIFD, RPEM	tRNA nucleotidyltransferase, CCA-adding, 1	612907	TRNT1	51095	ENSG00000072756,ENST00000251607;;;ENST00000251607	pseudogenes on chromosomes 1 and 22	Retinitis pigmentosa and erythrocytic microcytosis	616959	AR	3	Trnt1
3p26.2	3:3126940-3153435	TRNT1, SIFD, RPEM	tRNA nucleotidyltransferase, CCA-adding, 1	612907	TRNT1	51095	ENSG00000072756,ENST00000251607;;;ENST00000251607	pseudogenes on chromosomes 1 and 22	Sideroblastic anemia with B-cell immunodeficiency, periodic fevers, and developmental delay	616084	AR	3	Trnt1
3p26.2	3:3149633-3179717	CRBN, MRT2	Cereblon	609262	CRBN	51185	ENSG00000113851,ENST00000231948;;;ENST00000231948	between D3S3525 and D3S1560	Intellectual developmental disorder, autosomal recessive 2	607417	AR	3	Crbn
3p26.1-p25.1	3:4000001-16300000	ARHI2	Age-related hearing impairment 2	612976		100302721		associated with rs11928865, rs779701, and rs779706	{Age-related hearing impairment 2}	612976		2	
3p26.1	3:4034486-4467269	SUMF1, FGE	Sulfatase-modifying factor-1	607939	SUMF1	285362	ENSG00000144455,ENST00000272902;;;ENST00000272902		Multiple sulfatase deficiency	272200	AR	3	Sumf1
3p26.1	3:4493348-4847506	ITPR1, SCA15, SCA16, SCA29	Inositol 1,4,5-triphosphate receptor, type 1	147265	ITPR1	3708	ENSG00000150995,ENST00000649015;;;ENST00000649015		Gillespie syndrome	206700	AD, AR	3	Itpr1
3p26.1	3:4493348-4847506	ITPR1, SCA15, SCA16, SCA29	Inositol 1,4,5-triphosphate receptor, type 1	147265	ITPR1	3708	ENSG00000150995,ENST00000649015;;;ENST00000649015		Spinocerebellar ataxia 15	606658	AD	3	Itpr1
3p26.1	3:4493348-4847506	ITPR1, SCA15, SCA16, SCA29	Inositol 1,4,5-triphosphate receptor, type 1	147265	ITPR1	3708	ENSG00000150995,ENST00000649015;;;ENST00000649015		Spinocerebellar ataxia 29, congenital nonprogressive	117360	AD	3	Itpr1
3p26.1	3:6861115-7741533	GRM7, MGLUR7, NEDSHBA	Glutamate receptor, metabotropic, 7	604101	GRM7	2917	ENSG00000196277,ENST00000357716;;;ENST00000357716		Neurodevelopmental disorder with seizures, hypotonia, and brain abnormalities	618922	AR	3	Grm7
3p25-p22	3:8100001-43600000	OVCAS1	Ovarian cancer, susceptibility to, 1	607893		574048		between D3S1597 and D3S3611	{Ovarian cancer, susceptibility to}	607893		2	
3p25.3	3:8733802-8746758	CAV3, LQT9, MPDT, RMD2	Caveolin-3	601253	CAV3	859	ENSG00000182533,ENST00000343849;;;ENST00000343849	within 7-10kb of OXTR	Cardiomyopathy, familial hypertrophic	192600	AD, DD	3	Cav3
3p25.3	3:8733802-8746758	CAV3, LQT9, MPDT, RMD2	Caveolin-3	601253	CAV3	859	ENSG00000182533,ENST00000343849;;;ENST00000343849	within 7-10kb of OXTR	Creatine phosphokinase, elevated serum	123320	AD	3	Cav3
3p25.3	3:8733802-8746758	CAV3, LQT9, MPDT, RMD2	Caveolin-3	601253	CAV3	859	ENSG00000182533,ENST00000343849;;;ENST00000343849	within 7-10kb of OXTR	Long QT syndrome 9	611818	AD	3	Cav3
3p25.3	3:8733802-8746758	CAV3, LQT9, MPDT, RMD2	Caveolin-3	601253	CAV3	859	ENSG00000182533,ENST00000343849;;;ENST00000343849	within 7-10kb of OXTR	Myopathy, distal, Tateyama type	614321	AD	3	Cav3
3p25.3	3:8733802-8746758	CAV3, LQT9, MPDT, RMD2	Caveolin-3	601253	CAV3	859	ENSG00000182533,ENST00000343849;;;ENST00000343849	within 7-10kb of OXTR	Rippling muscle disease 2	606072	AD	3	Cav3
3p25.3	3:9397615-9478154	SETD5, KIAA1757, MRD23	SET domain-containing protein 5	615743	SETD5	55209	ENSG00000168137,ENST00000402198;;;ENST00000402198		Intellectual developmental disorder, autosomal dominant 23	615761	AD	3	Setd5
3p25.3	3:9649505-9702393	MTMR14, C3orf29, HJUMPY	Myotubularin-related protein 14	611089	MTMR14	64419	ENSG00000163719,ENST00000296003;;;ENST00000296003		{Centronuclear myopathy, autosomal, modifier of}	160150	AD	3	Mtmr14
3p25.3	3:9731735-9748015	BRPF1, BR140, IDDDFP	Bromodomain- and PHD finger-containing protein 1, 140kD	602410	BRPF1	7862	ENSG00000156983,ENST00000383829;;;ENST00000383829		Intellectual developmental disorder with dysmorphic facies and ptosis	617333	AD	3	Brpf1
3p25.3	3:9749952-9791070	OGG1	8-hydroxyguanine DNA glycosylase	601982	OGG1	4968	ENSG00000114026,ENST00000344629;;;ENST00000344629		Renal cell carcinoma, clear cell, somatic	144700		3	Ogg1
3p25.3	3:9792518-9807101	ARPC4, ARC20, DEVLO	Actin-related protein 2/3 complex, subunit 4	604226	ARPC4	10093	ENSG00000241553,ENST00000397261;;;ENST00000397261		Developmental delay, language impairment, and ocular abnormalities	620141	AD	3	Arpc4
3p25.3	3:9866710-9880253	CIDEC, FSP27, CIDE3, FPLD5	Cell death-inducing DFFA-like effector C	612120	CIDEC	63924	ENSG00000187288,ENST00000336832;;;ENST00000336832	1 patient identified with mutation	?Lipodystrophy, familial partial, type 5	615238	AR	3	Cidec
3p25.3	3:9890610-9894349	JAGN1, SCN6	Jagunal homolog 1	616012	JAGN1	84522	ENSG00000171135,ENST00000647897;;;ENST00000647897		Neutropenia, severe congenital, 6, autosomal recessive	616022	AR	3	Jagn1
3p25.3	3:9917098-9933621	IL17RC, IL17RL, CANDF9	Interleukin 17 receptor C	610925	IL17RC	84818	ENSG00000163702,ENST00000403601;;;ENST00000403601		Candidiasis, familial, 9	616445	AR	3	Il17rc
3p25.3	3:9933834-9945406	CRELD1, AVSD2, JELANS	Cysteine-rich protein with EGF-like domains 1	607170	CRELD1	78987	ENSG00000163703,ENST00000452070;;;ENST00000452070		{Atrioventricular septal defect, susceptibility to, 2}	606217	AD	3	Creld1
3p25.3	3:9933834-9945406	CRELD1, AVSD2, JELANS	Cysteine-rich protein with EGF-like domains 1	607170	CRELD1	78987	ENSG00000163703,ENST00000452070;;;ENST00000452070		Atrioventricular septal defect, partial, with heterotaxy syndrome	606217	AD	3	Creld1
3p25.3	3:9933834-9945406	CRELD1, AVSD2, JELANS	Cysteine-rich protein with EGF-like domains 1	607170	CRELD1	78987	ENSG00000163703,ENST00000452070;;;ENST00000452070		Jeffries-Lakhani neurodevelopmental syndrome	620771	AR	3	Creld1
3p25.3	3:10026437-10101932	FANCD2, FANCD, FACD, FAD	Fanconi anemia, complementation group D2	613984	FANCD2	2177	ENSG00000144554,ENST00000675286;;;ENST00000675286		Fanconi anemia, complementation group D2	227646	AR	3	Fancd2
3p25.3	3:10141778-10153667	VHL	von Hippel-Lindau tumor suppressor	608537	VHL	7428	ENSG00000134086,ENST00000256474;;;ENST00000256474		Erythrocytosis, familial, 2	263400	AR	3	Vhl
3p25.3	3:10141778-10153667	VHL	von Hippel-Lindau tumor suppressor	608537	VHL	7428	ENSG00000134086,ENST00000256474;;;ENST00000256474		Hemangioblastoma, cerebellar, somatic			3	Vhl
3p25.3	3:10141778-10153667	VHL	von Hippel-Lindau tumor suppressor	608537	VHL	7428	ENSG00000134086,ENST00000256474;;;ENST00000256474		Pheochromocytoma	171300	AD	3	Vhl
3p25.3	3:10141778-10153667	VHL	von Hippel-Lindau tumor suppressor	608537	VHL	7428	ENSG00000134086,ENST00000256474;;;ENST00000256474		Renal cell carcinoma, somatic	144700		3	Vhl
3p25.3	3:10141778-10153667	VHL	von Hippel-Lindau tumor suppressor	608537	VHL	7428	ENSG00000134086,ENST00000256474;;;ENST00000256474		von Hippel-Lindau syndrome	193300	AD	3	Vhl
3p25.3	3:10285666-10292947	GHRL	Ghrelin	605353	GHRL	51738	ENSG00000157017,ENST00000335542;;;ENST00000335542		{Obesity, susceptibility to}	601665	AD, AR, Mu	3	Ghrl
3p25.3	3:10324023-10708116	ATP2B2, PMCA2, DFNA82	ATPase, Ca++ transporting, plasma membrane, 2	108733	ATP2B2	491	ENSG00000157087,ENST00000360273;;;ENST00000360273		Deafness, autosomal dominant 82	619804	AD	3	Atp2b2
3p25.3	3:10992748-11039247	SLC6A1, GABATR, MAE	Solute carrier family 6 (neurotransmitter transporter, GABA), member 1	137165	SLC6A1	6529	ENSG00000157103,ENST00000287766;;;ENST00000287766		Myoclonic-atonic epilepsy	616421	AD	3	Slc6a1
3p25.3	3:11272397-11576353	ATG7, APG7L, GSA7, SCAR31	Autophagy related 7	608760	ATG7	10533	ENSG00000197548,ENST00000693202;;;ENST00000693202		Spinocerebellar ataxia, autosomal recessive 31	619422	AR	3	Atg7
3p25.2	3:11721896-11846885	TAMM41, RAM41, C3orf31, COXPD56	TAM41 mitochondrial translocator assembly and maintenance homolog	614948	TAMM41	132001	ENSG00000144559,ENST00000455809;;;ENST00000455809		Combined oxidative phosphorylation deficiency 56	620139	AR	3	Tamm41
3p25.2	3:12004388-12192032	SYN2	Synapsin II	600755	SYN2	6854	ENSG00000157152,ENST00000621198;;;ENST00000621198		{Schizophrenia, susceptibility to}	181500	AD	3	Syn2
3p25.2	3:12287368-12434344	PPARG, PPARG1, PPARG2, FPLD3	Peroxisome proliferator activated receptor, gamma	601487	PPARG	5468	ENSG00000132170,ENST00000651735;;;ENST00000651735	PPARG1, PPARG2 from same gene	{Diabetes, type 2}	125853	AD	3	Pparg
3p25.2	3:12287368-12434344	PPARG, PPARG1, PPARG2, FPLD3	Peroxisome proliferator activated receptor, gamma	601487	PPARG	5468	ENSG00000132170,ENST00000651735;;;ENST00000651735	PPARG1, PPARG2 from same gene	Insulin resistance, severe, digenic	125853	AD	3	Pparg
3p25.2	3:12287368-12434344	PPARG, PPARG1, PPARG2, FPLD3	Peroxisome proliferator activated receptor, gamma	601487	PPARG	5468	ENSG00000132170,ENST00000651735;;;ENST00000651735	PPARG1, PPARG2 from same gene	Lipodystrophy, familial partial, type 3	604367	AD	3	Pparg
3p25.2	3:12287368-12434344	PPARG, PPARG1, PPARG2, FPLD3	Peroxisome proliferator activated receptor, gamma	601487	PPARG	5468	ENSG00000132170,ENST00000651735;;;ENST00000651735	PPARG1, PPARG2 from same gene	Obesity, severe	601665	AD, AR, Mu	3	Pparg
3p25.2	3:12480231-12539624	TSEN2, SEN2, PCH2B	tRNA splicing endonuclease, subunit 2	608753	TSEN2	80746	ENSG00000154743,ENST00000284995;;;ENST00000284995		Pontocerebellar hypoplasia type 2B	612389	AR	3	Tsen2
3p25.2	3:12583601-12664117	RAF1, CRAF, NS5, CMD1NN	Oncogene RAF1	164760	RAF1	5894	ENSG00000132155,ENST00000251849;;;ENST00000251849		Cardiomyopathy, dilated, 1NN	615916	AD	3	Raf1
3p25.2	3:12583601-12664117	RAF1, CRAF, NS5, CMD1NN	Oncogene RAF1	164760	RAF1	5894	ENSG00000132155,ENST00000251849;;;ENST00000251849		LEOPARD syndrome 2	611554	AD	3	Raf1
3p25.2	3:12583601-12664117	RAF1, CRAF, NS5, CMD1NN	Oncogene RAF1	164760	RAF1	5894	ENSG00000132155,ENST00000251849;;;ENST00000251849		Noonan syndrome 5	611553	AD	3	Raf1
3p25.2-p25.1	3:12897043-13283257	IQSEC1, KIAA0763, IDDSSBA	IQ motif- and Sec7 domain-containing protein 1	610166	IQSEC1	9922	ENSG00000144711,ENST00000613206;;;ENST00000613206		Intellectual developmental disorder with short stature and behavioral abnormalities	618687	AR	3	Iqsec1
3p25.1-p23	3:13200001-32000000	LGMD1H	Muscular dystrophy, limb-girdle, type 1H	613530		100529230		between D3S1263 and D3S1277	Muscular dystrophy, limb-girdle, type 1H	613530	AD	2	
3p25.1	3:13816258-13880071	WNT7A, SANTOS	Wingless-type MMTV integration site family, member 7A	601570	WNT7A	7476	ENSG00000154764,ENST00000285018;;;ENST00000285018	mutation identified in 1 SANTOS family	?Santos syndrome	613005	AR	3	Wnt7a
3p25.1	3:13816258-13880071	WNT7A, SANTOS	Wingless-type MMTV integration site family, member 7A	601570	WNT7A	7476	ENSG00000154764,ENST00000285018;;;ENST00000285018	mutation identified in 1 SANTOS family	Fuhrmann syndrome	228930	AR	3	Wnt7a
3p25.1	3:13816258-13880071	WNT7A, SANTOS	Wingless-type MMTV integration site family, member 7A	601570	WNT7A	7476	ENSG00000154764,ENST00000285018;;;ENST00000285018	mutation identified in 1 SANTOS family	Ulna and fibula, absence of, with severe limb deficiency	276820	AR	3	Wnt7a
3p25.1	3:14125052-14143680	TMEM43, ARVD5, ARVC5, EDMD7, AUNA3	Transmembrane protein 43	612048	TMEM43	79188	ENSG00000170876,ENST00000306077;;;ENST00000306077		Arrhythmogenic right ventricular dysplasia 5	604400	AD	3	Tmem43
3p25.1	3:14125052-14143680	TMEM43, ARVD5, ARVC5, EDMD7, AUNA3	Transmembrane protein 43	612048	TMEM43	79188	ENSG00000170876,ENST00000306077;;;ENST00000306077		Auditory neuropathy, autosomal dominant 3	619832	AD	3	Tmem43
3p25.1	3:14125052-14143680	TMEM43, ARVD5, ARVC5, EDMD7, AUNA3	Transmembrane protein 43	612048	TMEM43	79188	ENSG00000170876,ENST00000306077;;;ENST00000306077		Emery-Dreifuss muscular dystrophy 7, AD	614302	AD	3	Tmem43
3p25.1	3:14145147-14178601	XPC, XPCC	XPC complex subunit, DNA damage recognition and repair factor	613208	XPC	7508	ENSG00000154767,ENST00000285021;;;ENST00000285021		Xeroderma pigmentosum, group C	278720	AR	3	Xpc
3p25.1	3:14402576-14489349	SLC6A6, TAUT, HTRDC	Solute carrier family 6 (neurotransmitter transporter, taurine), member 6	186854	SLC6A6	6533	ENSG00000131389,ENST00000622186;;;ENST00000622186		Hypotaurinemic retinal degeneration and cardiomyopathy	145350	AR	3	Slc6a6
3p25.1	3:14651762-14672655	CCDC174, HSPC212, IHPM	Coiled-coil domain-containing protein 174	616735	CCDC174	51244	ENSG00000154781,ENST00000383794;;;ENST00000383794		Hypotonia, infantile, with psychomotor retardation	616816	AR	3	Ccdc174
3p25.1	3:15042251-15065315	MRPS25, COXPD50	Mitochondrial ribosomal protein S25	611987	MRPS25	64432	ENSG00000131368,ENST00000253686;;;ENST00000253686	mutation identified in 1 COXPD50 patient	?Combined oxidative phosphorylation deficiency 50	619025	AR	3	Mrps25
3p25.1	3:15070073-15099148	RBSN, ZFYVE20, KAREVS, MFANDO	Rabenosyn 5	609511	RBSN	64145	ENSG00000131381,ENST00000253699;;;ENST00000253699		Kariminejad neurodevelopmental syndrome	620937	AR	3	Rbsn
3p25.1	3:15070073-15099148	RBSN, ZFYVE20, KAREVS, MFANDO	Rabenosyn 5	609511	RBSN	64145	ENSG00000131381,ENST00000253699;;;ENST00000253699		Myelofibrosis, congenital, with anemia, neutropenia, developmental delay, and ocular abnormalities	620939	AR	3	Rbsn
3p25.1	3:15450133-15521706	COLQ, EAD, CMS5	Collagenic tail of endplate acetylcholinesterase	603033	COLQ	8292	ENSG00000206561,ENST00000383788;;;ENST00000383788		Myasthenic syndrome, congenital, 5	603034	AR	3	Colq
3p25.1	3:15601361-15722516	BTD	Biotinidase	609019	BTD	686	ENSG00000169814,ENST00000643237;;;ENST00000643237		Biotinidase deficiency	253260	AR	3	Btd
3p24-p21	3:16300001-54400000	ASPG4	Asperger syndrome, susceptibility to, 4	609954		100188800		max lod at D3S2432	{Asperger syndrome susceptibility 4}	609954		2	
3p24	3:16300001-30800000	ATOD9	Dermatitis, atopic, 9	613519		105463126		max lod at D3S1768	{Dermatitis, atopic, susceptibility to, 9}	613519		2	
3p24-p22	3:16300001-43600000	HSN1B	Hereditary sensory neuropathy, type IB	608088		378888		max lod at D3S2338	Neuropathy, hereditary sensory, type IB	608088	AD	2	
3p24.3	3:16300001-23800000	OS6	Osteoarthritis susceptibility 6	612401		100286836		associated with rs11718863 and rs7639618	{Osteoarthritis susceptibility 6}	612401		2	
3p24-p21.2	3:16300001-52300000	TRICY1	Trichilemmal cyst 1	609649		94014		max lod at D3S1277	Trichilemmal cyst 1	609649	AD	2	
3p24.3	3:18345377-18445592	SATB1, DEFDA, DHDBV	Special AT-rich sequence binding protein-1	602075	SATB1	6304	ENSG00000182568,ENST00000338745;;;ENST00000338745		den Hoed-de Boer-Voisin syndrome	619229	AD	3	Satb1
3p24.3	3:18345377-18445592	SATB1, DEFDA, DHDBV	Special AT-rich sequence binding protein-1	602075	SATB1	6304	ENSG00000182568,ENST00000338745;;;ENST00000338745		Developmental delay with dysmorphic facies and dental anomalies	619228	AD	3	Satb1
3p24.3	3:20160593-20186886	SGOL1, SGO, SGO1, CAID	Shugoshin-like 1	609168	SGO1	151648	ENSG00000129810,ENST00000412997;;;ENST00000412997		Chronic atrial and intestinal dysrhythmia	616201	AR	3	Sgo1
3p24.2-p23	3:23800001-32000000	FEB9	Febrile seizures, familial, 9	611634		100188849		between D3S3727 and D3S3567	Febrile seizures, familial, 9	611634	AD	2	
3p24.2	3:23916545-23924631	RPL15, DBA12	Ribosomal protein L15	604174	RPL15	6138	ENSG00000174748,ENST00000307839;;;ENST00000307839		Diamond-Blackfan anemia 12	615550	AD	3	Rpl15
3p24.2	3:24117153-24495708	THRB, ERBA2, THR1, PRTH	Thyroid hormone receptor, beta (avian erythroblastic leukemia viral (v-erb-a) oncogene homolog-2)	190160	THRB	7068	ENSG00000151090,ENST00000646209;;;ENST00000646209		Thyroid hormone resistance	188570	AD	3	Thrb
3p24.2	3:24117153-24495708	THRB, ERBA2, THR1, PRTH	Thyroid hormone receptor, beta (avian erythroblastic leukemia viral (v-erb-a) oncogene homolog-2)	190160	THRB	7068	ENSG00000151090,ENST00000646209;;;ENST00000646209		Thyroid hormone resistance, autosomal recessive	274300	AR	3	Thrb
3p24.2	3:24117153-24495708	THRB, ERBA2, THR1, PRTH	Thyroid hormone receptor, beta (avian erythroblastic leukemia viral (v-erb-a) oncogene homolog-2)	190160	THRB	7068	ENSG00000151090,ENST00000646209;;;ENST00000646209		Thyroid hormone resistance, selective pituitary	145650	AD	3	Thrb
3p24.2	3:24829321-25597932	RARB, HAP, MCOPS12	Retinoic acid receptor, beta polypeptide	180220	RARB	5915	ENSG00000077092,ENST00000330688;;;ENST00000330688	= HAP = HBV-activated protein	Microphthalmia, syndromic 12	615524	AD, AR	3	Rarb
3p24.2	3:25597905-25664907	TOP2B, BILU	Topoisomerase (DNA) II, beta, 180kD	126431	TOP2B	7155	ENSG00000077097,ENST00000264331;;;ENST00000264331		B-cell immunodeficiency, distal limb anomalies, and urogenital malformations	609296	AD	3	Top2b
3p24.2	3:25718944-25790039	NGLY1, PNG1, CDDG, CDG1V	N-glycanase 1	610661	NGLY1	55768	ENSG00000151092,ENST00000280700;;;ENST00000280700		Congenital disorder of deglycosylation 1	615273	AR	3	Ngly1
3p24.1	3:27106484-27369383	NEK10, CILD44	NIMA-related kinase 10	618726	NEK10	152110	ENSG00000163491,ENST00000691995;;;ENST00000691995		Ciliary dyskinesia, primary, 44	618781	AR	3	Nek10
3p24.1	3:30606356-30694142	TGFBR2, HNPCC6, AAT3, MFS2, LDS2	Transforming growth factor, beta receptor II, 70-80kD	190182	TGFBR2	7048	ENSG00000163513,ENST00000295754;;;ENST00000295754		Colorectal cancer, hereditary nonpolyposis, type 6	614331		3	Tgfbr2
3p24.1	3:30606356-30694142	TGFBR2, HNPCC6, AAT3, MFS2, LDS2	Transforming growth factor, beta receptor II, 70-80kD	190182	TGFBR2	7048	ENSG00000163513,ENST00000295754;;;ENST00000295754		Esophageal cancer, somatic	133239		3	Tgfbr2
3p24.1	3:30606356-30694142	TGFBR2, HNPCC6, AAT3, MFS2, LDS2	Transforming growth factor, beta receptor II, 70-80kD	190182	TGFBR2	7048	ENSG00000163513,ENST00000295754;;;ENST00000295754		Loeys-Dietz syndrome 2	610168	AD	3	Tgfbr2
3p23-p21	3:30800001-54400000	SCLC1	Small-cell cancer of lung	182280		7864		centromeric to ERBA2	Small-cell cancer of lung	182280	AD	2	
3p23	3:31532925-31637616	STT3B, SIMP, CDG1X	STT3B, subunit of the oligosaccharyltransferase complex (catalytic)	608605	STT3B	201595	ENSG00000163527,ENST00000295770;;;ENST00000295770		Congenital disorder of glycosylation, type Ix	615597	AR	3	Stt3b
3p22	3:32000001-43600000	HHV8S	Human herpesvirus 8, susceptibility to	614836		101056702			{Human herpesvirus 8, susceptibility to}	614836		2	
3p22.3	3:32106620-32168709	GPD1L, KIAA0089	Glycerol-3-phosphate dehydrogenase 1-like	611778	GPD1L	23171	ENSG00000152642,ENST00000282541;;;ENST00000282541		Brugada syndrome 2	611777	AD	3	Gpd1l
3p22.3	3:32817997-32897824	TRIM71, LIN41, HYC4	Tripartite motif-containing protein 71	618570	TRIM71	131405	ENSG00000206557,ENST00000383763;;;ENST00000383763		Hydrocephalus, congenital, 4	618667	AD	3	Trim71
3p22.3	3:32961108-33097146	GLB1, MPS4B	Galactosidase, beta-1	611458	GLB1	2720	ENSG00000170266,ENST00000307363;;;ENST00000307363	3p14.2-p11 excluded	GM1-gangliosidosis, type I	230500	AR	3	Glb1
3p22.3	3:32961108-33097146	GLB1, MPS4B	Galactosidase, beta-1	611458	GLB1	2720	ENSG00000170266,ENST00000307363;;;ENST00000307363	3p14.2-p11 excluded	GM1-gangliosidosis, type II	230600	AR	3	Glb1
3p22.3	3:32961108-33097146	GLB1, MPS4B	Galactosidase, beta-1	611458	GLB1	2720	ENSG00000170266,ENST00000307363;;;ENST00000307363	3p14.2-p11 excluded	GM1-gangliosidosis, type III	230650	AR	3	Glb1
3p22.3	3:32961108-33097146	GLB1, MPS4B	Galactosidase, beta-1	611458	GLB1	2720	ENSG00000170266,ENST00000307363;;;ENST00000307363	3p14.2-p11 excluded	Mucopolysaccharidosis type IVB (Morquio)	253010	AR	3	Glb1
3p22.3	3:33114014-33147773	CRTAP, CASP, OI7	Cartilage-associated protein	605497	CRTAP	10491	ENSG00000170275,ENST00000320954;;;ENST00000320954		Osteogenesis imperfecta, type VII	610682	AR	3	Crtap
3p22.3	3:33798630-33869703	PDCD6IP, AIP1, ALIX, KIAA1375, MCPH29	Programmed cell death 6-interacting protein	608074	PDCD6IP	10015	ENSG00000170248,ENST00000307296;;;ENST00000307296	mutation identified in 1 MCPH29 family	?Microcephaly 29, primary, autosomal recessive	620047	AR	3	Pdcd6ip
3p22.2	3:36400001-39300000	DDH2	Developmental dysplasia of the hip 2	615612		102775567		between rs4481097 and rs4626072	Developmental dysplasia of the hip 2	615612	AD	2	
3p22.2	3:36993466-37050846	MLH1, COCA2, LYNCH2, MMRCS1	DNA mismatch repair protein MLH1	120436	MLH1	4292	ENSG00000076242,ENST00000231790;;;ENST00000231790		Lynch syndrome 2	609310		3	Mlh1
3p22.2	3:36993466-37050846	MLH1, COCA2, LYNCH2, MMRCS1	DNA mismatch repair protein MLH1	120436	MLH1	4292	ENSG00000076242,ENST00000231790;;;ENST00000231790		Mismatch repair cancer syndrome 1	276300	AR	3	Mlh1
3p22.2	3:36993466-37050846	MLH1, COCA2, LYNCH2, MMRCS1	DNA mismatch repair protein MLH1	120436	MLH1	4292	ENSG00000076242,ENST00000231790;;;ENST00000231790		Muir-Torre syndrome	158320	AD	3	Mlh1
3p22.2	3:38007496-38029642	PLCD1, NDNC3	Phospholipase C, delta-1	602142	PLCD1	5333	ENSG00000187091,ENST00000334661;;;ENST00000334661		Nail disorder, nonsyndromic congenital, 3, (leukonychia)	151600	AD, AR	3	Plcd1
3p22.2	3:38138661-38143022	MYD88, MYD88D, IMD68	MYD88 innate immune signal transduction adaptor	602170	MYD88	4615	ENSG00000172936,ENST00000650905;;;ENST00000650905		Immunodeficiency 68	612260	AR	3	Myd88
3p22.2	3:38138661-38143022	MYD88, MYD88D, IMD68	MYD88 innate immune signal transduction adaptor	602170	MYD88	4615	ENSG00000172936,ENST00000650905;;;ENST00000650905		Macroglobulinemia, Waldenstrom, somatic	153600		3	Myd88
3p22.2	3:38453890-38493142	ACVR2B, ACTRIIB, HTX4	Activin A receptor, type IIB	602730	ACVR2B	93	ENSG00000114739,ENST00000352511;;;ENST00000352511		Heterotaxy, visceral, 4, autosomal	613751		3	Acvr2b
3p22.2	3:38548062-38649687	SCN5A, LQT3, VF1, HB1, SSS1, CMD1E, CDCD2	Sodium channel, voltage-gated, type V, alpha polypeptide	600163	SCN5A	6331	ENSG00000183873,ENST00000423572;;;ENST00000423572		{Sudden infant death syndrome, susceptibility to}	272120	AR	3	Scn5a
3p22.2	3:38548062-38649687	SCN5A, LQT3, VF1, HB1, SSS1, CMD1E, CDCD2	Sodium channel, voltage-gated, type V, alpha polypeptide	600163	SCN5A	6331	ENSG00000183873,ENST00000423572;;;ENST00000423572		Atrial fibrillation, familial, 10	614022	AD	3	Scn5a
3p22.2	3:38548062-38649687	SCN5A, LQT3, VF1, HB1, SSS1, CMD1E, CDCD2	Sodium channel, voltage-gated, type V, alpha polypeptide	600163	SCN5A	6331	ENSG00000183873,ENST00000423572;;;ENST00000423572		Brugada syndrome 1	601144	AD	3	Scn5a
3p22.2	3:38548062-38649687	SCN5A, LQT3, VF1, HB1, SSS1, CMD1E, CDCD2	Sodium channel, voltage-gated, type V, alpha polypeptide	600163	SCN5A	6331	ENSG00000183873,ENST00000423572;;;ENST00000423572		Cardiomyopathy, dilated, 1E	601154	AD	3	Scn5a
3p22.2	3:38548062-38649687	SCN5A, LQT3, VF1, HB1, SSS1, CMD1E, CDCD2	Sodium channel, voltage-gated, type V, alpha polypeptide	600163	SCN5A	6331	ENSG00000183873,ENST00000423572;;;ENST00000423572		Heart block, nonprogressive	113900	AD	3	Scn5a
3p22.2	3:38548062-38649687	SCN5A, LQT3, VF1, HB1, SSS1, CMD1E, CDCD2	Sodium channel, voltage-gated, type V, alpha polypeptide	600163	SCN5A	6331	ENSG00000183873,ENST00000423572;;;ENST00000423572		Heart block, progressive, type IA	113900	AD	3	Scn5a
3p22.2	3:38548062-38649687	SCN5A, LQT3, VF1, HB1, SSS1, CMD1E, CDCD2	Sodium channel, voltage-gated, type V, alpha polypeptide	600163	SCN5A	6331	ENSG00000183873,ENST00000423572;;;ENST00000423572		Long QT syndrome 3	603830	AD	3	Scn5a
3p22.2	3:38548062-38649687	SCN5A, LQT3, VF1, HB1, SSS1, CMD1E, CDCD2	Sodium channel, voltage-gated, type V, alpha polypeptide	600163	SCN5A	6331	ENSG00000183873,ENST00000423572;;;ENST00000423572		Sick sinus syndrome 1	608567	AR	3	Scn5a
3p22.2	3:38548062-38649687	SCN5A, LQT3, VF1, HB1, SSS1, CMD1E, CDCD2	Sodium channel, voltage-gated, type V, alpha polypeptide	600163	SCN5A	6331	ENSG00000183873,ENST00000423572;;;ENST00000423572		Ventricular fibrillation, familial, 1	603829		3	Scn5a
3p22.2	3:38696807-38816217	SCN10A, FEPS2	Sodium voltage-gated channel, alpha subunit 10	604427	SCN10A	6336	ENSG00000185313,ENST00000449082;;;ENST00000449082		Episodic pain syndrome, familial, 2	615551	AD	3	Scn10a
3p22.2	3:38845764-39051944	SCN11A, HSAN7, FEPS3	Sodium voltage-gated channel, alpha subunit 11	604385	SCN11A	11280	ENSG00000168356,ENST00000302328;;;ENST00000302328		Episodic pain syndrome, familial, 3	615552	AD	3	Scn11a
3p22.2	3:38845764-39051944	SCN11A, HSAN7, FEPS3	Sodium voltage-gated channel, alpha subunit 11	604385	SCN11A	11280	ENSG00000168356,ENST00000302328;;;ENST00000302328		Neuropathy, hereditary sensory and autonomic, type VII	615548	AD	3	Scn11a
3p22.2	3:39107680-39138900	TTC21A, STI2, SPGF37	Tetratricopeptide repeat domain-containing protein 21A	611430	TTC21A	199223	ENSG00000168026,ENST00000683103;;;ENST00000683103		Spermatogenic failure 37	618429	AR	3	Ttc21a
3p22.2	3:39263494-39292966	CX3CR1, GPR13, V28	Chemokine (C-X3-C) receptor 1 (G protein-coupled receptor-13)	601470	CX3CR1	1524	ENSG00000168329,ENST00000399220;;;ENST00000399220		{Coronary artery disease, resistance to}	607339		3	Cx3cr1
3p22.2	3:39263494-39292966	CX3CR1, GPR13, V28	Chemokine (C-X3-C) receptor 1 (G protein-coupled receptor-13)	601470	CX3CR1	1524	ENSG00000168329,ENST00000399220;;;ENST00000399220		{Macular degeneration, age-related, 12}	613784		3	Cx3cr1
3p22.2	3:39263494-39292966	CX3CR1, GPR13, V28	Chemokine (C-X3-C) receptor 1 (G protein-coupled receptor-13)	601470	CX3CR1	1524	ENSG00000168329,ENST00000399220;;;ENST00000399220		{Rapid progression to AIDS from HIV1 infection}	609423		3	Cx3cr1
3p22.1	3:39383370-39397351	SLC25A38, SIDBA2	Solute carrier family 25, member 38	610819	SLC25A38	54977	ENSG00000144659,ENST00000650617;;;ENST00000650617		Anemia, sideroblastic, 2, pyridoxine-refractory	205950	AR	3	Slc25a38
3p22.1	3:39406720-39412542	RPSA, LAMR1, LAMBR, ICAS	Ribosomal protein SA	150370	RPSA	3921	ENSG00000168028,ENST00000301821;;;ENST00000301821		Asplenia, isolated congenital	271400	AD	3	Rpsa
3p22.1	3:41199505-41240443	CTNNB1, NEDSDV, EVR7	Catenin (cadherin-associated protein), beta 1, 88kD	116806	CTNNB1	1499	ENSG00000168036,ENST00000349496;;;ENST00000349496		Colorectal cancer, somatic	114500		3	Ctnnb1
3p22.1	3:41199505-41240443	CTNNB1, NEDSDV, EVR7	Catenin (cadherin-associated protein), beta 1, 88kD	116806	CTNNB1	1499	ENSG00000168036,ENST00000349496;;;ENST00000349496		Exudative vitreoretinopathy 7	617572	AD	3	Ctnnb1
3p22.1	3:41199505-41240443	CTNNB1, NEDSDV, EVR7	Catenin (cadherin-associated protein), beta 1, 88kD	116806	CTNNB1	1499	ENSG00000168036,ENST00000349496;;;ENST00000349496		Hepatocellular carcinoma, somatic	114550		3	Ctnnb1
3p22.1	3:41199505-41240443	CTNNB1, NEDSDV, EVR7	Catenin (cadherin-associated protein), beta 1, 88kD	116806	CTNNB1	1499	ENSG00000168036,ENST00000349496;;;ENST00000349496		Medulloblastoma, somatic	155255		3	Ctnnb1
3p22.1	3:41199505-41240443	CTNNB1, NEDSDV, EVR7	Catenin (cadherin-associated protein), beta 1, 88kD	116806	CTNNB1	1499	ENSG00000168036,ENST00000349496;;;ENST00000349496		Neurodevelopmental disorder with spastic diplegia and visual defects	615075	AD	3	Ctnnb1
3p22.1	3:41199505-41240443	CTNNB1, NEDSDV, EVR7	Catenin (cadherin-associated protein), beta 1, 88kD	116806	CTNNB1	1499	ENSG00000168036,ENST00000349496;;;ENST00000349496		Ovarian cancer, somatic	167000		3	Ctnnb1
3p22.1	3:41199505-41240443	CTNNB1, NEDSDV, EVR7	Catenin (cadherin-associated protein), beta 1, 88kD	116806	CTNNB1	1499	ENSG00000168036,ENST00000349496;;;ENST00000349496		Pilomatricoma, somatic	132600		3	Ctnnb1
3p22.1	3:42013093-42225890	TRAK1, OIP106, KIAA1042, DEE68	Trafficking protein, kinesin-binding 1	608112	TRAK1	22906	ENSG00000182606,ENST00000327628;;;ENST00000327628		Developmental and epileptic encephalopathy 68	618201	AR	3	Trak1
3p22.1	3:42685537-42692544	KLHL40, SYRP, KBTBD5, NEM8	Kelch-like 40	615340	KLHL40	131377	ENSG00000157119,ENST00000287777;;;ENST00000287777		Nemaline myopathy 8, autosomal recessive	615348	AR	3	Klhl40
3p22.1	3:43079234-43106079	POMGNT2, GTDC2, C3orf39, AGO61, MDDGA8, MDDGC8	Protein O-mannose beta-1,2-N-acetylglucosaminyltransferase 2	614828	POMGNT2	84892	ENSG00000144647,ENST00000344697;;;ENST00000344697		Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 8	614830	AR	3	Pomgnt2
3p22.1	3:43079234-43106079	POMGNT2, GTDC2, C3orf39, AGO61, MDDGA8, MDDGC8	Protein O-mannose beta-1,2-N-acetylglucosaminyltransferase 2	614828	POMGNT2	84892	ENSG00000144647,ENST00000344697;;;ENST00000344697		Muscular dystrophy-dystroglycanopathy (limb-girdle) type C, 8	618135	AR	3	Pomgnt2
3p22.1-p21.33	3:43365848-43691594	ANO10, TMEM16K, SCAR10	Anoctamin 10	613726	ANO10	55129	ENSG00000160746,ENST00000292246;;;ENST00000292246		Spinocerebellar ataxia, autosomal recessive 10	613728	AR	3	Ano10
3p21	3:43600001-54400000	CELIAC9	Celiac disease, susceptibility to, 9	612007		100188871		associated with rs6441961	{Celiac disease, susceptibility to, 9}	612007		2	
3p21	3:43600001-54400000	HSCR6	Hirschsprung disease, susceptibility to, 6	606874		246321			{Hirschsprung disease, susceptibility to, 6}	606874		2	
3p21.3	3:43600001-50600000	IBD12	Inflammatory bowel disease 12	612241		100188952			{Inflammatory bowel disease 12}	612241		2	
3p21-p13	3:43600001-74100000	MPVQTL2	Mean platelet volume quantitative trait locus 2	612574		100271868		associated with rs12485738	[Mean platelet volume QTL2]	612574		2	
3p21	3:43600001-54400000	PSC	Cholangitis, primary sclerosing	613806		100653366			Cholangitis, primary sclerosing	613806		2	
3p21.33	3:43690870-43734371	ABHD5, CGI58, IECN2, NCIE2	Abhydrolase domain containing 5, lysophosphatidic acid acyltransferase	604780	ABHD5	51099	ENSG00000011198,ENST00000644371;;;ENST00000644371		Chanarin-Dorfman syndrome	275630	AR	3	Abhd5
3p21.31	3:44200001-50600000	ZD1	Zygodactyly 1	609815		780914		max lod at D3S2409	Zygodactyly 1	609815		2	
3p21.31	3:44761794-44868687	KIF15, KLP2, KNSL7, BRDCS2	Kinesin family, member 15	617569	KIF15	56992	ENSG00000163808,ENST00000326047;;;ENST00000326047	mutation identified in 1 BRDCS2 patient	?Braddock-Carey syndrome 2	619981	AR	3	Kif15
3p21.31	3:45026303-45036071	CLEC3B, TNA, MCDR4	C-type lectin domain family 3, member B	187520	CLEC3B	7123	ENSG00000163815,ENST00000296130;;;ENST00000296130		Macular dystrophy, retinal, 4	619977	AD	3	Clec3b
3p21.31	3:45388576-45549407	LARS2, PRLTS4, HLASA	Leucyl-tRNA synthetase, mitochondrial	604544	LARS2	23395	ENSG00000011376,ENST00000645846;;;ENST00000645846		Hydrops, lactic acidosis, and sideroblastic anemia	617021	AR	3	Lars2
3p21.31	3:45388576-45549407	LARS2, PRLTS4, HLASA	Leucyl-tRNA synthetase, mitochondrial	604544	LARS2	23395	ENSG00000011376,ENST00000645846;;;ENST00000645846		Perrault syndrome 4	615300	AR	3	Lars2
3p21.31	3:45823316-45915724	LZTFL1, BBS17	Leucine zipper transcription factor-like 1	606568	LZTFL1	54585	ENSG00000163818,ENST00000296135;;;ENST00000296135		Bardet-Biedl syndrome 17	615994	AR	3	Lztfl1
3p21.31	3:45917903-45995824	FYCO1, CATC2, CTRCT18	FYVE and coiled-coil domain containing 1	607182	FYCO1	79443	ENSG00000163820,ENST00000296137;;;ENST00000296137		Cataract 18, autosomal recessive	610019	AR	3	Fyco1
3p21.31	3:46354111-46360940	CCR2, CMKBR2, PCLUD	Chemokine (C-C) receptor 2	601267	CCR2	729230	ENSG00000121807,ENST00000445132;;;ENST00000445132		{HIV infection, susceptibility/resistance to}	609423		3	Ccr2
3p21.31	3:46354111-46360940	CCR2, CMKBR2, PCLUD	Chemokine (C-C) receptor 2	601267	CCR2	729230	ENSG00000121807,ENST00000445132;;;ENST00000445132		Polycystic lung disease	219600	AR	3	Ccr2
3p21.31	3:46370142-46376206	CCR5, CMKBR5, CCCKR5, IDDM22	Chemokine (C-C) receptor 5	601373	CCR5	1234	ENSG00000160791,ENST00000292303;;;ENST00000292303		{Diabetes mellitus, insulin-dependent, 22}	612522		3	Ccr5
3p21.31	3:46370142-46376206	CCR5, CMKBR5, CCCKR5, IDDM22	Chemokine (C-C) receptor 5	601373	CCR5	1234	ENSG00000160791,ENST00000292303;;;ENST00000292303		{Hepatitis C virus, resistance to}	609532		3	Ccr5
3p21.31	3:46370142-46376206	CCR5, CMKBR5, CCCKR5, IDDM22	Chemokine (C-C) receptor 5	601373	CCR5	1234	ENSG00000160791,ENST00000292303;;;ENST00000292303		{HIV infection, susceptibility/resistance to}	609423		3	Ccr5
3p21.31	3:46370142-46376206	CCR5, CMKBR5, CCCKR5, IDDM22	Chemokine (C-C) receptor 5	601373	CCR5	1234	ENSG00000160791,ENST00000292303;;;ENST00000292303		{West nile virus, susceptibility to}	610379		3	Ccr5
3p21.31	3:46693778-46710886	TMIE, DFNB6	Transmembrane inner ear-expressed gene	607237	TMIE	259236	ENSG00000181585,ENST00000643606;;;ENST00000643606		Deafness, autosomal recessive 6	600971	AR	3	Tmie
3p21.31	3:46857872-46882182	MYL3, CMH8	Myosin, light polypeptide-3, alkali; ventricular, skeletal, slow	160790	MYL3	4634	ENSG00000160808,ENST00000292327;;;ENST00000292327		Cardiomyopathy, hypertrophic, 8	608751	AD, AR	3	Myl3
3p21.31	3:46877721-46903799	PTH1R, PTHR1, PTHR, PFE, EKNS	Parathyroid hormone 1 receptor	168468	PTH1R	5745	ENSG00000160801,ENST00000449590;;;ENST00000449590		Chondrodysplasia, Blomstrand type	215045	AR	3	Pth1r
3p21.31	3:46877721-46903799	PTH1R, PTHR1, PTHR, PFE, EKNS	Parathyroid hormone 1 receptor	168468	PTH1R	5745	ENSG00000160801,ENST00000449590;;;ENST00000449590		Eiken syndrome	600002	AR	3	Pth1r
3p21.31	3:46877721-46903799	PTH1R, PTHR1, PTHR, PFE, EKNS	Parathyroid hormone 1 receptor	168468	PTH1R	5745	ENSG00000160801,ENST00000449590;;;ENST00000449590		Failure of tooth eruption, primary	125350	AD	3	Pth1r
3p21.31	3:46877721-46903799	PTH1R, PTHR1, PTHR, PFE, EKNS	Parathyroid hormone 1 receptor	168468	PTH1R	5745	ENSG00000160801,ENST00000449590;;;ENST00000449590		Metaphyseal chondrodysplasia, Murk Jansen type	156400	AD	3	Pth1r
3p21.31	3:46979666-47009701	NBEAL2, KIAA0540, GPS, BDPLT4	Neurobeachin-like 2	614169	NBEAL2	23218	ENSG00000160796,ENST00000450053;;;ENST00000450053		Gray platelet syndrome	139090	AR	3	Nbeal2
3p21.31	3:47016436-47164840	SETD2, SET2, HYPB, HBP231, KIAA1732, LLS, RAPAS, MRD70	SET domain-containing protein 2	612778	SETD2	29072	ENSG00000181555,ENST00000409792;;;ENST00000409792		Intellectual developmental disorder, autosomal dominant 70	620157	AD	3	Setd2
3p21.31	3:47016436-47164840	SETD2, SET2, HYPB, HBP231, KIAA1732, LLS, RAPAS, MRD70	SET domain-containing protein 2	612778	SETD2	29072	ENSG00000181555,ENST00000409792;;;ENST00000409792		Luscan-Lumish syndrome	616831	AD	3	Setd2
3p21.31	3:47016436-47164840	SETD2, SET2, HYPB, HBP231, KIAA1732, LLS, RAPAS, MRD70	SET domain-containing protein 2	612778	SETD2	29072	ENSG00000181555,ENST00000409792;;;ENST00000409792		Rabin-Pappas syndrome	620155	AD	3	Setd2
3p21.31	3:47381021-47413435	PTPN23, KIAA1471, HDPTP, NEDBASS	Protein-tyrosine phosphatase, nonreceptor-type, 23	606584	PTPN23	25930	ENSG00000076201,ENST00000265562;;;ENST00000265562		Neurodevelopmental disorder and structural brain anomalies with or without seizures and spasticity	618890	AR	3	Ptpn23
3p21.31	3:47585269-47781893	SMARCC1, BAF155, HYC5	SWI/SNF related, matrix-associated, actin-dependent regulator of chromatin, subfamily C, member 1	601732	SMARCC1	6599	ENSG00000173473,ENST00000254480;;;ENST00000254480		{Hydrocephalus, congenital, 5, susceptibility to}	620241	AD	3	Smarcc1
3p21.31	3:47803138-47850193	DHX30, DDX30, RETCOR, KIAA0890, NEDMIAL	DExH-box helicase 30	616423	DHX30	22907	ENSG00000132153,ENST00000445061;;;ENST00000445061		Neurodevelopmental disorder with variable motor and speech impairment	617804	AD	3	Dhx30
3p21.31	3:48465830-48467645	TREX1, AGS1, CRV, HERNS, RVCLS	3' repair exonuclease 1	606609	TREX1	11277	ENSG00000213689,ENST00000625293;;;ENST00000625293		{Systemic lupus erythematosus, susceptibility to}	152700	AD	3	Trex1
3p21.31	3:48465830-48467645	TREX1, AGS1, CRV, HERNS, RVCLS	3' repair exonuclease 1	606609	TREX1	11277	ENSG00000213689,ENST00000625293;;;ENST00000625293		Aicardi-Goutieres syndrome 1, dominant and recessive	225750	AD, AR	3	Trex1
3p21.31	3:48465830-48467645	TREX1, AGS1, CRV, HERNS, RVCLS	3' repair exonuclease 1	606609	TREX1	11277	ENSG00000213689,ENST00000625293;;;ENST00000625293		Chilblain lupus	610448	AD	3	Trex1
3p21.31	3:48465830-48467645	TREX1, AGS1, CRV, HERNS, RVCLS	3' repair exonuclease 1	606609	TREX1	11277	ENSG00000213689,ENST00000625293;;;ENST00000625293		Vasculopathy, retinal, with cerebral leukoencephalopathy and systemic manifestations	192315	AD	3	Trex1
3p21.31	3:48564073-48595329	COL7A1, NDNC8	Collagen VII, alpha-1 polypeptide	120120	COL7A1	1294	ENSG00000114270,ENST00000681320;;;ENST00000681320		Epidermolysis bullosa dystrophica inversa	226600	AR	3	Col7a1
3p21.31	3:48564073-48595329	COL7A1, NDNC8	Collagen VII, alpha-1 polypeptide	120120	COL7A1	1294	ENSG00000114270,ENST00000681320;;;ENST00000681320		Epidermolysis bullosa dystrophica, autosomal dominant	131750	AD	3	Col7a1
3p21.31	3:48564073-48595329	COL7A1, NDNC8	Collagen VII, alpha-1 polypeptide	120120	COL7A1	1294	ENSG00000114270,ENST00000681320;;;ENST00000681320		Epidermolysis bullosa dystrophica, autosomal recessive	226600	AR	3	Col7a1
3p21.31	3:48564073-48595329	COL7A1, NDNC8	Collagen VII, alpha-1 polypeptide	120120	COL7A1	1294	ENSG00000114270,ENST00000681320;;;ENST00000681320		Epidermolysis bullosa dystrophica, Bart type	132000	AD	3	Col7a1
3p21.31	3:48564073-48595329	COL7A1, NDNC8	Collagen VII, alpha-1 polypeptide	120120	COL7A1	1294	ENSG00000114270,ENST00000681320;;;ENST00000681320		Epidermolysis bullosa dystrophica, localisata variant	226600	AR	3	Col7a1
3p21.31	3:48564073-48595329	COL7A1, NDNC8	Collagen VII, alpha-1 polypeptide	120120	COL7A1	1294	ENSG00000114270,ENST00000681320;;;ENST00000681320		Epidermolysis bullosa pruriginosa	604129	AD, AR	3	Col7a1
3p21.31	3:48564073-48595329	COL7A1, NDNC8	Collagen VII, alpha-1 polypeptide	120120	COL7A1	1294	ENSG00000114270,ENST00000681320;;;ENST00000681320		Epidermolysis bullosa, pretibial	131850	AD, AR	3	Col7a1
3p21.31	3:48564073-48595329	COL7A1, NDNC8	Collagen VII, alpha-1 polypeptide	120120	COL7A1	1294	ENSG00000114270,ENST00000681320;;;ENST00000681320		Nail disorder, nonsyndromic congenital, 8	607523	AD	3	Col7a1
3p21.31	3:48564073-48595329	COL7A1, NDNC8	Collagen VII, alpha-1 polypeptide	120120	COL7A1	1294	ENSG00000114270,ENST00000681320;;;ENST00000681320		Transient bullous of the newborn	131705	AD, AR	3	Col7a1
3p21.31	3:48599002-48609646	UQCRC1, PKNPY	Ubiquinol-cytochrome c reductase core protein I	191328	UQCRC1	7384	ENSG00000010256,ENST00000203407;;;ENST00000203407	close upstream of COL7A1	Parkinsonism with polyneuropathy	619279	AD	3	Uqcrc1
3p21.31	3:48856926-48898882	SLC25A20, CACT, CAC	Solute carrier family 25 (carnitine/acylcarnitine translocase), member 20 (carnitine-acylcarnitine translocase)	613698	SLC25A20	788	ENSG00000178537,ENST00000319017;;;ENST00000319017	pseudogene on 6p12	Carnitine-acylcarnitine translocase deficiency	212138	AR	3	Slc25a20
3p21.31	3:48989908-49007153	P4HTM, PH4, HIDEA	Prolyl 4-hydroxylase, transmembrane	614584	P4HTM	54681	ENSG00000178467,ENST00000383729;;;ENST00000383729		Hypotonia, hypoventilation, impaired intellectual development, dysautonomia, epilepsy, and eye abnormalities	618493	AR	3	P4htm
3p21.31	3:49015488-49021505	DALRD3, DEE86	DALR anticodon-binding domain-containing protein 3	618904	DALRD3	55152	ENSG00000178149,ENST00000341949;;;ENST00000341949		Developmental and epileptic encephalopathy 86	618910	AR	3	Dalrd3
3p21.31	3:49020452-49023495	NDUFAF3, MC1DN18	NADH-ubiquinone oxidoreductase complex assembly factor 3	612911	NDUFAF3	25915	ENSG00000178057,ENST00000326925;;;ENST00000326925		Mitochondrial complex I deficiency, nuclear type 18	618240	AR	3	Ndufaf3
3p21.31	3:49024325-49029398	IMPDH2, IMPD2	Inosine-5'-monophosphate dehydrogenase, type II	146691	IMPDH2	3615	ENSG00000178035,ENST00000326739;;;ENST00000326739		[IMPDH2 enzyme activity, variation in]	617995		3	Impdh2
3p21.31	3:49029707-49094373	QRICH1, VERBRAS	Glutamine-rich protein 1	617387	QRICH1	54870	ENSG00000198218,ENST00000395443;;;ENST00000395443		Ververi-Brady syndrome	617982	AD	3	Qrich1
3p21.31	3:49095932-49104757	QARS1, QARS, GLNRS, MSCCA	Glutaminyl-tRNA synthetase 1	603727	QARS1	5859	ENSG00000172053,ENST00000306125;;;ENST00000306125		Microcephaly, progressive, seizures, and cerebral and cerebellar atrophy	615760	AR	3	Qars1
3p21.31	3:49121114-49133050	LAMB2, LAMS, NPHS5, PIERS	Laminin, beta-2 (laminin S)	150325	LAMB2	3913	ENSG00000172037,ENST00000305544;;;ENST00000305544		Nephrotic syndrome, type 5, with or without ocular abnormalities	614199	AR	3	Lamb2
3p21.31	3:49121114-49133050	LAMB2, LAMS, NPHS5, PIERS	Laminin, beta-2 (laminin S)	150325	LAMB2	3913	ENSG00000172037,ENST00000305544;;;ENST00000305544		Pierson syndrome	609049	AR	3	Lamb2
3p21.31	3:49171598-49176486	KLHDC8B, CHL	Kelch domain-containing protein 8B	613169	KLHDC8B	200942	ENSG00000185909,ENST00000332780;;;ENST00000332780		{Hodgkin lymphoma, susceptibility to}	236000	AR	3	Klhdc8b
3p21.31	3:49357176-49358353	GPX1, GPXD	Glutathione peroxidase-1	138320	GPX1	2876	ENSG00000233276,ENST00000419783;;;ENST00000419783	?pseudogene on 3p11-p12	Hemolytic anemia due to glutathione peroxidase deficiency	614164	AR	1	Gpx1
3p21.31	3:49359145-49411976	RHOA, ARHA, ARH12, RHOH12, EDFAOB	Ras homolog gene family, member A (oncogene RHO H12)	165390	RHOA	387	ENSG00000067560,ENST00000418115;;;ENST00000418115		Ectodermal dysplasia with facial dysmorphism and acral, ocular, and brain anomalies, somatic mosaic	618727		3	Rhoa
3p21.31	3:49416778-49422473	AMT, NKH, GCE2	Aminomethyltransferase (glycine cleavage system protein T)	238310	AMT	275	ENSG00000145020,ENST00000273588;;;ENST00000273588		Glycine encephalopathy 2	620398	AR	3	Amt
3p21.31	3:49468948-49535615	DAG1, DAG, MDDGC9, MDDGA9, LGMDR16	Dystrophin-associated glycoprotein-1	128239	DAG1	1605	ENSG00000173402,ENST00000308775;;;ENST00000308775		Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 9	616538	AR	3	Dag1
3p21.31	3:49468948-49535615	DAG1, DAG, MDDGC9, MDDGA9, LGMDR16	Dystrophin-associated glycoprotein-1	128239	DAG1	1605	ENSG00000173402,ENST00000308775;;;ENST00000308775		Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 9	613818	AR	3	Dag1
3p21.31	3:49719916-49723951	GMPPB, KIAA1851, MDDGA14, MDDGB14, MDDGC14, LGMDR19	GDP-mannose pyrophosphorylase B	615320	GMPPB	29925	ENSG00000173540,ENST00000308388;;;ENST00000308388		Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 14	615350	AR	3	Gmppb
3p21.31	3:49719916-49723951	GMPPB, KIAA1851, MDDGA14, MDDGB14, MDDGC14, LGMDR19	GDP-mannose pyrophosphorylase B	615320	GMPPB	29925	ENSG00000173540,ENST00000308388;;;ENST00000308388		Muscular dystrophy-dystroglycanopathy (congenital with impaired intellectual development), type B, 14	615351	AR	3	Gmppb
3p21.31	3:49719916-49723951	GMPPB, KIAA1851, MDDGA14, MDDGB14, MDDGC14, LGMDR19	GDP-mannose pyrophosphorylase B	615320	GMPPB	29925	ENSG00000173540,ENST00000308388;;;ENST00000308388		Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 14	615352	AR	3	Gmppb
3p21.31	3:49828601-49856564	TRAIP, TRIP, RNF206, SCKL9	TRAF-interacting protein	605958	TRAIP	10293	ENSG00000183763,ENST00000331456;;;ENST00000331456		Seckel syndrome 9	616777	AR	3	Traip
3p21.31	3:49887002-49903873	MST1R, RON, NPCA3	Macrophage stimulating 1 receptor (c-met-related tyrosine kinase)	600168	MST1R	4486	ENSG00000164078,ENST00000296474;;;ENST00000296474		{Nasopharyngeal carcinoma, susceptibility to, 3}	617075	AD	3	Mst1r
3p21.31	3:50191610-50197696	GNAT1, CSNBAD3, CSNB1G	Guanine nucleotide-binding protein (G protein), alpha-transducing (transducin) activity polypeptide-1	139330	GNAT1	2779	ENSG00000114349,ENST00000232461;;;ENST00000232461		Night blindness, congenital stationary, autosomal dominant 3	610444	AD	3	Gnat1
3p21.31	3:50191610-50197696	GNAT1, CSNBAD3, CSNB1G	Guanine nucleotide-binding protein (G protein), alpha-transducing (transducin) activity polypeptide-1	139330	GNAT1	2779	ENSG00000114349,ENST00000232461;;;ENST00000232461		Night blindness, congenital stationary, type 1G	616389	AR	3	Gnat1
3p21.31	3:50205271-50221486	SLC38A3, SN1, G17, DEE102	Solute carrier family 38, member 3	604437	SLC38A3	10991	ENSG00000188338,ENST00000614032;;;ENST00000614032		Developmental and epileptic encephalopathy 102	619881	AR	3	Slc38a3
3p21.31	3:50227068-50259362	GNAI2, GNAI2B, GIP	Guanine nucleotide-binding protein (G protein), alpha-inhibiting activity polypeptide-2	139360	GNAI2	2771	ENSG00000114353,ENST00000313601;;;ENST00000313601	on 12p13-p12, GNAI2L	Pituitary adenoma, ACTH-secreting, somatic			3	Gnai2
3p21.31	3:50227068-50259362	GNAI2, GNAI2B, GIP	Guanine nucleotide-binding protein (G protein), alpha-inhibiting activity polypeptide-2	139360	GNAI2	2771	ENSG00000114353,ENST00000313601;;;ENST00000313601	on 12p13-p12, GNAI2L	Ventricular tachycardia, somatic	192605		3	Gnai2
3p21.31	3:50296402-50299405	NAA80, FUS2, ANDS	N-alpha-acetyltransferase 80, NatH catalytic subunit	607073	NAA80	24142	ENSG00000243477,ENST00000443094;;;ENST00000443094	mutation identified in 1 ANDS family	?Auroneurodental syndrome	620830	AR	3	Naa80
3p21.31	3:50299893-50312381	HYAL1, MPS9	Hyaluronoglucosaminidase 1	607071	HYAL1	3373	ENSG00000114378,ENST00000395144;;;ENST00000395144		Mucopolysaccharidosis type IX	601492	AR	3	Hyal1
3p21.31	3:50317808-50322745	HYAL2, LUCA2, MCCS	Hyaluronoglucosaminidase 2	603551	HYAL2	8692	ENSG00000068001,ENST00000357750;;;ENST00000357750		Muggenthaler-Chowdhury-Chioza syndrome	621063	AR	3	Hyal2
3p21.31	3:50341112-50345732	ZMYND10, BLU	Zinc finger MYND domain-containing protein 10	607070	ZMYND10	51364	ENSG00000004838,ENST00000231749;;;ENST00000231749		Ciliary dyskinesia, primary, 22	615444	AR	3	Zmynd10
3p21.31	3:50347330-50350775	NPRL2, FFEVF2	NPR2-like protein, GATOR1 complex subunit	607072	NPRL2	10641	ENSG00000114388,ENST00000232501;;;ENST00000232501		Epilepsy, familial focal, with variable foci 2	617116	AD	3	Nprl2
3p21.31	3:50362613-50504244	CACNA2D2, KIAA0558, CASVDD	Calcium channel, voltage-dependent, alpha-2/delta subunit 2	607082	CACNA2D2	9254	ENSG00000007402,ENST00000424201;;;ENST00000424201		Cerebellar atrophy with seizures and variable developmental delay	618501	AR	3	Cacna2d2
3p21.2	3:50606489-50611774	CISH, BACTS2	Cytokine inducible SH2-containing protein	602441	CISH	1154	ENSG00000114737,ENST00000348721;;;ENST00000348721		{Bacteremia, susceptibility to}	614383		3	Cish
3p21.2	3:50606489-50611774	CISH, BACTS2	Cytokine inducible SH2-containing protein	602441	CISH	1154	ENSG00000114737,ENST00000348721;;;ENST00000348721		{Malaria, susceptibility to}	611162		3	Cish
3p21.2	3:50606489-50611774	CISH, BACTS2	Cytokine inducible SH2-containing protein	602441	CISH	1154	ENSG00000114737,ENST00000348721;;;ENST00000348721		{Tuberculosis, susceptibility to}	607948		3	Cish
3p21.2	3:50611520-50649291	MAPKAPK3, 3PK, MDPT3	Mitogen-activated protein kinase-activated protein kinase-3	602130	MAPKAPK3	7867	ENSG00000114738,ENST00000621469;;;ENST00000621469	mutation identified in 1 MDPT3 family	?Macular dystrophy, patterned, 3	617111	AD	3	Mapkapk3
3p21.2	3:50674927-51384198	DOCK3, NEDIDHA	Dedicator of cytokinesis 3	603123	DOCK3	1795	ENSG00000088538,ENST00000266037;;;ENST00000266037		Neurodevelopmental disorder with impaired intellectual development, hypotonia, and ataxia	618292	AR	3	Dock3
3p21.2	3:51385291-51389397	MANF, ARMET, ARP, DDDS	Mesencephalic astrocyte derived neurotrophic factor	601916	MANF	7873	ENSG00000145050,ENST00000528157;;;ENST00000528157		Diabetes, deafness, developmental delay, and short stature syndrome	620651	AR	3	Manf
3p21.2	3:51983535-51989197	ACY1, ACY1D	Aminoacylase-1	104620	ACY1	95	ENSG00000243989,ENST00000636358;;;ENST00000636358		Aminoacylase 1 deficiency	609924	AR	3	Acy1
3p21.2	3:52075226-52154423	POC1A, PIX2, SOFT	POC1 centriolar protein A	614783	POC1A	25886	ENSG00000164087,ENST00000296484;;;ENST00000296484		Short stature, onychodysplasia, facial dysmorphism, and hypotrichosis	614813	AR	3	Poc1a
3p21.2	3:52287828-52295257	GLYCTK, GLYCTK1	Glycerate kinase	610516	GLYCTK	132158	ENSG00000168237,ENST00000436784;;;ENST00000436784		D-glyceric aciduria	220120	AR	3	Glyctk
3p21.1	3:52310920-52400492	DNAH1, HL11, DNAHC1, HDHC7, SPGF18, CILD37	Dynein, axonemal, heavy chain-1	603332	DNAH1	25981	ENSG00000114841,ENST00000420323;;;ENST00000420323		Ciliary dyskinesia, primary, 37	617577	AR	3	Dnah1
3p21.1	3:52310920-52400492	DNAH1, HL11, DNAHC1, HDHC7, SPGF18, CILD37	Dynein, axonemal, heavy chain-1	603332	DNAH1	25981	ENSG00000114841,ENST00000420323;;;ENST00000420323		Spermatogenic failure 18	617576	AR	3	Dnah1
3p21.1	3:52401008-52410008	BAP1, TPDS1, KURIS, UVM2	BRCA1 associated protein-1 (ubiquitin carboxy-terminal hydrolase)	603089	BAP1	8314	ENSG00000163930,ENST00000460680;;;ENST00000460680		{Uveal melanoma, susceptibility to, 2}	606661	AD	3	Bap1
3p21.1	3:52401008-52410008	BAP1, TPDS1, KURIS, UVM2	BRCA1 associated protein-1 (ubiquitin carboxy-terminal hydrolase)	603089	BAP1	8314	ENSG00000163930,ENST00000460680;;;ENST00000460680		Kury-Isidor syndrome	619762	AD	3	Bap1
3p21.1	3:52401008-52410008	BAP1, TPDS1, KURIS, UVM2	BRCA1 associated protein-1 (ubiquitin carboxy-terminal hydrolase)	603089	BAP1	8314	ENSG00000163930,ENST00000460680;;;ENST00000460680		Tumor predisposition syndrome 1	614327	AD	3	Bap1
3p21.1	3:52451100-52454041	TNNC1, CMD1Z, CMH13	Troponin-C1, slow	191040	TNNC1	7134	ENSG00000114854,ENST00000232975;;;ENST00000232975		Cardiomyopathy, dilated, 1Z	611879	AD	3	Tnnc1
3p21.1	3:52451100-52454041	TNNC1, CMD1Z, CMH13	Troponin-C1, slow	191040	TNNC1	7134	ENSG00000114854,ENST00000232975;;;ENST00000232975		Cardiomyopathy, hypertrophic, 13	613243	AD	3	Tnnc1
3p21.1	3:52495338-52524495	STAB1, FEEL1, KIAA0246, HRFT	Stabilin 1	608560	STAB1	23166	ENSG00000010327,ENST00000321725;;;ENST00000321725		[Hyperferritinemia]	620729	AR	3	Stab1
3p21.1	3:52545367-52685913	PBRM1, PB1, BAF180, RCC	Polybromo 1	606083	PBRM1	55193	ENSG00000163939,ENST00000707071;;;ENST00000707071	mutation identified in 1 ccRCC family	?Renal cell carcinoma, clear cell	144700		3	Pbrm1
3p21.1	3:53066853-53130435	RFT1, CDG1N	RFT1 homolog	611908	RFT1	91869	ENSG00000163933,ENST00000296292;;;ENST00000296292		Congenital disorder of glycosylation, type In	612015	AR	3	Rft1
3p21.1	3:53161209-53192717	PRKCD, CVID9, ALPS3	Protein kinase C, delta	176977	PRKCD	5580	ENSG00000163932,ENST00000330452;;;ENST00000330452	mutation identified in 1 family	Autoimmune lymphoproliferative syndrome, type III	615559	AR	3	Prkcd
3p21.1	3:53224712-53256022	TKT, SDDHD	Transketolase	606781	TKT	7086	ENSG00000163931,ENST00000462138;;;ENST00000462138		Short stature, developmental delay, and congenital heart defects	617044	AR	3	Tkt
3p21.1	3:53494611-53813733	CACNA1D, CACNL1A2, CCHL1A2, SANDD, PASNA	Calcium channel, voltage-dependent, L type, alpha 1D subunit	114206	CACNA1D	776	ENSG00000157388,ENST00000350061;;;ENST00000350061		Primary aldosteronism, seizures, and neurologic abnormalities	615474	AD	3	Cacna1d
3p21.1	3:53494611-53813733	CACNA1D, CACNL1A2, CCHL1A2, SANDD, PASNA	Calcium channel, voltage-dependent, L type, alpha 1D subunit	114206	CACNA1D	776	ENSG00000157388,ENST00000350061;;;ENST00000350061		Sinoatrial node dysfunction and deafness	614896	AR	3	Cacna1d
3p14-q13	3:54400001-122200000	KTCN3	Keratoconus 3	608586		406215			Keratoconus 3	608586	AD	2	
3p14.3	3:55465715-55505263	WNT5A	Wingless-type MMTV integration site family, member 5A	164975	WNT5A	7474	ENSG00000114251,ENST00000264634;;;ENST00000264634		Robinow syndrome, autosomal dominant 1	180700	AD	3	Wnt5a
3p14.3	3:57089982-57170317	IL17RD, SEF, HH18	Interleukin 17, receptor D (Sef, zebrafish, homolog of)	606807	IL17RD	54756	ENSG00000144730,ENST00000296318;;;ENST00000296318		Hypogonadotropic hypogonadism 18 with or without anosmia	615267	AD, AR, DD	3	Il17rd
3p14.3	3:57197838-57227615	HESX1, RPX, CPHD5	Homeobox gene expressed in ES cells	601802	HESX1	8820	ENSG00000163666,ENST00000295934;;;ENST00000295934		Growth hormone deficiency with pituitary anomalies	182230	AD, AR	3	Hesx1
3p14.3	3:57197838-57227615	HESX1, RPX, CPHD5	Homeobox gene expressed in ES cells	601802	HESX1	8820	ENSG00000163666,ENST00000295934;;;ENST00000295934		Pituitary hormone deficiency, combined, 5	182230	AD, AR	3	Hesx1
3p14.3	3:57197838-57227615	HESX1, RPX, CPHD5	Homeobox gene expressed in ES cells	601802	HESX1	8820	ENSG00000163666,ENST00000295934;;;ENST00000295934		Septooptic dysplasia	182230	AD, AR	3	Hesx1
3p14.3	3:57227729-57273471	APPL1, APPL, MODY14	Adaptor protein containing PH domain, PTB domain, and leucine zipper motif 1	604299	APPL1	26060	ENSG00000157500,ENST00000288266;;;ENST00000288266		{Maturity-onset diabetes of the young, type 14}	616511	AD	3	Appl1
3p14.3	3:57293700-57556034	DNAH12, DNAHC3, HL19, SPGF100	Dynein, heavy chain-5	603340	DNAH12	201625	ENSG00000174844,ENST00000495027;;;ENST00000495027		Spermatogenic failure 100	621209	AR	3	Dnah12
3p14.3	3:58008422-58172251	FLNB, SCT, AOI, LRS1	Filamin B	603381	FLNB	2317	ENSG00000136068,ENST00000295956;;;ENST00000295956		Atelosteogenesis, type I	108720	AD	3	Flnb
3p14.3	3:58008422-58172251	FLNB, SCT, AOI, LRS1	Filamin B	603381	FLNB	2317	ENSG00000136068,ENST00000295956;;;ENST00000295956		Atelosteogenesis, type III	108721	AD	3	Flnb
3p14.3	3:58008422-58172251	FLNB, SCT, AOI, LRS1	Filamin B	603381	FLNB	2317	ENSG00000136068,ENST00000295956;;;ENST00000295956		Boomerang dysplasia	112310	AD	3	Flnb
3p14.3	3:58008422-58172251	FLNB, SCT, AOI, LRS1	Filamin B	603381	FLNB	2317	ENSG00000136068,ENST00000295956;;;ENST00000295956		Larsen syndrome	150250	AD	3	Flnb
3p14.3	3:58008422-58172251	FLNB, SCT, AOI, LRS1	Filamin B	603381	FLNB	2317	ENSG00000136068,ENST00000295956;;;ENST00000295956		Spondylocarpotarsal synostosis syndrome	272460	AR	3	Flnb
3p14.3	3:58192257-58210972	DNASE1L3, SLEB16	Deoxyribonuclease I-like 3	602244	DNASE1L3	1776	ENSG00000163687,ENST00000394549;;;ENST00000394549		Systemic lupus erythematosus 16	614420	AR	3	Dnase1l3
3p14.3	3:58427630-58433832	PDHB, PDHBD	Pyruvate dehydrogenase E1, subunit beta	179060	PDHB	5162	ENSG00000168291,ENST00000302746;;;ENST00000302746		Pyruvate dehydrogenase E1-beta deficiency	614111	AR	3	Pdhb
3p14.3	3:58505136-58537190	ACOX2, BRCACOX, CBAS6	Acyl-Coenzyme A oxidase 2, branched chain	601641	ACOX2	8309	ENSG00000168306,ENST00000302819;;;ENST00000302819		Bile acid synthesis defect, congenital, 6	617308	AR	3	Acox2
3p14.1-q12.3	3:63800001-103100000	HYT7	Hypertension, essential, susceptibility to, 7	610948		100188825			{Hypertension, essential, susceptibility to, 7}	610948		2	
3p14.1	3:63863144-64003462	ATXN7, SCA7, OPCA3	Ataxin 7	607640	ATXN7	6314	ENSG00000163635,ENST00000674280;;;ENST00000674280		Spinocerebellar ataxia 7	164500	AD	3	Atxn7
3p14.1	3:66133610-66378927	SLC25A26, SAMC, COXPD28	Solute carrier family 25 (mitochondrial carrier, phosphate carrier), member 26	611037	SLC25A26	115286	ENSG00000144741,ENST00000354883;;;ENST00000354883		Combined oxidative phosphorylation deficiency 28	616794	AR	3	Slc25a26
3p14.1	3:68975225-69013684	EOGT, EOGT1, C3orf64, AOS4	EGF domain-specific O-linked N-acetylglucosamine transferase	614789	EOGT	285203	ENSG00000163378,ENST00000383701;;;ENST00000383701		Adams-Oliver syndrome 4	615297	AR	3	Eogt
3p14.1	3:69106065-69122595	LMOD3, NEM10	Leiomodin 3	616112	LMOD3	56203	ENSG00000163380,ENST00000420581;;;ENST00000420581		Nemaline myopathy 10	616165	AR	3	Lmod3
3p13	3:69739464-69968332	MITF, WS2A, CMM8, COMMAD	Microphthalmia-associated transcription factor	156845	MITF	4286	ENSG00000187098,ENST00000352241;;;ENST00000352241		{Melanoma, cutaneous malignant, susceptibility to, 8}	614456		3	Mitf
3p13	3:69739464-69968332	MITF, WS2A, CMM8, COMMAD	Microphthalmia-associated transcription factor	156845	MITF	4286	ENSG00000187098,ENST00000352241;;;ENST00000352241		COMMAD syndrome	617306	AR	3	Mitf
3p13	3:69739464-69968332	MITF, WS2A, CMM8, COMMAD	Microphthalmia-associated transcription factor	156845	MITF	4286	ENSG00000187098,ENST00000352241;;;ENST00000352241		Tietz albinism-deafness syndrome	103500	AD	3	Mitf
3p13	3:69739464-69968332	MITF, WS2A, CMM8, COMMAD	Microphthalmia-associated transcription factor	156845	MITF	4286	ENSG00000187098,ENST00000352241;;;ENST00000352241		Waardenburg syndrome, type 2A	193510	AD	3	Mitf
3p13	3:70954708-71583978	FOXP1, QRF1	Forkhead box P1	605515	FOXP1	27086	ENSG00000114861,ENST00000649528;;;ENST00000649528		Intellectual developmental disorder with language impairment with or without autistic features	613670	AD	3	Foxp1
3p13	3:71771655-71785148	PROK2, PK2, BV8, HH4	Prokineticin 2	607002	PROK2	60675	ENSG00000163421,ENST00000295619;;;ENST00000295619		Hypogonadotropic hypogonadism 4 with or without anosmia	610628	AD	3	Prok2
3p13	3:72725272-72848445	SHQ1, DYT35, NEDDS	SHQ1, H/ACA ribonucleoprotein assembly factor	613663	SHQ1	55164	ENSG00000144736,ENST00000325599;;;ENST00000325599	mutation identified in 1 DYT35 family	?Dystonia 35, childhood-onset	619921	AR	3	Shq1
3p13	3:72725272-72848445	SHQ1, DYT35, NEDDS	SHQ1, H/ACA ribonucleoprotein assembly factor	613663	SHQ1	55164	ENSG00000144736,ENST00000325599;;;ENST00000325599	mutation identified in 1 DYT35 family	Neurodevelopmental disorder with dystonia and seizures	619922	AR	3	Shq1
3p12-q13	3:74100001-122200000	DYX5	Dyslexia, susceptibility to, 5	606896		171089		?same locus as SSD	{Dyslexia, susceptibility to, 5}	606896		2	
3p12-q13	3:74100001-122200000	SSD	Speech-sound disorder	608445		404713		?same locus as DYX5	{Speech-sound disorder}	608445		2	
3p12.3	3:75906675-77649964	ROBO2, SAX3, KIAA1568	Roundabout guidance receptor 2	602431	ROBO2	6092	ENSG00000185008,ENST00000696593;;;ENST00000696593		Vesicoureteral reflux 2	610878	AD	3	Robo2
3p12.3	3:78597239-79767998	ROBO1, DUTT1, SAX3, CPHD8, NYS8, NORS	Roundabout guidance receptor 1	602430	ROBO1	6091	ENSG00000169855,ENST00000464233;;;ENST00000464233	mutation identified in 1 NYS8 family	?Nystagmus 8, congenital, autosomal recessive	257400	AR	3	Robo1
3p12.3	3:78597239-79767998	ROBO1, DUTT1, SAX3, CPHD8, NYS8, NORS	Roundabout guidance receptor 1	602430	ROBO1	6091	ENSG00000169855,ENST00000464233;;;ENST00000464233	mutation identified in 1 NYS8 family	Neurooculorenal syndrome	620305	AR	3	Robo1
3p12.3	3:78597239-79767998	ROBO1, DUTT1, SAX3, CPHD8, NYS8, NORS	Roundabout guidance receptor 1	602430	ROBO1	6091	ENSG00000169855,ENST00000464233;;;ENST00000464233	mutation identified in 1 NYS8 family	Pituitary hormone deficiency, combined or isolated, 8	620303	AD	3	Robo1
3p12.2	3:81489703-81761645	GBE1, GSD4, APBD	Glycogen branching enzyme	607839	GBE1	2632	ENSG00000114480,ENST00000429644;;;ENST00000429644		Glycogen storage disease IV	232500	AR	3	Gbe1
3p12.2	3:81489703-81761645	GBE1, GSD4, APBD	Glycogen branching enzyme	607839	GBE1	2632	ENSG00000114480,ENST00000429644;;;ENST00000429644		Polyglucosan body disease, adult form	263570	AR	3	Gbe1
3p11.2	3:87227309-87255556	CHMP2B, DMT1, VPS2B, FTDALS7	Charged multivesicular body protein 2B	609512	CHMP2B	25978	ENSG00000083937,ENST00000263780;;;ENST00000263780		Frontotemporal dementia and/or amyotrophic lateral sclerosis 7	600795	AD	3	Chmp2b
3p11.2	3:87259404-87276584	POU1F1, PIT1, CPHD1	POU domain, class 1, transcription factor 1 (Pit1, growth hormone factor 1)	173110	POU1F1	5449	ENSG00000064835,ENST00000350375;;;ENST00000350375		Pituitary hormone deficiency, combined or isolated, 1	613038	AD, AR	3	Pou1f1
3q11.1	3:93873051-93973896	PROS1, THPH5, THPH6	Protein S, alpha	176880	PROS1	5627	ENSG00000184500,ENST00000394236;;;ENST00000394236	pseudogene PROSP contiguous on chr.3	Thrombophilia 5 due to protein S deficiency, autosomal dominant	612336	AD	3	Pros1
3q11.1	3:93873051-93973896	PROS1, THPH5, THPH6	Protein S, alpha	176880	PROS1	5627	ENSG00000184500,ENST00000394236;;;ENST00000394236	pseudogene PROSP contiguous on chr.3	Thrombophilia 5 due to protein S deficiency, autosomal recessive	614514	AR	3	Pros1
3q11.1-q11.2	3:93980155-94055678	ARL13B, ARL2L1, JBTS8	ADP ribosylation factor-like GTPase 13B	608922	ARL13B	200894	ENSG00000169379,ENST00000394222;;;ENST00000394222		Joubert syndrome 8	612291	AR	3	Arl13b
3q11.2-q13.12	3:94000001-108200000	CAMPD1	Camptodactyly 1	114200		100381210		between D3S2465 and D3S3044	Camptodactyly 1	114200	AD	2	
3q11.2	3:94063061-94131832	NSUN3, COXPD48	NOP2/SUN RNA methyltransferase family, member 3	617491	NSUN3	63899	ENSG00000178694,ENST00000314622;;;ENST00000314622		Combined oxidative phosphorylation deficiency 48	619012	AR	3	Nsun3
3q11.2	3:97764521-97801242	ARL6, BBS3, RP55	ADP ribosylation factor-like GTPase 6	608845	ARL6	84100	ENSG00000113966,ENST00000463745;;;ENST00000463745		{Bardet-Biedl syndrome 1, modifier of}	209900	AR, DR	3	Arl6
3q11.2	3:97764521-97801242	ARL6, BBS3, RP55	ADP ribosylation factor-like GTPase 6	608845	ARL6	84100	ENSG00000113966,ENST00000463745;;;ENST00000463745		Bardet-Biedl syndrome 3	600151	AR	3	Arl6
3q11.2	3:97764521-97801242	ARL6, BBS3, RP55	ADP ribosylation factor-like GTPase 6	608845	ARL6	84100	ENSG00000113966,ENST00000463745;;;ENST00000463745		Retinitis pigmentosa 55	613575	AR	3	Arl6
3q11.2	3:98570488-98593611	CPOX, HARPO	Coproporphyrinogen oxidase	612732	CPOX	1371	ENSG00000080819,ENST00000647941;;;ENST00000647941		Coproporphyria	121300	AD, AR	3	Cpox
3q11.2	3:98570488-98593611	CPOX, HARPO	Coproporphyrinogen oxidase	612732	CPOX	1371	ENSG00000080819,ENST00000647941;;;ENST00000647941		Harderoporphyria	618892	AR	3	Cpox
3q12.1-q12.2	3:100260992-100325238	TBC1D23, PCH11	TBC1 domain family, member 23	617687	TBC1D23	55773	ENSG00000036054,ENST00000394144;;;ENST00000394144		Pontocerebellar hypoplasia, type 11	617695	AR	3	Tbc1d23
3q12.2	3:100709290-100748967	TFG, HMSNP, SPG57	Trafficking from ER to Golgi regulator	602498	TFG	10342	ENSG00000114354,ENST00000240851;;;ENST00000240851	fused with NR4A3 or NTRK1; mutation identified in 1 SPG57 family	?Spastic paraplegia 57, autosomal recessive	615658	AR	3	Tfg
3q12.2	3:100709290-100748967	TFG, HMSNP, SPG57	Trafficking from ER to Golgi regulator	602498	TFG	10342	ENSG00000114354,ENST00000240851;;;ENST00000240851	fused with NR4A3 or NTRK1; mutation identified in 1 SPG57 family	Hereditary motor and sensory neuropathy, Okinawa type	604484	AD	3	Tfg
3q12.3	3:101222546-101320575	IMPG2, IPM200, RP56, VMD5	Interphotoreceptor matrix proteoglycan 2	607056	IMPG2	50939	ENSG00000081148,ENST00000193391;;;ENST00000193391		Macular dystrophy, vitelliform, 5	616152	AD	3	Impg2
3q12.3	3:101222546-101320575	IMPG2, IPM200, RP56, VMD5	Interphotoreceptor matrix proteoglycan 2	607056	IMPG2	50939	ENSG00000081148,ENST00000193391;;;ENST00000193391		Retinitis pigmentosa 56	613581	AR	3	Impg2
3q12.3	3:101561868-101566446	TRMT10C, RG9MTD1, MRPP1, COXPD30	tRNA methyltransferase 10C, mitochondrial RNase P subunit	615423	TRMT10C	54931	ENSG00000174173,ENST00000309922;;;ENST00000309922		Combined oxidative phosphorylation deficiency 30	616974	AR	3	Trmt10c
3q12.3	3:101648889-101677132	ZBTB11, MRT69	Zinc finger- and BTB domain-containing protein 11	618181	ZBTB11	27107	ENSG00000066422,ENST00000312938;;;ENST00000312938		Intellectual developmental disorder, autosomal recessive 69	618383	AR	3	Zbtb11
3q13	3:103100001-122200000	CHDS5	Coronary heart disease, susceptibility to, 5	608901					{Coronary heart disease, susceptibility to, 5}	608901		2	
3q13.1	3:103100001-111600000	MHS4	Malignant hyperthermia susceptibility 4	600467		4265			{Malignant hyperthermia susceptibility 4}	600467	AD	2	
3q13.11	3:105655461-105869449	CBLB, ADMIO3	CAS-BR-M murine ecotropic retroviral transforming sequence B	604491	CBLB	868	ENSG00000114423,ENST00000394030;;;ENST00000394030		Autoimmune disease, multisystem, infantile-onset, 3	620430	AR	3	Cblb
3q13.12-q13.13	3:108160812-108222424	IFT57, ESRRBL1, HIPPI, OFD18	Intraflagellar transport 57 (HIP1 protein interactor)	606621	IFT57	55081	ENSG00000114446,ENST00000264538;;;ENST00000264538	mutation identified in 1 OFD18 family	?Orofaciodigital syndrome XVIII	617927	AR	3	Ift57
3q13.13-q13.2	3:111542197-111665996	CD96, TACTILE	CD96 antigen	606037	CD96	10225	ENSG00000153283,ENST00000352690;;;ENST00000352690		C syndrome	211750	AD	3	Cd96
3q13.2-q13.33	3:111600001-122200000	STUT3	Stuttering, familial persistent, 3	614655		100909386		max lod at D3S1310	Stuttering, familial persistent, 3	614655		2	
3q13.2	3:112086389-112136381	C3orf52, TTMP, HYPT15	Chromosome 3 open reading frame 52	611956	C3orf52	79669	ENSG00000114529,ENST00000264848;;;ENST00000264848		Hypotrichosis 15	620177	AR	3	BC016579
3q13.2	3:113002444-113019671	NEPRO, C3orf17, ANXD3	Nucleolus and neural progenitor protein	617089	RMP64	25871	ENSG00000163608,ENST00000314400;;;ENST00000314400		Anauxetic dysplasia 3	618853	AR	3	Nepro
3q13.2	3:113286930-113441514	CFAP44, WDR52, SPGF20	Cilia- and flagella-associated protein 44	617559	CFAP44	55779	ENSG00000206530,ENST00000393845;;;ENST00000393845		Spermatogenic failure 20	617593	AR	3	Cfap44
3q13.31	3:113700001-117600000	DEL3q13.31, C13DELq13.31	Chromosome 3q13.31 deletion syndrome	615433					Chromosome 3q13.31 deletion syndrome	615433	AD	4	
3q13.31	3:113747035-113812056	ATP6V1A, HO68, ARCL2D, DEE93	ATPase, H+ transporting, V1 subunit A	607027	ATP6V1A	523	ENSG00000114573,ENST00000273398;;;ENST00000273398		Cutis laxa, autosomal recessive, type IID	617403	AR	3	Atp6v1a
3q13.31	3:113747035-113812056	ATP6V1A, HO68, ARCL2D, DEE93	ATPase, H+ transporting, V1 subunit A	607027	ATP6V1A	523	ENSG00000114573,ENST00000273398;;;ENST00000273398		Developmental and epileptic encephalopathy 93	618012	AD	3	Atp6v1a
3q13.31	3:114127580-114199407	DRD3, ETM1, FET1	Dopamine receptor D3	126451	DRD3	1814	ENSG00000151577,ENST00000383673;;;ENST00000383673		{Essential tremor, hereditary, 1}	190300	AD	3	Drd3
3q13.31	3:114127580-114199407	DRD3, ETM1, FET1	Dopamine receptor D3	126451	DRD3	1814	ENSG00000151577,ENST00000383673;;;ENST00000383673		{Schizophrenia, susceptibility to}	181500	AD	3	Drd3
3q13.31	3:114314500-115147288	ZBTB20, ZNF288, DPZF, PRIMS	Zinc finger and BTB-domain containing 20	606025	ZBTB20	26137	ENSG00000181722,ENST00000675478;;;ENST00000675478		Primrose syndrome	259050	AD	3	Zbtb20
3q13.32-q13.33	3:119294383-119420714	ARHGAP31, CDGAP, KIAA1204, AOS1	Rho GTPase-activating protein 31	610911	ARHGAP31	57514	ENSG00000031081,ENST00000264245;;;ENST00000264245		Adams-Oliver syndrome 1	100300	AD	3	Arhgap31
3q13.33	3:119468963-119494708	POGLUT1, CLP46, KTELC1, RUMI, C3orf9, DDD4, LGMDR21	Protein O-glucosyltransferase 1	615618	POGLUT1	56983	ENSG00000163389,ENST00000295588;;;ENST00000295588		Dowling-Degos disease 4	615696	AD	3	Poglut1
3q13.33	3:119468963-119494708	POGLUT1, CLP46, KTELC1, RUMI, C3orf9, DDD4, LGMDR21	Protein O-glucosyltransferase 1	615618	POGLUT1	56983	ENSG00000163389,ENST00000295588;;;ENST00000295588		Muscular dystrophy, limb-girdle, autosomal recessive 21	617232	AR	3	Poglut1
3q13.33	3:119498547-119525090	TIMMDC1, C3orf1, MC1DN31	Translocase of inner mitochondrial membrane domain-containing protein 1	615534	TIMMDC1	51300	ENSG00000113845,ENST00000494664;;;ENST00000494664		Mitochondrial complex I deficiency, nuclear type 31	618251	AR	3	Timmdc1
3q13.33	3:119642056-119660883	POPDC2, POP2, CCCM2	Popeye domain-containing protein 2	605823	POPDC2	64091	ENSG00000121577,ENST00000493094;;;ENST00000493094		Cardiac conduction disease with or without cardiomyopathy 2	621367	AR	3	Popdc2
3q13.33	3:119703022-119767102	CFAP91, MAATS1, AAT1, C3orf15, SPGF51	Cilia- and flagella-associated protein 91	609910	CFAP91	89876	ENSG00000183833,ENST00000273390;;;ENST00000273390		Spermatogenic failure 51	619177	AR	3	Cfap91
3q13.33	3:120165478-120285222	GPR156, GABABL, DFNB121	G protein-coupled receptor 156	610464	GPR156	165829	ENSG00000175697,ENST00000464295;;;ENST00000464295		Deafness, autosomal recessive 121	620551	AR	3	Gpr156
3q13.33	3:120628172-120682239	HGD, AKU	Homogentisate 1,2-dioxygenase (homogentisate oxidase)	607474	HGD	3081	ENSG00000113924,ENST00000283871;;;ENST00000283871		Alkaptonuria	203500	AR	3	Hgd
3q13.33	3:120684938-120742680	RABL3, PNCA5	RAB, member of RAS oncogene family-like 3	618542	RABL3	285282	ENSG00000144840,ENST00000273375;;;ENST00000273375	mutation identified in 1 PNCA5 family	{?Pancreatic cancer, susceptibility to, 5}	618680	AD	3	Rabl3
3q13.33	3:121769761-121835060	IQCB1, NPHP5, KIAA0036	IQ motif-containing protein B1	609237	IQCB1	9657	ENSG00000173226,ENST00000310864;;;ENST00000310864		Senior-Loken syndrome 5	609254	AR	3	Iqcb1
3q13.33	3:121987323-122061655	ILDR1, DFNB42	Immunoglobulin-like domain-containing receptor 1	609739	ILDR1	286676	ENSG00000145103,ENST00000344209;;;ENST00000344209		Deafness, autosomal recessive 42	609646	AR	3	Ildr1
3q13.33-q21.1	3:122183668-122291629	CASR, HHC1, PCAR1, FIH, EIG8, HYPOC1	Calcium-sensing receptor	601199	CASR	846	ENSG00000036828,ENST00000639785;;;ENST00000639785	mutation identified in 1 EIG8 family	{?Epilepsy idiopathic generalized, susceptibility to, 8}	612899	AD	3	Casr
3q13.33-q21.1	3:122183668-122291629	CASR, HHC1, PCAR1, FIH, EIG8, HYPOC1	Calcium-sensing receptor	601199	CASR	846	ENSG00000036828,ENST00000639785;;;ENST00000639785	mutation identified in 1 EIG8 family	Hyperparathyroidism, neonatal	239200	AD, AR	3	Casr
3q13.33-q21.1	3:122183668-122291629	CASR, HHC1, PCAR1, FIH, EIG8, HYPOC1	Calcium-sensing receptor	601199	CASR	846	ENSG00000036828,ENST00000639785;;;ENST00000639785	mutation identified in 1 EIG8 family	Hypocalcemia, autosomal dominant	601198	AD	3	Casr
3q13.33-q21.1	3:122183668-122291629	CASR, HHC1, PCAR1, FIH, EIG8, HYPOC1	Calcium-sensing receptor	601199	CASR	846	ENSG00000036828,ENST00000639785;;;ENST00000639785	mutation identified in 1 EIG8 family	Hypocalcemia, autosomal dominant, with Bartter syndrome	601198	AD	3	Casr
3q13.33-q21.1	3:122183668-122291629	CASR, HHC1, PCAR1, FIH, EIG8, HYPOC1	Calcium-sensing receptor	601199	CASR	846	ENSG00000036828,ENST00000639785;;;ENST00000639785	mutation identified in 1 EIG8 family	Hypocalciuric hypercalcemia, type I	145980	AD	3	Casr
3q21	3:122200001-129500000	ATOD1	Dermatitis, atopic, 1	603165		64069		max lod at D3S3606	{Dermatitis, atopic, susceptibility to, 1}	603165	AD	2	
3q21	3:122200001-129500000	FGQTL6, BWQTL3	Fasting plasma glucose level QTL 6; Birth weight QTL 3	613460		100499168		associated with rs11708067 and rs11708067	[Birth weight QTL 3]	613460		2	
3q21	3:122200001-129500000	FGQTL6, BWQTL3	Fasting plasma glucose level QTL 6; Birth weight QTL 3	613460		100499168		associated with rs11708067 and rs11708067	[Fasting plasma glucose level QTL 6]	613460		2	
3q21-q24	3:122200001-149200000	GLC1C	Glaucoma 1, open angle, C	601682		2723			Glaucoma 1C, primary open angle	601682	AD	2	
3q21-q22	3:122200001-139000000	HCFP1, MBS2	Facial paresis, hereditary congenital, 1	601471		7880			Facial paresis, hereditary congenital, 1	601471	AD	2	
3q21	3:122200001-129500000	PSORS5	Psoriasis susceptibility 5	604316		63870			{Psoriasis susceptibility 5}	604316		2	
3q21.1	3:122325248-122341969	CSTA, STFA, STF1, AREI, PSS4	Cystatin A (stefin A)	184600	CSTA	1475	ENSG00000121552,ENST00000264474;;;ENST00000264474		Peeling skin syndrome 4	607936	AR	3	Csta1,Csta2,Csta3,Cstdc3,Cstdc4,Cstdc5,Cstdc6,Stfa1,Stfa2,Stfa2l1,Stfa3
3q21.1	3:123282296-123449090	ADCY5, FDFM, DSKOD	Adenylate cyclase-5	600293	ADCY5	111	ENSG00000173175,ENST00000462833;;;ENST00000462833		Dyskinesia with orofacial involvement, autosomal dominant	606703	AD	3	Adcy5
3q21.1	3:123282296-123449090	ADCY5, FDFM, DSKOD	Adenylate cyclase-5	600293	ADCY5	111	ENSG00000173175,ENST00000462833;;;ENST00000462833		Dyskinesia with orofacial involvement, autosomal recessive	619647	AR	3	Adcy5
3q21.1	3:123282296-123449090	ADCY5, FDFM, DSKOD	Adenylate cyclase-5	600293	ADCY5	111	ENSG00000173175,ENST00000462833;;;ENST00000462833		Neurodevelopmental disorder with hyperkinetic movements and dyskinesia	619651	AR	3	Adcy5
3q21.1	3:123610049-123884332	MYLK, MLCK, AAT7, MMIHS1	Myosin-light-polypeptide kinase	600922	MYLK	4638	ENSG00000065534,ENST00000360304;;;ENST00000360304	pseudogene on 3p13	Aortic aneurysm, familial thoracic 7	613780	AD	3	Mylk
3q21.1	3:123610049-123884332	MYLK, MLCK, AAT7, MMIHS1	Myosin-light-polypeptide kinase	600922	MYLK	4638	ENSG00000065534,ENST00000360304;;;ENST00000360304	pseudogene on 3p13	Megacystis-microcolon-intestinal hypoperistalsis syndrome 1	249210	AR	3	Mylk
3q21.2	3:124730452-124749273	UMPS, OPRT	Uridine monophosphate synthetase (orotate phosphoribosyl transferase and orotidine-5'-decarboxylase)	613891	UMPS	7372	ENSG00000114491,ENST00000232607;;;ENST00000232607		Orotic aciduria	258900	AR	3	Umps
3q21.2	3:125225669-125375354	ZNF148, ZFP148, GDACCF	Zinc finger protein-148	601897	ZNF148	7707	ENSG00000163848,ENST00000360647;;;ENST00000360647		Global developmental delay, absent or hypoplastic corpus callosum, and dysmorphic facies	617260	AD	3	Zfp148
3q21.3	3:126481166-126517773	UROC1, UROCD	Urocanase domain-containing protein 1	613012	UROC1	131669	ENSG00000159650,ENST00000290868;;;ENST00000290868	mutation identified in 1 UROCD patient	?Urocanase deficiency	276880	AR	3	Uroc1
3q21.3	3:126983115-127037389	PLXNA1, NOVP, NOV, PLXN1, DWOPNED	Plexin A1 (NOV transmembrane protein)	601055	PLXNA1	5361	ENSG00000114554,ENST00000393409;;;ENST00000393409		Dworschak-Punetha neurodevelopmental syndrome	619955	AR	3	Plxna1
3q21.3	3:127598411-127622436	MCM2, CDCL1, DFNA70	Minichromosome maintenance complex component 2 (mitotin)	116945	MCM2	4171	ENSG00000073111,ENST00000265056;;;ENST00000265056	mutation identified in 1 DFNA70 family	?Deafness, autosomal dominant 70	616968	AD	3	Mcm2
3q21.3	3:128051641-128071683	SEC61A1, SEC61, ADTKD5, CVID15	SEC61 translocon, alpha-1 subunit	609213	SEC61A1	29927	ENSG00000058262,ENST00000243253;;;ENST00000243253	mutation identified in 1 SCN11 patient	?Neutropenia, severe congenital, 11, autosomal dominant	620674	AD	3	Sec61a1
3q21.3	3:128051641-128071683	SEC61A1, SEC61, ADTKD5, CVID15	SEC61 translocon, alpha-1 subunit	609213	SEC61A1	29927	ENSG00000058262,ENST00000243253;;;ENST00000243253	mutation identified in 1 SCN11 patient	Immunodeficiency, common variable, 15	620670	AD	3	Sec61a1
3q21.3	3:128051641-128071683	SEC61A1, SEC61, ADTKD5, CVID15	SEC61 translocon, alpha-1 subunit	609213	SEC61A1	29927	ENSG00000058262,ENST00000243253;;;ENST00000243253	mutation identified in 1 SCN11 patient	Tubulointerstitial kidney disease, autosomal dominant, 5	617056	AD	3	Sec61a1
3q21.3	3:128153481-128426223	EEFSEC, SELB, EFSEC, NEDPSB	Eukaryotic elongation factor, selenocysteine-tRNA-specific	607695	EEFSEC	60678	ENSG00000132394,ENST00000254730;;;ENST00000254730		Neurodevelopmental disorder with progressive spasticity and brain abnormalities	621102	AR	3	Eefsec
3q21.3	3:128479422-128493201	GATA2, DCML, MONOMAC, IMD21	GATA-binding protein-2	137295	GATA2	2624	ENSG00000179348,ENST00000341105;;;ENST00000341105		{Leukemia, acute myeloid, susceptibility to}	601626	AD, SMu	3	Gata2
3q21.3	3:128479422-128493201	GATA2, DCML, MONOMAC, IMD21	GATA-binding protein-2	137295	GATA2	2624	ENSG00000179348,ENST00000341105;;;ENST00000341105		{Myelodysplastic syndrome, susceptibility to}	614286		3	Gata2
3q21.3	3:128479422-128493201	GATA2, DCML, MONOMAC, IMD21	GATA-binding protein-2	137295	GATA2	2624	ENSG00000179348,ENST00000341105;;;ENST00000341105		Emberger syndrome	614038	AD	3	Gata2
3q21.3	3:128479422-128493201	GATA2, DCML, MONOMAC, IMD21	GATA-binding protein-2	137295	GATA2	2624	ENSG00000179348,ENST00000341105;;;ENST00000341105		Immunodeficiency 21	614172	AD	3	Gata2
3q21.3	3:128726183-128814798	RAB7A, RAB7, CMT2B, PSN	Ras-associated protein RAB7A	602298	RAB7A	7879	ENSG00000075785,ENST00000265062;;;ENST00000265062		Charcot-Marie-Tooth disease, type 2B	600882	AD	3	Rab7
3q21.3	3:128879620-128913114	ACAD9, MC1DN20	Acyl-CoA dehydrogenase family, member 9	611103	ACAD9	28976	ENSG00000177646,ENST00000308982;;;ENST00000308982		Mitochondrial complex I deficiency, nuclear type 20	611126	AR	3	Acad9
3q21.3	3:129054845-129062406	GP9	Glycoprotein IX, platelet	173515	GP9	2815	ENSG00000169704,ENST00000307395;;;ENST00000307395		Bernard-Soulier syndrome, type C	231200	AR	3	Gp9
3q21.3	3:129167827-129183896	CNBP, ZNF9, CNBP1, DM2, PROMM	CCHC-type zinc finger nucleic acid-binding protein	116955	CNBP	7555	ENSG00000169714,ENST00000422453;;;ENST00000422453		Myotonic dystrophy 2	602668	AD	3	Cnbp
3q21.3	3:129249606-129277773	COPG1, IMD128	Coatomer protein complex, subunit gamma-1	615525	COPG1	22820	ENSG00000181789,ENST00000314797;;;ENST00000314797	mutation identified in 1 IMD128 family	?Immunodeficiency 128	620983	AR	3	Copg1
3q21.3	3:129430947-129439948	MBD4, MED1, TPDS2	Methyl-CpG-binding domain protein 4	603574	MBD4	8930	ENSG00000129071,ENST00000429544;;;ENST00000429544		{Uveal melanoma, susceptibility to, 1}	606660	AD	3	Mbd4
3q21.3	3:129430947-129439948	MBD4, MED1, TPDS2	Methyl-CpG-binding domain protein 4	603574	MBD4	8930	ENSG00000129071,ENST00000429544;;;ENST00000429544		Tumor predisposition syndrome 2	619975	AR	3	Mbd4
3q21.3-q22.1	3:129440224-129520507	IFT122, WDR10, CED1	Intraflagellar transport 122	606045	IFT122	55764	ENSG00000163913,ENST00000348417;;;ENST00000348417		Cranioectodermal dysplasia 1	218330	AR	3	Ift122
3q22-q24	3:129500001-149200000	AD15	Alzheimer disease 15	604154		100188838		max lod at D3S1579	{Alzheimer disease-15}	604154		2	
3q22	3:129500001-139000000	DFNA18	Deafness, autosomal dominant 18	606012		85507			Deafness, autosomal dominant 18	606012	AD	2	
3q22-q24	3:129500001-149200000	DWS, C3DELq22q24, DEL3q22q24	Dandy-Walker syndrome	220200		1858		ZIC1 and ZIC4 good candidate genes	Dandy-Walker syndrome	220200	IC	4	
3q22-q24	3:129500001-149200000	OTSC5	Otosclerosis 5	608787		317682		max lod at D3S1569	Otosclerosis 5	608787	AD	2	
3q22	3:129500001-139000000	PARK21	Parkinson disease 21	616361		108353827		conflicting mapping on 20pter-p12	Parkinson disease 21	616361	AD	2	
3q22	3:129500001-139000000	SLSN3	Senior-Loken syndrome 3	606995		260432		?allelic with NPHP3	Senior-Loken syndrome 3	606995	AR	2	
3q22.1	3:129528639-129535344	RHO, RP4, OPN2, CSNBAD1	Rhodopsin (opsin 2)	180380	RHO	6010	ENSG00000163914,ENST00000296271;;;ENST00000296271		Night blindness, congenital stationary, autosomal dominant 1	610445	AD	3	Rho
3q22.1	3:129528639-129535344	RHO, RP4, OPN2, CSNBAD1	Rhodopsin (opsin 2)	180380	RHO	6010	ENSG00000163914,ENST00000296271;;;ENST00000296271		Retinitis pigmentosa 4, autosomal dominant or recessive	613731	AD, AR	3	Rho
3q22.1	3:129528639-129535344	RHO, RP4, OPN2, CSNBAD1	Rhodopsin (opsin 2)	180380	RHO	6010	ENSG00000163914,ENST00000296271;;;ENST00000296271		Retinitis punctata albescens	136880	AD, AR	3	Rho
3q22.1	3:129555214-129606676	PLXND1, CHTD9	Plexin D1	604282	PLXND1	23129	ENSG00000004399,ENST00000324093;;;ENST00000324093		Congenital heart defects, multiple types, 9	620294	AR	3	Plxnd1
3q22.1	3:129974720-129977935	TRH	Thyrotropin-releasing hormone	613879	TRH	7200	ENSG00000170893,ENST00000302649;;;ENST00000302649		Thyrotropin-releasing hormone deficiency	275120	AR	1	Trh
3q22.1	3:130850595-131016712	ATP2C1, BCPM, HHD	ATPase, Ca(2+)-sequestering	604384	ATP2C1	27032	ENSG00000017260,ENST00000510168;;;ENST00000510168		Hailey-Hailey disease	169600	AD	3	Atp2c1
3q22.1	3:131462212-131502971	MRPL3, MRL3, COXPD9	Mitochondrial ribosomal protein L3	607118	MRPL3	11222	ENSG00000114686,ENST00000264995;;;ENST00000264995		Combined oxidative phosphorylation deficiency 9	614582	AR	3	Mrpl3
3q22.1	3:132654430-132679794	UBA5, UBE1DC1, DEE44, SCAR24	Ubiquitin-like modifier activating enzyme 5	610552	UBA5	79876	ENSG00000081307,ENST00000356232;;;ENST00000356232	mutation identified in 1 SCAR24 family	?Spinocerebellar ataxia, autosomal recessive 24	617133	AR	3	Uba5
3q22.1	3:132654430-132679794	UBA5, UBE1DC1, DEE44, SCAR24	Ubiquitin-like modifier activating enzyme 5	610552	UBA5	79876	ENSG00000081307,ENST00000356232;;;ENST00000356232	mutation identified in 1 SCAR24 family	Developmental and epileptic encephalopathy 44	617132	AR	3	Uba5
3q22.1	3:132680609-132722409	NPHP3, NPH3, RHPD1, MKS7	Nephrocystin 3	608002	NPHP3	27031	ENSG00000113971,ENST00000337331;;;ENST00000337331		Meckel syndrome 7	267010	AR	3	Nphp3
3q22.1	3:132680609-132722409	NPHP3, NPH3, RHPD1, MKS7	Nephrocystin 3	608002	NPHP3	27031	ENSG00000113971,ENST00000337331;;;ENST00000337331		Nephronophthisis 3	604387	AR	3	Nphp3
3q22.1	3:132680609-132722409	NPHP3, NPH3, RHPD1, MKS7	Nephrocystin 3	608002	NPHP3	27031	ENSG00000113971,ENST00000337331;;;ENST00000337331		Renal-hepatic-pancreatic dysplasia 1	208540	AR	3	Nphp3
3q22.1	3:133400056-133475208	BFSP2, CP49, CP47, CTRCT12	Beaded filament structural protein 2 (cytoskeletal protein, 49 kD)	603212	BFSP2	8419	ENSG00000170819,ENST00000302334;;;ENST00000302334		Cataract 12, multiple types	611597	AD	3	Bfsp2
3q22.1	3:133661998-133796641	TF, TFQTL1	Transferrin	190000	TF	7018	ENSG00000091513,ENST00000402696;;;ENST00000402696		Atransferrinemia	209300	AR	3	Trf
3q22.1-q22.2	3:133932701-134029925	SLCO2A1, OATP2A1, PGT, SLC21A2, PHOAR2, PHOAD	Solute carrier organic anion transporter family, member 2A1	601460	SLCO2A1	6578	ENSG00000174640,ENST00000310926;;;ENST00000310926		Hypertrophic osteoarthropathy, primary, autosomal dominant	167100	AD	3	Slco2a1
3q22.1-q22.2	3:133932701-134029925	SLCO2A1, OATP2A1, PGT, SLC21A2, PHOAR2, PHOAD	Solute carrier organic anion transporter family, member 2A1	601460	SLCO2A1	6578	ENSG00000174640,ENST00000310926;;;ENST00000310926		PHOAR2-enteropathy syndrome	614441	AR	3	Slco2a1
3q22.2	3:134485724-134782559	CEP63, SCKL6	Centrosomal protein, 63kD	614724	CEP63	80254	ENSG00000182923,ENST00000675561;;;ENST00000675561	mutation identified in 1 family	?Seckel syndrome 6	614728	AR	3	Cep63
3q22.2	3:134599923-134651022	KY, MFM7	Kyphoscoliosis peptidase	605739	KY	339855	ENSG00000174611,ENST00000423778;;;ENST00000423778		Myopathy, myofibrillar, 7	617114	AR	3	Ky
3q22.3	3:136148917-136196335	MSL2, KIAA1585, KBHS	MSL complex subunit 2	614802	MSL2	55167	ENSG00000174579,ENST00000309993;;;ENST00000309993		Karayol-Borroto-Haghshenas neurodevelopmental syndrome	620985	AD	3	Msl2
3q22.3	3:136250340-136330169	PCCB	Propionyl Coenzyme A carboxylase, beta polypeptide	232050	PCCB	5096	ENSG00000114054,ENST00000251654;;;ENST00000251654	pccB complementation group	Propionicacidemia	606054	AR	3	Pccb
3q22.3	3:136336236-136752378	STAG1, MRD47	Stromal antigen 1	604358	STAG1	10274	ENSG00000118007,ENST00000383202;;;ENST00000383202		Intellectual developmental disorder, autosomal dominant 47	617635	AD	3	Stag1
3q22.3	3:138061990-138115608	DZIP1L, DZIP2, PKD5	DAZ-interacting zinc finger protein 1-like	617570	DZIP1L	199221	ENSG00000158163,ENST00000327532;;;ENST00000327532		Polycystic kidney disease 5	617610	AR	3	Dzip1l
3q22.3	3:138160988-138174921	DBR1, XGIP	Debranching RNA lariats 1	607024	DBR1	51163	ENSG00000138231,ENST00000260803;;;ENST00000260803		{Encephalitis, acute, infection (viral)-induced, susceptibility to, 11}	619441	AR	3	Dbr1
3q22.3	3:138160988-138174921	DBR1, XGIP	Debranching RNA lariats 1	607024	DBR1	51163	ENSG00000138231,ENST00000260803;;;ENST00000260803		Xerosis and growth failure with immune and pulmonary dysfunction syndrome	620510	AR	3	Dbr1
3q22.3	3:138347648-138405535	MRAS, RRAS3, NS11	Muscle Ras viral oncogene homolog	608435	MRAS	22808	ENSG00000158186,ENST00000423968;;;ENST00000423968		Noonan syndrome 11	618499	AD	3	Mras
3q22.3	3:138944224-138947137	FOXL2, BPES, BPES1, PFRK, POF3	Forkhead transcription factor FOXL2	605597	FOXL2	668	ENSG00000183770,ENST00000648323;;;ENST00000648323		Blepharophimosis, epicanthus inversus, and ptosis, types 1 and 2	110100	AD, AR	3	Foxl2
3q22.3	3:138944224-138947137	FOXL2, BPES, BPES1, PFRK, POF3	Forkhead transcription factor FOXL2	605597	FOXL2	668	ENSG00000183770,ENST00000648323;;;ENST00000648323		Premature ovarian failure 3	608996	AD	3	Foxl2
3q23	3:139000001-143100000	STQTL10	Stature quantitative trait locus 10	612221		100270794		associated with rs6440003	{Stature QTL 10}	612221		2	
3q23	3:139343994-139357140	MRPS22, C3orf5, COXPD5, ODG7	Mitochondrial ribosomal protein S22	605810	MRPS22	56945	ENSG00000175110,ENST00000680020;;;ENST00000680020		Combined oxidative phosphorylation deficiency 5	611719	AR	3	Mrps22
3q23	3:139343994-139357140	MRPS22, C3orf5, COXPD5, ODG7	Mitochondrial ribosomal protein S22	605810	MRPS22	56945	ENSG00000175110,ENST00000680020;;;ENST00000680020		Ovarian dysgenesis 7	618117	AR	3	Mrps22
3q23	3:139357406-139389680	COPB2, MCPH19, OPDD	Coatomer protein complex, subunit beta-2	606990	COPB2	9276	ENSG00000184432,ENST00000333188;;;ENST00000333188	mutation identified in 1 MCPH19 family	?Microcephaly 19, primary, autosomal recessive	617800	AR	3	Copb2
3q23	3:139357406-139389680	COPB2, MCPH19, OPDD	Coatomer protein complex, subunit beta-2	606990	COPB2	9276	ENSG00000184432,ENST00000333188;;;ENST00000333188	mutation identified in 1 MCPH19 family	Osteoporosis, childhood- or juvenile-onset, with developmental delay	619884	AD	3	Copb2
3q23	3:140941836-140980995	SLC25A36, PNC2, HHF8	Solute carrier family 25 (mitochondrial carrier, pyrimidine nucleotide transporter), member 36	616149	SLC25A36	55186	ENSG00000114120,ENST00000324194;;;ENST00000324194		Hyperinsulinemic hypoglycemia, familial, 8	620211	AR	3	Slc25a36
3q23	3:142449235-142578733	ATR, FRP1, SCKL1, FCTCS	ATR serine/threonine kinase	601215	ATR	545	ENSG00000175054,ENST00000350721;;;ENST00000350721	mutation identified in 1 FCTCS family	?Cutaneous telangiectasia and cancer syndrome, familial	614564	AD	3	Atr
3q23	3:142449235-142578733	ATR, FRP1, SCKL1, FCTCS	ATR serine/threonine kinase	601215	ATR	545	ENSG00000175054,ENST00000350721;;;ENST00000350721	mutation identified in 1 FCTCS family	Seckel syndrome 1	210600	AR	3	Atr
3q23	3:142596393-142713664	PLS1, DFNA76	Plastin-1	602734	PLS1	5357	ENSG00000120756,ENST00000457734;;;ENST00000457734		Deafness, autosomal dominant 76	618787	AD	3	Pls1
3q24-q26	3:143100001-183000000	HDLCQ5	High density lipoprotein cholesterol level QTL 5	610761		100188818		max lod at D3S3053	[High density lipoprotein cholesterol level QTL 5]	610761		2	
3q24	3:143265222-143848468	SLC9A9, AUTS16	Solute carrier family 9 (sodium/hydrogen exchanger), member A9	608396	SLC9A9	285195	ENSG00000181804,ENST00000316549;;;ENST00000316549	mutation identified in 1 family	{?Autism susceptibility 16}	613410		3	Slc9a9
3q24	3:146069440-146161184	PLOD2, LH2, TLH, BRKS2	Procollagen-lysine, 2-oxoglutarate 5-dioxygenase (lysine hydroxylase) 2	601865	PLOD2	5352	ENSG00000152952,ENST00000282903;;;ENST00000282903		Bruck syndrome 2	609220	AR	3	Plod2
3q24	3:147409365-147416719	ZIC1, CRS6, BAIDCS	Zic family, member 1	600470	ZIC1	7545	ENSG00000152977,ENST00000282928;;;ENST00000282928	mutation identified in 1 CRS6 family	?Craniosynostosis 6	616602	AD	3	Zic1
3q24	3:147409365-147416719	ZIC1, CRS6, BAIDCS	Zic family, member 1	600470	ZIC1	7545	ENSG00000152977,ENST00000282928;;;ENST00000282928	mutation identified in 1 CRS6 family	Structural brain anomalies with impaired intellectual development and craniosynostosis	618736	AD	3	Zic1
3q24	3:148697903-148743003	AGTR1, AGTR1A, AT2R1	Angiotensin receptor 1	106165	AGTR1	185	ENSG00000144891,ENST00000349243;;;ENST00000349243		{Hypertension, essential}	145500	Mu	3	Agtr1a,Agtr1b
3q24	3:148697903-148743003	AGTR1, AGTR1A, AT2R1	Angiotensin receptor 1	106165	AGTR1	185	ENSG00000144891,ENST00000349243;;;ENST00000349243		Renal tubular dysgenesis	267430	AR	3	Agtr1a,Agtr1b
3q24	3:148991540-149031775	GYG1, GSD15	Glycogenin 1	603942	GYG1	2992	ENSG00000163754,ENST00000345003;;;ENST00000345003	mutation identified in 1 GSD15 patient	?Glycogen storage disease XV	613507	AR	3	Gyg1
3q24	3:148991540-149031775	GYG1, GSD15	Glycogenin 1	603942	GYG1	2992	ENSG00000163754,ENST00000345003;;;ENST00000345003	mutation identified in 1 GSD15 patient	Polyglucosan body myopathy 2	616199	AR	3	Gyg1
3q24	3:149129638-149173732	HPS3	HPS3 biogenesis of lysosomal organelles complex 2 subunit 1	606118	HPS3	84343	ENSG00000163755,ENST00000296051;;;ENST00000296051		Hermansky-Pudlak syndrome 3	614072	AR	3	Hps3
3q24-q25.1	3:149162414-149221829	CP	Ceruloplasmin	117700	CP	1356	ENSG00000047457,ENST00000264613;;;ENST00000264613	~15cM from TF	Aceruloplasminemia	604290	AR	3	Cp
3q25-q27	3:149200001-188200000	ASPG1	Asperger syndrome, susceptibility to, 1	608638		431710		max lod with D3S3037	{Asperger syndrome susceptibility 1}	608638	IC, Mu	2	
3q25-q27	3:149200001-188200000	AUTS8	Autism, susceptibility to, 8	607373		282553			{Autism susceptibility 8}	607373	IC, Mu	2	
3q25-q26	3:149200001-183000000	CELIAC10	Celiac disease, susceptibility to, 10	612008		100188872		associated with rs17810546	{Celiac disease, susceptibility to, 10}	612008		2	
3q25-q26	3:149200001-183000000	ETL6	Epilepsy, familial temporal lobe, 6	615697		103106902		between D3S1584 and D3S3520	Epilepsy, familial temporal lobe, 6	615697	AD	2	
3q25.1	3:149812688-149962139	RNF13, DEE73	RING finger protein 13	609247	RNF13	11342	ENSG00000082996,ENST00000392894;;;ENST00000392894		Developmental and epileptic encephalopathy 73	618379	AD	3	Rnf13
3q25.1	3:150926163-150972999	CLRN1, USH3A, USH3, RP61	Clarin 1	606397	CLRN1	7401	ENSG00000163646,ENST00000327047;;;ENST00000327047	frequent in Finland; ?digenic interaction with MYO7A	Retinitis pigmentosa 61	614180		3	Clrn1
3q25.1	3:150926163-150972999	CLRN1, USH3A, USH3, RP61	Clarin 1	606397	CLRN1	7401	ENSG00000163646,ENST00000327047;;;ENST00000327047	frequent in Finland; ?digenic interaction with MYO7A	Usher syndrome, type 3A	276902	AR	3	Clrn1
3q25.1	3:151085664-151436653	MED12L, NOPAR, KIAA1635, NIZIDS	Mediator complex subunit 12-like	611318	MED12L	116931	ENSG00000144893,ENST00000687756;;;ENST00000687756		Nizon-Isidor syndrome	618872	AD	3	Med12l
3q25.1	3:151336843-151384753	P2RY12, P2Y12, BDPLT8	Purinergic receptor P2Y, G protein-coupled, 12	600515	P2RY12	64805	ENSG00000169313,ENST00000302632;;;ENST00000302632		Bleeding disorder, platelet-type, 8	609821	AR	3	P2ry12
3q25.2	3:155024202-155183729	MME, CD10, CALLA, NEP, CMT2T, SCA43	Membrane metallo-endopeptidase (common acute lymphocytic leukemia antigen)	120520	MME	4311	ENSG00000196549,ENST00000360490;;;ENST00000360490	mutation identified in 1 SCA43 family	?Spinocerebellar ataxia 43	617018	AD	3	Mme
3q25.2	3:155024202-155183729	MME, CD10, CALLA, NEP, CMT2T, SCA43	Membrane metallo-endopeptidase (common acute lymphocytic leukemia antigen)	120520	MME	4311	ENSG00000196549,ENST00000360490;;;ENST00000360490	mutation identified in 1 SCA43 family	Charcot-Marie-Tooth disease, axonal, type 2T	617017	AD, AR	3	Mme
3q25.3	3:155300001-161000000	BWQTL2	Birth weight quantitative trait locus 2	613459		100502569		associated with rs900400	[Birth weight QTL 2]	613459		2	
3q25.31	3:155450934-155745071	PLCH1, PLCL3, KIAA1069, HPE14	Phospholipase C, eta-1	612835	PLCH1	23007	ENSG00000114805,ENST00000460012;;;ENST00000460012		Holoprosencephaly 14	619895	AR	3	Plch1
3q25.31	3:155821024-155854427	SLC33A1, ACATN, AT1, SPG42, HPBDS	Solute carrier family 33 (acetyl-CoA transporter), member 1	603690	SLC33A1	9197	ENSG00000169359,ENST00000643144;;;ENST00000643144		Huppke-Brendel syndrome	614482	AR	3	Slc33a1
3q25.31	3:155821024-155854427	SLC33A1, ACATN, AT1, SPG42, HPBDS	Solute carrier family 33 (acetyl-CoA transporter), member 1	603690	SLC33A1	9197	ENSG00000169359,ENST00000643144;;;ENST00000643144		Spastic paraplegia 42, autosomal dominant	612539	AD	3	Slc33a1
3q25.32	3:158110089-158545730	RSRC1, SRRP53, MRT70	Arginine/serine-rich coiled-coil protein 1	613352	RSRC1	51319	ENSG00000174891,ENST00000611884;;;ENST00000611884		Intellectual developmental disorder, autosomal recessive 70	618402	AR	3	Rsrc1
3q25.32	3:158644527-158695581	GFM1, EFG1, GFM, COXPD1	Mitochondrial elongation factor G1	606639	GFM1	85476	ENSG00000168827,ENST00000486715;;;ENST00000486715		Combined oxidative phosphorylation deficiency 1	609060	AR	3	Gfm1
3q25.33	3:159300001-161000000	PBC1	Biliary cirrhosis, primary, 1	109720				associated with rs6441286 and rs574808	Biliary cirrhosis, primary, 1	109720	AD	2	
3q25.33	3:160256986-160399225	IFT80, KIAA1374, WDR56, SRTD2, ATD2	Intraflagellar transport 80	611177	IFT80	57560	ENSG00000068885,ENST00000326448;;;ENST00000326448		Short-rib thoracic dysplasia 2 with or without polydactyly	611263	AR	3	Ift80
3q26	3:161000001-183000000	AGA1, MPB	Alopecia, androgenetic, 1	109200		100188784			Alopecia, androgenetic, 1	109200	AD	2	
3q26.1-q26.3	3:161000001-183000000	MNG3	Multinodular goiter-3	606082		94337			Goiter, multinodular, 3	606082		2	
3q26	3:161000001-183000000	MYP8	Myopia 8	609257		553192			Myopia 8	609257	Mu	2	
3q26.1	3:161083883-161105349	B3GALT3, GLCT3, GLOB	UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase 3	603094	B3GALNT1	8706	ENSG00000169255,ENST00000320474;;;ENST00000320474		[Blood group, globoside system]	615021		3	B3galnt1
3q26.1	3:161083883-161105349	B3GALT3, GLCT3, GLOB	UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase 3	603094	B3GALNT1	8706	ENSG00000169255,ENST00000320474;;;ENST00000320474		[Blood group, P1PK system, P(k) phenotype]	111400		3	B3galnt1
3q26.1	3:164978898-165090232	SI	Sucrase-isomaltase	609845	SI	6476	ENSG00000090402,ENST00000264382;;;ENST00000264382		Sucrase-isomaltase deficiency, congenital	222900	AR	3	Sis
3q26.1	3:165772904-165837423	BCHE, CHE1, BCHED	Butyrylcholinesterase	177400	BCHE	590	ENSG00000114200,ENST00000264381;;;ENST00000264381	distal to CP, TF	{Apnea, postanesthetic, susceptibility to, due to BCHE deficiency}	617936	AR	3	Bche
3q26.1	3:165772904-165837423	BCHE, CHE1, BCHED	Butyrylcholinesterase	177400	BCHE	590	ENSG00000114200,ENST00000264381;;;ENST00000264381	distal to CP, TF	Butyrylcholinesterase deficiency	617936	AR	3	Bche
3q26.1	3:167683298-167734892	PDCD10, TFAR15, CCM3	Programmed cell death 10	609118	PDCD10	11235	ENSG00000114209,ENST00000392750;;;ENST00000392750		Cerebral cavernous malformations-3	603285	AD	3	Pdcd10
3q26.1	3:167735721-167825569	SERPINI1, PI12	Protease inhibitor 12	602445	SERPINI1	5274	ENSG00000163536,ENST00000446050;;;ENST00000446050		Encephalopathy, familial, with neuroserpin inclusion bodies	604218	AD	3	Serpini1
3q26.2-q26.31	3:167900001-176000000	APMR2	Alopecia-intellectual disability syndrome 2	610422		100049544		between D3S1564 and D3S2427	Alopecia-intellectual disability syndrome 2	610422	AR	2	
3q26.2-q26.33	3:167900001-183000000	FEB10	Febrile seizures, familial, 10	612637		100271923		between D3S3656 and D3S1232	Febrile seizures, familial, 10	612637		2	
3q26.2	3:169083507-169663712	MECOM, EVI1, RUSAT2	MDS1 and EVS1 complex locus	165215	MECOM	2122	ENSG00000085276,ENST00000651503;;;ENST00000651503		Radioulnar synostosis with amegakaryocytic thrombocytopenia 2	616738	AD	3	Mecom
3q26.2	3:169764610-169765060	TERC, TRC3, TR, DKCA1, PFBMFT2	Telomerase RNA component	602322	TERC	7012	ENSG00000270141,ENST00000602385;;;ENST00000602385		Dyskeratosis congenita, autosomal dominant 1	127550	AD	3	
3q26.2	3:169764610-169765060	TERC, TRC3, TR, DKCA1, PFBMFT2	Telomerase RNA component	602322	TERC	7012	ENSG00000270141,ENST00000602385;;;ENST00000602385		Pulmonary fibrosis and/or bone marrow failure syndrome, telomere-related, 2	614743	AD	3	
3q26.2	3:169911572-169939175	SAMD7, MDCD	Sterile alpha motif domain-containing protein 7	620493	SAMD7	344658	ENSG00000187033,ENST00000335556;;;ENST00000335556		Macular dystrophy with or without cone dysfunction	620762	AR	3	Samd7
3q26.2	3:170418868-170434691	CLDN11, OTM, OSP, HLD22	Claudin 11 (oligodendrocyte transmembrane protein)	601326	CLDN11	5010	ENSG00000013297,ENST00000064724;;;ENST00000064724		Leukodystrophy, hypomyelinating, 22	619328	AD	3	Cldn11
3q26.2	3:170459548-170586075	SLC7A14, KIAA1613, RP68	Solute carrier family 7, member 14	615720	SLC7A14	57709	ENSG00000013293,ENST00000231706;;;ENST00000231706		Retinitis pigmentosa 68	615725	AR	3	Slc7a14
3q26.2	3:170996347-171026720	SLC2A2, GLUT2	Solute carrier family 2 (facilitated glucose transporter), member 2	138160	SLC2A2	6514	ENSG00000163581,ENST00000314251;;;ENST00000314251		{Diabetes mellitus, noninsulin-dependent}	125853	AD	3	Slc2a2
3q26.2	3:170996347-171026720	SLC2A2, GLUT2	Solute carrier family 2 (facilitated glucose transporter), member 2	138160	SLC2A2	6514	ENSG00000163581,ENST00000314251;;;ENST00000314251		Fanconi-Bickel syndrome	227810	AR	3	Slc2a2
3q26.2-q26.31	3:171058414-171460408	TNIK, KIAA0551, MRT54	TRAF2-and NCK-interacting kinase	610005	TNIK	23043	ENSG00000154310,ENST00000436636;;;ENST00000436636		Intellectual developmental disorder, autosomal recessive 54	617028	AR	3	Tnik
3q26.31	3:171600404-171810483	PLD1, CVDP1	Phospholipase D1, phosphatidylcholine-specific	602382	PLD1	5337	ENSG00000075651,ENST00000351298;;;ENST00000351298		Cardiac valvular dysplasia 1	212093	AR	3	Pld1
3q26.31	3:172443291-172448456	GHSR, GHDP	Growth hormone secretagogue receptor	601898	GHSR	2693	ENSG00000121853,ENST00000241256;;;ENST00000241256		Growth hormone deficiency, isolated partial	615925	AD, AR	3	Ghsr
3q26.31	3:172889357-173141235	SPATA16, SPGF6	Spermatogenesis-associated protein 16	609856	SPATA16	83893	ENSG00000144962,ENST00000351008;;;ENST00000351008	mutation identified in 1 SPGF6 family	?Spermatogenic failure 6	102530	AR	3	Spata16
3q26.31	3:173395952-174294372	NLGN1	Neuroligin 1	600568	NLGN1	22871	ENSG00000169760,ENST00000695368;;;ENST00000695368		{Autism, susceptibility to, 20}	618830	AD	3	Nlgn1
3q26.32	3:177019344-177201800	TBL1XR1, TBLR1, IRA1, C21, MRD41	Transducin-beta-like 1 receptor 1	608628	TBL1XR1	79718	ENSG00000177565,ENST00000457928;;;ENST00000457928		Intellectual developmental disorder, autosomal dominant 41	616944	AD	3	Tbl1xr1
3q26.32	3:177019344-177201800	TBL1XR1, TBLR1, IRA1, C21, MRD41	Transducin-beta-like 1 receptor 1	608628	TBL1XR1	79718	ENSG00000177565,ENST00000457928;;;ENST00000457928		Pierpont syndrome	602342	AD	3	Tbl1xr1
3q26.32	3:179148126-179240093	PIK3CA, CLOVE, MCAP, MCM, MCMTC, CWS5, CLAPO, CCM4, HMH	Phosphatidylinositol 3-kinase, catalytic, alpha polypeptide	171834	PIK3CA	5290	ENSG00000121879,ENST00000263967;;;ENST00000263967		Breast cancer, somatic	114480		3	Pik3ca
3q26.32	3:179148126-179240093	PIK3CA, CLOVE, MCAP, MCM, MCMTC, CWS5, CLAPO, CCM4, HMH	Phosphatidylinositol 3-kinase, catalytic, alpha polypeptide	171834	PIK3CA	5290	ENSG00000121879,ENST00000263967;;;ENST00000263967		Cerebral cavernous malformations 4, somatic	619538		3	Pik3ca
3q26.32	3:179148126-179240093	PIK3CA, CLOVE, MCAP, MCM, MCMTC, CWS5, CLAPO, CCM4, HMH	Phosphatidylinositol 3-kinase, catalytic, alpha polypeptide	171834	PIK3CA	5290	ENSG00000121879,ENST00000263967;;;ENST00000263967		CLAPO syndrome, somatic	613089		3	Pik3ca
3q26.32	3:179148126-179240093	PIK3CA, CLOVE, MCAP, MCM, MCMTC, CWS5, CLAPO, CCM4, HMH	Phosphatidylinositol 3-kinase, catalytic, alpha polypeptide	171834	PIK3CA	5290	ENSG00000121879,ENST00000263967;;;ENST00000263967		CLOVE syndrome, somatic	612918		3	Pik3ca
3q26.32	3:179148126-179240093	PIK3CA, CLOVE, MCAP, MCM, MCMTC, CWS5, CLAPO, CCM4, HMH	Phosphatidylinositol 3-kinase, catalytic, alpha polypeptide	171834	PIK3CA	5290	ENSG00000121879,ENST00000263967;;;ENST00000263967		Colorectal cancer, somatic	114500		3	Pik3ca
3q26.32	3:179148126-179240093	PIK3CA, CLOVE, MCAP, MCM, MCMTC, CWS5, CLAPO, CCM4, HMH	Phosphatidylinositol 3-kinase, catalytic, alpha polypeptide	171834	PIK3CA	5290	ENSG00000121879,ENST00000263967;;;ENST00000263967		Cowden syndrome 5	615108		3	Pik3ca
3q26.32	3:179148126-179240093	PIK3CA, CLOVE, MCAP, MCM, MCMTC, CWS5, CLAPO, CCM4, HMH	Phosphatidylinositol 3-kinase, catalytic, alpha polypeptide	171834	PIK3CA	5290	ENSG00000121879,ENST00000263967;;;ENST00000263967		Gastric cancer, somatic	613659		3	Pik3ca
3q26.32	3:179148126-179240093	PIK3CA, CLOVE, MCAP, MCM, MCMTC, CWS5, CLAPO, CCM4, HMH	Phosphatidylinositol 3-kinase, catalytic, alpha polypeptide	171834	PIK3CA	5290	ENSG00000121879,ENST00000263967;;;ENST00000263967		Hemifacial myohyperplasia, somatic	606773		3	Pik3ca
3q26.32	3:179148126-179240093	PIK3CA, CLOVE, MCAP, MCM, MCMTC, CWS5, CLAPO, CCM4, HMH	Phosphatidylinositol 3-kinase, catalytic, alpha polypeptide	171834	PIK3CA	5290	ENSG00000121879,ENST00000263967;;;ENST00000263967		Hepatocellular carcinoma, somatic	114550		3	Pik3ca
3q26.32	3:179148126-179240093	PIK3CA, CLOVE, MCAP, MCM, MCMTC, CWS5, CLAPO, CCM4, HMH	Phosphatidylinositol 3-kinase, catalytic, alpha polypeptide	171834	PIK3CA	5290	ENSG00000121879,ENST00000263967;;;ENST00000263967		Keratosis, seborrheic, somatic	182000		3	Pik3ca
3q26.32	3:179148126-179240093	PIK3CA, CLOVE, MCAP, MCM, MCMTC, CWS5, CLAPO, CCM4, HMH	Phosphatidylinositol 3-kinase, catalytic, alpha polypeptide	171834	PIK3CA	5290	ENSG00000121879,ENST00000263967;;;ENST00000263967		Macrodactyly, somatic	155500		3	Pik3ca
3q26.32	3:179148126-179240093	PIK3CA, CLOVE, MCAP, MCM, MCMTC, CWS5, CLAPO, CCM4, HMH	Phosphatidylinositol 3-kinase, catalytic, alpha polypeptide	171834	PIK3CA	5290	ENSG00000121879,ENST00000263967;;;ENST00000263967		Megalencephaly-capillary malformation-polymicrogyria syndrome, somatic	602501		3	Pik3ca
3q26.32	3:179148126-179240093	PIK3CA, CLOVE, MCAP, MCM, MCMTC, CWS5, CLAPO, CCM4, HMH	Phosphatidylinositol 3-kinase, catalytic, alpha polypeptide	171834	PIK3CA	5290	ENSG00000121879,ENST00000263967;;;ENST00000263967		Nevus, epidermal, somatic mosaic	162900		3	Pik3ca
3q26.32	3:179148126-179240093	PIK3CA, CLOVE, MCAP, MCM, MCMTC, CWS5, CLAPO, CCM4, HMH	Phosphatidylinositol 3-kinase, catalytic, alpha polypeptide	171834	PIK3CA	5290	ENSG00000121879,ENST00000263967;;;ENST00000263967		Nonsmall cell lung cancer, somatic	211980		3	Pik3ca
3q26.32	3:179148126-179240093	PIK3CA, CLOVE, MCAP, MCM, MCMTC, CWS5, CLAPO, CCM4, HMH	Phosphatidylinositol 3-kinase, catalytic, alpha polypeptide	171834	PIK3CA	5290	ENSG00000121879,ENST00000263967;;;ENST00000263967		Ovarian cancer, somatic	167000		3	Pik3ca
3q26.33	3:179396088-179527798	GNB4, CMTD1F	Guanine nucleotide-binding protein, beta-4	610863	GNB4	59345	ENSG00000114450,ENST00000232564;;;ENST00000232564		Charcot-Marie-Tooth disease, dominant intermediate F	615185	AD	3	Gnb4
3q26.33	3:180614008-180679489	CCDC39	Coiled-coil domain-containing protein 39	613798	CCDC39	339829	ENSG00000284862,ENST00000476379;;;ENST00000476379		Ciliary dyskinesia, primary, 14	613807	AR	3	Ccdc39
3q26.33	3:180912670-180982753	FXR1, MYORIBF, CMYO9A, CMYO9B	FMR1 autosomal homolog 1	600819	FXR1	8087	ENSG00000114416,ENST00000357559;;;ENST00000357559	mutation identified in 1 CMYP9A family	?Congenital myopathy 9A with respiratory insufficiency and bone fractures	618822	AR	3	Fxr1
3q26.33	3:180912670-180982753	FXR1, MYORIBF, CMYO9A, CMYO9B	FMR1 autosomal homolog 1	600819	FXR1	8087	ENSG00000114416,ENST00000357559;;;ENST00000357559	mutation identified in 1 CMYP9A family	Congenital myopathy 9B, proximal, with minicore lesions	618823	AR	3	Fxr1
3q26.33	3:180983709-180989838	DNAJC19, TIM14	DnaJ (Hsp40) homolog, subfamily C, member 19 (translocase of inner mitochondrial membrane 14, yeast, homolog of)	608977	DNAJC19	131118	ENSG00000205981,ENST00000382564;;;ENST00000382564		3-methylglutaconic aciduria, type V	610198	AR	3	Dnajc19
3q26.33	3:181711925-181714436	SOX2, MCOPS3	SRY (sex determining region Y)-box 2	184429	SOX2	6657	ENSG00000181449,ENST00000325404;;;ENST00000325404		Microphthalmia, syndromic 3	206900	AD	3	Sox2
3q26.33	3:181711925-181714436	SOX2, MCOPS3	SRY (sex determining region Y)-box 2	184429	SOX2	6657	ENSG00000181449,ENST00000325404;;;ENST00000325404		Optic nerve hypoplasia and abnormalities of the central nervous system	206900	AD	3	Sox2
3q27	3:183000001-188200000	AOMS1, SYNX	Abdominal obesity-metabolic syndrome QTL1	605552		65076		epistatic gene on 17p12	Abdominal obesity-metabolic syndrome 1	605552	AD	2	
3q27-q28	3:183000001-192600000	SPG14	Spastic paraplegia 14, autosomal recessive	605229		57309			Spastic paraplegia 14, autosomal recessive	605229	AR	2	
3q27.1	3:183015218-183116196	MCCC1, MCCA	3-Methylcrotonyl-CoA carboxylase 1	609010	MCCC1	56922	ENSG00000078070,ENST00000265594;;;ENST00000265594		3-Methylcrotonyl-CoA carboxylase 1 deficiency	210200	AR	3	Mccc1
3q27.1	3:183635623-183684519	KLHL24, KRIP6, EBS6, CMH29	Kelch-like 24	611295	KLHL24	54800	ENSG00000114796,ENST00000242810;;;ENST00000242810		Cardiomyopathy, familial hypertrophic, 29, with polyglucosan bodies	620236	AR	3	Klhl24
3q27.1	3:183635623-183684519	KLHL24, KRIP6, EBS6, CMH29	Kelch-like 24	611295	KLHL24	54800	ENSG00000114796,ENST00000242810;;;ENST00000242810		Epidermolysis bullosa simplex 6, generalized intermediate, with or without cardiomyopathy	617294	AD	3	Klhl24
3q27.1	3:183697797-183812624	YEATS2, KIAA1197, FAME4	YEATS domain-containing protein 2	613373	YEATS2	55689	ENSG00000163872,ENST00000305135;;;ENST00000305135	mutation identifed in 1 FAME4 family	?Epilepsy, myoclonic, familial adult, 4	615127	AD	3	Yeats2
3q27.1	3:184135358-184145311	EIF2B5, CACH, CLE, VWM5	Eukaryotic translation initiation factor 2B, subunit 5	603945	EIF2B5	8893	ENSG00000145191,ENST00000648915;;;ENST00000648915		Leukoencephalopathy with vanishing white matter 5, with or without ovarian failure	620315	AR	3	Eif2b5
3q27.1	3:184155377-184173614	DVL3, DRS3	Dishevelled 3 (homologous to Drosophila dsh)	601368	DVL3	1857	ENSG00000161202,ENST00000313143;;;ENST00000313143		Robinow syndrome, autosomal dominant 3	616894	AD	3	Dvl3
3q27.1	3:184174855-184184091	AP2M1, CLAPM1, MRD60	Adaptor-related protein complex 2, mu 1 subunit	601024	AP2M1	1173	ENSG00000161203,ENST00000292807;;;ENST00000292807		Intellectual developmental disorder 60 with seizures	618587	AD	3	Ap2m1
3q27.1	3:184242301-184249525	ALG3, NOT56L, CDGS4, CDG1D	ALG3 alpha-1,3-mannosyltransferase	608750	ALG3	10195	ENSG00000214160,ENST00000397676;;;ENST00000397676		Congenital disorder of glycosylation, type Id	601110	AR	3	Alg3
3q27.1	3:184314606-184335358	EIF4G1, EIF4G, PARK18	Eukaryotic translation initiation factor 4 gamma, 1	600495	EIF4G1	1981	ENSG00000114867,ENST00000346169;;;ENST00000346169	amplified in squamous cell lung cancer	{Parkinson disease 18}	614251	AD	3	Eif4g1
3q27.1	3:184346185-184361605	CLCN2, EGMA, ECA2, EGI11, EJM8, LKPAT, HALD2	Chloride channel-2	600570	CLCN2	1181	ENSG00000114859,ENST00000265593;;;ENST00000265593		{Epilepsy, idiopathic generalized, susceptibility to, 11}	607628	AD	3	Clcn2
3q27.1	3:184346185-184361605	CLCN2, EGMA, ECA2, EGI11, EJM8, LKPAT, HALD2	Chloride channel-2	600570	CLCN2	1181	ENSG00000114859,ENST00000265593;;;ENST00000265593		{Epilepsy, juvenile absence, susceptibility to, 2}	607628	AD	3	Clcn2
3q27.1	3:184346185-184361605	CLCN2, EGMA, ECA2, EGI11, EJM8, LKPAT, HALD2	Chloride channel-2	600570	CLCN2	1181	ENSG00000114859,ENST00000265593;;;ENST00000265593		{Epilepsy, juvenile myoclonic, susceptibility to, 8}	607628	AD	3	Clcn2
3q27.1	3:184346185-184361605	CLCN2, EGMA, ECA2, EGI11, EJM8, LKPAT, HALD2	Chloride channel-2	600570	CLCN2	1181	ENSG00000114859,ENST00000265593;;;ENST00000265593		Hyperaldosteronism, familial, type II	605635	AD	3	Clcn2
3q27.1	3:184346185-184361605	CLCN2, EGMA, ECA2, EGI11, EJM8, LKPAT, HALD2	Chloride channel-2	600570	CLCN2	1181	ENSG00000114859,ENST00000265593;;;ENST00000265593		Leukoencephalopathy with ataxia	615651	AR	3	Clcn2
3q27.1	3:184371935-184379688	THPO, MGDF, MPLLG, TPO, THCYT1, THC9, CAMT2	Thrombopoietin (megakaryocyte growth and development factor)	600044	THPO	7066	ENSG00000090534,ENST00000647395;;;ENST00000647395		Amegakaryocytic thrombocytopenia, congenital, 2	620481	AR	3	Thpo
3q27.1	3:184371935-184379688	THPO, MGDF, MPLLG, TPO, THCYT1, THC9, CAMT2	Thrombopoietin (megakaryocyte growth and development factor)	600044	THPO	7066	ENSG00000090534,ENST00000647395;;;ENST00000647395		Thrombocythemia 1	187950	AD	3	Thpo
3q27.1	3:184371935-184379688	THPO, MGDF, MPLLG, TPO, THCYT1, THC9, CAMT2	Thrombopoietin (megakaryocyte growth and development factor)	600044	THPO	7066	ENSG00000090534,ENST00000647395;;;ENST00000647395		Thrombocytopenia 9	620478	AD	3	Thpo
3q27.2	3:185190624-185254049	EHHADH, PBFE, LBFP, FRTS3	Enoyl-Coenzyme A, hydratase/3-hydroxyacyl Coenzyme A dehydrogenase	607037	EHHADH	1962	ENSG00000113790,ENST00000231887;;;ENST00000231887	mutation identified in 1 family	?Fanconi renotubular syndrome 3	615605	AD	3	Ehhadh
3q27.2	3:185506262-185552588	LIPH, LAH2, ARWH2, HYPT7	Lipase H	607365	LIPH	200879	ENSG00000163898,ENST00000296252;;;ENST00000296252		Hypotrichosis 7	604379	AR	3	Liph
3q27.2	3:185506262-185552588	LIPH, LAH2, ARWH2, HYPT7	Lipase H	607365	LIPH	200879	ENSG00000163898,ENST00000296252;;;ENST00000296252		Woolly hair, autosomal recessive 2 with or without hypotrichosis	604379	AR	3	Liph
3q27.2	3:185643130-185825042	IGF2BP2, IMP2	Insulin-like growth factor 2 mRNA-binding protein 2	608289	IGF2BP2	10644	ENSG00000073792,ENST00000382199;;;ENST00000382199		{Diabetes mellitus, noninsulin-dependent, susceptibility to}	125853	AD	3	Igf2bp2
3q27.3	3:186538443-186544380	CRYGS, CRYG8, CTRCT20	Crystallin, gamma S	123730	CRYGS	1427	ENSG00000213139,ENST00000307944;;;ENST00000307944		Cataract 20, multiple types	116100	AD	3	Crygs
3q27.3	3:186570720-186585793	DNAJB11, HEDJ, DJ9, ABBP2, PKD6	DNAJ/HSP40 homolog, subfamily B, member 11	611341	DNAJB11	51726	ENSG00000090520,ENST00000265028;;;ENST00000265028		Polycystic kidney disease 6 with or without polycystic liver disease	618061	AD	3	Dnajb11
3q27.3	3:186613060-186621318	AHSG, APMR1	Alpha-2HS-glycoprotein	138680	AHSG	197	ENSG00000145192,ENST00000411641;;;ENST00000411641	mutation identified in 1 APMR1 family	?Alopecia-intellectual disability syndrome 1	203650	AR	3	Ahsg
3q27.3	3:186666014-186678234	HRG, THPH11	Histidine-rich glycoprotein	142640	HRG	3273	ENSG00000113905,ENST00000232003;;;ENST00000232003		Thrombophilia 11 due to HRG deficiency	613116	AD	3	Hrg
3q27.3	3:186717359-186744410	KNG1, KNG, HAE6	Kininogen 1	612358	KNG1	3827	ENSG00000113889,ENST00000644859;;;ENST00000644859		[High molecular weight kininogen deficiency]	228960	AR	3	Kng1,Kng2
3q27.3	3:186717359-186744410	KNG1, KNG, HAE6	Kininogen 1	612358	KNG1	3827	ENSG00000113889,ENST00000644859;;;ENST00000644859		[Kininogen deficiency]	228960	AR	3	Kng1,Kng2
3q27.3	3:186717359-186744410	KNG1, KNG, HAE6	Kininogen 1	612358	KNG1	3827	ENSG00000113889,ENST00000644859;;;ENST00000644859		Angioedema, hereditary, 6	619363	AD	3	Kng1,Kng2
3q27.3	3:186783577-186789897	EIF4A2, NEDHSS	Eukaryotic translation initiation factor-4A, isoform 2	601102	EIF4A2	1974	ENSG00000156976,ENST00000323963;;;ENST00000323963		Neurodevelopmental disorder with hypotonia and speech delay, with or without seizures	620455	AD, AR	3	Eif4a2
3q27.3	3:186789900-186806482	RFC4, MRMNS	Replication factor C4, 37kD (activator 1, 37kD)	102577	RFC4	5984	ENSG00000163918,ENST00000296273;;;ENST00000296273		Morimoto-Ryu-Malicdan neuromuscular syndrome	621010	AR	3	Rfc4
3q27.3	3:186842710-186858463	ADIPOQ, APM1, GBP28, ADIPQTL1	Adipocyte-, C1q-, and collagen domain-containing	605441	ADIPOQ	9370	ENSG00000181092,ENST00000320741;;;ENST00000320741		Adiponectin deficiency	612556	AD	3	Adipoq
3q27.3	3:187217282-187291737	MASP1, CRARF, 3MC1	Mannan-binding lectin serine protease-1 (C4/C2 activating component of Ra-reactive factor)	600521	MASP1	5648	ENSG00000127241,ENST00000296280;;;ENST00000296280		3MC syndrome 1	257920	AR	3	Masp1
3q27.3-q28	3:188153021-188890671	LPP	Lipoma-preferred-partner gene	600700	LPP	4026	ENSG00000145012,ENST00000617246;;;ENST00000617246	fused with HMGIC in lipoma; fused with MLL in leukemia	Leukemia, acute myeloid	601626	AD, SMu	3	Lpp
3q27.3-q28	3:188153021-188890671	LPP	Lipoma-preferred-partner gene	600700	LPP	4026	ENSG00000145012,ENST00000617246;;;ENST00000617246	fused with HMGIC in lipoma; fused with MLL in leukemia	Lipoma			3	Lpp
3q28	3:188200001-192600000	CELIAC11	Celiac disease, susceptibility to, 11	612009		100188873		associated with rs1464510	{Celiac disease, susceptibility to, 11}	612009		2	
3q28	3:188200001-192600000	LNCR5	Lung cancer susceptibility 5	614210		100682395		associated with rs4488809	{Lung cancer susceptibility 5}	614210		2	
3q28	3:189596746-189897276	TP63, TP73L, KET, EEC3, SHFM4, LMS, RHS, OFC8	Tumor protein p63 (tumor protein p73-like)	603273	TP63	8626	ENSG00000073282,ENST00000264731;;;ENST00000264731		ADULT syndrome	103285	AD	3	Trp63
3q28	3:189596746-189897276	TP63, TP73L, KET, EEC3, SHFM4, LMS, RHS, OFC8	Tumor protein p63 (tumor protein p73-like)	603273	TP63	8626	ENSG00000073282,ENST00000264731;;;ENST00000264731		Ectrodactyly, ectodermal dysplasia, and cleft lip/palate syndrome 3	604292	AD	3	Trp63
3q28	3:189596746-189897276	TP63, TP73L, KET, EEC3, SHFM4, LMS, RHS, OFC8	Tumor protein p63 (tumor protein p73-like)	603273	TP63	8626	ENSG00000073282,ENST00000264731;;;ENST00000264731		Hay-Wells syndrome	106260	AD	3	Trp63
3q28	3:189596746-189897276	TP63, TP73L, KET, EEC3, SHFM4, LMS, RHS, OFC8	Tumor protein p63 (tumor protein p73-like)	603273	TP63	8626	ENSG00000073282,ENST00000264731;;;ENST00000264731		Limb-mammary syndrome	603543	AD	3	Trp63
3q28	3:189596746-189897276	TP63, TP73L, KET, EEC3, SHFM4, LMS, RHS, OFC8	Tumor protein p63 (tumor protein p73-like)	603273	TP63	8626	ENSG00000073282,ENST00000264731;;;ENST00000264731		Orofacial cleft 8	618149		3	Trp63
3q28	3:189596746-189897276	TP63, TP73L, KET, EEC3, SHFM4, LMS, RHS, OFC8	Tumor protein p63 (tumor protein p73-like)	603273	TP63	8626	ENSG00000073282,ENST00000264731;;;ENST00000264731		Premature ovarian failure 21	620311	AD	3	Trp63
3q28	3:189596746-189897276	TP63, TP73L, KET, EEC3, SHFM4, LMS, RHS, OFC8	Tumor protein p63 (tumor protein p73-like)	603273	TP63	8626	ENSG00000073282,ENST00000264731;;;ENST00000264731		Rapp-Hodgkin syndrome	129400	AD	3	Trp63
3q28	3:189596746-189897276	TP63, TP73L, KET, EEC3, SHFM4, LMS, RHS, OFC8	Tumor protein p63 (tumor protein p73-like)	603273	TP63	8626	ENSG00000073282,ENST00000264731;;;ENST00000264731		Split-hand/foot malformation 4	605289	AD	3	Trp63
3q28	3:189956728-190122278	P3H2, LEPREL1, MCVD	Prolyl 3-hydroxylase 2	610341	P3H2	55214	ENSG00000090530,ENST00000319332;;;ENST00000319332		Myopia, high, with cataract and vitreoretinal degeneration	614292	AR	3	P3h2
3q28	3:190290361-190412138	CLDN16, PCLN1, HOMG3	Claudin 16 (paracellin 1)	603959	CLDN16	10686	ENSG00000113946,ENST00000264734;;;ENST00000264734		Hypomagnesemia 3, renal	248250	AR	3	Cldn16
3q28	3:190305707-190322446	CLDN1, SEMP1, ILVASC	Claudin 1	603718	CLDN1	9076	ENSG00000163347,ENST00000295522;;;ENST00000295522		Ichthyosis, leukocyte vacuoles, alopecia, and sclerosing cholangitis	607626	AR	3	Cldn1
3q28	3:191329394-191398659	CCDC50, C3orf6, DFNA44	Coiled-coil domain-containing protein 50	611051	CCDC50	152137	ENSG00000152492,ENST00000392455;;;ENST00000392455	mutation identified in 1 DFNA44 family	?Deafness, autosomal dominant 44	607453	AD	3	Ccdc50
3q28-q29	3:192139390-192727541	FGF12, FHF1, DEE47	Fibroblast growth factor-12	601513	FGF12	2257	ENSG00000114279,ENST00000445105;;;ENST00000445105		Developmental and epileptic encephalopathy 47	617166	AD	3	Fgf12
3q29	3:192600001-198295559	DEL3q29, MICRODEL3q29	Chromosome 3q29 microdeletion syndrome	609425				contiguous gene deletion syndrome	Chromosome 3q29 microdeletion syndrome	609425	IC	4	
3q29	3:192600001-198295559	DUP3q29, MICRODUP3q29	Chromosome 3q29 microduplication syndrome	611936				contiguous gene duplication syndrome	Chromosome 3q29 microduplication syndrome	611936	AD	4	
3q29	3:193593208-193697811	OPA1, NTG, NPG, BERHS, MTDPS14	OPA1 mitochondrial dynamin-like GTPase	605290	OPA1	4976	ENSG00000198836,ENST00000361510;;;ENST00000361510	mutation identified in 1 MTDPS14 family	?Mitochondrial DNA depletion syndrome 14 (encephalocardiomyopathic type)	616896	AR	3	Opa1
3q29	3:193593208-193697811	OPA1, NTG, NPG, BERHS, MTDPS14	OPA1 mitochondrial dynamin-like GTPase	605290	OPA1	4976	ENSG00000198836,ENST00000361510;;;ENST00000361510	mutation identified in 1 MTDPS14 family	{Glaucoma, normal tension, susceptibility to}	606657		3	Opa1
3q29	3:193593208-193697811	OPA1, NTG, NPG, BERHS, MTDPS14	OPA1 mitochondrial dynamin-like GTPase	605290	OPA1	4976	ENSG00000198836,ENST00000361510;;;ENST00000361510	mutation identified in 1 MTDPS14 family	Behr syndrome	210000	AR	3	Opa1
3q29	3:193593208-193697811	OPA1, NTG, NPG, BERHS, MTDPS14	OPA1 mitochondrial dynamin-like GTPase	605290	OPA1	4976	ENSG00000198836,ENST00000361510;;;ENST00000361510	mutation identified in 1 MTDPS14 family	Optic atrophy 1	165500	AD	3	Opa1
3q29	3:193593208-193697811	OPA1, NTG, NPG, BERHS, MTDPS14	OPA1 mitochondrial dynamin-like GTPase	605290	OPA1	4976	ENSG00000198836,ENST00000361510;;;ENST00000361510	mutation identified in 1 MTDPS14 family	Optic atrophy plus syndrome	125250	AD	3	Opa1
3q29	3:194402677-194494334	ATP13A3, AFURS1, PPH5	ATPase 13A3	610232	ATP13A3	79572	ENSG00000133657,ENST00000645319;;;ENST00000645319		Pulmonary hypertension, primary, 5	265400	AR	3	Atp13a3
3q29	3:196049284-196082090	TFRC, TFR, CD71, IMD46	Transferrin receptor	190010	TFRC	7037	ENSG00000072274,ENST00000360110;;;ENST00000360110		Immunodeficiency 46	616740	AR	3	Tfrc
3q29	3:196216534-196233427	SLC51A, OSTA, PFIC6	Solute carrier family 51, alpha subunit (organic solute transporter, alpha)	612084	SLC51A	200931	ENSG00000163959,ENST00000296327;;;ENST00000296327	mutation identified in 1 PFIC6 patient	?Cholestasis, progressive familial intrahepatic, 6	619484	AR	3	Slc51a
3q29	3:196234368-196287726	PCYT1A, CTPCT, PCYT1, SMDCRD, CGL5	Phosphate cytidylyltransferase 1, choline, alpha isoform	123695	PCYT1A	5130	ENSG00000161217,ENST00000431016;;;ENST00000431016		Lipodystrophy, congenital generalized, type 5	620680	AR	3	Pcyt1a
3q29	3:196234368-196287726	PCYT1A, CTPCT, PCYT1, SMDCRD, CGL5	Phosphate cytidylyltransferase 1, choline, alpha isoform	123695	PCYT1A	5130	ENSG00000161217,ENST00000431016;;;ENST00000431016		Spondylometaphyseal dysplasia with cone-rod dystrophy	608940	AR	3	Pcyt1a
3q29	3:196291219-196318240	DYNLT2B, TCTEX1D2, SRTD17	Dynein light chain Tctex-type 2B	617353	DYNLT2B	255758	ENSG00000213123,ENST00000325318;;;ENST00000325318		Short-rib thoracic dysplasia 17 with or without polydactyly	617405	AR	3	Dynlt2b
3q29	3:196468783-196503768	RNF168, RIDL	RING finger protein 168	612688	RNF168	165918	ENSG00000163961,ENST00000318037;;;ENST00000318037		RIDDLE syndrome	611943	AR	3	Rnf168
3q29	3:196639694-196662004	NRROS, LRRC33, SENEBAC	Negative regulator of oxygen species	615322	NRROS	375387	ENSG00000174004,ENST00000328557;;;ENST00000328557		Seizures, early-onset, with neurodegeneration and brain calcification	618875	AR	3	Nrros
3q29	3:196706277-196712250	CEP19, C3orf34, MOSPGF	Centrosomal protein, 19kD	615586	CEP19	84984	ENSG00000174007,ENST00000409690;;;ENST00000409690	mutation identified in 1 family	Morbid obesity and spermatogenic failure	615703	AR	3	Cep19
3q29	3:196739857-196832647	PAK2, PAK65, KNO2	p21-activated kinase 2	605022	PAK2	5062	ENSG00000180370,ENST00000327134;;;ENST00000327134	deleted in 3q29 microdeletion syndrome; mutation identified in 1 KNO2 family	?Knobloch syndrome 2	618458	AD	3	Pak2
3q29	3:197668867-197749820	RUBCN, RUBICON, KIAA0226, SCAR15	RUN domain and cysteine-rich domain containing, Beclin 1-interacting protein	613516	RUBCN	9711	ENSG00000145016,ENST00000296343;;;ENST00000296343		Spinocerebellar ataxia, autosomal recessive 15	615705	AR	3	Rubcn
3q29	3:197950190-197956610	RPL35A, DBA5	Ribosomal protein L35A	180468	RPL35A	6165	ENSG00000182899,ENST00000647248;;;ENST00000647248	previous assignment to chr.18 in error	Diamond-Blackfan anemia 5	612528	AD	3	Rpl35a
4p16	4:1-11300000	CRSA, CRS3	Craniosynostosis, Adelaide type	600593		7885			Craniosynostosis, Adelaide type	600593	?AD	2	
4p16-q34	4:1-182300000	INTLQ1	Intelligence quantitative trait locus 1	603783		100462721		associated with D4S2943, MSX1, and D4S1607	{Intelligence QTL1}	603783		2	
4p	4:1-50000001	MHW1	Mental health wellness 1	603663		10386		at D4S2949	{Mental health wellness-1}	603663		2	
4p16-p15	4:1-35800000	MNDEC	Microtia with nasolacrimal duct imperforation and eye coloboma	611863		100188855		copy number variant (CNV) association	Microtia with nasolacrimal duct imperforation and eye coloboma	611863		4	
4p16	4:1-11300000	PLSA1, PLSA	Primary lateral sclerosis, adult, 1	611637		100240702		max lod at D4S2936	Primary lateral sclerosis, adult, 1	611637	AD	2	
4p16-p15.2	4:1-27700000	SLEB3	Systemic lupus erythematosus, susceptibility to, 3	605480		64695			{Systemic lupus erythematosus, susceptibility to, 3}	605480	AD	2	
4p16-p15	4:1-35800000	SPG38	Spastic paraplegia 38, autosomal dominant	612335		100049707		between D4S432 and D4S1599	Spastic paraplegia 38, autosomal dominant	612335	AD	2	
4p16.3	4:1-4500000	WHS	Wolf-Hirschhorn syndrome	194190				contiguous gene syndrome; critical region 200kb region 1.9Mb from telomere	Wolf-Hirschhorn syndrome	194190	IC	4	
4p16.3	4:337814-384868	ZNF141, D4S90, PAPA6	Zinc finger protein-141 (clone pHZ-44)	194648	ZNF141	7700	ENSG00000131127,ENST00000240499;;;ENST00000240499	1 family identified with mutation	?Polydactyly, postaxial, type A6	615226	AR	3	
4p16.3	4:499210-540200	PIGG, GPI7, NEDHSCA, EMM	Phosphatidylinositol glycan anchor biosynthesis class G protein	616918	PIGG	54872	ENSG00000174227,ENST00000453061;;;ENST00000453061		[Blood group, EMM system]	619812	AR	3	Pigg
4p16.3	4:499210-540200	PIGG, GPI7, NEDHSCA, EMM	Phosphatidylinositol glycan anchor biosynthesis class G protein	616918	PIGG	54872	ENSG00000174227,ENST00000453061;;;ENST00000453061		Neurodevelopmental disorder with or without hypotonia, seizures, and cerebellar atrophy	616917	AR	3	Pigg
4p16.3	4:625573-670782	PDE6B, PDEB, RP40, CSNBAD2	Phosphodiesterase 6B	180072	PDE6B	5158	ENSG00000133256,ENST00000496514;;;ENST00000496514		Night blindness, congenital stationary, autosomal dominant 2	163500	AD	3	Pde6b
4p16.3	4:625573-670782	PDE6B, PDEB, RP40, CSNBAD2	Phosphodiesterase 6B	180072	PDE6B	5158	ENSG00000133256,ENST00000496514;;;ENST00000496514		Retinitis pigmentosa-40	613801	AR	3	Pde6b
4p16.3	4:784957-826129	CPLX1, CPX1, DEE63	Complexin 1	605032	CPLX1	10815	ENSG00000168993,ENST00000304062;;;ENST00000304062		Developmental and epileptic encephalopathy 63	617976	AR	3	Cplx1
4p16.3	4:978991-993404	SLC26A1, SAT1, CAON1, HYSULF	Solute carrier family 26 (sulfate transporter), member 1	610130	SLC26A1	10861	ENSG00000145217,ENST00000398516;;;ENST00000398516	mutation identified in 1 CAON1 patient and 1 HYSULF patient	?Hypersulfaturia	620372	AR	3	Slc26a1
4p16.3	4:978991-993404	SLC26A1, SAT1, CAON1, HYSULF	Solute carrier family 26 (sulfate transporter), member 1	610130	SLC26A1	10861	ENSG00000145217,ENST00000398516;;;ENST00000398516	mutation identified in 1 CAON1 patient and 1 HYSULF patient	?Nephrolithiasis, calcium oxalate, 1	167030	AR	3	Slc26a1
4p16.3	4:986997-1004564	IDUA, IDA	Iduronidase, alpha-L-	252800	IDUA	3425	ENSG00000127415,ENST00000514224;;;ENST00000514224		Mucopolysaccharidosis Ih	607014	AR	3	Idua
4p16.3	4:986997-1004564	IDUA, IDA	Iduronidase, alpha-L-	252800	IDUA	3425	ENSG00000127415,ENST00000514224;;;ENST00000514224		Mucopolysaccharidosis Ih/s	607015	AR	3	Idua
4p16.3	4:986997-1004564	IDUA, IDA	Iduronidase, alpha-L-	252800	IDUA	3425	ENSG00000127415,ENST00000514224;;;ENST00000514224		Mucopolysaccharidosis Is	607016	AR	3	Idua
4p16.3	4:1056251-1113710	RNF212, ZHP3, SPGF62	RING finger protein 212	612041	RNF212	285498	ENSG00000178222,ENST00000433731;;;ENST00000433731	mutation identified in 1 SPGF62 family	?Spermatogenic failure 62	619673	AR	3	Rnf212
4p16.3	4:1056251-1113710	RNF212, ZHP3, SPGF62	RING finger protein 212	612041	RNF212	285498	ENSG00000178222,ENST00000433731;;;ENST00000433731	mutation identified in 1 SPGF62 family	Recombination rate QTL 1	612042		3	Rnf212
4p16.3	4:1211445-1250355	CTBP1, HADDTS	C-terminal binding protein 1	602618	CTBP1	1487	ENSG00000159692,ENST00000382952;;;ENST00000382952		Hypotonia, ataxia, developmental delay, and tooth enamel defect syndrome	617915	AD	3	Ctbp1
4p16.3	4:1342011-1395989	UVSSA, KIAA1530, UVSS3	UV-stimulated scaffold protein A	614632	UVSSA	57654	ENSG00000163945,ENST00000389851;;;ENST00000389851		UV-sensitive syndrome 3	614640	AR	3	Uvssa
4p16.3	4:1793293-1808867	FGFR3, ACH	Fibroblast growth factor receptor-3	134934	FGFR3	2261	ENSG00000068078,ENST00000440486;;;ENST00000440486		Achondroplasia	100800	AD	3	Fgfr3
4p16.3	4:1793293-1808867	FGFR3, ACH	Fibroblast growth factor receptor-3	134934	FGFR3	2261	ENSG00000068078,ENST00000440486;;;ENST00000440486		Bladder cancer, somatic	109800		3	Fgfr3
4p16.3	4:1793293-1808867	FGFR3, ACH	Fibroblast growth factor receptor-3	134934	FGFR3	2261	ENSG00000068078,ENST00000440486;;;ENST00000440486		CATSHL syndrome	610474	AD, AR	3	Fgfr3
4p16.3	4:1793293-1808867	FGFR3, ACH	Fibroblast growth factor receptor-3	134934	FGFR3	2261	ENSG00000068078,ENST00000440486;;;ENST00000440486		Cervical cancer, somatic	603956		3	Fgfr3
4p16.3	4:1793293-1808867	FGFR3, ACH	Fibroblast growth factor receptor-3	134934	FGFR3	2261	ENSG00000068078,ENST00000440486;;;ENST00000440486		Colorectal cancer, somatic	114500		3	Fgfr3
4p16.3	4:1793293-1808867	FGFR3, ACH	Fibroblast growth factor receptor-3	134934	FGFR3	2261	ENSG00000068078,ENST00000440486;;;ENST00000440486		Crouzon syndrome with acanthosis nigricans	612247	AD	3	Fgfr3
4p16.3	4:1793293-1808867	FGFR3, ACH	Fibroblast growth factor receptor-3	134934	FGFR3	2261	ENSG00000068078,ENST00000440486;;;ENST00000440486		Hypochondroplasia	146000	AD	3	Fgfr3
4p16.3	4:1793293-1808867	FGFR3, ACH	Fibroblast growth factor receptor-3	134934	FGFR3	2261	ENSG00000068078,ENST00000440486;;;ENST00000440486		LADD syndrome 2	620192	AD	3	Fgfr3
4p16.3	4:1793293-1808867	FGFR3, ACH	Fibroblast growth factor receptor-3	134934	FGFR3	2261	ENSG00000068078,ENST00000440486;;;ENST00000440486		Muenke syndrome	602849	AD	3	Fgfr3
4p16.3	4:1793293-1808867	FGFR3, ACH	Fibroblast growth factor receptor-3	134934	FGFR3	2261	ENSG00000068078,ENST00000440486;;;ENST00000440486		Nevus, epidermal, somatic	162900		3	Fgfr3
4p16.3	4:1793293-1808867	FGFR3, ACH	Fibroblast growth factor receptor-3	134934	FGFR3	2261	ENSG00000068078,ENST00000440486;;;ENST00000440486		SADDAN	616482	AD	3	Fgfr3
4p16.3	4:1793293-1808867	FGFR3, ACH	Fibroblast growth factor receptor-3	134934	FGFR3	2261	ENSG00000068078,ENST00000440486;;;ENST00000440486		Spermatocytic seminoma, somatic	273300		3	Fgfr3
4p16.3	4:1793293-1808867	FGFR3, ACH	Fibroblast growth factor receptor-3	134934	FGFR3	2261	ENSG00000068078,ENST00000440486;;;ENST00000440486		Thanatophoric dysplasia, type I	187600	AD	3	Fgfr3
4p16.3	4:1793293-1808867	FGFR3, ACH	Fibroblast growth factor receptor-3	134934	FGFR3	2261	ENSG00000068078,ENST00000440486;;;ENST00000440486		Thanatophoric dysplasia, type II	187601	AD	3	Fgfr3
4p16.3	4:1811479-1856156	LETM1, CONDMIM	Leucine zipper/EF-hand-containing transmembrane protein 1	604407	LETM1	3954	ENSG00000168924,ENST00000302787;;;ENST00000302787		Neurodegeneration, childhood-onset, with multisystem involvement due to mitochondrial dysfunction	620089	AR	3	Letm1
4p16.3	4:1871393-1982192	NSD2, WHSC1, MMSET, RAUST	Nuclear receptor-binding SET domain protein 2	602952	NSD2	7468	ENSG00000109685,ENST00000508803;;;ENST00000508803		Rauch-Steindl syndrome	619695	AD	3	Nsd2
4p16.3	4:2059327-2069089	NAT8L, CML3, NACED	N-acetyltransferase 8-like	610647	NAT8L	339983	ENSG00000185818,ENST00000423729;;;ENST00000423729	mutation identified in 1 patient	?N-acetylaspartate deficiency	614063	AR	3	Nat8l
4p16.3	4:2793085-2841096	SH3BP2, CRPM	SH3-domain binding protein 2	602104	SH3BP2	6452	ENSG00000087266,ENST00000503393;;;ENST00000503393		Cherubism	118400	AD	3	Sh3bp2
4p16.3	4:2843844-2930062	ADD1	Adducin-1, alpha	102680	ADD1	118	ENSG00000087274,ENST00000683351;;;ENST00000683351		{Hypertension, essential, salt-sensitive}	145500	Mu	3	Add1
4p16.3	4:3074681-3243960	HTT, HD, IT15, LOMARS	Huntingtin	613004	HTT	3064	ENSG00000197386,ENST00000355072;;;ENST00000355072	distal to D4S10	Huntington disease	143100	AD	3	Htt
4p16.3	4:3074681-3243960	HTT, HD, IT15, LOMARS	Huntingtin	613004	HTT	3064	ENSG00000197386,ENST00000355072;;;ENST00000355072	distal to D4S10	Lopes-Maciel-Rodan syndrome	617435	AR	3	Htt
4p16.3	4:3463306-3501482	DOK7, C4orf25, CMS10, FADS3	Downstream of tyrosine kinase 7	610285	DOK7	285489	ENSG00000175920,ENST00000340083;;;ENST00000340083	mutation identified in 1 FADS3 family	Fetal akinesia deformation sequence 3	618389	AR	3	Dok7
4p16.3	4:3463306-3501482	DOK7, C4orf25, CMS10, FADS3	Downstream of tyrosine kinase 7	610285	DOK7	285489	ENSG00000175920,ENST00000340083;;;ENST00000340083	mutation identified in 1 FADS3 family	Myasthenic syndrome, congenital, 10	254300	AR	3	Dok7
4p16.3	4:3503612-3532422	LRPAP1, A2MRAP, MYP23	Low density lipoprotein-related protein-associated protein 1 (alpha-2-macroglobulin receptor-associated protein 1)	104225	LRPAP1	4043	ENSG00000163956,ENST00000650182;;;ENST00000650182		Myopia 23, autosomal recessive	615431	AR	3	Lrpap1
4p16.2	4:4859665-4863936	MSX1, HOX7, HYD1, OFC5, STHAG1, ECTD3	MSH homeobox 1	142983	MSX1	4487	ENSG00000163132,ENST00000382723;;;ENST00000382723		Ectodermal dysplasia 3, Witkop type	189500	AD	3	Msx1
4p16.2	4:4859665-4863936	MSX1, HOX7, HYD1, OFC5, STHAG1, ECTD3	MSH homeobox 1	142983	MSX1	4487	ENSG00000163132,ENST00000382723;;;ENST00000382723		Orofacial cleft 5	608874	AD	3	Msx1
4p16.2	4:4859665-4863936	MSX1, HOX7, HYD1, OFC5, STHAG1, ECTD3	MSH homeobox 1	142983	MSX1	4487	ENSG00000163132,ENST00000382723;;;ENST00000382723		Tooth agenesis, selective, 1, with or without orofacial cleft	106600	AD	3	Msx1
4p16.2	4:5529011-5709548	EVC2, LBN, WAD	EvC ciliary complex subunit 2 (limbin)	607261	EVC2	132884	ENSG00000173040,ENST00000344408;;;ENST00000344408		Ellis-van Creveld syndrome	225500	AR	3	Evc2
4p16.2	4:5529011-5709548	EVC2, LBN, WAD	EvC ciliary complex subunit 2 (limbin)	607261	EVC2	132884	ENSG00000173040,ENST00000344408;;;ENST00000344408		Weyers acrofacial dysostosis	193530	AD	3	Evc2
4p16.2	4:5711201-5829057	EVC	EvC ciliary complex subunit 1	604831	EVC	2121	ENSG00000072840,ENST00000264956;;;ENST00000264956	mutation identified in 1 WAD patient	?Weyers acrofacial dysostosis	193530	AD	3	Evc
4p16.2	4:5711201-5829057	EVC	EvC ciliary complex subunit 1	604831	EVC	2121	ENSG00000072840,ENST00000264956;;;ENST00000264956	mutation identified in 1 WAD patient	Ellis-van Creveld syndrome	225500	AR	3	Evc
4p16.1	4:6269850-6303265	WFS1, WFRS, WFS, DFNA6, DFNA14, DFNA38, WFSL, CTRCT41	Wolframin ER transmembrane glycoprotein	606201	WFS1	7466	ENSG00000109501,ENST00000226760;;;ENST00000226760	mutation identified in 1 CTRCT41 family	?Cataract 41	116400	AD	3	Wfs1
4p16.1	4:6269850-6303265	WFS1, WFRS, WFS, DFNA6, DFNA14, DFNA38, WFSL, CTRCT41	Wolframin ER transmembrane glycoprotein	606201	WFS1	7466	ENSG00000109501,ENST00000226760;;;ENST00000226760	mutation identified in 1 CTRCT41 family	{Diabetes mellitus, noninsulin-dependent, association with}	125853	AD	3	Wfs1
4p16.1	4:6269850-6303265	WFS1, WFRS, WFS, DFNA6, DFNA14, DFNA38, WFSL, CTRCT41	Wolframin ER transmembrane glycoprotein	606201	WFS1	7466	ENSG00000109501,ENST00000226760;;;ENST00000226760	mutation identified in 1 CTRCT41 family	Deafness, autosomal dominant 6/14/38	600965	AD	3	Wfs1
4p16.1	4:6269850-6303265	WFS1, WFRS, WFS, DFNA6, DFNA14, DFNA38, WFSL, CTRCT41	Wolframin ER transmembrane glycoprotein	606201	WFS1	7466	ENSG00000109501,ENST00000226760;;;ENST00000226760	mutation identified in 1 CTRCT41 family	Wolfram syndrome 1	222300	AR	3	Wfs1
4p16.1	4:6269850-6303265	WFS1, WFRS, WFS, DFNA6, DFNA14, DFNA38, WFSL, CTRCT41	Wolframin ER transmembrane glycoprotein	606201	WFS1	7466	ENSG00000109501,ENST00000226760;;;ENST00000226760	mutation identified in 1 CTRCT41 family	Wolfram-like syndrome, autosomal dominant	614296	AD	3	Wfs1
4p16.1	4:6575189-6623362	MAN2B2, CDG1EE	Mannosidase, alpha, class 2B, member 2	618899	MAN2B2	23324	ENSG00000013288,ENST00000285599;;;ENST00000285599		Congenital disorder of glycosylation type 1EE with or without immunodeficiency	621140	AR	3	Man2b2
4p16.1	4:8846076-8871839	HMX1, H6	Homeobox (H6 family) 1	142992	HMX1	3166	ENSG00000215612,ENST00000400677;;;ENST00000400677		Oculoauricular syndrome	612109	AR	3	Hmx1
4p16.1	4:9771025-10040270	SLC2A9, GLUT9, UAQTL2	Solute carrier family 2 (facilitated glucose transporter), member 9	606142	SLC2A9	56606	ENSG00000109667,ENST00000264784;;;ENST00000264784		{Uric acid concentration, serum, QTL 2}	612076	AD, AR	3	Slc2a9
4p16.1	4:9771025-10040270	SLC2A9, GLUT9, UAQTL2	Solute carrier family 2 (facilitated glucose transporter), member 9	606142	SLC2A9	56606	ENSG00000109667,ENST00000264784;;;ENST00000264784		Hypouricemia, renal, 2	612076	AD, AR	3	Slc2a9
4p16.1	4:9781634-9784009	DRD5, DRD1B, DRD1L2	Dopamine receptor D5	126453	DRD5	1816	ENSG00000169676,ENST00000304374;;;ENST00000304374	pseudogenes on 2p11 and 1q21	{Attention deficit-hyperactivity disorder, susceptibility to}	143465	AD	3	Drd5
4p16.1	4:9781634-9784009	DRD5, DRD1B, DRD1L2	Dopamine receptor D5	126453	DRD5	1816	ENSG00000169676,ENST00000304374;;;ENST00000304374	pseudogenes on 2p11 and 1q21	{Blepharospasm, primary benign}	606798	AD	3	Drd5
4p16.1	4:10074339-10116799	WDR1, PFITS	WD repeat-containing protein 1	604734	WDR1	9948	ENSG00000071127,ENST00000499869;;;ENST00000499869		Periodic fever, immunodeficiency, and thrombocytopenia syndrome	150550	AR	3	Wdr1
4p15-p14	4:11300001-41200000	BMIQ7	Body mass index quantitative trait locus 7	608410		404683			{Obesity, susceptibility to, BMIQ7}	608410		2	
4p15	4:11300001-35800000	EPPS	Epilepsy, partial, with pericentral spikes	607221		266789			Epilepsy, partial, with pericentral spikes	607221		2	
4p15.3	4:11300001-21300000	HDL3, HLN2	Huntington disease-like 3	604802		53369			Huntington disease-like 3	604802	AR	2	
4p15.3	4:11300001-21300000	STQTL13	Stature quantitative trait locus 13	612226		100270796		associated with rs16896068	{Stature QTL 13}	612226		2	
4p15.33	4:13367724-13484340	RAB28, CORD18	Ras-associated protein 28	612994	RAB28	9364	ENSG00000157869,ENST00000330852;;;ENST00000330852		Cone-rod dystrophy 18	615374	AR	3	Rab28
4p15.33	4:13540830-13547744	NKX3-2, BAPX1, SMMD	NK3 homeobox 1	602183	NKX3-2	579	ENSG00000109705,ENST00000382438;;;ENST00000382438		Spondylo-megaepiphyseal-metaphyseal dysplasia	613330	AR	3	Nkx3-2
4p15.32	4:15469865-15601557	CC2D2A, KIAA1345, MKS6, COACH2, RP93	Coiled-coil and C2 domains-containing protein 2A	612013	CC2D2A	57545	ENSG00000048342,ENST00000424120;;;ENST00000424120		COACH syndrome 2	619111	AR	3	Cc2d2a
4p15.32	4:15469865-15601557	CC2D2A, KIAA1345, MKS6, COACH2, RP93	Coiled-coil and C2 domains-containing protein 2A	612013	CC2D2A	57545	ENSG00000048342,ENST00000424120;;;ENST00000424120		Joubert syndrome 9	612285	AR	3	Cc2d2a
4p15.32	4:15469865-15601557	CC2D2A, KIAA1345, MKS6, COACH2, RP93	Coiled-coil and C2 domains-containing protein 2A	612013	CC2D2A	57545	ENSG00000048342,ENST00000424120;;;ENST00000424120		Meckel syndrome 6	612284	AR	3	Cc2d2a
4p15.32	4:15469865-15601557	CC2D2A, KIAA1345, MKS6, COACH2, RP93	Coiled-coil and C2 domains-containing protein 2A	612013	CC2D2A	57545	ENSG00000048342,ENST00000424120;;;ENST00000424120		Retinitis pigmentosa 93	619845	AR	3	Cc2d2a
4p15.32	4:15968228-16084023	PROM1, PROML1, AC133, RP41, CORD12, CD133, MCDR2, STGD4	Prominin 1	604365	PROM1	8842	ENSG00000007062,ENST00000447510;;;ENST00000447510		Cone-rod dystrophy 12	612657	AD, AR	3	Prom1
4p15.32	4:15968228-16084023	PROM1, PROML1, AC133, RP41, CORD12, CD133, MCDR2, STGD4	Prominin 1	604365	PROM1	8842	ENSG00000007062,ENST00000447510;;;ENST00000447510		Macular dystrophy, retinal, 2	608051	AD	3	Prom1
4p15.32	4:15968228-16084023	PROM1, PROML1, AC133, RP41, CORD12, CD133, MCDR2, STGD4	Prominin 1	604365	PROM1	8842	ENSG00000007062,ENST00000447510;;;ENST00000447510		Retinitis pigmentosa 41	612095	AR	3	Prom1
4p15.32	4:15968228-16084023	PROM1, PROML1, AC133, RP41, CORD12, CD133, MCDR2, STGD4	Prominin 1	604365	PROM1	8842	ENSG00000007062,ENST00000447510;;;ENST00000447510		Stargardt disease 4	603786	AD	3	Prom1
4p15.32	4:16160505-16227390	TAPT1, CMVFR, OCLSBG	Transmembrane anterior posterior transformation 1	612758	TAPT1	202018	ENSG00000169762,ENST00000405303;;;ENST00000405303		Osteochondrodysplasia, complex lethal, Symoens-Barnes-Gistelinck type	616897	AR	3	Tapt1
4p15.32	4:17486395-17512090	QDPR, DHPR	Quinoid dihydropteridine reductase	612676	QDPR	5860	ENSG00000151552,ENST00000281243;;;ENST00000281243		Hyperphenylalaninemia, BH4-deficient, C	261630	AR	3	Qdpr
4p15.32	4:17515165-17527104	CLRN2, DFNB117	Clarin 2	618988	CLRN2	645104	ENSG00000249581,ENST00000511148;;;ENST00000511148		Deafness, autosomal recessive 117	619174	AR	3	Clrn2
4p15.2	4:24795573-24800842	SOD3	Superoxide dismutase-3, extracellular	185490	SOD3	6649	ENSG00000109610,ENST00000382120;;;ENST00000382120		[Superoxide dismutase, elevated extracellular]			3	Sod3
4p15.2	4:25120014-25160582	SEPSECS, SLA, LP, PCH2D	O-phosphoserine tRNA-selenocysteine tRNA synthase	613009	SEPSECS	51091	ENSG00000109618,ENST00000382103;;;ENST00000382103		Pontocerebellar hypoplasia type 2D	613811	AR	3	Sepsecs
4p15.2	4:25655851-25678748	SLC34A2, PULAM	Solute carrier family 34 (sodium/phosphate cotransporter), member 2	604217	SLC34A2	10568	ENSG00000157765,ENST00000382051;;;ENST00000382051		Pulmonary alveolar microlithiasis	265100	AR	3	Slc34a2
4p15.2	4:26105449-26435131	RBPJ, RBPSUH, IGKJRB1, AOS3	Recombination signal-binding protein 1 for kappa J region	147183	RBPJ	3516	ENSG00000168214,ENST00000355476;;;ENST00000355476	pseudogenes at 9q13, 9p13, and 3q25	Adams-Oliver syndrome 3	614814	AD	3	Rbpj
4p15.1-q12	4:27700001-58500000	NPC1, NPCA1	Nasopharyngeal carcinoma 1	607107		257641		?associated with acyl-CoA thioesterase 7-like	{Nasopharyngeal carcinoma 1}	607107		2	
4p14	4:38787569-38805644	TLR1, TIL. LPRS5	Toll-like receptor-1	601194	TLR1	7096	ENSG00000174125,ENST00000308979;;;ENST00000308979		{Leprosy, protection against}	613223		3	Tlr1
4p14	4:38787569-38805644	TLR1, TIL. LPRS5	Toll-like receptor-1	601194	TLR1	7096	ENSG00000174125,ENST00000308979;;;ENST00000308979		{Leprosy, susceptibility to, 5}	613223		3	Tlr1
4p14	4:39182529-39285810	WDR19, SRTD5, ATD5, NPHP13, CED4, SPGF72	WD repeat-containing protein 19	608151	WDR19	57728	ENSG00000157796,ENST00000399820;;;ENST00000399820	mutation identified in 1 CED4 family and 1 SRTD5 family	?Spermatogenic failure 72	619867	AR	3	Wdr19
4p14	4:39182529-39285810	WDR19, SRTD5, ATD5, NPHP13, CED4, SPGF72	WD repeat-containing protein 19	608151	WDR19	57728	ENSG00000157796,ENST00000399820;;;ENST00000399820	mutation identified in 1 CED4 family and 1 SRTD5 family	Cranioectodermal dysplasia 4	614378	AR	3	Wdr19
4p14	4:39182529-39285810	WDR19, SRTD5, ATD5, NPHP13, CED4, SPGF72	WD repeat-containing protein 19	608151	WDR19	57728	ENSG00000157796,ENST00000399820;;;ENST00000399820	mutation identified in 1 CED4 family and 1 SRTD5 family	Nephronophthisis 13	614377	AR	3	Wdr19
4p14	4:39182529-39285810	WDR19, SRTD5, ATD5, NPHP13, CED4, SPGF72	WD repeat-containing protein 19	608151	WDR19	57728	ENSG00000157796,ENST00000399820;;;ENST00000399820	mutation identified in 1 CED4 family and 1 SRTD5 family	Senior-Loken syndrome 8	616307	AR	3	Wdr19
4p14	4:39182529-39285810	WDR19, SRTD5, ATD5, NPHP13, CED4, SPGF72	WD repeat-containing protein 19	608151	WDR19	57728	ENSG00000157796,ENST00000399820;;;ENST00000399820	mutation identified in 1 CED4 family and 1 SRTD5 family	Short-rib thoracic dysplasia 5 with or without polydactyly	614376	AR	3	Wdr19
4p14	4:39287456-39366362	RFC1, RECC1, CANVAS	Replication factor C1, 145kD (activator 1, 145kD)	102579	RFC1	5981	ENSG00000035928,ENST00000349703;;;ENST00000349703		Cerebellar ataxia, neuropathy, and vestibular areflexia syndrome	614575	AR	3	Rfc1
4p14	4:39459056-39479506	LIAS, PDHLD, HGCLAS	Lipoic acid synthase	607031	LIAS	11019	ENSG00000121897,ENST00000640888;;;ENST00000640888		Hyperglycinemia, lactic acidosis, and seizures	614462	AR	3	Lias
4p14	4:39498755-39527439	UGDH, UDPGDH, DEE84	UDP-glucose dehydrogenase	603370	UGDH	7358	ENSG00000109814,ENST00000316423;;;ENST00000316423		Developmental and epileptic encephalopathy 84	618792	AR	3	Ugdh
4p14	4:40191080-40246967	RHOH, ARHH, TTF, IMD129	Ras homolog gene family, member H	602037	RHOH	399	ENSG00000168421,ENST00000381799;;;ENST00000381799		Immunodeficiency 129	618307	AR	3	Rhoh
4p13-q21	4:41200001-87100000	NRCLP2	Narcolepsy 2	605841		100918		max lod at D4S2987	Narcolepsy 2	605841		2	
4p13	4:41256928-41268455	UCHL1, PARK5, SPG79, NDGOA, SPG79A	Ubiquitin C-terminal esterase L1	191342	UCHL1	7345	ENSG00000154277,ENST00000284440;;;ENST00000284440	mutation identified in 1 PARK5 family	{?Parkinson disease 5, susceptibility to}	613643	AD	3	Uchl1
4p13	4:41256928-41268455	UCHL1, PARK5, SPG79, NDGOA, SPG79A	Ubiquitin C-terminal esterase L1	191342	UCHL1	7345	ENSG00000154277,ENST00000284440;;;ENST00000284440	mutation identified in 1 PARK5 family	Spastic paraplegia 79A, autosomal dominant	620221	AD	3	Uchl1
4p13	4:41256928-41268455	UCHL1, PARK5, SPG79, NDGOA, SPG79A	Ubiquitin C-terminal esterase L1	191342	UCHL1	7345	ENSG00000154277,ENST00000284440;;;ENST00000284440	mutation identified in 1 PARK5 family	Spastic paraplegia 79B, autosomal recessive	615491	AR	3	Uchl1
4p13	4:41744082-41748725	PHOX2B, NBPHOX, PMX2B, NBLST2, CCHS	Paired mesoderm homeobox 2B	603851	PHOX2B	8929	ENSG00000109132,ENST00000226382;;;ENST00000226382		{Neuroblastoma, susceptibility to, 2}	613013		3	Phox2b
4p13	4:41744082-41748725	PHOX2B, NBPHOX, PMX2B, NBLST2, CCHS	Paired mesoderm homeobox 2B	603851	PHOX2B	8929	ENSG00000109132,ENST00000226382;;;ENST00000226382		Central hypoventilation syndrome, congenital, 1, with or without Hirschsprung disease	209880	AD	3	Phox2b
4p13	4:41744082-41748725	PHOX2B, NBPHOX, PMX2B, NBLST2, CCHS	Paired mesoderm homeobox 2B	603851	PHOX2B	8929	ENSG00000109132,ENST00000226382;;;ENST00000226382		Neuroblastoma with Hirschsprung disease	613013		3	Phox2b
4p13	4:41990530-42090461	SLC30A9, C4orf1, HUEL, BILAPES	Solute carrier family 30 (zinc transporter), member 9	604604	SLC30A9	10463	ENSG00000014824,ENST00000264451;;;ENST00000264451		Birk-Landau-Perez syndrome	617595	AR	3	Slc30a9
4p13	4:42892713-43030658	GRXCR1	Glutaredoxin, cysteine-rich, 1	613283	GRXCR1	389207	ENSG00000215203,ENST00000399770;;;ENST00000399770		Deafness, autosomal recessive 25	613285	AR	3	Grxcr1
4p12	4:44678420-44700928	GUF1, EF4, DEE40	GUF1 homolog, GTPase	617064	GUF1	60558	ENSG00000151806,ENST00000281543;;;ENST00000281543	mutation identified in 1 DEE40 family	?Developmental and epileptic encephalopathy 40	617065	AR	3	Guf1
4p12	4:46243548-46390300	GABRA2, DEE78	Gamma-aminobutyric acid (GABA) A receptor, alpha-2	137140	GABRA2	2555	ENSG00000151834,ENST00000381620;;;ENST00000381620		{Alcohol dependence, susceptibility to}	103780	Mu	3	Gabra2
4p12	4:46243548-46390300	GABRA2, DEE78	Gamma-aminobutyric acid (GABA) A receptor, alpha-2	137140	GABRA2	2555	ENSG00000151834,ENST00000381620;;;ENST00000381620		Developmental and epileptic encephalopathy 78	618557	AD	3	Gabra2
4p12	4:46993647-47426447	GABRB1, DEE45	Gamma-aminobutyric acid (GABA) A receptor, beta-1	137190	GABRB1	2560	ENSG00000163288,ENST00000295454;;;ENST00000295454		Developmental and epileptic encephalopathy 45	617153	AD	3	Gabrb1
4p12	4:47594001-47838067	CORIN, CRN, TMPRSS10, ATC2, PEE5, CMH30	Corin, serine peptidase	605236	CORIN	10699	ENSG00000145244,ENST00000273857;;;ENST00000273857	mutation identified in 1 CMH30 family	?Cardiomyopathy, familial hypertrophic, 30, atrial	620734	AR	3	Corin
4p12	4:47594001-47838067	CORIN, CRN, TMPRSS10, ATC2, PEE5, CMH30	Corin, serine peptidase	605236	CORIN	10699	ENSG00000145244,ENST00000273857;;;ENST00000273857	mutation identified in 1 CMH30 family	Preeclampsia/eclampsia 5	614595	AD	3	Corin
4p12	4:47935977-48016681	CNGA1, CNCG1, RP49	Cyclic nucleotide gated channel, alpha 1	123825	CNGA1	1259	ENSG00000198515,ENST00000514170;;;ENST00000514170		Retinitis pigmentosa 49	613756	AR	3	Cnga1
4p11	4:48497357-48780279	FRYL, KIAA0826, PCBS	FRY-like transcription coactivator	620798	FRYL	285527	ENSG00000075539,ENST00000358350;;;ENST00000358350		Pan-Chung-Bellen syndrome	621049	AD	3	Fryl
4q	4:50000001-190214555	MHW2	Mental health wellness 2	603664		50979		at D4S397	{Mental health wellness-2}	603664		2	
4q	4:50000001-190214555	PSORS3	Psoriasis susceptibility 3	601454		7889			{Psoriasis susceptibility 3}	601454		2	
4q	4:50000001-190214555	WM2	Macroglobulinemia, Waldenstrom, susceptibility to, 2	610430		100188811		between D4S2910 and D4S1539	{Macroglobulinemia, Waldenstrom, susceptibility to, 2}	610430		2	
4q12-q13.2	4:51800001-69400000	DFNB55	Deafness, autosomal recessive 55	609952		494148		max lod at D4S2638	Deafness, autosomal recessive 55	609952	AR	2	
4q12-q13.1	4:51800001-65500000	MRT31	Intellectual developmental disorder, autosomal recessive 31	614329		100852399		between rs11944876 and rs6551838	Intellectual developmental disorder, autosomal recessive 31	614329	AR	2	
4q12	4:51800001-58500000	MYP9	Myopia 9	609258		553194			Myopia 9	609258	Mu	2	
4q12	4:51800001-58500000	TAPVR1	Total anomalous pulmonary venous return 1	106700		6893		between D4S1630 and D4S3019; ?mutation in KDR	Total anomalous pulmonary venous return	106700	AD	2	
4q12	4:52020706-52038299	SGCB, LGMDR4	Sarcoglycan, beta (43kD dystrophin-associated glycoprotein)	600900	SGCB	6443	ENSG00000163069,ENST00000381431;;;ENST00000381431		Muscular dystrophy, limb-girdle, autosomal recessive 4	604286	AR	3	Sgcb
4q12	4:54009789-54091879	CHIC2, BTL	Cysteine-rich hydrophobic domain 2 (Brx-like gene translocated in leukemia)	604332	CHIC2	26511	ENSG00000109220,ENST00000263921;;;ENST00000263921		{Leukemia, acute myeloid}	601626	AD, SMu	3	Chic2
4q12	4:54100163-54102498	GSX2, GSH2, DMJDS2	GS homeobox 2	616253	GSX2	170825	ENSG00000180613,ENST00000326902;;;ENST00000326902		Diencephalic-mesencephalic junction dysplasia syndrome 2	618646	AR	3	Gsx2
4q12	4:54229293-54298245	PDGFRA	Platelet-derived growth factor receptor, alpha polypeptide	173490	PDGFRA	5156	ENSG00000134853,ENST00000257290;;;ENST00000257290	same 700bp segment as KIT; fused to BCR or FIP1L1	Gastrointestinal stromal tumor/GIST-plus syndrome, somatic or familial	175510		3	Pdgfra
4q12	4:54229293-54298245	PDGFRA	Platelet-derived growth factor receptor, alpha polypeptide	173490	PDGFRA	5156	ENSG00000134853,ENST00000257290;;;ENST00000257290	same 700bp segment as KIT; fused to BCR or FIP1L1	Hypereosinophilic syndrome, idiopathic, resistant to imatinib	607685	IC, SMu	3	Pdgfra
4q12	4:54657957-54740715	KIT, PBT, MASTC	Hardy-Zuckerman 4 feline sarcoma (v-kit) oncogene	164920	KIT	3815	ENSG00000157404,ENST00000288135;;;ENST00000288135	same 700bp segment as PDGFRA	Gastrointestinal stromal tumor, familial	606764	AD, IC	3	Kit
4q12	4:54657957-54740715	KIT, PBT, MASTC	Hardy-Zuckerman 4 feline sarcoma (v-kit) oncogene	164920	KIT	3815	ENSG00000157404,ENST00000288135;;;ENST00000288135	same 700bp segment as PDGFRA	Germ cell tumors, somatic	273300		3	Kit
4q12	4:54657957-54740715	KIT, PBT, MASTC	Hardy-Zuckerman 4 feline sarcoma (v-kit) oncogene	164920	KIT	3815	ENSG00000157404,ENST00000288135;;;ENST00000288135	same 700bp segment as PDGFRA	Leukemia, acute myeloid, somatic	601626		3	Kit
4q12	4:54657957-54740715	KIT, PBT, MASTC	Hardy-Zuckerman 4 feline sarcoma (v-kit) oncogene	164920	KIT	3815	ENSG00000157404,ENST00000288135;;;ENST00000288135	same 700bp segment as PDGFRA	Mastocytosis, cutaneous	154800	AD	3	Kit
4q12	4:54657957-54740715	KIT, PBT, MASTC	Hardy-Zuckerman 4 feline sarcoma (v-kit) oncogene	164920	KIT	3815	ENSG00000157404,ENST00000288135;;;ENST00000288135	same 700bp segment as PDGFRA	Mastocytosis, systemic, somatic	154800		3	Kit
4q12	4:54657957-54740715	KIT, PBT, MASTC	Hardy-Zuckerman 4 feline sarcoma (v-kit) oncogene	164920	KIT	3815	ENSG00000157404,ENST00000288135;;;ENST00000288135	same 700bp segment as PDGFRA	Piebaldism	172800	AD	3	Kit
4q12	4:55078481-55125595	KDR	Kinase insert domain receptor	191306	KDR	3791	ENSG00000128052,ENST00000263923;;;ENST00000263923	?mutant in TAPVR1	{Hemangioma, capillary infantile, susceptibility to}	602089	AD	3	Kdr
4q12	4:55078481-55125595	KDR	Kinase insert domain receptor	191306	KDR	3791	ENSG00000128052,ENST00000263923;;;ENST00000263923	?mutant in TAPVR1	Hemangioma, capillary infantile, somatic	602089		3	Kdr
4q12	4:55346242-55373100	SRD5A3, SRD5A2L, CDG1Q, KRIZI	Steroid 5-alpha-reductase 3	611715	SRD5A3	79644	ENSG00000128039,ENST00000264228;;;ENST00000264228		Congenital disorder of glycosylation, type Iq	612379	AR	3	Srd5a3
4q12	4:55346242-55373100	SRD5A3, SRD5A2L, CDG1Q, KRIZI	Steroid 5-alpha-reductase 3	611715	SRD5A3	79644	ENSG00000128039,ENST00000264228;;;ENST00000264228		Kahrizi syndrome	612713	AR	3	Srd5a3
4q12	4:55395957-55453397	TMEM165, FT27, CDG2K	Transmembrane protein 165	614726	TMEM165	55858	ENSG00000134851,ENST00000381334;;;ENST00000381334		Congenital disorder of glycosylation, type IIk	614727	AR	3	Tmem165
4q12	4:55948945-56033361	CEP135, KIAA0635, MCPH8	Centrosomal protein, 135kD	611423	CEP135	9662	ENSG00000174799,ENST00000257287;;;ENST00000257287		Microcephaly 8, primary, autosomal recessive	614673	AR	3	Cep135
4q12	4:56410507-56464578	PAICS, AIRC, PAICSD	Phosphoribosylaminoimidazole carboxylase	172439	PAICS	10606	ENSG00000128050,ENST00000512576;;;ENST00000512576	bifunctional enzyme; mutation identified in 1 PAICSD family	?Phosphoribosylaminoimidazole carboxylase deficiency	619859	AR	3	Paics
4q12	4:56467617-56503681	SRP72, BMFS1	Signal recognition particle, 72kD	602122	SRP72	6731	ENSG00000174780,ENST00000642900;;;ENST00000642900		Bone marrow failure syndrome 1	614675	AD	3	Srp72
4q12	4:56809860-56821869	SPINK2, SPGF29	Serine protease inhibitor, Kazal-type, 2	605753	SPINK2	6691	ENSG00000128040,ENST00000506738;;;ENST00000506738	mutation identified in 1 SPGF29 family	?Spermatogenic failure 29	618091	AR	3	Spink2
4q12	4:56907900-56935844	REST, NRSF, WT6, GINGF5, HGF5, DFNA27	RE1-silencing transcription factor	600571	REST	5978	ENSG00000084093,ENST00000309042;;;ENST00000309042		{Wilms tumor 6, susceptibility to}	616806	AD	3	Rest
4q12	4:56907900-56935844	REST, NRSF, WT6, GINGF5, HGF5, DFNA27	RE1-silencing transcription factor	600571	REST	5978	ENSG00000084093,ENST00000309042;;;ENST00000309042		Deafness, autosomal dominant 27	612431	AD	3	Rest
4q12	4:56907900-56935844	REST, NRSF, WT6, GINGF5, HGF5, DFNA27	RE1-silencing transcription factor	600571	REST	5978	ENSG00000084093,ENST00000309042;;;ENST00000309042		Fibromatosis, gingival, 5	617626	AD	3	Rest
4q12	4:57030773-57110385	IGFBP7, MAC25, RAMSVPS	Insulin-like growth factor-binding protein-7	602867	IGFBP7	3490	ENSG00000163453,ENST00000295666;;;ENST00000295666		Retinal arterial macroaneurysm with supravalvular pulmonic stenosis	614224	AR	3	Igfbp7
4q13-q21	4:58500001-87100000	AIS4, VAMAS5	Autoimmune disease, susceptibility to, 4	609400		619405		between D4S392 and D4S3042	{Autoimmune disease, susceptibility to, 4}	609400		2	
4q13.1	4:64276298-64409460	TECRL, TERL, SRD5A2L2, GPSN2L, CPVT3	Trans-2,3-enoyl-CoA reductase-like protein	617242	TECRL	253017	ENSG00000205678,ENST00000381210;;;ENST00000381210		Ventricular tachycardia, catecholaminergic polymorphic, 3	614021	AR	3	Tecrl
4q13.2-q21.3	4:65500001-87100000	ETL3, FMTLE	Epilepsy, familial temporal lobe, 3	611630		100188848		max lod at D4S1517	Epilepsy, familial temporal lobe, 3	611630	AD	2	
4q13.2	4:67737118-67754388	GNRHR, LHRHR, HH7	Gonadotropin-releasing hormone receptor	138850	GNRHR	2798	ENSG00000109163,ENST00000226413;;;ENST00000226413	placed at 4q12 or 4q13 by some	Hypogonadotropic hypogonadism 7 without anosmia	146110	AR	3	Gnrhr
4q13.2	4:68537173-68576322	UGT2B17, BMND12	UDP-glucuronyltransferase, family 2, beta-17	601903	UGT2B17	7367	ENSG00000197888,ENST00000317746;;;ENST00000317746		{Bone mineral density QTL 12, osteoporosis}	612560		3	Ugt2b1,Ugt2b35,Ugt2b36,Ugt2b37,Ugt2b38,Ugt2b5
4q13.3	4:70430492-70482997	MUC7	Mucin 7, salivary	158375	MUC7	4589	ENSG00000171195,ENST00000304887;;;ENST00000304887		{Asthma, protection against}	600807	AD	3	
4q13.3	4:70518569-70532743	AMTN, AI3B	Amelotin	610912	AMTN	401138	ENSG00000187689,ENST00000339336;;;ENST00000339336	mutation identified in 1 AI3B family	?Amelogenesis imperfecta, type IIIB	617607	AD	3	Amtn
4q13.3	4:70592256-70607288	AMBN, AI1F	Ameloblastin	601259	AMBN	258	ENSG00000178522,ENST00000322937;;;ENST00000322937	mutation identified in 1 AI1F family	Amelogenesis imperfecta, type IF	616270	AR	3	Ambn
4q13.3	4:70628744-70646824	ENAM, AIH2, AI1C	Enamelin	606585	ENAM	10117	ENSG00000132464,ENST00000396073;;;ENST00000396073		Amelogenesis imperfecta, type IB	104500	AD	3	Enam
4q13.3	4:70628744-70646824	ENAM, AIH2, AI1C	Enamelin	606585	ENAM	10117	ENSG00000132464,ENST00000396073;;;ENST00000396073		Amelogenesis imperfecta, type IC	204650	AR	3	Enam
4q13.3	4:71062660-71572083	SLC4A4, NBC1, KNBC, PRTAO	Solute carrier family 4, sodium bicarbonate cotransporter, member 4	603345	SLC4A4	8671	ENSG00000080493,ENST00000264485;;;ENST00000264485		Proximal renal tubular acidosis-ocular anomaly syndrome	604278	AR	3	Slc4a4
4q13.3	4:72280969-72569221	ADAMTS3, HKLLS3	ADAM metallopeptidase with thrombospondin type 1 motif, 3	605011	ADAMTS3	9508	ENSG00000156140,ENST00000286657;;;ENST00000286657		Hennekam lymphangiectasia-lymphedema syndrome 3	618154	AR	3	Adamts3
4q13.3	4:73073376-73258798	ANKRD17, GTAR, CAGS	Ankyrin repeat domain-containing protein 17	615929	ANKRD17	26057	ENSG00000132466,ENST00000358602;;;ENST00000358602		Chopra-Amiel-Gordon syndrome	619504	AD	3	Ankrd17
4q13.3	4:73404287-73421482	ALB, ANALBA, FDAH, FDAHT	Albumin	103600	ALB	213	ENSG00000163631,ENST00000295897;;;ENST00000295897	mutation identified in 1 FDAHT family	?[Dysalbuminemic hypertriiodothyroninemia]	615999	AD, AR	3	Alb
4q13.3	4:73404287-73421482	ALB, ANALBA, FDAH, FDAHT	Albumin	103600	ALB	213	ENSG00000163631,ENST00000295897;;;ENST00000295897	mutation identified in 1 FDAHT family	[Dysalbuminemic hyperthyroxinemia]	615999	AD, AR	3	Alb
4q13.3	4:73404287-73421482	ALB, ANALBA, FDAH, FDAHT	Albumin	103600	ALB	213	ENSG00000163631,ENST00000295897;;;ENST00000295897	mutation identified in 1 FDAHT family	Analbuminemia	616000	AR	3	Alb
4q13.3	4:73436221-73456174	AFP, HPAFP, AFPD	Alpha-fetoprotein	104150	AFP	174	ENSG00000081051,ENST00000395792;;;ENST00000395792	order: 5'-ALB-3'--5'-AFP-3'	[Hereditary persistence of alpha-fetoprotein]	615970	AD	3	Afp
4q13.3	4:73436221-73456174	AFP, HPAFP, AFPD	Alpha-fetoprotein	104150	AFP	174	ENSG00000081051,ENST00000395792;;;ENST00000395792	order: 5'-ALB-3'--5'-AFP-3'	Alpha-fetoprotein deficiency	615969	AR	3	Afp
4q21	4:75300001-87100000	DEL4q21, C4DELq21	Chromosome 4q21 deletion syndrome	613509				contiguous gene deletion if at least 30 genes	Chromosome 4q21 deletion syndrome	613509	IC	4	
4q21-q31	4:75300001-154600000	OFC4	Orofacial cleft 4	608371		474387			Orofacial cleft 4	608371		2	
4q21-q23	4:75300001-100100000	PFM3	Parietal foramina 3	609566		619475		maximum lod between D4S2986 and D4S421	Parietal foramina 3	609566	AD	2	
4q21.1	4:75556066-75565893	ODAPH, C4orf26	Odontogenesis-associated phosphoprotein	614829	ODAPH	152816	ENSG00000174792,ENST00000311623;;;ENST00000311623		Amelogenesis imperfecta, type IIA4	614832	AR	3	Odaph
4q21.1	4:76114664-76148397	NUP54, DYT37	Nucleoporin, 54kD	607607	NUP54	53371	ENSG00000138750,ENST00000264883;;;ENST00000264883		Dystonia 37, early-onset, with striatal lesions	620427	AR	3	Nup54
4q21.1	4:76158737-76234532	SCARB2, CD36L2, LIMPII, AMRF, EPM4	Scavenger receptor class B, member 2	602257	SCARB2	950	ENSG00000138760,ENST00000264896;;;ENST00000264896		Epilepsy, progressive myoclonic 4, with or without renal failure	254900	AR	3	Scarb2
4q21.21	4:78057323-78544269	FRAS1, FRASRS1	Fraser extracellular matrix complex subunit 1	607830	FRAS1	80144	ENSG00000138759,ENST00000512123;;;ENST00000512123		Fraser syndrome 1	219000	AR	3	Fras1
4q21.21	4:79901146-80073472	ANTXR2, CMG2, HFS	Anthrax toxin receptor 2	608041	ANTXR2	118429	ENSG00000163297,ENST00000403729;;;ENST00000403729		Hyaline fibromatosis syndrome	228600	AR	3	Antxr2
4q21.21	4:80185270-80204329	PRDM8, EPM10	PR domain-containing protein 8	616639	PRDM8	56978	ENSG00000152784,ENST00000415738;;;ENST00000415738	mutation identified in 1 EPM10 family	?Epilepsy, progressive myoclonic, 10	616640	AR	3	Prdm8
4q21.21	4:80266588-80291017	FGF5, TCMGLY	Fibroblast growth factor-5	165190	FGF5	2250	ENSG00000138675,ENST00000312465;;;ENST00000312465		Trichomegaly	190330	AR	3	Fgf5
4q21.21	4:81087370-81217836	PRKG2, PRKGR2, AMD4, SMDP	Protein kinase, cGMP-dependent, type II	601591	PRKG2	5593	ENSG00000138669,ENST00000264399;;;ENST00000264399	mutation identified in 1 SMDP family	Acromesomelic dysplasia 4	619636	AR	3	Prkg2
4q21.21	4:81087370-81217836	PRKG2, PRKGR2, AMD4, SMDP	Protein kinase, cGMP-dependent, type II	601591	PRKG2	5593	ENSG00000138669,ENST00000264399;;;ENST00000264399	mutation identified in 1 SMDP family	Spondylometaphyseal dysplasia, Pagnamenta type	619638	AR	3	Prkg2
4q21.22	4:82422564-82430462	HNRNPDL, HNRPDL, JKTBP, LGMDD3	Heterogeneous nuclear ribonucleoprotein D-like protein	607137	HNRNPDL	9987	ENSG00000152795,ENST00000295470;;;ENST00000295470		Muscular dystrophy, limb-girdle, autosomal dominant 3	609115	AD	3	Hnrnpdl
4q21.22	4:82629539-82798796	SCD5, ACOD4, DFNA79	Stearoyl-CoA desaturase 5	608370	SCD5	79966	ENSG00000145284,ENST00000319540;;;ENST00000319540	mutation identified in 1 DFNA79 family	?Deafness, autosomal dominant 79	619086	AD	3	
4q21.22	4:82818509-82900569	SEC31A, SEC31L1, KIAA0905, NEDSOSB, HPBKS	SEC31 homolog A, COPII coat complex component	610257	SEC31A	22872	ENSG00000138674,ENST00000395310;;;ENST00000395310	mutation identified in 1 NEDSOSB family	?Halperin-Birk syndrome	618651	AR	3	Sec31a
4q21.23	4:83263824-83285134	COQ2, COQ10D1, MSA1	Coenzyme Q2, polyprenyltransferase	609825	COQ2	27235	ENSG00000173085,ENST00000647002;;;ENST00000647002		{Multiple system atrophy, susceptibility to}	146500	AD, AR	3	Coq2
4q21.23	4:83263824-83285134	COQ2, COQ10D1, MSA1	Coenzyme Q2, polyprenyltransferase	609825	COQ2	27235	ENSG00000173085,ENST00000647002;;;ENST00000647002		Coenzyme Q10 deficiency, primary, 1	607426	AR	3	Coq2
4q21.23	4:84669597-84966690	WDFY3, ALFY, BCHS, MCPH18	WD repeat- and FYVE domain-containing protein 3	617485	WDFY3	23001	ENSG00000163625,ENST00000295888;;;ENST00000295888	mutation identified in 1 MCPH18 family	?Microcephaly 18, primary, autosomal dominant	617520	AD	3	Wdfy3
4q22.1	4:87100001-92800000	ATOD8	Dermatitis, atopic, 8	613518		105463125			{Dermatitis, atopic, susceptibility to, 8}	613518		2	
4q22	4:87100001-97900000	MUSQTL1	Musical aptitude quantitative trait locus 1	612343		100192307		near D4S423 and D4S2460	[Musical aptitude QTL 1]	612343		2	
4q22-q27	4:87100001-122800000	MYP11	Myopia 11	609994		594832		max lod at D4S1564	Myopia 11	609994		2	
4q22.1	4:87303794-87322882	HSD17B13, SCDR9, FLDP	17-beta-hydroxysteroid dehydrogenase XIII	612127	HSD17B13	345275	ENSG00000170509,ENST00000328546;;;ENST00000328546		{Fatty liver disease, protection from}	620116	AD	3	Hsd17b13
4q22.1	4:87608529-87616873	DSPP, DPP, DGI1, DFNA39, DTDP2	Dentin sialophosphoprotein	125485	DSPP	1834	ENSG00000152591,ENST00000651931;;;ENST00000651931		Deafness, autosomal dominant 39, with dentinogenesis	605594	AD	3	Dspp
4q22.1	4:87608529-87616873	DSPP, DPP, DGI1, DFNA39, DTDP2	Dentin sialophosphoprotein	125485	DSPP	1834	ENSG00000152591,ENST00000651931;;;ENST00000651931		Dentin dysplasia, type II	125420	AD	3	Dspp
4q22.1	4:87608529-87616873	DSPP, DPP, DGI1, DFNA39, DTDP2	Dentin sialophosphoprotein	125485	DSPP	1834	ENSG00000152591,ENST00000651931;;;ENST00000651931		Dentinogenesis imperfecta, Shields type II	125490	AD	3	Dspp
4q22.1	4:87608529-87616873	DSPP, DPP, DGI1, DFNA39, DTDP2	Dentin sialophosphoprotein	125485	DSPP	1834	ENSG00000152591,ENST00000651931;;;ENST00000651931		Dentinogenesis imperfecta, Shields type III	125500	AD	3	Dspp
4q22.1	4:87650280-87664357	DMP1, ARHR, ARHP	Dentin matrix acidic phosphoprotein	600980	DMP1	1758	ENSG00000152592,ENST00000339673;;;ENST00000339673		Hypophosphatemic rickets, AR	241520	AR	3	Dmp1
4q22.1	4:88007635-88077777	PKD2	Polycystin-2	173910	PKD2	5311	ENSG00000118762,ENST00000237596;;;ENST00000237596		Polycystic kidney disease 2	613095	AD	3	Pkd2
4q22.1	4:88090264-88231626	ABCG2, BCRP, ABCP, UAQTL1, GOUT1	ATP-binding cassette, subfamily G, member 2	603756	ABCG2	9429	ENSG00000118777,ENST00000237612;;;ENST00000237612		[Junior blood group system]	614490		3	Abcg2,Abcg3
4q22.1	4:88090264-88231626	ABCG2, BCRP, ABCP, UAQTL1, GOUT1	ATP-binding cassette, subfamily G, member 2	603756	ABCG2	9429	ENSG00000118777,ENST00000237612;;;ENST00000237612		[Uric acid concentration, serum, QTL1]	138900	?AD	3	Abcg2,Abcg3
4q22.1	4:88257620-88284561	PPM1K, PP2CM, PTMP, MSUDMV	Protein phosphatase, PP2C domain-containing, 1K	611065	PPM1K	152926	ENSG00000163644,ENST00000608933;;;ENST00000608933		Maple syrup urine disease, mild variant	615135	AR	3	Ppm1k
4q22.1	4:88520998-88523776	PIGY, HPMRS6	Phosphatidylinositol glycan, class Y	610662	PIGY	84992	ENSG00000255072,ENST00000527353;;;ENST00000527353		Hyperphosphatasia with impaired intellectual development syndrome 6	616809	AR	3	Pigyl
4q22.1	4:89724099-89838304	SNCA, NACP, PARK1, PARK4	Synuclein, alpha (non A4 component of amyloid precursor)	163890	SNCA	6622	ENSG00000145335,ENST00000394991;;;ENST00000394991		Dementia, Lewy body	127750	AD	3	Snca
4q22.1	4:89724099-89838304	SNCA, NACP, PARK1, PARK4	Synuclein, alpha (non A4 component of amyloid precursor)	163890	SNCA	6622	ENSG00000145335,ENST00000394991;;;ENST00000394991		Parkinson disease 1	168601	AD	3	Snca
4q22.1	4:89724099-89838304	SNCA, NACP, PARK1, PARK4	Synuclein, alpha (non A4 component of amyloid precursor)	163890	SNCA	6622	ENSG00000145335,ENST00000394991;;;ENST00000394991		Parkinson disease 4	605543	AD	3	Snca
4q22.1-q22.2	4:92303966-93810456	GRID2, SCAR18	Glutamate receptor, ionotropic, delta-2	602368	GRID2	2895	ENSG00000152208,ENST00000282020;;;ENST00000282020		Spinocerebellar ataxia, autosomal recessive 18	616204	AR	3	Grid2
4q22.2	4:93828753-93830964	ATOH1, ATH1, DFNA89	Atonal bHLH transcription factor 1	601461	ATOH1	474	ENSG00000172238,ENST00000306011;;;ENST00000306011	mutation identified in DFNA89 family	?Deafness, autosomal dominant 89	620284	AD	3	Atoh1
4q22.3	4:94207608-94291292	SMARCAD1, KIAA1122, ETL1, HEL1, ADERM, BASNS, HRZ	SWI/SNF-related, matrix-associated actin-dependent regulator of chromatin, subfamily A, DEAD/H box-containing, 1	612761	SMARCAD1	56916	ENSG00000163104,ENST00000354268;;;ENST00000354268		Adermatoglyphia	136000	AD	3	Smarcad1
4q22.3	4:94207608-94291292	SMARCAD1, KIAA1122, ETL1, HEL1, ADERM, BASNS, HRZ	SWI/SNF-related, matrix-associated actin-dependent regulator of chromatin, subfamily A, DEAD/H box-containing, 1	612761	SMARCAD1	56916	ENSG00000163104,ENST00000354268;;;ENST00000354268		Basan syndrome	129200	AD	3	Smarcad1
4q22.3	4:94207608-94291292	SMARCAD1, KIAA1122, ETL1, HEL1, ADERM, BASNS, HRZ	SWI/SNF-related, matrix-associated actin-dependent regulator of chromatin, subfamily A, DEAD/H box-containing, 1	612761	SMARCAD1	56916	ENSG00000163104,ENST00000354268;;;ENST00000354268		Huriez syndrome	181600	AD	3	Smarcad1
4q22.3	4:94757955-95158450	BMPR1B, ALK6, AMD3, BDA2, BDA1D	Bone morphogenetic protein receptor, type IB	603248	BMPR1B	658	ENSG00000138696,ENST00000515059;;;ENST00000515059		Acromesomelic dysplasia 3	609441	AR	3	Bmpr1b
4q22.3	4:94757955-95158450	BMPR1B, ALK6, AMD3, BDA2, BDA1D	Bone morphogenetic protein receptor, type IB	603248	BMPR1B	658	ENSG00000138696,ENST00000515059;;;ENST00000515059		Brachydactyly, type A1, D	616849	AD	3	Bmpr1b
4q22.3	4:94757955-95158450	BMPR1B, ALK6, AMD3, BDA2, BDA1D	Bone morphogenetic protein receptor, type IB	603248	BMPR1B	658	ENSG00000138696,ENST00000515059;;;ENST00000515059		Brachydactyly, type A2	112600	AD	3	Bmpr1b
4q22.3	4:95840093-95841464	PDHA2, SPGF70	Pyruvate dehydrogenase E1, subunit alpha-2	179061	PDHA2	5161	ENSG00000163114,ENST00000295266;;;ENST00000295266		Spermatogenic failure 70	619828	AR	3	Pdha2
4q23	4:98261384-98443858	RAP1GDS1	RAP1, GTP-GDP dissociation stimulator 1	179502	RAP1GDS1	5910	ENSG00000138698,ENST00000408927;;;ENST00000408927	fusion partner with NUP98 in ALL	Alfadhel syndrome	620655	AR	3	Rap1gds1
4q23	4:98879276-98929133	EIF4E, EIF4EL1, AUTS19	Eukaryotic translation initiation factor 4E	133440	EIF4E	1977	ENSG00000151247,ENST00000450253;;;ENST00000450253	pseudogene on 20	{Autism, susceptibility to, 19}	615091		3	Eif4e
4q23	4:99070978-99088788	ADH5, FDH, AMEDS, BMFS7	Alcohol dehydrogenase (class III), chi polypeptide	103710	ADH5	128	ENSG00000197894,ENST00000296412;;;ENST00000296412	AMEDS is digenic with ALDH2	AMED syndrome, digenic	619151	DR	3	Adh5
4q23	4:99304971-99321401	ADH1B, ADH2	Alcohol dehydrogenase IB (class I), beta polypeptide	103720	ADH1B	125	ENSG00000196616,ENST00000305046;;;ENST00000305046		{Aerodigestive tract cancer, squamous cell, alcohol-related, protection against}	103780	Mu	3	Adh1
4q23	4:99304971-99321401	ADH1B, ADH2	Alcohol dehydrogenase IB (class I), beta polypeptide	103720	ADH1B	125	ENSG00000196616,ENST00000305046;;;ENST00000305046		{Alcohol dependence, protection against}	103780	Mu	3	Adh1
4q23	4:99336497-99352746	ADH1C, ADH3	Alcohol dehydrogenase IC (class I), gamma polypeptide	103730	ADH1C	126	ENSG00000248144,ENST00000515683;;;ENST00000515683		{Alcohol dependence, protection against}	103780	Mu	3	Adh1
4q23	4:99336497-99352746	ADH1C, ADH3	Alcohol dehydrogenase IC (class I), gamma polypeptide	103730	ADH1C	126	ENSG00000248144,ENST00000515683;;;ENST00000515683		{Parkinson disease, susceptibility to}	168600	AD, Mu	3	Adh1
4q23	4:99546711-99564039	TRMT10A, RG9MTD2, MSSGM1	tRNA methyltransferase 10A	616013	TRMT10A	93587	ENSG00000145331,ENST00000394876;;;ENST00000394876		Microcephaly, short stature, and impaired glucose metabolism 1	616033	AR	3	Trmt10a
4q23	4:99564130-99623997	MTTP	Microsomal triglyceride transfer protein, 88kD	157147	MTTP	4547	ENSG00000138823,ENST00000265517;;;ENST00000265517		Abetalipoproteinemia	200100	AR	3	Mttp
4q24-q28	4:100100001-138500000	HWE2	Epilepsy, hot water, 2	613340		100415904		between D4S1572 and D4S2277	Epilepsy, hot water, 2	613340		2	
4q24	4:100100001-106700000	MGR1, MA	Migraine with or without aura, susceptibility to, 1	157300		192115			{Migraine with or without aura, susceptibility to, 1}	157300	AD	2	
4q24	4:100100001-106700000	OCA5	Albinism, oculocutaneous, type V	615312		101926885		max lod at D4S961	Albinism, oculocutaneous, type V	615312	AR	2	
4q24	4:101023418-101347526	PPP3CA, PPP2B, CALNA, CNA1, DEE91, ACCIID	Protein phosphatase 3, catalytic subunit, alpha isoform (calcineurin A alpha)	114105	PPP3CA	5530	ENSG00000138814,ENST00000394854;;;ENST00000394854		Arthrogryposis, cleft palate, craniosynostosis, and impaired intellectual development	618265	AD	3	Ppp3ca
4q24	4:101023418-101347526	PPP3CA, PPP2B, CALNA, CNA1, DEE91, ACCIID	Protein phosphatase 3, catalytic subunit, alpha isoform (calcineurin A alpha)	114105	PPP3CA	5530	ENSG00000138814,ENST00000394854;;;ENST00000394854		Developmental and epileptic encephalopathy 91	617711	AD	3	Ppp3ca
4q24	4:102251041-102345482	SLC39A8, BIGM103, CDG2N	Solute carrier family 39 (zinc transporter), member 8	608732	SLC39A8	64116	ENSG00000138821,ENST00000356736;;;ENST00000356736		Congenital disorder of glycosylation, type IIn	616721	AR	3	Slc39a8
4q24	4:102501359-102617302	NFKB1, CVID12	Nuclear factor kappa-B, subunit 1 (p105, p50)	164011	NFKB1	4790	ENSG00000109320,ENST00000226574;;;ENST00000226574		Immunodeficiency, common variable, 12	616576	AD	3	Nfkb1
4q24	4:102630770-102760968	MANBA, MANB1	Mannosidase, beta A, lysosomal	609489	MANBA	4126	ENSG00000109323,ENST00000647097;;;ENST00000647097	linked in mouse to Adl-3	Mannosidosis, beta	248510	AR	3	Manba
4q24	4:102868992-102892807	CISD2, WFS2, ZCD2, ERIS	CDGSH iron sulfur domain protein 2	611507	CISD2	493856	ENSG00000145354,ENST00000273986;;;ENST00000273986		Wolfram syndrome 2	604928	AR	3	Cisd2
4q24	4:103105811-103198343	CENPE, MCPH13	Centromere autoantigen E, 312kD	117143	CENPE	1062	ENSG00000138778,ENST00000265148;;;ENST00000265148	mutation identified in 1 MCPH13 family	?Microcephaly 13, primary, autosomal recessive	616051	AR	3	Cenpe
4q24	4:103586031-103719985	TACR3, NK3R, HH11	Tachykinin receptor 3	162332	TACR3	6870	ENSG00000169836,ENST00000304883;;;ENST00000304883		Hypogonadotropic hypogonadism 11 with or without anosmia	614840	AR	3	Tacr3
4q24	4:105145875-105279803	TET2, KIAA1546, MDS, IMD75	tet methylcytosine dioxygenase 2	612839	TET2	54790	ENSG00000168769,ENST00000380013;;;ENST00000380013		Immunodeficiency 75	619126	AR	3	Tet2
4q24	4:105145875-105279803	TET2, KIAA1546, MDS, IMD75	tet methylcytosine dioxygenase 2	612839	TET2	54790	ENSG00000168769,ENST00000380013;;;ENST00000380013		Myelodysplastic syndrome, somatic	614286		3	Tet2
4q24	4:105369077-105474070	PPA2, SCFI, SCFAI	Pyrophosphatase, inorganic, 2	609988	PPA2	27068	ENSG00000138777,ENST00000341695;;;ENST00000341695	mutation identified in 1 SCFAI family	?Sudden cardiac failure, alcohol-induced	617223	AR	3	Ppa2
4q24	4:105369077-105474070	PPA2, SCFI, SCFAI	Pyrophosphatase, inorganic, 2	609988	PPA2	27068	ENSG00000138777,ENST00000341695;;;ENST00000341695	mutation identified in 1 SCFAI family	Sudden cardiac failure, infantile	617222	AR	3	Ppa2
4q24	4:106041599-106316683	TBCK, IHPRF3	TBC1 domain-containing kinase	616899	TBCK	93627	ENSG00000145348,ENST00000394708;;;ENST00000394708		Hypotonia, infantile, with psychomotor retardation and characteristic facies 3	616900	AR	3	Tbck
4q24	4:106315544-106349456	AIMP1, SCYE1, EMAP2, EMAPII, HLD3	ARS-interacting multifunctional protein 1	603605	AIMP1	9255	ENSG00000164022,ENST00000672341;;;ENST00000672341		Leukodystrophy, hypomyelinating, 3	260600	AR	3	Aimp1
4q25	4:106700001-113200000	ATFB5	Atrial fibrillation, familial, 5	611494		100188842		association with rs2200733 and rs10033464	{Atrial fibrillation, familial, 5}	611494		2	
4q25	4:106700001-113200000	LGV1	Longevity 1, QTL	152430		140802		maximum lod at D4S1564	[Longevity 1]	152430		2	
4q25	4:107824563-107915047	SGMS2, SMS2, CDL	Sphingomyelin synthase 2	611574	SGMS2	166929	ENSG00000164023,ENST00000690982;;;ENST00000690982		Calvarial doughnut lesions with bone fragility with or without spondylometaphyseal dysplasia	126550	AD	3	Sgms2
4q25	4:107931549-107953461	CYP2U1, SPG56	Cytochrome P450, family 2, subfamily U, polypeptide 1	610670	CYP2U1	113612	ENSG00000155016,ENST00000332884;;;ENST00000332884		Spastic paraplegia 56, autosomal recessive	615030	AR	3	Cyp2u1
4q25	4:107989889-108035171	HADH, HADHSC, SCHAD, HHF4	3-hydroxyacyl-CoA dehydrogenase	601609	HADH	3033	ENSG00000138796,ENST00000309522;;;ENST00000309522		3-hydroxyacyl-CoA dehydrogenase deficiency	231530	AR	3	Hadh
4q25	4:107989889-108035171	HADH, HADHSC, SCHAD, HHF4	3-hydroxyacyl-CoA dehydrogenase	601609	HADH	3033	ENSG00000138796,ENST00000309522;;;ENST00000309522		Hyperinsulinemic hypoglycemia, familial, 4	609975	AR	3	Hadh
4q25	4:108047548-108168932	LEF1, ECTD1, ECTD17	Lymphoid enhancer-binding factor-1	153245	LEF1	51176	ENSG00000138795,ENST00000265165;;;ENST00000265165		Ectodermal dysplasia 17 with or without limb malformations	621224	AD	3	Lef1
4q25	4:108808725-109302658	COL25A1, CLAC, CFEOM5	Collagen, type XXV, alpha-1 polypeptide	610004	COL25A1	84570	ENSG00000188517,ENST00000399132;;;ENST00000399132		Fibrosis of extraocular muscles, congenital, 5	616219	AR	3	Col25a1
4q25	4:109730982-109801999	CFI, FI, AHUS3, ARMD13	Complement factor I	217030	CFI	3426	ENSG00000205403,ENST00000394634;;;ENST00000394634	40kb distal to EGF	{Hemolytic uremic syndrome, atypical, susceptibility to, 3}	612923	AD	3	Cfi
4q25	4:109730982-109801999	CFI, FI, AHUS3, ARMD13	Complement factor I	217030	CFI	3426	ENSG00000205403,ENST00000394634;;;ENST00000394634	40kb distal to EGF	{Macular degeneration, age-related, 13, susceptibility to}	615439	AD	3	Cfi
4q25	4:109730982-109801999	CFI, FI, AHUS3, ARMD13	Complement factor I	217030	CFI	3426	ENSG00000205403,ENST00000394634;;;ENST00000394634	40kb distal to EGF	Complement factor I deficiency	610984	AR	3	Cfi
4q25	4:109848107-109872315	LRIT3, FIGLER4, CSNB1F	Leucine-rich repeat, immunoglobulin-like, and transmembrane domains-containing protein 3	615004	LRIT3	345193	ENSG00000183423,ENST00000594814;;;ENST00000594814		Night blindness, congenital stationary (complete), 1F, autosomal recessive	615058	AR	3	Lrit3
4q25	4:109912883-110013766	EGF, URG, HOMG4	Epidermal growth factor (urogastrone)	131530	EGF	1950	ENSG00000138798,ENST00000265171;;;ENST00000265171	mutation identified in 1 HOMG4 family	?Hypomagnesemia 4, renal	611718	AR	3	Egf
4q25	4:110617423-110642123	PITX2, IDG2, RIEG1, RGS, IGDS2, ASGD4	Paired-like homeodomain transcription factor-2	601542	PITX2	5308	ENSG00000164093,ENST00000644743;;;ENST00000644743		Anterior segment dysgenesis 4	137600	AD	3	Pitx2
4q25	4:110617423-110642123	PITX2, IDG2, RIEG1, RGS, IGDS2, ASGD4	Paired-like homeodomain transcription factor-2	601542	PITX2	5308	ENSG00000164093,ENST00000644743;;;ENST00000644743		Axenfeld-Rieger syndrome, type 1	180500	AD	3	Pitx2
4q25	4:110617423-110642123	PITX2, IDG2, RIEG1, RGS, IGDS2, ASGD4	Paired-like homeodomain transcription factor-2	601542	PITX2	5308	ENSG00000164093,ENST00000644743;;;ENST00000644743		Ring dermoid of cornea	180550	AD	3	Pitx2
4q25	4:112297369-112442621	ALPK1, LAK, KIAA1527, ROSAH	Alpha-kinase 1	607347	ALPK1	80216	ENSG00000073331,ENST00000650871;;;ENST00000650871		ROSAH syndrome	614979	AD	3	Alpk1
4q25	4:112637143-112657586	LARP7, PIP7S, ALAZS	La ribonucleoprotein 7, transcriptional regulator	612026	LARP7	51574	ENSG00000174720,ENST00000344442;;;ENST00000344442		Alazami syndrome	615071	AR	3	Larp7,Larp7-ps
4q25-q26	4:112705622-113383736	ANK2, LQT4	Ankyrin-2, nonerythrocytic	106410	ANK2	287	ENSG00000145362,ENST00000357077;;;ENST00000357077		Cardiac arrhythmia, ankyrin-B-related	600919	AD	3	Ank2
4q25-q26	4:112705622-113383736	ANK2, LQT4	Ankyrin-2, nonerythrocytic	106410	ANK2	287	ENSG00000145362,ENST00000357077;;;ENST00000357077		Long QT syndrome 4	600919	AD	3	Ank2
4q26	4:118280038-118353003	PRSS12, BSSP3, MRT1	Protease, serine, 12	606709	PRSS12	8492	ENSG00000164099,ENST00000296498;;;ENST00000296498		Intellectual developmental disorder, autosomal recessive 1	249500	AR	3	Prss12
4q26	4:118722823-118836126	SEC24D, KIAA0755, CLCRP2	SEC24-related gene family, member D	607186	SEC24D	9871	ENSG00000150961,ENST00000280551;;;ENST00000280551		Cole-Carpenter syndrome 2	616294	AR	3	Sec24d
4q26	4:119135832-119187789	MYOZ2, CMH16	Myozenin 2	605602	MYOZ2	51778	ENSG00000172399,ENST00000307128;;;ENST00000307128		Cardiomyopathy, hypertrophic, 16	613838	AD	3	Myoz2
4q26	4:119212601-119295518	USP53, KIAA1350, PFIC7	Ubiquitin-specific peptidase 53	617431	USP53	54532	ENSG00000145390,ENST00000692078;;;ENST00000692078		Cholestasis, progressive familial intrahepatic, 7, with or without hearing loss	619658	AR	3	Usp53
4q27	4:119900001-122800000	CELIAC6, AIS5	Celiac disease, susceptibility to, 6	611598		100188846			{Autoimmune disease, susceptibility to, 5}	611598		2	
4q27	4:119900001-122800000	CELIAC6, AIS5	Celiac disease, susceptibility to, 6	611598		100188846			{Celiac disease, susceptibility to, 6}	611598		2	
4q27	4:119900001-122800000	IDDM23	Diabetes mellitus, insulin-dependent, 23	612622		100271697		associated with rs6534347	{Diabetes mellitus, insulin-dependent, 23}	612622		2	
4q27-q28.2	4:119900001-130100000	MRT29	Intellectual developmental disorder, autosomal recessive 29	614333		100852393		between rs10518325 and rs10518608	Intellectual developmental disorder, autosomal recessive 29	614333	AR	2	
4q27	4:120684291-120922726	PRDM5, BCS2	PR domain-containing protein 5	614161	PRDM5	11107	ENSG00000138738,ENST00000264808;;;ENST00000264808		Brittle cornea syndrome 2	614170	AR	3	Prdm5
4q27	4:121035613-121072535	NDNF, C4orf31, NORD, HH25	Neuron-derived neurotrophic factor	616506	NDNF	79625	ENSG00000173376,ENST00000379692;;;ENST00000379692		Hypogonadotropic hypogonadism 25 with anosmia	618841	AD	3	Ndnf
4q27	4:121667946-121696980	ANXA5, ENX2, RPRGL3	Annexin A5 (endonexin II)	131230	ANXA5	308	ENSG00000164111,ENST00000296511;;;ENST00000296511		{Pregnancy loss, recurrent, susceptibility to, 3}	614391	AD	3	Anxa5
4q27	4:121801323-121817021	EXOSC9, PMSCL1, PCH1D	Exosome component 9	606180	EXOSC9	5393	ENSG00000123737,ENST00000243498;;;ENST00000243498		Pontocerebellar hypoplasia, type 1D	618065	AR	3	Exosc9
4q27	4:121824329-121870474	BBS7	BBS7 gene	607590	BBS7	55212	ENSG00000138686,ENST00000264499;;;ENST00000264499		Bardet-Biedl syndrome 7	615984	AR	3	Bbs7
4q27	4:121874481-121952060	TRPC3, TRP3, SCA41	Transient receptor potential cation channel, subfamily C, member 3	602345	TRPC3	7222	ENSG00000138741,ENST00000379645;;;ENST00000379645	mutation identified in one SCA41 patient	?Spinocerebellar ataxia 41	616410	AD	3	Trpc3
4q27	4:122152331-122362752	BLTP1, KIAA1109, ALKKUCS	Bridge-like lipid transfer protein family, member 1	611565	BLTP1	84162	ENSG00000138688,ENST00000679879;;;ENST00000679879		Alkuraya-Kucinskas syndrome	617822	AR	3	Bltp1
4q27	4:122610108-122621066	IL21, CVID11	Interleukin 21	605384	IL21	59067	ENSG00000138684,ENST00000648588;;;ENST00000648588	mutation identified in 1 CVID11 patient	?Immunodeficiency, common variable, 11	615767	AR	3	Il21
4q27	4:122700442-122744939	BBS12, FLJ35630, C4orf24	BBS12 gene	610683	BBS12	166379	ENSG00000181004,ENST00000314218;;;ENST00000314218	1Mb centromeric to BBS	Bardet-Biedl syndrome 12	615989	AR	3	Bbs12
4q28-q31	4:122800001-154600000	SF	Stoltzfus blood group	111800		6420		~25cM from MNSs	[Blood group, Stoltzfus system]	111800		2	
4q28.1	4:122923078-123319433	AFG2A, SPATA5, SPAF, NEDHSB	AFG2 AAA ATPase homolog A	613940	AFG2A	166378	ENSG00000145375,ENST00000274008;;;ENST00000274008		Neurodevelopmental disorder with hearing loss, seizures, and brain abnormalities	616577	AR	3	Afg2a
4q28.1	4:125314955-125492932	FAT4, VMLDS2, HKLLS2	FAT atypical cadherin 4	612411	FAT4	79633	ENSG00000196159,ENST00000394329;;;ENST00000394329		Hennekam lymphangiectasia-lymphedema syndrome 2	616006	AR	3	Fat4
4q28.1	4:125314955-125492932	FAT4, VMLDS2, HKLLS2	FAT atypical cadherin 4	612411	FAT4	79633	ENSG00000196159,ENST00000394329;;;ENST00000394329		Van Maldergem syndrome 2	615546	AR	3	Fat4
4q28.1	4:127632957-127726737	INTU, KIAA1284, PDZK6, SRTD20, OFD17	Inturned planar cell polarity protein	610621	INTU	27152	ENSG00000164066,ENST00000335251;;;ENST00000335251	mutation identified in 1 SRTD20 patient and 1 OFD17 patient	?Orofaciodigital syndrome XVII	617926	AR	3	Intu
4q28.1	4:127632957-127726737	INTU, KIAA1284, PDZK6, SRTD20, OFD17	Inturned planar cell polarity protein	610621	INTU	27152	ENSG00000164066,ENST00000335251;;;ENST00000335251	mutation identified in 1 SRTD20 patient and 1 OFD17 patient	?Short-rib thoracic dysplasia 20 with polydactyly	617925	AR	3	Intu
4q28.1	4:127880893-127899224	PLK4, STK18, SAK, MCCRP2	Polo-like kinase 4 (serine/threonine protein kinase-18)	605031	PLK4	10733	ENSG00000142731,ENST00000270861;;;ENST00000270861		Microcephaly and chorioretinopathy, autosomal recessive, 2	616171	AR	3	Plk4
4q28.2	4:127917732-127965963	MFSD8, MGC33302, CLN7, CCMD	Major facilitator superfamily domain-containing protein 8	611124	MFSD8	256471	ENSG00000164073,ENST00000641686;;;ENST00000641686		Ceroid lipofuscinosis, neuronal, 7	610951	AR	3	Mfsd8
4q28.2	4:127917732-127965963	MFSD8, MGC33302, CLN7, CCMD	Major facilitator superfamily domain-containing protein 8	611124	MFSD8	256471	ENSG00000164073,ENST00000641686;;;ENST00000641686		Macular dystrophy with central cone involvement	616170	AR	3	Mfsd8
4q31	4:138500001-154600000	AAA2	Aortic aneurysm, familial abdominal 2	609782		100505390		max lod at D4S1644	Aortic aneurysm, familial abdominal 2	609782		2	
4q31-q34	4:138500001-182300000	PAND3	Panic disorder 3	609985		677663		max lod at D4S413	Panic disorder 3	609985		2	
4q31-q34	4:138500001-182300000	PSORS9	Psoriasis susceptibility 9	607857		359825		max lod at D4S1597	{Psoriasis susceptibility 9}	607857		2	
4q31	4:138500001-154600000	STQTL12	Stature quantitative trait locus 12	612224		100301523		associated with rs6854783	{Stature QTL 12}	612224		2	
4q31.1	4:139301505-139391384	NAA15, NARG1, NATH, MRD50	N-alpha-acetyltransferase 15, NatA auxiliary subunit	608000	NAA15	80155	ENSG00000164134,ENST00000296543;;;ENST00000296543		Intellectual developmental disorder, autosomal dominant 50, with behavioral abnormalities	617787	AD	3	Naa15
4q31.1	4:139438376-139476609	RAB33B, SMC2	Ras-associated protein RAB33B	605950	RAB33B	83452	ENSG00000172007,ENST00000305626;;;ENST00000305626		Smith-McCort dysplasia 2	615222	AR	3	Rab33b
4q31.21	4:143336876-143474565	GAB1, DFNB26	Grb2-associated binding protein 1	604439	GAB1	2549	ENSG00000109458,ENST00000262994;;;ENST00000262994	mutation identified in 1 family	?Deafness, autosomal recessive 26	605428	AR	3	Gab1
4q31.21	4:143995188-144019380	GYPB, SS	Glycophorin B	617923	GYPB	2994	ENSG00000250361,ENST00000502664;;;ENST00000502664		[Blood group, Ss]	111740		3	Gypa
4q31.21	4:143995188-144019380	GYPB, SS	Glycophorin B	617923	GYPB	2994	ENSG00000250361,ENST00000502664;;;ENST00000502664		{Malaria, resistance to}	611162		3	Gypa
4q31.21	4:144109303-144140718	GYPA, MN, GPA	Glycophorin A	617922	GYPA	2993	ENSG00000170180,ENST00000641688;;;ENST00000641688		[Blood group, MNSs system]	111300		3	Gypa
4q31.21	4:144109303-144140718	GYPA, MN, GPA	Glycophorin A	617922	GYPA	2993	ENSG00000170180,ENST00000641688;;;ENST00000641688		{Malaria, resistance to}	611162		3	Gypa
4q31.21	4:145619385-145660033	MMAA	Metabolism of cobalamin associated A	607481	MMAA	166785	ENSG00000151611,ENST00000649156;;;ENST00000649156		Methylmalonic aciduria, vitamin B12-responsive, cblA type	251100	AR	3	Mmaa
4q31.22	4:146253981-146521940	SLC10A7, SSASKS	Solute carrier family 10 (sodium/bile acid cotransporter family), member 7	611459	SLC10A7	84068	ENSG00000120519,ENST00000335472;;;ENST00000335472		Short stature, amelogenesis imperfecta, and skeletal dysplasia with scoliosis	618363	AR	3	Slc10a7
4q31.22	4:146706617-146945864	TTC29, SPGF42	Tetratricopeptide repeat domain-containing protein 29	618735	TTC29	83894	ENSG00000137473,ENST00000325106;;;ENST00000325106		Spermatogenic failure 42	618745	AR	3	Ttc29
4q31.22-q31.23	4:147481097-147544954	EDNRA, MFDA	Endothelin receptor type A	131243	EDNRA	1909	ENSG00000151617,ENST00000651419;;;ENST00000651419		{Migraine, resistance to}	157300	AD	3	Ednra
4q31.22-q31.23	4:147481097-147544954	EDNRA, MFDA	Endothelin receptor type A	131243	EDNRA	1909	ENSG00000151617,ENST00000651419;;;ENST00000651419		Mandibulofacial dysostosis with alopecia	616367	AD	3	Ednra
4q31.23	4:148078764-148445322	NR3C2, MLR, MCR	Nuclear receptor subfamily 3, group C, member 2 (mineralocorticoid receptor; aldosterone receptor)	600983	NR3C2	4306	ENSG00000151623,ENST00000358102;;;ENST00000358102		Hypertension, early-onset, autosomal dominant, with exacerbation in pregnancy	605115		3	Nr3c2
4q31.23	4:148078764-148445322	NR3C2, MLR, MCR	Nuclear receptor subfamily 3, group C, member 2 (mineralocorticoid receptor; aldosterone receptor)	600983	NR3C2	4306	ENSG00000151623,ENST00000358102;;;ENST00000358102		Pseudohypoaldosteronism type I, autosomal dominant	177735	AD	3	Nr3c2
4q31.3-q32.3	4:150200001-169200000	HSCR9	Hirschsprung disease, susceptibility to, 9	611644		100188850		between D4S3049 and D4S1566	{Hirschsprung disease, susceptibility to, 9}	611644		2	
4q31.3	4:150264435-151015727	LRBA, LBA, CDC4L, CVID8	Lipopolysaccharide-responsive, beige-like anchor protein	606453	LRBA	987	ENSG00000198589,ENST00000651943;;;ENST00000651943		Immunodeficiency, common variable, 8, with autoimmunity	614700	AR	3	Lrba
4q31.3	4:150582151-150584693	MAB21L2, MCSKS14	mab-21 like 2	604357	MAB21L2	10586	ENSG00000181541,ENST00000317605;;;ENST00000317605		Microphthalmia/coloboma and skeletal dysplasia syndrome	615877	AD, AR	3	Mab21l2
4q31.3	4:151670504-151761007	GATB, PET112, COXPD41	Glutamyl-tRNA amidotransferase, subunit B	603645	GATB	5188	ENSG00000059691,ENST00000263985;;;ENST00000263985	mutation identified in 1 COXPD41 family	?Combined oxidative phosphorylation deficiency 41	618838	AR	3	Gatb
4q31.3	4:152320544-152536092	FBXW7, AGO, CDC4, DEDHIL	F-box and WD40 domain protein 7	606278	FBXW7	55294	ENSG00000109670,ENST00000281708;;;ENST00000281708		Developmental delay, hypotonia, and impaired language	620012	AD	3	Fbxw7
4q31.3	4:153152163-153339317	TRIM2, KIAA0517, CMT2R	Tripartite motif-containing protein 2	614141	TRIM2	23321	ENSG00000109654,ENST00000338700;;;ENST00000338700		Charcot-Marie-Tooth disease, type 2R	615490	AR	3	Trim2
4q31.3	4:153684280-153710637	TLR2, TIL4	Toll-like receptor-2	603028	TLR2	7097	ENSG00000137462,ENST00000642700;;;ENST00000642700		{Colorectal cancer, susceptibility to}	114500	AD, SMu	3	Tlr2
4q31.3	4:153684280-153710637	TLR2, TIL4	Toll-like receptor-2	603028	TLR2	7097	ENSG00000137462,ENST00000642700;;;ENST00000642700		{Leprosy, susceptibility to}	246300	AD	3	Tlr2
4q31.3	4:153684280-153710637	TLR2, TIL4	Toll-like receptor-2	603028	TLR2	7097	ENSG00000137462,ENST00000642700;;;ENST00000642700		{Mycobacterium tuberculosis, susceptibility to}	607948		3	Tlr2
4q31.3	4:154562980-154572807	FGB	Fibrinogen, beta polypeptide	134830	FGB	2244	ENSG00000171564,ENST00000302068;;;ENST00000302068	4q31 by A; proximal to GYPB/GYPA	Afibrinogenemia, congenital	202400	AR	3	Fgb
4q31.3	4:154562980-154572807	FGB	Fibrinogen, beta polypeptide	134830	FGB	2244	ENSG00000171564,ENST00000302068;;;ENST00000302068	4q31 by A; proximal to GYPB/GYPA	Dysfibrinogenemia, congenital	616004	AD	3	Fgb
4q31.3	4:154562980-154572807	FGB	Fibrinogen, beta polypeptide	134830	FGB	2244	ENSG00000171564,ENST00000302068;;;ENST00000302068	4q31 by A; proximal to GYPB/GYPA	Hypofibrinogenemia, congenital	202400	AR	3	Fgb
4q31.3	4:154583126-154590742	FGA, AMYLD2	Fibrinogen, alpha chain	134820	FGA	2243	ENSG00000171560,ENST00000403106;;;ENST00000403106		Afibrinogenemia, congenital	202400	AR	3	Fga
4q31.3	4:154583126-154590742	FGA, AMYLD2	Fibrinogen, alpha chain	134820	FGA	2243	ENSG00000171560,ENST00000403106;;;ENST00000403106		Amyloidosis, hereditary systemic 2	105200	AD	3	Fga
4q31.3	4:154583126-154590742	FGA, AMYLD2	Fibrinogen, alpha chain	134820	FGA	2243	ENSG00000171560,ENST00000403106;;;ENST00000403106		Dysfibrinogenemia, congenital	616004	AD	3	Fga
4q31.3	4:154583126-154590742	FGA, AMYLD2	Fibrinogen, alpha chain	134820	FGA	2243	ENSG00000171560,ENST00000403106;;;ENST00000403106		Hypodysfibrinogenemia, congenital	616004	AD	3	Fga
4q32-q34	4:154600001-182300000	RP29	Retinitis pigmentosa 29	612165		54110		maximum lod at D4S415	Retinitis pigmentosa 29	612165	AR	2	
4q32.1-q32.2	4:154600001-163600000	TRIP4q32.1q32.2, C4TRIPq32.1q32.2	Chromosome 4q32.1-q32.2 triplication syndrome	613603					Chromosome 4q32.1-q32.2 triplication syndrome	613603	AD	4	
4q32.1	4:154604136-154612656	FGG	Fibrinogen, gamma polypeptide	134850	FGG	2266	ENSG00000171557,ENST00000336098;;;ENST00000336098	linked to MN	Afibrinogenemia, congenital	202400	AR	3	Fgg
4q32.1	4:154604136-154612656	FGG	Fibrinogen, gamma polypeptide	134850	FGG	2266	ENSG00000171557,ENST00000336098;;;ENST00000336098	linked to MN	Dysfibrinogenemia, congenital	616004	AD	3	Fgg
4q32.1	4:154604136-154612656	FGG	Fibrinogen, gamma polypeptide	134850	FGG	2266	ENSG00000171557,ENST00000336098;;;ENST00000336098	linked to MN	Hypodysfibrinogenemia	616004	AD	3	Fgg
4q32.1	4:154604136-154612656	FGG	Fibrinogen, gamma polypeptide	134850	FGG	2266	ENSG00000171557,ENST00000336098;;;ENST00000336098	linked to MN	Hypofibrinogenemia, congenital	202400	AR	3	Fgg
4q32.1	4:154740838-154753120	LRAT, LCA14	Lecithin retinol acyltransferase	604863	LRAT	9227	ENSG00000121207,ENST00000336356;;;ENST00000336356		Leber congenital amaurosis 14	613341	AR	3	Lrat
4q32.1	4:154740838-154753120	LRAT, LCA14	Lecithin retinol acyltransferase	604863	LRAT	9227	ENSG00000121207,ENST00000336356;;;ENST00000336356		Retinal dystrophy, early-onset severe	613341	AR	3	Lrat
4q32.1	4:154740838-154753120	LRAT, LCA14	Lecithin retinol acyltransferase	604863	LRAT	9227	ENSG00000121207,ENST00000336356;;;ENST00000336356		Retinitis pigmentosa, juvenile	613341	AR	3	Lrat
4q32.1	4:155666848-155737059	GUCY1A1, GUCY1A3, GUC1A3, GUCSA3, MYMY6	Guanylate cyclase 1, soluble, alpha 1	139396	GUCY1A1	2982	ENSG00000164116,ENST00000506455;;;ENST00000506455		Moyamoya 6 with achalasia	615750	AR	3	Gucy1a1
4q32.1	4:155903696-155920406	TDO2, TPH2, TRPO, HYPTRP	Tryptophan oxygenase	191070	TDO2	6999	ENSG00000151790,ENST00000536354;;;ENST00000536354	mutation identified in 1 HYPTRP patient	[?Hypertryptophanemia]	600627	AR	3	Tdo2
4q32.1	4:157076150-157172090	GLRB, HKPX2	Glycine receptor, beta subunit	138492	GLRB	2743	ENSG00000109738,ENST00000264428;;;ENST00000264428		Hyperekplexia 2	614619	AR	3	Glrb
4q32.1	4:157220120-157366075	GRIA2, GLUR2, NEDLIB	Glutamate receptor, ionotropic, AMPA 2	138247	GRIA2	2891	ENSG00000120251,ENST00000264426;;;ENST00000264426		Neurodevelopmental disorder with language impairment and behavioral abnormalities	618917	AD	3	Gria2
4q32.1	4:158672296-158709623	ETFDH, MADD	Electron transfer flavoprotein:ubiquinone oxidoreductase	231675	ETFDH	2110	ENSG00000171503,ENST00000511912;;;ENST00000511912		Glutaric acidemia IIC	231680	AR	3	Etfdh
4q32.1	4:159103079-159360173	RAPGEF2, NRAPGEP, RAGEF, KIAA0313	Rap guanine nucleotide exchange factor 2	609530	RAPGEF2	9693	ENSG00000109756,ENST00000691494;;;ENST00000691494	mutation identified in 1 FAME7 patient	?Epilepsy, familial adult myoclonic, 7	618075	AD	3	Rapgef2
4q32.2	4:163103929-163166890	NAF1, PFBMFT7	Nuclear assembly factor 1 ribonucleoprotein	617868	NAF1	92345	ENSG00000145414,ENST00000274054;;;ENST00000274054		Pulmonary fibrosis and/or bone marrow failure syndrome, telomere-related, 7	620365	AD	3	Naf1
4q32.3	4:163600001-169200000	CINN	Cinnamon odor, pleasantness of	611109		100188835		max lod at AFM295YES	[Cinnamon odor, pleasantness of]	611109		2	
4q32.3	4:163600001-169200000	HDLCQ4	High density lipoprotein cholesterol level QTL 4	610239		100188806		between D4S1597 and D4S1539	[High density lipoprotein cholesterol level QTL 4]	610239		2	
4q32.3	4:165327669-165343164	MSMO1, SC4MOL, ERG25, MCCPD	Methylsterol monooxygenase 1	607545	MSMO1	6307	ENSG00000052802,ENST00000261507;;;ENST00000261507		Microcephaly, congenital cataract, and psoriasiform dermatitis	616834	AR	3	Msmo1
4q32.3	4:165379008-165498547	CPE, BDVS	Carboxypeptidase E	114855	CPE	1363	ENSG00000109472,ENST00000402744;;;ENST00000402744		BDV syndrome	619326	AR	3	Cpe
4q32.3	4:165873237-166104457	TLL1, TLL, ASD6	Tolloid-like 1	606742	TLL1	7092	ENSG00000038295,ENST00000061240;;;ENST00000061240		Atrial septal defect 6	613087	AD	3	Tll1
4q32.3	4:168497052-168928441	PALLD, KIAA0992, PNCA1	Palladin, cytoskeletal-associated protein	608092	PALLD	23022	ENSG00000129116,ENST00000505667;;;ENST00000505667		{Pancreatic cancer, susceptibility to, 1}	606856	AD	3	Palld
4q33-qter	4:169200001-190214555	HCA1	Hypercalciuria, absorptive, 1	607258		266790			Hypercalciuria, absorptive	607258		2	
4q33	4:169392809-169612583	NEK1, SRTD6, SRPS2A, ALS24, OFD2	NIMA-related kinase 1	604588	NEK1	4750	ENSG00000137601,ENST00000507142;;;ENST00000507142	1 patient showed heterozygous NEK2 and DYNC2H1 mutations; mutation identified in 1 OFD2 family	?Orofaciodigital syndrome II	252100	AR	3	Nek1
4q33	4:169392809-169612583	NEK1, SRTD6, SRPS2A, ALS24, OFD2	NIMA-related kinase 1	604588	NEK1	4750	ENSG00000137601,ENST00000507142;;;ENST00000507142	1 patient showed heterozygous NEK2 and DYNC2H1 mutations; mutation identified in 1 OFD2 family	{Amyotrophic lateral sclerosis, susceptibility to, 24}	617892	AD	3	Nek1
4q33	4:169392809-169612583	NEK1, SRTD6, SRPS2A, ALS24, OFD2	NIMA-related kinase 1	604588	NEK1	4750	ENSG00000137601,ENST00000507142;;;ENST00000507142	1 patient showed heterozygous NEK2 and DYNC2H1 mutations; mutation identified in 1 OFD2 family	Short-rib thoracic dysplasia 6 with or without polydactyly	263520	AR, DR	3	Nek1
4q33	4:169620578-169723673	CLCN3, NEDHYBA, NEDSBA	Chloride channel-3	600580	CLCN3	1182	ENSG00000109572,ENST00000513761;;;ENST00000513761	mutation identified in 1 NEDSBA family	Neurodevelopmental disorder with hypotonia and brain abnormalities	619512	AD	3	Clcn3
4q33	4:169620578-169723673	CLCN3, NEDHYBA, NEDSBA	Chloride channel-3	600580	CLCN3	1182	ENSG00000109572,ENST00000513761;;;ENST00000513761	mutation identified in 1 NEDSBA family	Neurodevelopmental disorder with seizures and brain abnormalities	619517	AR	3	Clcn3
4q34.1	4:174490175-174522893	HPGD, PGDH1, PHOAR1	Hydroxyprostaglandin dehydrogenase 15-(NAD)	601688	HPGD	3248	ENSG00000164120,ENST00000296522;;;ENST00000296522	mutation identified in 1 DIGC family	?Digital clubbing, isolated congenital	119900	AR	3	Hpgd
4q34.1	4:174490175-174522893	HPGD, PGDH1, PHOAR1	Hydroxyprostaglandin dehydrogenase 15-(NAD)	601688	HPGD	3248	ENSG00000164120,ENST00000296522;;;ENST00000296522	mutation identified in 1 DIGC family	Cranioosteoarthropathy	259100	AR	3	Hpgd
4q34.1	4:174490175-174522893	HPGD, PGDH1, PHOAR1	Hydroxyprostaglandin dehydrogenase 15-(NAD)	601688	HPGD	3248	ENSG00000164120,ENST00000296522;;;ENST00000296522	mutation identified in 1 DIGC family	Hypertrophic osteoarthropathy, primary, autosomal recessive 1	259100	AR	3	Hpgd
4q34.3-q35.2	4:176600001-190214555	HMSN5	Hereditary motor and sensory neuropathy V	600361		101059903		D4S1552 and D4S2930	Hereditary motor and sensory neuropathy V	600361	AD	2	
4q34.3-q35.1	4:176600001-186200000	SCA30	Spinocerebellar ataxia 30	613371		100359393		between rs1397413 and rs2175476; max lod 3.0	?Spinocerebellar ataxia 30	613371	AD	2	
4q34.3	4:176683538-176792922	VEGFC, VRP, LMPHM4	Vascular endothelial growth factor C	601528	VEGFC	7424	ENSG00000150630,ENST00000618562;;;ENST00000618562		Lymphatic malformation 4	615907	AD	3	Vegfc
4q34.3	4:177430774-177442437	AGA	Aspartylglucosaminidase	613228	AGA	175	ENSG00000038002,ENST00000264595;;;ENST00000264595		Aspartylglucosaminuria	208400	AR	3	Aga
4q34.3-q35.1	4:181447613-182803024	TENM3, ODZ3, TNM3, KIAA1455, MCOPCB9, MCOPS15	Teneurin transmembrane protein 3	610083	TENM3	55714	ENSG00000218336,ENST00000511685;;;ENST00000511685	mutation identified in 1 MCOPCB9 family	?Microphthalmia/coloboma 9	615145	AR	3	Tenm3
4q34.3-q35.1	4:181447613-182803024	TENM3, ODZ3, TNM3, KIAA1455, MCOPCB9, MCOPS15	Teneurin transmembrane protein 3	610083	TENM3	55714	ENSG00000218336,ENST00000511685;;;ENST00000511685	mutation identified in 1 MCOPCB9 family	Microphthalmia, syndromic 15	615145	AR	3	Tenm3
4q35-qter	4:182300001-190214555	DFNA24	Deafness, autosomal dominant 24	606282		23723			Deafness, autosomal dominant 24	606282	AD	2	
4q35	4:182300001-190214555	DKBI	Dyskeratosis, hereditary benign intraepithelial	127600		80870			Dyskeratosis, hereditary benign intraepithelial	127600	AD	2	
4q35	4:182300001-190214555	FSHD1, FSHD1A	Facioscapulohumeral muscular dystrophy 1	158900				due to D4Z4 macrosatellite repeat on 4q35	Facioscapulohumeral muscular dystrophy 1	158900	AD	4	
4q35.1	4:183659293-183713589	TRAPPC11, C4orf41, LGMDR18	Trafficking protein particle complex, subunit 11	614138	TRAPPC11	60684	ENSG00000168538,ENST00000334690;;;ENST00000334690		Muscular dystrophy, limb-girdle, autosomal recessive 18	615356	AR	3	Trappc11
4q35.1	4:184649738-184694952	PRIMPOL, CCDC111, MYP22	Primase and DNA directed polymerase	615421	PRIMPOL	201973	ENSG00000164306,ENST00000314970;;;ENST00000314970		Myopia 22, autosomal dominant	615420	AD	3	Primpol
4q35.1	4:185143266-185150382	SLC25A4, ANT1, T1, PEO3, PEO2, MTDPS12A, PEOA2	Solute carrier family 25 (mitochondrial carrier) member 4 (adenine nucleotide translocator-1, skeletal muscle)	103220	SLC25A4	291	ENSG00000151729,ENST00000281456;;;ENST00000281456		Mitochondrial DNA depletion syndrome 12A (cardiomyopathic type) AD	617184	AD	3	Slc25a4
4q35.1	4:185143266-185150382	SLC25A4, ANT1, T1, PEO3, PEO2, MTDPS12A, PEOA2	Solute carrier family 25 (mitochondrial carrier) member 4 (adenine nucleotide translocator-1, skeletal muscle)	103220	SLC25A4	291	ENSG00000151729,ENST00000281456;;;ENST00000281456		Mitochondrial DNA depletion syndrome 12B (cardiomyopathic type) AR	615418	AR	3	Slc25a4
4q35.1	4:185143266-185150382	SLC25A4, ANT1, T1, PEO3, PEO2, MTDPS12A, PEOA2	Solute carrier family 25 (mitochondrial carrier) member 4 (adenine nucleotide translocator-1, skeletal muscle)	103220	SLC25A4	291	ENSG00000151729,ENST00000281456;;;ENST00000281456		Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 2	609283	AD	3	Slc25a4
4q35.1	4:185399537-185425964	UFSP2, C4orf20, BHD, SEMDDR, DEE106	UFM1-specific peptidase 2	611482	UFSP2	55325	ENSG00000109775,ENST00000264689;;;ENST00000264689	mutation identified in 1 BHD family	?Hip dysplasia, Beukes type	142669	AD	3	Ufsp2
4q35.1	4:185399537-185425964	UFSP2, C4orf20, BHD, SEMDDR, DEE106	UFM1-specific peptidase 2	611482	UFSP2	55325	ENSG00000109775,ENST00000264689;;;ENST00000264689	mutation identified in 1 BHD family	Developmental and epileptic encephalopathy 106	620028	AR	3	Ufsp2
4q35.1	4:185399537-185425964	UFSP2, C4orf20, BHD, SEMDDR, DEE106	UFM1-specific peptidase 2	611482	UFSP2	55325	ENSG00000109775,ENST00000264689;;;ENST00000264689	mutation identified in 1 BHD family	Spondyloepimetaphyseal dysplasia, Di Rocco type	617974	AD	3	Ufsp2
4q35.1	4:186069156-186088073	TLR3, IMD83	Toll-like receptor-3	603029	TLR3	7098	ENSG00000164342,ENST00000296795;;;ENST00000296795		{HIV1 infection, resistance to}	609423		3	Tlr3
4q35.1	4:186069156-186088073	TLR3, IMD83	Toll-like receptor-3	603029	TLR3	7098	ENSG00000164342,ENST00000296795;;;ENST00000296795		{Immunodeficiency 83, susceptibility to viral infections}	613002	AD, AR	3	Tlr3
4q35.1-q35.2	4:186191567-186213463	CYP4V2, BCD	Cytochrome P450, family 4, subfamily V, polypeptide 2	608614	CYP4V2	285440	ENSG00000145476,ENST00000378802;;;ENST00000378802		Bietti crystalline corneoretinal dystrophy	210370	AR	3	Cyp4v3
4q35.2	4:186210853-186258471	KLKB1, KLK3, PKKD	Kallikrein B plasma 1 (Fletcher factor)	229000	KLKB1	3818	ENSG00000164344,ENST00000264690;;;ENST00000264690	similar to F11	Fletcher factor (prekallikrein) deficiency	612423	AR	3	Klkb1
4q35.2	4:186266189-186290710	F11	Coagulation factor XI (plasma thromboplastin antecedent)	264900	F11	2160	ENSG00000088926,ENST00000403665;;;ENST00000403665	not closely linked to MNS	Factor XI deficiency, autosomal dominant	612416		3	F11
4q35.2	4:186266189-186290710	F11	Coagulation factor XI (plasma thromboplastin antecedent)	264900	F11	2160	ENSG00000088926,ENST00000403665;;;ENST00000403665	not closely linked to MNS	Factor XI deficiency, autosomal recessive	612416		3	F11
5p	5:1-48800001	ASD1	Atrial septal defect 1	108800		431		max lod at D5S406	Atrial septal defect 1	108800	AD	2	
5p15.33	5:1-4400000	BCC3	Basal cell carcinoma, susceptibility to, 3	613059		100307120			{Basal cell carcinoma, susceptibility to, 3}	613059		2	
5p15.33	5:1-4400000	GLM8	Glioma susceptibility 8	613033		100316847		associated with rs2736100	{Glioma susceptibility 8}	613033		2	
5p15.33	5:1-4400000	LNCR3	Lung cancer susceptibility 3	612571		100271687		associated with rs402710 and rs2736100	{Lung cancer susceptibility 3}	612571		2	
5p	5:1-48800001	MHS6	Malignant hyperthermia susceptibility 6	601888		4266			{Malignant hyperthermia susceptibility 6}	601888		2	
5p15.33-p15.2	5:1-15000000	MYP16	Myopia 16	612554		100270641		max lod at D5S2505	Myopia 16	612554		2	
5p15	5:1-18400000	TST2	Tuberculin skin test reactivity quantitative trait locus	613637		100526823		max lod at 16:2.70Mb	[Tuberculin skin test reactivity QTL]	613637		2	
5p15.33	5:218320-268746	SDHA, SDH1, SDHF, CMD1GG, PPGL5, MC2DN1, NDAXOA	Succinate dehydrogenase complex, flavoprotein subunit A	600857	SDHA	6389	ENSG00000073578,ENST00000264932;;;ENST00000264932	copy on 3q29	Cardiomyopathy, dilated, 1GG	613642	AR	3	Sdha
5p15.33	5:218320-268746	SDHA, SDH1, SDHF, CMD1GG, PPGL5, MC2DN1, NDAXOA	Succinate dehydrogenase complex, flavoprotein subunit A	600857	SDHA	6389	ENSG00000073578,ENST00000264932;;;ENST00000264932	copy on 3q29	Mitochondrial complex II deficiency, nuclear type 1	252011	AR	3	Sdha
5p15.33	5:218320-268746	SDHA, SDH1, SDHF, CMD1GG, PPGL5, MC2DN1, NDAXOA	Succinate dehydrogenase complex, flavoprotein subunit A	600857	SDHA	6389	ENSG00000073578,ENST00000264932;;;ENST00000264932	copy on 3q29	Neurodegeneration with ataxia and late-onset optic atrophy	619259	AD	3	Sdha
5p15.33	5:218320-268746	SDHA, SDH1, SDHF, CMD1GG, PPGL5, MC2DN1, NDAXOA	Succinate dehydrogenase complex, flavoprotein subunit A	600857	SDHA	6389	ENSG00000073578,ENST00000264932;;;ENST00000264932	copy on 3q29	Pheochromocytoma/paraganglioma syndrome 5	614165	AD	3	Sdha
5p15.33	5:470456-524449	SLC9A3, NHE3, DIAR8	Solute carrier family 9 (sodium/hydrogen exchanger), member 3	182307	SLC9A3	6550	ENSG00000066230,ENST00000264938;;;ENST00000264938	pseudogene on chr.10	Diarrhea 8, secretory sodium, congenital	616868	AR	3	Slc9a3
5p15.33	5:892884-919348	TRIP13, 16E1BP, MVA3, OZEMA9	Thyroid hormone receptor interactor 13	604507	TRIP13	9319	ENSG00000071539,ENST00000166345;;;ENST00000166345		Mosaic variegated aneuploidy syndrome 3	617598	AR	3	Trip13
5p15.33	5:892884-919348	TRIP13, 16E1BP, MVA3, OZEMA9	Thyroid hormone receptor interactor 13	604507	TRIP13	9319	ENSG00000071539,ENST00000166345;;;ENST00000166345		Oocyte/zygote/embryo maturation arrest 9	619011	AR	3	Trip13
5p15.33	5:1201595-1225111	SLC6A19, HND	Solute carrier family 6 (neurotransmitter transporter), member 19	608893	SLC6A19	340024	ENSG00000174358,ENST00000304460;;;ENST00000304460		Hartnup disorder	234500	AR	3	Slc6a19
5p15.33	5:1253167-1295068	TERT, TCS1, EST2, DKCA2, DKCB4, PFBMFT1, CMM9	Telomerase reverse transcriptase	187270	TERT	7015	ENSG00000164362,ENST00000310581;;;ENST00000310581	deleted in cri du chat	{Leukemia, acute myeloid}	601626	AD, SMu	3	Tert
5p15.33	5:1253167-1295068	TERT, TCS1, EST2, DKCA2, DKCB4, PFBMFT1, CMM9	Telomerase reverse transcriptase	187270	TERT	7015	ENSG00000164362,ENST00000310581;;;ENST00000310581	deleted in cri du chat	{Melanoma, cutaneous malignant, 9}	615134	AD	3	Tert
5p15.33	5:1253167-1295068	TERT, TCS1, EST2, DKCA2, DKCB4, PFBMFT1, CMM9	Telomerase reverse transcriptase	187270	TERT	7015	ENSG00000164362,ENST00000310581;;;ENST00000310581	deleted in cri du chat	Dyskeratosis congenita, autosomal dominant 2	613989	AD, AR	3	Tert
5p15.33	5:1253167-1295068	TERT, TCS1, EST2, DKCA2, DKCB4, PFBMFT1, CMM9	Telomerase reverse transcriptase	187270	TERT	7015	ENSG00000164362,ENST00000310581;;;ENST00000310581	deleted in cri du chat	Dyskeratosis congenita, autosomal recessive 4	613989	AD, AR	3	Tert
5p15.33	5:1253167-1295068	TERT, TCS1, EST2, DKCA2, DKCB4, PFBMFT1, CMM9	Telomerase reverse transcriptase	187270	TERT	7015	ENSG00000164362,ENST00000310581;;;ENST00000310581	deleted in cri du chat	Pulmonary fibrosis and/or bone marrow failure syndrome, telomere-related, 1	614742	AD	3	Tert
5p15.33	5:1392794-1445440	SLC6A3, DAT1, PKDYS1	Solute carrier family 6 (neurotransmitter transporter, dopamine), member 3	126455	SLC6A3	6531	ENSG00000142319,ENST00000270349;;;ENST00000270349		{Nicotine dependence, protection against}	188890		3	Slc6a3
5p15.33	5:1392794-1445440	SLC6A3, DAT1, PKDYS1	Solute carrier family 6 (neurotransmitter transporter, dopamine), member 3	126455	SLC6A3	6531	ENSG00000142319,ENST00000270349;;;ENST00000270349		Parkinsonism-dystonia, infantile, 1	613135	AR	3	Slc6a3
5p15.33	5:1801407-1816048	NDUFS6, MC1DN9	NADH-ubiquinone oxidoreductase subunit S6	603848	NDUFS6	4726	ENSG00000145494,ENST00000274137;;;ENST00000274137		Mitochondrial complex I deficiency, nuclear type 9	618232	AR	3	Ndufs6
5p15.32	5:4400001-6300000	MCDR3	Macular dystrophy, retinal, 3	608850				duplication of cis regulatory element cCRE10 downstream of IRX1	Macular dystrophy, retinal, 3	608850	AD	4	
5p15.31	5:6599239-6633044	NSUN2, TRM4, SAKI, MISU, MRT5	NOP2/SUN RNA methyltransferase family, member 2	610916	NSUN2	54888	ENSG00000037474,ENST00000264670;;;ENST00000264670		Intellectual developmental disorder, autosomal recessive 5	611091	AR	3	Nsun2
5p15.31	5:7850859-7901113	MTRR	Methionine synthase reductase	602568	MTRR	4552	ENSG00000124275,ENST00000440940;;;ENST00000440940		{Neural tube defects, folate-sensitive, susceptibility to}	601634	AR	3	Mtrr
5p15.31	5:7850859-7901113	MTRR	Methionine synthase reductase	602568	MTRR	4552	ENSG00000124275,ENST00000440940;;;ENST00000440940		Homocystinuria-megaloblastic anemia, cbl E type	236270	AR	3	Mtrr
5p15.2-p14	5:9900001-28900000	ADIPQTL2, CAQ5	Adiponectin, serum level of, QTL 2	606770		171511		near D5S817	{Adiponectin, serum level of, QTL2}	606770		2	
5p15.2-p14.3	5:9900001-23300000	ANIB4	Aneurysm, intracranial berry, 4	610213		724058		max lod at D5S1954	Aneurysm, intracranial berry, 4	610213		2	
5p15.2	5:10249921-10266412	CCT5, KIAA0098, CCTE, HSNSP	chaperonin containing TCP1, subunit 5 (epsilon)	610150	CCT5	22948	ENSG00000150753,ENST00000280326;;;ENST00000280326	mutation identified in 1 HSNSP family	?Neuropathy, hereditary sensory, with spastic paraplegia	256840	AR	3	Cct5
5p15.2	5:10353695-10440388	MARCHF6, MARCH6, TEB4, DOA10, KIAA0597, FAME3	Membrane-associated RING-CH finger protein 6	613297	MARCHF6	10299	ENSG00000145495,ENST00000274140;;;ENST00000274140		Epilepsy, familial adult myoclonic, 3	613608	AD	3	Marchf6
5p15.2	5:13690328-14011818	DNAH5, HL1, PCD, CILD3	Dynein, axonemal, heavy chain 5	603335	DNAH5	1767	ENSG00000039139,ENST00000265104;;;ENST00000265104		Ciliary dyskinesia, primary, 3, with or without situs inversus	608644	AR	3	Dnah5
5p15.2	5:14143342-14510204	TRIO, MRD44, MRD63	Triple functional domain	601893	TRIO	7204	ENSG00000038382,ENST00000344204;;;ENST00000344204		Intellectual developmental disorder, autosomal dominant 44, with microcephaly	617061	AD	3	Trio
5p15.2	5:14143342-14510204	TRIO, MRD44, MRD63	Triple functional domain	601893	TRIO	7204	ENSG00000038382,ENST00000344204;;;ENST00000344204		Intellectual developmental disorder, autosomal dominant 63, with macrocephaly	618825	AD	3	Trio
5p15.2	5:14664718-14716525	OTULIN, FAM105B, GUM, AIPDS, IMD107, AIPDSA	OTU deubiquitinase with linear linkage specificity	615712	OTULIN	90268	ENSG00000154124,ENST00000284274;;;ENST00000284274		{Immunodeficiency 107, susceptibility to invasive staphylococcus aureus infection}	619986	AD	3	Otulin
5p15.2	5:14664718-14716525	OTULIN, FAM105B, GUM, AIPDS, IMD107, AIPDSA	OTU deubiquitinase with linear linkage specificity	615712	OTULIN	90268	ENSG00000154124,ENST00000284274;;;ENST00000284274		Autoinflammation, panniculitis, and dermatosis syndrome, autosomal dominant	621030	AD	3	Otulin
5p15.2	5:14664718-14716525	OTULIN, FAM105B, GUM, AIPDS, IMD107, AIPDSA	OTU deubiquitinase with linear linkage specificity	615712	OTULIN	90268	ENSG00000154124,ENST00000284274;;;ENST00000284274		Autoinflammation, panniculitis, and dermatosis syndrome, autosomal recessive	617099	AR	3	Otulin
5p15.2	5:14704800-14871778	ANKH, HANK, ANK, CMDJ, CCAL2, CPPDD	ANKH inorganic pyrophosphate transport regulator	605145	ANKH	56172	ENSG00000154122,ENST00000284268;;;ENST00000284268		Chondrocalcinosis 2	118600	AD	3	Ank
5p15.2	5:14704800-14871778	ANKH, HANK, ANK, CMDJ, CCAL2, CPPDD	ANKH inorganic pyrophosphate transport regulator	605145	ANKH	56172	ENSG00000154122,ENST00000284268;;;ENST00000284268		Craniometaphyseal dysplasia	123000	AD	3	Ank
5p15.1-p13.3	5:15000001-33800000	MYP19	Myopia 19, autosomal dominant	613969		100653370		highest lod at D5S419	Myopia 19	613969	AD	2	
5p15.1	5:15000001-18400000	PVNH3	Periventricular nodular heterotopia 3	608098		100302681			Periventricular nodular heterotopia 3	608098		2	
5p15.1	5:16473053-16616997	RETREG1, FAM134B, HSAN2B	Reticulophagy regulator 1	613114	RETREG1	54463	ENSG00000154153,ENST00000306320;;;ENST00000306320		Neuropathy, hereditary sensory and autonomic, type IIB	613115	AR	3	Retreg1
5p13	5:28900001-42500000	ADHD4	Attention deficit-hyperactivity disorder, susceptibility to, 4	608906		450090			{Attention deficit-hyperactivity disorder, susceptibility to, 4}	608906		2	
5p13.3-p13.2	5:28900001-38400000	BDA1B	Brachydactyly, type A1, locus B	607004		246260			Brachydactyly, type A1, B	607004	AD	2	
5p13	5:28900001-42500000	DUP5p13, C5DUPp13	Chromosome 5p13 duplication syndrome	613174					Chromosome 5p13 duplication syndrome	613174	IC	4	
5p13-q12	5:28900001-67400000	HYT6	Hypertension, essential, susceptibility to, 6	610262		100188808			{Hypertension, essential, susceptibility to, 6}	145500	Mu	2	
5p13	5:28900001-42500000	KYPSC1	Kyphoscoliosis 1	610170		780921			Kyphoscoliosis 1	610170		2	
5p13.3	5:32690872-32791720	NPR3, ANPRC, BOMOS	Natriuretic peptide receptor C	108962	NPR3	4883	ENSG00000113389,ENST00000265074;;;ENST00000265074		Boudin-Mortier syndrome	619543	AR	3	Npr3
5p13.3	5:33440696-33468091	TARS1, TARS, TTD7	Threonyl-tRNA synthetase 1	187790	TARS1	6897	ENSG00000113407,ENST00000265112;;;ENST00000265112	linked to LARS	Trichothiodystrophy 7, nonphotosensitive	618546	AR	3	Tars1
5p13.2	5:33800001-38400000	MS3	Multiple sclerosis, susceptibility to, 3	612595		100271695		associated with rs6897932	{Multiple sclerosis, susceptibility to, 3}	612595		2	
5p13.2	5:33944623-33984693	SLC45A2, MATP, AIM1, SHEP5, OCA4	Solute carrier family 45, member 2	606202	SLC45A2	51151	ENSG00000164175,ENST00000296589;;;ENST00000296589		[Skin/hair/eye pigmentation 5, black/nonblack hair]	227240	AR	3	Slc45a2
5p13.2	5:33944623-33984693	SLC45A2, MATP, AIM1, SHEP5, OCA4	Solute carrier family 45, member 2	606202	SLC45A2	51151	ENSG00000164175,ENST00000296589;;;ENST00000296589		[Skin/hair/eye pigmentation 5, dark/fair skin]	227240	AR	3	Slc45a2
5p13.2	5:33944623-33984693	SLC45A2, MATP, AIM1, SHEP5, OCA4	Solute carrier family 45, member 2	606202	SLC45A2	51151	ENSG00000164175,ENST00000296589;;;ENST00000296589		[Skin/hair/eye pigmentation 5, dark/light eyes]	227240	AR	3	Slc45a2
5p13.2	5:33944623-33984693	SLC45A2, MATP, AIM1, SHEP5, OCA4	Solute carrier family 45, member 2	606202	SLC45A2	51151	ENSG00000164175,ENST00000296589;;;ENST00000296589		Albinism, oculocutaneous, type IV	606574	AR	3	Slc45a2
5p13.2	5:33986165-34008050	AMACR, CBAS4, AMACRD	Alpha-methylacyl-CoA racemase	604489	AMACR	23600	ENSG00000242110,ENST00000335606;;;ENST00000335606		Alpha-methylacyl-CoA racemase deficiency	614307	AR	3	Amacr
5p13.2	5:33986165-34008050	AMACR, CBAS4, AMACRD	Alpha-methylacyl-CoA racemase	604489	AMACR	23600	ENSG00000242110,ENST00000335606;;;ENST00000335606		Bile acid synthesis defect, congenital, 4	214950	AR	3	Amacr
5p13.2	5:34929559-34958964	DNAJC21, DNAJA5, BMFS3	DNAJ/HSP40 homolog, subfamily C, member 21	617048	DNAJC21	134218	ENSG00000168724,ENST00000648817;;;ENST00000648817		Bone marrow failure syndrome 3	617052	AR	3	Dnajc21
5p13.2	5:34998102-35047949	AGXT2, AGT2, BAIBA	Alanine-glyoxylate aminotransferase 2	612471	AGXT2	64902	ENSG00000113492,ENST00000231420;;;ENST00000231420		[Beta-aminoisobutyric acid, urinary excretion of]	210100	AR	3	Agxt2
5p13.2	5:35048756-35230487	PRLR, MFAB, HPRL	Prolactin receptor	176761	PRLR	5618	ENSG00000113494,ENST00000618457;;;ENST00000618457		Hyperprolactinemia	615555	AD, AR	3	Prlr
5p13.2	5:35048756-35230487	PRLR, MFAB, HPRL	Prolactin receptor	176761	PRLR	5618	ENSG00000113494,ENST00000618457;;;ENST00000618457		Multiple fibroadenomas of the breast	615554	AD	3	Prlr
5p13.2	5:35617863-35814611	SPEF2, KPL2, KIAA1770, SPGF43	Sperm flagellar protein 2	610172	SPEF2	79925	ENSG00000152582,ENST00000356031;;;ENST00000356031		Spermatogenic failure 43	618751	AR	3	Spef2
5p13.2	5:35856891-35879603	IL7R, IL7RA, CD127, IMD104	Interleukin-7 receptor	146661	IL7R	3575	ENSG00000168685,ENST00000303115;;;ENST00000303115		Immunodeficiency 104, severe combined	608971	AR	3	Il7r
5p13.2	5:36098407-36151887	LMBRD2, DENBA	LMBR1 domain-containing protein 2	619490	LMBRD2	92255	ENSG00000164187,ENST00000296603;;;ENST00000296603		Developmental delay with variable neurologic and brain abnormalities	619694	AD	3	Lmbrd2
5p13.2	5:36192589-36242279	NADK2, C5orf33, DECRD	NAD kinase 2, mitochondrial	615787	NADK2	133686	ENSG00000152620,ENST00000381937;;;ENST00000381937		2,4-dienoyl-CoA reductase deficiency	616034	AR	3	Nadk2
5p13.2	5:36596588-36688334	SLC1A3, EAAT1, EA6	Solute carrier family 1 (glial high affinity glutamate transporter), member 3	600111	SLC1A3	6507	ENSG00000079215,ENST00000265113;;;ENST00000265113		Episodic ataxia, type 6	612656	AD	3	Slc1a3
5p13.2	5:36876769-37066413	NIPBL, CDLS1	Nipped-B-like (delangin)	608667	NIPBL	25836	ENSG00000164190,ENST00000282516;;;ENST00000282516		Cornelia de Lange syndrome 1	122470	AD	3	Nipbl
5p13.2	5:37075669-37249376	CPLANE1, C5orf42, JBTS17, OFD6	Ciliogenesis and planar polarity effector complex, subunit 1	614571	CPLANE1	65250	ENSG00000197603,ENST00000651892;;;ENST00000651892		Joubert syndrome 17	614615	AR	3	Cplane1
5p13.2	5:37075669-37249376	CPLANE1, C5orf42, JBTS17, OFD6	Ciliogenesis and planar polarity effector complex, subunit 1	614571	CPLANE1	65250	ENSG00000197603,ENST00000651892;;;ENST00000651892		Orofaciodigital syndrome VI	277170	AR	3	Cplane1
5p13.2	5:37288137-37371106	NUP155, KIAA0791, ATFB15	Nucleoporin, 155kD	606694	NUP155	9631	ENSG00000113569,ENST00000231498;;;ENST00000231498	mutation identified in 1 ATFB15 family	?Atrial fibrillation 15	615770	AR	3	Nup155
5p13.2	5:37812677-37840041	GDNF, HSCR3	Glial cell line derived neurotrophic factor	600837	GDNF	2668	ENSG00000168621,ENST00000326524;;;ENST00000326524		{Hirschsprung disease, susceptibility to, 3}	613711	AD	3	Gdnf
5p13.1	5:38400001-42500000	IBD18	Inflammatory bowel disease 18	612262		100190931		associated with rs1373692	{Inflammatory bowel disease 18}	612262		2	
5p13.1	5:38474668-38608403	LIFR, STWS, SWS, SJS2	Leukemia inhibitory factor receptor	151443	LIFR	3977	ENSG00000113594,ENST00000453190;;;ENST00000453190		Stuve-Wiedemann syndrome/Schwartz-Jampel type 2 syndrome	601559	AR	3	Lifr
5p13.1	5:38846012-38945579	OSMR, OSMRB, PLCA1	Oncostatin M receptor	601743	OSMR	9180	ENSG00000145623,ENST00000274276;;;ENST00000274276		Amyloidosis, primary localized cutaneous, 1	105250	AD	3	Osmr
5p13.1	5:39105252-39274528	FYB1, SLAP130, ADAP, THC3	FYN-binding protein 1	602731	FYB1	2533	ENSG00000082074,ENST00000512982;;;ENST00000512982		Thrombocytopenia 3	273900	AR	3	Fyb1
5p13.1	5:39284140-39364495	C9, C9D, ARMD15	Complement component-9	120940	C9	735	ENSG00000113600,ENST00000263408;;;ENST00000263408		{Macular degeneration, age-related, 15, susceptibility to}	615591	AD	3	C9
5p13.1	5:39284140-39364495	C9, C9D, ARMD15	Complement component-9	120940	C9	735	ENSG00000113600,ENST00000263408;;;ENST00000263408		C9 deficiency	613825		3	C9
5p13.1	5:40909497-40984643	C7	Complement component-7	217070	C7	730	ENSG00000112936,ENST00000313164;;;ENST00000313164		C7 deficiency	610102		3	C7
5p13.1	5:41142116-41261469	C6	Complement component-6	217050	C6	729	ENSG00000039537,ENST00000337836;;;ENST00000337836		C6 deficiency	612446	AR	3	C6
5p13.1	5:41730065-41870425	OXCT1, OXCT, SCOT	3-oxoacid CoA transferase 1	601424	OXCT1	5019	ENSG00000083720,ENST00000196371;;;ENST00000196371		Succinyl CoA:3-oxoacid CoA transferase deficiency	245050	AR	3	Oxct1
5p13.1-p12	5:42423439-42721878	GHR, GHIP	Growth hormone receptor	600946	GHR	2690	ENSG00000112964,ENST00000230882;;;ENST00000230882		{Hypercholesterolemia, familial, modifier of}	143890	AD, AR	3	Ghr
5p13.1-p12	5:42423439-42721878	GHR, GHIP	Growth hormone receptor	600946	GHR	2690	ENSG00000112964,ENST00000230882;;;ENST00000230882		Growth hormone insensitivity, partial	604271	AD	3	Ghr
5p13.1-p12	5:42423439-42721878	GHR, GHIP	Growth hormone receptor	600946	GHR	2690	ENSG00000112964,ENST00000230882;;;ENST00000230882		Increased responsiveness to growth hormone	604271	AD	3	Ghr
5p13.1-p12	5:42423439-42721878	GHR, GHIP	Growth hormone receptor	600946	GHR	2690	ENSG00000112964,ENST00000230882;;;ENST00000230882		Laron dwarfism	262500	AR	3	Ghr
5p12	5:43602675-43707396	NNT, GCCD4	Nicotinamide nucleotide transhydrogenase	607878	NNT	23530	ENSG00000112992,ENST00000344920;;;ENST00000344920		Glucocorticoid deficiency 4, with or without mineralocorticoid deficiency	614736	AR	3	Nnt
5p12	5:44300247-44389420	FGF10, LADD3	Fibroblast growth factor-10	602115	FGF10	2255	ENSG00000070193,ENST00000264664;;;ENST00000264664		Aplasia of lacrimal and salivary glands	180920	AD	3	Fgf10
5p12	5:44300247-44389420	FGF10, LADD3	Fibroblast growth factor-10	602115	FGF10	2255	ENSG00000070193,ENST00000264664;;;ENST00000264664		LADD syndrome 3	620193	AD	3	Fgf10
5p12	5:45254948-45696380	HCN1, BCNG1, DEE24, GEFSP10	Hyperpolarization-activated cyclic nucleotide-gated potassium channel 1	602780	HCN1	348980	ENSG00000164588,ENST00000303230;;;ENST00000303230		Developmental and epileptic encephalopathy 24	615871	AD	3	Hcn1
5p12	5:45254948-45696380	HCN1, BCNG1, DEE24, GEFSP10	Hyperpolarization-activated cyclic nucleotide-gated potassium channel 1	602780	HCN1	348980	ENSG00000164588,ENST00000303230;;;ENST00000303230		Generalized epilepsy with febrile seizures plus, type 10	618482	AD	3	Hcn1
5q	5:48800001-181538259	BSZQTL2	Bone size quantitative trait locus 2	609657		100188794			{Bone size QTL}	609657		2	
5q11.2	5:51400001-59600000	BDPLT9	Bleeding disorder, platelet-type, 9	614200		116814567			Bleeding disorder, platelet-type, 9	614200	AD	2	
5q11.2	5:52989352-53094779	ITGA2, CD49B, BR, FMAIT3	Integrin, alpha-2 (glycoprotein Ia; antigen CD49B)	192974	ITGA2	3673	ENSG00000164171,ENST00000296585;;;ENST00000296585		Fetomaternal alloimmune thrombocytopenia 3	621267	AD	3	Itga2
5q11.2	5:53095679-53109757	MOCS2, MPTS, MOCODB1	Molybdenum cofactor synthesis-2	603708	MOCS2	4338	ENSG00000164172,ENST00000396954;;;ENST00000396954		Molybdenum cofactor deficiency B1	252160	AR	3	Mocs2
5q11.2	5:53560639-53683338	NDUFS4, AQDQ, MC1DN1	NADH-ubiquinone oxidoreductase subunit S4	602694	NDUFS4	4724	ENSG00000164258,ENST00000296684;;;ENST00000296684		Mitochondrial complex I deficiency, nuclear type 1	252010	AR	3	Ndufs4
5q11.2	5:54455699-54456377	HSPB3, HSPL27, HMND4	Heat-shock 27kD protein 3	604624	HSPB3	8988	ENSG00000169271,ENST00000302005;;;ENST00000302005	mutation identified in 1 HMND4 family	?Neuronopathy, distal hereditary motor, autosomal dominant 4	613376	AD	3	Hspb3
5q11.2	5:55219564-55227315	MCIDAS, IDAS, CILD42	IDAS	614086	MCIDAS	345643	ENSG00000234602,ENST00000513312;;;ENST00000513312		Ciliary dyskinesia, primary, 42	618695	AR	3	Mcidas
5q11.2	5:55231152-55233608	CCNO, UNG2, CILD29	Cyclin O	607752	CCNO	10309	ENSG00000152669,ENST00000282572;;;ENST00000282572		Ciliary dyskinesia, primary, 29	615872	AR	3	Ccno
5q11.2	5:55839789-55922850	IL31RA, GLMR, GPL, PLCA2	Interleukin 31 receptor A	609510	IL31RA	133396	ENSG00000164509,ENST00000652347;;;ENST00000652347	mutation identified in 1 PLCA2 patient	?Amyloidosis, primary localized cutaneous, 2	613955	AD	3	Il31ra
5q11.2	5:55935095-55994963	IL6ST, HIES4A, HIES4B, STWS2, IMD94	Interleukin 6 cytokine family signal transducer	600694	IL6ST	3572	ENSG00000134352,ENST00000381298;;;ENST00000381298	mutation identified in one IMD94 patient	?Immunodeficiency 94 with autoinflammation and dysmorphic facies	619750	AD	3	Il6st
5q11.2	5:55935095-55994963	IL6ST, HIES4A, HIES4B, STWS2, IMD94	Interleukin 6 cytokine family signal transducer	600694	IL6ST	3572	ENSG00000134352,ENST00000381298;;;ENST00000381298	mutation identified in one IMD94 patient	Hyper-IgE syndrome 4A, autosomal dominant, with recurrent infections	619752	AD	3	Il6st
5q11.2	5:55935095-55994963	IL6ST, HIES4A, HIES4B, STWS2, IMD94	Interleukin 6 cytokine family signal transducer	600694	IL6ST	3572	ENSG00000134352,ENST00000381298;;;ENST00000381298	mutation identified in one IMD94 patient	Hyper-IgE syndrome 4B, autosomal recessive, with recurrent infections	618523	AR	3	Il6st
5q11.2	5:55935095-55994963	IL6ST, HIES4A, HIES4B, STWS2, IMD94	Interleukin 6 cytokine family signal transducer	600694	IL6ST	3572	ENSG00000134352,ENST00000381298;;;ENST00000381298	mutation identified in one IMD94 patient	Stuve-Wiedemann syndrome 2	619751	AR	3	Il6st
5q11.2	5:56815549-56896152	MAP3K1, MEKK1, MEKK, SRXY6	Mitogen-activated protein kinase kinase kinase 1	600982	MAP3K1	4214	ENSG00000095015,ENST00000399503;;;ENST00000399503		46XY sex reversal 6	613762	AD	3	Map3k1
5q11.2-q12.1	5:58969038-60522128	PDE4D, DPDE3, ACRDYS2	Phosphodiesterase-4D, cAMP-specific (dunce, Drosophila, homolog of, phosphodiesterase-E3)	600129	PDE4D	5144	ENSG00000113448,ENST00000340635;;;ENST00000340635		Acrodysostosis 2, with or without hormone resistance	614613	AD	3	Pde4d
5q12	5:59600001-67400000	DEL5q12, C5DELq12	Chromosome 5q12 deletion syndrome	615668					Chromosome 5q12 deletion syndrome	615668	AD	4	
5q12-q14	5:59600001-93000000	EJM4	Myoclonic epilepsy, juvenile, 4	611364		100126594		max lod at D5S459	Myoclonic epilepsy, juvenile, 4	611364	AD	2	
5q12	5:59600001-67400000	STRK1	Stroke, susceptibility to, 1	606799				association with PDE4D	{Stroke, susceptibility to, 1}	606799		2	
5q12.1	5:60866454-60945070	ERCC8, CKN1, CSA, UVSS2	ERCC excision repair 8, CSA ubiquitin ligase complex subunit	609412	ERCC8	1161	ENSG00000049167,ENST00000676185;;;ENST00000676185		Cockayne syndrome, type A	216400	AR	3	Ercc8
5q12.1	5:60866454-60945070	ERCC8, CKN1, CSA, UVSS2	ERCC excision repair 8, CSA ubiquitin ligase complex subunit	609412	ERCC8	1161	ENSG00000049167,ENST00000676185;;;ENST00000676185		UV-sensitive syndrome 2	614621	AR	3	Ercc8
5q12.1	5:60945205-61153026	NDUFAF2, NDUFA12L, MMTN, B17.2L, MC1DN10	NADH-ubiquinone oxidoreductase complex assembly factor 2	609653	NDUFAF2	91942	ENSG00000164182,ENST00000296597;;;ENST00000296597	pseudogene on chr.2	Mitochondrial complex I deficiency, nuclear type 10	618233	AR	3	Ndufaf2
5q12.1	5:61332258-61546172	ZSWIM6, KIAA1577, AFND, NEDMAGA	Zinc finger SWIM domain-containing protein 6	615951	ZSWIM6	57688	ENSG00000130449,ENST00000252744;;;ENST00000252744		Acromelic frontonasal dysostosis	603671	AD	3	Zswim6
5q12.1	5:61332258-61546172	ZSWIM6, KIAA1577, AFND, NEDMAGA	Zinc finger SWIM domain-containing protein 6	615951	ZSWIM6	57688	ENSG00000130449,ENST00000252744;;;ENST00000252744		Neurodevelopmental disorder with movement abnormalities, abnormal gait, and autistic features	617865	AD	3	Zswim6
5q12.1	5:62306206-62391025	KIF2A, CDCBM3	Kinesin, heavy chain, 2	602591	KIF2A	3796	ENSG00000068796,ENST00000407818;;;ENST00000407818		Cortical dysplasia, complex, with other brain malformations 3	615411	AD	3	Kif2a
5q12.3	5:63957874-63962445	HTR1A, ADRB2RL1, PFMCD	5-hydroxytryptamine (serotonin) receptor-1A	109760	HTR1A	3350	ENSG00000178394,ENST00000323865;;;ENST00000323865	mutation identified in 1 PFMCD patient	?Periodic fever, menstrual cycle dependent	614674	AD	3	Htr1a
5q12.3	5:64768918-65018763	CWC27, SDCCAG10, RPSKA	CWC27 spliceosome-associated cyclophilin	617170	CWC27	10283	ENSG00000153015,ENST00000381070;;;ENST00000381070		Retinitis pigmentosa with or without skeletal anomalies	250410	AR	3	Cwc27
5q13-q14	5:67400001-93000000	AAT2, FAA2	Aortic aneurysm, familial thoracic 2	607087		252843			Aortic aneurysm, familial thoracic 2	607087		2	
5q13-q22	5:67400001-115900000	GINGF2, GGF2, HGF2	Fibromatosis, gingival, 2	605544		64644		formerly GINGF2 used for a locus on 2p16-p13	Fibromatosis, gingival, 2	605544		2	
5q13	5:67400001-77600000	TSHQTL1	Thyroid-stimulating hormone level QTL 1	612306		100190789		associated with rs4704397	[Thyroid-stimulating hormone level QTL 1]	612306		2	
5q13.1	5:68215756-68301821	PIK3R1, GRB1, AGM7, SHORT, IMD36	Phosphatidylinositol 3-kinase, regulatory, 1	171833	PIK3R1	5295	ENSG00000145675,ENST00000521381;;;ENST00000521381		Agammaglobulinemia 7, autosomal recessive	615214	AR	3	Pik3r1
5q13.1	5:68215756-68301821	PIK3R1, GRB1, AGM7, SHORT, IMD36	Phosphatidylinositol 3-kinase, regulatory, 1	171833	PIK3R1	5295	ENSG00000145675,ENST00000521381;;;ENST00000521381		Immunodeficiency 36	616005	AD	3	Pik3r1
5q13.1	5:68215756-68301821	PIK3R1, GRB1, AGM7, SHORT, IMD36	Phosphatidylinositol 3-kinase, regulatory, 1	171833	PIK3R1	5295	ENSG00000145675,ENST00000521381;;;ENST00000521381		SHORT syndrome	269880	AD	3	Pik3r1
5q13.2	5:69415116-69444330	MARVELD2, MARVD2, TRIC, DFNB49	Marvel domain-containing protein 2 (tricellulin)	610572	MARVELD2	153562	ENSG00000152939,ENST00000325631;;;ENST00000325631		Deafness, autosomal recessive 49	610153	AR	3	Marveld2
5q13.2	5:69492547-69558104	OCLN, BLCPMG, PTORCH1	Occludin	602876	OCLN	100506658	ENSG00000197822,ENST00000396442;;;ENST00000396442		Pseudo-TORCH syndrome 1	251290	AR	3	Ocln
5q13.2	5:70049523-70090528	SMN2	Survival of motor neuron 2, centromeric	601627	SMN2	6607	ENSG00000205571,ENST00000380743;;;ENST00000380743		{Spinal muscular atrophy, type III, modifier of}	253400	AR	3	Smn1
5q13.2	5:70924941-70966375	SMN1, SMA1, SMA2, SMA3, SMA4	Survival of motor neuron 1, telomeric	600354	SMN1	6606	ENSG00000172062,ENST00000380707;;;ENST00000380707		Spinal muscular atrophy-1	253300	AR	3	Smn1
5q13.2	5:70924941-70966375	SMN1, SMA1, SMA2, SMA3, SMA4	Survival of motor neuron 1, telomeric	600354	SMN1	6606	ENSG00000172062,ENST00000380707;;;ENST00000380707		Spinal muscular atrophy-2	253550	AR	3	Smn1
5q13.2	5:70924941-70966375	SMN1, SMA1, SMA2, SMA3, SMA4	Survival of motor neuron 1, telomeric	600354	SMN1	6606	ENSG00000172062,ENST00000380707;;;ENST00000380707		Spinal muscular atrophy-3	253400	AR	3	Smn1
5q13.2	5:70924941-70966375	SMN1, SMA1, SMA2, SMA3, SMA4	Survival of motor neuron 1, telomeric	600354	SMN1	6606	ENSG00000172062,ENST00000380707;;;ENST00000380707		Spinal muscular atrophy-4	271150	AR	3	Smn1
5q13.2	5:71455651-71578288	BDP1, TFNR, DFNB112	B double prime 1, subunit of RNA polymerase III transcription initiation factor IIIB	607012	BDP1	55814	ENSG00000145734,ENST00000358731;;;ENST00000358731	mutation identified in 1 DFNB112 family	?Deafness, autosomal recessive 112	618257	AR	3	Bdp1
5q13.2	5:71587340-71658706	MCCC2, MCCB	3-Methylcrotonyl-CoA carboxylase 2	609014	MCCC2	64087	ENSG00000131844,ENST00000340941;;;ENST00000340941		3-Methylcrotonyl-CoA carboxylase 2 deficiency	210210	AR	3	Mccc2
5q13.2	5:71719275-71721045	CARTPT, CART	Cocaine- and amphetamine-regulated transcript prepropeptide	602606	CARTPT	9607	ENSG00000164326,ENST00000296777;;;ENST00000296777	mutation identified in 1 family	{?Obesity, susceptibility to}	601665	AD, AR, Mu	3	Cartpt
5q13.2	5:72107475-72209565	MAP1B, PVNH9, DFNA83	Microtubule-associated protein-1B	157129	MAP1B	4131	ENSG00000131711,ENST00000296755;;;ENST00000296755	mutation identified in 1 DFNA83 family	?Deafness, autosomal dominant 83	619808	AD	3	Map1b
5q13.2	5:72107475-72209565	MAP1B, PVNH9, DFNA83	Microtubule-associated protein-1B	157129	MAP1B	4131	ENSG00000131711,ENST00000296755;;;ENST00000296755	mutation identified in 1 DFNA83 family	Periventricular nodular heterotopia 9	618918	AD	3	Map1b
5q13.3	5:74640023-74721288	HEXB	Hexosaminidase B, beta polypeptide	606873	HEXB	3074	ENSG00000049860,ENST00000261416;;;ENST00000261416		Sandhoff disease, infantile, juvenile, and adult forms	268800	AR	3	Hexb
5q13.3	5:74721206-74767117	GFM2, EFG2, RRF	Mitochondrial elongation factor G2	606544	GFM2	84340	ENSG00000164347,ENST00000296805;;;ENST00000296805		Combined oxidative phosphorylation deficiency 39	618397	AR	3	Gfm2
5q13.3	5:75336529-75362116	HMGCR, LDLCQ3, LGMDR28	3-hydroxy-3-methylglutaryl-Coenzyme A reductase; HMG CoA reductase	142910	HMGCR	3156	ENSG00000113161,ENST00000287936;;;ENST00000287936	mutation identified in 1 MYPLG family	[Low density lipoprotein cholesterol level QTL 3]	620410		3	Hmgcr
5q13.3	5:75336529-75362116	HMGCR, LDLCQ3, LGMDR28	3-hydroxy-3-methylglutaryl-Coenzyme A reductase; HMG CoA reductase	142910	HMGCR	3156	ENSG00000113161,ENST00000287936;;;ENST00000287936	mutation identified in 1 MYPLG family	[Statins, response to]	620410		3	Hmgcr
5q13.3	5:75336529-75362116	HMGCR, LDLCQ3, LGMDR28	3-hydroxy-3-methylglutaryl-Coenzyme A reductase; HMG CoA reductase	142910	HMGCR	3156	ENSG00000113161,ENST00000287936;;;ENST00000287936	mutation identified in 1 MYPLG family	Muscular dystrophy, limb-girdle, autosomal recessive 28	620375	AR	3	Hmgcr
5q13.3	5:75368486-75511981	CERT1, COL4A3BP, GPBP, CERT, NEDHSF	Ceramide transporter 1	604677	CERT1	10087	ENSG00000113163,ENST00000643780;;;ENST00000643780		Neurodevelopmental disorder with hypotonia, speech delay, and dysmorphic facies	616351	AD	3	Cert1
5q13.3	5:77086715-77428256	PDE8B, PPNAD3, ADSD	Phosphodiesterase 8B	603390	PDE8B	8622	ENSG00000113231,ENST00000264917;;;ENST00000264917		Pigmented nodular adrenocortical disease, primary, 3	614190		3	Pde8b
5q13.3	5:77086715-77428256	PDE8B, PPNAD3, ADSD	Phosphodiesterase 8B	603390	PDE8B	8622	ENSG00000113231,ENST00000264917;;;ENST00000264917		Striatal degeneration, autosomal dominant	609161	AD	3	Pde8b
5q14	5:77600001-93000000	HBT	Telangiectasia, hereditary benign	187260		338411		max lod at D5S641	Telangiectasia, hereditary benign	187260	AD	2	
5q14.1-q21.3	5:77600001-110200000	KTCN5	Keratoconus 5	614622		100885801		between D5S2499 and D5S495	Keratoconus 5	614622	AD	2	
5q14.1	5:78000522-78294698	AP3B1, ADTB3A, HPS2	Adaptor-related protein complex 3, beta 1 subunit (adaptin, beta-3a)	603401	AP3B1	8546	ENSG00000132842,ENST00000255194;;;ENST00000255194		Hermansky-Pudlak syndrome 2	608233	AR	3	Ap3b1
5q14.1	5:78777209-78985958	ARSB, MPS6	Arylsulfatase B	611542	ARSB	411	ENSG00000113273,ENST00000264914;;;ENST00000264914		Mucopolysaccharidosis type VI (Maroteaux-Lamy)	253200	AR	3	Arsb
5q14.1	5:78997564-79069674	DMGDH, DMGDHD	Dimethylglycine dehydrogenase	605849	DMGDH	29958	ENSG00000132837,ENST00000255189;;;ENST00000255189		Dimethylglycine dehydrogenase deficiency	605850	AR	3	Dmgdh
5q14.1	5:80626226-80654983	DHFR	Dihydrofolate reductase	126060	DHFR	1719	ENSG00000228716,ENST00000439211;;;ENST00000439211		Megaloblastic anemia due to dihydrofolate reductase deficiency	613839	AR	3	Dhfr
5q14.1	5:80654652-80876815	MSH3, FAP4	mutS homolog 3	600887	MSH3	4437	ENSG00000113318,ENST00000265081;;;ENST00000265081	5' to DHFR	Endometrial carcinoma, somatic	608089		3	Msh3
5q14.1	5:80654652-80876815	MSH3, FAP4	mutS homolog 3	600887	MSH3	4437	ENSG00000113318,ENST00000265081;;;ENST00000265081	5' to DHFR	Familial adenomatous polyposis 4	617100	AR	3	Msh3
5q14.2	5:82100001-83500000	VUR4	Vesicoureteral reflux 4	614317		100820757		closest marker rs1501656	Vesicoureteral reflux 4	614317		2	
5q14.2	5:82273320-82278354	RPS23, BTDD, MCINS	Ribosomal protein S23	603683	RPS23	6228	ENSG00000186468,ENST00000296674;;;ENST00000296674		Brachycephaly, trichomegaly, and developmental delay	617412	AD	3	Rps23
5q14.2	5:83077547-83374473	XRCC4, SSMED	X-ray repair cross complementing 4	194363	XRCC4	7518	ENSG00000152422,ENST00000396027;;;ENST00000396027	between D5S427 and D5S401	Short stature, microcephaly, and endocrine dysfunction	616541	AR	3	Xrcc4
5q14.2-q14.3	5:83471744-83582302	VCAN, CSPG2, WGN, WGN1, ERVR	Versican (chondroitin sulfate proteoglycan-2)	118661	VCAN	1462	ENSG00000038427,ENST00000265077;;;ENST00000265077		Wagner syndrome 1	143200	AD	3	Vcan
5q14.3-q15	5:83500001-98900000	PVNH5	Periventricular nodular heterotopia 5	612881				deletion range 6.3-17Mb, common range 5.8Mb	Periventricular nodular heterotopia 5	612881		4	
5q14.3	5:87267883-87391916	RASA1, GAP, CMAVM1, PKWS	RAS p21 protein activator 1 (GTPase activating protein)	139150	RASA1	5921	ENSG00000145715,ENST00000274376;;;ENST00000274376		Basal cell carcinoma, somatic	605462		3	Rasa1
5q14.3	5:87267883-87391916	RASA1, GAP, CMAVM1, PKWS	RAS p21 protein activator 1 (GTPase activating protein)	139150	RASA1	5921	ENSG00000145715,ENST00000274376;;;ENST00000274376		Capillary malformation-arteriovenous malformation 1	608354	AD	3	Rasa1
5q14.3	5:88717117-88904105	MEF2C, C5DELq14.3, DEL5q14.3, NEDHSIL	MADS box transcription enhancer factor 2, polypeptide C (myocyte enhancer factor 2C)	600662	MEF2C	4208	ENSG00000081189,ENST00000504921;;;ENST00000504921		Chromosome 5q14.3 deletion syndrome	613443	AD	4	Mef2c
5q14.3	5:88717117-88904105	MEF2C, C5DELq14.3, DEL5q14.3, NEDHSIL	MADS box transcription enhancer factor 2, polypeptide C (myocyte enhancer factor 2C)	600662	MEF2C	4208	ENSG00000081189,ENST00000504921;;;ENST00000504921		Neurodevelopmental disorder with hypotonia, stereotypic hand movements, and impaired language	613443	AD	3	Mef2c
5q14.3	5:90558797-91164437	ADGRV1, GPR98, MASS1, VLGR1, KIAA0686, FEB4, USH2C	Adhesion G protein-coupled receptor V1	602851	ADGRV1	84059	ENSG00000164199,ENST00000405460;;;ENST00000405460	mutation identified in 1 FEB4 family	?Febrile seizures, familial, 4	604352	AD	3	Adgrv1
5q14.3	5:90558797-91164437	ADGRV1, GPR98, MASS1, VLGR1, KIAA0686, FEB4, USH2C	Adhesion G protein-coupled receptor V1	602851	ADGRV1	84059	ENSG00000164199,ENST00000405460;;;ENST00000405460	mutation identified in 1 FEB4 family	Usher syndrome, type 2C	605472	AR, DD	3	Adgrv1
5q14.3	5:90558797-91164437	ADGRV1, GPR98, MASS1, VLGR1, KIAA0686, FEB4, USH2C	Adhesion G protein-coupled receptor V1	602851	ADGRV1	84059	ENSG00000164199,ENST00000405460;;;ENST00000405460	mutation identified in 1 FEB4 family	Usher syndrome, type 2C, GPR98/PDZD7 digenic	605472	AR, DD	3	Adgrv1
5q15	5:93583222-93594611	NR2F1, TFCOUP1, ERBAL3, EAR3, BBSOAS	Nuclear receptor subfamily 2, group F, member 1 (transcription factor COUP 1)	132890	NR2F1	7025	ENSG00000175745,ENST00000327111;;;ENST00000327111		Bosch-Boonstra-Schaaf optic atrophy syndrome	615722	AD	3	Nr2f1
5q15	5:94150851-94618604	KIAA0825, PAPA10	KIAA0825 gene	617266	KIAA0825	285600	ENSG00000185261,ENST00000682413;;;ENST00000682413		Polydactyly, postaxial, type A10	618498	AR	3	2210408I21Rik
5q15	5:95463894-95554977	SKIC3, TTC37, KIAA0372	SKI3 subunit of superkiller complex	614589	SKIC3	9652	ENSG00000198677,ENST00000358746;;;ENST00000358746		Trichohepatoenteric syndrome 1	222470	AR	3	Skic3
5q15	5:95555101-95605102	ARSK, MPS10	Arylsulfatase K	610011	ARSK	153642	ENSG00000164291,ENST00000380009;;;ENST00000380009		Mucopolysaccharidosis, type X	619698	AR	3	Arsk
5q15	5:95961429-96774683	CAST, PLACK	Calpastatin	114090	CAST	831	ENSG00000310517,ENST00000675179;;;ENST00000675179		Peeling skin with leukonychia, acral punctate keratoses, cheilitis, and knuckle pads	616295	AR	3	Cast
5q15	5:96390333-96433248	PCSK1, NEC1, PC1, PC3, BMIQ12	Proprotein convertase subtilisin/kexin type 1	162150	PCSK1	5122	ENSG00000175426,ENST00000311106;;;ENST00000311106		{Obesity, susceptibility to, BMIQ12}	612362		3	Pcsk1
5q15	5:96390333-96433248	PCSK1, NEC1, PC1, PC3, BMIQ12	Proprotein convertase subtilisin/kexin type 1	162150	PCSK1	5122	ENSG00000175426,ENST00000311106;;;ENST00000311106		Endocrinopathy due to proprotein convertase 1/3 deficiency	600955	AR	3	Pcsk1
5q15-q21.1	5:98853985-98929007	CHD1, PILBOS	Chromodomain helicase DNA binding protein-1	602118	CHD1	1105	ENSG00000153922,ENST00000614616;;;ENST00000614616		Pilarowski-Bjornsson syndrome	617682	AD	3	Chd1
5q21	5:98900001-110200000	MGR8	Migraine, susceptibility to, 8	609570		100188790			{Migraine, susceptibility to, 8}	609570		2	
5q21.1	5:103120301-103212799	PPIP5K2, HISPPD1, VIP2, KIAA0433, DFNB100	Histidine acid phosphatase domain-containing protein 1	611648	PPIP5K2	23262	ENSG00000145725,ENST00000358359;;;ENST00000358359		Deafness, autosomal recessive 100	618422	AR	3	Ppip5k2
5q22	5:110200001-115900000	EOE2	Esophagitis, eosinophilic, 2	613412		100499167		association with rs3806932	{Esophagitis, eosinophilic, 2}	613412	Mu	2	
5q22.1-q32	5:110200001-150400000	GLC1M	Glaucoma 1, open angle, M	610535		777643		between D5S2051 and D5S2090	Glaucoma 1, open angle, M	610535	AD	2	
5q22.1	5:110738145-110765157	SLC25A46, HMSN6B, PCH1E	Solute carrier family 25, member 46	610826	SLC25A46	91137	ENSG00000164209,ENST00000355943;;;ENST00000355943		Neuropathy, hereditary motor and sensory, type VIB	616505	AR	3	Slc25a46
5q22.1	5:110738145-110765157	SLC25A46, HMSN6B, PCH1E	Solute carrier family 25, member 46	610826	SLC25A46	91137	ENSG00000164209,ENST00000355943;;;ENST00000355943		Pontocerebellar hypoplasia, type 1E	619303	AR	3	Slc25a46
5q22.1	5:111092348-111130502	WDR36, TAWDRP, GLC1G	WD repeat-containing protein 36	609669	WDR36	134430	ENSG00000134987,ENST00000513710;;;ENST00000513710		Glaucoma 1, open angle, G	609887		3	Wdr36
5q22.2	5:112707498-112846239	APC, GS, FPC, BTPS2, DESMD	APC regulator of WNT signaling pathway	611731	APC	324	ENSG00000134982,ENST00000257430;;;ENST00000257430	150kb distal to MCC	Adenoma, periampullary, somatic	175100		3	Apc
5q22.2	5:112707498-112846239	APC, GS, FPC, BTPS2, DESMD	APC regulator of WNT signaling pathway	611731	APC	324	ENSG00000134982,ENST00000257430;;;ENST00000257430	150kb distal to MCC	Adenomatous polyposis coli	175100	AD	3	Apc
5q22.2	5:112707498-112846239	APC, GS, FPC, BTPS2, DESMD	APC regulator of WNT signaling pathway	611731	APC	324	ENSG00000134982,ENST00000257430;;;ENST00000257430	150kb distal to MCC	Brain tumor-polyposis syndrome 2	175100	AD	3	Apc
5q22.2	5:112707498-112846239	APC, GS, FPC, BTPS2, DESMD	APC regulator of WNT signaling pathway	611731	APC	324	ENSG00000134982,ENST00000257430;;;ENST00000257430	150kb distal to MCC	Colorectal cancer, somatic	114500		3	Apc
5q22.2	5:112707498-112846239	APC, GS, FPC, BTPS2, DESMD	APC regulator of WNT signaling pathway	611731	APC	324	ENSG00000134982,ENST00000257430;;;ENST00000257430	150kb distal to MCC	Desmoid disease, hereditary	135290	AD	3	Apc
5q22.2	5:112707498-112846239	APC, GS, FPC, BTPS2, DESMD	APC regulator of WNT signaling pathway	611731	APC	324	ENSG00000134982,ENST00000257430;;;ENST00000257430	150kb distal to MCC	Gardner syndrome	175100	AD	3	Apc
5q22.2	5:112707498-112846239	APC, GS, FPC, BTPS2, DESMD	APC regulator of WNT signaling pathway	611731	APC	324	ENSG00000134982,ENST00000257430;;;ENST00000257430	150kb distal to MCC	Gastric adenocarcinoma and proximal polyposis of the stomach	619182	AD	3	Apc
5q22.2	5:112707498-112846239	APC, GS, FPC, BTPS2, DESMD	APC regulator of WNT signaling pathway	611731	APC	324	ENSG00000134982,ENST00000257430;;;ENST00000257430	150kb distal to MCC	Gastric cancer, somatic	613659		3	Apc
5q22.2	5:112707498-112846239	APC, GS, FPC, BTPS2, DESMD	APC regulator of WNT signaling pathway	611731	APC	324	ENSG00000134982,ENST00000257430;;;ENST00000257430	150kb distal to MCC	Hepatoblastoma, somatic	114550		3	Apc
5q22.2	5:113022106-113488453	MCC	MCC regulator of WNT signaling pathway	159350	MCC	4163	ENSG00000171444,ENST00000408903;;;ENST00000408903		Colorectal cancer, somatic	114500		3	Mcc
5q22.3	5:114055978-114496496	KCNN2, SK2, DYT34, NEDMAB	Potassium channel, calcium-activated, intermediate/small conductance, subfamily N, member 2	605879	KCNN2	3781	ENSG00000080709,ENST00000673685;;;ENST00000673685		?Dystonia 34, myoclonic	619724	AD	3	Kcnn2
5q22.3	5:114055978-114496496	KCNN2, SK2, DYT34, NEDMAB	Potassium channel, calcium-activated, intermediate/small conductance, subfamily N, member 2	605879	KCNN2	3781	ENSG00000080709,ENST00000673685;;;ENST00000673685		Neurodevelopmental disorder with or without variable movement or behavioral abnormalities	619725	AD	3	Kcnn2
5q22.3	5:115124772-115180294	TRIM36, RBCC728, ANPH1	Tripartite motif-containing protein 36	609317	TRIM36	55521	ENSG00000152503,ENST00000513154;;;ENST00000513154	mutation identified in 1 ANPH1 patient	?Anencephaly 1	206500	AR	3	Trim36
5q23-q35	5:115900001-181538259	SCZD1	Schizophrenia susceptibility locus, chromosome 5-related	181510		6377		max lod at D5S820	{Schizophrenia}	181500	AD	2	
5q23.1	5:119452497-119542332	HSD17B4, PRLTS1	Hydroxysteroid (17-beta) dehydrogenase 4	601860	HSD17B4	3295	ENSG00000133835,ENST00000510025;;;ENST00000510025		D-bifunctional protein deficiency	261515	AR	3	Hsd17b4
5q23.1	5:119452497-119542332	HSD17B4, PRLTS1	Hydroxysteroid (17-beta) dehydrogenase 4	601860	HSD17B4	3295	ENSG00000133835,ENST00000510025;;;ENST00000510025		Perrault syndrome 1	233400	AR	3	Hsd17b4
5q23.1	5:122063195-122078259	LOX, AAT10	Lysyl oxidase	153455	LOX	4015	ENSG00000113083,ENST00000231004;;;ENST00000231004		Aortic aneurysm, familial thoracic 10	617168	AD	3	Lox
5q23.2	5:122100001-127900000	ADLDAT	Leukodystrophy, demyelinating, adult-onset, autosomal dominant, atypical	621061				deletion upstream of LMNB1	Leukodystrophy, demyelinating, adult-onset, autosomal dominant, atypical	621061	AD	4	
5q23.2	5:122100001-127900000	ADLDTY	Leukodystrophy, demyelinating, adult-onset, autosomal dominant, typical	169500				tandem duplication resulting in extra copy of LMNB1	Leukodystrophy, demyelinating, adult-onset, autosomal dominant, typical	169500	AD	4	
5q23.2	5:123089241-123194266	PRDM6, PRISM, PDA3	PR domain-containing protein 6	616982	PRDM6	93166	ENSG00000061455,ENST00000407847;;;ENST00000407847		Patent ductus arteriosus 3	617039	AD	3	Prdm6
5q23.2	5:123344892-123423842	CEP120, CCDC100, SRTD13, JBTS31	Centrosomal protein, 120kD	613446	CEP120	153241	ENSG00000168944,ENST00000306467;;;ENST00000306467		Joubert syndrome 31	617761	AR	3	Cep120
5q23.2	5:123344892-123423842	CEP120, CCDC100, SRTD13, JBTS31	Centrosomal protein, 120kD	613446	CEP120	153241	ENSG00000168944,ENST00000306467;;;ENST00000306467		Short-rib thoracic dysplasia 13 with or without polydactyly	616300	AR	3	Cep120
5q23.2	5:126541841-126595219	ALDH7A1, ATQ1, EPD, PDE, EPEO4	Aldehyde dehydrogenase 7 family, member A1 (antiquitin 1)	107323	ALDH7A1	501	ENSG00000164904,ENST00000409134;;;ENST00000409134		Epilepsy, early-onset, 4, vitamin B6-dependent	266100	AR	3	Aldh7a1
5q23.2	5:126776623-126837020	LMNB1, ADLD, MCPH26, ADLDAT	Lamin B1	150340	LMNB1	4001	ENSG00000113368,ENST00000261366;;;ENST00000261366		Microcephaly 26, primary, autosomal dominant	619179	AD	3	Lmnb1
5q23.2	5:127229300-127461222	MEGF10, KIAA1780, CMYO10A, CMYO10B	Multiple epidermal growth factor-like domains 10	612453	MEGF10	84466	ENSG00000145794,ENST00000503335;;;ENST00000503335		Congenital myopathy 10A, severe variant	614399	AR	3	Megf10
5q23.2	5:127229300-127461222	MEGF10, KIAA1780, CMYO10A, CMYO10B	Multiple epidermal growth factor-like domains 10	612453	MEGF10	84466	ENSG00000145794,ENST00000503335;;;ENST00000503335		Congenital myopathy 10B, mild variant	620249	AR	3	Megf10
5q23.3	5:128083766-128189677	SLC12A2, NKCC1, KILQS	Solute carrier family 12 (sodium/potassium/chloride transporters), member 2	600840	SLC12A2	6558	ENSG00000064651,ENST00000262461;;;ENST00000262461		Deafness, autosomal dominant 78	619081	AD	3	Slc12a2
5q23.3	5:128083766-128189677	SLC12A2, NKCC1, KILQS	Solute carrier family 12 (sodium/potassium/chloride transporters), member 2	600840	SLC12A2	6558	ENSG00000064651,ENST00000262461;;;ENST00000262461		Delpire-McNeill syndrome	619083	AD	3	Slc12a2
5q23.3	5:128083766-128189677	SLC12A2, NKCC1, KILQS	Solute carrier family 12 (sodium/potassium/chloride transporters), member 2	600840	SLC12A2	6558	ENSG00000064651,ENST00000262461;;;ENST00000262461		Kilquist syndrome	619080	AR	3	Slc12a2
5q23.3	5:128257909-128538245	FBN2, CCA, EOMD	Fibrillin-2	612570	FBN2	2201	ENSG00000138829,ENST00000262464;;;ENST00000262464		Contractural arachnodactyly, congenital	121050	AD	3	Fbn2
5q23.3	5:128257909-128538245	FBN2, CCA, EOMD	Fibrillin-2	612570	FBN2	2201	ENSG00000138829,ENST00000262464;;;ENST00000262464		Macular degeneration, early-onset	616118	AD	3	Fbn2
5q23.3	5:129460298-129738683	ADAMTS19, CVDP2	ADAM metallopeptidase domain with thrombospondin type 1 motif, 19	607513	ADAMTS19	171019	ENSG00000145808,ENST00000274487;;;ENST00000274487		Cardiac valvular dysplasia 2	620067	AR	3	Adamts19
5q23.3	5:129748094-129766732	MINAR2, KIAA1024L, DFNB120	Membrane integral NOTCH2-associated receptor 2	620215	MINAR2	100127206	ENSG00000186367,ENST00000564719;;;ENST00000564719		Deafness, autosomal recessive 120	620238	AR	3	Minar2
5q23.3	5:131159027-131165256	HINT1, PRKCNH1, NMAN	Histidine triad nucleotide-binding protein 1 (protein kinase C inhibitor 1)	601314	HINT1	3094	ENSG00000169567,ENST00000304043;;;ENST00000304043		Neuromyotonia and axonal neuropathy, autosomal recessive	137200	AR	3	Hint1
5q23.3-q31.1	5:131170944-131205428	LYRM7, MZM1L, MC3DN8	LYR motif-containing protein 7	615831	LYRM7	90624	ENSG00000186687,ENST00000379380;;;ENST00000379380		Mitochondrial complex III deficiency, nuclear type 8	615838	AR	3	Lyrm7
5q31-q33	5:131200001-160500000	AITD2	Autoimmune thyroid disease, susceptibility to, 2	608174		387579			{Autoimmune thyroid disease, susceptibility to, 2}	608174		2	
5q31-q33	5:131200001-160500000	ATOD6	Dermatitis, atopic, 6	605845		114477		between D5S436 and D5S643	{Dermatitis, atopic, susceptibility to, 6}	605845		2	
5q31-q33	5:131200001-160500000	CELIAC2	Celiac disease, susceptibility to, 2	609754		317782			{Celiac disease, susceptibility to, 2}	609754		2	
5q31	5:131200001-145100000	DFNA54	Deafness, autosomal dominant 54	615649		448962		between D5S1972 and D5S410	Deafness, autosomal dominant 54	615649	AD	2	
5q31-q33	5:131200001-160500000	EOS	Eosinophilia, familial	131400		7908			Eosinophilia, familial	131400	AD	2	
5q31	5:131200001-145100000	IBD5	Inflammatory bowel disease 5	606348		50941			{Inflammatory bowel disease 5}	606348		2	
5q31.1-q33.1	5:131200001-153300000	IDDM18	Insulin-dependent diabetes mellitus-18	605598		57044		close to IL12B	{Diabetes mellitus, insulin-dependent, 18}	605598		2	
5q31.1	5:131200001-136900000	IGES	Immunoglobulin E concentration, serum	147061		3478			{?Allergy and asthma susceptibility}	147061		2	
5q31.1	5:131200001-136900000	LBNBG	Liebenberg syndrome	186550					Liebenberg syndrome	186550	AD	4	
5q31	5:131200001-145100000	PDB4	Paget disease of bone 4	606263		94003			Paget disease of bone 4	606263	AD	2	
5q31-q33	5:131200001-160500000	PFBI	Plasmodium falciparum blood infection levels	248310		7910			{Malaria, intensity of infection}	248310	AR	2	
5q31.1-q33.1	5:131200001-153300000	PSORS11	Psoriasis susceptibility 11	612599		100271719		associated with rs10045431	{Psoriasis susceptibility 11}	612599		2	
5q31	5:131200001-145100000	RLS8	Restless legs syndrome, susceptibility to, 8	615197		101448072			{Restless legs syndrome 8}	615197		2	
5q31-q33	5:131200001-160500000	SM1	Schistosoma mansoni infection, susceptibility/resistance to	181460		7911			{Schistosoma mansoni infection, susceptibility/resistance to}	181460	AD	2	
5q31.1	5:131641714-131797017	FNIP1, KIAA1961, IMD93	Folliculin-interacting protein 1	610594	FNIP1	96459	ENSG00000217128,ENST00000510461;;;ENST00000510461		Immunodeficiency 93 and hypertrophic cardiomyopathy	619705	AR	3	Fnip1
5q31.1	5:132190147-132227853	P4HA2, MYP25	Procollagen-proline, 2-oxoglutarate-4-dioxygenase, alpha subunit, isoform 2	600608	P4HA2	8974	ENSG00000072682,ENST00000360568;;;ENST00000360568		Myopia 25, autosomal dominant	617238	AD	3	P4ha2
5q31.1	5:132257696-132273454	RIL	LIM domain protein ril	603422	PDLIM4	8572	ENSG00000131435,ENST00000253754;;;ENST00000253754		{Osteoporosis, susceptibility to}	166710	AD	3	Pdlim4
5q31.1	5:132294394-132344190	SLC22A4, OCTN1	Solute carrier family 22 (organic cation transporter), member 4	604190	SLC22A4	6583	ENSG00000197208,ENST00000200652;;;ENST00000200652		{Rheumatoid arthritis, susceptibility to}	180300		3	Slc22a4
5q31.1	5:132369710-132395612	SLC22A5, OCTN2, CDSP, SCD	Solute carrier, family 22 (organic cation transporter), member 5	603377	SLC22A5	6584	ENSG00000197375,ENST00000245407;;;ENST00000245407		Carnitine deficiency, systemic primary	212140	AR	3	Slc22a21,Slc22a5
5q31.1	5:132481609-132490773	IRF1, MAR, IMD117	Interferon regulatory factor-1	147575	IRF1	3659	ENSG00000125347,ENST00000245414;;;ENST00000245414		Gastric cancer, somatic	613659		3	Irf1
5q31.1	5:132481609-132490773	IRF1, MAR, IMD117	Interferon regulatory factor-1	147575	IRF1	3659	ENSG00000125347,ENST00000245414;;;ENST00000245414		Immunodeficiency 117, mycobacteriosis, autosomal recessive	620668	AR	3	Irf1
5q31.1	5:132481609-132490773	IRF1, MAR, IMD117	Interferon regulatory factor-1	147575	IRF1	3659	ENSG00000125347,ENST00000245414;;;ENST00000245414		Nonsmall cell lung cancer, somatic	211980		3	Irf1
5q31.1	5:132556977-132646349	RAD50, NBSLD	RAD50 double strand break repair protein	604040	RAD50	10111	ENSG00000113522,ENST00000378823;;;ENST00000378823		Nijmegen breakage syndrome-like disorder	613078	AR	3	Rad50
5q31.1	5:132656522-132661110	IL13, ALRH, BHR1	Interleukin-13	147683	IL13	3596	ENSG00000169194,ENST00000304506;;;ENST00000304506		{Allergic rhinitis, susceptibility to}	607154		3	Il13
5q31.1	5:132656522-132661110	IL13, ALRH, BHR1	Interleukin-13	147683	IL13	3596	ENSG00000169194,ENST00000304506;;;ENST00000304506		{Asthma, susceptibility to}	600807	AD	3	Il13
5q31.1	5:132861185-132866651	GDF9, POF14	Growth/differentiation factor 9	601918	GDF9	2661	ENSG00000164404,ENST00000687138;;;ENST00000687138		Premature ovarian failure 14	618014	AR	3	Gdf9
5q31.1	5:132866642-132868847	UQCRQ, QPC, MC3DN4	Ubiquinol-cytochrome c reductase, complex III subunit VII, 9.5kD	612080	UQCRQ	27089	ENSG00000164405,ENST00000378670;;;ENST00000378670		Mitochondrial complex III deficiency, nuclear type 4	615159	AR	3	Uqcrq
5q31.1	5:132875395-132963634	AFF4, AF5Q31, CHOPS	AF4/FMR2 family, member 4	604417	AFF4	27125	ENSG00000072364,ENST00000265343;;;ENST00000265343		CHOPS syndrome	616368	AD	3	Aff4
5q31.1	5:134194332-134226073	PPP2CA, NEDLBA, HJS3	Protein phosphatase-2 (formerly 2A), catalytic subunit, alpha isoform	176915	PPP2CA	5515	ENSG00000113575,ENST00000481195;;;ENST00000481195		Houge-Janssens syndrome 3	618354	AD	3	Ppp2ca
5q31.1	5:134601149-134632828	SAR1B, CMRD, SARA2, ANDD	Secretion-associated Ras-related GTPase 1B	607690	SAR1B	51128	ENSG00000152700,ENST00000402673;;;ENST00000402673		Chylomicron retention disease	246700	AR	3	Sar1b
5q31.1	5:134738548-134752157	CAMLG, CDG2Z	Calcium-modulating cyclophilin ligand	601118	CAMLG	819	ENSG00000164615,ENST00000297156;;;ENST00000297156	mutation identified in 1 CDG2Z patient	?Congenital disorder of glycosylation, type IIz	620201	AR	3	Caml
5q31.1	5:134873770-134901635	TXNDC15, C5orf14, BUG, MKS14	Thioredoxin domain-containing protein 15	617778	TXNDC15	79770	ENSG00000113621,ENST00000358387;;;ENST00000358387		Meckel syndrome 14	619879	AR	3	Txndc15
5q31.1	5:135027734-135034789	PITX1, PTX1, BFT, POTX, CCF	Paired-like homeodomain transcription factor-1	602149	PITX1	5307	ENSG00000069011,ENST00000265340;;;ENST00000265340		Clubfoot, congenital, with or without deficiency of long bones and/or mirror-image polydactyly	119800	AD	3	Pitx1
5q31.1	5:135534282-135535964	NEUROG1, NEUROD3, CCDDRD	Neurogenin 1	601726	NEUROG1	4762	ENSG00000181965,ENST00000314744;;;ENST00000314744		Cranial dysinnervation disorder, congenital, with absent corneal reflex and developmental delay	620469	AR	3	Neurog1
5q31.1	5:136028988-136063818	TGFBI, CSD2, CDGG1, CSD, BIGH3, CDG2, EBMD	Transforming growth factor, beta-induced, 68kD	601692	TGFBI	7045	ENSG00000120708,ENST00000442011;;;ENST00000442011		Corneal dystrophy, Avellino type	607541	AD	3	Tgfbi
5q31.1	5:136028988-136063818	TGFBI, CSD2, CDGG1, CSD, BIGH3, CDG2, EBMD	Transforming growth factor, beta-induced, 68kD	601692	TGFBI	7045	ENSG00000120708,ENST00000442011;;;ENST00000442011		Corneal dystrophy, epithelial basement membrane	121820	AD	3	Tgfbi
5q31.1	5:136028988-136063818	TGFBI, CSD2, CDGG1, CSD, BIGH3, CDG2, EBMD	Transforming growth factor, beta-induced, 68kD	601692	TGFBI	7045	ENSG00000120708,ENST00000442011;;;ENST00000442011		Corneal dystrophy, Groenouw type I	121900	AD	3	Tgfbi
5q31.1	5:136028988-136063818	TGFBI, CSD2, CDGG1, CSD, BIGH3, CDG2, EBMD	Transforming growth factor, beta-induced, 68kD	601692	TGFBI	7045	ENSG00000120708,ENST00000442011;;;ENST00000442011		Corneal dystrophy, lattice type I	122200	AD	3	Tgfbi
5q31.1	5:136028988-136063818	TGFBI, CSD2, CDGG1, CSD, BIGH3, CDG2, EBMD	Transforming growth factor, beta-induced, 68kD	601692	TGFBI	7045	ENSG00000120708,ENST00000442011;;;ENST00000442011		Corneal dystrophy, lattice type IIIA	608471	AD	3	Tgfbi
5q31.1	5:136028988-136063818	TGFBI, CSD2, CDGG1, CSD, BIGH3, CDG2, EBMD	Transforming growth factor, beta-induced, 68kD	601692	TGFBI	7045	ENSG00000120708,ENST00000442011;;;ENST00000442011		Corneal dystrophy, Reis-Bucklers type	608470	AD	3	Tgfbi
5q31.1	5:136028988-136063818	TGFBI, CSD2, CDGG1, CSD, BIGH3, CDG2, EBMD	Transforming growth factor, beta-induced, 68kD	601692	TGFBI	7045	ENSG00000120708,ENST00000442011;;;ENST00000442011		Corneal dystrophy, Thiel-Behnke type	602082	AD	3	Tgfbi
5q31.2	5:137617500-137736089	KLHL3, PHA2D	Kelch-like 3	605775	KLHL3	26249	ENSG00000146021,ENST00000309755;;;ENST00000309755		Pseudohypoaldosteronism, type IID	614495	AD, AR	3	Klhl3
5q31.2	5:137867860-137887851	MYOT, TTOD, MFM3	Myotilin (titin immunoglobulin domain protein)	604103	MYOT	9499	ENSG00000120729,ENST00000239926;;;ENST00000239926		Myopathy, myofibrillar, 3	609200	AD	3	Myot
5q31.2	5:138115175-138139428	NME5, NM23H5, CILD48	NME/NM23 family, member 5	603575	NME5	8382	ENSG00000112981,ENST00000265191;;;ENST00000265191		Ciliary dyskinesia, primary, 48, without situs inversus	620032	AR	3	Nme5
5q31.2	5:138179112-138187723	KIF20A, RAB6KIFL, RCM6	Kinesin family member 20A	605664	KIF20A	10112	ENSG00000112984,ENST00000394894;;;ENST00000394894	mutation identified in 1 RCM6 family	?Cardiomyopathy, familial restrictive, 6	619433	AR	3	Kif20a
5q31.2	5:138352685-138437027	KDM3B, C5orf7, KIAA1082, JMJD1B, DIJOS	Lysine demethylase 3B	609373	KDM3B	51780	ENSG00000120733,ENST00000314358;;;ENST00000314358		Diets-Jongmans syndrome	618846	AD	3	Kdm3b
5q31.2	5:138439057-138446965	REEP2, C5orf19, SPG72A, SPG72B	Receptor expression-enhancing protein 2	609347	REEP2	51308	ENSG00000132563,ENST00000378339;;;ENST00000378339	mutation identified in 1 SPG72B family	?Spastic paraplegia 72B, autosomal recessive	620606	AR	3	Reep2
5q31.2	5:138439057-138446965	REEP2, C5orf19, SPG72A, SPG72B	Receptor expression-enhancing protein 2	609347	REEP2	51308	ENSG00000132563,ENST00000378339;;;ENST00000378339	mutation identified in 1 SPG72B family	Spastic paraplegia 72A, autosomal dominant	615625	AD	3	Reep2
5q31.2	5:138553756-138575401	HSPA9, HSPA9B, MOT2, GRP75, EVPLS, SIDBA4	Heat-shock 70kD protein-9 (mortalin)	600548	HSPA9	3313	ENSG00000113013,ENST00000297185;;;ENST00000297185		Anemia, sideroblastic, 4	182170	AD	3	Hspa9
5q31.2	5:138553756-138575401	HSPA9, HSPA9B, MOT2, GRP75, EVPLS, SIDBA4	Heat-shock 70kD protein-9 (mortalin)	600548	HSPA9	3313	ENSG00000113013,ENST00000297185;;;ENST00000297185		Even-plus syndrome	616854	AR	3	Hspa9
5q31.2	5:138753425-138935034	CTNNA1, MDPT2	Catenin (cadherin-associated protein), alpha 1, 102kD	116805	CTNNA1	1495	ENSG00000044115,ENST00000302763;;;ENST00000302763		Macular dystrophy, patterned, 2	608970	AD	3	Ctnna1
5q31.2	5:138946724-139198368	SIL1, BAP, MSS	SIL1 nucleotide exchange factor	608005	SIL1	64374	ENSG00000120725,ENST00000394817;;;ENST00000394817		Marinesco-Sjogren syndrome	248800	AR	3	Sil1
5q31.2	5:139274101-139331677	MATR3, MPD2, ALS21	Matrin 3	164015	MATR3	9782	ENSG00000015479,ENST00000394805;;;ENST00000394805		Amyotrophic lateral sclerosis 21	606070	AD	3	Matr3
5q31.2	5:139475533-139482758	STING1, TMEM173, MPYS, SAVI	Stimulator of interferon response cGAMP interactor 1	612374	STING1	340061	ENSG00000184584,ENST00000330794;;;ENST00000330794		STING-associated vasculopathy, infantile-onset	615934	AD	3	Sting1
5q31.3	5:140114109-140125619	PURA, PUR1, NEDRIHF	Purine-rich element binding protein A	600473	PURA	5813	ENSG00000185129,ENST00000331327;;;ENST00000331327		Neurodevelopmental disorder with neonatal respiratory insufficiency, hypotonia, and feeding difficulties	616158	AD	3	Pura
5q31.3	5:140332843-140346603	HBEGF, DTR, DTSF, HEGFL	Heparin-binding EGF-like growth factor (diphtheria toxin receptor)	126150	HBEGF	1839	ENSG00000113070,ENST00000230990;;;ENST00000230990		{Diphtheria, susceptibility to}			1	Hbegf
5q31.3	5:140645285-140647630	NDUFA2, MC1DN13	NADH-ubiquinone oxidoreductase subunit A2	602137	NDUFA2	4695	ENSG00000131495,ENST00000252102;;;ENST00000252102		Mitochondrial complex I deficiency, nuclear type 13	618235	AR	3	Ndufa2
5q31.3	5:140673905-140691370	HARS1, HARS, USH3B, CMT2W	Histidyl-tRNA synthetase 1	142810	HARS1	3035	ENSG00000170445,ENST00000504156;;;ENST00000504156		Charcot-Marie-Tooth disease, axonal, type 2W	616625	AD	3	Hars1
5q31.3	5:140673905-140691370	HARS1, HARS, USH3B, CMT2W	Histidyl-tRNA synthetase 1	142810	HARS1	3035	ENSG00000170445,ENST00000504156;;;ENST00000504156		Usher syndrome type 3B	614504	AR	3	Hars1
5q31.3	5:140691455-140699305	HARS2, HARSL, HARSR, HO3, PRLTS2	Histidyl-tRNA synthetase 2	600783	HARS2	23438	ENSG00000112855,ENST00000230771;;;ENST00000230771		Perrault syndrome 2	614926	AR	3	Hars2
5q31.3	5:141485030-141512975	PCDHGC4, NEDGS	Protocadherin-gamma, subfamily C, member 4	606305	PCDHGC4	56098	ENSG00000242419,ENST00000306593;;;ENST00000306593		Neurodevelopmental disorder with poor growth and skeletal anomalies	619880	AR	3	Pcdhgc4
5q31.3	5:141515021-141619000	DIAPH1, DFNA1, LFHL1, SCBMS	Diaphanous-related formin 1	602121	DIAPH1	1729	ENSG00000131504,ENST00000389054;;;ENST00000389054		Deafness, autosomal dominant 1, with or without thrombocytopenia	124900	AD	3	Diaph1
5q31.3	5:141515021-141619000	DIAPH1, DFNA1, LFHL1, SCBMS	Diaphanous-related formin 1	602121	DIAPH1	1729	ENSG00000131504,ENST00000389054;;;ENST00000389054		Seizures, cortical blindness, microcephaly syndrome	616632	AR	3	Diaph1
5q31.3	5:141943581-141958202	PCDH12, VECAD2, DMJDS1	Protocadherin 12 (cadherin, vascular endothelial, 2)	605622	PCDH12	51294	ENSG00000113555,ENST00000231484;;;ENST00000231484		Diencephalic-mesencephalic junction dysplasia syndrome 1	251280	AR	3	Pcdh12
5q31.3	5:142310430-142325021	SPRY4, HH17	SPRY domain containing 4	607984	SPRY4	81848	ENSG00000187678,ENST00000434127;;;ENST00000434127		Hypogonadotropic hypogonadism 17 with or without anosmia	615266	AD	3	Spry4
5q31.3	5:142770377-143229011	ARHGAP26, GRAF	RHO GTPase-activating protein 26	605370	ARHGAP26	23092	ENSG00000145819,ENST00000645722;;;ENST00000645722		Leukemia, juvenile myelomonocytic, somatic	607785		3	Arhgap26
5q31.3	5:143277931-143435512	NR3C1, GCR, GRL, GCRST	Nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor)	138040	NR3C1	2908	ENSG00000113580,ENST00000394464;;;ENST00000394464		Glucocorticoid resistance	615962	AD	3	Nr3c1
5q31.3	5:144158162-144170659	YIPF5, SMAP5, YIP1A, MEDS2	Yip1 domain family, member 5	611483	YIPF5	81555	ENSG00000145817,ENST00000274496;;;ENST00000274496		Microcephaly, epilepsy, and diabetes syndrome 2	619278	AR	3	Yipf5
5q32	5:145100001-150400000	EMP	Myeloproliferative disorder, chronic, with eosinophilia	131440				ETV6-PDGFRB fusion gene	Myeloproliferative disorder, chronic, with eosinophilia	131440	AD	4	
5q32	5:145857670-145931673	GRXCR2, DFNB101	Glutaredoxin, cysteine-rich, 2	615762	GRXCR2	643226	ENSG00000204928,ENST00000377976;;;ENST00000377976	mutation identified in 1 DFNB101 family	?Deafness, autosomal recessive 101	615837	AR	3	Grxcr2
5q32	5:146113034-146182650	LARS1, LARS, LFIS, ILFS1	Leucyl-tRNA synthetase 1	151350	LARS1	51520	ENSG00000133706,ENST00000394434;;;ENST00000394434	mutation identified in 1 family	?Infantile liver failure syndrome 1	615438	AR	3	Lars1
5q32	5:146338839-146341728	POU4F3, BRN3C, DFNA15, DFNA52	POU domain, class 4, transcription factor-3	602460	POU4F3	5459	ENSG00000091010,ENST00000646991;;;ENST00000646991		Deafness, autosomal dominant 15/52	602459	AD	3	Pou4f3
5q32	5:146580742-147081520	PPP2R2B	Protein phosphatase 2, regulatory subunit B, beta	604325	PPP2R2B	5521	ENSG00000156475,ENST00000394411;;;ENST00000394411		Spinocerebellar ataxia 12	604326	AD	3	Ppp2r2b
5q32	5:147824582-147839196	SPINK1, PSTI, PCTT, TATI, TCP	Serine protease inhibitor, Kazal type I (pancreatic secretory trypsin inhibitor)	167790	SPINK1	6690	ENSG00000164266,ENST00000296695;;;ENST00000296695		{Fibrocalculous pancreatic diabetes, susceptibility to}	608189	AD, AR	3	Spink1
5q32	5:147824582-147839196	SPINK1, PSTI, PCTT, TATI, TCP	Serine protease inhibitor, Kazal type I (pancreatic secretory trypsin inhibitor)	167790	SPINK1	6690	ENSG00000164266,ENST00000296695;;;ENST00000296695		Pancreatitis, hereditary	167800	AD	3	Spink1
5q32	5:147824582-147839196	SPINK1, PSTI, PCTT, TATI, TCP	Serine protease inhibitor, Kazal type I (pancreatic secretory trypsin inhibitor)	167790	SPINK1	6690	ENSG00000164266,ENST00000296695;;;ENST00000296695		Tropical calcific pancreatitis	608189	AD, AR	3	Spink1
5q32	5:147878711-147882191	SCGB3A2, UGRP1	Secretoglobin, family 3A, member 2 (uteroglobin-related protein 1)	606531	SCGB3A2	117156	ENSG00000164265,ENST00000296694;;;ENST00000296694		{Asthma, susceptibility to}	600807	AD	3	Scgb3a2
5q32	5:148063980-148137382	SPINK5, LEKTI	Serine protease inhibitor, Kazal type, 5	605010	SPINK5	11005	ENSG00000133710,ENST00000256084;;;ENST00000256084		Netherton syndrome	256500	AR	3	Spink5
5q32	5:148383958-148442836	FBXO38, FBX38, MOKA, HMND6	F-box only protein 38	608533	FBXO38	81545	ENSG00000145868,ENST00000340253;;;ENST00000340253		Neuronopathy, distal hereditary motor, autosomal dominant 6	615575	AD	3	Fbxo38
5q32	5:148826611-148828623	ADRB2	Adrenergic, beta-2-, receptor, surface	109690	ADRB2	154	ENSG00000169252,ENST00000305988;;;ENST00000305988		Beta-2-adrenoreceptor agonist, reduced response to			3	Adrb2
5q32	5:148982150-149063062	SH3TC2, KIAA1985, MNMN	SH3 domain and tetratricopeptide repeat domain 2	608206	SH3TC2	79628	ENSG00000169247,ENST00000515425;;;ENST00000515425		Charcot-Marie-Tooth disease, type 4C	601596	AR	3	Sh3tc2
5q32	5:148982150-149063062	SH3TC2, KIAA1985, MNMN	SH3 domain and tetratricopeptide repeat domain 2	608206	SH3TC2	79628	ENSG00000169247,ENST00000515425;;;ENST00000515425		Mononeuropathy of the median nerve, mild	613353	AD	3	Sh3tc2
5q32	5:149857953-149944793	PDE6A, PDEA, RP43	Phosphodiesterase 6A	180071	PDE6A	5145	ENSG00000132915,ENST00000255266;;;ENST00000255266		Retinitis pigmentosa 43	613810	AR	3	Pde6a
5q32	5:149960758-149987400	SLC26A2, DTD, DTDST, D5S1708, EDM4	Solute carrier family 26 (sulfate transporter), member 2 (diastrophic dysplasia sulfate transporter)	606718	SLC26A2	1836	ENSG00000155850,ENST00000286298;;;ENST00000286298	distal to APC	Achondrogenesis Ib	600972	AR	3	Slc26a2
5q32	5:149960758-149987400	SLC26A2, DTD, DTDST, D5S1708, EDM4	Solute carrier family 26 (sulfate transporter), member 2 (diastrophic dysplasia sulfate transporter)	606718	SLC26A2	1836	ENSG00000155850,ENST00000286298;;;ENST00000286298	distal to APC	Atelosteogenesis, type II	256050	AR	3	Slc26a2
5q32	5:149960758-149987400	SLC26A2, DTD, DTDST, D5S1708, EDM4	Solute carrier family 26 (sulfate transporter), member 2 (diastrophic dysplasia sulfate transporter)	606718	SLC26A2	1836	ENSG00000155850,ENST00000286298;;;ENST00000286298	distal to APC	De la Chapelle dysplasia	256050	AR	3	Slc26a2
5q32	5:149960758-149987400	SLC26A2, DTD, DTDST, D5S1708, EDM4	Solute carrier family 26 (sulfate transporter), member 2 (diastrophic dysplasia sulfate transporter)	606718	SLC26A2	1836	ENSG00000155850,ENST00000286298;;;ENST00000286298	distal to APC	Diastrophic dysplasia	222600	AR	3	Slc26a2
5q32	5:149960758-149987400	SLC26A2, DTD, DTDST, D5S1708, EDM4	Solute carrier family 26 (sulfate transporter), member 2 (diastrophic dysplasia sulfate transporter)	606718	SLC26A2	1836	ENSG00000155850,ENST00000286298;;;ENST00000286298	distal to APC	Diastrophic dysplasia, broad bone-platyspondylic variant	222600	AR	3	Slc26a2
5q32	5:149960758-149987400	SLC26A2, DTD, DTDST, D5S1708, EDM4	Solute carrier family 26 (sulfate transporter), member 2 (diastrophic dysplasia sulfate transporter)	606718	SLC26A2	1836	ENSG00000155850,ENST00000286298;;;ENST00000286298	distal to APC	Epiphyseal dysplasia, multiple, 4	226900	AR	3	Slc26a2
5q32	5:150053295-150113365	CSF1R, FMS, HDLS1, BANDDOS	Colony-stimulating factor-1 receptor; oncogene FMS (McDonough feline sarcoma)	164770	CSF1R	1436	ENSG00000182578,ENST00000675795;;;ENST00000675795	FMS2 is 5' end	Brain abnormalities, neurodegeneration, and dysosteosclerosis	618476	AR	3	Csf1r
5q32	5:150053295-150113365	CSF1R, FMS, HDLS1, BANDDOS	Colony-stimulating factor-1 receptor; oncogene FMS (McDonough feline sarcoma)	164770	CSF1R	1436	ENSG00000182578,ENST00000675795;;;ENST00000675795	FMS2 is 5' end	Leukoencephalopathy, diffuse hereditary, with spheroids 1	221820	AD	3	Csf1r
5q32	5:150113839-150155845	PDGFRB, PDGFR, IBGC4, IMF1, PENTT, KOGS, OPDKD	Platelet-derived growth factor receptor, beta polypeptide	173410	PDGFRB	5159	ENSG00000113721,ENST00000261799;;;ENST00000261799	mutation identified in 1 OPDKD family	?Ocular pterygium-digital keloid dysplasia syndrome	621091	AD	3	Pdgfrb
5q32	5:150113839-150155845	PDGFRB, PDGFR, IBGC4, IMF1, PENTT, KOGS, OPDKD	Platelet-derived growth factor receptor, beta polypeptide	173410	PDGFRB	5159	ENSG00000113721,ENST00000261799;;;ENST00000261799	mutation identified in 1 OPDKD family	Basal ganglia calcification, idiopathic, 4	615007	AD	3	Pdgfrb
5q32	5:150113839-150155845	PDGFRB, PDGFR, IBGC4, IMF1, PENTT, KOGS, OPDKD	Platelet-derived growth factor receptor, beta polypeptide	173410	PDGFRB	5159	ENSG00000113721,ENST00000261799;;;ENST00000261799	mutation identified in 1 OPDKD family	Kosaki overgrowth syndrome	616592	AD	3	Pdgfrb
5q32	5:150113839-150155845	PDGFRB, PDGFR, IBGC4, IMF1, PENTT, KOGS, OPDKD	Platelet-derived growth factor receptor, beta polypeptide	173410	PDGFRB	5159	ENSG00000113721,ENST00000261799;;;ENST00000261799	mutation identified in 1 OPDKD family	Myofibromatosis, infantile, 1	228550	AD	3	Pdgfrb
5q32	5:150113839-150155845	PDGFRB, PDGFR, IBGC4, IMF1, PENTT, KOGS, OPDKD	Platelet-derived growth factor receptor, beta polypeptide	173410	PDGFRB	5159	ENSG00000113721,ENST00000261799;;;ENST00000261799	mutation identified in 1 OPDKD family	Premature aging syndrome, Penttinen type	601812	AD	3	Pdgfrb
5q32	5:150219491-150290130	CAMK2A, KIAA0968, CAMKA, MRD53, MRT63	Calcium/calmodulin-dependent protein kinase II-alpha	114078	CAMK2A	815	ENSG00000070808,ENST00000671881;;;ENST00000671881	mutation identified in 1 MRT63 family	?Intellectual developmental disorder, autosomal recessive 63	618095	AR	3	Camk2a
5q32	5:150219491-150290130	CAMK2A, KIAA0968, CAMKA, MRD53, MRT63	Calcium/calmodulin-dependent protein kinase II-alpha	114078	CAMK2A	815	ENSG00000070808,ENST00000671881;;;ENST00000671881	mutation identified in 1 MRT63 family	Intellectual developmental disorder, autosomal dominant 53	617798	AD	3	Camk2a
5q32-q33.1	5:150357697-150400293	TCOF1, MFD1, TCS1	Treacle	606847	TCOF1	6949	ENSG00000070814,ENST00000643257;;;ENST00000643257	prox. to SPARC	Treacher Collins syndrome 1	154500	AD	3	Tcof1
5q33.1-q35.2	5:150400001-177100000	FECD5, FCD3	Corneal dystrophy, Fuchs endothelial, 5	613269		100380874		flanked by D5S470 and D5S2108	Corneal dystrophy, Fuchs endothelial, 5	613269		2	
5q33.1	5:150442635-150449739	RPS14, EMTB	Ribosomal protein S14	130620	RPS14	6208	ENSG00000164587,ENST00000407193;;;ENST00000407193		Macrocytic anemia, refractory, due to 5q deletion, somatic	153550		3	Rps14
5q33.1	5:150497779-150558211	NDST1, HSST, MRT46	N-deacetylase/N-sulfotransferase (heparan sulfate-N-deacetylase/N-sulfotransferase)	600853	NDST1	3340	ENSG00000070614,ENST00000261797;;;ENST00000261797		Intellectual developmental disorder, autosomal recessive 46	616116	AR	3	Ndst1
5q33.1	5:150846521-150902402	IRGM, LRG47, IFI1, IBD19	Immunity-related GTPase family, M	608212	IRGM	345611	ENSG00000237693,ENST00000522154;;;ENST00000522154		{Inflammatory bowel disease (Crohn disease) 19}	612278		3	Igtp,Irgm1,Irgm2
5q33.1	5:150846521-150902402	IRGM, LRG47, IFI1, IBD19	Immunity-related GTPase family, M	608212	IRGM	345611	ENSG00000237693,ENST00000522154;;;ENST00000522154		{Mycobacterium tuberculosis, protection against}	607948		3	Igtp,Irgm1,Irgm2
5q33.1	5:151253185-151270440	GM2A	GM2 ganglioside activator protein	613109	GM2A	2760	ENSG00000196743,ENST00000357164;;;ENST00000357164	pseudogene on chr.3	GM2-gangliosidosis, AB variant	272750	AR	3	Gm2a
5q33.1	5:151314972-151347559	SLC36A2, PAT2	Solute carrier family 36 (proton/amino acid symporter), member 2	608331	SLC36A2	153201	ENSG00000186335,ENST00000335244;;;ENST00000335244		[Hyperglycinuria]	138500	AD	3	Slc36a2
5q33.1	5:151314972-151347559	SLC36A2, PAT2	Solute carrier family 36 (proton/amino acid symporter), member 2	608331	SLC36A2	153201	ENSG00000186335,ENST00000335244;;;ENST00000335244		[Iminoglycinuria]	242600	AR, DR	3	Slc36a2
5q33.1	5:151504092-151594819	FAT2, MEGF1, SCA45	FAT atypical cadherin 2	604269	FAT2	2196	ENSG00000086570,ENST00000261800;;;ENST00000261800		Spinocerebellar ataxia 45	617769	AD	3	Fat2
5q33.1	5:151661096-151686915	SPARC, ON, OI17	Osteonectin (secreted protein, acidic, cysteine-rich)	182120	SPARC	6678	ENSG00000113140,ENST00000231061;;;ENST00000231061		Osteogenesis imperfecta, type XVII	616507	AR	3	Sparc
5q33.1	5:151822513-151924851	GLRA1, STHE, HKPX1	Glycine receptor, alpha-1 polypeptide	138491	GLRA1	2741	ENSG00000145888,ENST00000274576;;;ENST00000274576		Hyperekplexia 1	149400	AD, AR	3	Glra1
5q33.2	5:153489615-153813869	GRIA1, GLUR1, MRD67, MRT76	Glutamate receptor, ionotropic, AMPA 1	138248	GRIA1	2890	ENSG00000155511,ENST00000285900;;;ENST00000285900	mutation identified in 1 MRT76 patient	?Intellectual developmental disorder, autosomal recessive 76	619931	AR	3	Gria1
5q33.2	5:153489615-153813869	GRIA1, GLUR1, MRD67, MRT76	Glutamate receptor, ionotropic, AMPA 1	138248	GRIA1	2890	ENSG00000155511,ENST00000285900;;;ENST00000285900	mutation identified in 1 MRT76 patient	Intellectual developmental disorder, autosomal dominant 67	619927	AD	3	Gria1
5q33.2	5:154887411-154938211	GEMIN5, NEDCAM	GEM-associated protein 5	607005	GEMIN5	25929	ENSG00000082516,ENST00000285873;;;ENST00000285873		Neurodevelopmental disorder with cerebellar atrophy and motor dysfunction	619333	AR	3	Gemin5
5q33.2-q33.3	5:155727832-156767788	SGCD, SGD, LGMDR6, CMD1L	Sarcoglycan, delta (35kD dystrophin-associated glycoprotein)	601411	SGCD	6444	ENSG00000170624,ENST00000337851;;;ENST00000337851	mutant in Syrian hamster cardiomyopathy	Cardiomyopathy, dilated, 1L	606685		3	Sgcd
5q33.2-q33.3	5:155727832-156767788	SGCD, SGD, LGMDR6, CMD1L	Sarcoglycan, delta (35kD dystrophin-associated glycoprotein)	601411	SGCD	6444	ENSG00000170624,ENST00000337851;;;ENST00000337851	mutant in Syrian hamster cardiomyopathy	Muscular dystrophy, limb-girdle, autosomal recessive 6	601287	AR	3	Sgcd
5q33.3	5:157085832-157109044	HAVCR2, TIM3, SPTCL	Hepatitis A virus cellular receptor 2	606652	HAVCR2	84868	ENSG00000135077,ENST00000307851;;;ENST00000307851		T-cell lymphoma, subcutaneous panniculitis-like	618398	AR	3	Havcr2
5q33.3	5:157180840-157255185	ITK, EMT, LPFS1	T-cell-specific tyrosine kinase; homolog of mouse T-cell itk/tsk tyrosine kinase	186973	ITK	3702	ENSG00000113263,ENST00000422843;;;ENST00000422843		Lymphoproliferative syndrome 1	613011	AR	3	Itk
5q33.3	5:157266123-157395594	CYFIP2, DEE65	Cytoplasmic FMRP interacting protein 2	606323	CYFIP2	26999	ENSG00000055163,ENST00000620254;;;ENST00000620254		Developmental and epileptic encephalopathy 65	618008	AD	3	Cyfip2
5q33.3	5:157460213-157474722	NIPAL4, ICHYN, ARCI6	NIPA-like domain-containing 4	609383	NIPAL4	348938	ENSG00000172548,ENST00000311946;;;ENST00000311946		Ichthyosis, congenital, autosomal recessive 6	612281	AR	3	Nipal4
5q33.3	5:157731420-157741449	THG1L, THG1, ICF45, IHG1, SCAR28	tRNA-histidine guanylyltransferase 1-like protein	618802	THG1L	54974	ENSG00000113272,ENST00000231198;;;ENST00000231198		Spinocerebellar ataxia, autosomal recessive 28	618800	AR	3	Thg1l
5q33.3	5:157743712-157760709	LSM11, AGS8	Lsm11, U7 small nuclear RNA-associated protein	617910	LSM11	134353	ENSG00000155858,ENST00000286307;;;ENST00000286307	mutation identified in 1 AGS8 family	?Aicardi-Goutieres syndrome 8	619486	AR	3	Lsm11
5q33.3	5:159314780-159330487	IL12B, NKSF2, IMD29	Interleukin-12B (natural killer cell stimulatory factor-2, cytotoxic lymphocyte maturation factor-2, p40)	161561	IL12B	3593	ENSG00000113302,ENST00000231228;;;ENST00000231228	between GLR1 and GABRA1	Immunodeficiency 29, mycobacteriosis	614890	AR	3	Il12b
5q34-q35.2	5:160500001-177100000	NIDDM4	Diabetes mellitus, noninsulin-dependent, 4	608036		100188782			{Diabetes mellitus, noninsulin-dependent}	125853	AD	2	
5q34	5:161288436-161548404	GABRB2, DEE92	Gamma-aminobutyric acid (GABA) A receptor, beta-2	600232	GABRB2	2561	ENSG00000145864,ENST00000393959;;;ENST00000393959		Developmental and epileptic encephalopathy 92	617829	AD	3	Gabrb2
5q34	5:161847191-161899971	GABRA1, EJM5, ECA4, DEE19	Gamma-aminobutyric acid (GABA) A receptor, alpha-1	137160	GABRA1	2554	ENSG00000022355,ENST00000393943;;;ENST00000393943	in same 200kb as GABRG2	{Epilepsy, childhood absence, susceptibility to, 4}	611136		3	Gabra1
5q34	5:161847191-161899971	GABRA1, EJM5, ECA4, DEE19	Gamma-aminobutyric acid (GABA) A receptor, alpha-1	137160	GABRA1	2554	ENSG00000022355,ENST00000393943;;;ENST00000393943	in same 200kb as GABRG2	{Epilepsy, juvenile myoclonic, susceptibility to, 5}	611136		3	Gabra1
5q34	5:161847191-161899971	GABRA1, EJM5, ECA4, DEE19	Gamma-aminobutyric acid (GABA) A receptor, alpha-1	137160	GABRA1	2554	ENSG00000022355,ENST00000393943;;;ENST00000393943	in same 200kb as GABRG2	Developmental and epileptic encephalopathy 19	615744	AD	3	Gabra1
5q34	5:162067465-162155539	GABRG2, DEE74, FEB8, ECA2, GEFSP3	Gamma-aminobutyric acid (GABA) A receptor, gamma-2	137164	GABRG2	2566	ENSG00000113327,ENST00000639213;;;ENST00000639213	in alpha/beta/gamma cluster	Developmental and epileptic encephalopathy 74	618396	AD	3	Gabrg2
5q34	5:162067465-162155539	GABRG2, DEE74, FEB8, ECA2, GEFSP3	Gamma-aminobutyric acid (GABA) A receptor, gamma-2	137164	GABRG2	2566	ENSG00000113327,ENST00000639213;;;ENST00000639213	in alpha/beta/gamma cluster	Febrile seizures, familial, 8	607681	AD	3	Gabrg2
5q34	5:162067465-162155539	GABRG2, DEE74, FEB8, ECA2, GEFSP3	Gamma-aminobutyric acid (GABA) A receptor, gamma-2	137164	GABRG2	2566	ENSG00000113327,ENST00000639213;;;ENST00000639213	in alpha/beta/gamma cluster	Generalized epilepsy with febrile seizures plus, type 3	607681	AD	3	Gabrg2
5q34	5:163460632-163491941	HMMR	Hyaluronan-mediated motility receptor (RHAMM)	600936	HMMR	3161	ENSG00000072571,ENST00000393915;;;ENST00000393915		{Breast cancer, susceptibility to}	114480	AD, SMu	3	Hmmr
5q34	5:168291645-168472303	WWC1, KIBRA, KIAA0869, MEMRYQTL	WW and C2 domains-containing protein 1	610533	WWC1	23286	ENSG00000113645,ENST00000265293;;;ENST00000265293		[Memory, enhanced, QTL]	615602		3	Wwc1
5q34	5:168486471-168519301	RARS1, RARS, HLD9	Arginyl-tRNA synthetase 1	107820	RARS1	5917	ENSG00000113643,ENST00000231572;;;ENST00000231572		Leukodystrophy, hypomyelinating, 9	616140	AR	3	Rars1
5q35.1	5:169637275-170083382	DOCK2, IMD40	Dedicator of cytokinesis 2	603122	DOCK2	1794	ENSG00000134516,ENST00000520908;;;ENST00000520908		Immunodeficiency 40	616433	AR	3	Dock2
5q35.1	5:170105897-170109737	FOXI1, FKHL10, FREAC6	Forkhead box I1	601093	FOXI1	2299	ENSG00000168269,ENST00000306268;;;ENST00000306268	some patients have digenic mutations with SLC26A4	Enlarged vestibular aqueduct	600791	AR	3	Foxi1
5q35.1	5:170246233-170297777	LCP2, SLP76, IMD81	Lymphocyte cytosolic protein-2 (SH2 domain-containing leukocyte protein of 76kD)	601603	LCP2	3937	ENSG00000043462,ENST00000046794;;;ENST00000046794		Immunodeficiency 81	619374	AR	3	Lcp2
5q35.1	5:170374671-170389367	KCNMB1	Potassium large conductance calcium-activated channel, subfamily M, beta member 1	603951	KCNMB1	3779	ENSG00000145936,ENST00000274629;;;ENST00000274629		{Hypertension, diastolic, resistance to}	608622	AD	3	Kcnmb1
5q35.1	5:171387116-171410900	NPM1	Nucleophosmin 1 (nucleolar phosphoprotein B23, numatrin)	164040	NPM1	4869	ENSG00000181163,ENST00000296930;;;ENST00000296930	fused with RARA in APL	Leukemia, acute myeloid, somatic	601626		3	Npm1
5q35.1	5:171861549-172006638	FBXW11, FBXW1B, BTRC2, BTRCP2, NEDJED	F-box and WD40 domain protein 11	605651	FBXW11	23291	ENSG00000072803,ENST00000517395;;;ENST00000517395		Neurodevelopmental, jaw, eye, and digital syndrome	618914	AD	3	Fbxw11
5q35.1	5:172325181-172454525	SH3PXD2B, TKS4, KIAA1295, FTHS	SH3 and PX domains-containing protein 2B	613293	SH3PXD2B	285590	ENSG00000174705,ENST00000311601;;;ENST00000311601		Frank-ter Haar syndrome	249420	AR	3	Sh3pxd2b
5q35.1	5:172834251-172952683	ERGIC1, ERGIC32, KIAA1181, AMC2	Endoplasmic reticulum-golgi intermediate compartment protein 1	617946	ERGIC1	57222	ENSG00000113719,ENST00000393784;;;ENST00000393784	mutation identified in 1 AMCN family	?Arthrogryposis multiplex congenita 2, neurogenic type	208100	AR	3	Ergic1
5q35.1	5:173144531-173164387	BNIP1, NIP1, SEDH	BCL2/adenovirus E1B 19kD protein-interacting protein 1	603291	BNIP1	662	ENSG00000113734,ENST00000351486;;;ENST00000351486		Spondylopeiphyseal dysplasia, Holling type	621345	AR	3	Bnip1
5q35.1	5:173232109-173235206	NKX2-5, NKX2E, CSX, CHNG5, VSD3, HLHS2	NK2 homeobox-5 gene	600584	NKX2-5	1482	ENSG00000183072,ENST00000329198;;;ENST00000329198	near border with 5q35	Atrial septal defect 7, with or without AV conduction defects	108900	AD	3	Nkx2-5
5q35.1	5:173232109-173235206	NKX2-5, NKX2E, CSX, CHNG5, VSD3, HLHS2	NK2 homeobox-5 gene	600584	NKX2-5	1482	ENSG00000183072,ENST00000329198;;;ENST00000329198	near border with 5q35	Conotruncal heart malformations, variable	217095		3	Nkx2-5
5q35.1	5:173232109-173235206	NKX2-5, NKX2E, CSX, CHNG5, VSD3, HLHS2	NK2 homeobox-5 gene	600584	NKX2-5	1482	ENSG00000183072,ENST00000329198;;;ENST00000329198	near border with 5q35	Hypoplastic left heart syndrome 2	614435	AD	3	Nkx2-5
5q35.1	5:173232109-173235206	NKX2-5, NKX2E, CSX, CHNG5, VSD3, HLHS2	NK2 homeobox-5 gene	600584	NKX2-5	1482	ENSG00000183072,ENST00000329198;;;ENST00000329198	near border with 5q35	Hypothyroidism, congenital nongoitrous, 5	225250	AD	3	Nkx2-5
5q35.1	5:173232109-173235206	NKX2-5, NKX2E, CSX, CHNG5, VSD3, HLHS2	NK2 homeobox-5 gene	600584	NKX2-5	1482	ENSG00000183072,ENST00000329198;;;ENST00000329198	near border with 5q35	Tetralogy of Fallot	187500	AD	3	Nkx2-5
5q35.1	5:173232109-173235206	NKX2-5, NKX2E, CSX, CHNG5, VSD3, HLHS2	NK2 homeobox-5 gene	600584	NKX2-5	1482	ENSG00000183072,ENST00000329198;;;ENST00000329198	near border with 5q35	Ventricular septal defect 3	614432	AD	3	Nkx2-5
5q35.2	5:173300001-177100000	MENOQ4	Menopause, natural, age at, QTL4	612886		100302519		associated with rs365132, rs7718874, rs402511, rs691141, rs2278493	{Menopause, natural, age at, QTL4}	612886		2	
5q35.2	5:174724582-174730896	MSX2, CRS2, HOX8	msh homeobox 2	123101	MSX2	4488	ENSG00000120149,ENST00000239243;;;ENST00000239243		Craniosynostosis 2	604757	AD	3	Msx2
5q35.2	5:174724582-174730896	MSX2, CRS2, HOX8	msh homeobox 2	123101	MSX2	4488	ENSG00000120149,ENST00000239243;;;ENST00000239243		Parietal foramina 1	168500	AD	3	Msx2
5q35.2	5:174724582-174730896	MSX2, CRS2, HOX8	msh homeobox 2	123101	MSX2	4488	ENSG00000120149,ENST00000239243;;;ENST00000239243		Parietal foramina with cleidocranial dysplasia	168550	AD	3	Msx2
5q35.2	5:176620082-176630534	SNCB	Synuclein, beta	602569	SNCB	6620	ENSG00000074317,ENST00000393693;;;ENST00000393693		Dementia, Lewy body	127750	AD	3	Sncb
5q35.2	5:177086915-177098144	FGFR4	Fibroblast growth factor receptor-4	134935	FGFR4	2264	ENSG00000160867,ENST00000292408;;;ENST00000292408	distal to DRD1	{Cancer progression/metastasis}			3	Fgfr4
5q35.3	5:177131798-177300213	NSD1, ARA267, STO, SOTOS	Nuclear receptor binding SET domain protein 1	606681	NSD1	64324	ENSG00000165671,ENST00000439151;;;ENST00000439151	fusion gene with NUP98 in AML	Sotos syndrome	117550	AD	3	Nsd1
5q35.3	5:177384434-177398848	SLC34A1, SLC17A2, NPT2, NPHLOP1, FRTS2, HCINF2	Solute carrier family 34 (sodium phosphate cotransporter), member 1	182309	SLC34A1	6569	ENSG00000131183,ENST00000324417;;;ENST00000324417	mutation identified in 1 FRTS2 family	?Fanconi renotubular syndrome 2	613388	AR	3	Slc34a1
5q35.3	5:177384434-177398848	SLC34A1, SLC17A2, NPT2, NPHLOP1, FRTS2, HCINF2	Solute carrier family 34 (sodium phosphate cotransporter), member 1	182309	SLC34A1	6569	ENSG00000131183,ENST00000324417;;;ENST00000324417	mutation identified in 1 FRTS2 family	Hypercalcemia, infantile, 2	616963	AR	3	Slc34a1
5q35.3	5:177384434-177398848	SLC34A1, SLC17A2, NPT2, NPHLOP1, FRTS2, HCINF2	Solute carrier family 34 (sodium phosphate cotransporter), member 1	182309	SLC34A1	6569	ENSG00000131183,ENST00000324417;;;ENST00000324417	mutation identified in 1 FRTS2 family	Nephrolithiasis/osteoporosis, hypophosphatemic, 1	612286	AD	3	Slc34a1
5q35.3	5:177402141-177409564	F12, HAF, HAE3	Coagulation factor XII (Hageman factor)	610619	F12	2161	ENSG00000131187,ENST00000253496;;;ENST00000253496		Angioedema, hereditary, 3	610618	AD	3	F12
5q35.3	5:177402141-177409564	F12, HAF, HAE3	Coagulation factor XII (Hageman factor)	610619	F12	2161	ENSG00000131187,ENST00000253496;;;ENST00000253496		Factor XII deficiency	234000	AR	3	F12
5q35.3	5:177511577-177516961	DDX41, ABS, MPLPF	DEAD-box helicase 41	608170	DDX41	51428	ENSG00000183258,ENST00000330503;;;ENST00000330503		{Myeloproliferative/lymphoproliferative neoplasms, familial (multiple types), susceptibility to}	616871	AD	3	Ddx41
5q35.3	5:177600132-177610330	B4GALT7, XGALT1, XGPT1, EDSSPD1	Beta-1,4-galactosyltransferase 7	604327	B4GALT7	11285	ENSG00000027847,ENST00000029410;;;ENST00000029410		Ehlers-Danlos syndrome, spondylodysplastic type, 1	130070	AR	3	B4galt7
5q35.3	5:177992235-177996242	PROP1, CPHD2	Prophet of Pit1, paired-like homeodomain transcription factor	601538	PROP1	5626	ENSG00000175325,ENST00000308304;;;ENST00000308304		Pituitary hormone deficiency, combined, 2	262600	AR	3	Prop1
5q35.3	5:178149463-178153885	NHP2, NOLA2, DKCB2	NHP2 ribonucleoprotein	606470	NHP2	55651	ENSG00000145912,ENST00000274606;;;ENST00000274606		Dyskeratosis congenita, autosomal recessive 2	613987	AR	3	Nhp2
5q35.3	5:178207144-178232822	PHYKPL, AGXT2L2, PHLU	5-phosphohydroxy-L-lysine phospho-lyase	614683	PHYKPL	85007	ENSG00000175309,ENST00000308158;;;ENST00000308158	mutation identified in 1 PHLU patient	[?Phosphohydroxylysinuria]	615011	AR	3	Phykpl
5q35.3	5:178978327-178995320	GRM6, MGLUR6, CSNB1B	Glutamate receptor, metabotropic, 6	604096	GRM6	2916	ENSG00000113262,ENST00000517717;;;ENST00000517717		Night blindness, congenital stationary (complete), 1B, autosomal recessive	257270	AR	3	Grm6
5q35.3	5:179110853-179345461	ADAMTS2, NPI, EDSDERMS	ADAM metallopeptidase with thrombospondin type 1 motif, 2 (procollagen I N-proteinase)	604539	ADAMTS2	9509	ENSG00000087116,ENST00000251582;;;ENST00000251582		Ehlers-Danlos syndrome, dermatosparaxis type	225410	AR	3	Adamts2
5q35.3	5:179614178-179634784	HNRNPH1, HNRPH1, NEDCDS	Heterogeneous nuclear ribonucleoprotein H1	601035	HNRNPH1	3187	ENSG00000169045,ENST00000393432;;;ENST00000393432		Neurodevelopmental disorder with craniofacial dysmorphism and skeletal defects	620083	AD	3	Hnrnph1
5q35.3	5:179793986-179796647	LTC4S	Leukotriene C4 synthase	246530	LTC4S	4056	ENSG00000213316,ENST00000292596;;;ENST00000292596		Leukotriene C4 synthase deficiency	614037	AR	1	Ltc4s
5q35.3	5:179806393-179838078	SQSTM1, P62, PDB3, FTDALS3, NADGP, DMRV	Sequestosome 1	601530	SQSTM1	8878	ENSG00000161011,ENST00000389805;;;ENST00000389805		Frontotemporal dementia and/or amyotrophic lateral sclerosis 3	616437	AD	3	Sqstm1
5q35.3	5:179806393-179838078	SQSTM1, P62, PDB3, FTDALS3, NADGP, DMRV	Sequestosome 1	601530	SQSTM1	8878	ENSG00000161011,ENST00000389805;;;ENST00000389805		Myopathy, distal, with rimmed vacuoles	617158	AD	3	Sqstm1
5q35.3	5:179806393-179838078	SQSTM1, P62, PDB3, FTDALS3, NADGP, DMRV	Sequestosome 1	601530	SQSTM1	8878	ENSG00000161011,ENST00000389805;;;ENST00000389805		Neurodegeneration with ataxia, dystonia, and gaze palsy, childhood-onset	617145	AR	3	Sqstm1
5q35.3	5:179806393-179838078	SQSTM1, P62, PDB3, FTDALS3, NADGP, DMRV	Sequestosome 1	601530	SQSTM1	8878	ENSG00000161011,ENST00000389805;;;ENST00000389805		Paget disease of bone 3	167250	AD	3	Sqstm1
5q35.3	5:180601506-180650298	FLT4, VEGFR3, PCL, LMPHM1, CHTD7	fms-related tyrosine kinase-4 (vascular endothelial growth factor receptor 3)	136352	FLT4	2324	ENSG00000037280,ENST00000261937;;;ENST00000261937		Congenital heart defects, multiple types, 7	618780	AD	3	Flt4
5q35.3	5:180601506-180650298	FLT4, VEGFR3, PCL, LMPHM1, CHTD7	fms-related tyrosine kinase-4 (vascular endothelial growth factor receptor 3)	136352	FLT4	2324	ENSG00000037280,ENST00000261937;;;ENST00000261937		Hemangioma, capillary infantile, somatic	602089		3	Flt4
5q35.3	5:180601506-180650298	FLT4, VEGFR3, PCL, LMPHM1, CHTD7	fms-related tyrosine kinase-4 (vascular endothelial growth factor receptor 3)	136352	FLT4	2324	ENSG00000037280,ENST00000261937;;;ENST00000261937		Lymphatic malformation 1	153100	AD	3	Flt4
6p25	6:1-7100000	CLLS4	Leukemia, chronic lymphocytic susceptibility to, 4	612558		100270643		associated with rs872071	{Leukemia, chronic lymphocytic susceptibility to, 4}	612558		2	
6pter-p24	6:1-13400000	DEL6pter, C6DELpter	Chromosome 6pter-p24 deletion syndrome	612582					Chromosome 6pter-p24 deletion syndrome	612582	IC	4	
6p25.3-p22.3	6:1-25200000	INTLQ3	Intelligence quantitative trait locus 3	610294		100462722			{Intelligence QTL3}	610294		2	
6p25	6:1-7100000	LRSL	Larsen-like syndrome	608545		406214			Larsen-like syndrome	608545	IC	2	
6p25.3	6:391752-411443	IRF4, LSIRF, SHEP8, IMD131	Interferon regulatory factor-4	601900	IRF4	3662	ENSG00000137265,ENST00000380956;;;ENST00000380956	dysregulated in t(6;14)	[Skin/hair/eye pigmentation, variation in, 8]	611724		3	Irf4
6p25.3	6:391752-411443	IRF4, LSIRF, SHEP8, IMD131	Interferon regulatory factor-4	601900	IRF4	3662	ENSG00000137265,ENST00000380956;;;ENST00000380956	dysregulated in t(6;14)	Immunodeficiency 131	621097	AD, AR	3	Irf4
6p25.3	6:485154-693139	EXOC2, SEC5L1, SEC5, NEDFACH	Exocyst complex component 2	615329	EXOC2	55770	ENSG00000112685,ENST00000230449;;;ENST00000230449		Neurodevelopmental disorder with dysmorphic facies and cerebellar hypoplasia	619306	AR	3	Exoc2
6p25.3	6:1609915-1613897	FOXC1, FKHL7, FREAC3, IRID1, RIEG3, ASGD3	Forkhead, Drosophila, homolog-like 7	601090	FOXC1	2296	ENSG00000054598,ENST00000645831;;;ENST00000645831		Anterior segment dysgenesis 3, multiple subtypes	601631	AD	3	Foxc1
6p25.3	6:1609915-1613897	FOXC1, FKHL7, FREAC3, IRID1, RIEG3, ASGD3	Forkhead, Drosophila, homolog-like 7	601090	FOXC1	2296	ENSG00000054598,ENST00000645831;;;ENST00000645831		Axenfeld-Rieger syndrome, type 3	602482	AD	3	Foxc1
6p25.2	6:2948159-2971793	SERPINB6, PI6, PTI, SPI3, DFNB91	Protease inhibitor 6 (placental thrombin inhibitor)	173321	SERPINB6	5269	ENSG00000124570,ENST00000380539;;;ENST00000380539	mutation identified in 1 DFNB91 family	?Deafness, autosomal recessive 91	613453	AR	3	Serpinb6a,Serpinb6b,Serpinb6c,Serpinb6d,Serpinb6e
6p25.2	6:2999894-3019755	NQO2, NMOR2	NAD(P)H dehydrogenase, quinone 2 (NAD(P)H menadione oxidoreductase-1, dioxin-inducible-2)	160998	NQO2	4835	ENSG00000124588,ENST00000380455;;;ENST00000380455		{?Breast cancer susceptibility}	114480	AD, SMu	1	Nqo2
6p25.2	6:3063967-3115187	RIPK1, RIP1, RIP, IMD57, AIEFL	Receptor-interacting serine/threonine kinase 1	603453	RIPK1	8737	ENSG00000137275,ENST00000259808;;;ENST00000259808		Autoinflammation with episodic fever and lymphadenopathy	618852	AD	3	Ripk1
6p25.2	6:3063967-3115187	RIPK1, RIP1, RIP, IMD57, AIEFL	Receptor-interacting serine/threonine kinase 1	603453	RIPK1	8737	ENSG00000137275,ENST00000259808;;;ENST00000259808		Immunodeficiency 57 with autoinflammation	618108	AR	3	Ripk1
6p25.2	6:3153666-3157544	TUBB2A, CDCBM5	Tubulin, beta-2A	615101	TUBB2A	7280	ENSG00000137267,ENST00000333628;;;ENST00000333628		Cortical dysplasia, complex, with other brain malformations 5	615763	AD	3	Tubb2a
6p25.2	6:3224277-3227653	TUBB2B, CDCBM7	Tubulin, beta-2B	612850	TUBB2B	347733	ENSG00000137285,ENST00000259818;;;ENST00000259818	TUBB2A is 70kb telomeric to TUBB2B	Cortical dysplasia, complex, with other brain malformations 7	610031	AD	3	Tubb2b
6p25.1	6:5031753-5260950	LYRM4, ISD11, C6orf149, COXPD19	LYR motif-containing protein 4	613311	LYRM4	57128	ENSG00000214113,ENST00000330636;;;ENST00000330636	mutation identified in 1 family	?Combined oxidative phosphorylation deficiency 19	615595	AR	3	Lyrm4
6p25.1	6:5249934-5771583	FARS2, FARS1, COXPD14, SPG77	Phenylalanyl-tRNA synthetase 2, mitochondrial	611592	FARS2	10667	ENSG00000145982,ENST00000274680;;;ENST00000274680		Combined oxidative phosphorylation deficiency 14	614946	AR	3	Fars2
6p25.1	6:5249934-5771583	FARS2, FARS1, COXPD14, SPG77	Phenylalanyl-tRNA synthetase 2, mitochondrial	611592	FARS2	10667	ENSG00000145982,ENST00000274680;;;ENST00000274680		Spastic paraplegia 77, autosomal recessive	617046	AR	3	Fars2
6p25.1	6:6144084-6320662	F13A1, F13A	Coagulation factor XIII, A polypeptide	134570	F13A1	2162	ENSG00000124491,ENST00000264870;;;ENST00000264870		{Myocardial infarction, protection against}	608446		3	F13a1
6p25.1	6:6144084-6320662	F13A1, F13A	Coagulation factor XIII, A polypeptide	134570	F13A1	2162	ENSG00000124491,ENST00000264870;;;ENST00000264870		{Venous thrombosis, protection against}	188050	AD	3	F13a1
6p25.1	6:6144084-6320662	F13A1, F13A	Coagulation factor XIII, A polypeptide	134570	F13A1	2162	ENSG00000124491,ENST00000264870;;;ENST00000264870		Factor XIIIA deficiency	613225	AR	3	F13a1
6p24.3	6:7100001-10600000	OFC1, CL	Orofacial cleft-1 (cleft lip with or without cleft palate; isolated cleft palate)	119530		4963		probable heterogeneity	Orofacial cleft-1	119530	AD	2	
6p24.3	6:7541671-7586714	DSP, KPPS2, PPKS2, DCWHKTA	Desmoplakin	125647	DSP	1832	ENSG00000096696,ENST00000379802;;;ENST00000379802	splice variants result in DP I and DP II	Arrhythmogenic right ventricular dysplasia 8	607450	AD	3	Dsp
6p24.3	6:7541671-7586714	DSP, KPPS2, PPKS2, DCWHKTA	Desmoplakin	125647	DSP	1832	ENSG00000096696,ENST00000379802;;;ENST00000379802	splice variants result in DP I and DP II	Cardiomyopathy, dilated, with woolly hair and keratoderma	605676	AR	3	Dsp
6p24.3	6:7541671-7586714	DSP, KPPS2, PPKS2, DCWHKTA	Desmoplakin	125647	DSP	1832	ENSG00000096696,ENST00000379802;;;ENST00000379802	splice variants result in DP I and DP II	Dilated cardiomyopathy with woolly hair, keratoderma, and tooth agenesis	615821	AD	3	Dsp
6p24.3	6:7541671-7586714	DSP, KPPS2, PPKS2, DCWHKTA	Desmoplakin	125647	DSP	1832	ENSG00000096696,ENST00000379802;;;ENST00000379802	splice variants result in DP I and DP II	Epidermolysis bullosa, lethal acantholytic	609638	AR	3	Dsp
6p24.3	6:7541671-7586714	DSP, KPPS2, PPKS2, DCWHKTA	Desmoplakin	125647	DSP	1832	ENSG00000096696,ENST00000379802;;;ENST00000379802	splice variants result in DP I and DP II	Keratosis palmoplantaris striata II	612908	AD	3	Dsp
6p24.3	6:7726099-7881728	BMP6, IO	Bone morphogenetic protein-6	112266	BMP6	654	ENSG00000153162,ENST00000283147;;;ENST00000283147		{Iron overload, susceptibility to}	620121	AD	3	Bmp6
6p24.3	6:8013567-8064414	BLOC1S5, BLOS5, MUTED, HPS11	Biogenesis of lysosome-related organelles complex 1, subunit 5	607289	BLOC1S5	63915	ENSG00000188428,ENST00000397457;;;ENST00000397457		Hermansky-Pudlak syndrome 11	619172	AR	3	Bloc1s5
6p24.3	6:10396677-10419659	TFAP2A, AP2TF, BOFS	Transcription factor AP-2 alpha (activating enhancer-binding protein 2 alpha)	107580	TFAP2A	7020	ENSG00000137203,ENST00000379613;;;ENST00000379613		Branchiooculofacial syndrome	113620	AD	3	Tfap2a
6p24.3-p24.2	6:10521351-10629368	GCNT2, Ii, CTRCT13	Glucosaminyl (N-acetyl) transferase 2, I-branching enzyme	600429	GCNT2	2651	ENSG00000111846,ENST00000495262;;;ENST00000495262	previously assigned to 9q21	[Blood group, Ii]	110800	AD	3	Gcnt2
6p24.3-p24.2	6:10521351-10629368	GCNT2, Ii, CTRCT13	Glucosaminyl (N-acetyl) transferase 2, I-branching enzyme	600429	GCNT2	2651	ENSG00000111846,ENST00000495262;;;ENST00000495262	previously assigned to 9q21	Adult i phenotype without cataract	110800	AD	3	Gcnt2
6p24.3-p24.2	6:10521351-10629368	GCNT2, Ii, CTRCT13	Glucosaminyl (N-acetyl) transferase 2, I-branching enzyme	600429	GCNT2	2651	ENSG00000111846,ENST00000495262;;;ENST00000495262	previously assigned to 9q21	Cataract 13 with adult i phenotype	116700	AR	3	Gcnt2
6p24.2	6:10762723-10838539	MAK, RP62	Male germ cell-associated kinase	154235	MAK	4117	ENSG00000111837,ENST00000354489;;;ENST00000354489		Retinitis pigmentosa 62	614181	AR	3	Mak
6p24.2	6:10873223-10882041	GCM2, GCMB, HRPT4, FIH2	Glial cells missing transcription factor 2	603716	GCM2	9247	ENSG00000124827,ENST00000379491;;;ENST00000379491		Hyperparathyroidism 4	617343	AD	3	Gcm2
6p24.2	6:10873223-10882041	GCM2, GCMB, HRPT4, FIH2	Glial cells missing transcription factor 2	603716	GCM2	9247	ENSG00000124827,ENST00000379491;;;ENST00000379491		Hypoparathyroidism, familial isolated 2	618883	AD, AR	3	Gcm2
6p24.2	6:10887052-10974309	SYCP2L, C6orf177, POF24	Synaptonemal complex protein 2-like	616799	SYCP2L	221711	ENSG00000153157,ENST00000283141;;;ENST00000283141		Premature ovarian failure 24	620840	AR	3	Sycp2l
6p24.1	6:11600001-13400000	HDLCQ7	High density lipoprotein cholesterol level QTL7	618979		131341973			[High density lipoprotein cholesterol level QTL7]	618979		2	
6p24.1	6:12230516-12297194	EDN1, ARCND3, QME	Endothelin-1	131240	EDN1	1906	ENSG00000078401,ENST00000379375;;;ENST00000379375		Auriculocondylar syndrome 3	615706	AR	3	Edn1
6p24.1	6:12230516-12297194	EDN1, ARCND3, QME	Endothelin-1	131240	EDN1	1906	ENSG00000078401,ENST00000379375;;;ENST00000379375		Question mark ears, isolated	612798	AD	3	Edn1
6p24.1	6:12716767-13287837	PHACTR1, KIAA1733, DEE70	Phosphatase and actin regulator 1	608723	PHACTR1	221692	ENSG00000112137,ENST00000332995;;;ENST00000332995		Developmental and epileptic encephalopathy 70	618298	AD	3	Phactr1
6p24.1	6:13304951-13328537	TBC1D7, PIG51, TBC7, MGCPH	TBC1 domain family, member 7	612655	TBC1D7	51256	ENSG00000145979,ENST00000379300;;;ENST00000379300		Macrocephaly/megalencephaly syndrome, autosomal recessive	248000	AR	3	Tbc1d7
6p23	6:13400001-15200000	ETM3	Tremor, hereditary essential, 3	611456		101027378		max lod at D6S1630 and D6S1605	Essential tremor, hereditary, 3	611456		2	
6p23	6:13400001-15200000	SCZD3	Schizophrenia susceptibility locus, chromosome 6-related	600511		6365		?same as DTNBP1; cognitive deficit type	{Schizophrenia}	181500	AD	2	
6p22	6:15200001-30500000	ALPQTL3	Alkaline phosphatase, plasma level of, QTL 3	612368		100196915		linkage with rs9467160	{Alkaline phosphatase, plasma level of, QTL3}	612368		2	
6p22.3	6:15200001-25200000	BWQTL4	Birth weight quantitative trait locus 4	615192		101448071		associated with rs7756992	[Birth weight QTL4]	615192		2	
6p22.3	6:15200001-25200000	CIHL	Hearing loss, cisplatin-induced, susceptibility to	613290		100381207		associated with rs12201199	{?Hearing loss, cisplatin-induced, susceptibility to}	613290		2	
6p22-p21	6:15200001-46200000	DYX2	Dyslexia, susceptibility to, 2	600202				?between D6S105 and TNFB	{Dyslexia, susceptibility to, 2}	600202	AD	2	
6p22	6:15200001-30500000	NBLST4	Neuroblastoma, susceptibility to, 4	613015		100306937		associated with rs6939340, rs4712653, rs9295536	{Neuroblastoma, susceptibility to, 4}	613015		2	
6p22.3-p21.3	6:15200001-36600000	OTSC3	Otosclerosis 3	608244		170532			Otosclerosis 3	608244	AD	2	
6p22.3	6:15246069-15522042	JARID2, JMJ, DIDDF	Jumonji and AT-rich interaction domain containing 2	601594	JARID2	3720	ENSG00000008083,ENST00000341776;;;ENST00000341776		Developmental delay with variable intellectual disability and dysmorphic facies	620098	AD	3	Jarid2
6p22.3	6:15522807-15663058	DTNBP1, HPS7	Dystrobrevin-binding protein 1 (dysbindin)	607145	DTNBP1	84062	ENSG00000047579,ENST00000344537;;;ENST00000344537		Hermansky-Pudlak syndrome 7	614076	AR	3	Dtnbp1
6p22.3	6:16299112-16761460	ATXN1, ATX1, SCA1	Ataxin-1	601556	ATXN1	6310	ENSG00000124788,ENST00000436367;;;ENST00000436367		Spinocerebellar ataxia 1	164400	AD	3	Atxn1
6p22.3	6:17393595-17557780	CAP2, CMD2I	Cyclase-associated actin cytoskeleton regulatory protein 2	618385	CAP2	10486	ENSG00000112186,ENST00000229922;;;ENST00000229922		Cardiomyopathy, dilated, 2I	620462	AR	3	Cap2
6p22.3	6:18120440-18122677	NHLRC1, MELF2	NHL repeat-containing 1 gene (malin)	608072	NHLRC1	378884	ENSG00000187566,ENST00000340650;;;ENST00000340650		Myoclonic epilepsy of Lafora 2	620681	AR	3	Nhlrc1
6p22.3	6:18128311-18155169	TPMT, TPMTD	Thiopurine S-methyltransferase	187680	TPMT	7172	ENSG00000137364,ENST00000309983;;;ENST00000309983		{Thiopurines, poor metabolism of, 1}	610460	AR	3	Tpmt
6p22.3	6:18223860-18264530	DEK, D6S231E	DEK oncogene	125264	DEK	7913	ENSG00000124795,ENST00000652689;;;ENST00000652689	fused with CAN in t(6;9)	Leukemia, acute nonlymphocytic	125264		2	Dek
6p22.3	6:21593751-21598619	SOX4, IDDSDF	SRY (sex determining region Y)-box 4	184430	SOX4	6659	ENSG00000124766,ENST00000244745;;;ENST00000244745		Intellectual developmental disorder with speech delay and dysmorphic facies	618506	AD	3	Sox4
6p22.3	6:24171755-24383292	DCDC2, RU2, KIAA1154, NPHP19, DFNB66, NSC	Doublecortin domain-containing protein 2	605755	DCDC2	51473	ENSG00000146038,ENST00000378454;;;ENST00000378454	mutation identified in 1 DFNB66 family	?Deafness, autosomal recessive 66	610212	AR	3	Dcdc2a
6p22.3	6:24171755-24383292	DCDC2, RU2, KIAA1154, NPHP19, DFNB66, NSC	Doublecortin domain-containing protein 2	605755	DCDC2	51473	ENSG00000146038,ENST00000378454;;;ENST00000378454	mutation identified in 1 DFNB66 family	Nephronophthisis 19	616217	AR	3	Dcdc2a
6p22.3	6:24171755-24383292	DCDC2, RU2, KIAA1154, NPHP19, DFNB66, NSC	Doublecortin domain-containing protein 2	605755	DCDC2	51473	ENSG00000146038,ENST00000378454;;;ENST00000378454	mutation identified in 1 DFNB66 family	Sclerosing cholangitis, neonatal	617394	AR	3	Dcdc2a
6p22.3	6:24494969-24537207	ALDH5A1, SSADH	Succinic semialdehyde dehydrogenase	610045	ALDH5A1	7915	ENSG00000112294,ENST00000357578;;;ENST00000357578		Succinic semialdehyde dehydrogenase deficiency	271980	AR	3	Aldh5a1
6p22.3	6:24649979-24666899	TDP2, TTRAP	Tyrosyl-DNA phosphodiesterase 2	605764	TDP2	51567	ENSG00000111802,ENST00000378198;;;ENST00000378198		Spinocerebellar ataxia, autosomal recessive 23	616949	AR	3	Tdp2
6p22.3	6:24774937-24786099	GMNN, MGORS6	Geminin DNA replication inhibitor	602842	GMNN	51053	ENSG00000112312,ENST00000230056;;;ENST00000230056		Meier-Gorlin syndrome 6	616835	AD	3	Gmnn
6p22.3	6:24804284-25042168	RIPOR2, FAM65B, C6orf32, KIAA0386, PL48, DFNB104, DFNA21	RHO family interacting cell polarization regulator 2	611410	RIPOR2	9750	ENSG00000111913,ENST00000643898;;;ENST00000643898	mutation identified in 1 DFNB104 family	?Deafness, autosomal recessive 104	616515	AR	3	Ripor2
6p22.3	6:24804284-25042168	RIPOR2, FAM65B, C6orf32, KIAA0386, PL48, DFNB104, DFNA21	RHO family interacting cell polarization regulator 2	611410	RIPOR2	9750	ENSG00000111913,ENST00000643898;;;ENST00000643898	mutation identified in 1 DFNB104 family	Deafness, autosomal dominant 21	607017	AD	3	Ripor2
6p22.2	6:25200001-27100000	MVCD7	Microvascular complications of diabetes, susceptibility to, 7	612635		131554433			{Microvascular complications of diabetes, susceptibility to, 7}	612635		2	
6p22.2	6:25200001-27100000	TFQTL2	Transferring serum level quantitative trait locus 2	614193		131554434			[Transferrin serum level quantitative trait locus 2]	614193		2	
6p22.2	6:25844856-25874243	SLC17A3, NPT4, UAQTL4, GOUT4	Solute carrier family 17 (sodium phosphate cotransporter), member 3	611034	SLC17A3	10786	ENSG00000124564,ENST00000397060;;;ENST00000397060		[Uric acid concentration, serum, QTL4]	612671	AD	3	Slc17a3
6p22.2	6:25844856-25874243	SLC17A3, NPT4, UAQTL4, GOUT4	Solute carrier family 17 (sodium phosphate cotransporter), member 3	611034	SLC17A3	10786	ENSG00000124564,ENST00000397060;;;ENST00000397060		{Gout susceptibility 4}	612671	AD	3	Slc17a3
6p22.2	6:26087429-26098343	HFE, HLA-H, HFE1	Homeostatic iron regulator	613609	HFE	3077	ENSG00000010704,ENST00000357618;;;ENST00000357618		Hemochromatosis, type 1	235200	AR	3	Hfe
6p22.2	6:26103933-26104337	H4C3, HIST1H4C, H4FG, TEBIVANED1	H4 clustered histone 3	602827	H4C3	8364	ENSG00000197061,ENST00000377803;;;ENST00000377803		Tessadori-Bicknell-van Haaften neurodevelopmental syndrome 1	619758	AD	3	H4c1,H4c11,H4c12,H4c14,H4c16,H4c17,H4c18,H4c2,H4c3,H4c4,H4c6,H4c8,H4c9
6p22.2	6:26156329-26157115	H1-4, HIST1H1E, H1F4, RMNS	H1.4 linker histone, cluster member	142220	H1-4	3008	ENSG00000168298,ENST00000304218;;;ENST00000304218		Rahman syndrome	617537	AD	3	H1f4
6p22.2	6:26204610-26205021	H4C5, HIST1H4E, H4FJ, TEBIVANED3	H4 clustered histone 5	602830	H4C5	8367	ENSG00000276966,ENST00000615164;;;ENST00000615164		Tessadori-Bicknell-van Haaften neurodevelopmental syndrome 3	619950	AD	3	H4c1,H4c11,H4c12,H4c14,H4c16,H4c17,H4c18,H4c2,H4c3,H4c4,H4c6,H4c8,H4c9
6p22.1	6:27100001-30500000	STQTL18	Stature quantitative trait locus 18	612892		100302683		associated with rs10946808	{Stature QTL 18}	612892		2	
6p22.1	6:27139282-27139678	H4C9, HIST1H4I, H4FM, H4M, TEBIVANED4	H4 clustered histone 9	602833	H4C9	8294	ENSG00000276180,ENST00000615353;;;ENST00000615353		Tessadori-Bicknell-van Haaften neurodevelopmental syndrome 4	619951	AD	3	H4c1,H4c11,H4c12,H4c14,H4c16,H4c17,H4c18,H4c2,H4c3,H4c4,H4c6,H4c8,H4c9
6p22.1	6:27824092-27824480	H4C11, HIST1H4J, H4FE, TEBIVANED2	H4 clustered histone 11	602826	H4C11	8363	ENSG00000197238,ENST00000355057;;;ENST00000355057	mutation identified in 1 TEBIVANED2 patient	?Tessadori-Bicknell-van Haaften neurodevelopmental syndrome 2	619759	AD	3	H4c1,H4c11,H4c12,H4c14,H4c16,H4c17,H4c18,H4c2,H4c3,H4c4,H4c6,H4c8,H4c9
6p22.1	6:29108058-29114770	OR2J3, C3HEXS	Olfactory receptor, family 2, subfamily J, member 3	615016	OR2J3	442186	ENSG00000204701,ENST00000641151;;;ENST00000641151		[C3HEX, ability to smell]	615082	AD	3	Or2j3
6p22.1	6:29602238-29633183	GABBR1, GABABR1, NEDLC	Gamma-aminobutyric acid B receptor 1	603540	GABBR1	2550	ENSG00000204681,ENST00000377034;;;ENST00000377034		Neurodevelopmental disorder with language delay and variable cognitive abnormalities	620502	AD	3	Gabbr1
6p22.1	6:29657092-29672365	MOG, NRCLP7	Myelin-oligodendrocyte glycoprotein	159465	MOG	4340	ENSG00000204655,ENST00000376917;;;ENST00000376917	60kb telomeric to HLA-F; mutation identified in 1 NRCLP7 family	?Narcolepsy 7	614250	AD	3	Mog
6p22.1	6:29672392-29681152	ZFP57, TNDM1	ZFP57 zinc finger protein	612192	ZFP57	346171	ENSG00000204644,ENST00000376883;;;ENST00000376883		Diabetes mellitus, transient neonatal 1	601410	AD, AR	3	Zfp57
6p22.1	6:29826474-29831021	HLA-G	HLA-G histocompatibility antigen, class I	142871	HLA-G	3135	ENSG00000204632,ENST00000360323;;;ENST00000360323		{Asthma, susceptibility to}	600807	AD	2	H2-D1,H2-K1,H2-Q1,H2-Q10,H2-Q2,H2-Q4,H2-Q6,H2-Q7,H2-Q8,H2-T23
6p22.1	6:29942532-29945870	HLA-A	Major histocompatibility complex, class I, A	142800	HLA-A	3105	ENSG00000206503,ENST00000376809;;;ENST00000376809		{Hypersensitivity syndrome, carbamazepine-induced, susceptibility to}	608579		3	H2-D1,H2-K1,H2-Q1,H2-Q10,H2-Q2,H2-Q4,H2-Q6,H2-Q7,H2-Q8,H2-T23
6p21.3	6:30500001-36600000	ATPLS	Antiphospholipid syndrome, familial	107320		100499532		possible linkage with HLA-DRB1*14	?Antiphospholipid syndrome, familial	107320	AD	2	
6p21.3	6:30500001-36600000	CTEPH1	Pulmonary hypertension, chronic thromboembolic, without deep vein thrombosis, susceptibility to	612862		100302516		associated with DPB1*0202	{Pulmonary hypertension, chronic thromboembolic, without deep vein thrombosis, susceptibility to}	612862		2	
6p21.3	6:30500001-36600000	DFNA31	Deafness, autosomal dominant 31	608645		347737		between D6S276 and D6S273	Deafness, autosomal dominant 31	608645	AD	2	
6p21	6:30500001-46200000	EJM3	Epilepsy, juvenile myoclonic 3	608816		449018			Epilepsy, juvenile myoclonic 3	608816		2	
6p21.33	6:30500001-32100000	FL1	Follicular lymphoma, susceptibility to, 1	613024		100306940		associated with rs6457327	{Follicular lymphoma, susceptibility to, 1}	613024		2	
6p21.3	6:30500001-36600000	GPA, WG	Granulomatosis with polyangiitis	608710		474168			Granulomatosis with polyangiitis	608710		2	
6p21.3	6:30500001-36600000	IBD3	Inflammatory bowel disease 3	604519		30829			{Inflammatory bowel disease 3}	604519	AD	2	
6p21.3	6:30500001-36600000	IDDM1	Insulin-dependent diabetes mellitus-1	222100				linkage or association, with HLA	{Diabetes mellitus, insulin-dependent-1}	222100	AR	2	
6p21.3	6:30500001-36600000	IGAD1	Immunoglobulin A deficiency	137100		10986			Immunoglobulin A deficiency	137100	AD, AR, IC	2	
6p21.3-p21.2	6:30500001-40500000	LAP	Laryngeal adductor paralysis	150270		7939		?linkage to HLA and GLO1	?Laryngeal adductor paralysis	150270	AD	2	
6p21.33	6:30500001-32100000	LNCR4	Lung cancer susceptibility 4	612593		100271693		associated with rs3117582 and rs3131379	{Lung cancer susceptibility 4}	612593		2	
6p21.3	6:30500001-36600000	MBNP	Membranous nephropathy, susceptibility to	614692		101154649			{?Membranous nephropathy, susceptibility to}	614692		2	
6p21.3-p21.2	6:30500001-40500000	MPVQTL4	Mean platelet volume quantitative trait locus 4	614644		100887753		associated with rs210134	Mean platelet volume QTL4	614644		2	
6p21.3	6:30500001-36600000	MYAS1	Myasthenia gravis with thymus hyperplasia	607085		246750			Myasthenia gravis with thymus hyperplasia	607085		2	
6p21.3	6:30500001-36600000	NKS1, EC1	Susceptibility to lysis by alloreactive natural killer cells	272370		4819			{Lysis by alloreactive natural killer cells, susceptibility to}	272370	AR	2	
6p21.3	6:30500001-36600000	NPCA2	Nasopharyngeal carcinoma, susceptibility to, 2	161550		100312951		associated with rs2517713 and rs2975042	{Nasopharyngeal carcinoma, susceptibility to, 2}	161550		2	
6p21.3	6:30500001-36600000	PBC2	Biliary cirrhosis, primary, 2	613007		100303716		associated with rs2856683	{Biliary cirrhosis, primary, 2}	613007		2	
6p21.3	6:30500001-36600000	PBCA	Pancreatic beta cell, agenesis of	600089		7962		uniparental disomy	?Diabetes mellitus, insulin-dependent, neonatal	600089	AR	2	
6p21.3	6:30500001-36600000	PBLT	Panbronchiolitis, diffuse	604809					Panbronchiolitis, diffuse	604809	Mu	2	
6p21.3	6:30500001-36600000	PDCOS	Podoconiosis, susceptibility to	614590		100885774			{Podoconiosis, susceptibility to}	614590		2	
6p21	6:30500001-46200000	RLS6	Restless legs syndrome, susceptibility to, 6	611185		100302512		associated with rs9296249 and rs9357271	{Restless legs syndrome 6}	611185		2	
6p21.3	6:30500001-36600000	RWS	Ragweed sensitivity	179450		7937		?linkage or association, with HLA	?Ragweed sensitivity	179450	AD	2	
6p21.3	6:30500001-36600000	VAMAS6	Vitiligo-associated multiple autoimmune disease susceptibility 6	193200		246319		possible second locus on 1p31.3-p32.2	{Vitiligo-associated multiple autoimmune disease susceptibility 6}	193200	AR	2	
6p21.33	6:30653127-30673006	DHX16, DDX16, DBP2, PRP8, NMOAS	DEAH-box helicase 16	603405	DHX16	8449	ENSG00000204560,ENST00000376442;;;ENST00000376442		Neuromuscular disease and ocular or auditory anomalies with or without seizures	618733	AD	3	Dhx16
6p21.33	6:30720352-30725422	TUBB, TUBB5, M40, CDCBM6, CSCSC1	Tubulin, beta polypeptide	191130	TUBB	203068	ENSG00000196230,ENST00000327892;;;ENST00000327892		Cortical dysplasia, complex, with other brain malformations 6	615771	AD	3	Tubb5
6p21.33	6:30720352-30725422	TUBB, TUBB5, M40, CDCBM6, CSCSC1	Tubulin, beta polypeptide	191130	TUBB	203068	ENSG00000196230,ENST00000327892;;;ENST00000327892		Symmetric circumferential skin creases, congenital, 1	156610	AD	3	Tubb5
6p21.33	6:30914238-30926459	VARS2, KIAA1885, COXPD20	Valyl-tRNA synthetase 2	612802	VARS2	57176	ENSG00000137411,ENST00000676266;;;ENST00000676266		Combined oxidative phosphorylation deficiency 20	615917	AR	3	Vars2
6p21.33	6:31115087-31120446	CDSN, HTSS1, HYPT2, PSS1	Corneodesmosin	602593	CDSN	1041	ENSG00000204539,ENST00000376288;;;ENST00000376288		Hypotrichosis 2	146520	AD	3	Cdsn
6p21.33	6:31115087-31120446	CDSN, HTSS1, HYPT2, PSS1	Corneodesmosin	602593	CDSN	1041	ENSG00000204539,ENST00000376288;;;ENST00000376288		Peeling skin syndrome 1	270300	AR	3	Cdsn
6p21.33	6:31268749-31272092	HLA-C, PSORS1	Major histocompatibility complex, class I, C	142840	HLA-C	3107	ENSG00000204525,ENST00000376228;;;ENST00000376228		{HIV-1 viremia, susceptibility to}	609423		3	H2-D1,H2-K1,H2-M10.1,H2-M10.2,H2-M10.4,H2-M2,H2-M3,H2-Q1,H2-Q10,H2-Q2,H2-Q4,H2-Q6,H2-Q7,H2-Q8,H2-T23
6p21.33	6:31268749-31272092	HLA-C, PSORS1	Major histocompatibility complex, class I, C	142840	HLA-C	3107	ENSG00000204525,ENST00000376228;;;ENST00000376228		{Psoriasis susceptibility 1}	177900	Mu	3	H2-D1,H2-K1,H2-M10.1,H2-M10.2,H2-M10.4,H2-M2,H2-M3,H2-Q1,H2-Q10,H2-Q2,H2-Q4,H2-Q6,H2-Q7,H2-Q8,H2-T23
6p21.33	6:31353875-31357179	HLA-B, SPDA1	Major histocompatibility complex, class I, B	142830	HLA-B	3106	ENSG00000234745,ENST00000412585;;;ENST00000412585		{Ankylosing spondylitis, susceptibility to, 1}	106300	Mu	3	H2-D1,H2-K1,H2-M10.1,H2-M10.2,H2-M10.4,H2-M2,H2-M3,H2-Q1,H2-Q10,H2-Q2,H2-Q4,H2-Q6,H2-Q7,H2-Q8,H2-T23
6p21.33	6:31353875-31357179	HLA-B, SPDA1	Major histocompatibility complex, class I, B	142830	HLA-B	3106	ENSG00000234745,ENST00000412585;;;ENST00000412585		{Severe cutaneous adverse reaction, susceptibility to}	608579		3	H2-D1,H2-K1,H2-M10.1,H2-M10.2,H2-M10.4,H2-M2,H2-M3,H2-Q1,H2-Q10,H2-Q2,H2-Q4,H2-Q6,H2-Q7,H2-Q8,H2-T23
6p21.33	6:31353875-31357179	HLA-B, SPDA1	Major histocompatibility complex, class I, B	142830	HLA-B	3106	ENSG00000234745,ENST00000412585;;;ENST00000412585		{Stevens-Johnson syndrome, susceptibility to}	608579		3	H2-D1,H2-K1,H2-M10.1,H2-M10.2,H2-M10.4,H2-M2,H2-M3,H2-Q1,H2-Q10,H2-Q2,H2-Q4,H2-Q6,H2-Q7,H2-Q8,H2-T23
6p21.33	6:31353875-31357179	HLA-B, SPDA1	Major histocompatibility complex, class I, B	142830	HLA-B	3106	ENSG00000234745,ENST00000412585;;;ENST00000412585		{Toxic epidermal necrolysis, susceptibility to}	608579		3	H2-D1,H2-K1,H2-M10.1,H2-M10.2,H2-M10.4,H2-M2,H2-M3,H2-Q1,H2-Q10,H2-Q2,H2-Q4,H2-Q6,H2-Q7,H2-Q8,H2-T23
6p21.33	6:31546851-31558829	NFKBIL1	Nuclear factor-kappa-B inhibitor-like protein 1	601022	NFKBIL1	4795	ENSG00000204498,ENST00000376148;;;ENST00000376148		{Rheumatoid arthritis, susceptibility to}	180300		3	Nfkbil1
6p21.33	6:31560610-31574324	LTA, TNFB	Lymphotoxin alpha (formerly tumor necrosis factor beta)	153440	LTA	4049	ENSG00000226979,ENST00000418386;;;ENST00000418386	cen-DR-21OH-C4-BF-C2-TNF-LTA-HLA-B	{Leprosy, susceptibility to, 4}	610988		3	Lta
6p21.33	6:31560610-31574324	LTA, TNFB	Lymphotoxin alpha (formerly tumor necrosis factor beta)	153440	LTA	4049	ENSG00000226979,ENST00000418386;;;ENST00000418386	cen-DR-21OH-C4-BF-C2-TNF-LTA-HLA-B	{Myocardial infarction, susceptibility to}	608446		3	Lta
6p21.33	6:31560610-31574324	LTA, TNFB	Lymphotoxin alpha (formerly tumor necrosis factor beta)	153440	LTA	4049	ENSG00000226979,ENST00000418386;;;ENST00000418386	cen-DR-21OH-C4-BF-C2-TNF-LTA-HLA-B	{Psoriatic arthritis, susceptibility to}	607507		3	Lta
6p21.33	6:31575565-31578336	TNF, TNFA, IMD127	Tumor necrosis factor (cachectin)	191160	TNF	7124	ENSG00000232810,ENST00000449264;;;ENST00000449264	mutation identified in 1 IMD127 family	?Immunodeficiency 127	620977	AR	3	Tnf
6p21.33	6:31575565-31578336	TNF, TNFA, IMD127	Tumor necrosis factor (cachectin)	191160	TNF	7124	ENSG00000232810,ENST00000449264;;;ENST00000449264	mutation identified in 1 IMD127 family	{Asthma, susceptibility to}	600807	AD	3	Tnf
6p21.33	6:31575565-31578336	TNF, TNFA, IMD127	Tumor necrosis factor (cachectin)	191160	TNF	7124	ENSG00000232810,ENST00000449264;;;ENST00000449264	mutation identified in 1 IMD127 family	{Dementia, vascular, susceptibility to}			3	Tnf
6p21.33	6:31575565-31578336	TNF, TNFA, IMD127	Tumor necrosis factor (cachectin)	191160	TNF	7124	ENSG00000232810,ENST00000449264;;;ENST00000449264	mutation identified in 1 IMD127 family	{Malaria, cerebral, susceptibility to}	611162		3	Tnf
6p21.33	6:31575565-31578336	TNF, TNFA, IMD127	Tumor necrosis factor (cachectin)	191160	TNF	7124	ENSG00000232810,ENST00000449264;;;ENST00000449264	mutation identified in 1 IMD127 family	{Migraine without aura, susceptibility to}	157300	AD	3	Tnf
6p21.33	6:31575565-31578336	TNF, TNFA, IMD127	Tumor necrosis factor (cachectin)	191160	TNF	7124	ENSG00000232810,ENST00000449264;;;ENST00000449264	mutation identified in 1 IMD127 family	{Septic shock, susceptibility to}			3	Tnf
6p21.33	6:31588895-31593006	NCR3, 1C7, NKP30, CD337, MALS	Natural cytotoxicity triggering receptor 3	611550	NCR3	259197	ENSG00000204475,ENST00000340027;;;ENST00000340027		{Malaria, mild, susceptibility to}	609148		3	Ncr3-ps
6p21.33	6:31666080-31670067	CSNK2B, POBINDS	Casein kinase-2, beta polypeptide	115441	CSNK2B	1460	ENSG00000204435,ENST00000375882;;;ENST00000375882		Poirier-Bienvenu neurodevelopmental syndrome	618732	AD	3	Csnk2b
6p21.33	6:31686955-31703324	ABHD16A, BAT5, D6S82E, SPG86	Abhydrolase domain-containing 16A, phospholipase	142620	ABHD16A	7920	ENSG00000204427,ENST00000395952;;;ENST00000395952		Spastic paraplegia 86, autosomal recessive	619735	AR	3	Abhd16a
6p21.33	6:31720296-31726714	MPIG6B, G6B, C6orf25, THAMY	Megakaryocyte and platelet inhibitory receptor G6B	606520	MPIG6B	80739	ENSG00000204420,ENST00000649779;;;ENST00000649779	mutation identified in 1 THAMY family	?Thrombocytopenia, anemia, and myelofibrosis	617441	AR	3	Mpig6b
6p21.33	6:31740005-31762676	MSH5, POF13, SPGF74	mutS homolog 5	603382	MSH5	4439	ENSG00000204410,ENST00000375750;;;ENST00000375750	mutation identified in POF13 family	?Premature ovarian failure 13	617442	AR	3	Msh5
6p21.33	6:31740005-31762676	MSH5, POF13, SPGF74	mutS homolog 5	603382	MSH5	4439	ENSG00000204410,ENST00000375750;;;ENST00000375750	mutation identified in POF13 family	Spermatogenic failure 74	619937	AR	3	Msh5
6p21.33	6:31777518-31795752	VARS1, VARS, G7A, VARS2, NDMSCA	Valyl-tRNA synthetase 1	192150	VARS1	7407	ENSG00000204394,ENST00000375663;;;ENST00000375663		Neurodevelopmental disorder with microcephaly, seizures, and cortical atrophy	617802	AR	3	Vars1
6p21.33	6:31857659-31862821	NEU1, NEU, SIAL1	Neuraminidase 1 (lysosomal sialidase; sialidase 1)	608272	NEU1	4758	ENSG00000204386,ENST00000375631;;;ENST00000375631		Sialidosis, type I	256550	AR	3	Neu1
6p21.33	6:31857659-31862821	NEU1, NEU, SIAL1	Neuraminidase 1 (lysosomal sialidase; sialidase 1)	608272	NEU1	4758	ENSG00000204386,ENST00000375631;;;ENST00000375631		Sialidosis, type II	256550	AR	3	Neu1
6p21.33	6:31863192-31878997	SLC44A4, CTL4, C6orf29, DFNA72	Solute carrier family 44, member 4	606107	SLC44A4	80736	ENSG00000204385,ENST00000229729;;;ENST00000229729	mutation identified in 1 DFNA72 family	?Deafness, autosomal dominant 72	617606	AD	3	Slc44a4
6p21.33	6:31897783-31945672	C2, ARMD14	Complement component-2	613927	C2	717	ENSG00000166278,ENST00000299367;;;ENST00000299367	no crossover with BF	{Macular degeneration, age-related, 14, reduced risk of}	615489	DD	3	C2
6p21.33	6:31897783-31945672	C2, ARMD14	Complement component-2	613927	C2	717	ENSG00000166278,ENST00000299367;;;ENST00000299367	no crossover with BF	C2 deficiency	217000	AR	3	C2
6p21.33	6:31946095-31952084	CFB, BF, GBG, AHUS4, ARMD14, CFBD	Complement factor B	138470	CFB	629	ENSG00000243649,ENST00000425368;;;ENST00000425368		{Hemolytic uremic syndrome, atypical, susceptibility to, 4}	612924	AD	3	Cfb
6p21.33	6:31946095-31952084	CFB, BF, GBG, AHUS4, ARMD14, CFBD	Complement factor B	138470	CFB	629	ENSG00000243649,ENST00000425368;;;ENST00000425368		{Macular degeneration, age-related, 14, reduced risk of}	615489	DD	3	Cfb
6p21.33	6:31946095-31952084	CFB, BF, GBG, AHUS4, ARMD14, CFBD	Complement factor B	138470	CFB	629	ENSG00000243649,ENST00000425368;;;ENST00000425368		Complement factor B deficiency	615561	AR	3	Cfb
6p21.33	6:31959175-31969751	SKIC2, SKIV2L, SKI2, SKI2W, THES2	SKI2 subunit of superkiller complex	600478	SKIC2	6499	ENSG00000204351,ENST00000375394;;;ENST00000375394		Trichohepatoenteric syndrome 2	614602	AR	3	Skic2
6p21.33	6:31982057-32002681	C4A, C4S, C4AD	Complement component-4A	120810	C4A	720	ENSG00000244731,ENST00000428956;;;ENST00000428956	order:  HLA-B, C2, BF, C4A, C4B, CYP21, DR	[Blood group, Rodgers]	614374		3	C4a,C4b
6p21.33	6:31982057-32002681	C4A, C4S, C4AD	Complement component-4A	120810	C4A	720	ENSG00000244731,ENST00000428956;;;ENST00000428956	order:  HLA-B, C2, BF, C4A, C4B, CYP21, DR	C4a deficiency	614380	AR	3	C4a,C4b
6p21.33	6:32014795-32035418	C4B, C4F, C4BD	Complement component-4B	120820	C4B	721	ENSG00000224389,ENST00000435363;;;ENST00000435363	10kb from C4S	C4B deficiency	614379		3	C4a,C4b
6p21.33	6:32038415-32041644	CYP21A2, CYP21, CA21H	Cytochrome P450, subfamily XXIA, polypeptide 2 (steroid 21-hydroxylase)	613815	CYP21A2	1589	ENSG00000231852,ENST00000644719;;;ENST00000644719	linked to C2, C4, BF; 2 loci, A and B; only B active; pseudogene CYP21P contiguous on 6p	Adrenal hyperplasia, congenital, due to 21-hydroxylase deficiency	201910	AR	3	Cyp21a1
6p21.33	6:32038415-32041644	CYP21A2, CYP21, CA21H	Cytochrome P450, subfamily XXIA, polypeptide 2 (steroid 21-hydroxylase)	613815	CYP21A2	1589	ENSG00000231852,ENST00000644719;;;ENST00000644719	linked to C2, C4, BF; 2 loci, A and B; only B active; pseudogene CYP21P contiguous on 6p	Hyperandrogenism, nonclassic type, due to 21-hydroxylase deficiency	201910	AR	3	Cyp21a1
6p21.33-p21.32	6:32041153-32109338	TNXB, TNX, TNXB1, TNXBS, TNXB2, EDSCLL1, VUR8	Tenascin XB	600985	TNXB	7148	ENSG00000168477,ENST00000644971;;;ENST00000644971		Ehlers-Danlos syndrome, classic-like, 1	606408	AR	3	Tnxb
6p21.33-p21.32	6:32041153-32109338	TNXB, TNX, TNXB1, TNXBS, TNXB2, EDSCLL1, VUR8	Tenascin XB	600985	TNXB	7148	ENSG00000168477,ENST00000644971;;;ENST00000644971		Vesicoureteral reflux 8	615963	AD	3	Tnxb
6p21.32	6:32393339-32407181	BTNL2, SS2	Butyrophilin-like protein 2	606000	BTNL2	56244	ENSG00000204290,ENST00000454136;;;ENST00000454136		{Sarcoidosis, susceptibility to, 2}	612387	AD	3	Btnl2
6p21.32	6:32578775-32589848	HLA-DRB1, SS1	Major histocompatibility complex, class II, DR beta-1	142857	HLA-DRB1	3123	ENSG00000196126,ENST00000360004;;;ENST00000360004		{Multiple sclerosis, susceptibility to, 1}	126200	Mu	3	H2-Eb1,H2-Eb2
6p21.32	6:32578775-32589848	HLA-DRB1, SS1	Major histocompatibility complex, class II, DR beta-1	142857	HLA-DRB1	3123	ENSG00000196126,ENST00000360004;;;ENST00000360004		{Sarcoidosis, susceptibility to, 1}	181000	AD	3	H2-Eb1,H2-Eb2
6p21.32	6:32637406-32655272	HLA-DQA1, CELIAC1	Major histocompatibility complex, class II, DQ alpha-1	146880	HLA-DQA1	3117	ENSG00000196735,ENST00000343139;;;ENST00000343139		{Celiac disease, susceptibility to}	212750	AR, Mu	3	H2-Aa
6p21.32	6:32659467-32666657	HLA-DQB1, CELIAC1	Major histocompatibility complex, class II, DQ beta-1	604305	HLA-DQB1	3119	ENSG00000179344,ENST00000434651;;;ENST00000434651		{Celiac disease, susceptibility to}	212750	AR, Mu	3	H2-Ab1
6p21.32	6:32659467-32666657	HLA-DQB1, CELIAC1	Major histocompatibility complex, class II, DQ beta-1	604305	HLA-DQB1	3119	ENSG00000179344,ENST00000434651;;;ENST00000434651		{Creutzfeldt-Jakob disease, variant, resistance to}	123400	AD	3	H2-Ab1
6p21.32	6:32659467-32666657	HLA-DQB1, CELIAC1	Major histocompatibility complex, class II, DQ beta-1	604305	HLA-DQB1	3119	ENSG00000179344,ENST00000434651;;;ENST00000434651		{Multiple sclerosis, susceptibility to, 1}	126200	Mu	3	H2-Ab1
6p21.32	6:32821831-32838739	TAP2, ABCB3, PSF2, RING11, MHC1D2	Transporter 2, ATP-binding cassette, subfamily B	170261	TAP2	6891	ENSG00000204267,ENST00000374897;;;ENST00000374897	tel-TAP1-LMP2-LMP1-TAP2-cen	MHC class I deficiency 2	620813	AR	3	Tap2
6p21.32	6:32840717-32844679	PSMB8, LMP7, RING10, JMP, NKJO, ALDD, PRAAS1	Proteasome subunit, beta type, 8 (large multifunctional protease-7)	177046	PSMB8	5696	ENSG00000204264,ENST00000374882;;;ENST00000374882	between TAP1 and TAP2	Proteasome-associated autoinflammatory syndrome 1 and digenic forms	256040	AR	3	Psmb8
6p21.32	6:32845209-32853704	TAP1, ABCB2, RING4, PSF1, MHC1D1	Transporter 1, ATP-binding cassette, subfamily B	170260	TAP1	6890	ENSG00000168394,ENST00000354258;;;ENST00000354258	~7kb telomeric to TAP2	MHC class I deficiency 1	604571	AR	3	Tap1
6p21.32	6:32854192-32859851	PSMB9, LMP2, RING12, PRAAS6	Proteasome subunit, beta type, 9	177045	PSMB9	5698	ENSG00000240065,ENST00000374859;;;ENST00000374859		Proteasome-associated autoinflammatory syndrome 6	620796	AD	3	Psmb9
6p21.32	6:33075990-33089696	HLA-DPB1	Major histocompatibility complex, class II, DP beta-1	142858	HLA-DPB1	3115	ENSG00000223865,ENST00000418931;;;ENST00000418931		{Beryllium disease, chronic, susceptibility to}			3	
6p21.32	6:33162694-33193519	COL11A2, DFNA13, DFNB53, FBCG2, OSMEDA, OSMEDB	Collagen XI, alpha-2 polypeptide	120290	COL11A2	1302	ENSG00000204248,ENST00000341947;;;ENST00000341947	45kb centromeric of HLA-DPB2; 3'--5'-cen	Deafness, autosomal dominant 13	601868	AD	3	Col11a2
6p21.32	6:33162694-33193519	COL11A2, DFNA13, DFNB53, FBCG2, OSMEDA, OSMEDB	Collagen XI, alpha-2 polypeptide	120290	COL11A2	1302	ENSG00000204248,ENST00000341947;;;ENST00000341947	45kb centromeric of HLA-DPB2; 3'--5'-cen	Deafness, autosomal recessive 53	609706	AR	3	Col11a2
6p21.32	6:33162694-33193519	COL11A2, DFNA13, DFNB53, FBCG2, OSMEDA, OSMEDB	Collagen XI, alpha-2 polypeptide	120290	COL11A2	1302	ENSG00000204248,ENST00000341947;;;ENST00000341947	45kb centromeric of HLA-DPB2; 3'--5'-cen	Fibrochondrogenesis 2	614524	AD, AR	3	Col11a2
6p21.32	6:33162694-33193519	COL11A2, DFNA13, DFNB53, FBCG2, OSMEDA, OSMEDB	Collagen XI, alpha-2 polypeptide	120290	COL11A2	1302	ENSG00000204248,ENST00000341947;;;ENST00000341947	45kb centromeric of HLA-DPB2; 3'--5'-cen	Otospondylomegaepiphyseal dysplasia, autosomal dominant	184840	AD	3	Col11a2
6p21.32	6:33162694-33193519	COL11A2, DFNA13, DFNB53, FBCG2, OSMEDA, OSMEDB	Collagen XI, alpha-2 polypeptide	120290	COL11A2	1302	ENSG00000204248,ENST00000341947;;;ENST00000341947	45kb centromeric of HLA-DPB2; 3'--5'-cen	Otospondylomegaepiphyseal dysplasia, autosomal recessive	215150	AR	3	Col11a2
6p21.32	6:33200867-33204437	SLC39A7, D6S2244E, HKE4, AGM9	Solute carrier family 39 (zinc transporter), member 7 (Ke4 gene, mouse, homolog of)	601416	SLC39A7	7922	ENSG00000112473,ENST00000374677;;;ENST00000374677		Agammaglobulinemia 9, autosomal recessive	619693	AR	3	Slc39a7
6p21.32	6:33299694-33314078	TAPBP, TPSN, MHC1D3	TAP-binding protein (tapasin)	601962	TAPBP	6892	ENSG00000231925,ENST00000434618;;;ENST00000434618	mutation identified in 1 MCH1D3 patient	?MHC class I deficiency 3	620814	AR	3	Tapbp
6p21.32	6:33418167-33453689	SYNGAP1, MRD5	Synaptic Ras GTPase activating protein 1	603384	SYNGAP1	8831	ENSG00000197283,ENST00000646630;;;ENST00000646630		Intellectual developmental disorder, autosomal dominant 5	612621	AD	3	Syngap1
6p21.31	6:33500001-36600000	STQTL19	Stature quantitative trait locus 19	612893		100302684		associated with rs1776897	{Stature QTL 19}	612893		2	
6p21.31	6:33621322-33696562	ITPR3, CMT1J, IMD133	Inositol 1,4,5-triphosphate receptor, type 3	147267	ITPR3	3710	ENSG00000096433,ENST00000605930;;;ENST00000605930		Charcot-Marie-Tooth disease, demyelinating, type 1J	620111	AD	3	Itpr3
6p21.31	6:33621322-33696562	ITPR3, CMT1J, IMD133	Inositol 1,4,5-triphosphate receptor, type 3	147267	ITPR3	3710	ENSG00000096433,ENST00000605930;;;ENST00000605930		Immunodeficiency 133 with ectodermal dysplasia with or without peripheral neuropathy	621254	AD	3	Itpr3
6p21.31	6:33696764-33711700	UQCC2, C6orf126, M19, MC3DN7	Ubiquinol-cytochrome c reductase complex assembly factor 2	614461	UQCC2	84300	ENSG00000137288,ENST00000607484;;;ENST00000607484		Mitochondrial complex III deficiency, nuclear type 7	615824	AR	3	Uqcc2
6p21.31	6:33771213-33789130	LEMD2, NET25, CTRCT42, MARUPS	LEM domain-containing protein 2	616312	LEMD2	221496	ENSG00000161904,ENST00000293760;;;ENST00000293760		Cataract 46, juvenile-onset	212500	AR	3	Lemd2
6p21.31	6:33771213-33789130	LEMD2, NET25, CTRCT42, MARUPS	LEM domain-containing protein 2	616312	LEMD2	221496	ENSG00000161904,ENST00000293760;;;ENST00000293760		Marbach-Rustad progeroid syndrome	619322	AD	3	Lemd2
6p21.31	6:34236873-34246231	HMGA1, HMGIY	High-mobility group AT-hook 1	600701	HMGA1	3159	ENSG00000137309,ENST00000311487;;;ENST00000311487		{Type 2 diabetes mellitus, susceptibility to}	125853	AD	3	Hmga1,Hmga1b
6p21.31	6:34417454-34426069	RPS10, DBA9	Ribosomal protein S10	603632	RPS10	6204	ENSG00000124614,ENST00000648437;;;ENST00000648437		Diamond-Blackfan anemia 9	613308	AD	3	Rps10
6p21.31	6:35213956-35253079	SCUBE3, SSFSC2	Signal peptide-, CUB domain-,  and EGF-like domains-containing protein 3	614708	SCUBE3	222663	ENSG00000146197,ENST00000274938;;;ENST00000274938		Short stature, facial dysmorphism, and skeletal anomalies with or without cardiac anomalies 2	619184	AR	3	Scube3
6p21.31	6:35297818-35321771	DEF6, IBP, SLAT, IMD87	DEF6 guanine nucleotide exchange factor	610094	DEF6	50619	ENSG00000023892,ENST00000316637;;;ENST00000316637		Immunodeficiency 87 and autoimmunity	619573	AR	3	Def6
6p21.31	6:35452338-35467102	FANCE, FACE	Fanconi anemia, complementation group E gene	613976	FANCE	2178	ENSG00000112039,ENST00000229769;;;ENST00000229769		Fanconi anemia, complementation group E	600901	AR	3	Fance
6p21.31	6:35497874-35512896	TULP1, RP14, LCA15	TUB-like protein 1	602280	TULP1	7287	ENSG00000112041,ENST00000229771;;;ENST00000229771		Leber congenital amaurosis 15	613843	AR	3	Tulp1
6p21.31	6:35497874-35512896	TULP1, RP14, LCA15	TUB-like protein 1	602280	TULP1	7287	ENSG00000112041,ENST00000229771;;;ENST00000229771		Retinitis pigmentosa 14	600132	AR	3	Tulp1
6p21.31	6:35573590-35728583	FKBP5, FKBP51	FK506-binding protein 5	602623	FKBP5	2289	ENSG00000096060,ENST00000357266;;;ENST00000357266		{Major depressive disorder and accelerated response to antidepressant drug treatment}	608516		3	Fkbp5
6p21.31	6:35731524-35749079	ARMC12, SPGF90	Armadillo repeat-containing protein 12	620377	ARMC12	221481	ENSG00000157343,ENST00000373866;;;ENST00000373866		Spermatogenic failure 90	620744	AR	3	Armc12
6p21.31	6:35805352-35824070	LHFPL5, TMHS, DFNB67	LHFPL tetraspan subfamily, member 5	609427	LHFPL5	222662	ENSG00000197753,ENST00000360215;;;ENST00000360215		Deafness, autosomal recessive 67	610265	AR	3	Lhfpl5
6p21.31	6:35943516-36024641	SLC26A8, TAT1, SPGF3	Solute carrier family 26 (sulfate transporter), member 8	608480	SLC26A8	116369	ENSG00000112053,ENST00000490799;;;ENST00000490799		Spermatogenic failure 3	606766	AD, AR	3	Slc26a8
6p21.31	6:36243168-36313955	PNPLA1, ARCI10	Patatin-like phospholipase domain-containing protein 1	612121	PNPLA1	285848	ENSG00000180316,ENST00000636260;;;ENST00000636260		Ichthyosis, congenital, autosomal recessive 10	615024	AR	3	Pnpla1
6p21.2	6:36854829-36874803	PPIL1, CYPL1, PCH14	Peptidylprolyl isomerase (cyclophilin)-like 1	601301	PPIL1	51645	ENSG00000137168,ENST00000373699;;;ENST00000373699	previously assigned to chr.2	Pontocerebellar hypoplasia, type 14	619301	AR	3	Ppil1
6p21.2	6:38715311-39030792	DNAH8, HDHC9, SPGF46	Dynein, axonemal, heavy chain 8	603337	DNAH8	1769	ENSG00000124721,ENST00000327475;;;ENST00000327475		Spermatogenic failure 46	619095	AR	3	Dnah8
6p21.2	6:39792376-39904869	DAAM2, KIAA0381, NPHS24	Dishevelled-associated activator of morphogenesis 2	606627	DAAM2	23500	ENSG00000146122,ENST00000274867;;;ENST00000274867		Nephrotic syndrome, type 24	619263	AR	3	Daam2
6p21.2	6:39904170-39934462	MOCS1, MOCODA	Molybdenum cofactor synthesis-1	603707	MOCS1	4337	ENSG00000124615,ENST00000340692;;;ENST00000340692		Molybdenum cofactor deficiency A	252150	AR	3	Mocs1
6p21.1-p12.2	6:40500001-53000000	MGR3	Migraine with or without aura, susceptibility to, 3	607498		337892		lod 5.78 at D6S452	{Migraine with or without aura, susceptibility to, 3}	607498	AD	2	
6p21.1	6:40500001-46200000	PPR1	Photoparoxysmal response 1	132100		100528023		max lod at D6S2427	Photoparoxysmal response 1	132100	AD	2	
6p21.1	6:41158508-41163116	TREM2, PLOSL2, AD17	Triggering receptor expressed on myeloid cells 2	605086	TREM2	54209	ENSG00000095970,ENST00000373113;;;ENST00000373113		{Alzheimer disease 17, susceptibility to}	615080	AR	3	Trem2
6p21.1	6:41158508-41163116	TREM2, PLOSL2, AD17	Triggering receptor expressed on myeloid cells 2	605086	TREM2	54209	ENSG00000095970,ENST00000373113;;;ENST00000373113		Polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy 2	618193	AR	3	Trem2
6p21.1	6:42050524-42087462	TAF8, TBN, NEDMLHB	TATA-box binding protein-associated factor 8	609514	TAF8	129685	ENSG00000137413,ENST00000372977;;;ENST00000372977		Neurodevelopmental disorder with severe motor impairment, absent language, cerebral hypomyelination, and brain atrophy	619972	AR	3	Taf8
6p21.1	6:42173364-42180056	GUCA1A, GCAP, COD3, CORD14	Guanylate cyclase activator 1A, retina	600364	GUCA1A	2978	ENSG00000048545,ENST00000372958;;;ENST00000372958		Cone dystrophy-3	602093	AD	3	Guca1a
6p21.1	6:42173364-42180056	GUCA1A, GCAP, COD3, CORD14	Guanylate cyclase activator 1A, retina	600364	GUCA1A	2978	ENSG00000048545,ENST00000372958;;;ENST00000372958		Cone-rod dystrophy 14	602093	AD	3	Guca1a
6p21.1	6:42183284-42194956	GUCA1B, GCAP2, GUCA2, RP48	Guanylate cyclase activator 1B, retina	602275	GUCA1B	2979	ENSG00000112599,ENST00000230361;;;ENST00000230361		Retinitis pigmentosa 48	613827	AD	3	Guca1b
6p21.1	6:42696598-42722597	PRPH2, DS, RP7, PRPH, AVMD, AOFMD, CACD2, MDBS1	Peripherin 2	179605	PRPH2	5961	ENSG00000112619,ENST00000230381;;;ENST00000230381	digenic RP with ROM1	Choroidal dystrophy, central areolar 2	613105	AD	3	Prph2
6p21.1	6:42696598-42722597	PRPH2, DS, RP7, PRPH, AVMD, AOFMD, CACD2, MDBS1	Peripherin 2	179605	PRPH2	5961	ENSG00000112619,ENST00000230381;;;ENST00000230381	digenic RP with ROM1	Leber congenital amaurosis 18	608133	AD, AR, DD	3	Prph2
6p21.1	6:42696598-42722597	PRPH2, DS, RP7, PRPH, AVMD, AOFMD, CACD2, MDBS1	Peripherin 2	179605	PRPH2	5961	ENSG00000112619,ENST00000230381;;;ENST00000230381	digenic RP with ROM1	Macular dystrophy, patterned, 1	169150	AD	3	Prph2
6p21.1	6:42696598-42722597	PRPH2, DS, RP7, PRPH, AVMD, AOFMD, CACD2, MDBS1	Peripherin 2	179605	PRPH2	5961	ENSG00000112619,ENST00000230381;;;ENST00000230381	digenic RP with ROM1	Macular dystrophy, vitelliform, 3	608161	AD	3	Prph2
6p21.1	6:42696598-42722597	PRPH2, DS, RP7, PRPH, AVMD, AOFMD, CACD2, MDBS1	Peripherin 2	179605	PRPH2	5961	ENSG00000112619,ENST00000230381;;;ENST00000230381	digenic RP with ROM1	Retinitis pigmentosa 7 and digenic form	608133	AD, AR, DD	3	Prph2
6p21.1	6:42696598-42722597	PRPH2, DS, RP7, PRPH, AVMD, AOFMD, CACD2, MDBS1	Peripherin 2	179605	PRPH2	5961	ENSG00000112619,ENST00000230381;;;ENST00000230381	digenic RP with ROM1	Retinitis punctata albescens	136880	AD, AR	3	Prph2
6p21.1	6:42916053-42925838	PTCRA, IMD126	Pre-T-cell receptor, alpha-chain precursor	606817	PTCRA	171558	ENSG00000171611,ENST00000304672;;;ENST00000304672		Immunodeficiency 126	620931	AR	3	Ptcra
6p21.1	6:42928002-42939294	CNPY3, TNRC5, PRAT4A, ERDA5, DEE60	Canopy 3, zebrafish, homolog of	610774	CNPY3	10695	ENSG00000137161,ENST00000372836;;;ENST00000372836		Developmental and epileptic encephalopathy 60	617929	AR	3	Cnpy3
6p21.1	6:42960754-42963880	GNMT	Glycine N-methyltransferase	606628	GNMT	27232	ENSG00000124713,ENST00000372808;;;ENST00000372808		Glycine N-methyltransferase deficiency	606664	AR	3	Gnmt
6p21.1	6:42963865-42979181	PEX6, PXAAA1, PAF2, PBD4A, PDB4B, HMLR2	Peroxisomal biogenesis factor 6 (peroxisomal AAA-type ATPase 1)	601498	PEX6	5190	ENSG00000124587,ENST00000304611;;;ENST00000304611		Heimler syndrome 2	616617	AR	3	Pex6
6p21.1	6:42963865-42979181	PEX6, PXAAA1, PAF2, PBD4A, PDB4B, HMLR2	Peroxisomal biogenesis factor 6 (peroxisomal AAA-type ATPase 1)	601498	PEX6	5190	ENSG00000124587,ENST00000304611;;;ENST00000304611		Peroxisome biogenesis disorder 4A (Zellweger)	614862	AR	3	Pex6
6p21.1	6:42963865-42979181	PEX6, PXAAA1, PAF2, PBD4A, PDB4B, HMLR2	Peroxisomal biogenesis factor 6 (peroxisomal AAA-type ATPase 1)	601498	PEX6	5190	ENSG00000124587,ENST00000304611;;;ENST00000304611		Peroxisome biogenesis disorder 4B	614863	AD, AR	3	Pex6
6p21.1	6:42984570-43012342	PPP2R5D, MRD35, HJS1	Protein phosphatase-2, regulatory subunit B (B56), delta isoform	601646	PPP2R5D	5528	ENSG00000112640,ENST00000485511;;;ENST00000485511		Houge-Janssens syndrome 1	616355	AD	3	Ppp2r5d
6p21.1	6:43037617-43053851	CUL7, 3M1	Cullin 7	609577	CUL7	9820	ENSG00000044090,ENST00000265348;;;ENST00000265348		3-M syndrome 1	273750	AR	3	Cul7
6p21.1	6:43059631-43075093	KLC4, CONDRHN	Kinesin light chain 4	620909	KLC4	89953	ENSG00000137171,ENST00000347162;;;ENST00000347162	mutation identified in 1 CONDRHN family	?Neurodegeneration, early-childhood-onset, with retinitis pigmentosa, sensorineural hearing loss, and demyelinating peripheral neuropathy	621129	AR	3	Klc4
6p21.1	6:43517089-43562407	POLR1C, RPA39, RPA40, RPAC1, RPA5, TCS3, HLD11	Polymerase I, RNA, subunit C	610060	POLR1C	9533	ENSG00000171453,ENST00000642195;;;ENST00000642195		Leukodystrophy, hypomyelinating, 11	616494	AR	3	Polr1c
6p21.1	6:43517089-43562407	POLR1C, RPA39, RPA40, RPAC1, RPA5, TCS3, HLD11	Polymerase I, RNA, subunit C	610060	POLR1C	9533	ENSG00000171453,ENST00000642195;;;ENST00000642195		Treacher Collins syndrome 3	248390	AR	3	Polr1c
6p21.1	6:43576185-43620523	POLH, XPV	Polymerase, DNA, eta	603968	POLH	5429	ENSG00000170734,ENST00000372236;;;ENST00000372236		Xeroderma pigmentosum, variant type	278750	AR	3	Polh
6p21.1	6:43620494-43631333	GTPBP2, JABELS	GTP-binding protein 2	607434	GTPBP2	54676	ENSG00000172432,ENST00000307126;;;ENST00000307126		Jaberi-Elahi syndrome	617988	AR	3	Gtpbp2
6p21.1	6:43645036-43672600	RSPH9, CILD12	Radial spoke head 9 homolog	612648	RSPH9	221421	ENSG00000172426,ENST00000372163;;;ENST00000372163		Ciliary dyskinesia, primary, 12	612650	AR	3	Rsph9
6p21.1	6:43770211-43786487	VEGF, MVCD1	Vascular endothelial growth factor	192240	VEGFA	7422	ENSG00000112715,ENST00000672860;;;ENST00000672860		{Microvascular complications of diabetes 1}	603933		3	Vegfa
6p21.1	6:44126633-44155519	TMEM63B, DEE118	Transmembrane protein 63B	619952	TMEM63B	55362	ENSG00000137216,ENST00000323267;;;ENST00000323267		Developmental and epileptic encephalopathy 118	621250	AD	3	Tmem63b
6p21.1	6:44192721-44218234	MYMX, CFZS2	Myomixer	619912	MYMX	101929726	ENSG00000262179,ENST00000573382;;;ENST00000573382		Carey-Fineman-Ziter syndrome 2	619941	AR	3	Mymx
6p21.1	6:44254101-44257890	SLC35B2, PAPST1, SLL, HLD26	Solute carrier family 35 (3'-phosphoadenosine 5'-phosphosulfate transporter), member B2	610788	SLC35B2	347734	ENSG00000157593,ENST00000393812;;;ENST00000393812		Leukodystrophy, hypomyelinating, 26, with chondrodysplasia	620269	AR	3	Slc35b2
6p21.1	6:44298731-44313347	AARS2, KIAA1270, MTALARS, COXPD8, LKENP	Alanyl-tRNA synthetase 2	612035	AARS2	57505	ENSG00000124608,ENST00000244571;;;ENST00000244571		Combined oxidative phosphorylation deficiency 8	614096	AR	3	Aars2
6p21.1	6:44298731-44313347	AARS2, KIAA1270, MTALARS, COXPD8, LKENP	Alanyl-tRNA synthetase 2	612035	AARS2	57505	ENSG00000124608,ENST00000244571;;;ENST00000244571		Leukoencephalopathy, progressive, with ovarian failure	615889	AR	3	Aars2
6p21.1	6:45328330-45551082	RUNX2, CBFA1, PEBP2A1, AML3, CCD, CLCD	Runt-related transcription factor 2	600211	RUNX2	860	ENSG00000124813,ENST00000647337;;;ENST00000647337		Cleidocranial dysplasia	119600	AD	3	Runx2
6p21.1	6:45328330-45551082	RUNX2, CBFA1, PEBP2A1, AML3, CCD, CLCD	Runt-related transcription factor 2	600211	RUNX2	860	ENSG00000124813,ENST00000647337;;;ENST00000647337		Cleidocranial dysplasia, forme fruste, dental anomalies only	119600	AD	3	Runx2
6p21.1	6:45328330-45551082	RUNX2, CBFA1, PEBP2A1, AML3, CCD, CLCD	Runt-related transcription factor 2	600211	RUNX2	860	ENSG00000124813,ENST00000647337;;;ENST00000647337		Cleidocranial dysplasia, forme fruste, with brachydactyly	119600	AD	3	Runx2
6p21.1	6:45328330-45551082	RUNX2, CBFA1, PEBP2A1, AML3, CCD, CLCD	Runt-related transcription factor 2	600211	RUNX2	860	ENSG00000124813,ENST00000647337;;;ENST00000647337		Metaphyseal dysplasia with maxillary hypoplasia with or without brachydactyly	156510	AD	3	Runx2
6p21.1	6:45880827-46129819	CLIC5, DFNB103	Chloride intracellular channel 5	607293	CLIC5	53405	ENSG00000112782,ENST00000339561;;;ENST00000339561	mutation identified in 1 DFNB103 family	?Deafness, autosomal recessive 103	616042	AR	3	Clic5
6p12-q12	6:46200001-69200000	CTRCT28, ARCC1	Cataract 28	609026		493862			{Cataract 28, age-related cortical, susceptibility to}	609026		2	
6p12	6:46200001-57200000	NYS2, NYSA	Nystagmus 2, congenital, autosomal dominant	164100		4933			Nystagmus 2, congenital, autosomal dominant	164100	AD	2	
6p12.3	6:46704201-46735721	PLA2G7, PAFAH, PAFAD	Phospholipase A2, group VII (platelet-activating factor acetylhydrolase)	601690	PLA2G7	7941	ENSG00000146070,ENST00000274793;;;ENST00000274793		Platelet-activating factor acetylhydrolase deficiency	614278	AR	3	Pla2g7
6p12.3	6:47477789-47627263	CD2AP, CMS	CD2-associated protein	604241	CD2AP	23607	ENSG00000198087,ENST00000359314;;;ENST00000359314		Glomerulosclerosis, focal segmental, 3	607832		3	Cd2ap
6p12.3	6:49430360-49463253	MMUT, MUT, MCM	Methylmalonyl-CoA mutase	609058	MMUT	4594	ENSG00000146085,ENST00000274813;;;ENST00000274813		Methylmalonic aciduria, mut(0) type	251000	AR	3	Mmut
6p12.3	6:49605175-49636839	RHAG, RH50A, OHST, RHNR	Rhesus blood group-associated glycoprotein	180297	RHAG	6005	ENSG00000112077,ENST00000371175;;;ENST00000371175		Anemia, hemolytic, Rh-null, regulator type	268150	AR	3	Rhag
6p12.3	6:49605175-49636839	RHAG, RH50A, OHST, RHNR	Rhesus blood group-associated glycoprotein	180297	RHAG	6005	ENSG00000112077,ENST00000371175;;;ENST00000371175		Overhydrated hereditary stomatocytosis	185000	AD	3	Rhag
6p12.3	6:50818355-50847619	TFAP2B, CHAR, PDA2	Transcription factor AP-2 beta (activating enhancer-binding protein 2 beta)	601601	TFAP2B	7021	ENSG00000008196,ENST00000393655;;;ENST00000393655		Char syndrome	169100	AD	3	Tfap2b
6p12.3	6:50818355-50847619	TFAP2B, CHAR, PDA2	Transcription factor AP-2 beta (activating enhancer-binding protein 2 beta)	601601	TFAP2B	7021	ENSG00000008196,ENST00000393655;;;ENST00000393655		Patent ductus arteriosus 2	617035	AD	3	Tfap2b
6p12.3-p12.2	6:51615299-52087615	PKHD1, PCYT, ARPKD, PKD4	PKHD1 ciliary IPT domain containing fibrocystin/polyductin	606702	PKHD1	5314	ENSG00000170927,ENST00000371117;;;ENST00000371117		Polycystic kidney disease 4, with or without hepatic disease	263200	AR	3	Pkhd1
6p12.2-q12	6:51800001-69200000	MRT24	Intellectual developmental disorder, autosomal recessive 24	614345		100852402		between rs651733 and rs1508668	Intellectual developmental disorder, autosomal recessive 24	614345	AR	2	
6p12.2	6:52236681-52245689	IL17F, ML1, CANDF6	Interleukin 17F	606496	IL17F	112744	ENSG00000112116,ENST00000336123;;;ENST00000336123	mutation identified in 1 CANDF6 family	?Candidiasis, familial, 6, autosomal dominant	613956		3	Il17f
6p12.2	6:52420342-52497198	EFHC1, FLJ10466, EJM1, JAE, EJA1	EF hand domain (C-terminal)-containing 1	608815	EFHC1	114327	ENSG00000096093,ENST00000371068;;;ENST00000371068		{Epilepsy, juvenile absence, susceptibility to, 1}	607631	AD	3	Efhc1
6p12.2	6:52420342-52497198	EFHC1, FLJ10466, EJM1, JAE, EJA1	EF hand domain (C-terminal)-containing 1	608815	EFHC1	114327	ENSG00000096093,ENST00000371068;;;ENST00000371068		{Myoclonic epilepsy, juvenile, susceptibility to, 1}	254770	AD	3	Efhc1
6p12.1	6:53001303-53061824	CILK1, ICK, MRK, KIAA0936, ECO, EJM10, CED6	Ciliogenesis associated kinase 1	612325	CILK1	22858	ENSG00000112144,ENST00000676107;;;ENST00000676107		{Epilepsy, juvenile myoclonic, susceptibility to, 10}	617924	AD	3	Cilk1
6p12.1	6:53001303-53061824	CILK1, ICK, MRK, KIAA0936, ECO, EJM10, CED6	Ciliogenesis associated kinase 1	612325	CILK1	22858	ENSG00000112144,ENST00000676107;;;ENST00000676107		Cranioectodermal dysplasia 6	621337	AR	3	Cilk1
6p12.1	6:53001303-53061824	CILK1, ICK, MRK, KIAA0936, ECO, EJM10, CED6	Ciliogenesis associated kinase 1	612325	CILK1	22858	ENSG00000112144,ENST00000676107;;;ENST00000676107		Endocrine-cerebroosteodysplasia	612651	AR	3	Cilk1
6p12.1	6:53267404-53348950	ELOVL5, HELO1, SCA38	Elongation of very long chain fatty acids-like 5	611805	ELOVL5	60481	ENSG00000012660,ENST00000304434;;;ENST00000304434		Spinocerebellar ataxia 38	615957	AD	3	Elovl5
6p12.1	6:53497341-53545101	GCLC, GLCLC, CNSHA7	Glutamate-cysteine ligase, catalytic subunit	606857	GCLC	2729	ENSG00000001084,ENST00000650454;;;ENST00000650454		{Myocardial infarction, susceptibility to}	608446		3	Gclc
6p12.1	6:53497341-53545101	GCLC, GLCLC, CNSHA7	Glutamate-cysteine ligase, catalytic subunit	606857	GCLC	2729	ENSG00000001084,ENST00000650454;;;ENST00000650454		Anemia, congenital, nonspherocytic hemolytic, 7	230450	AR	3	Gclc
6p12.1	6:54018970-54266280	MLIP, C6orf142, MMCKR	Muscular LMNA-interating protein	614106	MLIP	90523	ENSG00000146147,ENST00000502396;;;ENST00000502396		Myopathy with myalgia, increased serum creatine kinase, and with or without episodic rhabdomyolysis	620138	AR	3	Mlip
6p12.1	6:56457996-56954830	DST, BPAG1, DMH, D6S1101, HSAN6, EBS3	Dystonin (bullous pemphigoid antigen 1)	113810	DST	667	ENSG00000151914,ENST00000680361;;;ENST00000680361		Epidermolysis bullosa simplex 3, localized or generalized intermediate, with bp230 deficiency	615425	AR	3	Dst
6p12.1	6:56457996-56954830	DST, BPAG1, DMH, D6S1101, HSAN6, EBS3	Dystonin (bullous pemphigoid antigen 1)	113810	DST	667	ENSG00000151914,ENST00000680361;;;ENST00000680361		Neuropathy, hereditary sensory and autonomic, type VI	614653	AR	3	Dst
6p12.1-p11.2	6:57186992-57222307	RAB23	Ras-associated protein RAB23	606144	RAB23	51715	ENSG00000112210,ENST00000468148;;;ENST00000468148		Carpenter syndrome	201000	AR	3	Rab23
6p11	6:57200001-59800000	AITD1	Autoimmune thyroid disease, susceptibility to, 1	608173		387578			{Autoimmune thyroid disease, susceptibility to, 1}	608173		2	
6q	6:59800001-170805979	BPPV	Vertigo, benign paroxysmal positional	193007		619536		max lod at D6S1556	Vestibulopathy, familial	193007	AD	2	
6q11-q14	6:59800001-87300000	DEL6q11q14, C6DELq11q14	Chromosome 6q11-q14 deletion syndrome	613544				contiguous gene deletion syndrome	Chromosome 6q11-q14 deletion syndrome	613544	IC	4	
6q12	6:62700001-69200000	ADHD3	Attention deficit-hyperactivity disorder, susceptibility to, 3	608905		450089			{Attention deficit-hyperactivity disorder, susceptibility to, 3}	608905		2	
6q12-q16	6:62700001-105000000	CMD1K	Cardiomyopathy, dilated, 1K	605582		65014			Cardiomyopathy, dilated, 1K	605582		2	
6q12-q15	6:62700001-92500000	MRT30	Intellectual developmental disorder, autosomal recessive 30	614342		100852401		between rs4612125 and rs285651	Intellectual developmental disorder, autosomal recessive 30	614342	AR	2	
6q12	6:63719980-65707226	EYS, RP25	Eyes shut, Drosophila, homolog of	612424	EYS	346007	ENSG00000188107,ENST00000503581;;;ENST00000503581		Retinitis pigmentosa 25	602772	AR	3	
6q13-q16.1	6:69200001-98900000	OTSC7	Otosclerosis 7	611572		399516		between D6S1036 and D6S300	Otosclerosis 7	611572	AD	2	
6q13-q26	6:69200001-164100000	SCZD5	Schizophrenia susceptibility locus, chromosome 6q-related	603175				max lod at D6S1626 and D6S292	{Schizophrenia}	181500	AD	2	
6q13	6:69674010-69797010	LMBRD1, LMBD1, NESI, MAHCF	LMBR1 domain-containing protein 1	612625	LMBRD1	55788	ENSG00000168216,ENST00000649934;;;ENST00000649934		Methylmalonic aciduria and homocystinuria, cblF type	277380	AR	3	Lmbrd1
6q13	6:70215061-70303084	COL9A1, EDM6, STL4	Collagen IX, alpha-1 polypeptide	120210	COL9A1	1297	ENSG00000112280,ENST00000357250;;;ENST00000357250	mutation identified in 1 EDM6 family	?Epiphyseal dysplasia, multiple, 6	614135	AD	3	Col9a1
6q13	6:70215061-70303084	COL9A1, EDM6, STL4	Collagen IX, alpha-1 polypeptide	120210	COL9A1	1297	ENSG00000112280,ENST00000357250;;;ENST00000357250	mutation identified in 1 EDM6 family	Stickler syndrome, type IV	614134	AR	3	Col9a1
6q13	6:72622064-73198853	KCNQ5, MRD46	Potassium channel, voltage-gated, KQT-like subfamily, member 5	607357	KCNQ5	56479	ENSG00000185760,ENST00000370398;;;ENST00000370398		Intellectual developmental disorder, autosomal dominant 46	617601	AD	3	Kcnq5
6q13	6:73362658-73364171	KHDC3L, C6orf221, ECAT1, HYDM2	KH domain containing 3-like, subcortical maternal complex member	611687	KHDC3L	154288	ENSG00000203908,ENST00000370367;;;ENST00000370367		Hydatidiform mole, recurrent, 2	614293	AR	3	Khdc3
6q13	6:73461737-73509236	MTO1, COXPD10	Mitochondrial tRNA translation optimization 1	614667	MTO1	25821	ENSG00000135297,ENST00000498286;;;ENST00000498286		Combined oxidative phosphorylation deficiency 10	614702	AR	3	Mto1
6q13	6:73593379-73653992	SLC17A5, SIASD, SLD	Solute carrier family 17 (sodium phosphate), member 5	604322	SLC17A5	26503	ENSG00000119899,ENST00000355773;;;ENST00000355773		Salla disease	604369	AR	3	Slc17a5
6q13	6:73593379-73653992	SLC17A5, SIASD, SLD	Solute carrier family 17 (sodium phosphate), member 5	604322	SLC17A5	26503	ENSG00000119899,ENST00000355773;;;ENST00000355773		Sialic acid storage disorder, infantile	269920	AR	3	Slc17a5
6q13-q14.1	6:75084326-75206053	COL12A1, UCMD2, BTHLM2, EDSMYP	Collagen, type XII, alpha-1	120320	COL12A1	1303	ENSG00000111799,ENST00000322507;;;ENST00000322507	mutation identified in 1 UCMD2 family	?Ullrich congenital muscular dystrophy 2	616470	AR	3	Col12a1
6q13-q14.1	6:75084326-75206053	COL12A1, UCMD2, BTHLM2, EDSMYP	Collagen, type XII, alpha-1	120320	COL12A1	1303	ENSG00000111799,ENST00000322507;;;ENST00000322507	mutation identified in 1 UCMD2 family	Bethlem myopathy 2	616471	AD	3	Col12a1
6q14-q16	6:75200001-105000000	ATFB2	Atrial fibrillation, familial, 2	608988		619478		max lod between  D6S286 and D6S1021	Atrial fibrillation, familial, 2	608988		2	
6q14	6:75200001-87300000	CORD7	Cone-rod dystrophy 7	603649				maximum LOD at D6S280	Cone-rod dystrophy 7	603649	AD	2	
6q14.1	6:75200001-83200000	SHFLD2	Split-hand/foot malformation with long bone deficiency 2	610685		791123		between rs623155 and rs1547251	Split-hand/foot malformation with long bone deficiency 2	610685		2	
6q14.1	6:75291859-75493800	FILIP1, KIAA1275, NMDF	Filamin A-interacting protein	607307	FILIP1	27145	ENSG00000118407,ENST00000237172;;;ENST00000237172		Neuromuscular disorder, congenital, with dysmorphic facies	620775	AR	3	Filip1
6q14.1	6:75749239-75919537	MYO6, DFNA22, DFNB37	Myosin VI	600970	MYO6	4646	ENSG00000196586,ENST00000369977;;;ENST00000369977		Deafness, autosomal dominant 22	606346	AD	3	Myo6
6q14.1	6:75749239-75919537	MYO6, DFNA22, DFNB37	Myosin VI	600970	MYO6	4646	ENSG00000196586,ENST00000369977;;;ENST00000369977		Deafness, autosomal dominant 22, with hypertrophic cardiomyopathy	606346	AD	3	Myo6
6q14.1	6:75749239-75919537	MYO6, DFNA22, DFNB37	Myosin VI	600970	MYO6	4646	ENSG00000196586,ENST00000369977;;;ENST00000369977		Deafness, autosomal recessive 37	607821	AR	3	Myo6
6q14.1	6:75921114-76072662	IMPG1, IPM150, VMD4, RP91	Interphotoreceptor matrix proteoglycan-1	602870	IMPG1	3617	ENSG00000112706,ENST00000369950;;;ENST00000369950		Macular dystrophy, vitelliform, 4	616151	AD, AR	3	Impg1
6q14.1	6:75921114-76072662	IMPG1, IPM150, VMD4, RP91	Interphotoreceptor matrix proteoglycan-1	602870	IMPG1	3617	ENSG00000112706,ENST00000369950;;;ENST00000369950		Retinitis pigmentosa 91	153870	AD	3	Impg1
6q14.1	6:78934419-79078254	PHIP, CHUJANS, DIDOD	Pleckstrin homology domain-interacting protein	612870	PHIP	55023	ENSG00000146247,ENST00000275034;;;ENST00000275034		Chung-Jansen syndrome	617991	AD	3	Phip
6q14.1	6:79484991-79538782	LCA5, C6orf152	Lebercilin	611408	LCA5	167691	ENSG00000135338,ENST00000369846;;;ENST00000369846		Leber congenital amaurosis 5	604537	AR	3	Lca5
6q14.1	6:79914814-79947553	ELOVL4, ADMD, STGD2, STGD3, ISQMR, SCA34	Elongation of very long chain fatty acids 4	605512	ELOVL4	6785	ENSG00000118402,ENST00000369816;;;ENST00000369816		Ichthyosis, spastic quadriplegia, and impaired intellectual development	614457	AR	3	Elovl4
6q14.1	6:79914814-79947553	ELOVL4, ADMD, STGD2, STGD3, ISQMR, SCA34	Elongation of very long chain fatty acids 4	605512	ELOVL4	6785	ENSG00000118402,ENST00000369816;;;ENST00000369816		Spinocerebellar ataxia 34	133190	AD	3	Elovl4
6q14.1	6:79914814-79947553	ELOVL4, ADMD, STGD2, STGD3, ISQMR, SCA34	Elongation of very long chain fatty acids 4	605512	ELOVL4	6785	ENSG00000118402,ENST00000369816;;;ENST00000369816		Stargardt disease 3	600110	AD	3	Elovl4
6q14.1	6:80106610-80466676	BCKDHB, E1B, MSUD1B	Branched chain keto acid dehydrogenase E1, beta polypeptide	248611	BCKDHB	594	ENSG00000083123,ENST00000320393;;;ENST00000320393		Maple syrup urine disease, type Ib	620698	AR	3	Bckdhb
6q14.1	6:81745730-81752681	TENT5A, FAM46A, C6orf37, OI18	Terminal nucleotidyltransferase 5A	611357	TENT5A	55603	ENSG00000112773,ENST00000320172;;;ENST00000320172		Osteogenesis imperfecta, type XVIII	617952	AR	3	Tent5a
6q14.1	6:83148705-83193900	PGM3, AGM1, IMD23	Phosphoglucomutase-3 (N-acetylglucosamine-phosphate mutase 1)	172100	PGM3	5238	ENSG00000013375,ENST00000513973;;;ENST00000513973		Immunodeficiency 23	615816	AR	3	Pgm3
6q14.2	6:83853229-83857515	RIPPLY2, C6orf59, SCDO6	Ripply transcriptional repressor 2	609891	RIPPLY2	134701	ENSG00000203877,ENST00000369689;;;ENST00000369689	mutation identified in 1 SCDO6 family	?Spondylocostal dysostosis 6	616566	AR	3	Ripply2
6q14.2	6:84033178-84146282	MRAP2, C6orf117, BMIQ18	Melanocortin 2 receptor accessory protein 2	615410	MRAP2	112609	ENSG00000135324,ENST00000257776;;;ENST00000257776	mutation identified in 1 BMIQ18 individual	{?Obesity, susceptibility to, BMIQ18}	615457	AD	3	Mrap2
6q14.3	6:84732496-84764598	TBX18, CAKUT2	T-box 18	604613	TBX18	9096	ENSG00000112837,ENST00000369663;;;ENST00000369663		Congenital anomalies of kidney and urinary tract 2	143400	AD	3	Tbx18
6q14.3	6:85450083-85495784	NT5E, NT5	5' nucleotidase, ecto (CD73)	129190	NT5E	4907	ENSG00000135318,ENST00000257770;;;ENST00000257770		Calcification of joints and arteries	211800	AR	3	Nt5e
6q14.3	6:85505496-85593858	SNX14, SCAR20	Sorting nexin 14	616105	SNX14	57231	ENSG00000135317,ENST00000314673;;;ENST00000314673		Spinocerebellar ataxia, autosomal recessive 20	616354	AR	3	Snx14
6q14.3	6:87155565-87265943	ZNF292, ZFP292, KIAA0530, MRD64	Zinc finger protein 292	616213	ZNF292	23036	ENSG00000188994,ENST00000369577;;;ENST00000369577		Intellectual developmental disorder, autosomal dominant 64	619188	AD	3	Zfp292
6q15	6:87300001-92500000	CFAP206, SPGF102	Cilia- and flagella-associated protein 206	621376				mutation identified in 1 SPGF102 patient	?Spermatogenic failure 102	621387	AR	3	
6q15	6:87472974-87512336	SLC35A1, CST, CDG2F	Solute carrier family 35 (CMP-sialic acid transporter), member 1	605634	SLC35A1	10559	ENSG00000164414,ENST00000369552;;;ENST00000369552		Congenital disorder of glycosylation, type IIf	603585	AR	3	Slc35a1
6q15	6:87513938-87589987	RARS2, RARSL, PCH6	Arginyl-tRNA synthetase 2	611524	RARS2	57038	ENSG00000146282,ENST00000369536;;;ENST00000369536		Pontocerebellar hypoplasia, type 6	611523	AR	3	Rars2
6q15	6:88046901-88066838	SPACA1, SAMP32, SPGF85	Sperm acrosome-associated 1	612739	SPACA1	81833	ENSG00000118434,ENST00000237201;;;ENST00000237201	mutation identified in 1 SPGF85 family	?Spermatogenic failure 85	620490	AR	3	Spaca1
6q15	6:89364616-89412273	RRAGD, RAGD, HOMG7	RAS-related GTP-binding protein D	608268	RRAGD	58528	ENSG00000025039,ENST00000369415;;;ENST00000369415		Hypomagnesemia 7, renal, with or without dilated cardiomyopathy	620152	AD	3	Rragd
6q15	6:89926528-90296843	BACH2, IMD60	BTB and CNC homology 2	605394	BACH2	60468	ENSG00000112182,ENST00000257749;;;ENST00000257749		Immunodeficiency 60 and autoimmunity	618394	AD	3	Bach2
6q15	6:90513579-90587072	MAP3K7, TAK1, CSCF, FMD2	Mitogen-activated protein kinase kinase kinase 7	602614	MAP3K7	6885	ENSG00000135341,ENST00000369329;;;ENST00000369329		Cardiospondylocarpofacial syndrome	157800	AD	3	Map3k7
6q15	6:90513579-90587072	MAP3K7, TAK1, CSCF, FMD2	Mitogen-activated protein kinase kinase kinase 7	602614	MAP3K7	6885	ENSG00000135341,ENST00000369329;;;ENST00000369329		Frontometaphyseal dysplasia 2	617137	AD	3	Map3k7
6q16.1	6:96889315-96897891	NDUFAF4, HRPAP20, C6orf66, MC1DN15	NADH-ubiquinone oxidoreductase complex assembly factor 4	611776	NDUFAF4	29078	ENSG00000123545,ENST00000316149;;;ENST00000316149		Mitochondrial complex I deficiency, nuclear type 15	618237	AR	3	Ndufaf4
6q16.1-q16.2	6:98868535-98947946	FBXL4, FBL4, MTDPS13	F-box and leucine-rich repeat protein 4	605654	FBXL4	26235	ENSG00000112234,ENST00000369244;;;ENST00000369244		Mitochondrial DNA depletion syndrome 13 (encephalomyopathic type)	615471	AR	3	Fbxl4
6q16.2-q22.1	6:98900001-117900000	LMPHM2	Lymphatic malformation 2	611944		100188865		max lod at D6S1671	Lymphatic malformation 2	611944	AD	2	
6q16.2	6:99432325-99517846	USP45, LCA19	Ubiquitin-specific protease 45	618439	USP45	85015	ENSG00000123552,ENST00000500704;;;ENST00000500704	mutation identified in 1 LCA19 patient	?Leber congenital amaurosis 19	618513	AR	3	Usp45
6q16.2	6:99592885-99593339	DHS6S1, MCDR1, PBCRA	DNase1 hypersensitivity, chromosome 6, site 1	616842		111365204		upstream of PRDM13 and CCNC	Chorioretinal atrophy, progressive bifocal	600790	AD	3	
6q16.2	6:99592885-99593339	DHS6S1, MCDR1, PBCRA	DNase1 hypersensitivity, chromosome 6, site 1	616842		111365204		upstream of PRDM13 and CCNC	Macular dystrophy 1	136550	AD	3	
6q16.2	6:99606833-99615562	PRDM13, CDIDHH, PCH17	PR domain-containing protein 13	616741	PRDM13	59336	ENSG00000112238,ENST00000369215;;;ENST00000369215		Cerebellar dysfunction, impaired intellectual development, and hypogonadotropic hypogonadism	619761	AR	3	Prdm13
6q16.2	6:99606833-99615562	PRDM13, CDIDHH, PCH17	PR domain-containing protein 13	616741	PRDM13	59336	ENSG00000112238,ENST00000369215;;;ENST00000369215		Pontocerebellar hypoplasia, type 17	619909	AR	3	Prdm13
6q16.3-q22.31	6:100000001-125800000	GEFSP8	Generalized epilepsy with febrile seizures plus, type 8	613828		100653381		between D6S962 and D6S287	Generalized epilepsy with febrile seizures plus, type 8	613828		2	
6q16.3	6:100508194-100881329	ASCC3, p200, MRT81	Activating signal cointegrator 1 complex, subunit 3	614217	ASCC3	10973	ENSG00000112249,ENST00000369162;;;ENST00000369162		Intellectual developmental disorder, autosomal recessive 81	620700	AR	3	Ascc3
6q16.3	6:101393708-102070083	GRIK2, GLUR6, MRT6, NEDLAS	Glutamate receptor, ionotropic, kainate 2	138244	GRIK2	2898	ENSG00000164418,ENST00000369134;;;ENST00000369134		Intellectual developmental disorder, autosomal recessive 6	611092	AR	3	Grik2
6q16.3	6:101393708-102070083	GRIK2, GLUR6, MRT6, NEDLAS	Glutamate receptor, ionotropic, kainate 2	138244	GRIK2	2898	ENSG00000164418,ENST00000369134;;;ENST00000369134		Neurodevelopmental disorder with impaired language and ataxia and with or without seizures	619580	AD	3	Grik2
6q16.3	6:104728094-104859919	HACE1, KIAA1320, SPPRS	HECT domain- and ankyrin repeat-containing E3 ubiquitin protein ligase 1	610876	HACE1	57531	ENSG00000085382,ENST00000262903;;;ENST00000262903		Spastic paraplegia and psychomotor retardation with or without seizures	616756	AR	3	Hace1
6q21	6:105000001-114200000	HTX3	Heterotaxy, visceral, 3, autosomal	606325		116629			?Heterotaxy, visceral, 3, autosomal	606325		2	
6q21	6:105000001-114200000	IDDM15	Insulin-dependent diabetes mellitus-15	601666		3414			{Diabetes mellitus, insulin-dependent, 15}	601666		2	
6q21	6:105000001-114200000	LGV2	Longevity 2	606460		100329168		associated with rs2802292	[Longevity 2]	606460		2	
6q21	6:105000001-114200000	MCOPS8, MMEP	Microphthalmia, syndromic 8	601349				translocation with 13q12	Microphthalmia, syndromic 8	601349	?AD	2	
6q21	6:105000001-114200000	MENAQ2	Menarche, age at, QTL2	612882		100302562		associated with rs7759938	{Menarche, age at, QTL2}	612882		2	
6q21-q22	6:105000001-130000000	PLF	Pulmonary function	608852		450095		close to D6S281	{Pulmonary function}	608852		2	
6q21	6:105096822-105137157	POPDC1, BVES, HBVES, POPDC1, LGMDR25	Popeye domain cAMP effector 1	604577	POPDC1	11149	ENSG00000112276,ENST00000314641;;;ENST00000314641		Muscular dystrophy, limb-girdle, autosomal recessive 25	616812	AR	3	Popdc1
6q21	6:105157900-105180014	POPDC3, POP3, LGMDR26	Popeye domain-containing protein 3	605824	POPDC3	64208	ENSG00000132429,ENST00000254765;;;ENST00000254765		Muscular dystrophy, limb-girdle, autosomal recessive 26	618848	AR	3	Popdc3
6q21	6:106184476-106325760	ATG5, APG5, APG5L, ASP, SCAR25	Autophagy related 5	604261	ATG5	9474	ENSG00000057663,ENST00000369076;;;ENST00000369076	mutation identified in one SCAR25 family	?Spinocerebellar ataxia, autosomal recessive 25	617584	AR	3	Atg5
6q21	6:106570771-106630491	RTN4IP1, NIMP, OPA10	Reticulon 4-interacting protein 1	610502	RTN4IP1	84816	ENSG00000130347,ENST00000369063;;;ENST00000369063		Optic atrophy 10 with or without ataxia, impaired intellectual development and seizures	616732	AR	3	Rtn4ip1
6q21	6:106629578-106668417	QRSL1, GATA, COXPD40	Glutaminyl-tRNA synthase (glutamine-hydrolyzing)-like protein 1	617209	QRSL1	55278	ENSG00000130348,ENST00000369046;;;ENST00000369046		Combined oxidative phosphorylation deficiency 40	618835	AR	3	Qrsl1
6q21	6:107152562-107459564	PDSS2, DLP1, C6orf210, COQ10D3	Prenyl diphosphate synthase, subunit 2	610564	PDSS2	57107	ENSG00000164494,ENST00000369037;;;ENST00000369037		Coenzyme Q10 deficiency, primary, 3	614652	AR	3	Pdss2
6q21	6:107490117-107661306	SOBP, JXC1, MRAMS	Sine oculis-binding protein homolog	613667	SOBP	55084	ENSG00000112320,ENST00000317357;;;ENST00000317357	mutation identified in 1 MRAMS family	?Impaired intellectual development, anterior maxillary protrusion, and strabismus	613671	AR	3	Sobp
6q21	6:107867756-107958208	SEC63, PCLD2	SEC63 homolog, protein translocation regulator	608648	SEC63	11231	ENSG00000025796,ENST00000369002;;;ENST00000369002		Polycystic liver disease 2	617004	AD	3	Sec63
6q21	6:108041409-108074741	OSTM1, GL, OPTB5	Osteopetrosis associated transmembrane protein 1 (grey-lethal, mouse, homolog of)	607649	OSTM1	28962	ENSG00000081087,ENST00000193322;;;ENST00000193322		Osteopetrosis, autosomal recessive 5	259720	AR	3	Ostm1
6q21	6:108848422-109053040	ARMC2, SPGF38	Armadillo repeat-containing protein 2	618424	ARMC2	84071	ENSG00000118690,ENST00000392644;;;ENST00000392644		Spermatogenic failure 38	618433	AR	3	Armc2
6q21	6:109366514-109382467	CD164, DFNA66	CD164 antigen	603356	CD164	8763	ENSG00000135535,ENST00000310786;;;ENST00000310786	mutation identified in 1 DFNA66 family	?Deafness, autosomal dominant 66	616969	AD	3	Cd164
6q21	6:109462594-109483219	ZBTB24, PATZ2, ZNF450, KIAA0441, ICF2	Zinc finger- and BTB domain-containing protein 24	614064	ZBTB24	9841	ENSG00000112365,ENST00000230122;;;ENST00000230122		Immunodeficiency-centromeric instability-facial anomalies syndrome 2	614069	AR	3	Zbtb24
6q21	6:109492855-109691202	AK9, SPGF89	Adenylate kinase 9	615358	AK9	221264	ENSG00000155085,ENST00000424296;;;ENST00000424296		Spermatogenic failure 89	620705	AR	3	Ak9
6q21	6:109691296-109825426	FIG4, KIAA0274, SAC3, ALS11, YVS, BTOP	FIG4 phosphoinositide 5-phosphatase	609390	FIG4	9896	ENSG00000112367,ENST00000230124;;;ENST00000230124	mutation identified in 1 BTOP family	?Polymicrogyria, bilateral temporooccipital	612691	AR	3	Fig4
6q21	6:109691296-109825426	FIG4, KIAA0274, SAC3, ALS11, YVS, BTOP	FIG4 phosphoinositide 5-phosphatase	609390	FIG4	9896	ENSG00000112367,ENST00000230124;;;ENST00000230124	mutation identified in 1 BTOP family	Amyotrophic lateral sclerosis 11	612577	AD	3	Fig4
6q21	6:109691296-109825426	FIG4, KIAA0274, SAC3, ALS11, YVS, BTOP	FIG4 phosphoinositide 5-phosphatase	609390	FIG4	9896	ENSG00000112367,ENST00000230124;;;ENST00000230124	mutation identified in 1 BTOP family	Charcot-Marie-Tooth disease, type 4J	611228	AR	3	Fig4
6q21	6:109691296-109825426	FIG4, KIAA0274, SAC3, ALS11, YVS, BTOP	FIG4 phosphoinositide 5-phosphatase	609390	FIG4	9896	ENSG00000112367,ENST00000230124;;;ENST00000230124	mutation identified in 1 BTOP family	Yunis-Varon syndrome	216340	AR	3	Fig4
6q21	6:110099819-110179670	WASF1, WAVE, WAVE1, SCAR1, NEDALVS	WAS protein family member 1	605035	WASF1	8936	ENSG00000112290,ENST00000392589;;;ENST00000392589		Neurodevelopmental disorder with absent language and variable seizures	618707	AD	3	Wasf1
6q21	6:110180427-110232232	CDC40, PRP17, PCH15	Cell division cycle 40	605585	CDC40	51362	ENSG00000168438,ENST00000307731;;;ENST00000307731	mutation identified in 1 PCH15 patient	?Pontocerebellar hypoplasia, type 15	619302	AR	3	Cdc40
6q21	6:110609978-110815855	CDK19, KIAA1028, DEE87	Cyclin-dependent kinase 19	614720	CDK19	23097	ENSG00000155111,ENST00000368911;;;ENST00000368911		Developmental and epileptic encephalopathy 87	618916	AD	3	Cdk19
6q21	6:111555381-111605878	TRAF3IP2, C6orf5, ACT1, CIKS, C6orf4, C6orf6, PSORS13, CANDF8	TRAF3-interacting protein 2	607043	TRAF3IP2	10758	ENSG00000056972,ENST00000368761;;;ENST00000368761	mutation identified in 1 family with CANDF8	?Candidiasis, familial, 8	615527	AR	3	Traf3ip2
6q21	6:111555381-111605878	TRAF3IP2, C6orf5, ACT1, CIKS, C6orf4, C6orf6, PSORS13, CANDF8	TRAF3-interacting protein 2	607043	TRAF3IP2	10758	ENSG00000056972,ENST00000368761;;;ENST00000368761	mutation identified in 1 family with CANDF8	{Psoriasis susceptibility 13}	614070		3	Traf3ip2
6q21	6:112052813-112069686	CCN6, WISP3, PPAC, PPRD	Cellular communication network factor 6	603400	CCN6	8838	ENSG00000112761,ENST00000368666;;;ENST00000368666		Progressive pseudorheumatoid dysplasia	208230	AR	3	Ccn6
6q21	6:112107931-112254985	LAMA4, LAMA3, CMD1JJ	Laminin, alpha-4	600133	LAMA4	3910	ENSG00000112769,ENST00000230538;;;ENST00000230538		Cardiomyopathy, dilated, 1JJ	615235	AD	3	Lama4
6q22-q24	6:114200001-148500000	FEB5	Febrile seizures, familial, 5	609255		619398		between D6S1572 and D6S472	Febrile seizures, familial, 5	609255	AD	2	
6q22-q24	6:114200001-148500000	FIQTL1	Fasting insulin level quantitative trait locus 1	606035		619503		max lod at D6S1569	[Fasting insulin level quantitative trait locus 1]	606035		2	
6q22-q23	6:114200001-138300000	IGAN1	IgA nephropathy, susceptibility to, 1	161950		60498			{IgA nephropathy, susceptibility to, 1}	161950	?AD	2	
6q22-q23	6:114200001-138300000	SM2	Hepatic fibrosis susceptibility due to Schistosoma mansoni infection	604201		53366		?polymorphism of INFGR1	{Hepatic fibrosis susceptibility due to Schistosoma mansoni infection}	604201		2	
6q22.1	6:116118909-116217144	COL10A1	Collagen X, alpha-1 polypeptide	120110	COL10A1	1300	ENSG00000123500,ENST00000651968;;;ENST00000651968		Metaphyseal chondrodysplasia, Schmid type	156500	AD	3	Col10a1
6q22.1	6:116254171-116444861	DSE, SART2, EDSMC2	Dermatan sulfate epimerase	605942	DSE	29940	ENSG00000111817,ENST00000644252;;;ENST00000644252		Ehlers-Danlos syndrome, musculocontractural type 2	615539	AR	3	Dse
6q22.1	6:116274858-116279930	TSPYL1, TSPYL, SIDDT	Y-encoded testis-specific protein-like	604714	TSPYL1	7259	ENSG00000189241,ENST00000368608;;;ENST00000368608		Sudden infant death with dysgenesis of the testes syndrome	608800	AR	3	Tspyl1
6q22.1	6:116616479-116632985	RSPH4A, CILD11	Radial spoke head component 4A	612647	RSPH4A	345895	ENSG00000111834,ENST00000229554;;;ENST00000229554		Ciliary dyskinesia, primary, 11	612649	AR	3	Rsph4a
6q22.1	6:116877242-116932161	RFX6, RFXDC1, MTCHRS	Regulatory factor X, 6	612659	RFX6	222546	ENSG00000185002,ENST00000332958;;;ENST00000332958		Mitchell-Riley syndrome	615710	AR	3	Rfx6
6q22.1	6:117675469-117710727	NUS1, NGBR, C6orf68, CDG1AA, MRD55	NUS1 dehydrodolichyl diphosphate synthase subunit	610463	NUS1	116150	ENSG00000153989,ENST00000368494;;;ENST00000368494	mutation identified in 1 CDG1AA family	?Congenital disorder of glycosylation, type 1aa	617082	AR	3	Nus1
6q22.1	6:117675469-117710727	NUS1, NGBR, C6orf68, CDG1AA, MRD55	NUS1 dehydrodolichyl diphosphate synthase subunit	610463	NUS1	116150	ENSG00000153989,ENST00000368494;;;ENST00000368494	mutation identified in 1 CDG1AA family	Intellectual developmental disorder, autosomal dominant 55, with seizures	617831	AD	3	Nus1
6q22.3-q23.1	6:118100001-130900000	HBFQTL2, FCP	Fetal hemoglobin quantitative trait locus 2	142470		7954			Fetal hemoglobin quantitative trait locus 2	142470	AD	2	
6q22.31	6:118460772-118710089	CEP85L, C6orf204, LIS10	CEP85-like protein	618865	CEP85L	387119	ENSG00000111860,ENST00000368491;;;ENST00000368491		Lissencephaly 10	618873	AD	3	Cep85l
6q22.31	6:118548296-118561716	PLN, PLB, CMD1P, CMH18	Phospholamban	172405	PLN	5350	ENSG00000198523,ENST00000357525;;;ENST00000357525		Cardiomyopathy, dilated, 1P	609909		3	Pln
6q22.31	6:118548296-118561716	PLN, PLB, CMD1P, CMH18	Phospholamban	172405	PLN	5350	ENSG00000198523,ENST00000357525;;;ENST00000357525		Cardiomyopathy, hypertrophic, 18	613874	AD	3	Pln
6q22.31	6:118813455-118935159	MCM9, MCMDC1, ODG4	Minichromosome maintenance complex component 9	610098	MCM9	254394	ENSG00000111877,ENST00000619706;;;ENST00000619706		Ovarian dysgenesis 4	616185	AR	3	Mcm9
6q22.31	6:121079494-121334729	TBC1D32, BROMI, RP100, ALHSA, OFD9	TBC1 domain family, member 32	615867	TBC1D32	221322	ENSG00000146350,ENST00000398212;;;ENST00000398212		Alsahan-Harris syndrome	621307	AR	3	Tbc1d32
6q22.31	6:121079494-121334729	TBC1D32, BROMI, RP100, ALHSA, OFD9	TBC1 domain family, member 32	615867	TBC1D32	221322	ENSG00000146350,ENST00000398212;;;ENST00000398212		Orofaciodigital syndrome IX	258865	AR	3	Tbc1d32
6q22.31	6:121079494-121334729	TBC1D32, BROMI, RP100, ALHSA, OFD9	TBC1 domain family, member 32	615867	TBC1D32	221322	ENSG00000146350,ENST00000398212;;;ENST00000398212		Retinitis pigmentosa 100	621280	AR	3	Tbc1d32
6q22.31	6:121435646-121449727	GJA1, CX43, ODDD, SDTY3, ODOD, HSS, CMDR, EKVP3	Gap junction protein, alpha-1, 43kD (connexin 43)	121014	GJA1	2697	ENSG00000152661,ENST00000282561;;;ENST00000282561	pseudogene on chr.5	Craniometaphyseal dysplasia, autosomal recessive	218400	AR	3	Gja1
6q22.31	6:121435646-121449727	GJA1, CX43, ODDD, SDTY3, ODOD, HSS, CMDR, EKVP3	Gap junction protein, alpha-1, 43kD (connexin 43)	121014	GJA1	2697	ENSG00000152661,ENST00000282561;;;ENST00000282561	pseudogene on chr.5	Erythrokeratodermia variabilis et progressiva 3	617525	AD	3	Gja1
6q22.31	6:121435646-121449727	GJA1, CX43, ODDD, SDTY3, ODOD, HSS, CMDR, EKVP3	Gap junction protein, alpha-1, 43kD (connexin 43)	121014	GJA1	2697	ENSG00000152661,ENST00000282561;;;ENST00000282561	pseudogene on chr.5	Oculodentodigital dysplasia	164200	AD	3	Gja1
6q22.31	6:121435646-121449727	GJA1, CX43, ODDD, SDTY3, ODOD, HSS, CMDR, EKVP3	Gap junction protein, alpha-1, 43kD (connexin 43)	121014	GJA1	2697	ENSG00000152661,ENST00000282561;;;ENST00000282561	pseudogene on chr.5	Oculodentodigital dysplasia, autosomal recessive	257850	AR	3	Gja1
6q22.31	6:121435646-121449727	GJA1, CX43, ODDD, SDTY3, ODOD, HSS, CMDR, EKVP3	Gap junction protein, alpha-1, 43kD (connexin 43)	121014	GJA1	2697	ENSG00000152661,ENST00000282561;;;ENST00000282561	pseudogene on chr.5	Palmoplantar keratoderma with congenital alopecia	104100	AD	3	Gja1
6q22.31	6:121435646-121449727	GJA1, CX43, ODDD, SDTY3, ODOD, HSS, CMDR, EKVP3	Gap junction protein, alpha-1, 43kD (connexin 43)	121014	GJA1	2697	ENSG00000152661,ENST00000282561;;;ENST00000282561	pseudogene on chr.5	Syndactyly, type III	186100	AD	3	Gja1
6q22.31	6:123216339-123636950	TRDN, TDN, CARDAR	Triadin	603283	TRDN	10345	ENSG00000186439,ENST00000334268;;;ENST00000334268		Cardiac arrhythmia syndrome, with or without skeletal muscle weakness	615441	AR	3	Trdn
6q22.33	6:128883138-129516566	LAMA2, LAMM, MDC1A	Laminin, alpha-2 (merosin)	156225	LAMA2	3908	ENSG00000196569,ENST00000421865;;;ENST00000421865		Muscular dystrophy, congenital, merosin deficient or partially deficient	607855	AR	3	Lama2
6q22.33	6:128883138-129516566	LAMA2, LAMM, MDC1A	Laminin, alpha-2 (merosin)	156225	LAMA2	3908	ENSG00000196569,ENST00000421865;;;ENST00000421865		Muscular dystrophy, limb-girdle, autosomal recessive 23	618138	AR	3	Lama2
6q23-q25	6:130000001-160600000	BMIQ3	Body mass index quantitative trait locus 3	607446		337895		max lod at D6S305	[Body mass index QTL3]	607446		2	
6q23	6:130000001-138300000	HCHGQ1	Hematocrit/hemoglobin quantitative trait locus 1	609319		100381204			[Hematocrit/hemoglobin quantitative trait locus 1]	609319		2	
6q23-q25	6:130000001-160600000	LNCR1	Lung cancer 1	608935		450093		max hlod at D6S2436	{Lung cancer susceptibility}	608935		2	
6q23-q24	6:130000001-148500000	MAFD6, BPAD	Major affective disorder 6	611536		100188844			{Major affective disorder 6}	611536		2	
6q23	6:130000001-138300000	RP63	Retinitis pigmentosa 63	614494		100862681		between D6S457 and D6S1656	Retinitis pigmentosa 63	614494	AD	2	
6q23	6:130000001-138300000	SLEB13	Systemic lupus erythematosus, susceptibility to, 13	612378		100196918		associated with rs5029939	{Systemic lupus erythematosus, susceptibility to, 13}	612378	AD	2	
6q23-q24.1	6:130000001-142200000	SPG25	Spastic paraplegia 25, autosomal recessive, with disc herniation	608220		387583			Spastic paraplegia 25, autosomal recessive	608220	AR	2	
6q23.2	6:131573226-131584329	ARG1	Arginase, liver	608313	ARG1	383	ENSG00000118520,ENST00000368087;;;ENST00000368087		Argininemia	207800	AR	3	Arg1
6q23.2	6:131573966-131628313	MED23, MRT18	Mediator complex subunit 23	605042	MED23	9439	ENSG00000112282,ENST00000368068;;;ENST00000368068		Intellectual developmental disorder, autosomal recessive 18, with or without epilepsy	614249	AR	3	Med23
6q23.2	6:131808020-131895155	ENPP1, PDNP1, NPPS, M6S1, PCA1, ARHR2, COLED	Ectonucleotide pyrophosphatase/phosphodiesterase 1 (Ly-41 antigen, mouse, homolog of)	173335	ENPP1	5167	ENSG00000197594,ENST00000647893;;;ENST00000647893		{Diabetes mellitus, non-insulin-dependent, susceptibility to}	125853	AD	3	Enpp1
6q23.2	6:131808020-131895155	ENPP1, PDNP1, NPPS, M6S1, PCA1, ARHR2, COLED	Ectonucleotide pyrophosphatase/phosphodiesterase 1 (Ly-41 antigen, mouse, homolog of)	173335	ENPP1	5167	ENSG00000197594,ENST00000647893;;;ENST00000647893		{Obesity, susceptibility to}	601665	AD, AR, Mu	3	Enpp1
6q23.2	6:131808020-131895155	ENPP1, PDNP1, NPPS, M6S1, PCA1, ARHR2, COLED	Ectonucleotide pyrophosphatase/phosphodiesterase 1 (Ly-41 antigen, mouse, homolog of)	173335	ENPP1	5167	ENSG00000197594,ENST00000647893;;;ENST00000647893		Arterial calcification, generalized, of infancy, 1	208000	AR	3	Enpp1
6q23.2	6:131808020-131895155	ENPP1, PDNP1, NPPS, M6S1, PCA1, ARHR2, COLED	Ectonucleotide pyrophosphatase/phosphodiesterase 1 (Ly-41 antigen, mouse, homolog of)	173335	ENPP1	5167	ENSG00000197594,ENST00000647893;;;ENST00000647893		Cole disease	615522	AD	3	Enpp1
6q23.2	6:131808020-131895155	ENPP1, PDNP1, NPPS, M6S1, PCA1, ARHR2, COLED	Ectonucleotide pyrophosphatase/phosphodiesterase 1 (Ly-41 antigen, mouse, homolog of)	173335	ENPP1	5167	ENSG00000197594,ENST00000647893;;;ENST00000647893		Hypophosphatemic rickets, autosomal recessive, 2	613312	AR	3	Enpp1
6q23.2	6:131948176-131951372	CCN2, CTGF, NOV2, SEMDLSL, KMD	Cellular communication network factor 2	121009	CCN2	1490	ENSG00000118523,ENST00000367976;;;ENST00000367976	mutation identified in 1 SEMDLSL family	?Spondyloepimetaphyseal dysplasia, Li-Shao-Li type	621099	AD	3	Ccn2
6q23.2	6:131948176-131951372	CCN2, CTGF, NOV2, SEMDLSL, KMD	Cellular communication network factor 2	121009	CCN2	1490	ENSG00000118523,ENST00000367976;;;ENST00000367976	mutation identified in 1 SEMDLSL family	Kyphomelic dysplasia	211350	AR	3	Ccn2
6q23.2	6:133240593-133532128	EYA4, DFNA10, CMD1J	EYA transcriptional coactivator and phosphatase 4	603550	EYA4	2070	ENSG00000112319,ENST00000355286;;;ENST00000355286	mutation identified in 1 CMD1J family	?Cardiomyopathy, dilated, 1J	605362	AD	3	Eya4
6q23.2	6:133240593-133532128	EYA4, DFNA10, CMD1J	EYA transcriptional coactivator and phosphatase 4	603550	EYA4	2070	ENSG00000112319,ENST00000355286;;;ENST00000355286	mutation identified in 1 CMD1J family	Deafness, autosomal dominant 10	601316	AD	3	Eya4
6q23.3	6:134700001-138300000	MPVQTL5	Mean platelet volume quantitative trait locus 5	614645		100887752		associated with rs9399137	Mean platelet volume QTL5	614645		2	
6q23.3	6:135181308-135219172	MYB	Avian myeloblastosis viral (v-myb) oncogene homolog	189990	MYB	4602	ENSG00000118513,ENST00000341911;;;ENST00000341911		{T-cell acute lymphoblastic leukemia}			3	Myb
6q23.3	6:135283532-135497740	AHI1	Abelson helper integration site 1	608894	AHI1	54806	ENSG00000135541,ENST00000265602;;;ENST00000265602		Joubert syndrome 3	608629	AR	3	Ahi1
6q23.3	6:136822592-136913934	PEX7, RCDP1, PBD9B	Peroxisomal biogenesis factor-7	601757	PEX7	5191	ENSG00000112357,ENST00000318471;;;ENST00000318471		Peroxisome biogenesis disorder 9B	614879	AR	3	Pex7
6q23.3	6:136822592-136913934	PEX7, RCDP1, PBD9B	Peroxisomal biogenesis factor-7	601757	PEX7	5191	ENSG00000112357,ENST00000318471;;;ENST00000318471		Rhizomelic chondrodysplasia punctata, type 1	215100	AR	3	Pex7
6q23.3	6:137197484-137219385	IFNGR1, IMD27A, IMD27B	Immune interferon, receptor for	107470	IFNGR1	3459	ENSG00000027697,ENST00000367739;;;ENST00000367739		{H. pylori infection, susceptibility to}	600263		3	Ifngr1
6q23.3	6:137197484-137219385	IFNGR1, IMD27A, IMD27B	Immune interferon, receptor for	107470	IFNGR1	3459	ENSG00000027697,ENST00000367739;;;ENST00000367739		{Hepatitis B virus infection, susceptibility to}	610424		3	Ifngr1
6q23.3	6:137197484-137219385	IFNGR1, IMD27A, IMD27B	Immune interferon, receptor for	107470	IFNGR1	3459	ENSG00000027697,ENST00000367739;;;ENST00000367739		{Tuberculosis infection, protection against}	607948		3	Ifngr1
6q23.3	6:137197484-137219385	IFNGR1, IMD27A, IMD27B	Immune interferon, receptor for	107470	IFNGR1	3459	ENSG00000027697,ENST00000367739;;;ENST00000367739		{Tuberculosis, susceptibility to}	607948		3	Ifngr1
6q23.3	6:137197484-137219385	IFNGR1, IMD27A, IMD27B	Immune interferon, receptor for	107470	IFNGR1	3459	ENSG00000027697,ENST00000367739;;;ENST00000367739		Immunodeficiency 27A, mycobacteriosis, AR	209950	AR	3	Ifngr1
6q23.3	6:137197484-137219385	IFNGR1, IMD27A, IMD27B	Immune interferon, receptor for	107470	IFNGR1	3459	ENSG00000027697,ENST00000367739;;;ENST00000367739		Immunodeficiency 27B, mycobacteriosis, AD	615978	AD	3	Ifngr1
6q23.3	6:137866349-137883312	TNFAIP3, A20, OTUD7C, AIFBL1	Tumor necrosis factor-alpha-induced protein 3	191163	TNFAIP3	7128	ENSG00000118503,ENST00000612899;;;ENST00000612899		Autoinflammatory syndrome, familial, Behcet-like 1	616744	AD	3	Tnfaip3
6q23.3	6:138088505-138107419	PERP, OLMS2, EKVP7	p53 effector related to PMP22	609301	PERP	64065	ENSG00000112378,ENST00000421351;;;ENST00000421351		Erythrokeratodermia variabilis et progressiva 7	619209	AR	3	Perp
6q23.3	6:138088505-138107419	PERP, OLMS2, EKVP7	p53 effector related to PMP22	609301	PERP	64065	ENSG00000112378,ENST00000421351;;;ENST00000421351		Olmsted syndrome 2	619208	AD	3	Perp
6q24-q25	6:138300001-160600000	DEL6q24q25, C6DELq25q25	Chromosome 6q24-q25 deletion syndrome	612863					Chromosome 6q25-q25 deletion syndrome	612863	AD	4	
6q24-q25	6:138300001-160600000	STQTL1	Stature quantitative trait locus 1	606255				associated with rs4896582 and rs3748069	{Stature QTL 1}	606255		2	
6q24	6:138300001-148500000	TNDM1	Transient neonatal diabetes mellitus 1	601410				disordered imprinting of PLAGL1 and HYMAI	{Diabetes mellitus, transient neonatal 1}	601410	AD, AR	4	
6q24.1	6:138903493-138988253	REPS1, NBIA7	RALBP1-associated EPS domain-containing protein 1	614825	REPS1	85021	ENSG00000135597,ENST00000450536;;;ENST00000450536	mutation identified in 1 NBIA7 family	?Neurodegeneration with brain iron accumulation 7	617916	AR	3	Reps1
6q24.1	6:139371807-139374648	CITED2, MRG1, P35SRJ, VSD2, ASD8	CBP/p300-interacting transactivator, with glu/asp-rich C-terminal domain, 2	602937	CITED2	10370	ENSG00000164442,ENST00000367651;;;ENST00000367651	?pseudogene on 1q22	Atrial septal defect 8	614433	AD	3	Cited2
6q24.1	6:139371807-139374648	CITED2, MRG1, P35SRJ, VSD2, ASD8	CBP/p300-interacting transactivator, with glu/asp-rich C-terminal domain, 2	602937	CITED2	10370	ENSG00000164442,ENST00000367651;;;ENST00000367651	?pseudogene on 1q22	Ventricular septal defect 2	614431	AD	3	Cited2
6q24.2	6:142302007-142446261	ADGRG6, PR126, VIGR, LCCS9	Adhesion G protein-coupled receptor G6	612243	ADGRG6	57211	ENSG00000112414,ENST00000367609;;;ENST00000367609		Lethal congenital contracture syndrome 9	616503	AR	3	Adgrg6
6q24.2	6:142751469-142945733	HIVEP2, MRD43	Human immunodeficiency virus type I enhancer-binding protein-2	143054	HIVEP2	3097	ENSG00000010818,ENST00000367603;;;ENST00000367603		Intellectual developmental disorder, autosomal dominant 43	616977	AD	3	Hivep2
6q24.2	6:143450805-143490616	PEX3, PBD10A, PBD10B	Peroxisomal biogenesis factor-3	603164	PEX3	8504	ENSG00000034693,ENST00000367591;;;ENST00000367591	mutation identified in 1 PBD10B patient	?Peroxisome biogenesis disorder 10B	617370	AR	3	Pex3
6q24.2	6:143450805-143490616	PEX3, PBD10A, PBD10B	Peroxisomal biogenesis factor-3	603164	PEX3	8504	ENSG00000034693,ENST00000367591;;;ENST00000367591	mutation identified in 1 PBD10B patient	Peroxisome biogenesis disorder 10A (Zellweger)	614882	AR	3	Pex3
6q24.2	6:143843338-143863812	LTV1, IPHAK	LTV1 ribosome biogenesis factor	620074	LTV1	84946	ENSG00000135521,ENST00000367576;;;ENST00000367576		Inflammatory poikiloderma with hair abnormalities and acral keratoses	620199	AR	3	Ltv1
6q24.2	6:144139963-144191939	STX11, FHL4, HPLH4, HLH4	Syntaxin-11	605014	STX11	8676	ENSG00000135604,ENST00000367568;;;ENST00000367568		Hemophagocytic lymphohistiocytosis, familial, 4	603552	AR	3	Stx11
6q24.3	6:145383353-145736023	EPM2A, MELF2	EPM2A glucan phosphatase, laforin	607566	EPM2A	7957	ENSG00000112425,ENST00000367519;;;ENST00000367519		Myoclonic epilepsy of Lafora 1	254780	AR	3	Epm2a
6q24.3	6:146027707-146437601	GRM1, MGLUR1, GRM1A, SCAR13, SCA44	Glutamate receptor, metabotropic, 1	604473	GRM1	2911	ENSG00000152822,ENST00000282753;;;ENST00000282753		Spinocerebellar ataxia 44	617691	AD	3	Grm1
6q24.3	6:146027707-146437601	GRM1, MGLUR1, GRM1A, SCAR13, SCA44	Glutamate receptor, metabotropic, 1	604473	GRM1	2911	ENSG00000152822,ENST00000282753;;;ENST00000282753		Spinocerebellar ataxia, autosomal recessive 13	614831	AR	3	Grm1
6q24.3	6:146543833-146554953	RAB32, PARK26	Ras-associated protein RAB32	612906	RAB32	10981	ENSG00000118508,ENST00000367495;;;ENST00000367495		{Parkinson disease 26, autosomal dominant, susceptibility to}	620923	AD	3	Rab32
6q24.3-q25.1	6:148193468-148552044	SASH1, KIAA0790, CAPOK, DUH1	Sterile alpha motifs- and SH3 domain-containing protein 1	607955	SASH1	23328	ENSG00000111961,ENST00000367467;;;ENST00000367467	mutation identified in 1 CAPOK family	?Cancer, alopecia, pigment dyscrasia, onychodystrophy, and keratoderma	618373	AR	3	Sash1
6q24.3-q25.1	6:148193468-148552044	SASH1, KIAA0790, CAPOK, DUH1	Sterile alpha motifs- and SH3 domain-containing protein 1	607955	SASH1	23328	ENSG00000111961,ENST00000367467;;;ENST00000367467	mutation identified in 1 CAPOK family	Dyschromatosis universalis hereditaria 1	127500	AD	3	Sash1
6q25	6:148500001-160600000	BMND11	Bone mineral density quantitative trait locus 11	612114		100188884		associated with rs4870044, rs1038304, and rs1999805	[Bone mineral density QTL 11]	612114		2	
6q25	6:148500001-160600000	IDDM21	Diabetes mellitus, insulin-dependent, 21	612521				associated with rs1738074	{Diabetes mellitus, insulin-dependent, 21}	612521		2	
6q25-q27	6:148500001-170805979	IDDM8	Insulin-dependent diabetes mellitus-8	600883		3407			{Diabetes mellitus, insulin-dependent, 8}	600883		2	
6q25	6:148500001-160600000	LPRS2	Leprosy, susceptibility to, 2	607572				association with PARK2	{Leprosy, susceptibility to, 2}	607572		2	
6q25-q26	6:148500001-164100000	RCD1	Retinal cone dystrophy-1	180020		5953			?Retinal cone dystrophy-1	180020	AD	2	
6q25.1	6:149217926-149411607	TAB2, MAP3K7IP2, KIAA0733, CHTD2	Tak1 (MAP3K7) binding protein 2	605101	TAB2	23118	ENSG00000055208,ENST00000637181;;;ENST00000637181		Congenital heart defects, nonsyndromic, 2	614980	AD	3	Tab2
6q25.1	6:149400262-149401278	SUMO4, IDDM5	Small ubiquitin-like modifier 4	608829	SUMO4	387082	ENSG00000177688,ENST00000326669;;;ENST00000326669		{Diabetes mellitus, insulin-dependent, 5}	600320		3	
6q25.1	6:150369012-150405969	IYD, DEHAL1, TDH4	Iodotyrosine deiodinase	612025	IYD	389434	ENSG00000009765,ENST00000344419;;;ENST00000344419		Thyroid dyshormonogenesis 4	274800	AR	3	Iyd
6q25.1	6:151404762-151452126	RMND1, COXPD11	Required for meiotic nuclear division 1 homolog	614917	RMND1	55005	ENSG00000155906,ENST00000444024;;;ENST00000444024		Combined oxidative phosphorylation deficiency 11	614922	AR	3	Rmnd1
6q25.1-q25.2	6:151656672-152129619	ESR1, ESR, ESTRR	Estrogen receptor 1	133430	ESR1	2099	ENSG00000091831,ENST00000206249;;;ENST00000206249		{Migraine, susceptibility to}	157300	AD	3	Esr1
6q25.1-q25.2	6:151656672-152129619	ESR1, ESR, ESTRR	Estrogen receptor 1	133430	ESR1	2099	ENSG00000091831,ENST00000206249;;;ENST00000206249		{Myocardial infarction, susceptibility to}	608446		3	Esr1
6q25.1-q25.2	6:151656672-152129619	ESR1, ESR, ESTRR	Estrogen receptor 1	133430	ESR1	2099	ENSG00000091831,ENST00000206249;;;ENST00000206249		Breast cancer, somatic	114480		3	Esr1
6q25.1-q25.2	6:151656672-152129619	ESR1, ESR, ESTRR	Estrogen receptor 1	133430	ESR1	2099	ENSG00000091831,ENST00000206249;;;ENST00000206249		Estrogen resistance	615363	AR	3	Esr1
6q25.2	6:152121687-152637362	SYNE1, KIAA0796, KIAA1756, KIAA1262, SCAR8, EDMD4, AMC3	Spectrin repeat-containing nuclear envelope protein 1 (nesprin 1)	608441	SYNE1	23345	ENSG00000131018,ENST00000367255;;;ENST00000367255		Arthrogryposis multiplex congenita 3, myogenic type	618484	AR	3	Syne1
6q25.2	6:152121687-152637362	SYNE1, KIAA0796, KIAA1756, KIAA1262, SCAR8, EDMD4, AMC3	Spectrin repeat-containing nuclear envelope protein 1 (nesprin 1)	608441	SYNE1	23345	ENSG00000131018,ENST00000367255;;;ENST00000367255		Emery-Dreifuss muscular dystrophy 4, autosomal dominant	612998	AD	3	Syne1
6q25.2	6:152121687-152637362	SYNE1, KIAA0796, KIAA1756, KIAA1262, SCAR8, EDMD4, AMC3	Spectrin repeat-containing nuclear envelope protein 1 (nesprin 1)	608441	SYNE1	23345	ENSG00000131018,ENST00000367255;;;ENST00000367255		Spinocerebellar ataxia, autosomal recessive 8	610743	AR	3	Syne1
6q25.3	6:155200001-160600000	CELIAC12	Celiac disease, susceptibility to, 12	612010		100188874		in LD block containing TAGAP	{Celiac disease, susceptibility to, 12}	612010		2	
6q25.3	6:156776026-157210779	ARID1B, BAF250B, KIAA1235, MRD12, CSS1	AT-rich interaction domain-containing protein 1B	614556	ARID1B	57492	ENSG00000049618,ENST00000636930;;;ENST00000636930		Coffin-Siris syndrome 1	135900	AD	3	Arid1b
6q25.3	6:158109519-158168262	SERAC1, MEGDEL	Serine active site-containing protein 1	614725	SERAC1	84947	ENSG00000122335,ENST00000647468;;;ENST00000647468		3-methylglutaconic aciduria with deafness, encephalopathy, and Leigh-like syndrome	614739	AR	3	Serac1
6q25.3	6:158168350-158199344	GTF2H5, TTD3, TFB5, C6orf175, TTDA	General transcription factor IIH, polypeptide 5	608780	GTF2H5	404672	ENSG00000272047,ENST00000607778;;;ENST00000607778		Trichothiodystrophy 3, photosensitive	616395	AR	3	Gtf2h5
6q25.3	6:158962980-159000202	RSPH3, RSHL2, RSP3, CILD32	Radial spoke head 3	615876	RSPH3	83861	ENSG00000130363,ENST00000367069;;;ENST00000367069		Ciliary dyskinesia, primary, 32	616481	AR	3	Rsph3a,Rsph3b
6q25.3	6:159669069-159762281	SOD2, MNSOD, MVCD6	Superoxide dismutase-2, mitochondrial	147460	SOD2	6648	ENSG00000291237,ENST00000538183;;;ENST00000538183		{Microvascular complications of diabetes 6}	612634		3	Sod2
6q25.3	6:159762045-159779112	ACAT2	Acetyl-Coenzyme A acetyltransferase 2 (acetoacetyl Coenzyme A thiolase)	100678	ACAT2	39	ENSG00000120437,ENST00000367048;;;ENST00000367048	encoded on strand opposite TCP1	?ACAT2 deficiency	614055	IC	1	Acat2,Acat3
6q25.3	6:159778498-159789602	TCP1, CCT1, IDDPMGS	T-complex 1	186980	TCP1	6950	ENSG00000120438,ENST00000321394;;;ENST00000321394		Intellectual developmental disorder with polymicrogyria and seizures	621021	AD	3	Tcp1
6q25.3	6:159799455-159820704	PNLDC1, TRIMMER, SPGF57	PARN-like ribonuclease domain-containing exonuclease 1	619529	PNLDC1	154197	ENSG00000146453,ENST00000392167;;;ENST00000392167		Spermatogenic failure 57	619528	AR	3	Pnldc1
6q25.3	6:159969082-160111504	IGF2R, MPRI	Insulin-like growth factor-2 receptor (mannose-6-phosphate receptor, cation-independent)	147280	IGF2R	3482	ENSG00000197081,ENST00000356956;;;ENST00000356956	behaves as a tumor suppressor	Hepatocellular carcinoma, somatic	114550		3	Igf2r
6q25.3-q26	6:160531482-160664275	LPA	Apolipoprotein Lp(a)	152200	LPA	4018	ENSG00000198670,ENST00000316300;;;ENST00000316300	absent in mice	[LPA deficiency, congenital]	618807	AD	3	
6q25.3-q26	6:160531482-160664275	LPA	Apolipoprotein Lp(a)	152200	LPA	4018	ENSG00000198670,ENST00000316300;;;ENST00000316300	absent in mice	{Coronary artery disease, susceptibility to}	618807	AD	3	
6q26-q27	6:160600001-170805979	DFNB38	Deafness, autosomal recessive 38	608219		337991			Deafness, autosomal recessive 38	608219	AR	2	
6q26-q27	6:160600001-170805979	MRT28	Intellectual developmental disorder, autosomal recessive 28	614347		100852396		between rs6935718 and rs3886091	Intellectual developmental disorder, autosomal recessive 28	614347	AR	2	
6q26	6:160702193-160754097	PLG, HAE4	Plasminogen	173350	PLG	5340	ENSG00000122194,ENST00000308192;;;ENST00000308192	20cM from TCP10A	Angioedema, hereditary, 4	619360	AD	3	Plg
6q26	6:160702193-160754097	PLG, HAE4	Plasminogen	173350	PLG	5340	ENSG00000122194,ENST00000308192;;;ENST00000308192	20cM from TCP10A	Dysplasminogenemia	217090	AR	3	Plg
6q26	6:160702193-160754097	PLG, HAE4	Plasminogen	173350	PLG	5340	ENSG00000122194,ENST00000308192;;;ENST00000308192	20cM from TCP10A	Plasminogen deficiency, type I	217090	AR	3	Plg
6q26	6:161347417-162727766	PRKN, PARK2, PDJ	Parkin RBR E3 ubiquitin protein ligase	602544	PRKN	5071	ENSG00000185345,ENST00000366898;;;ENST00000366898	shares 5' regulatory region and both 3' UTRs with PACRG	Adenocarcinoma of lung, somatic	211980		3	Prkn
6q26	6:161347417-162727766	PRKN, PARK2, PDJ	Parkin RBR E3 ubiquitin protein ligase	602544	PRKN	5071	ENSG00000185345,ENST00000366898;;;ENST00000366898	shares 5' regulatory region and both 3' UTRs with PACRG	Ovarian cancer, somatic	167000		3	Prkn
6q26	6:161347417-162727766	PRKN, PARK2, PDJ	Parkin RBR E3 ubiquitin protein ligase	602544	PRKN	5071	ENSG00000185345,ENST00000366898;;;ENST00000366898	shares 5' regulatory region and both 3' UTRs with PACRG	Parkinson disease, juvenile, type 2	600116	AR	3	Prkn
6q27	6:164100001-170805979	CHDM	Chordoma	215400				associated with duplication of the T gene	{Chordoma, susceptibility to}	215400	AD	4	
6q27	6:164100001-170805979	KAZA3	Kala-azar, susceptibility to, 3	611382		101241899			{Kala-azar, susceptibility to, 3}	611382		2	
6q27	6:165327289-165988052	PDE10A, IOLOD, ADSD2	Phosphodiesterase 10A	610652	PDE10A	10846	ENSG00000112541,ENST00000539869;;;ENST00000539869		Dyskinesia, limb and orofacial, infantile-onset	616921	AR	3	Pde10a
6q27	6:165327289-165988052	PDE10A, IOLOD, ADSD2	Phosphodiesterase 10A	610652	PDE10A	10846	ENSG00000112541,ENST00000539869;;;ENST00000539869		Striatal degeneration, autosomal dominant	616922	AD	3	Pde10a
6q27	6:166157656-166168655	TBXT, T, TFT, SAVA	T-box transcription factor T	601397	TBXT	6862	ENSG00000164458,ENST00000366876;;;ENST00000366876		{Neural tube defects, susceptibility to}	182940	AD	3	T
6q27	6:166157656-166168655	TBXT, T, TFT, SAVA	T-box transcription factor T	601397	TBXT	6862	ENSG00000164458,ENST00000366876;;;ENST00000366876		Sacral agenesis with vertebral anomalies	615709	AR	3	T
6q27	6:166364919-166382940	MPC1, BRP44L, MPYCD	Mitochondrial pyruvate carrier 1	614738	MPC1	51660	ENSG00000060762,ENST00000360961;;;ENST00000360961		Mitochondrial pyruvate carrier deficiency	614741	AR	3	Mpc1
6q27	6:166922113-166956550	RNASET2, RNASE6PL	Ribonuclease T2	612944	RNASET2	8635	ENSG00000026297,ENST00000508775;;;ENST00000508775		Leukoencephalopathy, cystic, without megalencephaly	612951	AR	3	Rnaset2a,Rnaset2b
6q27	6:166999397-167052718	FGFR1OP, FOP	Fibroblast growth factor receptor-1 oncogene partner	605392	CEP43	11116	ENSG00000213066,ENST00000366847;;;ENST00000366847	fusion gene with ZNF198, CEP1, and FGFR1	Myeloproliferative disorder	605392		2	Cep43
6q27	6:168441184-168667992	SMOC2, SMAP2, DTDP1	Secreted modular calcium-binding protein 2	607223	SMOC2	64094	ENSG00000112562,ENST00000356284;;;ENST00000356284		Dentin dysplasia, type I, with microdontia and misshapen teeth	125400	AR	3	Smoc2
6q27	6:169215785-169253846	THBS2, EDSCLL3	Thrombospondin 2	188061	THBS2	7058	ENSG00000186340,ENST00000617924;;;ENST00000617924	mutation identifed in 1 EDSCL3 family	?Ehlers-Danlos syndrome, classic-like, 3	620865	AD	3	Thbs2
6q27	6:169215785-169253846	THBS2, EDSCLL3	Thrombospondin 2	188061	THBS2	7058	ENSG00000186340,ENST00000617924;;;ENST00000617924	mutation identifed in 1 EDSCL3 family	{Lumbar disc herniation, susceptibility to}	603932		3	Thbs2
6q27	6:169751306-169781600	ERMARD, C6orf70, PVNH6	Endoplasmic reticulum membrane-associated RNA degradation protein	615532	ERMARD	55780	ENSG00000130023,ENST00000366773;;;ENST00000366773		?Periventricular nodular heterotopia 6	615544	AD	3	Ermard,Ermardl1,Ermardl2
6q27	6:170282206-170291078	DLL1, DELTA1, NEDBAS	Delta-like canonical Notch ligand 1	606582	DLL1	28514	ENSG00000198719,ENST00000366756;;;ENST00000366756		Neurodevelopmental disorder with nonspecific brain abnormalities and with or without seizures	618709	AD	3	Dll1
6q27	6:170535120-170553307	PSMB1, NEDMHAL	Proteasome subunit, beta type, 1	602017	PSMB1	5689	ENSG00000008018,ENST00000262193;;;ENST00000262193	mutation identified in 1 NEDNHAL family	?Neurodevelopmental disorder with microcephaly, hypotonia, and absent language	620038	AR	3	Psmb1
6q27	6:170554369-170572859	TBP, SCA17, HDL4	TATA box binding protein	600075	TBP	6908	ENSG00000112592,ENST00000392092;;;ENST00000392092		{Parkinson disease, susceptibility to}	168600	AD, Mu	3	Tbp
6q27	6:170554369-170572859	TBP, SCA17, HDL4	TATA box binding protein	600075	TBP	6908	ENSG00000112592,ENST00000392092;;;ENST00000392092		Spinocerebellar ataxia 17	607136	AD	3	Tbp
7p22.3-p21.3	7:1-13700000	HYPT10	Hypotrichosis 10	614238		100736251		between D7S1532 and D7S3047	Hypotrichosis 10	614238	AR	2	
7p22.3	7:192571-260772	FAM20C, DMP4	Family with sequence similarity 20, member C	611061	FAM20C	56975	ENSG00000177706,ENST00000313766;;;ENST00000313766		Raine syndrome	259775	AR	3	Fam20c
7p22.3	7:549197-728934	PRKAR1B, MASNS	Protein kinase, cAMP-dependent, regulatory, type I, beta	176911	PRKAR1B	5575	ENSG00000188191,ENST00000537384;;;ENST00000537384		Marbach-Schaaf neurodevelopmental syndrome	619680	AD	3	Prkar1b
7p22.3	7:726699-786475	DNAAF5, HEATR2, CILD18	Dynein axonemal assembly factor 5	614864	DNAAF5	54919	ENSG00000164818,ENST00000297440;;;ENST00000297440		Ciliary dyskinesia, primary, 18	614874	AR	3	Dnaaf5
7p22.3	7:876554-896436	GET4, C7orf20, CEE, CDG2Y	Guided entry of tail-anchored proteins factor 4	612056	GET4	51608	ENSG00000239857,ENST00000265857;;;ENST00000265857	mutation identified in 1 CDG2Y patient	?Congenital disorder of glycosylation, type IIy	620200	AR	3	Get4
7p22.3	7:1470277-1504389	INTS1, INT1, KIAA1440, NDCAGF	Integrator complex subunit 1	611345	INTS1	26173	ENSG00000164880,ENST00000404767;;;ENST00000404767		Neurodevelopmental disorder with cataracts, poor growth, and dysmorphic facies	618571	AR	3	Ints1
7p22.3	7:1666064-1747946	ELFN1, PPP1R28, DONDS	Extracellular leucine-rich repeat and fibronectin type III domain-containing protein 1	614964	ELFN1	392617	ENSG00000225968,ENST00000424383;;;ENST00000424383		Dursun-Ozgul neurodevelopmental syndrome	621344	AR	3	Elfn1
7p22.3	7:1815795-2232945	MAD1L1, TXBP181, MVA7	Mitotic arrest-deficient 1, yeast, homolog-like 1	602686	MAD1L1	8379	ENSG00000002822,ENST00000265854;;;ENST00000265854		Lymphoma, B-cell, somatic			3	Mad1l1
7p22.3	7:1815795-2232945	MAD1L1, TXBP181, MVA7	Mitotic arrest-deficient 1, yeast, homolog-like 1	602686	MAD1L1	8379	ENSG00000002822,ENST00000265854;;;ENST00000265854		Mosaic variegated aneuploidy syndrome 7 with inflammation and tumor predisposition	620189	AR	3	Mad1l1
7p22.3	7:1815795-2232945	MAD1L1, TXBP181, MVA7	Mitotic arrest-deficient 1, yeast, homolog-like 1	602686	MAD1L1	8379	ENSG00000002822,ENST00000265854;;;ENST00000265854		Prostate cancer, somatic	176807		3	Mad1l1
7p22.3	7:2234195-2242205	MRM2, FTSJ2, FJH1, MTDPS17	Mitochondrial ribosomal RNA methyltransferase 2	606906	MRM2	29960	ENSG00000122687,ENST00000242257;;;ENST00000242257		Mitochondrial DNA depletion syndrome 17	618567	AR	3	Mrm2
7p22.3	7:2512529-2529177	LFNG, SCDO3	LFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase	602576	LFNG	3955	ENSG00000106003,ENST00000222725;;;ENST00000222725		Spondylocostal dysostosis 3, autosomal recessive	609813	AR	3	Lfng
7p22.3	7:2537810-2555524	BRAT1, BAAT1, C7orf27, RMFSL, NEDCAS	BRCA1-associated ATM activator 1	614506	BRAT1	221927	ENSG00000106009,ENST00000340611;;;ENST00000340611		Neurodevelopmental disorder with cerebellar atrophy and with or without seizures	618056	AR	3	Brat1
7p22.3	7:2537810-2555524	BRAT1, BAAT1, C7orf27, RMFSL, NEDCAS	BRCA1-associated ATM activator 1	614506	BRAT1	221927	ENSG00000106009,ENST00000340611;;;ENST00000340611		Rigidity and multifocal seizure syndrome, lethal neonatal	614498	AR	3	Brat1
7p22.3	7:2558979-2614728	IQCE, KIAA1023, PAPA7	IQ domain-containing protein E	617631	IQCE	23288	ENSG00000106012,ENST00000402050;;;ENST00000402050		Polydactyly, postaxial, type A7	617642	AR	3	Iqce
7p22.2	7:2906142-3043867	CARD11, CARMA1, BIMP3, PPBL, BENTA, IMD11A	Caspase recruitment domain-containing protein 11	607210	CARD11	84433	ENSG00000198286,ENST00000396946;;;ENST00000396946		B-cell expansion with NFKB and T-cell anergy	616452	AD	3	Card11
7p22.2	7:2906142-3043867	CARD11, CARMA1, BIMP3, PPBL, BENTA, IMD11A	Caspase recruitment domain-containing protein 11	607210	CARD11	84433	ENSG00000198286,ENST00000396946;;;ENST00000396946		Immunodeficiency 11A	615206	AR	3	Card11
7p22.2	7:2906142-3043867	CARD11, CARMA1, BIMP3, PPBL, BENTA, IMD11A	Caspase recruitment domain-containing protein 11	607210	CARD11	84433	ENSG00000198286,ENST00000396946;;;ENST00000396946		Immunodeficiency 11B with atopic dermatitis	617638	AD	3	Card11
7p22.1	7:4500001-7200000	STBMS1	Strabismus, susceptibility to, 1	185100		100188805		max lod at marker 1911/1912	{Strabismus, susceptibility to, 1}	185100		2	
7p22.1	7:4775623-4794397	AP5Z1, KIAA0415, SPG48	Adaptor-related protein complex 5, zeta-1 subunit	613653	AP5Z1	9907	ENSG00000242802,ENST00000649063;;;ENST00000649063		Spastic paraplegia 48, autosomal recessive	613647	AR	3	Ap5z1
7p22.1	7:5190233-5233855	WIPI2, IDDSSA	WD40 repeat protein interacting with phosphoinositides 2	609225	WIPI2	26100	ENSG00000157954,ENST00000288828;;;ENST00000288828	mutation identified in 1 IDDSSA family	?Intellectual developmental disorder with short stature and variable skeletal anomalies	618453	AR	3	Wipi2
7p22.1	7:5527148-5530601	ACTB, BRWS1, BNS, CSMH, DDS1, BRWS1, THC8	Actin, beta	102630	ACTB	60	ENSG00000075624,ENST00000646664;;;ENST00000646664		Baraitser-Winter syndrome 1	243310	AD	3	Actb
7p22.1	7:5527148-5530601	ACTB, BRWS1, BNS, CSMH, DDS1, BRWS1, THC8	Actin, beta	102630	ACTB	60	ENSG00000075624,ENST00000646664;;;ENST00000646664		Becker nevus, syndromic or isolated, somatic mosaic	604919		3	Actb
7p22.1	7:5527148-5530601	ACTB, BRWS1, BNS, CSMH, DDS1, BRWS1, THC8	Actin, beta	102630	ACTB	60	ENSG00000075624,ENST00000646664;;;ENST00000646664		Congenital smooth muscle hamartoma with or without hemihypertrophy, somatic mosaic	620470		3	Actb
7p22.1	7:5527148-5530601	ACTB, BRWS1, BNS, CSMH, DDS1, BRWS1, THC8	Actin, beta	102630	ACTB	60	ENSG00000075624,ENST00000646664;;;ENST00000646664		Dystonia-deafness syndrome 1	607371	AD	3	Actb
7p22.1	7:5527148-5530601	ACTB, BRWS1, BNS, CSMH, DDS1, BRWS1, THC8	Actin, beta	102630	ACTB	60	ENSG00000075624,ENST00000646664;;;ENST00000646664		Thrombocytopenia 8, with dysmorphic features and developmental delay	620475	AD	3	Actb
7p22.1	7:5620047-5781663	RNF216, TRIAD3, ZIN, CAHH	RING finger protein 216	609948	RNF216	54476	ENSG00000011275,ENST00000389902;;;ENST00000389902		Cerebellar ataxia and hypogonadotropic hypogonadism	212840	AR	3	Rnf216
7p22.1	7:5970925-6009106	PMS2, PMSL2, HNPCC4, LYNCH4	PMS1 homolog 2, mismatch repair system component	600259	PMS2	5395	ENSG00000122512,ENST00000265849;;;ENST00000265849		Lynch syndrome 4	614337		3	Pms2
7p22.1	7:5970925-6009106	PMS2, PMSL2, HNPCC4, LYNCH4	PMS1 homolog 2, mismatch repair system component	600259	PMS2	5395	ENSG00000122512,ENST00000265849;;;ENST00000265849		Mismatch repair cancer syndrome 4	619101	AR	3	Pms2
7p22.1	7:6009272-6023834	AIMP2, JTV1, HLD17	Aminoacyl tRNA synthetase complex-interacting multifunctional protein 2	600859	AIMP2	7965	ENSG00000106305,ENST00000223029;;;ENST00000223029		Leukodystrophy, hypomyelinating, 17	618006	AR	3	Aimp2
7p22.1	7:6022247-6059175	EIF2AK1, HRI, LEMSPAD	Eukaryotic translation initiation factor 2-alpha kinase 1	613635	EIF2AK1	27102	ENSG00000086232,ENST00000199389;;;ENST00000199389	mutation identified in 1 LEMSPAD patient	?Leukoencephalopathy, motor delay, spasticity, and dysarthria syndrome	618878	AD	3	Eif2ak1
7p22.1	7:6374527-6403967	RAC1, MRD48	Rac family small GTPase 1	602048	RAC1	5879	ENSG00000136238,ENST00000348035;;;ENST00000348035		Intellectual developmental disorder, autosomal dominant 48	617751	AD	3	Rac1
7p22.1	7:6461089-6484152	KDELR2, ELP1, OI21	KDEL endoplasmic reticulum protein retention receptor 2	609024	KDELR2	11014	ENSG00000136240,ENST00000258739;;;ENST00000258739		Osteogenesis imperfecta, type XXI	619131	AR	3	Kdelr2
7p21-p15	7:7200001-28800000	MDDC	Macular dystrophy, dominant cystoid	153880		1541		?allelic to RP9	Macular dystrophy, dominant cystoid	153880	AD	2	
7p21.3	7:7968796-8089080	GLCCI1, TSSN1, GCTR	Glucocorticoid-induced transcript 1	614283	GLCCI1	113263	ENSG00000106415,ENST00000223145;;;ENST00000223145		{Glucocorticoid therapy, response to}	614400		3	Glcci1
7p21.3	7:10931943-10940153	COXFA4, NDUFA4, MC4DN21	Cytochrome c oxidase subunit FA4	603833	COXFA4	4697	ENSG00000189043,ENST00000339600;;;ENST00000339600	mutation identified in 1 MC4DN21 family	?Mitochondrial complex IV deficiency, nuclear type 21	619065	AR	3	Coxfa4
7p21.3	7:12211294-12243367	TMEM106B, HLD16	Transmembrane protein 106B	613413	TMEM106B	54664	ENSG00000106460,ENST00000396668;;;ENST00000396668		Leukodystrophy, hypomyelinating, 16	617964	AD	3	Tmem106b
7p21.2-p14.3	7:13700001-34900000	EDSS2	Ectodermal dysplasia-syndactyly syndrome 2	613576		100505394		between D7S488 and D7S817	Ectodermal dysplasia-syndactyly syndrome 2	613576	AR	2	
7p21.2	7:13700001-16500000	FGQTL4	Fasting plasma glucose level QTL 4	613462		100499169		associated with rs2191349	[Fasting plasma glucose level QTL 4]	613462		2	
7p21.2	7:16087525-16421538	CRPPA, ISPD, MDDGA7, MDDGC7, LGMDR20	CDP-L-ribitol pyrophosphorylase A	614631	CRPPA	729920	ENSG00000214960,ENST00000407010;;;ENST00000407010		Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 7	614643	AR	3	Crppa
7p21.2	7:16087525-16421538	CRPPA, ISPD, MDDGA7, MDDGC7, LGMDR20	CDP-L-ribitol pyrophosphorylase A	614631	CRPPA	729920	ENSG00000214960,ENST00000407010;;;ENST00000407010		Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 7	616052	AR	3	Crppa
7p21.1	7:16791811-16804999	AGR2, AG2, RIFTD	Anterior gradient 2, protein disulphide isomerase family member	606358	AGR2	10551	ENSG00000106541,ENST00000419304;;;ENST00000419304		Respiratory infections, recurrent, and failure to thrive with or without diarrhea	620233	AR	3	Agr2
7p21.1	7:17298652-17346147	AHR, RP85, FVH3	Aryl hydrocarbon receptor	600253	AHR	196	ENSG00000106546,ENST00000242057;;;ENST00000242057	mutation identified in 1 RP85 family	?Retinitis pigmentosa 85	618345	AR	3	Ahr
7p21.1	7:17298652-17346147	AHR, RP85, FVH3	Aryl hydrocarbon receptor	600253	AHR	196	ENSG00000106546,ENST00000242057;;;ENST00000242057	mutation identified in 1 RP85 family	Foveal hypoplasia 3	620958	AR	3	Ahr
7p21.1	7:18086825-19002416	HDAC9, MITR, HDAC7B, KIAA0744, ARCND4	Histone deacetylase 9	606543	HDAC9	9734	ENSG00000048052,ENST00000686413;;;ENST00000686413	mutation identified in 1 ARCND4 family	?Auriculocondylar syndrome 4	620457	AD	3	Hdac9
7p21.1	7:19113047-19117636	TWIST1, ACS3, SCS, CRS1, SWCOS	TWIST, Drosophila, homolog of, 1	601622	TWIST1	7291	ENSG00000122691,ENST00000242261;;;ENST00000242261		Craniosynostosis 1	123100	AD	3	Twist1
7p21.1	7:19113047-19117636	TWIST1, ACS3, SCS, CRS1, SWCOS	TWIST, Drosophila, homolog of, 1	601622	TWIST1	7291	ENSG00000122691,ENST00000242261;;;ENST00000242261		Robinow-Sorauf syndrome	180750	AD	3	Twist1
7p21.1	7:19113047-19117636	TWIST1, ACS3, SCS, CRS1, SWCOS	TWIST, Drosophila, homolog of, 1	601622	TWIST1	7291	ENSG00000122691,ENST00000242261;;;ENST00000242261		Saethre-Chotzen syndrome with or without eyelid anomalies	101400	AD	3	Twist1
7p21.1	7:19113047-19117636	TWIST1, ACS3, SCS, CRS1, SWCOS	TWIST, Drosophila, homolog of, 1	601622	TWIST1	7291	ENSG00000122691,ENST00000242261;;;ENST00000242261		Sweeney-Cox syndrome	617746	AD	3	Twist1
7p15-p14	7:20900001-43300000	ASRT2	Asthma-related traits, susceptibilty to, 2	608584		141462386			{Asthma-related traits, susceptibilty to, 2}	608584		2	
7p15-p13	7:20900001-45400000	FGQTL2, BWQTL1	Fasting plasma glucose level QTL 2; Birth weight QTL 1	613219		100379216		associated with rs4607517	[Birth weight QTL 1]	613219		2	
7p15-p13	7:20900001-45400000	FGQTL2, BWQTL1	Fasting plasma glucose level QTL 2; Birth weight QTL 1	613219		100379216		associated with rs4607517	[Fasting plasma glucose level QTL 2]	613219		2	
7p15	7:20900001-28800000	MYP17, MYP4	Myopia 17	608367		100359401		previously assigned to 7q36 (MYP4)	Myopia 17	608367	AD	2	
7p15	7:20900001-28800000	STQTL17	Stature quantitative trait locus 17	612737		100301526		associated with rs1635852 and rs849140	{Stature QTL 17}	612737		2	
7p15.3	7:21543039-21901839	DNAH11, DNAHC11, CILD7, DNAHBL	Dynein, axonemal, heavy chain-11	603339	DNAH11	8701	ENSG00000105877,ENST00000409508;;;ENST00000409508		Ciliary dyskinesia, primary, 7, with or without situs inversus	611884	AR	3	Dnah11
7p15.3	7:22727200-22731998	IL6, IFNB2, BSF2, HSF, HGF	Interleukin-6 (interferon, beta-2)	147620	IL6	3569	ENSG00000136244,ENST00000258743;;;ENST00000258743		{Crohn disease-associated growth failure}	266600	Mu	3	Il6
7p15.3	7:22727200-22731998	IL6, IFNB2, BSF2, HSF, HGF	Interleukin-6 (interferon, beta-2)	147620	IL6	3569	ENSG00000136244,ENST00000258743;;;ENST00000258743		{Intracranial hemorrhage in brain cerebrovascular malformations, susceptibility to}	108010	SMu	3	Il6
7p15.3	7:22727200-22731998	IL6, IFNB2, BSF2, HSF, HGF	Interleukin-6 (interferon, beta-2)	147620	IL6	3569	ENSG00000136244,ENST00000258743;;;ENST00000258743		{Kaposi sarcoma in HIV+, susceptibility to}	148000	AD	3	Il6
7p15.3	7:22727200-22731998	IL6, IFNB2, BSF2, HSF, HGF	Interleukin-6 (interferon, beta-2)	147620	IL6	3569	ENSG00000136244,ENST00000258743;;;ENST00000258743		{Rheumatoid arthritis, systemic juvenile}	604302		3	Il6
7p15.3	7:22727200-22731998	IL6, IFNB2, BSF2, HSF, HGF	Interleukin-6 (interferon, beta-2)	147620	IL6	3569	ENSG00000136244,ENST00000258743;;;ENST00000258743		{Type 1 diabetes mellitus}	222100	AR	3	Il6
7p15.3	7:22727200-22731998	IL6, IFNB2, BSF2, HSF, HGF	Interleukin-6 (interferon, beta-2)	147620	IL6	3569	ENSG00000136244,ENST00000258743;;;ENST00000258743		{Type 2 diabetes mellitus}	125853	AD	3	Il6
7p15.3	7:22812974-22822849	TOMM7, GMPGS	Translocase of outer mitochondrial membrane 7	607980	TOMM7	54543	ENSG00000196683,ENST00000358435;;;ENST00000358435		Garg-Mishra progeroid syndrome	620601	AR	3	Tomm7
7p15.3	7:22895843-23014130	HYCC1, FAM126A, DRCTNNB1A, HLD5	Hyccin, PI4KA lipid kinase complex, subunit 1	610531	HYCC1	84668	ENSG00000122591,ENST00000432176;;;ENST00000432176		Leukodystrophy, hypomyelinating, 5	610532	AR	3	Hycc1
7p15.3	7:23105785-23177914	KLHL7, RP42, PERCHING	Kelch-like 7	611119	KLHL7	55975	ENSG00000122550,ENST00000339077;;;ENST00000339077		PERCHING syndrome	617055	AR	3	Klhl7
7p15.3	7:23105785-23177914	KLHL7, RP42, PERCHING	Kelch-like 7	611119	KLHL7	55975	ENSG00000122550,ENST00000339077;;;ENST00000339077		Retinitis pigmentosa 42	612943	AD	3	Klhl7
7p15.3	7:23246775-23275108	GPNMB, PLCA3	Glycoprotein NMB	604368	GPNMB	10457	ENSG00000136235,ENST00000258733;;;ENST00000258733		Amyloidosis, primary localized cutaneous, 3	617920	AR	3	Gpnmb
7p15.3	7:24698355-24795539	GSDME, DFNA5	Gasdermin E	608798	GSDME	1687	ENSG00000105928,ENST00000645220;;;ENST00000645220		Deafness, autosomal dominant 5	600994	AD	3	Gsdme
7p15.3	7:25118656-25125260	CYCS, CYC, THC4	Cytochrome C, somatic	123970	CYCS	54205	ENSG00000172115,ENST00000305786;;;ENST00000305786		Thrombocytopenia 4	612004	AD	3	Cycs
7p15.2	7:26189927-26200746	HNRNPA2B1, HNRPA2B1, IBMPFD2, OPMD2	Heterogeneous nuclear ribonucleoprotein A2/B1	600124	HNRNPA2B1	3181	ENSG00000122566,ENST00000618183;;;ENST00000618183	mutation identified in 1 IBMPFD2 family	?Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2	615422	AD	3	Hnrnpa2b1
7p15.2	7:26189927-26200746	HNRNPA2B1, HNRPA2B1, IBMPFD2, OPMD2	Heterogeneous nuclear ribonucleoprotein A2/B1	600124	HNRNPA2B1	3181	ENSG00000122566,ENST00000618183;;;ENST00000618183	mutation identified in 1 IBMPFD2 family	Oculopharyngeal muscular dystrophy 2	620460	AD	3	Hnrnpa2b1
7p15.2	7:26291862-26374383	SNX10, OPTB8	Sorting nexin 10	614780	SNX10	29887	ENSG00000086300,ENST00000338523;;;ENST00000338523		Osteopetrosis, autosomal recessive 8	615085	AR	3	Snx10
7p15.2	7:27092993-27096000	HOXA1, HOX1F, BSAS	Homeobox A1	142955	HOXA1	3198	ENSG00000105991,ENST00000643460;;;ENST00000643460		Athabaskan brainstem dysgenesis syndrome	601536	AR	3	Hoxa1
7p15.2	7:27092993-27096000	HOXA1, HOX1F, BSAS	Homeobox A1	142955	HOXA1	3198	ENSG00000105991,ENST00000643460;;;ENST00000643460		Bosley-Salih-Alorainy syndrome	601536	AR	3	Hoxa1
7p15.2	7:27100354-27102683	HOXA2, MCOHI	Homeobox A2	604685	HOXA2	3199	ENSG00000105996,ENST00000222718;;;ENST00000222718	mutation identified in 1 MCOHICP family	?Microtia, hearing impairment, and cleft palate (AR)	612290	AD, AR	3	Hoxa2
7p15.2	7:27100354-27102683	HOXA2, MCOHI	Homeobox A2	604685	HOXA2	3199	ENSG00000105996,ENST00000222718;;;ENST00000222718	mutation identified in 1 MCOHICP family	Microtia with or without hearing impairment (AD)	612290	AD, AR	3	Hoxa2
7p15.2	7:27181157-27185232	HOXA11, HOX1I, RUSAT1	Homeobox A11	142958	HOXA11	3207	ENSG00000005073,ENST00000006015;;;ENST00000006015		Radioulnar synostosis with amegakaryocytic thrombocytopenia 1	605432	AD	3	Hoxa11
7p15.2	7:27194364-27200091	HOXA13, HOX1J	Homeobox A13	142959	HOXA13	3209	ENSG00000106031,ENST00000649031;;;ENST00000649031	mutation identified in 1 GTMS family	?Guttmacher syndrome	176305	AD	3	Hoxa13
7p15.2	7:27194364-27200091	HOXA13, HOX1J	Homeobox A13	142959	HOXA13	3209	ENSG00000106031,ENST00000649031;;;ENST00000649031	mutation identified in 1 GTMS family	Hand-foot-genital syndrome	140000	AD	3	Hoxa13
7p14	7:28800001-43300000	HHT4	Telangiectasia, hereditary hemorrhagic, type 4	610655		791087		between D7S2252 and D7S510	Telangiectasia, hereditary hemorrhagic, type 4	610655	AD	2	
7p14.3	7:30005923-30026702	FKBP14, EDSKSCL2	FK506-binding protein 14	614505	FKBP14	55033	ENSG00000106080,ENST00000222803;;;ENST00000222803		Ehlers-Danlos syndrome, kyphoscoliotic type, 2	614557	AR	3	Fkbp14
7p14.3	7:30594735-30634033	GARS1, GARS, SMAD1, CMT2D, HMND5, SMAJI	Glycyl-tRNA synthetase 1	600287	GARS1	2617	ENSG00000106105,ENST00000389266;;;ENST00000389266		Charcot-Marie-Tooth disease, type 2D	601472	AD	3	Gars1
7p14.3	7:30594735-30634033	GARS1, GARS, SMAD1, CMT2D, HMND5, SMAJI	Glycyl-tRNA synthetase 1	600287	GARS1	2617	ENSG00000106105,ENST00000389266;;;ENST00000389266		Neuronopathy, distal hereditary motor, autosomal dominant 5	600794	AD	3	Gars1
7p14.3	7:30594735-30634033	GARS1, GARS, SMAD1, CMT2D, HMND5, SMAJI	Glycyl-tRNA synthetase 1	600287	GARS1	2617	ENSG00000106105,ENST00000389266;;;ENST00000389266		Spinal muscular atrophy, infantile, James type	619042	AD	3	Gars1
7p14.3	7:30911853-30925516	AQP1, CHIP28, CO	Aquaporin-1 (channel-forming integral protein, 28kD)	107776	AQP1	358	ENSG00000240583,ENST00000311813;;;ENST00000311813		[Aquaporin-1 deficiency]	110450		3	Aqp1
7p14.3	7:30911853-30925516	AQP1, CHIP28, CO	Aquaporin-1 (channel-forming integral protein, 28kD)	107776	AQP1	358	ENSG00000240583,ENST00000311813;;;ENST00000311813		[Blood group, Colton]	110450		3	Aqp1
7p14.3	7:30963953-30979528	GHRHR, GHRFR, IGHD4	Growth hormone releasing hormone receptor	139191	GHRHR	2692	ENSG00000106128,ENST00000326139;;;ENST00000326139		Growth hormone deficiency, isolated, type IV	618157	AR	3	Ghrhr
7p14.3	7:31616777-32428224	PDE1C, HCAM3, DFNA74	Phosphodiesterase 1C	602987	PDE1C	5137	ENSG00000154678,ENST00000396191;;;ENST00000396191	mutation identified in 1 DFNA74 family	?Deafness, autosomal dominant 74	618140	AD	3	Pde1c
7p14.3	7:31687215-31708455	GSBS	G-substrate	604088	PPP1R17	10842	ENSG00000106341,ENST00000342032;;;ENST00000342032		{Hypercholesterolemia, susceptibility to}	143890	AD, AR	3	Ppp1r17
7p14.3	7:33014113-33062776	NT5C3A, NT5C3, UMPH1, PSN1, CNSHA8	5' nucleotidase, cytosolic IIIA (uridine 5' monophosphate hydrolase 1)	606224	NT5C3A	51251	ENSG00000122643,ENST00000610140;;;ENST00000610140	pseudogenes on chr.4 and chr.7	Anemia, congenital, nonspherocytic hemolytic, 8	266120	AR	3	Nt5c3
7p14.3	7:33094797-33109404	RP9, PAP1	RP9 pre-mRNA splicing factor	607331	RP9	6100	ENSG00000164610,ENST00000297157;;;ENST00000297157	mutation identified in 1 patient	?Retinitis pigmentosa 9	180104	AD	3	Rp9
7p14.3	7:33129285-33635767	PTHB1, BBS9	Parathyroid hormone-responsive B1 gene	607968	BBS9	27241	ENSG00000122507,ENST00000242067;;;ENST00000242067		Bardet-Biedl syndrome 9	615986	AR	3	Bbs9
7p14.3	7:33904915-34156427	BMPER, CV2	BMP binding endothelial regulator	608699	BMPER	168667	ENSG00000164619,ENST00000649409;;;ENST00000649409		Diaphanospondylodysostosis	608022	AR	3	Bmper
7p14.3	7:34658218-34878332	NPSR1, GPR154, GPRA, VRR1, PGR14, FNSS3	Neuropeptide S receptor 1	608595	NPSR1	387129	ENSG00000187258,ENST00000360581;;;ENST00000360581	mutation identified in 1 FNSS3 family	?Short sleep, familial natural, 3	621336	AD	3	Npsr1
7p14.2	7:35202430-35254100	TBX20, ASD4	T-box 20	606061	TBX20	57057	ENSG00000164532,ENST00000408931;;;ENST00000408931		Atrial septal defect 4	611363		3	Tbx20
7p14.2	7:36389862-36453791	ANLN, FSFS8	Actin-binding protein anillin	616027	ANLN	54443	ENSG00000011426,ENST00000265748;;;ENST00000265748		Focal segmental glomerulosclerosis 8	616032	AD	3	Anln
7p14.1	7:37848597-37900397	NME8, TXNDC3, SPTRX2, CILD6	NME/NM23 family member 8	607421	NME8	51314	ENSG00000086288,ENST00000199447;;;ENST00000199447	mutation identified in 1 CILD6 patient	?Ciliary dyskinesia, primary, 6	610852	AR	3	Nme8
7p14.1	7:37905932-37916817	SFRP4, FRPHE, PYL	Secreted frizzled-related protein 4	606570	SFRP4	6424	ENSG00000106483,ENST00000436072;;;ENST00000436072		Pyle disease	265900	AR	3	Sfrp4
7p14.1	7:38722974-38909191	VPS41, SCAR29	VPS41 subunit of HOPS complex	605485	VPS41	27072	ENSG00000006715,ENST00000310301;;;ENST00000310301		Spinocerebellar ataxia, autosomal recessive 29	619389	AR	3	Vps41
7p14.1	7:38977909-39468601	POU6F2, WTSL, WT5	POU domain, class 6, transcription factor 2	609062	POU6F2	11281	ENSG00000106536,ENST00000518318;;;ENST00000518318		{Wilms tumor susceptibility-5}	601583	AD, SMu	3	Pou6f2
7p14.1	7:39623572-39708120	RALA, HINCONS	RAS-like protooncogene A	179550	RALA	5898	ENSG00000006451,ENST00000005257;;;ENST00000005257		Hiatt-Neu-Cooper neurodevelopmental syndrome	619311	AD	3	Rala
7p14.1	7:39950256-40099580	CDK13, CDC2L5, CHED, CHDFIDD	Cyclin-dependent kinase 13	603309	CDK13	8621	ENSG00000065883,ENST00000181839;;;ENST00000181839		Congenital heart defects, dysmorphic facial features, and intellectual developmental disorder	617360	AD	3	Cdk13
7p14.1	7:40126027-40134622	MPLKIP, C7orf11, ABHS, TTDN1, TTD4	M-phase specific PLK1 interacting protein	609188	MPLKIP	136647	ENSG00000168303,ENST00000306984;;;ENST00000306984		Trichothiodystrophy 4, nonphotosensitive	234050	AR	3	Mplkip,Mplkipl1
7p14.1	7:40135005-41038816	SUGCT, C7orf10, GA3	Succinyl-CoA:glutarate-CoA transferase	609187	SUGCT	79783	ENSG00000175600,ENST00000335693;;;ENST00000335693		Glutaric aciduria III	231690	AR	3	Sugct
7p14.1	7:41960949-42264268	GLI3, PAPA, PAPB	GLI-Kruppel family member GLI3 (oncogene GLI3)	165240	GLI3	2737	ENSG00000106571,ENST00000395925;;;ENST00000395925	amplified in glioblastoma	Greig cephalopolysyndactyly syndrome	175700	AD	3	Gli3
7p14.1	7:41960949-42264268	GLI3, PAPA, PAPB	GLI-Kruppel family member GLI3 (oncogene GLI3)	165240	GLI3	2737	ENSG00000106571,ENST00000395925;;;ENST00000395925	amplified in glioblastoma	Pallister-Hall syndrome	146510	AD	3	Gli3
7p14.1	7:41960949-42264268	GLI3, PAPA, PAPB	GLI-Kruppel family member GLI3 (oncogene GLI3)	165240	GLI3	2737	ENSG00000106571,ENST00000395925;;;ENST00000395925	amplified in glioblastoma	Polydactyly, postaxial, types A1 and B	174200	AD	3	Gli3
7p14.1	7:41960949-42264268	GLI3, PAPA, PAPB	GLI-Kruppel family member GLI3 (oncogene GLI3)	165240	GLI3	2737	ENSG00000106571,ENST00000395925;;;ENST00000395925	amplified in glioblastoma	Polydactyly, preaxial, type IV	174700	AD	3	Gli3
7p13-q32	7:43300001-132900000	SRS2	Silver-Russell syndrome	618905				maternal uniparental disomy of chromosome 7; 7p13-p11.2 and 7q32 have been implicated	Silver-Russell syndrome 2	618905	AD	4	
7p13	7:43758122-43807342	BLVRA	Biliverdin reductase A	109750	BLVRA	644	ENSG00000106605,ENST00000265523;;;ENST00000265523		Hyperbiliverdinemia	614156	AD, AR	3	Blvra
7p13	7:44062727-44065567	PGAM2, PGAMM, GSD10	Phosphoglycerate mutase, muscle form	612931	PGAM2	5224	ENSG00000164708,ENST00000297283;;;ENST00000297283		Glycogen storage disease X	261670	AR	3	Pgam2
7p13	7:44104345-44114560	AEBP1, ACLP	AE-binding protein 1	602981	AEBP1	165	ENSG00000106624,ENST00000223357;;;ENST00000223357		Ehlers-Danlos syndrome, classic-like, 2	618000	AR	3	Aebp1
7p13	7:44143213-44189439	GCK, HHF3, PNDM1	Glucokinase (hexokinase-4)	138079	GCK	2645	ENSG00000106633,ENST00000403799;;;ENST00000403799	proximal to TCRB	Diabetes mellitus, noninsulin-dependent, late onset	125853	AD	3	Gck
7p13	7:44143213-44189439	GCK, HHF3, PNDM1	Glucokinase (hexokinase-4)	138079	GCK	2645	ENSG00000106633,ENST00000403799;;;ENST00000403799	proximal to TCRB	Diabetes mellitus, permanent neonatal 1	606176	AR	3	Gck
7p13	7:44143213-44189439	GCK, HHF3, PNDM1	Glucokinase (hexokinase-4)	138079	GCK	2645	ENSG00000106633,ENST00000403799;;;ENST00000403799	proximal to TCRB	Hyperinsulinemic hypoglycemia, familial, 3	602485	AD	3	Gck
7p13	7:44143213-44189439	GCK, HHF3, PNDM1	Glucokinase (hexokinase-4)	138079	GCK	2645	ENSG00000106633,ENST00000403799;;;ENST00000403799	proximal to TCRB	MODY, type II	125851	AD	3	Gck
7p13	7:44217154-44326013	CAMK2B, MRD54	Calcium/calmodulin-dependent protein kinase II-beta	607707	CAMK2B	816	ENSG00000058404,ENST00000395749;;;ENST00000395749		Intellectual developmental disorder, autosomal dominant 54	617799	AD	3	Camk2b
7p13	7:44512535-44541330	NPC1L1, LDLCQ7	NPC1-like intracellular cholesterol transporter 1	608010	NPC1L1	29881	ENSG00000015520,ENST00000381160;;;ENST00000381160		[Ezetimibe, nonresponse to]	617966		3	Npc1l1
7p13	7:44512535-44541330	NPC1L1, LDLCQ7	NPC1-like intracellular cholesterol transporter 1	608010	NPC1L1	29881	ENSG00000015520,ENST00000381160;;;ENST00000381160		[Low density lipoprotein cholesterol level QTL 7]	617966		3	Npc1l1
7p13	7:44606627-44709066	OGDH, OGDHD	Oxoglutarate dehydrogenase, lipoamide (alpha-ketoglutarate dehydrogenase)	613022	OGDH	4967	ENSG00000105953,ENST00000222673;;;ENST00000222673		Oxoglutarate dehydrogenase deficiency	203740	AR	3	Ogdh
7p13	7:44999746-45076470	CCM2, C7orf22, MGC4067	CCM2 scaffold protein	607929	CCM2	83605	ENSG00000136280,ENST00000258781;;;ENST00000258781		Cerebral cavernous malformations-2	603284	AD	3	Ccm2
7p12.3	7:45574140-45723116	ADCY1, DFNB44	Adenylate cyclase-1, brain	103072	ADCY1	107	ENSG00000164742,ENST00000297323;;;ENST00000297323	mutation identified in 1 DFNB44 family	?Deafness, autosomal recessive 44	610154	AR	3	Adcy1
7p12.3	7:47774614-47960906	PKD1L1, HTX8	Polycystin 1L1	609721	PKD1L1	168507	ENSG00000158683,ENST00000289672;;;ENST00000289672		Heterotaxy, visceral, 8, autosomal	617205	AR	3	Pkd1l1
7p12.2	7:49000001-50500000	ALL2	Leukemia, acute lymphoblastic, susceptibility to, 2	613067		100310786		associated with rs11978267	{Leukemia, acute lymphoblastic, susceptibility to, 2}	613067		2	
7p12.2	7:49840654-50093246	ZPBP, SP38, SPGF66	Zona pellucida-binding protein	608498	ZPBP	11055	ENSG00000042813,ENST00000046087;;;ENST00000046087	mutation identified in 1 SPGF66 patient	?Spermatogenic failure 66	619799	AR	3	Zpbp
7p12.2	7:50303455-50405101	IKZF1, ZNFN1A1, IK1, LYF1, CVID13	Ikaros family zinc finger 1	603023	IKZF1	10320	ENSG00000185811,ENST00000331340;;;ENST00000331340	fused with BCL6 in DLBL	Immunodeficiency, common variable, 13	616873	AD	3	Ikzf1
7p12.2-p12.1	7:50458442-50565405	DDC	DOPA decarboxylase (aromatic L-amino acid decarboxylase)	107930	DDC	1644	ENSG00000132437,ENST00000444124;;;ENST00000444124		Aromatic L-amino acid decarboxylase deficiency	608643	AR	3	Ddc
7p12.1-q21	7:50500001-98400000	CMH21	Cardiomyopathy, familial hypertrophic, 21	614676		100909387		max lod at D7S669	Cardiomyopathy, hypertrophic, 21	614676	AD	2	
7p11-q21	7:53900001-98400000	HPC4	Prostate cancer, hereditary, 4	608658		408260			{Prostate cancer, susceptibility to, 4}	608658		2	
7p11.2	7:53900001-58100000	NYS3	Nystagmus 3, congenital, autosomal dominant	608345		4934		translocation t(7;15)(p11.2;q11.2)	Nystagmus 3, congenital, autosomal dominant	608345	AD	2	
7p11.2	7:55019017-55211628	EGFR, NNCIS	Epidermal growth factor receptor	131550	EGFR	1956	ENSG00000146648,ENST00000275493;;;ENST00000275493	same as oncogene ERBB	{Nonsmall cell lung cancer, susceptibility to}	211980	AD, SMu	3	Egfr
7p11.2	7:55019017-55211628	EGFR, NNCIS	Epidermal growth factor receptor	131550	EGFR	1956	ENSG00000146648,ENST00000275493;;;ENST00000275493	same as oncogene ERBB	Adenocarcinoma of lung, response to tyrosine kinase inhibitor in	211980	AD, SMu	3	Egfr
7p11.2	7:55019017-55211628	EGFR, NNCIS	Epidermal growth factor receptor	131550	EGFR	1956	ENSG00000146648,ENST00000275493;;;ENST00000275493	same as oncogene ERBB	Neonatal nephrocutaneous inflammatory syndrome	616069	AR	3	Egfr
7p11.2	7:55019017-55211628	EGFR, NNCIS	Epidermal growth factor receptor	131550	EGFR	1956	ENSG00000146648,ENST00000275493;;;ENST00000275493	same as oncogene ERBB	Nonsmall cell lung cancer, response to tyrosine kinase inhibitor in	211980	AD, SMu	3	Egfr
7p11.2	7:56011064-56051444	PSPH, PSP, PSPHD	Phosphoserine phosphatase	172480	PSPH	5723	ENSG00000146733,ENST00000275605;;;ENST00000275605		Phosphoserine phosphatase deficiency	614023	AR	3	Psph
7p11.2	7:56101573-56106476	CHCHD2, PARK22	Coiled-coil-helix-coiled-coil-helix domain-containing protein 2	616244	CHCHD2	51142	ENSG00000106153,ENST00000395422;;;ENST00000395422		Parkinson disease 22, autosomal dominant	616710	AD	3	Chchd2
7q11.2	7:62100001-77900000	ANIB1	Aneurysm, intracranial berry, 1	105800		116833		in or near ELN	Aneurysm, intracranial berry, 1	105800	AD	2	
7q11.2-q21.3	7:62100001-98400000	EEC1	Ectrodactyly, ectodermal dysplasia, cleft lip/palate, 1	129900		1913			?EEC syndrome-1	129900	AD	2	
7q11.2	7:62100001-77900000	EOE1, EE	Esophagitis, eosinophilic, 1	610247		100302511		associated with rs2302009	{Esophagitis, eosinophilic, 1}	610247	Mu	2	
7q11.21	7:65960684-65982213	GUSB, MPS7	Glucuronidase, beta-	611499	GUSB	2990	ENSG00000169919,ENST00000304895;;;ENST00000304895		Mucopolysaccharidosis VII	253220	AR	3	Gusb
7q11.21	7:66075819-66093576	ASL, ASLD	Argininosuccinate lyase	608310	ASL	435	ENSG00000126522,ENST00000304874;;;ENST00000304874		Argininosuccinic aciduria	207900	AR	3	Asl
7q11.21	7:66628881-66643229	KCTD7, EPM3, CLN14	Potassium channel tetramerization domain containing 7	611725	KCTD7	154881	ENSG00000243335,ENST00000639828;;;ENST00000639828		Epilepsy, progressive myoclonic 3, with or without intracellular inclusions	611726	AR	3	Kctd7
7q11.21	7:66987680-66995586	SBDS, SDS	SBDS ribosome maturation factor	607444	SBDS	51119	ENSG00000126524,ENST00000246868;;;ENST00000246868		{Aplastic anemia, susceptibility to}	609135		3	Sbds
7q11.21	7:66987680-66995586	SBDS, SDS	SBDS ribosome maturation factor	607444	SBDS	51119	ENSG00000126524,ENST00000246868;;;ENST00000246868		Shwachman-Diamond syndrome 1	260400	AR	3	Sbds
7q11.22	7:69598475-70793506	AUTS2, KIAA0442, MRD26	Activator of transcription and developmental regulator	607270	AUTS2	26053	ENSG00000158321,ENST00000342771;;;ENST00000342771	translocation break at 7q11.2	Intellectual developmental disorder, autosomal dominant 26	615834	AD	3	Auts2
7q11.23	7:72700001-77900000	DEL7q11.23, C7DELq11.23	Chromosome 7q11.23 deletion syndrome, distal, 1.2Mb	613729				contiguous gene deletion syndrome	Chromosome 7q11.23 deletion syndrome, distal, 1.2Mb	613729		4	
7q11.23	7:72700001-77900000	DUP7q11.23, C7DUPq11.23	Chromosome 7q11.23 duplication syndrome	609757					Chromosome 7q11.23 duplication syndrome	609757	AD	4	
7q11.23	7:72700001-77900000	WBS, WMS, WS, DEL7q11, C7DELq11	Williams-Beuren syndrome (chromosome 7q11.23 deletion syndrome)	194050				contiguous gene syndrome	Williams-Beuren syndrome	194050	AD	4	
7q11.23	7:73328161-73358625	FKBP6, SPGF77	FK506-binding protein 6	604839	FKBP6	8468	ENSG00000077800,ENST00000252037;;;ENST00000252037		Spermatogenic failure 77	620103	AR	3	Fkbp6
7q11.23	7:73680918-73683453	DNAJC30, WBSCR18, LHONAR1, MC1DN38	DNAJ/HSP40 homolog, subfamily C, member 30	618202	DNAJC30	84277	ENSG00000176410,ENST00000395176;;;ENST00000395176		Leber-like hereditary optic neuropathy, autosomal recessive 1	619382	AR	3	Dnajc30
7q11.23	7:74028173-74069907	ELN, SVAS, ADCL1	Elastin	130160	ELN	2006	ENSG00000049540,ENST00000252034;;;ENST00000252034		Cutis laxa, autosomal dominant	123700	AD	3	Eln
7q11.23	7:74028173-74069907	ELN, SVAS, ADCL1	Elastin	130160	ELN	2006	ENSG00000049540,ENST00000252034;;;ENST00000252034		Supravalvar aortic stenosis	185500	AD	3	Eln
7q11.23	7:74774011-74789315	NCF1, CGD1	Neutrophil cytosolic factor-1, 47kD	608512	NCF1	653361	ENSG00000158517,ENST00000289473;;;ENST00000289473		Chronic granulomatous disease 1, autosomal recessive	233700	AR	3	Ncf1
7q11.23	7:75915155-75986855	POR	Cytochrome P450 oxidoreductase	124015	POR	5447	ENSG00000127948,ENST00000461988;;;ENST00000461988		Antley-Bixler syndrome with genital anomalies and disordered steroidogenesis	201750	AR	3	Por
7q11.23	7:75915155-75986855	POR	Cytochrome P450 oxidoreductase	124015	POR	5447	ENSG00000127948,ENST00000461988;;;ENST00000461988		Disordered steroidogenesis due to cytochrome P450 oxidoreductase	613571		3	Por
7q11.23	7:76048106-76067508	MDH2, DEE51	Malate dehydrogenase 2	154100	MDH2	4191	ENSG00000146701,ENST00000315758;;;ENST00000315758		Developmental and epileptic encephalopathy 51	617339	AR	3	Mdh2
7q11.23	7:76302673-76304292	HSPB1, HSP27, CMT2F, HMND3	Heat-shock 27kD protein-1	602195	HSPB1	3315	ENSG00000106211,ENST00000248553;;;ENST00000248553		Charcot-Marie-Tooth disease, axonal, type 2F	606595	AD	3	Hspb1
7q11.23	7:76302673-76304292	HSPB1, HSP27, CMT2F, HMND3	Heat-shock 27kD protein-1	602195	HSPB1	3315	ENSG00000106211,ENST00000248553;;;ENST00000248553		Neuronopathy, distal hereditary motor, autosomal dominant 3	608634	AD	3	Hspb1
7q11.23	7:76326799-76358991	YWHAG, DEE56	Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, gamma isoform	605356	YWHAG	7532	ENSG00000170027,ENST00000307630;;;ENST00000307630		Developmental and epileptic encephalopathy 56	617665	AD	3	Ywhag
7q11.23	7:76397522-76442069	ZP3, ZP3A, ZP3B, OZEMA3	Zona pellucida glycoprotein-3 (sperm receptor)	182889	ZP3	7784	ENSG00000188372,ENST00000394857;;;ENST00000394857		Oocyte/zygote/embryo maturation arrest 3	617712	AD	3	Zp3
7q11.23	7:77122615-77295204	CCDC146, KIAA1505, SPGF94	Coiled-coil domain-containing protein 146	619829	CCDC146	57639	ENSG00000135205,ENST00000285871;;;ENST00000285871		Spermatogenic failure 94	620850	AR	3	Ccdc146
7q11.23	7:77537295-77640069	PTPN12, PTPG1	Protein tyrosine phosphatase, nonreceptor-type, 12	600079	PTPN12	5782	ENSG00000127947,ENST00000248594;;;ENST00000248594		Colon cancer, somatic	114500		3	Ptpn12
7q21-q22	7:77900001-107800000	MHS3	Malignant hyperthermia susceptibility 3	154276		7977		?mutation in CACNA2	{Malignant hyperthermia susceptibility 3}	154276	AD	2	
7q21	7:77900001-98400000	STQTL11	Stature quantitative trait locus 11	612223		100270795		associated with rs2282978	{Stature QTL 11}	612223		2	
7q21.11	7:78017055-79453667	MAGI2, AIP1, KIAA0705, NPHS15	Membrane-associated guanylate kinase, WW and PDZ domains-containing, 2	606382	MAGI2	9863	ENSG00000187391,ENST00000354212;;;ENST00000354212		Nephrotic syndrome, type 15	617609	AR	3	Magi2
7q21.11	7:80134831-80226181	GNAI1, NEDHISB	Guanine nucleotide-binding protein (G protein), alpha-inhibiting activity polypeptide-1	139310	GNAI1	2770	ENSG00000127955,ENST00000649796;;;ENST00000649796		Neurodevelopmental disorder with hypotonia, impaired speech, and behavioral abnormalities	619854	AD	3	Gnai1
7q21.11	7:80602207-80679274	CD36, CHDS7, BDPLT10	CD36 antigen (collagen type I)	173510	CD36	948	ENSG00000135218,ENST00000447544;;;ENST00000447544		{Coronary heart disease, susceptibility to, 7}	610938		3	Cd36
7q21.11	7:80602207-80679274	CD36, CHDS7, BDPLT10	CD36 antigen (collagen type I)	173510	CD36	948	ENSG00000135218,ENST00000447544;;;ENST00000447544		{Malaria, cerebral, reduced risk of}	611162		3	Cd36
7q21.11	7:80602207-80679274	CD36, CHDS7, BDPLT10	CD36 antigen (collagen type I)	173510	CD36	948	ENSG00000135218,ENST00000447544;;;ENST00000447544		{Malaria, cerebral, susceptibility to}	611162		3	Cd36
7q21.11	7:80602207-80679274	CD36, CHDS7, BDPLT10	CD36 antigen (collagen type I)	173510	CD36	948	ENSG00000135218,ENST00000447544;;;ENST00000447544		Platelet glycoprotein IV deficiency	608404	AR	3	Cd36
7q21.11	7:81699010-81770047	HGF, DFNB39	Hepatic growth factor	142409	HGF	3082	ENSG00000019991,ENST00000222390;;;ENST00000222390		Deafness, autosomal recessive 39	608265	AR	3	Hgf
7q21.11	7:81946444-82443956	CACNA2D1, CACNA2, CACNL2A, DEE110	Calcium channel, voltage-dependent, alpha-2/delta subunit	114204	CACNA2D1	781	ENSG00000153956,ENST00000356860;;;ENST00000356860		Developmental and epileptic encephalopathy 110	620149	AR	3	Cacna2d1
7q21.11	7:82754012-83162884	PCLO, PCH3	Piccolo, mouse, homolog of	604918	PCLO	27445	ENSG00000186472,ENST00000333891;;;ENST00000333891		Pontocerebellar hypoplasia, type 3	608027	AR	3	Pclo
7q21.11	7:83955777-84492725	SEMA3A, SEMAD, COLL1, HH16	Semaphorin 3A	603961	SEMA3A	10371	ENSG00000075213,ENST00000265362;;;ENST00000265362		{Hypogonadotropic hypogonadism 16 with or without anosmia}	614897	AD	3	Sema3a
7q21.12	7:87365896-87476027	ABCB4, PGY3, MDR3, ICP3	ATP-binding cassette, subfamily B, member 4 (P-glycoprotein-3/multiple drug resistance-3)	171060	ABCB4	5244	ENSG00000005471,ENST00000649586;;;ENST00000649586	within 500kb of MDR1	Cholestasis, intrahepatic, of pregnancy, 3	614972	AD, AR	3	Abcb4
7q21.12	7:87365896-87476027	ABCB4, PGY3, MDR3, ICP3	ATP-binding cassette, subfamily B, member 4 (P-glycoprotein-3/multiple drug resistance-3)	171060	ABCB4	5244	ENSG00000005471,ENST00000649586;;;ENST00000649586	within 500kb of MDR1	Cholestasis, progressive familial intrahepatic 3	602347	AR	3	Abcb4
7q21.12	7:87365896-87476027	ABCB4, PGY3, MDR3, ICP3	ATP-binding cassette, subfamily B, member 4 (P-glycoprotein-3/multiple drug resistance-3)	171060	ABCB4	5244	ENSG00000005471,ENST00000649586;;;ENST00000649586	within 500kb of MDR1	Gallbladder disease 1	600803	AD, AR	3	Abcb4
7q21.12	7:87503017-87713295	ABCB1, PGY1, MDR1, IBD13, ENPAT	ATP-binding cassette, subfamily B, member 1 (P-glycoprotein-1/multiple drug resistance-1)	171050	ABCB1	5243	ENSG00000085563,ENST00000622132;;;ENST00000622132		{Colchicine resistance}	120080		3	Abcb1a,Abcb1b
7q21.12	7:87503017-87713295	ABCB1, PGY1, MDR1, IBD13, ENPAT	ATP-binding cassette, subfamily B, member 1 (P-glycoprotein-1/multiple drug resistance-1)	171050	ABCB1	5243	ENSG00000085563,ENST00000622132;;;ENST00000622132		{Inflammatory bowel disease 13}	612244		3	Abcb1a,Abcb1b
7q21.12	7:87503017-87713295	ABCB1, PGY1, MDR1, IBD13, ENPAT	ATP-binding cassette, subfamily B, member 1 (P-glycoprotein-1/multiple drug resistance-1)	171050	ABCB1	5243	ENSG00000085563,ENST00000622132;;;ENST00000622132		Encephalopathy, acute transient	620950	AR	3	Abcb1a,Abcb1b
7q21.12	7:87934251-88202889	ADAM22, DEE61	ADAM metallopeptidase domain 22	603709	ADAM22	53616	ENSG00000008277,ENST00000413139;;;ENST00000413139		Developmental and epileptic encephalopathy 61	617933	AR	3	Adam22
7q21.13	7:90245174-90323723	CFAP69, C7orf63, SPGF24	Cilia- and flagella-associated protein 69	617949	CFAP69	79846	ENSG00000105792,ENST00000389297;;;ENST00000389297		Spermatogenic failure 24	617959	AR	3	Cfap69
7q21.2	7:91940862-92110673	AKAP9, YOTIAO, AKAP450, LQT11	A-kinase anchor protein 9	604001	AKAP9	10142	ENSG00000127914,ENST00000356239;;;ENST00000356239	mutation identified in 1 LQT11 family	?Long QT syndrome 11	611820	AD	3	Akap9
7q21.2	7:92198969-92246100	KRIT1, CCM1, CAM	KRIT1 ankyrin repeat-containing protein 1	604214	KRIT1	889	ENSG00000001631,ENST00000394505;;;ENST00000394505		Cavernous malformations of CNS and retina	116860	AD	3	Krit1
7q21.2	7:92198969-92246100	KRIT1, CCM1, CAM	KRIT1 ankyrin repeat-containing protein 1	604214	KRIT1	889	ENSG00000001631,ENST00000394505;;;ENST00000394505		Cerebral cavernous malformations-1	116860	AD	3	Krit1
7q21.2	7:92198969-92246100	KRIT1, CCM1, CAM	KRIT1 ankyrin repeat-containing protein 1	604214	KRIT1	889	ENSG00000001631,ENST00000394505;;;ENST00000394505		Hyperkeratotic cutaneous capillary-venous malformations associated with cerebral capillary malformations	116860	AD	3	Krit1
7q21.2	7:92447482-92495769	GATAD1, ODAG, CMD2B	GATA zinc finger domain-containing protein 1	614518	GATAD1	57798	ENSG00000157259,ENST00000287957;;;ENST00000287957	mutation identified in 1 GATAD1 family	?Cardiomyopathy, dilated, 2B	614672	AR	3	Gatad1
7q21.2	7:92487025-92528520	PEX1, ZWS1, PBD1A, PBD1B, HMLR1	Peroxisome biogenesis factor-1	602136	PEX1	5189	ENSG00000127980,ENST00000248633;;;ENST00000248633		Heimler syndrome 1	234580	AR	3	Pex1
7q21.2	7:92487025-92528520	PEX1, ZWS1, PBD1A, PBD1B, HMLR1	Peroxisome biogenesis factor-1	602136	PEX1	5189	ENSG00000127980,ENST00000248633;;;ENST00000248633		Peroxisome biogenesis disorder 1A (Zellweger)	214100	AR	3	Pex1
7q21.2	7:92487025-92528520	PEX1, ZWS1, PBD1A, PBD1B, HMLR1	Peroxisome biogenesis factor-1	602136	PEX1	5189	ENSG00000127980,ENST00000248633;;;ENST00000248633		Peroxisome biogenesis disorder 1B (NALD/IRD)	601539	AR	3	Pex1
7q21.2	7:92604921-92836573	CDK6, PLSTIRE, MCPH12	Cyclin-dependent kinase 6	603368	CDK6	1021	ENSG00000105810,ENST00000424848;;;ENST00000424848	mutation identified in 1 MCPH12 family	?Microcephaly 12, primary, autosomal recessive	616080	AR	3	Cdk6
7q21.2	7:93099518-93117979	SAMD9, NFTC, MIRAGE, M7MLS2	Sterile alpha motif domain-containing protein 9	610456	SAMD9	54809	ENSG00000205413,ENST00000379958;;;ENST00000379958		MIRAGE syndrome	617053	AD	3	
7q21.2	7:93099518-93117979	SAMD9, NFTC, MIRAGE, M7MLS2	Sterile alpha motif domain-containing protein 9	610456	SAMD9	54809	ENSG00000205413,ENST00000379958;;;ENST00000379958		Monosomy 7 myelodysplasia and leukemia syndrome 2	619041	AD	3	
7q21.2	7:93099518-93117979	SAMD9, NFTC, MIRAGE, M7MLS2	Sterile alpha motif domain-containing protein 9	610456	SAMD9	54809	ENSG00000205413,ENST00000379958;;;ENST00000379958		Tumoral calcinosis, familial, normophosphatemic	610455	AR	3	
7q21.2	7:93130056-93148385	SAMD9L, ATXPC, M7MLS1, SCA49	Sterile alpha motif domain-containing 9-like	611170	SAMD9L	219285	ENSG00000177409,ENST00000318238;;;ENST00000318238	mutation identified in 1 SCA49 family	?Spinocerebellar ataxia 49	619806	AD	3	Samd9l
7q21.2	7:93130056-93148385	SAMD9L, ATXPC, M7MLS1, SCA49	Sterile alpha motif domain-containing 9-like	611170	SAMD9L	219285	ENSG00000177409,ENST00000318238;;;ENST00000318238	mutation identified in 1 SCA49 family	Ataxia-pancytopenia syndrome	159550	AD	3	Samd9l
7q21.2	7:93130056-93148385	SAMD9L, ATXPC, M7MLS1, SCA49	Sterile alpha motif domain-containing 9-like	611170	SAMD9L	219285	ENSG00000177409,ENST00000318238;;;ENST00000318238	mutation identified in 1 SCA49 family	Monosomy 7 myelodysplasia and leukemia syndrome 1	252270	AD	3	Samd9l
7q21.2-q21.3	7:93232366-93361123	VPS50, CCDC132, KIAA1861, NEDMSC	VPS50, EARP/GARPII complex subunit	616465	VPS50	55610	ENSG00000004766,ENST00000305866;;;ENST00000305866		Neurodevelopmental disorder with microcephaly, seizures, and neonatal cholestasis	619685	AR	3	Vps50
7q21.3	7:93300001-98400000	MVCD5	Microvascular complications of diabetes 5	612633				see PON1 polymorphism	{Microvascular complications of diabetes 5}	612633		2	
7q21.3	7:93424486-93574724	CALCR, CRT	Calcitonin receptor	114131	CALCR	799	ENSG00000004948,ENST00000426151;;;ENST00000426151	not deleted in Williams syndrome	{Osteoporosis, postmenopausal, susceptibility}	166710	AD	3	Calcr
7q21.3	7:93962762-94004355	BET1, MDRP	Bet1 golgi vesicular membrane-trafficking protein	605456	BET1	10282	ENSG00000105829,ENST00000222547;;;ENST00000222547		Muscular dystrophy, congenital, with rapid progression	254100	AR	3	Bet1
7q21.3	7:94394895-94431227	COL1A2, EDSCV, EDSARTH2	Collagen I, alpha-2 polypeptide	120160	COL1A2	1278	ENSG00000164692,ENST00000297268;;;ENST00000297268	~17cM from CF	{Osteoporosis, postmenopausal}	166710	AD	3	Col1a2
7q21.3	7:94394895-94431227	COL1A2, EDSCV, EDSARTH2	Collagen I, alpha-2 polypeptide	120160	COL1A2	1278	ENSG00000164692,ENST00000297268;;;ENST00000297268	~17cM from CF	Combined osteogenesis imperfecta and Ehlers-Danlos syndrome 2	619120	AD	3	Col1a2
7q21.3	7:94394895-94431227	COL1A2, EDSCV, EDSARTH2	Collagen I, alpha-2 polypeptide	120160	COL1A2	1278	ENSG00000164692,ENST00000297268;;;ENST00000297268	~17cM from CF	Ehlers-Danlos syndrome, arthrochalasia type, 2	617821	AD	3	Col1a2
7q21.3	7:94394895-94431227	COL1A2, EDSCV, EDSARTH2	Collagen I, alpha-2 polypeptide	120160	COL1A2	1278	ENSG00000164692,ENST00000297268;;;ENST00000297268	~17cM from CF	Ehlers-Danlos syndrome, cardiac valvular type	225320	AR	3	Col1a2
7q21.3	7:94394895-94431227	COL1A2, EDSCV, EDSARTH2	Collagen I, alpha-2 polypeptide	120160	COL1A2	1278	ENSG00000164692,ENST00000297268;;;ENST00000297268	~17cM from CF	Osteogenesis imperfecta, type II	166210	AD	3	Col1a2
7q21.3	7:94394895-94431227	COL1A2, EDSCV, EDSARTH2	Collagen I, alpha-2 polypeptide	120160	COL1A2	1278	ENSG00000164692,ENST00000297268;;;ENST00000297268	~17cM from CF	Osteogenesis imperfecta, type III	259420	AD	3	Col1a2
7q21.3	7:94394895-94431227	COL1A2, EDSCV, EDSARTH2	Collagen I, alpha-2 polypeptide	120160	COL1A2	1278	ENSG00000164692,ENST00000297268;;;ENST00000297268	~17cM from CF	Osteogenesis imperfecta, type IV	166220	AD	3	Col1a2
7q21.3	7:94584980-94656133	SGCE, DYT11	Sarcoglycan, epsilon	604149	SGCE	8910	ENSG00000127990,ENST00000648936;;;ENST00000648936	pseudogene on 2q21; maternally imprinted	Dystonia-11, myoclonic	159900	AD	3	Sgce
7q21.3	7:95404862-95435028	PON2	Paraoxonase-2	602447	PON2	5445	ENSG00000105854,ENST00000222572;;;ENST00000222572		{Coronary artery disease, susceptibility to}			3	Pon2
7q21.3	7:96120220-96322098	SLC25A13, CTLN2, NICCD	Solute carrier family 25 (mitochondrial carrier, citrin), member 13	603859	SLC25A13	10165	ENSG00000004864,ENST00000265631;;;ENST00000265631		Citrullinemia, adult-onset type II	603471	AR	3	Slc25a13
7q21.3	7:96120220-96322098	SLC25A13, CTLN2, NICCD	Solute carrier family 25 (mitochondrial carrier, citrin), member 13	603859	SLC25A13	10165	ENSG00000004864,ENST00000265631;;;ENST00000265631		Citrullinemia, type II, neonatal-onset	605814	AR	3	Slc25a13
7q21.3	7:97020396-97024831	DLX5, SHFM1D, SHFM1	Distal-less homeobox 5	600028	DLX5	1749	ENSG00000105880,ENST00000648378;;;ENST00000648378	mutation identified in 1 SHFM1D family	?Split-hand/foot malformation 1 with sensorineural hearing loss	220600	AR	3	Dlx5
7q21.3	7:97020396-97024831	DLX5, SHFM1D, SHFM1	Distal-less homeobox 5	600028	DLX5	1749	ENSG00000105880,ENST00000648378;;;ENST00000648378	mutation identified in 1 SHFM1D family	Split-hand/foot malformation 1	183600	AD	3	Dlx5
7q21.3	7:97851677-97928441	ASNS, ASNSD	Asparagine synthetase	108370	ASNS	440	ENSG00000070669,ENST00000394308;;;ENST00000394308	temperature sensitive G1 mutant	Asparagine synthetase deficiency	615574	AR	3	Asns
7q22	7:98400001-107800000	AUTS1	Autism, susceptibility to, 1	209850		100188832			{Autism susceptibility 1}	209850	IC, Mu	2	
7q22	7:98400001-107800000	IBD11	Inflammatory bowel disease 11	191390		100529151		associated with MUC3A	{Inflammatory bowel disease 11}	191390	Mu	2	
7q22	7:98400001-107800000	PAPA4	Polydactyly, postaxial, type A4	608562		450096		highest lod with D7S1799	Polydactyly, postaxial, type A4	608562		2	
7q22-q32	7:98400001-132900000	SCA18, SMNA	Spinal cerebellar ataxia 18	607458		94008		between D7S2418 and D7S1804	Spinocerebellar ataxia 18	607458	AD	2	
7q22.1	7:98878532-99013241	TRRAP, DEDDFA, DFNA75	Transformation/transcription domain-associated protein	603015	TRRAP	8295	ENSG00000196367,ENST00000456197;;;ENST00000456197	?mutation identified in 1 DFNA75 family	?Deafness, autosomal dominant 75	618778	AD	3	Trrap
7q22.1	7:98878532-99013241	TRRAP, DEDDFA, DFNA75	Transformation/transcription domain-associated protein	603015	TRRAP	8295	ENSG00000196367,ENST00000456197;;;ENST00000456197	?mutation identified in 1 DFNA75 family	Developmental delay with or without dysmorphic facies and autism	618454	AD	3	Trrap
7q22.1	7:99145804-99219419	KPNA7, OZEMA17	Karyopherin alpha 7	614107	KPNA7	402569	ENSG00000185467,ENST00000327442;;;ENST00000327442		Oocyte/zygote/embryo maturation arrest 17	620319	AR	3	Kpna7
7q22.1	7:99374259-99394816	ARPC1B, ARC41, IMD71	Actin-related protein 2/3 complex, subunit 1B	604223	ARPC1B	10095	ENSG00000130429,ENST00000646101;;;ENST00000646101		Immunodeficiency 71 with inflammatory disease and congenital thrombocytopenia	617718	AR	3	Arpc1b
7q22.1	7:99648194-99679996	CYP3A5, P450PCN3	Cytochrome P450, subfamily IIIA, polypeptide 5	605325	CYP3A5	1577	ENSG00000106258,ENST00000222982;;;ENST00000222982		{Hypertension, salt-sensitive essential, susceptibility to}	145500	Mu	3	Cyp3a11,Cyp3a13,Cyp3a16,Cyp3a25,Cyp3a41a,Cyp3a41b,Cyp3a44,Cyp3a59
7q22.1	7:99756967-99784184	CYP3A4, VDDR3	Cytochrome P450, subfamily IIIA (nifedipine oxidase) polypeptide 4	124010	CYP3A4	1576	ENSG00000160868,ENST00000651514;;;ENST00000651514		Vitamin D-dependent rickets, type 3	619073	AD	3	Cyp3a13
7q22.1	7:100100794-100109039	AP4M1, SPG50, CPSQ3	Adaptor-related protein complex 4, mu-1 subunit	602296	AP4M1	9179	ENSG00000221838,ENST00000359593;;;ENST00000359593		Spastic paraplegia 50, autosomal recessive	612936	AR	3	Ap4m1
7q22.1	7:100107070-100127171	TAF6, TAF2E, TAFII80, ALYUS	TAF6 RNA polymerase II, TATA box-binding protein-associated factor, 80kD	602955	TAF6	6878	ENSG00000106290,ENST00000453269;;;ENST00000453269		Alazami-Yuan syndrome	617126	AR	3	Taf6
7q22.1	7:100154423-100158723	TRAPPC14, MAP11, C7orf43, MCPH25	Trafficking protein particle complex subunit 14	618350	TRAPPC14	55262	ENSG00000146826,ENST00000316937;;;ENST00000316937	mutation identified in 1 MCHP25 family	?Microcephaly 25, primary, autosomal recessive	618351	AR	3	Trappc14
7q22.1	7:100177724-100219334	STAG3, POF8, SPGF61	Stromalin 3	608489	STAG3	10734	ENSG00000066923,ENST00000615138;;;ENST00000615138		Premature ovarian failure 8	615723	AR	3	Stag3
7q22.1	7:100177724-100219334	STAG3, POF8, SPGF61	Stromalin 3	608489	STAG3	10734	ENSG00000066923,ENST00000615138;;;ENST00000615138		Spermatogenic failure 61	619672	AR	3	Stag3
7q22.1	7:100620420-100641552	TFR2, HFE3	Transferrin receptor 2	604720	TFR2	7036	ENSG00000106327,ENST00000223051;;;ENST00000223051		Hemochromatosis, type 3	604250	AR	3	Tfr2
7q22.1	7:100643097-100656448	ACTL6B, BAF53B, IDDSSAD, DEE76	Actin-like 6B	612458	ACTL6B	51412	ENSG00000077080,ENST00000160382;;;ENST00000160382		Developmental and epileptic encephalopathy 76	618468	AR	3	Actl6b
7q22.1	7:100643097-100656448	ACTL6B, BAF53B, IDDSSAD, DEE76	Actin-like 6B	612458	ACTL6B	51412	ENSG00000077080,ENST00000160382;;;ENST00000160382		Intellectual developmental disorder with severe speech and ambulation defects	618470	AD	3	Actl6b
7q22.1	7:100673740-100679169	GNB2, SSS4, NEDHYDF	Guanine nucleotide-binding protein, beta polypeptide-2	139390	GNB2	2783	ENSG00000172354,ENST00000303210;;;ENST00000303210	mutation identified in 1 SSS4 family	?Sick sinus syndrome 4	619464	AD	3	Gnb2
7q22.1	7:100673740-100679169	GNB2, SSS4, NEDHYDF	Guanine nucleotide-binding protein, beta polypeptide-2	139390	GNB2	2783	ENSG00000172354,ENST00000303210;;;ENST00000303210	mutation identified in 1 SSS4 family	Neurodevelopmental disorder with hypotonia and dysmorphic facies	619503	AD	3	Gnb2
7q22.1	7:100720468-100723700	EPO, MVCD2, ECYT5, DBAL	Erythropoietin	133170	EPO	2056	ENSG00000130427,ENST00000252723;;;ENST00000252723	mutation identified in 1 DBAL family	?Diamond-Blackfan anemia-like	617911	AR	3	Epo
7q22.1	7:100720468-100723700	EPO, MVCD2, ECYT5, DBAL	Erythropoietin	133170	EPO	2056	ENSG00000130427,ENST00000252723;;;ENST00000252723	mutation identified in 1 DBAL family	{Microvascular complications of diabetes 2}	612623		3	Epo
7q22.1	7:100720468-100723700	EPO, MVCD2, ECYT5, DBAL	Erythropoietin	133170	EPO	2056	ENSG00000130427,ENST00000252723;;;ENST00000252723	mutation identified in 1 DBAL family	Erythrocytosis, familial, 5	617907	AD	3	Epo
7q22.1	7:100802565-100827523	EPHB4, HTK, MYK1, HFASD, CMAVM2, LMPHM7	Ephrin receptor EphB4 (hepatoma transmembrane kinase)	600011	EPHB4	2050	ENSG00000196411,ENST00000358173;;;ENST00000358173		Capillary malformation-arteriovenous malformation 2	618196	AD	3	Ephb4
7q22.1	7:100802565-100827523	EPHB4, HTK, MYK1, HFASD, CMAVM2, LMPHM7	Ephrin receptor EphB4 (hepatoma transmembrane kinase)	600011	EPHB4	2050	ENSG00000196411,ENST00000358173;;;ENST00000358173		Lymphatic malformation 7	617300	AD	3	Ephb4
7q22.1	7:100889994-100896994	ACHE, YT	Acetylcholinesterase (YT blood group)	100740	ACHE	43	ENSG00000087085,ENST00000241069;;;ENST00000241069	blood group YT (112100) = epitope of ACHE	[Blood group, Yt system]	112100		3	Ache
7q22.1	7:101127104-101139247	PAI1, PLANH1, SERPINE1	Plasminogen activator inhibitor, type I	173360	SERPINE1	5054	ENSG00000106366,ENST00000223095;;;ENST00000223095		{Transcription of plasminogen activator inhibitor, modulator of}			3	Serpine1
7q22.1	7:101127104-101139247	PAI1, PLANH1, SERPINE1	Plasminogen activator inhibitor, type I	173360	SERPINE1	5054	ENSG00000106366,ENST00000223095;;;ENST00000223095		Plasminogen activator inhibitor-1 deficiency	613329	AD, AR	3	Serpine1
7q22.1	7:101154476-101161276	AP1S1, CLAPS1, AP19, MEDNIK	Adaptor-related protein complex 1, sigma 1 subunit	603531	AP1S1	1174	ENSG00000106367,ENST00000337619;;;ENST00000337619		MEDNIK syndrome	609313	AR	3	Ap1s1
7q22.1	7:101205984-101217581	PLOD3, LH3, BCARD	Procollagen-lysine, 2-oxoglutarate 5-dioxygenase 3 (lysyl hydroxylase 3)	603066	PLOD3	8985	ENSG00000106397,ENST00000223127;;;ENST00000223127		BCARD syndrome (lysyl hydroxylase 3 deficiency)	612394	AR	3	Plod3
7q22.1	7:101816007-102283958	CUX1, CUTL1, CDP, NEDDMS	Cut-like homeobox 1	116896	CUX1	1523	ENSG00000257923,ENST00000292535;;;ENST00000292535		Neurodevelopmental disorder with developmental delay and with or without motor or speech delay	618330	AD	3	Cux1
7q22.1	7:103297435-103347542	PMPCB, MPPB	Peptidase, mitochondrial processing, beta	603131	PMPCB	9512	ENSG00000105819,ENST00000249269;;;ENST00000249269		Multiple mitochondrial dysfunctions syndrome 6	617954	AR	3	Pmpcb
7q22.1	7:103352730-103446207	SLC26A5, PRES, DFNB61	Solute carrier family 26, member 5	604943	SLC26A5	375611	ENSG00000170615,ENST00000306312;;;ENST00000306312	mutation identified in 1 DFNB61 family	?Deafness, autosomal recessive 61	613865	AR	3	Slc26a5
7q22.1	7:103471789-103989658	RELN, RL, LIS2, ETL7	Reelin	600514	RELN	5649	ENSG00000189056,ENST00000428762;;;ENST00000428762		{Epilepsy, familial temporal lobe, 7}	616436	AD	3	Reln
7q22.1	7:103471789-103989658	RELN, RL, LIS2, ETL7	Reelin	600514	RELN	5649	ENSG00000189056,ENST00000428762;;;ENST00000428762		Lissencephaly 2 (Norman-Roberts type)	257320	AR	3	Reln
7q22.3-q31.1	7:104900001-115000000	CMD1Q	Cardiomyopathy, dilated, 1Q	609915		664728		between D7S2545 and D7S2554	Cardiomyopathy, dilated, 1Q	609915		2	
7q22.3	7:104900001-107800000	MPVQTL6	Mean platelet volume quantitative trait locus 6	614646		100887751		associated with rs342293	Mean platelet volume QTL6	614646		2	
7q22.3	7:105014205-105115019	KMT2E, MLL5, ODLURO	Lysine (K)-specific methyltransferase 2E	608444	KMT2E	55904	ENSG00000005483,ENST00000311117;;;ENST00000311117		O'Donnell-Luria-Rodan syndrome	618512	AD	3	Kmt2e
7q22.3	7:105456501-105522271	PUS7, KIAA1897, IDDABS	Pseudouridylate synthase 7, putative	616261	PUS7	54517	ENSG00000091127,ENST00000469408;;;ENST00000469408		Intellectual developmental disorder with abnormal behavior, microcephaly, and short stature	618342	AR	3	Pus7
7q22.3	7:105532201-105567677	RINT1, ILFS3	RAD50-interacting protein 1	610089	RINT1	60561	ENSG00000135249,ENST00000257700;;;ENST00000257700		Infantile liver failure syndrome 3	618641	AR	3	Rint1
7q22.3	7:106865282-106908980	PIK3CG, IMD97	Phosphatidylinositol 3-kinase, catalytic, gamma	601232	PIK3CG	5294	ENSG00000105851,ENST00000496166;;;ENST00000496166		Immunodeficiency 97 with autoinflammation	619802	AR	3	Pik3cg
7q22.3	7:107201372-107563920	COG5, GOLTC1, GTC90, CDG2I	Component of oligomeric golgi complex 5	606821	COG5	10466	ENSG00000164597,ENST00000297135;;;ENST00000297135		Congenital disorder of glycosylation, type IIi	613612	AR	3	Cog5
7q22.3	7:107660828-107717809	SLC26A4, PDS, DFNB4, EVA, TDH2B	Solute carrier family 26 (sulfate transporter), member 4	605646	SLC26A4	5172	ENSG00000091137,ENST00000644269;;;ENST00000644269	some patients have digenic mutations with FOXI1	Deafness, autosomal recessive 4, with enlarged vestibular aqueduct	600791	AR	3	Slc26a4
7q22.3	7:107660828-107717809	SLC26A4, PDS, DFNB4, EVA, TDH2B	Solute carrier family 26 (sulfate transporter), member 4	605646	SLC26A4	5172	ENSG00000091137,ENST00000644269;;;ENST00000644269	some patients have digenic mutations with FOXI1	Pendred syndrome	274600	AR	3	Slc26a4
7q22.3-q31.1	7:107765469-107803223	SLC26A3, DRA, CLD	Solute carrier family 26 (sulfate transporter), member 3	126650	SLC26A3	1811	ENSG00000091138,ENST00000340010;;;ENST00000340010	5' and close to PDS	Diarrhea 1, secretory chloride, congenital	214700	AR	3	Slc26a3
7q31	7:107800001-127500000	AUTS9	Autism, susceptibility to, 9	611015				max lod near D7S530	{Autism, susceptibility to, 9}	611015		2	
7q31	7:107800001-127500000	DFNB14	Deafness, autosomal recessive 14	603678		1706		?same as DFNB17	Deafness, autosomal recessive 14	603678	AR	2	
7q31	7:107800001-127500000	DFNB17	Deafness, autosomal recessive 17	603010		1709			Deafness, autosomal recessive 17	603010	AR	2	
7q31.1	7:107891107-107921198	DLD, LAD, PHE3, DLDD	Dihydrolipoamide dehydrogenase (E3 component of pyruvate dehydrogenase complex, 2-oxo-glutarate complex)	238331	DLD	1738	ENSG00000091140,ENST00000205402;;;ENST00000205402		Dihydrolipoamide dehydrogenase deficiency	246900	AR	3	Dld
7q31.1	7:107923799-108003161	LAMB1, LIS5	Laminin, beta-1	150240	LAMB1	3912	ENSG00000091136,ENST00000222399;;;ENST00000222399		Lissencephaly 5	615191	AR	3	Lamb1
7q31.1	7:108147649-108456720	NRCAM, NEDNMS	Neuronal cell adhesion molecule	601581	NRCAM	4897	ENSG00000091129,ENST00000379028;;;ENST00000379028		Neurodevelopmental disorder with neuromuscular and skeletal abnormalities	619833	AR	3	Nrcam
7q31.1	7:108470417-108528178	PNPLA8, MMLA	Patatin-like phospholipase domain-containing protein 8	612123	PNPLA8	50640	ENSG00000135241,ENST00000257694;;;ENST00000257694		Mitochondrial myopathy with lactic acidosis	251950	AR	3	Pnpla8
7q31.1	7:113876777-113919009	PPP1R3A, PPP1R3	Protein phosphatase 1, regulatory subunit 3A	600917	PPP1R3A	5506	ENSG00000154415,ENST00000284601;;;ENST00000284601		Insulin resistance, severe, digenic	125853	AD	3	Ppp1r3a
7q31.1	7:114086327-114693765	FOXP2, SPCH1, TNRC10, CAGH44	Forkhead box P2	605317	FOXP2	93986	ENSG00000128573,ENST00000350908;;;ENST00000350908		Speech-language disorder-1	602081	AD	3	Foxp2
7q31.1-q31.2	7:114922094-115019917	MDFIC, HIC, LMPHM12	MYOD family inhibitor domain-containing protein	614511	MDFIC	29969	ENSG00000135272,ENST00000393486;;;ENST00000393486		Lymphatic malformation 12	620014	AR	3	Mdfic
7q31.2	7:116525009-116561185	CAV1, BSCL3, CGL3, PPH3, LCCNS	Caveolin-1	601047	CAV1	857	ENSG00000105974,ENST00000341049;;;ENST00000341049		Lipodystrophy, congenital generalized, type 3	612526	AR	3	Cav1
7q31.2	7:116525009-116561185	CAV1, BSCL3, CGL3, PPH3, LCCNS	Caveolin-1	601047	CAV1	857	ENSG00000105974,ENST00000341049;;;ENST00000341049		Lipodystrophy, familial partial, type 7	606721	AD	3	Cav1
7q31.2	7:116525009-116561185	CAV1, BSCL3, CGL3, PPH3, LCCNS	Caveolin-1	601047	CAV1	857	ENSG00000105974,ENST00000341049;;;ENST00000341049		Pulmonary hypertension, primary, 3	615343	AD	3	Cav1
7q31.2	7:116672196-116798377	MET, DFNB97, OSFD, DA11	MET protooncogene, receptor tyrosine kinase	164860	MET	4233	ENSG00000105976,ENST00000397752;;;ENST00000397752	mutation identified in 1 DFNB97 family and 1 DA11 family	?Arthrogryposis, distal, type 11	620019	AD	3	Met
7q31.2	7:116672196-116798377	MET, DFNB97, OSFD, DA11	MET protooncogene, receptor tyrosine kinase	164860	MET	4233	ENSG00000105976,ENST00000397752;;;ENST00000397752	mutation identified in 1 DFNB97 family and 1 DA11 family	?Deafness, autosomal recessive 97	616705	AR	3	Met
7q31.2	7:116672196-116798377	MET, DFNB97, OSFD, DA11	MET protooncogene, receptor tyrosine kinase	164860	MET	4233	ENSG00000105976,ENST00000397752;;;ENST00000397752	mutation identified in 1 DFNB97 family and 1 DA11 family	{Osteofibrous dysplasia, susceptibility to}	607278	AD	3	Met
7q31.2	7:116672196-116798377	MET, DFNB97, OSFD, DA11	MET protooncogene, receptor tyrosine kinase	164860	MET	4233	ENSG00000105976,ENST00000397752;;;ENST00000397752	mutation identified in 1 DFNB97 family and 1 DA11 family	Hepatocellular carcinoma, childhood type, somatic	114550		3	Met
7q31.2	7:116672196-116798377	MET, DFNB97, OSFD, DA11	MET protooncogene, receptor tyrosine kinase	164860	MET	4233	ENSG00000105976,ENST00000397752;;;ENST00000397752	mutation identified in 1 DFNB97 family and 1 DA11 family	Renal cell carcinoma, papillary, 1, familial and somatic	605074		3	Met
7q31.2	7:117480025-117668665	CFTR, ABCC7, CF, MRP7	Cystic fibrosis transmembrane conductance regulator (ATP-binding cassette, subfamily C, member 7)	602421	CFTR	1080	ENSG00000001626,ENST00000003084;;;ENST00000003084	distal and 5' to MET	{Bronchiectasis with or without elevated sweat chloride 1, modifier of}	211400	AD	3	Cftr
7q31.2	7:117480025-117668665	CFTR, ABCC7, CF, MRP7	Cystic fibrosis transmembrane conductance regulator (ATP-binding cassette, subfamily C, member 7)	602421	CFTR	1080	ENSG00000001626,ENST00000003084;;;ENST00000003084	distal and 5' to MET	{Hypertrypsinemia, neonatal}			3	Cftr
7q31.2	7:117480025-117668665	CFTR, ABCC7, CF, MRP7	Cystic fibrosis transmembrane conductance regulator (ATP-binding cassette, subfamily C, member 7)	602421	CFTR	1080	ENSG00000001626,ENST00000003084;;;ENST00000003084	distal and 5' to MET	{Pancreatitis, hereditary}	167800	AD	3	Cftr
7q31.2	7:117480025-117668665	CFTR, ABCC7, CF, MRP7	Cystic fibrosis transmembrane conductance regulator (ATP-binding cassette, subfamily C, member 7)	602421	CFTR	1080	ENSG00000001626,ENST00000003084;;;ENST00000003084	distal and 5' to MET	Congenital bilateral absence of vas deferens	277180	AR	3	Cftr
7q31.2	7:117480025-117668665	CFTR, ABCC7, CF, MRP7	Cystic fibrosis transmembrane conductance regulator (ATP-binding cassette, subfamily C, member 7)	602421	CFTR	1080	ENSG00000001626,ENST00000003084;;;ENST00000003084	distal and 5' to MET	Cystic fibrosis	219700	AR	3	Cftr
7q31.2	7:117480025-117668665	CFTR, ABCC7, CF, MRP7	Cystic fibrosis transmembrane conductance regulator (ATP-binding cassette, subfamily C, member 7)	602421	CFTR	1080	ENSG00000001626,ENST00000003084;;;ENST00000003084	distal and 5' to MET	Sweat chloride elevation without CF			3	Cftr
7q31.3	7:117700001-127500000	STQTL2	Stature quantitative trait locus 2	606256		192143		max lod at D7S195	{Stature QTL 2}	606256		2	
7q31.31	7:120787320-120858335	TSPAN12, NET2, EVR5	Tetraspanin 12	613138	TSPAN12	23554	ENSG00000106025,ENST00000222747;;;ENST00000222747		Exudative vitreoretinopathy 5	613310	AD	3	Tspan12
7q31.32	7:122073549-122144249	AASS	Alpha-aminoadipic semialdehyde synthase	605113	AASS	10157	ENSG00000008311,ENST00000417368;;;ENST00000417368		Hyperlysinemia	238700	AR	3	Aass
7q31.32	7:122301303-122310723	FEZF1, FEZ, ZNF312B, HH22	FEZ family zinc finger protein 1	613301	FEZF1	389549	ENSG00000128610,ENST00000442488;;;ENST00000442488		Hypogonadotropic hypogonadism 22, with or without anosmia	616030	AR	3	Fezf1
7q31.32	7:122994704-122995700	TAS2R16, T2R16, BGLPT	Taste receptor type 2, member 16	604867	TAS2R16	50833	ENSG00000128519,ENST00000249284;;;ENST00000249284		[Beta-glycopyranoside tasting]	617956	AD	3	Tas2r118
7q31.32	7:122994704-122995700	TAS2R16, T2R16, BGLPT	Taste receptor type 2, member 16	604867	TAS2R16	50833	ENSG00000128519,ENST00000249284;;;ENST00000249284		{Alcohol dependence, susceptibility to}	103780	Mu	3	Tas2r118
7q31.32	7:123655866-123664290	LMOD2, CLMOD, CMD2G	Leiomodin 2	608006	LMOD2	442721	ENSG00000170807,ENST00000458573;;;ENST00000458573		Cardiomyopathy, dilated, 2G	619897	AR	3	Lmod2
7q31.33	7:124822386-124929825	POT1, PFBMFT8, CRMCC3, TPDS3	Protection of telomeres 1	606478	POT1	25913	ENSG00000128513,ENST00000357628;;;ENST00000357628	mutation identified in 1 PFBMFT8 family and 1 CRMCC3 family	?Cerebroretinal microangiopathy with calcifications and cysts 3	620368	AR	3	Pot1a,Pot1b
7q31.33	7:124822386-124929825	POT1, PFBMFT8, CRMCC3, TPDS3	Protection of telomeres 1	606478	POT1	25913	ENSG00000128513,ENST00000357628;;;ENST00000357628	mutation identified in 1 PFBMFT8 family and 1 CRMCC3 family	?Pulmonary fibrosis and/or bone marrow failure syndrome, telomere-related, 8	620367	AD	3	Pot1a,Pot1b
7q31.33	7:124822386-124929825	POT1, PFBMFT8, CRMCC3, TPDS3	Protection of telomeres 1	606478	POT1	25913	ENSG00000128513,ENST00000357628;;;ENST00000357628	mutation identified in 1 PFBMFT8 family and 1 CRMCC3 family	Tumor predisposition syndrome 3	615848	AD	3	Pot1a,Pot1b
7q32	7:127500001-132900000	BCC6	Basal cell carcinoma, susceptibility to, 6	613063		100307123		associated with rs157935	{Basal cell carcinoma, susceptibility to, 6}	613063		2	
7q32	7:127500001-132900000	PBC4	Biliary cirrhosis, primary, 4	614220		100689215		associated with rs10488631	Biliary cirrhosis, primary, 4	614220		2	
7q32	7:127500001-132900000	PPR3	Photoparoxysmal response 3	609573		619471		max lod at D7S1804	Photoparoxysmal response 3	609573		2	
7q32-q33	7:127500001-138500000	SCA32	Spinocerebellar ataxia 32	613909				between rs3847110 and rs2241728	Spinocerebellar ataxia 32	613909	AD	2	
7q32.1	7:127610292-127618142	PAX4, MODY9, KPD	Paired box homeotic gene-4	167413	PAX4	5078	ENSG00000106331,ENST00000639438;;;ENST00000639438		{Diabetes mellitus, ketosis-prone, susceptibility to}	612227	AD, AR	3	Pax4
7q32.1	7:127610292-127618142	PAX4, MODY9, KPD	Paired box homeotic gene-4	167413	PAX4	5078	ENSG00000106331,ENST00000639438;;;ENST00000639438		Diabetes mellitus, type 2	125853	AD	3	Pax4
7q32.1	7:127610292-127618142	PAX4, MODY9, KPD	Paired box homeotic gene-4	167413	PAX4	5078	ENSG00000106331,ENST00000639438;;;ENST00000639438		Maturity-onset diabetes of the young, type IX	612225		3	Pax4
7q32.1	7:128241278-128257629	LEP, OB, LEPD	Leptin (murine obesity homolog)	164160	LEP	3952	ENSG00000174697,ENST00000308868;;;ENST00000308868	in mouse cen-Cola-2-Met-ob-Cpa-Tcrb-tel	Obesity, morbid, due to leptin deficiency	614962	AR	3	Lep
7q32.1	7:128297685-128343908	RBM28, ANES	RNA-binding motif protein 28	612074	RBM28	55131	ENSG00000106344,ENST00000223073;;;ENST00000223073	mutation identified in 1 ANES family	?Alopecia, neurologic defects, and endocrinopathy syndrome	612079	AR	3	Rbm28
7q32.1	7:128392277-128409982	IMPDH1, RP10, LCA11	Inosine-5'-monophosphate dehydrogenase, type I	146690	IMPDH1	3614	ENSG00000106348,ENST00000338791;;;ENST00000338791	pseudogene on 16p13.13	Leber congenital amaurosis 11	613837	AD	3	Impdh1
7q32.1	7:128392277-128409982	IMPDH1, RP10, LCA11	Inosine-5'-monophosphate dehydrogenase, type I	146690	IMPDH1	3614	ENSG00000106348,ENST00000338791;;;ENST00000338791	pseudogene on 16p13.13	Retinitis pigmentosa 10	180105	AD	3	Impdh1
7q32.1	7:128772485-128775794	OPN1SW, BCP, CBT	Blue cone pigment (opsin 1, short-wave-sensitive)	613522	OPN1SW	611	ENSG00000128617,ENST00000249389;;;ENST00000249389		Colorblindness, tritan	190900	AD	3	Opn1sw
7q32.1	7:128830406-128859272	FLNC, FLN2, ABPA, ABPL, MFM5, MPD4, CMH26, RCM5, ARVC15	Filamin C (actin-binding protein-280)	102565	FLNC	2318	ENSG00000128591,ENST00000325888;;;ENST00000325888		Arrhythmogenic right ventricular dysplasia, familial	617047	AD	3	Flnc
7q32.1	7:128830406-128859272	FLNC, FLN2, ABPA, ABPL, MFM5, MPD4, CMH26, RCM5, ARVC15	Filamin C (actin-binding protein-280)	102565	FLNC	2318	ENSG00000128591,ENST00000325888;;;ENST00000325888		Cardiomyopathy, familial hypertrophic, 26	617047	AD	3	Flnc
7q32.1	7:128830406-128859272	FLNC, FLN2, ABPA, ABPL, MFM5, MPD4, CMH26, RCM5, ARVC15	Filamin C (actin-binding protein-280)	102565	FLNC	2318	ENSG00000128591,ENST00000325888;;;ENST00000325888		Cardiomyopathy, familial restrictive 5	617047	AD	3	Flnc
7q32.1	7:128830406-128859272	FLNC, FLN2, ABPA, ABPL, MFM5, MPD4, CMH26, RCM5, ARVC15	Filamin C (actin-binding protein-280)	102565	FLNC	2318	ENSG00000128591,ENST00000325888;;;ENST00000325888		Myopathy, distal, 4	614065	AD	3	Flnc
7q32.1	7:128830406-128859272	FLNC, FLN2, ABPA, ABPL, MFM5, MPD4, CMH26, RCM5, ARVC15	Filamin C (actin-binding protein-280)	102565	FLNC	2318	ENSG00000128591,ENST00000325888;;;ENST00000325888		Myopathy, myofibrillar, 5	609524	AD	3	Flnc
7q32.1	7:128937032-128950038	IRF5, IBD14, SLEB10	Interferon regulatory factor 5	607218	IRF5	3663	ENSG00000128604,ENST00000357234;;;ENST00000357234		{Inflammatory bowel disease 14}	612245		3	Irf5
7q32.1	7:128937032-128950038	IRF5, IBD14, SLEB10	Interferon regulatory factor 5	607218	IRF5	3663	ENSG00000128604,ENST00000357234;;;ENST00000357234		{Systemic lupus erythematosus, susceptibility to, 10}	612251	AD	3	Irf5
7q32.1	7:128954185-129056193	TNPO3, TRNSR, LGMDD2	Transportin 3	610032	TNPO3	23534	ENSG00000064419,ENST00000265388;;;ENST00000265388		Muscular dystrophy, limb-girdle, autosomal dominant 2	608423	AD	3	Tnpo3
7q32.1	7:129188633-129213545	SMO, SMOH, CRJS, PHLS	Smoothened, frizzled class receptor	601500	SMO	6608	ENSG00000128602,ENST00000249373;;;ENST00000249373		Basal cell carcinoma, somatic	605462		3	Smo
7q32.1	7:129188633-129213545	SMO, SMOH, CRJS, PHLS	Smoothened, frizzled class receptor	601500	SMO	6608	ENSG00000128602,ENST00000249373;;;ENST00000249373		Curry-Jones syndrome, somatic mosaic	601707		3	Smo
7q32.1	7:129188633-129213545	SMO, SMOH, CRJS, PHLS	Smoothened, frizzled class receptor	601500	SMO	6608	ENSG00000128602,ENST00000249373;;;ENST00000249373		Pallister-Hall-like syndrome	241800	AR	3	Smo
7q32.2-q36.1	7:129600001-152800000	HYSP3	Hypospadias 3, autosomal	146450		100689211		between D7S2519 and D7S2442.	Hypospadias 3, autosomal	146450	AD, Mu	2	
7q32.2	7:129774692-129774769	MIR96, MIRN96, DFNA50	Micro RNA 96	611606	MIR96	407053	ENSG00000199158,ENST00000362288		Deafness, autosomal dominant 50	613074	AD	3	Mir96
7q32.2	7:130393771-130441741	CEP41, TSGA14, JBTS15	Centrosomal protein, 41kD	610523	CEP41	95681	ENSG00000106477,ENST00000223208;;;ENST00000223208		Joubert syndrome 15	614464	AR	3	Cep41
7q32.3	7:130800001-132900000	BMIQ1	Body mass index quantitative trait locus 1	606641		170815		max lod at D7S1804	[Body mass index QTL1]	606641		2	
7q33	7:134646853-134679816	BPGM, ECYT8	2,3-bisphosphoglycerate mutase	613896	BPGM	669	ENSG00000172331,ENST00000344924;;;ENST00000344924		Erythrocytosis, familial, 8	222800	AR	3	Bpgm
7q33	7:135557917-135648753	NUP205, C7orf14, KIAA0225, NPHS13	Nucleoporin, 205kD	614352	NUP205	23165	ENSG00000155561,ENST00000285968;;;ENST00000285968	mutation identified in 1 NPHS13 family	?Nephrotic syndrome, type 13	616893	AR	3	Nup205
7q33	7:138076459-138118305	AKR1D1, SRD5B1, CBAS2	Bile acid synthesis defect, congenital, 2	604741	AKR1D1	6718	ENSG00000122787,ENST00000242375;;;ENST00000242375		Bile acid synthesis defect, congenital, 2	235555	AR	3	Akr1d1
7q34	7:138500001-143400000	BDPLT14	Bleeding disorder, platelet-type, 14	614158		116814566			Bleeding disorder, platelet-type, 14	614158	AD	2	
7q34-q36	7:138500001-159345973	DFNB13	Deafness, autosomal recessive 13	603098		1705			Deafness, autosomal recessive 13	603098	AR	2	
7q34-q36	7:138500001-159345973	HMND1, DHMN1	Neuronopathy, distal hereditary motor, autosomal dominant 1	182960					Neuronopathy, distal hereditary motor, autosomal dominant 1	182960	AD	4	
7q34-q36	7:138500001-159345973	OTSC2	Otosclerosis 2	605727		93999			Otosclerosis 2	605727	AD	2	
7q34	7:138706294-138798196	ATP6V0A4, ATP6N1B, VPP2, RTA1C, DRTA3	ATPase, H+ transporting, V0 subunit A4	605239	ATP6V0A4	50617	ENSG00000105929,ENST00000310018;;;ENST00000310018		Distal renal tubular acidosis 3, with or without sensorineural hearing loss	602722	AR	3	Atp6v0a4
7q34	7:138831381-138981389	KIAA1549, RP86	KIAA1549 gene	613344	KIAA1549	57670	ENSG00000122778,ENST00000422774;;;ENST00000422774		Retinitis pigmentosa 86	618613	AR	3	D630045J12Rik
7q34	7:139133778-139191986	TTC26, IFT56, BRENS	Tetratricopeptide repeat domain-containing protein 26	617453	IFT56	79989	ENSG00000105948,ENST00000464848;;;ENST00000464848		Biliary, renal, neurologic, and skeletal syndrome	619534	AR	3	Ift56
7q34	7:139778242-140020293	TBXAS1, GHOSAL, CYP5	Thromboxane A synthase 1, platelet	274180	TBXAS1	6916	ENSG00000059377,ENST00000448866;;;ENST00000448866		Ghosal hematodiaphyseal syndrome	231095	AR	3	Tbxas1
7q34	7:140713328-140924929	BRAF, NS7	B-Raf protooncogene, serine/threonine kinase	164757	BRAF	673	ENSG00000157764,ENST00000646891;;;ENST00000646891	pseudogene BRAF2 on Xq13 or 7q	Adenocarcinoma of lung, somatic	211980		3	Braf
7q34	7:140713328-140924929	BRAF, NS7	B-Raf protooncogene, serine/threonine kinase	164757	BRAF	673	ENSG00000157764,ENST00000646891;;;ENST00000646891	pseudogene BRAF2 on Xq13 or 7q	Cardiofaciocutaneous syndrome	115150	AD	3	Braf
7q34	7:140713328-140924929	BRAF, NS7	B-Raf protooncogene, serine/threonine kinase	164757	BRAF	673	ENSG00000157764,ENST00000646891;;;ENST00000646891	pseudogene BRAF2 on Xq13 or 7q	Colorectal cancer, somatic	114500		3	Braf
7q34	7:140713328-140924929	BRAF, NS7	B-Raf protooncogene, serine/threonine kinase	164757	BRAF	673	ENSG00000157764,ENST00000646891;;;ENST00000646891	pseudogene BRAF2 on Xq13 or 7q	LEOPARD syndrome 3	613707	AD	3	Braf
7q34	7:140713328-140924929	BRAF, NS7	B-Raf protooncogene, serine/threonine kinase	164757	BRAF	673	ENSG00000157764,ENST00000646891;;;ENST00000646891	pseudogene BRAF2 on Xq13 or 7q	Melanoma, malignant, somatic	155600		3	Braf
7q34	7:140713328-140924929	BRAF, NS7	B-Raf protooncogene, serine/threonine kinase	164757	BRAF	673	ENSG00000157764,ENST00000646891;;;ENST00000646891	pseudogene BRAF2 on Xq13 or 7q	Nonsmall cell lung cancer, somatic	211980		3	Braf
7q34	7:140713328-140924929	BRAF, NS7	B-Raf protooncogene, serine/threonine kinase	164757	BRAF	673	ENSG00000157764,ENST00000646891;;;ENST00000646891	pseudogene BRAF2 on Xq13 or 7q	Noonan syndrome 7	613706	AD	3	Braf
7q34	7:141551410-141655244	AGK, MULK, MTDPS10, CATC5, CTRCT38	Acylglycerol kinase	610345	AGK	55750	ENSG00000006530,ENST00000649286;;;ENST00000649286		Cataract 38, autosomal recessive	614691	AR	3	Agk
7q34	7:141551410-141655244	AGK, MULK, MTDPS10, CATC5, CTRCT38	Acylglycerol kinase	610345	AGK	55750	ENSG00000006530,ENST00000649286;;;ENST00000649286		Sengers syndrome	212350	AR	3	Agk
7q34	7:141708353-141731271	WEE2, WEE1B, OZEMA5	Wee1 homolog 2	614084	WEE2	494551	ENSG00000214102,ENST00000397541;;;ENST00000397541		Oocyte/zygote/embryo maturation arrest 5	617996	AR	3	Wee2
7q34	7:141738321-141750488	SSBP1, SSBP, OPA13	Single-stranded DNA-binding protein 1	600439	SSBP1	6742	ENSG00000106028,ENST00000265304;;;ENST00000265304		Optic atrophy 13 with retinal and foveal abnormalities	165510	AD	3	Ssbp1
7q34	7:141972631-141973773	TAS2R38, T2R61, PTC, THIOT	Taste receptor, type 2, member 38	607751	TAS2R38	5726	ENSG00000257138,ENST00000547270;;;ENST00000547270		[Phenylthiocarbamide tasting]	171200	AD	3	Tas2r138
7q34	7:142749472-142753072	PRSS1, TRY1	Protease, serine, 1 (trypsin 1)	276000	PRSS1	5644	ENSG00000204983,ENST00000311737;;;ENST00000311737	8 trypsinogen genes embedded in TCRB locus	Pancreatitis, hereditary	167800	AD	3	Prss1,Prss1l,Prss2,Prss3,Prss3l,Try10,Try4,Try5
7q34	7:142770970-142774560	PRSS2, TRY2	Protease, serine, 2 (trypsin 2)	601564	PRSS2	5645	ENSG00000275896,ENST00000539842;;;ENST00000539842		{Pancreatitis, chronic, protection against}	167800	AD	3	Prss1,Prss1l,Prss2,Prss3,Prss3l,Try10,Try4,Try5
7q34	7:142871208-142885745	TRPV6, ECAC2, CAT1, CATL, HRPTTN	Transient receptor potential cation channel, subfamily V, member 6	606680	TRPV6	55503	ENSG00000165125,ENST00000359396;;;ENST00000359396		Hyperparathyroidism, transient neonatal	618188	AR	3	Trpv6
7q34	7:142941114-142962363	KEL	Kell blood group	613883	KEL	3792	ENSG00000197993,ENST00000355265;;;ENST00000355265		[Blood group, Kell]	110900		3	Kel
7q34	7:143288351-143307696	CASP2, NEDD2, ICH1, MRT80	Caspase 2, apoptosis-related cysteine protease (neural precursor cell expressed, developmentally down-regulated 2)	600639	CASP2	835	ENSG00000106144,ENST00000310447;;;ENST00000310447		Intellectual developmental disorder, autosomal recessive 80, with variant lissencephaly	620653	AR	3	Casp2
7q34	7:143316111-143352083	CLCN1	Chloride channel-1, skeletal muscle	118425	CLCN1	1180	ENSG00000188037,ENST00000343257;;;ENST00000343257		Myotonia congenita, dominant	160800	AD	3	Clcn1
7q34	7:143316111-143352083	CLCN1	Chloride channel-1, skeletal muscle	118425	CLCN1	1180	ENSG00000188037,ENST00000343257;;;ENST00000343257		Myotonia congenita, recessive	255700	AR	3	Clcn1
7q34	7:143316111-143352083	CLCN1	Chloride channel-1, skeletal muscle	118425	CLCN1	1180	ENSG00000188037,ENST00000343257;;;ENST00000343257		Myotonia levior	160800	AD	3	Clcn1
7q35-q36	7:143400001-159345973	OPDG, GPDS1, PDS1	Ocular pigment dispersion with or without glaucoma	600510		7986			Ocular pigment dispersion with or without glaucoma	600510	AD	2	
7q35-q36	7:143400001-159345973	SLI4	Specific language impairment 4	612514		100233227		associated with rs1723629	{Specific language impairment 4}	612514		2	
7q35	7:144396894-144410227	NOBOX, POF5	NOBOX oogenesis homeobox	610934	NOBOX	135935	ENSG00000106410,ENST00000467773		Premature ovarian failure 5	611548	AD	3	Nobox
7q35	7:144451941-144836437	TPK1, THMD5	Thiamine pyrophosphokinase	606370	TPK1	27010	ENSG00000196511,ENST00000360057;;;ENST00000360057		Thiamine metabolism dysfunction syndrome 5 (episodic encephalopathy type)	614458	AR	3	Tpk1
7q35-q36.1	7:146116801-148420998	CNTNAP2, CASPR2, NRXN4, AUTS15, PTHSL1	Contactin-associated protein-like 2	604569	CNTNAP2	26047	ENSG00000174469,ENST00000361727;;;ENST00000361727		{Autism susceptibility 15}	612100		3	Cntnap2
7q35-q36.1	7:146116801-148420998	CNTNAP2, CASPR2, NRXN4, AUTS15, PTHSL1	Contactin-associated protein-like 2	604569	CNTNAP2	26047	ENSG00000174469,ENST00000361727;;;ENST00000361727		Pitt-Hopkins like syndrome 1	610042	AR	3	Cntnap2
7q36	7:148200001-159345973	ACRPS	Acropectoral syndrome	605967		85505			Acropectoral syndrome	605967	AD	2	
7q36	7:148200001-159345973	AD10	Alzheimer disease-10	609636		780912		max lod with D7S798	Alzheimer disease-10	609636	AD	2	
7q36	7:148200001-159345973	AUTS10	Autism, susceptibility to, 10	611016				max lod at D7S483	{Autism, susceptibility to, 10}	611016		2	
7q36.1	7:148807383-148884291	EZH2, EZH1, WVS	Enhancer of zeste, Drosophila, homolog of, 2	601573	EZH2	2146	ENSG00000106462,ENST00000320356;;;ENST00000320356	pseudogene on 21q22	Weaver syndrome	277590	AD	3	Ezh2
7q36.1	7:149838375-149867479	ZNF862, GINGF6	Zinc finger protein 862	620974	ZNF862	643641	ENSG00000106479,ENST00000223210;;;ENST00000223210	mutation identified in 1 GINGF6 family	?Fibromatosis, gingival 6	620999	AD	3	
7q36.1	7:150737418-150743646	GIMAP5, IAN4L1, IMAP3, NCPH2	GTPase, IMAP family, member 5	608086	GIMAP5	55340	ENSG00000196329,ENST00000358647;;;ENST00000358647		Portal hypertension, noncirrhotic, 2	619463	AR	3	Gimap3,Gimap5
7q36.1	7:150944961-150978321	KCNH2, LQT2, HERG, SQT1	Potassium voltage-gated channel, subfamily H, member 2 (human ether-a-go-go-related gene)	152427	KCNH2	3757	ENSG00000055118,ENST00000262186;;;ENST00000262186		Long QT syndrome 2	613688	AD	3	Kcnh2
7q36.1	7:150944961-150978321	KCNH2, LQT2, HERG, SQT1	Potassium voltage-gated channel, subfamily H, member 2 (human ether-a-go-go-related gene)	152427	KCNH2	3757	ENSG00000055118,ENST00000262186;;;ENST00000262186		Short QT syndrome 1	609620		3	Kcnh2
7q36.1	7:150991017-151014588	NOS3	Nitric oxide synthase 3, endothelial cell	163729	NOS3	4846	ENSG00000164867,ENST00000297494;;;ENST00000297494		{Alzheimer disease, late-onset, susceptibility to}	104300	AD	3	Nos3
7q36.1	7:150991017-151014588	NOS3	Nitric oxide synthase 3, endothelial cell	163729	NOS3	4846	ENSG00000164867,ENST00000297494;;;ENST00000297494		{Coronary artery spasm 1, susceptibility to}			3	Nos3
7q36.1	7:150991017-151014588	NOS3	Nitric oxide synthase 3, endothelial cell	163729	NOS3	4846	ENSG00000164867,ENST00000297494;;;ENST00000297494		{Hypertension, pregnancy-induced}	189800	AD	3	Nos3
7q36.1	7:150991017-151014588	NOS3	Nitric oxide synthase 3, endothelial cell	163729	NOS3	4846	ENSG00000164867,ENST00000297494;;;ENST00000297494		{Hypertension, susceptibility to}	145500	Mu	3	Nos3
7q36.1	7:150991017-151014588	NOS3	Nitric oxide synthase 3, endothelial cell	163729	NOS3	4846	ENSG00000164867,ENST00000297494;;;ENST00000297494		{Ischemic stroke, susceptibility to}	601367	Mu	3	Nos3
7q36.1	7:150991017-151014588	NOS3	Nitric oxide synthase 3, endothelial cell	163729	NOS3	4846	ENSG00000164867,ENST00000297494;;;ENST00000297494		{Placental abruption}			3	Nos3
7q36.1	7:151053815-151057897	CDK5, LIS7	Cyclin-dependent kinase 5	123831	CDK5	1020	ENSG00000164885,ENST00000485972;;;ENST00000485972	mutation identified in 1 LIS7 family	?Lissencephaly 7 with cerebellar hypoplasia	616342	AR	3	Cdk5
7q36.1	7:151058200-151076527	SLC4A2, AE2, EPB3L1, OPTB9	Solute carrier family 4, anion exchanger, member 2 (erythrocyte membrane protein band 3-like 1)	109280	SLC4A2	6522	ENSG00000164889,ENST00000413384;;;ENST00000413384	mutation identified in 1 OPTB9 patient	?Osteopetrosis, autosomal recessive 9	620366	AR	3	Slc4a2
7q36.1	7:151175698-151187792	ASB10, GLC1F	Ankyrin repeat- and SOCS box-containing protein 10	615054	ASB10	136371	ENSG00000146926,ENST00000420175;;;ENST00000420175		Glaucoma 1, open angle, F	603383	AD	3	Asb10
7q36.1	7:151556127-151877115	PRKAG2, WPWS, CMH6, GSDH	Protein kinase, AMP-activated, noncatalytic, gamma-2	602743	PRKAG2	51422	ENSG00000106617,ENST00000287878;;;ENST00000287878		Cardiomyopathy, hypertrophic 6	600858	AD	3	Prkag2
7q36.1	7:151556127-151877115	PRKAG2, WPWS, CMH6, GSDH	Protein kinase, AMP-activated, noncatalytic, gamma-2	602743	PRKAG2	51422	ENSG00000106617,ENST00000287878;;;ENST00000287878		Glycogen storage disease of heart, lethal congenital	261740	AD	3	Prkag2
7q36.1	7:151556127-151877115	PRKAG2, WPWS, CMH6, GSDH	Protein kinase, AMP-activated, noncatalytic, gamma-2	602743	PRKAG2	51422	ENSG00000106617,ENST00000287878;;;ENST00000287878		Wolff-Parkinson-White syndrome	194200	AD	3	Prkag2
7q36.1	7:152134925-152436003	KMT2C, MLL3, KIAA1506, KLEFS2	Lysine (K)-specific methyltransferase 2C	606833	KMT2C	58508	ENSG00000055609,ENST00000262189;;;ENST00000262189		Kleefstra syndrome 2	617768	AD	3	Kmt2c
7q36.1	7:152644776-152676141	XRCC2, FANCU, SPGF50, POF17	X-ray repair cross complementing 2	600375	XRCC2	7516	ENSG00000196584,ENST00000359321;;;ENST00000359321	mutation identified in 1 FANCU patient and 1 POF17 patient	?Fanconi anemia, complementation group U	617247	AR	3	Xrcc2
7q36.1	7:152644776-152676141	XRCC2, FANCU, SPGF50, POF17	X-ray repair cross complementing 2	600375	XRCC2	7516	ENSG00000196584,ENST00000359321;;;ENST00000359321	mutation identified in 1 FANCU patient and 1 POF17 patient	?Premature ovarian failure 17	619146	AR	3	Xrcc2
7q36.1	7:152644776-152676141	XRCC2, FANCU, SPGF50, POF17	X-ray repair cross complementing 2	600375	XRCC2	7516	ENSG00000196584,ENST00000359321;;;ENST00000359321	mutation identified in 1 FANCU patient and 1 POF17 patient	Spermatogenic failure 50	619145	AR	3	Xrcc2
7q36.2	7:153748133-154894285	DPP6, VF2, MRD33	Dipeptidylpeptidase VI	126141	DPP6	1804	ENSG00000130226,ENST00000377770;;;ENST00000377770		{Ventricular fibrillation, paroxysmal familial, 2}	612956	AD	3	Dpp6
7q36.2	7:153748133-154894285	DPP6, VF2, MRD33	Dipeptidylpeptidase VI	126141	DPP6	1804	ENSG00000130226,ENST00000377770;;;ENST00000377770		Intellectual developmental disorder, autosomal dominant 33	616311	AD	3	Dpp6
7q36.3	7:155200001-159345973	SCZD16, C16DUPq36.3, DUP7q36.3	Chromosome 7q36.3 duplication syndrome, 362kb	613959				362kb duplication that includes VIPR2	Schizophrenia 16	613959		4	
7q36.3	7:155799980-155812463	SHH, HPE3, HLP3, SMMCI, MCOPCB5	Sonic hedgehog signaling molecule	600725	SHH	6469	ENSG00000164690,ENST00000297261;;;ENST00000297261	separate from TPT1	Holoprosencephaly 3	142945	AD	3	Shh
7q36.3	7:155799980-155812463	SHH, HPE3, HLP3, SMMCI, MCOPCB5	Sonic hedgehog signaling molecule	600725	SHH	6469	ENSG00000164690,ENST00000297261;;;ENST00000297261	separate from TPT1	Microphthalmia/coloboma 5	611638	AD	3	Shh
7q36.3	7:155799980-155812463	SHH, HPE3, HLP3, SMMCI, MCOPCB5	Sonic hedgehog signaling molecule	600725	SHH	6469	ENSG00000164690,ENST00000297261;;;ENST00000297261	separate from TPT1	Single median maxillary central incisor	147250	AD	3	Shh
7q36.3	7:156669012-156893183	LMBR1, ACHP, C7orf2, LSS, TPTPS	Limb development membrane protein 1	605522	LMBR1	64327	ENSG00000105983,ENST00000353442;;;ENST00000353442		Acheiropody	200500	AR	3	Lmbr1
7q36.3	7:156669012-156893183	LMBR1, ACHP, C7orf2, LSS, TPTPS	Limb development membrane protein 1	605522	LMBR1	64327	ENSG00000105983,ENST00000353442;;;ENST00000353442		Laurin-Sandrow syndrome	135750	AD	3	Lmbr1
7q36.3	7:156669012-156893183	LMBR1, ACHP, C7orf2, LSS, TPTPS	Limb development membrane protein 1	605522	LMBR1	64327	ENSG00000105983,ENST00000353442;;;ENST00000353442		Syndactyly, type IV	186200	AD	3	Lmbr1
7q36.3	7:156669012-156893183	LMBR1, ACHP, C7orf2, LSS, TPTPS	Limb development membrane protein 1	605522	LMBR1	64327	ENSG00000105983,ENST00000353442;;;ENST00000353442		Triphalangeal thumb-polysyndactyly syndrome	190605	AD	3	Lmbr1
7q36.3	7:156790708-156793079	ZRS	ZPA regulatory sequence	620738		105804841			Polydactyly, preaxial II	174500	AD	3	
7q36.3	7:156790708-156793079	ZRS	ZPA regulatory sequence	620738		105804841			Tibia, hypoplasia or aplasia of, with polydactyly	188740	AD, AR	3	
7q36.3	7:156790708-156793079	ZRS	ZPA regulatory sequence	620738		105804841			Triphalangeal thumb	174500	AD	3	
7q36.3	7:157004854-157010663	MNX1, HLXB9, HOXHB9, SCRA1	Motor neuron and pancreas homeobox 1	142994	MNX1	3110	ENSG00000130675,ENST00000252971;;;ENST00000252971		Currarino syndrome	176450	AD	3	Mnx1
7q36.3	7:157138926-157269370	UBE3C, HECTH2, KIAA0010, KIAA10, NEDSMBA	Ubiquitin protein ligase E3C	614454	UBE3C	9690	ENSG00000009335,ENST00000348165;;;ENST00000348165	mutation identified in 1 NDSMBA	Neurodevelopmental disorder with absent speech and movement and behavioral abnormalities	620270	AR	3	Ube3c
7q36.3	7:157337004-157417439	DNAJB6, MRJ, DJ4, LGMDD1	DNAJ/HSP40 homolog, subfamily B, member 6	611332	DNAJB6	10049	ENSG00000105993,ENST00000262177;;;ENST00000262177		Muscular dystrophy, limb-girdle, autosomal dominant 1	603511	AD	3	Dnajb6
7q36.3	7:158631169-158704804	NCAPG2, CAPG2, MTB, 3KS	Non-SMC condensin II complex subunit G2	608532	NCAPG2	54892	ENSG00000146918,ENST00000356309;;;ENST00000356309		Khan-Khan-Katsanis syndrome	618460	AR	3	Ncapg2
7q36.3	7:158839245-158958698	DYNC2I1, WDR60, SRTD8, SRPS6	Dynein 2 intermediate chain 1	615462	DYNC2I1	55112	ENSG00000126870,ENST00000407559;;;ENST00000407559		Short-rib thoracic dysplasia 8 with or without polydactyly	615503	AR	3	Dync2i1
Chr.7	7:1-159345973	AIS2, VAMAS3	Autoimmune disease, susceptibility to, 2	608391		378426			{Autoimmune disease, susceptibility to, 2}	608391		2	
8p23.3-p22	8:1-19200000	DBA2	Diamond-Blackfan anemia 2	606129		114086			Diamond-Blackfan anemia 2	606129		2	
8p23-p21	8:1-29000000	GEFSP6	Generalized epilepsy with febrile seizures plus, type 6	612279		100190787		between D8S1706 and D8S549	Generalized epilepsy with febrile seizures plus, type 6	612279		2	
8p23	8:1-12800000	MYP10	Myopia 10	609259		553195			Myopia 10	609259	Mu	2	
8p23	8:1-12800000	WS2C	Waardenburg syndrome, type 2C	606662		170594			Waardenburg syndrome, type 2C	606662		2	
8p23.3	8:1753059-1786570	CLN8, EPMR	CLN8 transmembrane ER and ERGIC protein	607837	CLN8	2055	ENSG00000182372,ENST00000331222;;;ENST00000331222		Ceroid lipofuscinosis, neuronal, 8	600143	AR	3	Cln8
8p23.3	8:1753059-1786570	CLN8, EPMR	CLN8 transmembrane ER and ERGIC protein	607837	CLN8	2055	ENSG00000182372,ENST00000331222;;;ENST00000331222		Ceroid lipofuscinosis, neuronal, 8, Northern epilepsy variant	610003	AR	3	Cln8
8p23.3	8:1823329-1958641	ARHGEF10, KIAA0294, SNCV	Rho guanine nucleotide exchange factor 10	608136	ARHGEF10	9639	ENSG00000104728,ENST00000349830;;;ENST00000349830	mutation identified in 1 SNCV family	?Slowed nerve conduction velocity, AD	608236	AD	3	Arhgef10
8p23.1	8:6300001-12800000	DIH2	Diaphragmatic hernia 2	222400		780899			Diaphragmatic hernia 2	222400	IC	2	
8p23.1	8:6300001-12800000	SLEB12	Systemic lupus erythematosus, susceptibility to, 12	612254		100190928		associated with rs13277113	{Systemic lupus erythematosus, susceptibility to, 12}	612254	AD	2	
8p23.1	8:6406627-6648508	MCPH1	Microcephalin	607117	MCPH1	79648	ENSG00000147316,ENST00000344683;;;ENST00000344683	genetic heterogeneity	Microcephaly 1, primary, autosomal recessive	251200	AR	3	Mcph1
8p23.1	8:6499632-6563245	ANGPT2, ANG2, LMPHM10	Angiopoietin 2	601922	ANGPT2	285	ENSG00000091879,ENST00000629816;;;ENST00000629816	close to MCPH1	Lymphatic malformation 10	619369	AD	3	Angpt2
8p23.1	8:8783354-8893630	MFHAS1, MASL1	Malignant fibrous histiocytoma-amplified sequences with leucine-rich tandem repeats-1	605352	MFHAS1	9258	ENSG00000147324,ENST00000276282;;;ENST00000276282		Malignant fibrous histiocytoma	605352		2	Mfhas1
8p23.1	8:9002897-9100104	ERI1, HEXO, SEMDGC, HXAL	Exoribonuclease 1	608739	ERI1	90459	ENSG00000104626,ENST00000250263;;;ENST00000250263		Hoxha-Aliu syndrome	620662	AR	3	Eri1
8p23.1	8:9002897-9100104	ERI1, HEXO, SEMDGC, HXAL	Exoribonuclease 1	608739	ERI1	90459	ENSG00000104626,ENST00000250263;;;ENST00000250263		Spondyloepimetaphyseal dysplasia, Guo-Campeau type	620663	AR	3	Eri1
8p23.1	8:10606349-10655143	RP1L1, OCMD, RP88	RP1-like protein 1	608581	RP1L1	94137	ENSG00000183638,ENST00000382483;;;ENST00000382483		Occult macular dystrophy	613587	AD	3	Rp1l1
8p23.1	8:10606349-10655143	RP1L1, OCMD, RP88	RP1-like protein 1	608581	RP1L1	94137	ENSG00000183638,ENST00000382483;;;ENST00000382483		Retinitis pigmentosa 88	618826	AR	3	Rp1l1
8p23.1	8:11494387-11564599	BLK, MODY11	BLK protooncogene, SRC family tyrosinase kinase	191305	BLK	640	ENSG00000136573,ENST00000259089;;;ENST00000259089		Maturity-onset diabetes of the young, type 11	613375	AD	3	Blk
8p23.1	8:11676935-11760002	GATA4, ASD2, VSD1, TACHD, TOF	GATA-binding protein-4	600576	GATA4	2626	ENSG00000136574,ENST00000532059;;;ENST00000532059	mutations identified in 1 TACHD family	?Testicular anomalies with or without congenital heart disease	615542	AD	3	Gata4
8p23.1	8:11676935-11760002	GATA4, ASD2, VSD1, TACHD, TOF	GATA-binding protein-4	600576	GATA4	2626	ENSG00000136574,ENST00000532059;;;ENST00000532059	mutations identified in 1 TACHD family	Atrial septal defect 2	607941	AD	3	Gata4
8p23.1	8:11676935-11760002	GATA4, ASD2, VSD1, TACHD, TOF	GATA-binding protein-4	600576	GATA4	2626	ENSG00000136574,ENST00000532059;;;ENST00000532059	mutations identified in 1 TACHD family	Atrioventricular septal defect 4	614430	AD	3	Gata4
8p23.1	8:11676935-11760002	GATA4, ASD2, VSD1, TACHD, TOF	GATA-binding protein-4	600576	GATA4	2626	ENSG00000136574,ENST00000532059;;;ENST00000532059	mutations identified in 1 TACHD family	Tetralogy of Fallot	187500	AD	3	Gata4
8p23.1	8:11676935-11760002	GATA4, ASD2, VSD1, TACHD, TOF	GATA-binding protein-4	600576	GATA4	2626	ENSG00000136574,ENST00000532059;;;ENST00000532059	mutations identified in 1 TACHD family	Ventricular septal defect 1	614429	AD	3	Gata4
8p23.1	8:11795582-11839298	FDFT1, DGPT, SQSD	Farnesyl-diphosphate farnesyltransferase 1 (squalene synthase)	184420	FDFT1	2222	ENSG00000079459,ENST00000220584;;;ENST00000220584		Squalene synthase deficiency	618156	AR	3	Fdft1
8p23.1	8:11842524-11868087	CTSB, CPSB, RECEUP	Cathepsin B (regulatory element, cis-acting, enhancer upstream of CTSB, included)	116810	CTSB	1508	ENSG00000164733,ENST00000353047;;;ENST00000353047	KWE due to duplication upstream of CTSB that disrupts a cis-acting regulatory element	Keratolytic winter erythema	148370	AD	4	Ctsb
8p22	8:12800001-19200000	ANIB11	Aneurysm, intracranial berry, 11	614252		100750328		max lod at D8S552	Aneurysm, intracranial berry, 11	614252		2	
8p22	8:12800001-19200000	CHDS9	Coronary heart disease, susceptibility to, 9	612030		100188877		max lod at D8S1106	{Coronary heart disease, susceptibility to, 9}	612030		2	
8p22-p21.3	8:12800001-23500000	DFNB71	Deafness, autosomal recessive 71	612789		100302513		max lod at D8S261	Deafness, autosomal recessive 71	612789	AR	2	
8p22	8:13083361-13604620	DLC1	DLC1 Rho GTPase activating protein	604258	DLC1	10395	ENSG00000164741,ENST00000276297;;;ENST00000276297		Colorectal cancer, somatic	114500		3	Dlc1
8p22	8:15417188-15852091	TUSC3, M33, D8S1992, MRT7, MRT22	Tumor suppressor candidate 3	601385	TUSC3	7991	ENSG00000104723,ENST00000503731;;;ENST00000503731		Intellectual developmental disorder, autosomal recessive 7	611093	AR	3	Tusc3
8p22	8:16107881-16192651	MSR1, SCARA1, SRA	Macrophage scavenger receptor	153622	MSR1	4481	ENSG00000038945,ENST00000262101;;;ENST00000262101	~11cM distal to LPL	Barrett esophagus/esophageal adenocarcinoma	614266		3	Msr1
8p22	8:16992181-17002345	FGF20, RHDA2	Fibroblast growth factor-20	605558	FGF20	26281	ENSG00000078579,ENST00000180166;;;ENST00000180166	mutation identified in 1 RHDA2 family	?Renal hypodysplasia/aplasia 2	615721	AR	3	Fgf20
8p22	8:17246958-17333455	VPS37A, HCRP1, SPG53	VPS37A subunit of ESCRIT-I	609927	VPS37A	137492	ENSG00000155975,ENST00000324849;;;ENST00000324849		Spastic paraplegia 53, autosomal recessive	614898	AR	3	Vps37a
8p22	8:17576433-17643144	PDGFRL, PDGRL, PRLTS	Platelet-derived growth factor receptor-like	604584	PDGFRL	5157	ENSG00000104213,ENST00000251630;;;ENST00000251630		Colorectal cancer, somatic	114500		3	Pdgfrl
8p22	8:17576433-17643144	PDGFRL, PDGRL, PRLTS	Platelet-derived growth factor receptor-like	604584	PDGFRL	5157	ENSG00000104213,ENST00000251630;;;ENST00000251630		Hepatocellular cancer, somatic	114550		3	Pdgfrl
8p22	8:18055992-18084961	ASAH1, AC, SMAPME	N-acylsphingosine amidohydrolase (acid ceramidase) 1	613468	ASAH1	427	ENSG00000104763,ENST00000637790;;;ENST00000637790		Farber lipogranulomatosis	228000	AR	3	Asah1
8p22	8:18055992-18084961	ASAH1, AC, SMAPME	N-acylsphingosine amidohydrolase (acid ceramidase) 1	613468	ASAH1	427	ENSG00000104763,ENST00000637790;;;ENST00000637790		Spinal muscular atrophy with progressive myoclonic epilepsy	159950	AR	3	Asah1
8p22	8:18386301-18401218	NAT2, AAC2	Arylamine N-acetyltransferase-2	612182	NAT2	10	ENSG00000156006,ENST00000286479;;;ENST00000286479	acetylation polymorphism	[Acetylation, slow]	243400	AR	3	Nat1,Nat2,Nat3
8p21	8:19200001-29000000	SCZD6	Schizophrenia susceptibility locus, chromosome 8p-related	603013		8400		?neuregulin 1	{Schizophrenia}	181500	AD	2	
8p21.3	8:19404161-19757908	CSGALNACT1, SDJLABA	Chondroitin sulfate N-acetylgalactosaminyltransferase 1	616615	CSGALNACT1	55790	ENSG00000147408,ENST00000692225;;;ENST00000692225		Skeletal dysplasia, mild, with joint laxity and advanced bone age	618870	AR	3	Csgalnact1
8p21.3	8:19939253-19967259	LPL, LIPD, HDLCQ11	Lipoprotein lipase	609708	LPL	4023	ENSG00000175445,ENST00000650287;;;ENST00000650287		[High density lipoprotein cholesterol level QTL 11]	238600	AR	3	Lpl
8p21.3	8:19939253-19967259	LPL, LIPD, HDLCQ11	Lipoprotein lipase	609708	LPL	4023	ENSG00000175445,ENST00000650287;;;ENST00000650287		Combined hyperlipidemia, familial	144250	AD	3	Lpl
8p21.3	8:19939253-19967259	LPL, LIPD, HDLCQ11	Lipoprotein lipase	609708	LPL	4023	ENSG00000175445,ENST00000650287;;;ENST00000650287		Lipoprotein lipase deficiency	238600	AR	3	Lpl
8p21.3	8:20197381-20221696	ATP6V1B2, ATP6B2, VPP3, DOOD, ZLS2	ATPase, H+ transporting, V1 subunit B2	606939	ATP6V1B2	526	ENSG00000147416,ENST00000276390;;;ENST00000276390		Deafness, congenital, with onychodystrophy, autosomal dominant	124480	AD	3	Atp6v1b2
8p21.3	8:20197381-20221696	ATP6V1B2, ATP6B2, VPP3, DOOD, ZLS2	ATPase, H+ transporting, V1 subunit B2	606939	ATP6V1B2	526	ENSG00000147416,ENST00000276390;;;ENST00000276390		Zimmermann-Laband syndrome 2	616455	AD	3	Atp6v1b2
8p21.3	8:20246165-20303963	LZTS1, F37, FEZ1	Leucine zipper, putative tumor suppressor 1	606551	LZTS1	11178	ENSG00000061337,ENST00000381569;;;ENST00000381569		Esophageal squamous cell carcinoma, somatic	133239		3	Lzts1
8p21.3	8:22039672-22048809	FGF17, HH20	Fibroblast growth factor 17	603725	FGF17	8822	ENSG00000158815,ENST00000359441;;;ENST00000359441		Hypogonadotropic hypogonadism 20 with or without anosmia	615270	AD	3	Fgf17
8p21.3	8:22114419-22131052	HR, AU, MUHH1	HR lysine demethylase and nuclear receptor corepressor	602302	HR	55806	ENSG00000168453,ENST00000381418;;;ENST00000381418		Alopecia universalis	203655	AR	3	Hr
8p21.3	8:22114419-22131052	HR, AU, MUHH1	HR lysine demethylase and nuclear receptor corepressor	602302	HR	55806	ENSG00000168453,ENST00000381418;;;ENST00000381418		Atrichia with papular lesions	209500	AR	3	Hr
8p21.3	8:22130458-22131010	HRURF, U2HR	HR upstream open reading frame, U2HR	619257	HRURF	120766137	ENSG00000288677,ENST00000518377;;;ENST00000518377		Hypotrichosis 4	146550	AD	3	
8p21.3	8:22146830-22156806	LGI3, IDDMDS	Leucine-rich gene, glioma-inactivated, 3	608302	LGI3	203190	ENSG00000168481,ENST00000306317;;;ENST00000306317		Intellectual developmental disorder with muscle tone abnormalities and distal skeletal defects	620007	AR	3	Lgi3
8p21.3	8:22157383-22164479	SFTPC, SFTP2, SMDP2	Surfactant, pulmonary-associated protein C (pulmonary surfactant apoprotein-2, SP-C)	178620	SFTPC	6440	ENSG00000168484,ENST00000679463;;;ENST00000679463		Surfactant metabolism dysfunction, pulmonary, 2	610913	AD	3	Sftpc
8p21.3	8:22165372-22212326	BMP1, OI13	Bone morphogenetic protein-1	112264	BMP1	649	ENSG00000168487,ENST00000306385;;;ENST00000306385	1kb 3' to SFTP2	Osteogenesis imperfecta, type XIII	614856	AR	3	Bmp1
8p21.3	8:22367278-22434129	SLC39A14, ZIP14, KIAA0062, HMNDYT2, HCIN	Solute carrier family 39 (zinc transporter), member 14	608736	SLC39A14	23516	ENSG00000104635,ENST00000381237;;;ENST00000381237	mutation identified in 1 HCTN family	?Hyperostosis cranalis interna	144755	AD	3	Slc39a14
8p21.3	8:22367278-22434129	SLC39A14, ZIP14, KIAA0062, HMNDYT2, HCIN	Solute carrier family 39 (zinc transporter), member 14	608736	SLC39A14	23516	ENSG00000104635,ENST00000381237;;;ENST00000381237	mutation identified in 1 HCTN family	Hypermanganesemia with dystonia 2	617013	AR	3	Slc39a14
8p21.3	8:22950813-23020199	RHOBTB2, DBC2, KIAA0717, DEE64	Rho-related BTB domain-containing protein 2	607352	RHOBTB2	23221	ENSG00000008853,ENST00000251822;;;ENST00000251822		Developmental and epileptic encephalopathy 64	618004	AD	3	Rhobtb2
8p21.3	8:23020133-23069031	TNFRSF10B, DR5, TRAILR2	Tumor necrosis factor receptor superfamily, member 10B	603612	TNFRSF10B	8795	ENSG00000120889,ENST00000276431;;;ENST00000276431		Squamous cell carcinoma, head and neck	275355	AR	3	Tnfrsf10b
8p21.2	8:23701740-23706756	NKX2-6, CSX2, CTHM	NK2, Drosophila, homolog of, 6	611770	NKX2-6	137814	ENSG00000180053,ENST00000325017;;;ENST00000325017		Conotruncal heart malformations	217095		3	Nkx2-6
8p21.2	8:23701740-23706756	NKX2-6, CSX2, CTHM	NK2, Drosophila, homolog of, 6	611770	NKX2-6	137814	ENSG00000180053,ENST00000325017;;;ENST00000325017		Persistent truncus arteriosus	217095		3	Nkx2-6
8p21.2	8:24950955-24956612	NEFL, CMT2E, CMT1F, CMTDIG	Neurofilament, light polypeptide	162280	NEFL	4747	ENSG00000277586,ENST00000610854;;;ENST00000610854		Charcot-Marie-Tooth disease, dominant intermediate G	617882	AD	3	Nefl
8p21.2	8:24950955-24956612	NEFL, CMT2E, CMT1F, CMTDIG	Neurofilament, light polypeptide	162280	NEFL	4747	ENSG00000277586,ENST00000610854;;;ENST00000610854		Charcot-Marie-Tooth disease, type 1F	607734	AD, AR	3	Nefl
8p21.2	8:24950955-24956612	NEFL, CMT2E, CMT1F, CMTDIG	Neurofilament, light polypeptide	162280	NEFL	4747	ENSG00000277586,ENST00000610854;;;ENST00000610854		Charcot-Marie-Tooth disease, type 2E	607684	AD	3	Nefl
8p21.2	8:25419258-25425040	GNRH1, LNRH, HH12	Gonadotropin-releasing hormone-1 (luteinizing-releasing hormone)	152760	GNRH1	2796	ENSG00000147437,ENST00000421054;;;ENST00000421054	mutation identified in 1 HH12 family	?Hypogonadotropic hypogonadism 12 with or without anosmia	614841	AR	3	Gnrh1
8p21.2	8:27459756-27479261	CHRNA2	Cholinergic receptor, nicotinic, alpha polypeptide-2	118502	CHRNA2	1135	ENSG00000120903,ENST00000407991;;;ENST00000407991		Epilepsy, nocturnal frontal lobe, type 4	610353	AD	3	Chrna2
8p21.2-p21.1	8:27491143-27548626	EPHX2	Epoxide hydrolase 2, cytoplasmic	132811	EPHX2	2053	ENSG00000120915,ENST00000521400;;;ENST00000521400		{Hypercholesterolemia, familial, due to LDLR defect, modifier of}	143890	AD, AR	3	Ephx2
8p21.1	8:27500001-29000000	GULOP, GULO	Gulonolactone (L-) oxidase pseudogene	240400	GULOP	2989			Scurvy			3	
8p21.1-q13.3	8:27500001-72000000	SPG37	Spastic paraplegia 37	611945		100049159		max lod at D8S601	Spastic paraplegia 37, autosomal dominant	611945	AD	2	
8p21.1	8:27771974-27819660	ESCO2, RBS, JHS	Establishment of sister chromatid cohesion N-acetyltransferase 2	609353	ESCO2	157570	ENSG00000171320,ENST00000305188;;;ENST00000305188		Juberg-Hayward syndrome	216100	AR	3	Esco2
8p21.1	8:27771974-27819660	ESCO2, RBS, JHS	Establishment of sister chromatid cohesion N-acetyltransferase 2	609353	ESCO2	157570	ENSG00000171320,ENST00000305188;;;ENST00000305188		Roberts-SC phocomelia syndrome	268300	AR	3	Esco2
8p21.1	8:28607736-28756562	EXTL3, EXTR1, ISDNA	Exostosin-like 3	605744	EXTL3	2137	ENSG00000012232,ENST00000220562;;;ENST00000220562		Immunoskeletal dysplasia with neurodevelopmental abnormalities	617425	AR	3	Extl3
8p12-q22	8:29000001-105100000	AD12	Alzheimer disease 12	611073		100188830		max lod at D8S1119	{Alzheimer disease 12}	611073		2	
8p12	8:29000001-36700000	THPH9	Thrombophilia due to decreased release of tissue plasminogen activator	612348		137299211			?Thrombophilia 9 due to decreased release of tissue plasminogen	612348		2	
8p12	8:30578318-30658236	GTF2E2, TTD6	General transcription factor IIE, polypeptide 2, beta subunit, 34kD	189964	GTF2E2	2961	ENSG00000197265,ENST00000355904;;;ENST00000355904		Trichothiodystrophy 6, nonphotosensitive	616943	AR	3	Gtf2e2
8p12	8:30678066-30727846	GSR, GSRD, CNSHA10	Glutathione reductase	138300	GSR	2936	ENSG00000104687,ENST00000221130;;;ENST00000221130		Anemia, congenital, nonspherocytic hemolytic, 10, glutathione reductase deficient	618660	AR	3	Gsr
8p12	8:30831544-30913008	TEX15, SPGF25	Testis-expressed gene 15	605795	TEX15	56154	ENSG00000133863,ENST00000643185;;;ENST00000643185		Spermatogenic failure 25	617960	AR	3	Tex15
8p12	8:31033810-31176138	RECQL2, RECQ3, WRN	DNA helicase, RecQ-like 2	604611	WRN	7486	ENSG00000165392,ENST00000298139;;;ENST00000298139		Werner syndrome	277700	AR	3	Wrn
8p12	8:31639245-32774046	NRG1, HGL, HRGA, ARIA	Neuregulin 1 (heregulin, alpha, 45kD; ERBB2 p185-activator)	142445	NRG1	3084	ENSG00000157168,ENST00000405005;;;ENST00000405005		{?Schizophrenia, susceptibility to}	603013		1	Nrg1
8p12	8:33498722-33513135	TTI2, C8orf41, MRT39	TELO2-interacting protein 2	614426	TTI2	80185	ENSG00000129696,ENST00000431156;;;ENST00000431156		Intellectual developmental disorder, autosomal recessive 39	615541	AR	3	Tti2
8p11	8:36700001-45200000	SCLL	Chromosome 8p11 myeloproliferative syndrome (stem cell leukemia/lymphoma)	613523				translocation of FGFR1 (8p11) and various partners	Chromosome 8p11 myeloproliferative syndrome	613523		4	
8p11.23	8:36784374-36936125	KCNU1, SLO3, SPGF79	Potassium channel, subfamily U, member 1	615215	KCNU1	157855	ENSG00000215262,ENST00000399881;;;ENST00000399881		Spermatogenic failure 79	620196	AR	3	Kcnu1
8p11.23	8:37736634-37758422	ERLIN2, SPFH2, C8orf2, SPG18A, SPG18B	Endoplasmic reticulum lipid raft-associated protein 2	611605	ERLIN2	11160	ENSG00000147475,ENST00000519638;;;ENST00000519638		Spastic paraplegia 18A, autosomal dominant	620512	AD	3	Erlin2
8p11.23	8:37736634-37758422	ERLIN2, SPFH2, C8orf2, SPG18A, SPG18B	Endoplasmic reticulum lipid raft-associated protein 2	611605	ERLIN2	11160	ENSG00000147475,ENST00000519638;;;ENST00000519638		Spastic paraplegia 18B, autosomal recessive	611225	AR	3	Erlin2
8p11.23	8:37762546-37779768	PLPBP, PROSC, EPVB6D, EPEO1	Pyridoxal phosphate-binding protein	604436	PLPBP	11212	ENSG00000147471,ENST00000328195;;;ENST00000328195		Epilepsy, early-onset, 1, vitamin B6-dependent	617290	AR	3	Plpbp
8p11.23	8:37962990-37966599	ADRB3	Adrenergic, beta-3-, receptor	109691	ADRB3	155	ENSG00000188778,ENST00000345060;;;ENST00000345060		{Obesity, susceptibility to}	601665	AD, AR, Mu	3	Adrb3
8p11.23	8:38142700-38150952	STAR	Steroidogenic acute regulatory protein	600617	STAR	6770	ENSG00000147465,ENST00000276449;;;ENST00000276449		Lipoid adrenal hyperplasia	201710	AR	3	Star
8p11.23	8:38163321-38176730	LSM1, CASM, FICUS	LSM1 homolog, mRNA degradation-associated	607281	LSM1	27257	ENSG00000175324,ENST00000311351;;;ENST00000311351		FICUS syndrome	621193	AR	3	Lsm1
8p11.23	8:38231585-38273647	DDHD2, KIAA0725, SPG54	DDHD domain-containing protein 2	615003	DDHD2	23259	ENSG00000085788,ENST00000397166;;;ENST00000397166		Spastic paraplegia 54, autosomal recessive	615033	AR	3	Ddhd2
8p11.23	8:38411143-38468635	FGFR1, FLT2, OGD, KAL2, HH2, HRTFDS, ECCL	Fibroblast growth factor receptor-1 (fms-related tyrosine kinase-2)	136350	FGFR1	2260	ENSG00000077782,ENST00000447712;;;ENST00000447712	fused with BCR, CEP1, FOP, FIM in hematologic malignancies	Encephalocraniocutaneous lipomatosis, somatic mosaic	613001		3	Fgfr1
8p11.23	8:38411143-38468635	FGFR1, FLT2, OGD, KAL2, HH2, HRTFDS, ECCL	Fibroblast growth factor receptor-1 (fms-related tyrosine kinase-2)	136350	FGFR1	2260	ENSG00000077782,ENST00000447712;;;ENST00000447712	fused with BCR, CEP1, FOP, FIM in hematologic malignancies	Hartsfield syndrome	615465	AD	3	Fgfr1
8p11.23	8:38411143-38468635	FGFR1, FLT2, OGD, KAL2, HH2, HRTFDS, ECCL	Fibroblast growth factor receptor-1 (fms-related tyrosine kinase-2)	136350	FGFR1	2260	ENSG00000077782,ENST00000447712;;;ENST00000447712	fused with BCR, CEP1, FOP, FIM in hematologic malignancies	Hypogonadotropic hypogonadism 2 with or without anosmia	147950	AD	3	Fgfr1
8p11.23	8:38411143-38468635	FGFR1, FLT2, OGD, KAL2, HH2, HRTFDS, ECCL	Fibroblast growth factor receptor-1 (fms-related tyrosine kinase-2)	136350	FGFR1	2260	ENSG00000077782,ENST00000447712;;;ENST00000447712	fused with BCR, CEP1, FOP, FIM in hematologic malignancies	Jackson-Weiss syndrome	123150	AD	3	Fgfr1
8p11.23	8:38411143-38468635	FGFR1, FLT2, OGD, KAL2, HH2, HRTFDS, ECCL	Fibroblast growth factor receptor-1 (fms-related tyrosine kinase-2)	136350	FGFR1	2260	ENSG00000077782,ENST00000447712;;;ENST00000447712	fused with BCR, CEP1, FOP, FIM in hematologic malignancies	Osteoglophonic dysplasia	166250	AD	3	Fgfr1
8p11.23	8:38411143-38468635	FGFR1, FLT2, OGD, KAL2, HH2, HRTFDS, ECCL	Fibroblast growth factor receptor-1 (fms-related tyrosine kinase-2)	136350	FGFR1	2260	ENSG00000077782,ENST00000447712;;;ENST00000447712	fused with BCR, CEP1, FOP, FIM in hematologic malignancies	Pfeiffer syndrome	101600	AD	3	Fgfr1
8p11.23	8:38411143-38468635	FGFR1, FLT2, OGD, KAL2, HH2, HRTFDS, ECCL	Fibroblast growth factor receptor-1 (fms-related tyrosine kinase-2)	136350	FGFR1	2260	ENSG00000077782,ENST00000447712;;;ENST00000447712	fused with BCR, CEP1, FOP, FIM in hematologic malignancies	Trigonocephaly 1	190440	AD	3	Fgfr1
8p11.22	8:38996973-39105261	ADAM9, MDC9, MCMP, CORD9	ADAM metallopeptidase domain 9	602713	ADAM9	8754	ENSG00000168615,ENST00000487273;;;ENST00000487273		Cone-rod dystrophy 9	612775	AR	3	Adam9
8p11.21	8:41653225-41896741	ANK1, SPH1	Ankyrin-1, erythrocytic	612641	ANK1	286	ENSG00000029534,ENST00000289734;;;ENST00000289734		Spherocytosis, type 1	182900	AD, AR	3	Ank1
8p11.21	8:41929479-42051987	KAT6A, MYST3, MOZ, ZNF220, ARTHS	K(lysine) acetyltransferase 6A	601408	KAT6A	7994	ENSG00000083168,ENST00000265713;;;ENST00000265713		Arboleda-Tham syndrome	616268	AD	3	Kat6a
8p11.21	8:42271302-42332460	IKBKB, NFKBIKB, IMD15B, IMD15A	Inhibitor of nuclear factor kappa-B kinase, subunit beta	603258	IKBKB	3551	ENSG00000104365,ENST00000520810;;;ENST00000520810		Immunodeficiency 15A	618204	AD	3	Ikbkb
8p11.21	8:42271302-42332460	IKBKB, NFKBIKB, IMD15B, IMD15A	Inhibitor of nuclear factor kappa-B kinase, subunit beta	603258	IKBKB	3551	ENSG00000104365,ENST00000520810;;;ENST00000520810		Immunodeficiency 15B	615592	AR	3	Ikbkb
8p11.21	8:42416475-42541954	SLC20A2, MLVAR, GLVR2, IBGC1, IBGC2	Solute carrier family 20, phosphate transporter, member 2	158378	SLC20A2	6575	ENSG00000168575,ENST00000520262;;;ENST00000520262		Basal ganglia calcification, idiopathic, 1	213600	AD	3	Slc20a2
8p11.21	8:42836674-42843325	THAP1, DYT6	THAP domain-containing protein 1	609520	THAP1	55145	ENSG00000131931,ENST00000254250;;;ENST00000254250		Dystonia 6, torsion	602629	AD	3	Thap1
8p11.21	8:42849637-42897299	RNF170, SNAX1, SPG85	RING finger protein 170	614649	RNF170	81790	ENSG00000120925,ENST00000527424;;;ENST00000527424		Ataxia, sensory, 1, autosomal dominant	608984	AD	3	Rnf170
8p11.21	8:42849637-42897299	RNF170, SNAX1, SPG85	RING finger protein 170	614649	RNF170	81790	ENSG00000120925,ENST00000527424;;;ENST00000527424		Spastic paraplegia 85, autosomal recessive	619686	AR	3	Rnf170
8p11.21	8:43093515-43123434	POMK, SGK196, MDDGA12, MDDGC12	Protein-O-mannose kinase	615247	POMK	84197	ENSG00000185900,ENST00000331373;;;ENST00000331373	mutation in 1 MDDGC12 family has been reported	?Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 12	616094	AR	3	Pomk
8p11.21	8:43093515-43123434	POMK, SGK196, MDDGA12, MDDGC12	Protein-O-mannose kinase	615247	POMK	84197	ENSG00000185900,ENST00000331373;;;ENST00000331373	mutation in 1 MDDGC12 family has been reported	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 12	615249	AR	3	Pomk
8p11.21-p11.1	8:43140464-43202855	HGSNAT, TMEM76, MPS3C, RP73	Heparan-alpha-glucosaminide N-acetyltransferase	610453	HGSNAT	138050	ENSG00000165102,ENST00000379644;;;ENST00000379644		Mucopolysaccharidosis type IIIC (Sanfilippo C)	252930	AR	3	Hgsnat
8p11.21-p11.1	8:43140464-43202855	HGSNAT, TMEM76, MPS3C, RP73	Heparan-alpha-glucosaminide N-acetyltransferase	610453	HGSNAT	138050	ENSG00000165102,ENST00000379644;;;ENST00000379644		Retinitis pigmentosa 73	616544	AR	3	Hgsnat
8q	8:45200001-145138636	CCAL1	Chondrocalcinosis 1	600668		882			Chondrocalcinosis with early-onset osteoarthritis	600668	AD	2	
8q	8:45200001-145138636	HBFQTL4	Fetal hemoglobin quantitative trait locus 4	606789		171515			Fetal hemoglobin quantitative trait locus 4	606789		2	
8q11.1-q13.3	8:45200001-72000000	PAFC	Preauricular fistulae, congenital	128700		404715		between D8S532 and D8S279	?Preauricular fistulae, congenital	128700	AD	2	
8q11.2-q13.2	8:47200001-69600000	GCCD3, FGD3, GCCD2	Glucocorticoid deficiency 3	609197		619477		between D8S285 and D8S1718	Glucocorticoid deficiency 3	609197	AR	2	
8q11.21	8:47260878-47736306	SPIDR, KIAA0146, ODG9	Scaffolding protein involved in DNA repair	615384	SPIDR	23514	ENSG00000164808,ENST00000297423;;;ENST00000297423		Ovarian dysgenesis 9	619665	AR	3	Spidr
8q11.21	8:47773111-47960136	PRKDC, HYRC1, DNPK1, IMD26	Protein kinase, DNA-activated, catalytic polypeptide (hyperradiosensitivity of murine SCID mutation, complementing-1)	600899	PRKDC	5591	ENSG00000253729,ENST00000314191;;;ENST00000314191		Immunodeficiency 26, with or without neurologic abnormalities	615966	AR	3	Prkdc
8q11.21	8:47960941-47978160	MCM4, NKGCD, NKCD, IMD54	Minichromosome maintenance complex component 4	602638	MCM4	4173	ENSG00000104738,ENST00000649973;;;ENST00000649973		Immunodeficiency 54	609981	AR	3	Mcm4
8q11.21	8:48710789-48735311	CLXN, EFCAB1, CILD53	Calaxin	619564	CLXN	79645	ENSG00000034239,ENST00000262103;;;ENST00000262103		Ciliary dyskinesia, primary, 53	620642	AR	3	Clxn
8q11.23	8:52622458-52714435	RB1CC1, CC1, KIAA0203	RB1-inducible coiled-coil 1	606837	RB1CC1	9821	ENSG00000023287,ENST00000025008;;;ENST00000025008		Breast cancer, somatic	114480		3	Rb1cc1
8q11.23	8:54457935-54460892	SOX17, VUR3, PPH7	SRY-box 17	610928	SOX17	64321	ENSG00000164736,ENST00000297316;;;ENST00000297316		Pulmonary hypertension, primary, 7	621248	AD	3	Sox17
8q11.23	8:54457935-54460892	SOX17, VUR3, PPH7	SRY-box 17	610928	SOX17	64321	ENSG00000164736,ENST00000297316;;;ENST00000297316		Vesicoureteral reflux 3	613674	AD	3	Sox17
8q11.23-q12.1	8:54559185-54871234	RP1, ORP1	RP1 axonemal microtubule-associated protein	603937	RP1	6101	ENSG00000104237,ENST00000220676;;;ENST00000220676		Retinitis pigmentosa 1	180100	AD, AR	3	Rp1
8q12.1	8:54600001-60600000	ANIB10	Aneurysm, intracranial berry, 10	612587		100271689		associated with rs10958409	{Aneurysm, intracranial berry, 10}	612587		2	
8q12	8:54600001-65100000	IS3	Scoliosis, isolated, susceptibility to, 3	608765					{Scoliosis, isolated, susceptibility to, 3}	608765		2	
8q12-q13	8:54600001-72000000	MTBS2	Mycobacterium tuberculosis, susceptibility to, 2	611046		100188829		max lod at D8S1723	{Mycobacterium tuberculosis, susceptibility to, 2}	611046		2	
8q12.1	8:55879835-56014169	LYN, SAIDV	LYN protooncogene, SRC family tyrosine kinase	165120	LYN	4067	ENSG00000254087,ENST00000519728;;;ENST00000519728		Autoinflammatory disease, systemic, with vasculitis	620376	AD	3	Lyn
8q12.1	8:56112942-56113982	MOS, MSV, OZEMA20	MOS protooncogene, serine/threonine kinase	190060	MOS	4342	ENSG00000172680,ENST00000311923;;;ENST00000311923		Oocyte/zygote/embryo maturation arrest 20	620383	AR	3	Mos
8q12.1	8:56160909-56211273	PLAG1, SGPA, PSA, SRS4	PLAG1 zinc finger protein	603026	PLAG1	5324	ENSG00000181690,ENST00000316981;;;ENST00000316981	fused with CTNNB1 in SGPA	Adenomas, salivary gland pleomorphic, somatic	181030		3	Plag1
8q12.1	8:56160909-56211273	PLAG1, SGPA, PSA, SRS4	PLAG1 zinc finger protein	603026	PLAG1	5324	ENSG00000181690,ENST00000316981;;;ENST00000316981	fused with CTNNB1 in SGPA	Silver-Russell syndrome 4	618907	AD	3	Plag1
8q12.1	8:56957931-56993867	IMPAD1, GPAPP, IMPA3	Inositol monophosphatase domain-containing protein 1	614010	BPNT2	54928	ENSG00000104331,ENST00000262644;;;ENST00000262644		Chondrodysplasia with joint dislocations, GPAPP type	614078	AR	3	Bpnt2
8q12.1	8:60185412-60281400	CA8, CALS, CARP, SCAR34	Carbonic anhydrase VIII	114815	CA8	767	ENSG00000178538,ENST00000317995;;;ENST00000317995		Spinocerebellar ataxia, autosomal recessive 34	613227	AR	3	Car8
8q12.2-q21.2	8:60600001-85900000	DEL8q12q21, C8DELq12q21	Bor-Duane hydrocephalus contiguous gene syndrome (chromosome 8q12.1-q21.2 deletion syndrome)	600257					Bor-Duane hydrocephalus contiguous gene syndrome	600257	AD	4	
8q12.2-q21.2	8:60600001-85900000	HDCPH1	Hydrocephalus, autosomal dominant	123155		137299210			?Hydrocephalus, autosomal dominant	123155	AD	2	
8q12.2	8:60678740-60868028	CHD7, HH5	Chromodomain helicase DNA binding protein 7	608892	CHD7	55636	ENSG00000171316,ENST00000423902;;;ENST00000423902		CHARGE syndrome	214800	AD	3	Chd7
8q12.2	8:60678740-60868028	CHD7, HH5	Chromodomain helicase DNA binding protein 7	608892	CHD7	55636	ENSG00000171316,ENST00000423902;;;ENST00000423902		Hypogonadotropic hypogonadism 5 with or without anosmia	612370	AD	3	Chd7
8q12.3	8:61500556-61714592	ASPH, HAAH, FDLAB	Aspartate beta-hydroxylase (junctin; junctate)	600582	ASPH	444	ENSG00000198363,ENST00000379454;;;ENST00000379454		Traboulsi syndrome	601552	AR	3	Asph
8q12.3	8:63058409-63086053	TTPA, TTP1, AVED	Tocopherol, alpha, transfer protein	600415	TTPA	7274	ENSG00000137561,ENST00000260116;;;ENST00000260116		Ataxia with isolated vitamin E deficiency	277460	AR	3	Ttpa
8q12.3	8:64586575-64798737	CYP7B1, CBAS3, SPG5A	Cytochrome P450, subfamily VIIB (oxysterol 7-alpha-hydroxylase), polypeptide 1	603711	CYP7B1	9420	ENSG00000172817,ENST00000310193;;;ENST00000310193		Bile acid synthesis defect, congenital, 3	613812	AR	3	Cyp7b1
8q12.3	8:64586575-64798737	CYP7B1, CBAS3, SPG5A	Cytochrome P450, subfamily VIIB (oxysterol 7-alpha-hydroxylase), polypeptide 1	603711	CYP7B1	9420	ENSG00000172817,ENST00000310193;;;ENST00000310193		Spastic paraplegia 5A, autosomal recessive	270800	AR	3	Cyp7b1
8q13-q23	8:65100001-116700000	CMT2H	Charcot-Marie-Tooth disease, axonal, type 2H	607731		619496		between D8S1807 and D8S548	Charcot-Marie-Tooth disease, axonal, type 2H	607731	AR	2	
8q13	8:65100001-72000000	DEL8q13, C8DELq13	Mesomelia-synostoses syndrome (Chromosome 8q13 deletion syndrome)	600383				contiguous gene deletion of SULF1 and SLCO5A1	Mesomelia-synostoses syndrome	600383	AD	4	
8q13	8:65100001-72000000	DURS1, DUS	Duane retraction syndrome 1	126800		10674			Duane retraction syndrome 1	126800	AD	2	
8q13-q21	8:65100001-92300000	FEB1	Febrile seizures, familial, 1	121210		2233			Febrile seizures, familial, 1	121210	AD	2	
8q13.1-q13.2	8:67064368-67196614	CSPP1, CSPP, JBTS21	Centrosome spindle pole-associated protein 1	611654	CSPP1	79848	ENSG00000104218,ENST00000678616;;;ENST00000678616		Joubert syndrome 21	615636	AR	3	Cspp1
8q13.2	8:67173511-67343781	ARFGEF1, ARFGEP1, BIG1, P200, DEDISB	ADP-ribosylation factor guanine nucleotide exchange factor 1	604141	ARFGEF1	10565	ENSG00000066777,ENST00000262215;;;ENST00000262215		Developmental delay, impaired speech, and behavioral abnormalities, with or without seizures	619964	AD	3	Arfgef1
8q13.2	8:67422038-67746360	CPA6, CPAH, ETL5, FEB11	Carboxypeptidase A6	609562	CPA6	57094	ENSG00000165078,ENST00000297770;;;ENST00000297770		Epilepsy, familial temporal lobe, 5	614417	AD, AR	3	Cpa6
8q13.2	8:67422038-67746360	CPA6, CPAH, ETL5, FEB11	Carboxypeptidase A6	609562	CPA6	57094	ENSG00000165078,ENST00000297770;;;ENST00000297770		Febrile seizures, familial, 11	614418	AR	3	Cpa6
8q13.3	8:71197433-71548094	EYA1, BOR, BOS1, OTFCS	EYA transcriptional coactivator and phosphatase 1	601653	EYA1	2138	ENSG00000104313,ENST00000340726;;;ENST00000340726	mutation identified in 1 OTFCS family	?Otofaciocervical syndrome	166780	AD	3	Eya1
8q13.3	8:71197433-71548094	EYA1, BOR, BOS1, OTFCS	EYA transcriptional coactivator and phosphatase 1	601653	EYA1	2138	ENSG00000104313,ENST00000340726;;;ENST00000340726	mutation identified in 1 OTFCS family	Anterior segment anomalies with or without cataract	602588	AD	3	Eya1
8q13.3	8:71197433-71548094	EYA1, BOR, BOS1, OTFCS	EYA transcriptional coactivator and phosphatase 1	601653	EYA1	2138	ENSG00000104313,ENST00000340726;;;ENST00000340726	mutation identified in 1 OTFCS family	Branchiootic syndrome 1	602588	AD	3	Eya1
8q13.3	8:71197433-71548094	EYA1, BOR, BOS1, OTFCS	EYA transcriptional coactivator and phosphatase 1	601653	EYA1	2138	ENSG00000104313,ENST00000340726;;;ENST00000340726	mutation identified in 1 OTFCS family	Branchiootorenal syndrome 1, with or without cataracts	113650	AD	3	Eya1
8q21.11	8:72000001-74600000	DEL8q21.11, C8DELq21.11	Chromosome 8q21.11 deletion syndrome	614230				contiguous gene deletion; minimal region (GRCh37, 8:77226464-77766239)	Chromosome 8q21.11 deletion syndrome	614230	AD, IC	4	
8q21-q22	8:72000001-105100000	OPA6	Optic atrophy 6	258500		777778		between D8S1702 and D8S1794	Optic atrophy 6	258500	AR	2	
8q21.11	8:72021250-72090010	TRPA1, ANKTM1, FEPS1	Transient receptor potential cation channel, subfamily A, member 1	604775	TRPA1	8989	ENSG00000104321,ENST00000262209;;;ENST00000262209	mutation identified in 1 FEPS1 family	?Episodic pain syndrome, familial, 1	615040	AD	3	Trpa1
8q21.11	8:73976195-73982783	TMEM70, MC5DN2	Transmembrane protein 70	612418	TMEM70	54968	ENSG00000175606,ENST00000312184;;;ENST00000312184		Mitochondrial complex V (ATP synthase) deficiency, nuclear type 2	614052	AR	3	Tmem70
8q21.11	8:74234700-74321540	JPH1, JP1, CMT2K, CMYO25	Junctophilin 1	605266	JPH1	56704	ENSG00000104369,ENST00000342232;;;ENST00000342232	mutation identified in 1 CMT2Km family	{?Charcot-Marie-Tooth disease, axonal, autosomal dominant, type 2K, modifier of}	607831	AD, AR	3	Jph1
8q21.11	8:74234700-74321540	JPH1, JP1, CMT2K, CMYO25	Junctophilin 1	605266	JPH1	56704	ENSG00000104369,ENST00000342232;;;ENST00000342232	mutation identified in 1 CMT2Km family	Congenital myopathy 25	620964	AR	3	Jph1
8q21.11	8:74350403-74488872	GDAP1, CMT4A, CMT2K, CMTRIA	Ganglioside-induced differentiation-associated protein 1	606598	GDAP1	54332	ENSG00000104381,ENST00000220822;;;ENST00000220822		Charcot-Marie-Tooth disease, axonal, type 2K	607831	AD, AR	3	Gdap1
8q21.11	8:74350403-74488872	GDAP1, CMT4A, CMT2K, CMTRIA	Ganglioside-induced differentiation-associated protein 1	606598	GDAP1	54332	ENSG00000104381,ENST00000220822;;;ENST00000220822		Charcot-Marie-Tooth disease, axonal, with vocal cord paresis	607706	AR	3	Gdap1
8q21.11	8:74350403-74488872	GDAP1, CMT4A, CMT2K, CMTRIA	Ganglioside-induced differentiation-associated protein 1	606598	GDAP1	54332	ENSG00000104381,ENST00000220822;;;ENST00000220822		Charcot-Marie-Tooth disease, recessive intermediate, A	608340	AR	3	Gdap1
8q21.11	8:74350403-74488872	GDAP1, CMT4A, CMT2K, CMTRIA	Ganglioside-induced differentiation-associated protein 1	606598	GDAP1	54332	ENSG00000104381,ENST00000220822;;;ENST00000220822		Charcot-Marie-Tooth disease, type 4A	214400	AR	3	Gdap1
8q21.13	8:74700001-83500000	STQTL15	Stature quantitative trait locus 15	612578		100270801		associated with rs2220456	{Stature QTL 15}	612578		2	
8q21.13	8:76980258-77001044	PEX2, PAF1, PMP35, PBD5A, PBD5B, PXMP3	Peroxisome biogenesis factor 2	170993	PEX2	5828	ENSG00000164751,ENST00000357039;;;ENST00000357039		Peroxisome biogenesis disorder 5A (Zellweger)	614866	AR	3	Pex2
8q21.13	8:76980258-77001044	PEX2, PAF1, PMP35, PBD5A, PBD5B, PXMP3	Peroxisome biogenesis factor 2	170993	PEX2	5828	ENSG00000164751,ENST00000357039;;;ENST00000357039		Peroxisome biogenesis disorder 5B	614867	AR	3	Pex2
8q21.13	8:78675044-78805463	IL7, IMD130	Interleukin-7	146660	IL7	3574	ENSG00000104432,ENST00000263851;;;ENST00000263851		Immunodeficiency 130 with HPV-related verrucosis	618309	AR	3	Il7
8q21.13	8:79918717-80030259	MRPS28, MRPS35, COXPD47	Mitochondrial ribosomal protein S28	611990	MRPS28	28957	ENSG00000147586,ENST00000276585;;;ENST00000276585	mutation identified in 1 COXPD47 patient	?Combined oxidative phosphorylation deficiency 47	618958	AR	3	Mrps28
8q21.13	8:81440326-81447439	PMP2, CMT1G	Peripheral myelin protein-2	170715	PMP2	5375	ENSG00000147588,ENST00000256103;;;ENST00000256103		Charcot-Marie-Tooth disease, demyelinating, type 1G	618279	AD	3	Pmp2
8q21.13	8:81656914-81686325	IMPA1, MRT59	Inositol(myo)-1(or 4)-monophosphatase-1	602064	IMPA1	3612	ENSG00000133731,ENST00000256108;;;ENST00000256108		Intellectual developmental disorder, autosomal recessive 59	617323	AR	3	Impa1
8q21.2	8:85464007-85481493	CA2	Carbonic anhydrase II	611492	CA2	760	ENSG00000104267,ENST00000285379;;;ENST00000285379	CA1, CA2 linked in monkey and mouse	Osteopetrosis, autosomal recessive 3, with renal tubular acidosis	259730	AR	3	Car2
8q21.3	8:86574179-86743634	CNGB3, ACHM3, ACHM1	Cyclic nucleotide-gated channel, beta-3	605080	CNGB3	54714	ENSG00000170289,ENST00000320005;;;ENST00000320005		Achromatopsia 3	262300	AR	3	Cngb3
8q21.3	8:89933331-89984667	NBN, NBS1	Nibrin	602667	NBN	4683	ENSG00000104320,ENST00000265433;;;ENST00000265433		Aplastic anemia	609135		3	Nbn
8q21.3	8:89933331-89984667	NBN, NBS1	Nibrin	602667	NBN	4683	ENSG00000104320,ENST00000265433;;;ENST00000265433		Leukemia, acute lymphoblastic	613065		3	Nbn
8q21.3	8:89933331-89984667	NBN, NBS1	Nibrin	602667	NBN	4683	ENSG00000104320,ENST00000265433;;;ENST00000265433		Nijmegen breakage syndrome	251260	AR	3	Nbn
8q21.3	8:91070344-91087093	OTUD6B, DUBA5, IDDFSDA	OTU domain-containing protein 6B	612021	OTUD6B	51633	ENSG00000155100,ENST00000404789;;;ENST00000404789		Intellectual developmental disorder with dysmorphic facies, seizures, and distal limb anomalies	617452	AR	3	Otud6b
8q22	8:92300001-105100000	DFNB118	Deafness, autosomal recessive 118, with cochlear aplasia	619553				deletion of 200kb downstream of GDF6	Deafness, autosomal recessive 118, with cochlear aplasia	619553	AR	4	
8q22.1	8:92300001-97900000	DUP8q22.1, C8DUPq22.1	Chromosome 8q22.1 duplication syndrome (Leri pleonosteosis)	151200				duplication of 0.9-1.2 Mb on 8q22.1	Leri pleonosteosis chromosome duplication syndrome	151200	AD	4	
8q22	8:92300001-105100000	HTC1	Hypertrichosis universalis congenita, Ambras type	145701		3341			?Hypertrichosis universalis congenita, Ambras type	145701	AD	2	
8q22.1	8:92300001-97900000	NMLFS, DEL8q22.1, C8DELq22.1	Nablus mask-like facial syndrome (chromosome 8q22.1 deletion syndrome)	608156					Nablus mask-like facial syndrome	608156	AD	4	
8q22.1	8:93700550-93731527	CIBAR1, FAM92A, FAM92A1, PAPA9	CBY1 interacting BAR domain contain 1	617273	CIBAR1	137392	ENSG00000188343,ENST00000518322;;;ENST00000518322	mutation identified in 1 PAPA9 family	?Polydactyly, postaxial, type A9	618219	AR	3	Cibar1
8q22.1	8:93754844-93832653	TMEM67, MKS3, JBTS6, NPHP11	Transmembrane protein 67 (meckelin)	609884	TMEM67	91147	ENSG00000164953,ENST00000453321;;;ENST00000453321	mutation identified in 1 RHYNS patient	?RHYNS syndrome	602152	AR	3	Tmem67
8q22.1	8:93754844-93832653	TMEM67, MKS3, JBTS6, NPHP11	Transmembrane protein 67 (meckelin)	609884	TMEM67	91147	ENSG00000164953,ENST00000453321;;;ENST00000453321	mutation identified in 1 RHYNS patient	{Bardet-Biedl syndrome 14, modifier of}	615991	AR	3	Tmem67
8q22.1	8:93754844-93832653	TMEM67, MKS3, JBTS6, NPHP11	Transmembrane protein 67 (meckelin)	609884	TMEM67	91147	ENSG00000164953,ENST00000453321;;;ENST00000453321	mutation identified in 1 RHYNS patient	COACH syndrome 1	216360	AR	3	Tmem67
8q22.1	8:93754844-93832653	TMEM67, MKS3, JBTS6, NPHP11	Transmembrane protein 67 (meckelin)	609884	TMEM67	91147	ENSG00000164953,ENST00000453321;;;ENST00000453321	mutation identified in 1 RHYNS patient	Joubert syndrome 6	610688	AR	3	Tmem67
8q22.1	8:93754844-93832653	TMEM67, MKS3, JBTS6, NPHP11	Transmembrane protein 67 (meckelin)	609884	TMEM67	91147	ENSG00000164953,ENST00000453321;;;ENST00000453321	mutation identified in 1 RHYNS patient	Meckel syndrome 3	607361	AR	3	Tmem67
8q22.1	8:93754844-93832653	TMEM67, MKS3, JBTS6, NPHP11	Transmembrane protein 67 (meckelin)	609884	TMEM67	91147	ENSG00000164953,ENST00000453321;;;ENST00000453321	mutation identified in 1 RHYNS patient	Nephronophthisis 11	613550	AR	3	Tmem67
8q22.1	8:93916923-93926068	PDP1, PPM2C, PDPC	Pyruvate dehydrogenase phosphatase catalytic subunit 1	605993	PDP1	54704	ENSG00000164951,ENST00000297598;;;ENST00000297598		Pyruvate dehydrogenase phosphatase deficiency	608782	AR	3	Pdp1
8q22.1	8:94371960-94475115	RAD54B	RAD54 homolog B	604289	RAD54B	25788	ENSG00000197275,ENST00000336148;;;ENST00000336148		Colon cancer, somatic	114500		3	Rad54b
8q22.1	8:94371960-94475115	RAD54B	RAD54 homolog B	604289	RAD54B	25788	ENSG00000197275,ENST00000336148;;;ENST00000336148		Lymphoma, non-Hodgkin, somatic	605027		3	Rad54b
8q22.1	8:94641174-94707466	ESRP1, RMB35A, DFNB109	Epithelial splicing regulatory protein 1	612959	ESRP1	54845	ENSG00000104413,ENST00000433389;;;ENST00000433389	mutation identified in 1 DFNB109 family	?Deafness, autosomal recessive 109	618013	AR	3	Esrp1
8q22.1	8:94823287-94881746	INTS8, INT8, NEDCHS	Integrator complex subunit 8	611351	INTS8	55656	ENSG00000164941,ENST00000523731;;;ENST00000523731	mutation identified in 1 NEDCHS family	?Neurodevelopmental disorder with cerebellar hypoplasia and spasticity	618572	AR	3	Ints8
8q22.1	8:94895799-95118496	NDUFAF6, C8orf38, MC1DN17, FRTS5	NADH-ubiquinone oxidoreductase complex assembly factor 6	612392	NDUFAF6	137682	ENSG00000156170,ENST00000396124;;;ENST00000396124		Fanconi renotubular syndrome 5	618913	AR	3	Ndufaf6
8q22.1	8:94895799-95118496	NDUFAF6, C8orf38, MC1DN17, FRTS5	NADH-ubiquinone oxidoreductase complex assembly factor 6	612392	NDUFAF6	137682	ENSG00000156170,ENST00000396124;;;ENST00000396124		Mitochondrial complex I deficiency, nuclear type 17	618239	AR	3	Ndufaf6
8q22.1	8:95244913-95269201	CFAP418, C8orf37, CORD16, RP64, BBS21	Cilia- and flagella-associated protein 418	614477	CFAP418	157657	ENSG00000156172,ENST00000286688;;;ENST00000286688		Bardet-Biedl syndrome 21	617406	AR	3	Cfap418
8q22.1	8:95244913-95269201	CFAP418, C8orf37, CORD16, RP64, BBS21	Cilia- and flagella-associated protein 418	614477	CFAP418	157657	ENSG00000156172,ENST00000286688;;;ENST00000286688		Cone-rod dystrophy 16	614500	AR	3	Cfap418
8q22.1	8:95244913-95269201	CFAP418, C8orf37, CORD16, RP64, BBS21	Cilia- and flagella-associated protein 418	614477	CFAP418	157657	ENSG00000156172,ENST00000286688;;;ENST00000286688		Retinitis pigmentosa 64	614500	AR	3	Cfap418
8q22.1	8:96142333-96160806	GDF6, MCOP4, KFS1, MCOPCB6, LCA17, SYNS4	Growth/differentiation factor 6	601147	GDF6	392255	ENSG00000156466,ENST00000287020;;;ENST00000287020		Klippel-Feil syndrome 1, autosomal dominant	118100	AD	3	Gdf6
8q22.1	8:96142333-96160806	GDF6, MCOP4, KFS1, MCOPCB6, LCA17, SYNS4	Growth/differentiation factor 6	601147	GDF6	392255	ENSG00000156466,ENST00000287020;;;ENST00000287020		Leber congenital amaurosis 17	615360	AR	3	Gdf6
8q22.1	8:96142333-96160806	GDF6, MCOP4, KFS1, MCOPCB6, LCA17, SYNS4	Growth/differentiation factor 6	601147	GDF6	392255	ENSG00000156466,ENST00000287020;;;ENST00000287020		Microphthalmia with coloboma 6, digenic	613703	AD	3	Gdf6
8q22.1	8:96142333-96160806	GDF6, MCOP4, KFS1, MCOPCB6, LCA17, SYNS4	Growth/differentiation factor 6	601147	GDF6	392255	ENSG00000156466,ENST00000287020;;;ENST00000287020		Microphthalmia, isolated 4	613094		3	Gdf6
8q22.1	8:96142333-96160806	GDF6, MCOP4, KFS1, MCOPCB6, LCA17, SYNS4	Growth/differentiation factor 6	601147	GDF6	392255	ENSG00000156466,ENST00000287020;;;ENST00000287020		Multiple synostoses syndrome 4	617898	AD	3	Gdf6
8q22.1	8:96222947-96235545	UQCRB, UQBP, QPC, MC3DN3	Ubiquinol-cytochrome c reductase binding protein	191330	UQCRB	7381	ENSG00000156467,ENST00000287022;;;ENST00000287022		Mitochondrial complex III deficiency, nuclear type 3	615158	AR	3	Uqcrb
8q22.1	8:96261902-96336995	PTDSS1, PSS1, KIAA0024, LMHD	Phosphatidylserine synthase 1	612792	PTDSS1	9791	ENSG00000156471,ENST00000517309;;;ENST00000517309		Lenz-Majewski hyperostotic dwarfism	151050	AD	3	Ptdss1
8q22.2	8:98117293-98159835	POP1, ANXD2	POP1 homolog, ribonuclease P/MRP subunit	602486	POP1	10940	ENSG00000104356,ENST00000401707;;;ENST00000401707		Anauxetic dysplasia 2	617396	AR	3	Pop1
8q22.2	8:99013274-99877580	VPS13B, KIAA0532, COH1	Vacuolar protein sorting 12 homolog B	607817	VPS13B	157680	ENSG00000132549,ENST00000357162;;;ENST00000357162		Cohen syndrome	216550	AR	3	Vps13b
8q22.2	8:100133351-100150569	FBXO43, EMI2, ERP1, FBX43, SPGF64, OZEMA12	F-box only protein 43	609110	FBXO43	286151	ENSG00000156509,ENST00000428847;;;ENST00000428847		Oocyte/zygote/embryo maturation arrest 12	619697	AR	3	Fbxo43
8q22.2	8:100133351-100150569	FBXO43, EMI2, ERP1, FBX43, SPGF64, OZEMA12	F-box only protein 43	609110	FBXO43	286151	ENSG00000156509,ENST00000428847;;;ENST00000428847		Spermatogenic failure 64	619696	AR	3	Fbxo43
8q22.2	8:100158038-100241904	SPAG1, CILD28	Sperm-associated antigen-1	603395	SPAG1	6674	ENSG00000104450,ENST00000388798;;;ENST00000388798		Ciliary dyskinesia, primary, 28	615505	AR	3	Spag1
8q22.3	8:100500001-105100000	KTWS, KTS	Klippel-Trenaunay-Weber syndrome	149000		791122		translocation with 14q13	Klippel-Trenaunay-Weber syndrome	149000	IC	2	
8q22.3	8:100500001-105100000	MMD2	Miyoshi muscular dystrophy 2	613318		100505381		max lod at D10S2325	Miyoshi muscular dystrophy 2	613318		2	
8q22.3	8:101492439-101681200	GRHL2, TFCP2L3, DFNA28, ECTDS, PPCD4	Grainyhead-like 2	608576	GRHL2	79977	ENSG00000083307,ENST00000646743;;;ENST00000646743		Corneal dystrophy, posterior polymorphous, 4	618031	AD	3	Grhl2
8q22.3	8:101492439-101681200	GRHL2, TFCP2L3, DFNA28, ECTDS, PPCD4	Grainyhead-like 2	608576	GRHL2	79977	ENSG00000083307,ENST00000646743;;;ENST00000646743		Deafness, autosomal dominant 28	608641	AD	3	Grhl2
8q22.3	8:101492439-101681200	GRHL2, TFCP2L3, DFNA28, ECTDS, PPCD4	Grainyhead-like 2	608576	GRHL2	79977	ENSG00000083307,ENST00000646743;;;ENST00000646743		Ectodermal dysplasia/short stature syndrome	616029	AR	3	Grhl2
8q22.3	8:102204501-102238961	RRM2B, P53R2, PEOA5, MTDPS8A, MTDPS8B, RCDFRD	Ribonucleotide reductase regulatory TP53 inducible subunit M2B	604712	RRM2B	50484	ENSG00000048392,ENST00000251810;;;ENST00000251810		Mitochondrial DNA depletion syndrome 8A (encephalomyopathic type with renal tubulopathy)	612075	AR	3	Rrm2b
8q22.3	8:102204501-102238961	RRM2B, P53R2, PEOA5, MTDPS8A, MTDPS8B, RCDFRD	Ribonucleotide reductase regulatory TP53 inducible subunit M2B	604712	RRM2B	50484	ENSG00000048392,ENST00000251810;;;ENST00000251810		Mitochondrial DNA depletion syndrome 8B (MNGIE type)	612075	AR	3	Rrm2b
8q22.3	8:102204501-102238961	RRM2B, P53R2, PEOA5, MTDPS8A, MTDPS8B, RCDFRD	Ribonucleotide reductase regulatory TP53 inducible subunit M2B	604712	RRM2B	50484	ENSG00000048392,ENST00000251810;;;ENST00000251810		Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 5	613077	AD	3	Rrm2b
8q22.3	8:102204501-102238961	RRM2B, P53R2, PEOA5, MTDPS8A, MTDPS8B, RCDFRD	Ribonucleotide reductase regulatory TP53 inducible subunit M2B	604712	RRM2B	50484	ENSG00000048392,ENST00000251810;;;ENST00000251810		Rod-cone dystrophy, sensorineural deafness, and Fanconi-type renal dysfunction	268315	AR	3	Rrm2b
8q22.3	8:102252273-102412700	UBR5, EDD1, HYD, KIAA0896, NEDSBH	Ubiquitin protein ligase E3 component n-recognin 5	608413	UBR5	51366	ENSG00000104517,ENST00000520539;;;ENST00000520539		Neurodevelopmental disorder with speech delay and behavioral abnormalities	621372	AD	3	Ubr5
8q22.3	8:103298494-103332866	FZD6, NDNC1	Frizzled class receptor 6	603409	FZD6	8323	ENSG00000164930,ENST00000358755;;;ENST00000358755		Nail disorder, nonsyndromic congenital, 1	161050	AR	3	Fzd6
8q22.3	8:103371538-103382989	CTHRC1	Collagen triple-helix repeat-containing protein 1	610635	CTHRC1	115908	ENSG00000164932,ENST00000330295;;;ENST00000330295		Barrett esophagus/esophageal adenocarcinoma	614266		3	Cthrc1
8q22.3	8:103398638-103415107	SLC25A32, MFT, GLYB, RREI	Solute carrier family 25 (mitochondrial carrier, folate), member 32	138480	SLC25A32	81034	ENSG00000164933,ENST00000297578;;;ENST00000297578	mutation identified in 1 RREI patient	?Exercise intolerance, riboflavin-responsive	616839	AR	3	Slc25a32
8q22.3	8:103500610-104256094	RIMS2, KIAA0751, RIM2, OBOE, CRSDS	Regulating synaptic membrane exocytosis-2	606630	RIMS2	9699	ENSG00000176406,ENST00000696799;;;ENST00000696799		Cone-rod synaptic disorder syndrome, congenital nonprogressive	618970	AR	3	Rims2
8q22.3	8:104379431-104467055	DPYS, DHP	Dihydropyrimidinase	613326	DPYS	1807	ENSG00000147647,ENST00000351513;;;ENST00000351513		Dihydropyrimidinuria	222748	AR	3	Dpys
8q22.3	8:104489236-104589258	LRP12, MIG13A, ALS28	Low density lipoprotein receptor-related protein 12	618299	LRP12	29967	ENSG00000147650,ENST00000276654;;;ENST00000276654		Amyotrophic lateral sclerosis 28	620452	AD	3	Lrp12
8q22.3	8:104489236-104589258	LRP12, MIG13A, ALS28	Low density lipoprotein receptor-related protein 12	618299	LRP12	29967	ENSG00000147650,ENST00000276654;;;ENST00000276654		Oculopharyngodistal myopathy 1	164310	AD	3	Lrp12
8q23	8:105100001-116700000	CRCS6	Colorectal cancer, susceptibility to, 6	612231		100187710		associated with rs16892766	{Colorectal cancer, susceptibility to, 6}	612231		2	
8q23	8:105100001-116700000	GLC1D	Glaucoma 1, open angle, D	602429		2724			Glaucoma 1D, primary open angle	602429		2	
8q23	8:105100001-116700000	HDLCQ2	High density lipoprotein cholesterol level QTL 2	607053		353127			[High density lipoprotein cholesterol level QTL 2]	607053		2	
8q23-q24	8:105100001-145138636	HT	Hashimoto thyroiditis	140300		140805		?chr.12	Hashimoto thyroiditis	140300	AD	2	
8q23	8:105100001-116700000	LBMQTL1	Lean body mass quantitative trait locus 1	612729		100294719		associated with rs16892496 and rs7832552	[Lean body mass QTL 1]	612729		2	
8q23	8:105100001-116700000	MYMY3	Moyamoya disease 3	608796		493818		max lod at D8S546	Moyamoya disease 3	608796		2	
8q23.1	8:105318438-105804539	ZFPM2, FOG2, DIH3, SRXY9	Zinc finger protein, multitype 2 (friend of GATA2)	603693	ZFPM2	23414	ENSG00000169946,ENST00000407775;;;ENST00000407775		46XY sex reversal 9	616067	AD	3	Zfpm2
8q23.1	8:105318438-105804539	ZFPM2, FOG2, DIH3, SRXY9	Zinc finger protein, multitype 2 (friend of GATA2)	603693	ZFPM2	23414	ENSG00000169946,ENST00000407775;;;ENST00000407775		Diaphragmatic hernia 3	610187	AD	3	Zfpm2
8q23.1	8:105318438-105804539	ZFPM2, FOG2, DIH3, SRXY9	Zinc finger protein, multitype 2 (friend of GATA2)	603693	ZFPM2	23414	ENSG00000169946,ENST00000407775;;;ENST00000407775		Tetralogy of Fallot	187500	AD	3	Zfpm2
8q23.1	8:106270178-106752694	OXR1, CHEGDD	Oxidation resistance 1	605609	OXR1	55074	ENSG00000164830,ENST00000517566;;;ENST00000517566		Cerebellar hypoplasia/atrophy, epilepsy, and global developmental delay	213000	AR	3	Oxr1
8q23.1	8:107249482-107497918	ANGPT1, ANG1, HAE5	Angiopoietin-1	601667	ANGPT1	284	ENSG00000154188,ENST00000517746;;;ENST00000517746	mutation identified in 1 HAE5 family	?Angioedema, hereditary, 5	619361	AD	3	Angpt1
8q23.1	8:107899316-108083620	RSPO2, CRISTIN2, TETAMS2, HHRRD	R-spondin member 2	610575	RSPO2	340419	ENSG00000147655,ENST00000276659;;;ENST00000276659	mutation identified in 1 HHRRD family	?Humerofemoral hypoplasia with radiotibial ray deficiency	618022	AR	3	Rspo2
8q23.1	8:107899316-108083620	RSPO2, CRISTIN2, TETAMS2, HHRRD	R-spondin member 2	610575	RSPO2	340419	ENSG00000147655,ENST00000276659;;;ENST00000276659	mutation identified in 1 HHRRD family	Tetraamelia syndrome 2	618021	AR	3	Rspo2
8q23.1	8:109086585-109121565	TRHR, CHNG7	Thyrotropin-releasing hormone receptor	188545	TRHR	7201	ENSG00000174417,ENST00000518632;;;ENST00000518632		Hypothyroidism, congenital, nongoitrous, 7	618573	AR	3	Trhr
8q23.1-q23.2	8:109362461-109537207	PKHD1L1, DFNB124	PKHD1-like 1	607843	PKHD1L1	93035	ENSG00000205038,ENST00000378402;;;ENST00000378402		Deafness, autosomal recessive 124	620794	AR	3	Pkhd1l1
8q23.3	8:115408496-115668975	TRPS1	Zinc finger transcription factor TRPS1	604386	TRPS1	7227	ENSG00000104447,ENST00000395715;;;ENST00000395715		Trichorhinophalangeal syndrome, type I	190350	AD	3	Trps1
8q23.3	8:115408496-115668975	TRPS1	Zinc finger transcription factor TRPS1	604386	TRPS1	7227	ENSG00000104447,ENST00000395715;;;ENST00000395715		Trichorhinophalangeal syndrome, type III	190351	AD	3	Trps1
8q24	8:116700001-145138636	BMND10	Bone mineral density quantitative trait locus 10	612113		100188883		associated with rs6469804 and rs6993813	[Bone mineral density QTL 10]	612113		2	
8q24	8:116700001-145138636	BSZQTL3	Bone size quantitative trait locus 3	610649		100188815			[Bone size quantitative trait locus 3]	610649		2	
8q24	8:116700001-145138636	CRCS2	Colorectal cancer, susceptibility to, 2	611469		100188841		associated with rs7014346	{Colorectal cancer, susceptibility to, 2}	611469		2	
8q24	8:116700001-145138636	ECA1	Epilepsy, childhood absence, 1	600131		50966			Epilepsy, childhood absence, 1	600131	AD	2	
8q24	8:116700001-145138636	EIG1	Epilepsy, idiopathic generalized, susceptibility to 1	600669		1957		?same as EBN2	{Epilepsy, idiopathic generalized, susceptibility to, 1}	600669	AD	2	
8q24	8:116700001-145138636	HPC10	Prostate cancer, hereditary, 10	611100		100188834		strongest assoc. with rs1447295	{Prostate cancer, hereditary, 10}	611100		2	
8q24.1	8:116700001-126300000	THM	Tibial hemimelia	275220		117193			?Tibial hemimelia	275220	AR	2	
8q24.11-q24.13	8:116700001-126300000	TRPS2, LGCR, LGS	Trichorhinophalangeal syndrome, type II (Langer-Giedion syndrome)	150230				contiguous gene syndrome involving TRPS1 and EXT1	Trichorhinophalangeal syndrome, type II	150230	AD	4	
8q24.11	8:116845934-116874776	RAD21, SCC1, NXP1, KIAA0078, CDLS4, MGS	RAD21 cohesin complex component	606462	RAD21	5885	ENSG00000164754,ENST00000297338;;;ENST00000297338	mutation identified in 1 MGS family	?Mungan syndrome	611376	AR	3	Rad21
8q24.11	8:116845934-116874776	RAD21, SCC1, NXP1, KIAA0078, CDLS4, MGS	RAD21 cohesin complex component	606462	RAD21	5885	ENSG00000164754,ENST00000297338;;;ENST00000297338	mutation identified in 1 MGS family	Cornelia de Lange syndrome 4	614701	AD	3	Rad21
8q24.11	8:116950217-117176714	SLC30A8, ZNT8	Solute carrier family 30 (zinc transporter), member 8	611145	SLC30A8	169026	ENSG00000164756,ENST00000456015;;;ENST00000456015		{Diabetes mellitus, noninsulin-dependent, susceptibility to}	125853	AD	3	Slc30a8
8q24.11	8:117794490-118111826	EXT1	Exostosin 1	608177	EXT1	2131	ENSG00000182197,ENST00000378204;;;ENST00000378204	distal to TRPS1	Chondrosarcoma	215300	SMu	3	Ext1
8q24.11	8:117794490-118111826	EXT1	Exostosin 1	608177	EXT1	2131	ENSG00000182197,ENST00000378204;;;ENST00000378204	distal to TRPS1	Exostoses, multiple, type 1	133700	AD	3	Ext1
8q24.11-q24.12	8:118131825-118621963	SAMD12	Sterile alpha motif domain containing 12	618073	SAMD12	401474	ENSG00000177570,ENST00000314727;;;ENST00000314727		Epilepsy, familial adult myoclonic, 1	601068	AD	3	Samd12
8q24.12	8:118923557-118951885	TNFRSF11B, OPG, OCIF, PDB5	Tumor necrosis factor receptor superfamily, member 11B (osteoprotegerin)	602643	TNFRSF11B	4982	ENSG00000164761,ENST00000297350;;;ENST00000297350		Paget disease of bone 5, juvenile-onset	239000	AR	3	Tnfrsf11b
8q24.12	8:118952263-119108455	COLEC10, CLL1, 3MC3	Collectin 10	607620	COLEC10	10584	ENSG00000184374,ENST00000332843;;;ENST00000332843		3MC syndrome 3	248340	AR	3	Colec10
8q24.12	8:119730774-119832841	TAF2, TAF2B, TAFII150, CIF150, MRT40	TAF2 RAN polymerase II, TATA box-binding protein-associated factor, 150kD	604912	TAF2	6873	ENSG00000064313,ENST00000378164;;;ENST00000378164		Intellectual developmental disorder, autosomal recessive 40	615599	AR	3	Taf2
8q24.13-q24.22	8:121500001-135400000	ARHI1	Age-related hearing impairment 1	612448		100233147		between rs3765212 and rs4601326	{Age-related hearing impairment 1}	612448		2	
8q24.13-q24.21	8:121500001-130400000	PPKP1B	Keratoderma, palmoplantar, punctate type IB	614936		101154752		between D8S1804 and D8S1720	Keratoderma, palmoplantar, punctate type IB	614936	AD	2	
8q24.13	8:124474880-124488618	RNF139, TRC8, RCA1	RING finger protein 139	603046	RNF139	11236	ENSG00000170881,ENST00000303545;;;ENST00000303545		Renal cell carcinoma	144700		3	Rnf139
8q24.13	8:124539123-124549979	NDUFB9, UQOR22, MC1DN24	NADH-ubiquinone oxidoreductase subunit B9	601445	NDUFB9	4715	ENSG00000147684,ENST00000276689;;;ENST00000276689	mutation identified in 1 MC1DN24 family	?Mitochondrial complex I deficiency, nuclear type 24	618245	AR	3	Ndufb9
8q24.13	8:125024260-125091792	WASHC5, KIAA0196, SPG8, RTSC1	WASH complex, subunit 5	610657	WASHC5	9897	ENSG00000164961,ENST00000318410;;;ENST00000318410		Ritscher-Schinzel syndrome 1	220210	AR	3	Washc5
8q24.13	8:125024260-125091792	WASHC5, KIAA0196, SPG8, RTSC1	WASH complex, subunit 5	610657	WASHC5	9897	ENSG00000164961,ENST00000318410;;;ENST00000318410		Spastic paraplegia 8, autosomal dominant	603563	AD	3	Washc5
8q24.13	8:125091860-125367120	NSMCE2, NSE2, MMS21	NSE2 (MMS21) homolog, SMC5-SMC6 complex SUMO ligase	617246	NSMCE2	286053	ENSG00000156831,ENST00000287437;;;ENST00000287437		Seckel syndrome 10	617253	AR	3	Nsmce2
8q24.21	8:127735434-127742951	MYC	MYC protooncogene, bHLH transcription factor	190080	MYC	4609	ENSG00000136997,ENST00000621592;;;ENST00000621592	cen-5'-3'-ter	Burkitt lymphoma, somatic	113970		3	Myc
8q24.21	8:129351694-129680239	CCDC26, RAM, GLM7	CCDC26 long non-coding RNA	613040	CCDC26	137196	ENSG00000229140,ENST00000446592		{Glioma susceptibility 7}	613032		3	
8q24.22	8:132120861-132481095	KCNQ3, EBN2, BFNC2	Potassium voltage-gated channel, KQT-like subfamily, member 3	602232	KCNQ3	3786	ENSG00000184156,ENST00000388996;;;ENST00000388996		Seizures, benign neonatal, 2	121201	AD	3	Kcnq3
8q24.22	8:132570416-132702913	DNAAF11, LRRC6, LRTP, CILD19	Dynein, axonemal, assembly factor 11	614930	DNAAF11	23639	ENSG00000129295,ENST00000620350;;;ENST00000620350		Ciliary dyskinesia, primary, 19	614935	AR	3	Dnaaf11
8q24.22	8:132866958-133134899	TG, AITD3, TDH3	Thyroglobulin	188450	TG	7038	ENSG00000042832,ENST00000220616;;;ENST00000220616	distal to MYC	{Autoimmune thyroid disease, susceptibility to, 3}	608175		3	Tg
8q24.22	8:132866958-133134899	TG, AITD3, TDH3	Thyroglobulin	188450	TG	7038	ENSG00000042832,ENST00000220616;;;ENST00000220616	distal to MYC	Thyroid dyshormonogenesis 3	274700	AR	3	Tg
8q24.22	8:133237175-133297252	NDRG1, HMSNL, CMT4D	N-myc downstream-regulated gene 1	605262	NDRG1	10397	ENSG00000104419,ENST00000323851;;;ENST00000323851		Charcot-Marie-Tooth disease, type 4D	601455	AR	3	Ndrg1
8q24.22	8:134477788-134832339	ZFAT1, ZNF406, AITD3	Zinc finger gene in autoimmune thyroid disease 1	610931	ZFAT	57623	ENSG00000066827,ENST00000377838;;;ENST00000377838		{Autoimmune thyroid disease, susceptibility to, 3}	608175		3	Zfat
8q24.3	8:138900001-145138636	OFC12	Orofacial cleft 12	612858		100302515		associated with rs987525	Orofacial cleft 12	612858	AD	2	
8q24.3	8:139600838-139703123	KCNK9, TASK32, BIBARS	Potassium channel, subfamily K, member 9	605874	KCNK9	51305	ENSG00000169427,ENST00000520439;;;ENST00000520439		Birk-Barel syndrome	612292	AD	3	Kcnk9
8q24.3	8:139727725-140458579	TRAPPC9, NIBP, KIAA1882, MRT13	Trafficking protein particle complex 9	611966	TRAPPC9	83696	ENSG00000167632,ENST00000438773;;;ENST00000438773		Intellectual developmental disorder, autosomal recessive 13	613192	AR	3	Trappc9
8q24.3	8:140520156-140642313	AGO2, EIF2C2, LESKRES	Argonaute RISC component 2	606229	AGO2	27161	ENSG00000123908,ENST00000220592;;;ENST00000220592		Lessel-Kreienkamp syndrome	619149	AD	3	Ago2
8q24.3	8:142740949-142742406	SLURP1, MDM	Secreted LY6/uPAR-related protein 1	606119	SLURP1	57152	ENSG00000126233,ENST00000246515;;;ENST00000246515		Meleda disease	248300	AR	3	Slurp1
8q24.3	8:142872357-142879825	CYP11B1, P450C11, FHI	Cytochrome P450, subfamily XIB, polypeptide 1 (11-beta-hydroxylase; corticosteroid methyl-oxidase II (CMO II))	610613	CYP11B1	1584	ENSG00000160882,ENST00000292427;;;ENST00000292427	chimeric CYP11B1/CYP11B2 gene = anti-Lepore-like	Adrenal hyperplasia, congenital, due to 11-beta-hydroxylase deficiency	202010	AR	3	Cyp11b1,Cyp11b2
8q24.3	8:142872357-142879825	CYP11B1, P450C11, FHI	Cytochrome P450, subfamily XIB, polypeptide 1 (11-beta-hydroxylase; corticosteroid methyl-oxidase II (CMO II))	610613	CYP11B1	1584	ENSG00000160882,ENST00000292427;;;ENST00000292427	chimeric CYP11B1/CYP11B2 gene = anti-Lepore-like	Aldosteronism, glucocorticoid-remediable	103900	AD	3	Cyp11b1,Cyp11b2
8q24.3	8:142910559-142917843	CYP11B2	Cytochrome P450, subfamily XIB, polypeptide 2	124080	CYP11B2	1585	ENSG00000179142,ENST00000323110;;;ENST00000323110		{Low renin hypertension, susceptibility to}			3	Cyp11b1,Cyp11b2
8q24.3	8:142910559-142917843	CYP11B2	Cytochrome P450, subfamily XIB, polypeptide 2	124080	CYP11B2	1585	ENSG00000179142,ENST00000323110;;;ENST00000323110		Aldosterone to renin ratio raised			3	Cyp11b1,Cyp11b2
8q24.3	8:142910559-142917843	CYP11B2	Cytochrome P450, subfamily XIB, polypeptide 2	124080	CYP11B2	1585	ENSG00000179142,ENST00000323110;;;ENST00000323110		Hypoaldosteronism, congenital, due to CMO I deficiency	203400	AR	3	Cyp11b1,Cyp11b2
8q24.3	8:142910559-142917843	CYP11B2	Cytochrome P450, subfamily XIB, polypeptide 2	124080	CYP11B2	1585	ENSG00000179142,ENST00000323110;;;ENST00000323110		Hypoaldosteronism, congenital, due to CMO II deficiency	610600	AR	3	Cyp11b1,Cyp11b2
8q24.3	8:143213218-143217170	GPIHBP1, HYPL1D	Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1	612757	GPIHBP1	338328	ENSG00000277494,ENST00000622500;;;ENST00000622500		Hyperlipoproteinemia, type 1D	615947	AR	3	Gpihbp1
8q24.3	8:143428064-143430732	MAFA, RIPE3B1, INSDM	MAF bZIP transcription factor A	610303	MAFA	389692	ENSG00000182759,ENST00000333480;;;ENST00000333480		Insulinomatosis and diabetes mellitus	147630	AD	3	Mafa
8q24.3	8:143579728-143597415	EEF1D, EF1D, NEDTCHAL	Eukaryotic translation elongation factor 1, delta	130592	EEF1D	1936	ENSG00000104529,ENST00000618139;;;ENST00000618139		Neurodevelopmental disorder with thin corpus callosum, hypotonia, and absent language	621150	AR	3	Eef1d
8q24.3	8:143723933-143733779	FAM83H, AI3A	Family with sequence similarity 83, member H	611927	FAM83H	286077	ENSG00000180921,ENST00000388913;;;ENST00000388913		Amelogenesis imperfecta, type IIIA	130900	AD	3	Fam83h
8q24.3	8:143816344-143829315	PUF60, FIR, SIAHBP1, VRJS	Poly-U-binding splicing factor, 60kD	604819	PUF60	22827	ENSG00000179950,ENST00000526683;;;ENST00000526683		Verheij syndrome	615583	AD	3	Puf60
8q24.3	8:143915153-143976745	PLEC1, PLEC, PLTN, LGMDR17, EBS5A, EBS5B, EBS5C, EBS5D	Plectin 1	601282	PLEC	5339	ENSG00000178209,ENST00000345136;;;ENST00000345136	mutation identified in 1 EBS5D family	?Epidermolysis bullosa simplex 5D, generalized intermediate, autosomal recessive	616487	AR	3	Plec
8q24.3	8:143915153-143976745	PLEC1, PLEC, PLTN, LGMDR17, EBS5A, EBS5B, EBS5C, EBS5D	Plectin 1	601282	PLEC	5339	ENSG00000178209,ENST00000345136;;;ENST00000345136	mutation identified in 1 EBS5D family	Epidermolysis bullosa simplex 5A, Ogna type	131950	AD	3	Plec
8q24.3	8:143915153-143976745	PLEC1, PLEC, PLTN, LGMDR17, EBS5A, EBS5B, EBS5C, EBS5D	Plectin 1	601282	PLEC	5339	ENSG00000178209,ENST00000345136;;;ENST00000345136	mutation identified in 1 EBS5D family	Epidermolysis bullosa simplex 5B, with muscular dystrophy	226670	AR	3	Plec
8q24.3	8:143915153-143976745	PLEC1, PLEC, PLTN, LGMDR17, EBS5A, EBS5B, EBS5C, EBS5D	Plectin 1	601282	PLEC	5339	ENSG00000178209,ENST00000345136;;;ENST00000345136	mutation identified in 1 EBS5D family	Epidermolysis bullosa simplex 5C, with pyloric atresia	612138	AR	3	Plec
8q24.3	8:143915153-143976745	PLEC1, PLEC, PLTN, LGMDR17, EBS5A, EBS5B, EBS5C, EBS5D	Plectin 1	601282	PLEC	5339	ENSG00000178209,ENST00000345136;;;ENST00000345136	mutation identified in 1 EBS5D family	Muscular dystrophy, limb-girdle, autosomal recessive 17	613723	AR	3	Plec
8q24.3	8:144050322-144063961	OPLAH, OPLAHD	5-oxoprolinase (ATP-hydrolyzing)	614243	OPLAH	26873	ENSG00000178814,ENST00000618853;;;ENST00000618853		5-oxoprolinase deficiency	260005	AD, AR	3	Oplah
8q24.3	8:144082634-144086216	GPAA1, GAA1, GPIBD15	Glycophosphatidylinositol anchor attachment protein 1	603048	GPAA1	8733	ENSG00000197858,ENST00000355091;;;ENST00000355091		Glycosylphosphatidylinositol biosynthesis defect 15	617810	AR	3	Gpaa1
8q24.3	8:144095076-144097525	CYC1, MC3DN6	Cytochrome c1	123980	CYC1	1537	ENSG00000179091,ENST00000318911;;;ENST00000318911		Mitochondrial complex III deficiency, nuclear type 6	615453	AR	3	Cyc1
8q24.3	8:144098637-144103773	SHARPIN, SIPL1, AIFID	SHANK-associated RH domain interactor	611885	SHARPIN	81858	ENSG00000179526,ENST00000398712;;;ENST00000398712		Autoinflammation with episodic fever and immune dysregulation	620795	AR	3	Sharpin
8q24.3	8:144314584-144326852	DGAT1, ARGP1, DIAR7	Diacylglycerol O-acyltransferase 1	604900	DGAT1	8694	ENSG00000185000,ENST00000528718;;;ENST00000528718		Diarrhea 7, protein-losing enteropathy type	615863	AR	3	Dgat1
8q24.3	8:144358552-144361272	SLC52A2, GPR172A, GPCR41, PAR1, FLJ11856, BVVLS2	Solute carrier family 52, riboflavin transporter, member 2	607882	SLC52A2	79581	ENSG00000185803,ENST00000643944;;;ENST00000643944		Brown-Vialetto-Van Laere syndrome 2	614707	AR	3	Slc52a2
8q24.3	8:144393231-144409335	CPSF1, CPSF160, MYP27	Cleavage and polyadenylation specificity factor 1	606027	CPSF1	29894	ENSG00000071894,ENST00000616140;;;ENST00000616140		Myopia 27	618827	AD	3	Cpsf1
8q24.3	8:144412414-144416844	SLC39A4, ZIP4	Solute carrier family 36 (zinc transporter), member 4	607059	SLC39A4	55630	ENSG00000147804,ENST00000301305;;;ENST00000301305		Acrodermatitis enteropathica	201100	AR	3	Slc39a4
8q24.3	8:144428775-144444440	TONSL, NFKBIL2, IKBR, SEMDSP	Tonsoku-like DNA repair protein	604546	TONSL	4796	ENSG00000160949,ENST00000409379;;;ENST00000409379		Spondyloepimetaphyseal dysplasia, sponastrime type	271510	AR	3	Tonsl
8q24.3	8:144511288-144517833	RECQL4, RTS, RECQ4	DNA helicase, RecQ-like 4	603780	RECQL4	9401	ENSG00000160957,ENST00000617875;;;ENST00000617875		Baller-Gerold syndrome	218600	AR	3	Recql4
8q24.3	8:144511288-144517833	RECQL4, RTS, RECQ4	DNA helicase, RecQ-like 4	603780	RECQL4	9401	ENSG00000160957,ENST00000617875;;;ENST00000617875		RAPADILINO syndrome	266280	AR	3	Recql4
8q24.3	8:144511288-144517833	RECQL4, RTS, RECQ4	DNA helicase, RecQ-like 4	603780	RECQL4	9401	ENSG00000160957,ENST00000617875;;;ENST00000617875		Rothmund-Thomson syndrome, type 2	268400	AR	3	Recql4
Chr.8	8:1-145138636	AIS3, VAMAS4	Autoimmune disease, susceptibility to, 3	608392		378427			{Autoimmune disease, susceptibility to, 3}	608392		2	
9p	9:1-43000001	DEL9p, C9DELp	Chromosome 9p deletion syndrome	158170					Chromosome 9p deletion syndrome	158170	AD	4	
9p24.3	9:1-2200000	DEL9p24.3, C9DELp24.3, SRXY4	Chromosome 9p24.3 deletion syndrome	154230					46XY sex reversal 4	154230	IC	4	
9p	9:1-43000001	HDLCQ1	High density lipoprotein cholesterol level QTL 1	606613		192144			[High density lipoprotein cholesterol level QTL 1]	606613		2	
9p24	9:1-9000000	MRD2	Intellectual developmental disorder, autosomal dominant 2	614113				2 patients reported with genomic deletion or rearrangement including disruption of DOCK8	Intellectual developmental disorder, autosomal dominant 2	614113	AD	4	
9p24-p22	9:1-19900000	RLS3	Restless legs syndrome, susceptibility to, 3	610438		100188812		associated with rs4626664 and rs1975197	{Restless legs syndrome 3}	610438		2	
9p24.3	9:211257-465255	DOCK8, HIES2	Dedicator of cytokinesis 8	611432	DOCK8	81704	ENSG00000107099,ENST00000432829;;;ENST00000432829		Hyper-IgE syndrome 2, autosomal recessive, with recurrent infections	243700	AR	3	Dock8
9p24.3	9:470295-746103	KANK1, KANK, ANKRD15, KIAA0172, CPSQ2	KN motif- and ankyrin repeat domain-containing protein 1	607704	KANK1	23189	ENSG00000107104,ENST00000382297;;;ENST00000382297		Cerebral palsy, spastic quadriplegic, 2	612900		3	Kank1
9p24.3	9:2015347-2193620	SMARCA2, SNF2L2, NCBRS, BIS	SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2	600014	SMARCA2	6595	ENSG00000080503,ENST00000349721;;;ENST00000349721		Blepharophimosis-impaired intellectual development syndrome	619293	AD	3	Smarca2
9p24.3	9:2015347-2193620	SMARCA2, SNF2L2, NCBRS, BIS	SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2	600014	SMARCA2	6595	ENSG00000080503,ENST00000349721;;;ENST00000349721		Nicolaides-Baraitser syndrome	601358	AD	3	Smarca2
9p24.2	9:2621787-2660056	VLDLR, CAMRQ1	Very low density lipoprotein receptor	192977	VLDLR	7436	ENSG00000147852,ENST00000382100;;;ENST00000382100		Cerebellar hypoplasia, impaired intellectual development, and dysequilibrium syndrome 1	224050	AR	3	Vldlr
9p24.2	9:2717510-2730037	KCNV2, KV11.1, CDSRR	Potassium channel, voltage-gated, subfamily V, member 2	607604	KCNV2	169522	ENSG00000168263,ENST00000382082;;;ENST00000382082		Cone dystrophy with supernormal rod responses	610356	AR	3	Kcnv2
9p24.2	9:3824127-4490465	GLIS3, ZNF515, NDH	GLIS family zinc finger protein 3	610192	GLIS3	169792	ENSG00000107249,ENST00000381971;;;ENST00000381971		Diabetes mellitus, neonatal, with congenital hypothyroidism	610199	AR	3	Glis3
9p24.2	9:4490468-4587469	SLC1A1, EAAC1, SCZD18, DCBXA	Solute carrier family 1, member 1 (high-affinity glutamate transporter; excitatory amino acid carrier 1)	133550	SLC1A1	6505	ENSG00000106688,ENST00000262352;;;ENST00000262352	mutation identified in 1 SCZD18 family	{?Schizophrenia susceptibility 18}	615232		3	Slc1a1
9p24.2	9:4490468-4587469	SLC1A1, EAAC1, SCZD18, DCBXA	Solute carrier family 1, member 1 (high-affinity glutamate transporter; excitatory amino acid carrier 1)	133550	SLC1A1	6505	ENSG00000106688,ENST00000262352;;;ENST00000262352	mutation identified in 1 SCZD18 family	Dicarboxylic aminoaciduria	222730	AR	3	Slc1a1
9p24.1-p22.1	9:4600001-19900000	FECD7, FCD4	Corneal dystrophy, Fuchs endothelial, 7	613271		100380875		max lod at D9S256	Corneal dystrophy, Fuchs endothelial, 7	613271		2	
9p24.1	9:4984390-5129948	JAK2, THCYT3	Janus kinase 2 (a protein-tyrosine kinase)	147796	JAK2	3717	ENSG00000096968,ENST00000381652;;;ENST00000381652		{Budd-Chiari syndrome, somatic}	600880		3	Jak2
9p24.1	9:4984390-5129948	JAK2, THCYT3	Janus kinase 2 (a protein-tyrosine kinase)	147796	JAK2	3717	ENSG00000096968,ENST00000381652;;;ENST00000381652		Erythrocytosis, somatic	133100		3	Jak2
9p24.1	9:4984390-5129948	JAK2, THCYT3	Janus kinase 2 (a protein-tyrosine kinase)	147796	JAK2	3717	ENSG00000096968,ENST00000381652;;;ENST00000381652		Leukemia, acute myeloid, somatic	601626		3	Jak2
9p24.1	9:4984390-5129948	JAK2, THCYT3	Janus kinase 2 (a protein-tyrosine kinase)	147796	JAK2	3717	ENSG00000096968,ENST00000381652;;;ENST00000381652		Myelofibrosis, somatic	254450		3	Jak2
9p24.1	9:4984390-5129948	JAK2, THCYT3	Janus kinase 2 (a protein-tyrosine kinase)	147796	JAK2	3717	ENSG00000096968,ENST00000381652;;;ENST00000381652		Polycythemia vera, somatic	263300		3	Jak2
9p24.1	9:4984390-5129948	JAK2, THCYT3	Janus kinase 2 (a protein-tyrosine kinase)	147796	JAK2	3717	ENSG00000096968,ENST00000381652;;;ENST00000381652		Thrombocythemia 3	614521	AD, SMu	3	Jak2
9p24.1	9:5450542-5470554	CD274, PDCD1LG1, B7H1, ADMIO5	CD274 molecule	605402	CD274	29126	ENSG00000120217,ENST00000381577;;;ENST00000381577	mutation identified in 1 ADMIO5 family	?Autoimmune disease, multisystem, infantile-onset, 5	621235	AR	3	Cd274
9p24.1	9:5629107-5778633	RIC1, CIP150, KIAA1432, CATIFA	RIC1 homolog, RAB6A GEF complex partner 1	610354	RIC1	57589	ENSG00000107036,ENST00000414202;;;ENST00000414202		CATIFA syndrome	618761	AR	3	Ric1
9p24.1	9:6532467-6645729	GLDC, HYGN1, GCSP, GCE1, NKH	Glycine dehydrogenase (decarboxylating; glycine decarboxylase, glycine cleavage system protein P)	238300	GLDC	2731	ENSG00000178445,ENST00000321612;;;ENST00000321612		Glycine encephalopathy1	605899	AR	3	Gldc
9p23-p21.2	9:9000001-28000000	DFNB83	Deafness, autosomal recessive 83	613685		100359400		between rs4742645 and rs1471364	Deafness, autosomal recessive 83	613685	AR	2	
9p23-p11	9:9000001-43000000	FRDA2	Friedreich ataxia 2	601992		2420			Friedreich ataxia 2	601992	AR	2	
9p23-p13.3	9:9000001-36300000	MRT16	Intellectual developmental disorder, autosomal recessive 16	614208		100689014		between rs10738277 and rs12376565	Intellectual developmental disorder, autosomal recessive 16	614208	AR	2	
9p23	9:12693385-12710285	TYRP1, CAS2, GP75, SHEP11	Tyrosinase-related protein 1	115501	TYRP1	7306	ENSG00000107165,ENST00000388918;;;ENST00000388918		[Skin/hair/eye pigmentation, variation in, 11 (Melanesian blond hair)]	612271		3	Tyrp1
9p23	9:12693385-12710285	TYRP1, CAS2, GP75, SHEP11	Tyrosinase-related protein 1	115501	TYRP1	7306	ENSG00000107165,ENST00000388918;;;ENST00000388918		Albinism, oculocutaneous, type III	203290	AR	3	Tyrp1
9p23	9:13105707-13279692	MPDZ, MUPP1, HYC2	Multiple PDZ domain protein	603785	MPDZ	8777	ENSG00000107186,ENST00000319217;;;ENST00000319217		Hydrocephalus, congenital, 2, with or without brain or eye anomalies	615219	AR	3	Mpdz
9p23-p22.3	9:14081843-14532077	NFIB, MACID	Nuclear factor I/B	600728	NFIB	4781	ENSG00000147862,ENST00000380953;;;ENST00000380953		Macrocephaly, acquired, with impaired intellectual development	618286	AD	3	Nfib
9p22-p21	9:14200001-33200000	DFNA47, DFNB83	Deafness, autosomal dominant 47	608652		246289		between D9S268 and D9S942; possibly allelic to DFNB83	Deafness, autosomal dominant 47	608652	AD	2	
9p22-p21	9:14200001-33200000	LALL	Lymphomatous acute lymphoblastic leukemia	247640		8009			Leukemia, acute lymphoblastic	247640	AR	2	
9p22.3	9:14737152-14910995	FREM1, C9orf154, BNAR, MOTA, TRIGNO2	FRAS1-related extracellular matrix protein 1	608944	FREM1	158326	ENSG00000164946,ENST00000380880;;;ENST00000380880		Bifid nose with or without anorectal and renal anomalies	608980	AR	3	Frem1
9p22.3	9:14737152-14910995	FREM1, C9orf154, BNAR, MOTA, TRIGNO2	FRAS1-related extracellular matrix protein 1	608944	FREM1	158326	ENSG00000164946,ENST00000380880;;;ENST00000380880		Manitoba oculotrichoanal syndrome	248450	AR	3	Frem1
9p22.3	9:14737152-14910995	FREM1, C9orf154, BNAR, MOTA, TRIGNO2	FRAS1-related extracellular matrix protein 1	608944	FREM1	158326	ENSG00000164946,ENST00000380880;;;ENST00000380880		Trigonocephaly 2	614485	AD	3	Frem1
9p22.3-p22.2	9:16409503-16870670	BNC2, LUTO	Basonuclin 2	608669	BNC2	54796	ENSG00000173068,ENST00000380672;;;ENST00000380672		Lower urinary tract obstruction, congenital	618612	AD	3	Bnc2
9p22.1	9:18500001-19900000	AD11	Alzheimer disease 11	609790		100188795		between D9S157 and D9S259	Alzheimer disease-11	609790		2	
9p21	9:19900001-33200000	AAA3	Aneurysm, familial abdominal 3	611891		100188857		associated with rs10757278	{Aneurysm, familial abdominal 3}	611891		2	
9p21	9:19900001-33200000	ANIB6	Aneurysm, intracranial berry, 6	611892		100188858		associated with rs10757278	{Aneurysm, intracranial berry, 6}	611892		2	
9p21	9:19900001-33200000	BCC5	Basal cell carcinoma, susceptibility to, 5	613062		100307122		associated with rs2151280	{Basal cell carcinoma, susceptibility to, 5}	613062		2	
9p21	9:19900001-33200000	CHDS8	Coronary heart disease, susceptibility to, 8	611139		100188836		strongest linkage with dbSNP rs1333049	{Coronary heart disease, susceptibility to, 8}	611139		2	
9p21.3	9:19900001-25600000	GLM5	Glioma susceptibility 5	613030		100415894		associated with rs4977756	{Glioma susceptibility 5}	613030		2	
9p21	9:19900001-33200000	MFT2, TEM	Trichoepithelioma, multiple familial, 2	612099		100188881		max lod at D9S171	Trichoepithelioma, multiple familial, 2	612099		2	
9p21.3	9:20655625-20995950	FOCAD, KIAA1797, SCOLIV	Focadhesin	614606	FOCAD	54914	ENSG00000188352,ENST00000338382;;;ENST00000338382		Liver disease, severe congenital	619991	AR	3	Focad
9p21.3	9:21440439-21441316	IFNA1, IFNA@	Interferon, alpha-1	147660	IFNA1	3439	ENSG00000197919,ENST00000276927;;;ENST00000276927	very close to IFF by Fd, LD; 15-30 genes	Interferon, alpha, deficiency			1	Ifna1,Ifna11,Ifna12,Ifna13,Ifna14,Ifna15,Ifna16,Ifna2,Ifna4,Ifna5,Ifna6,Ifna7,Ifna9,Ifnab
9p21.3	9:21802636-21941115	MTAP, DMSMFH	Methylthioadenosine phosphorylase	156540	MTAP	4507	ENSG00000099810,ENST00000644715;;;ENST00000644715		Diaphyseal medullary stenosis with malignant fibrous histiocytoma	112250	AD	3	Mtap
9p21.3	9:21967752-21995324	CDKN2A, MTS1, P16, MLM, CMM2	Cyclin-dependent kinase inhibitor 2A (p16, inhibits CDK4)	600160	CDKN2A	1029	ENSG00000147889,ENST00000304494;;;ENST00000304494		{Melanoma and neural system tumor syndrome}	155755	AD	3	Cdkn2a,Cdkn2b
9p21.3	9:21967752-21995324	CDKN2A, MTS1, P16, MLM, CMM2	Cyclin-dependent kinase inhibitor 2A (p16, inhibits CDK4)	600160	CDKN2A	1029	ENSG00000147889,ENST00000304494;;;ENST00000304494		{Melanoma-pancreatic cancer syndrome}	606719	AD	3	Cdkn2a,Cdkn2b
9p21.3	9:21967752-21995324	CDKN2A, MTS1, P16, MLM, CMM2	Cyclin-dependent kinase inhibitor 2A (p16, inhibits CDK4)	600160	CDKN2A	1029	ENSG00000147889,ENST00000304494;;;ENST00000304494		{Melanoma, cutaneous malignant, 2}	155601	AD	3	Cdkn2a,Cdkn2b
9p21.2	9:26903372-26947242	PLAA, PLAP, NDMSBA	Phospholipase A2-activating protein	603873	PLAA	9373	ENSG00000137055,ENST00000397292;;;ENST00000397292		Neurodevelopmental disorder with progressive microcephaly, spasticity, and brain anomalies	617527	AR	3	Plaa
9p21.2	9:26947110-27066134	IFT74, CCDC2, CMG1, BBS22, JBTS40, SPGF58	Intraflagellar transport 74	608040	IFT74	80173	ENSG00000096872,ENST00000380062;;;ENST00000380062		Bardet-Biedl syndrome 22	617119	AR	3	Ift74
9p21.2	9:26947110-27066134	IFT74, CCDC2, CMG1, BBS22, JBTS40, SPGF58	Intraflagellar transport 74	608040	IFT74	80173	ENSG00000096872,ENST00000380062;;;ENST00000380062		Joubert syndrome 40	619582	AR	3	Ift74
9p21.2	9:26947110-27066134	IFT74, CCDC2, CMG1, BBS22, JBTS40, SPGF58	Intraflagellar transport 74	608040	IFT74	80173	ENSG00000096872,ENST00000380062;;;ENST00000380062		Spermatogenic failure 58	619585	AR	3	Ift74
9p21.2	9:27109225-27230174	TEK, TIE2, VMCM, GLC3E	TEK tyrosine kinase, endothelial	600221	TEK	7010	ENSG00000120156,ENST00000380036;;;ENST00000380036		Glaucoma 3, primary congenital, E	617272	AD	3	Tek
9p21.2	9:27109225-27230174	TEK, TIE2, VMCM, GLC3E	TEK tyrosine kinase, endothelial	600221	TEK	7010	ENSG00000120156,ENST00000380036;;;ENST00000380036		Venous malformations, multiple cutaneous and mucosal	600195	AD	3	Tek
9p21.2	9:27546546-27573866	C9orf72, FTDALS1, FTDALS, ALSFTD	Chromosome 9 open reading frame 72	614260	C9orf72	203228	ENSG00000147894,ENST00000380003;;;ENST00000380003		Frontotemporal dementia and/or amyotrophic lateral sclerosis 1	105550	AD	3	C9orf72
9p21.1	9:32455302-32526196	RIGI, DDX58, SGMRT2	RNA sensor RIG-I	609631	RIGI	23586	ENSG00000107201,ENST00000379883;;;ENST00000379883		Singleton-Merten syndrome 2	616298	AD	3	Rigi
9p21.1	9:32540544-32552586	TOPORS, P53BP3, LUN, RP31	Topoisomerase I-binding arginine/serine-rich protein	609507	TOPORS	10210	ENSG00000197579,ENST00000360538;;;ENST00000360538		Retinitis pigmentosa 31	609923	AD	3	Topors
9p21.1	9:32972616-33025120	APTX, AOA, AOA1	Aprataxin	606350	APTX	54840	ENSG00000137074,ENST00000379817;;;ENST00000379817		Ataxia, early-onset, with oculomotor apraxia and hypoalbuminemia	208920	AR	3	Aptx
9p21.1	9:33104077-33185089	B4GALT1, GGTB2, GT1, GTB, CDG2D, CLDLFIB	Glycoprotein-4-beta-galactosyltransferase-2 (EC 2.4.1.22)	137060	B4GALT1	2683	ENSG00000086062,ENST00000379731;;;ENST00000379731		Combined low LDL and fibrinogen	620364	AR	3	B4galt1
9p21.1	9:33104077-33185089	B4GALT1, GGTB2, GT1, GTB, CDG2D, CLDLFIB	Glycoprotein-4-beta-galactosyltransferase-2 (EC 2.4.1.22)	137060	B4GALT1	2683	ENSG00000086062,ENST00000379731;;;ENST00000379731		Congenital disorder of glycosylation, type IId	607091	AR	3	B4galt1
9p13	9:33200001-39000000	PEE3	Preeclampsia/eclampsia 3	609403		780909			Preeclampsia/eclampsia 3	609403		2	
9p13.3	9:33383191-33402568	AQP7, GLYCQTL	Aquaporin-7	602974	AQP7	364	ENSG00000165269,ENST00000297988;;;ENST00000297988		[Glycerol quantitative trait locus]	614411	AR	3	Aqp7
9p13.3	9:33441160-33447593	AQP3	Aquaporin-3	600170	AQP3	360	ENSG00000165272,ENST00000297991;;;ENST00000297991	incorrectly mapped to chr.7	[Blood group GIL]	607457		3	Aqp3
9p13.3	9:34179005-34252523	UBAP1, UBAP, SPG80	Ubiquitin-associated protein 1	609787	UBAP1	51271	ENSG00000165006,ENST00000297661;;;ENST00000297661		Spastic paraplegia 80, autosomal dominant	618418	AD	3	Ubap1
9p13.3	9:34329569-34343699	NUDT2, APAH1, IDDPN	Nudix hydrolase 2	602852	NUDT2	318	ENSG00000164978,ENST00000379158;;;ENST00000379158		Intellectual developmental disorder with or without peripheral neuropathy	619844	AR	3	Nudt2
9p13.3	9:34366666-34376898	MYORG, NET37, KIAA1161, IBGC7	Myogenesis-regulating glycosidase	618255	MYORG	57462	ENSG00000164976,ENST00000297625;;;ENST00000297625		Basal ganglia calcification, idiopathic, 7, autosomal recessive	618317	AR	3	Myorg
9p13.3	9:34458805-34520984	DNAI1, CILD1, ICS, PCD	Dynein, axonemal, intermediate chain 1	604366	DNAI1	27019	ENSG00000122735,ENST00000242317;;;ENST00000242317		Ciliary dyskinesia, primary, 1, with or without situs inversus	244400	AR	3	Dnai1
9p13.3	9:34634722-34637787	SIGMAR1, SRBP, ALS16, HMNR2	Sigma nonopioid intracellular receptor 1	601978	SIGMAR1	10280	ENSG00000147955,ENST00000277010;;;ENST00000277010	mutation identified in 1 ALS16 family and 1 HMNR2 family	?Amyotrophic lateral sclerosis 16, juvenile	614373	AR	3	Sigmar1
9p13.3	9:34634722-34637787	SIGMAR1, SRBP, ALS16, HMNR2	Sigma nonopioid intracellular receptor 1	601978	SIGMAR1	10280	ENSG00000147955,ENST00000277010;;;ENST00000277010	mutation identified in 1 ALS16 family and 1 HMNR2 family	?Neuronopathy, distal hereditary motor, autosomal recessive 2	605726	AR	3	Sigmar1
9p13.3	9:34646675-34651035	GALT	Galactose-1-phosphate uridyltransferase	606999	GALT	2592	ENSG00000213930,ENST00000378842;;;ENST00000378842		Galactosemia	230400	AR	3	Galt
9p13.3	9:34652185-34661902	IL11RA, CRSDA	Interleukin-11 receptor, alpha	600939	IL11RA	3590	ENSG00000137070,ENST00000441545;;;ENST00000441545		Craniosynostosis and dental anomalies	614188	AR	3	Il11ra1,Il11ra2,Il11ra3
9p13.3	9:35056064-35072625	VCP, IBMPFD1, CMT2Y, FTDALS6	Valosin-containing protein	601023	VCP	7415	ENSG00000165280,ENST00000358901;;;ENST00000358901		Charcot-Marie-Tooth disease, type 2Y	616687	AD	3	Vcp
9p13.3	9:35056064-35072625	VCP, IBMPFD1, CMT2Y, FTDALS6	Valosin-containing protein	601023	VCP	7415	ENSG00000165280,ENST00000358901;;;ENST00000358901		Frontotemporal dementia and/or amyotrophic lateral sclerosis 6	613954	AD	3	Vcp
9p13.3	9:35056064-35072625	VCP, IBMPFD1, CMT2Y, FTDALS6	Valosin-containing protein	601023	VCP	7415	ENSG00000165280,ENST00000358901;;;ENST00000358901		Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia 1	167320	AD	3	Vcp
9p13.3	9:35073839-35079942	XRCC9, FANCG	X-ray repair cross complementing 9 (FA complementation group G)	602956	FANCG	2189	ENSG00000221829,ENST00000378643;;;ENST00000378643		Fanconi anemia, complementation group G	614082	AR	3	Fancg
9p13.3	9:35088688-35096591	PIGO, HPMRS2	Phosphatidylinositol glycan, class O	614730	PIGO	84720	ENSG00000165282,ENST00000378617;;;ENST00000378617		Hyperphosphatasia with impaired intellectual development syndrome 2	614749	AR	3	Pigo
9p13.3	9:35490111-35561895	RUSC2, KIAA0375, IPORIN, MRT61	RUN and SH3 domain-containing 2	611053	RUSC2	9853	ENSG00000198853,ENST00000361226;;;ENST00000361226		Intellectual developmental disorder, autosomal recessive 61	617773	AR	3	Rusc2
9p13.3	9:35657750-35658019	RMRP, RMRPR, CHH	Mitochondrial RNA-processing endoribonuclease	157660	RMRP	6023	ENSG00000277027,ENST00000363046;;;ENST00000363046		Anauxetic dysplasia 1	607095	AR	3	Rmrp
9p13.3	9:35657750-35658019	RMRP, RMRPR, CHH	Mitochondrial RNA-processing endoribonuclease	157660	RMRP	6023	ENSG00000277027,ENST00000363046;;;ENST00000363046		Cartilage-hair hypoplasia	250250	AR	3	Rmrp
9p13.3	9:35657750-35658019	RMRP, RMRPR, CHH	Mitochondrial RNA-processing endoribonuclease	157660	RMRP	6023	ENSG00000277027,ENST00000363046;;;ENST00000363046		Metaphyseal dysplasia without hypotrichosis	250460	AR	3	Rmrp
9p13.3	9:35681993-35690056	TPM2, TMSB, AMCD1, DA1, DA2B4, CMYO23	Tropomyosin-2, beta	190990	TPM2	7169	ENSG00000198467,ENST00000645482;;;ENST00000645482		Arthrogryposis, distal, type 1A	108120	AD	3	Tpm2
9p13.3	9:35681993-35690056	TPM2, TMSB, AMCD1, DA1, DA2B4, CMYO23	Tropomyosin-2, beta	190990	TPM2	7169	ENSG00000198467,ENST00000645482;;;ENST00000645482		Arthrogryposis, distal, type 2B4	108120	AD	3	Tpm2
9p13.3	9:35681993-35690056	TPM2, TMSB, AMCD1, DA1, DA2B4, CMYO23	Tropomyosin-2, beta	190990	TPM2	7169	ENSG00000198467,ENST00000645482;;;ENST00000645482		Congenital myopathy 23	609285	AD	3	Tpm2
9p13.3	9:35736866-35749228	GBA2, KIAA1605, SPG46	Glucosidase, beta, acid 2	609471	GBA2	57704	ENSG00000070610,ENST00000378103;;;ENST00000378103		Spastic paraplegia 46, autosomal recessive	614409	AR	3	Gba2
9p13.3	9:35791591-35809731	NPR2, ANPRB, AMD1, ECDM, SNSK	Natiuretic peptide receptor 2	108961	NPR2	4882	ENSG00000159899,ENST00000342694;;;ENST00000342694		Acromesomelic dysplasia 1, Maroteaux type	602875	AR	3	Npr2
9p13.3	9:35791591-35809731	NPR2, ANPRB, AMD1, ECDM, SNSK	Natiuretic peptide receptor 2	108961	NPR2	4882	ENSG00000159899,ENST00000342694;;;ENST00000342694		Epiphyseal chondrodysplasia, Miura type	615923	AD	3	Npr2
9p13.3	9:35791591-35809731	NPR2, ANPRB, AMD1, ECDM, SNSK	Natiuretic peptide receptor 2	108961	NPR2	4882	ENSG00000159899,ENST00000342694;;;ENST00000342694		Short stature with nonspecific skeletal abnormalities	616255	AD	3	Npr2
9p13.3	9:36169388-36171334	CCIN, SPGF91	Calicin	603960	CCIN	881	ENSG00000185972,ENST00000335119;;;ENST00000335119		Spermatogenic failure 91	620838	AR	3	Ccin
9p13.3	9:36214441-36276978	GNE, GLCNE, IBM2, DMRV, NM, THC12	UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase	603824	GNE	10020	ENSG00000159921,ENST00000642385;;;ENST00000642385		Nonaka myopathy	605820	AR	3	Gne
9p13.3	9:36214441-36276978	GNE, GLCNE, IBM2, DMRV, NM, THC12	UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase	603824	GNE	10020	ENSG00000159921,ENST00000642385;;;ENST00000642385		Sialuria	269921	AD	3	Gne
9p13.3	9:36214441-36276978	GNE, GLCNE, IBM2, DMRV, NM, THC12	UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase	603824	GNE	10020	ENSG00000159921,ENST00000642385;;;ENST00000642385		Thrombocytopenia 12 with or without myopathy	620757	AR	3	Gne
9p13.2	9:36833269-37034268	PAX5, BSAP, ALL3	Paired box homeotic gene-5 (B-cell lineage specific activator protein)	167414	PAX5	5079	ENSG00000196092,ENST00000358127;;;ENST00000358127		{Leukemia, acute lymphoblastic, susceptibility to, 3}	615545		3	Pax5
9p13.2	9:37422435-37439494	GRHPR, GLXR	Glyoxylate reductase/hydroxypyruvate reductase	604296	GRHPR	9380	ENSG00000137106,ENST00000318158;;;ENST00000318158		Hyperoxaluria, primary, type II	260000	AR	3	Grhpr
9p13.2	9:37779714-37785092	EXOSC3, RRP40, PCH1B	Exosome component 3	606489	EXOSC3	51010	ENSG00000107371,ENST00000327304;;;ENST00000327304		Pontocerebellar hypoplasia, type 1B	614678	AR	3	Exosc3
9p13.1-q21.11	9:37900001-69300000	OTSC8	Otosclerosis 8	612096		100151644		between D9S970 and D9S1799	Otosclerosis 8	612096	AD	2	
9p12-q12	9:39000001-61500000	ACP	Cerebral palsy, ataxic, autosomal recessive	605388		60502			Cerebral palsy, ataxic, autosomal recessive	605388	AR	2	
9p11	9:40000001-43000000	MROS	Melkersson-Rosenthal syndrome	155900		8011			?Melkersson-Rosenthal syndrome	155900	AD	2	
9q	9:43000001-138394717	HCHGQ2	Hematocrit/hemoglobin quantitative trait locus 2	609320		100381205			[Hematocrit/hemoglobin quantitative trait locus 2]	609320		2	
9q	9:43000001-138394717	SPG19	Spastic paraplegia-19	607152		140907			Spastic paraplegia 19, autosomal dominant	607152	AD	2	
9q13	9:61500001-65000000	CMD1B, CMPD1, FDC	Cardiomyopathy, dilated-1B, autosomal dominant	600884		1218			Cardiomyopathy, dilated 1B	600884	AD	2	
9q13-q22	9:61500001-99800000	CTRCT26, CAAR	Cataract 26, multiple types	605749		81863			Cataract 26, multiple types	605749		2	
9q13-q21	9:61500001-87800000	GSM1, GSP	Geniospasm 1	190100		2933			Geniospasm	190100	AD	2	
9q21.11	9:65000001-69300000	DFNA51, C9DUPq21.11, DUP9q21.11	Deafness, autosomal dominant 51 (chromosome 9q21.11 duplication syndrome)	613558				259kb duplication involving TJP2 and FAM189A2	Deafness, autosomal dominant 51	613558	AD	4	
9q21-q22	9:65000001-99800000	ETL4, ETOLM	Epilepsy, familial temporal lobe, 4	611631		100144434		between GATA152H04 and D9S253	Epilepsy, familial temporal lobe, 4	611631	AD	2	
9q21	9:65000001-87800000	PVOP2	Pelvic organ prolapse, susceptibility to, 2	613088		100312955		between rs4077632 and rs10868525	{Pelvic organ prolapse, susceptibility to, 2}	613088		2	
9q21.11	9:69012504-69014113	PRKACG, BDPLT19	Protein kinase, cAMP-dependent, catalytic, gamma	176893	PRKACG	5568	ENSG00000165059,ENST00000377276;;;ENST00000377276	mutation identified in 1 BDPLT19 family	?Bleeding disorder, platelet-type, 19	616176	AR	3	
9q21.11	9:69035752-69079076	FXN, FRDA, FARR, X25	Frataxin	606829	FXN	2395	ENSG00000165060,ENST00000484259;;;ENST00000484259		Friedreich ataxia	229300	AR	3	Fxn
9q21.11	9:69035752-69079076	FXN, FRDA, FARR, X25	Frataxin	606829	FXN	2395	ENSG00000165060,ENST00000484259;;;ENST00000484259		Friedreich ataxia with retained reflexes	229300	AR	3	Fxn
9q21.11	9:69121264-69255208	TJP2, ZO2, PFIC4, FHCA1	Tight junction protein 2	607709	TJP2	9414	ENSG00000119139,ENST00000377245;;;ENST00000377245		Cholestasis, progressive familial intrahepatic 4	615878	AR	3	Tjp2
9q21.11	9:69121264-69255208	TJP2, ZO2, PFIC4, FHCA1	Tight junction protein 2	607709	TJP2	9414	ENSG00000119139,ENST00000377245;;;ENST00000377245		Hypercholanemia, familial 1	607748	AR	3	Tjp2
9q21.12	9:70258978-70354873	SMC5, SMC5L1, KIAA0594, ATELS2	Structural maintenance of chromosomes 5	609386	SMC5	23137	ENSG00000198887,ENST00000361138;;;ENST00000361138		Atelis syndrome 2	620185	AR	3	Smc5
9q21.12-q21.13	9:70529060-71446971	TRPM3, MLSN2, LTRPC3, KIAA1616, NEDFSS, CTRCT50	Transient receptor potential cation channel, subfamily M, member 3	608961	TRPM3	80036	ENSG00000083067,ENST00000677713;;;ENST00000677713	mutation identified in 1 CTRCT50 family	?Cataract 50 with or without glaucoma	620253	AD	3	Trpm3
9q21.12-q21.13	9:70529060-71446971	TRPM3, MLSN2, LTRPC3, KIAA1616, NEDFSS, CTRCT50	Transient receptor potential cation channel, subfamily M, member 3	608961	TRPM3	80036	ENSG00000083067,ENST00000677713;;;ENST00000677713	mutation identified in 1 CTRCT50 family	Neurodevelopmental disorder with hypotonia, dysmorphic facies, and skeletal anomalies, with or without seizures	620224	AD	3	Trpm3
9q21.12	9:70809975-70810084	MIR204, MIRN204, RDICC	Micro RNA 204	610942	MIR204	406987	ENSG00000207935,ENST00000385200		Retinal dystrophy and iris coloboma with or without cataract	616722	AD	3	Mir204
9q21.13	9:72521608-72838297	TMC1, DFNB7, DFNB11, DFNA36	Transmembrane channel-like protein 1	606706	TMC1	117531	ENSG00000165091,ENST00000297784;;;ENST00000297784		Deafness, autosomal dominant 36	606705	AD	3	Tmc1
9q21.13	9:72521608-72838297	TMC1, DFNB7, DFNB11, DFNA36	Transmembrane channel-like protein 1	606706	TMC1	117531	ENSG00000165091,ENST00000297784;;;ENST00000297784		Deafness, autosomal recessive 7	600974	AR	3	Tmc1
9q21.13	9:74497335-74693177	RORB, RZRB, EIG15	RAR-related orphan receptor B	601972	RORB	6096	ENSG00000198963,ENST00000376896;;;ENST00000376896		{Epilepsy, idiopathic generalized, susceptibility to, 15}	618357	AD	3	Rorb
9q21.13	9:74722495-74887921	TRPM6, CHAK2, HOMG1	Transient receptor potential cation channel, subfamily M, member 6	607009	TRPM6	140803	ENSG00000119121,ENST00000360774;;;ENST00000360774		Hypomagnesemia 1, intestinal	602014	AR	3	Trpm6
9q21.2	9:77177534-77421537	VPS13A, CHAC	Vacuolar protein sorting 13 homolog A (chorein)	605978	VPS13A	23230	ENSG00000197969,ENST00000360280;;;ENST00000360280		Choreoacanthocytosis	200150	AR	3	Vps13a
9q21.2	9:77716097-78031811	GNAQ, SWS, CMC1	Guanine nucleotide-binding protein (G protein), q	600998	GNAQ	2776	ENSG00000156052,ENST00000286548;;;ENST00000286548	pseudogene on 2q	Capillary malformations, congenital, 1, somatic, mosaic	163000		3	Gnaq
9q21.2	9:77716097-78031811	GNAQ, SWS, CMC1	Guanine nucleotide-binding protein (G protein), q	600998	GNAQ	2776	ENSG00000156052,ENST00000286548;;;ENST00000286548	pseudogene on 2q	Sturge-Weber syndrome, somatic, mosaic	185300		3	Gnaq
9q21.2	9:78236075-78279690	CEP78, CRDHL	Centrosomal protein, 78kD	617110	CEP78	84131	ENSG00000148019,ENST00000643273;;;ENST00000643273		Cone-rod dystrophy and hearing loss	617236	AR	3	Cep78
9q21.2	9:78297125-78330093	PSAT1, PSAT, EPIP, PSATD, NLS2	Phosphoserine aminotransferase 1	610936	PSAT1	29968	ENSG00000135069,ENST00000376588;;;ENST00000376588		Neu-Laxova syndrome 2	616038	AR	3	Psat1
9q21.2	9:78297125-78330093	PSAT1, PSAT, EPIP, PSATD, NLS2	Phosphoserine aminotransferase 1	610936	PSAT1	29968	ENSG00000135069,ENST00000376588;;;ENST00000376588		Phosphoserine aminotransferase deficiency	610992	AR	3	Psat1
9q21.3-q22	9:78500001-99800000	FHL1, HPLH1, HLH1	Hemophagocytic lymphohistiocytosis, familial, 1	267700		27259			Hemophagocytic lymphohistiocytosis, familial, 1	267700	AR	2	
9q21.32	9:83968083-83980615	HNRNPK, HNRPK, AUKS	Heterogeneous nuclear ribonucleoprotein K	600712	HNRNPK	3190	ENSG00000165119,ENST00000376263;;;ENST00000376263		Au-Kline syndrome	616580	AD	3	Hnrnpk
9q21.33	9:84668522-85027054	NTRK2, TRKB, OBHD, DEE58	Neurotrophic tyrosine kinase, receptor, type 2	600456	NTRK2	4915	ENSG00000148053,ENST00000277120;;;ENST00000277120		Developmental and epileptic encephalopathy 58	617830	AD	3	Ntrk2
9q21.33	9:84668522-85027054	NTRK2, TRKB, OBHD, DEE58	Neurotrophic tyrosine kinase, receptor, type 2	600456	NTRK2	4915	ENSG00000148053,ENST00000277120;;;ENST00000277120		Obesity, hyperphagia, and developmental delay	613886	AD	3	Ntrk2
9q21.33	9:85546539-85805483	AGTPBP1, NNA1, KIAA1035, CCP1, CONDCA	ATP/GTP-binding protein 1	606830	AGTPBP1	23287	ENSG00000135049,ENST00000357081;;;ENST00000357081		Neurodegeneration, childhood-onset, with cerebellar atrophy	618276	AR	3	Agtpbp1
9q21.33	9:86264546-86282538	ISCA1, HBLD2, HISCA, MMDS5	Iron-sulfur cluster assembly 1	611006	ISCA1	81689	ENSG00000135070,ENST00000375991;;;ENST00000375991		Multiple mitochondrial dysfunctions syndrome 5	617613	AR	3	AK157302,Isca1
9q22	9:87800001-99800000	JOAG2	Glaucoma, primary open angle, juvenile-onset, 2	608695		574078		between D9S1803 and D9S196	Glaucoma, primary open angle, juvenile-onset, 2	608695		2	
9q22	9:87800001-99800000	STQTL8	Stature quantitative trait locus 8	610114		100037266		between GATA81C04M and ATA18A07M	{Stature QTL 8}	610114		2	
9q22.2	9:89318500-89367117	SECISBP2, SBP2, THMA1	Selenocysteine insertion sequence-binding protein 2	607693	SECISBP2	79048	ENSG00000187742,ENST00000375807;;;ENST00000375807		Thyroid hormone metabolism, abnormal, 1	609698	AR	3	Secisbp2
9q22.2	9:90801600-90898549	SYK, IMD82	Protein-tyrosine kinase SYK	600085	SYK	6850	ENSG00000165025,ENST00000375754;;;ENST00000375754		Immunodeficiency 82 with systemic inflammation	619381	AD	3	Syk
9q22.31	9:91213823-91361918	AUH	AU-specific RNA-binding protein (3-methylglutaconyl-CoA hydratase)	600529	AUH	549	ENSG00000148090,ENST00000375731;;;ENST00000375731		3-methylglutaconic aciduria, type I	250950	AR	3	Auh
9q22.31	9:91722601-91950228	ROR2, BDB1, BDB, NTRKR2	Receptor tyrosine kinase-like orphan receptor 2	602337	ROR2	4920	ENSG00000169071,ENST00000375708;;;ENST00000375708		Brachydactyly, type B1	113000	AD	3	Ror2
9q22.31	9:91722601-91950228	ROR2, BDB1, BDB, NTRKR2	Receptor tyrosine kinase-like orphan receptor 2	602337	ROR2	4920	ENSG00000169071,ENST00000375708;;;ENST00000375708		Robinow syndrome, autosomal recessive	268310	AR	3	Ror2
9q22.31	9:92031147-92115413	SPTLC1, LBC1, SPT1, HSN1, HSAN, ALS27	Serine palmitoyltransferase, long-chain base subunit 1	605712	SPTLC1	10558	ENSG00000090054,ENST00000262554;;;ENST00000262554		Amyotrophic lateral sclerosis 27, juvenile	620285	AD	3	Sptlc1
9q22.31	9:92031147-92115413	SPTLC1, LBC1, SPT1, HSN1, HSAN, ALS27	Serine palmitoyltransferase, long-chain base subunit 1	605712	SPTLC1	10558	ENSG00000090054,ENST00000262554;;;ENST00000262554		Neuropathy, hereditary sensory and autonomic, type IA	162400	AD	3	Sptlc1
9q22.31	9:92210207-92293697	IARS1, IARS, GRIDHH	Isoleucine-tRNA synthetase 1	600709	IARS1	3376	ENSG00000196305,ENST00000443024;;;ENST00000443024		Growth retardation, impaired intellectual development, hypotonia, and hepatopathy	617093	AR	3	Iars1
9q22.31	9:92456205-92482506	ASPN, PLAP1, OS3	Asporin	608135	ASPN	54829	ENSG00000106819,ENST00000375543		{Lumbar disc degeneration}	603932		3	Aspn
9q22.31	9:92456205-92482506	ASPN, PLAP1, OS3	Asporin	608135	ASPN	54829	ENSG00000106819,ENST00000375543		{Osteoarthritis susceptibility 3}	607850	AD	3	Aspn
9q22.31	9:92711363-92764833	BICD2, KIAA0699, SMALED2A, SMALED2B	BICD carbo adaptor 2	609797	BICD2	23299	ENSG00000185963,ENST00000356884;;;ENST00000356884		Spinal muscular atrophy, lower extremity-predominant, 2A, autosomal dominant	615290	AD	3	Bicd2
9q22.31	9:92711363-92764833	BICD2, KIAA0699, SMALED2A, SMALED2B	BICD carbo adaptor 2	609797	BICD2	23299	ENSG00000185963,ENST00000356884;;;ENST00000356884		Spinal muscular atrophy, lower extremity-predominant, 2B, autosomal dominant	618291	AD	3	Bicd2
9q22.32	9:94558720-94593824	FBP2, CORLK	Fructose-1,6-bisphosphatase 2	603027	FBP2	8789	ENSG00000130957,ENST00000375337;;;ENST00000375337	mutation identified in 1 CORLK family	?Leukodystrophy, childhood-onset, remitting	619864	AD	3	Fbp2
9q22.32	9:94603133-94640263	FBP1	Fructose-bisphosphatase 1	611570	FBP1	2203	ENSG00000165140,ENST00000375326;;;ENST00000375326		Fructose-1,6-bisphosphatase deficiency	229700	AR	3	Fbp1
9q22.32	9:94726699-95150224	AOPEP, C9orf3, DYT31	Aminopeptidase O	619600	AOPEP	84909	ENSG00000148120,ENST00000375315;;;ENST00000375315		Dystonia 31	619565	AR	3	Aopep
9q22.32	9:95099054-95317709	FANCC, FACC	Fanconi anemia, complementation group C	613899	FANCC	2176	ENSG00000158169,ENST00000289081;;;ENST00000289081		Fanconi anemia, complementation group C	227645	AR	3	Fancc
9q22.32	9:95442980-95516971	PTCH1, NBCCS, BCNS1, HPE7	Patched 1	601309	PTCH1	5727	ENSG00000185920,ENST00000331920;;;ENST00000331920		Basal cell carcinoma, somatic	605462		3	Ptch1
9q22.32	9:95442980-95516971	PTCH1, NBCCS, BCNS1, HPE7	Patched 1	601309	PTCH1	5727	ENSG00000185920,ENST00000331920;;;ENST00000331920		Basal cell nevus syndrome 1	109400	AD	3	Ptch1
9q22.32	9:95442980-95516971	PTCH1, NBCCS, BCNS1, HPE7	Patched 1	601309	PTCH1	5727	ENSG00000185920,ENST00000331920;;;ENST00000331920		Holoprosencephaly 7	610828	AD	3	Ptch1
9q22.32	9:95875691-96041092	ERCC6L2, RAD26L, BMFS2	ERCC6 excision repair 6-like 2	615667	ERCC6L2	375748	ENSG00000182150,ENST00000653738;;;ENST00000653738		Bone marrow failure syndrome 2	615715	AR	3	Ercc6l2
9q22.32	9:96235306-96302176	HSD17B3, EDH17B3	Hydroxysteroid (17-beta) dehydrogenase 3	605573	HSD17B3	3293	ENSG00000130948,ENST00000375263;;;ENST00000375263		Pseudohermaphroditism, male, with gynecomastia	264300	AR	3	Hsd17b3
9q22.33	9:97412096-97496125	TDRD7, KIAA1529, TRAP, CATC4, CTRCT36	Tudor domain-containing protein 7	611258	TDRD7	23424	ENSG00000196116,ENST00000355295;;;ENST00000355295		Cataract 36	613887	AR	3	Tdrd7
9q22.33	9:97654398-97697340	XPA, XPAC	XPA complementing gene	611153	XPA	7507	ENSG00000136936,ENST00000375128;;;ENST00000375128		Xeroderma pigmentosum, group A	278700	AR	3	Xpa
9q22.33	9:97853226-97856717	FOXE1, FKHL15, TITF2, TTF2, NMTC4, BAMLAZ	Forkhead box E1 (thyroid transcription factor-2)	602617	FOXE1	2304	ENSG00000178919,ENST00000375123;;;ENST00000375123		{Thyroid cancer, nonmedullary, 4}	616534	AD	3	Foxe1
9q22.33	9:97853226-97856717	FOXE1, FKHL15, TITF2, TTF2, NMTC4, BAMLAZ	Forkhead box E1 (thyroid transcription factor-2)	602617	FOXE1	2304	ENSG00000178919,ENST00000375123;;;ENST00000375123		Bamforth-Lazarus syndrome	241850	AR	3	Foxe1
9q22.33	9:98056732-98083077	NANS, SAS, SEMDG	N-acetylneuraminic acid synthase (sialic acid synthase)	605202	NANS	54187	ENSG00000095380,ENST00000210444;;;ENST00000210444		Spondyloepimetaphyseal dysplasia, Genevieve type	610442	AR	3	Nans
9q22.33	9:98288109-98708935	GABBR2, GPR51, DEE59, NDPLHS	Gamma-aminobutyric acid B receptor 2	607340	GABBR2	9568	ENSG00000136928,ENST00000259455;;;ENST00000259455		{Nicotine dependence, protection against}	188890		3	Gabbr2
9q22.33	9:98288109-98708935	GABBR2, GPR51, DEE59, NDPLHS	Gamma-aminobutyric acid B receptor 2	607340	GABBR2	9568	ENSG00000136928,ENST00000259455;;;ENST00000259455		{Nicotine dependence, susceptibility to}	188890		3	Gabbr2
9q22.33	9:98288109-98708935	GABBR2, GPR51, DEE59, NDPLHS	Gamma-aminobutyric acid B receptor 2	607340	GABBR2	9568	ENSG00000136928,ENST00000259455;;;ENST00000259455		Developmental and epileptic encephalopathy 59	617904	AD	3	Gabbr2
9q22.33	9:98288109-98708935	GABBR2, GPR51, DEE59, NDPLHS	Gamma-aminobutyric acid B receptor 2	607340	GABBR2	9568	ENSG00000136928,ENST00000259455;;;ENST00000259455		Neurodevelopmental disorder with poor language and loss of hand skills	617903	AD	3	Gabbr2
9q22.33	9:98732009-98796555	ANKS6, PKDR1, NPHP16	Ankyrin repeat and sterile alpha motif domains-containing protein 6	615370	ANKS6	203286	ENSG00000165138,ENST00000353234;;;ENST00000353234		Nephronophthisis 16	615382	AR	3	Anks6
9q22.33	9:98807670-98850081	GALNT12, CRCS1	UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 12	610290	GALNT12	79695	ENSG00000119514,ENST00000375011;;;ENST00000375011		{Colorectal cancer, susceptibility to, 1}	608812		3	Galnt12
9q22.33	9:99103647-99154192	TGFBR1, ALK5, AAT5, LDS1, MSSE	Transforming growth factor, beta receptor I (activin A receptor type II-like kinase, 53kD)	190181	TGFBR1	7046	ENSG00000106799,ENST00000374994;;;ENST00000374994		{Multiple self-healing squamous epithelioma, susceptibility to}	132800	AD	3	Tgfbr1
9q22.33	9:99103647-99154192	TGFBR1, ALK5, AAT5, LDS1, MSSE	Transforming growth factor, beta receptor I (activin A receptor type II-like kinase, 53kD)	190181	TGFBR1	7046	ENSG00000106799,ENST00000374994;;;ENST00000374994		Loeys-Dietz syndrome 1	609192	AD	3	Tgfbr1
9q22.33	9:99216425-99221942	ALG2, CDGII, CMSTA3, CMS14	ALG2 alpha-1,3/1,6-mannosyltransferase	607905	ALG2	85365	ENSG00000119523,ENST00000476832;;;ENST00000476832		Congenital disorder of glycosylation, type Ii	607906	AR	3	Alg2
9q22.33	9:99216425-99221942	ALG2, CDGII, CMSTA3, CMS14	ALG2 alpha-1,3/1,6-mannosyltransferase	607905	ALG2	85365	ENSG00000119523,ENST00000476832;;;ENST00000476832		Myasthenic syndrome, congenital, 14, with tubular aggregates	616228	AR	3	Alg2
9q31.1	9:99800001-105400000	CHDT3	Congenital heart defects, multiple types, 3	614954		101154642		max lod at D9S1690	Congenital heart defects, multiple types, 3	614954	AD	2	
9q31-q32	9:99800001-114900000	HNP1	Hypertensive nephropathy	608026		574045			Hypertensive nephropathy	608026		2	
9q31	9:99800001-112100000	HSCR5	Hirschsprung disease, susceptibility to, 5	600156		404720			{Hirschsprung disease, susceptibility to, 5}	600156	AD	2	
9q31	9:99800001-112100000	PAND2	Panic disorder 2	607853		619493		max lod at D9S271	Panic disorder 2	607853		2	
9q31-q34	9:99800001-138394717	SPDA2	Spondyloarthropathy, susceptibility to, 2	183840		791255		max lod at D9S1776	{Spondyloarthropathy, susceptibility to, 2}	183840	AD	2	
9q31.1	9:99821885-99866891	CSMF	Chondrosarcoma, extraskeletal myxoid, fused to EWS in	600542	NR4A3	8013	ENSG00000119508,ENST00000395097;;;ENST00000395097	t(9;17)(q22;q11); t(9;22)(q22;q11-q12)	Chondrosarcoma, extraskeletal myxoid	612237		3	Nr4a3
9q31.1	9:100099243-100302175	INVS, INV, NPHP2, NPH2	Inversin	243305	INVS	27130	ENSG00000119509,ENST00000262457;;;ENST00000262457		Nephronophthisis 2, infantile	602088	AR	3	Invs
9q31.1	9:101360417-101385006	BAAT, HCHO, FHCA3	Bile acid coenzyme A:amino acid N-acyltransferase (glycine N-choloyltransferase)	602938	BAAT	570	ENSG00000136881,ENST00000259407;;;ENST00000259407		Hypercholanemia, familial 3	619232	AR	3	Baat
9q31.1	9:101420560-101435774	ALDOB	Aldolase B, fructose-bisphosphatase	612724	ALDOB	229	ENSG00000136872,ENST00000647789;;;ENST00000647789		Fructose intolerance, hereditary	229600	AR	3	Aldob
9q31.1	9:104781006-104928155	ABCA1, ABC1, HPALP1, TGD, HDLCQTL13	ATP-binding cassette 1	600046	ABCA1	19	ENSG00000165029,ENST00000374736;;;ENST00000374736		HDL deficiency, familial, 1	604091	AD	3	Abca1
9q31.1	9:104781006-104928155	ABCA1, ABC1, HPALP1, TGD, HDLCQTL13	ATP-binding cassette 1	600046	ABCA1	19	ENSG00000165029,ENST00000374736;;;ENST00000374736		Tangier disease	205400	AR	3	Abca1
9q31.1-q31.2	9:105244651-105438504	SLC44A1, CTL1, CDW92, CONATOC	Solute carrier family 44, member 1	606105	SLC44A1	23446	ENSG00000070214,ENST00000374720;;;ENST00000374720		Neurodegeneration, childhood-onset, with ataxia, tremor, optic atrophy, and cognitive decline	618868	AR	3	Slc44a1
9q31.2-q34.2	9:105400001-134500000	IS4	Scoliosis, idiopathic, susceptibility to, 4	612238		100190785		max lod at D9S2157	{Scoliosis, idiopathic, susceptibility to, 4}	612238		2	
9q31.2	9:105400001-108500000	MENAQ3	Menarche, age at, QTL3	612883		100302563		associated with rs2090409	{Menarche, age at, QTL3}	612883		2	
9q31.2	9:105558130-105641118	FKTN, FCMD, CMD1X, LGMDR13, MDDGA4, MDDGB4, MDDGC4	Fukutin	607440	FKTN	2218	ENSG00000106692,ENST00000357998;;;ENST00000357998		Cardiomyopathy, dilated, 1X	611615	AR	3	Fktn
9q31.2	9:105558130-105641118	FKTN, FCMD, CMD1X, LGMDR13, MDDGA4, MDDGB4, MDDGC4	Fukutin	607440	FKTN	2218	ENSG00000106692,ENST00000357998;;;ENST00000357998		Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 4	253800	AR	3	Fktn
9q31.2	9:105558130-105641118	FKTN, FCMD, CMD1X, LGMDR13, MDDGA4, MDDGB4, MDDGC4	Fukutin	607440	FKTN	2218	ENSG00000106692,ENST00000357998;;;ENST00000357998		Muscular dystrophy-dystroglycanopathy (congenital without impaired intellectual development), type B, 4	613152	AR	3	Fktn
9q31.2	9:105558130-105641118	FKTN, FCMD, CMD1X, LGMDR13, MDDGA4, MDDGB4, MDDGC4	Fukutin	607440	FKTN	2218	ENSG00000106692,ENST00000357998;;;ENST00000357998		Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 4	611588	AR	3	Fktn
9q31.2	9:105662457-105663124	TAL2	T-cell acute lymphocytic leukemia-2	186855	TAL2	6887	ENSG00000186051,ENST00000334077;;;ENST00000334077	33kb from breakpoint in t(7;9)	Leukemia, T-cell acute lymphocytic, somatic	613065		3	Tal2
9q31.2	9:105694541-105776629	TMEM38B, TRICB, OI14	Transmembrane protein 38B	611236	TMEM38B	55151	ENSG00000095209,ENST00000374692;;;ENST00000374692		Osteogenesis imperfecta, type XIV	615066	AR	3	Tmem38b
9q31.2	9:106860158-107013634	ZNF462, KIAA1803, WSKA	Zinc finger protein 462	617371	ZNF462	58499	ENSG00000148143,ENST00000277225;;;ENST00000277225		Weiss-Kruszka syndrome	618619	AD	3	Zfp462
9q31.3	9:108862266-108863756	ACTL7A, SPGF86	Actin-like 7A	604303	ACTL7A	10881	ENSG00000187003,ENST00000333999;;;ENST00000333999		Spermatogenic failure 86	620499	AR	3	Actl7a
9q31.3	9:108867517-108934124	ELP1, IKBKAP, IKAP	Elongator complex protein 1	603722	ELP1	8518	ENSG00000070061,ENST00000374647;;;ENST00000374647		{Medulloblastoma}	155255	AD, AR, SMu	3	Elp1
9q31.3	9:108867517-108934124	ELP1, IKBKAP, IKAP	Elongator complex protein 1	603722	ELP1	8518	ENSG00000070061,ENST00000374647;;;ENST00000374647		Dysautonomia, familial	223900	AR	3	Elp1
9q31.3	9:109130293-109167249	FRRS1L, C9orf4, CG6, DEE37	Ferric-chelate reductase 1-like	604574	FRRS1L	23732	ENSG00000260230,ENST00000561981;;;ENST00000561981		Developmental and epileptic encephalopathy 37	616981	AR	3	Frrs1l
9q31.3	9:110668791-110806558	MUSK, CMS9, FADS1	Receptor tyrosine kinase MuSK	601296	MUSK	4593	ENSG00000030304,ENST00000374448;;;ENST00000374448		Fetal akinesia deformation sequence 1	208150	AR	3	Musk
9q31.3	9:110668791-110806558	MUSK, CMS9, FADS1	Receptor tyrosine kinase MuSK	601296	MUSK	4593	ENSG00000030304,ENST00000374448;;;ENST00000374448		Myasthenic syndrome, congenital, 9, associated with acetylcholine receptor deficiency	616325	AR	3	Musk
9q31.3	9:111686171-111794937	SHOC1, C9orf84, ZIP2, SPGF75	Shortage in chiasmata 1	618038	SHOC1	158401	ENSG00000165181,ENST00000682961;;;ENST00000682961		Spermatogenic failure 75	619949	AR	3	Shoc1
9q32-q33	9:112100001-127500000	ARMD10	Macular degeneration, age-related, 10	611488					Macular degeneration, age-related, 10	611488		2	
9q32-q33	9:112100001-127500000	EIG3	Epilepsy, idiopathic generalized, susceptibility to 3	608762		432400			{Epilepsy, idiopathic generalized, susceptibility to, 3}	608762	AR	2	
9q32	9:112100001-114900000	IBD16	Inflammatory bowel disease 16, susceptibility to	612259		100190930			{Inflammatory bowel disease 16}	612259		2	
9q32	9:113221544-113264492	SLC31A1, COPT1, CTR1, NSCT	Solute carrier family 31 (copper transporter), member 1	603085	SLC31A1	1317	ENSG00000136868,ENST00000374212;;;ENST00000374212		Neurodegeneration and seizures due to copper transport defect	620306	AR	3	Slc31a1
9q32	9:113275658-113292905	PRPF4, PRP4, HPRP4, RP70	Pre-mRNA processing factor 4	607795	PRPF4	9128	ENSG00000136875,ENST00000374198;;;ENST00000374198		Retinitis pigmentosa 70	615922	AD	3	Prpf4
9q32	9:113386312-113401284	ALAD, ALADH, PBGS	Aminolevulinate, delta-, dehydratase	125270	ALAD	210	ENSG00000148218,ENST00000409155;;;ENST00000409155	linked to ABO; ORM-ALAD-AK-ABO	{Lead poisoning, susceptibility to}	612740	AR	3	Alad
9q32	9:113386312-113401284	ALAD, ALADH, PBGS	Aminolevulinate, delta-, dehydratase	125270	ALAD	210	ENSG00000148218,ENST00000409155;;;ENST00000409155	linked to ABO; ORM-ALAD-AK-ABO	Porphyria, acute hepatic	612740	AR	3	Alad
9q32	9:114091638-114099292	KIF12, PFIC8	Kinesin family member 12	611278	KIF12	113220	ENSG00000136883,ENST00000640217;;;ENST00000640217		Cholestasis, progressive familial intrahepatic, 8	619662	AR	3	Kif12
9q32	9:114154098-114312511	COL27A1, KIAA1870, STLS	Collagen, type XXVII, alpha-1	608461	COL27A1	85301	ENSG00000196739,ENST00000356083;;;ENST00000356083		Steel syndrome	615155	AR	3	Col27a1
9q32	9:114402080-114505473	WHRN, CIP98, KIAA1526, DFNB31, USH2D	Whirlin	607928	WHRN	25861	ENSG00000095397,ENST00000362057;;;ENST00000362057		Deafness, autosomal recessive 31	607084	AR	3	Whrn
9q32	9:114402080-114505473	WHRN, CIP98, KIAA1526, DFNB31, USH2D	Whirlin	607928	WHRN	25861	ENSG00000095397,ENST00000362057;;;ENST00000362057		Usher syndrome, type 2D	611383	AR	3	Whrn
9q33	9:114900001-127500000	ASRT8	Asthma-related traits, susceptibility to, 8	613207		100415896		associated with rs3789873	{Asthma-related traits, susceptibility to, 8}	613207		2	
9q33.1	9:115019575-115118157	TNC, HXB, DFNA56	Tenascin C (hexabrachion)	187380	TNC	3371	ENSG00000041982,ENST00000350763;;;ENST00000350763	proximal to ABL	Deafness, autosomal dominant 56	615629	AD	3	Tnc
9q33.1	9:116687305-116701299	TRIM32, HT2A, LGMDR8, BBS11	Tripartite-motif-containing protein 32	602290	TRIM32	22954	ENSG00000119401,ENST00000450136;;;ENST00000450136	mutation identified in 1 BBS11 family	?Bardet-Biedl syndrome 11	615988	AR	3	Trim32
9q33.1	9:116687305-116701299	TRIM32, HT2A, LGMDR8, BBS11	Tripartite-motif-containing protein 32	602290	TRIM32	22954	ENSG00000119401,ENST00000450136;;;ENST00000450136	mutation identified in 1 BBS11 family	Muscular dystrophy, limb-girdle, autosomal recessive 8	254110	AR	3	Trim32
9q33.2	9:120388875-120580167	CDK5RAP2, KIAA1633, MCPH3	CDK5 regulatory subunit-associated protein 2	608201	CDK5RAP2	55755	ENSG00000136861,ENST00000349780;;;ENST00000349780		Microcephaly 3, primary, autosomal recessive	604804	AR	3	Cdk5rap2
9q33.2	9:120952335-121074865	C5, C5D, ECLZB	Complement component-5	120900	C5	727	ENSG00000106804,ENST00000223642;;;ENST00000223642		[Eculizumab, poor response to]	615749	AD	3	AI182371,Hc
9q33.2	9:120952335-121074865	C5, C5D, ECLZB	Complement component-5	120900	C5	727	ENSG00000106804,ENST00000223642;;;ENST00000223642		C5 deficiency	609536	AR	3	AI182371,Hc
9q33.2	9:121201483-121332842	GSN, AMYLD4	Gelsolin	137350	GSN	2934	ENSG00000148180,ENST00000432226;;;ENST00000432226	40kb proximal to ABL	Amyloidosis, Finnish type	105120	AD	3	Gsn
9q33.2	9:122132466-122159779	NDUFA8, MC1DN37	NADH-ubiquinone oxidoreductase subunit A8	603359	NDUFA8	4702	ENSG00000119421,ENST00000373768;;;ENST00000373768		Mitochondrial complex I deficiency, nuclear type 37	619272	AR	3	Ndufa8
9q33.3	9:123354065-123380326	CRB2, FSGS9, VMCKD	Crumbs cell polarity complex component 2	609720	CRB2	286204	ENSG00000148204,ENST00000373631;;;ENST00000373631		Focal segmental glomerulosclerosis 9	616220	AR	3	Crb2
9q33.3	9:123354065-123380326	CRB2, FSGS9, VMCKD	Crumbs cell polarity complex component 2	609720	CRB2	286204	ENSG00000148204,ENST00000373631;;;ENST00000373631		Ventriculomegaly with cystic kidney disease	219730	AR	3	Crb2
9q33.3	9:124481236-124507399	NR5A1, FTZF1, FTZ1, SF1, AD4BP, POF7, SRXY3, SPGF8, SRXX4	Nuclear receptor subfamily 5, group A, member 1	184757	NR5A1	2516	ENSG00000136931,ENST00000373588;;;ENST00000373588		46XX sex reversal 4	617480	AD	3	Nr5a1
9q33.3	9:124481236-124507399	NR5A1, FTZF1, FTZ1, SF1, AD4BP, POF7, SRXY3, SPGF8, SRXX4	Nuclear receptor subfamily 5, group A, member 1	184757	NR5A1	2516	ENSG00000136931,ENST00000373588;;;ENST00000373588		46XY sex reversal 3	612965	AD	3	Nr5a1
9q33.3	9:124481236-124507399	NR5A1, FTZF1, FTZ1, SF1, AD4BP, POF7, SRXY3, SPGF8, SRXX4	Nuclear receptor subfamily 5, group A, member 1	184757	NR5A1	2516	ENSG00000136931,ENST00000373588;;;ENST00000373588		Adrenocortical insufficiency	612964	AD	3	Nr5a1
9q33.3	9:124481236-124507399	NR5A1, FTZF1, FTZ1, SF1, AD4BP, POF7, SRXY3, SPGF8, SRXX4	Nuclear receptor subfamily 5, group A, member 1	184757	NR5A1	2516	ENSG00000136931,ENST00000373588;;;ENST00000373588		Premature ovarian failure 7	612964	AD	3	Nr5a1
9q33.3	9:124481236-124507399	NR5A1, FTZF1, FTZ1, SF1, AD4BP, POF7, SRXY3, SPGF8, SRXX4	Nuclear receptor subfamily 5, group A, member 1	184757	NR5A1	2516	ENSG00000136931,ENST00000373588;;;ENST00000373588		Spermatogenic failure 8	613957	AD	3	Nr5a1
9q33.3	9:124517275-124771311	NR6A1, GCNF, RTR	Nuclear receptor subfamily 6, group A, member 1	602778	NR6A1	2649	ENSG00000148200,ENST00000487099;;;ENST00000487099		Oculovertebral syndrome	621277	AD	3	Nr6a1
9q33.3	9:124857883-124861957	RPL35, DBA19	Ribosomal protein L35	618315	RPL35	11224	ENSG00000136942,ENST00000348462;;;ENST00000348462	mutation identified in 1 DBA19 family	?Diamond-Blackfan anemia 19	618312	AD	3	Rpl35
9q33.3	9:126613928-126701032	LMX1B, NPS1, FSGS10	LIM homeobox transcription factor 1, beta	602575	LMX1B	4010	ENSG00000136944,ENST00000373474;;;ENST00000373474		Focal segmental glomerulosclerosis 10	256020	AD	3	Lmx1b
9q33.3	9:126613928-126701032	LMX1B, NPS1, FSGS10	LIM homeobox transcription factor 1, beta	602575	LMX1B	4010	ENSG00000136944,ENST00000373474;;;ENST00000373474		Nail-patella syndrome	161200	AD	3	Lmx1b
9q33.3-q34.11	9:127451486-127503501	LRSAM1, TAL, RIFLE, CMT2P	Leucine-rich repeat- and sterile alpha motif-containing 1	610933	LRSAM1	90678	ENSG00000148356,ENST00000300417;;;ENST00000300417		Charcot-Marie-Tooth disease, axonal, type 2P	614436	AD, AR	3	Lrsam1
9q34.1	9:127500001-133100000	CLLS3	Leukemia, chronic lymphocytic, susceptibility to, 3	612557		100270642		associated with SNP -6531 upstream of DAPK1 promoter	{Leukemia, chronic lymphocytic, susceptibility to, 3}	612557		2	
9q34	9:127500001-138394717	DYT23	Dystonia 23	614860		115029024		linkage to D9S159 and D9S1818	Dystonia 23	614860	AD	2	
9q34	9:127500001-138394717	KTCN6	Keratoconus 6	614623		100885802		max lod at 159cM	Keratoconus 6	614623	AD	2	
9q34.11	9:127611912-127696029	STXBP1, UNC18, DEE4	Syntaxin-binding protein 1	602926	STXBP1	6812	ENSG00000136854,ENST00000373299;;;ENST00000373299		Developmental and epileptic encephalopathy 4	612164	AD, AR	3	Stxbp1
9q34.11	9:127785918-127786007	MIR2861, MIRN2861, BMND15	Micro RNA 2861	613405	MIR2861	100422910	ENSG00000284547,ENST00000636310		[Bone mineral density QTL 15]	613418	AD, AR	3	Mir2861
9q34.11	9:127815016-127854658	ENG, END, HHT1, ORW	Endoglin	131195	ENG	2022	ENSG00000106991,ENST00000373203;;;ENST00000373203		Telangiectasia, hereditary hemorrhagic, type 1	187300	AD	3	Eng
9q34.11	9:127866480-127879621	AK1, CNSHA3	Adenylate kinase-1	103000	AK1	203	ENSG00000106992,ENST00000644144;;;ENST00000644144		Anemia, congenital, nonspherocytic hemolytic, 3, adenylate kinase deficient	612631	AR	3	Ak1
9q34.11	9:127935099-127937854	DPM2, CDG1U	Dolichyl-phosphate mannosyltransferase 2, regulatory subunit	603564	DPM2	8818	ENSG00000136908,ENST00000314392;;;ENST00000314392		Congenital disorder of glycosylation, type Iu	615042	AR	3	Dpm2
9q34.11	9:128203379-128255244	DNM1, DEE31A, DEE31B	Dynamin-1	602377	DNM1	1759	ENSG00000106976,ENST00000372923;;;ENST00000372923		Developmental and epileptic encephalopathy 31A, autosomal dominant	616346	AD	3	Dnm1
9q34.11	9:128203379-128255244	DNM1, DEE31A, DEE31B	Dynamin-1	602377	DNM1	1759	ENSG00000106976,ENST00000372923;;;ENST00000372923		Developmental and epileptic encephalopathy 31B, autosomal recessive	620352	AR	3	Dnm1
9q34.11	9:128255829-128276007	GOLGA2, GM130, DEDHMB	Golgin A2	602580	GOLGA2	2801	ENSG00000167110,ENST00000611957;;;ENST00000611957		Developmental delay with hypotonia, myopathy, and brain abnormalities	620240	AR	3	Golga2
9q34.11	9:128322839-128334072	COQ4, COQ10D7, SPAX10	Coenzyme Q4	612898	COQ4	51117	ENSG00000167113,ENST00000300452;;;ENST00000300452		Coenzyme Q10 deficiency, primary, 7	616276	AR	3	Coq4
9q34.11	9:128322839-128334072	COQ4, COQ10D7, SPAX10	Coenzyme Q4	612898	COQ4	51117	ENSG00000167113,ENST00000300452;;;ENST00000300452		Spastic ataxia 10, autosomal recessive	620666	AR	3	Coq4
9q34.11	9:128340527-128361470	SLC27A4, FATP4, IPS	Solute carrier family 27 (fatty acid transporter), member 4	604194	SLC27A4	10999	ENSG00000167114,ENST00000300456;;;ENST00000300456		Ichthyosis prematurity syndrome	608649	AR	3	Slc27a4
9q34.11	9:128504692-128542288	GLE1, GLE1L, LCCS, LCCS1, CAAHD	GLE1, RNA export mediator	603371	GLE1	2733	ENSG00000119392,ENST00000309971;;;ENST00000309971		Congenital arthrogryposis with anterior horn cell disease	611890	AR	3	Gle1
9q34.11	9:128504692-128542288	GLE1, GLE1L, LCCS, LCCS1, CAAHD	GLE1, RNA export mediator	603371	GLE1	2733	ENSG00000119392,ENST00000309971;;;ENST00000309971		Lethal congenital contracture syndrome 1	253310	AR	3	Gle1
9q34.11	9:128552587-128633662	SPTAN1, NEAS, DEE5, HMND11, DEVEP, SPG91	Spectrin, alpha, nonerythrocytic-1 (alpha-fodrin)	182810	SPTAN1	6709	ENSG00000197694,ENST00000372739;;;ENST00000372739		Developmental and epileptic encephalopathy 5	613477	AD	3	Sptan1
9q34.11	9:128552587-128633662	SPTAN1, NEAS, DEE5, HMND11, DEVEP, SPG91	Spectrin, alpha, nonerythrocytic-1 (alpha-fodrin)	182810	SPTAN1	6709	ENSG00000197694,ENST00000372739;;;ENST00000372739		Developmental delay with or without epilepsy	620540	AD	3	Sptan1
9q34.11	9:128552587-128633662	SPTAN1, NEAS, DEE5, HMND11, DEVEP, SPG91	Spectrin, alpha, nonerythrocytic-1 (alpha-fodrin)	182810	SPTAN1	6709	ENSG00000197694,ENST00000372739;;;ENST00000372739		Neuronopathy, distal hereditary motor, autosomal dominant 11	620528	AD	3	Sptan1
9q34.11	9:128552587-128633662	SPTAN1, NEAS, DEE5, HMND11, DEVEP, SPG91	Spectrin, alpha, nonerythrocytic-1 (alpha-fodrin)	182810	SPTAN1	6709	ENSG00000197694,ENST00000372739;;;ENST00000372739		Spastic paraplegia 91, autosomal dominant, with or without cerebellar ataxia	620538	AD	3	Sptan1
9q34.11	9:128633653-128684460	DYNC2I2, WDR34, SRTD11	Dynein 2 intermediate chain 2	613363	DYNC2I2	89891	ENSG00000119333,ENST00000372715;;;ENST00000372715		Short-rib thoracic dysplasia 11 with or without polydactyly	615633	AR	3	Dync2i2
9q34.11	9:128683424-128696396	SET, MRD58	SET gene	600960	SET	6418	ENSG00000119335,ENST00000322030;;;ENST00000322030	fused with CAIN in acute undifferentiated leukemia	Intellectual developmental disorder, autosomal dominant 58	618106	AD	3	Set
9q34.11	9:128819651-128829794	SPOUT1, CENP32, C9orf114, NEDGSB	SPOUT domain-containing methyltransferase 1	617614	SPOUT1	51490	ENSG00000198917,ENST00000361256;;;ENST00000361256		Neurodevelopmental disorder with poor growth, seizures, and brain abnormalities	621154	AR	3	Spout1
9q34.11	9:128882133-128918039	LRRC8A, KIAA1437, AGM5	Leucine-rich repeat-containing 8A	608360	LRRC8A	56262	ENSG00000136802,ENST00000372600;;;ENST00000372600	mutation identified in 1 AGM5 patient	?Agammaglobulinemia 5	613506	AD	3	Lrrc8a
9q34.11	9:128945530-128947603	DOLK, TMEM15, DK1, SEC59, KIAA1094, CDG1M	Dolichol kinase	610746	DOLK	22845	ENSG00000175283,ENST00000372586;;;ENST00000372586		Congenital disorder of glycosylation, type Im	610768	AR	3	Dolk
9q34.11	9:128947699-129007096	NUP188, KIAA1069, SANDSTEF	Nucleoporin, 188kD	615587	NUP188	23511	ENSG00000095319,ENST00000372577;;;ENST00000372577		Sandestig-Stefanova syndrome	618804	AR	3	Nup188
9q34.11	9:129094794-129110793	CRAT, CAT1, NBIA8	Carnitine acetyltransferase	600184	CRAT	1384	ENSG00000095321,ENST00000318080;;;ENST00000318080	mutation identified in 1 NBIA8 patient	?Neurodegeneration with brain iron accumulation 8	617917	AR	3	Crat
9q34.11	9:129110950-129148946	PTPA, PPP2R4, PARK25	Protein phosphatase 2 phosphatase activator	600756	PTPA	5524	ENSG00000119383,ENST00000393370;;;ENST00000393370	proximal to ABL	Parkinson disease 25, autosomal recessive early-onset, with impaired intellectual development	620482	AR	3	Ptpa
9q34.11	9:129812942-129824136	TOR1A, DYT1, AMC5	Torsin 1A	605204	TOR1A	1861	ENSG00000136827,ENST00000351698;;;ENST00000351698		{Dystonia-1, modifier of}			3	Tor1a
9q34.11	9:129812942-129824136	TOR1A, DYT1, AMC5	Torsin 1A	605204	TOR1A	1861	ENSG00000136827,ENST00000351698;;;ENST00000351698		Arthrogryposis multiplex congenita 5	618947	AR	3	Tor1a
9q34.11	9:129812942-129824136	TOR1A, DYT1, AMC5	Torsin 1A	605204	TOR1A	1861	ENSG00000136827,ENST00000351698;;;ENST00000351698		Dystonia-1, torsion	128100	AD	3	Tor1a
9q34.11	9:130444707-130501274	ASS1, ASS	Argininosuccinate synthetase 1	603470	ASS1	445	ENSG00000130707,ENST00000352480;;;ENST00000352480	14 pseudogenes on 11 chromosomes, including X and Y and ASSP2 on 6p23-q12	Citrullinemia	215700	AR	3	Ass1
9q34.12	9:130664594-130682983	PRDM12, HSAN8	PR domain-containing protein 12	616458	PRDM12	59335	ENSG00000130711,ENST00000253008;;;ENST00000253008		Neuropathy, hereditary sensory and autonomic, type VIII	616488	AR	3	Prdm12
9q34.12	9:130693760-130704894	EXOSC2, RRP4, SHRF	Exosome component 2	602238	EXOSC2	23404	ENSG00000130713,ENST00000372358;;;ENST00000372358		Short stature, hearing loss, retinitis pigmentosa, and distinctive facies	617763	AR	3	Exosc2
9q34.12	9:130713043-130887675	ABL1, CHDSKM	ABL protooncogene 1, nonreceptor tyrosine kinase	189980	ABL1	25	ENSG00000097007,ENST00000318560;;;ENST00000318560	fusion hybrid gene with BCR1 in CML	Congenital heart defects and skeletal malformations syndrome	617602	AD	3	Abl1
9q34.12	9:130713043-130887675	ABL1, CHDSKM	ABL protooncogene 1, nonreceptor tyrosine kinase	189980	ABL1	25	ENSG00000097007,ENST00000318560;;;ENST00000318560	fusion hybrid gene with BCR1 in CML	Leukemia, Philadelphia chromosome-positive, resistant to imatinib	608232	SMu	3	Abl1
9q34.12	9:131009174-131094473	LAMC3, OCCM	Laminin, gamma-3	604349	LAMC3	10319	ENSG00000050555,ENST00000361069;;;ENST00000361069		Cortical malformations, occipital	614115	AR	3	Lamc3
9q34.13	9:131100001-133100000	ALPQTL1	Alkaline phosphatase, plasma level of, QTL 1	171720		100196909		linkage with rs657152	{Alkaline phosphatase, plasma level of, QTL1}	171720	?AD	2	
9q34.13	9:131125586-131234663	NUP214, D9S46E, CAN, CAIN, IIAE9	Nucleoporin, 214kD	114350	NUP214	8021	ENSG00000126883,ENST00000359428;;;ENST00000359428	fused with DEK in AML; fused with ABL1 in T-ALL	{Encephalopathy, acute, infection-induced, susceptibility to, 9}	618426	AR	3	Nup214
9q34.13	9:131125586-131234663	NUP214, D9S46E, CAN, CAIN, IIAE9	Nucleoporin, 214kD	114350	NUP214	8021	ENSG00000126883,ENST00000359428;;;ENST00000359428	fused with DEK in AML; fused with ABL1 in T-ALL	Leukemia, acute myeloid, somatic	601626		3	Nup214
9q34.13	9:131125586-131234663	NUP214, D9S46E, CAN, CAIN, IIAE9	Nucleoporin, 214kD	114350	NUP214	8021	ENSG00000126883,ENST00000359428;;;ENST00000359428	fused with DEK in AML; fused with ABL1 in T-ALL	Leukemia, T-cell acute lymphoblastic, somatic	613065		3	Nup214
9q34.13	9:131502918-131523799	POMT1, MDDGA1, MDDGB1, MDDGC1, LGMDR11	Protein O-mannosyltransferase 1	607423	POMT1	10585	ENSG00000130714,ENST00000402686;;;ENST00000402686		Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 1	236670	AR	3	Pomt1
9q34.13	9:131502918-131523799	POMT1, MDDGA1, MDDGB1, MDDGC1, LGMDR11	Protein O-mannosyltransferase 1	607423	POMT1	10585	ENSG00000130714,ENST00000402686;;;ENST00000402686		Muscular dystrophy-dystroglycanopathy (congenital with impaired intellectual development), type B, 1	613155	AR	3	Pomt1
9q34.13	9:131502918-131523799	POMT1, MDDGA1, MDDGB1, MDDGC1, LGMDR11	Protein O-mannosyltransferase 1	607423	POMT1	10585	ENSG00000130714,ENST00000402686;;;ENST00000402686		Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 1	609308	AR	3	Pomt1
9q34.13	9:131860112-132079867	MED27, CRSP8, CRAP34, NEDSCAC	Mediator complex subunit 27	605044	MED27	9442	ENSG00000160563,ENST00000292035;;;ENST00000292035		Neurodevelopmental disorder with spasticity, cataracts, and cerebellar hypoplasia	619286	AR	3	Med27
9q34.13	9:132161689-132244526	NTNG2, NEDBASH	Netrin G2	618689	NTNG2	84628	ENSG00000196358,ENST00000393229;;;ENST00000393229		Neurodevelopmental disorder with behavioral abnormalities, absent speech, and hypotonia	618718	AR	3	Ntng2
9q34.13	9:132261356-132356744	SETX, SCAN2, AOA2, ALS4	Senataxin	608465	SETX	23064	ENSG00000107290,ENST00000224140;;;ENST00000224140		Amyotrophic lateral sclerosis 4, juvenile	602433	AD	3	Setx
9q34.13	9:132261356-132356744	SETX, SCAN2, AOA2, ALS4	Senataxin	608465	SETX	23064	ENSG00000107290,ENST00000224140;;;ENST00000224140		Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2	606002	AR	3	Setx
9q34.13	9:132891349-132945378	TSC1, LAM	Hamartin (tuberous sclerosis 1 gene)	605284	TSC1	7248	ENSG00000165699,ENST00000298552;;;ENST00000298552	linked to ABO, ABL	Focal cortical dysplasia, type II, somatic	607341		3	Tsc1
9q34.13	9:132891349-132945378	TSC1, LAM	Hamartin (tuberous sclerosis 1 gene)	605284	TSC1	7248	ENSG00000165699,ENST00000298552;;;ENST00000298552	linked to ABO, ABL	Lymphangioleiomyomatosis	606690		3	Tsc1
9q34.13	9:132891349-132945378	TSC1, LAM	Hamartin (tuberous sclerosis 1 gene)	605284	TSC1	7248	ENSG00000165699,ENST00000298552;;;ENST00000298552	linked to ABO, ABL	Tuberous sclerosis-1	191100	AD	3	Tsc1
9q34.13	9:132945531-132993434	GFI1B, BDPLT17	Growth factor-independent 1B	604383	GFI1B	8328	ENSG00000165702,ENST00000372122;;;ENST00000372122		Bleeding disorder, platelet-type, 17	187900	AD, AR	3	Gfi1b
9q34.13	9:133061981-133071861	CEL, BSSL, CELL, MODY8	Carboxyl-ester lipase (bile-salt stimulated lipase)	114840	CEL	1056	ENSG00000170835,ENST00000372080;;;ENST00000372080		Maturity-onset diabetes of the young, type VIII	609812	AD	3	Cel
9q34.2	9:133250401-133275201	ABO	ABO glycosyltransferase	110300	ABO	28	ENSG00000175164,ENST00000453660	linked to AK1	[Blood group, ABO system]	616093		3	Abo
9q34.2	9:133351758-133356487	SURF1, CMT4K, MC4DN1	Surfeit-1	185620	SURF1	6834	ENSG00000148290,ENST00000371974;;;ENST00000371974	distal to ABL, CAN	Charcot-Marie-Tooth disease, type 4K	616684	AR	3	Surf1
9q34.2	9:133351758-133356487	SURF1, CMT4K, MC4DN1	Surfeit-1	185620	SURF1	6834	ENSG00000148290,ENST00000371974;;;ENST00000371974	distal to ABL, CAN	Mitochondrial complex IV deficiency, nuclear type 1	220110	AR	3	Surf1
9q34.2	9:133414337-133459386	ADAMTS13, VWFCP, TTP	ADAM metallopeptidase domain with thrombospondin type 1 motif, 13	604134	ADAMTS13	11093	ENSG00000160323,ENST00000355699;;;ENST00000355699		Thrombotic thrombocytopenic purpura, hereditary	274150	AR	3	Adamts13
9q34.2	9:133514586-133524959	MYMK, TMEM8C	Myomaker	615345	MYMK	389827	ENSG00000187616,ENST00000339996;;;ENST00000339996		Carey-Fineman-Ziter syndrome	254940	AR	3	Mymk
9q34.2	9:133532164-133575519	ADAMTSL2, KIAA0605, GPHYSD1	ADAMTS-like protein 2	612277	ADAMTSL2	9719	ENSG00000197859,ENST00000651351;;;ENST00000651351		Geleophysic dysplasia 1	231050	AR	3	Adamtsl2
9q34.2	9:133636363-133659329	DBH, ORTHYP1	Dopamine-beta-hydroxylase	609312	DBH	1621	ENSG00000123454,ENST00000393056;;;ENST00000393056	tightly linked to ABO	Orthostatic hypotension 1, due to DBH deficiency	223360	AR	3	Dbh
9q34.2	9:133659418-133739955	SARDH, SARD, SAR	Sarcosine dehydrogenase	604455	SARDH	1757	ENSG00000123453,ENST00000439388;;;ENST00000439388		[Sarcosinemia]	268900	AR	3	Sardh
9q34.3	9:134641803-134844843	COL5A1, EDSCL1, FMDMF	Collagen V, alpha-1 polypeptide	120215	COL5A1	1289	ENSG00000130635,ENST00000371817;;;ENST00000371817		Ehlers-Danlos syndrome, classic type, 1	130000	AD	3	Col5a1
9q34.3	9:134641803-134844843	COL5A1, EDSCL1, FMDMF	Collagen V, alpha-1 polypeptide	120215	COL5A1	1289	ENSG00000130635,ENST00000371817;;;ENST00000371817		Fibromuscular dysplasia, multifocal	619329	AD	3	Col5a1
9q34.3	9:135499965-135504673	MRPS2, COXPD36	Mitochondrial ribosomal protein S2	611971	MRPS2	51116	ENSG00000122140,ENST00000241600;;;ENST00000241600		Combined oxidative phosphorylation deficiency 36	617950	AR	3	Mrps2
9q34.3	9:135693407-135702112	SOHLH1, NOHLH, TEB2, ODG5, SPGF32	Spermatogenesis- and oogenesis-specific basic helix-loop-helix protein 1	610224	SOHLH1	402381	ENSG00000165643,ENST00000425225;;;ENST00000425225		Ovarian dysgenesis 5	617690	AR	3	Sohlh1
9q34.3	9:135693407-135702112	SOHLH1, NOHLH, TEB2, ODG5, SPGF32	Spermatogenesis- and oogenesis-specific basic helix-loop-helix protein 1	610224	SOHLH1	402381	ENSG00000165643,ENST00000425225;;;ENST00000425225		Spermatogenic failure 32	618115	AD	3	Sohlh1
9q34.3	9:135702185-135795502	KCNT1, KIAA1422, DEE14, ENFL5	Potassium channel, subfamily T, member 1	608167	KCNT1	57582	ENSG00000107147,ENST00000371757;;;ENST00000371757		Developmental and epileptic encephalopathy 14	614959	AD	3	Kcnt1
9q34.3	9:135702185-135795502	KCNT1, KIAA1422, DEE14, ENFL5	Potassium channel, subfamily T, member 1	608167	KCNT1	57582	ENSG00000107147,ENST00000371757;;;ENST00000371757		Epilepsy nocturnal frontal lobe, 5	615005	AD	3	Kcnt1
9q34.3	9:135808487-135907546	CAMSAP1, CDCBM12	Calmodulin-regulated spectrin-associated protein 1	613774	CAMSAP1	157922	ENSG00000130559,ENST00000389532;;;ENST00000389532		Cortical dysplasia, complex, with other brain malformations 12	620316	AR	3	Camsap1
9q34.3	9:136196250-136205128	LHX3, CPHD3	LIM/homeodomain protein LHX3	600577	LHX3	8022	ENSG00000107187,ENST00000371748;;;ENST00000371748	in mouse, close to Notch1; centromeric to ABL	Pituitary hormone deficiency, combined, 3	221750	AR	3	Lhx3
9q34.3	9:136363956-136373669	CARD9, CANDF2, IMD103	Caspase recruitment domain-containing protein 9	607212	CARD9	64170	ENSG00000187796,ENST00000371732;;;ENST00000371732		Immunodeficiency 103, susceptibility to fungal infection	212050	AR	3	Card9
9q34.3	9:136375571-136400170	SNAPC4, SNAP190, NEDRSO	Small nuclear RNA-activating protein complex, polypeptide 4	602777	SNAPC4	6621	ENSG00000165684,ENST00000684778;;;ENST00000684778		Neurodevelopmental disorder with motor regression, progressive spastic paraplegia, and oromotor dysfunction	620515	AR	3	Snapc4
9q34.3	9:136410658-136423761	PMPCA, KIAA0123, SCAR2	Peptidase, mitochondrial processing, alpha	613036	PMPCA	23203	ENSG00000165688,ENST00000371717;;;ENST00000371717		Spinocerebellar ataxia, autosomal recessive 2	213200	AR	3	Pmpca
9q34.3	9:136428619-136439845	INPP5E, MORMS, JBTS1, CORS1	Inositol polyphosphate-5-phosphatase, 72kD	613037	INPP5E	56623	ENSG00000148384,ENST00000371712;;;ENST00000371712		Impaired intellectual development, truncal obesity, retinal dystrophy, and micropenis syndrome	610156	AR	3	Inpp5e
9q34.3	9:136428619-136439845	INPP5E, MORMS, JBTS1, CORS1	Inositol polyphosphate-5-phosphatase, 72kD	613037	INPP5E	56623	ENSG00000148384,ENST00000371712;;;ENST00000371712		Joubert syndrome 1	213300	AR	3	Inpp5e
9q34.3	9:136494433-136546048	NOTCH1, TAN1, AOS5, AOVD1	Notch receptor 1	190198	NOTCH1	4851	ENSG00000148400,ENST00000651671;;;ENST00000651671		Adams-Oliver syndrome 5	616028	AD	3	Notch1
9q34.3	9:136494433-136546048	NOTCH1, TAN1, AOS5, AOVD1	Notch receptor 1	190198	NOTCH1	4851	ENSG00000148400,ENST00000651671;;;ENST00000651671		Aortic valve disease 1	109730	AD	3	Notch1
9q34.3	9:136673143-136687457	AGPAT2, LPAAB, BSCL, BSCL1	1-acylglycerol-3-phosphate O-acyltransferase 2 (lysophosphatidic acid acyltransferase-beta)	603100	AGPAT2	10555	ENSG00000169692,ENST00000371696;;;ENST00000371696		Lipodystrophy, congenital generalized, type 1	608594	AR	3	Agpat2
9q34.3	9:137007234-137028922	ABCA2, ABC2, IDPOGSA	ATP-binding cassette 2	600047	ABCA2	20	ENSG00000107331,ENST00000341511;;;ENST00000341511		Intellectual developmental disorder with poor growth and with or without seizures or ataxia	618808	AR	3	Abca2
9q34.3	9:137086985-137109183	MAN1B1, MRT15	Mannosidase, alpha, class 1B member 1	604346	MAN1B1	11253	ENSG00000177239,ENST00000371589;;;ENST00000371589		Rafiq syndrome	614202	AR	3	Man1b1
9q34.3	9:137139154-137168756	GRIN1, NMDAR1, NDHMSR, NDHMSD, DEE101	Glutamate receptor, ionotropic, N-methyl D-aspartate 1	138249	GRIN1	2902	ENSG00000176884,ENST00000371561;;;ENST00000371561		Developmental and epileptic encephalopathy 101	619814	AR	3	Grin1
9q34.3	9:137139154-137168756	GRIN1, NMDAR1, NDHMSR, NDHMSD, DEE101	Glutamate receptor, ionotropic, N-methyl D-aspartate 1	138249	GRIN1	2902	ENSG00000176884,ENST00000371561;;;ENST00000371561		Neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal dominant	614254	AD	3	Grin1
9q34.3	9:137139154-137168756	GRIN1, NMDAR1, NDHMSR, NDHMSD, DEE101	Glutamate receptor, ionotropic, N-methyl D-aspartate 1	138249	GRIN1	2902	ENSG00000176884,ENST00000371561;;;ENST00000371561		Neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal recessive	617820	AR	3	Grin1
9q34.3	9:137191619-137200741	TPRN, C9orf75, DFNB79	Taperin	613354	TPRN	286262	ENSG00000176058,ENST00000409012;;;ENST00000409012		Deafness, autosomal recessive 79	613307	AR	3	Tprn
9q34.3	9:137229730-137236555	SLC34A3, NPTIIC, HHRH	Solute carrier family 34 (sodium/phosphate cotransporter), member 3	609826	SLC34A3	142680	ENSG00000198569,ENST00000673835;;;ENST00000673835		Hypophosphatemic rickets with hypercalciuria	241530	AR	3	Slc34a3
9q34.3	9:137241287-137243707	TUBB4B, TUBB2C, LCAEOD	Tubulin, beta-4B	602660	TUBB4B	10383	ENSG00000188229,ENST00000340384;;;ENST00000340384		Leber congenital amaurosis with early-onset deafness	617879	AD	3	Tubb4b
9q34.3	9:137447570-137459334	NSMF, NELF, HH9	NMDA receptor synaptonuclear signaling and neuronal migration factor	608137	NSMF	26012	ENSG00000165802,ENST00000371475;;;ENST00000371475		Hypogonadotropic hypogonadism 9 with or without anosmia	614838	AD	3	Nsmf
9q34.3	9:137619005-137836127	EHMT1, EUHMTASE1, KMT1D, DEL9q34, KLEFS1	Euchromatic histone methyltransferase 1	607001	EHMT1	79813	ENSG00000181090,ENST00000460843;;;ENST00000460843		Kleefstra syndrome 1	610253	AD	3	Ehmt1
9q34.3	9:137877782-138124619	CACNA1B, CACNL1A5, NEDNEH	Calcium channel, voltage-dependent, L type, alpha 1B subunit	601012	CACNA1B	774	ENSG00000148408,ENST00000371372;;;ENST00000371372		Neurodevelopmental disorder with seizures and nonepileptic hyperkinetic movements	618497	AR	3	Cacna1b
10p	10:1-39800001	BMIQ8	Body mass index quantitative trait locus 8	603188		56694			{Obesity, susceptibility to, BMIQ8}	603188		2	
10p	10:1-39800001	BULN	Bulimia nervosa, susceptibility to	607499		337893		between D10S1430 and D10S1423	{Bulimia nervosa, susceptibility to}	607499	Mu	2	
10p15	10:1-6600000	PFFE1	Plasmodium falciparum fever episodes QTL1	611384		101910199			{Plasmodium falciparum fever episodes QTL1}	611384		2	
10pter-q11	10:1-51100000	ST12, PAC1	Suppression of tumorigenicity 12, prostate	601188					Prostate adenocarcinoma	601188		2	
10p15.3	10:46455-76621	TUBB8, OZEMA2	Tubulin, beta 8	616768	TUBB8	347688	ENSG00000261456,ENST00000568584;;;ENST00000568584		Oocyte/zygote/embryo maturation arrest 2	616780	AD, AR	3	
10p15.3	10:130088-254637	ZMYND11, BS69, BRAM1, MRD30	Zinc finger MYND domain-containing protein 11	608668	ZMYND11	10771	ENSG00000015171,ENST00000381604;;;ENST00000381604		Intellectual developmental disorder, autosomal dominant 30	616083	AD	3	Zmynd11
10p15.3	10:1056385-1132372	WDR37, NOCGUS	WD repeat-containing protein 37	618586	WDR37	22884	ENSG00000047056,ENST00000263150;;;ENST00000263150		Neurooculocardiogenitourinary syndrome	618652	AD	3	Wdr37
10p15.2	10:3137727-3172841	PITRM1, MP1, PREP, SCAR30	Pitrilysin metallopeptidase 1	618211	PITRM1	10531	ENSG00000107959,ENST00000224949;;;ENST00000224949		Spinocerebellar ataxia, autosomal recessive 30	619405	AR	3	Pitrm1
10p15.2	10:3775996-3785209	KLF6, COPEB, BCD1, ZF9	Kruppel-like factor-6	602053	KLF6	1316	ENSG00000067082,ENST00000497571;;;ENST00000497571		Gastric cancer, somatic	613659		3	Klf6
10p15.2	10:3775996-3785209	KLF6, COPEB, BCD1, ZF9	Kruppel-like factor-6	602053	KLF6	1316	ENSG00000067082,ENST00000497571;;;ENST00000497571		Prostate cancer, somatic	176807		3	Klf6
10p15.1	10:3800001-6600000	MS2	Multiple sclerosis, susceptibility to, 2	612594		100271694		associated with rs12722489 and rs2104286	{Multiple sclerosis, susceptibility to, 2}	612594		2	
10p15.1	10:4987775-5018000	AKR1C2, DDH2, DD2, HAKRD, SRXY8	Aldo-keto reductase family 1, member C2 (dihydrodiol dehydrogenase, type II)	600450	AKR1C2	1646	ENSG00000151632,ENST00000380753;;;ENST00000380753		46XY sex reversal 8	614279	AR	3	Akr1c12,Akr1c13,Akr1c14,Akr1c18,Akr1c19,Akr1c20,Akr1c21,Akr1c6,Akr1cl
10p15.1	10:5196837-5218949	AKR1C4, CHDR, CDR, HAKRA, DD4	Aldo-keto reductase family 1, member C4 (chlordecone reductase)	600451	AKR1C4	1109	ENSG00000198610,ENST00000263126;;;ENST00000263126		{46XY sex reversal 8, modifier of}	614279	AR	3	Akr1c12,Akr1c13,Akr1c14,Akr1c18,Akr1c19,Akr1c20,Akr1c21,Akr1c6,Akr1cl
10p15.1	10:6010689-6062367	IL2RA, CD25, IL2R, IDDM10, IMD41	Interleukin-2 receptor, alpha	147730	IL2RA	3559	ENSG00000134460,ENST00000379959;;;ENST00000379959		{Diabetes, mellitus, insulin-dependent, susceptibility to, 10}	601942		3	Il2ra
10p15.1	10:6010689-6062367	IL2RA, CD25, IL2R, IDDM10, IMD41	Interleukin-2 receptor, alpha	147730	IL2RA	3559	ENSG00000134460,ENST00000379959;;;ENST00000379959		Immunodeficiency 41 with lymphoproliferation and autoimmunity	606367	AR	3	Il2ra
10p14-p12	10:6600001-29300000	ARVD6	Arrhythmogenic right ventricular dysplasia 6	604401		27038			Arrhythmogenic right ventricular dysplasia 6	604401		2	
10p14	10:6600001-12200000	CRCS5	Colorectal cancer, susceptibility to, 5	612230		100188887		associated with rs10795668	{Colorectal cancer, susceptibility to, 5}	612230		2	
10p14-p13	10:6600001-17300000	DGCR2, DGS2	DiGeorge syndrome chromosome region-2	601362		8026			DiGeorge syndrome/velocardiofacial syndrome complex-2	601362		2	
10p14	10:8045333-8075198	GATA3, HDR, HDRS	GATA-binding protein-3	131320	GATA3	2625	ENSG00000107485,ENST00000379328;;;ENST00000379328		Hypoparathyroidism, sensorineural deafness, and renal dysplasia	146255	AD	3	Gata3
10p14	10:10462550-11336675	CELF2, CUGBP2, ETR3, BRUNOL3, DEE97	CUGbp- and ELAV-like family, member 2	602538	CELF2	10659	ENSG00000048740,ENST00000633077;;;ENST00000633077		Developmental and epileptic encephalopathy 97	619561	AD	3	Celf2
10p14	10:12068954-12123221	DHTKD1, KIAA1630, AAKAD, CMT2Q	Dehydrogenase E1 and transketolase domains-containing protein 1	614984	DHTKD1	55526	ENSG00000181192,ENST00000263035;;;ENST00000263035	mutation identified in 1 CMT2Q family	?Charcot-Marie-Tooth disease, axonal, type 2Q	615025	AD	3	Dhtkd1
10p14	10:12068954-12123221	DHTKD1, KIAA1630, AAKAD, CMT2Q	Dehydrogenase E1 and transketolase domains-containing protein 1	614984	DHTKD1	55526	ENSG00000181192,ENST00000263035;;;ENST00000263035	mutation identified in 1 CMT2Q family	Alpha-aminoadipic and alpha-ketoadipic aciduria	204750	AR	3	Dhtkd1
10p13	10:12200001-17300000	AD7	Alzheimer disease 7	606187		114475		max LOD at D10S1423	Alzheimer disease-7	606187		2	
10p13	10:12200001-17300000	LPRS	Leprosy, paucibacillary type, susceptibility to	609888		81861			{Leprosy, paucibacillary type, susceptibility to}	609888		2	
10p13	10:13100082-13138308	OPTN, GLC1E, FIP2, HYPL, NRP, ALS12	Optineurin	602432	OPTN	10133	ENSG00000123240,ENST00000378747;;;ENST00000378747		{Glaucoma, normal tension, susceptibility to}	606657		3	Optn
10p13	10:13100082-13138308	OPTN, GLC1E, FIP2, HYPL, NRP, ALS12	Optineurin	602432	OPTN	10133	ENSG00000123240,ENST00000378747;;;ENST00000378747		Amyotrophic lateral sclerosis 12 with or without frontotemporal dementia	613435	AD, AR	3	Optn
10p13	10:13100082-13138308	OPTN, GLC1E, FIP2, HYPL, NRP, ALS12	Optineurin	602432	OPTN	10133	ENSG00000123240,ENST00000378747;;;ENST00000378747		Glaucoma 1, open angle, E	137760	AD	3	Optn
10p13	10:13161558-13211110	MCM10, CNA43, IMD80	Minichromosome maintenance complex component 10	609357	MCM10	55388	ENSG00000065328,ENST00000378714;;;ENST00000378714		Immunodeficiency 80 with or without cardiomyopathy	619313	AR	3	Mcm10
10p13	10:13277799-13300064	PHYH, PAHX	Phytanoyl-CoA hydroxylase	602026	PHYH	5264	ENSG00000107537,ENST00000263038;;;ENST00000263038		Refsum disease	266500	AR	3	Phyh
10p13	10:13317428-13348293	SEPHS1, SPS1, VERBRAS2	Selenophosphate synthetase 1	600902	SEPHS1	22929	ENSG00000086475,ENST00000327347;;;ENST00000327347		Ververi-Brady syndrome 2	621325	AD	3	Sephs1
10p13	10:13643706-14330924	FRMD4A, KIAA1294, CCAFCA	FERM domain-containing protein 4A	616305	FRMD4A	55691	ENSG00000151474,ENST00000357447;;;ENST00000357447	mutation identified in 1 CCAFCA family	?Corpus callosum, agenesis of, with facial anomalies and cerebellar ataxia	616819	AR	3	Frmd4a
10p13	10:14897359-14954432	DCLRE1C, ARTEMIS, SCIDA	DNA cross-link repair protein 1C	605988	DCLRE1C	64421	ENSG00000152457,ENST00000378278;;;ENST00000378278		Omenn syndrome	603554	AR	3	Dclre1c
10p13	10:14897359-14954432	DCLRE1C, ARTEMIS, SCIDA	DNA cross-link repair protein 1C	605988	DCLRE1C	64421	ENSG00000152457,ENST00000378278;;;ENST00000378278		Severe combined immunodeficiency, Athabascan type	602450	AR	3	Dclre1c
10p13	10:15513954-15719922	ITGA8, RHDA1	Integrin, alpha-8	604063	ITGA8	8516	ENSG00000077943,ENST00000378076;;;ENST00000378076		Renal hypodysplasia/aplasia 1	191830	AR	3	Itga8
10p13	10:16823966-17129811	CUBN, IFCR, IGS1	Cubilin (intrinsic factor-cobalamin receptor)	602997	CUBN	8029	ENSG00000107611,ENST00000377833;;;ENST00000377833		[Proteinuria, chronic benign]	618884	AR	3	Cubn
10p13	10:16823966-17129811	CUBN, IFCR, IGS1	Cubilin (intrinsic factor-cobalamin receptor)	602997	CUBN	8029	ENSG00000107611,ENST00000377833;;;ENST00000377833		Imerslund-Grasbeck syndrome 1	261100	AR	3	Cubn
10p13	10:17228241-17237593	VIM, CTRCT30	Vimentin	193060	VIM	7431	ENSG00000026025,ENST00000544301;;;ENST00000544301		Cataract 30, pulverulent	116300	AD	3	Vim
10p12.33	10:17589032-17617374	HACD1, PTPLA, CMYO11	3-hydroxyacyl-CoA dehydratase 1	610467	HACD1	9200	ENSG00000165996,ENST00000361271;;;ENST00000361271		Congenital myopathy 11	619967	AR	3	Hacd1
10p12.33-p12.31	10:18140424-18543557	CACNB2	Calcium channel, voltage-dependent, beta 2 subunit	600003	CACNB2	783	ENSG00000165995,ENST00000324631;;;ENST00000324631		Brugada syndrome 4	611876	AD	3	Cacnb2
10p12.31	10:18545561-18659327	NSUN6, MRT82	NOP2/SUN RNA methyltransferase family, member 6	617199	NSUN6	221078	ENSG00000241058,ENST00000377304;;;ENST00000377304		Intellectual developmental disorder, autosomal recessive 82	620779	AR	3	Nsun6
10p12.31	10:21533756-21743630	AF10	ALL1 fused gene from chromosome 10	602409	MLLT10	8028	ENSG00000078403,ENST00000307729;;;ENST00000307729	fuses with MLL and HEAB	Leukemia, acute myeloid	601626	AD, SMu	3	Mllt10
10p12.2	10:23192312-23194245	PTF1A, PACA, PAGEN2	Pancreas transcription factor 1, alpha subunit	607194	PTF1A	256297	ENSG00000168267,ENST00000376504;;;ENST00000376504		Pancreatic agenesis 2	615935	AR	3	Ptf1a
10p12.2	10:23192312-23194245	PTF1A, PACA, PAGEN2	Pancreas transcription factor 1, alpha subunit	607194	PTF1A	256297	ENSG00000168267,ENST00000376504;;;ENST00000376504		Pancreatic and cerebellar agenesis	609069	AR	3	Ptf1a
10p12.1	10:25934229-26212532	MYO3A, DFNB30, DFNA90	Myosin IIIA	606808	MYO3A	53904	ENSG00000095777,ENST00000642920;;;ENST00000642920		Deafness, autosomal dominant 90	620722	AD	3	Myo3a
10p12.1	10:25934229-26212532	MYO3A, DFNB30, DFNA90	Myosin IIIA	606808	MYO3A	53904	ENSG00000095777,ENST00000642920;;;ENST00000642920		Deafness, autosomal recessive 30	607101	AR	3	Myo3a
10p12.1	10:26697701-26746798	PDSS1, TPT, COQ1, COQ10D2	Prenyl diphosphate synthase, subunit 1	607429	PDSS1	23590	ENSG00000148459,ENST00000376215;;;ENST00000376215		Coenzyme Q10 deficiency, primary, 2	614651	AR	3	Pdss1
10p12.1	10:26947582-27100494	ANKRD26, KIAA1074, THC2	Ankyrin repeat domain-containing protein 26	610855	ANKRD26	22852	ENSG00000107890,ENST00000376087;;;ENST00000376087		Thrombocytopenia 2	188000	AD	3	Ankrd26
10p12.1	10:27110111-27154384	YME1L1, YME1L, PAMP, OPA11	Mitochondrial escape 1-like 1	607472	YME1L1	10730	ENSG00000136758,ENST00000376016;;;ENST00000376016	mutation identified in1 OPA11 family	?Optic atrophy 11	617302	AR	3	Yme1l1
10p12.1	10:27182838-27242111	ACBD5, KIAA1996, RDLKD	Acyl-CoA-binding domain-containing protein 5	616618	ACBD5	91452	ENSG00000107897,ENST00000396271;;;ENST00000396271		Retinal dystrophy with leukodystrophy	618863	AR	3	Acbd5
10p12.1	10:27504304-27542239	RAB18, WARBM3	Ras-associated protein RAB18	602207	RAB18	22931	ENSG00000099246,ENST00000356940;;;ENST00000356940		Warburg micro syndrome 3	614222	AR	3	Rab18
10p12.1	10:27812168-27999675	ODAD2, ARMC4, CILD23	Outer dynein arm docking complex subunit 2	615408	ODAD2	55130	ENSG00000169126,ENST00000305242;;;ENST00000305242		Ciliary dyskinesia, primary, 23	615451	AR	3	Odad2
10p12.1	10:28532779-28623112	WAC, KIAA1844, DESSH	WW domain-containing adaptor with coiled-coil region	615049	WAC	51322	ENSG00000095787,ENST00000354911;;;ENST00000354911		Desanto-Shinawi syndrome	616708	AD	3	Wac
10p11.23-q21.1	10:29300001-59400000	DFNB33	Deafness, autosomal recessive 33	607239		170508		prev. assignment to chr. 9 an error	Deafness, autosomal recessive 33	607239	AR	2	
10p11.23	10:29457338-29736936	SVIL, MFM10	Supervillin	604126	SVIL	6840	ENSG00000197321,ENST00000355867;;;ENST00000355867		Myofibrillar myopathy 10	619040	AR	3	Svil
10p11.23	10:30309801-30349278	MTPAP, PAPD1, SPAX4	Mitochondrial poly(A) polymerase	613669	MTPAP	55149	ENSG00000107951,ENST00000263063;;;ENST00000263063	mutation identified in 1 SPAX4 family	?Spastic ataxia 4, autosomal recessive	613672	AR	3	Mtpap
10p11.23	10:30434021-30461833	MAP3K8, COT, EST, TPL2	Mitogen-activated protein kinase kinase kinase 8 (cancer Osaka thyroid oncogene)	191195	MAP3K8	1326	ENSG00000107968,ENST00000263056;;;ENST00000263056		Lung cancer, somatic	211980		3	Map3k8
10p11.22	10:31100001-34200000	EIG5	Epilepsy, idiopathic generalized, susceptibility to, 5	611934		100188861		max lod at D10S1426	{Epilepsy, idiopathic generalized, susceptibility to, 5}	611934		2	
10p11.22	10:31318417-31529804	ZEB1, TCF8, NIL2A, PPCD3, FECD6	Zinc finger E box-binding homeobox 1	189909	ZEB1	6935	ENSG00000148516,ENST00000424869;;;ENST00000424869		Corneal dystrophy, Fuchs endothelial, 6	613270	AD	3	Zeb1
10p11.22	10:31318417-31529804	ZEB1, TCF8, NIL2A, PPCD3, FECD6	Zinc finger E box-binding homeobox 1	189909	ZEB1	6935	ENSG00000148516,ENST00000424869;;;ENST00000424869		Corneal dystrophy, posterior polymorphous, 3	609141	AD	3	Zeb1
10p11.21-q21.1	10:34200001-59400000	USH1K	Usher syndrome, type IK	614990		101180907		max lod at D10S539	Usher syndrome, type IK	614990	AR	2	
10q	10:39800001-133797422	AITD4	Autoimmune thyroid disease, susceptibility to, 4	608176		387581			{Autoimmune thyroid disease, susceptibility to, 4}	608176		2	
10q11.2-q21	10:41600001-68800000	STHAG5	Tooth agenesis, selective, 5	610926		100188748		D10S604 and D10S568	Tooth agenesis, selective, 5	610926		2	
10q11.21	10:42782795-42834937	BMS1, BMS1L, KIAA0187, ACC	BMS1 ribosome biogenesis factor	611448	BMS1	9790	ENSG00000165733,ENST00000374518;;;ENST00000374518	mutation identified in one ACC family	?Aplasia cutis congenita, nonsyndromic	107600	AD	3	Bms1
10q11.21	10:43077069-43130351	RET, MEN2A, HSCR1	RET transforming sequence; oncogene RET	164761	RET	5979	ENSG00000165731,ENST00000355710;;;ENST00000355710		{Hirschsprung disease, protection against}	142623	AD	3	Ret
10q11.21	10:43077069-43130351	RET, MEN2A, HSCR1	RET transforming sequence; oncogene RET	164761	RET	5979	ENSG00000165731,ENST00000355710;;;ENST00000355710		{Hirschsprung disease, susceptibility to, 1}	142623	AD	3	Ret
10q11.21	10:43077069-43130351	RET, MEN2A, HSCR1	RET transforming sequence; oncogene RET	164761	RET	5979	ENSG00000165731,ENST00000355710;;;ENST00000355710		Medullary thyroid carcinoma	155240	AD	3	Ret
10q11.21	10:43077069-43130351	RET, MEN2A, HSCR1	RET transforming sequence; oncogene RET	164761	RET	5979	ENSG00000165731,ENST00000355710;;;ENST00000355710		Multiple endocrine neoplasia IIA	171400	AD	3	Ret
10q11.21	10:43077069-43130351	RET, MEN2A, HSCR1	RET transforming sequence; oncogene RET	164761	RET	5979	ENSG00000165731,ENST00000355710;;;ENST00000355710		Multiple endocrine neoplasia IIB	162300	AD	3	Ret
10q11.21	10:43077069-43130351	RET, MEN2A, HSCR1	RET transforming sequence; oncogene RET	164761	RET	5979	ENSG00000165731,ENST00000355710;;;ENST00000355710		Pheochromocytoma	171300	AD	3	Ret
10q11.21	10:44370165-44385097	CXCL12, SDF1	Chemokine, C-X-C motif, ligand 12 (stromal cell-derived factor 1)	600835	CXCL12	6387	ENSG00000107562,ENST00000343575;;;ENST00000343575		{AIDS, resistance to}	609423		3	Cxcl12
10q11.21	10:45374216-45446117	ALOX5	Arachidonate 5-lipoxygenase	152390	ALOX5	240	ENSG00000012779,ENST00000374391;;;ENST00000374391		{Asthma, diminished response to antileukotriene treatment in}	600807	AD	3	Alox5
10q11.21	10:45374216-45446117	ALOX5	Arachidonate 5-lipoxygenase	152390	ALOX5	240	ENSG00000012779,ENST00000374391;;;ENST00000374391		{Atherosclerosis, susceptibility to}			3	Alox5
10q11.22	10:46033313-46046269	MSMB, HPC13	Microseminoprotein, beta	157145	MSMB	4477	ENSG00000263639,ENST00000582163;;;ENST00000582163		{Prostate cancer, hereditary, 13}	611928		3	Msmb
10q11.22	10:47322454-47327588	GDF2, BMP9, HHT5	Growth differentiation factor 2 (bone morphogenetic protein 9)	605120	GDF2	2658	ENSG00000263761,ENST00000581492;;;ENST00000581492		Telangiectasia, hereditary hemorrhagic, type 5	615506	AD	3	Gdf2
10q11.22	10:47348363-47357881	RBP3, RP66	Retinol-binding protein-3, interstitial	180290	RBP3	5949	ENSG00000265203,ENST00000584701;;;ENST00000584701	1 family identified with mutation	?Retinitis pigmentosa 66	615233	AR	3	Rbp3
10q11.23-q22.3	10:48600001-80300000	HYPT9	Hypotrichosis 9	614237		100736250		between D10S538 and D10S2327	Hypotrichosis 9	614237	AR	2	
10q11.23	10:49297050-49327492	C10orf71, CEFIP, CMD1QQ	Chromosome 10 open reading frame 71	621202	C10orf71	118461	ENSG00000177354,ENST00000374144;;;ENST00000374144		Cardiomyopathy, dilated, 1QQ	621251	AD	3	3425401B19Rik
10q11.23	10:49434881-49539538	ERCC6, CKN2, COFS1, CSB, ARMD5, UVSS1, POF11	ERCC excision repair 6, chromatin remodeling factor	609413	ERCC6	2074	ENSG00000225830,ENST00000355832;;;ENST00000355832	mutation identified in 1 DSCS family	?De Sanctis-Cacchione syndrome	278800	AR	3	Ercc6
10q11.23	10:49434881-49539538	ERCC6, CKN2, COFS1, CSB, ARMD5, UVSS1, POF11	ERCC excision repair 6, chromatin remodeling factor	609413	ERCC6	2074	ENSG00000225830,ENST00000355832;;;ENST00000355832	mutation identified in 1 DSCS family	{Lung cancer, susceptibility to}	211980	AD, SMu	3	Ercc6
10q11.23	10:49434881-49539538	ERCC6, CKN2, COFS1, CSB, ARMD5, UVSS1, POF11	ERCC excision repair 6, chromatin remodeling factor	609413	ERCC6	2074	ENSG00000225830,ENST00000355832;;;ENST00000355832	mutation identified in 1 DSCS family	{Macular degeneration, age-related, susceptibility to, 5}	613761		3	Ercc6
10q11.23	10:49434881-49539538	ERCC6, CKN2, COFS1, CSB, ARMD5, UVSS1, POF11	ERCC excision repair 6, chromatin remodeling factor	609413	ERCC6	2074	ENSG00000225830,ENST00000355832;;;ENST00000355832	mutation identified in 1 DSCS family	Cerebrooculofacioskeletal syndrome 1	214150	AR	3	Ercc6
10q11.23	10:49434881-49539538	ERCC6, CKN2, COFS1, CSB, ARMD5, UVSS1, POF11	ERCC excision repair 6, chromatin remodeling factor	609413	ERCC6	2074	ENSG00000225830,ENST00000355832;;;ENST00000355832	mutation identified in 1 DSCS family	Cockayne syndrome, type B	133540	AR	3	Ercc6
10q11.23	10:49434881-49539538	ERCC6, CKN2, COFS1, CSB, ARMD5, UVSS1, POF11	ERCC excision repair 6, chromatin remodeling factor	609413	ERCC6	2074	ENSG00000225830,ENST00000355832;;;ENST00000355832	mutation identified in 1 DSCS family	Premature ovarian failure 11	616946	AD	3	Ercc6
10q11.23	10:49434881-49539538	ERCC6, CKN2, COFS1, CSB, ARMD5, UVSS1, POF11	ERCC excision repair 6, chromatin remodeling factor	609413	ERCC6	2074	ENSG00000225830,ENST00000355832;;;ENST00000355832	mutation identified in 1 DSCS family	UV-sensitive syndrome 1	600630	AR	3	Ercc6
10q11.23	10:49609095-49667942	CHAT, CMS6	Choline acetyltransferase	118490	CHAT	1103	ENSG00000070748,ENST00000337653;;;ENST00000337653		Myasthenic syndrome, congenital, 6, presynaptic	254210	AR	3	Chat
10q11.23	10:49610310-49612720	SLC18A3, VACHT, CMS21	Solute carrier family 18 (vesicular acetylcholine), member 3	600336	SLC18A3	6572	ENSG00000187714,ENST00000374115;;;ENST00000374115		Myasthenic syndrome, congenital, 21, presynaptic	617239	AR	3	Slc18a3
10q11.23-q21.1	10:50990888-52298350	PRKG1, PRKG1B, PRKGR1B, AAT8	Protein kinase, cGMP-dependent, regulatory, type I	176894	PRKG1	5592	ENSG00000185532,ENST00000373980;;;ENST00000373980		Aortic aneurysm, familial thoracic 8	615436	AD	3	Prkg1
10q21	10:51100001-68800000	ALL1	Leukemia, acute lymphocytic, susceptibility to, 1	613065		100310785		associated with rs10821936	{Leukemia, acute lymphocytic, susceptibility to, 1}	613065		2	
10q21	10:51100001-68800000	ALPQTL4	Alkaline phosphatase, plasma level of, QTL 4	612369		100196916		linkage with rs12355784	{Alkaline phosphatase, plasma level of, QTL4}	612369		2	
10q21	10:51100001-68800000	IBD15	Inflammatory bowel disease 15	612255		100190929		association with rs10761659	{Inflammatory bowel disease 15}	612255		2	
10q21	10:51100001-68800000	MAFD8	Major affective disorder 8	612357		100196912		associated with rs20994336	{Major affective disorder-8, susceptibility to}	612357		2	
10q21.1	10:51100001-59400000	MYP15	Myopia 15	612717		100294716		max lod at D10S1643	Myopia 15	612717	AD	2	
10q21.1	10:52765380-52772784	MBL2, MBL, MBP1, MBL2D, MBPD	Mannose-binding lectin 2, soluble (opsonic defect)	154545	MBL2	4153	ENSG00000165471,ENST00000674931;;;ENST00000674931	near MEN2A	{Chronic infections, due to MBL deficiency}	614372	AD	3	Mbl2
10q21.1	10:53802771-55627942	PCDH15, DFNB23, USH1F	Protocadherin 15	605514	PCDH15	65217	ENSG00000150275,ENST00000644397;;;ENST00000644397		Deafness, autosomal recessive 23	609533	AR	3	Pcdh15
10q21.1	10:53802771-55627942	PCDH15, DFNB23, USH1F	Protocadherin 15	605514	PCDH15	65217	ENSG00000150275,ENST00000644397;;;ENST00000644397		Usher syndrome, type 1D/F digenic	601067	AR, DR	3	Pcdh15
10q21.1	10:53802771-55627942	PCDH15, DFNB23, USH1F	Protocadherin 15	605514	PCDH15	65217	ENSG00000150275,ENST00000644397;;;ENST00000644397		Usher syndrome, type 1F	602083	AR	3	Pcdh15
10q21.1	10:58385410-58399220	TFAM, TCF6L2, TCF6L1, TCF6L3, MTTF1, TCF6, MTDPS15	Transcription factor A, mitochondrial	600438	TFAM	7019	ENSG00000108064,ENST00000487519;;;ENST00000487519	mutation identified in 1 MTDPS15 family	?Mitochondrial DNA depletion syndrome 15 (hepatocerebral type)	617156	AR	3	Tfam
10q21.1	10:58512220-58831435	BICC1, BICC, CYSRD	Bicaudal C, Drosophila, homolog of, 1	614295	BICC1	80114	ENSG00000122870,ENST00000373886;;;ENST00000373886		{Renal dysplasia, cystic, susceptibility to}	601331	AD	3	Bicc1
10q21.2	10:60026298-60733528	ANK3, MRT37	Ankyrin-3, node of Ranvier	600465	ANK3	288	ENSG00000151150,ENST00000280772;;;ENST00000280772		Intellectual developmental disorder, autosomal recessive 37	615493	AR	3	Ank3
10q21.2	10:62374369-62480285	ZNF365, UAN	Zinc finger protein 365	607818	ZNF365	22891	ENSG00000138311,ENST00000395254;;;ENST00000395254		{Nephrolithiasis, uric acid, susceptibility to}	605990		3	Zfp365
10q21.3-q22.1	10:62800001-73100000	HCFP2	Facial paresis, hereditary congenital, 2	604185		22811			Facial paresis, hereditary congenital, 2	604185	AD	2	
10q21.3-q22.3	10:62800001-80300000	HWE1	Epilepsy, hot water, 1	613339		100415903		max lod at D10S412	Epilepsy, hot water, 1	613339	AD	2	
10q21.3	10:62811996-62819167	EGR2, KROX20, CHN1	KROX-20, Drosophila, homolog of (early growth response-2)	129010	EGR2	1959	ENSG00000122877,ENST00000242480;;;ENST00000242480		Charcot-Marie-Tooth disease, type 1D	607678	AD	3	Egr2
10q21.3	10:62811996-62819167	EGR2, KROX20, CHN1	KROX-20, Drosophila, homolog of (early growth response-2)	129010	EGR2	1959	ENSG00000122877,ENST00000242480;;;ENST00000242480		Dejerine-Sottas disease	145900	AD, AR	3	Egr2
10q21.3	10:62811996-62819167	EGR2, KROX20, CHN1	KROX-20, Drosophila, homolog of (early growth response-2)	129010	EGR2	1959	ENSG00000122877,ENST00000242480;;;ENST00000242480		Hypomyelinating neuropathy, congenital, 1	605253	AD, AR	3	Egr2
10q21.3	10:65912523-67763594	CTNNA3, ARVD13	Catenin, alpha-3	607667	CTNNA3	29119	ENSG00000183230,ENST00000433211;;;ENST00000433211		Arrhythmogenic right ventricular dysplasia 13	615616	AD	3	Ctnna3
10q21.3	10:67796669-67838188	DNAJC12, JDP1, HPANBH4	DNAJ/HSP40 homolog, subfamily C, member 12	606060	DNAJC12	56521	ENSG00000108176,ENST00000225171;;;ENST00000225171		Hyperphenylalaninemia, mild, non-BH4-deficient	617384	AR	3	Dnajc12
10q21.3	10:68087897-68212017	MYPN, CMD1DD, CMH22, RCM4, CMYO24	Myopalladin	608517	MYPN	84665	ENSG00000138347,ENST00000358913;;;ENST00000358913		Cardiomyopathy, dilated, 1KK	615248	AD	3	Mypn
10q21.3	10:68087897-68212017	MYPN, CMD1DD, CMH22, RCM4, CMYO24	Myopalladin	608517	MYPN	84665	ENSG00000138347,ENST00000358913;;;ENST00000358913		Cardiomyopathy, familial restrictive, 4	615248	AD	3	Mypn
10q21.3	10:68087897-68212017	MYPN, CMD1DD, CMH22, RCM4, CMYO24	Myopalladin	608517	MYPN	84665	ENSG00000138347,ENST00000358913;;;ENST00000358913		Cardiomyopathy, hypertrophic, 22	615248	AD	3	Mypn
10q21.3	10:68087897-68212017	MYPN, CMD1DD, CMH22, RCM4, CMYO24	Myopalladin	608517	MYPN	84665	ENSG00000138347,ENST00000358913;;;ENST00000358913		Congenital myopathy 24	617336	AR	3	Mypn
10q21.3	10:68230595-68232113	ATOH7, PHPVAR, NCRNA	Atonal, Drosophila, homolog of, 7	609875	ATOH7	220202	ENSG00000179774,ENST00000373673;;;ENST00000373673		Persistent hyperplastic primary vitreous, autosomal recessive	221900	AR	3	Atoh7
10q21.3	10:68414064-68472521	DNA2, DNA2L, KIAA0083, PEOA6, SCKL8, RTS4	DNA replication helicase/nuclease 2	601810	DNA2	1763	ENSG00000138346,ENST00000358410;;;ENST00000358410		Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 6	615156	AD	3	Dna2
10q21.3	10:68414064-68472521	DNA2, DNA2L, KIAA0083, PEOA6, SCKL8, RTS4	DNA replication helicase/nuclease 2	601810	DNA2	1763	ENSG00000138346,ENST00000358410;;;ENST00000358410		Rothmund-Thomson syndrome, type 4	620819	AR	3	Dna2
10q21.3	10:68414064-68472521	DNA2, DNA2L, KIAA0083, PEOA6, SCKL8, RTS4	DNA replication helicase/nuclease 2	601810	DNA2	1763	ENSG00000138346,ENST00000358410;;;ENST00000358410		Seckel syndrome 8	615807	AR	3	Dna2
10q22-q24	10:68800001-104000000	ATFB1	Atrial fibrillation, familial, 1	608583		406216			Atrial fibrillation, familial, 1	608583	AD	2	
10q22-q23	10:68800001-95300000	MGR12	Migraine, with or without aura, susceptibility to, 12	611706		100188851		max lod at 100cM	{Migraine, with or without aura, susceptibility to, 12}	611706	AD	2	
10q22.1-q24.1	10:68800001-97500000	SPG27	Spastic paraplegia-27, autosomal recessive	609041		414886		between  D10S606 and D10S1758	Spastic paraplegia 27, autosomal recessive	609041	AR	2	
10q22	10:68800001-80300000	SQTL1	Smoking as a quantitative trait locus 1	611003		100188827		near D10S1432	{Smoking as a quantitative trait locus 1}	611003		2	
10q22.1	10:68827531-68895432	STOX1, PEE4	Storkhead box 1	609397	STOX1	219736	ENSG00000165730,ENST00000298596;;;ENST00000298596		Preeclampsia/eclampsia 4	609404	AD	3	Stox1
10q22.1	10:68988803-69016982	KIFBP, KIAA1279	Kinesin family binding protein	609367	KIFBP	26128	ENSG00000198954,ENST00000361983;;;ENST00000361983		Goldberg-Shprintzen megacolon syndrome	609460	AR	3	Kifbp
10q22.1	10:69220332-69267552	HKDC1, RP92	Hexokinase domain-containing protein 1	617221	HKDC1	80201	ENSG00000156510,ENST00000354624;;;ENST00000354624		Retinitis pigmentosa 92	619614	AR	3	Hkdc1
10q22.1	10:69270000-69401882	HK1, HKD, HMSNR, RP79, NEDVIBA, CNSHA5	Hexokinase-1	142600	HK1	3098	ENSG00000156515,ENST00000359426;;;ENST00000359426		Anemia, congenital, nonspherocytic hemolytic, 5, hexokinase deficient	235700	AR	3	Hk1
10q22.1	10:69270000-69401882	HK1, HKD, HMSNR, RP79, NEDVIBA, CNSHA5	Hexokinase-1	142600	HK1	3098	ENSG00000156515,ENST00000359426;;;ENST00000359426		Neurodevelopmental disorder with visual defects and brain anomalies	618547	AD	3	Hk1
10q22.1	10:69270000-69401882	HK1, HKD, HMSNR, RP79, NEDVIBA, CNSHA5	Hexokinase-1	142600	HK1	3098	ENSG00000156515,ENST00000359426;;;ENST00000359426		Neuropathy, hereditary motor and sensory, Russe type	605285	AR	3	Hk1
10q22.1	10:69270000-69401882	HK1, HKD, HMSNR, RP79, NEDVIBA, CNSHA5	Hexokinase-1	142600	HK1	3098	ENSG00000156515,ENST00000359426;;;ENST00000359426		Retinitis pigmentosa 79	617460	AD	3	Hk1
10q22.1	10:69571485-69573422	NEUROG3, NGN3, ATOH5	Neurogenin 3	604882	NEUROG3	50674	ENSG00000122859,ENST00000242462;;;ENST00000242462		Diarrhea 4, malabsorptive, congenital	610370	AR	3	Neurog3
10q22.1	10:69801906-69959144	COL13A1, CMS19	Collagen XIII, alpha-1 polypeptide	120350	COL13A1	1305	ENSG00000197467,ENST00000645393;;;ENST00000645393	~550kb proximal to P4HA	Myasthenic syndrome, congenital, 19	616720	AR	3	Col13a1
10q22.1	10:70431936-70447951	NODAL, HTX5	Nodal, mouse, homolog of	601265	NODAL	4838	ENSG00000156574,ENST00000287139;;;ENST00000287139		Heterotaxy, visceral, 5, autosomal	270100	AD	3	Nodal
10q22.1	10:70597348-70602741	PRF1, HPLH2, FLH2	Perforin	170280	PRF1	5551	ENSG00000180644,ENST00000441259;;;ENST00000441259	mistakenly assigned to chr.17	Aplastic anemia	609135		3	Prf1
10q22.1	10:70597348-70602741	PRF1, HPLH2, FLH2	Perforin	170280	PRF1	5551	ENSG00000180644,ENST00000441259;;;ENST00000441259	mistakenly assigned to chr.17	Hemophagocytic lymphohistiocytosis, familial, 2	603553	AR	3	Prf1
10q22.1	10:70597348-70602741	PRF1, HPLH2, FLH2	Perforin	170280	PRF1	5551	ENSG00000180644,ENST00000441259;;;ENST00000441259	mistakenly assigned to chr.17	Lymphoma, non-Hodgkin	605027		3	Prf1
10q22.1	10:70815948-70881184	SGPL1, SPL, RENI, NPHS14	Sphingosine-1-phosphate lyase 1	603729	SGPL1	8879	ENSG00000166224,ENST00000373202;;;ENST00000373202		RENI syndrome	617575	AR	3	Sgpl1
10q22.1	10:70882280-70888565	PCBD1, DCOH	Pterin-4a-carbinolamine dehydratase 1	126090	PCBD1	5092	ENSG00000166228,ENST00000299299;;;ENST00000299299		Hyperphenylalaninemia, BH4-deficient, D	264070	AR	3	Pcbd1
10q22.1	10:71319259-71381423	SLC29A3, ENT3, PHID, HCLAP	Solute carrier family 29 (nucleoside transporter), member 3	612373	SLC29A3	55315	ENSG00000198246,ENST00000373189;;;ENST00000373189		Histiocytosis-lymphadenopathy plus syndrome	602782	AR	3	Slc29a3
10q22.1	10:71396920-71815947	CDH23, USH1D, DFNB12, PITA5	Cadherin-23 (otocadherin)	605516	CDH23	64072	ENSG00000107736,ENST00000224721;;;ENST00000224721	between D10S529 and D10S573	{Pituitary adenoma 5, multiple types}	617540	AD	3	Cdh23
10q22.1	10:71396920-71815947	CDH23, USH1D, DFNB12, PITA5	Cadherin-23 (otocadherin)	605516	CDH23	64072	ENSG00000107736,ENST00000224721;;;ENST00000224721	between D10S529 and D10S573	Deafness, autosomal recessive 12	601386	AR	3	Cdh23
10q22.1	10:71396920-71815947	CDH23, USH1D, DFNB12, PITA5	Cadherin-23 (otocadherin)	605516	CDH23	64072	ENSG00000107736,ENST00000224721;;;ENST00000224721	between D10S529 and D10S573	Usher syndrome, type 1D	601067	AR, DR	3	Cdh23
10q22.1	10:71396920-71815947	CDH23, USH1D, DFNB12, PITA5	Cadherin-23 (otocadherin)	605516	CDH23	64072	ENSG00000107736,ENST00000224721;;;ENST00000224721	between D10S529 and D10S573	Usher syndrome, type 1D/F digenic	601067	AR, DR	3	Cdh23
10q22.1	10:71816298-71851251	PSAP, SAP1, PSAPD, PARK24	Prosaposin (sphingolipid activator protein-1)	176801	PSAP	5660	ENSG00000197746,ENST00000394936;;;ENST00000394936		{Parkinson disease 24, autosomal dominant, susceptibility to}	619491	AD	3	Psap
10q22.1	10:71816298-71851251	PSAP, SAP1, PSAPD, PARK24	Prosaposin (sphingolipid activator protein-1)	176801	PSAP	5660	ENSG00000197746,ENST00000394936;;;ENST00000394936		Combined SAP deficiency	611721	AR	3	Psap
10q22.1	10:71816298-71851251	PSAP, SAP1, PSAPD, PARK24	Prosaposin (sphingolipid activator protein-1)	176801	PSAP	5660	ENSG00000197746,ENST00000394936;;;ENST00000394936		Gaucher disease, atypical	610539		3	Psap
10q22.1	10:71816298-71851251	PSAP, SAP1, PSAPD, PARK24	Prosaposin (sphingolipid activator protein-1)	176801	PSAP	5660	ENSG00000197746,ENST00000394936;;;ENST00000394936		Krabbe disease, atypical	611722	AR	3	Psap
10q22.1	10:71816298-71851251	PSAP, SAP1, PSAPD, PARK24	Prosaposin (sphingolipid activator protein-1)	176801	PSAP	5660	ENSG00000197746,ENST00000394936;;;ENST00000394936		Metachromatic leukodystrophy due to SAP-b deficiency	249900	AR	3	Psap
10q22.1	10:71964395-72013558	CHST3, C6ST, C6ST1, HSD	Carbohydrate sulfotransferase 3	603799	CHST3	9469	ENSG00000122863,ENST00000373115;;;ENST00000373115		Spondyloepiphyseal dysplasia with congenital joint dislocations	143095	AR	3	Chst3
10q22.1	10:72096032-72217134	ASCC1, p50, SMABF2	Activating signal cointegrator 1 complex, subunit 1	614215	ASCC1	51008	ENSG00000138303,ENST00000672957;;;ENST00000672957		Barrett esophagus/esophageal adenocarcinoma	614266		3	Ascc1
10q22.1	10:72096032-72217134	ASCC1, p50, SMABF2	Activating signal cointegrator 1 complex, subunit 1	614215	ASCC1	51008	ENSG00000138303,ENST00000672957;;;ENST00000672957		Spinal muscular atrophy with congenital bone fractures 2	616867	AR	3	Ascc1
10q22.1	10:72367340-72626079	MICU1, CBARA1, MPXPS	Mitochondrial calcium uptake protein 1	605084	MICU1	10367	ENSG00000107745,ENST00000361114;;;ENST00000361114		Myopathy with extrapyramidal signs	615673	AR	3	Micu1
10q22.2	10:73168119-73244504	FAM149B1, KIAA0974, JBTS36	Family with sequence similarity 149, member B1	618413	FAM149B1	317662	ENSG00000138286,ENST00000242505;;;ENST00000242505		Joubert syndrome 36	618763	AR	3	Fam149b
10q22.2	10:73248849-73252644	MRPS16, COXPD2	Mitochondrial ribosomal protein S16	609204	MRPS16	51021	ENSG00000182180,ENST00000372945;;;ENST00000372945		Combined oxidative phosphorylation deficiency 2	610498	AR	3	Mrps16
10q22.2	10:73253762-73362979	CFAP70, TTC18, SPGF41	Cilia- and flagella-associated protein 70	618661	CFAP70	118491	ENSG00000156042,ENST00000355577;;;ENST00000355577	mutation identified in 1 SPGF41 patient	?Spermatogenic failure 41	618670	AR	3	Cfap70
10q22.2	10:73812501-73874555	CAMK2G, CAMKG, MRD59	Calcium/calmodulin-dependent protein kinase (CaM kinase) II gamma	602123	CAMK2G	818	ENSG00000148660,ENST00000423381;;;ENST00000423381	in intron of PCDH15	Intellectual developmental disorder, autosomal dominant 59	618522	AD	3	Camk2g
10q22.2	10:73908832-73917494	PLAU, URK, QPD, BDPLT5	Plasminogen activator, urokinase	191840	PLAU	5328	ENSG00000122861,ENST00000372764;;;ENST00000372764	proximal to HOX11	{Alzheimer disease, late-onset, susceptibility to}	104300	AD	3	Plau
10q22.2	10:73908832-73917494	PLAU, URK, QPD, BDPLT5	Plasminogen activator, urokinase	191840	PLAU	5328	ENSG00000122861,ENST00000372764;;;ENST00000372764	proximal to HOX11	Quebec platelet disorder	601709	AD	3	Plau
10q22.2	10:73998116-74121363	VCL, CMD1W, CMH15	Vinculin	193065	VCL	7414	ENSG00000035403,ENST00000211998;;;ENST00000211998		Cardiomyopathy, dilated, 1W	611407		3	Vcl
10q22.2	10:73998116-74121363	VCL, CMD1W, CMH15	Vinculin	193065	VCL	7414	ENSG00000035403,ENST00000211998;;;ENST00000211998		Cardiomyopathy, hypertrophic, 15	613255	AD	3	Vcl
10q22.2	10:74151221-74709290	ADK	Adenosine kinase	102750	ADK	132	ENSG00000156110,ENST00000539909;;;ENST00000539909		Hypermethioninemia due to adenosine kinase deficiency	614300	AR	3	Adk
10q22.2	10:74824936-75032624	KAT6B, MYST4, MORF, GTPTS	Lysine acetyltransferase 6B	605880	KAT6B	23522	ENSG00000156650,ENST00000287239;;;ENST00000287239		Genitopatellar syndrome	606170	AD	3	Kat6b
10q22.2	10:74824936-75032624	KAT6B, MYST4, MORF, GTPTS	Lysine acetyltransferase 6B	605880	KAT6B	23522	ENSG00000156650,ENST00000287239;;;ENST00000287239		SBBYSS syndrome	603736	AD	3	Kat6b
10q22.2-q22.3	10:75431624-76560168	LRMDA, C10orf11, OCA7	Leucine-rich melanocyte differentiation-associated protein	614537	LRMDA	83938	ENSG00000148655,ENST00000611255;;;ENST00000611255		Albinism, oculocutaneous, type VII	615179	AR	3	Lrmda
10q22.3	10:75900001-80300000	SCZD11	Schizophrenia susceptibility locus, chromosome 10q-related	608078		404686		between D10S1677 and D10S1753	{Schizophrenia}	181500	AD	2	
10q22.3	10:75900001-80300000	SLEN1	Systemic lupus erythematosus with nephritis, susceptibility to, 1	607965		192677			{Systemic lupus erythematosus with nephritis, susceptibility to, 1}	607965		2	
10q22.3	10:75900001-80300000	SS3	Sarcoidosis, susceptibility to, 3	612388		100196919		associated with rs2789679 and rs1049550	{Sarcoidosis, susceptibility to, 3}	612388		2	
10q22.3	10:76869602-77637808	KCNMA1, SLO, PNKD3, CADEDS, IEG16, LIWAS	Potassium large conductance calcium-activated channel, subfamily M, alpha member 1 (slowpoke, Drosophila, homolog of)	600150	KCNMA1	3778	ENSG00000156113,ENST00000286628;;;ENST00000286628		{Epilepsy, idiopathic generalized, susceptibility to, 16}	618596	AD	3	Kcnma1
10q22.3	10:76869602-77637808	KCNMA1, SLO, PNKD3, CADEDS, IEG16, LIWAS	Potassium large conductance calcium-activated channel, subfamily M, alpha member 1 (slowpoke, Drosophila, homolog of)	600150	KCNMA1	3778	ENSG00000156113,ENST00000286628;;;ENST00000286628		Cerebellar atrophy, developmental delay, and seizures	617643	AR	3	Kcnma1
10q22.3	10:76869602-77637808	KCNMA1, SLO, PNKD3, CADEDS, IEG16, LIWAS	Potassium large conductance calcium-activated channel, subfamily M, alpha member 1 (slowpoke, Drosophila, homolog of)	600150	KCNMA1	3778	ENSG00000156113,ENST00000286628;;;ENST00000286628		Liang-Wang syndrome	618729	AD	3	Kcnma1
10q22.3	10:76869602-77637808	KCNMA1, SLO, PNKD3, CADEDS, IEG16, LIWAS	Potassium large conductance calcium-activated channel, subfamily M, alpha member 1 (slowpoke, Drosophila, homolog of)	600150	KCNMA1	3778	ENSG00000156113,ENST00000286628;;;ENST00000286628		Paroxysmal nonkinesigenic dyskinesia, 3, with or without generalized epilepsy	609446	AD	3	Kcnma1
10q22.3	10:77790791-77940736	DLG5, PDLG, KIAA0583, YUVOB	Discs large MAGUK scaffold protein 5	604090	DLG5	9231	ENSG00000151208,ENST00000372391;;;ENST00000372391		Yuksel-Vogel-Bauser syndrome	620703	AR	3	Dlg5
10q22.3	10:77975149-78029515	POLR3A, RPC1, RPC155, ADDH, HLD7, WDRTS	Polymerase III, RNA, subunit A	614258	POLR3A	11128	ENSG00000148606,ENST00000372371;;;ENST00000372371		Leukodystrophy, hypomyelinating, 7, with or without oligodontia and/or hypogonadotropic hypogonadism	607694	AR	3	Polr3a
10q22.3	10:77975149-78029515	POLR3A, RPC1, RPC155, ADDH, HLD7, WDRTS	Polymerase III, RNA, subunit A	614258	POLR3A	11128	ENSG00000148606,ENST00000372371;;;ENST00000372371		Wiedemann-Rautenstrauch syndrome	264090	AR	3	Polr3a
10q22.3	10:78033863-78056806	RPS24, DBA3	Ribosomal protein S24	602412	RPS24	6229	ENSG00000138326,ENST00000372360;;;ENST00000372360		Diamond-blackfan anemia 3	610629	AD	3	Rps24
10q22.3	10:79068966-79316519	ZMIZ1, RAI17, KIAA1224, ZIMP10, NEDDFSA	Zinc finger MIZ-domain containing 1	607159	ZMIZ1	57178	ENSG00000108175,ENST00000334512;;;ENST00000334512		Neurodevelopmental disorder with dysmorphic facies and distal skeletal anomalies	618659	AD	3	Zmiz1
10q22.3	10:79555852-79560407	SFTPA2, SPA2, COLEC5, ILD2	Surfactant, pulmonary-associated protein A2	178642	SFTPA2	729238	ENSG00000185303,ENST00000372325;;;ENST00000372325	contiguous with SFTPA1	Interstitial lung disease 2	178500	AD	3	Sftpa1
10q22.3	10:79610939-79615455	SFTPA1, SFTP1, ILD1	Surfactant, pulmonary-associated protein A1	178630	SFTPA1	653509	ENSG00000122852,ENST00000398636;;;ENST00000398636	contiguous with SFTPA2	Interstitial lung disease 1	619611	AD, AR	3	Sftpa1
10q22.3	10:79691500-79826594	NUTM2B-AS1, OPML1	NUTM2B antisense RNA 1	618639	NUTM2B-AS1	101060691	ENSG00000225484,ENST00000665716	mutation identified in 1 OPML1 family	?Oculopharyngeal myopathy with leukoencephalopathy 1	618637	AD	3	
10q22.3	10:80150889-80205808	ANXA11, ANX11, ALS23, IBMWMA	Annexin A11 (annexin XI)	602572	ANXA11	311	ENSG00000122359,ENST00000422982;;;ENST00000422982		Amyotrophic lateral sclerosis 23	617839	AD	3	Anxa11
10q22.3	10:80150889-80205808	ANXA11, ANX11, ALS23, IBMWMA	Annexin A11 (annexin XI)	602572	ANXA11	311	ENSG00000122359,ENST00000422982;;;ENST00000422982		Inclusion body myopathy and brain white matter abnormalities	619733	AD	3	Anxa11
10q22.3	10:80271820-80289658	MAT1A, MATA1, SAMS1	Methionine adenosyltransferase I, alpha	610550	MAT1A	4143	ENSG00000151224,ENST00000372213;;;ENST00000372213		Hypermethioninemia, persistent, autosomal dominant, due to methionine adenosyltransferase I/III deficiency	250850	AD, AR	3	Mat1a
10q22.3	10:80271820-80289658	MAT1A, MATA1, SAMS1	Methionine adenosyltransferase I, alpha	610550	MAT1A	4143	ENSG00000151224,ENST00000372213;;;ENST00000372213		Methionine adenosyltransferase deficiency, autosomal recessive	250850	AD, AR	3	Mat1a
10q23-q24	10:80300001-104000000	CPROTQ	C-reactive protein QTL	611920		100188860		max lod at D10S1239	[C-reactive protein QTL]	611920		2	
10q23	10:80300001-95300000	DEL10q23, C10DELq23	Chromosome 10q22.3-q23.2 deletion syndrome	612242					Chromosome 10q22.3-q23.2 deletion syndrome	612242		4	
10q23-q24	10:80300001-104000000	IBD20	Inflammatory bowel disease 20	612288		100190788		associated with rs11190140	{Inflammatory bowel disease 20}	612288		2	
10q23.1	10:84194537-84219621	CDHR1, PCDH21, PRCAD, CORD15, RP65	Cadherin-related family, member 1	609502	CDHR1	92211	ENSG00000148600,ENST00000623527;;;ENST00000623527		Cone-rod dystrophy 15	613660	AR	3	Cdhr1
10q23.1	10:84194537-84219621	CDHR1, PCDH21, PRCAD, CORD15, RP65	Cadherin-related family, member 1	609502	CDHR1	92211	ENSG00000148600,ENST00000623527;;;ENST00000623527		Macular dystrophy, retinal	613660	AR	3	Cdhr1
10q23.1	10:84194537-84219621	CDHR1, PCDH21, PRCAD, CORD15, RP65	Cadherin-related family, member 1	609502	CDHR1	92211	ENSG00000148600,ENST00000623527;;;ENST00000623527		Retinitis pigmentosa 65	613660	AR	3	Cdhr1
10q23.1	10:84245053-84259960	RGR, RP44	Retinal G protein coupled receptor	600342	RGR	5995	ENSG00000148604,ENST00000652092;;;ENST00000652092		Retinitis pigmentosa 44	613769		3	Rgr
10q23.2	10:86666788-86736072	LDB3, ZASP, CYPHER, KIAA01613, MFM4, CMD1C, CMH24, LVNC3, CMD2L	LIM domain binding 3	605906	LDB3	11155	ENSG00000122367,ENST00000361373;;;ENST00000361373		Cardiomyopathy, dilated, 1C, with or without LVNC	601493	AD	3	Ldb3
10q23.2	10:86666788-86736072	LDB3, ZASP, CYPHER, KIAA01613, MFM4, CMD1C, CMH24, LVNC3, CMD2L	LIM domain binding 3	605906	LDB3	11155	ENSG00000122367,ENST00000361373;;;ENST00000361373		Cardiomyopathy, dilated, 2L	621237	AR	3	Ldb3
10q23.2	10:86666788-86736072	LDB3, ZASP, CYPHER, KIAA01613, MFM4, CMD1C, CMH24, LVNC3, CMD2L	LIM domain binding 3	605906	LDB3	11155	ENSG00000122367,ENST00000361373;;;ENST00000361373		Cardiomyopathy, hypertrophic, 24	601493	AD	3	Ldb3
10q23.2	10:86666788-86736072	LDB3, ZASP, CYPHER, KIAA01613, MFM4, CMD1C, CMH24, LVNC3, CMD2L	LIM domain binding 3	605906	LDB3	11155	ENSG00000122367,ENST00000361373;;;ENST00000361373		Left ventricular noncompaction 3	601493	AD	3	Ldb3
10q23.2	10:86666788-86736072	LDB3, ZASP, CYPHER, KIAA01613, MFM4, CMD1C, CMH24, LVNC3, CMD2L	LIM domain binding 3	605906	LDB3	11155	ENSG00000122367,ENST00000361373;;;ENST00000361373		Myopathy, myofibrillar, 4	609452	AD	3	Ldb3
10q23.2	10:86755763-86932844	BMPR1A, ACVRLK3, ALK3	Bone morphogenetic protein receptor, type IA	601299	BMPR1A	657	ENSG00000107779,ENST00000372037;;;ENST00000372037		Polyposis syndrome, hereditary mixed, 2	610069		3	Bmpr1a
10q23.2	10:86755763-86932844	BMPR1A, ACVRLK3, ALK3	Bone morphogenetic protein receptor, type IA	601299	BMPR1A	657	ENSG00000107779,ENST00000372037;;;ENST00000372037		Polyposis, juvenile intestinal	174900	AD	3	Bmpr1a
10q23.2	10:87050202-87094843	GLUD1	Glutamate dehydrogenase-1	138130	GLUD1	2746	ENSG00000148672,ENST00000277865;;;ENST00000277865	pseudogene on Xq26-q28	Hyperinsulinism-hyperammonemia syndrome	606762	AD	3	Glud1
10q23.2	10:87504893-87553461	MINPP1, HIPER1, PCH16	Multiple inositol polyphosphate phosphatase 1	605391	MINPP1	9562	ENSG00000107789,ENST00000371996;;;ENST00000371996		{Thyroid carcinoma, follicular}	188470	AD, SMu	3	Minpp1
10q23.2	10:87504893-87553461	MINPP1, HIPER1, PCH16	Multiple inositol polyphosphate phosphatase 1	605391	MINPP1	9562	ENSG00000107789,ENST00000371996;;;ENST00000371996		Pontocerebellar hypoplasia, type 16	619527	AR	3	Minpp1
10q23.2-q23.31	10:87659878-87747705	PAPSS2, ATPSK2, BCYM4	3'-phosphoadenosine 5'-phosphosulfate synthase 2	603005	PAPSS2	9060	ENSG00000198682,ENST00000456849;;;ENST00000456849		Brachyolmia 4 with mild epiphyseal and metaphyseal changes	612847	AR	3	Papss2
10q23.31	10:87700001-91100000	IDDM24	Diabetes mellitus, insulin-dependent, 24	613006		100303715		associated with rs10509540	{Diabetes mellitus, insulin-dependent, 24}	613006		2	
10q23.3	10:87700001-95300000	RCM2	Cardiomyopathy, familial restrictive, 2	609578		619468		max lod at D10S1242	Cardiomyopathy, familial restrictive, 2	609578		2	
10q23.31	10:87751512-87841361	ATAD1, THORASE, HKPX4	ATPase family, AAA domain-containing, member 1	614452	ATAD1	84896	ENSG00000138138,ENST00000680024;;;ENST00000680024		Hyperekplexia 4	618011	AR	3	Atad1
10q23.31	10:87859158-87863533	KLLN, CWS4	Killin	612105	KLLN	100144748	ENSG00000227268,ENST00000445946;;;ENST00000445946		Cowden syndrome 4	615107	IC	3	
10q23.31	10:87863625-87971930	PTEN, MMAC1, GLM2, CWS1	Phosphatase and tensin homolog (mutated in multiple advanced cancers 1)	601728	PTEN	5728	ENSG00000171862,ENST00000371953;;;ENST00000371953		{Glioma susceptibility 2}	613028	AD	3	Pten
10q23.31	10:87863625-87971930	PTEN, MMAC1, GLM2, CWS1	Phosphatase and tensin homolog (mutated in multiple advanced cancers 1)	601728	PTEN	5728	ENSG00000171862,ENST00000371953;;;ENST00000371953		{Meningioma}	607174	AD	3	Pten
10q23.31	10:87863625-87971930	PTEN, MMAC1, GLM2, CWS1	Phosphatase and tensin homolog (mutated in multiple advanced cancers 1)	601728	PTEN	5728	ENSG00000171862,ENST00000371953;;;ENST00000371953		Cowden syndrome 1	158350	AD	3	Pten
10q23.31	10:87863625-87971930	PTEN, MMAC1, GLM2, CWS1	Phosphatase and tensin homolog (mutated in multiple advanced cancers 1)	601728	PTEN	5728	ENSG00000171862,ENST00000371953;;;ENST00000371953		Lhermitte-Duclos disease	158350	AD	3	Pten
10q23.31	10:87863625-87971930	PTEN, MMAC1, GLM2, CWS1	Phosphatase and tensin homolog (mutated in multiple advanced cancers 1)	601728	PTEN	5728	ENSG00000171862,ENST00000371953;;;ENST00000371953		Macrocephaly/autism syndrome	605309	AD	3	Pten
10q23.31	10:87863625-87971930	PTEN, MMAC1, GLM2, CWS1	Phosphatase and tensin homolog (mutated in multiple advanced cancers 1)	601728	PTEN	5728	ENSG00000171862,ENST00000371953;;;ENST00000371953		Prostate cancer, somatic	176807		3	Pten
10q23.31	10:88757226-88779626	LIPN, LIPL4, ARCI8, LI4	Lipase family, member N	613924	LIPN	643418	ENSG00000204020,ENST00000404459;;;ENST00000404459		Ichthyosis, congenital, autosomal recessive 8	613943	AR	3	Lipn
10q23.31	10:88935074-88991337	ACTA2, ACTSA, AAT6, MYMY5, SMDYS	Actin, alpha-2, smooth muscle, aorta	102620	ACTA2	59	ENSG00000107796,ENST00000224784;;;ENST00000224784		Aortic aneurysm, familial thoracic 6	611788	AD	3	Acta2
10q23.31	10:88935074-88991337	ACTA2, ACTSA, AAT6, MYMY5, SMDYS	Actin, alpha-2, smooth muscle, aorta	102620	ACTA2	59	ENSG00000107796,ENST00000224784;;;ENST00000224784		Moyamoya disease 5	614042		3	Acta2
10q23.31	10:88935074-88991337	ACTA2, ACTSA, AAT6, MYMY5, SMDYS	Actin, alpha-2, smooth muscle, aorta	102620	ACTA2	59	ENSG00000107796,ENST00000224784;;;ENST00000224784		Smooth muscle dysfunction syndrome	613834	AD	3	Acta2
10q23.31	10:88964050-89017059	FAS, TNFRSF6, APT1, CD95, ALPS1A	Fas cell surface death receptor	134637	FAS	355	ENSG00000026103,ENST00000652046;;;ENST00000652046		{Autoimmune lymphoproliferative syndrome}	601859	AD	3	Fas
10q23.31	10:88964050-89017059	FAS, TNFRSF6, APT1, CD95, ALPS1A	Fas cell surface death receptor	134637	FAS	355	ENSG00000026103,ENST00000652046;;;ENST00000652046		Autoimmune lymphoproliferative syndrome, type IA	601859	AD	3	Fas
10q23.31	10:88964050-89017059	FAS, TNFRSF6, APT1, CD95, ALPS1A	Fas cell surface death receptor	134637	FAS	355	ENSG00000026103,ENST00000652046;;;ENST00000652046		Squamous cell carcinoma, burn scar-related, somatic			3	Fas
10q23.31	10:89213572-89414679	LIPA, CESD	Lipase A, lysosomal acid, cholesterol esterase	613497	LIPA	3988	ENSG00000107798,ENST00000336233;;;ENST00000336233	?close to GOT	Cholesteryl ester storage disease	278000	AR	3	Lipa
10q23.31	10:89213572-89414679	LIPA, CESD	Lipase A, lysosomal acid, cholesterol esterase	613497	LIPA	3988	ENSG00000107798,ENST00000336233;;;ENST00000336233	?close to GOT	Wolman disease	620151	AR	3	Lipa
10q23.31	10:89430299-89556704	SLC16A12, MCT12, CTRCT47	Solute carrier family 16 (monocarboxylic acid transporter), member 12	611910	SLC16A12	387700	ENSG00000152779,ENST00000371790;;;ENST00000371790	mutation identified in 1 CTRCT47 family	Cataract 47, juvenile, with microcornea	612018	AD	3	Slc16a12
10q23.33	10:92593130-92655395	KIF11, KNSL1, MCLMR	Kinesin family member 11	148760	KIF11	3832	ENSG00000138160,ENST00000260731;;;ENST00000260731		Microcephaly with or without chorioretinopathy, lymphedema, or impaired intellectual development	152950	AD	3	Kif11
10q23.33	10:93060798-93069540	CYP26C1, FFDD4	Cytochrome P450, subfamily XXVIC, polypeptide 1	608428	CYP26C1	340665	ENSG00000187553,ENST00000651965;;;ENST00000651965		Focal facial dermal dysplasia 4	614974	AR	3	Cyp26c1
10q23.33	10:93306429-93482334	MYOF, FER1L3, HAE7	Myoferlin	604603	MYOF	26509	ENSG00000138119,ENST00000359263;;;ENST00000359263	mutation identified in 1 HAE7 family	?Angioedema, hereditary, 7	619366	AD	3	Myof
10q23.33	10:93496612-93529092	CEP55, MARCH	Centrosomal protein, 55kD	610000	CEP55	55165	ENSG00000138180,ENST00000371485;;;ENST00000371485		Multinucleated neurons, anhydramnios, renal dysplasia, cerebellar hypoplasia, and hydranencephaly	236500	AR	3	Cep55
10q23.33	10:93566665-93590072	FFAR4, O3FAR1, GPR120, PGR4, BMIQ10	Free fatty acid receptor 4	609044	FFAR4	338557	ENSG00000186188,ENST00000371481;;;ENST00000371481		{Obesity, susceptibility to}	607514		3	Ffar4
10q23.33	10:93591694-93601744	RBP4, RDCCAS, MCOPCB10	Retinol-binding protein-4, interstitial	180250	RBP4	5950	ENSG00000138207,ENST00000371464;;;ENST00000371464	just centromeric of CYP2C cluster	Microphthalmia/coloboma 10	616428	AD	3	Rbp4
10q23.33	10:93591694-93601744	RBP4, RDCCAS, MCOPCB10	Retinol-binding protein-4, interstitial	180250	RBP4	5950	ENSG00000138207,ENST00000371464;;;ENST00000371464	just centromeric of CYP2C cluster	Retinal dystrophy, iris coloboma, and comedogenic acne syndrome	615147	AR	3	Rbp4
10q23.33	10:93612537-93666010	PDE6C, PDEA2, COD4	Phosphodiesterase 6C	600827	PDE6C	5146	ENSG00000095464,ENST00000371447;;;ENST00000371447		Cone dystrophy 4	613093	AR	3	Pde6c
10q23.33	10:93667883-93702959	FRA10AC1, FRA10A, C10orf4, NEDGFC	FRA10A associated CGG repeat 1	608866	FRA10AC1	118924	ENSG00000148690,ENST00000359204;;;ENST00000359204		Neurodevelopmental disorder with growth retardation, dysmorphic facies, and corpus callosum abnormalities	620113	AR	3	Fra10ac1
10q23.33	10:93757936-93798159	LGI1, EPT, ETL1, ADLTE, ADPEAF	Leucine-rich gene, glioma-inactivated, 1	604619	LGI1	9211	ENSG00000108231,ENST00000371418;;;ENST00000371418		Epilepsy, familial temporal lobe, 1	600512	AD	3	Lgi1
10q23.33	10:93993931-94332823	PLCE1, KIAA1516, NPHS3	Phospholipase C, epsilon-1	608414	PLCE1	51196	ENSG00000138193,ENST00000371380;;;ENST00000371380		Nephrotic syndrome, type 3	610725	AR	3	Plce1
10q23.33	10:94545788-94613905	HELLS, LSH, ICF4	Helicase, lymphoid-specific	603946	HELLS	3070	ENSG00000119969,ENST00000348459;;;ENST00000348459		Immunodeficiency-centromeric instability-facial anomalies syndrome 4	616911	AR	3	Hells
10q23.33	10:94762681-94855547	CYP2C, CYP2C19	Cytochrome P450, subfamily IIC (mephenytoin 4'-hydroxylase)	124020	CYP2C19	1557	ENSG00000165841,ENST00000371321;;;ENST00000371321	4 genes in order: cen-C18-C19-C9-C8-tel	Clopidogrel, impaired responsiveness to	609535	AR	3	Cyp2c29,Cyp2c37,Cyp2c38,Cyp2c39,Cyp2c50
10q23.33	10:94762681-94855547	CYP2C, CYP2C19	Cytochrome P450, subfamily IIC (mephenytoin 4'-hydroxylase)	124020	CYP2C19	1557	ENSG00000165841,ENST00000371321;;;ENST00000371321	4 genes in order: cen-C18-C19-C9-C8-tel	Mephenytoin poor metabolizer	609535	AR	3	Cyp2c29,Cyp2c37,Cyp2c38,Cyp2c39,Cyp2c50
10q23.33	10:94762681-94855547	CYP2C, CYP2C19	Cytochrome P450, subfamily IIC (mephenytoin 4'-hydroxylase)	124020	CYP2C19	1557	ENSG00000165841,ENST00000371321;;;ENST00000371321	4 genes in order: cen-C18-C19-C9-C8-tel	Omeprazole poor metabolizer	609535	AR	3	Cyp2c29,Cyp2c37,Cyp2c38,Cyp2c39,Cyp2c50
10q23.33	10:94762681-94855547	CYP2C, CYP2C19	Cytochrome P450, subfamily IIC (mephenytoin 4'-hydroxylase)	124020	CYP2C19	1557	ENSG00000165841,ENST00000371321;;;ENST00000371321	4 genes in order: cen-C18-C19-C9-C8-tel	Proguanil poor metabolizer	609535	AR	3	Cyp2c29,Cyp2c37,Cyp2c38,Cyp2c39,Cyp2c50
10q23.33	10:94938658-94990091	CYP2C9	Cytochrome P450, subfamily IIC (mephenytoin 4-hydroxylase), polypeptide 9	601130	CYP2C9	1559	ENSG00000138109,ENST00000260682;;;ENST00000260682		Tolbutamide poor metabolizer			3	Cyp2c29,Cyp2c37,Cyp2c38,Cyp2c39,Cyp2c50
10q23.33	10:94938658-94990091	CYP2C9	Cytochrome P450, subfamily IIC (mephenytoin 4-hydroxylase), polypeptide 9	601130	CYP2C9	1559	ENSG00000138109,ENST00000260682;;;ENST00000260682		Warfarin sensitivity	122700	AD	3	Cyp2c29,Cyp2c37,Cyp2c38,Cyp2c39,Cyp2c50
10q23.33	10:95036772-95069497	CYP2C8, CYP2C8DM	Cytochrome P450, subfamily IIc, polypeptide 8	601129	CYP2C8	1558	ENSG00000138115,ENST00000371270;;;ENST00000371270		{Drug metabolism, altered, CYP2C8-related}	618018		3	Cyp2c37,Cyp2c40,Cyp2c50,Cyp2c54,Cyp2c65,Cyp2c66,Cyp2c67,Cyp2c68,Cyp2c69
10q24	10:95300001-104000000	AD6	Alzheimer disease 6	605526		64851			Alzheimer disease 6	605526		2	
10q24.1-q25.1	10:95300001-110100000	CMTD1A	Charcot-Marie-Tooth disease, dominant intermediate A	620378		130068899			Charcot-Marie-Tooth disease, dominant intermediate A	620378	AD	2	
10q24	10:95300001-104000000	HYPOFP	Hypoplastic femurs and pelvis	619545				duplication of ~500kb on 10q24	Hypoplastic femurs and pelvis	619545	AD	4	
10q24	10:95300001-104000000	SHFM3, SHSF3, DUP10q24, C10DUPq24	Split-hand/foot malformation 3 (Chromosome 10q24 duplication syndrome)	246560				contiguous gene duplication syndrome	Split-hand/foot malformation 3, gene duplication syndrome	246560	AD	4	
10q24.1	10:95605941-95656711	ALDH18A1, PYCS, GSAS, ARCL3A, SPG9A, SPG9B, ADCL3	Aldehyde dehydrogenase 18 family, member A1 (1-pyrroline-5-carboxylate synthetase)	138250	ALDH18A1	5832	ENSG00000059573,ENST00000371224;;;ENST00000371224	GOT1 and GSAS in same pathway	Cutis laxa, autosomal dominant 3	616603	AD	3	Aldh18a1
10q24.1	10:95605941-95656711	ALDH18A1, PYCS, GSAS, ARCL3A, SPG9A, SPG9B, ADCL3	Aldehyde dehydrogenase 18 family, member A1 (1-pyrroline-5-carboxylate synthetase)	138250	ALDH18A1	5832	ENSG00000059573,ENST00000371224;;;ENST00000371224	GOT1 and GSAS in same pathway	Cutis laxa, autosomal recessive, type IIIA	219150	AR	3	Aldh18a1
10q24.1	10:95605941-95656711	ALDH18A1, PYCS, GSAS, ARCL3A, SPG9A, SPG9B, ADCL3	Aldehyde dehydrogenase 18 family, member A1 (1-pyrroline-5-carboxylate synthetase)	138250	ALDH18A1	5832	ENSG00000059573,ENST00000371224;;;ENST00000371224	GOT1 and GSAS in same pathway	Spastic paraplegia 9A, autosomal dominant	601162	AD	3	Aldh18a1
10q24.1	10:95605941-95656711	ALDH18A1, PYCS, GSAS, ARCL3A, SPG9A, SPG9B, ADCL3	Aldehyde dehydrogenase 18 family, member A1 (1-pyrroline-5-carboxylate synthetase)	138250	ALDH18A1	5832	ENSG00000059573,ENST00000371224;;;ENST00000371224	GOT1 and GSAS in same pathway	Spastic paraplegia 9B, autosomal recessive	616586	AR	3	Aldh18a1
10q24.1	10:95663401-95693927	TCTN3, TECT3, C10orf61, OFD4, JBTS18	Tectonic family, member 3	613847	TCTN3	26123	ENSG00000119977,ENST00000371217;;;ENST00000371217		Joubert syndrome 18	614815	AR	3	Tctn3
10q24.1	10:95663401-95693927	TCTN3, TECT3, C10orf61, OFD4, JBTS18	Tectonic family, member 3	613847	TCTN3	26123	ENSG00000119977,ENST00000371217;;;ENST00000371217		Orofaciodigital syndrome IV	258860	AR	3	Tctn3
10q24.1	10:95694185-95877266	ENTPD1, CD39, SPG64	Ectonucleoside triphosphate diphosphohydrolase 1 (CD39 antigen)	601752	ENTPD1	953	ENSG00000138185,ENST00000371205;;;ENST00000371205		Spastic paraplegia 64, autosomal recessive	615683	AR	3	Entpd1
10q24.1	10:96189171-96271569	BLNK, SLP65, AGM4	B-cell linker protein (SH2 domain-containing leukocyte protein, 65kD)	604515	BLNK	29760	ENSG00000095585,ENST00000224337;;;ENST00000224337	mutation identified in 1 AGM4 family	?Agammaglobulinemia 4	613502	AR	3	Blnk
10q24.1	10:97435909-97446006	EXOSC1, CSL4, PCH1F	Exosome component 1	606493	EXOSC1	51013	ENSG00000171311,ENST00000370902;;;ENST00000370902	mutation identified in 1 PCH1F patient	?Pontocerebellar hypoplasia, type 1F	619304	AR	3	Exosc1
10q24.2	10:97584389-97612802	HOGA1, DHDPSL, HP3	4-hydroxy-2-oxoglutarate aldolase 1	613597	HOGA1	112817	ENSG00000241935,ENST00000370646;;;ENST00000370646		Hyperoxaluria, primary, type III	613616	AR	3	Hoga1
10q24.2	10:97640671-97676434	PI4K2A, NEDMSB	Phosphatidylinositol 4-kinase type 2 alpha	609763	PI4K2A	55361	ENSG00000155252,ENST00000370631;;;ENST00000370631		Neurodevelopmental disorder with hyperkinetic movements, seizures and structural brain abnormalities	620732	AR	3	Pi4k2a
10q24.2	10:98413948-98446935	HPS1	HPS1 biogenesis of lysosomal organelles complex 3 subunit 1	604982	HPS1	3257	ENSG00000107521,ENST00000361490;;;ENST00000361490		Hermansky-Pudlak syndrome 1	203300	AR	3	Hps1
10q24.2	10:98457077-99315951	HPSE2, HPA2, UFS1	Heparanase 2	613469	HPSE2	60495	ENSG00000172987,ENST00000370552;;;ENST00000370552		Urofacial syndrome 1	236730	AR	3	Hpse2
10q24.2	10:99396870-99430624	GOT1, ASTQTL1	Glutamic-oxaloacetic transaminase 1, soluble	138180	GOT1	2805	ENSG00000120053,ENST00000370508;;;ENST00000370508	10q26.1 = conflicting localization	Aspartate aminotransferase, serum level of, QTL1	614419		3	Got1
10q24.2	10:99694293-99732127	COX15, MC4DN6	Cytochrome c oxidase, subunit 15	603646	COX15	1355	ENSG00000014919,ENST00000016171;;;ENST00000016171		Mitochondrial complex IV deficiency, nuclear type 6	615119	AR	3	Cox15
10q24.2	10:99782640-99852594	ABCC2, CMOAT	ATP-binding cassette, subfamily C, member 2 (canalicular multispecific organic anion transporter)	601107	ABCC2	1244	ENSG00000023839,ENST00000647814;;;ENST00000647814		Dubin-Johnson syndrome	237500	AR	3	Abcc2
10q24.2	10:99875571-100009947	DNMBP, TUBA, KIAA1010, CTRCT48	Dynamin-binding protein	611282	DNMBP	23268	ENSG00000107554,ENST00000324109;;;ENST00000324109		Cataract 48	618415	AR	3	Dnmbp
10q24.2	10:100042193-100081869	CPN1, SCPN, CPN	Carboxypeptidase N, polypeptide 1, 50-kD	603103	CPN1	1369	ENSG00000120054,ENST00000370418;;;ENST00000370418		Carboxypeptidase N deficiency	212070	AR	3	Cpn1
10q24.31	10:100150094-100186029	ERLIN1, SPG62	Endoplasmic reticulum lipid raft-associated protein 1	611604	ERLIN1	10613	ENSG00000107566,ENST00000421367;;;ENST00000421367		Spastic paraplegia 62, autosomal recessive	615681	AR	3	Erlin1
10q24.31	10:100186319-100229596	CHUK, IKBKA, NFKBIKA, IKKA, IKK1, BPS2	Component of nuclear factor kappa-B kinase complex	600664	CHUK	1147	ENSG00000213341,ENST00000370397;;;ENST00000370397	mutation identified in 1 BPS2 patient and 1 family	?Cocoon syndrome	613630	AR	3	Chuk
10q24.31	10:100186319-100229596	CHUK, IKBKA, NFKBIKA, IKKA, IKK1, BPS2	Component of nuclear factor kappa-B kinase complex	600664	CHUK	1147	ENSG00000213341,ENST00000370397;;;ENST00000370397	mutation identified in 1 BPS2 patient and 1 family	?Popliteal pterygium syndrome, Bartsocas-Papas type 2	619339	AR	3	Chuk
10q24.31	10:100232298-100267638	CWF19L1, C19L1, SCAR17	CWF19-like cell cycle control factor 1	616120	CWF19L1	55280	ENSG00000095485,ENST00000354105;;;ENST00000354105		Spinocerebellar ataxia, autosomal recessive 17	616127	AR	3	Cwf19l1
10q24.31	10:100523729-100529923	NDUFB8, MC1DN32	NADH-ubiquinone oxidoreductase subunit B8	602140	NDUFB8	4714	ENSG00000166136,ENST00000299166;;;ENST00000299166	previously assigned to 12q21	Mitochondrial complex I deficiency, nuclear type 32	618252	AR	3	Ndufb8
10q24.31	10:100735396-100829944	PAX2, PAPRS, FSGS7	Paired box homeotic gene-2	167409	PAX2	5076	ENSG00000075891,ENST00000355243;;;ENST00000355243		Glomerulosclerosis, focal segmental, 7	616002	AD	3	Pax2
10q24.31	10:100735396-100829944	PAX2, PAPRS, FSGS7	Paired box homeotic gene-2	167409	PAX2	5076	ENSG00000075891,ENST00000355243;;;ENST00000355243		Papillorenal syndrome	120330	AD	3	Pax2
10q24.31	10:100912963-100965134	SLF2, FAM178A, C10orf6, ATELS1	SMC5-SMC6 complex localization factor 2	610348	SLF2	55719	ENSG00000119906,ENST00000238961;;;ENST00000238961		Atelis syndrome 1	620184	AR	3	Slf2
10q24.31	10:100987543-100994403	TWNK, C10orf2, TWINKLE, PEOA3, IOSCA, MTDPS7, PRLTS5	Twinkle mtDNA helicase	606075	TWNK	56652	ENSG00000107815,ENST00000311916;;;ENST00000311916	PEO digenic with POLG	Mitochondrial DNA depletion syndrome 7 (hepatocerebral type)	271245	AR	3	Twnk
10q24.31	10:100987543-100994403	TWNK, C10orf2, TWINKLE, PEOA3, IOSCA, MTDPS7, PRLTS5	Twinkle mtDNA helicase	606075	TWNK	56652	ENSG00000107815,ENST00000311916;;;ENST00000311916	PEO digenic with POLG	Perrault syndrome 5	616138	AR	3	Twnk
10q24.31	10:100987543-100994403	TWNK, C10orf2, TWINKLE, PEOA3, IOSCA, MTDPS7, PRLTS5	Twinkle mtDNA helicase	606075	TWNK	56652	ENSG00000107815,ENST00000311916;;;ENST00000311916	PEO digenic with POLG	Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 3	609286	AD	3	Twnk
10q24.31	10:101007679-101031129	PDZD7, DFNB57	PDZ domain-containing 7	612971	PDZD7	79955	ENSG00000186862,ENST00000619208;;;ENST00000619208		{Retinal disease in Usher syndrome type IIA, modifier of}	276901	AR	3	Pdzd7
10q24.31	10:101007679-101031129	PDZD7, DFNB57	PDZ domain-containing 7	612971	PDZD7	79955	ENSG00000186862,ENST00000619208;;;ENST00000619208		Deafness, autosomal recessive 57	618003	AR	3	Pdzd7
10q24.31	10:101007679-101031129	PDZD7, DFNB57	PDZ domain-containing 7	612971	PDZD7	79955	ENSG00000186862,ENST00000619208;;;ENST00000619208		Usher syndrome, type IIC, GPR98/PDZD7 digenic	605472	AR, DD	3	Pdzd7
10q24.32-q25.1	10:101200001-110100000	ECTD5	Ectodermal dysplasia 5, hair/nail type	614927		101101769		between D10S1239 and D10S1264	Ectodermal dysplasia 5, hair/nail type	614927	AR	2	
10q24.32	10:101226994-101229463	LBX1, LBX1H, CCHS3	Lady bird late, Drosophila, homolog of, 1	604255	LBX1	10660	ENSG00000138136,ENST00000370193;;;ENST00000370193	mutation identified in 1 CCHS3 family	?Central hypoventilation syndrome, congenital, 3	619483	AR	3	Lbx1
10q24.32	10:101770109-101780369	FGF8, HH6	Fibroblast growth factor-8	600483	FGF8	2253	ENSG00000107831,ENST00000320185;;;ENST00000320185		Hypogonadotropic hypogonadism 6 with or without anosmia	612702	AD	3	Fgf8
10q24.32	10:102065349-102068036	HPS6, RU	HPS6 biogenesis of lysosomal organelles complex 2 subunit 3	607522	HPS6	79803	ENSG00000166189,ENST00000299238;;;ENST00000299238		Hermansky-Pudlak syndrome 6	614075	AR	3	Hps6
10q24.32	10:102230189-102241512	PITX3, CTPP4, CTRCT11, ASGD1	Paired-like homeodomain transcription factor-3	602669	PITX3	5309	ENSG00000107859,ENST00000370002;;;ENST00000370002		Anterior segment dysgenesis 1, multiple subtypes	107250	AD	3	Pitx3
10q24.32	10:102230189-102241512	PITX3, CTPP4, CTRCT11, ASGD1	Paired-like homeodomain transcription factor-3	602669	PITX3	5309	ENSG00000107859,ENST00000370002;;;ENST00000370002		Cataract 11, multiple types	610623	AD, AR	3	Pitx3
10q24.32	10:102230189-102241512	PITX3, CTPP4, CTRCT11, ASGD1	Paired-like homeodomain transcription factor-3	602669	PITX3	5309	ENSG00000107859,ENST00000370002;;;ENST00000370002		Cataract 11, syndromic, autosomal recessive	610623	AD, AR	3	Pitx3
10q24.32	10:102230643-102382896	GBF1, CMT2GG	Golgi-specific brefeldin-A resistance factor 1	603698	GBF1	8729	ENSG00000107862,ENST00000369983;;;ENST00000369983		Charcot-Marie-Tooth disease, axonal, type 2GG	606483	AD	3	Gbf1
10q24.32	10:102394110-102402529	NFKB2, LYT10, CVID10	Nuclear factor kappa-B, subunit 2 (p49/p100)	164012	NFKB2	4791	ENSG00000077150,ENST00000661543;;;ENST00000661543		Immunodeficiency, common variable, 10	615577	AD	3	Nfkb2
10q24.32	10:102502819-102633535	SUFU, SUFUXL, SUFUH, JBTS32, BCNS2	Suppressor of fused	607035	SUFU	51684	ENSG00000107882,ENST00000369902;;;ENST00000369902		{Medulloblastoma}	155255	AD, AR, SMu	3	Sufu
10q24.32	10:102502819-102633535	SUFU, SUFUXL, SUFUH, JBTS32, BCNS2	Suppressor of fused	607035	SUFU	51684	ENSG00000107882,ENST00000369902;;;ENST00000369902		{Meningioma, familial, susceptibility to}	607174	AD	3	Sufu
10q24.32	10:102502819-102633535	SUFU, SUFUXL, SUFUH, JBTS32, BCNS2	Suppressor of fused	607035	SUFU	51684	ENSG00000107882,ENST00000369902;;;ENST00000369902		Basal cell nevus syndrome 2	620343		3	Sufu
10q24.32	10:102502819-102633535	SUFU, SUFUXL, SUFUH, JBTS32, BCNS2	Suppressor of fused	607035	SUFU	51684	ENSG00000107882,ENST00000369902;;;ENST00000369902		Joubert syndrome 32	617757	AR	3	Sufu
10q24.32	10:102644479-102658319	TRIM8, RNF27, GERP, FSGSNEDS	Tripartite motif-containing 8	606125	TRIM8	81603	ENSG00000171206,ENST00000643721;;;ENST00000643721		Focal segmental glomerulosclerosis and neurodevelopmental syndrome	619428	AD	3	Trim8
10q24.32	10:102673731-102714397	ARL3, ARFL3, JBTS35, RP83	ADP ribosylation factor-like GTPase 3	604695	ARL3	403	ENSG00000138175,ENST00000260746;;;ENST00000260746		Joubert syndrome 35	618161	AR	3	Arl3
10q24.32	10:102673731-102714397	ARL3, ARFL3, JBTS35, RP83	ADP ribosylation factor-like GTPase 3	604695	ARL3	403	ENSG00000138175,ENST00000260746;;;ENST00000260746		Retinitis pigmentosa 83	618173	AD	3	Arl3
10q24.32	10:102830531-102837413	CYP17A1, CYP17, P450C17	Cytochrome P450, family 17, subfamily A, polypeptide 1 (steroid 17-alpha-hydroxylase)	609300	CYP17A1	1586	ENSG00000148795,ENST00000369887;;;ENST00000369887	at least 2 genes; distal to GOT1	17-alpha-hydroxylase/17,20-lyase deficiency	202110	AR	3	Cyp17a1
10q24.32	10:102830531-102837413	CYP17A1, CYP17, P450C17	Cytochrome P450, family 17, subfamily A, polypeptide 1 (steroid 17-alpha-hydroxylase)	609300	CYP17A1	1586	ENSG00000148795,ENST00000369887;;;ENST00000369887	at least 2 genes; distal to GOT1	17,20-lyase deficiency, isolated	202110	AR	3	Cyp17a1
10q24.32	10:102918294-103090222	CNNM2, ACDP2, HOMG6, HOMGSMR	Cyclin M2	607803	CNNM2	54805	ENSG00000148842,ENST00000369878;;;ENST00000369878		Hypomagnesemia 6, renal	613882	AD	3	Cnnm2
10q24.32	10:102918294-103090222	CNNM2, ACDP2, HOMG6, HOMGSMR	Cyclin M2	607803	CNNM2	54805	ENSG00000148842,ENST00000369878;;;ENST00000369878		Hypomagnesemia, seizures, and impaired intellectual development 1	616418	AD, AR	3	Cnnm2
10q24.32-q24.33	10:103088017-103193272	NT5C2, NT5B, PNT5, SPG45	5' nucleotidase, cytosolic II	600417	NT5C2	22978	ENSG00000076685,ENST00000404739;;;ENST00000404739		Spastic paraplegia 45, autosomal recessive	613162	AR	3	Nt5c2
10q24.33	10:103389050-103396475	ATP5MD, USMG5, DAPIT, MC5DN6	ATP synthase membrane subunit DAPIT	615204	ATP5MK	84833	ENSG00000173915,ENST00000369815;;;ENST00000369815		Mitochondrial complex V (ATP synthase) deficiency, nuclear type 6	618683	AR	3	Atp5mk
10q24.33	10:103877569-103918184	STN1, OBFC1, AAF44, CRMCC2	STN1, CST complex subunit	613128	STN1	79991	ENSG00000107960,ENST00000224950;;;ENST00000224950		Cerebroretinal microangiopathy with calcifications and cysts 2	617341	AR	3	Stn1
10q25-q26	10:104000001-133797422	EIG4	Epilepsy, idiopathic generalized, susceptibility to 4	609750		780913		between D16S397 and D16S3095	{Epilepsy, idiopathic generalized, susceptibility to 4}	609750		2	
10q25	10:104000001-117300000	IDDM17	Insulin-dependent diabetes mellitus-17	603266		8691			{Diabetes mellitus, insulin-dependent, 17}	603266		2	
10q25.1	10:104031286-104085880	COL17A1, BPAG2, ERED, JEB4	Collagen XVII, alpha-1 polypeptide	113811	COL17A1	1308	ENSG00000065618,ENST00000648076;;;ENST00000648076		Epidermolysis bullosa, junctional 4, intermediate	619787	AR	3	Col17a1
10q25.1	10:104031286-104085880	COL17A1, BPAG2, ERED, JEB4	Collagen XVII, alpha-1 polypeptide	113811	COL17A1	1308	ENSG00000065618,ENST00000648076;;;ENST00000648076		Epithelial recurrent erosion dystrophy	122400	AD	3	Col17a1
10q25.1	10:104129888-104232364	CFAP43, WDR96, C10orf79, SPGF19, HYDNP1	Cilia- and flagella-associated protein 43	617558	CFAP43	80217	ENSG00000197748,ENST00000357060;;;ENST00000357060	mutation identified in 1 HYDNP1 family	Hydrocephalus, normal pressure, 1	236690	AD	3	Cfap43
10q25.1	10:104129888-104232364	CFAP43, WDR96, C10orf79, SPGF19, HYDNP1	Cilia- and flagella-associated protein 43	617558	CFAP43	80217	ENSG00000197748,ENST00000357060;;;ENST00000357060	mutation identified in 1 HYDNP1 family	Spermatogenic failure 19	617592	AR	3	Cfap43
10q25.1	10:104338520-104455102	CFAP58, SPGF49	Cilia- and flagella-associated protein 58	619129	CFAP58	159686	ENSG00000120051,ENST00000369704;;;ENST00000369704		Spermatogenic failure 49	619144	AR	3	Cfap58
10q25.1-q25.2	10:109996373-110135565	ADD3, ADDL, CPSQ3	Adducin-3, gamma	601568	ADD3	120	ENSG00000148700,ENST00000356080;;;ENST00000356080	fusion with NUP98 in T-ALL	Cerebral palsy, spastic quadriplegic, 3	617008	AR	3	Add3
10q25.2	10:110207605-110287365	MXI1	MAX-interacting protein 1	600020	MXI1	4601	ENSG00000119950,ENST00000332674;;;ENST00000332674		Neurofibrosarcoma, somatic			3	Mxi1
10q25.2	10:110207605-110287365	MXI1	MAX-interacting protein 1	600020	MXI1	4601	ENSG00000119950,ENST00000332674;;;ENST00000332674		Prostate cancer, somatic	176807		3	Mxi1
10q25.2	10:110567695-110606048	SMC3, CSPG6, HCAP, BAM, CDLS3	Structural maintenance of chromosomes 3	606062	SMC3	9126	ENSG00000108055,ENST00000361804;;;ENST00000361804		Cornelia de Lange syndrome 3	610759	AD	3	Smc3
10q25.2	10:110643245-110839468	RBM20	RNA-binding motif protein 20	613171	RBM20	282996	ENSG00000203867,ENST00000369519;;;ENST00000369519		Cardiomyopathy, dilated, 1DD	613172	AD	3	Rbm20
10q25.2	10:110898730-110919366	BBIP1, NCRNA00081, BBIP10, BBS18	BBSome interacting protein 1	613605	BBIP1	92482	ENSG00000214413,ENST00000448814;;;ENST00000448814		Bardet-Biedl syndrome 18	615995	AR	3	Bbip1
10q25.2	10:110919370-111013665	SHOC2, SIAA0862, SOC2, SUR8, NSLH1	SHOC2 leucine-rich repeat scaffold protein	602775	SHOC2	8036	ENSG00000108061,ENST00000369452;;;ENST00000369452		Noonan syndrome-like with loose anagen hair 1	607721	AD	3	Shoc2
10q25.2	10:111077029-111080907	ADRA2A, ADRA2R, FPLD8	Adrenergic, alpha-2A-, receptor	104210	ADRA2A	150	ENSG00000150594,ENST00000280155;;;ENST00000280155	mutation identified in 1 FPLD8 family	?Lipodystrophy, familial partial, type 8	620679	AD	3	Adra2a
10q25.2	10:112374116-112428376	ACSL5, FACL5, ACS5, DIAR13	Acyl-CoA synthetase long-chain family member 5	605677	ACSL5	51703	ENSG00000197142,ENST00000354655;;;ENST00000354655	mutation identified in 1 DIAR13 family	?Diarrhea 13	620357	AR	3	Acsl5
10q25.2-q25.3	10:112950247-113167678	TCF7L2, TCF4	Transcription factor 7-like 2	602228	TCF7L2	6934	ENSG00000148737,ENST00000355995;;;ENST00000355995		{Diabetes mellitus, type 2, susceptibility to}	125853	AD	3	Tcf7l2
10q25.3	10:113550831-113589602	HABP2, PHBP, HGFAL, FSAP, NMTC5	Hyaluronan-binding protein 2	603924	HABP2	3026	ENSG00000148702,ENST00000351270;;;ENST00000351270	mutation identified in 1 NMTC5 family	{?Thyroid cancer, nonmedullary, 5}	616535	AD	3	Habp2
10q25.3	10:113550831-113589602	HABP2, PHBP, HGFAL, FSAP, NMTC5	Hyaluronan-binding protein 2	603924	HABP2	3026	ENSG00000148702,ENST00000351270;;;ENST00000351270	mutation identified in 1 NMTC5 family	{Venous thromboembolism, susceptibility to}	188050	AD	3	Habp2
10q25.3	10:113854661-113917194	NHLRC2, FINCA	NHL repeat-containing protein 2	618277	NHLRC2	374354	ENSG00000196865,ENST00000369301;;;ENST00000369301		FINCA syndrome	618278	AR	3	Nhlrc2
10q25.3	10:114043866-114046904	ADRB1, ADRB1R, FNSS2	Adrenergic, beta-1-, receptor	109630	ADRB1	153	ENSG00000043591,ENST00000369295;;;ENST00000369295	mutation identified in 1 FNSS2 family	?[Short sleep, familial natural, 2]	618591	AD	3	Adrb1
10q25.3	10:114043866-114046904	ADRB1, ADRB1R, FNSS2	Adrenergic, beta-1-, receptor	109630	ADRB1	153	ENSG00000043591,ENST00000369295;;;ENST00000369295	mutation identified in 1 FNSS2 family	[Resting heart rate]	607276		3	Adrb1
10q25.3	10:116056925-116274705	GFRA1, GDNFRA, GDNFR, RHDA4	GDNF family receptor, alpha-1	601496	GFRA1	2674	ENSG00000151892,ENST00000355422;;;ENST00000355422		Renal hypodysplasia/aplasia 4	619887	AR	3	Gfra1
10q25.3	10:116545931-116567855	PNLIP, PNLIPD	Pancreatic lipase	246600	PNLIP	5406	ENSG00000175535,ENST00000369221;;;ENST00000369221	mutation identified in 1 family	?Pancreatic lipase deficiency	614338	AR	3	Pnlip
10q25.3	10:117128520-117138270	VAX1, MCOPS11	Ventral anterior homeobox 1	604294	VAX1	11023	ENSG00000148704,ENST00000369206;;;ENST00000369206	mutation identified in one MCOPS11 family	?Microphthalmia, syndromic 11	614402	AR	3	Vax1
10q25.3	10:117197489-117210299	KCNK18, TRESK, TRIK, MGR13	Potassium channel, subfamily K, member 18	613655	KCNK18	338567	ENSG00000186795,ENST00000334549;;;ENST00000334549		{Migraine, with or without aura, susceptibility to, 13}	613656	AD	3	Kcnk18
10q25.3	10:117241114-117279430	SLC18A2, VAT2, SVMT, PKDYS2	Solute carrier family 18 (vesicular monoamine), member 2	193001	SLC18A2	6571	ENSG00000165646,ENST00000644641;;;ENST00000644641		Parkinsonism-dystonia, infantile, 2	618049	AR	3	Slc18a2
10q25.3-q26.11	10:117277274-117375440	PDZD8, IDDADF	PDZ domain-containing protein 8	614235	PDZD8	118987	ENSG00000165650,ENST00000334464;;;ENST00000334464		Intellectual developmental disorder with autism and dysmorphic facies	620021	AR	3	Pdzd8
10q26	10:117300001-133797422	ARMD7	Age-related macular dystrophy 7	610149					{Macular degeneration, age-related, 7}	610149	AD	2	
10q26	10:117300001-133797422	CORD17	Cone-rod dystrophy 17	615163		101409267		between D10S1757 and D10S1782	Cone-rod dystrophy 17	615163	AD	2	
10q26	10:117300001-133797422	DEL10q26, C10q26DEL	Chromosome 10q26 deletion syndrome	609625					Chromosome 10q26 deletion syndrome	609625	AD	4	
10q26	10:117300001-133797422	ENDO1	Endometriosis, susceptibility to, 1	131200		100188863		max lod at D10S587	{Endometriosis, susceptibility to, 1}	131200	AR, Mu	2	
10q26	10:117300001-133797422	RRIS	Respiratory rhythmicity in sleep	609116		497662			[Respiratory rhythmicity in sleep]	609116		2	
10q26.11	10:117542746-117549546	EMX2	Empty spiracles homeobox 2	600035	EMX2	2018	ENSG00000170370,ENST00000553456;;;ENST00000553456	close to VAX1	Schizencephaly	269160		3	Emx2
10q26.11	10:119029714-119033730	NANOS1, NOS1, SPGF12	NANOS C2HC-type zinc finger 1	608226	NANOS1	340719	ENSG00000188613,ENST00000425699;;;ENST00000425699		Spermatogenic failure 12	615413	AD	3	Nanos1
10q26.11	10:119140767-119165714	SFXN4, COXPD18	Sideroflexin 4	615564	SFXN4	119559	ENSG00000183605,ENST00000355697;;;ENST00000355697		Combined oxidative phosphorylation deficiency 18	615578	AR	3	Sfxn4
10q26.11	10:119167720-119178812	PRDX3, AOP1, SCAR32, PPPCD	Peroxiredoxin 3 (antioxidant protein 1)	604769	PRDX3	10935	ENSG00000165672,ENST00000298510;;;ENST00000298510		Corneal dystrophy, punctiform and polychromatic pre-Descemet	619871	AD	3	Prdx3
10q26.11	10:119167720-119178812	PRDX3, AOP1, SCAR32, PPPCD	Peroxiredoxin 3 (antioxidant protein 1)	604769	PRDX3	10935	ENSG00000165672,ENST00000298510;;;ENST00000298510		Spinocerebellar ataxia, autosomal recessive 32	619862	AR	3	Prdx3
10q26.11	10:119651380-119677819	BAG3, MFM6, CMD1HH, CMT2JJ, HMND15	BCL2-associated athanogene 3	603883	BAG3	9531	ENSG00000151929,ENST00000369085;;;ENST00000369085	mutation identified in 1 HMND15 family	?Neuronopathy, distal hereditary motor, autosomal dominant 15	621094	AD	3	Bag3
10q26.11	10:119651380-119677819	BAG3, MFM6, CMD1HH, CMT2JJ, HMND15	BCL2-associated athanogene 3	603883	BAG3	9531	ENSG00000151929,ENST00000369085;;;ENST00000369085	mutation identified in 1 HMND15 family	Cardiomyopathy, dilated, 1HH	613881	AD	3	Bag3
10q26.11	10:119651380-119677819	BAG3, MFM6, CMD1HH, CMT2JJ, HMND15	BCL2-associated athanogene 3	603883	BAG3	9531	ENSG00000151929,ENST00000369085;;;ENST00000369085	mutation identified in 1 HMND15 family	Charcot-Marie-Tooth disease, axonal, type 2JJ	621095	AD	3	Bag3
10q26.11	10:119651380-119677819	BAG3, MFM6, CMD1HH, CMT2JJ, HMND15	BCL2-associated athanogene 3	603883	BAG3	9531	ENSG00000151929,ENST00000369085;;;ENST00000369085	mutation identified in 1 HMND15 family	Myopathy, myofibrillar, 6	612954	AD	3	Bag3
10q26.12	10:120851362-120909524	WDR11, DR11, KIAA1351, BRWD2, HH14	WD repeat-containing protein 11	606417	WDR11	55717	ENSG00000120008,ENST00000263461;;;ENST00000263461		Hypogonadotropic hypogonadism 14 with or without anosmia	614858	AD	3	Wdr11
10q26.12	10:120851362-120909524	WDR11, DR11, KIAA1351, BRWD2, HH14	WD repeat-containing protein 11	606417	WDR11	55717	ENSG00000120008,ENST00000263461;;;ENST00000263461		Intellectual developmental disorder, autosomal recessive 78	620237	AR	3	Wdr11
10q26.13	10:121478330-121598458	FGFR2, BEK, CFD1, JWS, TK14, BBDS	Fibroblast growth factor receptor-2 (bacteria-expressed kinase)	176943	FGFR2	2263	ENSG00000066468,ENST00000358487;;;ENST00000358487		?Scaphocephaly, maxillary retrusion, and impaired intellectual development	609579		3	Fgfr2
10q26.13	10:121478330-121598458	FGFR2, BEK, CFD1, JWS, TK14, BBDS	Fibroblast growth factor receptor-2 (bacteria-expressed kinase)	176943	FGFR2	2263	ENSG00000066468,ENST00000358487;;;ENST00000358487		Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis	207410	AD	3	Fgfr2
10q26.13	10:121478330-121598458	FGFR2, BEK, CFD1, JWS, TK14, BBDS	Fibroblast growth factor receptor-2 (bacteria-expressed kinase)	176943	FGFR2	2263	ENSG00000066468,ENST00000358487;;;ENST00000358487		Apert syndrome	101200	AD	3	Fgfr2
10q26.13	10:121478330-121598458	FGFR2, BEK, CFD1, JWS, TK14, BBDS	Fibroblast growth factor receptor-2 (bacteria-expressed kinase)	176943	FGFR2	2263	ENSG00000066468,ENST00000358487;;;ENST00000358487		Beare-Stevenson cutis gyrata syndrome	123790	AD	3	Fgfr2
10q26.13	10:121478330-121598458	FGFR2, BEK, CFD1, JWS, TK14, BBDS	Fibroblast growth factor receptor-2 (bacteria-expressed kinase)	176943	FGFR2	2263	ENSG00000066468,ENST00000358487;;;ENST00000358487		Bent bone dysplasia syndrome	614592	AD	3	Fgfr2
10q26.13	10:121478330-121598458	FGFR2, BEK, CFD1, JWS, TK14, BBDS	Fibroblast growth factor receptor-2 (bacteria-expressed kinase)	176943	FGFR2	2263	ENSG00000066468,ENST00000358487;;;ENST00000358487		Craniofacial-skeletal-dermatologic dysplasia	101600	AD	3	Fgfr2
10q26.13	10:121478330-121598458	FGFR2, BEK, CFD1, JWS, TK14, BBDS	Fibroblast growth factor receptor-2 (bacteria-expressed kinase)	176943	FGFR2	2263	ENSG00000066468,ENST00000358487;;;ENST00000358487		Craniosynostosis, nonspecific			3	Fgfr2
10q26.13	10:121478330-121598458	FGFR2, BEK, CFD1, JWS, TK14, BBDS	Fibroblast growth factor receptor-2 (bacteria-expressed kinase)	176943	FGFR2	2263	ENSG00000066468,ENST00000358487;;;ENST00000358487		Crouzon syndrome	123500	AD	3	Fgfr2
10q26.13	10:121478330-121598458	FGFR2, BEK, CFD1, JWS, TK14, BBDS	Fibroblast growth factor receptor-2 (bacteria-expressed kinase)	176943	FGFR2	2263	ENSG00000066468,ENST00000358487;;;ENST00000358487		Gastric cancer, somatic	613659		3	Fgfr2
10q26.13	10:121478330-121598458	FGFR2, BEK, CFD1, JWS, TK14, BBDS	Fibroblast growth factor receptor-2 (bacteria-expressed kinase)	176943	FGFR2	2263	ENSG00000066468,ENST00000358487;;;ENST00000358487		Jackson-Weiss syndrome	123150	AD	3	Fgfr2
10q26.13	10:121478330-121598458	FGFR2, BEK, CFD1, JWS, TK14, BBDS	Fibroblast growth factor receptor-2 (bacteria-expressed kinase)	176943	FGFR2	2263	ENSG00000066468,ENST00000358487;;;ENST00000358487		LADD syndrome 1	149730	AD	3	Fgfr2
10q26.13	10:121478330-121598458	FGFR2, BEK, CFD1, JWS, TK14, BBDS	Fibroblast growth factor receptor-2 (bacteria-expressed kinase)	176943	FGFR2	2263	ENSG00000066468,ENST00000358487;;;ENST00000358487		Pfeiffer syndrome	101600	AD	3	Fgfr2
10q26.13	10:121478330-121598458	FGFR2, BEK, CFD1, JWS, TK14, BBDS	Fibroblast growth factor receptor-2 (bacteria-expressed kinase)	176943	FGFR2	2263	ENSG00000066468,ENST00000358487;;;ENST00000358487		Saethre-Chotzen syndrome	101400	AD	3	Fgfr2
10q26.13	10:121478330-121598458	FGFR2, BEK, CFD1, JWS, TK14, BBDS	Fibroblast growth factor receptor-2 (bacteria-expressed kinase)	176943	FGFR2	2263	ENSG00000066468,ENST00000358487;;;ENST00000358487		Scaphocephaly and Axenfeld-Rieger anomaly			3	Fgfr2
10q26.13	10:122454653-122457352	LOC387715, ARMD8	LOC387715 gene	611313	ARMS2	387715	ENSG00000254636,ENST00000528446;;;ENST00000528446		{Macular degeneration, age-related, 8}	613778		3	
10q26.13	10:122461553-122514907	HTRA1, PRSS11, CARASIL2, CADASIL2	HTRA serine peptidase 1	602194	HTRA1	5654	ENSG00000166033,ENST00000368984;;;ENST00000368984		Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy 2	616779	AD	3	Htra1
10q26.13	10:122461553-122514907	HTRA1, PRSS11, CARASIL2, CADASIL2	HTRA serine peptidase 1	602194	HTRA1	5654	ENSG00000166033,ENST00000368984;;;ENST00000368984		Cerebral arteriopathy, autosomal recessive, with subcortical infarcts and leukoencephalopathy 2	600142	AR	3	Htra1
10q26.13	10:122990806-123008795	IKZF5, ZNFN1A5, PEGASUS, THC7	Ikaros family zinc finger 5	606238	IKZF5	64376	ENSG00000095574,ENST00000368886;;;ENST00000368886		Thrombocytopenia, autosomal dominant, 7	619130	AD	3	Ikzf5
10q26.13	10:123009006-123058290	ACADSB, SBCAD	Acyl-Coenzyme A dehydrogenase, short/branched chain	600301	ACADSB	36	ENSG00000196177,ENST00000358776;;;ENST00000358776		2-methylbutyrylglycinuria	610006	AR	3	Acadsb
10q26.13	10:124397303-124418923	OAT, GACR	Ornithine aminotransferase	613349	OAT	4942	ENSG00000065154,ENST00000368845;;;ENST00000368845	pseudogene at Xp11.2	Gyrate atrophy of choroid and retina with or without ornithinemia	258870	AR	3	Oat
10q26.2	10:125766453-125775821	MMP21, HTX7	Matrix metalloproteinase 21	608416	MMP21	118856	ENSG00000154485,ENST00000368808;;;ENST00000368808		Heterotaxy, visceral, 7, autosomal	616749	AR	3	Mmp21
10q26.2	10:125784980-125823258	UROS	Uroporphyrinogen III synthase	606938	UROS	7390	ENSG00000188690,ENST00000368797;;;ENST00000368797		Porphyria, congenital erythropoietic	263700	AR	3	Uros
10q26.3	10:129835233-129964274	EBF3, COE3, HADDS	Early B-cell factor 3	607407	EBF3	253738	ENSG00000108001,ENST00000440978;;;ENST00000440978		Hypotonia, ataxia, and delayed development syndrome	617330	AD	3	Ebf3
10q26.3	10:132783181-132786147	NKX6-2, NKX6B, NKX6.2, SPAX8	NK6 transcription factor related, locus 2 (Drosophila)	605955	NKX6-2	84504	ENSG00000148826,ENST00000368592;;;ENST00000368592		Spastic ataxia 8, autosomal recessive, with hypomyelinating leukodystrophy	617560	AR	3	Nkx6-2
10q26.3	10:133278635-133312337	TUBGCP2, GCP2, GRIP103, SPC97, ALP4, PAMDDFS	Tubulin-gamma complex-associated protein 2	617817	TUBGCP2	10844	ENSG00000130640,ENST00000252936;;;ENST00000252936		Pachygyria, microcephaly, developmental delay, and dysmorphic facies, with or without seizures	618737	AR	3	Tubgcp2
10q26.3	10:133362485-133373354	ECHS1, SCEH, ECHS1D	Enoyl-CoA hydratase, short-chain, 1, mitochondrial	602292	ECHS1	1892	ENSG00000127884,ENST00000368547;;;ENST00000368547		Mitochondrial short-chain enoyl-CoA hydratase 1 deficiency	616277	AR	3	Echs1
10q26.3	10:133553899-133568291	SYCE1, POF12, SPGF15	Synaptonemal complex central element protein 1	611486	SYCE1	93426	ENSG00000171772,ENST00000343131;;;ENST00000343131	mutation identified in 1 POF12 and 1 SPGF15 family	?Premature ovarian failure 12	616947	AR	3	Syce1
10q26.3	10:133553899-133568291	SYCE1, POF12, SPGF15	Synaptonemal complex central element protein 1	611486	SYCE1	93426	ENSG00000171772,ENST00000343131;;;ENST00000343131	mutation identified in 1 POF12 and 1 SPGF15 family	?Spermatogenic failure 15	616950	AR	3	Syce1
11p15-p14	11:1-31000000	DEL11p15p14, C11DELp15p14	Chromosome 11p15-p14 deletion syndrome (homozygous)	606528				contiguous gene deletion syndrome	Chromosome 11p15-p14 deletion syndrome	606528	AR	4	
11p15	11:1-22000000	GINGF4, HGF4, GGF4	Fibromatosis, gingival, 4	611010		100124414		between D11S1984 and D11S1338	Fibromatosis, gingival, 4	611010		2	
11p	11:1-53400001	HYPLIP2	Hyperlipidemia, combined, 2	604499		28515			Hyperlipidemia, combined, 2	604499		2	
11p15	11:1-22000000	IH, HHP	Hemihyperplasia, isolated	235000		100188864		epigenetic or uniparental disomy	Hemihypertrophy	235000	AD	2	
11p15	11:1-22000000	LVNC2	Left ventricular noncompaction 2	609470		619411		max lod at D11S902	Left ventricular noncompaction 2	609470		2	
11p15	11:1-22000000	NBLST7	Neuroblastoma, susceptibility to, 7	616792		107181289		associated with rs2168101	{Neuroblastoma, susceptibility to, 7}	616792		2	
11p15.5	11:1-2800000	SLEN3	Systemic lupus erythematosus with nephritis, susceptibility to, 3	607967		282849			{Systemic lupus erythematosus with nephritis, susceptibility to, 3}	607967		2	
11p15.5	11:298200-299526	IFITM5, OI5	Interferon-induced transmembrane protein 5	614757	IFITM5	387733	ENSG00000206013,ENST00000382614;;;ENST00000382614		Osteogenesis imperfecta, type V	610967	AD	3	Ifitm5
11p15.5	11:319676-320860	IFITM3	Interferon-induced transmembrane protein 3	605579	IFITM3	10410	ENSG00000142089,ENST00000399808;;;ENST00000399808		{Influenza, severe, susceptibility to}	614680		3	Ifitm1,Ifitm2,Ifitm3,Ifitm6,Ifitm7
11p15.5	11:494515-507242	RNH1, RNH, IIAE12	Ribonuclease/angiogenin inhibitor 1	173320	RNH1	6050	ENSG00000023191,ENST00000354420;;;ENST00000354420		{Encephalopathy, acute, infection-induced, susceptibility to, 12}	620461	AR	3	Rnh1
11p15.5	11:506462-554912	LRRC56, CILD39	Leucine-rich repeat-containing protein 56	618227	LRRC56	115399	ENSG00000161328,ENST00000270115;;;ENST00000270115		Ciliary dyskinesia, primary, 39	618254	AR	3	Lrrc56
11p15.5	11:532242-535576	HRAS	Harvey rat sarcoma viral (v-Ha-ras) oncogene homolog	190020	HRAS	3265	ENSG00000174775,ENST00000311189;;;ENST00000311189	pseudogene HRASP on X	Bladder cancer, somatic	109800		3	Hras
11p15.5	11:532242-535576	HRAS	Harvey rat sarcoma viral (v-Ha-ras) oncogene homolog	190020	HRAS	3265	ENSG00000174775,ENST00000311189;;;ENST00000311189	pseudogene HRASP on X	Congenital myopathy with excess of muscle spindles	218040	AD	3	Hras
11p15.5	11:532242-535576	HRAS	Harvey rat sarcoma viral (v-Ha-ras) oncogene homolog	190020	HRAS	3265	ENSG00000174775,ENST00000311189;;;ENST00000311189	pseudogene HRASP on X	Costello syndrome	218040	AD	3	Hras
11p15.5	11:532242-535576	HRAS	Harvey rat sarcoma viral (v-Ha-ras) oncogene homolog	190020	HRAS	3265	ENSG00000174775,ENST00000311189;;;ENST00000311189	pseudogene HRASP on X	Nevus sebaceous or woolly hair nevus, somatic	162900		3	Hras
11p15.5	11:532242-535576	HRAS	Harvey rat sarcoma viral (v-Ha-ras) oncogene homolog	190020	HRAS	3265	ENSG00000174775,ENST00000311189;;;ENST00000311189	pseudogene HRASP on X	Schimmelpenning-Feuerstein-Mims syndrome, somatic mosaic	163200		3	Hras
11p15.5	11:532242-535576	HRAS	Harvey rat sarcoma viral (v-Ha-ras) oncogene homolog	190020	HRAS	3265	ENSG00000174775,ENST00000311189;;;ENST00000311189	pseudogene HRASP on X	Spitz nevus or nevus spilus, somatic	137550		3	Hras
11p15.5	11:532242-535576	HRAS	Harvey rat sarcoma viral (v-Ha-ras) oncogene homolog	190020	HRAS	3265	ENSG00000174775,ENST00000311189;;;ENST00000311189	pseudogene HRASP on X	Thyroid carcinoma, follicular, somatic	188470		3	Hras
11p15.5	11:612555-615950	IRF7, IRF7A, IRF7B, IRF7C, IRF7H, IMD39	Interferon regulatory factor 7	605047	IRF7	3665	ENSG00000185507,ENST00000525445;;;ENST00000525445		Immunodeficiency 39	616345	AR	3	Irf7
11p15.5	11:637269-640706	DRD4	Dopamine receptor D4	126452	DRD4	1815	ENSG00000069696,ENST00000176183;;;ENST00000176183	proximal to HRAS	{Attention deficit-hyperactivity disorder}	143465	AD	3	Drd4
11p15.5	11:637269-640706	DRD4	Dopamine receptor D4	126452	DRD4	1815	ENSG00000069696,ENST00000176183;;;ENST00000176183	proximal to HRAS	Autonomic nervous system dysfunction			3	Drd4
11p15.5	11:644233-707083	DEAF1, SPN, ZMYND5, VSVS, NEDHELS	DEAF1 transcription factor	602635	DEAF1	10522	ENSG00000177030,ENST00000382409;;;ENST00000382409		Neurodevelopmental disorder with hypotonia, impaired expressive language, and with or without seizures	617171	AR	3	Deaf1
11p15.5	11:644233-707083	DEAF1, SPN, ZMYND5, VSVS, NEDHELS	DEAF1 transcription factor	602635	DEAF1	10522	ENSG00000177030,ENST00000382409;;;ENST00000382409		Vulto-van Silfout-de Vries syndrome	615828	AD	3	Deaf1
11p15.5	11:706231-727727	EPS8L2, EPS8R2, DFNB106	EPS8-like protein 2	614988	EPS8L2	64787	ENSG00000177106,ENST00000318562;;;ENST00000318562		Deafness autosomal recessive 106	617637	AR	3	Eps8l2
11p15.5	11:747464-765012	TALDO1	Transaldolase-1	602063	TALDO1	6888	ENSG00000177156,ENST00000319006;;;ENST00000319006	pseudogene on chr.1	Transaldolase deficiency	606003	AR	3	Taldo1
11p15.5	11:790475-798281	SLC25A22, GC1, DEE3	Solute carrier family 25 (mitochondrial carrier, glutamate), member 22	609302	SLC25A22	79751	ENSG00000177542,ENST00000628067;;;ENST00000628067		Developmental and epileptic encephalopathy 3	609304	AR	3	Slc25a22
11p15.5	11:799184-809501	PIDD1, LRDD, MRT75	p53-induced death domain protein 1	605247	PIDD1	55367	ENSG00000177595,ENST00000347755;;;ENST00000347755		Intellectual developmental disorder, autosomal recessive 75, with neuropsychiatric features and variant lissencephaly	619827	AR	3	Pidd1
11p15.5	11:818914-825573	PNPLA2, TTS2, ATGL	Patatin-like phospholipase domain-containing protein 2	609059	PNPLA2	57104	ENSG00000177666,ENST00000336615;;;ENST00000336615		Neutral lipid storage disease with myopathy	610717	AR	3	Pnpla2
11p15.5	11:832952-838831	CD151, PETA3, SFA1, MER2, EBS7	CD151 antigen	602243	CD151	977	ENSG00000177697,ENST00000397420;;;ENST00000397420		[Blood group, Raph]	179620		3	Cd151
11p15.5	11:832952-838831	CD151, PETA3, SFA1, MER2, EBS7	CD151 antigen	602243	CD151	977	ENSG00000177697,ENST00000397420;;;ENST00000397420		Epidermolysis bullosa simplex 7, with nephropathy and deafness	609057	AR	3	Cd151
11p15.5	11:1223066-1262172	MUC5B	Mucin 5, subtype B, tracheobronchial	600770	MUC5B	727897	ENSG00000117983,ENST00000529681;;;ENST00000529681		{Pulmonary fibrosis, idiopathic, susceptibility to}	178500	AD	3	Muc5b
11p15.5	11:1752755-1763927	CTSD, CPSD, CLN10	Cathepsin D (lysosomal aspartyl protease)	116840	CTSD	1509	ENSG00000117984,ENST00000236671;;;ENST00000236671		Ceroid lipofuscinosis, neuronal, 10	610127	AR	3	Ctsd
11p15.5	11:1838981-1841678	TNNI2, AMCD2B, DA2B1, FSSV	Troponin I, fast-twitch skeletal muscle isoform	191043	TNNI2	7136	ENSG00000130598,ENST00000381911;;;ENST00000381911		Arthrogryposis, distal, type 2B1	601680	AD	3	Tnni2
11p15.5	11:1919552-1938702	TNNT3, AMCD2B, DA2B2, FSSV	Troponin-T3, skeletal, fast	600692	TNNT3	7140	ENSG00000130595,ENST00000278317;;;ENST00000278317		Arthrogryposis, distal, type 2B2	618435	AD	3	Tnnt3
11p15.5	11:1998202-2003509	ICR1, BWS, WT2, SRS1	H19-IGF2-imprinting control region	616186		105259599			Beckwith-Wiedemann syndrome	130650	AD	3	
11p15.5	11:1998202-2003509	ICR1, BWS, WT2, SRS1	H19-IGF2-imprinting control region	616186		105259599			Silver-Russell syndrome 1	180860	AD	3	
11p15.5	11:1998202-2003509	ICR1, BWS, WT2, SRS1	H19-IGF2-imprinting control region	616186		105259599			Wilms tumor 2	194071	AD, SMu	3	
11p15.5	11:2129117-2149566	IGF2, GRDF, SRS3	Insulin-like growth factor-2, or somatomedin A	147470	IGF2	3481	ENSG00000167244,ENST00000416167;;;ENST00000416167	mutation identified in 1 GRDF family	Silver-Russell syndrome 3	616489	AD	3	Igf2
11p15.5	11:2159779-2161209	INS, MODY10, IDDM2, PNDM4	Insulin	176730	INS	3630	ENSG00000254647,ENST00000381330;;;ENST00000381330	5'--INS-12.6kb-IGF2--3'; cen-HBBC-10cM-INS-2cM-HRAS1-3cM-TH	Diabetes mellitus, insulin-dependent, 2	125852	AD	3	Ins1,Ins2
11p15.5	11:2159779-2161209	INS, MODY10, IDDM2, PNDM4	Insulin	176730	INS	3630	ENSG00000254647,ENST00000381330;;;ENST00000381330	5'--INS-12.6kb-IGF2--3'; cen-HBBC-10cM-INS-2cM-HRAS1-3cM-TH	Diabetes mellitus, permanent neonatal 4	618858	AD, AR	3	Ins1,Ins2
11p15.5	11:2159779-2161209	INS, MODY10, IDDM2, PNDM4	Insulin	176730	INS	3630	ENSG00000254647,ENST00000381330;;;ENST00000381330	5'--INS-12.6kb-IGF2--3'; cen-HBBC-10cM-INS-2cM-HRAS1-3cM-TH	Hyperproinsulinemia	616214	AD	3	Ins1,Ins2
11p15.5	11:2159779-2161209	INS, MODY10, IDDM2, PNDM4	Insulin	176730	INS	3630	ENSG00000254647,ENST00000381330;;;ENST00000381330	5'--INS-12.6kb-IGF2--3'; cen-HBBC-10cM-INS-2cM-HRAS1-3cM-TH	Maturity-onset diabetes of the young, type 10	613370	AD	3	Ins1,Ins2
11p15.5	11:2163929-2171815	TH, TYH	Tyrosine hydroxylase	191290	TH	7054	ENSG00000180176,ENST00000352909;;;ENST00000352909	distal to HRAS1	Segawa syndrome, recessive	605407	AR	3	Th
11p15.5	11:2376180-2397397	CD81, TAPA1, CVID6	CD81 antigen (target of antiproliferative antibody-1)	186845	CD81	975	ENSG00000110651,ENST00000263645;;;ENST00000263645		Immunodeficiency, common variable, 6	613496	AR	3	Cd81
11p15.5-p15.4	11:2445008-2849105	KCNQ1, KCNA9, LQT1, KVLQT1, ATFB3, SQT2	Potassium voltage-gated channel, KQT-like subfamily, member 1	607542	KCNQ1	3784	ENSG00000053918,ENST00000155840;;;ENST00000155840		{Long QT syndrome 1, acquired, susceptibility to}	192500	AD	3	Kcnq1
11p15.5-p15.4	11:2445008-2849105	KCNQ1, KCNA9, LQT1, KVLQT1, ATFB3, SQT2	Potassium voltage-gated channel, KQT-like subfamily, member 1	607542	KCNQ1	3784	ENSG00000053918,ENST00000155840;;;ENST00000155840		Atrial fibrillation, familial, 3	607554	AD	3	Kcnq1
11p15.5-p15.4	11:2445008-2849105	KCNQ1, KCNA9, LQT1, KVLQT1, ATFB3, SQT2	Potassium voltage-gated channel, KQT-like subfamily, member 1	607542	KCNQ1	3784	ENSG00000053918,ENST00000155840;;;ENST00000155840		Jervell and Lange-Nielsen syndrome	220400	AR	3	Kcnq1
11p15.5-p15.4	11:2445008-2849105	KCNQ1, KCNA9, LQT1, KVLQT1, ATFB3, SQT2	Potassium voltage-gated channel, KQT-like subfamily, member 1	607542	KCNQ1	3784	ENSG00000053918,ENST00000155840;;;ENST00000155840		Long QT syndrome 1	192500	AD	3	Kcnq1
11p15.5-p15.4	11:2445008-2849105	KCNQ1, KCNA9, LQT1, KVLQT1, ATFB3, SQT2	Potassium voltage-gated channel, KQT-like subfamily, member 1	607542	KCNQ1	3784	ENSG00000053918,ENST00000155840;;;ENST00000155840		Short QT syndrome 2	609621	AD	3	Kcnq1
11p15.5	11:2608328-2699994	KCNQ1OT1, LIT1	KCNQ1-opposite strand/antisense transcript 1	604115	KCNQ1OT1	10984	ENSG00000269821,ENST00000597346;;;ENST00000597346		Beckwith-Wiedemann syndrome	130650	AD	3	Kcnq1ot1
11p15.4	11:2883218-2885775	CDKN1C, KIP2, BWS, IMAGE	Cyclin-dependent kinase inhibitor 1C (p57, Kip2)	600856	CDKN1C	1028	ENSG00000129757,ENST00000440480;;;ENST00000440480	rare cause of BWS	Beckwith-Wiedemann syndrome	130650	AD	3	Cdkn1c
11p15.4	11:2883218-2885775	CDKN1C, KIP2, BWS, IMAGE	Cyclin-dependent kinase inhibitor 1C (p57, Kip2)	600856	CDKN1C	1028	ENSG00000129757,ENST00000440480;;;ENST00000440480	rare cause of BWS	IMAGE syndrome	614732	AD	3	Cdkn1c
11p15.4	11:2899691-2925246	SLC22A1L, BWSCR1A, IMPT1	Solute carrier family 22, member 1-like (Beckwith-Wiedemann region 1A; organic-cation transporter-like 2)	602631	SLC67A1	5002	ENSG00000110628,ENST00000649076;;;ENST00000649076		Breast cancer, somatic	114480		3	Slc22a18
11p15.4	11:2899691-2925246	SLC22A1L, BWSCR1A, IMPT1	Solute carrier family 22, member 1-like (Beckwith-Wiedemann region 1A; organic-cation transporter-like 2)	602631	SLC67A1	5002	ENSG00000110628,ENST00000649076;;;ENST00000649076		Lung cancer, somatic	211980		3	Slc22a18
11p15.4	11:2899691-2925246	SLC22A1L, BWSCR1A, IMPT1	Solute carrier family 22, member 1-like (Beckwith-Wiedemann region 1A; organic-cation transporter-like 2)	602631	SLC67A1	5002	ENSG00000110628,ENST00000649076;;;ENST00000649076		Rhabdomyosarcoma, somatic	268210		3	Slc22a18
11p15.4	11:3000929-3057423	CARS1, CARS, MDBH	Cysteinyl-tRNA synthetase 1	123859	CARS1	833	ENSG00000110619,ENST00000380525;;;ENST00000380525		Microcephaly, developmental delay, and brittle hair syndrome	618891	AR	3	Cars1
11p15.4	11:3797720-3826371	PGAP2, FRAG1, HPMRS3, MRT17, MRT21	Post-GPI attachment to proteins 2	615187	PGAP2	27315	ENSG00000148985,ENST00000278243;;;ENST00000278243		Hyperphosphatasia with impaired intellectual development syndrome 3	614207	AR	3	Pgap2
11p15.4	11:3854604-4093210	STIM1, TAM1, IMD10, STRMK	Stromal interaction molecule 1	605921	STIM1	6786	ENSG00000167323,ENST00000526596;;;ENST00000526596		Immunodeficiency 10	612783	AR	3	Stim1
11p15.4	11:3854604-4093210	STIM1, TAM1, IMD10, STRMK	Stromal interaction molecule 1	605921	STIM1	6786	ENSG00000167323,ENST00000526596;;;ENST00000526596		Myopathy, tubular aggregate, 1	160565	AD	3	Stim1
11p15.4	11:3854604-4093210	STIM1, TAM1, IMD10, STRMK	Stromal interaction molecule 1	605921	STIM1	6786	ENSG00000167323,ENST00000526596;;;ENST00000526596		Stormorken syndrome	185070	AD	3	Stim1
11p15.4	11:4094685-4138932	RRM1, PEOB6	Ribonucleotide reductase, M1 polypeptide	180410	RRM1	6240	ENSG00000167325,ENST00000300738;;;ENST00000300738		Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 6	620647	AD, AR	3	Rrm1
11p15.4	11:5225464-5227071	HBB, ECYT6	Hemoglobin beta	141900	HBB	3043	ENSG00000244734,ENST00000335295;;;ENST00000335295	pseudogene HBBP1 between HBG and HBD loci	{Malaria, resistance to}	611162		3	Hbb-b1,Hbb-b2,Hbb-bh2,Hbb-bs,Hbb-bt
11p15.4	11:5225464-5227071	HBB, ECYT6	Hemoglobin beta	141900	HBB	3043	ENSG00000244734,ENST00000335295;;;ENST00000335295	pseudogene HBBP1 between HBG and HBD loci	Delta-beta thalassemia	141749	AD	3	Hbb-b1,Hbb-b2,Hbb-bh2,Hbb-bs,Hbb-bt
11p15.4	11:5225464-5227071	HBB, ECYT6	Hemoglobin beta	141900	HBB	3043	ENSG00000244734,ENST00000335295;;;ENST00000335295	pseudogene HBBP1 between HBG and HBD loci	Erythrocytosis, familial, 6	617980	AD	3	Hbb-b1,Hbb-b2,Hbb-bh2,Hbb-bs,Hbb-bt
11p15.4	11:5225464-5227071	HBB, ECYT6	Hemoglobin beta	141900	HBB	3043	ENSG00000244734,ENST00000335295;;;ENST00000335295	pseudogene HBBP1 between HBG and HBD loci	Heinz body anemia	140700	AD	3	Hbb-b1,Hbb-b2,Hbb-bh2,Hbb-bs,Hbb-bt
11p15.4	11:5225464-5227071	HBB, ECYT6	Hemoglobin beta	141900	HBB	3043	ENSG00000244734,ENST00000335295;;;ENST00000335295	pseudogene HBBP1 between HBG and HBD loci	Hereditary persistence of fetal hemoglobin	141749	AD	3	Hbb-b1,Hbb-b2,Hbb-bh2,Hbb-bs,Hbb-bt
11p15.4	11:5225464-5227071	HBB, ECYT6	Hemoglobin beta	141900	HBB	3043	ENSG00000244734,ENST00000335295;;;ENST00000335295	pseudogene HBBP1 between HBG and HBD loci	Methemoglobinemia, beta type	617971	AD	3	Hbb-b1,Hbb-b2,Hbb-bh2,Hbb-bs,Hbb-bt
11p15.4	11:5225464-5227071	HBB, ECYT6	Hemoglobin beta	141900	HBB	3043	ENSG00000244734,ENST00000335295;;;ENST00000335295	pseudogene HBBP1 between HBG and HBD loci	Sickle cell disease	603903	AR	3	Hbb-b1,Hbb-b2,Hbb-bh2,Hbb-bs,Hbb-bt
11p15.4	11:5225464-5227071	HBB, ECYT6	Hemoglobin beta	141900	HBB	3043	ENSG00000244734,ENST00000335295;;;ENST00000335295	pseudogene HBBP1 between HBG and HBD loci	Thalassemia-beta, dominant inclusion-body	603902	AD	3	Hbb-b1,Hbb-b2,Hbb-bh2,Hbb-bs,Hbb-bt
11p15.4	11:5225464-5227071	HBB, ECYT6	Hemoglobin beta	141900	HBB	3043	ENSG00000244734,ENST00000335295;;;ENST00000335295	pseudogene HBBP1 between HBG and HBD loci	Thalassemia, beta	613985		3	Hbb-b1,Hbb-b2,Hbb-bh2,Hbb-bs,Hbb-bt
11p15.4	11:5232838-5234483	HBD	Hemoglobin delta	142000	HBD	3045	ENSG00000223609,ENST00000650601;;;ENST00000650601		Thalassemia due to Hb Lepore			3	Hbb-b1,Hbb-b2,Hbb-bh2,Hbb-bs,Hbb-bt
11p15.4	11:5232838-5234483	HBD	Hemoglobin delta	142000	HBD	3045	ENSG00000223609,ENST00000650601;;;ENST00000650601		Thalassemia, delta-			3	Hbb-b1,Hbb-b2,Hbb-bh2,Hbb-bs,Hbb-bt
11p15.4	11:5248269-5249857	HBG1	Hemoglobin, gamma A	142200	HBG1	3047	ENSG00000213934,ENST00000330597;;;ENST00000330597		Fetal hemoglobin quantitative trait locus 1	141749	AD	3	Hbb-bh0,Hbb-bh1
11p15.4	11:5253188-5254781	HBG2, TNCY	Hemoglobin, gamma G	142250	HBG2	3048	ENSG00000196565,ENST00000336906;;;ENST00000336906		Cyanosis, transient neonatal	613977	AD	3	Hbb-bh0,Hbb-bh1
11p15.4	11:5253188-5254781	HBG2, TNCY	Hemoglobin, gamma G	142250	HBG2	3048	ENSG00000196565,ENST00000336906;;;ENST00000336906		Fetal hemoglobin quantitative trait locus 1	141749	AD	3	Hbb-bh0,Hbb-bh1
11p15.4	11:5269925-5304186	LCRB	Locus control region beta	152424		109580095			Thalassemia, Hispanic gamma-delta-beta	613985		3	
11p15.4	11:6390474-6394996	SMPD1, NPD	Sphingomyelin phosphodiesterase-1, acid lysosomal	607608	SMPD1	6609	ENSG00000166311,ENST00000342245;;;ENST00000342245		Niemann-Pick disease, type A	257200	AR	3	Smpd1
11p15.4	11:6390474-6394996	SMPD1, NPD	Sphingomyelin phosphodiesterase-1, acid lysosomal	607608	SMPD1	6609	ENSG00000166311,ENST00000342245;;;ENST00000342245		Niemann-Pick disease, type B	607616	AR	3	Smpd1
11p15.4	11:6497280-6572020	DNHD1, FLJ00251, SPGF65	Dynein heavy chain domain 1	617277	DNHD1	144132	ENSG00000179532,ENST00000254579;;;ENST00000254579		Spermatogenic failure 65	619712	AR	3	Dnhd1
11p15.4	11:6612768-6619422	TPP1, CLN2, SCAR7	Tripeptidyl peptidase 1	607998	TPP1	1200	ENSG00000166340,ENST00000299427;;;ENST00000299427		Ceroid lipofuscinosis, neuronal, 2	204500	AR	3	Tpp1
11p15.4	11:6612768-6619422	TPP1, CLN2, SCAR7	Tripeptidyl peptidase 1	607998	TPP1	1200	ENSG00000166340,ENST00000299427;;;ENST00000299427		Spinocerebellar ataxia, autosomal recessive 7	609270	AR	3	Tpp1
11p15.4	11:6621330-6655809	DCHS1, PCDH16, FIB1, CDH19, VMLDS1, MVP2	Dachsous, Drosophila, homolog of, 1	603057	DCHS1	8642	ENSG00000166341,ENST00000299441;;;ENST00000299441		Mitral valve prolapse 2	607829	AD	3	Dchs1
11p15.4	11:6621330-6655809	DCHS1, PCDH16, FIB1, CDH19, VMLDS1, MVP2	Dachsous, Drosophila, homolog of, 1	603057	DCHS1	8642	ENSG00000166341,ENST00000299441;;;ENST00000299441		Van Maldergem syndrome 1	601390	AR	3	Dchs1
11p15.4	11:7987337-8001852	EIF3F, EIF3S5, MRT67	Eukaryotic translation initiation factor 3, subunit F	603914	EIF3F	8665	ENSG00000175390,ENST00000651655;;;ENST00000651655		Intellectual developmental disorder, autosomal recessive 67	618295	AR	3	Eif3f
11p15.4	11:8019245-8106243	TUB, RDOB	Tubby, mouse, homolog of	601197	TUB	7275	ENSG00000166402,ENST00000299506;;;ENST00000299506	mutation identified in 1 RDOB family	?Retinal dystrophy and obesity	616188	AR	3	Tub
11p15.4	11:8224309-8268787	LMO1, RBTN1, RHOM1	LIM domain only 1 (rhombotin 1)	186921	LMO1	4004	ENSG00000166407,ENST00000335790;;;ENST00000335790		Leukemia, T-cell acute lymphoblastic	186921		2	Lmo1
11p15.4	11:8334824-8594228	STK33, SPGF93	Serine/threonine protein kinase 33	607670	STK33	65975	ENSG00000130413,ENST00000687296;;;ENST00000687296	mutation identified in 1 SPGF93 family	?Spermatogenic failure 93	620849	AR	3	Stk33
11p15.4	11:9138825-9265350	DENND5A, RAB6IP1, KIAA1091, DEE49	DENN domain-containing protein 5A	617278	DENND5A	23258	ENSG00000184014,ENST00000328194;;;ENST00000328194		Developmental and epileptic encephalopathy 49	617281	AR	3	Dennd5a
11p15.4	11:9778668-10304841	SBF2, MTMR13, CMT4B2	SET binding factor 2 (myotubularin-related 13)	607697	SBF2	81846	ENSG00000133812,ENST00000256190;;;ENST00000256190		Charcot-Marie-Tooth disease, type 4B2	604563	AR	3	Sbf2
11p15.4	11:10450388-10507579	AMPD3	Adenosine monophosphate deaminase-3, isoform E	102772	AMPD3	272	ENSG00000133805,ENST00000396553;;;ENST00000396553		[AMP deaminase deficiency, erythrocytic]	612874	AR	3	Ampd3
11p15.3	11:12674421-12944737	TEAD1, TCF13, REF1	TEA domain family member 1	189967	TEAD1	7003	ENSG00000187079,ENST00000527636;;;ENST00000527636		Sveinsson chorioretinal atrophy	108985	AD	3	Tead1
11p15.3	11:13492054-13496181	PTH, FIH1	Parathyroid hormone	168450	PTH	5741	ENSG00000152266,ENST00000282091;;;ENST00000282091	~9cM distal to CALC1; distal to MYOD	Hypoparathyroidism, familial isolated 1	146200	AD, AR	3	Pth
11p15.3	11:13668668-13732346	FAR1, MLSTD2, PFCRD, CSPSD	Fatty acyl CoA reductase 1	616107	FAR1	84188	ENSG00000197601,ENST00000354817;;;ENST00000354817		Cataracts, spastic paraparesis, and speech delay	619338	AD	3	Far1
11p15.3	11:13668668-13732346	FAR1, MLSTD2, PFCRD, CSPSD	Fatty acyl CoA reductase 1	616107	FAR1	84188	ENSG00000197601,ENST00000354817;;;ENST00000354817		Peroxisomal fatty acyl-CoA reductase 1 disorder	616154	AR	3	Far1
11p15.2	11:14277920-14364506	RRAS2, TC21, NS12	Related Ras viral oncogene homolog 2	600098	RRAS2	22800	ENSG00000133818,ENST00000256196;;;ENST00000256196		Noonan syndrome 12	618624	AD	3	Rras2
11p15.2	11:14277920-14364506	RRAS2, TC21, NS12	Related Ras viral oncogene homolog 2	600098	RRAS2	22800	ENSG00000133818,ENST00000256196;;;ENST00000256196		Ovarian carcinoma			3	Rras2
11p15.2	11:14457512-14499811	COPB1, COPB, BARMACS	Coatomer protein complex, subunit beta 1	600959	COPB1	1315	ENSG00000129083,ENST00000439561;;;ENST00000439561		Baralle-Macken syndrome	619255	AR	3	Copb1
11p15.2	11:14877440-14892443	CYP2R1	Cytochrome P450, subfamily IIR, polypeptide 1 (vitamin D 25-hydroxylase)	608713	CYP2R1	120227	ENSG00000186104,ENST00000334636;;;ENST00000334636		Rickets due to defect in vitamin D 25-hydroxylation deficiency	600081	AR	3	Cyp2r1
11p15.2	11:15966449-16738477	SOX6, TOLCAS	SRY-box 6	607257	SOX6	55553	ENSG00000110693,ENST00000683767;;;ENST00000683767		Tolchin-Le Caignec syndrome	618971	AD	3	Sox6
11p15.1	11:17086575-17207986	PIK3C2A, CPK, OCSKD	Phosphatidylinositol 3-kinase, class 2, alpha	603601	PIK3C2A	5286	ENSG00000011405,ENST00000691414;;;ENST00000691414		Oculoskeletodental syndrome	618440	AR	3	Pik3c2a
11p15.1	11:17385248-17389346	KCNJ11, BIR, PHHI, HHF2, TNDM3, MODY13, PNDM2	Potassium inwardly-rectifying channel, subfamily J, member 11	600937	KCNJ11	3767	ENSG00000187486,ENST00000339994;;;ENST00000339994	4.5kb 3' of SUR	Diabetes mellitus, transient neonatal 3	610582	AD	3	Kcnj11
11p15.1	11:17385248-17389346	KCNJ11, BIR, PHHI, HHF2, TNDM3, MODY13, PNDM2	Potassium inwardly-rectifying channel, subfamily J, member 11	600937	KCNJ11	3767	ENSG00000187486,ENST00000339994;;;ENST00000339994	4.5kb 3' of SUR	Diabetes, permanent neonatal 2, with or without neurologic features	618856	AD	3	Kcnj11
11p15.1	11:17385248-17389346	KCNJ11, BIR, PHHI, HHF2, TNDM3, MODY13, PNDM2	Potassium inwardly-rectifying channel, subfamily J, member 11	600937	KCNJ11	3767	ENSG00000187486,ENST00000339994;;;ENST00000339994	4.5kb 3' of SUR	Hyperinsulinemic hypoglycemia, familial, 2	601820	AD, AR	3	Kcnj11
11p15.1	11:17385248-17389346	KCNJ11, BIR, PHHI, HHF2, TNDM3, MODY13, PNDM2	Potassium inwardly-rectifying channel, subfamily J, member 11	600937	KCNJ11	3767	ENSG00000187486,ENST00000339994;;;ENST00000339994	4.5kb 3' of SUR	Maturity-onset diabetes of the young, type 13	616329	AD	3	Kcnj11
11p15.1	11:17392498-17476845	ABCC8, SUR, PHHI, SUR1, HHF1, TNDM2, PNDM3, MODY12	ATP-binding cassette, subfamily C, member 8 (sulfonylurea receptor)	600509	ABCC8	6833	ENSG00000006071,ENST00000389817;;;ENST00000389817		Diabetes mellitus, noninsulin-dependent	125853	AD	3	Abcc8
11p15.1	11:17392498-17476845	ABCC8, SUR, PHHI, SUR1, HHF1, TNDM2, PNDM3, MODY12	ATP-binding cassette, subfamily C, member 8 (sulfonylurea receptor)	600509	ABCC8	6833	ENSG00000006071,ENST00000389817;;;ENST00000389817		Diabetes mellitus, permanent neonatal 3	618857	AD, AR	3	Abcc8
11p15.1	11:17392498-17476845	ABCC8, SUR, PHHI, SUR1, HHF1, TNDM2, PNDM3, MODY12	ATP-binding cassette, subfamily C, member 8 (sulfonylurea receptor)	600509	ABCC8	6833	ENSG00000006071,ENST00000389817;;;ENST00000389817		Diabetes mellitus, transient neonatal 2	610374	AD	3	Abcc8
11p15.1	11:17392498-17476845	ABCC8, SUR, PHHI, SUR1, HHF1, TNDM2, PNDM3, MODY12	ATP-binding cassette, subfamily C, member 8 (sulfonylurea receptor)	600509	ABCC8	6833	ENSG00000006071,ENST00000389817;;;ENST00000389817		Hyperinsulinemic hypoglycemia, familial, 1	256450	AD, AR	3	Abcc8
11p15.1	11:17392498-17476845	ABCC8, SUR, PHHI, SUR1, HHF1, TNDM2, PNDM3, MODY12	ATP-binding cassette, subfamily C, member 8 (sulfonylurea receptor)	600509	ABCC8	6833	ENSG00000006071,ENST00000389817;;;ENST00000389817		Hypoglycemia of infancy, leucine-sensitive	240800	AD	3	Abcc8
11p15.1	11:17392498-17476845	ABCC8, SUR, PHHI, SUR1, HHF1, TNDM2, PNDM3, MODY12	ATP-binding cassette, subfamily C, member 8 (sulfonylurea receptor)	600509	ABCC8	6833	ENSG00000006071,ENST00000389817;;;ENST00000389817		Maturity-onset diabetes of the young, type 12	621196	AD	3	Abcc8
11p15.1	11:17493900-17544416	USH1C, DFNB18A	USH1 protein network component harmonin	605242	USH1C	10083	ENSG00000006611,ENST00000005226;;;ENST00000005226	Acadian and Samaritan variety	Deafness, autosomal recessive 18A	602092	AR	3	Ush1c
11p15.1	11:17493900-17544416	USH1C, DFNB18A	USH1 protein network component harmonin	605242	USH1C	10083	ENSG00000006611,ENST00000005226;;;ENST00000005226	Acadian and Samaritan variety	Usher syndrome, type 1C	276904	AR	3	Ush1c
11p15.1	11:17547259-17646044	OTOG, OTGN, DFNB18B	Otogelin	604487	OTOG	340990	ENSG00000188162,ENST00000399397;;;ENST00000399397		Deafness, autosomal recessive 18B	614945	AR	3	Otog
11p15.1	11:17719571-17722136	MYOD1, MYF3, CMYO17	Myogenic differentiation 1	159970	MYOD1	4654	ENSG00000129152,ENST00000250003;;;ENST00000250003		Congenital myopathy 17	618975	AR	3	Myod1
11p15.1	11:17734781-17783057	KCNC1, EPM7	Potassium voltage-gated channel, Shaw-related subfamily, member 1	176258	KCNC1	3746	ENSG00000129159,ENST00000265969;;;ENST00000265969		Epilepsy, progressive myoclonic 7	616187	AD	3	Kcnc1
11p15.1	11:18278670-18322174	HPS5, RU2, KIAA1017	HPS5 biogenesis of lysosomal organelles complex 2 subunit 2	607521	HPS5	11234	ENSG00000110756,ENST00000349215;;;ENST00000349215		Hermansky-Pudlak syndrome 5	614074	AR	3	Hps5
11p15.1	11:18394563-18408425	LDHA, LDH1, GSD11	Lactate dehydrogenase A	150000	LDHA	3939	ENSG00000134333,ENST00000422447;;;ENST00000422447		Glycogen storage disease XI	612933	AR	3	Ldha
11p15.1	11:19182030-19201983	CSRP3, CRP3, CLP, CMD1M, CMH12	Cysteine- and glycine-rich protein 3	600824	CSRP3	8048	ENSG00000129170,ENST00000265968;;;ENST00000265968	mutation identified in 1 CMD1M family	?Cardiomyopathy, dilated, 1M	607482		3	Csrp3
11p15.1	11:19182030-19201983	CSRP3, CRP3, CLP, CMD1M, CMH12	Cysteine- and glycine-rich protein 3	600824	CSRP3	8048	ENSG00000129170,ENST00000265968;;;ENST00000265968	mutation identified in 1 CMD1M family	Cardiomyopathy, hypertrophic, 12	612124	AD	3	Csrp3
11p15.1	11:20599608-20659285	SLC6A5, GLYT2, HKPX3	Solute carrier family 6 (neurotransmitter transporter, glycine), member 5	604159	SLC6A5	9152	ENSG00000165970,ENST00000525748;;;ENST00000525748		Hyperekplexia 3	614618	AD, AR	3	Slc6a5
11p14	11:22000001-31000000	TST1	Tuberculin skin test reactivity, absence of	613636		100526790		at chr11:26.37M	[Tuberculin skin test reactivity, absence of]	613636		2	
11p14.3	11:22192473-22283357	ANO5, TMEM16E, GDD1, LGMDR12	Anoctamin 5	608662	ANO5	203859	ENSG00000171714,ENST00000324559;;;ENST00000324559		Gnathodiaphyseal dysplasia	166260	AD	3	Ano5
11p14.3	11:22192473-22283357	ANO5, TMEM16E, GDD1, LGMDR12	Anoctamin 5	608662	ANO5	203859	ENSG00000171714,ENST00000324559;;;ENST00000324559		Miyoshi muscular dystrophy 3	613319	AR	3	Ano5
11p14.3	11:22192473-22283357	ANO5, TMEM16E, GDD1, LGMDR12	Anoctamin 5	608662	ANO5	203859	ENSG00000171714,ENST00000324559;;;ENST00000324559		Muscular dystrophy, limb-girdle, autosomal recessive 12	611307	AR	3	Ano5
11p14.3	11:22622533-22625823	FANCF	Fanconi anemia, complementation group F	613897	FANCF	2188	ENSG00000183161,ENST00000327470;;;ENST00000327470		Fanconi anemia, complementation group F	603467	AR	3	Fancf
11p14.3	11:22626002-22813055	GAS2, DFNB125	Growth arrest-specific 2	602835	GAS2	2620	ENSG00000148935,ENST00000454584;;;ENST00000454584	mutation identified in 1 GAS2 family	?Deafness, autosomal recessive 125	620877	AR	3	Gas2
11p14.3-p14.2	11:26188808-26663289	ANO3, TMEM16C, C11orf25, DYT24	Anoctamin 3	610110	ANO3	63982	ENSG00000134343,ENST00000256737;;;ENST00000256737		Dystonia 24	615034	AD	3	Ano3
11p14.2-q12.3	11:26200001-63600000	DFNA59	Deafness, autosomal dominant 59	612642		100271924		between D22S929 and D11S480	Deafness, autosomal dominant 59	612642	AD	2	
11p14.1-p11.2	11:27200001-48800000	SPG41	Spastic paraplegia 41	613364		100359402		max lod 2.36; between D11S1324 and D11S1993	?Spastic paraplegia 41, autosomal dominant	613364	AD	2	
11p14.1	11:27338512-27363215	CCDC34, SPGF76	Coiled-coil domain-containing protein 34	612324	CCDC34	91057	ENSG00000109881,ENST00000328697;;;ENST00000328697		Spermatogenic failure 76	620084	AR	3	Ccdc34
11p14.1	11:27365961-27472790	LGR4, GPR48, BNMD17, DPSL	Leucine-rich repeat-containing G protein-coupled receptor 4	606666	LGR4	55366	ENSG00000205213,ENST00000379214;;;ENST00000379214	previously mapped to 5q34-q35.1	{Bone mineral density, low, susceptibility to}	615311	AD	3	Lgr4
11p14.1	11:27365961-27472790	LGR4, GPR48, BNMD17, DPSL	Leucine-rich repeat-containing G protein-coupled receptor 4	606666	LGR4	55366	ENSG00000205213,ENST00000379214;;;ENST00000379214	previously mapped to 5q34-q35.1	Delayed puberty, self-limited	619613	AD	3	Lgr4
11p14.1	11:30009730-30017030	KCNA4, KCNA8, MCIDDS	Potassium voltage-gated channel, shaker-related subfamily, member 4	176266	KCNA4	3739	ENSG00000182255,ENST00000328224;;;ENST00000328224	other map to 11p	Microcephaly, cataracts, impaired intellectual development, and dystonia with abnormal striatum	618284	AR	3	Kcna4
11p14.1	11:30231014-30235194	FSHB, HH24	Follicle-stimulating hormone, beta polypeptide	136530	FSHB	2488	ENSG00000131808,ENST00000533718;;;ENST00000533718	distal to AN2	Hypogonadotropic hypogonadism 24 without anosmia	229070	AR	3	Fshb
11p13-q12	11:31000001-63600000	CANDF3, CANDN1, FCNC	Candidiasis, familial, 3	607644		338434		between D11S1312 and D11S4191	Candidiasis, familial, 3	607644	AD	2	
11p13	11:31000001-36400000	DEL11p13, C11DELp13	Chromosome 11p13 deletion syndrome, distal	616902					Chromosome 11p13 deletion syndrome, distal	616902	AD	4	
11p13	11:31000001-36400000	DEL11p13, C11DELp13, WAGR	Wilms tumor, aniridia, genitourinary anomalies and impaired intellectual development syndrome (chromosome 11p13 deletion syndrome)	194072				deletion of WT1 and PAX6 genes	Wilms tumor, aniridia, genitourinary anomalies and impaired intellectual development syndrome	194072	AD, SMu	4	
11p13-p12	11:31000001-43400000	DFNB51	Deafness, autosomal recessive 51	609941		448963		max lod at D11S4102	Deafness, autosomal recessive 51	609941	AR	2	
11p13	11:31000001-36400000	ECT, BECTS	Centrotemporal epilepsy	117100		100379198		previously assigned to 15q14	Centrotemporal epilepsy	117100	IC	2	
11p13-p12	11:31000001-43400000	EVR3	Exudative vitreoretinopathy 3	605750		81864			Exudative vitreoretinopathy 3	605750	AD	2	
11p13-q14.1	11:31000001-85900000	MRT23	Intellectual developmental disorder, autosomal recessive 23	614344		100852398		between rs604518 and rs10899421	Intellectual developmental disorder, autosomal recessive 23	614344	AR	2	
11p13	11:31000001-36400000	MYP7	Myopia 7	609256		553190			Myopia 7	609256	Mu	2	
11p13-p12	11:31000001-43400000	WAGRO, DEL11p14p12	Wilms tumor, aniridia, genitourinary anomalies, impaired intellectual development and obesity syndrome	612469				contiguous gene deletion syndrome	WAGRO syndrome	612469	AD	4	
11p13	11:31509767-31790324	ELP4, PAX6NEB, AN2	Elongation protein 4, S. cerevisiae, homolog of	606985	ELP4	26610	ENSG00000109911,ENST00000640961;;;ENST00000640961	mutation identified in 1 AN2 patient	?Aniridia 2	617141	AD	3	Elp4
11p13	11:31789026-31817961	PAX6, AN2, MGDA, FVH1, ASGD5	Paired box homeotic gene-6	607108	PAX6	5080	ENSG00000007372,ENST00000640368;;;ENST00000640368	mutation identified in 1 patient each with MDGA, COLBN, or COLB	?Coloboma of optic nerve	120430	AD	3	Pax6
11p13	11:31789026-31817961	PAX6, AN2, MGDA, FVH1, ASGD5	Paired box homeotic gene-6	607108	PAX6	5080	ENSG00000007372,ENST00000640368;;;ENST00000640368	mutation identified in 1 patient each with MDGA, COLBN, or COLB	?Morning glory disc anomaly	120430	AD	3	Pax6
11p13	11:31789026-31817961	PAX6, AN2, MGDA, FVH1, ASGD5	Paired box homeotic gene-6	607108	PAX6	5080	ENSG00000007372,ENST00000640368;;;ENST00000640368	mutation identified in 1 patient each with MDGA, COLBN, or COLB	Aniridia	106210	AD	3	Pax6
11p13	11:31789026-31817961	PAX6, AN2, MGDA, FVH1, ASGD5	Paired box homeotic gene-6	607108	PAX6	5080	ENSG00000007372,ENST00000640368;;;ENST00000640368	mutation identified in 1 patient each with MDGA, COLBN, or COLB	Anterior segment dysgenesis 5, multiple subtypes	604229	AD	3	Pax6
11p13	11:31789026-31817961	PAX6, AN2, MGDA, FVH1, ASGD5	Paired box homeotic gene-6	607108	PAX6	5080	ENSG00000007372,ENST00000640368;;;ENST00000640368	mutation identified in 1 patient each with MDGA, COLBN, or COLB	Cataract with late-onset corneal dystrophy	106210	AD	3	Pax6
11p13	11:31789026-31817961	PAX6, AN2, MGDA, FVH1, ASGD5	Paired box homeotic gene-6	607108	PAX6	5080	ENSG00000007372,ENST00000640368;;;ENST00000640368	mutation identified in 1 patient each with MDGA, COLBN, or COLB	Foveal hypoplasia 1	136520	AD	3	Pax6
11p13	11:31789026-31817961	PAX6, AN2, MGDA, FVH1, ASGD5	Paired box homeotic gene-6	607108	PAX6	5080	ENSG00000007372,ENST00000640368;;;ENST00000640368	mutation identified in 1 patient each with MDGA, COLBN, or COLB	Keratitis	148190	AD	3	Pax6
11p13	11:31789026-31817961	PAX6, AN2, MGDA, FVH1, ASGD5	Paired box homeotic gene-6	607108	PAX6	5080	ENSG00000007372,ENST00000640368;;;ENST00000640368	mutation identified in 1 patient each with MDGA, COLBN, or COLB	Microphthalmia/coloboma 12	120200	AD	3	Pax6
11p13	11:31789026-31817961	PAX6, AN2, MGDA, FVH1, ASGD5	Paired box homeotic gene-6	607108	PAX6	5080	ENSG00000007372,ENST00000640368;;;ENST00000640368	mutation identified in 1 patient each with MDGA, COLBN, or COLB	Optic nerve hypoplasia	165550	AD	3	Pax6
11p13	11:32387775-32435539	WT1, NPHS4	WT1 transcription factor	607102	WT1	7490	ENSG00000184937,ENST00000452863;;;ENST00000452863	clumped: pter-FSHB-AN2-WT1-CAT	Denys-Drash syndrome	194080	AD, SMu	3	Wt1
11p13	11:32387775-32435539	WT1, NPHS4	WT1 transcription factor	607102	WT1	7490	ENSG00000184937,ENST00000452863;;;ENST00000452863	clumped: pter-FSHB-AN2-WT1-CAT	Frasier syndrome	136680	AD, SMu	3	Wt1
11p13	11:32387775-32435539	WT1, NPHS4	WT1 transcription factor	607102	WT1	7490	ENSG00000184937,ENST00000452863;;;ENST00000452863	clumped: pter-FSHB-AN2-WT1-CAT	Meacham syndrome	608978	AD	3	Wt1
11p13	11:32387775-32435539	WT1, NPHS4	WT1 transcription factor	607102	WT1	7490	ENSG00000184937,ENST00000452863;;;ENST00000452863	clumped: pter-FSHB-AN2-WT1-CAT	Mesothelioma, somatic	156240		3	Wt1
11p13	11:32387775-32435539	WT1, NPHS4	WT1 transcription factor	607102	WT1	7490	ENSG00000184937,ENST00000452863;;;ENST00000452863	clumped: pter-FSHB-AN2-WT1-CAT	Nephrotic syndrome, type 4	256370	AD	3	Wt1
11p13	11:32387775-32435539	WT1, NPHS4	WT1 transcription factor	607102	WT1	7490	ENSG00000184937,ENST00000452863;;;ENST00000452863	clumped: pter-FSHB-AN2-WT1-CAT	Wilms tumor, type 1	194070	AD, SMu	3	Wt1
11p13	11:33703010-33736479	CD59, MIC11	CD59 antigen (p18-20)	107271	CD59	966	ENSG00000085063,ENST00000642928;;;ENST00000642928	in mouse Ly-6 = multigene complex	Hemolytic anemia, CD59-mediated, with or without immune-mediated polyneuropathy	612300	AR	3	Cd59a,Cd59b
11p13	11:33858576-33892076	LMO2, RBTNL1, RHOM2, TTG2	LIM domain only 2 (rhombotin-like 1)	180385	LMO2	4005	ENSG00000135363,ENST00000257818;;;ENST00000257818	3rd rhombotin gene not on 11	Leukemia, acute T-cell	180385		2	Lmo2
11p13	11:34051731-34102610	CAPRIN1, M11S1, GPIAP1, GRIP137, CONDCAC, NEDLAAD	Cell cycle associated protein 1	601178	CAPRIN1	4076	ENSG00000135387,ENST00000341394;;;ENST00000341394		Neurodegeneration, childhood-onset, with cerebellar ataxia and cognitive decline	620636	AD	3	Caprin1
11p13	11:34051731-34102610	CAPRIN1, M11S1, GPIAP1, GRIP137, CONDCAC, NEDLAAD	Cell cycle associated protein 1	601178	CAPRIN1	4076	ENSG00000135387,ENST00000341394;;;ENST00000341394		Neurodevelopmental disorder with language impairment, autism, and attention deficit-hyperactivity disorder	620782	AD	3	Caprin1
11p13	11:34438934-34472060	CAT	Catalase	115500	CAT	847	ENSG00000121691,ENST00000241052;;;ENST00000241052	cen-CAT-WT1-AN2-pter	Acatalasemia	614097		3	Cat
11p13	11:34915920-34996128	PDHX, PDX1, E3BP, PDHXD	Pyruvate dehydrogenase complex, lipoyl-containing component X	608769	PDHX	8050	ENSG00000110435,ENST00000227868;;;ENST00000227868		Lacticacidemia due to PDX1 deficiency	245349	AR	3	Pdhx
11p13	11:35139171-35232402	CD44, MDU2, MDU3, MIC4, IN	CD44 antigen (homing function)	107269	CD44	960	ENSG00000026508,ENST00000428726;;;ENST00000428726		[Blood group, Indian system]	609027		3	Cd44
11p13	11:35251205-35420507	SLC1A2, EAAT2, DEE41	Solute carrier family 1 (glial high affinity glutamate transporter), member 2	600300	SLC1A2	6506	ENSG00000110436,ENST00000278379;;;ENST00000278379		Developmental and epileptic encephalopathy 41	617105	AD	3	Slc1a2
11p13	11:35662775-35818007	TRIM44, AN3	Tripartite motif-containing protein 44	612298	TRIM44	54765	ENSG00000166326,ENST00000299413;;;ENST00000299413	mutation identified in 1 AN3 family	?Aniridia 3	617142	AD	3	Trim44
11p12	11:36400001-43400000	BMND8	Bone mineral density QTL 8	611739		100188854		between D11S1392 and D11S4102	{Osteoporosis}	166710	AD	2	
11p12-p11	11:36400001-53400000	PSNP3	Supranuclear palsy, progressive, 3	610898		100038248			Supranuclear palsy, progressive, 3	610898		2	
11p12	11:36510353-36579762	RAG1	Recombination activating gene-1	179615	RAG1	5896	ENSG00000166349,ENST00000299440;;;ENST00000299440	assignment to 14 in error	Alpha/beta T-cell lymphopenia with gamma/delta T-cell expansion, severe cytomegalovirus infection, and autoimmunity	609889		3	Rag1
11p12	11:36510353-36579762	RAG1	Recombination activating gene-1	179615	RAG1	5896	ENSG00000166349,ENST00000299440;;;ENST00000299440	assignment to 14 in error	Combined cellular and humoral immune defects with granulomas	233650	AR	3	Rag1
11p12	11:36510353-36579762	RAG1	Recombination activating gene-1	179615	RAG1	5896	ENSG00000166349,ENST00000299440;;;ENST00000299440	assignment to 14 in error	Omenn syndrome	603554	AR	3	Rag1
11p12	11:36510353-36579762	RAG1	Recombination activating gene-1	179615	RAG1	5896	ENSG00000166349,ENST00000299440;;;ENST00000299440	assignment to 14 in error	Severe combined immunodeficiency, B cell-negative	601457	AR	3	Rag1
11p12	11:36590996-36598236	RAG2	Recombination activating gene-2	179616	RAG2	5897	ENSG00000175097,ENST00000311485;;;ENST00000311485	assignment to 14 in error	Combined cellular and humoral immune defects with granulomas	233650	AR	3	Rag2
11p12	11:36590996-36598236	RAG2	Recombination activating gene-2	179616	RAG2	5897	ENSG00000175097,ENST00000311485;;;ENST00000311485	assignment to 14 in error	Omenn syndrome	603554	AR	3	Rag2
11p12	11:36590996-36598236	RAG2	Recombination activating gene-2	179616	RAG2	5897	ENSG00000175097,ENST00000311485;;;ENST00000311485	assignment to 14 in error	Severe combined immunodeficiency, B cell-negative	601457	AR	3	Rag2
11p11	11:43400001-53400000	CLLS1	Leukemia, chronic lymphocytic, susceptibility to, 1	609630		100188791			{Leukemia, chronic lymphocytic, susceptibility to, 1}	609630		2	
11p11.2	11:43400001-48800000	PSS	Potocki-Shaffer syndrome	601224				contiguous gene syndrome caused by deletion of 11p11.2	Potocki-Shaffer syndrome	601224	AD	4	
11p11.2	11:44095678-44251962	EXT2, SSMS	Exostosin glycosyltransferase 2	608210	EXT2	2132	ENSG00000151348,ENST00000533608;;;ENST00000533608		Exostoses, multiple, type 2	133701	AD	3	Ext2
11p11.2	11:44095678-44251962	EXT2, SSMS	Exostosin glycosyltransferase 2	608210	EXT2	2132	ENSG00000151348,ENST00000533608;;;ENST00000533608		Seizures, scoliosis, and macrocephaly syndrome	616682	AR	3	Ext2
11p11.2	11:44260440-44310139	ALX4, PFM2, FPP, FND2, CRS5	Aristaless-like 4, mouse, homolog of	605420	ALX4	60529	ENSG00000052850,ENST00000652299;;;ENST00000652299		{Craniosynostosis 5, susceptibility to}	615529	AD	3	Alx4
11p11.2	11:44260440-44310139	ALX4, PFM2, FPP, FND2, CRS5	Aristaless-like 4, mouse, homolog of	605420	ALX4	60529	ENSG00000052850,ENST00000652299;;;ENST00000652299		Frontonasal dysplasia 2	613451	AR	3	Alx4
11p11.2	11:44260440-44310139	ALX4, PFM2, FPP, FND2, CRS5	Aristaless-like 4, mouse, homolog of	605420	ALX4	60529	ENSG00000052850,ENST00000652299;;;ENST00000652299		Parietal foramina 2	609597	AD	3	Alx4
11p11.2	11:45804079-45813016	SLC35C1, FUCT1, CDG2C	Solute carrier family 35, member C1 (GDP-Fucose transporter 1)	605881	SLC35C1	55343	ENSG00000181830,ENST00000314134;;;ENST00000314134		Congenital disorder of glycosylation, type IIc	266265	AR	3	Slc35c1
11p11.2	11:45885651-45906465	MAPK8IP1, IB1	Mitogen-activated protein kinase 8-interacting protein 1	604641	MAPK8IP1	9479	ENSG00000121653,ENST00000241014;;;ENST00000241014		{Diabetes mellitus, noninsulin-dependent}	125853	AD	3	Mapk8ip1
11p11.2	11:45909663-45918822	PEX16, PBD8A, PBD8B	Peroxisome biogenesis factor 16	603360	PEX16	9409	ENSG00000121680,ENST00000378750;;;ENST00000378750		Peroxisome biogenesis disorder 8A (Zellweger)	614876	AR	3	Pex16
11p11.2	11:45909663-45918822	PEX16, PBD8A, PBD8B	Peroxisome biogenesis factor 16	603360	PEX16	9409	ENSG00000121680,ENST00000378750;;;ENST00000378750		Peroxisome biogenesis disorder 8B	614877	AR	3	Pex16
11p11.2	11:45929319-46121454	PHF21A, BHC80, KIAA1696, IDDBCS	PHD finger protein 21A	608325	PHF21A	51317	ENSG00000135365,ENST00000676320;;;ENST00000676320		Intellectual developmental disorder with behavioral abnormalities and craniofacial dysmorphism with or without seizures	618725	AD	3	Phf21a
11p11.2	11:46277662-46321409	CREB3L1, OASIS, OI16	cAMP response element-binding protein 3-like 1	616215	CREB3L1	90993	ENSG00000157613,ENST00000621158;;;ENST00000621158		Osteogenesis imperfecta, type XVI	616229	AR	3	Creb3l1
11p11.2	11:46701031-46705912	ZNF408, EVR6, RP72	Zinc finger protein 408	616454	ZNF408	79797	ENSG00000175213,ENST00000311764;;;ENST00000311764	mutation identified in 1 EVR6 family	?Exudative vitreoretinopathy 6	616468	AD	3	Zfp408
11p11.2	11:46701031-46705912	ZNF408, EVR6, RP72	Zinc finger protein 408	616454	ZNF408	79797	ENSG00000175213,ENST00000311764;;;ENST00000311764	mutation identified in 1 EVR6 family	Retinitis pigmentosa 72	616469	AR	3	Zfp408
11p11.2	11:46719213-46739506	F2, THPH1, RPRGL2	Coagulation factor II (thrombin)	176930	F2	2147	ENSG00000180210,ENST00000311907;;;ENST00000311907		{Pregnancy loss, recurrent, susceptibility to, 2}	614390	AD	3	F2
11p11.2	11:46719213-46739506	F2, THPH1, RPRGL2	Coagulation factor II (thrombin)	176930	F2	2147	ENSG00000180210,ENST00000311907;;;ENST00000311907		{Stroke, ischemic, susceptibility to}	601367	Mu	3	F2
11p11.2	11:46719213-46739506	F2, THPH1, RPRGL2	Coagulation factor II (thrombin)	176930	F2	2147	ENSG00000180210,ENST00000311907;;;ENST00000311907		Dysprothrombinemia	613679	AR	3	F2
11p11.2	11:46719213-46739506	F2, THPH1, RPRGL2	Coagulation factor II (thrombin)	176930	F2	2147	ENSG00000180210,ENST00000311907;;;ENST00000311907		Hypoprothrombinemia	613679	AR	3	F2
11p11.2	11:46719213-46739506	F2, THPH1, RPRGL2	Coagulation factor II (thrombin)	176930	F2	2147	ENSG00000180210,ENST00000311907;;;ENST00000311907		Thrombophilia 1 due to thrombin defect	188050	AD	3	F2
11p11.2	11:46856717-46918550	LRP4, MEGF7, CLSS, SOST2, CMS17	Low density lipoprotein receptor-related protein 4	604270	LRP4	4038	ENSG00000134569,ENST00000378623;;;ENST00000378623	mutation identified in 1 CMS17 family	?Myasthenic syndrome, congenital, 17	616304	AR	3	Lrp4
11p11.2	11:46856717-46918550	LRP4, MEGF7, CLSS, SOST2, CMS17	Low density lipoprotein receptor-related protein 4	604270	LRP4	4038	ENSG00000134569,ENST00000378623;;;ENST00000378623	mutation identified in 1 CMS17 family	Cenani-Lenz syndactyly syndrome	212780	AR	3	Lrp4
11p11.2	11:46856717-46918550	LRP4, MEGF7, CLSS, SOST2, CMS17	Low density lipoprotein receptor-related protein 4	604270	LRP4	4038	ENSG00000134569,ENST00000378623;;;ENST00000378623	mutation identified in 1 CMS17 family	Sclerosteosis 2	614305	AD, AR	3	Lrp4
11p11.2	11:47177522-47186434	PACSIN3, CMYO27	Protein kinase C and casein kinase substrate in neurons 3	606513	PACSIN3	29763	ENSG00000165912,ENST00000298838;;;ENST00000298838		Congenital myopathy 27	621343	AR	3	Pacsin3
11p11.2	11:47214454-47239217	DDB2	Damage-specific DNA binding protein 2, 48kD	600811	DDB2	1643	ENSG00000134574,ENST00000256996;;;ENST00000256996		Xeroderma pigmentosum, group E, DDB-negative subtype	278740	AR	3	Ddb2
11p11.2	11:47239302-47248814	ACP2	Acid phosphatase 2, lysosomal	171650	ACP2	53	ENSG00000134575,ENST00000672073;;;ENST00000672073		?Lysosomal acid phosphatase deficiency	200950	AR	1	Acp2
11p11.2	11:47269188-47330031	MADD, DENN, NEDDISH, DEEAH	MAP kinase-activating death domain (differentially expressed in normal and neoplastic cells)	603584	MADD	8567	ENSG00000110514,ENST00000706887;;;ENST00000706887		DEEAH syndrome	619004	AR	3	Madd
11p11.2	11:47269188-47330031	MADD, DENN, NEDDISH, DEEAH	MAP kinase-activating death domain (differentially expressed in normal and neoplastic cells)	603584	MADD	8567	ENSG00000110514,ENST00000706887;;;ENST00000706887		Neurodevelopmental disorder with dysmorphic facies, impaired speech and hypotonia	619005	AR	3	Madd
11p11.2	11:47331406-47352702	MYBPC3, CMH4, CMD1MM, LVNC10	Myosin-binding protein C, cardiac	600958	MYBPC3	4607	ENSG00000134571,ENST00000545968;;;ENST00000545968		Cardiomyopathy, dilated, 1MM	615396	AD	3	Mybpc3
11p11.2	11:47331406-47352702	MYBPC3, CMH4, CMD1MM, LVNC10	Myosin-binding protein C, cardiac	600958	MYBPC3	4607	ENSG00000134571,ENST00000545968;;;ENST00000545968		Cardiomyopathy, hypertrophic, 4	115197	AD, AR	3	Mybpc3
11p11.2	11:47331406-47352702	MYBPC3, CMH4, CMD1MM, LVNC10	Myosin-binding protein C, cardiac	600958	MYBPC3	4607	ENSG00000134571,ENST00000545968;;;ENST00000545968		Left ventricular noncompaction 10	615396	AD	3	Mybpc3
11p11.2	11:47354860-47378547	SPI1, SFPI1, AGM10	SPI1 protooncogene	165170	SPI1	6688	ENSG00000066336,ENST00000378538;;;ENST00000378538		Agammaglobulinemia 10, autosomal dominant	619707	AD	3	Spi1
11p11.2	11:47407276-47416500	SLC39A13, ZIP13, EDSSPD3	Solute carrier family 39 (zinc transporter), member 13	608735	SLC39A13	91252	ENSG00000165915,ENST00000362021;;;ENST00000362021		Ehlers-Danlos syndrome, spondylodysplastic type, 3	612350	AR	3	Slc39a13
11p11.2	11:47418775-47426439	PSMC3, TBP1, DCIDP	Proteasome (prosome, macropain) 26S subunit, ATPase, 3	186852	PSMC3	5702	ENSG00000165916,ENST00000298852;;;ENST00000298852	mutation identified in 1 DCIDP family	?Deafness, cataract, impaired intellectual development, and polyneuropathy	619354	AR	3	Psmc3
11p11.2	11:47437764-47449136	RAPSN, CMS1D, CMS11, FADS2	Receptor-associated protein of the synapse, 43kD	601592	RAPSN	5913	ENSG00000165917,ENST00000298854;;;ENST00000298854		Fetal akinesia deformation sequence 2	618388	AR	3	Rapsn
11p11.2	11:47437764-47449136	RAPSN, CMS1D, CMS11, FADS2	Receptor-associated protein of the synapse, 43kD	601592	RAPSN	5913	ENSG00000165917,ENST00000298854;;;ENST00000298854		Myasthenic syndrome, congenital, 11, associated with acetylcholine receptor deficiency	616326	AR	3	Rapsn
11p11.2	11:47565599-47573461	PTPMT1, PLIP, NEDAXBA	Protein-tyrosine phosphatase, mitochondrial, 1	609538	PTPMT1	114971	ENSG00000110536,ENST00000326674;;;ENST00000326674		Neurodevelopmental disorder with ataxia and brain abnormalities	621199	AR	3	Ptpmt1
11p11.2	11:47579074-47584562	NDUFS3, MC1DN8	NADH-ubiquinone oxidoreductase core subunit S3	603846	NDUFS3	4722	ENSG00000213619,ENST00000263774;;;ENST00000263774		Mitochondrial complex I deficiency, nuclear type 8	618230	AR	3	Ndufs3
11p11.2	11:47778118-47848544	NUP160, KIAA0197, NPHS19	Nucleoporin, 160kD	607614	NUP160	23279	ENSG00000030066,ENST00000378460;;;ENST00000378460	mutation identified in 1 NPHS19 family	?Nephrotic syndrome, type 19	618178	AR	3	Nup160
11p11.2	11:47980559-48170839	PTPRJ, DEP1, THC10	Protein tyrosine phosphatase, receptor type, J polypeptide	600925	PTPRJ	5795	ENSG00000149177,ENST00000418331;;;ENST00000418331		Colon cancer, somatic	114500		3	Ptprj
11p11.2	11:47980559-48170839	PTPRJ, DEP1, THC10	Protein tyrosine phosphatase, receptor type, J polypeptide	600925	PTPRJ	5795	ENSG00000149177,ENST00000418331;;;ENST00000418331		Thrombocytopenia 10	620484	AR	3	Ptprj
11q12-q13.1	11:55800001-66100000	PURAQTL1	Polyunsaturated fatty acids plasma level QTL1	612795		100302559		associated with rs174537	[Polyunsaturated fatty acids plasma level QTL1]	612795		2	
11q12	11:55800001-63600000	SCA20, DUP11q12, C11DUPq12	Spinocerebellar ataxia 20 (chromosome 11q12 duplication syndrome, 260kb)	608687				contiguous gene duplication syndrome	Spinocerebellar ataxia 20	608687	AD	4	
11q12.1	11:57597685-57614848	SERPING1, C1NH, HAE1, HAE2	Serpin family G member 1 (complement component-1 inhibitor)	606860	SERPING1	710	ENSG00000149131,ENST00000278407;;;ENST00000278407		Angioedema, hereditary, 1 and 2	106100	AD, AR	3	Serping1
11q12.1	11:57597685-57614848	SERPING1, C1NH, HAE1, HAE2	Serpin family G member 1 (complement component-1 inhibitor)	606860	SERPING1	710	ENSG00000149131,ENST00000278407;;;ENST00000278407		Complement component 4, partial deficiency of	120790	AD	3	Serping1
11q12.1	11:57657762-57661865	CLP1, HEAB, PCH10	Cleavage and polyadenylation factor I subunit 1, yeast, homolog of	608757	CLP1	10978	ENSG00000172409,ENST00000533682;;;ENST00000533682		Pontocerebellar hypoplasia, type 10	615803	AR	3	Clp1
11q12.1	11:57712593-57740973	TMX2, NEDMCMS	Thioredoxin-related transmembrane protein 2	616715	TMX2	51075	ENSG00000213593,ENST00000278422;;;ENST00000278422		Neurodevelopmental disorder with microcephaly, cortical malformations, and spasticity	618730	AR	3	Tmx2
11q12.1	11:57761802-57819540	CTNND1, CTNND, BCDS2	Catenin (cadherin-associated protein), delta 1	601045	CTNND1	1500	ENSG00000198561,ENST00000399050;;;ENST00000399050		Blepharocheilodontic syndrome 2	617681	AD	3	Ctnnd1
11q12.1	11:59107237-59127412	FAM111B, POIKTMP	Family with sequence similarity 111, member B	615584	FAM111B	374393	ENSG00000189057,ENST00000343597;;;ENST00000343597		Poikiloderma, hereditary fibrosing, with tendon contractures, myopathy, and pulmonary fibrosis	615704	AD	3	
11q12.1	11:59142856-59155039	FAM111A, KIAA1895, KCS2, GCLEB	Family with sequence similarity 111, member A	615292	FAM111A	63901	ENSG00000166801,ENST00000675163;;;ENST00000675163		Gracile bone dysplasia	602361	AD	3	Fam111a
11q12.1	11:59142856-59155039	FAM111A, KIAA1895, KCS2, GCLEB	Family with sequence similarity 111, member A	615292	FAM111A	63901	ENSG00000166801,ENST00000675163;;;ENST00000675163		Kenny-Caffey syndrome, type 2	127000	AD	3	Fam111a
11q12.1	11:59208510-59212927	MPEG1, MPG1, IMD77	Macrophage expressed gene 1	610390	MPEG1	219972	ENSG00000197629,ENST00000361050;;;ENST00000361050		Immunodeficiency 77	619223	AD	3	Mpeg1,Pfpl
11q12.1	11:59754188-59805878	STX3, STX3A, DIAR12, MVID2, RDMVID	Syntaxin 3	600876	STX3	6809	ENSG00000166900,ENST00000337979;;;ENST00000337979		Diarrhea 12, with microvillus atrophy	619445	AR	3	Stx3
11q12.1	11:59754188-59805878	STX3, STX3A, DIAR12, MVID2, RDMVID	Syntaxin 3	600876	STX3	6809	ENSG00000166900,ENST00000337979;;;ENST00000337979		Retinal dystrophy and microvillus inclusion disease	619446	AR	3	Stx3
11q12.1	11:59829273-59845499	CBLIF, GIF, IF	Cobalamin-binding intrinsic factor (gastric intrinsic factor)	609342	CBLIF	2694	ENSG00000134812,ENST00000257248;;;ENST00000257248		Intrinsic factor deficiency	261000	AR	3	Cblif
11q12.2	11:60455847-60470752	MS4A1, CD20, CVID5	Membrane-spanning 4-domains, subfamily A, member 1	112210	MS4A1	931	ENSG00000156738,ENST00000345732;;;ENST00000345732	mutation identified in 1 CVID5 patient	?Immunodeficiency, common variable, 5	613495	AR	3	Ms4a1
11q12.2	11:60867542-60875687	ZP1, OZEMA1	Zona pellucida glycoprotein 1	195000	ZP1	22917	ENSG00000149506,ENST00000278853;;;ENST00000278853		Oocyte/zygote/embryo maturation arrest 1	615774	AR	3	Zp1
11q12.2	11:61299451-61333105	DDB1, WHIKERS	Damage-specific DNA binding protein 1, 127kD	600045	DDB1	1642	ENSG00000167986,ENST00000301764;;;ENST00000301764		White-Kernohan syndrome	619426	AD	3	Ddb1
11q12.2	11:61333228-61353426	TKFC, DAK, TKFCD	Triokinase and FMN cyclase	615844	TKFC	26007	ENSG00000149476,ENST00000394900;;;ENST00000394900		Triokinase and FMN cyclase deficiency syndrome	618805	AR	3	Tkfc
11q12.2	11:61362374-61376870	TMEM138, JBTS16	Transmembrane protein 138	614459	TMEM138	51524	ENSG00000149483,ENST00000278826;;;ENST00000278826		Joubert syndrome 16	614465	AR	3	Tmem138
11q12.2	11:61392587-61398846	TMEM216, JBTS2, CORS2, MKS2, RP98	Transmembrane protein 216	613277	TMEM216	51259	ENSG00000187049,ENST00000515837;;;ENST00000515837		Joubert syndrome 2	608091	AR	3	Tmem216
11q12.2	11:61392587-61398846	TMEM216, JBTS2, CORS2, MKS2, RP98	Transmembrane protein 216	613277	TMEM216	51259	ENSG00000187049,ENST00000515837;;;ENST00000515837		Meckel syndrome 2	603194	AR	3	Tmem216
11q12.2	11:61392587-61398846	TMEM216, JBTS2, CORS2, MKS2, RP98	Transmembrane protein 216	613277	TMEM216	51259	ENSG00000187049,ENST00000515837;;;ENST00000515837		Retinitis pigmentosa 98	620996	AR	3	Tmem216
11q12.2	11:61430124-61446733	SDHAF2, SDH5, PPGL2	Succinate dehydrogenase complex assembly factor 2	613019	SDHAF2	54949	ENSG00000167985,ENST00000301761;;;ENST00000301761		Pheochromocytoma/paraganglioma syndrome 2	601650	AD	3	Sdhaf2
11q12.2	11:61680391-61747001	DAGLA, KIAA0659, NOC2	Diacylglycerol lipase, alpha	614015	DAGLA	747	ENSG00000134780,ENST00000257215;;;ENST00000257215		Neuroocular syndrome 2, paroxysmal type	168885	AD	3	Dagla
11q12.2	11:61752636-61788518	MYRF, C11orf9, KIAA0954, MMERV, CUGS, NNO1	Myelin regulatory factor	608329	MYRF	745	ENSG00000124920,ENST00000278836;;;ENST00000278836		Cardiac-urogenital syndrome	618280	AD	3	Myrf
11q12.2	11:61752636-61788518	MYRF, C11orf9, KIAA0954, MMERV, CUGS, NNO1	Myelin regulatory factor	608329	MYRF	745	ENSG00000124920,ENST00000278836;;;ENST00000278836		Encephalitis/encephalopathy, mild, with reversible myelin vacuolization	618113	AD	3	Myrf
11q12.2	11:61752636-61788518	MYRF, C11orf9, KIAA0954, MMERV, CUGS, NNO1	Myelin regulatory factor	608329	MYRF	745	ENSG00000124920,ENST00000278836;;;ENST00000278836		Nanophthalmos 1	600165	AD	3	Myrf
11q12.3	11:61949821-61965515	BEST1, VMD2, ARB, RP50	Bestrophin 1	607854	BEST1	7439	ENSG00000167995,ENST00000378043;;;ENST00000378043	mutation identified in 1 MRCS family	?Microcornea, rod-cone dystrophy, cataract, and posterior staphyloma 2	193220	AD	3	Best1
11q12.3	11:61949821-61965515	BEST1, VMD2, ARB, RP50	Bestrophin 1	607854	BEST1	7439	ENSG00000167995,ENST00000378043;;;ENST00000378043	mutation identified in 1 MRCS family	Bestrophinopathy, autosomal recessive	611809		3	Best1
11q12.3	11:61949821-61965515	BEST1, VMD2, ARB, RP50	Bestrophin 1	607854	BEST1	7439	ENSG00000167995,ENST00000378043;;;ENST00000378043	mutation identified in 1 MRCS family	Macular dystrophy, vitelliform, 2	153700	AD	3	Best1
11q12.3	11:61949821-61965515	BEST1, VMD2, ARB, RP50	Bestrophin 1	607854	BEST1	7439	ENSG00000167995,ENST00000378043;;;ENST00000378043	mutation identified in 1 MRCS family	Retinitis pigmentosa-50	613194		3	Best1
11q12.3	11:61949821-61965515	BEST1, VMD2, ARB, RP50	Bestrophin 1	607854	BEST1	7439	ENSG00000167995,ENST00000378043;;;ENST00000378043	mutation identified in 1 MRCS family	Retinitis pigmentosa, concentric	613194		3	Best1
11q12.3	11:61949821-61965515	BEST1, VMD2, ARB, RP50	Bestrophin 1	607854	BEST1	7439	ENSG00000167995,ENST00000378043;;;ENST00000378043	mutation identified in 1 MRCS family	Vitreoretinochoroidopathy	193220	AD	3	Best1
11q12.3	11:61964285-61967634	FTH1, FTHL6, HFE5, NBIA9	Ferritin, heavy polypeptide 1	134770	FTH1	2495	ENSG00000167996,ENST00000273550;;;ENST00000273550	mutation identified in 1 HFE5 family	?Hemochromatosis, type 5	615517	AD	3	Fth1
11q12.3	11:61964285-61967634	FTH1, FTHL6, HFE5, NBIA9	Ferritin, heavy polypeptide 1	134770	FTH1	2495	ENSG00000167996,ENST00000273550;;;ENST00000273550	mutation identified in 1 HFE5 family	Neurodegeneration with brain iron accumulation 9	620669	AD	3	Fth1
11q12.3	11:62613257-62615116	ROM1, ROSP1, RP7	Rod outer segment membrane protein-1	180721	ROM1	6094	ENSG00000149489,ENST00000278833;;;ENST00000278833	digenic RP with RDS	Retinitis pigmentosa 7, digenic form	608133	AD, AR, DD	3	Rom1
11q12.3	11:62615296-62621986	B3GAT3, GLCATI, JDSCD	Beta-1,3-glucuronyltransferase 3	606374	B3GAT3	26229	ENSG00000149541,ENST00000265471;;;ENST00000265471	pseudogene on chr.3	Multiple joint dislocations, short stature, craniofacial dysmorphism, with or without congenital heart defects	245600	AR	3	B3gat3
11q12.3	11:62624829-62646613	GANAB, PKD3	Neutral alpha-glucosidase AB	104160	GANAB	23193	ENSG00000089597,ENST00000356638;;;ENST00000356638		Polycystic kidney disease 3	600666	AD	3	Ganab
11q12.3	11:62671673-62673686	UQCC3, C11orf83, MC3DN9	Ubiquinol-cytochrome c reductase complex assembly factor 3	616097	UQCC3	790955	ENSG00000204922,ENST00000377953;;;ENST00000377953	mutation identified in 1 MC3DN9 patient	?Mitochondrial complex III deficiency, nuclear type 9	616111	AR	3	Uqcc3
11q12.3	11:62690262-62709537	BSCL2, SPG17, PELD, HMND13	Seipin	606158	BSCL2	26580	ENSG00000168000,ENST00000360796;;;ENST00000360796		Encephalopathy, progressive, with or without lipodystrophy	615924	AR	3	Bscl2
11q12.3	11:62690262-62709537	BSCL2, SPG17, PELD, HMND13	Seipin	606158	BSCL2	26580	ENSG00000168000,ENST00000360796;;;ENST00000360796		Lipodystrophy, congenital generalized, type 2	269700	AR	3	Bscl2
11q12.3	11:62690262-62709537	BSCL2, SPG17, PELD, HMND13	Seipin	606158	BSCL2	26580	ENSG00000168000,ENST00000360796;;;ENST00000360796		Neuronopathy, distal hereditary motor, autosomal dominant 13	619112	AD	3	Bscl2
11q12.3	11:62690262-62709537	BSCL2, SPG17, PELD, HMND13	Seipin	606158	BSCL2	26580	ENSG00000168000,ENST00000360796;;;ENST00000360796		Silver spastic paraplegia syndrome	270685	AD	3	Bscl2
11q12.3	11:62806860-62832051	STX5, STX5A, CDG2AA	Syntaxin 5	603189	STX5	6811	ENSG00000162236,ENST00000294179;;;ENST00000294179	mutation identified in 1 CDG2AA family	?Congenital disorder of glycosylation, type IIaa	620454	AR	3	Stx5a
11q12.3	11:62841619-62841809	RNU2-2, DEE119	RNA, U2 small nuclear 2	621238	RNU2-2	26855	ENSG00000222328,ENST00000410396		Developmental and epileptic encephalopathy 119	621304	AD	3	
11q12.3-q13.1	11:63574462-63616927	PLAAT3, PLA2G16, HRASLS3, HRSL3, HREV107, FPLD9	Phospholipase A and acyltransferase 3	613867	PLAAT3	11145	ENSG00000176485,ENST00000415826;;;ENST00000415826		Lipodystrophy, familial partial, type 9	620683	AR	3	Plaat3
11q13	11:63600001-77400000	HMNR3	Neuronopathy, distal hereditary motor, autosomal recessive 3	607088		246751		no mutations found in IGHMBP2	Neuronopathy, distal hereditary motor, autosomal recessive 3	607088	AR	2	
11q13	11:63600001-77400000	HPC14	Prostate cancer, hereditary, 14	611958		100188867		associated with rs7931342	{Prostate cancer, hereditary, 14}	611958		2	
11q13	11:63600001-77400000	IDDM4	Insulin-dependent diabetes mellitus-4	600319		3403			{Diabetes mellitus, insulin-dependent, 4}	600319		2	
11q13	11:63600001-77400000	OTDD, DEL11q13, C11DELq13	Otodental dysplasia (chromosome 11q13 deletion syndrome)	166750				between rs9666584 and rs41408348	Otodental dysplasia chromosome deletion syndrome	166750	AD	4	
11q13	11:63600001-77400000	ST3	Suppression of tumorigenicity-3 (tumor-suppressor gene, HELA cell type)	191181		6762			Cervical carcinoma	191181		2	
11q13.1	11:63624087-63671974	ATL3, HSN1F	Atlastin GTPase 3	609369	ATL3	25923	ENSG00000184743,ENST00000398868;;;ENST00000398868		Neuropathy, hereditary sensory, type IF	615632	AD	3	Atl3
11q13.1	11:63839110-63911020	MARK2, EMK1, MRD76	MAP/microtubule affinity-regulating kinase 2	600526	MARK2	2011	ENSG00000072518,ENST00000402010;;;ENST00000402010		Intellectual developmental disorder, autosomal dominant 76	621285	AD	3	Mark2
11q13.1	11:63974620-63976543	COX8A, MC4DN15	Cytochrome c oxidase, subunit VIIIA	123870	COX8A	1351	ENSG00000176340,ENST00000314133;;;ENST00000314133	mutation identified in 1 MC4DN15 patient	?Mitochondrial complex IV deficiency, nuclear type 15	619059	AR	3	Cox8a
11q13.1	11:64205920-64223891	FERMT3, KIND3, URP2, MIG2B	FERM domain-containing kindlin 3	607901	FERMT3	83706	ENSG00000149781,ENST00000345728;;;ENST00000345728		Leukocyte adhesion deficiency, type III	612840	AR	3	Fermt3
11q13.1	11:64251530-64269452	PLCB3, SMDCD	Phospholipase C, beta 3 (phosphatidylinositol-specific)	600230	PLCB3	5331	ENSG00000149782,ENST00000279230;;;ENST00000279230	within 900kb of MEN1	Spondylometaphyseal dysplasia with corneal dystrophy	618961	AR	3	Plcb3
11q13.1	11:64291302-64300031	KCNK4, TRAAK, FHEIG	Potassium channel, subfamily K, member 4	605720	KCNK4	50801	ENSG00000182450,ENST00000422670;;;ENST00000422670		Facial dysmorphism, hypertrichosis, epilepsy, intellectual/developmental delay, and gingival overgrowth syndrome	618381	AD	3	Kcnk4
11q13.1	11:64591220-64602344	SLC22A12, OAT4L, URAT1	Solute carrier family 22 (urate transporter), member 12	607096	SLC22A12	116085	ENSG00000197891,ENST00000377574;;;ENST00000377574		Hypouricemia, renal	220150	AR	3	Slc22a12
11q13.1	11:64726911-64745456	RASGRP2, CDC25L	Ras guanyl nucleotide-releasing protein 2	605577	RASGRP2	10235	ENSG00000068831,ENST00000394432;;;ENST00000394432	mutation identified in 1 BDPLT18 family	?Bleeding disorder, platelet-type, 18	615888	AR	3	Rasgrp2
11q13.1	11:64746389-64760715	PYGM	Phosphorylase, glycogen, muscle	608455	PYGM	5837	ENSG00000068976,ENST00000164139;;;ENST00000164139		McArdle disease	232600	AR	3	Pygm
11q13.1	11:64803516-64811294	MEN1	Menin	613733	MEN1	4221	ENSG00000133895,ENST00000450708;;;ENST00000450708	linked distal to PYGM	Adrenal adenoma, somatic			3	Men1
11q13.1	11:64803516-64811294	MEN1	Menin	613733	MEN1	4221	ENSG00000133895,ENST00000450708;;;ENST00000450708	linked distal to PYGM	Angiofibroma, somatic			3	Men1
11q13.1	11:64803516-64811294	MEN1	Menin	613733	MEN1	4221	ENSG00000133895,ENST00000450708;;;ENST00000450708	linked distal to PYGM	Carcinoid tumor of lung			3	Men1
11q13.1	11:64803516-64811294	MEN1	Menin	613733	MEN1	4221	ENSG00000133895,ENST00000450708;;;ENST00000450708	linked distal to PYGM	Lipoma, somatic			3	Men1
11q13.1	11:64803516-64811294	MEN1	Menin	613733	MEN1	4221	ENSG00000133895,ENST00000450708;;;ENST00000450708	linked distal to PYGM	Multiple endocrine neoplasia 1	131100	AD	3	Men1
11q13.1	11:64803516-64811294	MEN1	Menin	613733	MEN1	4221	ENSG00000133895,ENST00000450708;;;ENST00000450708	linked distal to PYGM	Parathyroid adenoma, somatic			3	Men1
11q13.1	11:65014160-65022184	ARL2, MRCS1	ADP ribosylation factor-like GTPase 2	601175	ARL2	402	ENSG00000213465,ENST00000246747;;;ENST00000246747	mutation identified in 1 MRCS1 family	?Microcornea, rod-cone dystrophy, cataract, and posterior staphyloma 1	619082	AD	3	Arl2
11q13.1	11:65096214-65111862	VPS51, ANG2, PCH13	VPS51 subunit of GARP complex	615738	VPS51	738	ENSG00000149823,ENST00000279281;;;ENST00000279281		Pontocerebellar hypoplasia, type 13	618606	AR	3	Vps51
11q13.1	11:65122183-65127371	MRPL49, NOF1, COXPD60	Mitochondrial ribosomal protein L49	606866	MRPL49	740	ENSG00000149792,ENST00000279242;;;ENST00000279242		Combined oxidative phosphorylation deficiency 60	621195	AR	3	Mrpl49
11q13.1	11:65181373-65212006	CAPN1, SPG76	Calpain, large polypeptide L1	114220	CAPN1	823	ENSG00000014216,ENST00000279247;;;ENST00000279247		Spastic paraplegia 76, autosomal recessive	616907	AR	3	Capn1
11q13.1	11:65333852-65354262	DPF2, REQ, UBID4, CSS7	D4, zinc, and double PHD fingers family, member 2	601671	DPF2	5977	ENSG00000133884,ENST00000528416;;;ENST00000528416		Coffin-Siris syndrome 7	618027	AD	3	Dpf2
11q13.1	11:65525083-65538704	SCYL1, NTKL, SCAR21	SCY1-like 1	607982	SCYL1	57410	ENSG00000142186,ENST00000270176;;;ENST00000270176		Spinocerebellar ataxia, autosomal recessive 21	616719	AR	3	Scyl1
11q13.1	11:65538559-65558359	LTBP3, LTBP2, DASS, GPHYSD3	Latent transforming growth factor beta binding protein-3	602090	LTBP3	4054	ENSG00000168056,ENST00000301873;;;ENST00000301873		Dental anomalies and short stature	601216	AR	3	Ltbp3
11q13.1	11:65538559-65558359	LTBP3, LTBP2, DASS, GPHYSD3	Latent transforming growth factor beta binding protein-3	602090	LTBP3	4054	ENSG00000168056,ENST00000301873;;;ENST00000301873		Geleophysic dysplasia 3	617809	AD	3	Ltbp3
11q13.1	11:65653601-65663857	RELA, NFKB3, CMCU, AIF3BL3	RELA protooncogene, NF-kB subunit	164014	RELA	5970	ENSG00000173039,ENST00000406246;;;ENST00000406246		Autoinflammatory disease, familial, Behcet-like-3	618287	AD	3	Rela
11q13.1	11:65712018-65719604	KAT5, HTATIP, TIP60, ESA1, PLIP, NEDFASB	Lysine acetyltransferase 5	601409	KAT5	10524	ENSG00000172977,ENST00000341318;;;ENST00000341318		Neurodevelopmental disorder with dysmorphic facies, sleep disturbance, and brain abnormalities	619103	AD	3	Kat5
11q13.1	11:65717673-65720798	RNASEH2C, AYP1, FLJ20974, AGS3	Ribonuclease H2, subunit C	610330	RNASEH2C	84153	ENSG00000172922,ENST00000308418;;;ENST00000308418		Aicardi-Goutieres syndrome 3	610329	AR	3	Rnaseh2c
11q13.1	11:65866441-65872800	EFEMP2, FBLN4, UPH1, ARCL1B	EGF-containing fibulin-like extracellular matrix protein 2 (fibulin 4)	604633	EFEMP2	30008	ENSG00000172638,ENST00000307998;;;ENST00000307998		Cutis laxa, autosomal recessive, type IB	614437	AR	3	Efemp2
11q13.1	11:65883740-65888471	FIBP, TROFAS	Fibroblast growth factor, acidic, intracellular binding protein	608296	FIBP	9158	ENSG00000172500,ENST00000357519;;;ENST00000357519		Thauvin-Robinet-Faivre syndrome	617107	AR	3	Fibp
11q13.1	11:66002503-66004149	BANF1, BAF, NGPS	Barrier to autointegration factor 1	603811	BANF1	8815	ENSG00000175334,ENST00000312175;;;ENST00000312175		Nestor-Guillermo progeria syndrome	614008	AR	3	Banf1
11q13.1	11:66012008-66013505	CST6, ECTD15	Cystatin-M	601891	CST6	1474	ENSG00000175315,ENST00000312134;;;ENST00000312134	mutation identified in 1 ECTD15 family	?Ectodermal dysplasia 15, hypohidrotic/hair type	618535	AR	3	Cst6
11q13.1	11:66016752-66026479	CATSPER1, CATSPER, SPGF7	Cation channel, sperm-associated, 1	606389	CATSPER1	117144	ENSG00000175294,ENST00000312106;;;ENST00000312106		Spermatogenic failure 7	612997	AR	3	Catsper1
11q13.1	11:66052364-66069308	SF3B2, SF3B145, SAP145, CFM	Splicing factor 3B, subunit 2	605591	SF3B2	10992	ENSG00000087365,ENST00000322535;;;ENST00000322535		Craniofacial microsomia	164210	AD	3	Sf3b2
11q13.1-q13.2	11:66070272-66244744	PACS1, SHMS, MRD17	Phosphofurin acidic cluster sorting protein 1	607492	PACS1	55690	ENSG00000175115,ENST00000320580;;;ENST00000320580		Schuurs-Hoeijmakers syndrome	615009	AD	3	Pacs1
11q13.2	11:66243938-66267860	KLC2, SPOAN	Kinesin, light chain 2	611729	KLC2	64837	ENSG00000174996,ENST00000394067;;;ENST00000394067		Spastic paraplegia, optic atrophy, and neuropathy	609541	AR	3	Klc2
11q13.2	11:66291894-66296664	TMEM151A, EKD3, DYT36	Transmembrane protein 151A	620108	TMEM151A	256472	ENSG00000179292,ENST00000327259;;;ENST00000327259		Episodic kinesigenic dyskinesia 3	620245	AD	3	Tmem151a
11q13.2	11:66345374-66347629	B4GAT1, B3GNT1, IGNT, IGAT, MDDGA13	Beta-1,4glucuronyltransferase 1	605517	B4GAT1	11041	ENSG00000174684,ENST00000311181;;;ENST00000311181		Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 13	615287	AR	3	B4gat1
11q13.2	11:66510635-66533598	BBS1	BBS1 gene	209901	BBS1	582	ENSG00000174483,ENST00000318312;;;ENST00000318312		Bardet-Biedl syndrome 1	209900	AR, DR	3	Bbs1
11q13.2	11:66546395-66563334	ACTN3, ACTN3D	Actinin, alpha-3	102574	ACTN3	89	ENSG00000248746,ENST00000513398;;;ENST00000513398		[Alpha-actinin-3 deficiency]	617749	AR	3	Actn3
11q13.2	11:66546395-66563334	ACTN3, ACTN3D	Actinin, alpha-3	102574	ACTN3	89	ENSG00000248746,ENST00000513398;;;ENST00000513398		[Sprinting performance]	617749	AR	3	Actn3
11q13.2	11:66563464-66568606	CTSF, CLN13	Cathepsin F	603539	CTSF	8722	ENSG00000174080,ENST00000310325;;;ENST00000310325		Ceroid lipofuscinosis, neuronal, 13 (Kufs type)	615362	AR	3	Ctsf
11q13.2	11:66682497-66744682	SPTBN2, SCA5, SCAR14	Spectrin, beta, nonerythrocytic, 2	604985	SPTBN2	6712	ENSG00000173898,ENST00000533211;;;ENST00000533211		Spinocerebellar ataxia 5	600224	AD	3	Sptbn2
11q13.2	11:66682497-66744682	SPTBN2, SCA5, SCAR14	Spectrin, beta, nonerythrocytic, 2	604985	SPTBN2	6712	ENSG00000173898,ENST00000533211;;;ENST00000533211		Spinocerebellar ataxia, autosomal recessive 14	615386	AR	3	Sptbn2
11q13.2	11:66744769-66843516	C11orf80, HYDM4	Chromosome 11 open reading frame 80	616109	TOP6BL	79703	ENSG00000173715,ENST00000540737;;;ENST00000540737		Hydatidiform mole, recurrent, 4	618432	AR	3	Top6bl
11q13.2	11:66848420-66958383	PC	Pyruvate carboxylase	608786	PC	5091	ENSG00000173599,ENST00000393960;;;ENST00000393960		Pyruvate carboxylase deficiency	266150	AR	3	Pcx
11q13.2	11:67364168-67374177	CLCF1, BSF3, CLC, CISS2	Cardiotrophin-like cytokine	607672	CLCF1	23529	ENSG00000175505,ENST00000312438;;;ENST00000312438		Cold-induced sweating syndrome 2	610313	AR	3	Clcf1
11q13.2	11:67452403-67461752	CABP4, CRSD, CSNB2B	Calcium-binding protein 4	608965	CABP4	57010	ENSG00000175544,ENST00000325656;;;ENST00000325656		Cone-rod synaptic disorder, congenital nonprogressive	610427	AR	3	Cabp4
11q13.2	11:67483026-67491103	AIP, XAP2, ARA9, PITA1	Aryl hydrocarbon receptor-interacting protein	605555	AIP	9049	ENSG00000110711,ENST00000279146;;;ENST00000279146		Pituitary adenoma 1, multiple types	102200	AD, SMu	3	Aip
11q13.2	11:67483026-67491103	AIP, XAP2, ARA9, PITA1	Aryl hydrocarbon receptor-interacting protein	605555	AIP	9049	ENSG00000110711,ENST00000279146;;;ENST00000279146		Pituitary adenoma predisposition	102200	AD, SMu	3	Aip
11q13.2	11:67518912-67523446	CABP2, DFNB93	Calcium-binding protein 2	607314	CABP2	51475	ENSG00000167791,ENST00000294288;;;ENST00000294288		Deafness, autosomal recessive 93	614899	AR	3	Cabp2
11q13.2	11:67606936-67612554	NDUFV1, UQOR1, MC1DN4	NADH-ubiquinone oxidoreductase core subunit V1	161015	NDUFV1	4723	ENSG00000167792,ENST00000322776;;;ENST00000322776		Mitochondrial complex I deficiency, nuclear type 4	618225	AR	3	Ndufv1
11q13.2	11:67991100-68004097	UNC93B1, IIAE1	unc-93 homolog B1, TLR signaling regulator	608204	UNC93B1	81622	ENSG00000110057,ENST00000227471;;;ENST00000227471		{Encephalopathy, acute, infection-induced (herpes-specific), susceptibility to, 1}	610551	AR	3	Unc93b1
11q13.2	11:68030681-68036644	NDUFS8, MC1DN2	NADH-ubiquinone oxidoreductase core subunit S8	602141	NDUFS8	4728	ENSG00000110717,ENST00000313468;;;ENST00000313468	previously assigned to 3q28	Mitochondrial complex I deficiency, nuclear type 2	618222	AR	3	Ndufs8
11q13.2	11:68039025-68053762	TCIRG1, TIRC7, OC116, OPTB1	T-cell immune regulator 1	604592	TCIRG1	10312	ENSG00000110719,ENST00000265686;;;ENST00000265686		Osteopetrosis, autosomal recessive 1	259700	AR	3	Tcirg1
11q13.2	11:68052859-68121388	CHKA, CHK, NEDMIMS	Choline kinase, alpha	118491	CHKA	1119	ENSG00000110721,ENST00000265689;;;ENST00000265689		Neurodevelopmental disorder with microcephaly, movement abnormalities, and seizures	620023	AR	3	Chka
11q13.2	11:68154863-68213648	KMT5B, SUV420H1, CGI85, MRD51	Lysine methyltransferase 5B	610881	KMT5B	51111	ENSG00000110066,ENST00000304363;;;ENST00000304363		Intellectual developmental disorder, autosomal dominant 51	617788	AD	3	Kmt5b
11q13.2	11:68298412-68449275	LRP5, BMND1, LRP7, LR3, OPPG, OPTA1, EVR4, PCLD4	Low density lipoprotein receptor-related protein-5	603506	LRP5	4041	ENSG00000162337,ENST00000294304;;;ENST00000294304		[Bone mineral density variability 1, high bone mass]	601884	AD	3	Lrp5
11q13.2	11:68298412-68449275	LRP5, BMND1, LRP7, LR3, OPPG, OPTA1, EVR4, PCLD4	Low density lipoprotein receptor-related protein-5	603506	LRP5	4041	ENSG00000162337,ENST00000294304;;;ENST00000294304		Endosteal hyperostosis	144750	AD	3	Lrp5
11q13.2	11:68298412-68449275	LRP5, BMND1, LRP7, LR3, OPPG, OPTA1, EVR4, PCLD4	Low density lipoprotein receptor-related protein-5	603506	LRP5	4041	ENSG00000162337,ENST00000294304;;;ENST00000294304		Exudative vitreoretinopathy 4	601813	AD, AR	3	Lrp5
11q13.2	11:68298412-68449275	LRP5, BMND1, LRP7, LR3, OPPG, OPTA1, EVR4, PCLD4	Low density lipoprotein receptor-related protein-5	603506	LRP5	4041	ENSG00000162337,ENST00000294304;;;ENST00000294304		Osteopetrosis, autosomal dominant 1	607634	AD	3	Lrp5
11q13.2	11:68298412-68449275	LRP5, BMND1, LRP7, LR3, OPPG, OPTA1, EVR4, PCLD4	Low density lipoprotein receptor-related protein-5	603506	LRP5	4041	ENSG00000162337,ENST00000294304;;;ENST00000294304		Osteoporosis-pseudoglioma syndrome	259770	AR	3	Lrp5
11q13.2	11:68298412-68449275	LRP5, BMND1, LRP7, LR3, OPPG, OPTA1, EVR4, PCLD4	Low density lipoprotein receptor-related protein-5	603506	LRP5	4041	ENSG00000162337,ENST00000294304;;;ENST00000294304		Polycystic liver disease 4 with or without kidney cysts	617875	AD	3	Lrp5
11q13.2	11:68684544-68691175	GAL, GALN, GLNN, ETL8	Galanin	137035	GAL	51083	ENSG00000069482,ENST00000265643;;;ENST00000265643	mutation identified in 1 ETL8 family	?Epilepsy, familial temporal lobe, 8	616461	AD	3	Gal
11q13.3	11:68754620-68844277	CPT1A	Carnitine palmitoyltransferase I, liver	600528	CPT1A	1374	ENSG00000110090,ENST00000265641;;;ENST00000265641		CPT deficiency, hepatic, type IA	255120	AR	3	Cpt1a
11q13.3	11:68903891-68940601	IGHMBP2, SMUBP2, CATF1, SMARD1, HMNR1, CMT2S	Immunoglobulin mu binding protein 2	600502	IGHMBP2	3508	ENSG00000132740,ENST00000255078;;;ENST00000255078		Charcot-Marie-Tooth disease, axonal, type 2S	616155	AR	3	Ighmbp2
11q13.3	11:68903891-68940601	IGHMBP2, SMUBP2, CATF1, SMARD1, HMNR1, CMT2S	Immunoglobulin mu binding protein 2	600502	IGHMBP2	3508	ENSG00000132740,ENST00000255078;;;ENST00000255078		Neuronopathy, distal hereditary motor, autosomal recessive 1	604320	AR	3	Ighmbp2
11q13.3	11:69048932-69090597	TPCN2, TPC2, SHEP10	Two-pore segment channel 2	612163	TPCN2	219931	ENSG00000162341,ENST00000294309;;;ENST00000294309		[Skin/hair/eye pigmentation 10, blond/brown hair]	612267		3	Tpcn2
11q13.3	11:69641156-69654474	CCND1, PRAD1, BCL1	Cyclin D1	168461	CCND1	595	ENSG00000110092,ENST00000227507;;;ENST00000227507	pseudogene on 11q13	{Colorectal cancer, susceptibility to}	114500	AD, SMu	3	Ccnd1
11q13.3	11:69641156-69654474	CCND1, PRAD1, BCL1	Cyclin D1	168461	CCND1	595	ENSG00000110092,ENST00000227507;;;ENST00000227507	pseudogene on 11q13	{Multiple myeloma, susceptibility to}	254500	SMu	3	Ccnd1
11q13.3	11:69641156-69654474	CCND1, PRAD1, BCL1	Cyclin D1	168461	CCND1	595	ENSG00000110092,ENST00000227507;;;ENST00000227507	pseudogene on 11q13	{von Hippel-Lindau syndrome, modifier of}	193300	AD	3	Ccnd1
11q13.3	11:69771022-69775341	FGF4, HSTF1, SRTD22	Fibroblast growth factor-4 (heparin secretory transforming protein-1; Kaposi sarcoma oncogene)	164980	FGF4	2249	ENSG00000075388,ENST00000168712;;;ENST00000168712	coamplified with FGF3 in melanoma	Short-rib thoracic dysplasia 22 without polydactyly	621260	AR	3	Fgf4
11q13.3	11:69809968-69819416	FGF3, INT2	Fibroblast growth factor-3 (oncogene INT2)	164950	FGF3	2248	ENSG00000186895,ENST00000334134;;;ENST00000334134	35kb 5' to HST1	Deafness, congenital with inner ear agenesis, microtia, and microdontia	610706	AR	3	Fgf3
11q13.3	11:69965997-70189530	ANO1, TMEM16A, FLJ10261, INDMS, MYMY7	Anoctamin 1, calcium activated chloride channel	610108	ANO1	55107	ENSG00000131620,ENST00000355303;;;ENST00000355303	mutation identified in 1 INDMS family and 1 MYMY7 AR patient	?Intestinal dysmotility syndrome	620045	AR	3	Ano1
11q13.3	11:69965997-70189530	ANO1, TMEM16A, FLJ10261, INDMS, MYMY7	Anoctamin 1, calcium activated chloride channel	610108	ANO1	55107	ENSG00000131620,ENST00000355303;;;ENST00000355303	mutation identified in 1 INDMS family and 1 MYMY7 AR patient	Moyamoya disease 7	620687	AD, AR	3	Ano1
11q13.3	11:70203296-70207390	FADD, IMD90	FAS-associating protein with death domain	602457	FADD	8772	ENSG00000168040,ENST00000301838;;;ENST00000301838		Immunodeficiency 90 with encephalopathy, functional hyposplenia, and hepatic dysfunction	613759	AR	3	Fadd
11q13.3-q13.4	11:70467854-71253234	SHANK2, CORTBP1, AUTS17	SH3 and multiple ankyrin repeat domains 2	603290	SHANK2	22941	ENSG00000162105,ENST00000601538;;;ENST00000601538		{Autism susceptibility 17}	613436		3	Shank2
11q13.4	11:71427287-71449043	DHCR7, SLOS	Delta-7-dehydrocholesterol reductase	602858	DHCR7	1717	ENSG00000172893,ENST00000355527;;;ENST00000355527		Smith-Lemli-Opitz syndrome	270400	AR	3	Dhcr7
11q13.4	11:71453203-71501816	NADSYN1, VCRL3	NAD synthetase 1	608285	NADSYN1	55191	ENSG00000172890,ENST00000319023;;;ENST00000319023		Vertebral, cardiac, renal, and limb defects syndrome 3	618845	AR	3	Nadsyn1
11q13.4	11:71998909-72008200	IL18BP, FVH	Interleukin 18-binding protein	604113	IL18BP	10068	ENSG00000137496,ENST00000393703;;;ENST00000393703	mutation identified in 1 FVH patient	{?Hepatitis, fulminant viral, susceptibility to}	618549	AR	3	Il18bp
11q13.4	11:72080850-72110782	LRTOMT, LRTOMT1, LRTOMT2, DFNB63	Leucine-rich transmembrane O-methyltransferase	612414	LRTOMT	220074	ENSG00000284922,ENST00000307198		Deafness, autosomal recessive 63	611451	AR	3	Lrrc51,Tomt
11q13.4	11:72189709-72196323	FOLR1, NCFTD	Folate receptor, alpha	136430	FOLR1	2348	ENSG00000110195,ENST00000393676;;;ENST00000393676	telomeric of FGF3	Neurodegeneration due to cerebral folate transport deficiency	613068	AR	3	Folr1
11q13.4	11:72223563-72239147	INPPL1, OPSMD	Inositol polyphosphate phosphatase-like 1	600829	INPPL1	3636	ENSG00000165458,ENST00000298229;;;ENST00000298229		Opsismodysplasia	258480	AR	3	Inppl1
11q13.4	11:72239077-72244176	PHOX2A, ARIX, CFEOM2	Paired-like homeobox 2a	602753	PHOX2A	401	ENSG00000165462,ENST00000298231;;;ENST00000298231		Fibrosis of extraocular muscles, congenital, 2	602078	AR	3	Phox2a
11q13.4	11:72285495-72434531	CLPB, SKD3, MGCA7, MEGCANN, SCN9, MGCA7A	Caseinolytic peptidase B	616254	CLPB	81570	ENSG00000162129,ENST00000538039;;;ENST00000538039		3-methylglutaconic aciduria, type VIIA, autosomal dominant	619835	AD	3	Clpb
11q13.4	11:72285495-72434531	CLPB, SKD3, MGCA7, MEGCANN, SCN9, MGCA7A	Caseinolytic peptidase B	616254	CLPB	81570	ENSG00000162129,ENST00000538039;;;ENST00000538039		3-methylglutaconic aciduria, type VIIB, autosomal recessive	616271	AR	3	Clpb
11q13.4	11:72285495-72434531	CLPB, SKD3, MGCA7, MEGCANN, SCN9, MGCA7A	Caseinolytic peptidase B	616254	CLPB	81570	ENSG00000162129,ENST00000538039;;;ENST00000538039		Neutropenia, severe congenital, 9, autosomal dominant	619813	AD	3	Clpb
11q13.4	11:72576141-72674422	PDE2A, IDDPADS	Phosphodiesterase 2A	602658	PDE2A	5138	ENSG00000186642,ENST00000334456;;;ENST00000334456		Intellectual developmental disorder with paroxysmal dyskinesia or seizures	619150	AR	3	Pde2a
11q13.4	11:73376399-73397474	RELT, TNFRSF19L, AI3C	Receptor expressed in lymphoid tissues	611211	RELT	84957	ENSG00000054967,ENST00000064780;;;ENST00000064780		Amelogenesis imperfecta, type IIIC	618386	AR	3	Relt
11q13.4	11:73951026-73970281	DNAJB13, TSARG6, CILD34	DNAJ/HSP40 homolog, subfamily B, member 13	610263	DNAJB13	374407	ENSG00000187726,ENST00000339764;;;ENST00000339764		Ciliary dyskinesia, primary, 34	617091	AR	3	Dnajb13
11q13.4	11:73974672-73983202	UCP2, BMIQ4	Uncoupling protein-2	601693	UCP2	7351	ENSG00000175567,ENST00000663595;;;ENST00000663595		{Obesity, susceptibility to, BMIQ4}	607447		3	Ucp2
11q13.4	11:74000277-74009085	UCP3	Uncoupling protein-3	602044	UCP3	7352	ENSG00000175564,ENST00000314032;;;ENST00000314032		{Obesity, severe, and type II diabetes}	601665	AD, AR, Mu	3	Ucp3
11q13.4	11:74012718-74171002	C2CD3, OFD14	C2 calcium-dependent domain-containing protein 3	615944	C2CD3	26005	ENSG00000168014,ENST00000334126;;;ENST00000334126		Orofaciodigital syndrome XIV	615948	AR	3	C2cd3
11q13.4	11:74330316-74398433	PGM2L1, NEDHFS	Phosphoglucomutase 2-like 1	611610	PGM2L1	283209	ENSG00000165434,ENST00000298198;;;ENST00000298198		Neurodevelopmental disorder with hypotonia, dysmorphic facies, and skin abnormalities	620191	AR	3	Pgm2l1
11q13.4	11:74454841-74467549	KCNE3, HOKPP, HYPP	Potassium voltage-gated channel, ISK-related subfamily, member 3	604433	KCNE3	10008	ENSG00000175538,ENST00000310128;;;ENST00000310128	mutation identified in 1 BRGDA6 family	?Brugada syndrome 6	613119		3	Kcne3
11q13.4	11:74490519-74493724	LIPT2	Lipoyl(octanoyl) transferase 2	617659	LIPT2	387787	ENSG00000175536,ENST00000310109;;;ENST00000310109		Encephalopathy, neonatal severe, with lactic acidosis and brain abnormalities	617668	AR	3	Lipt2
11q13.4	11:74592582-74669341	POLD3, KIAA0039, IMD122	Polymerase (DNA-directed), delta 3, accessory subunit	611415	POLD3	10714	ENSG00000077514,ENST00000263681;;;ENST00000263681		Immunodeficiency 122	620869	AR	3	Pold3
11q13.5	11:75500001-77400000	ATOD7	Dermatitis, atopic, 7	613064		100310755		associated with rs7927894	{Dermatitis, atopic, susceptibility to, 7}	613064		2	
11q13.5	11:75562253-75572783	SERPINH1, SERPINH2, PPROM, CBP2, CBP1, OI10	Serpin peptidase inhibitor, clade H, member 1	600943	SERPINH1	871	ENSG00000149257,ENST00000358171;;;ENST00000358171		{Preterm premature rupture of the membranes, susceptibility to}	610504	Mu	3	Serpinh1
11q13.5	11:75562253-75572783	SERPINH1, SERPINH2, PPROM, CBP2, CBP1, OI10	Serpin peptidase inhibitor, clade H, member 1	600943	SERPINH1	871	ENSG00000149257,ENST00000358171;;;ENST00000358171		Osteogenesis imperfecta, type X	613848	AR	3	Serpinh1
11q13.5	11:76657524-76670747	LRRC32, GARP, D11S833E, CPPRDD	Leucine rich repeat containing 32	137207	LRRC32	2615	ENSG00000137507,ENST00000260061;;;ENST00000260061		Cleft palate, proliferative retinopathy, and developmental delay	619074	AR	3	Lrrc32
11q13.5	11:76860918-77026797	ACER3, APHC, PHCA, PLDECO	Alkaline ceramidase 3	617036	ACER3	55331	ENSG00000078124,ENST00000532485;;;ENST00000532485	mutation identified in 1 PLDECO family	?Leukodystrophy, progressive, early childhood-onset	617762	AR	3	Acer3
11q13.5	11:77066971-77126155	CAPN5, HTRA3, VRNI	Calpain 5	602537	CAPN5	726	ENSG00000149260,ENST00000648180;;;ENST00000648180		Vitreoretinopathy, neovascular inflammatory	193235	AD	3	Capn5
11q13.5	11:77128246-77215241	MYO7A, USH1B, DFNB2, DFNA11	Myosin VIIA	276903	MYO7A	4647	ENSG00000137474,ENST00000409709;;;ENST00000409709		Deafness, autosomal dominant 11	601317	AD	3	Myo7a
11q13.5	11:77128246-77215241	MYO7A, USH1B, DFNB2, DFNA11	Myosin VIIA	276903	MYO7A	4647	ENSG00000137474,ENST00000409709;;;ENST00000409709		Deafness, autosomal recessive 2	600060	AR	3	Myo7a
11q13.5	11:77128246-77215241	MYO7A, USH1B, DFNB2, DFNA11	Myosin VIIA	276903	MYO7A	4647	ENSG00000137474,ENST00000409709;;;ENST00000409709		Usher syndrome, type 1B	276900	AR	3	Myo7a
11q13.5-q14.1	11:77322017-77530009	PAK1, IDDMSSD	p21/CDC42/RAC1-activated kinase 1	602590	PAK1	5058	ENSG00000149269,ENST00000356341;;;ENST00000356341		Intellectual developmental disorder with macrocephaly, seizures, and speech delay	618158	AD	3	Pak1
11q14-q22	11:77400001-110600000	IHPS3	Pyloric stenosis, infantile hypertrophic, 3	612017		100188876		max lod at rs541821	Pyloric stenosis, infantile hypertrophic, 3	612017		2	
11q14-q21	11:77400001-97400000	SCZD2	Schizophrenia susceptibility locus, chromosome 11-related	603342		6378			{?Schizophrenia}	181500	AD	2	
11q14	11:77400001-93000000	SLEH1	Systemic lupus erythematosus with hemolytic anemia, susceptibility to, 1	607279		170682			{Systemic lupus erythematosus with hemolytic anemia}	607279		2	
11q14.1	11:78068297-78079862	NDUFC2, MC1DN36	NADH-ubiquinone oxidoreductase subunit C2	603845	NDUFC2	4718	ENSG00000151366,ENST00000281031;;;ENST00000281031		Mitochondrial complex I deficiency, nuclear type 36	619170	AR	3	Ndufc2
11q14.1	11:78100946-78139626	ALG8, CDG1H, PCLD3	ALG8 alpha-1,3-glucosyltransferase	608103	ALG8	79053	ENSG00000159063,ENST00000299626;;;ENST00000299626		Congenital disorder of glycosylation, type Ih	608104	AR	3	Alg8
11q14.1	11:78100946-78139626	ALG8, CDG1H, PCLD3	ALG8 alpha-1,3-glucosyltransferase	608103	ALG8	79053	ENSG00000159063,ENST00000299626;;;ENST00000299626		Polycystic liver disease 3 with or without kidney cysts	617874	AD	3	Alg8
11q14.1	11:78435968-78574864	NARS2, COXPD24, DFNB94	Asparaginyl-tRNA synthetase 2	612803	NARS2	79731	ENSG00000137513,ENST00000281038;;;ENST00000281038	mutation identified in 1 DFNB94 family	?Deafness, autosomal recessive 94	618434	AR	3	Nars2
11q14.1	11:78435968-78574864	NARS2, COXPD24, DFNB94	Asparaginyl-tRNA synthetase 2	612803	NARS2	79731	ENSG00000137513,ENST00000281038;;;ENST00000281038	mutation identified in 1 DFNB94 family	Combined oxidative phosphorylation deficiency 24	616239	AR	3	Nars2
11q14.1	11:78652829-79441030	TENM4, ODZ4, TNM4, DOC4, KIAA1302, ETM5	Teneurin transmembrane protein 4	610084	TENM4	26011	ENSG00000149256,ENST00000278550;;;ENST00000278550		Essential tremor, hereditary, 5	616736	AD	3	Tenm4
11q14.1	11:85628573-85636540	TMEM126B, MC1DN29	Transmembrane protein 126B	615533	TMEM126B	55863	ENSG00000171204,ENST00000358867;;;ENST00000358867		Mitochondrial complex I deficiency, nuclear type 29	618250	AR	3	Tmem126b
11q14.1	11:85647967-85656542	TMEM126A, OPA7	Transmembrane protein 126A	612988	TMEM126A	84233	ENSG00000171202,ENST00000304511;;;ENST00000304511		Optic atrophy 7	612989	AR	3	Tmem126a
11q14.2	11:85957175-86069860	PICALM, CALM, CLTH, LAP	Phosphatidylinositol-binding clathrin assembly protein	603025	PICALM	8301	ENSG00000073921,ENST00000393346;;;ENST00000393346	fuses with AF10 in t(10;11)	Leukemia, acute myeloid, somatic	601626		3	Picalm
11q14.2	11:86244753-86287615	EED, WAIT1, COGIS	Embryonic ectoderm development protein	605984	EED	8726	ENSG00000074266,ENST00000263360;;;ENST00000263360		Cohen-Gibson syndrome	617561	AD	3	Eed
11q14.2	11:86302240-86345943	HIKESHI, C11orf73, HLD13	Hikeshi	614908	HIKESHI	51501	ENSG00000149196,ENST00000278483;;;ENST00000278483		Leukodystrophy, hypomyelinating, 13	616881	AR	3	Hikeshi
11q14.2	11:86945679-86955395	FZD4, EVR1	Frizzled, Drosophila, homolog of, 4	604579	FZD4	8322	ENSG00000174804,ENST00000531380;;;ENST00000531380		Exudative vitreoretinopathy 1	133780	AD	3	Fzd4
11q14.2	11:86945679-86955395	FZD4, EVR1	Frizzled, Drosophila, homolog of, 4	604579	FZD4	8322	ENSG00000174804,ENST00000531380;;;ENST00000531380		Retinopathy of prematurity	133780	AD	3	Fzd4
11q14.2	11:88293592-88337736	CTSC, CPPI, PALS, PLS, HMS, PDON1, JPD	Cathepsin C	602365	CTSC	1075	ENSG00000109861,ENST00000227266;;;ENST00000227266		Haim-Munk syndrome	245010	AR	3	Ctsc
11q14.2	11:88293592-88337736	CTSC, CPPI, PALS, PLS, HMS, PDON1, JPD	Cathepsin C	602365	CTSC	1075	ENSG00000109861,ENST00000227266;;;ENST00000227266		Papillon-Lefevre syndrome	245000	AR	3	Ctsc
11q14.2	11:88293592-88337736	CTSC, CPPI, PALS, PLS, HMS, PDON1, JPD	Cathepsin C	602365	CTSC	1075	ENSG00000109861,ENST00000227266;;;ENST00000227266		Periodontitis 1, juvenile	170650	AR	3	Ctsc
11q14.3	11:89177875-89295759	TYR, SHEP3, CMM8, OCA1A, ATN	Tyrosinase	606933	TYR	7299	ENSG00000077498,ENST00000263321;;;ENST00000263321		[Skin/hair/eye pigmentation 3, blue/green eyes]	601800	AD	3	Tyr
11q14.3	11:89177875-89295759	TYR, SHEP3, CMM8, OCA1A, ATN	Tyrosinase	606933	TYR	7299	ENSG00000077498,ENST00000263321;;;ENST00000263321		[Skin/hair/eye pigmentation 3, light/dark/freckling skin]	601800	AD	3	Tyr
11q14.3	11:89177875-89295759	TYR, SHEP3, CMM8, OCA1A, ATN	Tyrosinase	606933	TYR	7299	ENSG00000077498,ENST00000263321;;;ENST00000263321		{Melanoma, cutaneous malignant, susceptibility to, 8}	601800	AD	3	Tyr
11q14.3	11:89177875-89295759	TYR, SHEP3, CMM8, OCA1A, ATN	Tyrosinase	606933	TYR	7299	ENSG00000077498,ENST00000263321;;;ENST00000263321		Albinism, oculocutaneous, type IA	203100	AR	3	Tyr
11q14.3	11:89177875-89295759	TYR, SHEP3, CMM8, OCA1A, ATN	Tyrosinase	606933	TYR	7299	ENSG00000077498,ENST00000263321;;;ENST00000263321		Albinism, oculocutaneous, type IB	606952	AR	3	Tyr
11q14.3	11:92969651-92984960	MTNR1B	Melatonin receptor 1B	600804	MTNR1B	4544	ENSG00000134640,ENST00000257068;;;ENST00000257068		{Diabetes mellitus, type 2, susceptibility to}	125853	AD	3	Mtnr1b
11q21-q22	11:93000001-110600000	FGQTL3	Fasting plasma glucose level QTL 3	613233		100379217		associated with rs10830963	[Fasting plasma glucose level QTL 3]	613233		2	
11q21	11:93661682-93730358	CEP295, KIAA1731, SCKL11	Centrosomal protein, 295kD	617728	CEP295	85459	ENSG00000166004,ENST00000325212;;;ENST00000325212		Seckel syndrome 11	620767	AR	3	Cep295
11q21	11:93784282-93814963	MED17, CRSP6, CRSP77, TRAP80, DRIP80	Mediator complex subunit 17	603810	MED17	9440	ENSG00000042429,ENST00000251871;;;ENST00000251871		Microcephaly, postnatal progressive, with seizures and brain atrophy	613668	AR	3	Med17
11q21	11:94021354-94114208	HEPHL1, ZP, HJDD	Hephaestin-like protein 1	618455	HEPHL1	341208	ENSG00000181333,ENST00000315765;;;ENST00000315765	mutation identified in 1 HJDD patient	?Abnormal hair, joint laxity, and developmental delay	261990	AR	3	Hephl1
11q21	11:94128841-94181968	PANX1, PX1, OZEMA7	Pannexin 1	608420	PANX1	24145	ENSG00000110218,ENST00000227638;;;ENST00000227638		Oocyte/zygote/embryo maturation arrest 7	618550	AD	3	Panx1
11q21	11:94415570-94512412	MRE11A, MRE11, ATLD	MRE11 homolog, double-strand break repair nuclease	600814	MRE11	4361	ENSG00000020922,ENST00000323929;;;ENST00000323929		Ataxia-telangiectasia-like disorder 1	604391	AR	3	Mre11a
11q21	11:94706460-94876748	AMOTL1, JEAP, CFCHS	Angiomotin-like 1	614657	AMOTL1	154810	ENSG00000166025,ENST00000433060;;;ENST00000433060		Craniofaciocardiohepatic syndrome	621192	AD	3	Amotl1
11q21	11:95790014-95832693	CEP57, PIG8, TSP57, KIAA0092, MVA2	Centrosomal protein 57kD	607951	CEP57	9702	ENSG00000166037,ENST00000325542;;;ENST00000325542		Mosaic variegated aneuploidy syndrome 2	614114	AR	3	Cep57
11q21	11:95832880-95924107	MTMR2, CMT4B1	Myotubularin-related protein 2	603557	MTMR2	8898	ENSG00000087053,ENST00000346299;;;ENST00000346299		Charcot-Marie-Tooth disease, type 4B1	601382	AR	3	Mtmr2
11q21	11:95976598-96343195	MAML2, MAM3	Mastermind-like 2	607537	MAML2	84441	ENSG00000184384,ENST00000524717;;;ENST00000524717	t(11;19)	Mucoepidermoid salivary gland carcinoma			3	Maml2
11q22-qter	11:97400001-135086622	ANC	Anal canal carcinoma	105580		8066		3p22 also deleted	?Anal canal carcinoma	105580	AD	2	
11q22.1	11:101029624-101129813	PGR	Progesterone receptor	607311	PGR	5241	ENSG00000082175,ENST00000325455;;;ENST00000325455	11q13 = earlier regionalization	?Progesterone resistance	264080	AR	2	Pgr
11q22.1	11:101451564-101584007	TRPC6, TRP6, FSGS2	Transient receptor potential channel-6	603652	TRPC6	7225	ENSG00000137672,ENST00000344327;;;ENST00000344327		Glomerulosclerosis, focal segmental, 2	603965	AD	3	Trpc6
11q22.1	11:102047437-102084554	CFAP300, C11orf70, CILD38	Cilia- and flagella-associated protein 300	618058	CFAP300	85016	ENSG00000137691,ENST00000434758;;;ENST00000434758		Ciliary dyskinesia, primary, 38	618063	AR	3	Cfap300
11q22.1	11:102110447-102233424	YAP1, COB1	YES1-associated transcriptional regulator	606608	YAP1	10413	ENSG00000137693,ENST00000282441;;;ENST00000282441		Coloboma, ocular, with or without hearing impairment, cleft lip/palate, and/or impaired intellectual development	120433	AD	3	Yap1
11q22.2	11:102576832-102625332	MMP20, AI2A2	Matrix metalloproteinase-20 (enamelysin)	604629	MMP20	9313	ENSG00000137674,ENST00000260228;;;ENST00000260228		Amelogenesis imperfecta, type IIA2	612529	AR	3	Mmp20
11q22.2	11:102835801-102843609	MMP3, STMY1, CHDS6	Matrix metalloproteinase 3 (stromelysin 1, progelatinase)	185250	MMP3	4314	ENSG00000149968,ENST00000299855;;;ENST00000299855		{Coronary heart disease, susceptibility to, 6}	614466		3	Mmp3
11q22.2	11:102942995-102955732	MMP13, CLG3, MANDP1, MDST	Matrix metalloproteinase 13 (collagenase 3)	600108	MMP13	4322	ENSG00000137745,ENST00000260302;;;ENST00000260302	mutation identified in 1 SEMDM family	?Spondyloepimetaphyseal dysplasia, Missouri type	602111	AD	3	Mmp13
11q22.2	11:102942995-102955732	MMP13, CLG3, MANDP1, MDST	Matrix metalloproteinase 13 (collagenase 3)	600108	MMP13	4322	ENSG00000137745,ENST00000260302;;;ENST00000260302	mutation identified in 1 SEMDM family	Metaphyseal anadysplasia 1	602111	AD	3	Mmp13
11q22.2	11:102942995-102955732	MMP13, CLG3, MANDP1, MDST	Matrix metalloproteinase 13 (collagenase 3)	600108	MMP13	4322	ENSG00000137745,ENST00000260302;;;ENST00000260302	mutation identified in 1 SEMDM family	Metaphyseal dysplasia, Spahr type	250400	AR	3	Mmp13
11q22.3	11:103109426-103479863	DYNC2H1, DNCH2, DHC2, ATD3, SRPS2B, SRTD3	Dynein, cytoplasmic-2, heavy chain-1	603297	DYNC2H1	79659	ENSG00000187240,ENST00000375735;;;ENST00000375735	1 patient showed heterozygous NEK2 and DYNC2H1 mutations	Short-rib thoracic dysplasia 3 with or without polydactyly	613091	AR, DR	3	Dync2h1
11q22.3	11:104883286-104898460	CASP12, CASP12P1	Caspase 12, apoptosis-related cysteine protease	608633	CASP12	100506742			{Sepsis, susceptibility to}			3	Casp12
11q22.3	11:105609994-105982090	GRIA4, GLUR4, NEDSGA	Glutamate receptor, ionotropic, AMPA 4	138246	GRIA4	2893	ENSG00000152578,ENST00000282499;;;ENST00000282499		Neurodevelopmental disorder with or without seizures and gait abnormalities	617864	AD	3	Gria4
11q22.3	11:107502727-107565735	ALKBH8, ABH8, MRT71	AlkB homolog 8, tRNA methyltransferase	613306	ALKBH8	91801	ENSG00000137760,ENST00000428149;;;ENST00000428149		Intellectual developmental disorder, autosomal recessive 71	618504	AR	3	Alkbh8
11q22.3	11:108116705-108147603	ACAT1	Acetyl-Coenzyme A acetyltransferase-1 (acetoacetyl Coenzyme A thiolase)	607809	ACAT1	38	ENSG00000075239,ENST00000265838;;;ENST00000265838	cluster: cen-STMY2-CLG-STMY1-ter	Alpha-methylacetoacetic aciduria	203750	AR	3	Acat1
11q22.3	11:108223067-108369102	ATM, ATA, AT1	ATM serine/threonine kinase	607585	ATM	472	ENSG00000149311,ENST00000675843;;;ENST00000675843		{Breast cancer, susceptibility to}	114480	AD, SMu	3	Atm
11q22.3	11:108223067-108369102	ATM, ATA, AT1	ATM serine/threonine kinase	607585	ATM	472	ENSG00000149311,ENST00000675843;;;ENST00000675843		Ataxia-telangiectasia	208900	AR	3	Atm
11q22.3	11:108223067-108369102	ATM, ATA, AT1	ATM serine/threonine kinase	607585	ATM	472	ENSG00000149311,ENST00000675843;;;ENST00000675843		Lymphoma, B-cell non-Hodgkin, somatic			3	Atm
11q22.3	11:108223067-108369102	ATM, ATA, AT1	ATM serine/threonine kinase	607585	ATM	472	ENSG00000149311,ENST00000675843;;;ENST00000675843		Lymphoma, mantle cell, somatic			3	Atm
11q22.3	11:108223067-108369102	ATM, ATA, AT1	ATM serine/threonine kinase	607585	ATM	472	ENSG00000149311,ENST00000675843;;;ENST00000675843		T-cell prolymphocytic leukemia, somatic			3	Atm
11q22.3	11:108505435-108607536	EXPH5, SLAC2B, KIAA0624, EBS4	Exophilin 5	612878	EXPH5	23086	ENSG00000110723,ENST00000265843;;;ENST00000265843		Epidermolysis bullosa simplex 4, localized or generalized intermediate, autosomal recessive	615028	AR	3	Exph5
11q22.3	11:110174922-110296614	RDX, DFNB24	Radixin	179410	RDX	5962	ENSG00000137710,ENST00000645495;;;ENST00000645495		Deafness, autosomal recessive 24	611022	AR	3	Rdx
11q23-q24	11:110600001-130900000	ADIPQTL4	Adiponectin, serum level of, quantitative trait locus locus 4	612629		100271698		between D11S925 and D11S968	{Adiponectin, serum level of, QTL4}	612629		2	
11q23	11:110600001-121300000	APOGCDS	Familial apolipoprotein gene cluster deletion syndrome	620058					Familial apolipoprotein gene cluster deletion syndrome	620058	AD	4	
11q23	11:110600001-121300000	BMND5	Bone mineral density QTL 5	609354		554315		between D11S901 and D11S925	[Bone mineral density QTL 5]	609354		2	
11q23	11:110600001-121300000	CRCS7	Colorectal cancer, susceptibility to, 7	612232		100187711		associated with rs3802842	{Colorectal cancer, susceptibility to, 7}	612232		2	
11q23	11:110600001-121300000	FLD1, NAFLD2	Fatty liver disease, susceptibility to, 2	613387		100462725		associated with rs2854116, rs2854117	{Fatty liver disease, susceptibility to, 2}	613387	Mu	2	
11q23	11:110600001-121300000	TCPT	Thrombocytopenia, Paris-Trousseau type (deletion 11q23 syndrome)	188025				contiguous gene deletion of 11q23	?Thrombocytopenia, Paris-Trousseau type	188025	IC	4	
11q23	11:110600001-121300000	TSG11	Tumor suppressor gene on chromosome 11	603040		50970			{Nonsmall cell lung cancer}	603040		2	
11q23.1	11:111383826-111514725	BTG4, PC3B, OZEMA8	BTG antiproliferation factor 4	605673	BTG4	54766	ENSG00000137707,ENST00000692032;;;ENST00000692032		Oocyte/zygote/embryo maturation arrest 8	619009	AR	3	Btg4
11q23.1	11:111688000-111766389	PPP2R1B	Protein phosphatase 2, structural/regulatory subunit A, beta	603113	PPP2R1B	5519	ENSG00000137713,ENST00000527614;;;ENST00000527614		Lung cancer, somatic	211980		3	Ppp2r1b
11q23.1	11:111768025-111871581	ALG9, DIBD1, CDG1L, GIKANIS	ALG9 alpha-1,2-mannosyltransferase	606941	ALG9	79796	ENSG00000086848,ENST00000616540;;;ENST00000616540		Congenital disorder of glycosylation, type Il	608776	AR	3	Alg9
11q23.1	11:111768025-111871581	ALG9, DIBD1, CDG1L, GIKANIS	ALG9 alpha-1,2-mannosyltransferase	606941	ALG9	79796	ENSG00000086848,ENST00000616540;;;ENST00000616540		Gillessen-Kaesbach-Nishimura syndrome	263210	AR	3	Alg9
11q23.1	11:111908564-111923740	CRYAB, CRYA2, CTPP2, CMD1II, CTRCT16, MFM2A, MFM2B	Crystallin, alpha B	123590	CRYAB	1410	ENSG00000109846,ENST00000650687;;;ENST00000650687		Cardiomyopathy, dilated, 1II	615184	AD	3	Cryab
11q23.1	11:111908564-111923740	CRYAB, CRYA2, CTPP2, CMD1II, CTRCT16, MFM2A, MFM2B	Crystallin, alpha B	123590	CRYAB	1410	ENSG00000109846,ENST00000650687;;;ENST00000650687		Cataract 16, multiple types	613763	AD, AR	3	Cryab
11q23.1	11:111908564-111923740	CRYAB, CRYA2, CTPP2, CMD1II, CTRCT16, MFM2A, MFM2B	Crystallin, alpha B	123590	CRYAB	1410	ENSG00000109846,ENST00000650687;;;ENST00000650687		Myopathy, myofibrillar, 2A, adult-onset	608810	AD	3	Cryab
11q23.1	11:111908564-111923740	CRYAB, CRYA2, CTPP2, CMD1II, CTRCT16, MFM2A, MFM2B	Crystallin, alpha B	123590	CRYAB	1410	ENSG00000109846,ENST00000650687;;;ENST00000650687		Myopathy, myofibrillar, 2B, infantile-onset	613869	AR	3	Cryab
11q23.1	11:112025408-112064404	DLAT, PDCE2	Dihydrolipoamide S-acetyltransferase	608770	DLAT	1737	ENSG00000150768,ENST00000280346;;;ENST00000280346		Pyruvate dehydrogenase E2 deficiency	245348	AR	3	Dlat
11q23.1	11:112086873-112095794	SDHD, PPGL1, MC2DN3	Succinate dehydrogenase complex, subunit D	602690	SDHD	6392	ENSG00000204370,ENST00000375549;;;ENST00000375549		Mitochondrial complex II deficiency, nuclear type 3	619167	AR	3	Sdhd
11q23.1	11:112086873-112095794	SDHD, PPGL1, MC2DN3	Succinate dehydrogenase complex, subunit D	602690	SDHD	6392	ENSG00000204370,ENST00000375549;;;ENST00000375549		Paraganglioma and gastric stromal sarcoma	606864		3	Sdhd
11q23.1	11:112086873-112095794	SDHD, PPGL1, MC2DN3	Succinate dehydrogenase complex, subunit D	602690	SDHD	6392	ENSG00000204370,ENST00000375549;;;ENST00000375549		Pheochromocytoma/paraganglioma syndrome 1	168000	AD	3	Sdhd
11q23.1	11:112226428-112233973	PTS	6-pyruvoyltetrahydropterin synthase	612719	PTS	5805	ENSG00000150787,ENST00000280362;;;ENST00000280362		Hyperphenylalaninemia, BH4-deficient, A	261640	AR	3	Pts
11q23.2	11:113314583-113373297	TTC12, TPARM, CILD45	Tetratricopeptide repeat domain 12	610732	TTC12	54970	ENSG00000149292,ENST00000529221;;;ENST00000529221		Ciliary dyskinesia, primary, 45	618801	AR	3	Ttc12
11q23.2	11:114059711-114256770	ZBTB16, ZNF145, PLZF	Zinc finger- and BTB domain-containing protein 16 (promyelocytic leukemia zinc finger)	176797	ZBTB16	7704	ENSG00000109906,ENST00000335953;;;ENST00000335953	fused with RARA in APL of t(11;17) type	Leukemia, acute promyelocytic, PL2F/RARA type			3	Zbtb16
11q23.2	11:114257806-114313536	NNMT	Nicotinamide N-methyltransferase	600008	NNMT	4837	ENSG00000166741,ENST00000299964;;;ENST00000299964		Homocysteine plasma level	600008		2	Nnmt
11q23.3-q24	11:114600001-130900000	AAT1, FAA1	Aortic aneurysm, familial thoracic 1	607086		252842			Aortic aneurysm, familial thoracic 1	607086		2	
11q23.3	11:114600001-121300000	HDLCQ14, HYLAP	High density lipoprotein cholesterol level quantitative trait locus 14	605201		56801			High density lipoprotein cholesterol level QTL14	605201		2	
11q23.3-q25	11:114600001-135086622	JBS	Jacobsen syndrome	147791				contiguous gene deletion syndrome	Jacobsen syndrome	147791	IC	4	
11q23.3	11:116748173-116772987	BUD13, ACHPS	BUD13 homolog	620691	BUD13	84811	ENSG00000137656,ENST00000260210;;;ENST00000260210		Achalasia-progeroid syndrome	621123	AR	3	Bud13
11q23.3	11:116773799-116788023	ZPR1, ZNF259, GKAF	ZPR1 zinc finger protein	603901	ZPR1	8882	ENSG00000109917,ENST00000227322;;;ENST00000227322	mutation identified in 1 GKAF patient	?Growth restriction, hypoplastic kidneys, alopecia, and distinctive facies	619321	AR	3	Zpr1
11q23.3	11:116789367-116792420	APOA5	Apolipoprotein A-V	606368	APOA5	116519	ENSG00000110243,ENST00000227665;;;ENST00000227665	proximal to APOA1, APOC3, APOA4	{Hypertriglyceridemia, susceptibility to}	145750	AD	3	Apoa5
11q23.3	11:116789367-116792420	APOA5	Apolipoprotein A-V	606368	APOA5	116519	ENSG00000110243,ENST00000227665;;;ENST00000227665	proximal to APOA1, APOC3, APOA4	Hyperchylomicronemia, late-onset	144650	AD	3	Apoa5
11q23.3	11:116820700-116823304	APOA4, ADTKD6	Apolipoprotein A-IV	107690	APOA4	337	ENSG00000110244,ENST00000357780;;;ENST00000357780	12 kb 3' to APOA1	Tubulointerstitial kidney disease, autosomal dominant 6	621106	AD	3	Apoa4
11q23.3	11:116829907-116833072	APOC3, HALP2	Apolipoprotein C-III	107720	APOC3	345	ENSG00000110245,ENST00000227667;;;ENST00000227667	2.6kb 3' to APOA1	Apolipoprotein C-III deficiency	614028		3	Apoc3
11q23.3	11:116835751-116837622	APOA1, HPALP2, AMYLD3	Apolipoprotein A-I	107680	APOA1	335	ENSG00000118137,ENST00000236850;;;ENST00000236850		Amyloidosis, hereditary systemic 3	620657	AD	3	Apoa1
11q23.3	11:116835751-116837622	APOA1, HPALP2, AMYLD3	Apolipoprotein A-I	107680	APOA1	335	ENSG00000118137,ENST00000236850;;;ENST00000236850		Hypoalphalipoproteinemia, primary, 2	618463	AR	3	Apoa1
11q23.3	11:116835751-116837622	APOA1, HPALP2, AMYLD3	Apolipoprotein A-I	107680	APOA1	335	ENSG00000118137,ENST00000236850;;;ENST00000236850		Hypoalphalipoproteinemia, primary, 2, intermediate	619836	AD	3	Apoa1
11q23.3	11:116843402-117098428	SIK3, KIAA0999, SEMDK	Salt-inducible kinase 3	614776	SIK3	23387	ENSG00000160584,ENST00000445177;;;ENST00000445177	mutation identified in 1 SEMDK family	?Spondyloepimetaphyseal dysplasia, Krakow type	618162	AR	3	Sik3
11q23.3	11:117321778-117413266	CEP164, KIAA1052	Centrosomal protein, 164kD	614848	CEP164	22897	ENSG00000110274,ENST00000278935;;;ENST00000278935		Nephronophthisis 15	614845	AR	3	Cep164
11q23.3	11:117820057-117828089	FXYD2, ATP1G1, HOMG2	FXYD domain-containing ion transport regulator 2 (sodium-potassium-ATPase, gamma polypeptide)	601814	FXYD2	486	ENSG00000137731,ENST00000292079;;;ENST00000292079		Hypomagnesemia 2, renal	154020	AD	3	Fxyd2
11q23.3	11:117986394-118003037	IL10RA, IL10R, IBD28	Interleukin-10 receptor, alpha	146933	IL10RA	3587	ENSG00000110324,ENST00000227752;;;ENST00000227752		Inflammatory bowel disease 28, early onset, autosomal recessive	613148	AR	3	Il10ra
11q23.3	11:118133377-118152823	SCN4B, LQT10, ATFB17	Sodium voltage-gated channel, beta subunit 4	608256	SCN4B	6330	ENSG00000177098,ENST00000324727;;;ENST00000324727		Atrial fibrillation, familial, 17	611819	AD	3	Scn4b
11q23.3	11:118133377-118152823	SCN4B, LQT10, ATFB17	Sodium voltage-gated channel, beta subunit 4	608256	SCN4B	6330	ENSG00000177098,ENST00000324727;;;ENST00000324727		Long QT syndrome 10	611819	AD	3	Scn4b
11q23.3	11:118162806-118176639	SCN2B, ATFB14	Sodium voltage-gated channel, beta subunit 1	601327	SCN2B	6327	ENSG00000149575,ENST00000278947;;;ENST00000278947		Atrial fibrillation, familial, 14	615378	AD	3	Scn2b
11q23.3	11:118253416-118264297	MPZL2, EVA1, EVA, DFNB111	Myelin protein zero-like 2	604873	MPZL2	10205	ENSG00000149573,ENST00000278937;;;ENST00000278937		Deafness, autosomal recessive 111	618145	AR	3	Mpzl2
11q23.3	11:118304730-118316173	CD3E, IMD18	CD3E antigen, epsilon polypeptide (TiT3 complex)	186830	CD3E	916	ENSG00000198851,ENST00000361763;;;ENST00000361763		Immunodeficiency 18	615615	AR	3	Cd3e
11q23.3	11:118304730-118316173	CD3E, IMD18	CD3E antigen, epsilon polypeptide (TiT3 complex)	186830	CD3E	916	ENSG00000198851,ENST00000361763;;;ENST00000361763		Immunodeficiency 18, SCID variant	615615	AR	3	Cd3e
11q23.3	11:118338954-118342705	CD3D, T3D, IMD19	CD3D antigen, delta polypeptide (TiT3 complex)	186790	CD3D	915	ENSG00000167286,ENST00000300692;;;ENST00000300692	3 CD3 genes in 50kb	Immunodeficiency 19, severe combined	615617	AR	3	Cd3d
11q23.3	11:118344344-118355161	CD3G, IMD17	CD3G antigen, gamma polypeptide (TiT3 complex)	186740	CD3G	917	ENSG00000160654,ENST00000532917;;;ENST00000532917		Immunodeficiency 17, CD3 gamma deficient	615607	AR	3	Cd3g
11q23.3	11:118359600-118399211	UBE4A, UFD2, E4, NEDHMS	Ubiquitination factor E4A	603753	UBE4A	9354	ENSG00000110344,ENST00000252108;;;ENST00000252108		Neurodevelopmental disorder with hypotonia and gross motor and speech delay	619639	AR	3	Ube4a
11q23.3	11:118436492-118526832	KMT2A, MLL, HRX, WDSTS	Lysine-specific methyltransferase 2E	159555	KMT2A	4297	ENSG00000118058,ENST00000534358;;;ENST00000534358	fuses with ENL, AF4, AF9, GMPS	Wiedemann-Steiner syndrome	605130	AD	3	Kmt2a
11q23.3	11:118572409-118603033	ARCN1, SSMG	Archain 1	600820	ARCN1	372	ENSG00000095139,ENST00000264028;;;ENST00000264028	60kb telomeric to MLL	Short stature-micrognathia syndrome	617164	AD	3	Arcn1
11q23.3	11:118606436-118658028	PHLDB1, LL5A, KIAA0638, OI23	Pleckstrin homology-like domain, family B, member 1	612834	PHLDB1	23187	ENSG00000019144,ENST00000600882;;;ENST00000600882		Osteogenesis imperfecta, type XXIII	620639	AR	3	Phldb1
11q23.3	11:118657316-118679650	TREH, TREHD	Trehalase	275360	TREH	11181	ENSG00000118094,ENST00000264029;;;ENST00000264029		Trehalase deficiency	612119	AR	3	Treh
11q23.3	11:118747763-118791744	DDX6, HLR2, IDDILF	DEAD-box helicase 6	600326	DDX6	1656	ENSG00000110367,ENST00000534980;;;ENST00000534980		Intellectual developmental disorder with impaired language and dysmorphic facies	618653	AD	3	Ddx6
11q23.3	11:118998138-119015793	CENATAC, CCDC84, MVA4	Centrosomal AT-AC splicing factor	620142	CENATAC	338657	ENSG00000186166,ENST00000334418;;;ENST00000334418	mutation identified in 1 MVA4 family	?Mosaic variegated aneuploidy syndrome 4	620153	AR	3	Cenatac
11q23.3	11:119018766-119024134	TRAPPC4, NEDESBA	Trafficking protein particle complex, subunit 4 (synbindin)	610971	TRAPPC4	51399	ENSG00000196655,ENST00000533632;;;ENST00000533632		Neurodevelopmental disorder with epilepsy, spasticity, and brain atrophy	618741	AR	3	Trappc4
11q23.3	11:119024112-119030877	SLC37A4, G6PT1, CDG2W	Solute carrier family 37 (glucose-6-phosphate transporter), member 4	602671	SLC37A4	2542	ENSG00000137700,ENST00000525102		Congenital disorder of glycosylation, type IIw	619525	AD	3	Slc37a4
11q23.3	11:119024112-119030877	SLC37A4, G6PT1, CDG2W	Solute carrier family 37 (glucose-6-phosphate transporter), member 4	602671	SLC37A4	2542	ENSG00000137700,ENST00000525102		Glycogen storage disease Ib	232220	AR	3	Slc37a4
11q23.3	11:119024112-119030877	SLC37A4, G6PT1, CDG2W	Solute carrier family 37 (glucose-6-phosphate transporter), member 4	602671	SLC37A4	2542	ENSG00000137700,ENST00000525102		Glycogen storage disease Ic	232240	AR	3	Slc37a4
11q23.3	11:119044188-119057205	HYOU1, IMD59	Hypoxia-upregulated 1	601746	HYOU1	10525	ENSG00000149428,ENST00000617285;;;ENST00000617285	mutation identified in 1 IMD59 patient	?Immunodeficiency 59 and hypoglycemia	233600	AR	3	Hyou1
11q23.3	11:119067818-119081972	VPS11, HLD12, DYT32	VPS11 core subunit of CORVET and HOPS complexes	608549	VPS11	55823	ENSG00000160695,ENST00000621676;;;ENST00000621676	mutation identified in 1 DYT32 patient	?Dystonia 32	619637	AR	3	Vps11
11q23.3	11:119067818-119081972	VPS11, HLD12, DYT32	VPS11 core subunit of CORVET and HOPS complexes	608549	VPS11	55823	ENSG00000160695,ENST00000621676;;;ENST00000621676	mutation identified in 1 DYT32 patient	Leukodystrophy, hypomyelinating, 12	616683	AR	3	Vps11
11q23.3	11:119084881-119093549	HMBS, PBGD, UPS, ENCEP, LENCEP	Hydroxymethylbilane synthase	609806	HMBS	3145	ENSG00000256269,ENST00000652429;;;ENST00000652429		Encephalopathy, porphyria-related	620704	AR	3	Hmbs
11q23.3	11:119084881-119093549	HMBS, PBGD, UPS, ENCEP, LENCEP	Hydroxymethylbilane synthase	609806	HMBS	3145	ENSG00000256269,ENST00000652429;;;ENST00000652429		Leukoencephalopathy, porphyria-related	620711	AR	3	Hmbs
11q23.3	11:119084881-119093549	HMBS, PBGD, UPS, ENCEP, LENCEP	Hydroxymethylbilane synthase	609806	HMBS	3145	ENSG00000256269,ENST00000652429;;;ENST00000652429		Porphyria, acute intermittent	176000	AD	3	Hmbs
11q23.3	11:119084881-119093549	HMBS, PBGD, UPS, ENCEP, LENCEP	Hydroxymethylbilane synthase	609806	HMBS	3145	ENSG00000256269,ENST00000652429;;;ENST00000652429		Porphyria, acute intermittent, nonerythroid variant	176000	AD	3	Hmbs
11q23.3	11:119093874-119101853	DPAGT1, DPAGT2, DGPT, CDG1J, CMSTA2, CMS13	Dolichyl-phosphate N-acetylglucosamine phosphotransferase	191350	DPAGT1	1798	ENSG00000172269,ENST00000354202;;;ENST00000354202		Congenital disorder of glycosylation, type Ij	608093	AR	3	Dpagt1
11q23.3	11:119093874-119101853	DPAGT1, DPAGT2, DGPT, CDG1J, CMSTA2, CMS13	Dolichyl-phosphate N-acetylglucosamine phosphotransferase	191350	DPAGT1	1798	ENSG00000172269,ENST00000354202;;;ENST00000354202		Myasthenic syndrome, congenital, 13, with tubular aggregates	614750	AR	3	Dpagt1
11q23.3	11:119206339-119308149	CBL, CBL2, NSLL	CBL protooncogene	165360	CBL	867	ENSG00000110395,ENST00000264033;;;ENST00000264033	mutation identified in 1 JMML family	?Juvenile myelomonocytic leukemia	607785	AD, SMu	3	Cbl
11q23.3	11:119206339-119308149	CBL, CBL2, NSLL	CBL protooncogene	165360	CBL	867	ENSG00000110395,ENST00000264033;;;ENST00000264033	mutation identified in 1 JMML family	Noonan syndrome-like disorder with or without juvenile myelomonocytic leukemia	613563	AD	3	Cbl
11q23.3	11:119338942-119346705	C1QTNF5, CTRP5, LORD	C1q- and tumor necrosis factor-related protein 5	608752	C1QTNF5	114902	ENSG00000223953,ENST00000528368;;;ENST00000528368		Retinal degeneration, late-onset, autosomal dominant	605670	AD	3	C1qtnf5
11q23.3	11:119338942-119346705	MFRP, MCOP5, NNO2	Membrane-type frizzled-related protein	606227	MFRP	83552	ENSG00000235718,ENST00000619721;;;ENST00000619721		Microphthalmia, isolated 5	611040	AR	3	C1qtnf5,Mfrp
11q23.3	11:119338942-119346705	MFRP, MCOP5, NNO2	Membrane-type frizzled-related protein	606227	MFRP	83552	ENSG00000235718,ENST00000619721;;;ENST00000619721		Nanophthalmos 2	609549	AR	3	C1qtnf5,Mfrp
11q23.3	11:119638098-119729200	NECTIN1, PVRL1, HVEC, PVRR1, PRR1, ED4, OFC7, CLPED1	Nectin 1	600644	NECTIN1	5818	ENSG00000110400,ENST00000264025;;;ENST00000264025		Cleft lip/palate-ectodermal dysplasia syndrome	225060	AR	3	Nectin1
11q23.3	11:119638098-119729200	NECTIN1, PVRL1, HVEC, PVRR1, PRR1, ED4, OFC7, CLPED1	Nectin 1	600644	NECTIN1	5818	ENSG00000110400,ENST00000264025;;;ENST00000264025		Orofacial cleft 7	225060	AR	3	Nectin1
11q23.3	11:121101243-121191490	TECTA, DFNA8, DFNA12, DFNB21	Tectorin, alpha	602574	TECTA	7007	ENSG00000109927,ENST00000392793;;;ENST00000392793		Deafness, autosomal dominant 8/12	601543	AD	3	Tecta
11q23.3	11:121101243-121191490	TECTA, DFNA8, DFNA12, DFNB21	Tectorin, alpha	602574	TECTA	7007	ENSG00000109927,ENST00000392793;;;ENST00000392793		Deafness, autosomal recessive 21	603629	AR	3	Tecta
11q23.3-q24.1	11:121292771-121313410	SC5D, ERG3	Sterol C5-desaturase	602286	SC5D	6309	ENSG00000109929,ENST00000264027;;;ENST00000264027		Lathosterolosis	607330	AR	3	Sc5d
11q24-q25	11:121300001-135086622	ANIB7	Aneurysm, intracranial berry, 7	612161		100188885		between rs618176 and rs1940033	Aneurysm, intracranial berry, 7	612161		2	
11q24.1	11:121300001-124000000	CLLS5	Leukemia, chronic lymphocytic susceptibility to, 5	612559		100270644		associated with rs735665	{Leukemia, chronic lymphocytic susceptibility to, 5}	612559		2	
11q24	11:121300001-130900000	MGR9	Migraine with aura, susceptibility to, 9	609670		100415943		max lod at GATA64D03	{Migraine with aura, susceptibility to, 9}	609670		2	
11q24	11:121300001-130900000	NEDE	Nephropathy, progressive, with deafness	609469		619410		max lod at D11S4464	Nephropathy, progressive, with deafness	609469		2	
11q24.1	11:123069872-123195248	CLMP, ASAM, ACAM, CSBS	Coxsackievirus- and adenovirus receptor-like membrane protein	611693	CLMP	79827	ENSG00000166250,ENST00000448775;;;ENST00000448775		Congenital short bowel syndrome	615237	AR	3	Clmp
11q24.1	11:123629188-123654624	SCN3B, SCNB3, BRGDA7, ATFB16	Sodium voltage-gated channel, beta subunit 3	608214	SCN3B	55800	ENSG00000166257,ENST00000299333;;;ENST00000299333		Atrial fibrillation, familial, 16	613120	AD	3	Scn3b
11q24.1	11:123629188-123654624	SCN3B, SCNB3, BRGDA7, ATFB16	Sodium voltage-gated channel, beta subunit 3	608214	SCN3B	55800	ENSG00000166257,ENST00000299333;;;ENST00000299333		Brugada syndrome 7	613120	AD	3	Scn3b
11q24.2	11:124000001-127900000	MRD4	Intellectual developmental disorder, autosomal dominant 4	612581		112441440		translocation t(11;16)(q24.2;q24)	Intellectual developmental disorder, autosomal dominant 4	612581	AD	2	
11q24.2	11:124633113-124676303	SIAE, AIS6	Sialic acid acetylesterase	610079	SIAE	54414	ENSG00000110013,ENST00000263593;;;ENST00000263593		{Autoimmune disease, susceptibility to, 6}	613551		3	Siae
11q24.2	11:124753126-124762290	ESAM, NEDIHSS	Endothelial cell adhesion molecule	614281	ESAM	90952	ENSG00000149564,ENST00000278927;;;ENST00000278927		Neurodevelopmental disorder with intracranial hemorrhage, seizures, and spasticity	620371	AR	3	Esam
11q24.2	11:124865432-124881471	ROBO3, RBIG1, RIG1, HGPPS1	Roundabout guidance receptor 3	608630	ROBO3	64221	ENSG00000154134,ENST00000397801;;;ENST00000397801		Gaze palsy, familial horizontal, with progressive scoliosis, 1	607313	AR	3	Robo3
11q24.2	11:124883691-124897865	ROBO4, AOVD3	Roundabout guidance receptor 4	607528	ROBO4	54538	ENSG00000154133,ENST00000306534;;;ENST00000306534		Aortic valve disease 3	618496	AD	3	Robo4
11q24.2	11:124919205-124936047	HEPACAM, MLC2A, MLC2B	Hepatocyte cell adhesion molecule	611642	HEPACAM	220296	ENSG00000165478,ENST00000298251;;;ENST00000298251		Megalencephalic leukoencephalopathy with subcortical cysts 2A	613925	AR	3	Hepacam
11q24.2	11:124919205-124936047	HEPACAM, MLC2A, MLC2B	Hepatocyte cell adhesion molecule	611642	HEPACAM	220296	ENSG00000165478,ENST00000298251;;;ENST00000298251		Megalencephalic leukoencephalopathy with subcortical cysts 2B, remitting, with or without impaired intellectual development	613926	AD	3	Hepacam
11q24.2	11:125094389-125111626	TMEM218, JBTS39	Transmembrane protein 218	619285	TMEM218	219854	ENSG00000150433,ENST00000682305;;;ENST00000682305		Joubert syndrome 39	619562	AR	3	Tmem218
11q24.2	11:125591769-125623091	STT3A, ITM1, TMC, CDG1WAR, CDG1WAD	STT3A, subunit of the oligosaccharyltransferase complex (catalytic)	601134	STT3A	3703	ENSG00000134910,ENST00000392708;;;ENST00000392708		Congenital disorder of glycosylation, type Iw, autosomal dominant	619714	AD	3	Stt3a
11q24.2	11:125591769-125623091	STT3A, ITM1, TMC, CDG1WAR, CDG1WAD	STT3A, subunit of the oligosaccharyltransferase complex (catalytic)	601134	STT3A	3703	ENSG00000134910,ENST00000392708;;;ENST00000392708		Congenital disorder of glycosylation, type Iw, autosomal recessive	615596	AR	3	Stt3a
11q24.2	11:125625136-125681124	CHEK1, CHK1, OZEMA21	Checkpoint kinase 1	603078	CHEK1	1111	ENSG00000149554,ENST00000438015;;;ENST00000438015		Oocyte/zygote/embryo maturation arrest 21	620610	AD	3	Chek1
11q24.2	11:125883614-125900646	HYLS1, FLJ32915	HYLS1 centriolar and ciliogenesis-associated protein	610693	HYLS1	219844	ENSG00000198331,ENST00000425380;;;ENST00000425380		Hydrolethalus syndrome	236680	AR	3	Hyls1
11q24.2	11:125893485-125903206	PUS3, MRT55, NEDMIGS	Pseudouridylate synthase 3	616283	PUS3	83480	ENSG00000110060,ENST00000227474;;;ENST00000227474		Neurodevelopmental disorder with microcephaly and gray sclerae	617051	AR	3	Pus3
11q24.2	11:125956821-126063335	CDON, CDO, HPE11	Cell adhesion molecule-related/downregulated by oncogenes	608707	CDON	50937	ENSG00000064309,ENST00000531738;;;ENST00000531738		Holoprosencephaly 11	614226	AD	3	Cdon
11q24.2	11:126269154-126278126	FOXRED1, MC1DN19	FAD-dependent oxidoreductase domain-containing protein 1	613622	FOXRED1	55572	ENSG00000110074,ENST00000263578;;;ENST00000263578		Mitochondrial complex I deficiency, nuclear type 19	618241	AR	3	Foxred1
11q24.2	11:126283093-126294933	TIRAP, BACTS1	TIR domain-containing adaptor protein	606252	TIRAP	114609	ENSG00000150455,ENST00000392679;;;ENST00000392679		{Bacteremia, protection against}	614382		3	Tirap
11q24.2	11:126283093-126294933	TIRAP, BACTS1	TIR domain-containing adaptor protein	606252	TIRAP	114609	ENSG00000150455,ENST00000392679;;;ENST00000392679		{Malaria, protection against}	611162		3	Tirap
11q24.2	11:126283093-126294933	TIRAP, BACTS1	TIR domain-containing adaptor protein	606252	TIRAP	114609	ENSG00000150455,ENST00000392679;;;ENST00000392679		{Tuberculosis, protection against}	607948		3	Tirap
11q24.2	11:126304060-126350005	DCPS, HINT5, DCS1, ARS	Decapping enzyme, scavenger	610534	DCPS	28960	ENSG00000110063,ENST00000263579;;;ENST00000263579		Al-Raqad syndrome	616459	AR	3	Dcps
11q24.3	11:128685132-128813267	FLI1, BDPLT21	FLI1 protooncogene, ETS transcription factor	193067	FLI1	2313	ENSG00000151702,ENST00000527786;;;ENST00000527786	fused with EWS in Ewing sarcoma	Bleeding disorder, platelet-type, 21	617443	AD, AR	3	Fli1
11q24.3	11:128838020-128867296	KCNJ1, ROMK1	Potassium inwardly-rectifying channel, subfamily J, member 1	600359	KCNJ1	3758	ENSG00000151704,ENST00000392666;;;ENST00000392666		Bartter syndrome, type 2	241200	AR	3	Kcnj1
11q24.3	11:128891356-128921163	KCNJ5, GIRK4, KATP1, LQT13	Potassium inwardly-rectifying channel, subfamily J, member 5	600734	KCNJ5	3762	ENSG00000120457,ENST00000529694;;;ENST00000529694		Hyperaldosteronism, familial, type III	613677	AD	3	Kcnj5
11q24.3	11:128891356-128921163	KCNJ5, GIRK4, KATP1, LQT13	Potassium inwardly-rectifying channel, subfamily J, member 5	600734	KCNJ5	3762	ENSG00000120457,ENST00000529694;;;ENST00000529694		Long QT syndrome 13	613485	AD	3	Kcnj5
11q24.3	11:129899711-130002835	PRDM10, TRIS, KIAA1231, BHD2	PR domain-containing protein 10	618319	PRDM10	56980	ENSG00000170325,ENST00000360871;;;ENST00000360871	mutation identified in 1 BHD2 family	?Birt-Hogg-Dube syndrome 2	620459	AD	3	Prdm10
11q24.3	11:130159782-130210362	ST14, MTSP1, ARCI11	ST14 transmembrane serine protease matriptase	606797	ST14	6768	ENSG00000149418,ENST00000278742;;;ENST00000278742		Ichthyosis, congenital, autosomal recessive 11	602400	AR	3	St14
11q24.3	11:130448645-130476645	ADAMTS15, DA12	ADAM metallopeptidase domain with thrombospondin type 1 motif, 15	607509	ADAMTS15	170689	ENSG00000166106,ENST00000299164;;;ENST00000299164		Arthrogryposis, distal, type 12	620545	AR	3	Adamts15
11q25-qter	11:130900001-135086622	DFNB20	Deafness, autosomal recessive 20	604060		1713			Deafness, autosomal recessive 20	604060	AR	2	
11q25	11:132414981-133532501	OPCML	Opioid-binding protein/cell adhesion molecule-like	600632	OPCML	4978	ENSG00000183715,ENST00000524381;;;ENST00000524381		Ovarian cancer, somatic	167000		3	Opcml
11q25	11:134069072-134152001	JAM3	Junctional adhesion molecule 3	606871	JAM3	83700	ENSG00000166086,ENST00000299106;;;ENST00000299106		Hemorrhagic destruction of the brain, subependymal calcification, and cataracts	613730	AR	3	Jam3
11q25	11:134150113-134225461	NCAPD3, CAPD3, KIAA0056, MCPH22	Non-SMC condensin II complex subunit D3	609276	NCAPD3	23310	ENSG00000151503,ENST00000534548;;;ENST00000534548		Microcephaly 22, primary, autosomal recessive	617984	AR	3	Ncapd3
11q25	11:134253568-134265855	ACAD8	Acyl-CoA dehydrogenase family, member 8	604773	ACAD8	27034	ENSG00000151498,ENST00000281182;;;ENST00000281182		Isobutyryl-CoA dehydrogenase deficiency	611283	AR	3	Acad8
Chr.11	11:1-135086622	AOCH	Acromegaloid features, overgrowth, cleft palate, and hernia	606049		93956		pericentric inversion (46,XY,inv(11)(p15.3;q23.3))	Acromegaloid features, overgrowth, cleft palate, and hernia	606049		2	
12p13.3	12:1-10000000	MAFD9	Major affective disorder 9	612372		100196917		associated with rs1006737	{Major affective disorder-9, susceptibility to}	612372		2	
12p	12:1-35500001	PKS	Pallister-Killian syndrome	601803					Pallister-Killian syndrome	601803	SMo	4	
12p13.33	12:280057-389320	KDM5A, JARID1A, RBP2, RBBP2, NEDEHC	Lysine demethylase 5A	180202	KDM5A	5927	ENSG00000073614,ENST00000399788;;;ENST00000399788		El Hayek-Chahrour neurodevelopmental syndrome	620820	AR	3	Kdm5a
12p13.33	12:752579-911452	WNK1, PRKWNK1, KDP, PHA2C, HSAN2, HSN2	WNK lysine deficient protein kinase 1	605232	WNK1	65125	ENSG00000060237,ENST00000315939;;;ENST00000315939		Neuropathy, hereditary sensory and autonomic, type II	201300	AR	3	Wnk1
12p13.33	12:752579-911452	WNK1, PRKWNK1, KDP, PHA2C, HSAN2, HSN2	WNK lysine deficient protein kinase 1	605232	WNK1	65125	ENSG00000060237,ENST00000315939;;;ENST00000315939		Pseudohypoaldosteronism, type IIC	614492	AD	3	Wnk1
12p13.33	12:1791963-1918652	CACNA2D4, RCD4	Calcium channel, voltage-dependent, alpha-2/delta subunit 4	608171	CACNA2D4	93589	ENSG00000151062,ENST00000382722;;;ENST00000382722		Retinal cone dystrophy 4	610478	AR	3	Cacna2d4
12p13.33	12:1970780-2697950	CACNA1C, CACNL1A1, CCHL1A1, TS, LQT8, NEDHLSS	Calcium channel, voltage-dependent, L type, alpha 1C subunit	114205	CACNA1C	775	ENSG00000151067,ENST00000399655;;;ENST00000399655		Brugada syndrome 3	611875	AD	3	Cacna1c
12p13.33	12:1970780-2697950	CACNA1C, CACNL1A1, CCHL1A1, TS, LQT8, NEDHLSS	Calcium channel, voltage-dependent, L type, alpha 1C subunit	114205	CACNA1C	775	ENSG00000151067,ENST00000399655;;;ENST00000399655		Long QT syndrome 8	618447	AD	3	Cacna1c
12p13.33	12:1970780-2697950	CACNA1C, CACNL1A1, CCHL1A1, TS, LQT8, NEDHLSS	Calcium channel, voltage-dependent, L type, alpha 1C subunit	114205	CACNA1C	775	ENSG00000151067,ENST00000399655;;;ENST00000399655		Neurodevelopmental disorder with hypotonia, language delay, and skeletal defects with or without seizures	620029	AD	3	Cacna1c
12p13.33	12:1970780-2697950	CACNA1C, CACNL1A1, CCHL1A1, TS, LQT8, NEDHLSS	Calcium channel, voltage-dependent, L type, alpha 1C subunit	114205	CACNA1C	775	ENSG00000151067,ENST00000399655;;;ENST00000399655		Timothy syndrome	601005	AD	3	Cacna1c
12p13.33	12:2890891-2941138	TULP3, HRCDF	TUB-like protein 3	604730	TULP3	7289	ENSG00000078246,ENST00000448120;;;ENST00000448120		Hepatorenocardiac degenerative fibrosis	619902	AR	3	Tulp3
12p13.32	12:4273762-4305353	CCND2, MPPH3	Cyclin D2	123833	CCND2	894	ENSG00000118971,ENST00000261254;;;ENST00000261254		Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 3	615938	AD	3	Ccnd2
12p13.32	12:4368227-4379712	FGF23, ADHR, HPDR2, PHPTC, HFTC2	Fibroblast growth factor 23	605380	FGF23	8074	ENSG00000118972,ENST00000237837;;;ENST00000237837		Hypophosphatemic rickets, autosomal dominant	193100	AD	3	Fgf23
12p13.32	12:4368227-4379712	FGF23, ADHR, HPDR2, PHPTC, HFTC2	Fibroblast growth factor 23	605380	FGF23	8074	ENSG00000118972,ENST00000237837;;;ENST00000237837		Tumoral calcinosis, hyperphosphatemic, familial, 2	617993	AR	3	Fgf23
12p13.32	12:4487735-4538469	C12orf4, MRT66	Chromosome 12 open reading frame 4	616082	FERRY3	57102	ENSG00000047621,ENST00000261250;;;ENST00000261250		Intellectual developmental disorder, autosomal recessive 66	618221	AR	3	D6Wsu163e
12p13.32	12:4615518-4649051	AKAP3, AKAP110, FSP95, SOB1, SPGF82	A-kinase anchor protein 3	604689	AKAP3	10566	ENSG00000111254,ENST00000228850;;;ENST00000228850		Spermatogenic failure 82	620353	AR	3	Akap3
12p13.32	12:4649114-4694317	NDUFA9, MC1DN26	NADH-ubiquinone oxidoreductase subunit A9	603834	NDUFA9	4704	ENSG00000139180,ENST00000266544;;;ENST00000266544		Mitochondrial complex I deficiency, nuclear type 26	618247	AR	3	Ndufa9
12p13.32	12:4909905-4918256	KCNA1, AEMK, EA1	Potassium voltage-gated channel, shaker-related subfamily, member 1	176260	KCNA1	3736	ENSG00000111262,ENST00000382545;;;ENST00000382545	close to VWF	Episodic ataxia/myokymia syndrome	160120	AD	3	Kcna1
12p13.32	12:5043879-5046788	KCNA5, ATFB7	Potassium voltage-gated channel, shaker-related subfamily, member 5	176267	KCNA5	3741	ENSG00000130037,ENST00000252321;;;ENST00000252321		Atrial fibrillation, familial, 7	612240	AD	3	Kcna5
12p13.31	12:5948877-6124670	VWF, F8VWF	Coagulation factor VIII VWF (von Willebrand factor)	613160	VWF	7450	ENSG00000110799,ENST00000261405;;;ENST00000261405	pseudogene on chr. 22	von Willebrand disease, type 1	193400	AD	3	Vwf
12p13.31	12:5948877-6124670	VWF, F8VWF	Coagulation factor VIII VWF (von Willebrand factor)	613160	VWF	7450	ENSG00000110799,ENST00000261405;;;ENST00000261405	pseudogene on chr. 22	von Willebrand disease, type 3	277480	AR	3	Vwf
12p13.31	12:5948877-6124670	VWF, F8VWF	Coagulation factor VIII VWF (von Willebrand factor)	613160	VWF	7450	ENSG00000110799,ENST00000261405;;;ENST00000261405	pseudogene on chr. 22	von Willebrand disease, types 2A, 2B, 2M, and 2N	613554	AD, AR	3	Vwf
12p13.31	12:6328771-6342076	TNFRSF1A, TNFR1, TNFAR, FPF, MS5	Tumor necrosis factor receptor superfamily, member 1A	191190	TNFRSF1A	7132	ENSG00000067182,ENST00000162749;;;ENST00000162749		{Multiple sclerosis, susceptibility to, 5}	614810		3	Tnfrsf1a
12p13.31	12:6328771-6342076	TNFRSF1A, TNFR1, TNFAR, FPF, MS5	Tumor necrosis factor receptor superfamily, member 1A	191190	TNFRSF1A	7132	ENSG00000067182,ENST00000162749;;;ENST00000162749		Periodic fever, familial	142680	AD	3	Tnfrsf1a
12p13.31	12:6346847-6377359	SCNN1A, BESC2, LIDLS3, PHA1B1	Sodium channel, epithelial 1, subunit alpha	600228	SCNN1A	6337	ENSG00000111319,ENST00000228916;;;ENST00000228916	mutation identified in 1 LIDLS3 patient	?Liddle syndrome 3	618126	AD	3	Scnn1a
12p13.31	12:6346847-6377359	SCNN1A, BESC2, LIDLS3, PHA1B1	Sodium channel, epithelial 1, subunit alpha	600228	SCNN1A	6337	ENSG00000111319,ENST00000228916;;;ENST00000228916	mutation identified in 1 LIDLS3 patient	Bronchiectasis with or without elevated sweat chloride 2	613021	AD	3	Scnn1a
12p13.31	12:6346847-6377359	SCNN1A, BESC2, LIDLS3, PHA1B1	Sodium channel, epithelial 1, subunit alpha	600228	SCNN1A	6337	ENSG00000111319,ENST00000228916;;;ENST00000228916	mutation identified in 1 LIDLS3 patient	Pseudohypoaldosteronism, type IB1, autosomal recessive	264350	AR	3	Scnn1a
12p13.31	12:6443892-6451713	CD27, TNFRSF7, S152. LPFS2	CD27 antigen	186711	CD27	939	ENSG00000139193,ENST00000266557;;;ENST00000266557		Lymphoproliferative syndrome 2	615122	AR	3	Cd27
12p13.31	12:6462237-6470677	VAMP1, SYB1, SPAX1, CMS25	Vesicle-associated membrane protein-1 (synaptobrevin-1)	185880	VAMP1	6843	ENSG00000139190,ENST00000396308;;;ENST00000396308		Myasthenic syndrome, congenital, 25	618323	AR	3	Vamp1
12p13.31	12:6462237-6470677	VAMP1, SYB1, SPAX1, CMS25	Vesicle-associated membrane protein-1 (synaptobrevin-1)	185880	VAMP1	6843	ENSG00000139190,ENST00000396308;;;ENST00000396308		Spastic ataxia 1, autosomal dominant	108600	AD	3	Vamp1
12p13.31	12:6494102-6531955	NCAPD2, CNAP1, KIAA0159, MCPH21	Non-SMC condensin I complex subunit D2	615638	NCAPD2	9918	ENSG00000010292,ENST00000315579;;;ENST00000315579		Microcephaly 21, primary, autosomal recessive	617983	AR	3	Ncapd2
12p13.31	12:6570082-6607379	CHD4, SIHIWES	Chromodomain helicase DNA-binding protein-4	603277	CHD4	1108	ENSG00000111642,ENST00000544040;;;ENST00000544040		Sifrim-Hitz-Weiss syndrome	617159	AD	3	Chd4
12p13.31	12:6789528-6820799	CD4, OKT4D, IMD79	CD4 antigen (p55)	186940	CD4	920	ENSG00000010610,ENST00000011653;;;ENST00000011653	CD = \'cluster of differentiation\' = nomenclature of leukocyte differentiation antigens	Immunodeficiency 79	619238	AR	3	Cd4
12p13.31	12:6789528-6820799	CD4, OKT4D, IMD79	CD4 antigen (p55)	186940	CD4	920	ENSG00000010610,ENST00000011653;;;ENST00000011653	CD = \'cluster of differentiation\' = nomenclature of leukocyte differentiation antigens	OKT4 epitope deficiency	613949		3	Cd4
12p13.31	12:6840925-6847393	GNB3, CSNB1H	Guanine nucleotide-binding protein, beta polypeptide-3	139130	GNB3	2784	ENSG00000111664,ENST00000229264;;;ENST00000229264		{Hypertension, essential, susceptibility to}	145500	Mu	3	Gnb3
12p13.31	12:6840925-6847393	GNB3, CSNB1H	Guanine nucleotide-binding protein, beta polypeptide-3	139130	GNB3	2784	ENSG00000111664,ENST00000229264;;;ENST00000229264		Night blindness, congenital stationary, type 1H	617024	AR	3	Gnb3
12p13.31	12:6867420-6870948	TPI1, TPID	Triosephosphate isomerase-1	190450	TPI1	7167	ENSG00000111669,ENST00000396705;;;ENST00000396705		Hemolytic anemia due to triosephosphate isomerase deficiency	615512	AR	3	Tpi1
12p13.31	12:6904822-6914229	LRRC23, SPGF92	Leucine-rich repeat-containing protein 23	620708	LRRC23	10233	ENSG00000010626,ENST00000443597;;;ENST00000443597		Spermatogenic failure 92	620848	AR	3	Lrrc23
12p13.31	12:6924459-6942321	ATN1, DRPLA, HRS, NOD, CHEDDA	Atrophin 1	607462	ATN1	1822	ENSG00000111676,ENST00000396684;;;ENST00000396684		Congenital hypotonia, epilepsy, developmental delay, and digital anomalies	618494	AD	3	Atn1
12p13.31	12:6924459-6942321	ATN1, DRPLA, HRS, NOD, CHEDDA	Atrophin 1	607462	ATN1	1822	ENSG00000111676,ENST00000396684;;;ENST00000396684		Dentatorubral-pallidoluysian atrophy	125370	AD	3	Atn1
12p13.31	12:6943433-6946003	C12orf57, C10, TEMTYS	Chromosome 12 open reading frame 57	615140	C12orf57	113246	ENSG00000111678,ENST00000229281;;;ENST00000229281		Temtamy syndrome	218340	AR	3	Grcc10
12p13.31	12:6943816-6943878	RNU7-1, RNU7, AGS9	RNA, U7 small nuclear 1	617876	RNU7-1	100147744	ENSG00000238923,ENST00000458811		Aicardi-Goutieres syndrome 9	619487	AR	3	
12p13.31	12:6970913-6997428	EMG1, NEP1, C2F, BWCNS	EMG1 N1-specific pseudouridine methyltransferase	611531	EMG1	10436	ENSG00000126749,ENST00000599672;;;ENST00000599672		Bowen-Conradi syndrome	211180	AR	3	Emg1
12p13.31	12:7060718-7071032	C1S, EDSPD2	Complement component-1, s subcomponent	120580	C1S	716	ENSG00000182326,ENST00000360817;;;ENST00000360817		C1s deficiency	613783		3	C1s1,C1s2
12p13.31	12:7060718-7071032	C1S, EDSPD2	Complement component-1, s subcomponent	120580	C1S	716	ENSG00000182326,ENST00000360817;;;ENST00000360817		Ehlers-Danlos syndrome, periodontal type, 2	617174	AD	3	C1s1,C1s2
12p13.31	12:7080219-7092445	C1R, EDSPD1	Complement component-1, r subcomponent	613785	C1R	715	ENSG00000159403,ENST00000647956;;;ENST00000647956		Ehlers-Danlos syndrome, periodontal type, 1	130080	AD	3	C1ra,C1rb
12p13.31	12:7188653-7218574	PEX5, PXR1, PTS1R, PBD2A, PBD2B, RCDP5	Peroxisome biogenesis factor 5	600414	PEX5	5830	ENSG00000139197,ENST00000675855;;;ENST00000675855		Peroxisome biogenesis disorder 2A (Zellweger)	214110	AR	3	Pex5
12p13.31	12:7188653-7218574	PEX5, PXR1, PTS1R, PBD2A, PBD2B, RCDP5	Peroxisome biogenesis factor 5	600414	PEX5	5830	ENSG00000139197,ENST00000675855;;;ENST00000675855		Peroxisome biogenesis disorder 2B	202370	AR	3	Pex5
12p13.31	12:7188653-7218574	PEX5, PXR1, PTS1R, PBD2A, PBD2B, RCDP5	Peroxisome biogenesis factor 5	600414	PEX5	5830	ENSG00000139197,ENST00000675855;;;ENST00000675855		Rhizomelic chondrodysplasia punctata, type 5	616716	AR	3	Pex5
12p13.31	12:7689784-7695775	GDF3, KFS3, MCOPCB6, MCOP7	Growth differentiation factor 3	606522	GDF3	9573	ENSG00000184344,ENST00000329913;;;ENST00000329913		Klippel-Feil syndrome 3, autosomal dominant	613702		3	Gdf3
12p13.31	12:7689784-7695775	GDF3, KFS3, MCOPCB6, MCOP7	Growth differentiation factor 3	606522	GDF3	9573	ENSG00000184344,ENST00000329913;;;ENST00000329913		Microphthalmia, isolated 7	613704	AD	3	Gdf3
12p13.31	12:7689784-7695775	GDF3, KFS3, MCOPCB6, MCOP7	Growth differentiation factor 3	606522	GDF3	9573	ENSG00000184344,ENST00000329913;;;ENST00000329913		Microphthalmia, isolated, with coloboma 6	613703	AD	3	Gdf3
12p13.31	12:8082274-8097881	NECAP1, DEE21	NECAP endocytosis-associated protein 1	611623	NECAP1	25977	ENSG00000089818,ENST00000339754;;;ENST00000339754		Developmental and epileptic encephalopathy 21	615833	AR	3	Necap1
12p13.31	12:8602170-8612859	AICDA, AID, HIGM2	Activation-induced cytidine deaminase	605257	AICDA	57379	ENSG00000111732,ENST00000229335;;;ENST00000229335		Immunodeficiency with hyper-IgM, type 2	605258	AR	3	Aicda
12p13.31	12:8645943-8662826	MFAP5, MAGP2, AAT9	Microfibril-associated protein 5	601103	MFAP5	8076	ENSG00000197614,ENST00000359478;;;ENST00000359478		Aortic aneurysm, familial thoracic 9	616166	AD	3	Mfap5
12p13.31	12:8822621-8887459	A2ML1, OMS	Alpha-2-macroglobulin-like 1	610627	A2ML1	144568	ENSG00000166535,ENST00000299698;;;ENST00000299698		{Otitis media, susceptibility to}	166760	AD	3	
12p13.31	12:8913843-8941467	PHC1, EDR1, HPH1, RAE28, MCPH11	Polyhomeotic-like 1	602978	PHC1	1911	ENSG00000111752,ENST00000544916;;;ENST00000544916	mutations identified in 1 family	?Microcephaly 11, primary, autosomal recessive	615414	AR	3	Phc1
12p13.2-p11.23	12:10000001-27600000	DFNB62	Deafness, autosomal recessive 62	610143		692220		between D12S358 and D12S1042	Deafness, autosomal recessive 62	610143	AR	2	
12p13.2-q24.1	12:10000001-113900000	IBD2	Inflammatory bowel disease 2	601458		3378		mainly ulcerative colitis	{Inflammatory bowel disease 2}	601458		2	
12p13.2	12:10069554-10098985	CLEC1A, CLEC1	C-type lectin domain family 1, member A	606782	CLEC1A	51267	ENSG00000150048,ENST00000315330;;;ENST00000315330		{Aspergillosis, susceptibility to}	614079		3	Clec1a
12p13.2	12:10116777-10130304	CLEC7A, CLECSF12, DECTIN1, CANDF4	C-type lectin domain family 7, member A	606264	CLEC7A	64581	ENSG00000172243,ENST00000304084;;;ENST00000304084	in natural killer gene complex	{Aspergillosis, susceptibility to}	614079		3	Clec7a
12p13.2	12:10116777-10130304	CLEC7A, CLECSF12, DECTIN1, CANDF4	C-type lectin domain family 7, member A	606264	CLEC7A	64581	ENSG00000172243,ENST00000304084;;;ENST00000304084	in natural killer gene complex	Candidiasis, familial, 4, autosomal recessive	613108	AR	3	Clec7a
12p13.2	12:10158301-10176266	OLR1, LOX1	Low density lipoprotein, oxidized, receptor 1	602601	OLR1	4973	ENSG00000173391,ENST00000309539;;;ENST00000309539		{Myocardial infarction, susceptibility to}	608446		3	Olr1
12p13.2	12:11649674-11895377	ETV6, TEL, THC5	ETS variant transcription factor 6	600618	ETV6	2120	ENSG00000139083,ENST00000396373;;;ENST00000396373	fused to PDGFRB or AML1 in leukemia	Leukemia, acute myeloid, somatic	601626		3	Etv6
12p13.2	12:11649674-11895377	ETV6, TEL, THC5	ETS variant transcription factor 6	600618	ETV6	2120	ENSG00000139083,ENST00000396373;;;ENST00000396373	fused to PDGFRB or AML1 in leukemia	Thrombocytopenia 5	616216	AD	3	Etv6
12p13.2	12:12116025-12267044	LRP6, ADCAD2, STHAG7, EVR8	Low density lipoprotein receptor-related protein 6	603507	LRP6	4040	ENSG00000070018,ENST00000261349;;;ENST00000261349		{Coronary artery disease, autosomal dominant, 2}	610947	AD	3	Lrp6
12p13.2	12:12116025-12267044	LRP6, ADCAD2, STHAG7, EVR8	Low density lipoprotein receptor-related protein 6	603507	LRP6	4040	ENSG00000070018,ENST00000261349;;;ENST00000261349		Exudative vitreoretinopathy 8	621268	AD	3	Lrp6
12p13.2	12:12116025-12267044	LRP6, ADCAD2, STHAG7, EVR8	Low density lipoprotein receptor-related protein 6	603507	LRP6	4040	ENSG00000070018,ENST00000261349;;;ENST00000261349		Tooth agenesis, selective, 7	616724	AD	3	Lrp6
12p13.1	12:12717368-12722369	CDKN1B, KIP1, CDKN4, MEN4	Cyclin-dependent kinase inhibitor 1B (p27, Kip1)	600778	CDKN1B	1027	ENSG00000111276,ENST00000228872;;;ENST00000228872		Multiple endocrine neoplasia, type IV	610755	AD	3	Cdkn1b
12p13.1	12:12725917-12791466	APOLD1, VERGE, BDVAS	Apolipoprotein L domain-containing 1	612456	APOLD1	81575	ENSG00000178878,ENST00000356591;;;ENST00000356591	mutation identified in 1 BDVAS family	?Bleeding disorder, vascular-type	620715	AD	3	Apold1
12p13.1	12:13537337-13982134	GRIN2B, NMDAR2B, MRD6, DEE27	Glutamate receptor, ionotropic, N-methyl D-aspartate 2B	138252	GRIN2B	2904	ENSG00000273079,ENST00000609686;;;ENST00000609686		Developmental and epileptic encephalopathy 27	616139	AD	3	Grin2b
12p13.1	12:13537337-13982134	GRIN2B, NMDAR2B, MRD6, DEE27	Glutamate receptor, ionotropic, N-methyl D-aspartate 2B	138252	GRIN2B	2904	ENSG00000273079,ENST00000609686;;;ENST00000609686		Intellectual developmental disorder, autosomal dominant 6, with or without seizures	613970	AD	3	Grin2b
12p12.3	12:14612632-14696599	GUCY2C, GUC2C, DIAR6, MECIL	Guanylate cyclase 2C (heat stable enterotoxin receptor)	601330	GUCY2C	2984	ENSG00000070019,ENST00000261170;;;ENST00000261170		Diarrhea 6	614616	AD	3	Gucy2c
12p12.3	12:14612632-14696599	GUCY2C, GUC2C, DIAR6, MECIL	Guanylate cyclase 2C (heat stable enterotoxin receptor)	601330	GUCY2C	2984	ENSG00000070019,ENST00000261170;;;ENST00000261170		Meconium ileus	614665	AR	3	Gucy2c
12p12.3	12:14784582-14803478	WBP11, NPWBP, SIPP1, VCTERL	WW-binding protein 11	618083	WBP11	51729	ENSG00000084463,ENST00000261167;;;ENST00000261167		Vertebral, cardiac, tracheoesophageal, renal, and limb defects	619227	AD	3	Wbp11
12p12.3	12:14825569-14843526	ART4, DO, DOK1	ADP-ribosyltransferase-4 (Dombrock blood group)	110600	ART4	420	ENSG00000111339,ENST00000228936;;;ENST00000228936		[Blood group, Dombrock]	616060		3	Art4
12p12.3	12:14880864-14885854	MGP	Matrix Gla protein	154870	MGP	4256	ENSG00000111341,ENST00000539261;;;ENST00000539261		Keutel syndrome	245150	AR	3	Mgp
12p12.3	12:14973042-14981865	PDE6H, ACHM6	Phosphodiesterase 6H	601190	PDE6H	5149	ENSG00000139053,ENST00000266395;;;ENST00000266395		Achromatopsia 6	610024	AR	3	Pde6h
12p12.3	12:15322508-15598331	PTPRO, GLEPP1, NPHS6	Protein tyrosine phosphatase, receptor type, O	600579	PTPRO	5800	ENSG00000151490,ENST00000281171;;;ENST00000281171		Nephrotic syndrome, type 6	614196	AR	3	Ptpro
12p12.3	12:15620134-15789388	EPS8, DFNB102	Epidermal growth factor receptor pathway substrate-8	600206	EPS8	2059	ENSG00000151491,ENST00000281172;;;ENST00000281172	mutation identified in 1 DFNB102 family	?Deafness, autosomal recessive 102	615974	AR	3	Eps8
12p12.3	12:18645609-18738012	PLCZ1, SPGF17	Phospholipase C, zeta-1	608075	PLCZ1	89869	ENSG00000139151,ENST00000266505;;;ENST00000266505		Spermatogenic failure 17	617214	AR	3	Plcz1
12p12.2-p12.1	12:19800001-26300000	HYT4	Hypertension, essential, susceptibility to, 4	608742		444980			{Hypertension, essential, susceptibility to, 4}	145500	Mu	2	
12p12.2	12:20368537-20688583	PDE3A, HTNB	Phosphodiesterase 3A, cGMP-inhibited	123805	PDE3A	5139	ENSG00000172572,ENST00000359062;;;ENST00000359062		Hypertension and brachydactyly syndrome	112410	AD	3	Pde3a
12p12.2	12:20810705-20916911	SLCO1B3, OATP8, OATP1B3, SLC21A8, HBLRR	Solute carrier organic anion transporter family, member 1B3	605495	SLCO1B3	28234	ENSG00000111700,ENST00000381545;;;ENST00000381545	HBLRR digenic with SLCO1B1	Hyperbilirubinemia, Rotor type, digenic	237450	DR	3	Slco1b2
12p12.1	12:21131194-21239796	SLCO1B1, LST1, OATP2, OATPC, OATP1B1, HBLRR	Solute carrier organic anion transporter family, member 1B1	604843	SLCO1B1	10599	ENSG00000134538,ENST00000256958;;;ENST00000256958	HBLRR digenic with SLCO1B3	Hyperbilirubinemia, Rotor type, digenic	237450	DR	3	Slco1b2
12p12.1	12:21437655-21471250	PYROXD1, MFM8	Pyridine nucleotide-disulfide oxidoreductase domain-containing protein 1	617220	PYROXD1	79912	ENSG00000121350,ENST00000240651;;;ENST00000240651		Myopathy, myofibrillar, 8	617258	AR	3	Pyroxd1
12p12.1	12:21468910-21501635	RECQL, RECQL1, RECON	RecQ helicase-like (DNA helicase, RecQ-like 1)	600537	RECQL	5965	ENSG00000004700,ENST00000444129;;;ENST00000444129		RECON progeroid syndrome	620370	AR	3	Recql
12p12.1	12:21532577-21604847	GYS2	Glycogen synthase-2, liver	138571	GYS2	2998	ENSG00000111713,ENST00000261195;;;ENST00000261195		Glycogen storage disease 0, liver	240600	AR	3	Gys2
12p12.1	12:21635342-21657842	LDHB, LDHBD	Lactate dehydrogenase B	150100	LDHB	3945	ENSG00000111716,ENST00000350669;;;ENST00000350669		[Lactate dehydrogenase-B deficiency]	614128		3	Ldhb
12p12.1	12:21797389-21941426	ABCC9, SUR2, CMD1O, ATFB12, CANTU, IDMYS	ATP-binding cassette, subfamily C, member 9 (sulfonylurea receptor 2)	601439	ABCC9	10060	ENSG00000069431,ENST00000261200;;;ENST00000261200	mutation identified in 1 ATFB12 patient	?Atrial fibrillation, familial, 12	614050	AD	3	Abcc9
12p12.1	12:21797389-21941426	ABCC9, SUR2, CMD1O, ATFB12, CANTU, IDMYS	ATP-binding cassette, subfamily C, member 9 (sulfonylurea receptor 2)	601439	ABCC9	10060	ENSG00000069431,ENST00000261200;;;ENST00000261200	mutation identified in 1 ATFB12 patient	Cardiomyopathy, dilated, 1O	608569	AD	3	Abcc9
12p12.1	12:21797389-21941426	ABCC9, SUR2, CMD1O, ATFB12, CANTU, IDMYS	ATP-binding cassette, subfamily C, member 9 (sulfonylurea receptor 2)	601439	ABCC9	10060	ENSG00000069431,ENST00000261200;;;ENST00000261200	mutation identified in 1 ATFB12 patient	Hypertrichotic osteochondrodysplasia (Cantu syndrome)	239850	AD	3	Abcc9
12p12.1	12:21797389-21941426	ABCC9, SUR2, CMD1O, ATFB12, CANTU, IDMYS	ATP-binding cassette, subfamily C, member 9 (sulfonylurea receptor 2)	601439	ABCC9	10060	ENSG00000069431,ENST00000261200;;;ENST00000261200	mutation identified in 1 ATFB12 patient	Intellectual disability and myopathy syndrome	619719	AR	3	Abcc9
12p12.1	12:23529504-24562650	SOX5, LAMSHF	SRY-box 5	604975	SOX5	6660	ENSG00000134532,ENST00000451604;;;ENST00000451604	some LAMSHF patients have 12p12 deletions	Lamb-Shaffer syndrome	616803	AD	3	Sox5
12p12.1	12:25205246-25250929	KRAS, KRAS2, RASK2, NS, CFC2, RALD, OES	KRAS protooncogene, GTPase	190070	KRAS	3845	ENSG00000133703,ENST00000311936;;;ENST00000311936	pseudogene KRAS1P on 6p12-p11	Arteriovenous malformation of the brain, somatic	108010		3	Kras
12p12.1	12:25205246-25250929	KRAS, KRAS2, RASK2, NS, CFC2, RALD, OES	KRAS protooncogene, GTPase	190070	KRAS	3845	ENSG00000133703,ENST00000311936;;;ENST00000311936	pseudogene KRAS1P on 6p12-p11	Bladder cancer, somatic	109800		3	Kras
12p12.1	12:25205246-25250929	KRAS, KRAS2, RASK2, NS, CFC2, RALD, OES	KRAS protooncogene, GTPase	190070	KRAS	3845	ENSG00000133703,ENST00000311936;;;ENST00000311936	pseudogene KRAS1P on 6p12-p11	Breast cancer, somatic	114480		3	Kras
12p12.1	12:25205246-25250929	KRAS, KRAS2, RASK2, NS, CFC2, RALD, OES	KRAS protooncogene, GTPase	190070	KRAS	3845	ENSG00000133703,ENST00000311936;;;ENST00000311936	pseudogene KRAS1P on 6p12-p11	Cardiofaciocutaneous syndrome 2	615278	AD	3	Kras
12p12.1	12:25205246-25250929	KRAS, KRAS2, RASK2, NS, CFC2, RALD, OES	KRAS protooncogene, GTPase	190070	KRAS	3845	ENSG00000133703,ENST00000311936;;;ENST00000311936	pseudogene KRAS1P on 6p12-p11	Gastric cancer, somatic	613659		3	Kras
12p12.1	12:25205246-25250929	KRAS, KRAS2, RASK2, NS, CFC2, RALD, OES	KRAS protooncogene, GTPase	190070	KRAS	3845	ENSG00000133703,ENST00000311936;;;ENST00000311936	pseudogene KRAS1P on 6p12-p11	Leukemia, acute myeloid, somatic	601626		3	Kras
12p12.1	12:25205246-25250929	KRAS, KRAS2, RASK2, NS, CFC2, RALD, OES	KRAS protooncogene, GTPase	190070	KRAS	3845	ENSG00000133703,ENST00000311936;;;ENST00000311936	pseudogene KRAS1P on 6p12-p11	Lung cancer, somatic	211980		3	Kras
12p12.1	12:25205246-25250929	KRAS, KRAS2, RASK2, NS, CFC2, RALD, OES	KRAS protooncogene, GTPase	190070	KRAS	3845	ENSG00000133703,ENST00000311936;;;ENST00000311936	pseudogene KRAS1P on 6p12-p11	Noonan syndrome 3	609942	AD	3	Kras
12p12.1	12:25205246-25250929	KRAS, KRAS2, RASK2, NS, CFC2, RALD, OES	KRAS protooncogene, GTPase	190070	KRAS	3845	ENSG00000133703,ENST00000311936;;;ENST00000311936	pseudogene KRAS1P on 6p12-p11	Oculoectodermal syndrome, somatic	600268		3	Kras
12p12.1	12:25205246-25250929	KRAS, KRAS2, RASK2, NS, CFC2, RALD, OES	KRAS protooncogene, GTPase	190070	KRAS	3845	ENSG00000133703,ENST00000311936;;;ENST00000311936	pseudogene KRAS1P on 6p12-p11	Pancreatic carcinoma, somatic	260350		3	Kras
12p12.1	12:25205246-25250929	KRAS, KRAS2, RASK2, NS, CFC2, RALD, OES	KRAS protooncogene, GTPase	190070	KRAS	3845	ENSG00000133703,ENST00000311936;;;ENST00000311936	pseudogene KRAS1P on 6p12-p11	RAS-associated autoimmune leukoproliferative disorder	614470	AD	3	Kras
12p12.1	12:25205246-25250929	KRAS, KRAS2, RASK2, NS, CFC2, RALD, OES	KRAS protooncogene, GTPase	190070	KRAS	3845	ENSG00000133703,ENST00000311936;;;ENST00000311936	pseudogene KRAS1P on 6p12-p11	Schimmelpenning-Feuerstein-Mims syndrome, somatic mosaic	163200		3	Kras
12p12.1	12:26120030-26125037	BHLHE41, BHLHB3, DEC2, SHARP1, FNSS1	Basic helix-loop-helix domain-containing protein, member E41	606200	BHLHE41	79365	ENSG00000123095,ENST00000242728;;;ENST00000242728		[Short sleep, familial natural, 1]	612975	AD	3	Bhlhe41
12p11.23-q13.12	12:26300001-51100000	AD5	Alzheimer disease, familial, type 5	602096		8081			Alzheimer disease-5	602096	AD	2	
12p11.2-q13.1	12:26300001-54500000	ARCI7	Ichthyosis, congenital, autosomal recessive 7	615022		101202686		between D12S345 and D12S390	Ichthyosis, congenital, autosomal recessive 7	615022	AR	2	
12p11.2-q14	12:26300001-67300000	STQTL3	Stature quantitative trait locus 3	606257		282549		max lod at D12S398 and D12S10990	{Stature QTL 3}	606257		2	
12p11-q13	12:26300001-57700000	VUR7	Vesicoureteral reflux 7	615390		102095631		max lod at D12S1048	Vesicoureteral reflux 7	615390		2	
12p11.23	12:26335352-26833194	ITPR2, ANHD	Inositol 1,4,5-triphosphate receptor, type 2	600144	ITPR2	3709	ENSG00000123104,ENST00000381340;;;ENST00000381340	mutation has been identified in 1 ANHD family	?Anhidrosis, isolated, with normal sweat glands	106190	AR	3	Itpr2
12p11.23-p11.22	12:27524206-27695564	PPFIBP1, NEDSMBA	PPFIA-binding protein 1	603141	PPFIBP1	8496	ENSG00000110841,ENST00000228425;;;ENST00000228425		Neurodevelopmental disorder with seizures, microcephaly, and brain abnormalities	620024	AR	3	Ppfibp1
12p11.22	12:27958084-27972733	PTHLH, BDE2	Parathyroid hormone-like hormone	168470	PTHLH	5744	ENSG00000087494,ENST00000545234;;;ENST00000545234		Brachydactyly, type E2	613382	AD	3	Pthlh
12p11.21	12:30628988-30695869	IPO8, RANBP8, VISS	Importin 8	605600	IPO8	10526	ENSG00000133704,ENST00000256079;;;ENST00000256079		VISS syndrome	619472	AR	3	Ipo8
12p11.21	12:31073860-31104799	DDX11, CHLR1, KRG2	DEAD/H-box helicase 11	601150	DDX11	1663	ENSG00000013573,ENST00000542838;;;ENST00000542838		Warsaw breakage syndrome	613398	AR	3	Ddx11
12p11.21	12:32399558-32646050	FGD4, FRABIN, CMT4H	FYVE, RhoGEF, and PH domain-containing protein 4	611104	FGD4	121512	ENSG00000139132,ENST00000534526;;;ENST00000534526		Charcot-Marie-Tooth disease, type 4H	609311	AR	3	Fgd4
12p11.21	12:32679301-32745650	DNM1L, DRP1, DVLP, DYMPLE, EMPF1, OPA5	Dynamin 1-like	603850	DNM1L	10059	ENSG00000087470,ENST00000549701;;;ENST00000549701		Encephalopathy, lethal, due to defective mitochondrial peroxisomal fission 1	614388	AD, AR	3	Dnm1l
12p11.21	12:32679301-32745650	DNM1L, DRP1, DVLP, DYMPLE, EMPF1, OPA5	Dynamin 1-like	603850	DNM1L	10059	ENSG00000087470,ENST00000549701;;;ENST00000549701		Optic atrophy 5	610708	AD	3	Dnm1l
12p11.21	12:32746544-32755897	YARS2, TYRRS, MLASA2	Tyrosyl-tRNA synthetase 2	610957	YARS2	51067	ENSG00000139131,ENST00000324868;;;ENST00000324868		Myopathy, lactic acidosis, and sideroblastic anemia 2	613561	AR	3	Yars2
12p11.21	12:32790755-32896777	PKP2, ARVD9	Plakophilin-2	602861	PKP2	5318	ENSG00000057294,ENST00000340811;;;ENST00000340811	pseudogene on 12p13	Arrhythmogenic right ventricular dysplasia 9	609040	AD	3	Pkp2
12q	12:35500001-133275309	IHPS1, IHPS	Pyloric stenosis, infantile hypertrophic 1	179010					Pyloric stenosis, infantile hypertrophic 1	179010	AD, Mu	2	
12q12-q21	12:37800001-92200000	RLS1	Restless legs syndrome, susceptibility to, 1	102300		192142		between D12S1044 and D12S78	{Restless legs syndrome 1}	102300	AD	2	
12q12	12:38316687-38329721	ALG10B, KCR1, ALG10	ALG10 alpha-1,2-glucosyltransferase B	603313	ALG10B	144245	ENSG00000175548,ENST00000308742;;;ENST00000308742		{Long QT syndrome, acquired, reduced susceptibility to}	613688	AD	3	Alg10
12q12	12:39293228-39443120	KIF21A, KIAA1708, FEOM1, CFEOM1, CFEOM3B	Kinesin family member 21A	608283	KIF21A	55605	ENSG00000139116,ENST00000361418;;;ENST00000361418		Fibrosis of extraocular muscles, congenital, 1	135700	AD	3	Kif21a
12q12	12:39293228-39443120	KIF21A, KIAA1708, FEOM1, CFEOM1, CFEOM3B	Kinesin family member 21A	608283	KIF21A	55605	ENSG00000139116,ENST00000361418;;;ENST00000361418		Fibrosis of extraocular muscles, congenital, 3B	135700	AD	3	Kif21a
12q12	12:40224997-40369285	LRRK2, PARK8	Leucine-rich repeat kinase 2 (dardarin)	609007	LRRK2	120892	ENSG00000188906,ENST00000298910;;;ENST00000298910		{Parkinson disease 8}	607060	AD	3	Lrrk2
12q12	12:40692439-41072415	CNTN1, CMYO12	Contactin 1	600016	CNTN1	1272	ENSG00000018236,ENST00000551295;;;ENST00000551295		Congenital myopathy 12	612540	AR	3	Cntn1
12q12	12:42456757-42589746	PRICKLE1, RILP, EPM1B	Prickle-like 1	608500	PRICKLE1	144165	ENSG00000139174,ENST00000345127;;;ENST00000345127		Epilepsy, progressive myoclonic 1B	612437	AR	3	Prickle1
12q12	12:43758951-43789541	IRAK4, REN64, IPD1, IMD67	Interleukin 1 receptor-associated kinase 4	606883	IRAK4	51135	ENSG00000198001,ENST00000613694;;;ENST00000613694		Immunodeficiency 67	607676	AR	3	Irak4
12q12	12:45216095-45440404	ANO6, TMEM16F, SCTS, BDPLT7	Anoctamin 6	608663	ANO6	196527	ENSG00000177119,ENST00000320560;;;ENST00000320560		Scott syndrome	262890	AR	3	Ano6
12q12	12:45729706-45908037	ARID2, BAF200, KIAA1557, CSS6	AT-rich interaction domain-containing protein 2	609539	ARID2	196528	ENSG00000189079,ENST00000334344;;;ENST00000334344		Coffin-Siris syndrome 6	617808	AD	3	Arid2
12q13	12:46000001-57700000	BCC4	Basal cell carcinoma, susceptibility to, 4	613061		100307121		associated with rs11170164	{Basal cell carcinoma, susceptibility to, 4}	613061		2	
12q13	12:46000001-57700000	CMTS	Chronic mountain sickness, susceptibility to	616182		105180377			{Chronic mountain sickness, susceptibility to}	616182		2	
12q13-q14	12:46000001-67300000	DFNA48	Deafness, autosomal dominant 48	607841					Deafness, autosomal dominant 48	607841	AD	2	
12q13-q21	12:46000001-92200000	ENUR2	Enuresis, nocturnal, 2	600808		2032			Enuresis, nocturnal, 2	600808	AD	2	
12q13.11-q15	12:46000001-71100000	MRT25	Intellectual developmental disorder, autosomal recessive 25	614346		100852403		between rs4760658 and rs1882033	Intellectual developmental disorder, autosomal recessive 25	614346	AR	2	
12q13.1	12:46000001-54500000	MXLPO	Myxoid liposarcoma	613488				fusion of DDIT3 and FUS	Myxoid liposarcoma	613488		4	
12q13	12:46000001-57700000	SPDT	Spondyloepiphyseal dysplasia tarda, autosomal dominant	184100		103875461			Spondyloepiphyseal dysplasia tarda, autosomal dominant	184100	AD	2	
12q13.11	12:47841537-47904994	VDR	Vitamin D (1,25-dihydroxyvitamin D3) receptor	601769	VDR	7421	ENSG00000111424,ENST00000549336;;;ENST00000549336		Rickets, vitamin D-resistant, type IIA	277440	AR	3	Vdr
12q13.11	12:47972967-48006212	COL2A1, STL1, ACG2, SEDC, SEMDSTWK, EDMMD, OSCDP, VPED, PLSDT, ANFH1, LCPD, SEDSTN, SMDALG	Collagen II, alpha-1 polypeptide	120140	COL2A1	1280	ENSG00000139219,ENST00000380518;;;ENST00000380518	mutation identified in 1 VPED family	?Epiphyseal dysplasia, multiple, with myopia and deafness	132450	AD	3	Col2a1
12q13.11	12:47972967-48006212	COL2A1, STL1, ACG2, SEDC, SEMDSTWK, EDMMD, OSCDP, VPED, PLSDT, ANFH1, LCPD, SEDSTN, SMDALG	Collagen II, alpha-1 polypeptide	120140	COL2A1	1280	ENSG00000139219,ENST00000380518;;;ENST00000380518	mutation identified in 1 VPED family	?Vitreoretinopathy with phalangeal epiphyseal dysplasia	619248	AD	3	Col2a1
12q13.11	12:47972967-48006212	COL2A1, STL1, ACG2, SEDC, SEMDSTWK, EDMMD, OSCDP, VPED, PLSDT, ANFH1, LCPD, SEDSTN, SMDALG	Collagen II, alpha-1 polypeptide	120140	COL2A1	1280	ENSG00000139219,ENST00000380518;;;ENST00000380518	mutation identified in 1 VPED family	Achondrogenesis, type II or hypochondrogenesis	200610	AD	3	Col2a1
12q13.11	12:47972967-48006212	COL2A1, STL1, ACG2, SEDC, SEMDSTWK, EDMMD, OSCDP, VPED, PLSDT, ANFH1, LCPD, SEDSTN, SMDALG	Collagen II, alpha-1 polypeptide	120140	COL2A1	1280	ENSG00000139219,ENST00000380518;;;ENST00000380518	mutation identified in 1 VPED family	Avascular necrosis of the femoral head	608805	AD	3	Col2a1
12q13.11	12:47972967-48006212	COL2A1, STL1, ACG2, SEDC, SEMDSTWK, EDMMD, OSCDP, VPED, PLSDT, ANFH1, LCPD, SEDSTN, SMDALG	Collagen II, alpha-1 polypeptide	120140	COL2A1	1280	ENSG00000139219,ENST00000380518;;;ENST00000380518	mutation identified in 1 VPED family	Czech dysplasia	609162	AD	3	Col2a1
12q13.11	12:47972967-48006212	COL2A1, STL1, ACG2, SEDC, SEMDSTWK, EDMMD, OSCDP, VPED, PLSDT, ANFH1, LCPD, SEDSTN, SMDALG	Collagen II, alpha-1 polypeptide	120140	COL2A1	1280	ENSG00000139219,ENST00000380518;;;ENST00000380518	mutation identified in 1 VPED family	Kniest dysplasia	156550	AD	3	Col2a1
12q13.11	12:47972967-48006212	COL2A1, STL1, ACG2, SEDC, SEMDSTWK, EDMMD, OSCDP, VPED, PLSDT, ANFH1, LCPD, SEDSTN, SMDALG	Collagen II, alpha-1 polypeptide	120140	COL2A1	1280	ENSG00000139219,ENST00000380518;;;ENST00000380518	mutation identified in 1 VPED family	Legg-Calve-Perthes disease	150600	AD	3	Col2a1
12q13.11	12:47972967-48006212	COL2A1, STL1, ACG2, SEDC, SEMDSTWK, EDMMD, OSCDP, VPED, PLSDT, ANFH1, LCPD, SEDSTN, SMDALG	Collagen II, alpha-1 polypeptide	120140	COL2A1	1280	ENSG00000139219,ENST00000380518;;;ENST00000380518	mutation identified in 1 VPED family	Osteoarthritis with mild chondrodysplasia	604864	AD	3	Col2a1
12q13.11	12:47972967-48006212	COL2A1, STL1, ACG2, SEDC, SEMDSTWK, EDMMD, OSCDP, VPED, PLSDT, ANFH1, LCPD, SEDSTN, SMDALG	Collagen II, alpha-1 polypeptide	120140	COL2A1	1280	ENSG00000139219,ENST00000380518;;;ENST00000380518	mutation identified in 1 VPED family	Platyspondylic skeletal dysplasia, Torrance type	151210	AD	3	Col2a1
12q13.11	12:47972967-48006212	COL2A1, STL1, ACG2, SEDC, SEMDSTWK, EDMMD, OSCDP, VPED, PLSDT, ANFH1, LCPD, SEDSTN, SMDALG	Collagen II, alpha-1 polypeptide	120140	COL2A1	1280	ENSG00000139219,ENST00000380518;;;ENST00000380518	mutation identified in 1 VPED family	SED congenita	183900	AD	3	Col2a1
12q13.11	12:47972967-48006212	COL2A1, STL1, ACG2, SEDC, SEMDSTWK, EDMMD, OSCDP, VPED, PLSDT, ANFH1, LCPD, SEDSTN, SMDALG	Collagen II, alpha-1 polypeptide	120140	COL2A1	1280	ENSG00000139219,ENST00000380518;;;ENST00000380518	mutation identified in 1 VPED family	SMED Strudwick type	184250	AD	3	Col2a1
12q13.11	12:47972967-48006212	COL2A1, STL1, ACG2, SEDC, SEMDSTWK, EDMMD, OSCDP, VPED, PLSDT, ANFH1, LCPD, SEDSTN, SMDALG	Collagen II, alpha-1 polypeptide	120140	COL2A1	1280	ENSG00000139219,ENST00000380518;;;ENST00000380518	mutation identified in 1 VPED family	Spondyloepiphyseal dysplasia, Stanescu type	616583	AD	3	Col2a1
12q13.11	12:47972967-48006212	COL2A1, STL1, ACG2, SEDC, SEMDSTWK, EDMMD, OSCDP, VPED, PLSDT, ANFH1, LCPD, SEDSTN, SMDALG	Collagen II, alpha-1 polypeptide	120140	COL2A1	1280	ENSG00000139219,ENST00000380518;;;ENST00000380518	mutation identified in 1 VPED family	Spondylometaphyseal dysplasia, Algerian type	184253	AD	3	Col2a1
12q13.11	12:47972967-48006212	COL2A1, STL1, ACG2, SEDC, SEMDSTWK, EDMMD, OSCDP, VPED, PLSDT, ANFH1, LCPD, SEDSTN, SMDALG	Collagen II, alpha-1 polypeptide	120140	COL2A1	1280	ENSG00000139219,ENST00000380518;;;ENST00000380518	mutation identified in 1 VPED family	Spondyloperipheral dysplasia	271700	AD	3	Col2a1
12q13.11	12:47972967-48006212	COL2A1, STL1, ACG2, SEDC, SEMDSTWK, EDMMD, OSCDP, VPED, PLSDT, ANFH1, LCPD, SEDSTN, SMDALG	Collagen II, alpha-1 polypeptide	120140	COL2A1	1280	ENSG00000139219,ENST00000380518;;;ENST00000380518	mutation identified in 1 VPED family	Stickler syndrome, type I	108300	AD	3	Col2a1
12q13.11	12:47972967-48006212	COL2A1, STL1, ACG2, SEDC, SEMDSTWK, EDMMD, OSCDP, VPED, PLSDT, ANFH1, LCPD, SEDSTN, SMDALG	Collagen II, alpha-1 polypeptide	120140	COL2A1	1280	ENSG00000139219,ENST00000380518;;;ENST00000380518	mutation identified in 1 VPED family	Stickler syndrome, type I, nonsyndromic ocular	609508	AD	3	Col2a1
12q13.11	12:48105353-48146404	PFKM, GSD7	Phosphofructokinase, muscle type	610681	PFKM	5213	ENSG00000152556,ENST00000359794;;;ENST00000359794	incorrectly assigned to chr.1	Glycogen storage disease VII	232800	AR	3	Pfkm
12q13.12	12:48766194-48789974	ADCY6, LCCS8	Adenylate cyclase-6	600294	ADCY6	112	ENSG00000174233,ENST00000357869;;;ENST00000357869		Lethal congenital contracture syndrome 8	616287	AR	3	Adcy6
12q13.12	12:48904133-48921576	DRC2, CCDC65, CILD27	Dynein regulatory complex subunit 2	611088	DRC2	85478	ENSG00000139537,ENST00000320516;;;ENST00000320516		Ciliary dyskinesia, primary, 27	615504	AR	3	Ccdc65
12q13.12	12:48965340-48971735	WNT10B, SHFM6, STHAG8	Wingless-type MMTV integration site family, member 10B	601906	WNT10B	7480	ENSG00000169884,ENST00000301061;;;ENST00000301061		Split-hand/foot malformation 6	225300	AR	3	Wnt10b
12q13.12	12:48965340-48971735	WNT10B, SHFM6, STHAG8	Wingless-type MMTV integration site family, member 10B	601906	WNT10B	7480	ENSG00000169884,ENST00000301061;;;ENST00000301061		Tooth agenesis, selective, 8	617073	AD	3	Wnt10b
12q13.12	12:48978322-48982620	WNT1, INT1, OI15, BMND16	Wingless-type MMTV integration site family, member 1 (oncogene INT1)	164820	WNT1	7471	ENSG00000125084,ENST00000293549;;;ENST00000293549		{Osteoporosis, early-onset, susceptibility to, autosomal dominant}	615221	AD	3	Wnt1
12q13.12	12:48978322-48982620	WNT1, INT1, OI15, BMND16	Wingless-type MMTV integration site family, member 1 (oncogene INT1)	164820	WNT1	7471	ENSG00000125084,ENST00000293549;;;ENST00000293549		Osteogenesis imperfecta, type XV	615220	AR	3	Wnt1
12q13.12	12:49018978-49060794	KMT2D, MLL2, ALR, KABUK1, BCAHH	Lysine methyltransferase 2D	602113	KMT2D	8085	ENSG00000167548,ENST00000301067;;;ENST00000301067		Branchial arch abnormalities, choanal atresia, athelia, hearing loss, and hypothyroidism syndrome	620186	AD	3	Kmt2d
12q13.12	12:49018978-49060794	KMT2D, MLL2, ALR, KABUK1, BCAHH	Lysine methyltransferase 2D	602113	KMT2D	8085	ENSG00000167548,ENST00000301067;;;ENST00000301067		Kabuki syndrome 1	147920	AD	3	Kmt2d
12q13.12	12:49086656-49094801	DHH, SRXY7, GDMN	Desert hedgehog signaling molecule	605423	DHH	50846	ENSG00000139549,ENST00000649637;;;ENST00000649637		46XY gonadal dysgenesis with minifascicular neuropathy	607080	AR	3	Dhh
12q13.12	12:49086656-49094801	DHH, SRXY7, GDMN	Desert hedgehog signaling molecule	605423	DHH	50846	ENSG00000139549,ENST00000649637;;;ENST00000649637		46XY sex reversal 7	233420	AR	3	Dhh
12q13.12	12:49184795-49189080	TUBA1A, TUBA3, LIS3	Tubulin, alpha-1A	602529	TUBA1A	7846	ENSG00000167552,ENST00000301071;;;ENST00000301071		Lissencephaly 3	611603	AD	3	Tuba1a
12q13.12	12:49227926-49274600	TUBA1C, OZEMA24	Tubulin, alpha-1C	621161	TUBA1C	84790	ENSG00000167553,ENST00000301072;;;ENST00000301072		Oocyte/zygote/embryo maturation arrest 24	621232	AR	3	Tuba1c
12q13.12	12:49295147-49298686	PRPH	Peripherin	170710	PRPH	5630	ENSG00000135406,ENST00000257860;;;ENST00000257860		{Amyotrophic lateral sclerosis, susceptibility to}	105400	AD, AR	3	Prph
12q13.12	12:49950737-49958878	AQP2, NDI2	Aquaporin-2 (collecting duct)	107777	AQP2	359	ENSG00000167580,ENST00000199280;;;ENST00000199280		Diabetes insipidus, nephrogenic, 2	125800	AD, AR	3	Aqp2
12q13.12	12:49961872-49965682	AQP5, PPKB	Aquaporin-5	600442	AQP5	362	ENSG00000161798,ENST00000293599;;;ENST00000293599		Palmoplantar keratoderma, Bothnian type	600231	AD	3	Aqp5
12q13.12	12:49989162-50033440	RACGAP1, RCGAP1, MGCRACGAP, CYK4, CDAN3B	RAC GTPase-activating protein 1	604980	RACGAP1	29127	ENSG00000161800,ENST00000312377;;;ENST00000312377		Anemia, congenital dyserythropoietic, type IIIb, autosomal recessive	619789	AR	3	Racgap1
12q13.12	12:50085342-50100707	SMARCD1, BAF60A, CSS11	SW1/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 1	601735	SMARCD1	6602	ENSG00000066117,ENST00000394963;;;ENST00000394963		Coffin-Siris syndrome 11	618779	AD	3	Smarcd1
12q13.12	12:50104008-50111313	GPD1, HTGTI	Glycerol-3-phosphate dehydrogenase, soluble	138420	GPD1	2819	ENSG00000167588,ENST00000301149;;;ENST00000301149		Hypertriglyceridemia, transient infantile	614480	AR	3	Gpd1
12q13.12	12:50112236-50120453	COX14, C12orf62, MC4DN10	Cytochrome c oxidase assembly protein COX14	614478	COX14	84987	ENSG00000178449,ENST00000550487;;;ENST00000550487	mutation identified in 1 MC4DN10 family	?Mitochondrial complex IV deficiency, nuclear type 10	619053	AR	3	Cox14
12q13.12	12:50175788-50283520	LIMA1, EPLIN, SREBP3, LDLCQ8	LIM domain and actin-binding protein 1	608364	LIMA1	51474	ENSG00000050405,ENST00000341247;;;ENST00000341247		[Low density lipoprotein cholesterol level QTL 8]	618079		3	Lima1
12q13.12	12:50504985-50748657	DIP2B, KIAA1463	Disco-interacting protein 2 homolog B	611379	DIP2B	57609	ENSG00000066084,ENST00000301180;;;ENST00000301180		Intellectual developmental disorder, autosomal dominant, FRA12A type	136630	AD	3	Dip2b
12q13.12	12:50952263-51028886	SLC11A2, NRAMP2, DCT1, DMT1, AHMIO1	Solute carrier family 11 (proton-coupled divalent metal ion transporter) member 2	600523	SLC11A2	4891	ENSG00000110911,ENST00000262052;;;ENST00000262052		Anemia, hypochromic microcytic, with iron overload 1	206100	AR	3	Slc11a2
12q13.13	12:51591233-51812864	SCN8A, CIAT, DEE13, BFIS5, MYOCL2	Sodium voltage-gated channel, alpha subunit 8	600702	SCN8A	6334	ENSG00000196876,ENST00000627620;;;ENST00000627620	mutation identified in 1 MYOCL2 family	?Myoclonus, familial, 2	618364	AD	3	Scn8a
12q13.13	12:51591233-51812864	SCN8A, CIAT, DEE13, BFIS5, MYOCL2	Sodium voltage-gated channel, alpha subunit 8	600702	SCN8A	6334	ENSG00000196876,ENST00000627620;;;ENST00000627620	mutation identified in 1 MYOCL2 family	Cognitive impairment with or without cerebellar ataxia	614306	AD	3	Scn8a
12q13.13	12:51591233-51812864	SCN8A, CIAT, DEE13, BFIS5, MYOCL2	Sodium voltage-gated channel, alpha subunit 8	600702	SCN8A	6334	ENSG00000196876,ENST00000627620;;;ENST00000627620	mutation identified in 1 MYOCL2 family	Developmental and epileptic encephalopathy 13	614558	AD	3	Scn8a
12q13.13	12:51591233-51812864	SCN8A, CIAT, DEE13, BFIS5, MYOCL2	Sodium voltage-gated channel, alpha subunit 8	600702	SCN8A	6334	ENSG00000196876,ENST00000627620;;;ENST00000627620	mutation identified in 1 MYOCL2 family	Seizures, benign familial infantile, 5	617080	AD	3	Scn8a
12q13.13	12:51906944-51923361	ACVRL1, ACVRLK1, ALK1, HHT2	Activin A receptor, type II-like kinase 1	601284	ACVRL1	94	ENSG00000139567,ENST00000388922;;;ENST00000388922		Telangiectasia, hereditary hemorrhagic, type 2	600376	AD	3	Acvrl1
12q13.13	12:51951699-51997078	ACVR1B, ACVRLK4, ALK4	Activin A receptor, type IB	601300	ACVR1B	91	ENSG00000135503,ENST00000257963;;;ENST00000257963		Pancreatic cancer, somatic	260350		3	Acvr1b
12q13.13	12:52274645-52309163	KRT86, KRTHB6, HB6, NMLIX1	Keratin 86	601928	KRT86	3892	ENSG00000170442,ENST00000423955;;;ENST00000423955		Monilethrix 1	158000	AD	3	Krt86,Krt87
12q13.13	12:52285913-52291534	KRT81, KRTHB1, HB1, MNLIX2	Keratin 81	602153	KRT81	3887	ENSG00000205426,ENST00000327741;;;ENST00000327741		Monilethrix 2	621169	AD	3	Krt81,Krt87
12q13.13	12:52314301-52321398	KRT83, KRTHB3, HB3, MNLIX, EKVP5, MNLIX3	Keratin 83	602765	KRT83	3889	ENSG00000170523,ENST00000293670;;;ENST00000293670		Erythrokeratodermia variabilis et progressiva 5	617756	AR	3	Krt83,Krt87
12q13.13	12:52314301-52321398	KRT83, KRTHB3, HB3, MNLIX, EKVP5, MNLIX3	Keratin 83	602765	KRT83	3889	ENSG00000170523,ENST00000293670;;;ENST00000293670		Monilethrix 3	621170	AD	3	Krt83,Krt87
12q13.13	12:52360006-52367481	KRT85, KRTHB5, HB5, ECTD4	Keratin 85	602767	KRT85	3891	ENSG00000135443,ENST00000257901;;;ENST00000257901		Ectodermal dysplasia 4, hair/nail type	602032	AR	3	Krt85
12q13.13	12:52424070-52434371	KRT75, K6HF, PFB	Keratin 75	609025	KRT75	9119	ENSG00000170454,ENST00000252245;;;ENST00000252245		{Pseudofolliculitis barbae, susceptibility to}	612318		3	Krt75
12q13.13	12:52446651-52452146	KRT6B, PC4	Keratin 6B	148042	KRT6B	3854	ENSG00000185479,ENST00000252252;;;ENST00000252252		Pachyonychia congenita 4	615728	AD	3	Gm5414,Gm5478,Krt6a,Krt6b
12q13.13	12:52468516-52473805	KRT6C, PPKNEFD	Keratin 6C	612315	KRT6C	286887	ENSG00000170465,ENST00000252250;;;ENST00000252250		Palmoplantar keratoderma, nonepidermolytic, focal or diffuse	615735	AD	3	Gm5414,Gm5478,Krt6a,Krt6b
12q13.13	12:52487176-52493257	KRT6A, PC3	Keratin 6A	148041	KRT6A	3853	ENSG00000205420,ENST00000330722;;;ENST00000330722		Pachyonychia congenita 3	615726	AD	3	Gm5414,Gm5478,Krt6a,Krt6b
12q13.13	12:52514575-52520394	KRT5, DDD1, EBS2A, EBS2B, EBS2C, EBS2D, EBS2E, EBS2F	Keratin 5	148040	KRT5	3852	ENSG00000186081,ENST00000252242;;;ENST00000252242		Dowling-Degos disease 1	179850	AD	3	Krt5
12q13.13	12:52514575-52520394	KRT5, DDD1, EBS2A, EBS2B, EBS2C, EBS2D, EBS2E, EBS2F	Keratin 5	148040	KRT5	3852	ENSG00000186081,ENST00000252242;;;ENST00000252242		Epidermolysis bullosa simplex 2A, generalized severe	619555	AD	3	Krt5
12q13.13	12:52514575-52520394	KRT5, DDD1, EBS2A, EBS2B, EBS2C, EBS2D, EBS2E, EBS2F	Keratin 5	148040	KRT5	3852	ENSG00000186081,ENST00000252242;;;ENST00000252242		Epidermolysis bullosa simplex 2B, generalized intermediate	619588	AD	3	Krt5
12q13.13	12:52514575-52520394	KRT5, DDD1, EBS2A, EBS2B, EBS2C, EBS2D, EBS2E, EBS2F	Keratin 5	148040	KRT5	3852	ENSG00000186081,ENST00000252242;;;ENST00000252242		Epidermolysis bullosa simplex 2C, localized	619594	AD	3	Krt5
12q13.13	12:52514575-52520394	KRT5, DDD1, EBS2A, EBS2B, EBS2C, EBS2D, EBS2E, EBS2F	Keratin 5	148040	KRT5	3852	ENSG00000186081,ENST00000252242;;;ENST00000252242		Epidermolysis bullosa simplex 2D, generalized, intermediate or severe, autosomal recessive	619599	AR	3	Krt5
12q13.13	12:52514575-52520394	KRT5, DDD1, EBS2A, EBS2B, EBS2C, EBS2D, EBS2E, EBS2F	Keratin 5	148040	KRT5	3852	ENSG00000186081,ENST00000252242;;;ENST00000252242		Epidermolysis bullosa simplex 2E, with migratory circinate erythema	609352	AD	3	Krt5
12q13.13	12:52514575-52520394	KRT5, DDD1, EBS2A, EBS2B, EBS2C, EBS2D, EBS2E, EBS2F	Keratin 5	148040	KRT5	3852	ENSG00000186081,ENST00000252242;;;ENST00000252242		Epidermolysis bullosa simplex 2F, with mottled pigmentation	131960	AD	3	Krt5
12q13.13	12:52543909-52553145	KRT71, K6IRS1, KRT6IRS1, HYPT13	Keratin 71	608245	KRT71	112802	ENSG00000139648,ENST00000267119;;;ENST00000267119	mutation identified in 1 HYPT13 family	?Hypotrichosis 13	615896	AD	3	Krt71
12q13.13	12:52565782-52573843	KRT74, K6IRS4, KRT6IRS4, HTSS2, HYPT3, ADWH	Keratin 74	608248	KRT74	121391	ENSG00000170484,ENST00000305620;;;ENST00000305620	mutation identified in 1 HYPT3 family and ECTD7 family	?Ectodermal dysplasia 7, hair/nail type	614929	AR	3	Krt74
12q13.13	12:52565782-52573843	KRT74, K6IRS4, KRT6IRS4, HTSS2, HYPT3, ADWH	Keratin 74	608248	KRT74	121391	ENSG00000170484,ENST00000305620;;;ENST00000305620	mutation identified in 1 HYPT3 family and ECTD7 family	?Hypotrichosis 3	613981	AD	3	Krt74
12q13.13	12:52565782-52573843	KRT74, K6IRS4, KRT6IRS4, HTSS2, HYPT3, ADWH	Keratin 74	608248	KRT74	121391	ENSG00000170484,ENST00000305620;;;ENST00000305620	mutation identified in 1 HYPT3 family and ECTD7 family	Woolly hair, autosomal dominant	194300	AD	3	Krt74
12q13.13	12:52644558-52652211	KRT2, KRT2A, KRT2E	Keratin 2	600194	KRT2	3849	ENSG00000172867,ENST00000309680;;;ENST00000309680		Ichthyosis bullosa of Siemens	146800	AD	3	Krt2
12q13.13	12:52674736-52680407	KRT1, EPPK, NEPPK, EHK1, AEI2	Keratin 1	139350	KRT1	3848	ENSG00000167768,ENST00000252244;;;ENST00000252244	close to Hox-3 in mouse; class II keratin	Epidermolytic hyperkeratosis 1	113800	AD	3	Krt1
12q13.13	12:52674736-52680407	KRT1, EPPK, NEPPK, EHK1, AEI2	Keratin 1	139350	KRT1	3848	ENSG00000167768,ENST00000252244;;;ENST00000252244	close to Hox-3 in mouse; class II keratin	Ichthyosis histrix, Curth-Macklin type	146590	AD	3	Krt1
12q13.13	12:52674736-52680407	KRT1, EPPK, NEPPK, EHK1, AEI2	Keratin 1	139350	KRT1	3848	ENSG00000167768,ENST00000252244;;;ENST00000252244	close to Hox-3 in mouse; class II keratin	Ichthyosis, annular epidermolytic 2	620148	AD	3	Krt1
12q13.13	12:52674736-52680407	KRT1, EPPK, NEPPK, EHK1, AEI2	Keratin 1	139350	KRT1	3848	ENSG00000167768,ENST00000252244;;;ENST00000252244	close to Hox-3 in mouse; class II keratin	Keratosis palmoplantaris striata III	607654		3	Krt1
12q13.13	12:52674736-52680407	KRT1, EPPK, NEPPK, EHK1, AEI2	Keratin 1	139350	KRT1	3848	ENSG00000167768,ENST00000252244;;;ENST00000252244	close to Hox-3 in mouse; class II keratin	Palmoplantar keratoderma, epidermolytic, 2	620411	AD	3	Krt1
12q13.13	12:52674736-52680407	KRT1, EPPK, NEPPK, EHK1, AEI2	Keratin 1	139350	KRT1	3848	ENSG00000167768,ENST00000252244;;;ENST00000252244	close to Hox-3 in mouse; class II keratin	Palmoplantar keratoderma, nonepidermolytic	600962	AD	3	Krt1
12q13.13	12:52789685-52796117	KRT3, MECD2	Keratin 3	148043	KRT3	3850	ENSG00000186442,ENST00000417996;;;ENST00000417996		Meesmann corneal dystrophy 2	618767	AD	3	
12q13.13	12:52806549-52814116	KRT4, CYK4, WSN1	Keratin 4	123940	KRT4	3851	ENSG00000170477,ENST00000551956;;;ENST00000551956	class II keratin	White sponge nevus 1	193900	AD	3	Krt4
12q13.13	12:52948855-52952906	KRT18	Keratin 18	148070	KRT18	3875	ENSG00000111057,ENST00000388835;;;ENST00000388835	contiguous to KRT8, type II heteromer partner	{Cirrhosis, noncryptogenic, susceptibility to}	215600	AR	3	Krt18
12q13.13	12:52948855-52952906	KRT18	Keratin 18	148070	KRT18	3875	ENSG00000111057,ENST00000388835;;;ENST00000388835	contiguous to KRT8, type II heteromer partner	Cirrhosis, cryptogenic	215600	AR	3	Krt18
12q13.13	12:53307460-53321610	AAAS, AAA	Aladin WD repeat nucleoporin	605378	AAAS	8086	ENSG00000094914,ENST00000209873;;;ENST00000209873		Achalasia-addisonianism-alacrimia syndrome	231550	AR	3	Aaas
12q13.13	12:53326575-53344793	SP7, OSX, OI12	Transcription factor Sp7	606633	SP7	121340	ENSG00000170374,ENST00000536324;;;ENST00000536324		Osteogenesis imperfecta, type XII	613849	AR	3	Sp7
12q13.13	12:53423855-53431672	AMHR2, AMHR	Anti-Mullerian hormone receptor, type II	600956	AMHR2	269	ENSG00000135409,ENST00000257863;;;ENST00000257863		Persistent Mullerian duct syndrome, type II	261550	AR	3	Amhr2
12q13.13	12:53938831-53946544	HOXC13, HOX3G, ECTD9	Homeobox C13	142976	HOXC13	3229	ENSG00000123364,ENST00000243056;;;ENST00000243056	fused with NUP98 in AML	Ectodermal dysplasia 9, hair/nail type	614931	AR	3	Hoxc13
12q13.13	12:54280726-54287087	HNRNPA1, IBMPFD3, ALS20, MPD3	Heterogeneous nuclear ribonucleoprotein A1	164017	HNRNPA1	3178	ENSG00000135486,ENST00000340913;;;ENST00000340913	mutation identified in 1 IBMPFD3 family and 1 MPD3 family	?Inclusion body myopathy with early-onset Paget disease without frontotemporal dementia 3	615424	AD	3	Hnrnpa1
12q13.13	12:54280726-54287087	HNRNPA1, IBMPFD3, ALS20, MPD3	Heterogeneous nuclear ribonucleoprotein A1	164017	HNRNPA1	3178	ENSG00000135486,ENST00000340913;;;ENST00000340913	mutation identified in 1 IBMPFD3 family and 1 MPD3 family	?Myopathy, distal, 3	610099	AD	3	Hnrnpa1
12q13.13	12:54280726-54287087	HNRNPA1, IBMPFD3, ALS20, MPD3	Heterogeneous nuclear ribonucleoprotein A1	164017	HNRNPA1	3178	ENSG00000135486,ENST00000340913;;;ENST00000340913	mutation identified in 1 IBMPFD3 family and 1 MPD3 family	Amyotrophic lateral sclerosis 20	615426	AD	3	Hnrnpa1
12q13.13-q13.2	12:54497752-54548243	NCKAP1L, HEM1, IMD72	NCK associated protein 1-like	141180	NCKAP1L	3071	ENSG00000123338,ENST00000293373;;;ENST00000293373		Immunodeficiency 72 with autoinflammation	618982	AR	3	Nckap1l
12q13.2	12:55684568-55716400	ITGA7	Integrin, alpha-7	600536	ITGA7	3679	ENSG00000135424,ENST00000257879;;;ENST00000257879		Muscular dystrophy, congenital, due to ITGA7 deficiency	613204	AR	3	Itga7
12q13.2	12:55720393-55724705	RDH5	Retinol dehydrogenase-5	601617	RDH5	5959	ENSG00000135437,ENST00000257895;;;ENST00000257895		Fundus albipunctatus	136880	AD, AR	3	Rdh5
12q13.2	12:55743122-55757264	GDF11, BMP11, VHO	Growth/differentiation factor 11	603936	GDF11	10220	ENSG00000135414,ENST00000257868;;;ENST00000257868	mutation identified in 1 VHO family	?Vertebral hypersegmentation and orofacial anomalies	619122	AD	3	Gdf11
12q13.2	12:55835433-55842936	MMP19, MMP18, CODA	Matrix metalloproteinase-19	601807	MMP19	4327	ENSG00000123342,ENST00000322569;;;ENST00000322569	triplication in upstream regulatory region	Cavitary optic disc anomalies	611543	AD	3	Mmp19
12q13.2	12:55997276-56005525	SUOX	Sulfite oxidase	606887	SUOX	6821	ENSG00000139531,ENST00000266971;;;ENST00000266971		Sulfite oxidase deficiency	272300	AR	3	Suox
12q13.2	12:56041918-56044697	RPS26, DBA10	Ribosomal protein S26	603701	RPS26	6231	ENSG00000197728,ENST00000646449;;;ENST00000646449		Diamond-Blackfan anemia 10	613309	AD	3	Rps26
12q13.2	12:56080108-56103505	ERBB3, LCCS2, FERLK, VSCN1	Transformation gene ERBB-3	190151	ERBB3	2065	ENSG00000065361,ENST00000267101;;;ENST00000267101	mutations identified in 1 LCCS2 family and 1 FERLK family	?Lethal congenital contractural syndrome 2	607598	AR	3	Erbb3
12q13.2	12:56080108-56103505	ERBB3, LCCS2, FERLK, VSCN1	Transformation gene ERBB-3	190151	ERBB3	2065	ENSG00000065361,ENST00000267101;;;ENST00000267101	mutations identified in 1 LCCS2 family and 1 FERLK family	{?Erythroleukemia, familial, susceptibility to}	133180	AD	3	Erbb3
12q13.2	12:56080108-56103505	ERBB3, LCCS2, FERLK, VSCN1	Transformation gene ERBB-3	190151	ERBB3	2065	ENSG00000065361,ENST00000267101;;;ENST00000267101	mutations identified in 1 LCCS2 family and 1 FERLK family	Visceral neuropathy, familial, 1, autosomal recessive	243180	AR	3	Erbb3
12q13.2	12:56162359-56189483	SMARCC2, BAF170, CSS8	SW1/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily c, member 2	601734	SMARCC2	6601	ENSG00000139613,ENST00000550164;;;ENST00000550164		Coffin-Siris syndrome 8	618362	AD	3	Smarcc2
12q13.3	12:56200001-57700000	AAA4	Aortic aneurysm, familial abdominal 4	614375		100859927		associated with rs1466535	Aortic aneurysm, familial abdominal 4	614375		2	
12q13.3	12:56230051-56237846	SLC39A5, MYP24	Solute carrier family 39 (zinc transporter), member 5	608730	SLC39A5	283375	ENSG00000139540,ENST00000454355;;;ENST00000454355		Myopia 24, autosomal dominant	615946	AD	3	Slc39a5
12q13.3	12:56316936-56334000	PAN2, USP52, KIAA0710, DEDCRF	PABP-dependent poly(A) nuclease 2	617447	PAN2	9924	ENSG00000135473,ENST00000440411;;;ENST00000440411		Developmental delay with variable cardiac and renal congenital anomalies and dysmoprhic facies	621384		3	Pan2
12q13.3	12:56341597-56360107	STAT2, IMD44, PTORCH3	Signal transducer and activator of transcription 2	600556	STAT2	6773	ENSG00000170581,ENST00000314128;;;ENST00000314128		Immunodeficiency 44	616636	AR	3	Stat2
12q13.3	12:56341597-56360107	STAT2, IMD44, PTORCH3	Signal transducer and activator of transcription 2	600556	STAT2	6773	ENSG00000170581,ENST00000314128;;;ENST00000314128		Pseudo-TORCH syndrome 3	618886	AR	3	Stat2
12q13.3	12:56416363-56449426	TIMELESS, TIM, TIM1, FASPS4	Timeless circadian regulator	603887	TIMELESS	8914	ENSG00000111602,ENST00000553532;;;ENST00000553532	mutation identified in 1 FASPS4 family	?Advance sleep phase syndrome, familial, 4	620015	AD	3	Timeless
12q13.3	12:56449502-56456553	MIP, AQP0, CTRCT15	Major intrinsic protein of lens fiber	154050	MIP	4284	ENSG00000135517,ENST00000652304;;;ENST00000652304	slightly distal to AQP2	Cataract 15, multiple types	615274	AD	3	Mip
12q13.3	12:56638175-56645984	ATP5F1B, ATP5B, ATPSB, HUMOP2	ATP synthase F1, subunit beta	102910	ATP5F1B	506	ENSG00000110955,ENST00000262030;;;ENST00000262030	mutation identified in 1 HUMOP2 family	?Hypermetabolism due to uncoupled mitochondrial oxidative phosphorylation 2	620085	AD	3	Atp5f1b
12q13.3	12:56731580-56752323	PRIM1, PDIL	Primase, polypeptide-1, 49kD	176635	PRIM1	5557	ENSG00000198056,ENST00000338193;;;ENST00000338193		Primordial dwarfism-immunodeficiency-lipodystrophy syndrome	620005	AR	3	Prim1
12q13.3	12:56923133-56934408	SDR9C7, SDRO, ARCI13	Short chain dehydrogenase/reductase family 9C member 7	609769	SDR9C7	121214	ENSG00000170426,ENST00000293502;;;ENST00000293502		Ichthyosis, congenital, autosomal recessive 13	617574	AR	3	Sdr9c7
12q13.3	12:57010000-57016529	TAC3, NKNB, HH10	Tachykinin 3 (neuromedin K, neurokinin B)	162330	TAC3	6866	ENSG00000166863,ENST00000458521;;;ENST00000458521		Hypogonadotropic hypogonadism 10 with or without anosmia	614839	AR	3	Tac2
12q13.3	12:57028517-57051198	MYO1A, DIAR15	Myosin IA	601478	MYO1A	4640	ENSG00000166866,ENST00000300119;;;ENST00000300119	mutation identified in 1 DIAR15 patient	?Diarrhea 15, congenital	621179	AR	3	Myo1a
12q13.3	12:57095408-57111362	STAT6, HIES6	Signal transducer and activator of transcription-6, interleukin-4 induced	601512	STAT6	6778	ENSG00000166888,ENST00000300134;;;ENST00000300134		Hyper-IgE syndrome 6, autosomal dominant, with recurrent infections	620532	AD	3	Stat6
12q13.3	12:57128483-57213361	LRP1, A2MR, KPA, DDH3	Low density lipoprotein-related protein-1 (alpha-2-macroglobulin receptor)	107770	LRP1	4035	ENSG00000123384,ENST00000243077;;;ENST00000243077	mutation identified in 1 KPA family	?Keratosis pilaris atrophicans	604093	AR	3	Lrp1
12q13.3	12:57128483-57213361	LRP1, A2MR, KPA, DDH3	Low density lipoprotein-related protein-1 (alpha-2-macroglobulin receptor)	107770	LRP1	4035	ENSG00000123384,ENST00000243077;;;ENST00000243077	mutation identified in 1 KPA family	Developmental dysplasia of the hip 3	620690	AD	3	Lrp1
12q13.3	12:57229711-57234935	SHMT2, GLYA, NEDCASB	Serine hydroxymethyltransferase	138450	SHMT2	6472	ENSG00000182199,ENST00000328923;;;ENST00000328923	glycine A auxotroph	Neurodevelopmental disorder with cardiomyopathy, spasticity, and brain abnormalities	619121	AR	3	Shmt2
12q13.3	12:57243458-57251187	STAC3, NAM, CMYO13	SH3 and cystein-rich domains 3	615521	STAC3	246329	ENSG00000185482,ENST00000332782;;;ENST00000332782		Congenital myopathy 13	255995	AR	3	Stac3
12q13.3	12:57459785-57472268	GLI1, PAPA8, PPD1	GLI family zinc finger 1	165220	GLI1	2735	ENSG00000111087,ENST00000228682;;;ENST00000228682	mutation identified in 1 PPD1 family	Polydactyly, postaxial, type A8	618123	AR	3	Gli1
12q13.3	12:57459785-57472268	GLI1, PAPA8, PPD1	GLI family zinc finger 1	165220	GLI1	2735	ENSG00000111087,ENST00000228682;;;ENST00000228682	mutation identified in 1 PPD1 family	Polydactyly, preaxial I	174400	AR	3	Gli1
12q13.3	12:57488068-57516652	MARS1, MARS, MTRNS, METRS, ILLD, CMT2U, TTD9, SPG70	Methioninyl-tRNA synthetase 1	156560	MARS1	4141	ENSG00000166986,ENST00000262027;;;ENST00000262027	mutation identified in 1 TTD9 patient	?Trichothiodystrophy 9, nonphotosensitive	619692	AR	3	Mars1
12q13.3	12:57488068-57516652	MARS1, MARS, MTRNS, METRS, ILLD, CMT2U, TTD9, SPG70	Methioninyl-tRNA synthetase 1	156560	MARS1	4141	ENSG00000166986,ENST00000262027;;;ENST00000262027	mutation identified in 1 TTD9 patient	Charcot-Marie-Tooth disease, axonal, type 2U	616280	AD	3	Mars1
12q13.3	12:57488068-57516652	MARS1, MARS, MTRNS, METRS, ILLD, CMT2U, TTD9, SPG70	Methioninyl-tRNA synthetase 1	156560	MARS1	4141	ENSG00000166986,ENST00000262027;;;ENST00000262027	mutation identified in 1 TTD9 patient	Interstitial lung and liver disease	615486	AR	3	Mars1
12q13.3	12:57488068-57516652	MARS1, MARS, MTRNS, METRS, ILLD, CMT2U, TTD9, SPG70	Methioninyl-tRNA synthetase 1	156560	MARS1	4141	ENSG00000166986,ENST00000262027;;;ENST00000262027	mutation identified in 1 TTD9 patient	Spastic paraplegia 70, autosomal recessive	620323	AR	3	Mars1
12q13.3	12:57550044-57586633	KIF5A, NKHC, SPG10, NEIMY, ALS25	Kinesin family member 5A	602821	KIF5A	3798	ENSG00000155980,ENST00000455537;;;ENST00000455537		{Amyotrophic lateral sclerosis, susceptibility to, 25}	617921	AD	3	Kif5a
12q13.3	12:57550044-57586633	KIF5A, NKHC, SPG10, NEIMY, ALS25	Kinesin family member 5A	602821	KIF5A	3798	ENSG00000155980,ENST00000455537;;;ENST00000455537		Myoclonus, intractable, neonatal	617235	AD	3	Kif5a
12q13.3	12:57550044-57586633	KIF5A, NKHC, SPG10, NEIMY, ALS25	Kinesin family member 5A	602821	KIF5A	3798	ENSG00000155980,ENST00000455537;;;ENST00000455537		Spastic paraplegia 10, autosomal dominant	604187	AD	3	Kif5a
12q13.3	12:57623409-57633201	B4GALNT1, GALGT, GALNACT, SPG26	Beta-1,4-N-acetylgalactosaminyltransferase 1	601873	B4GALNT1	2583	ENSG00000135454,ENST00000341156;;;ENST00000341156		Spastic paraplegia 26, autosomal recessive	609195	AR	3	B4galnt1
12q14	12:57700001-67300000	GLC1P	Glaucoma 1, open angle, P	177700				caused by 300kb duplication	Glaucoma 1, open angle, P	177700	AD	4	
12q14.1	12:57747727-57752310	CDK4, CMM3	Cyclin-dependent kinase 4	123829	CDK4	1019	ENSG00000135446,ENST00000257904;;;ENST00000257904		{Melanoma, cutaneous malignant, 3}	609048	AD	3	Cdk4
12q14.1	12:57762334-57767078	CYP27B1, VDD1, PDDR	Cytochrome P450, subfamily XXVIIB, polypeptide 1	609506	CYP27B1	1594	ENSG00000111012,ENST00000228606;;;ENST00000228606		Vitamin D-dependent rickets, type I	264700	AR	3	Cyp27b1
12q14.1	12:57782787-57802856	TSFM, COXPD3	Ts translation elongation factor, mitochondrial	604723	TSFM	10102	ENSG00000123297,ENST00000652027;;;ENST00000652027		Combined oxidative phosphorylation deficiency 3	610505	AR	3	Tsfm
12q14.1	12:57797380-57818734	AVIL, NPHS21	Advillin	613397	AVIL	10677	ENSG00000135407,ENST00000549994;;;ENST00000549994		Nephrotic syndrome, type 21	618594	AR	3	Avil
12q14.2	12:62700001-64700000	AUTS13	Autism, susceptibility to, 13	610908		100188317		linkage with rs1445442	{Autism susceptibility 13}	610908		2	
12q14.2	12:63558913-63668805	DPY19L2, SPGF9	DPY19-like 2	613893	DPY19L2	283417	ENSG00000177990,ENST00000324472;;;ENST00000324472	pseudogene on 7p14.3	Spermatogenic failure 9	613958	AR	3	Dpy19l2
12q14.2	12:63779909-63809562	RXYLT1, TMEM5, MDDGA10	Ribitol xylosyltransferase 1	605862	RXYLT1	10329	ENSG00000118600,ENST00000261234;;;ENST00000261234		Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 10	615041	AR	3	Rxylt1
12q14.2	12:63844700-64162217	SRGAP1, KIAA1304, NMTC2	Slit-robo GTPase-activating protein, rho, 1	606523	SRGAP1	57522	ENSG00000196935,ENST00000355086;;;ENST00000355086		{Thyroid cancer, nonmedullary, 2}	188470	AD, SMu	3	Srgap1
12q14.2	12:64186316-64222296	KICS2, C12orf66, MRT83	KICSTOR subunit 2	617420	KICS2	144577	ENSG00000174206,ENST00000398055;;;ENST00000398055		Intellectual developmental disorder, autosomal recessive 83	621100	AR	3	Kics2
12q14.2	12:64452120-64502114	TBK1, NAK, FTDALS4, IIAE8, AIARV	TANK-binding kinase 1	604834	TBK1	29110	ENSG00000183735,ENST00000331710;;;ENST00000331710		{Encephalopathy, acute, infection-induced (herpes-specific), susceptibility to, 8}	617900	AD	3	Tbk1
12q14.2	12:64452120-64502114	TBK1, NAK, FTDALS4, IIAE8, AIARV	TANK-binding kinase 1	604834	TBK1	29110	ENSG00000183735,ENST00000331710;;;ENST00000331710		Autoinflammation with arthritis and vasculitis	620880	AR	3	Tbk1
12q14.2	12:64452120-64502114	TBK1, NAK, FTDALS4, IIAE8, AIARV	TANK-binding kinase 1	604834	TBK1	29110	ENSG00000183735,ENST00000331710;;;ENST00000331710		Frontotemporal dementia and/or amyotrophic lateral sclerosis 4	616439	AD	3	Tbk1
12q14.3	12:64700001-67300000	STQTL9	Stature quantitative trait locus 9	611547				associated with rs1042725	{Stature QTL 9}	611547		2	
12q14.3	12:64713449-64759406	GNS, G6S	N-acetylglucosamine-6-sulfatase	607664	GNS	2799	ENSG00000135677,ENST00000258145;;;ENST00000258145		Mucopolysaccharidosis type IIID	252940	AR	3	Gns
12q14.3	12:65169583-65248355	LEMD3, MAN1	LEM domain-containing 3	607844	LEMD3	23592	ENSG00000174106,ENST00000308330;;;ENST00000308330		Buschke-Ollendorff syndrome	166700	AD	3	Lemd3
12q14.3	12:65169583-65248355	LEMD3, MAN1	LEM domain-containing 3	607844	LEMD3	23592	ENSG00000174106,ENST00000308330;;;ENST00000308330		Osteopoikilosis with or without melorheostosis	166700	AD	3	Lemd3
12q14.3	12:65278683-65466907	MSRB3, DFNB74	Methionine sulfoxide reductase B3	613719	MSRB3	253827	ENSG00000174099,ENST00000308259;;;ENST00000308259		Deafness, autosomal recessive 74	613718	AR	3	Msrb3
12q14.3	12:65824460-65966291	HMGA2, HMGIC, BABL, SRS5	High-mobility group AT-hook 2	600698	HMGA2	8091	ENSG00000149948,ENST00000403681;;;ENST00000403681	fusion partners with RAD51B, ALDH2, COX6C, HEI10 in uterine leiomyomas	Silver-Russell syndrome 5	618908	AD	3	Hmga2
12q14.3	12:66189214-66254622	IRAK3, IRAKM, ASRT5	Interleukin 1 receptor-associated kinase 3	604459	IRAK3	11213	ENSG00000090376,ENST00000261233;;;ENST00000261233		{Asthma susceptibility 5}	611064		3	Irak3
12q14.3	12:66347431-67069338	GRIP1, FRASRS3	Glutamate receptor-interacting protein 1	604597	GRIP1	23426	ENSG00000155974,ENST00000359742;;;ENST00000359742		Fraser syndrome 3	617667	AR	3	Grip1
12q15	12:67300001-71100000	IBD26	Inflammatory bowel disease 26	612639		100271838		associated with rs1558744	{Inflammatory bowel disease 26}	612639		2	
12q15	12:68154768-68159740	IFNG, IFG, IFI, IMD69	Interferon, gamma	147570	IFNG	3458	ENSG00000111537,ENST00000229135;;;ENST00000229135	mutation identified in 1 IMD69 family	?Immunodeficiency 69, mycobacteriosis	618963	AR	3	Ifng
12q15	12:68154768-68159740	IFNG, IFG, IFI, IMD69	Interferon, gamma	147570	IFNG	3458	ENSG00000111537,ENST00000229135;;;ENST00000229135	mutation identified in 1 IMD69 family	{AIDS, rapid progression to}	609423		3	Ifng
12q15	12:68154768-68159740	IFNG, IFG, IFI, IMD69	Interferon, gamma	147570	IFNG	3458	ENSG00000111537,ENST00000229135;;;ENST00000229135	mutation identified in 1 IMD69 family	{Aplastic anemia}	609135		3	Ifng
12q15	12:68154768-68159740	IFNG, IFG, IFI, IMD69	Interferon, gamma	147570	IFNG	3458	ENSG00000111537,ENST00000229135;;;ENST00000229135	mutation identified in 1 IMD69 family	{Hepatitis C virus, response to therapy of}	609532		3	Ifng
12q15	12:68154768-68159740	IFNG, IFG, IFI, IMD69	Interferon, gamma	147570	IFNG	3458	ENSG00000111537,ENST00000229135;;;ENST00000229135	mutation identified in 1 IMD69 family	{TSC2 angiomyolipomas, renal, modifier of}	613254	AD	3	Ifng
12q15	12:68154768-68159740	IFNG, IFG, IFI, IMD69	Interferon, gamma	147570	IFNG	3458	ENSG00000111537,ENST00000229135;;;ENST00000229135	mutation identified in 1 IMD69 family	{Tuberculosis, protection against}	607948		3	Ifng
12q15	12:68610899-68671901	RAP1B, THC11	RAS-related protein RAP1B	179530	RAP1B	5908	ENSG00000127314,ENST00000250559;;;ENST00000250559		Thrombocytopenia 11 with multiple congenital anomalies and dysmorphic facies	620654	AD	3	Rap1b
12q15	12:68686978-68745809	NUP107, NUP84, NPHS11, ODG6, GAMOS7	Nucleoporin, 107kD	607617	NUP107	57122	ENSG00000111581,ENST00000229179;;;ENST00000229179	mutation identified in 1 ODG6 family	?Ovarian dysgenesis 6	618078	AR	3	Nup107
12q15	12:68686978-68745809	NUP107, NUP84, NPHS11, ODG6, GAMOS7	Nucleoporin, 107kD	607617	NUP107	57122	ENSG00000111581,ENST00000229179;;;ENST00000229179	mutation identified in 1 ODG6 family	Galloway-Mowat syndrome 7	618348	AR	3	Nup107
12q15	12:68686978-68745809	NUP107, NUP84, NPHS11, ODG6, GAMOS7	Nucleoporin, 107kD	607617	NUP107	57122	ENSG00000111581,ENST00000229179;;;ENST00000229179	mutation identified in 1 ODG6 family	Nephrotic syndrome, type 11	616730	AR	3	Nup107
12q15	12:68808172-68850686	MDM2, ACTFS, LSKB	MDM2 protooncogene	164785	MDM2	4193	ENSG00000135679,ENST00000258149;;;ENST00000258149	mutation identified in 1 LSKB patient	?Lessel-Kubisch syndrome	618681	AR	3	Mdm2
12q15	12:68808172-68850686	MDM2, ACTFS, LSKB	MDM2 protooncogene	164785	MDM2	4193	ENSG00000135679,ENST00000258149;;;ENST00000258149	mutation identified in 1 LSKB patient	{Accelerated tumor formation, susceptibility to}	614401	AD	3	Mdm2
12q15	12:69348381-69354234	LYZ, AMYLD5	Lysozyme	153450	LYZ	4069	ENSG00000090382,ENST00000261267;;;ENST00000261267		Amyloidosis, hereditary systemic 5	620658	AD	3	Lyz1,Lyz2,Lyz3
12q15	12:70243018-70354993	CNOT2, NOT2, IDNADFS	CCR4-NOT transcription complex, subunit 2	604909	CNOT2	4848	ENSG00000111596,ENST00000229195;;;ENST00000229195		Intellectual developmental disorder with nasal speech, dysmorphic facies, and variable skeletal anomalies	618608	AD	3	Cnot2
12q21-q23	12:71100001-108600000	DUH2	Dyschromatosis universalis hereditaria 2	612715		100301525		between rs1921045 and rs2373584	Dyschromatosis universalis hereditaria 2	612715		2	
12q21-q23	12:71100001-108600000	MYP3	Myopia, high grade, 3, autosomal dominant	603221		8782			Myopia-3	603221	AD	2	
12q21.1	12:71938845-72032440	TPH2, NTPH, ADHD7	Tryptophan hydroxylase 2	607478	TPH2	121278	ENSG00000139287,ENST00000333850;;;ENST00000333850	mutation identified in 1 ADHD7 family	{?Attention deficit-hyperactivity disorder, susceptibility to, 7}	613003		3	Tph2
12q21.1	12:71938845-72032440	TPH2, NTPH, ADHD7	Tryptophan hydroxylase 2	607478	TPH2	121278	ENSG00000139287,ENST00000333850;;;ENST00000333850	mutation identified in 1 ADHD7 family	{Unipolar depression, susceptibility to}	608516		3	Tph2
12q21.1	12:75040078-75209839	KCNC2, DEE103	Potassium voltage-gated channel, Shaw-related subfamily, member 2	176256	KCNC2	3747	ENSG00000166006,ENST00000549446;;;ENST00000549446	previously on 19q13.3-q13.4	Developmental and epileptic encephalopathy 103	619913	AD	3	Kcnc2
12q21.2	12:76344474-76348415	BBS10, C12orf58, FLJ23560	BBS10 gene	610148	BBS10	79738	ENSG00000179941,ENST00000650064;;;ENST00000650064		Bardet-Biedl syndrome 10	615987	AR	3	Bbs10
12q21.2	12:77571862-78213010	NAV3, POMFIl1, KIAA0938, NEDSFB	Neuron navigator 3	611629	NAV3	89795	ENSG00000067798,ENST00000397909;;;ENST00000397909		Neurodevelopmental disorder with poor or absent speech, dysmorphic facies, and behavioral abnormalities	621182	AR	3	Nav3
12q21.2	12:78863982-79452008	SYT1, BAGOS	Synaptotagmin-1	185605	SYT1	6857	ENSG00000067715,ENST00000261205;;;ENST00000261205		Baker-Gordon syndrome	618218	AD	3	Syt1
12q21.2-q21.31	12:79773563-79935460	PPP1R12A, MYPT1, GUBS	Protein phosphatase 1, regulatory subunit 12A (myosin phosphatase target subunit 1)	602021	PPP1R12A	4659	ENSG00000058272,ENST00000450142;;;ENST00000450142		Genitourinary and/or/brain malformation syndrome	618820	AD	3	Ppp1r12a
12q21.31	12:80099537-80380880	OTOGL, C12orf64, DFNB84B	Otogelin-like protein	614925	OTOGL	283310	ENSG00000165899,ENST00000547103;;;ENST00000547103		Deafness, autosomal recessive 84B	614944	AR	3	Otogl
12q21.31	12:80444235-80680273	PTPRQ, PTPGMC1, DFNB84A, DFNA73	Protein-tyrosine phosphatase, receptor-type, Q	603317	PTPRQ	374462	ENSG00000139304,ENST00000644991;;;ENST00000644991	mutation identified in 1 DFNA73 family	Deafness, autosomal dominant 73	617663	AD	3	Ptprq
12q21.31	12:80444235-80680273	PTPRQ, PTPGMC1, DFNB84A, DFNA73	Protein-tyrosine phosphatase, receptor-type, Q	603317	PTPRQ	374462	ENSG00000139304,ENST00000644991;;;ENST00000644991	mutation identified in 1 DFNA73 family	Deafness, autosomal recessive 84A	613391	AR	3	Ptprq
12q21.31	12:80716912-80719671	MYF5, EORVA	Myogenic factor-5	159990	MYF5	4617	ENSG00000111049,ENST00000228644;;;ENST00000228644		Ophthalmoplegia, external, with rib and vertebral anomalies	618155	AR	3	Myf5
12q21.31	12:85280220-85301784	ALX1, CART1, FND3	Aristaless-like homeobox 1 (cartilage homeoprotein 1)	601527	ALX1	8092	ENSG00000180318,ENST00000316824;;;ENST00000316824		Frontonasal dysplasia 3	613456	AR	3	Alx1
12q21.32	12:88049016-88142088	CEP290, KIAA0373, 3H11AG, JBTS5, SLSN6, LCA10, BBS14	Centrosomal protein, 290kD	610142	CEP290	80184	ENSG00000198707,ENST00000552810;;;ENST00000552810	mutation identified in 1 BBS14 family	?Bardet-Biedl syndrome 14	615991	AR	3	Cep290
12q21.32	12:88049016-88142088	CEP290, KIAA0373, 3H11AG, JBTS5, SLSN6, LCA10, BBS14	Centrosomal protein, 290kD	610142	CEP290	80184	ENSG00000198707,ENST00000552810;;;ENST00000552810	mutation identified in 1 BBS14 family	Joubert syndrome 5	610188	AR	3	Cep290
12q21.32	12:88049016-88142088	CEP290, KIAA0373, 3H11AG, JBTS5, SLSN6, LCA10, BBS14	Centrosomal protein, 290kD	610142	CEP290	80184	ENSG00000198707,ENST00000552810;;;ENST00000552810	mutation identified in 1 BBS14 family	Leber congenital amaurosis 10	611755		3	Cep290
12q21.32	12:88049016-88142088	CEP290, KIAA0373, 3H11AG, JBTS5, SLSN6, LCA10, BBS14	Centrosomal protein, 290kD	610142	CEP290	80184	ENSG00000198707,ENST00000552810;;;ENST00000552810	mutation identified in 1 BBS14 family	Meckel syndrome 4	611134	AR	3	Cep290
12q21.32	12:88049016-88142088	CEP290, KIAA0373, 3H11AG, JBTS5, SLSN6, LCA10, BBS14	Centrosomal protein, 290kD	610142	CEP290	80184	ENSG00000198707,ENST00000552810;;;ENST00000552810	mutation identified in 1 BBS14 family	Senior-Loken syndrome 6	610189	AR	3	Cep290
12q21.32	12:88142307-88199887	TMTC3, SMILE, LIS8	Transmembrane and tetratricopeptide repeat domains-containing protein 3	617218	TMTC3	160418	ENSG00000139324,ENST00000266712;;;ENST00000266712		Lissencephaly 8	617255	AR	3	Tmtc3
12q21.32	12:88492793-88580471	KITLG, MGF, SF, SCF, SHEP7, FPHH, DCUA, DFNA69, WS2F	KIT ligand (mast cell growth factor; steel, mouse, homolog of)	184745	KITLG	4254	ENSG00000049130,ENST00000644744;;;ENST00000644744	associated with dbSNP rs12821256	[Skin/hair/eye pigmentation 7, blond/brown hair]	611664		3	Kitl
12q21.32	12:88492793-88580471	KITLG, MGF, SF, SCF, SHEP7, FPHH, DCUA, DFNA69, WS2F	KIT ligand (mast cell growth factor; steel, mouse, homolog of)	184745	KITLG	4254	ENSG00000049130,ENST00000644744;;;ENST00000644744	associated with dbSNP rs12821256	Deafness, autosomal dominant 69, unilateral or asymmetric	616697	AD	3	Kitl
12q21.32	12:88492793-88580471	KITLG, MGF, SF, SCF, SHEP7, FPHH, DCUA, DFNA69, WS2F	KIT ligand (mast cell growth factor; steel, mouse, homolog of)	184745	KITLG	4254	ENSG00000049130,ENST00000644744;;;ENST00000644744	associated with dbSNP rs12821256	Hyperpigmentation with or without hypopigmentation	145250	AD	3	Kitl
12q21.32	12:88492793-88580471	KITLG, MGF, SF, SCF, SHEP7, FPHH, DCUA, DFNA69, WS2F	KIT ligand (mast cell growth factor; steel, mouse, homolog of)	184745	KITLG	4254	ENSG00000049130,ENST00000644744;;;ENST00000644744	associated with dbSNP rs12821256	Waardenburg syndrome, type 2F	619947	AR	3	Kitl
12q21.33	12:88600001-92200000	CNA1	Cornea plana 1, autosomal dominant	121400		1255		between D12S82 and D12S351	Cornea plana 1, autosomal dominant	121400	AD	2	
12q21.33	12:88600001-92200000	PACD	Corneal dystrophy, posterior amorphous	612868				contiguous gene deletion syndrome	Corneal dystrophy, posterior amorphous	612868	AD	4	
12q21.33	12:89347235-89352501	DUSP6, MKP3, PYST1, HH19	Dual-specificity phosphatase-6	602748	DUSP6	1848	ENSG00000139318,ENST00000279488;;;ENST00000279488		Hypogonadotropic hypogonadism 19 with or without anosmia	615269	AD	3	Dusp6
12q21.33	12:89401467-89526047	POC1B, PIX1, CORD20	POC1B antisense RNA 1	614784	POC1B	282809	ENSG00000139323,ENST00000313546;;;ENST00000313546		Cone-rod dystrophy 20	615973	AR	3	Poc1b
12q21.33	12:89588049-89709366	ATP2B1, PMCA1, MRD66	ATPase, Ca++ transporting, plasma membrane, 1	108731	ATP2B1	490	ENSG00000070961,ENST00000428670;;;ENST00000428670		Intellectual developmental disorder, autosomal dominant 66	619910	AD	3	Atp2b1
12q21.33	12:91050491-91058024	KERA, CNA2	Keratocan	603288	KERA	11081	ENSG00000139330,ENST00000266719;;;ENST00000266719		Cornea plana 2, autosomal recessive	217300	AR	3	Kera
12q21.33	12:91140484-91182817	DCN, CSCD	Decorin	125255	DCN	1634	ENSG00000011465,ENST00000052754;;;ENST00000052754	conflicting assignments to 12q23 and 12q13.2	Corneal dystrophy, congenital stromal	610048	AD	3	Dcn
12q22-q23.3	12:92200001-108600000	ETL2, FTLE	Epilepsy, familial temporal lobe	608096		619399		max lod at D12S1706	Epilepsy, familial temporal lobe, 2	608096	AD	2	
12q22-q23.2	12:92200001-103500000	MDD1	Major depressive disorder	608520		431708		max lod with D12S1706	Major depressive disorder 1	608516		2	
12q22	12:93677375-93894840	CRADD, RAIDD, MRT34	Caspase and RIP adaptor with death domain	603454	CRADD	8738	ENSG00000169372,ENST00000332896;;;ENST00000332896		Intellectual developmental disorder, autosomal recessive 34, with variant lissencephaly	614499	AR	3	Cradd
12q22	12:94265662-94460454	CEP83, CCDC41, NPHP18	Centrosomal protein, 83kD	615847	CEP83	51134	ENSG00000173588,ENST00000397809;;;ENST00000397809		Nephronophthisis 18	615862	AR	3	Cep83
12q22	12:94971333-95003697	NDUFA12, MC1DN23	NADH-ubiquinone oxidoreductase subunit A12	614530	NDUFA12	55967	ENSG00000184752,ENST00000327772;;;ENST00000327772		Mitochondrial complex I deficiency, nuclear type 23	618244	AR	3	Ndufa12
12q23-q24	12:95800001-133275309	SPG36	Spastic paraplegia-36	613096		791228		between D12S360 and D12S354	Spastic paraplegia 36, autosomal dominant	613096	AD	2	
12q23.1	12:95972662-95996344	HAL, HSTD	Histidine ammonia-lyase (histidase)	609457	HAL	3034	ENSG00000084110,ENST00000261208;;;ENST00000261208		[Histidinemia]	235800	AD, AR	3	Hal
12q23.1	12:96489577-96875555	CFAP54, SPGF98, CILD54	Cilia- and flagella-associated protein 54	621121	CFAP54	144535	ENSG00000188596,ENST00000524981;;;ENST00000524981		Ciliary dyskinesia, primary, 54	621125	AR	3	Cfap54
12q23.1	12:96489577-96875555	CFAP54, SPGF98, CILD54	Cilia- and flagella-associated protein 54	621121	CFAP54	144535	ENSG00000188596,ENST00000524981;;;ENST00000524981		Spermatogenic failure 98	621124	AR	3	Cfap54
12q23.1	12:98593686-98606367	SLC25A3, PHC	Solute carrier family 25 (mitochondrial carrier), member 3	600370	SLC25A3	5250	ENSG00000075415,ENST00000552981;;;ENST00000552981		Mitochondrial phosphate carrier deficiency	610773	AR	3	Slc25a3
12q23.1	12:100267177-100341715	SCYL2, CVAK104, KIAA1360, AMC4	SCY1-like protein 2	616365	SCYL2	55681	ENSG00000136021,ENST00000360820;;;ENST00000360820		Arthrogryposis multiplex congenita 4, neurogenic, with agenesis of the corpus callosum	618766	AR	3	Scyl2
12q23.1	12:100357074-100422055	SLC17A8, VGLUT3, DFNA25	Solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 8 (vesicular glutamate transporter 3)	607557	SLC17A8	246213	ENSG00000179520,ENST00000323346;;;ENST00000323346		Deafness, autosomal dominant 25	605583	AD	3	Slc17a8
12q23.1	12:100473866-100564414	NR1H4, FXR, RIP14, PFIC5	Nuclear receptor subfamily 1 group H member 4	603826	NR1H4	9971	ENSG00000012504,ENST00000392986;;;ENST00000392986		Cholestasis, progressive familial intrahepatic, 5	617049	AR	3	Nr1h4
12q23.2	12:101594971-101695841	MYBPC1, LCCS4, CMYO16	Myosin-binding protein C, slow type	160794	MYBPC1	4604	ENSG00000196091,ENST00000361466;;;ENST00000361466		Arthrogryposis, distal, type 1B	614335	AD	3	Mybpc1
12q23.2	12:101594971-101695841	MYBPC1, LCCS4, CMYO16	Myosin-binding protein C, slow type	160794	MYBPC1	4604	ENSG00000196091,ENST00000361466;;;ENST00000361466		Congenital myopathy 16	618524	AD	3	Mybpc1
12q23.2	12:101594971-101695841	MYBPC1, LCCS4, CMYO16	Myosin-binding protein C, slow type	160794	MYBPC1	4604	ENSG00000196091,ENST00000361466;;;ENST00000361466		Lethal congenital contracture syndrome 4	614915	AR	3	Mybpc1
12q23.2	12:101728648-101739462	SYCP3, SCP3, COR1, SPGF4, RPRGL4	Synaptonemal complex protein 3	604759	SYCP3	50511	ENSG00000139351,ENST00000392924;;;ENST00000392924		Pregnancy loss, recurrent, 4	270960	AD	3	1700013H16Rik,3830403N18Rik,Gm10058,Gm10096,Gm10147,Gm10230,Gm10486,Gm10487,Gm10488,Gm14525,Gm14632,Gm14819,Gm1993,Gm2012,Gm2030,Gm20736,Gm20792,Gm20817,Gm20820,Gm20824,Gm20838,Gm20843,Gm20888,Gm20890,Gm20911,Gm20937,Gm21094,Gm21095,Gm21117,Gm21173,Gm21209,Gm21256,Gm21258,Gm21294,Gm21488,Gm21497,Gm21518,Gm21739,Gm21760,Gm21858,Gm21861,Gm21865,Gm21996,Gm28102,Gm28510,Gm28553,Gm28576,Gm28827,Gm28870,Gm28891,Gm28897,Gm28919,Gm28961,Gm28998,Gm29110,Gm29276,Gm29554,Gm29564,Gm29582,Gm29866,Gm30737,Gm31571,Gm35134,Gm4297,Gm4836,Gm5168,Gm5169,Gm5934,Gm5935,Gm6121,Gm773,Slx,Sly,Sycp3,Xlr
12q23.2	12:101728648-101739462	SYCP3, SCP3, COR1, SPGF4, RPRGL4	Synaptonemal complex protein 3	604759	SYCP3	50511	ENSG00000139351,ENST00000392924;;;ENST00000392924		Spermatogenic failure 4	270960	AD	3	1700013H16Rik,3830403N18Rik,Gm10058,Gm10096,Gm10147,Gm10230,Gm10486,Gm10487,Gm10488,Gm14525,Gm14632,Gm14819,Gm1993,Gm2012,Gm2030,Gm20736,Gm20792,Gm20817,Gm20820,Gm20824,Gm20838,Gm20843,Gm20888,Gm20890,Gm20911,Gm20937,Gm21094,Gm21095,Gm21117,Gm21173,Gm21209,Gm21256,Gm21258,Gm21294,Gm21488,Gm21497,Gm21518,Gm21739,Gm21760,Gm21858,Gm21861,Gm21865,Gm21996,Gm28102,Gm28510,Gm28553,Gm28576,Gm28827,Gm28870,Gm28891,Gm28897,Gm28919,Gm28961,Gm28998,Gm29110,Gm29276,Gm29554,Gm29564,Gm29582,Gm29866,Gm30737,Gm31571,Gm35134,Gm4297,Gm4836,Gm5168,Gm5169,Gm5934,Gm5935,Gm6121,Gm773,Slx,Sly,Sycp3,Xlr
12q23.2	12:101745499-101830959	GNPTAB, GNPTA	N-acetylglucosamine-1-phosphate transferase, alpha/beta subunits	607840	GNPTAB	79158	ENSG00000111670,ENST00000299314;;;ENST00000299314	conflicting assignment to 4q	Mucolipidosis II alpha/beta	252500	AR	3	Gnptab
12q23.2	12:101745499-101830959	GNPTAB, GNPTA	N-acetylglucosamine-1-phosphate transferase, alpha/beta subunits	607840	GNPTAB	79158	ENSG00000111670,ENST00000299314;;;ENST00000299314	conflicting assignment to 4q	Mucolipidosis III alpha/beta	252600	AR	3	Gnptab
12q23.2	12:102073103-102120114	NUP37, p37, MCPH24	Nucleoporin, 37kD	609264	NUP37	79023	ENSG00000075188,ENST00000552283;;;ENST00000552283	mutation identified in 1 MCPH24 family	?Microcephaly 24, primary, autosomal recessive	618179	AR	3	Nup37
12q23.2	12:102395874-102481839	IGF1	Insulin-like growth factor-1, or somatomedin C	147440	IGF1	3479	ENSG00000017427,ENST00000337514;;;ENST00000337514		Insulin-like growth factor I deficiency	608747	AR	3	Igf1
12q23.2	12:102836889-102958441	PAH, PKU1	Phenylalanine hydroxylase	612349	PAH	5053	ENSG00000171759,ENST00000553106;;;ENST00000553106	close to IGF1	[Hyperphenylalaninemia, non-PKU mild]	261600	AR	3	Pah
12q23.2	12:102836889-102958441	PAH, PKU1	Phenylalanine hydroxylase	612349	PAH	5053	ENSG00000171759,ENST00000553106;;;ENST00000553106	close to IGF1	Phenylketonuria	261600	AR	3	Pah
12q23.3	12:104456948-104762014	CHST11, C4ST1, OCBMD	Carbohydrate sulfotransferase 11	610128	CHST11	50515	ENSG00000171310,ENST00000303694;;;ENST00000303694	mutation identified in 1 OCBMD family	?Osteochondrodysplasia, brachydactyly, and overlapping malformed digits	618167	AR	3	Chst11
12q23.3	12:105107731-105169130	WASHC4, KIAA1033, SWIP, MRT43	WASH complex, subunit 4	615748	WASHC4	23325	ENSG00000136051,ENST00000332180;;;ENST00000332180		Intellectual developmental disorder, autosomal recessive 43	615817	AR	3	Washc4
12q23.3	12:106357748-106510198	POLR3B, RPC2, C128, HLD8, CMT1I	Polymerase III, RNA, subunit B	614366	POLR3B	55703	ENSG00000013503,ENST00000228347;;;ENST00000228347		Charcot-Marie-Tooth disease, demyelinating, type 1I	619742	AD	3	Polr3b
12q23.3	12:106357748-106510198	POLR3B, RPC2, C128, HLD8, CMT1I	Polymerase III, RNA, subunit B	614366	POLR3B	55703	ENSG00000013503,ENST00000228347;;;ENST00000228347		Leukodystrophy, hypomyelinating, 8, with or without oligodontia and/or hypogonadotropic hypogonadism	614381	AR	3	Polr3b
12q23.3	12:106991364-107093549	CRY1, PHLL1, DSPD	Cryptochrome 1 (photolyase-like)	601933	CRY1	1407	ENSG00000008405,ENST00000008527;;;ENST00000008527		{Delayed sleep phase disorder, susceptibility to}	614163	AD	3	Cry1
12q23.3	12:108515277-108521210	FICD, HYPE, SPG92	FIC domain-containing protein adenylyltransferase	620875	FICD	11153	ENSG00000198855,ENST00000552695;;;ENST00000552695		Spastic paraplegia 92, autosomal recessive	620911	AR	3	Ficd
12q23.3	12:108561463-108569384	ISCU, HML	Iron-sulfur cluster assembly enzyme	611911	ISCU	23479	ENSG00000136003,ENST00000311893;;;ENST00000311893		Myopathy with lactic acidosis, hereditary	255125	AR	3	Iscu
12q24	12:108600001-133275309	CELIAC13	Celiac disease, susceptibility to, 13	612011		100188875		associated with rs3184504	{Celiac disease, susceptibility to, 13}	612011		2	
12q24	12:108600001-133275309	CIMT	Carotid intimal medial thickness	608447		404677		161cM from pter; near SCARB1	Carotid intimal medial thickness	608447		2	
12q24	12:108600001-133275309	PDA1	Patent ductus arteriosus	607411		100996949			{Patent ductus arteriosus, susceptibility to}	607411	AR	2	
12q24.1-q24.2	12:108600001-120300000	POROK2, PPPD1	Porokeratosis 2, palmar, plantar, and disseminated	175850		100196910		between D12S1613 and D12S1341	Porokeratosis 2, palmar, plantar, and disseminated	175850	AD	2	
12q24	12:108600001-133275309	SLEB4	Systemic lupus erythematosus, susceptibility to, 4	608437		404714			{Systemic lupus erythematosus, susceptibility to, 4}	608437	AD	2	
12q24.1	12:108600001-113900000	STUT2	Stuttering, familial persistent, 2	609261		100049543		max lod with PAH	Stuttering, familial persistent, 2	609261		2	
12q24.11	12:109097597-109110992	UNG, DGU, HIGM5	Uracil-DNA glycosylase	191525	UNG	7374	ENSG00000076248,ENST00000242576;;;ENST00000242576		Immunodeficiency with hyper IgM, type 5	608106	AR	3	Ung
12q24.11	12:109310468-109448379	MYO1H, CCHS2	Myosin IH	614636	MYO1H	283446	ENSG00000174527,ENST00000310903;;;ENST00000310903	mutation identified in 1 CCHS2 family	?Central hypoventilation syndrome, congenital, 2, and autonomic dysfunction	619482	AR	3	Myo1h
12q24.11	12:109477634-109547829	UBE3B, BPIDS, KOS	Ubiquitin-protein ligase E3B	608047	UBE3B	89910	ENSG00000151148,ENST00000342494;;;ENST00000342494		Kaufman oculocerebrofacial syndrome	244450	AR	3	Ube3b
12q24.11	12:109553715-109573504	MMAB	Metabolism of cobalamin associated B	607568	MMAB	326625	ENSG00000139428,ENST00000545712;;;ENST00000545712		Methylmalonic aciduria, vitamin B12-responsive, cblB type	251110	AR	3	Mmab
12q24.11	12:109573272-109598125	MVK, MVLK, POROK3	Mevalonate kinase	251170	MVK	4598	ENSG00000110921,ENST00000228510;;;ENST00000228510		Hyper-IgD syndrome	260920	AR	3	Mvk
12q24.11	12:109573272-109598125	MVK, MVLK, POROK3	Mevalonate kinase	251170	MVK	4598	ENSG00000110921,ENST00000228510;;;ENST00000228510		Mevalonic aciduria	610377	AR	3	Mvk
12q24.11	12:109573272-109598125	MVK, MVLK, POROK3	Mevalonate kinase	251170	MVK	4598	ENSG00000110921,ENST00000228510;;;ENST00000228510		Porokeratosis 3, multiple types	175900	AD	3	Mvk
12q24.11	12:109783087-109833398	TRPV4, VROAC, HMSN2C, CMT2C, SPSMA, SSQTL1, SMAL, BCYM3	Transient receptor potential cation channel, subfamily V, member 4 (vanilloid receptor-related osmotically activated channel)	605427	TRPV4	59341	ENSG00000111199,ENST00000261740;;;ENST00000261740	mutation identified in 1 ANFH2 family	?Avascular necrosis of femoral head, primary, 2	617383	AD	3	Trpv4
12q24.11	12:109783087-109833398	TRPV4, VROAC, HMSN2C, CMT2C, SPSMA, SSQTL1, SMAL, BCYM3	Transient receptor potential cation channel, subfamily V, member 4 (vanilloid receptor-related osmotically activated channel)	605427	TRPV4	59341	ENSG00000111199,ENST00000261740;;;ENST00000261740	mutation identified in 1 ANFH2 family	[Sodium serum level QTL 1]	613508		3	Trpv4
12q24.11	12:109783087-109833398	TRPV4, VROAC, HMSN2C, CMT2C, SPSMA, SSQTL1, SMAL, BCYM3	Transient receptor potential cation channel, subfamily V, member 4 (vanilloid receptor-related osmotically activated channel)	605427	TRPV4	59341	ENSG00000111199,ENST00000261740;;;ENST00000261740	mutation identified in 1 ANFH2 family	Brachyolmia type 3	113500	AD	3	Trpv4
12q24.11	12:109783087-109833398	TRPV4, VROAC, HMSN2C, CMT2C, SPSMA, SSQTL1, SMAL, BCYM3	Transient receptor potential cation channel, subfamily V, member 4 (vanilloid receptor-related osmotically activated channel)	605427	TRPV4	59341	ENSG00000111199,ENST00000261740;;;ENST00000261740	mutation identified in 1 ANFH2 family	Digital arthropathy-brachydactyly, familial	606835	AD	3	Trpv4
12q24.11	12:109783087-109833398	TRPV4, VROAC, HMSN2C, CMT2C, SPSMA, SSQTL1, SMAL, BCYM3	Transient receptor potential cation channel, subfamily V, member 4 (vanilloid receptor-related osmotically activated channel)	605427	TRPV4	59341	ENSG00000111199,ENST00000261740;;;ENST00000261740	mutation identified in 1 ANFH2 family	Hereditary motor and sensory neuropathy, type IIc	606071	AD	3	Trpv4
12q24.11	12:109783087-109833398	TRPV4, VROAC, HMSN2C, CMT2C, SPSMA, SSQTL1, SMAL, BCYM3	Transient receptor potential cation channel, subfamily V, member 4 (vanilloid receptor-related osmotically activated channel)	605427	TRPV4	59341	ENSG00000111199,ENST00000261740;;;ENST00000261740	mutation identified in 1 ANFH2 family	Metatropic dysplasia	156530	AD	3	Trpv4
12q24.11	12:109783087-109833398	TRPV4, VROAC, HMSN2C, CMT2C, SPSMA, SSQTL1, SMAL, BCYM3	Transient receptor potential cation channel, subfamily V, member 4 (vanilloid receptor-related osmotically activated channel)	605427	TRPV4	59341	ENSG00000111199,ENST00000261740;;;ENST00000261740	mutation identified in 1 ANFH2 family	Neuronopathy, distal hereditary motor, autosomal dominant 8	600175	AD	3	Trpv4
12q24.11	12:109783087-109833398	TRPV4, VROAC, HMSN2C, CMT2C, SPSMA, SSQTL1, SMAL, BCYM3	Transient receptor potential cation channel, subfamily V, member 4 (vanilloid receptor-related osmotically activated channel)	605427	TRPV4	59341	ENSG00000111199,ENST00000261740;;;ENST00000261740	mutation identified in 1 ANFH2 family	Parastremmatic dwarfism	168400	AD	3	Trpv4
12q24.11	12:109783087-109833398	TRPV4, VROAC, HMSN2C, CMT2C, SPSMA, SSQTL1, SMAL, BCYM3	Transient receptor potential cation channel, subfamily V, member 4 (vanilloid receptor-related osmotically activated channel)	605427	TRPV4	59341	ENSG00000111199,ENST00000261740;;;ENST00000261740	mutation identified in 1 ANFH2 family	Scapuloperoneal spinal muscular atrophy	181405	AD	3	Trpv4
12q24.11	12:109783087-109833398	TRPV4, VROAC, HMSN2C, CMT2C, SPSMA, SSQTL1, SMAL, BCYM3	Transient receptor potential cation channel, subfamily V, member 4 (vanilloid receptor-related osmotically activated channel)	605427	TRPV4	59341	ENSG00000111199,ENST00000261740;;;ENST00000261740	mutation identified in 1 ANFH2 family	SED, Maroteaux type	184095	AD	3	Trpv4
12q24.11	12:109783087-109833398	TRPV4, VROAC, HMSN2C, CMT2C, SPSMA, SSQTL1, SMAL, BCYM3	Transient receptor potential cation channel, subfamily V, member 4 (vanilloid receptor-related osmotically activated channel)	605427	TRPV4	59341	ENSG00000111199,ENST00000261740;;;ENST00000261740	mutation identified in 1 ANFH2 family	Spondylometaphyseal dysplasia, Kozlowski type	184252	AD	3	Trpv4
12q24.11	12:110124357-110218793	IFT81, DV1, CDV1R, SRTD19	Intraflagellar transport 81	605489	IFT81	28981	ENSG00000122970,ENST00000242591;;;ENST00000242591		Short-rib thoracic dysplasia 19 with or without polydactyly	617895	AR	3	Ift81
12q24.11	12:110280616-110351093	ATP2A2, ATP2B, DAR, RHABDO2	ATPase, Ca++ transporting, slow-twitch, cardiac muscle-2	108740	ATP2A2	488	ENSG00000174437,ENST00000539276;;;ENST00000539276		{Rhabdomyolysis, susceptibility to, 2}	621236	AD	3	Atp2a2
12q24.11	12:110280616-110351093	ATP2A2, ATP2B, DAR, RHABDO2	ATPase, Ca++ transporting, slow-twitch, cardiac muscle-2	108740	ATP2A2	488	ENSG00000174437,ENST00000539276;;;ENST00000539276		Acrokeratosis verruciformis	101900	AD	3	Atp2a2
12q24.11	12:110280616-110351093	ATP2A2, ATP2B, DAR, RHABDO2	ATPase, Ca++ transporting, slow-twitch, cardiac muscle-2	108740	ATP2A2	488	ENSG00000174437,ENST00000539276;;;ENST00000539276		Darier disease	124200	AD	3	Atp2a2
12q24.11	12:110372900-110403708	ANAPC7, APC7, FERBON	Anaphase-promoting complex, subunit 7	606949	ANAPC7	51434	ENSG00000196510,ENST00000455511;;;ENST00000455511		Ferguson-Bonni neurodevelopmental syndrome	619699	AR	3	Anapc7
12q24.11	12:110614129-110649430	TCTN1, TECT1, JBTS13	Tectonic family, member 1	609863	TCTN1	79600	ENSG00000204852,ENST00000397659;;;ENST00000397659		Joubert syndrome 13	614173	AR	3	Tctn1
12q24.11	12:110910845-110921449	MYL2, CMH10, MFM12	Myosin, light polypeptide-2, regulatory, cardiac, slow	160781	MYL2	4633	ENSG00000111245,ENST00000228841;;;ENST00000228841		Cardiomyopathy, hypertrophic, 10	608758	AD	3	Myl2
12q24.11	12:110910845-110921449	MYL2, CMH10, MFM12	Myosin, light polypeptide-2, regulatory, cardiac, slow	160781	MYL2	4633	ENSG00000111245,ENST00000228841;;;ENST00000228841		Myopathy, myofibrillar, 12, infantile-onset, with cardiomyopathy	619424	AR	3	Myl2
12q24.11-q24.12	12:111034165-111350554	CUX2, CDP2, CUTL2, DEE67	Cut-like homeobox 2	610648	CUX2	23316	ENSG00000111249,ENST00000261726;;;ENST00000261726		Developmental and epileptic encephalopathy 67	618141	AD	3	Cux2
12q24.12	12:111404730-111451623	SH2B3, LNK	SH2B adaptor protein 3	605093	SH2B3	10019	ENSG00000111252,ENST00000341259;;;ENST00000341259		Erythrocytosis, somatic	133100		3	Sh2b3
12q24.12	12:111404730-111451623	SH2B3, LNK	SH2B adaptor protein 3	605093	SH2B3	10019	ENSG00000111252,ENST00000341259;;;ENST00000341259		Myelofibrosis, somatic	254450		3	Sh2b3
12q24.12	12:111404730-111451623	SH2B3, LNK	SH2B adaptor protein 3	605093	SH2B3	10019	ENSG00000111252,ENST00000341259;;;ENST00000341259		Thrombocythemia, somatic	187950		3	Sh2b3
12q24.12	12:111452214-111599673	ATXN2, ATX2, SCA2, ASL13	Ataxin-2	601517	ATXN2	6311	ENSG00000204842,ENST00000673436;;;ENST00000673436		{Amyotrophic lateral sclerosis, susceptibility to, 13}	183090	AD	3	Atxn2
12q24.12	12:111452214-111599673	ATXN2, ATX2, SCA2, ASL13	Ataxin-2	601517	ATXN2	6311	ENSG00000204842,ENST00000673436;;;ENST00000673436		{Parkinson disease, late-onset, susceptibility to}	168600	AD, Mu	3	Atxn2
12q24.12	12:111452214-111599673	ATXN2, ATX2, SCA2, ASL13	Ataxin-2	601517	ATXN2	6311	ENSG00000204842,ENST00000673436;;;ENST00000673436		Spinocerebellar ataxia 2	183090	AD	3	Atxn2
12q24.12	12:111766933-111817532	ALDH2	Aldehyde dehydrogenase 2 family, mitochondrial	100650	ALDH2	217	ENSG00000111275,ENST00000261733;;;ENST00000261733		{Esophageal cancer, alcohol-related, susceptibility to}			3	Aldh2
12q24.12	12:111766933-111817532	ALDH2	Aldehyde dehydrogenase 2 family, mitochondrial	100650	ALDH2	217	ENSG00000111275,ENST00000261733;;;ENST00000261733		{Hangover, susceptibility to}	610251	AD	3	Aldh2
12q24.12	12:111766933-111817532	ALDH2	Aldehyde dehydrogenase 2 family, mitochondrial	100650	ALDH2	217	ENSG00000111275,ENST00000261733;;;ENST00000261733		{Sublingual nitroglycerin, susceptibility to poor response to}			3	Aldh2
12q24.12	12:111766933-111817532	ALDH2	Aldehyde dehydrogenase 2 family, mitochondrial	100650	ALDH2	217	ENSG00000111275,ENST00000261733;;;ENST00000261733		Alcohol sensitivity, acute	610251	AD	3	Aldh2
12q24.12-q24.13	12:111842228-111902222	MAPKAPK5, PRAK, NCFD	Mitogen-activated protein kinase-activated protein kinase 5	606723	MAPKAPK5	8550	ENSG00000089022,ENST00000550735;;;ENST00000550735		Neurocardiofaciodigital syndrome	619869	AR	3	Mapkapk5
12q24.13	12:112160195-112382431	HECTD4, C12orf51, NEDSSCC	HECT domain E3 ubiquitin protein ligase 4	620209	HECTD4	283450	ENSG00000173064,ENST00000682272;;;ENST00000682272		Neurodevelopmental disorder with seizures, spasticity, and complete or partial agenesis of the corpus callosum	620250	AR	3	Hectd4
12q24.13	12:112418947-112509918	PTPN11, PTP2C, SHP2, NS1, JMML, METCDS	Protein tyrosine phosphatase, nonreceptor-type, 11	176876	PTPN11	5781	ENSG00000179295,ENST00000351677;;;ENST00000351677		LEOPARD syndrome 1	151100	AD	3	Ptpn11
12q24.13	12:112418947-112509918	PTPN11, PTP2C, SHP2, NS1, JMML, METCDS	Protein tyrosine phosphatase, nonreceptor-type, 11	176876	PTPN11	5781	ENSG00000179295,ENST00000351677;;;ENST00000351677		Leukemia, juvenile myelomonocytic, somatic	607785		3	Ptpn11
12q24.13	12:112418947-112509918	PTPN11, PTP2C, SHP2, NS1, JMML, METCDS	Protein tyrosine phosphatase, nonreceptor-type, 11	176876	PTPN11	5781	ENSG00000179295,ENST00000351677;;;ENST00000351677		Metachondromatosis	156250	AD	3	Ptpn11
12q24.13	12:112418947-112509918	PTPN11, PTP2C, SHP2, NS1, JMML, METCDS	Protein tyrosine phosphatase, nonreceptor-type, 11	176876	PTPN11	5781	ENSG00000179295,ENST00000351677;;;ENST00000351677		Noonan syndrome 1	163950	AD	3	Ptpn11
12q24.13	12:112906962-112933219	OAS1, OIAS, IMD100	2',5'-oligoadenylate synthetase-1	164350	OAS1	4938	ENSG00000089127,ENST00000202917;;;ENST00000202917		Immunodeficiency 100 with pulmonary alveolar proteinosis and hypogammaglobulinemia	618042	AD	3	Oas1a,Oas1b,Oas1c,Oas1d,Oas1e,Oas1f,Oas1g,Oas1h
12q24.2-q24.3	12:113900001-133275309	CTRCT37, CCA5	Cataract 37	614422		100861439		between D12S1718 and D12S1723	Cataract 37, autosomal dominant	614422	AD	2	
12q24.2	12:113900001-120300000	NIDDM2	Diabetes mellitus, noninsulin-dependent, 2	601407		4813		no mutations found in HNF1A	Diabetes mellitus, noninsulin-dependent, 2	601407		2	
12q24.21	12:114353911-114408442	TBX5	T-box 5	601620	TBX5	6910	ENSG00000089225,ENST00000405440;;;ENST00000405440		Holt-Oram syndrome	142900	AD	3	Tbx5
12q24.21	12:114670255-114684175	TBX3	T-box 3	601621	TBX3	6926	ENSG00000135111,ENST00000349155;;;ENST00000349155		Ulnar-mammary syndrome	181450	AD	3	Tbx3
12q24.21	12:115958576-116277693	MED13L, THRAP2, PROSIT240, TRAP240L, KIAA1025, MRFACD	Mediator complex subunit 13-like	608771	MED13L	23389	ENSG00000123066,ENST00000281928;;;ENST00000281928		Impaired intellectual development and distinctive facial features with or without cardiac defects	616789	AD	3	Med13l
12q24.23	12:119178931-119194746	HSPB8, H11, E2IG1, CMT2L, HMND2, MFM13	Heat-shock 22-kD protein 8	608014	HSPB8	26353	ENSG00000152137,ENST00000281938;;;ENST00000281938		Charcot-Marie-Tooth disease, axonal, type 2L	608673	AD	3	Hspb8
12q24.23	12:119178931-119194746	HSPB8, H11, E2IG1, CMT2L, HMND2, MFM13	Heat-shock 22-kD protein 8	608014	HSPB8	26353	ENSG00000152137,ENST00000281938;;;ENST00000281938		Myopathy, myofibrillar, 13, with rimmed vacuoles	621078	AD	3	Hspb8
12q24.23	12:119178931-119194746	HSPB8, H11, E2IG1, CMT2L, HMND2, MFM13	Heat-shock 22-kD protein 8	608014	HSPB8	26353	ENSG00000152137,ENST00000281938;;;ENST00000281938		Neuronopathy, distal hereditary motor, autosomal dominant 2	158590	AD	3	Hspb8
12q24.23	12:119685791-119877320	CIT, STK21, CRIK, MCPH17	Citron rho-interacting serine/threonine kinase	605629	CIT	11113	ENSG00000122966,ENST00000392521;;;ENST00000392521		Microcephaly 17, primary, autosomal recessive	617090	AR	3	Cit
12q24.23	12:120291759-120291903	RNU4-2, NEDHAFA, RENU	RNA, U4 small nuclear 2	620823	RNU4-2	26834	ENSG00000202538,ENST00000365668;;;ENST00000365668		ReNU syndrome	620851	AD	3	
12q24.31	12:120300001-125400000	MPVQTL1	Mean platelet volume quantitative trait locus 1	612573		100271867		associated with rs7961894	[Mean platelet volume QTL1]	612573		2	
12q24.31	12:120438113-120440730	COX6A1, CMTRID	Cytochrome c oxidase, subunit VIa, polypeptide-1	602072	COX6A1	1337	ENSG00000111775,ENST00000229379;;;ENST00000229379	pseudogenes on chr.7 and chr.6	Charcot-Marie-Tooth disease, recessive intermediate D	616039	AR	3	Cox6a1
12q24.31	12:120446444-120463749	GATC, COXPD42	Glutamyl-tRNA amidotransferase, subunit C	617210	GATC	283459	ENSG00000257218,ENST00000551765;;;ENST00000551765		Combined oxidative phosphorylation deficiency 42	618839	AR	3	Gatc
12q24.31	12:120503279-120529158	COQ5, COQ10D9	Coenzyme Q5, methyltransferasef	616359	COQ5	84274	ENSG00000110871,ENST00000288532;;;ENST00000288532	mutation identified in 1 COQ10D9 family	?Coenzyme Q10 deficiency, primary, 9	619028	AR	3	Coq5
12q24.31	12:120725826-120740008	ACADS, SCAD	Acyl-Coenzyme A dehydrogenase, C-2 to C-3 short chain	606885	ACADS	35	ENSG00000122971,ENST00000242592;;;ENST00000242592		Acyl-CoA dehydrogenase, short-chain, deficiency of	201470	AR	3	Acads
12q24.31	12:120978543-121002512	HNF1A, TCF1, MODY3, IDDM20	HNF1 homeobox B	142410	HNF1A	6927	ENSG00000135100,ENST00000257555;;;ENST00000257555		{Diabetes mellitus, insulin-dependent}	222100	AR	3	Hnf1a
12q24.31	12:120978543-121002512	HNF1A, TCF1, MODY3, IDDM20	HNF1 homeobox B	142410	HNF1A	6927	ENSG00000135100,ENST00000257555;;;ENST00000257555		{Diabetes mellitus, noninsulin-dependent, 2}	125853	AD	3	Hnf1a
12q24.31	12:120978543-121002512	HNF1A, TCF1, MODY3, IDDM20	HNF1 homeobox B	142410	HNF1A	6927	ENSG00000135100,ENST00000257555;;;ENST00000257555		Diabetes mellitus, insulin-dependent, 20	612520		3	Hnf1a
12q24.31	12:120978543-121002512	HNF1A, TCF1, MODY3, IDDM20	HNF1 homeobox B	142410	HNF1A	6927	ENSG00000135100,ENST00000257555;;;ENST00000257555		Hepatic adenoma, somatic	142330		3	Hnf1a
12q24.31	12:120978543-121002512	HNF1A, TCF1, MODY3, IDDM20	HNF1 homeobox B	142410	HNF1A	6927	ENSG00000135100,ENST00000257555;;;ENST00000257555		MODY, type III	600496	AD	3	Hnf1a
12q24.31	12:120978543-121002512	HNF1A, TCF1, MODY3, IDDM20	HNF1 homeobox B	142410	HNF1A	6927	ENSG00000135100,ENST00000257555;;;ENST00000257555		Renal cell carcinoma	144700		3	Hnf1a
12q24.31	12:121626530-121643109	ORAI1, TMEM142A, CRACM1, IMD9, TAM2	ORAI calcium release-activated calcium modulator 1	610277	ORAI1	84876	ENSG00000276045,ENST00000646827		Immunodeficiency 9	612782	AR	3	Orai1
12q24.31	12:121626530-121643109	ORAI1, TMEM142A, CRACM1, IMD9, TAM2	ORAI calcium release-activated calcium modulator 1	610277	ORAI1	84876	ENSG00000276045,ENST00000646827		Myopathy, tubular aggregate, 2	615883	AD	3	Orai1
12q24.31	12:121790155-121832656	SETD1B, SET1B, KIAA1076, IDDSELD	SET domain-containing protein 1B	611055	SETD1B	23067	ENSG00000139718,ENST00000604567;;;ENST00000604567		Intellectual developmental disorder with seizures and language delay	619000	AD	3	Setd1b
12q24.31	12:121839527-121888611	HPD	4-hydroxyphenylpyruvate dioxygenase	609695	HPD	3242	ENSG00000158104,ENST00000289004;;;ENST00000289004		Hawkinsinuria	140350	AD	3	Hpd
12q24.31	12:121839527-121888611	HPD	4-hydroxyphenylpyruvate dioxygenase	609695	HPD	3242	ENSG00000158104,ENST00000289004;;;ENST00000289004		Tyrosinemia, type III	276710	AR	3	Hpd
12q24.31	12:121918592-122003919	CFAP251, WDR66, CFAP251, SPGF33	Cilia- and flagella-associated protein 251	618146	CFAP251	144406	ENSG00000158023,ENST00000288912;;;ENST00000288912		Spermatogenic failure 33	618152	AR	3	Cfap251
12q24.31	12:122207662-122227456	DIABLO, SMAC, DFNA64	Diablo IAP-binding mitochondrial protein	605219	DIABLO	56616	ENSG00000184047,ENST00000464942;;;ENST00000464942		Deafness, autosomal dominant 64	614152	AD	3	Diablo
12q24.31	12:122229564-122266494	VPS33A, MPSPS	VPS33A core subunit of CORVET and HOPS complexes	610034	VPS33A	65082	ENSG00000139719,ENST00000267199;;;ENST00000267199		Mucopolysaccharidosis-plus syndrome	617303	AR	3	Vps33a
12q24.31	12:122471600-122500932	ZCCHC8, PFBMFT5	Zinc finger CCHC domain-containing protein 8	616381	ZCCHC8	55596	ENSG00000033030,ENST00000633063;;;ENST00000633063	mutation identified in 1 PFBMFT5 family	?Pulmonary fibrosis and/or bone marrow failure syndrome, telomere-related, 5	618674	AD	3	Zcchc8
12q24.31	12:122774572-122827528	CCDC62, ERAP75, SPGF67	Coiled-coil domain-containing protein 62	613481	CCDC62	84660	ENSG00000130783,ENST00000253079;;;ENST00000253079	mutation identified in 1 SPGF67 patient	?Spermatogenic failure 67	619803	AR	3	Ccdc62
12q24.31	12:123232914-123257960	MTRFR, C12orf65, COXPD7, SPG55	Mitochondrial translation release factor in rescue	613541	MTRFR	91574	ENSG00000130921,ENST00000253233;;;ENST00000253233		Combined oxidative phosphorylation deficiency 7	613559	AR	3	Mtrfr
12q24.31	12:123232914-123257960	MTRFR, C12orf65, COXPD7, SPG55	Mitochondrial translation release factor in rescue	613541	MTRFR	91574	ENSG00000130921,ENST00000253233;;;ENST00000253233		Spastic paraplegia 55, autosomal recessive	615035	AR	3	Mtrfr
12q24.31	12:123470054-123533719	RILPL1, RLP1, GOSPEL, OPDM4	RAB-interacting lysosomal protein-like 1	614092	RILPL1	353116	ENSG00000188026,ENST00000376874;;;ENST00000376874		Oculopharyngodistal myopathy 4	619790	AD	3	Rilpl1
12q24.31	12:123620406-123633686	EIF2B1, EIF2BA, VWM1	Eukaryotic translation initiation factor 2B, subunit 1	606686	EIF2B1	1967	ENSG00000111361,ENST00000424014;;;ENST00000424014		Leukoencephalopathy with vanishing white matter 1, with or without ovarian failure	603896	AR	3	Eif2b1
12q24.31	12:123671113-123708399	TCTN2, TECT2, MKS8, JBTS24	Tectonic family, member 2	613846	TCTN2	79867	ENSG00000168778,ENST00000303372;;;ENST00000303372	mutation identified in 1 MKS8 family	?Meckel syndrome 8	613885	AR	3	Tctn2
12q24.31	12:123671113-123708399	TCTN2, TECT2, MKS8, JBTS24	Tectonic family, member 2	613846	TCTN2	79867	ENSG00000168778,ENST00000303372;;;ENST00000303372	mutation identified in 1 MKS8 family	Joubert syndrome 24	616654	AR	3	Tctn2
12q24.31	12:123712353-123761755	ATP6V0A2, WSS, ARCL2A	ATPase, H+ transporting, V0 subunit A2	611716	ATP6V0A2	23545	ENSG00000185344,ENST00000330342;;;ENST00000330342		Cutis laxa, autosomal recessive, type IIA	219200	AR	3	Atp6v0a2
12q24.31	12:123712353-123761755	ATP6V0A2, WSS, ARCL2A	ATPase, H+ transporting, V0 subunit A2	611716	ATP6V0A2	23545	ENSG00000185344,ENST00000330342;;;ENST00000330342		Wrinkly skin syndrome	278250	AR	3	Atp6v0a2
12q24.31	12:123762301-123935720	DNAH10, SPGF56	Dynein, axonemal, heavy chain 10	605884	DNAH10	196385	ENSG00000197653,ENST00000673944;;;ENST00000673944		Spermatogenic failure 56	619515	AR	3	Dnah10
12q24.31	12:124776856-124863864	SCARB1, CD36L1, CLA1, HDLQTL6	Scavenger receptor class B, member 1 (CD36 antigen-like 1)	601040	SCARB1	949	ENSG00000073060,ENST00000261693;;;ENST00000261693		[High density lipoprotein cholesterol level QTL6]	610762		3	Scarb1
12q24.31	12:124946826-124989131	DHX37, KIAA1517, NEDBAVC, SRXY11	DEAH-box helicase 37	617362	DHX37	57647	ENSG00000150990,ENST00000308736;;;ENST00000308736		46XY sex reversal 11	273250	AD	3	Dhx37
12q24.31	12:124946826-124989131	DHX37, KIAA1517, NEDBAVC, SRXY11	DEAH-box helicase 37	617362	DHX37	57647	ENSG00000150990,ENST00000308736;;;ENST00000308736		Neurodevelopmental disorder with brain anomalies and with or without vertebral or cardiac anomalies	618731	AR	3	Dhx37
12q24.33	12:131929276-131945896	PUS1, MLASA1	Pseudourine synthase 1	608109	PUS1	80324	ENSG00000177192,ENST00000376649;;;ENST00000376649		Myopathy, lactic acidosis, and sideroblastic anemia 1	600462	AR	3	Pus1
12q24.33	12:132618776-132622388	P2RX2, P2X2, DFNA41	Purinergic receptor P2X, ligand-gated ion channel, 2	600844	P2RX2	22953	ENSG00000187848,ENST00000643471;;;ENST00000643471		Deafness, autosomal dominant 41	608224	AD	3	P2rx2
12q24.33	12:132623762-132687342	POLE, CRCS12, FILS, IMAGEI	Polymerase, DNA, epsilon	174762	POLE	5426	ENSG00000177084,ENST00000320574;;;ENST00000320574		{Colorectal cancer, susceptibility to, 12}	615083	AD	3	Pole
12q24.33	12:132623762-132687342	POLE, CRCS12, FILS, IMAGEI	Polymerase, DNA, epsilon	174762	POLE	5426	ENSG00000177084,ENST00000320574;;;ENST00000320574		FILS syndrome	615139	AR	3	Pole
12q24.33	12:132623762-132687342	POLE, CRCS12, FILS, IMAGEI	Polymerase, DNA, epsilon	174762	POLE	5426	ENSG00000177084,ENST00000320574;;;ENST00000320574		IMAGE-I syndrome	618336	AR	3	Pole
12q24.33	12:132725503-132761832	ANKLE2, LEM4, KIAA0692, MCPH16	Ankyrin repeat- and LEM domain-containing protein 2	616062	ANKLE2	23141	ENSG00000176915,ENST00000357997;;;ENST00000357997		Microcephaly 16, primary, autosomal recessive	616681	AR	3	Ankle2
13pter-q12.13	13:1-27200000	FECD2, FCD1	Corneal dystrophy, Fuchs endothelial, 2	610158		100188278		max lod at D13S1304	Corneal dystrophy, Fuchs endothelial, 2	610158	AD	2	
13q	13:17700001-114364328	CLQTL1, CLF	Cholesterol level quantitative trait locus 1	604595		54501			[Cholesterol level QTL 1]	604595		2	
13q12.11	13:18900001-22600000	ADHD6	Attention deficit-hyperactivity disorder, susceptibility to, 6	612312		100190791		max lod at rs1974047	{Attention deficit-hyperactivity disorder, susceptibility to, 6}	612312		2	
13q12-q14	13:18900001-54700000	ATOD5	Dermatitis, atopic, 5	605844		117188		max lod at D13S218	{Dermatitis, atopic, susceptibility to, 5}	605844		2	
13q12.11	13:18900001-22600000	CFEOM3C, FEOM4	Fibrosis of extraocular muscles, congenital, 3C	609384					Fibrosis of extraocular muscles, congenital, 3C	609384	AD	2	
13q12	13:18900001-31600000	MCI2	Myocardial infarction, susceptibility to, 2	608557		100233226		defined by 4-SNP haplotype HapA	{Myocardial infarction, susceptibility to, 2}	608557		2	
13q12.11	13:19863840-20089115	ZMYM2, ZNF198, RAMP, FIM, NECRC	Zinc finger, MYM-type 2	602221	ZMYM2	7750	ENSG00000121741,ENST00000610343;;;ENST00000610343		Neurodevelopmental-craniofacial syndrome with variable renal and cardiac abnormalities	619522	AD	3	Zmym2
13q12.11	13:20138255-20161565	GJA3, CX46, CZP3, CAE3, CTRCT14	Gap junction protein, alpha-3, 46kD (connexin 46)	121015	GJA3	2700	ENSG00000121743,ENST00000241125;;;ENST00000241125		Cataract 14, multiple types	601885	AD	3	Gja3
13q12.11	13:20187470-20192938	GJB2, CX26, DFNB1A, PPK, DFNA3A, KID, HID, BAPS	Gap junction protein, beta-2, 26kD (connexin 26)	121011	GJB2	2706	ENSG00000165474,ENST00000382848;;;ENST00000382848		Bart-Pumphrey syndrome	149200	AD	3	Gjb2
13q12.11	13:20187470-20192938	GJB2, CX26, DFNB1A, PPK, DFNA3A, KID, HID, BAPS	Gap junction protein, beta-2, 26kD (connexin 26)	121011	GJB2	2706	ENSG00000165474,ENST00000382848;;;ENST00000382848		Deafness, autosomal dominant 3A	601544	AD	3	Gjb2
13q12.11	13:20187470-20192938	GJB2, CX26, DFNB1A, PPK, DFNA3A, KID, HID, BAPS	Gap junction protein, beta-2, 26kD (connexin 26)	121011	GJB2	2706	ENSG00000165474,ENST00000382848;;;ENST00000382848		Deafness, autosomal recessive 1A	220290	AR, DD	3	Gjb2
13q12.11	13:20187470-20192938	GJB2, CX26, DFNB1A, PPK, DFNA3A, KID, HID, BAPS	Gap junction protein, beta-2, 26kD (connexin 26)	121011	GJB2	2706	ENSG00000165474,ENST00000382848;;;ENST00000382848		Hystrix-like ichthyosis with deafness	602540	AD	3	Gjb2
13q12.11	13:20187470-20192938	GJB2, CX26, DFNB1A, PPK, DFNA3A, KID, HID, BAPS	Gap junction protein, beta-2, 26kD (connexin 26)	121011	GJB2	2706	ENSG00000165474,ENST00000382848;;;ENST00000382848		Keratitis-ichthyosis-deafness syndrome	148210	AD	3	Gjb2
13q12.11	13:20187470-20192938	GJB2, CX26, DFNB1A, PPK, DFNA3A, KID, HID, BAPS	Gap junction protein, beta-2, 26kD (connexin 26)	121011	GJB2	2706	ENSG00000165474,ENST00000382848;;;ENST00000382848		Keratoderma, palmoplantar, with deafness	148350	AD	3	Gjb2
13q12.11	13:20187470-20192938	GJB2, CX26, DFNB1A, PPK, DFNA3A, KID, HID, BAPS	Gap junction protein, beta-2, 26kD (connexin 26)	121011	GJB2	2706	ENSG00000165474,ENST00000382848;;;ENST00000382848		Vohwinkel syndrome	124500	AD	3	Gjb2
13q12.11	13:20221962-20232319	GJB6, CX30, DFNA3B, DFNB1B, ECTD2, HED2	Gap junction protein, beta-6 (connexin-30)	604418	GJB6	10804	ENSG00000121742,ENST00000647029;;;ENST00000647029		Deafness, autosomal dominant 3B	612643	AD	3	Gjb6
13q12.11	13:20221962-20232319	GJB6, CX30, DFNA3B, DFNB1B, ECTD2, HED2	Gap junction protein, beta-6 (connexin-30)	604418	GJB6	10804	ENSG00000121742,ENST00000647029;;;ENST00000647029		Deafness, autosomal recessive 1B	612645	AR	3	Gjb6
13q12.11	13:20221962-20232319	GJB6, CX30, DFNA3B, DFNB1B, ECTD2, HED2	Gap junction protein, beta-6 (connexin-30)	604418	GJB6	10804	ENSG00000121742,ENST00000647029;;;ENST00000647029		Deafness, digenic GJB2/GJB6	220290	AR, DD	3	Gjb6
13q12.11	13:20221962-20232319	GJB6, CX30, DFNA3B, DFNB1B, ECTD2, HED2	Gap junction protein, beta-6 (connexin-30)	604418	GJB6	10804	ENSG00000121742,ENST00000647029;;;ENST00000647029		Ectodermal dysplasia 2, Clouston type	129500	AD	3	Gjb6
13q12.11	13:21671073-21704498	FGF9, SYNS3	Fibroblast growth factor-9 (glia-activating factor)	600921	FGF9	2254	ENSG00000102678,ENST00000382353;;;ENST00000382353		Multiple synostoses syndrome 3	612961	AD	3	Fgf9
13q12.12	13:22600001-24900000	MYP20	Myopia 20, autosomal dominant	614166		100682326		associated with rs9318086	Myopia 20, autosomal dominant	614166		2	
13q12.12	13:23160508-23325162	SGCG, LGMDR5, DMDA1, SCG3	Sarcoglycan, gamma (35kD dystrophin-associated glycoprotein)	608896	SGCG	6445	ENSG00000102683,ENST00000218867;;;ENST00000218867		Muscular dystrophy, limb-girdle, autosomal recessive 5	253700	AR	3	Sgcg
13q12.12	13:23328830-23433702	SACS, ARSACS	Sacsin	604490	SACS	26278	ENSG00000151835,ENST00000382292;;;ENST00000382292		Spastic ataxia, Charlevoix-Saguenay type	270550	AR	3	Sacs
13q12.12	13:23730189-23889400	MIPEP, COXPD31	Mitochondrial intermediate peptidase	602241	MIPEP	4285	ENSG00000027001,ENST00000382172;;;ENST00000382172		Combined oxidative phosphorylation deficiency 31	617228	AR	3	Mipep
13q12.12-q12.13	13:24882279-24934000	CENPJ, CPAP, MCPH6, SCKL4	Centromeric protein J	609279	CPAP	55835	ENSG00000151849,ENST00000381884;;;ENST00000381884	mutation identified in 1 SCKL4 family	?Seckel syndrome 4	613676	AR	3	Cpap
13q12.12-q12.13	13:24882279-24934000	CENPJ, CPAP, MCPH6, SCKL4	Centromeric protein J	609279	CPAP	55835	ENSG00000151849,ENST00000381884;;;ENST00000381884	mutation identified in 1 SCKL4 family	Microcephaly 6, primary, autosomal recessive	608393	AR	3	Cpap
13q12.13	13:25371974-26025851	ATP8A2, ATPIB, CAMRQ4	ATPase, class I, type 8A, member 2	605870	ATP8A2	51761	ENSG00000132932,ENST00000381655;;;ENST00000381655		Cerebellar ataxia, impaired intellectual development, and dysequilibrium syndrome 4	615268	AR	3	Atp8a2
13q12.13	13:26132115-26223085	RNF6	RING finger protein-6	604242	RNF6	6049	ENSG00000127870,ENST00000381588;;;ENST00000381588		Esophageal carcinoma, somatic	133239		3	Rnf6
13q12.13	13:26254129-26405238	CDK8, IDDHBA	Cyclin-dependent kinase 8	603184	CDK8	1024	ENSG00000132964,ENST00000381527;;;ENST00000381527		Intellectual developmental disorder with hypotonia and behavioral abnormalities	618748	AD	3	Cdk8
13q12.2-q13	13:27200001-39500000	MBS, MBS1	Moebius syndrome	157900		4156			?Moebius syndrome	157900	AD, IC	2	
13q12.2	13:27251558-27256568	RPL21, HYPT12	Ribosomal protein L21	603636	RPL21	6144	ENSG00000122026,ENST00000311549;;;ENST00000311549		Hypotrichosis 12	615885	AD	3	Rpl21
13q12.2	13:27620743-27667411	POLR1D, RPA16, RPAC2, TCS2	Polymerase I, RNA, subunit D	613715	POLR1D	51082	ENSG00000186184,ENST00000302979;;;ENST00000302979		Treacher Collins syndrome 2	613717	AD, AR	3	Polr1d
13q12.2	13:27920000-27926313	PDX1, IPF1, MODY4, PAGEN1	Pancreas/duodenum homeobox protein 1	600733	PDX1	3651	ENSG00000139515,ENST00000381033;;;ENST00000381033		{Diabetes mellitus, type II, susceptibility to}	125853	AD	3	Pdx1
13q12.2	13:27920000-27926313	PDX1, IPF1, MODY4, PAGEN1	Pancreas/duodenum homeobox protein 1	600733	PDX1	3651	ENSG00000139515,ENST00000381033;;;ENST00000381033		MODY, type IV	606392		3	Pdx1
13q12.2	13:27920000-27926313	PDX1, IPF1, MODY4, PAGEN1	Pancreas/duodenum homeobox protein 1	600733	PDX1	3651	ENSG00000139515,ENST00000381033;;;ENST00000381033		Pancreatic agenesis 1	260370	AR	3	Pdx1
13q12.2	13:28003274-28100576	FLT3	fms-related tyrosine kinase-3	136351	FLT3	2322	ENSG00000122025,ENST00000241453;;;ENST00000241453		Leukemia, acute lymphoblastic, somatic	613065		3	Flt3
13q12.2	13:28003274-28100576	FLT3	fms-related tyrosine kinase-3	136351	FLT3	2322	ENSG00000122025,ENST00000241453;;;ENST00000241453		Leukemia, acute myeloid, reduced survival in, somatic	601626		3	Flt3
13q12.2	13:28003274-28100576	FLT3	fms-related tyrosine kinase-3	136351	FLT3	2322	ENSG00000122025,ENST00000241453;;;ENST00000241453		Leukemia, acute myeloid, somatic	601626		3	Flt3
13q12.3	13:28659130-28678959	POMP, UMP1, PRAAS2	Proteasome maturation protein	613386	POMP	51371	ENSG00000132963,ENST00000380842;;;ENST00000380842		Keratosis linearis with ichthyosis congenita and sclerosing keratoderma	601952	AR	3	Pomp
13q12.3	13:28659130-28678959	POMP, UMP1, PRAAS2	Proteasome maturation protein	613386	POMP	51371	ENSG00000132963,ENST00000380842;;;ENST00000380842		Proteasome-associated autoinflammatory syndrome 2	618048	AD	3	Pomp
13q12.3	13:30713485-30764426	ALOX5AP, FLAP	Arachidonate 5-lipoxygenase-activating protein	603700	ALOX5AP	241	ENSG00000132965,ENST00000380490;;;ENST00000380490		{Stroke, susceptibility to}	601367	Mu	3	Alox5ap
13q12.3	13:31199975-31332276	B3GLCT, B3GALTL, B3GTL	Beta 3-glucosyltransferase	610308	B3GLCT	145173	ENSG00000187676,ENST00000343307;;;ENST00000343307		Peters-plus syndrome	261540	AR	3	B3glct
13q13-q14.3	13:31600001-54700000	ENUR1	Enuresis, nocturnal, 1	600631		2031			Enuresis, nocturnal, 1	600631	AD	2	
13q13.1	13:31600001-33400000	HPRHP	Hypophosphatemic rickets and hyperparathyroidism	612089		100188880		?due to altered KLOTHO expression	Hypophosphatemic rickets and hyperparathyroidism	612089	AD	2	
13q13.1	13:32315077-32400268	BRCA2, FANCD1, BROVCA2, GLM3, PNCA2	BRCA2 DNA repair-associated protein	600185	BRCA2	675	ENSG00000139618,ENST00000380152;;;ENST00000380152		{Breast cancer, male, susceptibility to}	114480	AD, SMu	3	Brca2
13q13.1	13:32315077-32400268	BRCA2, FANCD1, BROVCA2, GLM3, PNCA2	BRCA2 DNA repair-associated protein	600185	BRCA2	675	ENSG00000139618,ENST00000380152;;;ENST00000380152		{Breast-ovarian cancer, familial, 2}	612555	AD	3	Brca2
13q13.1	13:32315077-32400268	BRCA2, FANCD1, BROVCA2, GLM3, PNCA2	BRCA2 DNA repair-associated protein	600185	BRCA2	675	ENSG00000139618,ENST00000380152;;;ENST00000380152		{Glioblastoma 3}	613029	AR	3	Brca2
13q13.1	13:32315077-32400268	BRCA2, FANCD1, BROVCA2, GLM3, PNCA2	BRCA2 DNA repair-associated protein	600185	BRCA2	675	ENSG00000139618,ENST00000380152;;;ENST00000380152		{Medulloblastoma}	155255	AD, AR, SMu	3	Brca2
13q13.1	13:32315077-32400268	BRCA2, FANCD1, BROVCA2, GLM3, PNCA2	BRCA2 DNA repair-associated protein	600185	BRCA2	675	ENSG00000139618,ENST00000380152;;;ENST00000380152		{Pancreatic cancer 2}	613347		3	Brca2
13q13.1	13:32315077-32400268	BRCA2, FANCD1, BROVCA2, GLM3, PNCA2	BRCA2 DNA repair-associated protein	600185	BRCA2	675	ENSG00000139618,ENST00000380152;;;ENST00000380152		{Prostate cancer}	176807	AD, SMu	3	Brca2
13q13.1	13:32315077-32400268	BRCA2, FANCD1, BROVCA2, GLM3, PNCA2	BRCA2 DNA repair-associated protein	600185	BRCA2	675	ENSG00000139618,ENST00000380152;;;ENST00000380152		Fanconi anemia, complementation group D1	605724	AR	3	Brca2
13q13.1	13:32315077-32400268	BRCA2, FANCD1, BROVCA2, GLM3, PNCA2	BRCA2 DNA repair-associated protein	600185	BRCA2	675	ENSG00000139618,ENST00000380152;;;ENST00000380152		Wilms tumor	194070	AD, SMu	3	Brca2
13q13.1	13:33016243-33066143	KL, KLOTHO, HFTC3	Klotho	604824	KL	9365	ENSG00000133116,ENST00000380099;;;ENST00000380099	mutation identified in 1 HFTC3 patient	?Tumoral calcinosis, hyperphosphatemic, familial, 3	617994	AR	3	Kl
13q13.2-q14.1	13:33400001-46700000	AUTS3	Autism, susceptibility to, 3	608049		387577			{Autism susceptibility 3}	608049	IC, Mu	2	
13q13.3	13:34900001-39500000	IBD27	Inflammatory bowel disease 27	612796		100302059			{Inflammatory bowel disease 27}	612796		2	
13q13.3-q21	13:34900001-72800000	PAPA5	Polydactyly, postaxial, type A5	263450		101241897		between D13S1288 and D13S632	Polydactyly, postaxial, type A5	263450	AR	2	
13q13.3	13:34942270-35672736	NBEA, NEDEGE	Neurobeachin	604889	NBEA	26960	ENSG00000172915,ENST00000379939;;;ENST00000379939	site of FRA13A	Neurodevelopmental disorder with or without early-onset generalized epilepsy	619157	AD	3	Nbea
13q13.3	13:35473789-35476689	MAB21L1, COFG	mab-21 like 1	601280	MAB21L1	4081	ENSG00000180660,ENST00000379919;;;ENST00000379919		Cerebellar, ocular, craniofacial, and genital syndrome	618479	AR	3	Mab21l1
13q13.3	13:36301638-36370180	SPART, KIAA0610, SPG20	Spartin	607111	SPART	23111	ENSG00000133104,ENST00000438666;;;ENST00000438666		Troyer syndrome	275900	AR	3	Spart
13q13.3	13:36819222-36829104	RFXAP, MHC2D4	Regulatory factor X-associated protein	601861	RFXAP	5994	ENSG00000133111,ENST00000255476;;;ENST00000255476		MHC class II deficiency 4	620817	AR	3	Rfxap
13q13.3	13:36844831-36920854	MADH9, SMAD9, MADH6, PPH2	Mothers against decapentaplegic, Drosophila, homolog of, 9	603295	SMAD9	4093	ENSG00000120693,ENST00000379826;;;ENST00000379826		Pulmonary hypertension, primary, 2	615342	AD	3	Smad9
13q13.3	13:36949738-36999367	ALG5, PKD7	ALG5 dolichyl-phosphate beta-glucosyltransferase	604565	ALG5	29880	ENSG00000120697,ENST00000239891;;;ENST00000239891		Polycystic kidney disease 7	620056	AD	3	Alg5
13q13.3	13:37000786-37009614	EXOSC8, OIP2, RRP43, PCH1C	Exosome component 8	606019	EXOSC8	11340	ENSG00000120699,ENST00000389704;;;ENST00000389704		Pontocerebellar hypoplasia, type 1C	616081	AR	3	Exosc8
13q13.3	13:38349851-38363619	UFM1, HLD14	Ubiquitin-fold modifier 1	610553	UFM1	51569	ENSG00000120686,ENST00000239878;;;ENST00000239878		Leukodystrophy, hypomyelinating, 14	617899	AR	3	Ufm1
13q13.3	13:38687077-38887131	FREM2, FRASRS2, CRYPTOP	FRAS1-related extracellular matrix protein 2	608945	FREM2	341640	ENSG00000150893,ENST00000280481;;;ENST00000280481		Cryptophthalmos, unilateral or bilateral, isolated	123570	AR	3	Frem2
13q13.3	13:38687077-38887131	FREM2, FRASRS2, CRYPTOP	FRAS1-related extracellular matrix protein 2	608945	FREM2	341640	ENSG00000150893,ENST00000280481;;;ENST00000280481		Fraser syndrome 2	617666	AR	3	Frem2
13q14	13:39500001-54700000	BMIQ2	Body mass index quantitative trait locus 2	606643		192149		max lod at D13S257	[Body mass index QTL2]	606643		2	
13q14	13:39500001-54700000	BMND9	Bone mineral density quantitative trait locus 9	612110		100188882		associated with rs9594759	[Bone mineral density QTL 9]	612110		2	
13q14	13:39500001-54700000	CLLS2, D13S25, DBM	Leukemia, chronic lymphocytic, susceptibility to, 2	109543		8101		>530kb telomeric to RB1	{Leukemia, chronic lymphocytic, susceptibility to, 2}	109543	AD	2	
13q14	13:39500001-54700000	DEL13q14, C13DELq14	Chromosome 13q14 deletion syndrome	613884					Chromosome 13q14 deletion syndrome	613884	AD, IC	4	
13q14	13:39500001-54700000	GER	Gastroesophageal reflux	109350		59330			Gastroesophageal reflux	109350	AD	2	
13q14.11	13:39500001-44600000	LPRS6	Leprosy, susceptibility to, 6	613407		100499166		associated with rs9533634 and rs3764147	{Leprosy, susceptibility to, 6}	613407		2	
13q14	13:39500001-54700000	RIEG2, RGS2	Rieger syndrome, type 2	601499		6012			Rieger syndrome, type 2	601499	AD	2	
13q14	13:39500001-54700000	SPG24	Spastic paraplegia 24, autosomal recessive	607584		338090			Spastic paraplegia 24, autosomal recessive	607584	AR	2	
13q14.11	13:39655627-39791666	COG6, COD2, KIAA1134, CDG2L, SHNS	Component of oligomeric golgi complex 6	606977	COG6	57511	ENSG00000133103,ENST00000455146;;;ENST00000455146		Congenital disorder of glycosylation, type IIl	614576	AR	3	Cog6
13q14.11	13:39655627-39791666	COG6, COD2, KIAA1134, CDG2L, SHNS	Component of oligomeric golgi complex 6	606977	COG6	57511	ENSG00000133103,ENST00000455146;;;ENST00000455146		Shaheen syndrome	615328	AR	3	Cog6
13q14.11	13:40555667-40666641	FOXO1A, FKHR	Forkhead box O1A (forkhead in rhabdomyosarcoma)	136533	FOXO1	2308	ENSG00000150907,ENST00000379561;;;ENST00000379561	chimeric with PAX3 in t(2;13); fuses with PAX3	Rhabdomyosarcoma, alveolar	268220	SMu	3	Foxo1
13q14.11	13:40789611-40812460	SLC25A15, ORNT1, HHH	Solute carrier family 25 (mitochondrial carrier), member 15 (ornithine transporter 1)	603861	SLC25A15	10166	ENSG00000102743,ENST00000338625;;;ENST00000338625	with deficiency of factors VII and X in 3 unrelated cases	Hyperornithinemia-hyperammonemia-homocitrullinemia syndrome	238970	AR	3	Slc25a15
13q14.11	13:41061509-41084006	WBP4, FBP21, NEDHFDB	WW domain-containing binding protein 4	604981	WBP4	11193	ENSG00000120688,ENST00000379487;;;ENST00000379487		Neurodevelopemental disorder with hypotonia, feeding difficulties, facial dysmorphism, and brain abnormalities	620852	AR	3	Wbp4
13q14.11	13:41566835-41961109	VWA8, KIAA0564, RP97	von Willebrand factor A domain-containing protein 8	617509	VWA8	23078	ENSG00000102763,ENST00000379310;;;ENST00000379310	mutation identified in 1 RP97 family	?Retinitis pigmentosa 97	620422	AD	3	Vwa8
13q14.11	13:42562736-42608013	TNFSF11, OPGL, TRANCE, OPTB2	Tumor necrosis factor ligand superfamily, member 11 (osteoprotegerin ligand)	602642	TNFSF11	8600	ENSG00000120659,ENST00000398795;;;ENST00000398795		Osteopetrosis, autosomal recessive 2	259710	AR	3	Tnfsf11
13q14.11	13:43879178-43893932	LACC1, C13orf31, JUVAR	Laccase (multicopper reductase) domain-containing protein 1	613409	LACC1	144811	ENSG00000179630,ENST00000325686;;;ENST00000325686		Juvenile arthritis	618795	AR	3	Lacc1
13q14.13	13:45337480-45337609	SNORA31, IIAE10	Small nucleolar RNA, H/ACA box, 31	619378	SNORA31	677814	ENSG00000199477,ENST00000362607		{Encephalopathy, acute, infection-induced (herpes-specific), susceptibility to, 10}	619396	AD	3	
13q14.13	13:45464939-45536701	COG3, SEC34, CDG2BB	Component of oligomeric golgi complex 3	606975	COG3	83548	ENSG00000136152,ENST00000349995;;;ENST00000349995		Congenital disorder of glycosylation, type IIbb	620546	AR	3	Cog3
13q14.2	13:46831546-46898082	HTR2A	5-hydroxytryptamine (serotonin) receptor-2A	182135	HTR2A	3356	ENSG00000102468,ENST00000542664;;;ENST00000542664		{Major depressive disorder, response to citalopram therapy in}	608516		3	Htr2a
13q14.2	13:46831546-46898082	HTR2A	5-hydroxytryptamine (serotonin) receptor-2A	182135	HTR2A	3356	ENSG00000102468,ENST00000542664;;;ENST00000542664		{Obsessive-compulsive disorder, susceptibility to}	164230	AD	3	Htr2a
13q14.2	13:46831546-46898082	HTR2A	5-hydroxytryptamine (serotonin) receptor-2A	182135	HTR2A	3356	ENSG00000102468,ENST00000542664;;;ENST00000542664		{Schizophrenia, susceptibility to}	181500	AD	3	Htr2a
13q14.2	13:47942656-48001273	SUCLA2, MTDPS5	Succinate-CoA ligase, ADP-forming, beta subunit	603921	SUCLA2	8803	ENSG00000136143,ENST00000646932;;;ENST00000646932		Mitochondrial DNA depletion syndrome 5 (encephalomyopathic with or without methylmalonic aciduria)	612073	AR	3	Sucla2
13q14.2	13:48037726-48052755	NUDT15, MTH2, NUDT15D	Nudix hydrolase 15	615792	NUDT15	55270	ENSG00000136159,ENST00000258662;;;ENST00000258662		{Thiopurines, poor metabolism of, 2}	616903	AD	3	Nudt15
13q14.2	13:48233206-48270357	ITM2B, BRI, ABRI, FBD, RDGCA	Integral membrane protein 2B (BRI gene)	603904	ITM2B	9445	ENSG00000136156,ENST00000647800;;;ENST00000647800	mutation identified in 1 RDGCA family	?Retinal dystrophy with inner retinal dysfunction and ganglion cell abnormalities	616079	AD	3	Itm2b
13q14.2	13:48233206-48270357	ITM2B, BRI, ABRI, FBD, RDGCA	Integral membrane protein 2B (BRI gene)	603904	ITM2B	9445	ENSG00000136156,ENST00000647800;;;ENST00000647800	mutation identified in 1 RDGCA family	Dementia, familial British	176500	AD	3	Itm2b
13q14.2	13:48233206-48270357	ITM2B, BRI, ABRI, FBD, RDGCA	Integral membrane protein 2B (BRI gene)	603904	ITM2B	9445	ENSG00000136156,ENST00000647800;;;ENST00000647800	mutation identified in 1 RDGCA family	Dementia, familial Danish	117300	AD	3	Itm2b
13q14.2	13:48303751-48481890	RB1	Retinoblastoma-1	614041	RB1	5925	ENSG00000139687,ENST00000267163;;;ENST00000267163		Bladder cancer, somatic	109800		3	Rb1
13q14.2	13:48303751-48481890	RB1	Retinoblastoma-1	614041	RB1	5925	ENSG00000139687,ENST00000267163;;;ENST00000267163		Osteosarcoma, somatic	259500		3	Rb1
13q14.2	13:48303751-48481890	RB1	Retinoblastoma-1	614041	RB1	5925	ENSG00000139687,ENST00000267163;;;ENST00000267163		Retinoblastoma	180200	AD, SMu	3	Rb1
13q14.2	13:48303751-48481890	RB1	Retinoblastoma-1	614041	RB1	5925	ENSG00000139687,ENST00000267163;;;ENST00000267163		Retinoblastoma, trilateral	180200	AD, SMu	3	Rb1
13q14.2	13:48303751-48481890	RB1	Retinoblastoma-1	614041	RB1	5925	ENSG00000139687,ENST00000267163;;;ENST00000267163		Small cell cancer of the lung, somatic	182280		3	Rb1
13q14.2	13:48389571-48444669	LPAR6, P2RY5, P2Y5, LAH3, ARWH1, HYPT8	Lysophosphatidic acid receptor 6	609239	LPAR6	10161	ENSG00000139679,ENST00000620633;;;ENST00000620633	in intron 17 of RB gene	Hypotrichosis 8	278150	AR	3	Lpar6
13q14.2	13:48389571-48444669	LPAR6, P2RY5, P2Y5, LAH3, ARWH1, HYPT8	Lysophosphatidic acid receptor 6	609239	LPAR6	10161	ENSG00000139679,ENST00000620633;;;ENST00000620633	in intron 17 of RB gene	Woolly hair, autosomal recessive 1, with or without hypotrichosis	278150	AR	3	Lpar6
13q14.2	13:49531946-49585558	RCBTB1, CLLD7, GLP, RDEOA	RCC1 domain- and BTB domain-containing protein 1	607867	RCBTB1	55213	ENSG00000136144,ENST00000378302;;;ENST00000378302		Retinal dystrophy with or without extraocular anomalies	617175	AR	3	Rcbtb1
13q14.2	13:49699320-49792682	KPNA3, SPG88	Karyopherin (importin) alpha-3	601892	KPNA3	3839	ENSG00000102753,ENST00000261667;;;ENST00000261667		Spastic paraplegia 88, autosomal dominant	620106	AD	3	Kpna3
13q14.3	13:50300001-54700000	STQTL20	Stature quantitative trait locus 20	612894		100302685		associated with rs3118914	{Stature QTL 20}	612894		2	
13q14.3	13:50909678-50970460	RNASEH2B, DLEU8, FLJ11712, AGS2	Ribonuclease H2, subunit B	610326	RNASEH2B	79621	ENSG00000136104,ENST00000336617;;;ENST00000336617		Aicardi-Goutieres syndrome 2	610181	AR	3	Rnaseh2b
13q14.3	13:51932669-52012132	ATP7B, WND	ATPase, Cu++ transporting, beta polypeptide	606882	ATP7B	540	ENSG00000123191,ENST00000242839;;;ENST00000242839		Wilson disease	277900	AR	3	Atp7b
13q14.3	13:52012398-52033600	ALG11, KIAA1266, CDG1P	ALG11 alpha-1,2-mannosyltransferase	613666	ALG11	440138	ENSG00000253710,ENST00000521508;;;ENST00000521508		Congenital disorder of glycosylation, type Ip	613661	AR	3	Alg11
13q14.3	13:52377167-52406172	THSD1, TMTSP, ANIB12, LMPHM13	Thrombospondin type 1 domain-containing protein 1	616821	THSD1	55901	ENSG00000136114,ENST00000258613;;;ENST00000258613	mutation identified in 1 ANIB12 family	?Aneurysm, intracranial berry, 12	618734	AD	3	Thsd1
13q14.3	13:52377167-52406172	THSD1, TMTSP, ANIB12, LMPHM13	Thrombospondin type 1 domain-containing protein 1	616821	THSD1	55901	ENSG00000136114,ENST00000258613;;;ENST00000258613	mutation identified in 1 ANIB12 family	Lymphatic malformation 13	620244	AR	3	Thsd1
13q21	13:54700001-72800000	ATXN8	Ataxin 8	613289	ATXN8	724066		CAG repeat results in polyglutamine expansion protein	Spinocerebellar ataxia 8	608768	AD	3	
13q21-q32	13:54700001-101100000	PAPA2	Postaxial polydactyly, type A2	602085		8103			Postaxial polydactyly, type A2	602085	AD	2	
13q21	13:54700001-72800000	SLI3	Specific language impairment QTL, 3	607134		780906		max with D13S1317	Specific language impairment QTL, 3	607134	Mu	2	
13q21.2	13:59665583-60163928	DIAPH3, DIA2, DRF3, AUNA1, NSDAN	Diaphanous-related formin 3	614567	DIAPH3	81624	ENSG00000139734,ENST00000400324;;;ENST00000400324		Auditory neuropathy, autosomal dominant 1	609129	AD	3	Diaph3
13q21.33	13:70107421-70171738	ATXN8OS, SCA8, KLHL1AS	Ataxin 8 opposite strand	603680	ATXN8OS	6315	ENSG00000230223,ENST00000424524;;;ENST00000424524	due to CTG repeat in untranslated DNA	{Parkinson disease, susceptibility to}	168600	AD, Mu	3	
13q21.33	13:70107421-70171738	ATXN8OS, SCA8, KLHL1AS	Ataxin 8 opposite strand	603680	ATXN8OS	6315	ENSG00000230223,ENST00000424524;;;ENST00000424524	due to CTG repeat in untranslated DNA	Spinocerebellar ataxia 8	608768	AD	3	
13q21.33-q22.1	13:72782133-73016461	PIBF1, JBTS33	Progesterone-induced blocking factor 1	607532	PIBF1	10464	ENSG00000083535,ENST00000326291;;;ENST00000326291		Joubert syndrome 33	617767	AR	3	Pibf1
13q22	13:72800001-78500000	DDH1	Developmental dysplasia of the hip 1	142700		780896			Developmental dysplasia of the hip 1	142700	Mu	2	
13q22-q32	13:72800001-101100000	PAND1	Panic disorder syndrome 1	167870		387572			Panic disorder syndrome 1	167870	?AD	2	
13q22.2	13:75283503-75482169	TBC1D4, AS160, KIAA0603, NIDDM5	TPC1 domain family, member 4	612465	TBC1D4	9882	ENSG00000136111,ENST00000377636;;;ENST00000377636		{Diabetes mellitus, noninsulin-dependent, 5}	616087		3	Tbc1d4
13q22.3	13:76992081-77005117	CLN5	CLN5 intracellular trafficking protein	608102	CLN5	1203	ENSG00000102805,ENST00000377453;;;ENST00000377453		Ceroid lipofuscinosis, neuronal, 5	256731	AR	3	Cln5
13q22.3	13:77005260-77027159	FBXL3, FBXL3A, FBL3, IDDSFAS	F-box and leucine-rich repeat protein 3	605653	FBXL3	26224	ENSG00000005812,ENST00000355619;;;ENST00000355619		Intellectual developmental disorder with short stature, facial anomalies, and speech defects	606220	AR	3	Fbxl3
13q22.3	13:77895487-77975527	EDNRB, HSCR2, ABCDS, WS4A	Endothelin receptor type B	131244	EDNRB	1910	ENSG00000136160,ENST00000646607;;;ENST00000646607	mutation identified in 1 ABCD family	?ABCD syndrome	600501	AR	3	Ednrb
13q22.3	13:77895487-77975527	EDNRB, HSCR2, ABCDS, WS4A	Endothelin receptor type B	131244	EDNRB	1910	ENSG00000136160,ENST00000646607;;;ENST00000646607	mutation identified in 1 ABCD family	{Hirschsprung disease, susceptibility to, 2}	600155	AD	3	Ednrb
13q22.3	13:77895487-77975527	EDNRB, HSCR2, ABCDS, WS4A	Endothelin receptor type B	131244	EDNRB	1910	ENSG00000136160,ENST00000646607;;;ENST00000646607	mutation identified in 1 ABCD family	Waardenburg syndrome, type 4A	277580	AD, AR	3	Ednrb
13q31.1	13:78598362-78603552	POU4F1, BRN3A, ATITHS	POU domain, class 4, transcription factor 1	601632	POU4F1	5457	ENSG00000152192,ENST00000377208;;;ENST00000377208		Ataxia, intention tremor, and hypotonia syndrome, childhood-onset	619352	AD	3	Pou4f1
13q31.1	13:80335976-80341126	SPRY2, IGAN3	Sprouty RTK signaling antagonist 2	602466	SPRY2	10253	ENSG00000136158,ENST00000377104;;;ENST00000377104	mutation identified in 1 IGAN3 family	{?IgA nephropathy, susceptibility to, 3}	616818	AD	3	Spry2
13q31.1	13:83877205-83882474	SLITRK1, KIAA1910, TTM	SLIT- and NTRK-like family, member 1	609678	SLITRK1	114798	ENSG00000178235,ENST00000674365;;;ENST00000674365	mutation identified in 1 TTM patient	?Trichotillomania	613229	AD, Mu	3	Slitrk1
13q31.1	13:83877205-83882474	SLITRK1, KIAA1910, TTM	SLIT- and NTRK-like family, member 1	609678	SLITRK1	114798	ENSG00000178235,ENST00000674365;;;ENST00000674365	mutation identified in 1 TTM patient	Tourette syndrome	137580	AD	3	Slitrk1
13q31.1	13:85792790-85799419	SLITRK6, DFNMYP	SLIT- and NTRK-like family, member 6	609681	SLITRK6	84189	ENSG00000184564,ENST00000647374;;;ENST00000647374		Deafness and myopia	221200	AR	3	Slitrk6
13q31.3	13:89400001-94400000	FGLDS2	Feingold syndrome 2	614326				contiguous gene deletion syndrome	Feingold syndrome 2	614326	AD	4	
13q31.3	13:89400001-94400000	PPR2	Photoparoxysmal response 2	609572		780910		max lod at D13S1230	Photoparoxysmal response 2	609572		2	
13q31.3-q32.1	13:93216529-94408020	GPC6, OMIMD1	Glypican 6	604404	GPC6	10082	ENSG00000183098,ENST00000377047;;;ENST00000377047		Omodysplasia 1	258315	AR	3	Gpc6
13q32	13:94400001-101100000	KTCN7	Keratoconus 7	614629		100887822		max lod at D13S159	Keratoconus 7	614629	AD	2	
13q32	13:94400001-101100000	MCOR, C13DELq32, DEL13q32	Microcoria, congenital (chromosome 13q32 deletion syndrome)	156600				35-80kb deletion encompassing TGDS and GPR180	Microcoria, congenital	156600	AD	4	
13q32	13:94400001-101100000	SCZD7	Schizophrenia susceptibility locus, chromosome 13q-related	603176		8401			{Schizophrenia}	181500	AD	2	
13q32	13:94400001-101100000	SLEB5	Systemic lupus erythematosus, susceptibility to, 5	609903		100188798		max lod at D13S892	{Systemic lupus erythematosus, susceptibility to, 5}	609903	AD	2	
13q32-q33	13:94400001-109600000	STQTL4	Stature quantitative trait locus 4	606258		282550		max lod at D13S779 and D13S797	{Stature QTL 4}	606258		2	
13q32.1	13:94436811-94549406	DCT, TYRP2, OCA8	Dopachrome tautomerase (dopachrome delta-isomerase; tyrosinase-related protein 2)	191275	DCT	1638	ENSG00000080166,ENST00000377028;;;ENST00000377028		Oculocutaneous albinism, type VIII	619165	AR	3	Dct
13q32.1	13:94574054-94596273	TGDS, SDR2E1, CATMANS	TDP-glucose 4,6-dehydratase	616146	TGDS	23483	ENSG00000088451,ENST00000261296;;;ENST00000261296		Catel-Manzke syndrome	616145	AR	3	Tgds
13q32.1	13:95433755-95579759	CLDN10, OSPL, CPETRL3, HELIX	Claudin 10	617579	CLDN10	9071	ENSG00000134873,ENST00000299339;;;ENST00000299339		HELIX syndrome	617671	AR	3	Cldn10
13q32.1	13:95578202-95644706	DZIP1, KIAA0996, SPGF47, MVP3	DAZ-interacting zinc finger protein 1	608671	DZIP1	22873	ENSG00000134874,ENST00000376829;;;ENST00000376829	mutation identified in 1 MVP3 family	?Mitral valve prolapse 3	610840	AD	3	Dzip1
13q32.1	13:95578202-95644706	DZIP1, KIAA0996, SPGF47, MVP3	DAZ-interacting zinc finger protein 1	608671	DZIP1	22873	ENSG00000134874,ENST00000376829;;;ENST00000376829	mutation identified in 1 MVP3 family	Spermatogenic failure 47	619102	AR	3	Dzip1
13q32.1	13:95677139-95794988	DNAJC3, PRKRI, P58, ACPHD	DnaJ, E. coli, homolog of, subfamily C, member 3 (protein kinase inhibitor p58)	601184	DNAJC3	5611	ENSG00000102580,ENST00000602402;;;ENST00000602402	mutation identified in 1 ACPHD family	Ataxia, combined cerebellar and peripheral, with hearing loss and diabetes mellitus	616192	AR	3	Dnajc3
13q32.1	13:96985713-96994730	OXGR1, GPR80, CAON2	Oxoglutarate receptor 1	606922	OXGR1	27199	ENSG00000165621,ENST00000541038;;;ENST00000541038		Nephrolithiasis, calcium oxalate, 2, with nephrocalcinosis	620374	AD	3	Oxgr1
13q32.3	13:99981784-99986765	ZIC2, HPE5	ZIC family, member 2	603073	ZIC2	7546	ENSG00000043355,ENST00000376335;;;ENST00000376335		Holoprosencephaly 5	609637	AD	3	Zic2
13q32.3	13:100089093-100530435	PCCA	Propionyl Coenzyme A carboxylase, alpha polypeptide	232000	PCCA	5095	ENSG00000175198,ENST00000376285;;;ENST00000376285		Propionicacidemia	606054	AR	3	Pcca
13q32.3	13:100603625-100675075	TMTC4, DFNB122	Transmembrane and tetratricopeptide repeat domains-containing protein 4	618203	TMTC4	84899	ENSG00000125247,ENST00000342624;;;ENST00000342624	mutation identified in 1 DFNB122 family	?Deafness, autosomal recessive 122	620714	AR	3	Tmtc4
13q32.3-q33.1	13:101053776-101417179	NALCN, IHPRF1, CLIFAHDD	Sodium leak channel, nonselective	611549	NALCN	259232	ENSG00000102452,ENST00000251127;;;ENST00000251127		Congenital contractures of the limbs and face, hypotonia, and developmental delay	616266	AD	3	Nalcn
13q32.3-q33.1	13:101053776-101417179	NALCN, IHPRF1, CLIFAHDD	Sodium leak channel, nonselective	611549	NALCN	259232	ENSG00000102452,ENST00000251127;;;ENST00000251127		Hypotonia, infantile, with psychomotor retardation and characteristic facies 1	615419	AR	3	Nalcn
13q33-q34	13:101100001-114364328	DEL13q33q34, C13DELq33q34	Chromosome 13q33-q34 deletion syndrome	619148					Chromosome 13q33-q34 deletion syndrome	619148	AD	4	
13q33.1-q34	13:101100001-114364328	OFC9	Orofacial cleft 9	610361		100462724		associated with rs1830756	Orofacial cleft 9	610361	AD	2	
13q33.1	13:101710804-102402443	FGF14, FHF4, SCA27A, SCA27B	Fibroblast growth factor-14	601515	FGF14	2259	ENSG00000102466,ENST00000376143;;;ENST00000376143		Spinocerebellar ataxia 27A	193003	AD	3	Fgf14
13q33.1	13:101710804-102402443	FGF14, FHF4, SCA27A, SCA27B	Fibroblast growth factor-14	601515	FGF14	2259	ENSG00000102466,ENST00000376143;;;ENST00000376143		Spinocerebellar ataxia 27B, late-onset	620174	AD	3	Fgf14
13q33.1	13:102596986-102679958	TPP2, IMD78	Tripeptidyl peptidase II	190470	TPP2	7174	ENSG00000134900,ENST00000376052;;;ENST00000376052		Immunodeficiency 78 with autoimmunity and developmental delay	619220	AR	3	Tpp2
13q33.1	13:102846032-102875995	ERCC5, XPG, COFS3	ERCC excision repair 5, endonuclease	133530	ERCC5	2073	ENSG00000134899,ENST00000652225;;;ENST00000652225		Cerebrooculofacioskeletal syndrome 3	616570	AR	3	Ercc5
13q33.1	13:102846032-102875995	ERCC5, XPG, COFS3	ERCC excision repair 5, endonuclease	133530	ERCC5	2073	ENSG00000134899,ENST00000652225;;;ENST00000652225		Xeroderma pigmentosum, group G	278780	AR	3	Ercc5
13q33.1	13:102846032-102875995	ERCC5, XPG, COFS3	ERCC excision repair 5, endonuclease	133530	ERCC5	2073	ENSG00000134899,ENST00000652225;;;ENST00000652225		Xeroderma pigmentosum, group G/Cockayne syndrome	278780	AR	3	Ercc5
13q33.1	13:103043998-103066417	SLC10A2, NTCP2, PBAM1	Solute carrier family 10 (sodium/bile acid cotransporter family), member 2	601295	SLC10A2	6555	ENSG00000125255,ENST00000245312;;;ENST00000245312	mutation identified in 1 PBAM1 patient	?Bile acid malabsorption, primary, 1	613291	AR	3	Slc10a2
13q33.2	13:104200001-106400000	VUR5	Vesicoureteral reflux 5	614318		100820760		nearest marker rs4476030	Vesicoureteral reflux 5	614318		2	
13q33.2	13:105465867-105491034	DAOA, G72	D-amino acid oxidase activator	607408	DAOA	267012	ENSG00000182346,ENST00000375936;;;ENST00000375936		{Schizophrenia}	181500	AD	2	
13q33.3	13:108207442-108218349	LIG4, LIG4S	Ligase IV, DNA, ATP-dependent	601837	LIG4	3981	ENSG00000174405,ENST00000442234;;;ENST00000442234		{Multiple myeloma, resistance to}	254500	SMu	3	Lig4
13q33.3	13:108207442-108218349	LIG4, LIG4S	Ligase IV, DNA, ATP-dependent	601837	LIG4	3981	ENSG00000174405,ENST00000442234;;;ENST00000442234		LIG4 syndrome	606593	AR	3	Lig4
13q34	13:109752695-109786583	IRS2	Insulin receptor substrate 2	600797	IRS2	8660	ENSG00000185950,ENST00000375856;;;ENST00000375856		{Diabetes mellitus, noninsulin-dependent}	125853	AD	3	Irs2
13q34	13:110148963-110307157	COL4A1, BSVD1, HANAC, ICH, BSVD, RATOR, PADMAL	Collagen IV, alpha-1 polypeptide	120130	COL4A1	1282	ENSG00000187498,ENST00000375820;;;ENST00000375820	mutation identified in 1 RATOR family	?Retinal arteries, tortuosity of	180000	AD	3	Col4a1
13q34	13:110148963-110307157	COL4A1, BSVD1, HANAC, ICH, BSVD, RATOR, PADMAL	Collagen IV, alpha-1 polypeptide	120130	COL4A1	1282	ENSG00000187498,ENST00000375820;;;ENST00000375820	mutation identified in 1 RATOR family	{Hemorrhage, intracerebral, susceptibility to}	614519		3	Col4a1
13q34	13:110148963-110307157	COL4A1, BSVD1, HANAC, ICH, BSVD, RATOR, PADMAL	Collagen IV, alpha-1 polypeptide	120130	COL4A1	1282	ENSG00000187498,ENST00000375820;;;ENST00000375820	mutation identified in 1 RATOR family	Angiopathy, hereditary, with nephropathy, aneurysms, and muscle cramps	611773	AD	3	Col4a1
13q34	13:110148963-110307157	COL4A1, BSVD1, HANAC, ICH, BSVD, RATOR, PADMAL	Collagen IV, alpha-1 polypeptide	120130	COL4A1	1282	ENSG00000187498,ENST00000375820;;;ENST00000375820	mutation identified in 1 RATOR family	Brain small vessel disease with or without ocular anomalies	175780	AD	3	Col4a1
13q34	13:110148963-110307157	COL4A1, BSVD1, HANAC, ICH, BSVD, RATOR, PADMAL	Collagen IV, alpha-1 polypeptide	120130	COL4A1	1282	ENSG00000187498,ENST00000375820;;;ENST00000375820	mutation identified in 1 RATOR family	Microangiopathy and leukoencephalopathy, pontine, autosomal dominant	618564	AD	3	Col4a1
13q34	13:110307284-110513209	COL4A2, BSVD2, ICH	Collagen IV, alpha-2 polypeptide	120090	COL4A2	1284	ENSG00000134871,ENST00000360467;;;ENST00000360467		{Hemorrhage, intracerebral, susceptibility to}	614519		3	Col4a2
13q34	13:110307284-110513209	COL4A2, BSVD2, ICH	Collagen IV, alpha-2 polypeptide	120090	COL4A2	1284	ENSG00000134871,ENST00000360467;;;ENST00000360467		Brain small vessel disease 2	614483	AD	3	Col4a2
13q34	13:110615460-110639996	NAXD, CARKD, PEBEL2	NAD(P)HX dehydratase	615910	NAXD	55739	ENSG00000213995,ENST00000680254;;;ENST00000680254		Encephalopathy, progressive, early-onset, with brain edema and/or leukoencephalopathy, 2	618321	AR	3	Naxd
13q34	13:110641410-110713522	CARS2, COXPD27	Cysteinyl-tRNA synthetase 2	612800	CARS2	79587	ENSG00000134905,ENST00000257347;;;ENST00000257347		Combined oxidative phosphorylation deficiency 27	616672	AR	3	Cars2
13q34	13:110712623-110723339	ING1	Inhibitor of growth 1	601566	ING1	3621	ENSG00000153487,ENST00000333219;;;ENST00000333219		Squamous cell carcinoma, head and neck, somatic	275355		3	Ing1
13q34	13:112690038-112887168	ATP11A, ATPIS, ATPIH, DFNA84, HLD24, AUNA2	ATPase, class VI, type 11A	605868	ATP11A	23250	ENSG00000068650,ENST00000375645;;;ENST00000375645	mutation identified in 1 HLD24 patient and 1 AUNA2 family	?Auditory neuropathy, autosomal dominant 2	620384	AD	3	Atp11a
13q34	13:112690038-112887168	ATP11A, ATPIS, ATPIH, DFNA84, HLD24, AUNA2	ATPase, class VI, type 11A	605868	ATP11A	23250	ENSG00000068650,ENST00000375645;;;ENST00000375645	mutation identified in 1 HLD24 patient and 1 AUNA2 family	?Leukodystrophy, hypomyelinating, 24	619851	AD	3	Atp11a
13q34	13:112690038-112887168	ATP11A, ATPIS, ATPIH, DFNA84, HLD24, AUNA2	ATPase, class VI, type 11A	605868	ATP11A	23250	ENSG00000068650,ENST00000375645;;;ENST00000375645	mutation identified in 1 HLD24 patient and 1 AUNA2 family	Deafness, autosomal dominant 84	619810	AD	3	Atp11a
13q34	13:113105791-113120685	F7	Coagulation factor VII	613878	F7	2155	ENSG00000057593,ENST00000346342;;;ENST00000346342		{Myocardial infarction, decreased susceptibility to}	608446		3	F7
13q34	13:113105791-113120685	F7	Coagulation factor VII	613878	F7	2155	ENSG00000057593,ENST00000346342;;;ENST00000346342		Factor VII deficiency	227500	AR	3	F7
13q34	13:113122799-113149529	F10	Coagulation factor X	613872	F10	2159	ENSG00000126218,ENST00000375559;;;ENST00000375559		Factor X deficiency	227600	AR	3	F10
13q34	13:113158648-113172386	PROZ, PZ	Protein Z	176895	PROZ	8858	ENSG00000126231,ENST00000375547;;;ENST00000375547		[Protein Z deficiency]	614024		3	Proz
13q34	13:113648199-113737736	GRK1, RHOK, RK	G protein-dependent receptor kinase 1 (rhodopsin kinase)	180381	GRK1	6011	ENSG00000185974,ENST00000335678;;;ENST00000335678		Oguchi disease-2	613411		3	Grk1
13q34	13:114314503-114327322	CHAMP1, ZNF828, C13orf8, KIAA1802, NEDHILD	Chromosome alignment-maintaining phosphoprotein 1	616327	CHAMP1	283489	ENSG00000198824,ENST00000361283;;;ENST00000361283		Neurodevelopmental disorder with hypotonia, impaired language, and dysmorphic features	616579	AD	3	Champ1
14p11.2-q13	14:8000001-37400000	ADIPQTL3, CAQ14	Adiponectin, serum level of, quantitative trait locus 3	606771		171512		between D14S608 and D14S599	{Adiponectin, serum level of, QTL3}	606771		2	
14q11-q22	14:17200001-57600000	DEL14q11q22, C14DELq11q22	Chromosome 14q11-q22 deletion syndrome	613457				contiguous gene syndrome	Chromosome 14q11-q22 deletion syndrome	613457	IC	4	
14q11-q12	14:17200001-32900000	IBD4	Inflammatory bowel disease 4	606675		50608			{Inflammatory bowel disease 4}	606675		2	
14q11.2-q12	14:18200001-32900000	DFNA53	Deafness, autosomal dominant 53	609965		353347		max lod at D14S1280	Deafness, autosomal dominant 53	609965	AD	2	
14q11.2-q13	14:18200001-37400000	HHPP	Hyperhidrosis palmaris et plantaris	144110		100861529		between D14S283 and D14S264	Hyperhidrosis palmaris et plantaris	144110	AD	2	
14q11.2-q12	14:18200001-32900000	MRT9	Intellectual developmental disorder, autosomal recessive 9	611095		100101424		between rs1998463 and rs243286	Intellectual developmental disorder, autosomal recessive 9	611095	AR	2	
14q11.2	14:18200001-24100000	NRCLP5	Narcolepsy 5	612851		100302514		associated with rs1154155, rs12587781, rs1263646	{Narcolepsy 5}	612851		2	
14q11.2-q12	14:18200001-32900000	PAURT1	Preauricular tag, isolated, autosomal dominant, 1	610420		101669760		between D14S990 and D14S264	Preauricular tag, isolated, autosomal dominant, 1	610420	AD	2	
14q11.2	14:18200001-24100000	RSCIS	Radiation sensitivity/chromosome instability syndrome, autosomal dominant	605463		64239			Radiation sensitivity/chromosome instability syndrome, autosomal dominant			1	
14q11.2-q12	14:18200001-32900000	SPD3	Synpolydactyly 3	610234		780922		max lod at D14S264	Synpolydactyly 3	610234	AD	2	
14q11.2	14:20286227-20305951	TTC5, NEDCAFD	Tetratricopeptide repeat domain-containing protein 5	619014	TTC5	91875	ENSG00000136319,ENST00000258821;;;ENST00000258821		Neurodevelopmental disorder with cerebral atrophy and variable facial dysmorphism	619244	AR	3	Ttc5
14q11.2	14:20446401-20454812	OSGEP, FLJ20411, GAMOS3	O-sialoglycoprotein endopeptidase	610107	OSGEP	55644	ENSG00000092094,ENST00000206542;;;ENST00000206542		Galloway-Mowat syndrome 3	617729	AR	3	Osgep
14q11.2	14:20469406-20477089	PNP, NP	Purine nucleoside phosphorylase	164050	PNP	4860	ENSG00000198805,ENST00000361505;;;ENST00000361505	centromeric to TCRA	Immunodeficiency due to purine nucleoside phosphorylase deficiency	613179	AR	3	Pnp,Pnp2
14q11.2	14:20684177-20694186	ANG, RNASE5, ALS9	Angiogenin	105850	ANG	283	ENSG00000214274,ENST00000397990;;;ENST00000397990	proximal to TCRA/TCRD	Amyotrophic lateral sclerosis 9	611895		3	Ang,Ang2,Ang3,Ang4,Ang5,Ang6
14q11.2	14:21209147-21269442	HNRNPC, HNRPC, MRD74	Heterogeneous nuclear ribonucleoprotein C	164020	HNRNPC	3183	ENSG00000092199,ENST00000553300;;;ENST00000553300		Intellectual developmental disorder, autosomal dominant 74	620688	AD	3	Hnrnpc
14q11.2	14:21280083-21351301	RPGRIP1, LCA6, CORD13	RPGR interacting protein 1	605446	RPGRIP1	57096	ENSG00000092200,ENST00000400017;;;ENST00000400017		Cone-rod dystrophy 13	608194	AR	3	Rpgrip1
14q11.2	14:21280083-21351301	RPGRIP1, LCA6, CORD13	RPGR interacting protein 1	605446	RPGRIP1	57096	ENSG00000092200,ENST00000400017;;;ENST00000400017		Leber congenital amaurosis 6	613826	AR	3	Rpgrip1
14q11.2	14:21351476-21384019	SUPT16H, SPT16, NEDDFAC	SPT16 homolog, facilitates chromatin remodeling subunit	605012	SUPT16H	11198	ENSG00000092201,ENST00000216297;;;ENST00000216297		Neurodevelopmental disorder with dysmorphic facies and thin corpus callosum	619480	AD	3	Supt16
14q11.2	14:21385199-21456123	CHD8, DUPLIN, KIAA1564, IDDAM	Chromodomain helicase DNA-binding protein 8	610528	CHD8	57680	ENSG00000100888,ENST00000646647;;;ENST00000646647		Intellectual developmental disorder with autism and macrocephaly	615032	AD	3	Chd8
14q11.2	14:21521080-21537121	SALL2, HSAL2, COLB	Sal-like 2	602219	SALL2	6297	ENSG00000165821,ENST00000537235;;;ENST00000537235	mutation identified in 1 COLB family	?Coloboma, ocular, autosomal recessive	216820	AR	3	Sall2
14q11.2	14:22547506-22552132	TRAC, TRCA, TRA, IMD7	T-cell receptor alpha	186880		28755	ENSG00000277734,-	cen--V-C--ter	Immunodeficiency 7, TCR-alpha/beta deficient	615387	AR	3	Trac
14q11.2	14:22773222-22819791	SLC7A7, LPI	Solute carrier family 7 (cationic amino acid transporter, y+ system), member 7	603593	SLC7A7	9056	ENSG00000155465,ENST00000674313;;;ENST00000674313		Lysinuric protein intolerance	222700	AR	3	Slc7a7
14q11.2	14:22836585-22847758	MMP14, WNCHRS	Matrix metalloproteinase 14 (membrane-inserted)	600754	MMP14	4323	ENSG00000157227,ENST00000311852;;;ENST00000311852		Winchester syndrome	277950	AR	3	Mmp14
14q11.2	14:23099062-23104989	CIROP, LMLN2, HTX12	Ciliated left-right organizer metallopeptidase	619703	CIROP	100128908	ENSG00000283654,ENST00000637218;;;ENST00000637218		Heterotaxy, visceral, 12, autosomal	619702	AR	3	Cirop
14q11.2	14:23117306-23119255	CEBPE, CRP1, SGD1, IMD108	CCAAT/enhancer-binding protein (C/EBP), epsilon	600749	CEBPE	1053	ENSG00000092067,ENST00000206513;;;ENST00000206513	mutation identified in 1 IMD108 family	?Immunodeficiency 108 with autoinflammation	260570	AR	3	Cebpe
14q11.2	14:23117306-23119255	CEBPE, CRP1, SGD1, IMD108	CCAAT/enhancer-binding protein (C/EBP), epsilon	600749	CEBPE	1053	ENSG00000092067,ENST00000206513;;;ENST00000206513	mutation identified in 1 IMD108 family	Specific granule deficiency	245480	AD, AR	3	Cebpe
14q11.2	14:23321457-23326163	PABPN1, PABP2, PAB2	Poly(A)-binding protein, nuclear 1	602279	PABPN1	8106	ENSG00000100836,ENST00000216727;;;ENST00000216727		Oculopharyngeal muscular dystrophy	164300	AD	3	Pabpn1
14q11.2	14:23381987-23408273	MYH6, ASD3, MYHCA, CMD1EE, CMH14, SSS3	Myosin, heavy polypeptide-6, cardiac muscle, alpha	160710	MYH6	4624	ENSG00000197616,ENST00000405093;;;ENST00000405093	mutation identified in 1 ASD3 family	?Atrial septal defect 3	614089	AD	3	Myh6
14q11.2	14:23381987-23408273	MYH6, ASD3, MYHCA, CMD1EE, CMH14, SSS3	Myosin, heavy polypeptide-6, cardiac muscle, alpha	160710	MYH6	4624	ENSG00000197616,ENST00000405093;;;ENST00000405093	mutation identified in 1 ASD3 family	{Sick sinus syndrome 3}	614090		3	Myh6
14q11.2	14:23381987-23408273	MYH6, ASD3, MYHCA, CMD1EE, CMH14, SSS3	Myosin, heavy polypeptide-6, cardiac muscle, alpha	160710	MYH6	4624	ENSG00000197616,ENST00000405093;;;ENST00000405093	mutation identified in 1 ASD3 family	Cardiomyopathy, dilated, 1EE	613252	AD	3	Myh6
14q11.2	14:23381987-23408273	MYH6, ASD3, MYHCA, CMD1EE, CMH14, SSS3	Myosin, heavy polypeptide-6, cardiac muscle, alpha	160710	MYH6	4624	ENSG00000197616,ENST00000405093;;;ENST00000405093	mutation identified in 1 ASD3 family	Cardiomyopathy, hypertrophic, 14	613251	AD	3	Myh6
14q11.2	14:23412740-23435660	MYH7, CMH1, MPD1, CMD1S, CMYO7A, CMYO7B	Myosin, heavy polypeptide-7, cardiac muscle, beta	160760	MYH7	4625	ENSG00000092054,ENST00000355349;;;ENST00000355349		Cardiomyopathy, dilated, 1S	613426	AD	3	Myh7
14q11.2	14:23412740-23435660	MYH7, CMH1, MPD1, CMD1S, CMYO7A, CMYO7B	Myosin, heavy polypeptide-7, cardiac muscle, beta	160760	MYH7	4625	ENSG00000092054,ENST00000355349;;;ENST00000355349		Cardiomyopathy, hypertrophic, 1	192600	AD, DD	3	Myh7
14q11.2	14:23412740-23435660	MYH7, CMH1, MPD1, CMD1S, CMYO7A, CMYO7B	Myosin, heavy polypeptide-7, cardiac muscle, beta	160760	MYH7	4625	ENSG00000092054,ENST00000355349;;;ENST00000355349		Congenital myopathy 7A, myosin storage, autosomal dominant	608358	AD	3	Myh7
14q11.2	14:23412740-23435660	MYH7, CMH1, MPD1, CMD1S, CMYO7A, CMYO7B	Myosin, heavy polypeptide-7, cardiac muscle, beta	160760	MYH7	4625	ENSG00000092054,ENST00000355349;;;ENST00000355349		Congenital myopathy 7B, myosin storage, autosomal recessive	255160	AR	3	Myh7
14q11.2	14:23412740-23435660	MYH7, CMH1, MPD1, CMD1S, CMYO7A, CMYO7B	Myosin, heavy polypeptide-7, cardiac muscle, beta	160760	MYH7	4625	ENSG00000092054,ENST00000355349;;;ENST00000355349		Laing distal myopathy	160500	AD	3	Myh7
14q11.2	14:23412740-23435660	MYH7, CMH1, MPD1, CMD1S, CMYO7A, CMYO7B	Myosin, heavy polypeptide-7, cardiac muscle, beta	160760	MYH7	4625	ENSG00000092054,ENST00000355349;;;ENST00000355349		Left ventricular noncompaction 5	613426	AD	3	Myh7
14q11.2	14:23520857-23555952	ZFHX2, ZFH5, ZNF409, KIAA1056, KIAA1762, MARSIS	Zinc finger homeobox 2	617828	ZFHX2	85446	ENSG00000136367,ENST00000419474;;;ENST00000419474	mutation identified in 1 MARSIS family	?Marsili syndrome	147430	AD	3	Zfhx2
14q11.2-q12	14:24078662-24114949	NRL, D14S46E, RP27, ESCS2	Neural retina leucine zipper	162080	NRL	4901	ENSG00000129535,ENST00000561028;;;ENST00000561028		Enhanced S-cone syndrome 2	621371	AR	3	Nrl
14q11.2-q12	14:24078662-24114949	NRL, D14S46E, RP27, ESCS2	Neural retina leucine zipper	162080	NRL	4901	ENSG00000129535,ENST00000561028;;;ENST00000561028		Retinitis pigmentosa 27	613750	AD	3	Nrl
14q11.2-q12	14:24094171-24104125	PCK2, PEPCK2	Phosphoenolpyruvate carboxykinase 2, mitochondrial	614095	PCK2	5106	ENSG00000100889,ENST00000216780;;;ENST00000216780		PEPCK deficiency, mitochondrial	261650	AR	1	Pck2
14q12-q22	14:24100001-57600000	ARVD3	Arrhythmogenic right ventricular dysplasia 3	602086		424		?distinct from ARVD1	Arrhythmogenic right ventricular dysplasia 3	602086	AD	2	
14q12	14:24100001-32900000	DFNB5	Deafness, autosomal recessive 5	600792		1697			Deafness, autosomal recessive 5	600792	AR	2	
14q12-q21	14:24100001-50400000	SPG32	Spastic paraplegia-32	611252		724107		between D14S264 and D14S978	Spastic paraplegia 32, autosomal recessive	611252	AR	2	
14q12	14:24146875-24160655	RNF31, ZIBRA, IMD115	RING finger protein 31	612487	RNF31	55072	ENSG00000092098,ENST00000324103;;;ENST00000324103		Immunodeficiency 115 with autoinflammation	620632	AR	3	Rnf31
14q12	14:24161265-24166565	IRF9, ISGF3, ISGF3G	Interferon regulatory factor 9	147574	IRF9	10379	ENSG00000213928,ENST00000396864;;;ENST00000396864		Immunodeficiency 65, susceptibility to viral infections	618648	AR	3	Irf9
14q12	14:24239640-24242674	TINF2, TIN2, DKCA3, DKCA5	TERF1-interacting nuclear factor 2	604319	TINF2	26277	ENSG00000092330,ENST00000267415;;;ENST00000267415		Dyskeratosis congenita, autosomal dominant 3	613990	AD	3	Tinf2
14q12	14:24239640-24242674	TINF2, TIN2, DKCA3, DKCA5	TERF1-interacting nuclear factor 2	604319	TINF2	26277	ENSG00000092330,ENST00000267415;;;ENST00000267415		Revesz syndrome	268130	AD	3	Tinf2
14q12	14:24249114-24263177	TGM1, ICR2, ARCI1	Transglutaminase-1 (K polypeptide epidermal type I, protein-glutamine gamma-glutamyltransferase)	190195	TGM1	7051	ENSG00000092295,ENST00000206765;;;ENST00000206765		Ichthyosis, congenital, autosomal recessive 1	242300	AR	3	Tgm1
14q12	14:28766787-28770277	FOXG1, FOXG1B, FKHL1, FKH2, QIN, BF1	Forkhead box G1B	164874	FOXG1	2290	ENSG00000176165,ENST00000313071;;;ENST00000313071		Rett syndrome, congenital variant	613454	AD	3	Foxg1
14q12	14:29576479-29927847	PRKD1, PRKCM, PKD, CHDED	Protein kinase D1	605435	PRKD1	5587	ENSG00000184304,ENST00000331968;;;ENST00000331968		Congenital heart defects and ectodermal dysplasia	617364	AD	3	Prkd1
14q12	14:30874559-30895615	COCH, DFNA9, DFNB110	Cochlin	603196	COCH	1690	ENSG00000100473,ENST00000396618;;;ENST00000396618	mutation identified in 1 DFNB110 family	?Deafness, autosomal recessive 110	618094	AR	3	Coch
14q12	14:30874559-30895615	COCH, DFNA9, DFNB110	Cochlin	603196	COCH	1690	ENSG00000100473,ENST00000396618;;;ENST00000396618	mutation identified in 1 DFNB110 family	Deafness, autosomal dominant 9	601369	AD	3	Coch
14q12	14:31025106-31096450	AP4S1, CPSQ6, SPG52	Adaptor-related protein complex 4, sigma-1 subunit	607243	AP4S1	11154	ENSG00000100478,ENST00000542754;;;ENST00000542754		Spastic paraplegia 52, autosomal recessive	614067	AR	3	Ap4s1
14q12	14:31561404-31861224	NUBPL, IND1, MC1DN21	Nucleotide-binding protein-like protein	613621	NUBPL	80224	ENSG00000151413,ENST00000281081;;;ENST00000281081		Mitochondrial complex I deficiency, nuclear type 21	618242	AR	3	Nubpl
14q13	14:32900001-37400000	HPE8	Holoprosencephaly 8	609408		619406		between D14S49 and D14S1014	Holoprosencephaly 8	609408		2	
14q13-q21	14:32900001-50400000	RLS2	Restless legs syndrome, susceptibility to, 2	608831		450097		max lod at D14S288	{Restless legs syndrome 2}	608831		2	
14q13.1	14:34432788-34462240	SPTSSA, C14orf147, SSSPTA, SPG90A, SPG90B	Serine palmitoyltransferase, small subunit, A	613540	SPTSSA	171546	ENSG00000165389,ENST00000298130;;;ENST00000298130	mutation identified in 1 SPG90B patient	?Spastic paraplegia 90B, autosomal recessive	620417	AD	3	Gm6993,Sptssa
14q13.1	14:34432788-34462240	SPTSSA, C14orf147, SSSPTA, SPG90A, SPG90B	Serine palmitoyltransferase, small subunit, A	613540	SPTSSA	171546	ENSG00000165389,ENST00000298130;;;ENST00000298130	mutation identified in 1 SPG90B patient	Spastic paraplegia 90A, autosomal dominant	620416	AD	3	Gm6993,Sptssa
14q13.1	14:34709113-34714593	CFL2, NEM7	Cofilin 2, muscle	601443	CFL2	1073	ENSG00000165410,ENST00000298159;;;ENST00000298159		Nemaline myopathy 7, autosomal recessive	610687	AR	3	Cfl2
14q13.2	14:34982992-35029567	SRP54, SCN8	Signal recognition particle, 54kD	604857	SRP54	6729	ENSG00000100883,ENST00000216774;;;ENST00000216774		Neutropenia, severe congenital, 8, autosomal dominant	618752	AD	3	Srp54a,Srp54b,Srp54c
14q13.2	14:35044907-35083383	FAM177A1, C14orf24, NEDWMG	Family with sequence similarity 177, member A1	619181	FAM177A1	283635	ENSG00000151327,ENST00000280987;;;ENST00000280987		Neurodevelopmental disorder with white matter abnormalities and gait disturbance	621152	AR	3	Fam177a,Fam177a2
14q13.2	14:35085472-35122298	PPP2R3C, G5PR, MEGD, SPGF36	Protein phosphatase 2, regulatory subunit B-double prime, gamma	615902	PPP2R3C	55012	ENSG00000092020,ENST00000261475;;;ENST00000261475		Myoectodermal gonadal dysgenesis syndrome	618419	AR	3	Ppp2r3c
14q13.2	14:35085472-35122298	PPP2R3C, G5PR, MEGD, SPGF36	Protein phosphatase 2, regulatory subunit B-double prime, gamma	615902	PPP2R3C	55012	ENSG00000092020,ENST00000261475;;;ENST00000261475		Spermatogenic failure 36	618420	AD	3	Ppp2r3c
14q13.2	14:35121839-35277622	PRORP, KIAA0391, COXPD54	Protein only RNase P catalytic subunit	609947	PRORP	9692	ENSG00000100890,ENST00000534898;;;ENST00000534898		Combined oxidative phosphorylation deficiency 54	619737	AR	3	Prorp
14q13.2	14:35278558-35317493	PSMA6, PROS27, P27K	Proteasome subunit, alpha-type, 6	602855	PSMA6	5687	ENSG00000100902,ENST00000261479;;;ENST00000261479		{Myocardial infarction, susceptibility to}	608446		3	Psma6
14q13.2	14:35401513-35404749	NFKBIA, IKBA, EDAID2	Nuclear factor kappa-B inhibitor, alpha	164008	NFKBIA	4792	ENSG00000100906,ENST00000216797;;;ENST00000216797		Ectodermal dysplasia and immunodeficiency 2	612132	AD	3	Nfkbia
14q13.2	14:35538356-35809295	RALGAPA1, GARNL1, TULIP1, GRIPE, KIAA0884, NEDHRIT	Ral GTPase activating protein, alpha subunit 1 (catalytic)	608884	RALGAPA1	253959	ENSG00000174373,ENST00000680220;;;ENST00000680220	pseudogene on 9q31.1	Neurodevelopmental disorder with hypotonia, neonatal respiratory insufficiency, and thermodysregulation	618797	AR	3	Ralgapa1
14q13.3	14:36516397-36520232	NKX2-1, TITF1, NKX2A, TTF1, NMTC1	NK2 homeobox 1	600635	NKX2-1	7080	ENSG00000136352,ENST00000354822;;;ENST00000354822		{Thyroid cancer, nonmedullary, 1}	188550	AD	3	Nkx2-1
14q13.3	14:36516397-36520232	NKX2-1, TITF1, NKX2A, TTF1, NMTC1	NK2 homeobox 1	600635	NKX2-1	7080	ENSG00000136352,ENST00000354822;;;ENST00000354822		Chorea, hereditary benign	118700	AD	3	Nkx2-1
14q13.3	14:36516397-36520232	NKX2-1, TITF1, NKX2A, TTF1, NMTC1	NK2 homeobox 1	600635	NKX2-1	7080	ENSG00000136352,ENST00000354822;;;ENST00000354822		Choreoathetosis, hypothyroidism, and neonatal respiratory distress	610978	AD	3	Nkx2-1
14q13.3	14:36657568-36679362	PAX9, STHAG3	Paired box gene 9	167416	PAX9	5083	ENSG00000198807,ENST00000361487;;;ENST00000361487		Tooth agenesis, selective, 3	604625	AD	3	Pax9
14q13.3	14:36677921-37172606	SLC25A21, ODC, MTDPS18	Solute carrier family 25 (mitochondrial oxodicarboxylate carrier), member 21	607571	SLC25A21	89874	ENSG00000183032,ENST00000331299;;;ENST00000331299	mutation identified in 1 MTDPS18 patient	?Mitochondrial DNA depletion syndrome 18	618811	AR	3	Slc25a21
14q21.1	14:39031919-39103235	SEC23A, CLSD	SEC23 homolog A, coat complex II component	610511	SEC23A	10484	ENSG00000100934,ENST00000307712;;;ENST00000307712		Craniolenticulosutural dysplasia	607812	AD, AR	3	Sec23a
14q21.1	14:39147814-39170333	TRAPPC6B, TPC6, NEDMEBA	Trafficking protein particle complex, subunit 6B	610397	TRAPPC6B	122553	ENSG00000182400,ENST00000330149;;;ENST00000330149		Neurodevelopmental disorder with microcephaly, epilepsy, and brain atrophy	617862	AR	3	Trappc6b
14q21.2-q22.3	14:43000001-57600000	MGR4, MGOA	Migraine without aura, susceptibility to, 4	607501		338342		between D14S976 and D14S978	{Migraine without aura, susceptibility to, 4}	607501	AD	2	
14q21.2	14:44962190-45074431	TOGARAM1, FAM179B, KIAA0423, JBTS37	TOG array regulator of axonemal microtubules 1	617618	TOGARAM1	23116	ENSG00000198718,ENST00000361462;;;ENST00000361462		Joubert syndrome 37	619185	AR	3	Togaram1
14q21.2	14:45135930-45200890	FANCM, KIAA1596, SPGF28, POF15	FANCM gene	609644	FANCM	57697	ENSG00000187790,ENST00000267430;;;ENST00000267430		Premature ovarian failure 15	618096	AR	3	Fancm
14q21.2	14:45135930-45200890	FANCM, KIAA1596, SPGF28, POF15	FANCM gene	609644	FANCM	57697	ENSG00000187790,ENST00000267430;;;ENST00000267430		Spermatogenic failure 28	618086	AR	3	Fancm
14q21.2	14:46651010-46651781	RPL10L, SPGF63	Ribosomal protein L10-like	619655	RPL10L	140801	ENSG00000165496,ENST00000298283;;;ENST00000298283	mutation identified in 1 SPGF63 family	?Spermatogenic failure 63	619689	AR	3	Rpl10l
14q21.3	14:49570988-49598710	RPS29, DBA13	Ribosomal protein S29	603633	RPS29	6235	ENSG00000213741,ENST00000245458;;;ENST00000245458		Diamond-Blackfan anemia 13	615909	AD	3	Rps29
14q21.3	14:49620799-49623481	MGAT2, CDGS2, CDG2A	Mannosyl (alpha-1,6-)-glycoprotein beta-1,2-N-acetylglucosaminyl- transferase	602616	MGAT2	4247	ENSG00000168282,ENST00000305386;;;ENST00000305386		Congenital disorder of glycosylation, type IIa	212066	AR	3	Mgat2
14q21.3	14:49625174-49635244	DNAAF2, KTU, C14orf104, CILD10	Dynein, axonemal, assembly factor 2	612517	DNAAF2	55172	ENSG00000165506,ENST00000298292;;;ENST00000298292		Ciliary dyskinesia, primary, 10	612518	AR	3	Dnaaf2
14q21.3	14:49782083-49852788	NEMF, SDCCAG1, IDDSAPN	Nuclear export mediator factor	608378	NEMF	9147	ENSG00000165525,ENST00000298310;;;ENST00000298310		Intellectual developmental disorder with speech delay and axonal peripheral neuropathy	619099	AR	3	Nemf
14q21.3	14:50117130-50231882	SOS2, NS9	SOS Ras/Rac guanine nucleotide exchange factor 2	601247	SOS2	6655	ENSG00000100485,ENST00000216373;;;ENST00000216373		Noonan syndrome 9	616559	AD	3	Sos2
14q21.3	14:50242434-50312229	L2HGDH, C14orf160, L2HGA	L-2-hydroxyglutarate dehydrogenase	609584	L2HGDH	79944	ENSG00000087299,ENST00000267436;;;ENST00000267436		L-2-hydroxyglutaric aciduria	236792	AR	3	L2hgdh
14q22-q23	14:50400001-67400000	CTRCT32, CTAA1, CAP, CTPP5	Cataract 32, multiple types	115650		1483		between D14S980 and D14S1069	Cataract 32, multiple types	115650	AD	2	
14q22.1-q22.3	14:50400001-57600000	FRIASS, DEL14q22, C14DELq22	Frias syndrome	609640				deletion spans 4.1 Mb on 14q22.1-q22.3	Frias syndrome	609640	AD	4	
14q22.1-q24.2	14:50400001-73300000	MYP18	Myopia 18	255500		100359406		between D14S984 and D14S999	Myopia 18	255500	AR	2	
14q22.1	14:50533082-50633068	ATL1, SPG3A, HSN1D	Atlastin GTPase 1	606439	ATL1	51062	ENSG00000198513,ENST00000358385;;;ENST00000358385		Neuropathy, hereditary sensory, type ID	613708	AD	3	Atl1
14q22.1	14:50533082-50633068	ATL1, SPG3A, HSN1D	Atlastin GTPase 1	606439	ATL1	51062	ENSG00000198513,ENST00000358385;;;ENST00000358385		Spastic paraplegia 3A, autosomal dominant	182600	AD	3	Atl1
14q22.1	14:50719763-50831503	NIN, KIAA1565, SCKL7	Ninein	608684	NIN	51199	ENSG00000100503,ENST00000530997;;;ENST00000530997	mutation identified in 1 SCKL7 family	?Seckel syndrome 7	614851	AR	3	Nin
14q22.1	14:50905217-50944483	PYGL	Phosphorylase, glycogen, liver	613741	PYGL	5836	ENSG00000100504,ENST00000216392;;;ENST00000216392		Glycogen storage disease VI	232700	AR	3	Pygl
14q22.1	14:52267698-52280914	PTGDR, AS1, ASRT1	Prostaglandin D2 receptor	604687	PTGDR	5729	ENSG00000168229,ENST00000306051;;;ENST00000306051		{Asthma, susceptibility to, 1}	607277		3	Ptgdr
14q22.1	14:52314312-52328598	PTGER2	Prostaglandin E receptor 2, EP2 subtype, 53kD	176804	PTGER2	5732	ENSG00000125384,ENST00000245457;;;ENST00000245457		{Asthma, aspirin-induced, susceptibility to}	208550	AR	3	Ptger2
14q22.1	14:52775193-52791607	GNPNAT1, GNA1, RHZDAN	Glucosamine-phosphate N-acetyltransferase 1	616510	GNPNAT1	64841	ENSG00000100522,ENST00000216410;;;ENST00000216410	mutation identified 1 RHZDAN family	?Rhizomelic dysplasia, Ain-Naz type	619598	AR	3	Gnpnat1
14q22.1	14:53036755-53153323	DDHD1, PAPLA1, KIAA1705, SPG28	DDHD domain-containing protein 1	614603	DDHD1	80821	ENSG00000100523,ENST00000673822;;;ENST00000673822		Spastic paraplegia 28, autosomal recessive	609340	AR	3	Ddhd1
14q22.2	14:53600001-55000000	CRCS8	Colorectal cancer, susceptibility to, 8	612589		100271690		associated with rs4444235	{Colorectal cancer, susceptibility to, 8}	612589		2	
14q22.2	14:53949736-53956891	BMP4, BMP2B1, BMP2B, MCOPS6, OFC11	Bone morphogenetic protein-4	112262	BMP4	652	ENSG00000125378,ENST00000245451;;;ENST00000245451		Microphthalmia, syndromic 6	607932	AD	3	Bmp4
14q22.2	14:53949736-53956891	BMP4, BMP2B1, BMP2B, MCOPS6, OFC11	Bone morphogenetic protein-4	112262	BMP4	652	ENSG00000125378,ENST00000245451;;;ENST00000245451		Orofacial cleft 11	600625	AD	3	Bmp4
14q22.2	14:54842017-54902826	GCH1, DYT5, HPABH4B	GTP cyclohydrolase 1	600225	GCH1	2643	ENSG00000131979,ENST00000491895;;;ENST00000491895		Dystonia, DOPA-responsive	128230	AD, AR	3	Gch1
14q22.2	14:54842017-54902826	GCH1, DYT5, HPABH4B	GTP cyclohydrolase 1	600225	GCH1	2643	ENSG00000131979,ENST00000491895;;;ENST00000491895		Hyperphenylalaninemia, BH4-deficient, B	233910	AR	3	Gch1
14q22.3	14:56579525-56663165	TMEM260, C14orf101, SHDRA	Transmembrane protein 260	617449	TMEM260	54916	ENSG00000070269,ENST00000261556;;;ENST00000261556		Structural heart defects and renal anomalies syndrome	617478	AR	3	Tmem260
14q22.3	14:56799905-56810479	OTX2, MCOPS5, CPHD6	Orthodenticle homeobox 2	600037	OTX2	5015	ENSG00000165588,ENST00000672264;;;ENST00000672264		Microphthalmia, syndromic 5	610125	AD	3	Otx2
14q22.3	14:56799905-56810479	OTX2, MCOPS5, CPHD6	Orthodenticle homeobox 2	600037	OTX2	5015	ENSG00000165588,ENST00000672264;;;ENST00000672264		Pituitary hormone deficiency, combined, 6	613986	AD	3	Otx2
14q22.3	14:56799905-56810479	OTX2, MCOPS5, CPHD6	Orthodenticle homeobox 2	600037	OTX2	5015	ENSG00000165588,ENST00000672264;;;ENST00000672264		Retinal dystrophy, early-onset, with or without pituitary dysfunction	610125	AD	3	Otx2
14q23	14:57600001-67400000	ANIB8	Aneurysm, intracranial berry, 8	612162		100188886		associated with rs767603	Aneurysm, intracranial berry, 8	612162		2	
14q23	14:57600001-67400000	EIG2	Epilepsy, idiopathic generalized, susceptibility to, 2	606972		353124			{Epilepsy, idiopathic generalized, susceptibility to, 2}	606972		2	
14q23.1	14:58427400-58562090	KIAA0586, TALPID3, JBTS23, SRTD14	KIAA0586 gene	610178	KIAA0586	9786	ENSG00000100578,ENST00000652326;;;ENST00000652326		Joubert syndrome 23	616490	AR	3	2700049A03Rik
14q23.1	14:58427400-58562090	KIAA0586, TALPID3, JBTS23, SRTD14	KIAA0586 gene	610178	KIAA0586	9786	ENSG00000100578,ENST00000652326;;;ENST00000652326		Short-rib thoracic dysplasia 14 with polydactyly	616546	AR	3	2700049A03Rik
14q23.1	14:58634061-58648321	DACT1, DPR1, DAPPER1, FRODO, TBS2	Dapper, antagonist of beta-catenin, 1	607861	DACT1	51339	ENSG00000165617,ENST00000395153;;;ENST00000395153		Townes-Brocks syndrome 2	617466	AD	3	Dact1
14q23.1	14:60435956-60515544	C14orf39, SIX6OS1, SPGF52, POF18	Chromosome 14 open reading frame 39	617307	C14orf39	317761	ENSG00000179008,ENST00000321731;;;ENST00000321731	mutation identified in 1 POF18 patient	?Premature ovarian failure 18	619203	AR	3	4930447C04Rik
14q23.1	14:60435956-60515544	C14orf39, SIX6OS1, SPGF52, POF18	Chromosome 14 open reading frame 39	617307	C14orf39	317761	ENSG00000179008,ENST00000321731;;;ENST00000321731	mutation identified in 1 POF18 patient	Spermatogenic failure 52	619202	AR	3	4930447C04Rik
14q23.1	14:60509146-60512850	SIX6, ODRMD	SIX homeobox 6	606326	SIX6	4990	ENSG00000184302,ENST00000327720;;;ENST00000327720		Optic disc anomalies with retinal and/or macular dystrophy	212550	AR	3	Six6
14q23.1	14:60643421-60649477	SIX1, BOS3, DFNA23	SIX homeobox 1	601205	SIX1	6495	ENSG00000126778,ENST00000645694;;;ENST00000645694		Branchiootic syndrome 3	608389	AD	3	Six1
14q23.1	14:60643421-60649477	SIX1, BOS3, DFNA23	SIX homeobox 1	601205	SIX1	6495	ENSG00000126778,ENST00000645694;;;ENST00000645694		Deafness, autosomal dominant 23	605192	AD	3	Six1
14q23.1	14:60971441-60981690	TRMT5, TRM5, KIAA1393, PNSED	tRNA methyltransferase 5	611023	TRMT5	57570	ENSG00000126814,ENST00000261249;;;ENST00000261249		Peripheral neuropathy with variable spasticity, exercise intolerance, and developmental delay	616539	AR	3	Trmt5
14q23.2	14:61600001-64300000	TELM	Telomere length, mean leukocyte	609113		550641		suggestive QTL on 12, 10q, 3p	[Telomere length, mean leukocyte]	609113		2	
14q23.2	14:62699464-63045458	KCNH5, DEE112	Potassium voltage-gated channel, subfamily H, member 5	605716	KCNH5	27133	ENSG00000140015,ENST00000322893;;;ENST00000322893		Developmental and epileptic encephalopathy 112	620537	AD	3	Kcnh5
14q23.2	14:63761596-64226449	SYNE2, NUANCE, KIAA1011, EDMD5	Spectrin repeat-containing nuclear envelope protein 2 (nesprin 2)	608442	SYNE2	23224	ENSG00000054654,ENST00000555002;;;ENST00000555002		Emery-Dreifuss muscular dystrophy 5, autosomal dominant	612999	AD	3	Syne2
14q23.2-q23.3	14:64226707-64338613	ESR2, ODG8	Estrogen receptor-2 (ER beta)	601663	ESR2	2100	ENSG00000140009,ENST00000341099;;;ENST00000341099	mutation identified in 1 ODG8 patient	?Ovarian dysgenesis 8	618187	AD	3	Esr2
14q23.3	14:64388353-64460025	MTHFD1, MTHFC, CIMAH	Methylenetetrahydrofolate dehydrogenase 1	172460	MTHFD1	4522	ENSG00000100714,ENST00000652337;;;ENST00000652337	trifunctional protein	{Neural tube defects, folate-sensitive, susceptibility to}	601634	AR	3	Mthfd1
14q23.3	14:64388353-64460025	MTHFD1, MTHFC, CIMAH	Methylenetetrahydrofolate dehydrogenase 1	172460	MTHFD1	4522	ENSG00000100714,ENST00000652337;;;ENST00000652337	trifunctional protein	Combined immunodeficiency and megaloblastic anemia with or without hyperhomocysteinemia	617780	AR	3	Mthfd1
14q23.3	14:64746283-64879907	SPTB, SPH2, EL3, HS2	Spectrin, beta, erythrocytic	182870	SPTB	6710	ENSG00000070182,ENST00000644917;;;ENST00000644917		Anemia, neonatal hemolytic, fatal or near-fatal	617948	AD, AR	3	Sptb
14q23.3	14:64746283-64879907	SPTB, SPH2, EL3, HS2	Spectrin, beta, erythrocytic	182870	SPTB	6710	ENSG00000070182,ENST00000644917;;;ENST00000644917		Elliptocytosis-3	617948	AD, AR	3	Sptb
14q23.3	14:64746283-64879907	SPTB, SPH2, EL3, HS2	Spectrin, beta, erythrocytic	182870	SPTB	6710	ENSG00000070182,ENST00000644917;;;ENST00000644917		Spherocytosis, type 2	616649	AD	3	Sptb
14q23.3	14:65006101-65102695	MAX, PDMCS	MYC associated factor X	154950	MAX	4149	ENSG00000125952,ENST00000358664;;;ENST00000358664	interacts with MYC	{Pheochromocytoma, susceptibility to}	171300	AD	3	Max
14q23.3	14:65006101-65102695	MAX, PDMCS	MYC associated factor X	154950	MAX	4149	ENSG00000125952,ENST00000358664;;;ENST00000358664	interacts with MYC	Polydactyly-macrocephaly syndrome	620712	AD	3	Max
14q23.3	14:65356842-65744121	FUT8, CDGF1	Fucosyltransferase 8	602589	FUT8	2530	ENSG00000033170,ENST00000673929;;;ENST00000673929		Congenital disorder of glycosylation with defective fucosylation 1	618005	AR	3	Fut8
14q23.3-q24.1	14:66508147-67735355	GPHN, GPH, KIAA1385, GEPH, MOCODC	Gephyrin	603930	GPHN	10243	ENSG00000171723,ENST00000478722;;;ENST00000478722		Molybdenum cofactor deficiency C	615501	AR	3	Gphn
14q24.1	14:67589311-67600268	PIGH	Phosphatidylinositol glycan, class H	600154	PIGH	5283	ENSG00000100564,ENST00000216452;;;ENST00000216452		Glycosylphosphatidylinositol biosynthesis defect 17	618010	AR	3	Pigh
14q24.1	14:67676800-67695764	RDH11, PSDR1, RALR1, RDJCSS	Retinol dehydrogenase 11	607849	RDH11	51109	ENSG00000072042,ENST00000381346;;;ENST00000381346	mutation identified in 1 RDJCSS family	?Retinal dystrophy, juvenile cataracts, and short stature syndrome	616108	AR	3	Rdh11
14q24.1	14:67701886-67734451	RDH12, LCA13	Retinol dehydrogenase 12	608830	RDH12	145226	ENSG00000139988,ENST00000551171;;;ENST00000551171	near RDH11	Leber congenital amaurosis 13	612712	AD, AR	3	Rdh12
14q24.1	14:67728892-67816590	ZFYVE26, KIAA0321, SPG15	Zinc finger FYVE domain-containing protein 26	612012	ZFYVE26	23503	ENSG00000072121,ENST00000347230;;;ENST00000347230		Spastic paraplegia 15, autosomal recessive	270700	AR	3	Zfyve26
14q24.1	14:68874128-68979302	ACTN1, BDPLT15	Actinin, alpha-1	102575	ACTN1	87	ENSG00000072110,ENST00000394419;;;ENST00000394419		Bleeding disorder, platelet-type, 15	615193	AD	3	Actn1
14q24.1	14:69775416-69797241	SLC10A1, NTCP1, FHCA2	Solute carrier family 10 (sodium/bile acid cotransporter family), member 1	182396	SLC10A1	6554	ENSG00000100652,ENST00000216540;;;ENST00000216540		Hypercholanemia, familial 2	619256	AR	3	Slc10a1
14q24.2	14:69879416-70032366	SMOC1, OAS	SPARC-related modular calcium-binding 1	608488	SMOC1	64093	ENSG00000198732,ENST00000361956;;;ENST00000361956		Microphthalmia with limb anomalies	206920	AR	3	Smoc1
14q24.2	14:70325081-70359683	COX16, MC4DN22	Cytochrome c oxidase assembly factor 16	618064	COX16	51241	ENSG00000133983,ENST00000389912;;;ENST00000389912		Mitochondrial complex IV deficiency, nuclear type 22	619355	AR	3	Cox16
14q24.2	14:73136417-73223691	PSEN1, AD3, ACNINV3, CMD1U	Presenilin 1	104311	PSEN1	5663	ENSG00000080815,ENST00000324501;;;ENST00000324501	mutation identified in 1 ACNINV3 family and 1 CMD1U family	?Acne inversa, familial, 3	613737	AD	3	Psen1
14q24.2	14:73136417-73223691	PSEN1, AD3, ACNINV3, CMD1U	Presenilin 1	104311	PSEN1	5663	ENSG00000080815,ENST00000324501;;;ENST00000324501	mutation identified in 1 ACNINV3 family and 1 CMD1U family	?Cardiomyopathy, dilated, 1U	613694	AD	3	Psen1
14q24.2	14:73136417-73223691	PSEN1, AD3, ACNINV3, CMD1U	Presenilin 1	104311	PSEN1	5663	ENSG00000080815,ENST00000324501;;;ENST00000324501	mutation identified in 1 ACNINV3 family and 1 CMD1U family	Alzheimer disease, type 3, with or without spastic paraparesis	607822	AD	3	Psen1
14q24.2	14:73136417-73223691	PSEN1, AD3, ACNINV3, CMD1U	Presenilin 1	104311	PSEN1	5663	ENSG00000080815,ENST00000324501;;;ENST00000324501	mutation identified in 1 ACNINV3 family and 1 CMD1U family	Dementia, frontotemporal	600274	AD	3	Psen1
14q24.2	14:73136417-73223691	PSEN1, AD3, ACNINV3, CMD1U	Presenilin 1	104311	PSEN1	5663	ENSG00000080815,ENST00000324501;;;ENST00000324501	mutation identified in 1 ACNINV3 family and 1 CMD1U family	Pick disease	172700	AD	3	Psen1
14q24.3	14:73300001-78800000	GLC3C	Glaucoma 3, primary congenital, C	613085		399565		between D14S61 and D14S1000	Glaucoma 3, primary congenital, C	613085		2	
14q24.3-q31	14:73300001-89300000	IDDM11	Insulin-dependent diabetes mellitus-11	601208		3410			{Diabetes mellitus, insulin-dependent, 11}	601208		2	
14q24.3	14:73300001-78800000	KTCN8	Keratoconus 8	614628		100885803		between rs1074501 and rs755212	Keratoconus 8	614628	AD	2	
14q24.3	14:73300001-78800000	MUSTQTL1	Muscle strength quantitative trait locus 1	612083		100192311			Muscle strength quantitative trait locus 1	612083		2	
14q24.3	14:73644986-73703732	DNAL1, C14orf168, CILD16	Dynein, axonemal, light chain 1	610062	DNAL1	83544	ENSG00000119661,ENST00000553645;;;ENST00000553645		Ciliary dyskinesia, primary, 16	614017	AR	3	Dnal1
14q24.3	14:73949918-73963670	COQ6, CGI10, COQ10D6	Coq6, S. cerevisiae, homolog of	614647	COQ6	51004	ENSG00000119723,ENST00000334571;;;ENST00000334571		Coenzyme Q10 deficiency, primary, 6	614650	AR	3	Coq6
14q24.3	14:74056847-74084453	ALDH6A1, MMSDH	Aldehyde dehydrogenase 6 family, member A1 (methylmalonate semialdehyde dehydrogenase)	603178	ALDH6A1	4329	ENSG00000119711,ENST00000553458;;;ENST00000553458		Methylmalonate semialdehyde dehydrogenase deficiency	614105	AR	3	Aldh6a1
14q24.3	14:74239449-74262738	VSX2, CHX10, HOX10, MCOP2, MCOPCB3	Visual system homeobox 2	142993	VSX2	338917	ENSG00000119614,ENST00000261980;;;ENST00000261980		Microphthalmia, isolated 2	610093	AR	3	Vsx2
14q24.3	14:74239449-74262738	VSX2, CHX10, HOX10, MCOP2, MCOPCB3	Visual system homeobox 2	142993	VSX2	338917	ENSG00000119614,ENST00000261980;;;ENST00000261980		Microphthalmia/coloboma 3	610092	AR	3	Vsx2
14q24.3	14:74285269-74302934	ABCD4, PXMP1L, P79R, PMP69, MAHCJ	ATP-binding cassette, subfamily D, member 4 (peroxisomal membrane protein 1-like)	603214	ABCD4	5826	ENSG00000119688,ENST00000356924;;;ENST00000356924		Methylmalonic aciduria and homocystinuria, cblJ type	614857	AR	3	Abcd4
14q24.3	14:74479935-74493512	NPC2, HE1	NPC intracellular cholesterol tranporter 2	601015	NPC2	10577	ENSG00000119655,ENST00000555619;;;ENST00000555619		Niemann-pick disease, type C2	607625	AR	3	Npc2
14q24.3	14:74493765-74497106	ISCA2, MMDS4	Iron-sulfur cluster assembly 2	615317	ISCA2	122961	ENSG00000165898,ENST00000556816;;;ENST00000556816		Multiple mitochondrial dysfunctions syndrome 4	616370	AR	3	Isca2
14q24.3	14:74498183-74612237	LTBP2, LTBP3, GLC3D, MSPKA, WMS3	Latent transforming growth factor beta binding protein-2	602091	LTBP2	4053	ENSG00000119681,ENST00000261978;;;ENST00000261978	mutation identified in 1 WMS3 family	?Weill-Marchesani syndrome 3, recessive	614819	AR	3	Ltbp2
14q24.3	14:74498183-74612237	LTBP2, LTBP3, GLC3D, MSPKA, WMS3	Latent transforming growth factor beta binding protein-2	602091	LTBP2	4053	ENSG00000119681,ENST00000261978;;;ENST00000261978	mutation identified in 1 WMS3 family	Glaucoma 3, primary congenital, D	613086		3	Ltbp2
14q24.3	14:74498183-74612237	LTBP2, LTBP3, GLC3D, MSPKA, WMS3	Latent transforming growth factor beta binding protein-2	602091	LTBP2	4053	ENSG00000119681,ENST00000261978;;;ENST00000261978	mutation identified in 1 WMS3 family	Microspherophakia and/or megalocornea, with ectopia lentis and with or without secondary glaucoma	251750	AR	3	Ltbp2
14q24.3	14:74881916-74903743	DLST, PPGL7	Dihydrolipoamide S-succinyltransferase (E2 component of 2-oxo-glutarate complex)	126063	DLST	1743	ENSG00000119689,ENST00000334220;;;ENST00000334220		Pheochromocytoma/paraganglioma syndrome 7	618475	AD	3	Dlst
14q24.3	14:75002921-75012366	EIF2B2, VWM2	Eukaryotic translation initiation factor 2B, subunit 2	606454	EIF2B2	8892	ENSG00000119718,ENST00000266126;;;ENST00000266126		Leukoencephalopathy with vanishing white matter 2, with or without ovarian failure	620312	AR	3	Eif2b2
14q24.3	14:75013775-75051467	MLH3, HNPCC7	DNA mismatch repair gene MLH3	604395	MLH3	27030	ENSG00000119684,ENST00000355774;;;ENST00000355774		{Endometrial cancer, susceptibility to}	608089	AD, SMu	3	Mlh3
14q24.3	14:75013775-75051467	MLH3, HNPCC7	DNA mismatch repair gene MLH3	604395	MLH3	27030	ENSG00000119684,ENST00000355774;;;ENST00000355774		Colorectal cancer, hereditary nonpolyposis, type 7	614385		3	Mlh3
14q24.3	14:75013775-75051467	MLH3, HNPCC7	DNA mismatch repair gene MLH3	604395	MLH3	27030	ENSG00000119684,ENST00000355774;;;ENST00000355774		Colorectal cancer, somatic	114500		3	Mlh3
14q24.3	14:75079353-75127202	NEK9, NERCC1, LCCS10, APUG, NC	NIMA-related kinase 9	609798	NEK9	91754	ENSG00000119638,ENST00000238616;;;ENST00000238616	mutation identified in 1 APUG family	?Arthrogryposis, Perthes disease, and upward gaze palsy	614262	AR	3	Nek9
14q24.3	14:75079353-75127202	NEK9, NERCC1, LCCS10, APUG, NC	NIMA-related kinase 9	609798	NEK9	91754	ENSG00000119638,ENST00000238616;;;ENST00000238616	mutation identified in 1 APUG family	Lethal congenital contracture syndrome 10	617022	AR	3	Nek9
14q24.3	14:75079353-75127202	NEK9, NERCC1, LCCS10, APUG, NC	NIMA-related kinase 9	609798	NEK9	91754	ENSG00000119638,ENST00000238616;;;ENST00000238616	mutation identified in 1 APUG family	Nevus comedonicus, somatic	617025		3	Nek9
14q24.3	14:75578620-75648167	FLVCR2, C14orf58, CCT, PVHH, EPV	FLVCR heme transporter 2	610865	FLVCR2	55640	ENSG00000119686,ENST00000238667;;;ENST00000238667		Proliferative vasculopathy and hydranencephaly-hydrocephaly syndrome	225790	AR	3	Flvcr2
14q24.3	14:75661246-75955079	TTLL5, STAMP, KIAA0998, CORD19	Tubulin tyrosine ligase-like 5	612268	TTLL5	23093	ENSG00000119685,ENST00000298832;;;ENST00000298832		Cone-rod dystrophy 19	615860	AR	3	Ttll5
14q24.3	14:75958097-75983011	TGFB3, ARVD1, RNHF, LDS5	Transforming growth factor, beta-3	190230	TGFB3	7043	ENSG00000119699,ENST00000238682;;;ENST00000238682		Arrhythmogenic right ventricular dysplasia 1	107970	AD	3	Tgfb3
14q24.3	14:75958097-75983011	TGFB3, ARVD1, RNHF, LDS5	Transforming growth factor, beta-3	190230	TGFB3	7043	ENSG00000119699,ENST00000238682;;;ENST00000238682		Loeys-Dietz syndrome 5	615582	AD	3	Tgfb3
14q24.3	14:75985763-76084073	IFT43, C14orf179, CED3, SRTD18, RP81	Intraflagellar transport 43	614068	IFT43	112752	ENSG00000119650,ENST00000314067;;;ENST00000314067	mutation identified in 1 CED3 family and 1 RP81 family	?Cranioectodermal dysplasia 3	614099	AR	3	Ift43
14q24.3	14:75985763-76084073	IFT43, C14orf179, CED3, SRTD18, RP81	Intraflagellar transport 43	614068	IFT43	112752	ENSG00000119650,ENST00000314067;;;ENST00000314067	mutation identified in 1 CED3 family and 1 RP81 family	?Retinitis pigmentosa 81	617871	AR	3	Ift43
14q24.3	14:75985763-76084073	IFT43, C14orf179, CED3, SRTD18, RP81	Intraflagellar transport 43	614068	IFT43	112752	ENSG00000119650,ENST00000314067;;;ENST00000314067	mutation identified in 1 CED3 family and 1 RP81 family	Short-rib thoracic dysplasia 18 with polydactyly	617866	AR	3	Ift43
14q24.3	14:76310777-76501837	ESRRB, ESRL2, DFNB35	Estrogen-related receptor beta	602167	ESRRB	2103	ENSG00000119715,ENST00000644823;;;ENST00000644823		Deafness, autosomal recessive 35	608565	AR	3	Esrrb
14q24.3	14:77024543-77028708	IRF2BPL, C14orf4, EAP1, NEDAMSS	Interferon regulatory factor 2-binding protein like	611720	IRF2BPL	64207	ENSG00000119669,ENST00000238647;;;ENST00000238647		Neurodevelopmental disorder with regression, abnormal movements, loss of speech, and seizures	618088	AD	3	Irf2bpl
14q24.3	14:77181798-77259495	TMEM63C, SPG87	Transmembrane protein 63C	619953	TMEM63C	57156	ENSG00000165548,ENST00000298351;;;ENST00000298351		Spastic paraplegia 87, autosomal recessive	619966	AR	3	Tmem63c
14q24.3	14:77274956-77320883	POMT2, MDDGA2, MDDGB2, MDDGC2, LGMDR14	Putative protein O-mannosyltransferase 2	607439	POMT2	29954	ENSG00000009830,ENST00000261534;;;ENST00000261534		Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 2	613150	AR	3	Pomt2
14q24.3	14:77274956-77320883	POMT2, MDDGA2, MDDGB2, MDDGC2, LGMDR14	Putative protein O-mannosyltransferase 2	607439	POMT2	29954	ENSG00000009830,ENST00000261534;;;ENST00000261534		Muscular dystrophy-dystroglycanopathy (congenital with impaired intellectual development), type B, 2	613156	AR	3	Pomt2
14q24.3	14:77274956-77320883	POMT2, MDDGA2, MDDGB2, MDDGC2, LGMDR14	Putative protein O-mannosyltransferase 2	607439	POMT2	29954	ENSG00000009830,ENST00000261534;;;ENST00000261534		Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 2	613158	AR	3	Pomt2
14q24.3	14:77321036-77331597	GSTZ1, MAAI, MAAID	Glutathione S-transferase, zeta-1 (maleylacetoacetate isomerase)	603758	GSTZ1	2954	ENSG00000100577,ENST00000216465;;;ENST00000216465		[Maleylacetoacetate isomerase deficiency]	617596	AR	3	Gstz1
14q24.3	14:77426675-77457601	VIPAS39, VIPAR, SPE39, C14orf133	VPS33B-interacting protein, apical-basolateral polarity regulator, spe-39 homolog	613401	VIPAS39	63894	ENSG00000151445,ENST00000557658;;;ENST00000557658		Arthrogryposis, renal dysfunction, and cholestasis 2	613404	AR	3	Vipas39
14q24.3	14:77505997-77616637	SPTLC2, KIAA0526, SPT2, LCB2, HSN1C, NSAN1C	Serine palmitoyltransferase, long-chain base subunit 2	605713	SPTLC2	9517	ENSG00000100596,ENST00000216484;;;ENST00000216484		Neuropathy, hereditary sensory and autonomic, type IC	613640	AD	3	Sptlc2
14q31	14:78800001-89300000	GRD1	Graves disease, susceptibility to, 1	275000		100312954		associated with rs2268458	{Graves disease, susceptibility to, 1}	275000	AR	2	
14q31	14:78800001-89300000	HPPD	Hypertelorism, preauricular sinus, punctal pits, and deafness	614187		100682260			Hypertelorism, preauricular sinus, punctal pits, and deafness	614187	AD	2	
14q31.1	14:80955621-81146306	TSHR, CHNG1	Thyroid-stimulating hormone receptor	603372	TSHR	7253	ENSG00000165409,ENST00000298171;;;ENST00000298171		Hyperthyroidism, familial gestational	603373	AD	3	Tshr
14q31.1	14:80955621-81146306	TSHR, CHNG1	Thyroid-stimulating hormone receptor	603372	TSHR	7253	ENSG00000165409,ENST00000298171;;;ENST00000298171		Hyperthyroidism, nonautoimmune	609152	AD	3	Tshr
14q31.1	14:80955621-81146306	TSHR, CHNG1	Thyroid-stimulating hormone receptor	603372	TSHR	7253	ENSG00000165409,ENST00000298171;;;ENST00000298171		Hypothyroidism, congenital, nongoitrous, 1	275200	AR	3	Tshr
14q31.1	14:80955621-81146306	TSHR, CHNG1	Thyroid-stimulating hormone receptor	603372	TSHR	7253	ENSG00000165409,ENST00000298171;;;ENST00000298171		Thyroid adenoma, hyperfunctioning, somatic	609152		3	Tshr
14q31.1	14:80955621-81146306	TSHR, CHNG1	Thyroid-stimulating hormone receptor	603372	TSHR	7253	ENSG00000165409,ENST00000298171;;;ENST00000298171		Thyroid carcinoma with thyrotoxicosis, somatic	609152		3	Tshr
14q31.1	14:81471547-81533853	SEL1L, NEDGSAF, NEDHGFA	SEL1L adaptor subunit ERAD E3 ubiquitin ligase	602329	SEL1L	6400	ENSG00000071537,ENST00000336735;;;ENST00000336735	mutation identified in 1 NEDGSAF family and 1 NEDHGFA family	?Neurodevelopmental disorder with poor growth, absent speech, progressive ataxia, and dysmorphic facies	621067	AR	3	Sel1l
14q31.1	14:81471547-81533853	SEL1L, NEDGSAF, NEDHGFA	SEL1L adaptor subunit ERAD E3 ubiquitin ligase	602329	SEL1L	6400	ENSG00000071537,ENST00000336735;;;ENST00000336735	mutation identified in 1 NEDGSAF family and 1 NEDHGFA family	Neurodevelopmental disorder with hypotonia, poor growth, dysmorphic facies, and agammaglobulinemia	621068	AR	3	Sel1l
14q31.3	14:87933014-87993667	GALC	Galactosylceramidase	606890	GALC	2581	ENSG00000054983,ENST00000261304;;;ENST00000261304		Krabbe disease	245200	AR	3	Galc
14q31.3	14:88385657-88470350	SPATA7, HSD3, LCA3, RP94	Spermatogenesis-associated protein 7	609868	SPATA7	55812	ENSG00000042317,ENST00000393545;;;ENST00000393545		Leber congenital amaurosis 3	604232	AR	3	Spata7
14q31.3	14:88385657-88470350	SPATA7, HSD3, LCA3, RP94	Spermatogenesis-associated protein 7	609868	SPATA7	55812	ENSG00000042317,ENST00000393545;;;ENST00000393545		Retinitis pigmentosa 94, variable age at onset, autosomal recessive	604232	AR	3	Spata7
14q31.3	14:88563037-88627596	ZC3H14, SUT2, MRT56	Zinc finger CCCH domain-containing protein 14	613279	ZC3H14	79882	ENSG00000100722,ENST00000251038;;;ENST00000251038		Intellectual developmental disorder, autosomal recessive 56	617125	AR	3	Zc3h14
14q31.3	14:88824153-88881079	TTC8, BBS8, RP51	Tetratricopeptide repeat domain 8	608132	TTC8	123016	ENSG00000165533,ENST00000380656;;;ENST00000380656	mutation identified in 1 RP51 family	?Retinitis pigmentosa 51	613464	AR	3	Ttc8
14q31.3	14:88824153-88881079	TTC8, BBS8, RP51	Tetratricopeptide repeat domain 8	608132	TTC8	123016	ENSG00000165533,ENST00000380656;;;ENST00000380656	mutation identified in 1 RP51 family	Bardet-Biedl syndrome 8	615985	AR	3	Ttc8
14q32	14:89300001-107043718	CHDS4	Coronary heart disease, susceptibility to, 4	608318		387585		highest LOD with D14S1426	{Coronary heart disease, susceptibility to, 4}	608318		2	
14q32	14:89300001-107043718	CKBE	Creatine kinase, ectopic expression	123270		1156		linked to IGH, PI; ?same locus as CKBB	[Creatine kinase, brain type, ectopic expression of]	123270		2	
14q32	14:89300001-107043718	DUP14q32, C14DUPq32	Chromosome 14q32 duplication syndrome, 700kB	616604				heterozygous germline duplication of 700kb	{Myeloproliferative neoplasms, familial, susceptibility to}	616604	AD	4	
14q32	14:89300001-107043718	GEVQ1	Gene expression, variation in, quantitative trait locus on chromosome 14	608875		474334			{Gene expression, variation in, QTL}	608875		2	
14q32	14:89300001-107043718	KAOGS	Kagami-Ogata syndrome	608149				uniparental isodisomy of imprinted region of chromosome 14	Kagami-Ogata syndrome	608149	AD	4	
14q32	14:89300001-107043718	MCOP1	Microphthalmia, isolated 1	251600		8113			Microphthalmia, isolated 1	251600	AR	2	
14q32	14:89300001-107043718	TEMPS	Temple syndrome (maternal uniparental disomy chromosome 14)	616222					Temple syndrome	616222	AD	4	
14q32.11	14:89954968-90044764	TDP1, SCAN1	Tyrosyl-DNA phosphodiesterase 1	607198	TDP1	55775	ENSG00000042088,ENST00000335725;;;ENST00000335725	mutation identified in 1 SCAN1 family	?Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 1	607250	AR	3	Tdp1
14q32.11	14:90256553-90275429	PSMC1, S4, NEDGTH	Proteasome 26S subunit, ATPase, 1	602706	PSMC1	5700	ENSG00000100764,ENST00000261303;;;ENST00000261303	mutation identified in 1 NEDGTH family	?Birk-Aharoni syndrome	620071	AR	3	Psmc1
14q32.11	14:90396502-90408268	CALM1, PHKD, CPVT4, LQT14	Calmodulin-1 (phosphorylase kinase, delta)	114180	CALM1	801	ENSG00000198668,ENST00000356978;;;ENST00000356978		Long QT syndrome 14	616247	AD	3	Calm1
14q32.11	14:90396502-90408268	CALM1, PHKD, CPVT4, LQT14	Calmodulin-1 (phosphorylase kinase, delta)	114180	CALM1	801	ENSG00000198668,ENST00000356978;;;ENST00000356978		Ventricular tachycardia, catecholaminergic polymorphic, 4	614916	AD	3	Calm1
14q32.11	14:91232532-91270790	GPR68, OGR1, AI2A6	G protein-coupled receptor 68	601404	GPR68	8111	ENSG00000119714,ENST00000650645;;;ENST00000650645		Amelogenesis imperfecta, hypomaturation type, IIA6	617217	AR	3	Gpr68
14q32.11-q32.12	14:91271323-91417820	CCDC88C, HKRP2, DAPLE, KIAA1509, HYC1, SCA40	Coiled-coil domain-containing protein 88C	611204	CCDC88C	440193	ENSG00000015133,ENST00000389857;;;ENST00000389857	mutation identified in 1 SCA40 family	?Spinocerebellar ataxia 40	616053	AD	3	Ccdc88c
14q32.11-q32.12	14:91271323-91417820	CCDC88C, HKRP2, DAPLE, KIAA1509, HYC1, SCA40	Coiled-coil domain-containing protein 88C	611204	CCDC88C	440193	ENSG00000015133,ENST00000389857;;;ENST00000389857	mutation identified in 1 SCA40 family	Hydrocephalus, congenital, 1	236600	AR	3	Ccdc88c
14q32.12	14:91869411-91947694	FBLN5, ARMD3, ADCL2, ARCL1A, CMT1H	Fibulin 5	604580	FBLN5	10516	ENSG00000140092,ENST00000342058;;;ENST00000342058	mutation identified in 1 ADCL2 patient	?Cutis laxa, autosomal dominant 2	614434	AD	3	Fbln5
14q32.12	14:91869411-91947694	FBLN5, ARMD3, ADCL2, ARCL1A, CMT1H	Fibulin 5	604580	FBLN5	10516	ENSG00000140092,ENST00000342058;;;ENST00000342058	mutation identified in 1 ADCL2 patient	Charcot-Marie-Tooth disease, demyelinating, type 1H	619764	AD	3	Fbln5
14q32.12	14:91869411-91947694	FBLN5, ARMD3, ADCL2, ARCL1A, CMT1H	Fibulin 5	604580	FBLN5	10516	ENSG00000140092,ENST00000342058;;;ENST00000342058	mutation identified in 1 ADCL2 patient	Cutis laxa, autosomal recessive, type IA	219100	AR	3	Fbln5
14q32.12	14:91869411-91947694	FBLN5, ARMD3, ADCL2, ARCL1A, CMT1H	Fibulin 5	604580	FBLN5	10516	ENSG00000140092,ENST00000342058;;;ENST00000342058	mutation identified in 1 ADCL2 patient	Macular degeneration, age-related, 3	608895	AD	3	Fbln5
14q32.12	14:91965991-92040059	TRIP11, TRIP230, CEV14, ACG1A, ODCD1	Thyroid hormone receptor interactor 11	604505	TRIP11	9321	ENSG00000100815,ENST00000267622;;;ENST00000267622		Achondrogenesis, type IA	200600	AR	3	Trip11
14q32.12	14:91965991-92040059	TRIP11, TRIP230, CEV14, ACG1A, ODCD1	Thyroid hormone receptor interactor 11	604505	TRIP11	9321	ENSG00000100815,ENST00000267622;;;ENST00000267622		Odontochondrodysplasia 1	184260	AR	3	Trip11
14q32.12	14:92044775-92106582	ATXN3, MJD, SCA3	Ataxin-3 (josephin)	607047	ATXN3	4287	ENSG00000066427,ENST00000644486;;;ENST00000644486		{Parkinson disease, late-onset, susceptibility to}	168600	AD, Mu	3	Atxn3
14q32.12	14:92044775-92106582	ATXN3, MJD, SCA3	Ataxin-3 (josephin)	607047	ATXN3	4287	ENSG00000066427,ENST00000644486;;;ENST00000644486		Machado-Joseph disease	109150	AD	3	Atxn3
14q32.12	14:92322581-92501481	SLC24A4, NCKX4, SHEP6, AI2A5	Solute carrier family 24 (sodium/potassium/calcium exchanger), member 4	609840	SLC24A4	123041	ENSG00000140090,ENST00000532405;;;ENST00000532405		[Skin/hair/eye pigmentation 6, blond/brown hair]	210750	AR	3	Slc24a4
14q32.12	14:92322581-92501481	SLC24A4, NCKX4, SHEP6, AI2A5	Solute carrier family 24 (sodium/potassium/calcium exchanger), member 4	609840	SLC24A4	123041	ENSG00000140090,ENST00000532405;;;ENST00000532405		[Skin/hair/eye pigmentation 6, blue/green eyes]	210750	AR	3	Slc24a4
14q32.12	14:92322581-92501481	SLC24A4, NCKX4, SHEP6, AI2A5	Solute carrier family 24 (sodium/potassium/calcium exchanger), member 4	609840	SLC24A4	123041	ENSG00000140090,ENST00000532405;;;ENST00000532405		Amelogenesis imperfecta, type IIA5	615887	AR	3	Slc24a4
14q32.12	14:93184974-93188463	LYSET, TMEM251, C14orf109, DMAN	Lysosomal enzyme trafficking factor	619332	LYSET	26175	ENSG00000153485,ENST00000415050;;;ENST00000415050		Dysostosis multiplex, Ain-Naz type	619345	AR	3	Lyset
14q32.12	14:93202894-93207065	GON7, C14orf142	GON7 subunit of KEOPS complex	617436	GON7	84520	ENSG00000170270,ENST00000306954;;;ENST00000306954		Galloway-Mowat syndrome 9	619603	AR	3	Gon7
14q32.12	14:93207256-93229215	UBR7, LICAS	Ubiquitin protein ligase E3 component N-recognin 7	613816	UBR7	55148	ENSG00000012963,ENST00000013070;;;ENST00000013070		Li-Campeau syndrome	619189	AR	3	Ubr7
14q32.13	14:94304248-94323336	CBG, SERPINA6	Corticosteroid-binding globulin	122500	SERPINA6	866	ENSG00000170099,ENST00000341584;;;ENST00000341584		Corticosteroid-binding globulin deficiency	611489	AD, AR	3	Serpina6
14q32.13	14:94376747-94390635	SERPINA1, PI, AAT	Alpha-1-antitrypsin (serpin peptidase inhibitor, clade A, member 1)	107400	SERPINA1	5265	ENSG00000197249,ENST00000393087;;;ENST00000393087		Emphysema due to AAT deficiency	613490	AR	3	Serpina1a,Serpina1b,Serpina1c,Serpina1d,Serpina1e
14q32.13	14:94376747-94390635	SERPINA1, PI, AAT	Alpha-1-antitrypsin (serpin peptidase inhibitor, clade A, member 1)	107400	SERPINA1	5265	ENSG00000197249,ENST00000393087;;;ENST00000393087		Emphysema-cirrhosis, due to AAT deficiency	613490	AR	3	Serpina1a,Serpina1b,Serpina1c,Serpina1d,Serpina1e
14q32.13	14:94376747-94390635	SERPINA1, PI, AAT	Alpha-1-antitrypsin (serpin peptidase inhibitor, clade A, member 1)	107400	SERPINA1	5265	ENSG00000197249,ENST00000393087;;;ENST00000393087		Hemorrhagic diathesis due to antithrombin Pittsburgh	613490	AR	3	Serpina1a,Serpina1b,Serpina1c,Serpina1d,Serpina1e
14q32.13	14:94612391-94624053	SERPINA3, AACT, ACT	Alpha-1-antichymotrypsin	107280	SERPINA3	12	ENSG00000196136,ENST00000393078;;;ENST00000393078	220kb from PI	Alpha-1-antichymotrypsin deficiency			3	Serpina3a,Serpina3b,Serpina3c,Serpina3f,Serpina3g,Serpina3i,Serpina3j,Serpina3k,Serpina3m,Serpina3n
14q32.13	14:94612391-94624053	SERPINA3, AACT, ACT	Alpha-1-antichymotrypsin	107280	SERPINA3	12	ENSG00000196136,ENST00000393078;;;ENST00000393078	220kb from PI	Cerebrovascular disease, occlusive			3	Serpina3a,Serpina3b,Serpina3c,Serpina3f,Serpina3g,Serpina3i,Serpina3j,Serpina3k,Serpina3m,Serpina3n
14q32.13	14:94768223-94770113	GSC, SAMS	Goosecoid	138890	GSC	145258	ENSG00000133937,ENST00000238558;;;ENST00000238558		Short stature, auditory canal atresia, mandibular hypoplasia, skeletal abnormalities	602471	AR	3	Gsc
14q32.13	14:95086228-95158010	DICER1, HERNA, KIAA0928, MNG1, RMSE2, GLOW	dicer 1, ribonuclease III	606241	DICER1	23405	ENSG00000100697,ENST00000343455;;;ENST00000343455		GLOW syndrome, somatic mosaic	618272		3	Dicer1
14q32.13	14:95086228-95158010	DICER1, HERNA, KIAA0928, MNG1, RMSE2, GLOW	dicer 1, ribonuclease III	606241	DICER1	23405	ENSG00000100697,ENST00000343455;;;ENST00000343455		Goiter, multinodular 1, with or without Sertoli-Leydig cell tumors	138800	AD	3	Dicer1
14q32.13	14:95086228-95158010	DICER1, HERNA, KIAA0928, MNG1, RMSE2, GLOW	dicer 1, ribonuclease III	606241	DICER1	23405	ENSG00000100697,ENST00000343455;;;ENST00000343455		Pleuropulmonary blastoma	601200	AD	3	Dicer1
14q32.13	14:95086228-95158010	DICER1, HERNA, KIAA0928, MNG1, RMSE2, GLOW	dicer 1, ribonuclease III	606241	DICER1	23405	ENSG00000100697,ENST00000343455;;;ENST00000343455		Rhabdomyosarcoma, embryonal, 2	180295		3	Dicer1
14q32.13	14:95535050-95544714	GLRX5, C14orf87, PRO1238, FLB4739, PRSA, SIDBA3, SPAHGC	Glutaredoxin 5	609588	GLRX5	51218	ENSG00000182512,ENST00000331334;;;ENST00000331334		Anemia, sideroblastic, 3, pyridoxine-refractory	616860	AR	3	Glrx5
14q32.13	14:95535050-95544714	GLRX5, C14orf87, PRO1238, FLB4739, PRSA, SIDBA3, SPAHGC	Glutaredoxin 5	609588	GLRX5	51218	ENSG00000182512,ENST00000331334;;;ENST00000331334		Spasticity, childhood-onset, with hyperglycinemia	616859	AR	3	Glrx5
14q32.13	14:95686426-95692628	TCL1B, TML1	TCL1 family AKT coactovator B	603769	TCL1B	9623	ENSG00000213231,ENST00000340722;;;ENST00000340722		Leukemia/lymphoma, T-cell	603769		2	Tcl1b1,Tcl1b2,Tcl1b3,Tcl1b4,Tcl1b5
14q32.13	14:95709947-95714125	TCL1A, TCL1	TCL1 family AKT coactivator A	186960	TCL1A	8115	ENSG00000100721,ENST00000402399;;;ENST00000402399		Leukemia/lymphoma, T-cell	186960		2	Tcl1
14q32.2	14:96392128-96489427	AK7, SPGF27	Adenylate kinase 7	615364	AK7	122481	ENSG00000140057,ENST00000267584;;;ENST00000267584	mutation identified in 1 SPGF27 family	?Spermatogenic failure 27	617965	AR	3	Ak7
14q32.2	14:96797382-96881609	VRK1, PCH1A, HMNR10	VRK serine/threonine kinase 1	602168	VRK1	7443	ENSG00000100749,ENST00000216639;;;ENST00000216639		Neuronopathy, distal hereditary motor, autosomal recessive 10	620542	AR	3	Vrk1
14q32.2	14:96797382-96881609	VRK1, PCH1A, HMNR10	VRK serine/threonine kinase 1	602168	VRK1	7443	ENSG00000100749,ENST00000216639;;;ENST00000216639		Pontocerebellar hypoplasia type 1A	607596	AR	3	Vrk1
14q32.2	14:99169287-99272197	BCL11B, CTIP2, IMD49, IDDFSTA	BAF chromatin remodeling complex subunit BCL11B	606558	BCL11B	64919	ENSG00000127152,ENST00000357195;;;ENST00000357195		Immunodeficiency 49, severe combined	617237	AD	3	Bcl11b
14q32.2	14:99169287-99272197	BCL11B, CTIP2, IMD49, IDDFSTA	BAF chromatin remodeling complex subunit BCL11B	606558	BCL11B	64919	ENSG00000127152,ENST00000357195;;;ENST00000357195		Intellectual developmental disorder with dysmorphic facies, speech delay, and T-cell abnormalities	618092	AD	3	Bcl11b
14q32.2	14:99481409-99512440	CCNK, IDDHDF	Cyclin K	603544	CCNK	8812	ENSG00000090061,ENST00000389879;;;ENST00000389879	mutation identified in 1 IDDHDF patient	?Intellectual developmental disorder with hypertelorism and distinctive facies	618147	AD	3	Ccnk
14q32.2	14:99737722-99942060	EML1, EMAPL, EMAP, BH	Echinoderm microtubule associated protein like 1	602033	EML1	2009	ENSG00000066629,ENST00000262233;;;ENST00000262233		Band heterotopia	600348	AR	3	Eml1
14q32.2	14:100239144-100282788	YY1, GADEVS	YY1 transcription factor	600013	YY1	7528	ENSG00000100811,ENST00000262238;;;ENST00000262238		Gabriele-de Vries syndrome	617557	AD	3	Yy1
14q32.2	14:100333790-100376327	WARS1, WARS, HMND9, NEDMSBA	Tryptophanyl-tRNA synthetase 1	191050	WARS1	7453	ENSG00000140105,ENST00000392882;;;ENST00000392882		Neurodevelopmental disorder with microcephaly and speech delay, with or without brain abnormalities	620317	AR	3	Wars1
14q32.2	14:100333790-100376327	WARS1, WARS, HMND9, NEDMSBA	Tryptophanyl-tRNA synthetase 1	191050	WARS1	7453	ENSG00000140105,ENST00000392882;;;ENST00000392882		Neuronopathy, distal hereditary motor, autosomal dominant 9	617721	AD	3	Wars1
14q32.31	14:101760573-101927992	PPP2R5C, HJS4	Protein phosphatase-2, regulatory subunit B (B56), gamma isoform	601645	PPP2R5C	5527	ENSG00000078304,ENST00000694906;;;ENST00000694906	pseudogene on 3p21	Houge-Janssens syndrome 4	621185	AD	3	Ppp2r5c
14q32.31	14:101964573-102056443	DYNC1H1, DNCL, DNECL, CMT2O, SMALED1, CDCBM13	Dynein, cytoplasmic-1, heavy chain-1	600112	DYNC1H1	1778	ENSG00000197102,ENST00000360184;;;ENST00000360184		Charcot-Marie-Tooth disease, axonal, type 2O	614228	AD	3	Dync1h1
14q32.31	14:101964573-102056443	DYNC1H1, DNCL, DNECL, CMT2O, SMALED1, CDCBM13	Dynein, cytoplasmic-1, heavy chain-1	600112	DYNC1H1	1778	ENSG00000197102,ENST00000360184;;;ENST00000360184		Cortical dysplasia, complex, with other brain malformations 13	614563	AD	3	Dync1h1
14q32.31	14:101964573-102056443	DYNC1H1, DNCL, DNECL, CMT2O, SMALED1, CDCBM13	Dynein, cytoplasmic-1, heavy chain-1	600112	DYNC1H1	1778	ENSG00000197102,ENST00000360184;;;ENST00000360184		Spinal muscular atrophy, lower extremity-predominant 1, AD	158600	AD	3	Dync1h1
14q32.31	14:102362941-102502477	TECPR2, KIAA0329, HSAN9	Tectonin beta-propeller repeat-containing protein 2	615000	TECPR2	9895	ENSG00000196663,ENST00000359520;;;ENST00000359520		Neuropathy, hereditary sensory and autonomic, type IX, with developmental delay	615031	AR	3	Tecpr2
14q32.32	14:102777449-102911500	TRAF3, CD40BP, LAP1, CAP1, CRAF1, IMD132A, IMD132B	TNF receptor-associated factor 3	601896	TRAF3	7187	ENSG00000131323,ENST00000392745;;;ENST00000392745	mutation identified in 1 IIAE5 patient	Immunodeficiency 132A	614849	AD	3	Traf3
14q32.32	14:102777449-102911500	TRAF3, CD40BP, LAP1, CAP1, CRAF1, IMD132A, IMD132B	TNF receptor-associated factor 3	601896	TRAF3	7187	ENSG00000131323,ENST00000392745;;;ENST00000392745	mutation identified in 1 IIAE5 patient	Immunodeficiency 132B	621096	AD	3	Traf3
14q32.32	14:102922663-102930842	AMN, IGS2	Amnion associated transmembrane protein	605799	AMN	81693	ENSG00000166126,ENST00000299155;;;ENST00000299155		Imerslund-Grasbeck syndrome 2	618882	AR	3	Amn
14q32.32	14:102932380-103057549	CDC42BPB, MRCKB, CHOCNS	CDC42-binding protein kinase, beta	614062	CDC42BPB	9578	ENSG00000198752,ENST00000361246;;;ENST00000361246		Chilton-Okur-Chung neurodevelopmental syndrome	619841	AD	3	Cdc42bpb
14q32.32-q32.33	14:103385415-103503831	MARK3, VIPB	MAP/microtubule affinity-regulating kinase-3	602678	MARK3	4140	ENSG00000075413,ENST00000429436;;;ENST00000429436	mutation identified in 1 VIPB family	?Visual impairment and progressive phthisis bulbi	618283	AR	3	Mark3
14q32.33	14:103500001-107043718	IGHR	Immunoglobulin heavy chain regulator	144120					?Hyperimmunoglobulin G1 syndrome	144120	AD	2	
14q32.33	14:103556551-103562657	BAG5, CMD2F	BAG cochaperone 5	603885	BAG5	9529	ENSG00000166170,ENST00000299204;;;ENST00000299204		Cardiomyopathy, dilated, 2F	619747	AR	3	Bag5
14q32.33	14:103562960-103590899	COA8, APOPT1, APOP, MC4DN17	Cytochrome c oxidase assembly factor 8	616003	COA8	84334	ENSG00000256053,ENST00000409074;;;ENST00000409074		Mitochondrial complex IV deficiency, nuclear type 17	619061	AR	3	Coa8
14q32.33	14:103697617-103715451	XRCC3, CMM6	X-ray repair corss complementing 3	600675	XRCC3	7517	ENSG00000126215,ENST00000555055;;;ENST00000555055		{Breast cancer, susceptibility to}	114480	AD, SMu	3	Xrcc3
14q32.33	14:103697617-103715451	XRCC3, CMM6	X-ray repair corss complementing 3	600675	XRCC3	7517	ENSG00000126215,ENST00000555055;;;ENST00000555055		{Melanoma, cutaneous malignant, 6}	613972		3	Xrcc3
14q32.33	14:103928456-104052667	TDRD9, C14orf75, HLS, SPNE, SPGF30	TUDOR domain-containing protein 9	617963	TDRD9	122402	ENSG00000156414,ENST00000409874;;;ENST00000409874	mutation identified in one SPGF30 family	?Spermatogenic failure 30	618110	AR	3	Tdrd9
14q32.33	14:104138587-104180894	KIF26A, KIAA1236, CDCBM11	Kinesin family member 26A	613231	KIF26A	26153	ENSG00000066735,ENST00000423312;;;ENST00000423312		Cortical dysplasia, complex, with other brain malformations 11	620156	AR	3	Kif26a
14q32.33	14:104681133-104722535	INF2, FSGS5, C14orf173, CMTDIE	Inverted formin 2	610982	INF2	64423	ENSG00000203485,ENST00000392634;;;ENST00000392634		Charcot-Marie-Tooth disease, dominant intermediate E	614455	AD	3	Inf2
14q32.33	14:104681133-104722535	INF2, FSGS5, C14orf173, CMTDIE	Inverted formin 2	610982	INF2	64423	ENSG00000203485,ENST00000392634;;;ENST00000392634		Glomerulosclerosis, focal segmental, 5	613237		3	Inf2
14q32.33	14:104724229-104747325	ADSS1, ADSSL1, MPD5	Adenylosuccinate synthase 1	612498	ADSS1	122622	ENSG00000185100,ENST00000330877;;;ENST00000330877		Myopathy, distal, 5	617030	AR	3	Adss1
14q32.33	14:104769349-104795748	AKT1, CWS6	AKT serine/threonine kinase 1	164730	AKT1	207	ENSG00000142208,ENST00000649815;;;ENST00000649815	proximal to IGH	Breast cancer, somatic	114480		3	Akt1
14q32.33	14:104769349-104795748	AKT1, CWS6	AKT serine/threonine kinase 1	164730	AKT1	207	ENSG00000142208,ENST00000649815;;;ENST00000649815	proximal to IGH	Colorectal cancer, somatic	114500		3	Akt1
14q32.33	14:104769349-104795748	AKT1, CWS6	AKT serine/threonine kinase 1	164730	AKT1	207	ENSG00000142208,ENST00000649815;;;ENST00000649815	proximal to IGH	Cowden syndrome 6	615109	AD	3	Akt1
14q32.33	14:104769349-104795748	AKT1, CWS6	AKT serine/threonine kinase 1	164730	AKT1	207	ENSG00000142208,ENST00000649815;;;ENST00000649815	proximal to IGH	Ovarian cancer, somatic	167000		3	Akt1
14q32.33	14:104769349-104795748	AKT1, CWS6	AKT serine/threonine kinase 1	164730	AKT1	207	ENSG00000142208,ENST00000649815;;;ENST00000649815	proximal to IGH	Proteus syndrome, somatic mosaic	176920		3	Akt1
14q32.33	14:104800554-104804712	ZBTB42, ZNF925, LCCS6	Zinc finger- and BTB domain-containing protein 42	613915	ZBTB42	100128927	ENSG00000179627,ENST00000342537;;;ENST00000342537	mutation identified in 1 LCCS6 family	?Lethal congenital contracture syndrome 6	616248	AR	3	Zbtb42
14q32.33	14:104924879-104937785	PLD4, SLEB18	Phospholipase D family, member 4	618488	PLD4	122618	ENSG00000166428,ENST00000392593;;;ENST00000392593		Systemic lupus erythematosus 18	621369	AR	3	Pld4
14q32.33	14:105140995-105168776	JAG2, LGMDR27	Jagged 2	602570	JAG2	3714	ENSG00000184916,ENST00000331782;;;ENST00000331782		Muscular dystrophy, limb-girdle, autosomal recessive 27	619566	AR	3	Jag2
14q32.33	14:105209286-105315589	BRF1, TAF3C, GTF3B, TF3B90, CFDS	BRF1, S. cerevisiae, homolog of (TATA box-binding protein-associated factor 3C)	604902	BRF1	2972	ENSG00000185024,ENST00000547530;;;ENST00000547530		Cerebellofaciodental syndrome	616202	AR	3	Brf1
14q32.33	14:105300774-105398147	PACS2, KIAA0602, DEE66	Phosphofurin acidic cluster sorting protein 2	610423	PACS2	23241	ENSG00000179364,ENST00000447393;;;ENST00000447393		Developmental and epileptic encephalopathy 66	618067	AD	3	Pacs2
14q32.33	14:105643203-105644789	IGHG2	Constant region of heavy chain of IgG2	147110		3501	ENSG00000211893,-	5'-G2-17kb-G4-3'; closeness of IGG3 and IGG1 known from Lepore-like myeloma protein	IgG2 deficiency, selective			3	Ighg,Ighg1,Ighg2a,Ighg2b,Ighg2c,Ighg3
14q32.33	14:105851966-105856217	IGHM, MU, AGM1	Constant region of heavy chain of IgM	147020		3507	ENSG00000211899,-		Agammaglobulinemia 1	601495	AR	3	Ighm
Chr.14	14:1-107043718	PHOBS	Phobia, specific	608251		404684			Phobia, specific	608251		2	
Chr.14	14:1-107043718	RC14S	Ring chromosome 14 syndrome	616606					Ring chromosome 14 syndrome	616606	IC	4	
15q11-q13	15:19000001-33400000	CELIAC5, GSES	Celiac disease, susceptibility to, 5	607202		338332		in homogeneous Finnish population	{Celiac disease, susceptibility to, 5}	607202		2	
15q11	15:19000001-25500000	DUP15q11-q13, C15DUPq11-q13, AUTS4	Chromosome 15q11-q13 duplication syndrome	608636					Chromosome 15q11-q13 duplication syndrome	608636	AD	4	
15q11-q13	15:19000001-33400000	GLC1I	Glaucoma 1, open angle, I	609745		497188		max lod at GABRB3	Glaucoma 1, open angle, I	609745		2	
15q11-qter	15:19000001-101991189	HCVS	Human coronavirus sensitivity	122460		3063			{Human coronavirus sensitivity}	122460	AD	2	
15q	15:19000001-101991189	HYT2	Hypertension, essential, susceptibility to, 2	604329		50986			{Hypertension, essential, susceptibility to, 2}	145500	Mu	2	
15q	15:19000001-101991189	LCS1, CHLS	Cholestasis-lymphedema syndrome	214900		84565			Cholestasis-lymphedema syndrome	214900	AR	2	
15q11-q13	15:19000001-33400000	PWS	Prader-Willi syndrome	176270				loss of paternal allele	Prader-Willi syndrome	176270	AD	4	
15q11.2	15:20500001-25500000	DEL15q11.2, C15DELq11.2	Chromosome 15q11.2 deletion syndrome	615656				deleted region spans 300-500kb between BP1 and BP2	Chromosome 15q11.2 deletion syndrome	615656	AD	4	
15q11.2-q12	15:20500001-27800000	MGR7	Migraine with aura, susceptibility to, 7	609179		553992		between D15S113 and D15S1019	{Migraine with aura, susceptibility to, 7}	609179		2	
15q11.2	15:22786225-22829789	NIPA1, SPG6	NIPA magnesium transporter 1	608145	NIPA1	123606	ENSG00000170113,ENST00000337435;;;ENST00000337435		Spastic paraplegia 6, autosomal dominant	600363	AD	3	Nipa1
15q11.2	15:23565674-23568044	MKRN3, ZFP127, ZNF127, CPPB2	Makorin 3	603856	MKRN3	7681	ENSG00000179455,ENST00000314520;;;ENST00000314520	expressed only from paternal allele	Precocious puberty, central, 2	615346	AD	3	Mkrn3
15q11.2	15:23643549-23647867	MAGEL2, NDNL1, SHFYNG	MAGE-like 2	605283	MAGEL2	54551	ENSG00000254585,ENST00000650528;;;ENST00000650528		Schaaf-Yang syndrome	615547	AD	3	Magel2
15q11.2	15:25333728-25439056	UBE3A, ANCR	Ubiquitin protein ligase E3A	601623	UBE3A	7337	ENSG00000114062,ENST00000648336;;;ENST00000648336	same location as PWS	Angelman syndrome	105830	AD	3	Ube3a
15q12	15:25500001-27800000	HPC7	Prostate cancer, hereditary, 7	610321		100188809			{Prostate cancer, hereditary, 7}	610321		2	
15q12-q15	15:25500001-44500000	MCOPCB2	Microphthalmia/coloboma 2	605738		80771			Microphthalmia/coloboma 2	605738	AD	2	
15q12	15:26543552-26773763	GABRB3, ECA5, DEE43	Gamma-aminobutyric acid (GABA) A receptor, beta-3	137192	GABRB3	2562	ENSG00000166206,ENST00000311550;;;ENST00000311550		{Epilepsy, childhood absence, susceptibility to, 5}	612269		3	Gabrb3
15q12	15:26543552-26773763	GABRB3, ECA5, DEE43	Gamma-aminobutyric acid (GABA) A receptor, beta-3	137192	GABRB3	2562	ENSG00000166206,ENST00000311550;;;ENST00000311550		Developmental and epileptic encephalopathy 43	617113	AD	3	Gabrb3
15q12	15:26866719-26949208	GABRA5, DEE79	Gamma-aminobutyric acid (GABA) A receptor, alpha-5	137142	GABRA5	2558	ENSG00000186297,ENST00000335625;;;ENST00000335625	100kb from GABRB3	Developmental and epileptic encephalopathy 79	618559	AD	3	Gabra5
15q12-q13.1	15:27719008-28099315	OCA2, P, PED, D15S12, BOCA, EYCL3, HCL3, SHEP1	Pink-eye dilution, murine, homolog of (oculocutaneous albinism II)	611409	OCA2	4948	ENSG00000104044,ENST00000354638;;;ENST00000354638	?hypopigmentation in PWS and AS	[Skin/hair/eye pigmentation 1, blond/brown hair]	227220	AR	3	Oca2
15q12-q13.1	15:27719008-28099315	OCA2, P, PED, D15S12, BOCA, EYCL3, HCL3, SHEP1	Pink-eye dilution, murine, homolog of (oculocutaneous albinism II)	611409	OCA2	4948	ENSG00000104044,ENST00000354638;;;ENST00000354638	?hypopigmentation in PWS and AS	[Skin/hair/eye pigmentation 1, blue/nonblue eyes]	227220	AR	3	Oca2
15q12-q13.1	15:27719008-28099315	OCA2, P, PED, D15S12, BOCA, EYCL3, HCL3, SHEP1	Pink-eye dilution, murine, homolog of (oculocutaneous albinism II)	611409	OCA2	4948	ENSG00000104044,ENST00000354638;;;ENST00000354638	?hypopigmentation in PWS and AS	Albinism, brown oculocutaneous	203200	AR	3	Oca2
15q12-q13.1	15:27719008-28099315	OCA2, P, PED, D15S12, BOCA, EYCL3, HCL3, SHEP1	Pink-eye dilution, murine, homolog of (oculocutaneous albinism II)	611409	OCA2	4948	ENSG00000104044,ENST00000354638;;;ENST00000354638	?hypopigmentation in PWS and AS	Albinism, oculocutaneous, type II	203200	AR	3	Oca2
15q13.1-q15.1	15:27800001-42500000	CILD4	Ciliary dyskinesia, primary, 4	608646		408257		between D15S1012 and D15S1048	Ciliary dyskinesia, primary, 4	608646	AR	2	
15q13-q14	15:27800001-39800000	HMPS1, CRAC1, CRCS4, DUP15q, C15DUPq	Polyposis syndrome, hereditary mixed 1	601228				duplication of 40kb of 15q resulting in overexpression of GREM1	{Colorectal cancer, susceptibility to, 4}	601228	AD	4	
15q13-q14	15:27800001-39800000	HMPS1, CRAC1, CRCS4, DUP15q, C15DUPq	Polyposis syndrome, hereditary mixed 1	601228				duplication of 40kb of 15q resulting in overexpression of GREM1	Polyposis syndrome, hereditary mixed 1	601228	AD	4	
15q13	15:27800001-33400000	SCZD13	Schizophrenia 13	613025		100329170		associated with deletion at 15q13.3	{Schizophrenia, susceptibility to, 13}	613025		2	
15q13	15:27800001-33400000	SRTD1, ATD1	Short-rib thoracic dysplasia 1 with or without polydactyly	208500		465			Short-rib thoracic dysplasia 1 with or without polydactyly	208500	AR	2	
15q13.1	15:28111040-28322179	HERC2, SHEP1, MRT38	HECT domain and RCC1-like domain 2	605837	HERC2	8924	ENSG00000128731,ENST00000261609;;;ENST00000261609	mutations in intron 4	[Skin/hair/eye pigmentation 1, blond/brown hair]	227220	AR	3	Herc2
15q13.1	15:28111040-28322179	HERC2, SHEP1, MRT38	HECT domain and RCC1-like domain 2	605837	HERC2	8924	ENSG00000128731,ENST00000261609;;;ENST00000261609	mutations in intron 4	[Skin/hair/eye pigmentation 1, blue/nonblue eyes]	227220	AR	3	Herc2
15q13.1	15:28111040-28322179	HERC2, SHEP1, MRT38	HECT domain and RCC1-like domain 2	605837	HERC2	8924	ENSG00000128731,ENST00000261609;;;ENST00000261609	mutations in intron 4	Intellectual developmental disorder, autosomal recessive 38	615516	AR	3	Herc2
15q13.1	15:29264989-29269822	NSMCE3, NDNL2, MAGEG1, LICS	NSE3 homolog, SMC5-SMC6 complex component	608243	NSMCE3	56160	ENSG00000185115,ENST00000332303;;;ENST00000332303		Lung disease, immunodeficiency, and chromosome breakage syndrome	617241	AR	3	Nscme3l,Nsmce3
15q13.3	15:30900001-33400000	DEL15q13.3, MICRODEL15q13.3	Chromosome 15q13.3 microdeletion syndrome	612001					Chromosome 15q13.3 microdeletion syndrome	612001		4	
15q13.3	15:30903852-30943108	FAN1, MTMR15, KIAA1018, KMIN	FANCD2/FANCI-associated nuclease 1	613534	FAN1	22909	ENSG00000198690,ENST00000362065;;;ENST00000362065		Interstitial nephritis, karyomegalic	614817	AR	3	Fan1
15q13.3	15:31001065-31161160	TRPM1, MLSN1, CSNB1C	Transient receptor potential cation channel, subfamily M, member 1 (melastatin)	603576	TRPM1	4308	ENSG00000134160,ENST00000256552;;;ENST00000256552		Night blindness, congenital stationary (complete), 1C, autosomal recessive	613216	AR	3	Trpm1
15q13.3	15:31475398-31870673	OTUD7A, OTUD7, C16orf15, CEZANNE2, NEDHS	OTU domain-containing protein 7A	612024	OTUD7A	161725	ENSG00000169918,ENST00000307050;;;ENST00000307050		Neurodevelopmental disorder with hypotonia and seizures	620790	AR	3	Otud7a
15q13.3-q14	15:33310967-33866102	RYR3, CMYO20	Ryanodine receptor-3	180903	RYR3	6263	ENSG00000198838,ENST00000634891;;;ENST00000634891		Congenital myopathy 20	620310	AR	3	Ryr3
15q14	15:33400001-39800000	DEL15q14, C15DELq14	Chromosome 15q14 deletion syndrome	616898					Chromosome 15q14 deletion syndrome	616898	AD	4	
15q14	15:33400001-39800000	EIG7, EJM2	Epilepsy, idiopathic generalized, susceptibility to, 7	604827		50715		?role of CHRNA7	{Epilepsy, idiopathic generalized, susceptibility to, 7}	604827	IC	2	
15q14	15:33400001-39800000	EIG7, EJM2	Epilepsy, idiopathic generalized, susceptibility to, 7	604827		50715		?role of CHRNA7	Epilepsy, juvenile myoclonic	604827	IC	2	
15q14	15:34229784-34338057	SLC12A6, KCC3A, KCC3B, KCC3, ACCPN, CMT2II	Solute carrier family 12 (potassium/chloride transporters), member 6	604878	SLC12A6	9990	ENSG00000140199,ENST00000354181;;;ENST00000354181		Agenesis of the corpus callosum with peripheral neuropathy	218000	AR	3	Slc12a6
15q14	15:34229784-34338057	SLC12A6, KCC3A, KCC3B, KCC3, ACCPN, CMT2II	Solute carrier family 12 (potassium/chloride transporters), member 6	604878	SLC12A6	9990	ENSG00000140199,ENST00000354181;;;ENST00000354181		Charcot-Marie-Tooth disease, axonal, type 2II	620068	AD	3	Slc12a6
15q14	15:34341719-34343136	NOP10, NOLA3, DKCB1, PFBMFT9, CHINE2	NOP10 ribonucleoprotein	606471	NOP10	55505	ENSG00000182117,ENST00000328848;;;ENST00000328848	mutation identified in 1 PFBMFT9 family and 1 DKCB1 family and 1 CHINE2 family	?Cataracts, hearing impairment, nephrotic syndrome, and enterocolitis 2	620425	AR	3	Nop10
15q14	15:34341719-34343136	NOP10, NOLA3, DKCB1, PFBMFT9, CHINE2	NOP10 ribonucleoprotein	606471	NOP10	55505	ENSG00000182117,ENST00000328848;;;ENST00000328848	mutation identified in 1 PFBMFT9 family and 1 DKCB1 family and 1 CHINE2 family	?Dyskeratosis congenita, autosomal recessive 1	224230	AR	3	Nop10
15q14	15:34341719-34343136	NOP10, NOLA3, DKCB1, PFBMFT9, CHINE2	NOP10 ribonucleoprotein	606471	NOP10	55505	ENSG00000182117,ENST00000328848;;;ENST00000328848	mutation identified in 1 PFBMFT9 family and 1 DKCB1 family and 1 CHINE2 family	?Pulmonary fibrosis and/or bone marrow failure syndrome, telomere-related, 9	620400	AD	3	Nop10
15q14	15:34790230-34795549	ACTC1, CMD1R, CMH11, ASD5, LVNC4	Actin, alpha, cardiac muscle	102540	ACTC1	70	ENSG00000159251,ENST00000290378;;;ENST00000290378		Atrial septal defect 5	612794	AD	3	Actc1
15q14	15:34790230-34795549	ACTC1, CMD1R, CMH11, ASD5, LVNC4	Actin, alpha, cardiac muscle	102540	ACTC1	70	ENSG00000159251,ENST00000290378;;;ENST00000290378		Cardiomyopathy, dilated, 1R	613424	AD	3	Actc1
15q14	15:34790230-34795549	ACTC1, CMD1R, CMH11, ASD5, LVNC4	Actin, alpha, cardiac muscle	102540	ACTC1	70	ENSG00000159251,ENST00000290378;;;ENST00000290378		Cardiomyopathy, hypertrophic, 11	612098	AD	3	Actc1
15q14	15:34790230-34795549	ACTC1, CMD1R, CMH11, ASD5, LVNC4	Actin, alpha, cardiac muscle	102540	ACTC1	70	ENSG00000159251,ENST00000290378;;;ENST00000290378		Left ventricular noncompaction 4	613424	AD	3	Actc1
15q14	15:36579626-36810244	CDIN1, C15orf41	CDAN1-interacting nuclease 1	615626	CDIN1	84529	ENSG00000186073,ENST00000566621;;;ENST00000566621		Dyserythropoietic anemia, congenital, type Ib	615631	AR	3	Cdin1
15q14	15:36889204-37101311	MEIS2, MRG1, CPCMR	Meis homeobox 2	601740	MEIS2	4212	ENSG00000134138,ENST00000561208;;;ENST00000561208		Cleft palate, cardiac defects, and impaired intellectual development	600987	AD	3	Meis2
15q14	15:38252836-38357249	SPRED1, NFLS, LGSS	Sprouty-related EVH1 domain-containing protein 1	609291	SPRED1	161742	ENSG00000166068,ENST00000299084;;;ENST00000299084		Legius syndrome	611431	AD	3	Spred1
15q14	15:38488103-38564814	RASGRP1, IMD64	Ras guanyl nucleotide releasing protein-1	603962	RASGRP1	10125	ENSG00000172575,ENST00000310803;;;ENST00000310803		Immunodeficiency 64	618534	AR	3	Rasgrp1
15q15	15:39800001-44500000	SCZD10	Schizophrenia 10	605419		63944		between D15S1042 and D15S659	{Schizophrenia 10}	605419	AD	2	
15q15.1	15:39934115-40035591	EIF2AK4, GCN2, KIAA1338, PVOD2	Eukaryotic translation initiation factor 2-alpha kinase 4	609280	EIF2AK4	440275	ENSG00000128829,ENST00000263791;;;ENST00000263791		Pulmonary venoocclusive disease 2	234810	AR	3	Eif2ak4
15q15.1	15:40161069-40221123	BUB1B, BUBR1, MVA1	BUB1 mitotic checkpoint serine/threonine kinase B	602860	BUB1B	701	ENSG00000156970,ENST00000287598;;;ENST00000287598		[Premature chromatid separation trait]	176430	AD	3	Bub1b
15q15.1	15:40161069-40221123	BUB1B, BUBR1, MVA1	BUB1 mitotic checkpoint serine/threonine kinase B	602860	BUB1B	701	ENSG00000156970,ENST00000287598;;;ENST00000287598		Colorectal cancer, somatic	114500		3	Bub1b
15q15.1	15:40161069-40221123	BUB1B, BUBR1, MVA1	BUB1 mitotic checkpoint serine/threonine kinase B	602860	BUB1B	701	ENSG00000156970,ENST00000287598;;;ENST00000287598		Mosaic variegated aneuploidy syndrome 1	257300	AR	3	Bub1b
15q15.1	15:40284256-40307935	PLCB2	Phospholipase C, beta-2	604114	PLCB2	5330	ENSG00000137841,ENST00000260402;;;ENST00000260402		Platelet PLC beta-2 deficiency			1	Plcb2
15q15.1	15:40382721-40394288	KNSTRN, C15orf23, SKAP, ROCHIS	Kinetochore-localized astrin/SPAG5 binding protein	614718	KNSTRN	90417	ENSG00000128944,ENST00000249776;;;ENST00000249776	mutation identified in 1 ROCHIS family	?Roifman-Chitayat syndrome, digenic	613328	DR	3	Knstrn
15q15.1	15:40405795-40435947	IVD	Isovaleryl Coenzyme A dehydrogenase	607036	IVD	3712	ENSG00000128928,ENST00000487418;;;ENST00000487418		Isovaleric acidemia	243500	AR	3	Ivd
15q15.1	15:40470984-40473158	CHST14, D4ST1, ATCS, EDSMC1	Carbohydrate (N-acetylgalactosamine 4-0) sulfotransferase 14	608429	CHST14	113189	ENSG00000169105,ENST00000306243;;;ENST00000306243		Ehlers-Danlos syndrome, musculocontractural type 1	601776	AR	3	Chst14
15q15.1	15:40520993-40565042	CCDC32, CFNDS, C15orf57	Coiled-coil domain-containing protein 32	618941	CCDC32	90416	ENSG00000128891,ENST00000416810;;;ENST00000416810		Cardiofacioneurodevelopmental syndrome	619123	AR	3	Ccdc32
15q15.1	15:40594249-40664342	KNL1, CASC5, AF15Q14, KIAA1570, D40, MCPH4	Kinetochore scaffold 1	609173	KNL1	57082	ENSG00000137812,ENST00000399668;;;ENST00000399668		Microcephaly 4, primary, autosomal recessive	604321	AR	3	Knl1
15q15.1	15:40694733-40732340	RAD51, RECA, MRMV2, FANCR	RAD51 recombinase	179617	RAD51	5888	ENSG00000051180,ENST00000267868;;;ENST00000267868		{Breast cancer, susceptibility to}	114480	AD, SMu	3	Rad51
15q15.1	15:40694733-40732340	RAD51, RECA, MRMV2, FANCR	RAD51 recombinase	179617	RAD51	5888	ENSG00000051180,ENST00000267868;;;ENST00000267868		Fanconi anemia, complementation group R	617244	AD	3	Rad51
15q15.1	15:40694733-40732340	RAD51, RECA, MRMV2, FANCR	RAD51 recombinase	179617	RAD51	5888	ENSG00000051180,ENST00000267868;;;ENST00000267868		Mirror movements 2	614508	AD	3	Rad51
15q15.1	15:40807089-40815084	ZFYVE19, ANCHR, PFIC9	Zinc finger FYVE domain-containing protein 19	619635	ZFYVE19	84936	ENSG00000166140,ENST00000355341;;;ENST00000355341		Cholestasis, progressive familial intrahepatic, 9	619849	AR	3	Zfyve19
15q15.1	15:40929340-40939073	DLL4, AOS6	Delta-like canonical Notch ligand 4	605185	DLL4	54567	ENSG00000128917,ENST00000249749;;;ENST00000249749		Adams-Oliver syndrome 6	616589	AD	3	Dll4
15q15.1	15:41231268-41281887	CHP1, SPAX9	Calcineurin like EF-hand protein 1	606988	CHP1	11261	ENSG00000187446,ENST00000334660;;;ENST00000334660	mutation identified in 1 SPAX9 family	?Spastic ataxia 9, autosomal recessive	618438	AR	3	Chp1
15q15.1	15:41387353-41403026	NDUFAF1, CIA30, CGI65, MC1DN11	NADH-ubiquinone oxidoreductase complex assembly factor 1	606934	NDUFAF1	51103	ENSG00000137806,ENST00000260361;;;ENST00000260361		Mitochondrial complex I deficiency, nuclear type 11	618234	AR	3	Ndufaf1
15q15.1	15:41621224-41769940	MGA, KIAA0518, POF26	MAX dimerization protein MGA	616061	MGA	23269	ENSG00000174197,ENST00000703841;;;ENST00000703841		Premature ovarian failure 26	621065	AD	3	Mga
15q15.1	15:41774484-41827855	MAPKBP1, JNKBP1, NPHP20	Mitogen-activated protein kinase-binding protein 1	616786	MAPKBP1	23005	ENSG00000137802,ENST00000457542;;;ENST00000457542		Nephronophthisis 20	617271	AR	3	Mapkbp1
15q15.1	15:42359501-42412317	CAPN3, CANP3, LGMDR1, LGMDD4	Calpain, large polypeptide L3	114240	CAPN3	825	ENSG00000092529,ENST00000397163;;;ENST00000397163		Muscular dystrophy, limb-girdle, autosomal dominant 4	618129	AD	3	Capn3
15q15.1	15:42359501-42412317	CAPN3, CANP3, LGMDR1, LGMDD4	Calpain, large polypeptide L3	114240	CAPN3	825	ENSG00000092529,ENST00000397163;;;ENST00000397163		Muscular dystrophy, limb-girdle, autosomal recessive 1	253600	AR	3	Capn3
15q15.2	15:42723544-42737128	CDAN1, CDA1, CDAN1A	Codanin 1	607465	CDAN1	146059	ENSG00000140326,ENST00000356231;;;ENST00000356231		Dyserythropoietic anemia, congenital, type Ia	224120	AR	3	Cdan1
15q15.2	15:42738730-42921000	TTBK2, SCA11	Tau tubulin kinase 2	611695	TTBK2	146057	ENSG00000128881,ENST00000267890;;;ENST00000267890		Spinocerebellar ataxia 11	604432	AD	3	Ttbk2
15q15.2	15:42942897-43106038	UBR1, JBS	Ubiquitin-protein ligase E3-alpha	605981	UBR1	197131	ENSG00000159459,ENST00000290650;;;ENST00000290650		Johanson-Blizzard syndrome	243800	AR	3	Ubr1
15q15.2	15:43197227-43225737	EPB42, SPH5	Erythrocyte surface protein band 4.2	177070	EPB42	2038	ENSG00000166947,ENST00000441366;;;ENST00000441366		Spherocytosis, type 5	612690		3	Epb42
15q15.2	15:43232590-43266928	TGM5, TGX, PSS2	Transglutaminase 5	603805	TGM5	9333	ENSG00000104055,ENST00000220420;;;ENST00000220420		Peeling skin syndrome 2	609796	AR	3	Tgm5
15q15.3	15:43300001-44500000	DEL15q15.3, C15DELq15.3	Chromosome 15q15.3 deletion syndrome	611102					Deafness and male infertility	611102	AR	4	
15q15.3	15:43371101-43409771	TUBGCP4, GCP4, MCCRP3	Tubulin-gamma complex-associated protein 4	609610	TUBGCP4	27229	ENSG00000137822,ENST00000564079;;;ENST00000564079		Microcephaly and chorioretinopathy, autosomal recessive, 3	616335	AR	3	Tubgcp4
15q15.3	15:43599563-43618800	STRC, DFNB16	Stereocilin	606440	STRC	161497	ENSG00000242866,ENST00000450892;;;ENST00000450892		Deafness, autosomal recessive 16	603720	AR	3	Strc
15q15.3	15:43870764-44199473	FRMD5, NEDEMA	FERM domain-containing protein 5	616309	FRMD5	84978	ENSG00000171877,ENST00000417257;;;ENST00000417257		Neurodevelopmental disorder with eye movement abnormalities and ataxia	620094	AD	3	Frmd5
15q21-q22	15:44500001-67200000	CTRCT25, CCSSO	Cataract 25	605728		80770			Cataract 25	605728		2	
15q21.1	15:44562696-44663662	SPG11, KIAA1840, FLJ21439, ALS5, CMT2X	SPG11 vesicle trafficking associated, spatacsin	610844	SPG11	80208	ENSG00000104133,ENST00000261866;;;ENST00000261866		Amyotrophic lateral sclerosis 5, juvenile	602099	AR	3	Spg11
15q21.1	15:44562696-44663662	SPG11, KIAA1840, FLJ21439, ALS5, CMT2X	SPG11 vesicle trafficking associated, spatacsin	610844	SPG11	80208	ENSG00000104133,ENST00000261866;;;ENST00000261866		Charcot-Marie-Tooth disease, axonal, type 2X	616668	AR	3	Spg11
15q21.1	15:44562696-44663662	SPG11, KIAA1840, FLJ21439, ALS5, CMT2X	SPG11 vesicle trafficking associated, spatacsin	610844	SPG11	80208	ENSG00000104133,ENST00000261866;;;ENST00000261866		Spastic paraplegia 11, autosomal recessive	604360	AR	3	Spg11
15q21.1	15:44665732-44711390	PATL2, PAT1A, OZEMA4	PAT1 homolog 2	614661	PATL2	197135	ENSG00000229474,ENST00000682850;;;ENST00000682850		Oocyte/zygote/embryo maturation arrest 4	617743	AR	3	Patl2
15q21.1	15:44711517-44718145	B2M, IMD43, AMYLD6, MHC1D4	Beta-2-microglobulin	109700	B2M	567	ENSG00000166710,ENST00000648006;;;ENST00000648006		Amyloidosis, hereditary systemic 6	620659	AD	3	B2m
15q21.1	15:44711517-44718145	B2M, IMD43, AMYLD6, MHC1D4	Beta-2-microglobulin	109700	B2M	567	ENSG00000166710,ENST00000648006;;;ENST00000648006		Immunodeficiency 43	241600	AR	3	B2m
15q21.1	15:44956687-44979229	TERB2, C15orf43, SPGF59	Telomere repeat-binding bouquet formation protein 2	617131	TERB2	145645	ENSG00000167014,ENST00000340827;;;ENST00000340827	mutation identified in 1 SPGF59 family	?Spermatogenic failure 59	619645	AR	3	Terb2
15q21.1	15:45023195-45077185	SORD, SORD1, HMNR8	Sorbitol dehydrogenase	182500	SORD	6652	ENSG00000140263,ENST00000267814;;;ENST00000267814		Neuronopathy, distal hereditary motor, autosomal recessive 8	618912	AR	3	Sord
15q21.1	15:45092650-45114172	DUOX2, THOX2, TDH6	Dual oxidase 2 (thyroid oxidase 2)	606759	DUOX2	50506	ENSG00000140279,ENST00000389039;;;ENST00000389039		Thyroid dyshormonogenesis 6	607200	AR	3	Duox2
15q21.1	15:45114326-45118421	DUOXA2, TDH5	Dual oxidase maturation factor 2	612772	DUOXA2	405753	ENSG00000140274,ENST00000323030;;;ENST00000323030	head-to-head with DUOX2	Thyroid dyshormonogenesis 5	274900	AR	3	Duoxa2
15q21.1	15:45361124-45402227	GATM, AGAT, CCDS3, FRTS1	L-arginine:glycine amidinotransferase	602360	GATM	2628	ENSG00000171766,ENST00000396659;;;ENST00000396659		Cerebral creatine deficiency syndrome 3	612718	AR	3	Gatm
15q21.1	15:45361124-45402227	GATM, AGAT, CCDS3, FRTS1	L-arginine:glycine amidinotransferase	602360	GATM	2628	ENSG00000171766,ENST00000396659;;;ENST00000396659		Fanconi renotubular syndrome 1	134600	AD	3	Gatm
15q21.1	15:45402336-45421415	AFG2B, SPATA5L1, DFNB119, NEDHLS	AFG2 AAA ATPase homolog B	619578	AFG2B	79029	ENSG00000171763,ENST00000305560;;;ENST00000305560		Deafness, autosomal recessive 119	619615	AR	3	Afg2b
15q21.1	15:45402336-45421415	AFG2B, SPATA5L1, DFNB119, NEDHLS	AFG2 AAA ATPase homolog B	619578	AFG2B	79029	ENSG00000171763,ENST00000305560;;;ENST00000305560		Neurodevelopmental disorder with hearing loss and spasticity	619616	AR	3	Afg2b
15q21.1	15:45587123-45609716	BLOC1S6, BLOS6, PLDN, PA, HPS9	Biogenesis of lysosome-related organelles complex 1, subunit 6	604310	BLOC1S6	26258	ENSG00000104164,ENST00000220531;;;ENST00000220531		Hermansky-Pudlak syndrome 9	614171	AR	3	Bloc1s6
15q21.1	15:45631148-45691281	SQOR, SQRDL	Sulfide quinone oxidoreductase	617658	SQOR	58472	ENSG00000137767,ENST00000260324;;;ENST00000260324		Sulfide:quinone oxidoreductase deficiency	619221	AR	3	Sqor
15q21.1	15:48120990-48142672	SLC24A5, NCKX5, SHEP4, OCA6	Solute carrier family 24 (sodium/potassium/calcium exchanger), member 5	609802	SLC24A5	283652	ENSG00000188467,ENST00000341459;;;ENST00000341459		[Skin/hair/eye pigmentation 4, fair/dark skin]	113750	AR	3	Slc24a5
15q21.1	15:48120990-48142672	SLC24A5, NCKX5, SHEP4, OCA6	Solute carrier family 24 (sodium/potassium/calcium exchanger), member 5	609802	SLC24A5	283652	ENSG00000188467,ENST00000341459;;;ENST00000341459		Albinism, oculocutaneous, type VI	113750	AR	3	Slc24a5
15q21.1	15:48206302-48304078	SLC12A1, NKCC2	Solute carrier family 12 (sodium/potassium/chloride transporters), member 1	600839	SLC12A1	6557	ENSG00000074803,ENST00000380993;;;ENST00000380993		Bartter syndrome, type 1	601678	AR	3	Slc12a1
15q21.1	15:48331095-48343373	DUT, BMFDMS	dUTP pyrophosphatase	601266	DUT	1854	ENSG00000128951,ENST00000331200;;;ENST00000331200		Bone marrow failure and diabetes mellitus syndrome	620044	AR	3	Dut
15q21.1	15:48408313-48645709	FBN1, MFS1, WMS2, SSKS, GPHYSD2, ACMICD, ECTOL1, MFLS	Fibrillin-1	134797	FBN1	2200	ENSG00000166147,ENST00000316623;;;ENST00000316623		Acromicric dysplasia	102370	AD	3	Fbn1
15q21.1	15:48408313-48645709	FBN1, MFS1, WMS2, SSKS, GPHYSD2, ACMICD, ECTOL1, MFLS	Fibrillin-1	134797	FBN1	2200	ENSG00000166147,ENST00000316623;;;ENST00000316623		Ectopia lentis, familial	129600	AD	3	Fbn1
15q21.1	15:48408313-48645709	FBN1, MFS1, WMS2, SSKS, GPHYSD2, ACMICD, ECTOL1, MFLS	Fibrillin-1	134797	FBN1	2200	ENSG00000166147,ENST00000316623;;;ENST00000316623		Geleophysic dysplasia 2	614185	AD	3	Fbn1
15q21.1	15:48408313-48645709	FBN1, MFS1, WMS2, SSKS, GPHYSD2, ACMICD, ECTOL1, MFLS	Fibrillin-1	134797	FBN1	2200	ENSG00000166147,ENST00000316623;;;ENST00000316623		Marfan lipodystrophy syndrome	616914	AD	3	Fbn1
15q21.1	15:48408313-48645709	FBN1, MFS1, WMS2, SSKS, GPHYSD2, ACMICD, ECTOL1, MFLS	Fibrillin-1	134797	FBN1	2200	ENSG00000166147,ENST00000316623;;;ENST00000316623		Marfan syndrome	154700	AD	3	Fbn1
15q21.1	15:48408313-48645709	FBN1, MFS1, WMS2, SSKS, GPHYSD2, ACMICD, ECTOL1, MFLS	Fibrillin-1	134797	FBN1	2200	ENSG00000166147,ENST00000316623;;;ENST00000316623		MASS syndrome	604308	AD	3	Fbn1
15q21.1	15:48408313-48645709	FBN1, MFS1, WMS2, SSKS, GPHYSD2, ACMICD, ECTOL1, MFLS	Fibrillin-1	134797	FBN1	2200	ENSG00000166147,ENST00000316623;;;ENST00000316623		Stiff skin syndrome	184900	AD	3	Fbn1
15q21.1	15:48408313-48645709	FBN1, MFS1, WMS2, SSKS, GPHYSD2, ACMICD, ECTOL1, MFLS	Fibrillin-1	134797	FBN1	2200	ENSG00000166147,ENST00000316623;;;ENST00000316623		Weill-Marchesani syndrome 2, dominant	608328	AD	3	Fbn1
15q21.1	15:48729083-48811069	CEP152, KIAA0912, MCPH9, SCKL5	Centrosomal protein, 152kD	613529	CEP152	22995	ENSG00000103995,ENST00000380950;;;ENST00000380950		Microcephaly 9, primary, autosomal recessive	614852	AR	3	Cep152
15q21.1	15:48729083-48811069	CEP152, KIAA0912, MCPH9, SCKL5	Centrosomal protein, 152kD	613529	CEP152	22995	ENSG00000103995,ENST00000380950;;;ENST00000380950		Seckel syndrome 5	613823	AR	3	Cep152
15q21.2-q21.3	15:49200001-58800000	AEXS	Aromatase excess syndrome	139300					Aromatase excess syndrome	139300	AD	4	
15q21.2	15:50241947-50265726	HDC	Histidine decarboxylase	142704	HDC	3067	ENSG00000140287,ENST00000267845;;;ENST00000267845		{Gilles de la Tourette syndrome, susceptibility to}	137580	AD	3	Hdc
15q21.2	15:50424405-50514421	USP8, HUMORF8, PITA4	Ubiquitin-specific protease 8	603158	USP8	9101	ENSG00000138592,ENST00000307179;;;ENST00000307179		Pituitary adenoma 4, ACTH-secreting, somatic	219090		3	Usp8
15q21.2	15:50557158-50686797	TRPM7, LTRPC7, CHAK, ALSPDC	Transient receptor potential cation channel, subfamily M, member 7	605692	TRPM7	54822	ENSG00000092439,ENST00000646667;;;ENST00000646667		{Amyotrophic lateral sclerosis-parkinsonism/dementia complex, susceptibility to}	105500	AD	3	Trpm7
15q21.2	15:50702266-50765706	SPPL2A, IMP3, IMD86	Signal peptide peptidase-like 2A	608238	SPPL2A	84888	ENSG00000138600,ENST00000261854;;;ENST00000261854		Immunodeficiency 86, mycobacteriosis	619549	AR	3	Sppl2a
15q21.2	15:50907492-51005895	AP4E1, SPG51, CPSQ4, STUT1	Adaptor-related protein complex 4, epsilon-1 subunit	607244	AP4E1	23431	ENSG00000081014,ENST00000261842;;;ENST00000261842		Spastic paraplegia 51, autosomal recessive	613744	AR	3	Ap4e1
15q21.2	15:50907492-51005895	AP4E1, SPG51, CPSQ4, STUT1	Adaptor-related protein complex 4, epsilon-1 subunit	607244	AP4E1	23431	ENSG00000081014,ENST00000261842;;;ENST00000261842		Stuttering, familial persistent, 1	184450	AD	3	Ap4e1
15q21.2	15:51208057-51338596	CYP19A1, CYP19, ARO	Cytochrome P450, family 19, subfamily A, polypeptide 1 (aromatization of androgens)	107910	CYP19A1	1588	ENSG00000137869,ENST00000396402;;;ENST00000396402	close to CYP11 in mouse	Aromatase deficiency	613546		3	Cyp19a1
15q21.2	15:51341655-51413365	GLDN, CRGL2, LCCS11	Gliomedin	608603	GLDN	342035	ENSG00000186417,ENST00000335449;;;ENST00000335449		Lethal congenital contracture syndrome 11	617194	AR	3	Gldn
15q21.2	15:51447791-51622771	DMXL2, RC3, KIAA0856, PEPNS, DFNA71, DEE81	DMX-like 2	612186	DMXL2	23312	ENSG00000104093,ENST00000560891;;;ENST00000560891	mutation identified in 1 PEPNS family and 1 DFNA71 family	?Deafness, autosomal dominant 71	617605	AD	3	Dmxl2
15q21.2	15:51447791-51622771	DMXL2, RC3, KIAA0856, PEPNS, DFNA71, DEE81	DMX-like 2	612186	DMXL2	23312	ENSG00000104093,ENST00000560891;;;ENST00000560891	mutation identified in 1 PEPNS family and 1 DFNA71 family	?Polyendocrine-polyneuropathy syndrome	616113	AR	3	Dmxl2
15q21.2	15:51447791-51622771	DMXL2, RC3, KIAA0856, PEPNS, DFNA71, DEE81	DMX-like 2	612186	DMXL2	23312	ENSG00000104093,ENST00000560891;;;ENST00000560891	mutation identified in 1 PEPNS family and 1 DFNA71 family	Developmental and epileptic encephalopathy 81	618663	AR	3	Dmxl2
15q21.2	15:52115100-52191392	GNB5, GB5, LDMLS1, LDMLS2	Guanine nucleotide-binding protein, beta-5	604447	GNB5	10681	ENSG00000069966,ENST00000261837;;;ENST00000261837		Lodder-Merla syndrome, type 1, with impaired intellectual development and cardiac arrhythmia	617173	AR	3	Gnb5
15q21.2	15:52115100-52191392	GNB5, GB5, LDMLS1, LDMLS2	Guanine nucleotide-binding protein, beta-5	604447	GNB5	10681	ENSG00000069966,ENST00000261837;;;ENST00000261837		Lodder-Merla syndrome, type 2, with developmental delay and with or without cardiac arrhythmia	617182	AR	3	Gnb5
15q21.2	15:52307283-52529050	MYO5A, MYH12, GS1	Myosin Va	160777	MYO5A	4644	ENSG00000197535,ENST00000399233;;;ENST00000399233		Griscelli syndrome, type 1	214450	AR	3	Myo5a
15q21.3	15:53513741-53762878	WDR72, AI2A3	WD repeat-containing protein 72	613214	WDR72	256764	ENSG00000166415,ENST00000360509;;;ENST00000360509		Amelogenesis imperfecta, type IIA3	613211	AR	3	Wdr72
15q21.3	15:55202966-55319123	RAB27A, RAM, GS2	Ras-associated protein RAB27A	603868	RAB27A	5873	ENSG00000069974,ENST00000336787;;;ENST00000336787		Griscelli syndrome, type 2	607624	AR	3	Rab27a
15q21.3	15:55319222-55355648	PIGB, DEE80	Phosphatidylinositol glycan, class B	604122	PIGB	9488	ENSG00000069943,ENST00000164305;;;ENST00000164305		Developmental and epileptic encephalopathy 80	618580	AR	3	Pigb
15q21.3	15:55417755-55508234	DNAAF4, DYX1C1, DYXC1, DYX1, CILD25	Dynein, axonemal, assembly factor 4	608706	DNAAF4	161582	ENSG00000256061,ENST00000321149;;;ENST00000321149	not confirmed by some studies	{Dyslexia, susceptibility to, 1}	127700	AD	3	Dnaaf4
15q21.3	15:55417755-55508234	DNAAF4, DYX1C1, DYXC1, DYX1, CILD25	Dynein, axonemal, assembly factor 4	608706	DNAAF4	161582	ENSG00000256061,ENST00000321149;;;ENST00000321149	not confirmed by some studies	Ciliary dyskinesia, primary, 25	615482	AR	3	Dnaaf4
15q21.3	15:56087280-56245082	RFX7, RFXDC2, MRD71	Regulatory factor X, 7	612660	RFX7	64864	ENSG00000181827,ENST00000559447;;;ENST00000559447		Intellectual developmental disorder, autosomal dominant 71, with behavioral abnormalities	620330	AD	3	Rfx7
15q21.3	15:56428724-56465137	MNS1, FLJ11222, HTX9	Meiosis-specific nuclear structural protein 1	610766	MNS1	55329	ENSG00000138587,ENST00000260453;;;ENST00000260453		Heterotaxy, visceral, 9, autosomal, with male infertility	618948	AR	3	Mns1
15q21.3	15:56918090-57291310	TCF12, HTF4, CRS3, HH26	Transcription factor-12 (HTF4, helix-loop-helix transcription factors-4)	600480	TCF12	6938	ENSG00000140262,ENST00000333725;;;ENST00000333725		Craniosynostosis 3	615314	AD	3	Tcf12
15q21.3	15:56918090-57291310	TCF12, HTF4, CRS3, HH26	Transcription factor-12 (HTF4, helix-loop-helix transcription factors-4)	600480	TCF12	6938	ENSG00000140262,ENST00000333725;;;ENST00000333725		Hypogonadotropic hypogonadism 26 with or without anosmia	619718	AD, AR	3	Tcf12
15q21.3	15:57591904-57685364	MYZAP, GCOM1, GUP, CMD2K	Myocardial zonula adherens protein	614071	MYZAP	100820829	ENSG00000263155,ENST00000267853;;;ENST00000267853		Cardiomyopathy, dilated, 2K	620894	AR	3	Myzap
15q21.3	15:57953429-58065711	ALDH1A2, RALDH2, DIH4	Aldehyde dehydrogenase 1 family, member A2 (retinaldehyde dehydrogenase 2)	603687	ALDH1A2	8854	ENSG00000128918,ENST00000249750;;;ENST00000249750		Diaphragmatic hernia 4, with cardiovascular defects	620025	AR	3	Aldh1a2
15q21.3	15:58431991-58569844	LIPC, HL, LIPH, HDLCQ12	Lipase C, hepatic	151670	LIPC	3990	ENSG00000166035,ENST00000299022;;;ENST00000299022		[High density lipoprotein cholesterol level QTL 12]	612797		3	Lipc
15q21.3	15:58431991-58569844	LIPC, HL, LIPH, HDLCQ12	Lipase C, hepatic	151670	LIPC	3990	ENSG00000166035,ENST00000299022;;;ENST00000299022		{Diabetes mellitus, noninsulin-dependent}	125853	AD	3	Lipc
15q21.3	15:58431991-58569844	LIPC, HL, LIPH, HDLCQ12	Lipase C, hepatic	151670	LIPC	3990	ENSG00000166035,ENST00000299022;;;ENST00000299022		Hepatic lipase deficiency	614025	AR	3	Lipc
15q21.3	15:58588809-58749707	ADAM10, MADM, RAK, AD18	ADAM metallopeptidase domain 10	602192	ADAM10	102	ENSG00000137845,ENST00000260408;;;ENST00000260408		{Alzheimer disease 18, susceptibility to}	615590		3	Adam10
15q21.3	15:58588809-58749707	ADAM10, MADM, RAK, AD18	ADAM metallopeptidase domain 10	602192	ADAM10	102	ENSG00000137845,ENST00000260408;;;ENST00000260408		Reticulate acropigmentation of Kitamura	615537	AD	3	Adam10
15q22-q24	15:58800001-78000000	GLC1N	Glaucoma 1, open angle, N	611274		777645		max lod at D15S125	Glaucoma 1, open angle, N	611274		2	
15q22-q23	15:58800001-72400000	USH1H	Usher syndrome, type 1H	612632		100271837		max lod at D15S980	Usher syndrome, type 1H	612632		2	
15q22.2	15:59132434-59372871	MYO1E, MYO1C, FSGS6	Myosin IE	601479	MYO1E	4643	ENSG00000157483,ENST00000288235;;;ENST00000288235		Glomerulosclerosis, focal segmental, 6	614131	AR	3	Myo1e
15q22.2	15:60488284-61229302	RORA, IDDECA	RAR-related orphan receptor A	600825	RORA	6095	ENSG00000069667,ENST00000335670;;;ENST00000335670		Intellectual developmental disorder with or without epilepsy or cerebellar ataxia	618060	AD	3	Rora
15q22.2	15:61852389-62060447	VPS13C, KIAA1421, PARK23	Vacuolar protein sorting 13 homolog C	608879	VPS13C	54832	ENSG00000129003,ENST00000644861;;;ENST00000644861		Parkinson disease 23, autosomal recessive, early onset	616840	AR	3	Vps13c
15q22.2	15:63042747-63071915	TPM1, CMH3, CMD1Y , LVNC9	Tropomyosin 1, alpha	191010	TPM1	7168	ENSG00000140416,ENST00000403994;;;ENST00000403994		Cardiomyopathy, dilated, 1Y	611878	AD	3	Tpm1
15q22.2	15:63042747-63071915	TPM1, CMH3, CMD1Y , LVNC9	Tropomyosin 1, alpha	191010	TPM1	7168	ENSG00000140416,ENST00000403994;;;ENST00000403994		Cardiomyopathy, hypertrophic, 3	115196	AD	3	Tpm1
15q22.2	15:63042747-63071915	TPM1, CMH3, CMD1Y , LVNC9	Tropomyosin 1, alpha	191010	TPM1	7168	ENSG00000140416,ENST00000403994;;;ENST00000403994		Left ventricular noncompaction 9	611878	AD	3	Tpm1
15q22.2	15:63321378-63381846	CA12	Carbonic anhydrase XII	603263	CA12	771	ENSG00000074410,ENST00000178638;;;ENST00000178638		Hyperchlorhidrosis, isolated	143860	AR	3	Car12
15q22.31	15:63608618-63833948	HERC1, MDFPMR	HECT domain and RCC1-like domain 1	605109	HERC1	8925	ENSG00000103657,ENST00000443617;;;ENST00000443617		Macrocephaly, dysmorphic facies, and psychomotor retardation	617011	AR	3	Herc1
15q22.31	15:64155817-64163022	PPIB, CYPB, OI9	Peptidyl-prolyl isomerase B	123841	PPIB	5479	ENSG00000166794,ENST00000300026;;;ENST00000300026		Osteogenesis imperfecta, type IX	259440	AR	3	Ppib
15q22.31	15:64387836-64455303	TRIP4, ASC1, SMABF1, MDCDC	Thyroid hormone receptor interactor 4	604501	TRIP4	9325	ENSG00000103671,ENST00000261884;;;ENST00000261884	mutation identified in 1 MDCDC family	?Muscular dystrophy, congenital, Davignon-Chauveau type	617066	AR	3	Trip4
15q22.31	15:64387836-64455303	TRIP4, ASC1, SMABF1, MDCDC	Thyroid hormone receptor interactor 4	604501	TRIP4	9325	ENSG00000103671,ENST00000261884;;;ENST00000261884	mutation identified in 1 MDCDC family	Spinal muscular atrophy with congenital bone fractures 1	616866	AR	3	Trip4
15q22.31	15:64963022-64989914	ACP33, MAST, SPG21	Acidic cluster protein, 33kD, (maspardin)	608181	SPG21	51324	ENSG00000090487,ENST00000204566;;;ENST00000204566		Mast syndrome	248900	AR	3	Spg21
15q22.31	15:65001512-65029639	MTFMT, COXPD15, MC1DN27	Mitochondrial methionyl-tRNA formyltransferase	611766	MTFMT	123263	ENSG00000103707,ENST00000220058;;;ENST00000220058		Combined oxidative phosphorylation deficiency 15	614947	AR	3	Mtfmt
15q22.31	15:65001512-65029639	MTFMT, COXPD15, MC1DN27	Mitochondrial methionyl-tRNA formyltransferase	611766	MTFMT	123263	ENSG00000103707,ENST00000220058;;;ENST00000220058		Mitochondrial complex I deficiency, nuclear type 27	618248	AR	3	Mtfmt
15q22.31	15:65045387-65053397	SLC51B, OSTB, PBAM2	Solute carrier family 51, beta subunit (organic solute transporter, beta)	612085	SLC51B	123264	ENSG00000186198,ENST00000334287;;;ENST00000334287	mutation identified in 1 PBAM2 family	?Bile acid malabsorption, primary, 2	619481	AR	3	Slc51b
15q22.31	15:65076746-65079948	KBTBD13, NEM6	Kelch repeat and BTB/POZ domains-containing protein 13	613727	KBTBD13	390594	ENSG00000234438,ENST00000432196;;;ENST00000432196		Nemaline myopathy 6, autosomal dominant	609273	AD	3	Kbtbd13
15q22.31	15:65148219-65185342	CLPX, EPP2	Caseinolytic mitochondrial matrix peptidase chaperone subunit	615611	CLPX	10845	ENSG00000166855,ENST00000300107;;;ENST00000300107	mutation identified in 1 EPP2 family	?Protoporphyria, erythropoietic, 2	618015	AD	3	Clpx
15q22.31	15:65194760-65211473	CILP	Cartilage intermediate layer protein	603489	CILP	8483	ENSG00000138615,ENST00000261883;;;ENST00000261883		{Lumbar disc disease, susceptibility to}	603932		3	Cilp
15q22.31	15:65304677-65304793	RNU5B-1, U5B1, NEDSJL	RNA, U5B small nuclear 1	621090	RNU5B-1	26832	ENSG00000200156,ENST00000363286		Neurodevelopmental disorder with seizures and joint laxity	621302	AD	3	
15q22.31	15:65611350-65661002	SLC24A1, NCKX1, CSNB1D	Solute carrier family 24 (sodium/potassium/calcium exchanger), member 1	603617	SLC24A1	9187	ENSG00000074621,ENST00000261892;;;ENST00000261892		Night blindness, congenital stationary (complete), 1D, autosomal recessive	613830	AR	3	Slc24a1
15q22.31	15:66386912-66491544	MAP2K1, PRKMK1, MKK1, MEK1, CFC3, MEL	Mitogen-activated protein kinase kinase 1	176872	MAP2K1	5604	ENSG00000169032,ENST00000307102;;;ENST00000307102	pseudogene on 8p21	Cardiofaciocutaneous syndrome 3	615279	AD	3	Map2k1
15q22.31	15:66386912-66491544	MAP2K1, PRKMK1, MKK1, MEK1, CFC3, MEL	Mitogen-activated protein kinase kinase 1	176872	MAP2K1	5604	ENSG00000169032,ENST00000307102;;;ENST00000307102	pseudogene on 8p21	Melorheostosis, isolated, somatic mosaic	155950		3	Map2k1
15q22.31	15:66702236-66782849	SMAD6, MADH6, AOVD2	SMAD family member 6	602931	SMAD6	4091	ENSG00000137834,ENST00000288840;;;ENST00000288840		{Craniosynostosis 7, susceptibility to}	617439	AD	3	Smad6
15q22.31	15:66702236-66782849	SMAD6, MADH6, AOVD2	SMAD family member 6	602931	SMAD6	4091	ENSG00000137834,ENST00000288840;;;ENST00000288840		{Radioulnar synostosis, nonsyndromic}	179300	AD	3	Smad6
15q22.31	15:66702236-66782849	SMAD6, MADH6, AOVD2	SMAD family member 6	602931	SMAD6	4091	ENSG00000137834,ENST00000288840;;;ENST00000288840		Aortic valve disease 2	614823	AD	3	Smad6
15q22.32	15:66900001-67000000	STQTL16	Stature quantitative trait locus 16	612579		100270802		associated with rs8038652	{Stature QTL 16}	612579		2	
15q22.33	15:67065602-67195169	SMAD3, MADH3, LDS3	SMAD family member 3	603109	SMAD3	4088	ENSG00000166949,ENST00000327367;;;ENST00000327367		Loeys-Dietz syndrome 3	613795	AD	3	Smad3
15q23-q26.3	15:67200001-101991189	GLM4	Glioma susceptibility 4	607248		338030		max lod at D15S130	{Glioma susceptibility 4}	607248		2	
15q23	15:67200667-67255198	AAGAB, p34, PPKP1A, PPKP1, KPPP1	Alpha- and gamma-adaptin-binding protein	614888	AAGAB	79719	ENSG00000103591,ENST00000261880;;;ENST00000261880		Keratoderma, palmoplantar, punctate type IA	148600	AD	3	Aagab
15q23	15:68206992-68257211	CLN6, CLN6A	CLN6 transmembrane ER protein	606725	CLN6	54982	ENSG00000128973,ENST00000249806;;;ENST00000249806		Ceroid lipofuscinosis, neuronal, 6A	601780	AR	3	Cln6
15q23	15:68206992-68257211	CLN6, CLN6A	CLN6 transmembrane ER protein	606725	CLN6	54982	ENSG00000128973,ENST00000249806;;;ENST00000249806		Ceroid lipofuscinosis, neuronal, 6B (Kufs type)	204300	AR	3	Cln6
15q23	15:68277745-68295862	FEM1B, KIAA0396, NEDBES	Fem-1 homolog B	613539	FEM1B	10116	ENSG00000169018,ENST00000306917;;;ENST00000306917		Neurodevelopmental disorder with behavioral, ear, and skeletal abnormalities	621263	AD	3	Fem1b
15q23	15:69414349-69448427	KIF23, KNSL5, MKLP1, CDAN3A	Kinesin family member 23	605064	KIF23	9493	ENSG00000137807,ENST00000679126;;;ENST00000679126		Anemia, congenital dyserythropoietic, type IIIA	105600	AD	3	Kif23
15q23	15:71096894-71783383	THSD4, ADAMTSL6, AAT12	Thrombospondin type-1 domain-containing 4	614476	THSD4	79875	ENSG00000187720,ENST00000261862;;;ENST00000261862		Aortic aneurysm, familial thoracic 12	619825	AD	3	Thsd4
15q23	15:71810554-71818253	NR2E3, PNR, ESCS1, RP37	Nuclear receptor subfamily 2, group E, member 3	604485	NR2E3	10002	ENSG00000278570,ENST00000617575;;;ENST00000617575	near BBS4	Enhanced S-cone syndrome 1	268100	AR	3	Nr2e3
15q23	15:71810554-71818253	NR2E3, PNR, ESCS1, RP37	Nuclear receptor subfamily 2, group E, member 3	604485	NR2E3	10002	ENSG00000278570,ENST00000617575;;;ENST00000617575	near BBS4	Retinitis pigmentosa 37	611131	AD, AR	3	Nr2e3
15q23	15:71822291-72118600	MYO9A, CMS24	Myosin IXa	604875	MYO9A	4649	ENSG00000066933,ENST00000356056;;;ENST00000356056		Myasthenic syndrome, congenital, 24, presynaptic	618198	AR	3	Myo9a
15q23	15:72340924-72376014	HEXA, TSD	Hexosaminidase A, alpha polypeptide	606869	HEXA	3073	ENSG00000213614,ENST00000268097;;;ENST00000268097	on 15q+ in APL	[Hex A pseudodeficiency]	272800	AR	3	Hexa
15q23	15:72340924-72376014	HEXA, TSD	Hexosaminidase A, alpha polypeptide	606869	HEXA	3073	ENSG00000213614,ENST00000268097;;;ENST00000268097	on 15q+ in APL	GM2-gangliosidosis, several forms	272800	AR	3	Hexa
15q23	15:72340924-72376014	HEXA, TSD	Hexosaminidase A, alpha polypeptide	606869	HEXA	3073	ENSG00000213614,ENST00000268097;;;ENST00000268097	on 15q+ in APL	Tay-Sachs disease	272800	AR	3	Hexa
15q24-q25	15:72400001-88500000	CILD8	Ciliary dyskinesia, primary, 8	612274		100190786		max lod at D15S154	Ciliary dyskinesia, primary, 8	612274	AR	2	
15q24	15:72400001-78000000	ENFL2	Epilepsy, nocturnal frontal lobe, type 2	603204		50971		some ENFL not on 20q or 15q	Epilepsy, nocturnal frontal lobe, type 2	603204	AD	2	
15q24	15:72400001-78000000	MRST	Impaired intellectual development with spasticity and tapetoretinal degeneration	602685		8126			Impaired intellectual development with spasticity and tapetoretinal degeneration	602685		2	
15q24.1	15:72686207-72738473	BBS4	BBS4 gene	600374	BBS4	585	ENSG00000140463,ENST00000268057;;;ENST00000268057		Bardet-Biedl syndrome 4	615982	AR	3	Bbs4
15q24.1	15:73319859-73368958	HCN4, SSS2, BRGDA8, EIG18	Hyperpolarization-activated cyclic nucleotide-gated potassium channel 4	605206	HCN4	10021	ENSG00000138622,ENST00000261917;;;ENST00000261917	mutation identified in 1 EIG18 family	{Epilepsy, idiopathic generalized, susceptibility to, 18}	619521	AD	3	Hcn4
15q24.1	15:73319859-73368958	HCN4, SSS2, BRGDA8, EIG18	Hyperpolarization-activated cyclic nucleotide-gated potassium channel 4	605206	HCN4	10021	ENSG00000138622,ENST00000261917;;;ENST00000261917	mutation identified in 1 EIG18 family	Brugada syndrome 8	613123		3	Hcn4
15q24.1	15:73319859-73368958	HCN4, SSS2, BRGDA8, EIG18	Hyperpolarization-activated cyclic nucleotide-gated potassium channel 4	605206	HCN4	10021	ENSG00000138622,ENST00000261917;;;ENST00000261917	mutation identified in 1 EIG18 family	Sick sinus syndrome 2	163800	AD	3	Hcn4
15q24.1	15:73443164-73560013	REC114, OZEMA10	Rec114 meiotic recombination protein	618421	REC114	283677	ENSG00000183324,ENST00000331090;;;ENST00000331090		Oocyte/zygote/embryo maturation arrest 10	619176	AR	3	Rec114
15q24.1	15:73926462-73952136	LOXL1, LOXL	Lysyl oxidase-like 1	153456	LOXL1	4016	ENSG00000129038,ENST00000261921;;;ENST00000261921		{Exfoliation syndrome, susceptibility to}	177650	AD	3	Loxl1
15q24.1	15:74179466-74212259	STRA6, MCOPS9, MCOPCB8	Stimulated by retinoic acid 6, mouse, homolog of	610745	STRA6	64220	ENSG00000137868,ENST00000395105;;;ENST00000395105		Microphthalmia, isolated, with coloboma 8	601186	AR	3	Stra6
15q24.1	15:74179466-74212259	STRA6, MCOPS9, MCOPCB8	Stimulated by retinoic acid 6, mouse, homolog of	610745	STRA6	64220	ENSG00000137868,ENST00000395105;;;ENST00000395105		Microphthalmia, syndromic 9	601186	AR	3	Stra6
15q24.1	15:74337762-74367646	CYP11A1, P450SCC	Cytochrome P450, subfamily XIA, polypeptide 1 (cholesterol side chain cleavage enzyme)	118485	CYP11A1	1583	ENSG00000140459,ENST00000268053;;;ENST00000268053		Adrenal insufficiency, congenital, with 46XY sex reversal, partial or complete	613743		3	Cyp11a1
15q24.1	15:74409289-74433958	SEMA7A, SEMAL, SEMAK1, CDW108, JMH, PFIC11	Semaphorin 7A	607961	SEMA7A	8482	ENSG00000138623,ENST00000261918;;;ENST00000261918	mutation identified in 1 PFIC11 patient	?Cholestasis, progressive familial intrahepatic, 11	619874	AR	3	Sema7a
15q24.1	15:74409289-74433958	SEMA7A, SEMAL, SEMAK1, CDW108, JMH, PFIC11	Semaphorin 7A	607961	SEMA7A	8482	ENSG00000138623,ENST00000261918;;;ENST00000261918	mutation identified in 1 PFIC11 patient	[Blood group, John-Milton-Hagen system]	614745		3	Sema7a
15q24.1	15:74630558-74696024	EDC3, YJDC, MRT50	Enhancer of mRNA decapping 3	609842	EDC3	80153	ENSG00000179151,ENST00000315127;;;ENST00000315127	mutation identified in 1 MRT50 family	?Intellectual developmental disorder, autosomal recessive 50	616460	AR	3	Edc3
15q24.1-q24.2	15:74890042-74902219	MPI, PMI1, CDG1B	Mannosephosphate isomerase (phosphomannose isomerase 1)	154550	MPI	4351	ENSG00000178802,ENST00000352410;;;ENST00000352410		Congenital disorder of glycosylation, type Ib	602579	AR	3	Mpi
15q24.2	15:74919791-74938073	COX5A, MC4DN20	Cytochrome C oxidase, subunit Va	603773	COX5A	9377	ENSG00000178741,ENST00000322347;;;ENST00000322347	pseudogene on 14q22	Mitochondrial complex IV deficiency, nuclear type 20	619064	AR	3	Cox5a
15q24.2	15:75355792-75368607	MAN2C1, MANA, CDDG2	Mannosidase, alpha, class 2C, member 1	154580	MAN2C1	4123	ENSG00000140400,ENST00000267978;;;ENST00000267978		Congenital disorder of deglycosylation 2	619775	AR	3	Man2c1
15q24.2	15:75369379-75455815	SIN3A, WITKOS	Sin3, yeast, homolog of, A	607776	SIN3A	25942	ENSG00000169375,ENST00000394947;;;ENST00000394947		Witteveen-Kolk syndrome	613406	AD	3	Sin3a
15q24.2	15:75598086-75626461	SNUPN, RNUT1, LGMDR29	Snurportin 1	607902	SNUPN	10073	ENSG00000169371,ENST00000308588;;;ENST00000308588		Muscular dystrophy, limb-girdle, autosomal recessive 29	620793	AR	3	Snupn
15q24.2	15:75903878-75942511	FBXO22, FBX22, TYMAS	F-box only protein 22	609096	FBXO22	26263	ENSG00000167196,ENST00000308275;;;ENST00000308275		Tayoun-Maawali syndrome	621184	AR	3	Fbxo22
15q24.2-q24.3	15:76215353-76311469	ETFA, GA2, MADD	Electron transfer flavoprotein, alpha polypeptide	608053	ETFA	2108	ENSG00000140374,ENST00000557943;;;ENST00000557943		Glutaric acidemia IIA	231680	AR	3	Etfa
15q24.3	15:76347904-76905340	SCAPER, KIAA1454, IDDRP	S-phase cyclin A-associated protein in the endoplasmic reticulum	611611	SCAPER	49855	ENSG00000140386,ENST00000563290;;;ENST00000563290		Intellectual developmental disorder and retinitis pigmentosa	618195	AR	3	Scaper
15q24.3	15:76994680-77037475	PSTPIP1, PSTPIP, CD2BP1, AICZC, PAPA	Proline-serine-threonine phosphatase-interacting protein 1	606347	PSTPIP1	9051	ENSG00000140368,ENST00000558012;;;ENST00000558012		Autoinflammatory syndrome with cytopenia, hyperzincemia, and hypercalprotectinemia	601979	AD	3	Pstpip1
15q24.3	15:76994680-77037475	PSTPIP1, PSTPIP, CD2BP1, AICZC, PAPA	Proline-serine-threonine phosphatase-interacting protein 1	606347	PSTPIP1	9051	ENSG00000140368,ENST00000558012;;;ENST00000558012		Pyogenic sterile arthritis, pyoderma gangrenosum, and acne	604416	AD	3	Pstpip1
15q24.3	15:77613027-77820900	LINGO1, LRRN6A, LERN1, MRT64	Leucine-rich repeat- and Ig domain-containing NOGO receptor-interacting protein 1	609791	LINGO1	84894	ENSG00000169783,ENST00000355300;;;ENST00000355300		Intellectual developmental disorder, autosomal recessive 64	618103	AR	3	Lingo1
15q24.3-q25.1	15:77994985-78077711	TBC1D2B, KIAA1055, NEDSGO	TBC1 domain family, member 2B	619152	TBC1D2B	23102	ENSG00000167202,ENST00000300584;;;ENST00000300584		Neurodevelopmental disorder with seizures and gingival overgrowth	619323	AR	3	Tbc1d2b
15q25	15:78000001-88500000	DEL15q25, C15DELq25	Chromosome 15q25 deletion syndrome	614294				chr15:82,889,423-83,552,890, NCBI36	Chromosome 15q25 deletion syndrome	614294	AD	4	
15q25-q26	15:78000001-101991189	DFNA30	Deafness, autosomal dominant 30	606451		23719			Deafness, autosomal dominant 30	606451	AD	2	
15q25.1-q26.1	15:78000001-93800000	POROK4, DSAP2	Porokeratosis 4, disseminated superficial actinic	607728		353147		between D15S1023 and D15S1030	Porokeratosis 4, disseminated superficial actinic	607728		2	
15q25.1	15:78104606-78131535	CIB2, KIP2	Calcium- and integrin-binding protein 2	605564	CIB2	10518	ENSG00000136425,ENST00000258930;;;ENST00000258930		Deafness, autosomal recessive 48	609439	AR	3	Cib2
15q25.1	15:78149362-78171945	IDH3A, RP90	Isocitrate dehydrogenase (NAD+) 3, catalytic, alpha subunit	601149	IDH3A	3419	ENSG00000166411,ENST00000299518;;;ENST00000299518		Retinitis pigmentosa 90	619007	AR	3	Idh3a
15q25.1	15:78437431-78501453	IREB2, NDCAMA	Iron-responsive element-binding protein-2	147582	IREB2	3658	ENSG00000136381,ENST00000258886;;;ENST00000258886		Neurodegeneration, early-onset, with choreoathetoid movements and microcytic anemia	618451	AR	3	Ireb2
15q25.1	15:78565520-78595269	CHRNA5, LNCR2	Cholinergic receptor, neuronal nicotinic, alpha polypeptide-5	118505	CHRNA5	1138	ENSG00000169684,ENST00000299565;;;ENST00000299565		{Lung cancer susceptibility 2}	612052		3	Chrna5
15q25.1	15:78565520-78595269	CHRNA5, LNCR2	Cholinergic receptor, neuronal nicotinic, alpha polypeptide-5	118505	CHRNA5	1138	ENSG00000169684,ENST00000299565;;;ENST00000299565		{Nicotine dependence, susceptibility to}	612052		3	Chrna5
15q25.1	15:78593052-78620996	CHRNA3, LNCR2, PAOD2, BAIPRCK	Cholinergic receptor, neuronal nicotinic, alpha polypeptide-3	118503	CHRNA3	1136	ENSG00000080644,ENST00000326828;;;ENST00000326828		{Lung cancer susceptibility 2}	612052		3	Chrna3
15q25.1	15:78593052-78620996	CHRNA3, LNCR2, PAOD2, BAIPRCK	Cholinergic receptor, neuronal nicotinic, alpha polypeptide-3	118503	CHRNA3	1136	ENSG00000080644,ENST00000326828;;;ENST00000326828		Bladder dysfunction, autonomic, with impaired pupillary reflex and secondary CAKUT	191800	AR	3	Chrna3
15q25.1	15:79209788-79209871	MIR184, MIRN184, KTCNCT, EDICT	Micro RNA 184	613146	MIR184	406960	ENSG00000207695,ENST00000384962		EDICT syndrome	614303	AD	3	Mir184
15q25.1	15:79843547-79897285	MTHFS, NEDMEHM	5,10-methenyltetrahydrofolate synthetase	604197	MTHFS	10588	ENSG00000136371,ENST00000258874;;;ENST00000258874		Neurodevelopmental disorder with microcephaly, epilepsy, and hypomyelination	618367	AR	3	Mthfs,Mthfsl
15q25.1	15:80152789-80186949	FAH	Fumarylacetoacetase	613871	FAH	2184	ENSG00000103876,ENST00000561421;;;ENST00000561421		Tyrosinemia, type I	276700	AR	3	Fah
15q25.1	15:80404382-80597933	ARNT2, WEDAS	Aryl hydrocarbon receptor nuclear translocator 2	606036	ARNT2	9915	ENSG00000172379,ENST00000303329;;;ENST00000303329	mutation identified in 1 WEDAS family	?Webb-Dattani syndrome	615926	AR	3	Arnt2
15q25.1	15:80946289-80989819	MESD, MESDC2, BOCA, KIAA0081, OI20	Mesoderm development LRP chaperone	607783	MESD	23184	ENSG00000117899,ENST00000261758;;;ENST00000261758		Osteogenesis imperfecta, type XX	618644	AR	3	Mesd
15q25.2	15:82130233-82262734	EFL1, RIA1, EFTUD1, FAM42A, SDS2	Elongation factor-like GTPase 1	617538	EFL1	79631	ENSG00000140598,ENST00000268206;;;ENST00000268206		Shwachman-Diamond syndrome 2	617941	AR	3	Efl1
15q25.2	15:82536750-82540457	RPS17, RPS17L1, RPS17L2, DBA4	Ribosomal protein S17	180472	RPS17	6218	ENSG00000182774,ENST00000647841;;;ENST00000647841	previously on chr.11; pseudogenes on 5q33-qter and 17q	Diamond-Blackfan anemia 4	612527	AD	3	Rps17
15q25.2	15:82659281-82709875	AP3B2, NAPTB, DEE48	Adaptor-related protein complex 3, beta 2 subunit	602166	AP3B2	8120	ENSG00000103723,ENST00000535359;;;ENST00000535359		Developmental and epileptic encephalopathy 48	617276	AR	3	Ap3b2
15q25.2	15:82834661-82986157	HOMER2, HOMER2B, HOMER2A, DFNA68	Homer scaffold protein 2	604799	HOMER2	9455	ENSG00000103942,ENST00000450735;;;ENST00000450735	mutation identified in 1 DFNA68 family	?Deafness, autosomal dominant 68	616707	AD	3	Homer2
15q25.2	15:83255884-83284664	BNC1, POF16	Basonuclin	601930	BNC1	646	ENSG00000169594,ENST00000345382;;;ENST00000345382	mutation identified in 1 POF16 family	?Premature ovarian failure 16	618723	AD	3	Bnc1
15q25.2	15:84639285-84654283	WDR73, HSPC264, GAMOS1	WD repeat-containing protein 73	616144	WDR73	84942	ENSG00000177082,ENST00000434634;;;ENST00000434634		Galloway-Mowat syndrome 1	251300	AR	3	Wdr73
15q25.3-q26.2	15:84700001-98000000	MDD2	Major depressive disorder 2	608691		431709			Major depressive disorder 2	608516		2	
15q25.3	15:84817356-84873479	ALPK3, MIDORI, KIAA1330, CMH27	Alpha kinase 3	617608	ALPK3	57538	ENSG00000136383,ENST00000258888;;;ENST00000258888		Cardiomyopathy, familial hypertrophic 27	618052	AR	3	Alpk3
15q25.3	15:84884662-84975649	SLC28A1, CNT1, URCTU	Solute carrier family 28 (sodium-coupled nucleoside transporter), member 1	606207	SLC28A1	9154	ENSG00000156222,ENST00000394573;;;ENST00000394573		[Uridine-cytidineuria]	618477	AR	3	Slc28a1
15q25.3	15:86079620-87031476	AGBL1, CCP4, FECD8	ATP/GTP-binding protein-like 1	615496	AGBL1	123624	ENSG00000273540,ENST00000614907;;;ENST00000614907		Corneal dystrophy, Fuchs endothelial, 8	615523	AD	3	Agbl1
15q26-qter	15:88500001-101991189	DEL15q26qter, C15DELq26qter	Chromosome 15q26-qter deletion syndrome	612626				contiguous gene deletion syndrome	Chromosome 15q26-qter deletion syndrome	612626	IC	4	
15q26.1	15:88500001-93800000	DIH1, HCD	Diaphragmatic hernia 1	142340		1732			Diaphragmatic hernia 1	142340	Mu	2	
15q26	15:88500001-101991189	IDDM3	Insulin-dependent diabetes mellitus-3	600318		3402			{Diabetes mellitus, insulin-dependent, 3}	600318		2	
15q26-qter	15:88500001-101991189	LVSKS	Levy-Shanske syndrome (tetrasomy 15q26)	614846					Levy-Shanske syndrome	614846	IC	4	
15q26.1-qter	15:88500001-101991189	OTSC1, OTS	Otosclerosis 1	166800		5012			Otosclerosis 1	166800	AD	2	
15q26.1	15:88500001-93800000	STRTS	Short tandem repeat, TTTG(4), thyroid-specific	620900					Hypothyroidism, congenital, nongoitrous, 3	609893	AD	3	
15q26	15:88500001-101991189	VVS	Syncope, familial vasovagal	609289		105031671			Syncope, familial vasovagal	609289	AD	2	
15q26.1	15:88803436-88875353	ACAN, AGC1, CSPG1, MSK16, SEDK, SSOAOD	Aggrecan (chondroitin sulfate proteoglycan-1, large aggregating proteoglycan, antigen identifies by monoclonal antibody A0122)	155760	ACAN	176	ENSG00000157766,ENST00000560601;;;ENST00000560601	mutation identified in 1 SEDK family	?Spondyloepiphyseal dysplasia, Kimberley type	608361	AD	3	Acan
15q26.1	15:88803436-88875353	ACAN, AGC1, CSPG1, MSK16, SEDK, SSOAOD	Aggrecan (chondroitin sulfate proteoglycan-1, large aggregating proteoglycan, antigen identifies by monoclonal antibody A0122)	155760	ACAN	176	ENSG00000157766,ENST00000560601;;;ENST00000560601	mutation identified in 1 SEDK family	Short stature and advanced bone age, with or without early-onset osteoarthritis and/or osteochondritis dissecans	165800	AD	3	Acan
15q26.1	15:88803436-88875353	ACAN, AGC1, CSPG1, MSK16, SEDK, SSOAOD	Aggrecan (chondroitin sulfate proteoglycan-1, large aggregating proteoglycan, antigen identifies by monoclonal antibody A0122)	155760	ACAN	176	ENSG00000157766,ENST00000560601;;;ENST00000560601	mutation identified in 1 SEDK family	Spondyloepimetaphyseal dysplasia, aggrecan type	612813	AR	3	Acan
15q26.1	15:89209869-89221579	RLBP1	Retinaldehyde-binding protein-1, cellular	180090	RLBP1	6017	ENSG00000140522,ENST00000268125;;;ENST00000268125		Bothnia retinal dystrophy	607475	AR	3	Rlbp1
15q26.1	15:89209869-89221579	RLBP1	Retinaldehyde-binding protein-1, cellular	180090	RLBP1	6017	ENSG00000140522,ENST00000268125;;;ENST00000268125		Fundus albipunctatus	136880	AD, AR	3	Rlbp1
15q26.1	15:89209869-89221579	RLBP1	Retinaldehyde-binding protein-1, cellular	180090	RLBP1	6017	ENSG00000140522,ENST00000268125;;;ENST00000268125		Newfoundland rod-cone dystrophy	607476		3	Rlbp1
15q26.1	15:89209869-89221579	RLBP1	Retinaldehyde-binding protein-1, cellular	180090	RLBP1	6017	ENSG00000140522,ENST00000268125;;;ENST00000268125		Retinitis punctata albescens	136880	AD, AR	3	Rlbp1
15q26.1	15:89243979-89317259	FANCI, KIAA1794	FANCI gene	611360	FANCI	55215	ENSG00000140525,ENST00000310775;;;ENST00000310775		Fanconi anemia, complementation group I	609053	AR	3	Fanci
15q26.1	15:89316320-89334824	POLG, POLG1, POLGA, PEO, SANDO, SCAE, MTDPS4A, MTDPS4B, MIRAS	Polymerase (DNA directed), gamma	174763	POLG	5428	ENSG00000140521,ENST00000268124;;;ENST00000268124	PEO also digenic with C10orf2	Mitochondrial DNA depletion syndrome 4A (Alpers type)	203700	AR	3	Polg
15q26.1	15:89316320-89334824	POLG, POLG1, POLGA, PEO, SANDO, SCAE, MTDPS4A, MTDPS4B, MIRAS	Polymerase (DNA directed), gamma	174763	POLG	5428	ENSG00000140521,ENST00000268124;;;ENST00000268124	PEO also digenic with C10orf2	Mitochondrial DNA depletion syndrome 4B (MNGIE type)	613662	AR	3	Polg
15q26.1	15:89316320-89334824	POLG, POLG1, POLGA, PEO, SANDO, SCAE, MTDPS4A, MTDPS4B, MIRAS	Polymerase (DNA directed), gamma	174763	POLG	5428	ENSG00000140521,ENST00000268124;;;ENST00000268124	PEO also digenic with C10orf2	Mitochondrial recessive ataxia syndrome (includes SANDO and SCAE)	607459	AR	3	Polg
15q26.1	15:89316320-89334824	POLG, POLG1, POLGA, PEO, SANDO, SCAE, MTDPS4A, MTDPS4B, MIRAS	Polymerase (DNA directed), gamma	174763	POLG	5428	ENSG00000140521,ENST00000268124;;;ENST00000268124	PEO also digenic with C10orf2	Progressive external ophthalmoplegia, autosomal dominant 1	157640	AD	3	Polg
15q26.1	15:89316320-89334824	POLG, POLG1, POLGA, PEO, SANDO, SCAE, MTDPS4A, MTDPS4B, MIRAS	Polymerase (DNA directed), gamma	174763	POLG	5428	ENSG00000140521,ENST00000268124;;;ENST00000268124	PEO also digenic with C10orf2	Progressive external ophthalmoplegia, autosomal recessive 1	258450	AR	3	Polg
15q26.1	15:89617309-89663049	KIF7, HLS2, ACLS, JBTS12, AGBK	Kinesin family member 7	611254	KIF7	374654	ENSG00000166813,ENST00000394412;;;ENST00000394412	mutation identified in 1 HLS2 family and 1 AGBK family	?Al-Gazali-Bakalinova syndrome	607131	AR	3	Kif7
15q26.1	15:89617309-89663049	KIF7, HLS2, ACLS, JBTS12, AGBK	Kinesin family member 7	611254	KIF7	374654	ENSG00000166813,ENST00000394412;;;ENST00000394412	mutation identified in 1 HLS2 family and 1 AGBK family	?Hydrolethalus syndrome 2	614120	AR	3	Kif7
15q26.1	15:89617309-89663049	KIF7, HLS2, ACLS, JBTS12, AGBK	Kinesin family member 7	611254	KIF7	374654	ENSG00000166813,ENST00000394412;;;ENST00000394412	mutation identified in 1 HLS2 family and 1 AGBK family	Acrocallosal syndrome	200990	AR	3	Kif7
15q26.1	15:89617309-89663049	KIF7, HLS2, ACLS, JBTS12, AGBK	Kinesin family member 7	611254	KIF7	374654	ENSG00000166813,ENST00000394412;;;ENST00000394412	mutation identified in 1 HLS2 family and 1 AGBK family	Joubert syndrome 12	200990	AR	3	Kif7
15q26.1	15:89664367-89679367	PLIN1, PLIN, FPLD4	Perilipin 1	170290	PLIN1	5346	ENSG00000166819,ENST00000300055;;;ENST00000300055		Lipodystrophy, familial partial, type 4	613877	AD	3	Plin1
15q26.1	15:89776332-89778754	MESP2, SCDO2	Mesoderm posterior bHLH transcription factor 2	605195	MESP2	145873	ENSG00000188095,ENST00000341735;;;ENST00000341735		Spondylocostal dysostosis 2, autosomal recessive	608681	AR	3	Mesp2
15q26.1	15:90083045-90102468	IDH2, IDPM, D2HGA2	Isocitrate dehydrogenase (NADP+) 2	147650	IDH2	3418	ENSG00000182054,ENST00000330062;;;ENST00000330062		D-2-hydroxyglutaric aciduria 2	613657		3	Idh2
15q26.1	15:90229975-90265759	CIB1, KIP, EV3	Calcium- and integrin-binding protein 1	602293	CIB1	10519	ENSG00000185043,ENST00000328649;;;ENST00000328649		{Epidermodysplasia verruciformis, susceptibility to, 3}	618267	AR	3	Cib1
15q26.1	15:90717346-90816166	RECQL3, RECQ2, BLM, BS, MGRISCE1	DNA helicase, RecQ-like 3	604610	BLM	641	ENSG00000197299,ENST00000355112;;;ENST00000355112		Bloom syndrome	210900	AR	3	Blm
15q26.1	15:90930180-90954093	UNC45A, SMAP1, GCUNC45, OOHE	unc-45 myosin chaperone A	611219	UNC45A	55898	ENSG00000140553,ENST00000418476;;;ENST00000418476		Osteootohepatoenteric syndrome	619377	AR	3	Unc45a
15q26.1	15:90998416-91022621	VPS33B, KDIDAR, PFIC12	VPS33B late endosome and lysosome associated	608552	VPS33B	26276	ENSG00000184056,ENST00000333371;;;ENST00000333371		Arthrogryposis, renal dysfunction, and cholestasis 1	208085	AR	3	Vps33b
15q26.1	15:90998416-91022621	VPS33B, KDIDAR, PFIC12	VPS33B late endosome and lysosome associated	608552	VPS33B	26276	ENSG00000184056,ENST00000333371;;;ENST00000333371		Cholestasis, progressive familial intrahepatic, 12	620010	AR	3	Vps33b
15q26.1	15:90998416-91022621	VPS33B, KDIDAR, PFIC12	VPS33B late endosome and lysosome associated	608552	VPS33B	26276	ENSG00000184056,ENST00000333371;;;ENST00000333371		Keratoderma-ichthyosis-deafness syndrome, autosomal recessive	620009	AR	3	Vps33b
15q26.1	15:92882843-92898747	CHASERR, LINC01578, NEDFSAB	CHD2-adjacent suppressive regulatory RNA	620993	CHASERR	100507217			Neurodevelopmental disorder with dysmorphic facies, absent speech and ambulation, and brain abnormalities	621012	AD	3	Chaserr
15q26.1	15:92900324-93027996	CHD2, DEE94	Chromodomain helicase DNA binding protein-2	602119	CHD2	1106	ENSG00000173575,ENST00000394196;;;ENST00000394196		Developmental and epileptic encephalopathy 94	615369	AD	3	Chd2
15q26.2	15:96326046-96340263	NR2F2, TFCOUP2, ARP1, CHTD4, SRXX5	Nuclear receptor subfamily 2, group F, member 2 (transcription factor COUP 2)	107773	NR2F2	7026	ENSG00000185551,ENST00000394166;;;ENST00000394166		46XX sex reversal 5	618901	AD	3	Nr2f2
15q26.2	15:96326046-96340263	NR2F2, TFCOUP2, ARP1, CHTD4, SRXX5	Nuclear receptor subfamily 2, group F, member 2 (transcription factor COUP 2)	107773	NR2F2	7026	ENSG00000185551,ENST00000394166;;;ENST00000394166		Congenital heart defects, multiple types, 4	615779	AD	3	Nr2f2
15q26.3	15:98648539-98964530	IGF1R	Insulin-like growth factor-1 receptor	147370	IGF1R	3480	ENSG00000140443,ENST00000650285;;;ENST00000650285		Insulin-like growth factor I, resistance to	270450	AD, AR	3	Igf1r
15q26.3	15:99565417-99716488	MEF2A, ADCAD1	MADS box transcription enhancer factor 2, polypeptide A (myocyte enhancer factor 2A)	600660	MEF2A	4205	ENSG00000068305,ENST00000557942;;;ENST00000557942		{Coronary artery disease, autosomal dominant, 1}	608320	AD	3	Mef2a
15q26.3	15:99971437-100341975	ADAMTS17, WMS4	ADAM metallopeptidase domain with thrombospondin type 1 motif, 17	607511	ADAMTS17	170691	ENSG00000140470,ENST00000268070;;;ENST00000268070		Weill-Marchesani 4 syndrome, recessive	613195	AR	3	Adamts17
15q26.3	15:100400395-100544683	CERS3, LASS3, ARCI9	Ceramide synthase 3	615276	CERS3	204219	ENSG00000154227,ENST00000679737;;;ENST00000679737		Ichthyosis, congenital, autosomal recessive 9	615023	AR	3	Cers3
15q26.3	15:100566924-100602184	LINS1, WINS1, FLJ10583, MRT27	Lines homolog 1	610350	LINS1	55180	ENSG00000140471,ENST00000314742;;;ENST00000314742		Intellectual developmental disorder, autosomal recessive 27	614340	AR	3	Lins1
15q26.3	15:100879831-100916626	ALDH1A3, ALDH6, MCOP8	Aldehyde dehydrogenase 1 family, member A3	600463	ALDH1A3	220	ENSG00000184254,ENST00000329841;;;ENST00000329841		Microphthalmia, isolated 8	615113	AR	3	Aldh1a3
15q26.3	15:100919357-101078257	LRRK1, OSMD	Leucine-rich repeat kinase 1	610986	LRRK1	79705	ENSG00000154237,ENST00000388948;;;ENST00000388948		Osteosclerotic metaphyseal dysplasia	615198	AR	3	Lrrk1
15q26.3	15:101175727-101252048	CHSY1, KIAA0990, TPBS	Carbohydrate synthase 1	608183	CHSY1	22856	ENSG00000131873,ENST00000254190;;;ENST00000254190		Temtamy preaxial brachydactyly syndrome	605282	AR	3	Chsy1
15q26.3	15:101632977-101652381	TM2D3, BLP2, NCRMS	TM2 domain-containing protein 3	610014	TM2D3	80213	ENSG00000184277,ENST00000333202;;;ENST00000333202		Neurocardiorenal malformation syndrome	621379	AR	3	Tm2d3
16p13	16:1-16700000	ADHD1	Attention deficit-hyperactivity disorder, susceptibility to, 1	608903		450087		max lod at D16S3114	{Attention deficit-hyperactivity disorder, susceptibility to, 1}	608903		2	
16p13	16:1-16700000	BMIQ5	Body mass index quantitative trait locus 5	608558		449016		near D16S404 and D16S764	[Body mass index QTL5]	608558		2	
16pter-p13	16:1-16700000	CHDS1	Coronary heart disease, susceptibility to, 1	607339		338334			{Coronary heart disease, susceptibility to}	607339		2	
16p13.3	16:1-7800000	DEL16p13.3, RSTSS	Chromosome 16p13.3 deletion syndrome (Rubinstein-Taybi deletion syndrome)	610543				contiguous gene deletion syndrome	Chromosome 16p13.3 deletion syndrome	610543		4	
16p13.3	16:1-7800000	DUP16p13.3, C16DUPq13.3	Chromosome 16p13.3 duplication syndrome	613458				contiguous gene duplication syndrome	Chromosome 16p13.3 duplication syndrome	613458	AD, IC	4	
16pter-p13.3	16:1-7800000	HBHR, ATR1	Alpha-thalassemia/impaired intellectual development syndrome, deletion type	141750				contiguous gene syndrome involving deletion of HBA1 and HBA2	Alpha-thalassemia/impaired intellectual development syndrome, deletion type	141750	AD	4	
16p	16:1-36800001	IBD8	Inflammatory bowel disease 8	606668		170595			{Inflammatory bowel disease 8}	606668		2	
16p13-p12	16:1-28500000	IHPS2	Pyloric stenosis, infantile hypertrophic, 2	610260		780923			Pyloric stenosis, infantile hypertrophic, 2	610260		2	
16p13.3	16:1-7800000	MCOPCT1	Microphthalmia with cataract 1	156850		8130		proximal to HBA1	Microphthalmia with cataract 1	156850	AD	2	
16p13.3	16:1-7800000	PKDTS	Polycystic kidney disease, infantile severe, with tuberous sclerosis	600273				contiguous gene syndrome caused by deletion of TSC2 and PKD1	Polycystic kidney disease, infantile severe, with tuberous sclerosis	600273	AD	4	
16p13.3	16:46407-53608	POLR3K, RPC11, HLD21	Polymerase III, RNA, subunit K	606007	POLR3K	51728	ENSG00000161980,ENST00000293860;;;ENST00000293860		Leukodystrophy, hypomyelinating, 21	619310	AR	3	Polr3k
16p13.3	16:85386-138673	NPRL3, CGTHBA, FFEVF3	Nitrogen permease regulator-like 3	600928	NPRL3	8131	ENSG00000103148,ENST00000611875;;;ENST00000611875		Epilepsy, familial focal, with variable foci 3	617118	AD	3	Nprl3
16p13.3	16:172876-173710	HBA2, HBH, ECYT7	Hemoglobin alpha-2	141850	HBA2	3040	ENSG00000188536,ENST00000251595;;;ENST00000251595		Erythrocytosis, familial, 7	617981	AD	3	Hba-a1,Hba-a2
16p13.3	16:172876-173710	HBA2, HBH, ECYT7	Hemoglobin alpha-2	141850	HBA2	3040	ENSG00000188536,ENST00000251595;;;ENST00000251595		Heinz body anemia	140700	AD	3	Hba-a1,Hba-a2
16p13.3	16:172876-173710	HBA2, HBH, ECYT7	Hemoglobin alpha-2	141850	HBA2	3040	ENSG00000188536,ENST00000251595;;;ENST00000251595		Hemoglobin H disease, deletional and nondeletional	613978		3	Hba-a1,Hba-a2
16p13.3	16:172876-173710	HBA2, HBH, ECYT7	Hemoglobin alpha-2	141850	HBA2	3040	ENSG00000188536,ENST00000251595;;;ENST00000251595		Thalassemia, alpha-	604131		3	Hba-a1,Hba-a2
16p13.3	16:176680-177522	HBA1, HBH, METHBA, ECYT7	Hemoglobin alpha-1	141800	HBA1	3039	ENSG00000206172,ENST00000320868;;;ENST00000320868	1, 2, or 3 loci; 5'-zeta-pseudozeta-pseudoalpha-alpha-2-alpha-1-3'	Erythrocytosis, familial, 7	617981	AD	3	Hba-a1,Hba-a2
16p13.3	16:176680-177522	HBA1, HBH, METHBA, ECYT7	Hemoglobin alpha-1	141800	HBA1	3039	ENSG00000206172,ENST00000320868;;;ENST00000320868	1, 2, or 3 loci; 5'-zeta-pseudozeta-pseudoalpha-alpha-2-alpha-1-3'	Heinz body anemias, alpha-	140700	AD	3	Hba-a1,Hba-a2
16p13.3	16:176680-177522	HBA1, HBH, METHBA, ECYT7	Hemoglobin alpha-1	141800	HBA1	3039	ENSG00000206172,ENST00000320868;;;ENST00000320868	1, 2, or 3 loci; 5'-zeta-pseudozeta-pseudoalpha-alpha-2-alpha-1-3'	Hemoglobin H disease, nondeletional	613978		3	Hba-a1,Hba-a2
16p13.3	16:176680-177522	HBA1, HBH, METHBA, ECYT7	Hemoglobin alpha-1	141800	HBA1	3039	ENSG00000206172,ENST00000320868;;;ENST00000320868	1, 2, or 3 loci; 5'-zeta-pseudozeta-pseudoalpha-alpha-2-alpha-1-3'	Methemoglobinemia, alpha type	617973	AD	3	Hba-a1,Hba-a2
16p13.3	16:176680-177522	HBA1, HBH, METHBA, ECYT7	Hemoglobin alpha-1	141800	HBA1	3039	ENSG00000206172,ENST00000320868;;;ENST00000320868	1, 2, or 3 loci; 5'-zeta-pseudozeta-pseudoalpha-alpha-2-alpha-1-3'	Thalassemias, alpha-	604131		3	Hba-a1,Hba-a2
16p13.3	16:287440-352723	AXIN1, AXIN, CMDOH	Axis inhibitor 1	603816	AXIN1	8312	ENSG00000103126,ENST00000262320;;;ENST00000262320	hypermethylation of AXIN1 promoter seen in 1 CDUP patient	?Caudal duplication anomaly	607864		3	Axin1
16p13.3	16:287440-352723	AXIN1, AXIN, CMDOH	Axis inhibitor 1	603816	AXIN1	8312	ENSG00000103126,ENST00000262320;;;ENST00000262320	hypermethylation of AXIN1 promoter seen in 1 CDUP patient	Craniometadiaphyseal osteosclerosis with hip dysplasia	620558	AR	3	Axin1
16p13.3	16:287440-352723	AXIN1, AXIN, CMDOH	Axis inhibitor 1	603816	AXIN1	8312	ENSG00000103126,ENST00000262320;;;ENST00000262320	hypermethylation of AXIN1 promoter seen in 1 CDUP patient	Hepatocellular carcinoma, somatic	114550		3	Axin1
16p13.3	16:527712-554636	CAPN15, SOLH, OGIN	Calpain 15	603267	CAPN15	6650	ENSG00000103326,ENST00000219611;;;ENST00000219611		Oculogastrointestinal neurodevelopmental syndrome	619318	AR	3	Capn15
16p13.3	16:569968-584109	PIGQ, MCAHS4, DEE77, GPIBD19	Phosphatidylinositol glycan anchor biosynthesis class Q protein	605754	PIGQ	9091	ENSG00000007541,ENST00000321878;;;ENST00000321878		Multiple congenital anomalies-hypotonia-seizures syndrome 4	618548	AR	3	Pigq
16p13.3	16:680410-682801	STUB1, CHIP, SCAR16, SCA48	STIP1 homologous and U box-containing protein 1	607207	STUB1	10273	ENSG00000103266,ENST00000219548;;;ENST00000219548		Spinocerebellar ataxia 48	618093	AD	3	Stub1
16p13.3	16:680410-682801	STUB1, CHIP, SCAR16, SCA48	STIP1 homologous and U box-containing protein 1	607207	STUB1	10273	ENSG00000103266,ENST00000219548;;;ENST00000219548		Spinocerebellar ataxia, autosomal recessive 16	615768	AR	3	Stub1
16p13.3	16:722582-726880	CCDC78, C16orf25, CNM4	Coiled-coil domain-containing protein 78	614666	CCDC78	124093	ENSG00000162004,ENST00000345165;;;ENST00000345165		Centronuclear myopathy 4	614807	AD	3	Ccdc78
16p13.3	16:853634-981613	LMF1, TMEM112	Lipase maturation factor 1	611761	LMF1	64788	ENSG00000103227,ENST00000262301;;;ENST00000262301		Lipase deficiency, combined	246650	AR	3	Lmf1
16p13.3	16:1153106-1221768	CACNA1H, EIG6, ECA6, HALD4	Calcium channel, voltage-dependent, T type, alpha-1H subunit	607904	CACNA1H	8912	ENSG00000196557,ENST00000348261;;;ENST00000348261		{Epilepsy, childhood absence, susceptibility to, 6}	611942		3	Cacna1h
16p13.3	16:1153106-1221768	CACNA1H, EIG6, ECA6, HALD4	Calcium channel, voltage-dependent, T type, alpha-1H subunit	607904	CACNA1H	8912	ENSG00000196557,ENST00000348261;;;ENST00000348261		{Epilepsy, idiopathic generalized, susceptibility to, 6}	611942		3	Cacna1h
16p13.3	16:1153106-1221768	CACNA1H, EIG6, ECA6, HALD4	Calcium channel, voltage-dependent, T type, alpha-1H subunit	607904	CACNA1H	8912	ENSG00000196557,ENST00000348261;;;ENST00000348261		Hyperaldosteronism, familial, type IV	617027	AD	3	Cacna1h
16p13.3	16:1351931-1364113	GNPTG, GNPTAG	N-acetylglucosamine-1-phosphotransferase, gamma subunit	607838	GNPTG	84572	ENSG00000090581,ENST00000204679;;;ENST00000204679		Mucolipidosis III gamma	252605	AR	3	Gnptg
16p13.3	16:1431078-1434441	PERCC1, ICR, DIAR11	Proline- and glutamate-rich protein with coiled-coil domain 1	618656	PERCC1	105371045	ENSG00000284395,ENST00000640283;;;ENST00000640283	Intestine Critical Region (ICR) upstream of PERCC1 deleted in DIAR11	Diarrhea 11, malabsorptive, congenital	618662	AR	3	Percc1
16p13.3	16:1444935-1475028	CLCN7, CLC7, OPTA2, OPTB4, HOD	Chloride channel-7	602727	CLCN7	1186	ENSG00000103249,ENST00000382745;;;ENST00000382745		Hypopigmentation, organomegaly, and delayed myelination and development	618541	AD	3	Clcn7
16p13.3	16:1444935-1475028	CLCN7, CLC7, OPTA2, OPTB4, HOD	Chloride channel-7	602727	CLCN7	1186	ENSG00000103249,ENST00000382745;;;ENST00000382745		Osteopetrosis, autosomal dominant 2	166600	AD	3	Clcn7
16p13.3	16:1444935-1475028	CLCN7, CLC7, OPTA2, OPTB4, HOD	Chloride channel-7	602727	CLCN7	1186	ENSG00000103249,ENST00000382745;;;ENST00000382745		Osteopetrosis, autosomal recessive 4	611490	AR	3	Clcn7
16p13.3	16:1493360-1510454	TELO2, TEL2, CLK2, KIAA0683, HCLK2, YHFS	Telomere maintenance 2	611140	TELO2	9894	ENSG00000100726,ENST00000262319;;;ENST00000262319		You-Hoover-Fong syndrome	616954	AR	3	Telo2
16p13.3	16:1510427-1612072	IFT140, KIAA0590, SRTD9, MZSDS, RP80, PKD9, CED5	Intraflagellar transport 140	614620	IFT140	9742	ENSG00000187535,ENST00000426508;;;ENST00000426508		{Polycystic kidney disease 9, susceptibility to}	621164	AD	3	Ift140
16p13.3	16:1510427-1612072	IFT140, KIAA0590, SRTD9, MZSDS, RP80, PKD9, CED5	Intraflagellar transport 140	614620	IFT140	9742	ENSG00000187535,ENST00000426508;;;ENST00000426508		Cranioectodermal dysplasia 5	621180	AR	3	Ift140
16p13.3	16:1510427-1612072	IFT140, KIAA0590, SRTD9, MZSDS, RP80, PKD9, CED5	Intraflagellar transport 140	614620	IFT140	9742	ENSG00000187535,ENST00000426508;;;ENST00000426508		Retinitis pigmentosa 80	617781	AR	3	Ift140
16p13.3	16:1510427-1612072	IFT140, KIAA0590, SRTD9, MZSDS, RP80, PKD9, CED5	Intraflagellar transport 140	614620	IFT140	9742	ENSG00000187535,ENST00000426508;;;ENST00000426508		Short-rib thoracic dysplasia 9 with or without polydactyly	266920	AR	3	Ift140
16p13.3	16:1706195-1770351	MAPK8IP3, SYD2, JSAP1, JIP3, NEDBA	Mitogen-activated protein kinase 8-interacting protein 3	605431	MAPK8IP3	23162	ENSG00000138834,ENST00000610761;;;ENST00000610761		Neurodevelopmental disorder with or without variable brain abnormalities	618443	AD	3	Mapk8ip3
16p13.3	16:1771895-1773134	MRPS34, MRPS12, COXPD32	Mitochondrial ribosomal protein S34	611994	MRPS34	65993	ENSG00000074071,ENST00000397375;;;ENST00000397375		Combined oxidative phosphorylation deficiency 32	617664	AR	3	Mrps34
16p13.3	16:1790413-1794908	IGFALS, ALS, ACLSD	Insulin-like growth factor-binding protein, acid-labile subunit	601489	IGFALS	3483	ENSG00000099769,ENST00000215539;;;ENST00000215539		Acid-labile subunit, deficiency of	615961	AR	3	Igfals
16p13.3	16:1807629-1827194	HAGH, GLO2, GLO2D	Hydroxyacyl glutathione hydrolase; glyoxalase II	138760	HAGH	3029	ENSG00000063854,ENST00000397356;;;ENST00000397356		[Glyoxalase II deficiency]	614033	AD	1	Hagh
16p13.3	16:1833986-1872164	MEIOB, SPGF22, POF23	Meiosis-specific protein with OB domains	617670	MEIOB	254528	ENSG00000162039,ENST00000325962;;;ENST00000325962		Premature ovarian failure 23	620686	AR	3	Meiob
16p13.3	16:1833986-1872164	MEIOB, SPGF22, POF23	Meiosis-specific protein with OB domains	617670	MEIOB	254528	ENSG00000162039,ENST00000325962;;;ENST00000325962		Spermatogenic failure 22	617706	AR	3	Meiob
16p13.3	16:1911475-1920940	HS3ST6, 3OST6, HAE8	Heparan sulfate-glucosamine 3-sulfotransferase 6	619210	HS3ST6	64711	ENSG00000162040,ENST00000454677;;;ENST00000454677	mutation identified in 1 HAE8 family	?Angioedema, hereditary, 8	619367	AD	3	Hs3st6
16p13.3	16:1943974-1954689	RPL3L, CMD2D	Ribosomal protein L3-like	617416	RPL3L	6123	ENSG00000140986,ENST00000268661;;;ENST00000268661		Cardiomyopathy, dilated, 2D	619371	AR	3	Rpl3l
16p13.3	16:1959538-1961975	NDUFB10, MC1DN35	NADH-ubiquinone oxidoreductase subunit B10	603843	NDUFB10	4716	ENSG00000140990,ENST00000268668;;;ENST00000268668	mutation identified in 1 MC1DN35 patient	?Mitochondrial complex I deficiency, nuclear type 35	619003	AR	3	Ndufb10
16p13.3	16:1984193-1987749	GFER, ERV1, ALR, MPMCD	Growth factor, ERV1-like	600924	GFER	2671	ENSG00000127554,ENST00000248114;;;ENST00000248114		Myopathy, mitochondrial progressive, with congenital cataract and developmental delay	613076	AR	3	Gfer
16p13.3	16:2039820-2047834	NTHL1, OCTS3, FAP3	Endonuclease III, E. coli, homolog of	602656	NTHL1	4913	ENSG00000065057,ENST00000651570;;;ENST00000651570		Familial adenomatous polyposis 3	616415	AR	3	Nthl1
16p13.3	16:2047985-2089491	TSC2, LAM	Tuberin (tuberous sclerosis 2 gene)	191092	TSC2	7249	ENSG00000103197,ENST00000219476;;;ENST00000219476	somatic mutation identified in 1 FCORD2 patient	?Focal cortical dysplasia, type II, somatic	607341		3	Tsc2
16p13.3	16:2047985-2089491	TSC2, LAM	Tuberin (tuberous sclerosis 2 gene)	191092	TSC2	7249	ENSG00000103197,ENST00000219476;;;ENST00000219476	somatic mutation identified in 1 FCORD2 patient	Lymphangioleiomyomatosis, somatic	606690		3	Tsc2
16p13.3	16:2047985-2089491	TSC2, LAM	Tuberin (tuberous sclerosis 2 gene)	191092	TSC2	7249	ENSG00000103197,ENST00000219476;;;ENST00000219476	somatic mutation identified in 1 FCORD2 patient	Tuberous sclerosis-2	613254	AD	3	Tsc2
16p13.3	16:2088708-2135898	PKD1	Polycystin-1	601313	PKD1	5310	ENSG00000008710,ENST00000262304;;;ENST00000262304		Polycystic kidney disease 1	173900	AD	3	Pkd1
16p13.3	16:2155782-2178129	TRAF7, RFWD1, CAFDADD	TNF receptor-associated factor 7	606692	TRAF7	84231	ENSG00000131653,ENST00000326181;;;ENST00000326181		Cardiac, facial, and digital anomalies with developmental delay	618164	AD	3	Traf7
16p13.3	16:2275881-2340728	ABCA3, ABC3, SMDP3	ATP-binding cassette-3	601615	ABCA3	21	ENSG00000167972,ENST00000301732;;;ENST00000301732		Surfactant metabolism dysfunction, pulmonary, 3	610921	AR	3	Abca3
16p13.3	16:2429447-2458854	CCNF, FBX1, FTDALS5	Cyclin F	600227	CCNF	899	ENSG00000162063,ENST00000397066;;;ENST00000397066		Frontotemporal dementia and/or amyotrophic lateral sclerosis 5	619141	AD	3	Ccnf
16p13.3	16:2475127-2505730	TBC1D24, KIAA1171, FIME, DEE16, DOORS, DFNB86, DFNA65, EPRPDC	TBC1 domain family, member 24	613577	TBC1D24	57465	ENSG00000162065,ENST00000646147;;;ENST00000646147		Deafness, autosomal dominant 65	616044	AD	3	Tbc1d24
16p13.3	16:2475127-2505730	TBC1D24, KIAA1171, FIME, DEE16, DOORS, DFNB86, DFNA65, EPRPDC	TBC1 domain family, member 24	613577	TBC1D24	57465	ENSG00000162065,ENST00000646147;;;ENST00000646147		Deafness, autosomal recessive 86	614617	AR	3	Tbc1d24
16p13.3	16:2475127-2505730	TBC1D24, KIAA1171, FIME, DEE16, DOORS, DFNB86, DFNA65, EPRPDC	TBC1 domain family, member 24	613577	TBC1D24	57465	ENSG00000162065,ENST00000646147;;;ENST00000646147		Developmental and epileptic encephalopathy 16	615338	AR	3	Tbc1d24
16p13.3	16:2475127-2505730	TBC1D24, KIAA1171, FIME, DEE16, DOORS, DFNB86, DFNA65, EPRPDC	TBC1 domain family, member 24	613577	TBC1D24	57465	ENSG00000162065,ENST00000646147;;;ENST00000646147		DOORS syndrome	220500	AR	3	Tbc1d24
16p13.3	16:2475127-2505730	TBC1D24, KIAA1171, FIME, DEE16, DOORS, DFNB86, DFNA65, EPRPDC	TBC1 domain family, member 24	613577	TBC1D24	57465	ENSG00000162065,ENST00000646147;;;ENST00000646147		Epilepsy, rolandic, with paroxysmal exercise-induce dystonia and writer's cramp	608105	AR	3	Tbc1d24
16p13.3	16:2475127-2505730	TBC1D24, KIAA1171, FIME, DEE16, DOORS, DFNB86, DFNA65, EPRPDC	TBC1 domain family, member 24	613577	TBC1D24	57465	ENSG00000162065,ENST00000646147;;;ENST00000646147		Myoclonic epilepsy, infantile, familial	605021	AR	3	Tbc1d24
16p13.3	16:2513726-2520218	ATP6V0C, ATP6L, ATP6C, EPEO3	ATPase, H+ transporting, V0 subunit C	108745	ATP6V0C	527	ENSG00000185883,ENST00000330398;;;ENST00000330398		Epilepsy, early-onset, 3, with or without developmental delay	620465	AD	3	Atp6v0c
16p13.3	16:2752638-2771412	SRRM2, SRM300, KIAA0324, MRD72	Serine/arginine repetitive matrix 2 (ser/arg-rich splicing factor-related nuclear matrix protein, 300kD)	606032	SRRM2	23524	ENSG00000167978,ENST00000301740;;;ENST00000301740		Intellectual developmental disorder, autosomal dominant 72	620439	AD	3	Srrm2
16p13.3	16:3012923-3014505	CLDN9, DFNB116	Claudin 9	615799	CLDN9	9080	ENSG00000213937,ENST00000445369;;;ENST00000445369		Deafness, autosomal recessive 116	619093	AR	3	Cldn9
16p13.3	16:3024035-3027750	THOC6, FSAP35, BBIS	THO complex subunit 6	615403	THOC6	79228	ENSG00000131652,ENST00000326266;;;ENST00000326266		Beaulieu-Boycott-Innes syndrome	613680	AR	3	Thoc6
16p13.3	16:3088890-3099294	ZSCAN10, ZFP206, OFNS	Zinc finger- and SCAN domain-containing protein 10	618365	ZSCAN10	84891	ENSG00000130182,ENST00000576985;;;ENST00000576985		Otofacial neurodevelopmental syndrome	620910	AR	3	Zscan10
16p13.3	16:3242027-3256633	MEFV, MEF, FMF, PAAND	MEFV innate immunity regulator, pyrin	608107	MEFV	4210	ENSG00000103313,ENST00000219596;;;ENST00000219596	between D16S80 and D16S283	Familial Mediterranean fever, AD	134610	AD	3	Mefv
16p13.3	16:3242027-3256633	MEFV, MEF, FMF, PAAND	MEFV innate immunity regulator, pyrin	608107	MEFV	4210	ENSG00000103313,ENST00000219596;;;ENST00000219596	between D16S80 and D16S283	Familial Mediterranean fever, AR	249100	AR	3	Mefv
16p13.3	16:3242027-3256633	MEFV, MEF, FMF, PAAND	MEFV innate immunity regulator, pyrin	608107	MEFV	4210	ENSG00000103313,ENST00000219596;;;ENST00000219596	between D16S80 and D16S283	Neutrophilic dermatosis, acute febrile	608068	AD	3	Mefv
16p13.3	16:3443611-3486963	NAA60, NAT15, IBGC9	N-alpha-acetyltransferase 60, NatF catalytic subunit	614246	NAA60	79903	ENSG00000122390,ENST00000407558;;;ENST00000407558		Basal ganglia calcification, idiopathic, 9, autosomal recessive	620786	AR	3	Naa60
16p13.3	16:3581181-3611606	SLX4, BTBD12, MUS312, KIAA1784, KIAA1987, FANCP	SLX4 structure-specific endonuclease subunit	613278	SLX4	84464	ENSG00000188827,ENST00000294008;;;ENST00000294008		Fanconi anemia, complementation group P	613951	AR	3	Slx4
16p13.3	16:3611760-3665461	DNASE1, DNL1	Deoxyribonuclease I	125505	DNASE1	1773	ENSG00000213918,ENST00000246949;;;ENST00000246949		{Systemic lupus erythematosus, susceptibility to}	152700	AD	3	Dnase1
16p13.3	16:3725054-3880713	CREBBP, CBP, RSTS1, MKHK1	CREB binding protein	600140	CREBBP	1387	ENSG00000005339,ENST00000262367;;;ENST00000262367	fusion partner with MORF in AML; fusion partner with MLL in therapy-related acute leukemia; fusion partner with MOZ in AML	Menke-Hennekam syndrome 1	618332	AD	3	Crebbp
16p13.3	16:3725054-3880713	CREBBP, CBP, RSTS1, MKHK1	CREB binding protein	600140	CREBBP	1387	ENSG00000005339,ENST00000262367;;;ENST00000262367	fusion partner with MORF in AML; fusion partner with MLL in therapy-related acute leukemia; fusion partner with MOZ in AML	Rubinstein-Taybi syndrome 1	180849	AD	3	Crebbp
16p13.3	16:4314761-4339595	GLIS2, NPHP7	GLIS family zinc finger protein 2	608539	GLIS2	84662	ENSG00000126603,ENST00000433375;;;ENST00000433375		Nephronophthisis 7	611498	AR	3	Glis2
16p13.3	16:4340251-4351321	PAM16, MAGMAS, SMDMDM	Presequence translocase-associated motor 16	614336	PAM16	51025	ENSG00000217930,ENST00000318059;;;ENST00000318059		Spondylometaphyseal dysplasia, Megarbane-Dagher-Melike type	613320	AR	3	Pam16
16p13.3	16:4777606-4791828	SEPTIN12, SEPT12, SPGF10	Septin 12	611562	SEPTIN12	124404	ENSG00000140623,ENST00000268231;;;ENST00000268231		Spermatogenic failure 10	614822	AD	3	Septin12
16p13.3	16:4796968-4802633	ROGDI, KTZS	Rogdi atypical leucine zipper	614574	ROGDI	79641	ENSG00000067836,ENST00000322048;;;ENST00000322048		Kohlschutter-Tonz syndrome	226750	AR	3	Rogdi
16p13.3	16:5071843-5087379	ALG1, HMAT1, HMT1, CDG1K	ALG1 chitobiosyldiphosphodolichol beta-mannosyltransferase	605907	ALG1	56052	ENSG00000033011,ENST00000262374;;;ENST00000262374		Congenital disorder of glycosylation, type Ik	608540	AR	3	Alg1
16p13.2	16:8674617-8784570	ABAT, GABAT	4-aminobutyrate aminotransferase	137150	ABAT	18	ENSG00000183044,ENST00000268251;;;ENST00000268251		GABA-transaminase deficiency	613163	AR	3	Abat
16p13.2	16:8797839-8849325	PMM2, CDG1A	Phosphomannomutase 2	601785	PMM2	5373	ENSG00000140650,ENST00000268261;;;ENST00000268261		Congenital disorder of glycosylation, type Ia	212065	AR	3	Pmm2
16p13.2	16:8892097-8963906	USP7, HAUSP, HAFOUS	Ubiquitin-specific protease-7, herpes virus-associated	602519	USP7	7874	ENSG00000187555,ENST00000344836;;;ENST00000344836		Hao-Fountain syndrome	616863	AD	3	Usp7
16p13.2	16:9753404-10182908	GRIN2A, NMDAR2A, FESD, LKS	Glutamate receptor, ionotropic, N-methyl D-aspartate 2A	138253	GRIN2A	2903	ENSG00000183454,ENST00000330684;;;ENST00000330684		Epilepsy, focal, with speech disorder and with or without impaired intellectual development	245570	AD	3	Grin2a
16p13.13	16:10528422-10580598	EMP2, NPHS10	Epithelial membrane protein 2	602334	EMP2	2013	ENSG00000213853,ENST00000359543;;;ENST00000359543		Nephrotic syndrome, type 10	615861	AR	3	Emp2
16p13.13	16:10866206-10943021	CIITA, MHC2TA, C2TA, MHC2D1	Class II major histocompatibility complex transactivator	600005	CIITA	4261	ENSG00000179583,ENST00000324288;;;ENST00000324288		{Rheumatoid arthritis, susceptibility to}	180300		3	Ciita
16p13.13	16:10866206-10943021	CIITA, MHC2TA, C2TA, MHC2D1	Class II major histocompatibility complex transactivator	600005	CIITA	4261	ENSG00000179583,ENST00000324288;;;ENST00000324288		MHC class II deficiency 1	209920	AR	3	Ciita
16p13.13	16:11254417-11256204	SOCS1, SSI1, CIS1, CISH1, AISIMD	Suppressor of cytokine signaling 1	603597	SOCS1	8651	ENSG00000185338,ENST00000332029;;;ENST00000332029		Autoinflammatory syndrome, familial, with or without immunodeficiency	619375	AD	3	Socs1
16p13.13	16:11547722-11640317	LITAF, CMT1C	LPS-induced TNFA factor	603795	LITAF	9516	ENSG00000189067,ENST00000622633;;;ENST00000622633		Charcot-Marie-Tooth disease, type 1C	601098	AD	3	Litaf
16p13.12	16:13920154-13952348	ERCC4, XPF, FANCQ, XFEPS	ERCC excision repair 4, endonuclease catalytic subunit	133520	ERCC4	2072	ENSG00000175595,ENST00000311895;;;ENST00000311895		Fanconi anemia, complementation group Q	615272	AR	3	Ercc4
16p13.12	16:13920154-13952348	ERCC4, XPF, FANCQ, XFEPS	ERCC excision repair 4, endonuclease catalytic subunit	133520	ERCC4	2072	ENSG00000175595,ENST00000311895;;;ENST00000311895		Xeroderma pigmentosum, group F	278760	AR	3	Ercc4
16p13.12	16:13920154-13952348	ERCC4, XPF, FANCQ, XFEPS	ERCC excision repair 4, endonuclease catalytic subunit	133520	ERCC4	2072	ENSG00000175595,ENST00000311895;;;ENST00000311895		Xeroderma pigmentosum, type F/Cockayne syndrome	278760	AR	3	Ercc4
16p13.12	16:13920154-13952348	ERCC4, XPF, FANCQ, XFEPS	ERCC excision repair 4, endonuclease catalytic subunit	133520	ERCC4	2072	ENSG00000175595,ENST00000311895;;;ENST00000311895		XFE progeroid syndrome	610965	AR	3	Ercc4
16p13.12	16:14435701-14630260	PARN, DAN, DKCB6, PFBMFT4	Polyadenylate-specific ribonuclease	604212	PARN	5073	ENSG00000140694,ENST00000437198;;;ENST00000437198		Dyskeratosis congenita, autosomal recessive 6	616353	AR	3	Parn
16p13.12	16:14435701-14630260	PARN, DAN, DKCB6, PFBMFT4	Polyadenylate-specific ribonuclease	604212	PARN	5073	ENSG00000140694,ENST00000437198;;;ENST00000437198		Pulmonary fibrosis and/or bone marrow failure syndrome, telomere-related, 4	616371	AD	3	Parn
16p13.11	16:15643382-15726353	NDE1, NUDE, LIS4, MHAC	nudE neurodevelopment protein 1	609449	NDE1	54820	ENSG00000072864,ENST00000396354;;;ENST00000396354		Lissencephaly 4 (with microcephaly)	614019	AR	3	Nde1
16p13.11	16:15643382-15726353	NDE1, NUDE, LIS4, MHAC	nudE neurodevelopment protein 1	609449	NDE1	54820	ENSG00000072864,ENST00000396354;;;ENST00000396354		Microhydranencephaly	605013	AR	3	Nde1
16p13.11	16:15703135-15857028	MYH11, AAT4, FAA4, VSCM2	Myosin, heavy polypeptide-11, smooth muscle	160745	MYH11	4629	ENSG00000133392,ENST00000300036;;;ENST00000300036	fused with CBFB by inversion in acute myelomonocytic leukemia	Aortic aneurysm, familial thoracic 4	132900	AD	3	Myh11
16p13.11	16:15703135-15857028	MYH11, AAT4, FAA4, VSCM2	Myosin, heavy polypeptide-11, smooth muscle	160745	MYH11	4629	ENSG00000133392,ENST00000300036;;;ENST00000300036	fused with CBFB by inversion in acute myelomonocytic leukemia	Megacystis-microcolon-intestinal hypoperistalsis syndrome 2	619351	AR	3	Myh11
16p13.11	16:15703135-15857028	MYH11, AAT4, FAA4, VSCM2	Myosin, heavy polypeptide-11, smooth muscle	160745	MYH11	4629	ENSG00000133392,ENST00000300036;;;ENST00000300036	fused with CBFB by inversion in acute myelomonocytic leukemia	Visceral myopathy 2	619350	AD	3	Myh11
16p13.11	16:15949143-16143053	ABCC1, MRP1, MRP, DFNA77	ATP-binding cassette, subfamily C, member 1 (multidrug resistance-associated protein 1)	158343	ABCC1	4363	ENSG00000103222,ENST00000399410;;;ENST00000399410	mutation identified in 1 DFNA77 family	?Deafness, autosomal dominant 77	618915	AD	3	Abcc1
16p13.11	16:16149565-16223494	ABCC6, ARA, ABC34, MLP1, PXE, GACI2	ATP-binding cassette, subfamily C, member 6	603234	ABCC6	368	ENSG00000091262,ENST00000205557;;;ENST00000205557		Arterial calcification, generalized, of infancy, 2	614473	AR	3	Abcc6
16p13.11	16:16149565-16223494	ABCC6, ARA, ABC34, MLP1, PXE, GACI2	ATP-binding cassette, subfamily C, member 6	603234	ABCC6	368	ENSG00000091262,ENST00000205557;;;ENST00000205557		Pseudoxanthoma elasticum	264800	AR	3	Abcc6
16p13.11	16:16149565-16223494	ABCC6, ARA, ABC34, MLP1, PXE, GACI2	ATP-binding cassette, subfamily C, member 6	603234	ABCC6	368	ENSG00000091262,ENST00000205557;;;ENST00000205557		Pseudoxanthoma elasticum, forme fruste	177850	AD	3	Abcc6
16p12	16:16700001-28500000	DEL16p12.1, C16DELp12.1	Chromosome 16p12.1 deletion syndrome, 520kb	136570				between 21.85-22.37 Mb	Chromosome 16p12.1 deletion syndrome, 520kb	136570		4	
16p12	16:16700001-28500000	MAFD4, BPAD	Major affective disorder 4	611247		100126593		max lod at D16S769	Major affective disorder 4	611247		2	
16p12.3-p12.1	16:16700001-28500000	RP22	Retinitis pigmentosa-22	602594		6114			Retinitis pigmentosa 22	602594		2	
16p12.3-q12.2	16:16700001-56000000	SLEB6	Systemic lupus erythematosus, susceptibility to, 6	609939					{Systemic lupus erythematosus, susceptibility to, 6}	609939	AD	2	
16p12.3	16:17101769-17470960	XYLT1, XT1, DBQD2	Xylosyltransferase 1	608124	XYLT1	64131	ENSG00000103489,ENST00000261381;;;ENST00000261381		{Pseudoxanthoma elasticum, modifier of severity of}	264800	AR	3	Xylt1
16p12.3	16:17101769-17470960	XYLT1, XT1, DBQD2	Xylosyltransferase 1	608124	XYLT1	64131	ENSG00000103489,ENST00000261381;;;ENST00000261381		Desbuquois dysplasia 2	615777	AR	3	Xylt1
16p12.3	16:18781295-18790334	RPS15A, DBA20	Ribosomal protein S15a	603674	RPS15A	6210	ENSG00000134419,ENST00000322989;;;ENST00000322989	mutation identified in 1 DBA20 family	?Diamond-Blackfan anemia 20	618313	AD	3	Rps15a
16p12.3	16:18791667-18801549	ARL6IP1, KIAA0069, SPG61	ADP ribosylation factor-like GTPase 6 interacting protein 1	607669	ARL6IP1	23204	ENSG00000170540,ENST00000304414;;;ENST00000304414		Spastic paraplegia 61, autosomal recessive	615685	AR	3	Arl6ip1
16p12.3	16:19067614-19083097	COQ7, CLK1, COQ10D8, HMNR9	COQ7, S. cerevisiae, homolog of	601683	COQ7	10229	ENSG00000167186,ENST00000321998;;;ENST00000321998		Coenzyme Q10 deficiency, primary, 8	616733	AR	3	Coq7
16p12.3	16:19067614-19083097	COQ7, CLK1, COQ10D8, HMNR9	COQ7, S. cerevisiae, homolog of	601683	COQ7	10229	ENSG00000167186,ENST00000321998;;;ENST00000321998		Neuronopathy, distal hereditary motor, autosomal recessive 9	620402	AR	3	Coq7
16p12.3	16:19555703-19701163	VPS35L, C16orf62, EC97, RTSC3	VPS35 endosomal protein-sorting factor-like	618981	VPS35L	57020	ENSG00000103544,ENST00000417362;;;ENST00000417362		Ritscher-Schinzel syndrome 3	619135	AR	3	Vps35l
16p12.3	16:19856691-19885634	GPRC5B, RAIG2, MLC3	G protein-coupled receptor, family C, group 5, member B	605948	GPRC5B	51704	ENSG00000167191,ENST00000300571;;;ENST00000300571		Megalencephalic leukoencephalopathy with subcortical cysts 3	620447	AD	3	Gprc5b
16p12.3	16:20333051-20356301	UMOD, ADTKD1	Uromodulin (uromucoid, Tamm-Horsfall glycoprotein)	191845	UMOD	7369	ENSG00000169344,ENST00000396138;;;ENST00000396138		Tubulointerstitial kidney disease, autosomal dominant, 1	162000	AD	3	Umod
16p12.3	16:20674405-20797581	ACSM3, SAH	Acyl-CoA synthetase medium-chain family member 3	145505	ACSM3	6296	ENSG00000005187,ENST00000289416;;;ENST00000289416		{?Hypertension, essential}			1	Acsm3
16p12.3	16:20733664-20741818	THUMPD1, NEDSOA	THUMP domain-containing protein 1	616662	THUMPD1	55623	ENSG00000066654,ENST00000396083;;;ENST00000396083		Neurodevelopmental disorder with speech delay and variable ocular anomalies	619989	AR	3	Thumpd1
16p12.3-p12.2	16:21197450-21214510	ZP2, OZEMA6	Zona pellucida glycoprotein 2	182888	ZP2	7783	ENSG00000103310,ENST00000574091;;;ENST00000574091		Oocyte/zygote/embryo maturation arrest 6	618353	AR	3	Zp2
16p12.2-p11.2	16:21200001-35300000	DEL16p12.1p11.2, C16DELp12.1p11.2	Chromosome 16p12.2-p11.2 deletion syndrome	613604				17.1-8.7 Mb contiguous gene deletion syndrome	Chromosome 16p12.2-p11.2 deletion syndrome	613604	IC	4	
16p12.2-q12.1	16:21200001-52600000	MRT10	Intellectual developmental disorder, autosomal recessive 10	611096		100101425		between rs724466 and rs3901517, rs7197568 and rs71972227	Intellectual developmental disorder, autosomal recessive 10	611096	AR	2	
16p12.2	16:21258521-21303062	CRYM, DFNA40	Crystallin, mu	123740	CRYM	1428	ENSG00000103316,ENST00000572914;;;ENST00000572914		Deafness, autosomal dominant 40	616357	AD	3	Crym
16p12.2	16:21663968-21760729	OTOA, DFNB22	Otoancorin	607038	OTOA	146183	ENSG00000155719,ENST00000646100;;;ENST00000646100		Deafness, autosomal recessive 22	607039	AR	3	Otoa
16p12.2	16:21953361-21983660	UQCRC2, MC3DN5	Ubiquinol-cytochrome c reductase core protein II	191329	UQCRC2	7385	ENSG00000140740,ENST00000268379;;;ENST00000268379		Mitochondrial complex III deficiency, nuclear type 5	615160	AR	3	Uqcrc2
16p12.2	16:23182745-23216883	SCNN1G, PHA1B3, BESC3, LDLS2	Sodium channel, epithelial 1, subunit gamma	600761	SCNN1G	6340	ENSG00000166828,ENST00000300061;;;ENST00000300061	same 400kb fragment as SCNN1B	Bronchiectasis with or without elevated sweat chloride 3	613071	AD	3	Scnn1g
16p12.2	16:23182745-23216883	SCNN1G, PHA1B3, BESC3, LDLS2	Sodium channel, epithelial 1, subunit gamma	600761	SCNN1G	6340	ENSG00000166828,ENST00000300061;;;ENST00000300061	same 400kb fragment as SCNN1B	Liddle syndrome 2	618114	AD	3	Scnn1g
16p12.2	16:23182745-23216883	SCNN1G, PHA1B3, BESC3, LDLS2	Sodium channel, epithelial 1, subunit gamma	600761	SCNN1G	6340	ENSG00000166828,ENST00000300061;;;ENST00000300061	same 400kb fragment as SCNN1B	Pseudohypoaldosteronism, type IB3, autosomal recessive	620126	AR	3	Scnn1g
16p12.2	16:23278231-23381294	SCNN1B, BESC1, LIDLS1, PHA1B2	Sodium channel, epithelial 1, subunit beta	600760	SCNN1B	6338	ENSG00000168447,ENST00000343070;;;ENST00000343070		Bronchiectasis with or without elevated sweat chloride 1	211400	AD	3	Scnn1b
16p12.2	16:23278231-23381294	SCNN1B, BESC1, LIDLS1, PHA1B2	Sodium channel, epithelial 1, subunit beta	600760	SCNN1B	6338	ENSG00000168447,ENST00000343070;;;ENST00000343070		Liddle syndrome 1	177200	AD	3	Scnn1b
16p12.2	16:23278231-23381294	SCNN1B, BESC1, LIDLS1, PHA1B2	Sodium channel, epithelial 1, subunit beta	600760	SCNN1B	6338	ENSG00000168447,ENST00000343070;;;ENST00000343070		Pseudohypoaldosteronism, type IB2, autosomal recessive	620125	AR	3	Scnn1b
16p12.2	16:23388493-23453189	COG7, CDG2E	Component of oligomeric golgi complex 7	606978	COG7	91949	ENSG00000168434,ENST00000307149;;;ENST00000307149		Congenital disorder of glycosylation, type IIe	608779	AR	3	Cog7
16p12.2	16:23520754-23557375	EARS2, KIAA1970, COXPD12	Glutamyl-tRNA synthetase 2	612799	EARS2	124454	ENSG00000103356,ENST00000449606;;;ENST00000449606		Combined oxidative phosphorylation deficiency 12	614924	AR	3	Ears2
16p12.2	16:23603165-23641310	PALB2, FANCN, PNCA3, BROVCA5	Partner and localizer of BRCA2	610355	PALB2	79728	ENSG00000083093,ENST00000261584;;;ENST00000261584		{Breast-ovarian cancer, familial, susceptibility to, 5}	620442	AD	3	Palb2
16p12.2	16:23603165-23641310	PALB2, FANCN, PNCA3, BROVCA5	Partner and localizer of BRCA2	610355	PALB2	79728	ENSG00000083093,ENST00000261584;;;ENST00000261584		{Pancreatic cancer, susceptibility to, 3}	613348	AD	3	Palb2
16p12.2	16:23603165-23641310	PALB2, FANCN, PNCA3, BROVCA5	Partner and localizer of BRCA2	610355	PALB2	79728	ENSG00000083093,ENST00000261584;;;ENST00000261584		Fanconi anemia, complementation group N	610832	AR	3	Palb2
16p12.1-p11.2	16:24200001-35300000	MMVP1, MVP, PMV	Mitral valve prolapse, myxomatous 1	157700		50951			Mitral valve prolapse, myxomatous 1	157700	AD	2	
16p12.1	16:24610205-24826218	TNRC6A, GW182, KIAA1460, FAME6	Trinucleotide repeat-containing gene 6A	610739	TNRC6A	27327	ENSG00000090905,ENST00000395799;;;ENST00000395799	mutation identified in 1 FAME6 family	?Epilepsy, familial adult myoclonic, 6	618074	AD	3	Tnrc6a
16p12.1	16:27402174-27452042	IL21R, IMD56	Interleukin 21 receptor	605383	IL21R	50615	ENSG00000103522,ENST00000337929;;;ENST00000337929	fusion partner with BCL6	Immunodeficiency 56	615207	AR	3	Il21r
16p12.1	16:27550144-27780344	KATNIP, KIAA0556	Katanin-interacting protein	616650	KATNIP	23247	ENSG00000047578,ENST00000261588;;;ENST00000261588		Joubert syndrome 26	616784	AR	3	Katnip
16p12.1	16:28466653-28492082	CLN3, BTS	CLN3 lysosomal/endosomal transmembrane protein, Battenin	607042	CLN3	1201	ENSG00000188603,ENST00000636147;;;ENST00000636147		Ceroid lipofuscinosis, neuronal, 3	204200	AR	3	Cln3
16p11.2	16:28500001-35300000	BMIQ16, DEL16p.11.2, C16DELp11.2	Chromosome 16p11.2 deletion syndrome, 220kb	613444					[Body mass index QTL16]	613444	AD, IC	4	
16p11.2	16:28500001-35300000	BMIQ16, DEL16p.11.2, C16DELp11.2	Chromosome 16p11.2 deletion syndrome, 220kb	613444					Chromosome 16p11.2 deletion syndrome, 220kb	613444	AD, IC	4	
16p11.2	16:28500001-35300000	DEL16p11.2, C16DELp11.2, AUTS14A	Chromosome 16p11.2 deletion syndrome, 593kb	611913					{Autism susceptibility 14A}	611913	AD	2	
16p11.2	16:28500001-35300000	DEL16p11.2, C16DELp11.2, AUTS14A	Chromosome 16p11.2 deletion syndrome, 593kb	611913					Chromosome 16p11.2 deletion syndrome, 593kb	611913	AD	4	
16p11.2	16:28500001-35300000	DUP16p11.2, C16DUPp11.2, AUTS14B	Chromosome 16p11.2 duplication syndrome	614671					{Autism, susceptibility to, 14B}	614671	AD, IC	2	
16p11.2	16:28500001-35300000	DUP16p11.2, C16DUPp11.2, AUTS14B	Chromosome 16p11.2 duplication syndrome	614671					Chromosome 16p11.2 duplication syndrome	614671	AD, IC	4	
16p11	16:28500001-36800000	INV16p11	Chromosome 16p11 inversion (0.45Mb)	615835					Chromosome 16p11 inversion	615835		4	
16p11.2	16:28842411-28846348	TUFM, EFTU, COXPD4	Tu translation elongation factor, mitochondrial	602389	TUFM	7284	ENSG00000178952,ENST00000313511;;;ENST00000313511	pseudogene on chr.17	Combined oxidative phosphorylation deficiency 4	610678	AR	3	Tufm
16p11.2	16:28878488-28904466	ATP2A1, SERCA1	ATPase, Ca++ transporting, fast-twitch, 1	108730	ATP2A1	487	ENSG00000196296,ENST00000395503;;;ENST00000395503		Brody myopathy	601003	AR	3	Atp2a1
16p11.2	16:28931971-28939342	CD19, CVID3	CD19 antigen	107265	CD19	930	ENSG00000177455,ENST00000538922;;;ENST00000538922		Immunodeficiency, common variable, 3	613493	AR	3	Cd19
16p11.2	16:28984803-28990784	LAT, IMD52	Linker for activation of T cells	602354	LAT	27040	ENSG00000213658,ENST00000395456;;;ENST00000395456		Immunodeficiency 52	617514	AR	3	Lat
16p11.2	16:29790751-29805385	KIF22, KNSL4, KID, OBP, SEMDJL2	Kinesin family member 22	603213	KIF22	3835	ENSG00000079616,ENST00000160827;;;ENST00000160827		Spondyloepimetaphyseal dysplasia with joint laxity, type 2	603546	AD	3	Kif22
16p11.2	16:29812193-29815881	PRRT2, PKC, DYT10, EKD1, BFIS2, BFIC2, ICCA	Proline-rich transmembrane protein 2	614386	PRRT2	112476	ENSG00000167371,ENST00000358758;;;ENST00000358758		Convulsions, familial infantile, with paroxysmal choreoathetosis	602066	AD	3	Prrt2
16p11.2	16:29812193-29815881	PRRT2, PKC, DYT10, EKD1, BFIS2, BFIC2, ICCA	Proline-rich transmembrane protein 2	614386	PRRT2	112476	ENSG00000167371,ENST00000358758;;;ENST00000358758		Episodic kinesigenic dyskinesia 1	128200	AD	3	Prrt2
16p11.2	16:29812193-29815881	PRRT2, PKC, DYT10, EKD1, BFIS2, BFIC2, ICCA	Proline-rich transmembrane protein 2	614386	PRRT2	112476	ENSG00000167371,ENST00000358758;;;ENST00000358758		Seizures, benign familial infantile, 2	605751	AD	3	Prrt2
16p11.2	16:30024427-30053040	TLCD3B, FAM57B, CORD22	TLC domain-containing protein 3B	615175	TLCD3B	83723	ENSG00000149926,ENST00000380495;;;ENST00000380495		Cone-rod dystrophy 22	619531	AR	3	Tlcd3b
16p11.2	16:30064279-30070420	ALDOA, GSD12	Aldolase A, fructose-bisphosphatase	103850	ALDOA	226	ENSG00000149925,ENST00000642816;;;ENST00000642816	pseudogenes on 3 and 10	Glycogen storage disease XII	611881	AR	3	Aldoa
16p11.2	16:30085793-30091924	TBX6, SCDO5	T-box 6	602427	TBX6	6911	ENSG00000149922,ENST00000395224;;;ENST00000395224		Spondylocostal dysostosis 5	122600	AD, AR	3	Tbx6
16p11.2	16:30183602-30189076	CORO1A, TACO, CLIPINA, IMD8	Coronin 1A	605000	CORO1A	11151	ENSG00000102879,ENST00000219150;;;ENST00000219150		Immunodeficiency 8	615401	AR	3	Coro1a
16p11.2	16:30370934-30377991	MYL11, MLC2B, MRLC2, MYLPF, DA1C	Myosin light chain 11	617378	MYL11	29895	ENSG00000180209,ENST00000322861;;;ENST00000322861		Arthrogryposis, distal, type 1C	619110	AD, AR	3	Mylpf
16p11.2	16:30699171-30741409	SRCAP, SWR1, KIAA0309, FLHS, DEHMBA	SNF2-related CBP activator protein	611421	SRCAP	10847	ENSG00000080603,ENST00000262518;;;ENST00000262518		Developmental delay, hypotonia, musculoskeletal defects, and behavioral abnormalities	619595	AD	3	Srcap
16p11.2	16:30699171-30741409	SRCAP, SWR1, KIAA0309, FLHS, DEHMBA	SNF2-related CBP activator protein	611421	SRCAP	10847	ENSG00000080603,ENST00000262518;;;ENST00000262518		Floating-Harbor syndrome	136140	AD	3	Srcap
16p11.2	16:30748425-30761176	PHKG2, GSD9C	Phosphorylase kinase catalytic subunit gamma 2	172471	PHKG2	5261	ENSG00000156873,ENST00000563588;;;ENST00000563588		Glycogen storage disease IXc	613027	AR	3	Phkg2
16p11.2	16:30957754-30984664	SETD1A, SET1A, SET1, KIAA0339, EPEO2, NEDSID	SET domain-containing protein 1A	611052	SETD1A	9739	ENSG00000099381,ENST00000262519;;;ENST00000262519		Epilepsy, early-onset, 2, with or without developmental delay	618832	AD	3	Setd1a
16p11.2	16:30957754-30984664	SETD1A, SET1A, SET1, KIAA0339, EPEO2, NEDSID	SET domain-containing protein 1A	611052	SETD1A	9739	ENSG00000099381,ENST00000262519;;;ENST00000262519		Neurodevelopmental disorder with speech impairment and dysmorphic facies	619056	AD	3	Setd1a
16p11.2	16:30985207-30989147	HSD3B7, CBAS1	3-beta-hydroxy-delta-5-C27-steroid oxidoreductase	607764	HSD3B7	80270	ENSG00000099377,ENST00000297679;;;ENST00000297679		Bile acid synthesis defect, congenital, 1	607765	AR	3	Hsd3b7
16p11.2	16:30989256-31010638	STX1B, GEFSP9	Syntaxin 1B	601485	STX1B	112755	ENSG00000099365,ENST00000215095;;;ENST00000215095		Generalized epilepsy with febrile seizures plus, type 9	616172	AD	3	Stx1b
16p11.2	16:31033095-31040168	STX4, STX4A, DFNB123	Syntaxin 4	186591	STX4	6810	ENSG00000103496,ENST00000313843;;;ENST00000313843	mutation identified in 1 DFNB123 family	?Deafness, autosomal recessive 123	620745	AR	3	Stx4a
16p11.2	16:31060847-31074240	ZNF668, NEDGEF	Zinc finger protein 668	617103	ZNF668	79759	ENSG00000167394,ENST00000300849;;;ENST00000300849		Neurodevelopmental disorder with poor growth, large ears, and dysmorphic facies	620194	AR	3	Zfp668
16p11.2	16:31090854-31094797	VKORC1, VKOR, VKCFD2, FLJ00289	Vitamin K epoxide reductase complex, subunit 1	608547	VKORC1	79001	ENSG00000167397,ENST00000394975;;;ENST00000394975		Vitamin K-dependent clotting factors, combined deficiency of, 2	607473	AR	3	Vkorc1
16p11.2	16:31090854-31094797	VKORC1, VKOR, VKCFD2, FLJ00289	Vitamin K epoxide reductase complex, subunit 1	608547	VKORC1	79001	ENSG00000167397,ENST00000394975;;;ENST00000394975		Warfarin resistance	122700	AD	3	Vkorc1
16p11.2	16:31108386-31117640	BCKDK, BDK, BCKDKD	Branched-chain alpha-keto acid dehydrogenase kinase	614901	BCKDK	10295	ENSG00000103507,ENST00000219794;;;ENST00000219794		Branched-chain keto acid dehydrogenase kinase deficiency	614923	AR	3	Bckdk
16p11.2	16:31117664-31131393	KAT8, MYST1, MOF, LIGOWS	K(lysine) acetyltransferase 8	609912	KAT8	84148	ENSG00000103510,ENST00000219797;;;ENST00000219797		Li-Ghorgani-Weisz-Hubshman syndrome	618974	AD	3	Kat8
16p11.2	16:31180110-31194871	FUS, TLS, ALS6, ETM4	FUS RNA-binding protein	137070	FUS	2521	ENSG00000089280,ENST00000254108;;;ENST00000254108	fused with DDIT3 in myxoid liposarcoma, with ERG in leukemia, and ATF1 in angiomatoid fibrous histiocytoma	Amyotrophic lateral sclerosis 6, with or without frontotemporal dementia	608030		3	Fus
16p11.2	16:31180110-31194871	FUS, TLS, ALS6, ETM4	FUS RNA-binding protein	137070	FUS	2521	ENSG00000089280,ENST00000254108;;;ENST00000254108	fused with DDIT3 in myxoid liposarcoma, with ERG in leukemia, and ATF1 in angiomatoid fibrous histiocytoma	Essential tremor, hereditary, 4	614782	AD	3	Fus
16p11.2	16:31427731-31428360	COX6A2, MC4DN18	Cytochrome c oxidase, subunit 6A2	602009	COX6A2	1339	ENSG00000156885,ENST00000287490;;;ENST00000287490		Mitochondrial complex IV deficiency, nuclear type 18	619062	AR	3	Cox6a2
16p11.2	16:31458304-31467167	ARMC5, AIMAH2	Armadillo repeat-containing protein 5	615549	ARMC5	79798	ENSG00000140691,ENST00000268314;;;ENST00000268314		{ACTH-independent macronodular adrenal hyperplasia 2}	615954	AD	3	Armc5
16p11.2	16:31483123-31490769	SLC5A2, SGLT2	Solute carrier family 5 (sodium/glucose cotransporter), member 2	182381	SLC5A2	6524	ENSG00000140675,ENST00000330498;;;ENST00000330498		Renal glucosuria	233100	AD, AR	3	Slc5a2
16q11-q22	16:36800001-74100000	AA2	Alopecia areata 2	610753		100034703		max lod at D16S415	Alopecia areata 2	610753	AD, AR	2	
16q11.1-q22	16:36800001-74100000	DUPC1	Dupuytren contracture 1	126900		780895		max lod at D16S415	Dupuytren contracture 1	126900	AD	2	
16q	16:36800001-90338345	PSORS8	Psoriasis susceptibility 8	610707		140454		proximal to D16S3034	{Psoriasis susceptibility 8}	610707		2	
16q	16:36800001-90338345	SLI1	Specific language impairment QTL, 1	606711		171013			Specific language impairment QTL, 1	606711	Mu	2	
16q	16:36800001-90338345	WT3	Wilms tumor-3	194090		8136		loss of heterozygosity	Wilms tumor, type 3	194090	AD	2	
16q11.2	16:46656132-46689178	VPS35, MEM3, PARK17	VPS35 retromer complex component	601501	VPS35	55737	ENSG00000069329,ENST00000299138;;;ENST00000299138		{Parkinson disease 17}	614203	AD	3	Vps35
16q11.2	16:46689659-46698394	ORC6, ORC6L	Origin recognition complex, subunit 6	607213	ORC6	23594	ENSG00000091651,ENST00000219097;;;ENST00000219097		Meier-Gorlin syndrome 3	613803	AR	3	Orc6
16q11.2	16:46884362-46931289	GPT2, ALT2, NEDSPM	Glutamate pyruvate transaminase 2	138210	GPT2	84706	ENSG00000166123,ENST00000340124;;;ENST00000340124		Neurodevelopmental disorder with microcephaly and spastic paraplegia	616281	AR	3	Gpt2
16q12	16:47000001-56000000	C16DUPq12, DUP16q12	Chromosome 16q12 duplication syndrome	619649					Chromosome 16q12 duplication syndrome	619649	AD	4	
16q12.1	16:47000001-52600000	STHAG2, HYD2	Tooth agenesis, selective, 2	602639		8137			Tooth agenesis, selective, 2	602639		2	
16q12.1-q23.1	16:47000001-79200000	STUT4	Stuttering, familial persistent, 4	614668		100909385		max lod at D16S3043	Stuttering, familial persistent, 4	614668		2	
16q12.1	16:47461299-47701523	PHKB	Phosphorylase kinase, beta polypeptide	172490	PHKB	5257	ENSG00000102893,ENST00000323584;;;ENST00000323584		Phosphorylase kinase deficiency of liver and muscle, autosomal recessive	261750	AR	3	Phkb
16q12.1	16:48164819-48247539	ABCC11, MRP8, EWWD, WW	ATP-binding cassette, subfamily C, member 11	607040	ABCC11	85320	ENSG00000121270,ENST00000356608;;;ENST00000356608		[Axillary odor, variation in]	117800	AD	3	
16q12.1	16:48164819-48247539	ABCC11, MRP8, EWWD, WW	ATP-binding cassette, subfamily C, member 11	607040	ABCC11	85320	ENSG00000121270,ENST00000356608;;;ENST00000356608		[Colostrum secretion, variation in]	117800	AD	3	
16q12.1	16:48164819-48247539	ABCC11, MRP8, EWWD, WW	ATP-binding cassette, subfamily C, member 11	607040	ABCC11	85320	ENSG00000121270,ENST00000356608;;;ENST00000356608		[Earwax, wet/dry]	117800	AD	3	
16q12.1	16:48360531-48387246	SIAH1, BURHAS	Seven in absentia, Drosophila, homolog of, 1	602212	SIAH1	6477	ENSG00000196470,ENST00000394725;;;ENST00000394725		Buratti-Harel syndrome	619314	AD	3	Siah1a,Siah1b
16q12.1	16:49487524-49859279	ZNF423, ZFP423, OAZ, KIAA0760, NPHP14, JBTS19	Zinc finger protein 423	604557	ZNF423	23090	ENSG00000102935,ENST00000563137;;;ENST00000563137		Joubert syndrome 19	614844	AD, AR	3	Zfp423
16q12.1	16:49487524-49859279	ZNF423, ZFP423, OAZ, KIAA0760, NPHP14, JBTS19	Zinc finger protein 423	604557	ZNF423	23090	ENSG00000102935,ENST00000563137;;;ENST00000563137		Nephronophthisis 14	614844	AD, AR	3	Zfp423
16q12.1	16:50065970-50107272	HEATR3, SYO1, DBA21	HEAT repeat-containing protein 3	614951	HEATR3	55027	ENSG00000155393,ENST00000299192;;;ENST00000299192		Diamond-Blackfan anemia 21	620072	AR	3	Heatr3
16q12.1	16:50693606-50733075	NOD2, CARD15, IBD1, CD, YAOS, BLAUS	Nucleotide-binding oligomerization domain protein 2	605956	NOD2	64127	ENSG00000167207,ENST00000647318;;;ENST00000647318		{Inflammatory bowel disease 1, Crohn disease}	266600	Mu	3	Nod2
16q12.1	16:50693606-50733075	NOD2, CARD15, IBD1, CD, YAOS, BLAUS	Nucleotide-binding oligomerization domain protein 2	605956	NOD2	64127	ENSG00000167207,ENST00000647318;;;ENST00000647318		{Yao syndrome}	617321	Mu	3	Nod2
16q12.1	16:50693606-50733075	NOD2, CARD15, IBD1, CD, YAOS, BLAUS	Nucleotide-binding oligomerization domain protein 2	605956	NOD2	64127	ENSG00000167207,ENST00000647318;;;ENST00000647318		Blau syndrome	186580	AD	3	Nod2
16q12.1	16:50742086-50801935	CYLD, CDMT, EAC, MFT1, KIAA0849, BRSS, FTDALS8	CYLD lysine-63 deubiquitinase	605018	CYLD	1540	ENSG00000083799,ENST00000427738;;;ENST00000427738	mutation identified in 1 FTDALS8 family	?Frontotemporal dementia and/or amyotrophic lateral sclerosis 8	619132	AD	3	Cyld
16q12.1	16:50742086-50801935	CYLD, CDMT, EAC, MFT1, KIAA0849, BRSS, FTDALS8	CYLD lysine-63 deubiquitinase	605018	CYLD	1540	ENSG00000083799,ENST00000427738;;;ENST00000427738	mutation identified in 1 FTDALS8 family	Brooke-Spiegler syndrome	605041	AD	3	Cyld
16q12.1	16:50742086-50801935	CYLD, CDMT, EAC, MFT1, KIAA0849, BRSS, FTDALS8	CYLD lysine-63 deubiquitinase	605018	CYLD	1540	ENSG00000083799,ENST00000427738;;;ENST00000427738	mutation identified in 1 FTDALS8 family	Cylindromatosis, familial	132700	AD	3	Cyld
16q12.1	16:50742086-50801935	CYLD, CDMT, EAC, MFT1, KIAA0849, BRSS, FTDALS8	CYLD lysine-63 deubiquitinase	605018	CYLD	1540	ENSG00000083799,ENST00000427738;;;ENST00000427738	mutation identified in 1 FTDALS8 family	Trichoepithelioma, multiple familial, 1	601606	AD	3	Cyld
16q12.1	16:51135982-51152334	SALL1, HSAL1, TBS	Sal-like 1	602218	SALL1	6299	ENSG00000103449,ENST00000251020;;;ENST00000251020		Townes-Brocks branchiootorenal-like syndrome	107480	AD	3	Sall1
16q12.1	16:51135982-51152334	SALL1, HSAL1, TBS	Sal-like 1	602218	SALL1	6299	ENSG00000103449,ENST00000251020;;;ENST00000251020		Townes-Brocks syndrome 1	107480	AD	3	Sall1
16q12.2	16:53434471-53491648	RBL2, BRUWAG	RB transcriptional corepressor-like 2	180203	RBL2	5934	ENSG00000103479,ENST00000262133;;;ENST00000262133		Brunet-Wagner neurodevelopmental syndrome	619690	AR	3	Rbl2
16q12.2	16:53598153-53703859	RPGRIP1L, KIAA1005, JBTS7, MKS5, COACH3	RPGRIP1-like	610937	RPGRIP1L	23322	ENSG00000103494,ENST00000647211;;;ENST00000647211	mutation identified in 1 COACH patient	?COACH syndrome 3	619113	AR	3	Rpgrip1l
16q12.2	16:53598153-53703859	RPGRIP1L, KIAA1005, JBTS7, MKS5, COACH3	RPGRIP1-like	610937	RPGRIP1L	23322	ENSG00000103494,ENST00000647211;;;ENST00000647211	mutation identified in 1 COACH patient	Joubert syndrome 7	611560	AR	3	Rpgrip1l
16q12.2	16:53598153-53703859	RPGRIP1L, KIAA1005, JBTS7, MKS5, COACH3	RPGRIP1-like	610937	RPGRIP1L	23322	ENSG00000103494,ENST00000647211;;;ENST00000647211	mutation identified in 1 COACH patient	Meckel syndrome 5	611561	AR	3	Rpgrip1l
16q12.2	16:53703963-54121941	FTO, GDFD, BMIQ14	FTO alpha-ketoglutarate dependent dioxygenase	610966	FTO	79068	ENSG00000140718,ENST00000471389;;;ENST00000471389		{Obesity, susceptibility to, BMIQ14}	612460	AR	3	Fto
16q12.2	16:53703963-54121941	FTO, GDFD, BMIQ14	FTO alpha-ketoglutarate dependent dioxygenase	610966	FTO	79068	ENSG00000140718,ENST00000471389;;;ENST00000471389		Growth retardation, developmental delay, facial dysmorphism	612938	AR	3	Fto
16q12.2	16:54930865-54934485	IRX5, HMMS	Iroquois homeobox protein 5	606195	IRX5	10265	ENSG00000176842,ENST00000394636;;;ENST00000394636		Hamamy syndrome	611174	AR	3	Irx5
16q12.2	16:55478830-55506691	MMP2, CLG4A, MONA	Matrix metalloproteinase 2 (gelatinase A, 72kD type IV collagenase)	120360	MMP2	4313	ENSG00000087245,ENST00000219070;;;ENST00000219070	near MT1,2	Multicentric osteolysis, nodulosis, and arthropathy	259600	AR	3	Mmp2
16q12.2	16:55655988-55706192	SLC6A2, NAT1, NET1	Solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2, cocaine- and antidepressant-sensitive	163970	SLC6A2	6530	ENSG00000103546,ENST00000568943;;;ENST00000568943	mutation identified in 1 ORSTI family	?Orthostatic intolerance	604715	AD	3	Slc6a2
16q12.2	16:55802851-55833096	CES1, SES1	Carboxylesterase 1 (monocyte/macrophage serine esterase 1)	114835	CES1	1066	ENSG00000198848,ENST00000360526;;;ENST00000360526		Drug metabolism, altered, CES1-related	618057	AD	3	Ces1a,Ces1b,Ces1c,Ces1d,Ces1e,Ces1f,Ces1g,Ces1h
16q13-q21	16:56000001-66600000	ANMA	Anisomastia	605746		80871			Anisomastia	605746		2	
16q13-q22.1	16:56000001-70800000	EKD2	Episodic kinesigenic dyskinesia 2	611031		100124415		max lod at D16S503	Episodic kinesigenic dyskinesia 2	611031	AD	2	
16q13	16:56191489-56357444	GNAO1, DEE17, NEDIM	Guanine nucleotide-binding protein (G protein), alpha-activating activity	139311	GNAO1	2775	ENSG00000087258,ENST00000262493;;;ENST00000262493	close to MT1 in mouse	Developmental and epileptic encephalopathy 17	615473	AD	3	Gnao1
16q13	16:56191489-56357444	GNAO1, DEE17, NEDIM	Guanine nucleotide-binding protein (G protein), alpha-activating activity	139311	GNAO1	2775	ENSG00000087258,ENST00000262493;;;ENST00000262493	close to MT1 in mouse	Neurodevelopmental disorder with involuntary movements	617493	AD	3	Gnao1
16q13	16:56361452-56425545	AMFR, GP78, SPG89	Autocrine motility factor receptor	603243	AMFR	267	ENSG00000159461,ENST00000290649;;;ENST00000290649		Spastic paraplegia 89, autosomal recessive	620379	AR	3	Amfr
16q13	16:56470403-56520024	BBS2, RP74	Bardet-Biedl syndrome 2	606151	BBS2	583	ENSG00000125124,ENST00000245157;;;ENST00000245157		Bardet-Biedl syndrome 2	615981	AR	3	Bbs2
16q13	16:56470403-56520024	BBS2, RP74	Bardet-Biedl syndrome 2	606151	BBS2	583	ENSG00000125124,ENST00000245157;;;ENST00000245157		Retinitis pigmentosa 74	616562	AR	3	Bbs2
16q13	16:56730129-56850286	NUP93, NIC96, KIAA0095, NPHS12	Nucleoporin, 93kD	614351	NUP93	9688	ENSG00000102900,ENST00000308159;;;ENST00000308159		Nephrotic syndrome, type 12	616892	AR	3	Nup93
16q13	16:56865207-56915850	SLC12A3, NCCT, TSC	Solute carrier family 12 (sodium/potassium/chloride transporters), member 3	600968	SLC12A3	6559	ENSG00000070915,ENST00000563236;;;ENST00000563236		Gitelman syndrome	263800	AR	3	Slc12a3
16q13	16:56961950-56983845	CETP, HDLCQ10	Cholesteryl ester transfer protein, plasma	118470	CETP	1071	ENSG00000087237,ENST00000200676;;;ENST00000200676		[High density lipoprotein cholesterol level QTL 10]	143470	AD	3	
16q13	16:56961950-56983845	CETP, HDLCQ10	Cholesteryl ester transfer protein, plasma	118470	CETP	1071	ENSG00000087237,ENST00000200676;;;ENST00000200676		Hyperalphalipoproteinemia	143470	AD	3	
16q13	16:57186152-57240469	RSPRY1, KIAA1972, SEMDFA	RING finger- and SPRY domain-containing protein 11	616585	RSPRY1	89970	ENSG00000159579,ENST00000394420;;;ENST00000394420		Spondyloepimetaphyseal dysplasia, Faden-Alkuraya type	616723	AR	3	Rspry1
16q13	16:57245259-57253635	ARL2BP, BART, RP82	ADP ribosylation factor-like GTPase 2 binding protein	615407	ARL2BP	23568	ENSG00000102931,ENST00000219204;;;ENST00000219204		Retinitis pigmentosa 82 with or without situs inversus	615434	AR	3	Arl2bp
16q21-q22	16:57300001-74100000	OPA8	Optic atrophy 8	616648		106783499		max lod at D16S752	Optic atrophy 8	616648	AD	2	
16q21	16:57447479-57461270	COQ9, C16orf49, COQ10D5	Coq9, S. cerevisiae, homolog of	612837	COQ9	57017	ENSG00000088682,ENST00000262507;;;ENST00000262507		Coenzyme Q10 deficiency, primary, 5	614654	AR	3	Coq9
16q21	16:57619738-57665567	ADGRG1, GPR56, TM7XN1, CDCBM15A, CDCBM14B	Adhesion G protein-coupled receptor G1	604110	ADGRG1	9289	ENSG00000205336,ENST00000562631;;;ENST00000562631		Cortical dysplasia, complex, with other brain malformations 14A, (bilateral frontoparietal)	606854	AR	3	Adgrg1
16q21	16:57619738-57665567	ADGRG1, GPR56, TM7XN1, CDCBM15A, CDCBM14B	Adhesion G protein-coupled receptor G1	604110	ADGRG1	9289	ENSG00000205336,ENST00000562631;;;ENST00000562631		Cortical dysplasia, complex, with other brain malformations 14B, (bilateral perisylvian)	615752		3	Adgrg1
16q21	16:57735770-57757244	KATNB1, LIS6	Katanin, p80 subunit, B1	602703	KATNB1	10300	ENSG00000140854,ENST00000379661;;;ENST00000379661		Lissencephaly 6, with microcephaly	616212	AR	3	Katnb1
16q21	16:57882340-57971128	CNGB1, CNCG3L, CNCG2, RP45	Cyclic nucleotide gated channel, beta 1	600724	CNGB1	1258	ENSG00000070729,ENST00000251102;;;ENST00000251102		Retinitis pigmentosa 45	613767	AR	3	Cngb1
16q21	16:57999603-58021618	USB1, C16orf57, PN	U6 small nuclear RNA biogenesis phosphodiesterase 1	613276	USB1	79650	ENSG00000103005,ENST00000219281;;;ENST00000219281		Poikiloderma with neutropenia	604173	AR	3	Usb1
16q21	16:58519951-58629826	CNOT1, NOT1, HPE12, VIBOS	CCR4-NOT transcription complex, subunit 1	604917	CNOT1	23019	ENSG00000125107,ENST00000317147;;;ENST00000317147		Holoprosencephaly 12, with or without pancreatic agenesis	618500	AD	3	Cnot1
16q21	16:58519951-58629826	CNOT1, NOT1, HPE12, VIBOS	CCR4-NOT transcription complex, subunit 1	604917	CNOT1	23019	ENSG00000125107,ENST00000317147;;;ENST00000317147		Vissers-Bodmer syndrome	619033	AD	3	Cnot1
16q21	16:58707131-58734316	GOT2, DEE82	Glutamic-oxaloacetic transaminase 2, mitochondrial	138150	GOT2	2806	ENSG00000125166,ENST00000245206;;;ENST00000245206	?pseudogenes on 12 and 1	Developmental and epileptic encephalopathy 82	618721	AR	3	Got2
16q21	16:64943753-65123744	CDH11, CAD11, ESWS, TBHS2	Cadherin-11 (OB-cadherin, osteoblast)	600023	CDH11	1009	ENSG00000140937,ENST00000268603;;;ENST00000268603		Elsahy-Waters syndrome	211380	AR	3	Cdh11
16q21	16:64943753-65123744	CDH11, CAD11, ESWS, TBHS2	Cadherin-11 (OB-cadherin, osteoblast)	600023	CDH11	1009	ENSG00000140937,ENST00000268603;;;ENST00000268603		Teebi hypertelorism syndrome 2	619736	AD	3	Cdh11
16q21	16:66427295-66495288	BEAN1, BEAN, SCA31	Brain-expressed, associated with NEDD4	612051	BEAN1	146227	ENSG00000166546,ENST00000536005;;;ENST00000536005		Spinocerebellar ataxia 31	117210	AD	3	Bean1
16q21	16:66508003-66550291	TK2, MTDPS2, PEOB3	Thymidine kinase, mitochondrial	188250	TK2	7084	ENSG00000166548,ENST00000544898;;;ENST00000544898	mutation identified in 1 PEOB3 family	?Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 3	617069	AR	3	Tk2
16q21	16:66508003-66550291	TK2, MTDPS2, PEOB3	Thymidine kinase, mitochondrial	188250	TK2	7084	ENSG00000166548,ENST00000544898;;;ENST00000544898	mutation identified in 1 PEOB3 family	Mitochondrial DNA depletion syndrome 2 (myopathic type)	609560	AR	3	Tk2
16q22	16:66600001-74100000	ANBC	Aneurysmal bone cysts	606179		114293		t(16:17); ?defect at 17p13	Aneurysmal bone cysts	606179		2	
16q22	16:66600001-74100000	C16DELq22, DEL16q22	Chromosome 16q22 deletion syndrome	614541					Chromosome 16q22 deletion syndrome	614541	IC	4	
16q22.1	16:66600001-70800000	CRCS9	Colorectal cancer, susceptibility to, 9	612590		100329169		associated with rs9929218	{Colorectal cancer, susceptibility to, 9}	612590		2	
16q22	16:66600001-74100000	NAIC	North American Indian childhood cirrhosis	604901					North American Indian childhood cirrhosis	604901		2	
16q22.1-q23.1	16:66600001-79200000	OTSC4	Otosclerosis 4	611571		286751		between D16S3107 and D16S3097	{Otosclerosis 4}	611571	AD	2	
16q22.1	16:66754640-66802025	TERB1, CCDC79, SPGF60	Telomere repeat-binding bouquet formation protein 1	617332	TERB1	283847	ENSG00000249961,ENST00000433154;;;ENST00000433154		Spermatogenic failure 60	619646	AR	3	Terb1
16q22.1	16:66802878-66830976	NAE1, APPBP1, NEDFIH	NEDD8 activating enzyme E1 subunit 1	603385	NAE1	8883	ENSG00000159593,ENST00000290810;;;ENST00000290810		Neurodevelopmental disorder with dysmorphic facies and ischiopubic hypoplasia	620210	AR	3	Nae1
16q22.1	16:67029149-67101058	CBFB, PEBP2B, CLCD2	Core-binding factor, beta subunit	121360	CBFB	865	ENSG00000067955,ENST00000412916;;;ENST00000412916	inv(16)(p13;q22); fuses to MYH11	Cleidocranial dysplasia 2	620099	AD	3	Cbfb
16q22.1	16:67163761-67169941	HSF4, CTM, CTRCT5	Heat-shock transcription factor 4	602438	HSF4	3299	ENSG00000102878,ENST00000521374;;;ENST00000521374		Cataract 5, multiple types	116800	AD	3	Hsf4
16q22.1	16:67170538-67175737	NOL3, NOP, MYC, ARC, FCM, MYOCL1	Nucleolar protein 3	605235	NOL3	8996	ENSG00000140939,ENST00000564992;;;ENST00000564992	mutation identified in 1 MYOCL1 family	?Myoclonus, familial, 1	614937	AD	3	Nol3
16q22.1	16:67429801-67437553	HSD11B2, HSD11K, AME	Hydroxysteroid (11-beta) dehydrogenase 2	614232	HSD11B2	3291	ENSG00000176387,ENST00000326152;;;ENST00000326152		Apparent mineralocorticoid excess	218030	AR	3	Hsd11b2
16q22.1	16:67482571-67483547	AGRP, ART, AGRT	Agouti-related neuropeptide	602311	AGRP	181	ENSG00000159723,ENST00000290953;;;ENST00000290953		{Leanness, inherited}	601665	AD, AR, Mu	3	Agrp
16q22.1	16:67482571-67483547	AGRP, ART, AGRT	Agouti-related neuropeptide	602311	AGRP	181	ENSG00000159723,ENST00000290953;;;ENST00000290953		{Obesity, late-onset}	601665	AD, AR, Mu	3	Agrp
16q22.1	16:67562526-67639177	CTCF, MRD21	CCCTC-binding factor	604167	CTCF	10664	ENSG00000102974,ENST00000264010;;;ENST00000264010		Intellectual developmental disorder, autosomal dominant 21	615502	AD	3	Ctcf
16q22.1	16:67645144-67657569	CARMIL2, RLTPR, IMD58	Capping protein regulator and myosin 1 linker 2	610859	CARMIL2	146206	ENSG00000159753,ENST00000334583;;;ENST00000334583		Immunodeficiency 58	618131	AR	3	Carmil2
16q22.1	16:67657512-67660260	ACD, PTOP, PIP1, TINT1, DKCA6, DKCB7	ACD shelterin complex subunit and telomerase recruitment factor	609377	ACD	65057	ENSG00000102977,ENST00000620761;;;ENST00000620761	mutation has been identified in 1 DKCA6 and 1 DKCB7 family	?Dyskeratosis congenita, autosomal dominant 6	616553	AD, AR	3	Acd
16q22.1	16:67657512-67660260	ACD, PTOP, PIP1, TINT1, DKCA6, DKCB7	ACD shelterin complex subunit and telomerase recruitment factor	609377	ACD	65057	ENSG00000102977,ENST00000620761;;;ENST00000620761	mutation has been identified in 1 DKCA6 and 1 DKCB7 family	?Dyskeratosis congenita, autosomal recessive 7	616553	AD, AR	3	Acd
16q22.1	16:67828157-67847693	CENPT, SSMGA	Centromere protein T	611510	CENPT	80152	ENSG00000102901,ENST00000562787;;;ENST00000562787	mutation identified in 1 SSMGA family	?Short stature and microcephaly with genital anomalies	618702	AR	3	Cenpt
16q22.1	16:67842320-67844195	THAP11, RONIN, MAHCL, SCA51	THAP domain-containing protein 11	609119	THAP11	57215	ENSG00000168286,ENST00000303596;;;ENST00000303596	mutation identified in 1 MAHCL patient	?Methylmalonic aciduria and homocystinuria, cblL type	620940	AR	3	Thap11
16q22.1	16:67842320-67844195	THAP11, RONIN, MAHCL, SCA51	THAP domain-containing protein 11	609119	THAP11	57215	ENSG00000168286,ENST00000303596;;;ENST00000303596	mutation identified in 1 MAHCL patient	Spinocerebellar ataxia 51	620947	AD	3	Thap11
16q22.1	16:67893254-67929676	PSKH1, PFIC13	Putative serine kinase H1	177015	PSKH1	5681	ENSG00000159792,ENST00000291041;;;ENST00000291041		Cholestasis, progressive familial intrahepatic, 13	620962	AR	3	Pskh1
16q22.1	16:67934506-67936850	PSMB10, MECL1, LMP10, PRAAS5, IMD121	Proteosome subunit, beta-type, 10	176847	PSMB10	5699	ENSG00000205220,ENST00000358514;;;ENST00000358514	3.1kb from LCAT	Immunodeficiency 121 with autoinflammation	620807	AD	3	Psmb10
16q22.1	16:67934506-67936850	PSMB10, MECL1, LMP10, PRAAS5, IMD121	Proteosome subunit, beta-type, 10	176847	PSMB10	5699	ENSG00000205220,ENST00000358514;;;ENST00000358514	3.1kb from LCAT	Proteasome-associated autoinflammatory syndrome 5	619175	AR	3	Psmb10
16q22.1	16:67939750-67944120	LCAT	Lecithin-cholesterol acyltransferase	606967	LCAT	3931	ENSG00000213398,ENST00000264005;;;ENST00000264005	very close to HP	Fish-eye disease	136120	AR	3	Lcat
16q22.1	16:67939750-67944120	LCAT	Lecithin-cholesterol acyltransferase	606967	LCAT	3931	ENSG00000213398,ENST00000264005;;;ENST00000264005	very close to HP	Norum disease	245900	AR	3	Lcat
16q22.1	16:68298034-68310946	SLC7A6OS, EPM12	Solute carrier family 7, member 6, opposite strand	619192	SLC7A6OS	84138	ENSG00000103061,ENST00000263997;;;ENST00000263997		Epilepsy, progressive myoclonic, 12	619191	AR	3	Slc7a6os
16q22.1	16:68311019-68360870	PRMT7, KIAA1933, SBIDDS	Protein arginine N-methyltransferase 7	610087	PRMT7	54496	ENSG00000132600,ENST00000441236;;;ENST00000441236		Short stature, brachydactyly, intellectual developmental disability, and seizures	617157	AR	3	Prmt7
16q22.1	16:68645310-68733771	CDH3, CDHP, PCAD, HJMD	Cadherin-3 (P-cadherin)	114021	CDH3	1001	ENSG00000062038,ENST00000264012;;;ENST00000264012	in mouse tightly linked to ECAD	Ectodermal dysplasia, ectrodactyly, and macular dystrophy	225280	AR	3	Cdh3
16q22.1	16:68645310-68733771	CDH3, CDHP, PCAD, HJMD	Cadherin-3 (P-cadherin)	114021	CDH3	1001	ENSG00000062038,ENST00000264012;;;ENST00000264012	in mouse tightly linked to ECAD	Hypotrichosis, congenital, with juvenile macular dystrophy	601553	AR	3	Cdh3
16q22.1	16:68737292-68835537	CDH1, UVO, LCAM, ECAD, BCDS1	Cadherin-1 (E-cadherin; uvomorulin)	192090	CDH1	999	ENSG00000039068,ENST00000261769;;;ENST00000261769	near LCAT	Blepharocheilodontic syndrome 1	119580	AD	3	Cdh1
16q22.1	16:68737292-68835537	CDH1, UVO, LCAM, ECAD, BCDS1	Cadherin-1 (E-cadherin; uvomorulin)	192090	CDH1	999	ENSG00000039068,ENST00000261769;;;ENST00000261769	near LCAT	Breast cancer, lobular, somatic	114480		3	Cdh1
16q22.1	16:68737292-68835537	CDH1, UVO, LCAM, ECAD, BCDS1	Cadherin-1 (E-cadherin; uvomorulin)	192090	CDH1	999	ENSG00000039068,ENST00000261769;;;ENST00000261769	near LCAT	Diffuse gastric and lobular breast cancer syndrome with or without cleft lip and/or palate	137215	AD	3	Cdh1
16q22.1	16:68737292-68835537	CDH1, UVO, LCAM, ECAD, BCDS1	Cadherin-1 (E-cadherin; uvomorulin)	192090	CDH1	999	ENSG00000039068,ENST00000261769;;;ENST00000261769	near LCAT	Endometrial carcinoma, somatic	608089		3	Cdh1
16q22.1	16:68737292-68835537	CDH1, UVO, LCAM, ECAD, BCDS1	Cadherin-1 (E-cadherin; uvomorulin)	192090	CDH1	999	ENSG00000039068,ENST00000261769;;;ENST00000261769	near LCAT	Ovarian cancer, somatic	167000		3	Cdh1
16q22.1	16:69311350-69326939	VPS4A, VPS4, CIMDAG	Vacuolar protein sorting 4 homolog A	609982	VPS4A	27183	ENSG00000132612,ENST00000254950;;;ENST00000254950		CIMDAG syndrome	619273	AD	3	Vps4a
16q22.1	16:69326428-69339564	COG8, DOR1, CDG2H	Component of oligomeric golgi complex 8	606979	COG8	84342	ENSG00000213380,ENST00000306875;;;ENST00000306875		Congenital disorder of glycosylation, type IIh	611182		3	Cog8
16q22.1	16:69933081-69933180	MIR140, MIRN140, SEDN	Micro RNA 140	611894	MIR140	406932	ENSG00000208017,ENST00000385282		Spondyloepiphyseal dysplasia, Nishimura type	618618	AD	3	Mir140
16q22.1	16:70252298-70289506	AARS1, AARS, CMT2N, DEE29, HDLS2, TTD8	Alanyl-tRNA synthetase 1	601065	AARS1	16	ENSG00000090861,ENST00000261772;;;ENST00000261772	mutation identified in 1 HDLS2 family	?Leukoencephalopathy, hereditary diffuse, with spheroids 2	619661	AD	3	Aars1
16q22.1	16:70252298-70289506	AARS1, AARS, CMT2N, DEE29, HDLS2, TTD8	Alanyl-tRNA synthetase 1	601065	AARS1	16	ENSG00000090861,ENST00000261772;;;ENST00000261772	mutation identified in 1 HDLS2 family	Charcot-Marie-Tooth disease, axonal, type 2N	613287	AD	3	Aars1
16q22.1	16:70252298-70289506	AARS1, AARS, CMT2N, DEE29, HDLS2, TTD8	Alanyl-tRNA synthetase 1	601065	AARS1	16	ENSG00000090861,ENST00000261772;;;ENST00000261772	mutation identified in 1 HDLS2 family	Developmental and epileptic encephalopathy 29	616339	AR	3	Aars1
16q22.1	16:70252298-70289506	AARS1, AARS, CMT2N, DEE29, HDLS2, TTD8	Alanyl-tRNA synthetase 1	601065	AARS1	16	ENSG00000090861,ENST00000261772;;;ENST00000261772	mutation identified in 1 HDLS2 family	Trichothiodystrophy 8, nonphotosensitive	619691	AR	3	Aars1
16q22.1	16:70454595-70480274	FCSK, FUK, CDGF2	Fucose kinase	608675	FCSK	197258	ENSG00000157353,ENST00000288078;;;ENST00000288078		Congenital disorder of glycosylation with defective fucosylation 2	618324	AR	3	Fcsk
16q22.1	16:70480567-70523554	COG4, COD1, CDG2J, SWILS	Component of oligomeric golgi complex 4	606976	COG4	25839	ENSG00000103051,ENST00000323786;;;ENST00000323786		Congenital disorder of glycosylation, type IIj	613489	AR	3	Cog4
16q22.1	16:70480567-70523554	COG4, COD1, CDG2J, SWILS	Component of oligomeric golgi complex 4	606976	COG4	25839	ENSG00000103051,ENST00000323786;;;ENST00000323786		Saul-Wilson syndrome	618150	AD	3	Cog4
16q22.1	16:70661204-70686053	MTSS2, MTSS1L, ABBA1, IDDOF	MTSS I-BAR domain containing 2 protein	616951	MTSS2	92154	ENSG00000132613,ENST00000338779;;;ENST00000338779		Intellectual developmental disorder with ocular anomalies and distinctive facial features	620086	AD	3	Mtss2
16q22.1-q22.2	16:70687439-70801158	VAC14, TAX1BP2, TRX, SNDC	VAC14 component of PIKFYVE complex	604632	VAC14	55697	ENSG00000103043,ENST00000261776;;;ENST00000261776		Striatonigral degeneration, childhood-onset	617054	AR	3	Vac14
16q22.2	16:70802084-71230722	HYDIN, HYDIN1, CILD5	HYDIN axonemal central pair apparatus protein	610812	HYDIN	54768	ENSG00000157423,ENST00000393567;;;ENST00000393567	duplicated copy on 1q21.1	Ciliary dyskinesia, primary, 5	608647	AR	3	Hydin
16q22.2	16:71565660-71577092	TAT	Tyrosine aminotransferase, soluble	613018	TAT	6898	ENSG00000198650,ENST00000355962;;;ENST00000355962		Tyrosinemia, type II	276600	AR	3	Tat
16q22.2	16:71729000-71808834	AP1G1, ADTG, CLAPG1, USRISD	Adaptor-related protein complex 1, gamma 1 subunit (adaptin, gamma)	603533	AP1G1	164	ENSG00000166747,ENST00000299980;;;ENST00000299980		Usmani-Riazuddin syndrome, autosomal dominant	619467	AD	3	Ap1g1
16q22.2	16:71729000-71808834	AP1G1, ADTG, CLAPG1, USRISD	Adaptor-related protein complex 1, gamma 1 subunit (adaptin, gamma)	603533	AP1G1	164	ENSG00000166747,ENST00000299980;;;ENST00000299980		Usmani-Riazuddin syndrome, autosomal recessive	619548	AR	3	Ap1g1
16q22.2	16:72008744-72027659	DHODH, URA1, POADS	Dihydroorotate dehydrogenase	126064	DHODH	1723	ENSG00000102967,ENST00000219240;;;ENST00000219240		Miller syndrome	263750	AR	3	Dhodh
16q22.2	16:72054505-72061055	HP	Haptoglobin	140100	HP	3240	ENSG00000257017,ENST00000355906;;;ENST00000355906	just distal to fra16q22.1	[Anhaptoglobinemia]	614081		3	Hp
16q22.2	16:72054505-72061055	HP	Haptoglobin	140100	HP	3240	ENSG00000257017,ENST00000355906;;;ENST00000355906	just distal to fra16q22.1	[Hypohaptoglobinemia]	614081		3	Hp
16q22.2	16:72093847-72112912	DHX38, DDX38, PRP16, RP84	DEAH-box helicase 38	605584	DHX38	9785	ENSG00000140829,ENST00000268482;;;ENST00000268482		Retinitis pigmentosa 84	618220	AR	3	Dhx38
16q22.2	16:72116657-72249949	PMFBP1, STAP, SPGF31	Polyamine-modulated factor 1-binding protein 1	618085	PMFBP1	83449	ENSG00000118557,ENST00000237353;;;ENST00000237353		Spermatogenic failure 31	618112	AR	3	Pmfbp1
16q22.2-q22.3	16:72782885-73891930	ZFHX3, ATBF1, ATFB8, SCA4	Zinc finger homeobox 3	104155	ZFHX3	463	ENSG00000140836,ENST00000268489;;;ENST00000268489		{Atrial fibrillation 8, susceptibility to}	613055	AD	3	Zfhx3
16q22.2-q22.3	16:72782885-73891930	ZFHX3, ATBF1, ATFB8, SCA4	Zinc finger homeobox 3	104155	ZFHX3	463	ENSG00000140836,ENST00000268489;;;ENST00000268489		Prostate cancer, somatic	176807		3	Zfhx3
16q22.2-q22.3	16:72782885-73891930	ZFHX3, ATBF1, ATFB8, SCA4	Zinc finger homeobox 3	104155	ZFHX3	463	ENSG00000140836,ENST00000268489;;;ENST00000268489		Spinocerebellar ataxia 4	600223	AD	3	Zfhx3
16q22.3-q23.1	16:72800001-79200000	KTCN2	Keratoconus 2	608932		450092			Keratoconus 2	608932		2	
16q23	16:74100001-84100000	BMND13	Bone mineral density quantitative trait locus 13	612727		100294717		associated with rs16945612	[Bone mineral density QTL 13]	612727		2	
16q23	16:74100001-84100000	HSCR8	Hirschsprung disease, susceptibility to, 8	608462		404719			{Hirschsprung disease, susceptibility to, 8}	608462		2	
16q23.1	16:74621399-74666877	RFWD3, FANCW	RING finger and WD repeat domains-containing protein 3	614151	RFWD3	55159	ENSG00000168411,ENST00000361070;;;ENST00000361070	mutation identified in 1 FANCW patient	?Fanconi anemia, complementation group W	617784	AR	3	Rfwd3
16q23.1	16:74712969-74774820	FA2H, FAAH, FAXDC1, FAH1, SCS7, SPG35	Fatty acid 2-hydroxylase	611026	FA2H	79152	ENSG00000103089,ENST00000219368;;;ENST00000219368		Spastic paraplegia 35, autosomal recessive	612319	AR	3	Fa2h
16q23.1	16:75111864-75116780	LDHD, DLACD	D-lactate dehydrogenase	607490	LDHD	197257	ENSG00000166816,ENST00000450168;;;ENST00000450168		D-lactic aciduria with susceptibility to gout	245450	AR	3	Ldhd
16q23.1	16:75472042-75495441	CHST6, MCDC1	Carbohydrate sulfotransferase-6 (GlcNAc-6-sulfotransferase, corneal)	605294	CHST6	4166	ENSG00000183196,ENST00000332272;;;ENST00000332272		Macular corneal dystrophy	217800	AR	3	Chst5
16q23.1	16:75536741-75556286	TMEM231, JBTS20, MKS11	Transmembrane protein 231	614949	TMEM231	79583	ENSG00000205084,ENST00000258173;;;ENST00000258173		Joubert syndrome 20	614970	AR	3	Tmem231
16q23.1	16:75536741-75556286	TMEM231, JBTS20, MKS11	Transmembrane protein 231	614949	TMEM231	79583	ENSG00000205084,ENST00000258173;;;ENST00000258173		Meckel syndrome 11	615397	AR	3	Tmem231
16q23.1	16:75627724-75647665	KARS1, KARS, CMTRIB, DFNB89, LEPID, DEAPLE	Lysyl-tRNA synthetase 1	601421	KARS1	3735	ENSG00000065427,ENST00000302445;;;ENST00000302445	mutation identified in 1 CMTRIB patient	?Charcot-Marie-Tooth disease, recessive intermediate, B	613641	AR	3	Kars1
16q23.1	16:75627724-75647665	KARS1, KARS, CMTRIB, DFNB89, LEPID, DEAPLE	Lysyl-tRNA synthetase 1	601421	KARS1	3735	ENSG00000065427,ENST00000302445;;;ENST00000302445	mutation identified in 1 CMTRIB patient	Deafness, autosomal recessive 89	613916	AR	3	Kars1
16q23.1	16:75627724-75647665	KARS1, KARS, CMTRIB, DFNB89, LEPID, DEAPLE	Lysyl-tRNA synthetase 1	601421	KARS1	3735	ENSG00000065427,ENST00000302445;;;ENST00000302445	mutation identified in 1 CMTRIB patient	Deafness, congenital, and adult-onset progressive leukoencephalopathy	619196	AR	3	Kars1
16q23.1	16:75627724-75647665	KARS1, KARS, CMTRIB, DFNB89, LEPID, DEAPLE	Lysyl-tRNA synthetase 1	601421	KARS1	3735	ENSG00000065427,ENST00000302445;;;ENST00000302445	mutation identified in 1 CMTRIB patient	Leukoencephalopathy, progressive, infantile-onset, with or without deafness	619147	AR	3	Kars1
16q23.1	16:77282128-77435034	ADAMTS18, MMCAT	ADAM metallopeptidase domain with thrombospondin type 1 motif, 18	607512	ADAMTS18	170692	ENSG00000140873,ENST00000282849;;;ENST00000282849		Microcornea, myopic chorioretinal atrophy, and telecanthus	615458	AR	3	Adamts18
16q23.1-q23.2	16:78099654-79212667	WWOX, FOR, SCAR12, DEE28	WW domain-containing oxidoreductase	605131	WWOX	51741	ENSG00000186153,ENST00000566780;;;ENST00000566780		Developmental and epileptic encephalopathy 28	616211	AR	3	Wwox
16q23.1-q23.2	16:78099654-79212667	WWOX, FOR, SCAR12, DEE28	WW domain-containing oxidoreductase	605131	WWOX	51741	ENSG00000186153,ENST00000566780;;;ENST00000566780		Esophageal squamous cell carcinoma, somatic	133239		3	Wwox
16q23.1-q23.2	16:78099654-79212667	WWOX, FOR, SCAR12, DEE28	WW domain-containing oxidoreductase	605131	WWOX	51741	ENSG00000186153,ENST00000566780;;;ENST00000566780		Spinocerebellar ataxia, autosomal recessive 12	614322	AR	3	Wwox
16q23.2	16:79202622-79600737	MAF, CCA4, CTRCT21, AYGRP	MAF bZIP transcription factor	177075	MAF	4094	ENSG00000178573,ENST00000326043;;;ENST00000326043		Ayme-Gripp syndrome	601088	AD	3	Maf
16q23.2	16:79202622-79600737	MAF, CCA4, CTRCT21, AYGRP	MAF bZIP transcription factor	177075	MAF	4094	ENSG00000178573,ENST00000326043;;;ENST00000326043		Cataract 21, multiple types	610202	AD	3	Maf
16q23.2	16:81081945-81096395	GCSH, MMDS7	Glycine cleavage system H protein	238330	GCSH	2653	ENSG00000140905,ENST00000315467;;;ENST00000315467		Multiple mitochondrial dysfunctions syndrome 7	620423	AR	3	Gcsh
16q23.2	16:81238689-81291142	BCO1, BCMO1, BCDO	Beta-carotene oxygenase 1	605748	BCO1	53630	ENSG00000135697,ENST00000258168;;;ENST00000258168	mutation identified in 1 HCVAD patient	?Hypercarotenemia and vitamin A deficiency, autosomal dominant	115300	AD	3	Bco1
16q23.2	16:81314962-81390809	GAN, GAN1	Gigaxonin	605379	GAN	8139	ENSG00000261609,ENST00000648994;;;ENST00000648994		Giant axonal neuropathy-1	256850	AR	3	Gan
16q23.3	16:81600001-84100000	ADIPQTL5	Adiponectin, serum level of, quantitative trait locus 5	613836		100653375		associated with rs3865188	[Adiponectin, serum level of, QTL5]	613836		2	
16q23.3	16:81739041-81962685	PLCG2, FCAS3, APLAID	Phospholipase C, gamma 2	600220	PLCG2	5336	ENSG00000197943,ENST00000564138;;;ENST00000564138		Autoinflammation, antibody deficiency, and immune dysregulation syndrome	614878	AD	3	Plcg2
16q23.3	16:81739041-81962685	PLCG2, FCAS3, APLAID	Phospholipase C, gamma 2	600220	PLCG2	5336	ENSG00000197943,ENST00000564138;;;ENST00000564138		Familial cold autoinflammatory syndrome 3	614468	AD	3	Plcg2
16q23.3	16:83899115-83927031	MLYCD, MCD	Malonyl-CoA decarboxylase	606761	MLYCD	23417	ENSG00000103150,ENST00000262430;;;ENST00000262430		Malonyl-CoA decarboxylase deficiency	248360	AR	3	Mlycd
16q23.3	16:84009667-84043372	SLC38A8, FVH2	Solute carrier family 38 (amino acid transporter), member 8	615585	SLC38A8	146167	ENSG00000166558,ENST00000299709;;;ENST00000299709		Foveal hypoplasia 2, with or without optic nerve misrouting and/or anterior segment dysgenesis	609218	AR	3	Slc38a8
16q23.3-q24.1	16:84053763-84116942	MBTPS1, S1P, SEDKF, CAOP	Membrane-bound transcription factor protease, site 1	603355	MBTPS1	8720	ENSG00000140943,ENST00000343411;;;ENST00000343411		CAOP syndrome	621252	AR	3	Mbtps1
16q23.3-q24.1	16:84053763-84116942	MBTPS1, S1P, SEDKF, CAOP	Membrane-bound transcription factor protease, site 1	603355	MBTPS1	8720	ENSG00000140943,ENST00000343411;;;ENST00000343411		Spondyloepiphyseal dysplasia, Kondo-Fu type	618392	AR	3	Mbtps1
16q24.1	16:84100001-87000000	HDLC3	High density lipoprotein cholesterol, low serum, 3	607687		353125			{High density lipoprotein cholesterol, low serum, 3}	607687		2	
16q24	16:84100001-90338345	STQTL22	Stature quantitative trait locus 22	613547		100529227		linked to rs299956 and rs2076962	{Stature QTL 22}	613547		2	
16q24.1	16:84145308-84177920	DNAAF1, LRRC50, ODA7, CILD13	Dynein, axonemal, assembly factor 1	613190	DNAAF1	123872	ENSG00000154099,ENST00000378553;;;ENST00000378553		Ciliary dyskinesia, primary, 13	613193	AR	3	Dnaaf1
16q24.1	16:85799695-85807068	COX4I1, COX4, MC4DN16	Cytochrome c oxidase, subunit IV, isoform 1	123864	COX4I1	1327	ENSG00000131143,ENST00000253452;;;ENST00000253452		Mitochondrial complex IV deficiency, nuclear type 16	619060	AR	3	Cox4i1
16q24.1	16:85899162-85922609	IRF8, ICSBP1, IMD32A, IMD32B	Interferon regulatory factor 8	601565	IRF8	3394	ENSG00000140968,ENST00000268638;;;ENST00000268638		Immunodeficiency 32A, mycobacteriosis, autosomal dominant	614893	AD	3	Irf8
16q24.1	16:85899162-85922609	IRF8, ICSBP1, IMD32A, IMD32B	Interferon regulatory factor 8	601565	IRF8	3394	ENSG00000140968,ENST00000268638;;;ENST00000268638		Immunodeficiency 32B, monocyte and dendritic cell deficiency, autosomal recessive	226990	AR	3	Irf8
16q24.1	16:86510527-86515422	FOXF1, FKHL5, ACDMPV	Forkhead box F1	601089	FOXF1	2294	ENSG00000103241,ENST00000262426;;;ENST00000262426		Alveolar capillary dysplasia with misalignment of pulmonary veins	265380	AD	3	Foxf1
16q24.1	16:86566829-86569728	FOXC2, FKHL14, MFH1	Forkhead box C2	602402	FOXC2	2303	ENSG00000176692,ENST00000649859;;;ENST00000649859		Lymphedema-distichiasis syndrome	153400	AD	3	Foxc2
16q24.1	16:86566829-86569728	FOXC2, FKHL14, MFH1	Forkhead box C2	602402	FOXC2	2303	ENSG00000176692,ENST00000649859;;;ENST00000649859		Lymphedema-distichiasis syndrome with renal disease and diabetes mellitus	153400	AD	3	Foxc2
16q24.1	16:86578549-86583478	FOXL1, FKHL11, FREAC7, FKH6, OTSC11	Forkhead box L1	603252	FOXL1	2300	ENSG00000176678,ENST00000320241;;;ENST00000320241		Otosclerosis 11	620576	AD	3	Foxl1
16q24.2	16:87326987-87392121	FBXO31, FBX31, FBXO14, FBX14, MRT45	F-box only protein 31	609102	FBXO31	79791	ENSG00000103264,ENST00000311635;;;ENST00000311635	mutation identified in 1 MRT45 family	?Intellectual developmental disorder, autosomal recessive 45	615979	AR	3	Fbxo31
16q24.2	16:87601835-87698156	JPH3, JP3, HDL2	Junctophilin 3	605268	JPH3	57338	ENSG00000154118,ENST00000284262;;;ENST00000284262	mutation identified in 1 HDL2 family	Huntington disease-like 2	606438	AD	3	Jph3
16q24.2	16:87881549-87936529	CA5A, CA5AD	Carbonic anhydrase VA (mitochondrial)	114761	CA5A	763	ENSG00000174990,ENST00000649794;;;ENST00000649794	pseudogene on 16p	Hyperammonemia due to carbonic anhydrase VA deficiency	615751	AR	3	Car5a
16q24.2	16:88100931-88440753	ZNF469, KIAA1858, BCS1	Zinc finger protein 469	612078	ZNF469	84627	ENSG00000225614,ENST00000565624;;;ENST00000565624		Brittle cornea syndrome 1	229200	AR	3	Zfp469
16q24.2	16:88643289-88651053	CYBA, CGD4	Cytochrome b-245, alpha polypeptide	608508	CYBA	1535	ENSG00000051523,ENST00000261623;;;ENST00000261623		Chronic granulomatous disease 4, autosomal recessive	233690	AR	3	Cyba
16q24.2	16:88651940-88663091	MVD, MPD, POROK7	Mevalonate pyrophosphate decarboxylase	603236	MVD	4597	ENSG00000167508,ENST00000301012;;;ENST00000301012		Porokeratosis 7, multiple types	614714	AD	3	Mvd
16q24.3	16:88700001-90338345	IHPS5	Pyloric stenosis, infantile hypertrophic, 5	612525		100270639		between rs7197068 and rs750740	Pyloric stenosis, infantile hypertrophic, 5	612525		2	
16q24.3	16:88706503-88715396	CTU2, C16orf84, NCS2, MFRG	Cytosolic thiouridylase, subunit 2	617057	CTU2	348180	ENSG00000174177,ENST00000453996;;;ENST00000453996		Microcephaly, facial dysmorphism, renal agenesis, and ambiguous genitalia syndrome	618142	AR	3	Ctu2
16q24.3	16:88715338-88785220	PIEZO1, FAM38A, MIB, DHS, LMPHM6, ER	PIEZO1 ion channel	611184	PIEZO1	9780	ENSG00000103335,ENST00000301015;;;ENST00000301015		[ER blood group system]	620207	AR	3	Piezo1
16q24.3	16:88715338-88785220	PIEZO1, FAM38A, MIB, DHS, LMPHM6, ER	PIEZO1 ion channel	611184	PIEZO1	9780	ENSG00000103335,ENST00000301015;;;ENST00000301015		Dehydrated hereditary stomatocytosis with or without pseudohyperkalemia and/or perinatal edema	194380	AD	3	Piezo1
16q24.3	16:88715338-88785220	PIEZO1, FAM38A, MIB, DHS, LMPHM6, ER	PIEZO1 ion channel	611184	PIEZO1	9780	ENSG00000103335,ENST00000301015;;;ENST00000301015		Lymphatic malformation 6	616843	AR	3	Piezo1
16q24.3	16:88803789-88809258	CDT1	Chromatin licensing and DNA replication factor 1	605525	CDT1	81620	ENSG00000167513,ENST00000301019;;;ENST00000301019		Meier-Gorlin syndrome 4	613804	AR	3	Cdt1
16q24.3	16:88809339-88811928	APRT, APRTD	Adenine phosphoribosyltransferase	102600	APRT	353	ENSG00000198931,ENST00000378364;;;ENST00000378364	telomeric to GALNS, transcribed in same cen-tel direction	Adenine phosphoribosyltransferase deficiency	614723	AR	3	Aprt
16q24.3	16:88813734-88856947	GALNS, MPS4A	Galactosamine (N-acetyl)-6-sulfate sulfatase	612222	GALNS	2588	ENSG00000141012,ENST00000268695;;;ENST00000268695	centromeric to APRT	Mucopolysaccharidosis IVA	253000	AR	3	Galns
16q24.3	16:88856220-88862678	TRAPPC2L, PERRB	Trafficking protein particle complex 2-like	610970	TRAPPC2L	51693	ENSG00000167515,ENST00000696289;;;ENST00000696289		Encephalopathy, progressive, early-onset, with episodic rhabdomyolysis	618331	AR	3	Trappc2l
16q24.3	16:89093852-89156233	ACSF3	Acyl-CoA synthetase family member 3	614245	ACSF3	197322	ENSG00000176715,ENST00000614302;;;ENST00000614302		Combined malonic and methylmalonic aciduria	614265	AR	3	Acsf3
16q24.3	16:89171748-89195492	CDH15, CDH14, CDH3, MRD3	Cadherin-15, M-cadherin (myotubule)	114019	CDH15	1013	ENSG00000129910,ENST00000289746;;;ENST00000289746	tightly linked to Aprt in mouse	Intellectual developmental disorder, autosomal dominant 3	612580	AD	3	Cdh15
16q24.3	16:89267630-89490561	ANKRD11, ANCO1, KBGS	Ankyrin repeat domain-containing protein 11	611192	ANKRD11	29123	ENSG00000167522,ENST00000301030;;;ENST00000301030		KBG syndrome	148050	AD	3	Ankrd11
16q24.3	16:89508388-89557768	SPG7, PGN, CMAR, CAR	SPG7 matrix AAA peptidase subunit, paraplegin	602783	SPG7	6687	ENSG00000197912,ENST00000645818;;;ENST00000645818		Spastic paraplegia 7, autosomal recessive	607259	AD, AR	3	Spg7
16q24.3	16:89560657-89566829	RPL13, BBC1, D16S44E, SEMDIST	Ribosomal protein L13	113703	RPL13	6137	ENSG00000167526,ENST00000311528;;;ENST00000311528		Spondyloepimetaphyseal dysplasia, Isidor-Toutain type	618728	AD	3	Rpl13
16q24.3	16:89644435-89657708	CHMP1A, PCOLN3, PRSM1, PCH8	Charged multivesicular body protein 1A	164010	CHMP1A	5119	ENSG00000131165,ENST00000397901;;;ENST00000397901		Pontocerebellar hypoplasia, type 8	614961	AR	3	Chmp1a
16q24.3	16:89686689-89696354	CDK10, PISSLRE, ALSAS	Cyclin-dependent kinase 10	603464	CDK10	8558	ENSG00000185324,ENST00000353379;;;ENST00000353379		Al Kaissi syndrome	617694	AR	3	Cdk10
16q24.3	16:89737549-89816647	FANCA, FACA, FA1, FA, FAA	Fanconi anemia, complementation group A	607139	FANCA	2175	ENSG00000187741,ENST00000389301;;;ENST00000389301	linkage heterogeneity	Fanconi anemia, complementation group A	227650	AR	3	Fanca
16q24.3	16:89918862-89920972	MC1R, SHEP2, CMM5	Melanocortin-1 receptor (alpha melanocyte-stimulating hormone receptor)	155555	MC1R	4157	ENSG00000258839,ENST00000555147;;;ENST00000555147		[Analgesia from kappa-opioid receptor agonist, female-specific]	613098		3	Mc1r
16q24.3	16:89918862-89920972	MC1R, SHEP2, CMM5	Melanocortin-1 receptor (alpha melanocyte-stimulating hormone receptor)	155555	MC1R	4157	ENSG00000258839,ENST00000555147;;;ENST00000555147		[Skin/hair/eye pigmentation 2, blond hair/fair skin]	266300	AR	3	Mc1r
16q24.3	16:89918862-89920972	MC1R, SHEP2, CMM5	Melanocortin-1 receptor (alpha melanocyte-stimulating hormone receptor)	155555	MC1R	4157	ENSG00000258839,ENST00000555147;;;ENST00000555147		[Skin/hair/eye pigmentation 2, red hair/fair skin]	266300	AR	3	Mc1r
16q24.3	16:89918862-89920972	MC1R, SHEP2, CMM5	Melanocortin-1 receptor (alpha melanocyte-stimulating hormone receptor)	155555	MC1R	4157	ENSG00000258839,ENST00000555147;;;ENST00000555147		{Albinism, oculocutaneous, type II, modifier of}	203200	AR	3	Mc1r
16q24.3	16:89918862-89920972	MC1R, SHEP2, CMM5	Melanocortin-1 receptor (alpha melanocyte-stimulating hormone receptor)	155555	MC1R	4157	ENSG00000258839,ENST00000555147;;;ENST00000555147		{Melanoma, cutaneous malignant, 5}	613099		3	Mc1r
16q24.3	16:89918862-89920972	MC1R, SHEP2, CMM5	Melanocortin-1 receptor (alpha melanocyte-stimulating hormone receptor)	155555	MC1R	4157	ENSG00000258839,ENST00000555147;;;ENST00000555147		{UV-induced skin damage}	266300	AR	3	Mc1r
16q24.3	16:89921925-89936097	TUBB3, TUBB4, CFEOM3A, CDCBM1	Tubulin, beta-3	602661	TUBB3	10381	ENSG00000258947,ENST00000315491;;;ENST00000315491		Cortical dysplasia, complex, with other brain malformations 1	614039	AD	3	Tubb3
16q24.3	16:89921925-89936097	TUBB3, TUBB4, CFEOM3A, CDCBM1	Tubulin, beta-3	602661	TUBB3	10381	ENSG00000258947,ENST00000315491;;;ENST00000315491		Fibrosis of extraocular muscles, congenital, 3A	600638	AD	3	Tubb3
16q24.3	16:90019633-90044960	DRC4, GAS8, GAS11, CILD33	Dynein regulatory complex subunit 4	605178	DRC4	2622	ENSG00000141013,ENST00000268699;;;ENST00000268699		Ciliary dyskinesia, primary, 33	616726	AR	3	Gas8
17p13	17:1-10800000	ASPG2	Asperger syndrome, susceptibility to, 2	608631		431711		breakpoints between CHRNE and GP1BA	{Asperger syndrome susceptibility 2}	608631	IC, Mu	2	
17p13.3	17:1-3400000	BCPR	Breast cancer-related regulator of TP53	113721					Breast cancer			1	
17p13	17:1-10800000	CTRCT24, CTAA2	Cataract 24, anterior polar	601202		1484			Cataract 24, anterior polar	601202	AD	2	
17p13.3	17:1-3400000	DDD3	Dowling-Degos disease 3	615674		102997065		max lod at D17S1529	Dowling-Degos disease 3	615674	AD	2	
17p13.3	17:1-3400000	DUP17p13.3, C17DUPp13.3	Chromosome 17p13.3 duplication syndrome	613215				includes LIS1 and/or YWHAE	Chromosome 17p13.3 duplication syndrome	613215	AD, IC	4	
17p13.3	17:1-3400000	MDLS, MDS, MDCR, DEL17p13.3, C17DELp13.3	Miller-Dieker lissencephaly syndrome (chromosome 17p13.3 deletion syndrome)	247200					Miller-Dieker lissencephaly syndrome	247200	AD	4	
17p13	17:1-10800000	NDNC7	Nail disorder, nonsyndromic congenital, 7 (onychodysplasia, isolated congenital)	605779		81866			Nail disorder, nonsyndromic congenital, 7	605779	AD	2	
17p13.3-p13.1	17:1-10800000	SHFLD3, DUP17p13.3, C17DUPp13.3	Split-hand/foot malformation with long bone deficiency 3	612576				max lod at or near D17S1533; contiguous gene duplication syndrome	Split-hand/foot malformation with long bone deficiency 3	612576	AD	4	
17p13	17:1-10800000	SXGQTL1	Sex hormone-binding globulin circulating level quantitative trait locus 1	613498		100528025		associated with rs1799941	[Sex hormone-binding globulin circulating level QTL 1]	613498		2	
17p13.3	17:508668-714839	VPS53, HCCS1, PCH2E	VPS53 subunit of GARP complex	615850	VPS53	55275	ENSG00000141252,ENST00000437048;;;ENST00000437048		Pontocerebellar hypoplasia, type 2E	615851	AR	3	Vps53
17p13.3	17:744421-754410	GEMIN4, NEDMCR	Neurodevelopmental disorder with microcephaly, cataracts, and renal abnormalities	606969	GEMIN4	50628	ENSG00000179409,ENST00000319004;;;ENST00000319004		Neurodevelopmental disorder with microcephaly, cataracts, and renal abnormalities	617913	AR	3	Gemin4
17p13.3	17:799310-979776	NXN, RRS2	Nucleoredoxin	612895	NXN	64359	ENSG00000167693,ENST00000336868;;;ENST00000336868		Robinow syndrome, autosomal recessive 2	618529	AR	3	Nxn
17p13.3	17:997129-1003671	TIMM22, TIM22, COXPD43	Translocase of inner mitochondrial membrane 22	607251	TIMM22	29928	ENSG00000177370,ENST00000327158;;;ENST00000327158	mutation identified in 1 COXPD43 patient	?Combined oxidative phosphorylation deficiency 43	618851	AR	3	Timm22
17p13.3	17:1270444-1271815	BHLHA9, BHLHF42, MSSD, CCSPD	Basic helix-loop-helix family, member A9	615416	BHLHA9	727857	ENSG00000205899,ENST00000391429;;;ENST00000391429	mutation identified in 1 CCSPD family	?Camptosynpolydactyly, complex	607539	AR	3	Bhlha9
17p13.3	17:1270444-1271815	BHLHA9, BHLHF42, MSSD, CCSPD	Basic helix-loop-helix family, member A9	615416	BHLHA9	727857	ENSG00000205899,ENST00000391429;;;ENST00000391429	mutation identified in 1 CCSPD family	Syndactyly, mesoaxial synostotic, with phalangeal reduction	609432	AR	3	Bhlha9
17p13.3	17:1494577-1516612	INPP5K, SKIP, MDCCAID	Inositol polyphosphate-5-phosphatase K	607875	INPP5K	51763	ENSG00000132376,ENST00000421807;;;ENST00000421807		Muscular dystrophy, congenital, with cataracts and intellectual disability	617404	AR	3	Inpp5k
17p13.3	17:1650629-1684867	PRPF8, PRPC8, RP13	Pre-mRNA processing factor 8	607300	PRPF8	10594	ENSG00000174231,ENST00000304992;;;ENST00000304992		Retinitis pigmentosa 13	600059	AD	3	Prpf8
17p13.3	17:1716523-1738585	WDR81, CAMRQ2, HYC3	WD repeat-containing protein 81	614218	WDR81	124997	ENSG00000167716,ENST00000409644;;;ENST00000409644		Cerebellar ataxia, impaired intellectual development, and dysquilibrium syndrome 2	610185	AR	3	Wdr81
17p13.3	17:1716523-1738585	WDR81, CAMRQ2, HYC3	WD repeat-containing protein 81	614218	WDR81	124997	ENSG00000167716,ENST00000409644;;;ENST00000409644		Hydrocephalus, congenital, 3, with brain anomalies	617967	AR	3	Wdr81
17p13.3	17:1742871-1755265	PLI, SERPINF2	Alpha-2-plasmin inhibitor	613168	SERPINF2	5345	ENSG00000167711,ENST00000453066;;;ENST00000453066		Alpha-2-plasmin inhibitor deficiency	262850	AR	3	Serpinf2
17p13.3	17:1762060-1777565	SERPINF1, PEDF, OI6	Serpin peptidase inhibitor, clade F, member 1	172860	SERPINF1	5176	ENSG00000132386,ENST00000254722;;;ENST00000254722	same region as RP13	Osteogenesis imperfecta, type VI	613982	AR	3	Serpinf1
17p13.3	17:1830005-1900082	RPA1, PFBMFT6	Replication protein A1, 70kD	179835	RPA1	6117	ENSG00000132383,ENST00000254719;;;ENST00000254719		Pulmonary fibrosis and/or bone marrow failure syndrome, telomere-related, 6	619767	AD	3	Rpa1
17p13.3	17:2030112-2043898	DPH1, DPH2L1, OVCA1, DEDSSH	Diphthamide biosynthesis protein 1	603527	DPH1	1801	ENSG00000108963,ENST00000263083;;;ENST00000263083		Developmental delay with short stature, dysmorphic facial features, and sparse hair	616901	AR	3	Dph1
17p13.3	17:2593183-2685615	PAFAH1B1, LIS1	Platelet-activating factor acetylhydrolase, isoform 1B, alpha subunit	601545	PAFAH1B1	5048	ENSG00000007168,ENST00000397195;;;ENST00000397195		Lissencephaly 1	607432	AD	3	Pafah1b1
17p13.3	17:2593183-2685615	PAFAH1B1, LIS1	Platelet-activating factor acetylhydrolase, isoform 1B, alpha subunit	601545	PAFAH1B1	5048	ENSG00000007168,ENST00000397195;;;ENST00000397195		Subcortical laminar heterotopia	607432	AD	3	Pafah1b1
17p13.2-p13.1	17:3400001-10800000	MRT33	Intellectual developmental disorder, autosomal recessive 33	614341		100852394		between rs1367950 and rs1826925	Intellectual developmental disorder, autosomal recessive 33	614341	AR	2	
17p13.2	17:3440019-3513858	SPATA22, SPGF96, POF25	Spermatogenesis-associated protein 22	617673	SPATA22	84690	ENSG00000141255,ENST00000572969;;;ENST00000572969		Premature ovarian failure 25	621002	AR	3	Spata22
17p13.2	17:3440019-3513858	SPATA22, SPGF96, POF25	Spermatogenesis-associated protein 22	617673	SPATA22	84690	ENSG00000141255,ENST00000572969;;;ENST00000572969		Spermatogenic failure 96	621001	AR	3	Spata22
17p13.2	17:3474110-3503405	ASPA	Aspartoacylase (aminoacylase-2)	608034	ASPA	443	ENSG00000108381,ENST00000263080;;;ENST00000263080		Canavan disease	271900	AR	3	Aspa
17p13.2	17:3510502-3557812	TRPV3, OLMS1, FNEPPK2	Transient receptor potential cation channel, subfamily V, member 3	607066	TRPV3	162514	ENSG00000167723,ENST00000576742;;;ENST00000576742	mutation identified in 1 FNEPPK2 family	?Palmoplantar keratoderma, nonepidermolytic, focal 2	616400	AD	3	Trpv3
17p13.2	17:3510502-3557812	TRPV3, OLMS1, FNEPPK2	Transient receptor potential cation channel, subfamily V, member 3	607066	TRPV3	162514	ENSG00000167723,ENST00000576742;;;ENST00000576742	mutation identified in 1 FNEPPK2 family	Olmsted syndrome 1	614594	AD	3	Trpv3
17p13.2	17:3608240-3636250	SHPK, CARKL	Sedoheptulokinase	605060	SHPK	23729	ENSG00000197417,ENST00000225519;;;ENST00000225519		[Sedoheptulokinase deficiency]	617213	AR	3	Shpk
17p13.2	17:3636459-3663103	CTNS	Cystinosin	606272	CTNS	1497	ENSG00000040531,ENST00000046640;;;ENST00000046640	?3 allelic forms	Cystinosis, atypical nephropathic	219800	AR	3	Ctns
17p13.2	17:3636459-3663103	CTNS	Cystinosin	606272	CTNS	1497	ENSG00000040531,ENST00000046640;;;ENST00000046640	?3 allelic forms	Cystinosis, late-onset juvenile or adolescent nephropathic	219900	AR	3	Ctns
17p13.2	17:3636459-3663103	CTNS	Cystinosin	606272	CTNS	1497	ENSG00000040531,ENST00000046640;;;ENST00000046640	?3 allelic forms	Cystinosis, nephropathic	219800	AR	3	Ctns
17p13.2	17:3636459-3663103	CTNS	Cystinosin	606272	CTNS	1497	ENSG00000040531,ENST00000046640;;;ENST00000046640	?3 allelic forms	Cystinosis, ocular nonnephropathic	219750	AR	3	Ctns
17p13.2	17:4498881-4539035	SPNS2, DFNB115	Sphingolipid transporter 2	612584	SPNS2	124976	ENSG00000183018,ENST00000329078;;;ENST00000329078	mutation identified in 1 DFNB115 patient	?Deafness, autosomal recessive 115	618457	AR	3	Spns2
17p13.2	17:4731428-4733607	MED11, NDDRSB	Mediator complex subunit 11	612383	MED11	400569	ENSG00000161920,ENST00000293777;;;ENST00000293777		Neurodegeneration with developmental delay, early respiratory failure, myoclonic seizures, and brain abnormalities	620327	AR	3	Med11
17p13.2	17:4739833-4746119	ZMYND15, SPGF14	Zinc finger MYND-containing protein 15	614312	ZMYND15	84225	ENSG00000141497,ENST00000433935;;;ENST00000433935	mutation identified in 1 SPGF14 family	?Spermatogenic failure 14	615842	AR	3	Zmynd15
17p13.2	17:4897771-4908677	CHRNE, SCCMS, CMS4A, CMS4B, CMS4C	Cholinergic receptor, nicotinic, epsilon polypeptide	100725	CHRNE	1145	ENSG00000108556,ENST00000649488;;;ENST00000649488		Myasthenic syndrome, congenital, 4A, slow-channel	605809	AD, AR	3	Chrne
17p13.2	17:4897771-4908677	CHRNE, SCCMS, CMS4A, CMS4B, CMS4C	Cholinergic receptor, nicotinic, epsilon polypeptide	100725	CHRNE	1145	ENSG00000108556,ENST00000649488;;;ENST00000649488		Myasthenic syndrome, congenital, 4B, fast-channel	616324	AR	3	Chrne
17p13.2	17:4897771-4908677	CHRNE, SCCMS, CMS4A, CMS4B, CMS4C	Cholinergic receptor, nicotinic, epsilon polypeptide	100725	CHRNE	1145	ENSG00000108556,ENST00000649488;;;ENST00000649488		Myasthenic syndrome, congenital, 4C, associated with acetylcholine receptor deficiency	608931	AR	3	Chrne
17p13.2	17:4932277-4935023	GP1BA, BSS, BDPLT1, VWDP, BDPLT3	Glycoprotein Ib, platelet, alpha polypeptide	606672	GP1BA	2811	ENSG00000185245,ENST00000329125;;;ENST00000329125		{Nonarteritic anterior ischemic optic neuropathy, susceptibility to}	258660	AR	3	Gp1ba
17p13.2	17:4932277-4935023	GP1BA, BSS, BDPLT1, VWDP, BDPLT3	Glycoprotein Ib, platelet, alpha polypeptide	606672	GP1BA	2811	ENSG00000185245,ENST00000329125;;;ENST00000329125		Bernard-Soulier syndrome, type A1 (recessive)	231200	AR	3	Gp1ba
17p13.2	17:4932277-4935023	GP1BA, BSS, BDPLT1, VWDP, BDPLT3	Glycoprotein Ib, platelet, alpha polypeptide	606672	GP1BA	2811	ENSG00000185245,ENST00000329125;;;ENST00000329125		Bernard-Soulier syndrome, type A2 (dominant)	153670	AD	3	Gp1ba
17p13.2	17:4932277-4935023	GP1BA, BSS, BDPLT1, VWDP, BDPLT3	Glycoprotein Ib, platelet, alpha polypeptide	606672	GP1BA	2811	ENSG00000185245,ENST00000329125;;;ENST00000329125		von Willebrand disease, platelet-type	177820	AD	3	Gp1ba
17p13.2	17:4937130-4940046	SLC25A11, SLC20A4, OGC, PPGL6	Solute carrier family 25 (mitochondrial carrier; oxoglutarate carrier), member 11	604165	SLC25A11	8402	ENSG00000108528,ENST00000225665;;;ENST00000225665		Pheochromocytoma/paraganglioma syndrome 6	618464	AD	3	Slc25a11
17p13.2	17:4945652-4948530	PFN1, ALS18	Profilin-1	176610	PFN1	5216	ENSG00000108518,ENST00000225655;;;ENST00000225655		Amyotrophic lateral sclerosis 18	614808		3	Pfn1
17p13.2	17:4948710-4957129	ENO3, GSD13	Enolase-3, beta, muscle	131370	ENO3	2027	ENSG00000108515,ENST00000519602;;;ENST00000519602		Glycogen storage disease XIII	612932	AR	3	Eno3
17p13.2	17:4997950-5028401	KIF1C, LTXS1, KIAA0706, SPAX2	Kinesin family member 1C	603060	KIF1C	10749	ENSG00000129250,ENST00000320785;;;ENST00000320785		Spastic ataxia 2, autosomal recessive	611302	AR	3	Kif1c
17p13.2	17:5032602-5042414	SLC52A1, GPR172B, GPCR42, PAR2, FLJ10060, RBFVD	Solute carrier family 52, riboflavin transporter, member 1	607883	SLC52A1	55065	ENSG00000132517,ENST00000254853;;;ENST00000254853		Riboflavin deficiency	615026	AD	3	Slc52a2
17p13.2	17:5384833-5419662	NUP88, FADS4	Nucleoporin, 88-kD	602552	NUP88	4927	ENSG00000108559,ENST00000573584;;;ENST00000573584		Fetal akinesia deformation sequence 4	618393	AR	3	Nup88
17p13.2	17:5432777-5439155	C1QBP, HABP1, COXPD33	Complement component C1q binding protein (hyaluronic acid-binding protein 1)	601269	C1QBP	708	ENSG00000108561,ENST00000225698;;;ENST00000225698		Combined oxidative phosphorylation deficiency 33	617713	AR	3	C1qbp
17p13.2	17:5501396-5584509	NLRP1, NALP1, KIAA0926, DEFCAP, CARD7, VAMAS1, MSPC, AIADK, JRRP	NLR family, pyrin domain containing 1	606636	NLRP1	22861	ENSG00000091592,ENST00000572272;;;ENST00000572272	mutation identified in 1 JRRP family	?Respiratory papillomatosis, juvenile recurrent, congenital	618803	AR	3	Nlrp1a,Nlrp1b
17p13.2	17:5501396-5584509	NLRP1, NALP1, KIAA0926, DEFCAP, CARD7, VAMAS1, MSPC, AIADK, JRRP	NLR family, pyrin domain containing 1	606636	NLRP1	22861	ENSG00000091592,ENST00000572272;;;ENST00000572272	mutation identified in 1 JRRP family	{Vitiligo-associated multiple autoimmune disease susceptibility 1}	606579		3	Nlrp1a,Nlrp1b
17p13.2	17:5501396-5584509	NLRP1, NALP1, KIAA0926, DEFCAP, CARD7, VAMAS1, MSPC, AIADK, JRRP	NLR family, pyrin domain containing 1	606636	NLRP1	22861	ENSG00000091592,ENST00000572272;;;ENST00000572272	mutation identified in 1 JRRP family	Autoinflammation with arthritis and dyskeratosis	617388	AD, AR	3	Nlrp1a,Nlrp1b
17p13.2	17:5501396-5584509	NLRP1, NALP1, KIAA0926, DEFCAP, CARD7, VAMAS1, MSPC, AIADK, JRRP	NLR family, pyrin domain containing 1	606636	NLRP1	22861	ENSG00000091592,ENST00000572272;;;ENST00000572272	mutation identified in 1 JRRP family	Palmoplantar carcinoma, multiple self-healing	615225	AD	3	Nlrp1a,Nlrp1b
17p13.2	17:6423738-6435121	AIPL1, LCA4	Arylhydrocarbon-interacting receptor protein-like 1	604392	AIPL1	23746	ENSG00000129221,ENST00000381129;;;ENST00000381129	LCA1 due to GUCY2D mutation also on 17p13.1	Cone-rod dystrophy	604393	AD, AR	3	Aipl1
17p13.2	17:6423738-6435121	AIPL1, LCA4	Arylhydrocarbon-interacting receptor protein-like 1	604392	AIPL1	23746	ENSG00000129221,ENST00000381129;;;ENST00000381129	LCA1 due to GUCY2D mutation also on 17p13.1	Leber congenital amaurosis 4	604393	AD, AR	3	Aipl1
17p13.2	17:6423738-6435121	AIPL1, LCA4	Arylhydrocarbon-interacting receptor protein-like 1	604392	AIPL1	23746	ENSG00000129221,ENST00000381129;;;ENST00000381129	LCA1 due to GUCY2D mutation also on 17p13.1	Retinitis pigmentosa, juvenile	604393	AD, AR	3	Aipl1
17p13.2-p13.1	17:6451263-6556555	PITPNM3, NIR1, CORD5	Phosphatidylinositol transfer protein, membrane-associated, 3	608921	PITPNM3	83394	ENSG00000091622,ENST00000262483;;;ENST00000262483		Cone-rod dystrophy 5	600977	AD	3	Pitpnm3
17p13.1	17:6500001-10800000	DEL17p13.1, C17DELp13.1	Chromosome 17p13.1 deletion syndrome	613776				contiguous gene deletion syndrome	Chromosome 17p13.1 deletion syndrome	613776	AD	4	
17p13.1	17:6500001-10800000	MGR10	Migraine with or without aura, susceptibility to, 10	610208		117204002			{Migraine with or without aura, susceptibility to, 10}	610208	AD	2	
17p13.1	17:6578147-6640711	KIAA0753, OFIP, OFD15, JBTS38, SRTD21	KIAA0753 gene	617112	KIAA0753	9851	ENSG00000198920,ENST00000361413;;;ENST00000361413	mutation identified in 1 OFD15 patient and 1 JBTS38 family	?Joubert syndrome 38	619476	AR	3	4933427D14Rik
17p13.1	17:6578147-6640711	KIAA0753, OFIP, OFD15, JBTS38, SRTD21	KIAA0753 gene	617112	KIAA0753	9851	ENSG00000198920,ENST00000361413;;;ENST00000361413	mutation identified in 1 OFD15 patient and 1 JBTS38 family	?Orofaciodigital syndrome XV	617127	AR	3	4933427D14Rik
17p13.1	17:6578147-6640711	KIAA0753, OFIP, OFD15, JBTS38, SRTD21	KIAA0753 gene	617112	KIAA0753	9851	ENSG00000198920,ENST00000361413;;;ENST00000361413	mutation identified in 1 OFD15 patient and 1 JBTS38 family	Short-rib thoracic dysplasia 21 without polydactyly	619479	AR	3	4933427D14Rik
17p13.1	17:6684719-6713369	SLC13A5, NACT, DEE25	Solute carrier family 13 (sodium-dependent citrate transporter), member 5	608305	SLC13A5	284111	ENSG00000141485,ENST00000433363;;;ENST00000433363		Developmental and epileptic encephalopathy 25, with amelogenesis imperfecta	615905	AR	3	Slc13a5
17p13.1	17:7187187-7220050	DLG4, PSD95, SAP90, MRD62	Discs large MAGUK scaffold protein 4	602887	DLG4	1742	ENSG00000132535,ENST00000399506;;;ENST00000399506		Intellectual developmental disorder, autosomal dominant 62	618793	AD	3	Dlg4
17p13.1	17:7217125-7225266	ACADVL, VLCAD	Acyl-Coenzyme A dehydrogenase, very long chain	609575	ACADVL	37	ENSG00000072778,ENST00000356839;;;ENST00000356839		VLCAD deficiency	201475	AR	3	Acadvl
17p13.1	17:7306999-7312463	EIF5A, FABAS	Eukaryotic translation initiation factor-5A	600187	EIF5A	1984	ENSG00000132507,ENST00000336458;;;ENST00000336458		Faundes-Banka syndrome	619376	AD	3	Eif5a
17p13.1	17:7445061-7457710	CHRNB1, ACHRB, SCCMS, CMS2A, CMS2C	Cholinergic receptor, nicotinic, beta polypeptide-1, muscle	100710	CHRNB1	1140	ENSG00000170175,ENST00000306071;;;ENST00000306071	mutation identified in 1 CMS2C family	?Myasthenic syndrome, congenital, 2C, associated with acetylcholine receptor deficiency	616314	AR	3	Chrnb1
17p13.1	17:7445061-7457710	CHRNB1, ACHRB, SCCMS, CMS2A, CMS2C	Cholinergic receptor, nicotinic, beta polypeptide-1, muscle	100710	CHRNB1	1140	ENSG00000170175,ENST00000306071;;;ENST00000306071	mutation identified in 1 CMS2C family	Myasthenic syndrome, congenital, 2A, slow-channel	616313	AD	3	Chrnb1
17p13.1	17:7484366-7514616	POLR2A, RPOL2, NEDHIB	Polymerase (RNA) II (DNA directed) polypeptide A, 220kD	180660	POLR2A	5430	ENSG00000181222,ENST00000617998		Neurodevelopmental disorder with hypotonia and variable intellectual and behavioral abnormalities	618603	AD	3	Polr2a
17p13.1	17:7583647-7588212	MPDU1, SL15, CDGIF	Mannose-P-dolichol utilization defect 1	604041	MPDU1	9526	ENSG00000129255,ENST00000250124;;;ENST00000250124		Congenital disorder of glycosylation, type If	609180	AR	3	Mpdu1
17p13.1	17:7668421-7687490	TP53, P53, LFS1 , BCC7, BMFS5	Tumor protein p53	191170	TP53	7157	ENSG00000141510,ENST00000269305;;;ENST00000269305		{Adrenocortical carcinoma, pediatric}	202300	AD	3	Trp53
17p13.1	17:7668421-7687490	TP53, P53, LFS1 , BCC7, BMFS5	Tumor protein p53	191170	TP53	7157	ENSG00000141510,ENST00000269305;;;ENST00000269305		{Basal cell carcinoma 7}	614740	AD	3	Trp53
17p13.1	17:7668421-7687490	TP53, P53, LFS1 , BCC7, BMFS5	Tumor protein p53	191170	TP53	7157	ENSG00000141510,ENST00000269305;;;ENST00000269305		{Choroid plexus papilloma}	260500	AD	3	Trp53
17p13.1	17:7668421-7687490	TP53, P53, LFS1 , BCC7, BMFS5	Tumor protein p53	191170	TP53	7157	ENSG00000141510,ENST00000269305;;;ENST00000269305		{Colorectal cancer}	114500	AD, SMu	3	Trp53
17p13.1	17:7668421-7687490	TP53, P53, LFS1 , BCC7, BMFS5	Tumor protein p53	191170	TP53	7157	ENSG00000141510,ENST00000269305;;;ENST00000269305		{Glioma susceptibility 1}	137800	AD, SMu	3	Trp53
17p13.1	17:7668421-7687490	TP53, P53, LFS1 , BCC7, BMFS5	Tumor protein p53	191170	TP53	7157	ENSG00000141510,ENST00000269305;;;ENST00000269305		{Osteosarcoma}	259500	SMu	3	Trp53
17p13.1	17:7668421-7687490	TP53, P53, LFS1 , BCC7, BMFS5	Tumor protein p53	191170	TP53	7157	ENSG00000141510,ENST00000269305;;;ENST00000269305		Bone marrow failure syndrome 5	618165	AD	3	Trp53
17p13.1	17:7668421-7687490	TP53, P53, LFS1 , BCC7, BMFS5	Tumor protein p53	191170	TP53	7157	ENSG00000141510,ENST00000269305;;;ENST00000269305		Breast cancer, somatic	114480		3	Trp53
17p13.1	17:7668421-7687490	TP53, P53, LFS1 , BCC7, BMFS5	Tumor protein p53	191170	TP53	7157	ENSG00000141510,ENST00000269305;;;ENST00000269305		Hepatocellular carcinoma, somatic	114550		3	Trp53
17p13.1	17:7668421-7687490	TP53, P53, LFS1 , BCC7, BMFS5	Tumor protein p53	191170	TP53	7157	ENSG00000141510,ENST00000269305;;;ENST00000269305		Li-Fraumeni syndrome	151623	AD	3	Trp53
17p13.1	17:7668421-7687490	TP53, P53, LFS1 , BCC7, BMFS5	Tumor protein p53	191170	TP53	7157	ENSG00000141510,ENST00000269305;;;ENST00000269305		Nasopharyngeal carcinoma, somatic	607107		3	Trp53
17p13.1	17:7668421-7687490	TP53, P53, LFS1 , BCC7, BMFS5	Tumor protein p53	191170	TP53	7157	ENSG00000141510,ENST00000269305;;;ENST00000269305		Pancreatic cancer, somatic	260350		3	Trp53
17p13.1	17:7686071-7703502	WRAP53, TCAB1, WDR79, DKCB3	WD repeat-containing protein antisense to TP53	612661	WRAP53	55135	ENSG00000141499,ENST00000396463;;;ENST00000396463		Dyskeratosis congenita, autosomal recessive 3	613988	AR	3	Wrap53
17p13.1	17:7717744-7833742	DNAH2, DNAHC2, SPGF45	Dynein, axonemal, heavy chain-2	603333	DNAH2	146754	ENSG00000183914,ENST00000572933;;;ENST00000572933		Spermatogenic failure 45	619094	AR	3	Dnah2
17p13.1	17:7834217-7854796	KDM6B, JMJD3, KIAA0346, NEDSST	Lysine demethylase 6B	611577	KDM6B	23135	ENSG00000132510,ENST00000448097;;;ENST00000448097		Stolerman neurodevelopmental syndrome	618505	AD	3	Kdm6b
17p13.1	17:7884796-7912755	CHD3, SNIBCPS	Chromodomain helicase DNA binding protein-3	602120	CHD3	1107	ENSG00000170004,ENST00000330494;;;ENST00000330494		Snijders Blok-Campeau syndrome	618205	AD	3	Chd3
17p13.1	17:8002615-8020342	GUCY2D, GUC2D, LCA1, CORD6, RCD2, CACD1, CSNB1I	Guanylate cyclase 2D, retinal	600179	GUCY2D	3000	ENSG00000132518,ENST00000254854;;;ENST00000254854	mutation identified in 1 CACD1 family	?Choroidal dystrophy, central areolar 1	215500	AD	3	Gucy2e
17p13.1	17:8002615-8020342	GUCY2D, GUC2D, LCA1, CORD6, RCD2, CACD1, CSNB1I	Guanylate cyclase 2D, retinal	600179	GUCY2D	3000	ENSG00000132518,ENST00000254854;;;ENST00000254854	mutation identified in 1 CACD1 family	Cone-rod dystrophy 6	601777	AD, AR	3	Gucy2e
17p13.1	17:8002615-8020342	GUCY2D, GUC2D, LCA1, CORD6, RCD2, CACD1, CSNB1I	Guanylate cyclase 2D, retinal	600179	GUCY2D	3000	ENSG00000132518,ENST00000254854;;;ENST00000254854	mutation identified in 1 CACD1 family	Leber congenital amaurosis 1	204000	AR	3	Gucy2e
17p13.1	17:8002615-8020342	GUCY2D, GUC2D, LCA1, CORD6, RCD2, CACD1, CSNB1I	Guanylate cyclase 2D, retinal	600179	GUCY2D	3000	ENSG00000132518,ENST00000254854;;;ENST00000254854	mutation identified in 1 CACD1 family	Night blindness, congenital stationary, type 1I	618555	AR	3	Gucy2e
17p13.1	17:8072636-8087716	ALOX12B, ARCI2	Archidonate 12-lipoxygenase, R type	603741	ALOX12B	242	ENSG00000179477,ENST00000647874;;;ENST00000647874		Ichthyosis, congenital, autosomal recessive 2	242100	AR	3	Alox12b
17p13.1	17:8095900-8118916	ALOXE3, ARCI3	Arachidonate lipoxygenase 3	607206	ALOXE3	59344	ENSG00000179148,ENST00000448843;;;ENST00000448843		Ichthyosis, congenital, autosomal recessive 3	606545	AR	3	Aloxe3
17p13.1	17:8120592-8126634	HES7, SCDO4	Hes family bHLH transcription factor 7	608059	HES7	84667	ENSG00000179111,ENST00000541682;;;ENST00000541682		Spondylocostal dysostosis 4, autosomal recessive	613686	AR	3	Hes7
17p13.1	17:8159147-8162948	VAMP2, SYB2, NEDHAHM	Vesicle-associated membrane protein-2 (synaptobrevin-2)	185881	VAMP2	6844	ENSG00000220205,ENST00000316509;;;ENST00000316509		Neurodevelopmental disorder with hypotonia and autistic features with or without hyperkinetic movements	618760	AD	3	Vamp2
17p13.1	17:8172457-8176380	TMEM107, MKS13, JBTS29	Transmembrane protein 107	616183	TMEM107	84314	ENSG00000179029,ENST00000437139;;;ENST00000437139	mutation identified in 1 JBTS29	?Joubert syndrome 29	617562	AR	3	Tmem107
17p13.1	17:8172457-8176380	TMEM107, MKS13, JBTS29	Transmembrane protein 107	616183	TMEM107	84314	ENSG00000179029,ENST00000437139;;;ENST00000437139	mutation identified in 1 JBTS29	Meckel syndrome 13	617562	AR	3	Tmem107
17p13.1	17:8172457-8176380	TMEM107, MKS13, JBTS29	Transmembrane protein 107	616183	TMEM107	84314	ENSG00000179029,ENST00000437139;;;ENST00000437139	mutation identified in 1 JBTS29	Orofaciodigital syndrome XVI	617563	AR	3	Tmem107
17p13.1	17:8173452-8173588	SNORD118, LCC	Small nucleolar RNA,  C/D box, 118	616663	SNORD118	727676	ENSG00000200463,ENST00000363593;;;ENST00000363593		Leukoencephalopathy, brain calcifications, and cysts	614561	AR	3	
17p13.1	17:8224815-8248056	CTC1, CRMCC, C17orf68, AAF132	Conserved telomere maintenance component 1	613129	CTC1	80169	ENSG00000178971,ENST00000651323;;;ENST00000651323		Cerebroretinal microangiopathy with calcifications and cysts	612199	AR	3	Ctc1
17p13.1	17:8310241-8322511	ARHGEF15, KIAA0915, BSVD5	Rho guanine nucleotide exchange factor 15	608504	ARHGEF15	22899	ENSG00000198844,ENST00000361926;;;ENST00000361926		Brain small vessel disease 5 with osteoporosis	621331	AD	3	Arhgef15
17p13.1	17:8377516-8383193	RPL26, DBA11	Ribosomal protein L26	603704	RPL26	6154	ENSG00000161970,ENST00000648839;;;ENST00000648839	mutation identified in 1 family	?Diamond-Blackfan anemia 11	614900	AD	3	Rpl26
17p13.1	17:8878916-8965707	PIK3R5, p101	Phosphatidylinositol 3-kinase, regulatory subunit 5	611317	PIK3R5	23533	ENSG00000141506,ENST00000447110;;;ENST00000447110		Ataxia-oculomotor apraxia 3	615217	AR	3	Pik3r5
17p13.1	17:9003087-9244000	NTN1, NTN1L, MRMV4	Netrin 1, mouse, homolog of	601614	NTN1	9423	ENSG00000065320,ENST00000173229;;;ENST00000173229		Mirror movements 4	618264	AD	3	Ntn1
17p13.1	17:9576642-9645554	CFAP52, WDR16, WDRPUH, HTX10	Cilia- and flagella-associated protein 52	609804	CFAP52	146845	ENSG00000166596,ENST00000352665;;;ENST00000352665		Heterotaxy, visceral, 10, autosomal, with male infertility	619607	AR	3	Cfap52
17p13.1	17:10390322-10421950	MYH8, DA7	Myosin, heavy polypeptide-8, skeletal muscle, perinatal	160741	MYH8	4626	ENSG00000133020,ENST00000403437;;;ENST00000403437		Carney complex variant	608837		3	Myh8
17p13.1	17:10390322-10421950	MYH8, DA7	Myosin, heavy polypeptide-8, skeletal muscle, perinatal	160741	MYH8	4626	ENSG00000133020,ENST00000403437;;;ENST00000403437		Trismus-pseudocamptodactyly syndrome	158300	AD	3	Myh8
17p13.1	17:10521148-10549658	MYH2, CMYO6	Myosin, heavy polypeptide-2, skeletal muscle, adult	160740	MYH2	4620	ENSG00000125414,ENST00000245503;;;ENST00000245503		Congenital myopathy 6 with ophthalmoplegia	605637	AD, AR	3	Myh2
17p13.1	17:10628532-10678417	MYH3, DA2A, DA2B3, DA8, CPSFS1A, CPSFS1B	Myosin, heavy polypeptide-3, skeletal muscle, embryonic	160720	MYH3	4621	ENSG00000109063,ENST00000583535;;;ENST00000583535		Arthrogryposis, distal, type 2A (Freeman-Sheldon)	193700	AD	3	Myh3
17p13.1	17:10628532-10678417	MYH3, DA2A, DA2B3, DA8, CPSFS1A, CPSFS1B	Myosin, heavy polypeptide-3, skeletal muscle, embryonic	160720	MYH3	4621	ENSG00000109063,ENST00000583535;;;ENST00000583535		Arthrogryposis, distal, type 2B3 (Sheldon-Hall)	618436	AD	3	Myh3
17p13.1	17:10628532-10678417	MYH3, DA2A, DA2B3, DA8, CPSFS1A, CPSFS1B	Myosin, heavy polypeptide-3, skeletal muscle, embryonic	160720	MYH3	4621	ENSG00000109063,ENST00000583535;;;ENST00000583535		Contractures, pterygia, and spondylocarpostarsal fusion syndrome 1A	178110	AD	3	Myh3
17p13.1	17:10628532-10678417	MYH3, DA2A, DA2B3, DA8, CPSFS1A, CPSFS1B	Myosin, heavy polypeptide-3, skeletal muscle, embryonic	160720	MYH3	4621	ENSG00000109063,ENST00000583535;;;ENST00000583535		Contractures, pterygia, and spondylocarpotarsal fusion syndrome 1B	618469	AR	3	Myh3
17p13.1	17:10672474-10697533	SCO1, SCOD1, MC4DN4	SCO cytochrome c oxidase assembly protein 1	603644	SCO1	6341	ENSG00000133028,ENST00000255390;;;ENST00000255390		Mitochondrial complex IV deficiency, nuclear type 4	619048	AR	3	Sco1
17p12	17:10800001-16100000	AOMS2	Abdominal obesity-metabolic syndrome QTL2	605572		65077		second QTL on 3q27	Abdominal obesity-metabolic syndrome	605572	AD	2	
17p12-q11.2	17:10800001-33500000	DFNB85	Deafness, autosomal recessive 85	613392		100359399		between rs230884 and rs12603885	Deafness, autosomal recessive 85	613392	AR	2	
17p12-q21.2	17:10800001-42800000	ECTD6	Ectodermal dysplasia 6, hair/nail type	614928		101101770		between D17S839 and D17S1299	Ectodermal dysplasia 6, hair/nail type	614928	AR	2	
17p12-p11.2	17:10800001-22700000	YUHAL	Yuan-Harel-Lupski syndrome	616652				contiguous gene duplication syndrome	Yuan-Harel-Lupski syndrome	616652	AD	4	
17p12	17:11598470-11969748	DNAH9, DNAH17L, DNEL1, CILD40	Dynein, axonemal, heavy chain 9	603330	DNAH9	1770	ENSG00000007174,ENST00000262442;;;ENST00000262442		Ciliary dyskinesia, primary, 40	618300	AR	3	Dnah9
17p12	17:12665890-12768949	MYOCD, MGBL	Myocardin	606127	MYOCD	93649	ENSG00000141052,ENST00000425538;;;ENST00000425538		Megabladder, congenital	618719	AD	3	Myocd
17p12	17:12991612-13018027	ELAC2, HPC2, COXPD17	elaC ribonuclease Z 2	605367	ELAC2	60528	ENSG00000006744,ENST00000338034;;;ENST00000338034	at ~365cR	{Prostate cancer, hereditary, 2, susceptibility to}	614731		3	Elac2
17p12	17:12991612-13018027	ELAC2, HPC2, COXPD17	elaC ribonuclease Z 2	605367	ELAC2	60528	ENSG00000006744,ENST00000338034;;;ENST00000338034	at ~365cR	Combined oxidative phosphorylation deficiency 17	615440	AR	3	Elac2
17p12	17:14069504-14208677	COX10, MC4DN3	Cytochrome c oxidase, subunit X	602125	COX10	1352	ENSG00000006695,ENST00000261643;;;ENST00000261643		Mitochondrial complex IV deficiency, nuclear type 3	619046	AR	3	Cox10
17p12	17:15229779-15265326	PMP22, CMT1A, CMT1E, DSS, CIDP	Peripheral myelin protein-22	601097	PMP22	5376	ENSG00000109099,ENST00000312280;;;ENST00000312280	mutation identified in 1 CIDP family	?Neuropathy, inflammatory demyelinating	139393	?AD	3	Pmp22
17p12	17:15229779-15265326	PMP22, CMT1A, CMT1E, DSS, CIDP	Peripheral myelin protein-22	601097	PMP22	5376	ENSG00000109099,ENST00000312280;;;ENST00000312280	mutation identified in 1 CIDP family	Charcot-Marie-Tooth disease, type 1A	118220	AD	3	Pmp22
17p12	17:15229779-15265326	PMP22, CMT1A, CMT1E, DSS, CIDP	Peripheral myelin protein-22	601097	PMP22	5376	ENSG00000109099,ENST00000312280;;;ENST00000312280	mutation identified in 1 CIDP family	Charcot-Marie-Tooth disease, type 1E	118300	AD	3	Pmp22
17p12	17:15229779-15265326	PMP22, CMT1A, CMT1E, DSS, CIDP	Peripheral myelin protein-22	601097	PMP22	5376	ENSG00000109099,ENST00000312280;;;ENST00000312280	mutation identified in 1 CIDP family	Dejerine-Sottas disease	145900	AD, AR	3	Pmp22
17p12	17:15229779-15265326	PMP22, CMT1A, CMT1E, DSS, CIDP	Peripheral myelin protein-22	601097	PMP22	5376	ENSG00000109099,ENST00000312280;;;ENST00000312280	mutation identified in 1 CIDP family	Neuropathy, recurrent, with pressure palsies	162500	AD	3	Pmp22
17p12	17:15229779-15265326	PMP22, CMT1A, CMT1E, DSS, CIDP	Peripheral myelin protein-22	601097	PMP22	5376	ENSG00000109099,ENST00000312280;;;ENST00000312280	mutation identified in 1 CIDP family	Roussy-Levy syndrome	180800	AD	3	Pmp22
17p12	17:15303812-15343671	TEKT3, SPGF81	Tektin 3	612683	TEKT3	64518	ENSG00000125409,ENST00000395930;;;ENST00000395930		Spermatogenic failure 81	620277	AR	3	Tekt3
17p12	17:15976560-15999704	ZSWIM7, SWS1, SPGF71, ODG10	Zinc finger SWIM domain-containing protein 7	614535	ZSWIM7	125150	ENSG00000214941,ENST00000399277;;;ENST00000399277	mutation identified in 1 ODG10 family	?Ovarian dysgenesis 10	619834	AR	3	Zswim7
17p12	17:15976560-15999704	ZSWIM7, SWS1, SPGF71, ODG10	Zinc finger SWIM domain-containing protein 7	614535	ZSWIM7	125150	ENSG00000214941,ENST00000399277;;;ENST00000399277	mutation identified in 1 ODG10 family	Spermatogenic failure 71	619831	AR	3	Zswim7
17p12	17:15999824-16045015	TTC19, MC3DN2	Tetratricopeptide repeat domain 19	613814	TTC19	54902	ENSG00000011295,ENST00000261647;;;ENST00000261647		Mitochondrial complex III deficiency, nuclear type 2	615157	AR	3	Ttc19
17p11	17:16100001-25100000	ADHD2	Attention deficit-hyperactivity disorder, susceptibility to, 2	608904		450088			{Attention deficit-hyperactivity disorder, susceptibility to, 2}	608904		2	
17p11.2	17:16100001-22700000	IS2, AIS2	Scoliosis, idiopathic 2	607354		282552		between D17S947 and D17S798	Scoliosis, idiopathic 2	607354		2	
17p11.2	17:16100001-22700000	PTLS	Potocki-Lupski syndrome	610883				contiguous gene syndrome	Potocki-Lupski syndrome	610883	IC	4	
17p11.2	17:16217210-16326411	PIGL, CHIME	Phosphatidylinositol glycan, class L	605947	PIGL	9487	ENSG00000108474,ENST00000225609;;;ENST00000225609		CHIME syndrome	280000	AR	3	Pigl
17p11.2	17:16939081-16972118	TNFRSF13B, TACI, CVID2	Tumor necrosis factor receptor superfamily, member 13B	604907	TNFRSF13B	23495	ENSG00000240505,ENST00000261652;;;ENST00000261652		Immunodeficiency, common variable, 2	240500	AD, AR	3	Tnfrsf13b
17p11.2	17:16939081-16972118	TNFRSF13B, TACI, CVID2	Tumor necrosis factor receptor superfamily, member 13B	604907	TNFRSF13B	23495	ENSG00000240505,ENST00000261652;;;ENST00000261652		Immunoglobulin A deficiency 2	609529		3	Tnfrsf13b
17p11.2	17:17212212-17237330	FLCN, BHD	Folliculin	607273	FLCN	201163	ENSG00000154803,ENST00000285071;;;ENST00000285071		Birt-Hogg-Dube syndrome	135150	AD	3	Flcn
17p11.2	17:17212212-17237330	FLCN, BHD	Folliculin	607273	FLCN	201163	ENSG00000154803,ENST00000285071;;;ENST00000285071		Colorectal cancer, somatic	114500		3	Flcn
17p11.2	17:17212212-17237330	FLCN, BHD	Folliculin	607273	FLCN	201163	ENSG00000154803,ENST00000285071;;;ENST00000285071		Pneumothorax, primary spontaneous	173600	AD	3	Flcn
17p11.2	17:17212212-17237330	FLCN, BHD	Folliculin	607273	FLCN	201163	ENSG00000154803,ENST00000285071;;;ENST00000285071		Renal carcinoma, chromophobe, somatic	144700		3	Flcn
17p11.2	17:17681458-17811453	RAI1, SMCR, SMS	Retinoic acid-induced gene 1	607642	RAI1	10743	ENSG00000108557,ENST00000353383;;;ENST00000353383		Smith-Magenis syndrome	182290	AD, IC	3	Rai1
17p11.2	17:17811334-17836986	SREBF1, IFAP2, HMD	Sterol regulatory element binding transcription factor 1	184756	SREBF1	6720	ENSG00000072310,ENST00000261646;;;ENST00000261646		Ichthyosis, follicular, with atrichia and photophobia syndrome 2	619016	AD	3	Srebf1
17p11.2	17:17811334-17836986	SREBF1, IFAP2, HMD	Sterol regulatory element binding transcription factor 1	184756	SREBF1	6720	ENSG00000072310,ENST00000261646;;;ENST00000261646		Mucoepithelial dysplasia, hereditary	158310	AD	3	Srebf1
17p11.2	17:18015059-18039168	ATPAF2, ATP12, MC5DN1	ATP synthase, mitochondrial F1 complex, assembly factor 2	608918	ATPAF2	91647	ENSG00000171953,ENST00000474627;;;ENST00000474627	mutation identified in 1 MC5DN1 patient	?Mitochondrial complex V (ATP synthase) deficiency, nuclear type 1	604273	AR	3	Atpaf2
17p11.2	17:18108756-18179800	MYO15A, DFNB3	Myosin XVA	602666	MYO15A	51168	ENSG00000091536,ENST00000647165;;;ENST00000647165		Deafness, autosomal recessive 3	600316	AR	3	Myo15a
17p11.2	17:18244815-18259022	FLII, CMD2J	FLII actin remodeling protein	600362	FLII	2314	ENSG00000177731,ENST00000327031;;;ENST00000327031		Cardiomyopathy, dilated, 2J	620635	AR	3	Flii
17p11.2	17:18260662-18266552	MIEF2, SMCR7, MID49, COXPD49	Mitochondrial elongation factor 2	615498	MIEF2	125170	ENSG00000177427,ENST00000323019;;;ENST00000323019	mutation identified in 1 COXPD49 patient	?Combined oxidative phosphorylation deficiency 49	619024	AR	3	Mief2
17p11.2	17:18271428-18314994	TOP3A, MGRISCE2, PEOB5	Topoisomerase (DNA) III, alpha	601243	TOP3A	7156	ENSG00000177302,ENST00000321105;;;ENST00000321105		Microcephaly, growth restriction, and increased sister chromatid exchange 2	618097	AR	3	Top3a
17p11.2	17:18271428-18314994	TOP3A, MGRISCE2, PEOB5	Topoisomerase (DNA) III, alpha	601243	TOP3A	7156	ENSG00000177302,ENST00000321105;;;ENST00000321105		Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 5	618098	AR	3	Top3a
17p11.2	17:19020656-19051373	GRAP, DFNB114	GRB2-related adaptor protein	604330	GRAP	10750	ENSG00000154016,ENST00000284154;;;ENST00000284154		Deafness, autosomal recessive 114	618456	AR	3	Grap
17p11.2	17:19334695-19377913	B9D1, MKSR1, MKS9, JBTS27	B9 domain-containing protein 1	614144	B9D1	27077	ENSG00000108641,ENST00000261499;;;ENST00000261499	mutation identified in 1 MKS9 patient	?Meckel syndrome 9	614209	AR	3	B9d1
17p11.2	17:19334695-19377913	B9D1, MKSR1, MKS9, JBTS27	B9 domain-containing protein 1	614144	B9D1	27077	ENSG00000108641,ENST00000261499;;;ENST00000261499	mutation identified in 1 MKS9 patient	Joubert syndrome 27	617120	AR	3	B9d1
17p11.2	17:19648136-19677596	ALDH3A2, ALDH10, SLS, FALDH	Aldehyde dehydrogenase 3 family, member A2 (fatty aldehyde dehydrogenase)	609523	ALDH3A2	224	ENSG00000072210,ENST00000176643;;;ENST00000176643		Sjogren-Larsson syndrome	270200	AR	3	Aldh3a2
17p11.2	17:21692523-21704612	KCNJ18, KIR2.6, TTPP2	Potassium channel, inwardly rectifying, subfamily J, member 18	613236	KCNJ18	100134444	ENSG00000260458,ENST00000567955;;;ENST00000567955		{Thyrotoxic periodic paralysis, susceptibility to, 2}	613239	AD	3	Kcnj12
17q11	17:25100001-33500000	AUTS6	Autism, susceptibility to, 6	609378		554314		max lod at D17S1800	{Autism susceptibility 6}	609378		2	
17q	17:25100001-83257441	HYT1	Hypertension, essential, susceptibility to, 1	603918		117191		~18cM distal to ACE	{Hypertension, essential, susceptibility to, 1}	145500	Mu	2	
17q11.2	17:27400001-33500000	CCL3L1, SCYA3L1, LD78	Chemokine, C-C motif, ligand 3-like 1	601395	CCL3L1	6349		varies in copy number 1-10	{HIV/AIDS, susceptibility to}	609423		3	Ccl3
17q11.2	17:27400001-33500000	DEL17q11.2, C17DELq11.2	Chromosome 17q11.2 deletion syndrome, 1.4Mb (NF1 microdeletion syndrome)	613675					Chromosome 17q11.2 deletion syndrome, 1.4Mb	613675	AD	4	
17q11.2	17:27400001-33500000	DUP17q11.2, C17DUPq11.2	Chromosome 17q11.2 duplication syndrome, 1.4-Mb	618874					Chromosome 17q11.2 duplication syndrome, 1.4-Mb	618874	AD, IC	4	
17q11.2-q24	17:27400001-72900000	MHS2	Malignant hyperthermia susceptibility 2	154275		4264		?due to mutation in SCN4A	{Malignant hyperthermia susceptibility 2}	154275	AD	2	
17q11.2	17:27400001-33500000	MPVQTL3	Mean platelet volume quantitative trait locus 3	612575		100271869		associated with rs2138852	[Mean platelet volume QTL3]	612575		2	
17q11.2	17:27756766-27800529	NOS2A, NOS2	Nitric oxide synthase 2A	163730	NOS2	4843	ENSG00000007171,ENST00000313735;;;ENST00000313735	?cluster of 3 NOS2 genes	{Malaria, resistance to}	611162		3	Nos2
17q11.2	17:28357647-28363683	TMEM199, VMA12, VPH2, C17orf32, CDG2P	Transmembrane protein 199	616815	VMA12	147007	ENSG00000244045,ENST00000292114;;;ENST00000292114		Congenital disorder of glycosylation, type IIp	616829	AR	3	Tmem199
17q11.2	17:28394642-28406592	SLC46A1, HCP1, PCFT	Solute carrier family 46 (folate transporter), member 1	611672	SLC46A1	113235	ENSG00000076351,ENST00000612814;;;ENST00000612814		Folate malabsorption, hereditary	229050	AR	3	Slc46a1
17q11.2	17:28506348-28538900	FOXN1, WHN, TIDAND, TLIND, TIDTA	Forkhead box N1 (winged helix nude)	600838	FOXN1	8456	ENSG00000109101,ENST00000579795;;;ENST00000579795	mutation identified in 1 TIDTA patient	?T-cell immunodeficiency with thymic aplasia	242700	AR	3	Foxn1
17q11.2	17:28506348-28538900	FOXN1, WHN, TIDAND, TLIND, TIDTA	Forkhead box N1 (winged helix nude)	600838	FOXN1	8456	ENSG00000109101,ENST00000579795;;;ENST00000579795	mutation identified in 1 TIDTA patient	T-cell immunodeficiency, congenital alopecia, and nail dystrophy	601705	AR	3	Foxn1
17q11.2	17:28506348-28538900	FOXN1, WHN, TIDAND, TLIND, TIDTA	Forkhead box N1 (winged helix nude)	600838	FOXN1	8456	ENSG00000109101,ENST00000579795;;;ENST00000579795	mutation identified in 1 TIDTA patient	T-cell lymphopenia, infantile, with or without nail dystrophy, autosomal dominant	618806	AD	3	Foxn1
17q11.2	17:28546707-28552628	UNC119, HRG4, IMD13, CORD24	unc-119 lipid binding chaperone	604011	UNC119	9094	ENSG00000109103,ENST00000335765;;;ENST00000335765	mutation identified in 1 IMD13 family	?Immunodeficiency 13	615518	AD	3	Unc119
17q11.2	17:28546707-28552628	UNC119, HRG4, IMD13, CORD24	unc-119 lipid binding chaperone	604011	UNC119	9094	ENSG00000109103,ENST00000335765;;;ENST00000335765	mutation identified in 1 IMD13 family	Cone-rod dystrophy 24	620342	AD	3	Unc119
17q11.2	17:28553387-28571524	PIGS, GPIBD18, DEE95	Phosphatidylinositol glycan, class S	610271	PIGS	94005	ENSG00000087111,ENST00000308360;;;ENST00000308360		Developmental and epileptic encephalopathy 95	618143	AR	3	Pigs
17q11.2	17:28714281-28718428	RAB34, RAH, OFD20	Ras-associated protein 34	610917	RAB34	83871	ENSG00000109113,ENST00000395245;;;ENST00000395245		Orofaciodigital syndrome XX	620718	AR	3	Rab34
17q11.2	17:28728788-28743455	NEK8, JCK, NPHP9, RHPD2, PKD8	NIMA-related kinase 8	609799	NEK8	284086	ENSG00000160602,ENST00000268766;;;ENST00000268766	mutations identified in 1 family with NPHP9	?Nephronophthisis 9	613824		3	Nek8
17q11.2	17:28728788-28743455	NEK8, JCK, NPHP9, RHPD2, PKD8	NIMA-related kinase 8	609799	NEK8	284086	ENSG00000160602,ENST00000268766;;;ENST00000268766	mutations identified in 1 family with NPHP9	Polycystic kidney disease 8	620903	AD	3	Nek8
17q11.2	17:28728788-28743455	NEK8, JCK, NPHP9, RHPD2, PKD8	NIMA-related kinase 8	609799	NEK8	284086	ENSG00000160602,ENST00000268766;;;ENST00000268766	mutations identified in 1 family with NPHP9	Renal-hepatic-pancreatic dysplasia 2	615415	AR	3	Nek8
17q11.2	17:28855016-28861061	ERAL1, ERAL1A, ERAL1B, PRLTS6	ERA G-protein-like 1	607435	ERAL1	26284	ENSG00000132591,ENST00000254928;;;ENST00000254928		Perrault syndrome 6	617565	AR	3	Eral1
17q11.2	17:29246859-29254494	CRYBA1, CRYB1, CTRCT10	Crystallin, beta A1	123610	CRYBA1	1411	ENSG00000108255,ENST00000225387;;;ENST00000225387	centromeric to NF1	Cataract 10, multiple types	600881	AD	3	Cryba1
17q11.2	17:29390363-29551903	TAOK1, PSK2, TAO1, MARKK, DDIB	TAO kinase 1	610266	TAOK1	57551	ENSG00000160551,ENST00000261716;;;ENST00000261716		Developmental delay with or without intellectual impairment or behavioral abnormalities	619575	AD	3	Taok1
17q11.2	17:30116816-30186475	NSRP1, NSRP70, CCDC55, NEDSSBA	Nuclear speckle splicing regulatory protein 1	616173	NSRP1	84081	ENSG00000126653,ENST00000247026;;;ENST00000247026		Neurodevelopmental disorder with spasticity, seizures, and brain abnormalities	620001	AR	3	Nsrp1
17q11.2	17:30194319-30235697	SLC6A4, HTT, OCD1	Solute carrier family 6 (neurotransmitter transporter, serotonin), member 4	182138	SLC6A4	6532	ENSG00000108576,ENST00000650711;;;ENST00000650711		{Anxiety-related personality traits}	607834		3	Slc6a4
17q11.2	17:30194319-30235697	SLC6A4, HTT, OCD1	Solute carrier family 6 (neurotransmitter transporter, serotonin), member 4	182138	SLC6A4	6532	ENSG00000108576,ENST00000650711;;;ENST00000650711		{Obsessive-compulsive disorder}	164230	AD	3	Slc6a4
17q11.2	17:30898986-30906238	TEFM, C17orf42, COXPD58	Transcription elongation factor, mitochondrial	616422	TEFM	79736	ENSG00000172171,ENST00000581216;;;ENST00000581216		Combined oxidative phosphorylation deficiency 58	620451	AR	3	Tefm
17q11.2	17:31094977-31377675	NF1, VRNF, WSS, NFNS	Neurofibromin (neurofibromatosis, type I)	613113	NF1	4763	ENSG00000196712,ENST00000358273;;;ENST00000358273		Leukemia, juvenile myelomonocytic	607785	AD, SMu	3	Nf1
17q11.2	17:31094977-31377675	NF1, VRNF, WSS, NFNS	Neurofibromin (neurofibromatosis, type I)	613113	NF1	4763	ENSG00000196712,ENST00000358273;;;ENST00000358273		Neurofibromatosis-Noonan syndrome	601321	AD	3	Nf1
17q11.2	17:31094977-31377675	NF1, VRNF, WSS, NFNS	Neurofibromin (neurofibromatosis, type I)	613113	NF1	4763	ENSG00000196712,ENST00000358273;;;ENST00000358273		Neurofibromatosis, familial spinal	162210	AD	3	Nf1
17q11.2	17:31094977-31377675	NF1, VRNF, WSS, NFNS	Neurofibromin (neurofibromatosis, type I)	613113	NF1	4763	ENSG00000196712,ENST00000358273;;;ENST00000358273		Neurofibromatosis, type 1	162200	AD	3	Nf1
17q11.2	17:31094977-31377675	NF1, VRNF, WSS, NFNS	Neurofibromin (neurofibromatosis, type I)	613113	NF1	4763	ENSG00000196712,ENST00000358273;;;ENST00000358273		Watson syndrome	193520	AD	3	Nf1
17q11.2	17:31937007-32001038	SUZ12, JJAZ1, KIAA0160, IMMAS	SUZ12 polycomb repressive complex 2 subunit	606245	SUZ12	23512	ENSG00000178691,ENST00000322652;;;ENST00000322652		Imagawa-Matsumoto syndrome	618786	AD	3	Suz12
17q11.2	17:32928153-32944315	TMEM98, NNO4	Transmembrane protein 98	615949	TMEM98	26022	ENSG00000006042,ENST00000579849;;;ENST00000579849		Nanophthalmos 4	615972	AD	3	Tmem98
17q12	17:33500001-39800000	DEL17q12, C17DELq12	Chromosome 17q12 deletion syndrome	614527					Chromosome 17q12 deletion syndrome	614527	AD	4	
17q12	17:33500001-39800000	DUP17q12, C17DUPq12	Chromosome 17q12 duplication syndrome	614526					Chromosome 17q12 duplication syndrome	614526	AD	4	
17q12	17:33500001-39800000	HPC11	Prostate cancer, hereditary, 11	611955				associated with rs4430796 and rs7501939	{Prostate cancer, hereditary, 11}	611955		2	
17q12	17:33500001-39800000	PBC5	Biliary cirrhosis, primary, 5	614221		100689212		associated with rs9303277	Biliary cirrhosis, primary, 5	614221		2	
17q12-q21	17:33500001-52100000	WT4	Wilms tumor-4	601363		8151			Wilms tumor, type 4	601363	AD	2	
17q12	17:34255285-34257203	CCL2, SCYA2, MCP1, MCAF	Small inducible cytokine A2 (monocyte chemotactic protein, homologous to mouse Sig-je)	158105	CCL2	6347	ENSG00000108691,ENST00000225831;;;ENST00000225831		{HIV-1, resistance to}	609423		3	Ccl12,Ccl2
17q12	17:34285742-34288334	CCL11, SCYA11	Chemokine, C-C motif, ligand 11	601156	CCL11	6356	ENSG00000172156,ENST00000305869;;;ENST00000305869		{Asthma, susceptibility to}	600807	AD	3	Ccl11
17q12	17:34285742-34288334	CCL11, SCYA11	Chemokine, C-C motif, ligand 11	601156	CCL11	6356	ENSG00000172156,ENST00000305869;;;ENST00000305869		{HIV1, resistance to}	609423		3	Ccl11
17q12	17:34579582-34639318	TMEM132E, DFNB99	Transmembrane protein 132E	616178	TMEM132E	124842	ENSG00000181291,ENST00000631683;;;ENST00000631683		Deafness, autosomal recessive 99	618481	AR	3	Tmem132e
17q12	17:34980512-35010872	LIG3, MTDPS20	Ligase III, DNA, ATP-dependent	600940	LIG3	3980	ENSG00000005156,ENST00000378526;;;ENST00000378526		Mitochondrial DNA depletion syndrome 20 (MNGIE type)	619780	AR	3	Lig3
17q12	17:35092221-35119860	RAD51D, RAD51L3, BROVCA4	RAD51 paralog D	602954	RAD51D	5892	ENSG00000185379,ENST00000345365;;;ENST00000345365		{Breast-ovarian cancer, familial, susceptibility to, 4}	614291		3	Rad51d
17q12	17:35147817-35189345	UNC45B, SMUNC45, CTRCT43, MFM11	unc-45 myosin chaperone B	611220	UNC45B	146862	ENSG00000141161,ENST00000394570;;;ENST00000394570	mutation identified in 1 CTRCT43 family	?Cataract 43	616279	AD	3	Unc45b
17q12	17:35147817-35189345	UNC45B, SMUNC45, CTRCT43, MFM11	unc-45 myosin chaperone B	611220	UNC45B	146862	ENSG00000141161,ENST00000394570;;;ENST00000394570	mutation identified in 1 CTRCT43 family	Myofibrillar myopathy 11	619178	AR	3	Unc45b
17q12	17:35543985-35560819	SLFN14, BDPLT20	Schlafen family, member 14	614958	SLFN14	342618	ENSG00000236320,ENST00000674182;;;ENST00000674182		Bleeding disorder, platelet-type, 20	616913	AD	3	Slfn14
17q12	17:35574795-35578571	PEX12, PBD3A	Peroxisome biogenesis factor 12	601758	PEX12	5193	ENSG00000108733,ENST00000225873;;;ENST00000225873		Peroxisome biogenesis disorder 3A (Zellweger)	614859	AR	3	Pex12
17q12	17:35574795-35578571	PEX12, PBD3A	Peroxisome biogenesis factor 12	601758	PEX12	5193	ENSG00000108733,ENST00000225873;;;ENST00000225873		Peroxisome biogenesis disorder 3B	266510	AR	3	Pex12
17q12	17:35744511-35753239	GAS2L2, GAR17, CILD41	Growth arrest-specific 2-like 2	611398	GAS2L2	246176	ENSG00000270765,ENST00000604641;;;ENST00000604641	mutation identified in 1 CILD41 patient	?Ciliary dyskinesia, primary, 41	618449	AR	3	Gas2l2
17q12	17:35809484-35847242	TAF15, TAF2N, RBP56	TAF15 RNA polymerase II, TATA box-binding protein-associated factor, 68kD	601574	TAF15	8148	ENSG00000270647,ENST00000605844;;;ENST00000605844	fusion gene with CSMF	Chondrosarcoma, extraskeletal myxoid	612237		1	Taf15
17q12	17:35871491-35880360	CCL5, SCYA5, D17S136E, TCP228	Chemokine, C-C motif, ligand 5	187011	CCL5	6352	ENSG00000271503,ENST00000605140;;;ENST00000605140		{HIV-1 disease, delayed progression of}	609423		3	Ccl5
17q12	17:35871491-35880360	CCL5, SCYA5, D17S136E, TCP228	Chemokine, C-C motif, ligand 5	187011	CCL5	6352	ENSG00000271503,ENST00000605140;;;ENST00000605140		{HIV-1 disease, rapid progression of}	609423		3	Ccl5
17q12	17:36088256-36090143	CCL3, SCYA3, MIP1A	Chemokine, C-C motif, ligand 3	182283	CCL3	6348	ENSG00000277632,ENST00000613922;;;ENST00000613922	in 47kb, CCL18-CCL3-CCL4	{HIV infection, resistance to}	609423		2	Ccl3
17q12	17:36486681-36499312	ZNHIT3, TRIP3, PEHO	Zinc finger HIT domain-containing protein 3	604500	ZNHIT3	9326	ENSG00000273611,ENST00000617429;;;ENST00000617429		PEHO syndrome	260565	AR	3	Znhit3
17q12	17:36534987-36539303	PIGW, HPMRS5	Phosphatidylinositol glycan, class W	610275	PIGW	284098	ENSG00000277161,ENST00000614443;;;ENST00000614443		Glycosylphosphatidylinositol biosynthesis defect 11	616025	AR	3	Pigw
17q12	17:37084992-37406836	ACACA, ACAC, ACC1, ACACAD	Acetyl-Coenzyme A carboxylase, alpha	200350	ACACA	31	ENSG00000278540,ENST00000616317;;;ENST00000616317		Acetyl-CoA carboxylase deficiency	613933	AR	3	Acaca
17q12	17:37686431-37745059	HNF1B, TCF2, HNF2, RCAD, T2D, ADTKD3	HNF1 homeobox B (transcription factor 2)	189907	HNF1B	6928	ENSG00000275410,ENST00000617811;;;ENST00000617811		{Renal cell carcinoma}	144700		3	Hnf1b
17q12	17:37686431-37745059	HNF1B, TCF2, HNF2, RCAD, T2D, ADTKD3	HNF1 homeobox B (transcription factor 2)	189907	HNF1B	6928	ENSG00000275410,ENST00000617811;;;ENST00000617811		Renal cysts and diabetes syndrome	137920	AD	3	Hnf1b
17q12	17:37686431-37745059	HNF1B, TCF2, HNF2, RCAD, T2D, ADTKD3	HNF1 homeobox B (transcription factor 2)	189907	HNF1B	6928	ENSG00000275410,ENST00000617811;;;ENST00000617811		Type 2 diabetes mellitus	125853	AD	3	Hnf1b
17q12	17:38324571-38343956	GPR179, GPR158L, GPR158L1, CSNB1E	G protein-coupled receptor 179	614515	GPR179	440435	ENSG00000277399,ENST00000616987;;;ENST00000616987		Night blindness, congenital stationary (complete), 1E, autosomal recessive	614565	AR	3	Gpr179
17q12	17:38733898-38749792	PCGF2, RNF110, ZNF144, MEL18, TPFS	Polycomb group ring finger 2	600346	PCGF2	7703	ENSG00000277258,ENST00000620225;;;ENST00000620225		Turnpenny-Fry syndrome	618371	AD	3	Pcgf2
17q12	17:39603768-39607920	NEUROD2, DEE72	Neurogenic differentiation 2	601725	NEUROD2	4761	ENSG00000171532,ENST00000302584;;;ENST00000302584		Developmental and epileptic encephalopathy 72	618374	AD	3	Neurod2
17q12	17:39665349-39666554	TCAP, LGMDR7, CMH25	Telethonin	604488	TCAP	8557	ENSG00000173991,ENST00000309889;;;ENST00000309889		Cardiomyopathy, hypertrophic, 25	607487	AD	3	Tcap
17q12	17:39665349-39666554	TCAP, LGMDR7, CMH25	Telethonin	604488	TCAP	8557	ENSG00000173991,ENST00000309889;;;ENST00000309889		Muscular dystrophy, limb-girdle, autosomal recessive 7	601954	AR	3	Tcap
17q12	17:39671122-39688057	PGAP3, PERLD1, CAB2, MGC9753, HPMRS4	Post-GPI attachment to proteins 3	611801	PGAP3	93210	ENSG00000161395,ENST00000300658;;;ENST00000300658		Hyperphosphatasia with impaired intellectual development syndrome 4	615716	AR	3	Pgap3
17q12	17:39688094-39728658	ERBB2, NGL, NEU, HER2, VSCN2	Avian erythroblastic leukemia viral (v-erb-b2) oncogene homolog 2 (neuro/glioblastoma derived oncogene homolog)	164870	ERBB2	2064	ENSG00000141736,ENST00000269571;;;ENST00000269571	mutation identified in 1 VSCN2 family	?Visceral neuropathy, familial, 2, autosomal recessive	619465	AR	3	Erbb2
17q12	17:39688094-39728658	ERBB2, NGL, NEU, HER2, VSCN2	Avian erythroblastic leukemia viral (v-erb-b2) oncogene homolog 2 (neuro/glioblastoma derived oncogene homolog)	164870	ERBB2	2064	ENSG00000141736,ENST00000269571;;;ENST00000269571	mutation identified in 1 VSCN2 family	Adenocarcinoma of lung, somatic	211980		3	Erbb2
17q12	17:39688094-39728658	ERBB2, NGL, NEU, HER2, VSCN2	Avian erythroblastic leukemia viral (v-erb-b2) oncogene homolog 2 (neuro/glioblastoma derived oncogene homolog)	164870	ERBB2	2064	ENSG00000141736,ENST00000269571;;;ENST00000269571	mutation identified in 1 VSCN2 family	Gastric cancer, somatic	613659		3	Erbb2
17q12	17:39688094-39728658	ERBB2, NGL, NEU, HER2, VSCN2	Avian erythroblastic leukemia viral (v-erb-b2) oncogene homolog 2 (neuro/glioblastoma derived oncogene homolog)	164870	ERBB2	2064	ENSG00000141736,ENST00000269571;;;ENST00000269571	mutation identified in 1 VSCN2 family	Glioblastoma, somatic	137800		3	Erbb2
17q12	17:39688094-39728658	ERBB2, NGL, NEU, HER2, VSCN2	Avian erythroblastic leukemia viral (v-erb-b2) oncogene homolog 2 (neuro/glioblastoma derived oncogene homolog)	164870	ERBB2	2064	ENSG00000141736,ENST00000269571;;;ENST00000269571	mutation identified in 1 VSCN2 family	Ovarian cancer, somatic	167000		3	Erbb2
17q12-q21.1	17:39757715-39864312	IKZF3, ZNFN1A3, AIOLOS, IMD84	Ikaros family zinc finger 3	606221	IKZF3	22806	ENSG00000161405,ENST00000346872;;;ENST00000346872	mutation identified in 1 IMD84 family	?Immunodeficiency 84	619437	AD	3	Ikzf3
17q21	17:39800001-52100000	ASRT6	Asthma-related traits, susceptibility to, 6	611403		100188840		strongly associated with rs7216389	{Asthma-related traits, susceptibility to, 6}	611403		2	
17q21	17:39800001-52100000	AUTS7	Autism, susceptibility to, 7	610676		100188816		max lod at D17S2180	{Autism susceptibility 7}	610676		2	
17q21-q22	17:39800001-59500000	MYP5	Myopia 5	608474		404682		between D17S787 and D17S1811	Myopia 5	608474	AD	2	
17q21-q22	17:39800001-59500000	PTLAH, FPAH	Patella aplasia or hypoplasia	168860		8830			Patella aplasia or hypoplasia	168860	AD	2	
17q21.1	17:40062193-40093867	THRA, ERBA1, THRA1, CHNG6	Thyroid hormone receptor, alpha (oncogene ERBA1)	190120	THRA	7067	ENSG00000126351,ENST00000450525;;;ENST00000450525		Hypothyroidism, congenital, nongoitrous, 6	614450	AD	3	Thra
17q21.2	17:40200001-42800000	IBD22	Inflammatory bowel disease 22	612380		100240732		associated with rs744166	{Inflammatory bowel disease 22}	612380		2	
17q21.2	17:40287879-40304657	CDC6, CDC18L, MGORS5	Cell division cycle 6	602627	CDC6	990	ENSG00000094804,ENST00000209728;;;ENST00000209728		Meier-Gorlin syndrome 5	613805	AR	3	Cdc6
17q21.2	17:40309180-40357643	RARA	Retinoic acid receptor, alpha polypeptide	180240	RARA	5914	ENSG00000131759,ENST00000254066;;;ENST00000254066	fused with MYL in APL	Leukemia, acute promyelocytic	612376		1	Rara
17q21.2	17:40388525-40417896	TOP2A, TOP2	Topoisomerase (DNA) II, alpha, 170kD	126430	TOP2A	7153	ENSG00000131747,ENST00000423485;;;ENST00000423485		DNA topoisomerase II, resistance to inhibition of, by amsacrine			3	Top2a
17q21.2	17:40624962-40647818	SMARCE1, BAF57, CSS5	SWI/SNF-related, matrix-associated, actin-dependent regulator of chromatin, subfamily E, member 1	603111	SMARCE1	6605	ENSG00000073584,ENST00000348513;;;ENST00000348513		{Meningioma, familial, susceptibility to}	607174	AD	3	Smarce1
17q21.2	17:40624962-40647818	SMARCE1, BAF57, CSS5	SWI/SNF-related, matrix-associated, actin-dependent regulator of chromatin, subfamily E, member 1	603111	SMARCE1	6605	ENSG00000073584,ENST00000348513;;;ENST00000348513		Coffin-Siris syndrome 5	616938	AD	3	Smarce1
17q21.2	17:40748021-40755542	KRT25, K25, KRT24IRS1, ARWH3	Keratin 25, type I	616646	KRT25	147183	ENSG00000204897,ENST00000312150;;;ENST00000312150		Woolly hair, autosomal recessive 3	616760	AR	3	Krt25
17q21.2	17:40818117-40822614	KRT10, EHK2A, EHK2B, BCIE, BIE, IHL	Keratin 10	148080	KRT10	3858	ENSG00000186395,ENST00000269576;;;ENST00000269576	mutation identified in 1 IHL family	?Ichthyosis histrix, Lambert type	146600	AD	3	Krt10
17q21.2	17:40818117-40822614	KRT10, EHK2A, EHK2B, BCIE, BIE, IHL	Keratin 10	148080	KRT10	3858	ENSG00000186395,ENST00000269576;;;ENST00000269576	mutation identified in 1 IHL family	Epidermolytic hyperkeratosis 2A, autosomal dominant	620150	AD	3	Krt10
17q21.2	17:40818117-40822614	KRT10, EHK2A, EHK2B, BCIE, BIE, IHL	Keratin 10	148080	KRT10	3858	ENSG00000186395,ENST00000269576;;;ENST00000269576	mutation identified in 1 IHL family	Epidermolytic hyperkeratosis 2B, autosomal recessive	620707	AR	3	Krt10
17q21.2	17:40818117-40822614	KRT10, EHK2A, EHK2B, BCIE, BIE, IHL	Keratin 10	148080	KRT10	3858	ENSG00000186395,ENST00000269576;;;ENST00000269576	mutation identified in 1 IHL family	Ichthyosis with confetti	609165	AD	3	Krt10
17q21.2	17:40818117-40822614	KRT10, EHK2A, EHK2B, BCIE, BIE, IHL	Keratin 10	148080	KRT10	3858	ENSG00000186395,ENST00000269576;;;ENST00000269576	mutation identified in 1 IHL family	Ichthyosis, annular epidermolytic 1	607602	AD	3	Krt10
17q21.2	17:40861303-40867223	KRT12, MECD1	Keratin 12	601687	KRT12	3859	ENSG00000187242,ENST00000251643;;;ENST00000251643		Meesmann corneal dystrophy 1	122100	AD	3	Krt12
17q21.2	17:41500981-41505612	KRT13, WSN2	Keratin 13	148065	KRT13	3860	ENSG00000171401,ENST00000246635;;;ENST00000246635	in same PFGE fragment as KRT10, KRT15	White sponge nevus 2	615785	AD	3	Krt13
17q21.2	17:41565836-41572059	KRT9, EPPK1	Keratin 9	607606	KRT9	3857	ENSG00000171403,ENST00000246662;;;ENST00000246662		Palmoplantar keratoderma, epidermolytic, 1	144200	AD	3	Krt9
17q21.2	17:41582279-41586895	KRT14, EBS1A, EBS1B, EBS1C, EBS1D	Keratin 14	148066	KRT14	3861	ENSG00000186847,ENST00000167586;;;ENST00000167586		Dermatopathia pigmentosa reticularis	125595	AD	3	Krt14
17q21.2	17:41582279-41586895	KRT14, EBS1A, EBS1B, EBS1C, EBS1D	Keratin 14	148066	KRT14	3861	ENSG00000186847,ENST00000167586;;;ENST00000167586		Epidermolysis bullosa simplex 1A, generalized severe	131760	AD	3	Krt14
17q21.2	17:41582279-41586895	KRT14, EBS1A, EBS1B, EBS1C, EBS1D	Keratin 14	148066	KRT14	3861	ENSG00000186847,ENST00000167586;;;ENST00000167586		Epidermolysis bullosa simplex 1B, generalized intermediate	131900	AD	3	Krt14
17q21.2	17:41582279-41586895	KRT14, EBS1A, EBS1B, EBS1C, EBS1D	Keratin 14	148066	KRT14	3861	ENSG00000186847,ENST00000167586;;;ENST00000167586		Epidermolysis bullosa simplex 1C, localized	131800	AD	3	Krt14
17q21.2	17:41582279-41586895	KRT14, EBS1A, EBS1B, EBS1C, EBS1D	Keratin 14	148066	KRT14	3861	ENSG00000186847,ENST00000167586;;;ENST00000167586		Epidermolysis bullosa simplex 1D, generalized, intermediate or severe, autosomal recessive	601001	AR	3	Krt14
17q21.2	17:41582279-41586895	KRT14, EBS1A, EBS1B, EBS1C, EBS1D	Keratin 14	148066	KRT14	3861	ENSG00000186847,ENST00000167586;;;ENST00000167586		Naegeli-Franceschetti-Jadassohn syndrome	161000	AD	3	Krt14
17q21.2	17:41609778-41612767	KRT16, FNEPPK, PC1	Keratin 16	148067	KRT16	3868	ENSG00000186832,ENST00000301653;;;ENST00000301653	probably 17q21-q22	Pachyonychia congenita 1	167200	AD	3	Krt16
17q21.2	17:41609778-41612767	KRT16, FNEPPK, PC1	Keratin 16	148067	KRT16	3868	ENSG00000186832,ENST00000301653;;;ENST00000301653	probably 17q21-q22	Palmoplantar keratoderma, nonepidermolytic, focal	613000	AD	3	Krt16
17q21.2	17:41619442-41624575	KRT17, PC2, PCHC1	Keratin 17	148069	KRT17	3872	ENSG00000128422,ENST00000311208;;;ENST00000311208	~5' to KRT16; probably 17q21-q22	Pachyonychia congenita 2	167210	AD	3	Krt17
17q21.2	17:41619442-41624575	KRT17, PC2, PCHC1	Keratin 17	148069	KRT17	3872	ENSG00000128422,ENST00000311208;;;ENST00000311208	~5' to KRT16; probably 17q21-q22	Steatocystoma multiplex	184500	AD	3	Krt17
17q21.2	17:41754609-41786711	JUP, DP3, PDGB, ARVD12	Junction plakoglobin	173325	JUP	3728	ENSG00000173801,ENST00000393931;;;ENST00000393931	mutation identified in 1 ARVD12 family	?Arrhythmogenic right ventricular dysplasia 12	611528	AD	3	Jup
17q21.2	17:41754609-41786711	JUP, DP3, PDGB, ARVD12	Junction plakoglobin	173325	JUP	3728	ENSG00000173801,ENST00000393931;;;ENST00000393931	mutation identified in 1 ARVD12 family	Naxos disease	601214	AR	3	Jup
17q21.2	17:41813004-41823213	FKBP10, FKBP65, OI11, BRKS1	FK506-binding protein 10	607063	FKBP10	60681	ENSG00000141756,ENST00000321562;;;ENST00000321562		Bruck syndrome 1	259450	AR	3	Fkbp10
17q21.2	17:41813004-41823213	FKBP10, FKBP65, OI11, BRKS1	FK506-binding protein 10	607063	FKBP10	60681	ENSG00000141756,ENST00000321562;;;ENST00000321562		Osteogenesis imperfecta, type XI	610968	AR	3	Fkbp10
17q21.2	17:41835685-41848384	KLHL10, SPGF11	Kelch-like 10	608778	KLHL10	317719	ENSG00000161594,ENST00000293303;;;ENST00000293303		Spermatogenic failure 11	615081	AD	3	Klhl10
17q21.2	17:41930617-41966503	ODAD4, TTC25, CILD35	Outer dynein arm docking complex subunit 4	617095	ODAD4	83538	ENSG00000204815,ENST00000377540;;;ENST00000377540		Ciliary dyskinesia, primary, 35	617092	AR	3	Odad4
17q21.2	17:41966795-41977740	CNP, CNP1, HLD20	2', 3' cyclic nucleotide 3' phosphohydrolase	123830	CNP	1267	ENSG00000173786,ENST00000393892;;;ENST00000393892	mutation identified in 1 HLD20 family	?Leukodystrophy, hypomyelinating, 20	619071	AR	3	Cnp
17q21.2	17:42184060-42185452	HCRT, OX, NRCLP1	Hypocretin	602358	HCRT	3060	ENSG00000161610,ENST00000293330;;;ENST00000293330	mutation identified in 1 NRCLP1 patient	?Narcolepsy 1	161400	AD	3	Hcrt
17q21.2	17:42199177-42288370	STAT5B, GHISID2	Signal transducer and activator of transcription 5B	604260	STAT5B	6777	ENSG00000173757,ENST00000293328;;;ENST00000293328	fused with RARA in PML	Growth hormone insensitivity with immune dysregulation 1, autosomal recessive	245590	AR	3	Stat5b
17q21.2	17:42199177-42288370	STAT5B, GHISID2	Signal transducer and activator of transcription 5B	604260	STAT5B	6777	ENSG00000173757,ENST00000293328;;;ENST00000293328	fused with RARA in PML	Growth hormone insensitivity with immune dysregulation 2, autosomal dominant	618985	AD	3	Stat5b
17q21.2	17:42313324-42388442	STAT3, APRF, HIES, ADMIO1	Signal transducer and activator of transcription-3 (acute-phase response factor)	102582	STAT3	6774	ENSG00000168610,ENST00000264657;;;ENST00000264657		Autoimmune disease, multisystem, infantile-onset, 1	615952	AD	3	Stat3
17q21.2	17:42313324-42388442	STAT3, APRF, HIES, ADMIO1	Signal transducer and activator of transcription-3 (acute-phase response factor)	102582	STAT3	6774	ENSG00000168610,ENST00000264657;;;ENST00000264657		Hyper-IgE syndrome 1, autosomal dominant, with recurrent infections	147060	AD	3	Stat3
17q21.2	17:42402449-42423256	CAVIN1, PTRF	Caveolae-associated protein 1	603198	CAVIN1	284119	ENSG00000177469,ENST00000357037;;;ENST00000357037		Lipodystrophy, congenital generalized, type 4	613327	AR	3	Cavin1
17q21.2	17:42458878-42522579	ATP6V0A1, ATP6N1A, VPP1, DEE104, NEDEBA	ATPase, H+ transporting, V0 subunit A1	192130	ATP6V0A1	535	ENSG00000033627,ENST00000343619;;;ENST00000343619		Developmental and epileptic encephalopathy 104	619970	AD	3	Atp6v0a1
17q21.2	17:42458878-42522579	ATP6V0A1, ATP6N1A, VPP1, DEE104, NEDEBA	ATPase, H+ transporting, V0 subunit A1	192130	ATP6V0A1	535	ENSG00000033627,ENST00000343619;;;ENST00000343619		Neurodevelopmental disorder with epilepsy and brain atrophy	619971	AR	3	Atp6v0a1
17q21.2	17:42536241-42544449	NAGLU, MPS3B, CMT2V	N-acetylglucosaminidase, alpha-	609701	NAGLU	4669	ENSG00000108784,ENST00000225927;;;ENST00000225927	mutation identified in 1 CMT2V family	?Charcot-Marie-Tooth disease, axonal, type 2V	616491	AD	3	Naglu
17q21.2	17:42536241-42544449	NAGLU, MPS3B, CMT2V	N-acetylglucosaminidase, alpha-	609701	NAGLU	4669	ENSG00000108784,ENST00000225927;;;ENST00000225927	mutation identified in 1 CMT2V family	Mucopolysaccharidosis type IIIB (Sanfilippo B)	252920	AR	3	Naglu
17q21.2	17:42562148-42566277	COASY, NBIA6, PCH12	Coenzyme A synthase	609855	COASY	80347	ENSG00000068120,ENST00000393818;;;ENST00000393818		Neurodegeneration with brain iron accumulation 6	615643	AR	3	Coasy
17q21.2	17:42562148-42566277	COASY, NBIA6, PCH12	Coenzyme A synthase	609855	COASY	80347	ENSG00000068120,ENST00000393818;;;ENST00000393818		Pontocerebellar hypoplasia, type 12	618266	AR	3	Coasy
17q21.2	17:42572310-42577831	PSMC3IP, TBPIP, GT198, HOP2, ODG3	PSMC3-interacting protein	608665	PSMC3IP	29893	ENSG00000131470,ENST00000393795;;;ENST00000393795		Ovarian dysgenesis 3	614324	AR	3	Psmc3ip
17q21.2	17:42609683-42615238	TUBG1, CDCBM4	Tubulin, gamma 1	191135	TUBG1	7283	ENSG00000131462,ENST00000251413;;;ENST00000251413		Cortical dysplasia, complex, with other brain malformations 4	615412	AD	3	Tubg1
17q21.2	17:42682531-42699993	CNTNAP1, CASPR, P190, CHN3	Contactin-associated protein 1	602346	CNTNAP1	8506	ENSG00000108797,ENST00000264638;;;ENST00000264638		Hypomyelinating neuropathy, congenital, 3	618186	AR	3	Cntnap1
17q21.2	17:42682531-42699993	CNTNAP1, CASPR, P190, CHN3	Contactin-associated protein 1	602346	CNTNAP1	8506	ENSG00000108797,ENST00000264638;;;ENST00000264638		Lethal congenital contracture syndrome 7	616286	AR	3	Cntnap1
17q21.2	17:42780610-42797066	WNK4, PRKWNK4, PHA2B	WNK lysine deficient protein kinase 4	601844	WNK4	65266	ENSG00000126562,ENST00000246914;;;ENST00000246914		Pseudohypoaldosteronism, type IIB	614491	AD	3	Wnk4
17q21.2	17:42797625-42798704	COA3, CCDC56, MC4DN14	Cytochrome c oxidase assembly factor 3	614775	COA3	28958	ENSG00000183978,ENST00000328434;;;ENST00000328434	mutation identified in 1 MC4DN14 patient	?Mitochondrial complex IV deficiency, nuclear type 14	619058	AR	3	Coa3
17q21.31	17:42800001-46800000	DUP17q21.31, C17DUPq21.31	Chromosome 17q21.31 duplication syndrome	613533				contiguous gene duplication syndrome	Chromosome 17q21.31 duplication syndrome	613533		4	
17q21.31-q22	17:42800001-59500000	MRT35	Intellectual developmental disorder, autosomal recessive 35	615162		101409266		between rs4792947 and rs11079258	Intellectual developmental disorder, autosomal recessive 35	615162	AR	2	
17q21.31	17:42800001-46800000	VBCH	Van Buchem disease	239100				52-kb deletion 35 kb downlstream of SOST	van Buchem disease	239100	AR	4	
17q21.31	17:42900799-42914438	G6PC1, G6PC, G6PT	Glucose-6-phosphatase, catalytic, 1	613742	G6PC1	2538	ENSG00000131482,ENST00000253801;;;ENST00000253801		Glycogen storage disease Ia	232200	AR	3	G6pc1
17q21.31	17:42998273-43002959	RPL27, DBA16	Ribosomal protein L27	607526	RPL27	6155	ENSG00000131469,ENST00000253788;;;ENST00000253788	mutation identified in 1 DBA16 patient	?Diamond-Blackfan anemia 16	617408	AD	3	Rpl27
17q21.31	17:43044295-43170327	BRCA1, PSCP, BROVCA1, PNCA4, FANCS	BRCA1 DNA repair-associated protein	113705	BRCA1	672	ENSG00000012048,ENST00000357654;;;ENST00000357654		{Breast-ovarian cancer, familial, 1}	604370	AD	3	Brca1
17q21.31	17:43044295-43170327	BRCA1, PSCP, BROVCA1, PNCA4, FANCS	BRCA1 DNA repair-associated protein	113705	BRCA1	672	ENSG00000012048,ENST00000357654;;;ENST00000357654		{Pancreatic cancer, susceptibility to, 4}	614320		3	Brca1
17q21.31	17:43044295-43170327	BRCA1, PSCP, BROVCA1, PNCA4, FANCS	BRCA1 DNA repair-associated protein	113705	BRCA1	672	ENSG00000012048,ENST00000357654;;;ENST00000357654		Fanconi anemia, complementation group S	617883	AR	3	Brca1
17q21.31	17:43640389-43661922	MEOX1, MOX1, KFS2	Mesenchyme homeobox 1	600147	MEOX1	4222	ENSG00000005102,ENST00000318579;;;ENST00000318579		Klippel-Feil syndrome 2	214300	AR	3	Meox1
17q21.31	17:43753738-43758791	SOST, VBCH, CDD, SOST1	Sclerostin	605740	SOST	50964	ENSG00000167941,ENST00000301691;;;ENST00000301691		Craniodiaphyseal dysplasia, autosomal dominant	122860	AD	3	Sost
17q21.31	17:43753738-43758791	SOST, VBCH, CDD, SOST1	Sclerostin	605740	SOST	50964	ENSG00000167941,ENST00000301691;;;ENST00000301691		Sclerosteosis 1	269500	AR	3	Sost
17q21.31	17:44004622-44009068	NAGS	N-acetylglutamate synthase	608300	NAGS	162417	ENSG00000161653,ENST00000293404;;;ENST00000293404		N-acetylglutamate synthase deficiency	237310	AR	3	Nags
17q21.31	17:44070673-44076344	G6PC3, UGRP, SCN4	Glucose-6-phosphatase, catalytic, 3	611045	G6PC3	92579	ENSG00000141349,ENST00000269097;;;ENST00000269097		Dursun syndrome	612541	AR	3	G6pc3
17q21.31	17:44070673-44076344	G6PC3, UGRP, SCN4	Glucose-6-phosphatase, catalytic, 3	611045	G6PC3	92579	ENSG00000141349,ENST00000269097;;;ENST00000269097		Neutropenia, severe congenital 4, autosomal recessive	612541	AR	3	G6pc3
17q21.31	17:44141930-44162476	HROB, MCM8IP, C17orf53, ODG11	Homologous recombination factor with OB-fold	618611	HROB	78995	ENSG00000125319,ENST00000585683;;;ENST00000585683		Ovarian dysgenesis 11	620897	AR	3	Hrob
17q21.31	17:44191805-44199884	ATXN7L3, SGF11, HATONS	ATNX7-like 3	619010	ATXN7L3	56970	ENSG00000087152,ENST00000587097;;;ENST00000587097		Harel-Tora neurodevelopmental syndrome	621377	AD	3	Atxn7l3
17q21.31	17:44205040-44221304	UBTF, UBF, CONDBA	Upstream binding transcription factor, RNA polymerase I	600673	UBTF	7343	ENSG00000108312,ENST00000436088;;;ENST00000436088		Neurodegeneration, childhood-onset, with brain atrophy	617672	AD	3	Ubtf
17q21.31	17:44248390-44268135	SLC4A1, AE1, EPB3, SPH4, SAO, CHC	Solute carrier family 4, anion exchanger, member 1 (erythrocyte membrane protein band 3, Diego blood group)	109270	SLC4A1	6521	ENSG00000004939,ENST00000262418;;;ENST00000262418		[Blood group, Diego]	110500		3	Slc4a1
17q21.31	17:44248390-44268135	SLC4A1, AE1, EPB3, SPH4, SAO, CHC	Solute carrier family 4, anion exchanger, member 1 (erythrocyte membrane protein band 3, Diego blood group)	109270	SLC4A1	6521	ENSG00000004939,ENST00000262418;;;ENST00000262418		[Blood group, Froese]	601551		3	Slc4a1
17q21.31	17:44248390-44268135	SLC4A1, AE1, EPB3, SPH4, SAO, CHC	Solute carrier family 4, anion exchanger, member 1 (erythrocyte membrane protein band 3, Diego blood group)	109270	SLC4A1	6521	ENSG00000004939,ENST00000262418;;;ENST00000262418		[Blood group, Swann]	601550		3	Slc4a1
17q21.31	17:44248390-44268135	SLC4A1, AE1, EPB3, SPH4, SAO, CHC	Solute carrier family 4, anion exchanger, member 1 (erythrocyte membrane protein band 3, Diego blood group)	109270	SLC4A1	6521	ENSG00000004939,ENST00000262418;;;ENST00000262418		[Blood group, Waldner]	112010		3	Slc4a1
17q21.31	17:44248390-44268135	SLC4A1, AE1, EPB3, SPH4, SAO, CHC	Solute carrier family 4, anion exchanger, member 1 (erythrocyte membrane protein band 3, Diego blood group)	109270	SLC4A1	6521	ENSG00000004939,ENST00000262418;;;ENST00000262418		[Blood group, Wright]	112050		3	Slc4a1
17q21.31	17:44248390-44268135	SLC4A1, AE1, EPB3, SPH4, SAO, CHC	Solute carrier family 4, anion exchanger, member 1 (erythrocyte membrane protein band 3, Diego blood group)	109270	SLC4A1	6521	ENSG00000004939,ENST00000262418;;;ENST00000262418		{Malaria, resistance to}	611162		3	Slc4a1
17q21.31	17:44248390-44268135	SLC4A1, AE1, EPB3, SPH4, SAO, CHC	Solute carrier family 4, anion exchanger, member 1 (erythrocyte membrane protein band 3, Diego blood group)	109270	SLC4A1	6521	ENSG00000004939,ENST00000262418;;;ENST00000262418		Cryohydrocytosis	185020	AD	3	Slc4a1
17q21.31	17:44248390-44268135	SLC4A1, AE1, EPB3, SPH4, SAO, CHC	Solute carrier family 4, anion exchanger, member 1 (erythrocyte membrane protein band 3, Diego blood group)	109270	SLC4A1	6521	ENSG00000004939,ENST00000262418;;;ENST00000262418		Distal renal tubular acidosis 1	179800	AD	3	Slc4a1
17q21.31	17:44248390-44268135	SLC4A1, AE1, EPB3, SPH4, SAO, CHC	Solute carrier family 4, anion exchanger, member 1 (erythrocyte membrane protein band 3, Diego blood group)	109270	SLC4A1	6521	ENSG00000004939,ENST00000262418;;;ENST00000262418		Distal renal tubular acidosis 4 with hemolytic anemia	611590	AR	3	Slc4a1
17q21.31	17:44248390-44268135	SLC4A1, AE1, EPB3, SPH4, SAO, CHC	Solute carrier family 4, anion exchanger, member 1 (erythrocyte membrane protein band 3, Diego blood group)	109270	SLC4A1	6521	ENSG00000004939,ENST00000262418;;;ENST00000262418		Ovalocytosis, SA type	166900	AD	3	Slc4a1
17q21.31	17:44248390-44268135	SLC4A1, AE1, EPB3, SPH4, SAO, CHC	Solute carrier family 4, anion exchanger, member 1 (erythrocyte membrane protein band 3, Diego blood group)	109270	SLC4A1	6521	ENSG00000004939,ENST00000262418;;;ENST00000262418		Spherocytosis, type 4	612653	AD	3	Slc4a1
17q21.31	17:44345302-44353106	GRN, CLN11, FTD2	Granulin	138945	GRN	2896	ENSG00000030582,ENST00000053867;;;ENST00000053867		Aphasia, primary progressive	607485	AD, AR	3	Grn
17q21.31	17:44345302-44353106	GRN, CLN11, FTD2	Granulin	138945	GRN	2896	ENSG00000030582,ENST00000053867;;;ENST00000053867		Ceroid lipofuscinosis, neuronal, 11	614706	AR	3	Grn
17q21.31	17:44345302-44353106	GRN, CLN11, FTD2	Granulin	138945	GRN	2896	ENSG00000030582,ENST00000053867;;;ENST00000053867		Frontotemporal dementia 2	607485	AD, AR	3	Grn
17q21.31	17:44372181-44389649	ITGA2B, GP2B, CD41B, GT1, BDPLT2, BDPLT16, FMAIT2	Integrin, alpha-2b (platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41B)	607759	ITGA2B	3674	ENSG00000005961,ENST00000262407;;;ENST00000262407	3' to GP3A; BAK platelet antigen	Bleeding disorder, platelet-type, 16, autosomal dominant	187800	AD	3	Itga2b
17q21.31	17:44372181-44389649	ITGA2B, GP2B, CD41B, GT1, BDPLT2, BDPLT16, FMAIT2	Integrin, alpha-2b (platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41B)	607759	ITGA2B	3674	ENSG00000005961,ENST00000262407;;;ENST00000262407	3' to GP3A; BAK platelet antigen	Fetomaternal alloimmune thrombocytopenia 2	621266	AD	3	Itga2b
17q21.31	17:44372181-44389649	ITGA2B, GP2B, CD41B, GT1, BDPLT2, BDPLT16, FMAIT2	Integrin, alpha-2b (platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41B)	607759	ITGA2B	3674	ENSG00000005961,ENST00000262407;;;ENST00000262407	3' to GP3A; BAK platelet antigen	Glanzmann thrombasthenia 1	273800	AR	3	Itga2b
17q21.31	17:44557484-44561262	FZD2, OMOD2	Frizzled class receptor 2	600667	FZD2	2535	ENSG00000180340,ENST00000315323;;;ENST00000315323		Omodysplasia 2	164745	AD	3	Fzd2
17q21.31	17:44849948-44899445	EFTUD2, KIAA0031, MFDGA	Elongation factor Tu GTP-binding domain-containing 2	603892	EFTUD2	9343	ENSG00000108883,ENST00000426333;;;ENST00000426333		Mandibulofacial dysostosis, Guion-Almeida type	610536	AD	3	Eftud2
17q21.31	17:44899729-44905390	DNAAF19, CCDC103, SMH, PR46B, CILD17	Dynein, axonemal, assembly factor 19	614677	DNAAF19	388389	ENSG00000167131,ENST00000417826;;;ENST00000417826		Ciliary dyskinesia, primary, 17	614679	AR	3	Ccdc103
17q21.31	17:44903159-44915500	GFAP, ALXDRD	Glial fibrillary acidic protein	137780	GFAP	2670	ENSG00000131095,ENST00000588735;;;ENST00000588735		Alexander disease	203450	AD	3	Gfap
17q21.31	17:45263119-45317020	MAP3K14, NIK, HSNIK, IMD112	Mitogen-activated protein kinase kinase kinase-14	604655	MAP3K14	9020	ENSG00000006062,ENST00000344686;;;ENST00000344686		Immunodeficiency 112	620449	AR	3	Map3k14
17q21.31	17:45434209-45490721	PLEKHM1, AP162, KIAA0356, OPTB6, OPTA3	Pleckstrin homology domain-containing protein, family M, member 1	611466	PLEKHM1	9842	ENSG00000225190,ENST00000430334;;;ENST00000430334	mutation identified in 1 OPTB6 family	?Osteopetrosis, autosomal recessive 6	611497	AR	3	Plekhm1
17q21.31	17:45434209-45490721	PLEKHM1, AP162, KIAA0356, OPTB6, OPTA3	Pleckstrin homology domain-containing protein, family M, member 1	611466	PLEKHM1	9842	ENSG00000225190,ENST00000430334;;;ENST00000430334	mutation identified in 1 OPTB6 family	Osteopetrosis, autosomal dominant 3	618107	AD	3	Plekhm1
17q21.31	17:45894554-46028334	MAPT, MTBT1, DDPAC, MSTD, FTD1	Microtubule-associated protein tau	157140	MAPT	4137	ENSG00000186868,ENST00000262410;;;ENST00000262410	see 6p21	{Parkinson disease, susceptibility to}	168600	AD, Mu	3	Mapt
17q21.31	17:45894554-46028334	MAPT, MTBT1, DDPAC, MSTD, FTD1	Microtubule-associated protein tau	157140	MAPT	4137	ENSG00000186868,ENST00000262410;;;ENST00000262410	see 6p21	Frontotemporal dementia 1, with or without parkinsonism	600274	AD	3	Mapt
17q21.31	17:45894554-46028334	MAPT, MTBT1, DDPAC, MSTD, FTD1	Microtubule-associated protein tau	157140	MAPT	4137	ENSG00000186868,ENST00000262410;;;ENST00000262410	see 6p21	Pick disease	172700	AD	3	Mapt
17q21.31	17:45894554-46028334	MAPT, MTBT1, DDPAC, MSTD, FTD1	Microtubule-associated protein tau	157140	MAPT	4137	ENSG00000186868,ENST00000262410;;;ENST00000262410	see 6p21	Supranuclear palsy, progressive	601104	AD	3	Mapt
17q21.31	17:45894554-46028334	MAPT, MTBT1, DDPAC, MSTD, FTD1	Microtubule-associated protein tau	157140	MAPT	4137	ENSG00000186868,ENST00000262410;;;ENST00000262410	see 6p21	Supranuclear palsy, progressive atypical	260540	AR	3	Mapt
17q21.31	17:46029916-46225367	KANSL1, KIAA1267, MSL1V1, KDVS	KAT8 regulatory NSL complex subunit 1	612452	KANSL1	284058	ENSG00000120071,ENST00000432791;;;ENST00000432791		Koolen-De Vries syndrome	610443	AD	3	Kansl1
17q21.31	17:46590669-46757464	NSF, DEE96	N-ethylmaleimide-sensitive factor	601633	NSF	4905	ENSG00000073969,ENST00000398238;;;ENST00000398238		Developmental and epileptic encephalopathy 96	619340	AD	3	Nsf
17q21.31-q21.32	17:46762506-46818692	WNT3, INT4, TETAMS	Wingless-type MMTV integration site family, member 3	165330	WNT3	7473	ENSG00000108379,ENST00000225512;;;ENST00000225512	mutation identified in 1 TETAMS1 family	?Tetra-amelia syndrome 1	273395	AR	3	Wnt3
17q21.32	17:46923160-46975890	GOSR2, GS27, EPM6, MYOS	Golgi snap receptor complex member 2	604027	GOSR2	9570	ENSG00000108433,ENST00000640051;;;ENST00000640051		Epilepsy, progressive myoclonic 6	614018	AR	3	Gosr2
17q21.32	17:46923160-46975890	GOSR2, GS27, EPM6, MYOS	Golgi snap receptor complex member 2	604027	GOSR2	9570	ENSG00000108433,ENST00000640051;;;ENST00000640051		Muscular dystrophy, congenital, with or without seizures	620166	AR	3	Gosr2
17q21.32	17:47189433-47227650	MYL4	Myosin, light polypeptide-4, alkali, atrial, embryonic	160770	MYL4	4635	ENSG00000198336,ENST00000393450;;;ENST00000393450	mutation identified in 1 ATFB18 family	?Atrial fibrillation, familial, 18	617280	AD	3	Myl4
17q21.32	17:47253827-47313743	ITGB3, GP3A, GT2, BDPLT24, FMAIT1	Integrin, beta-3 (platelet glycoprotein IIIa; antigen CD61)	173470	ITGB3	3690	ENSG00000259207,ENST00000559488;;;ENST00000559488	in same 260kb fragment as GP2B; PL(A) platelet antigen	Bleeding disorder, platelet-type, 24, autosomal dominant	619271	AD	3	Itgb3
17q21.32	17:47253827-47313743	ITGB3, GP3A, GT2, BDPLT24, FMAIT1	Integrin, beta-3 (platelet glycoprotein IIIa; antigen CD61)	173470	ITGB3	3690	ENSG00000259207,ENST00000559488;;;ENST00000559488	in same 260kb fragment as GP2B; PL(A) platelet antigen	Fetomaternal alloimmune thrombocytopenia 1	621264	AD	3	Itgb3
17q21.32	17:47253827-47313743	ITGB3, GP3A, GT2, BDPLT24, FMAIT1	Integrin, beta-3 (platelet glycoprotein IIIa; antigen CD61)	173470	ITGB3	3690	ENSG00000259207,ENST00000559488;;;ENST00000559488	in same 260kb fragment as GP2B; PL(A) platelet antigen	Glanzmann thrombasthenia 2	619267	AR	3	Itgb3
17q21.32	17:47733236-47746122	TBX21, TBET, IMD88	T-box 21	604895	TBX21	30009	ENSG00000073861,ENST00000177694;;;ENST00000177694	mutation identified in 1 IMD88 patient	?Immunodeficiency 88	619630	AR	3	Tbx21
17q21.32	17:47733236-47746122	TBX21, TBET, IMD88	T-box 21	604895	TBX21	30009	ENSG00000073861,ENST00000177694;;;ENST00000177694	mutation identified in 1 IMD88 patient	{Asthma, aspirin-induced, susceptibility to}	208550	AR	3	Tbx21
17q21.32	17:47733236-47746122	TBX21, TBET, IMD88	T-box 21	604895	TBX21	30009	ENSG00000073861,ENST00000177694;;;ENST00000177694	mutation identified in 1 IMD88 patient	Asthma and nasal polyps	208550	AR	3	Tbx21
17q21.32	17:47844908-47876311	SP6, KLF14, EPFN, AI1K	Transcription factor Sp6	608613	SP6	80320	ENSG00000189120,ENST00000536300;;;ENST00000536300		Amelogenesis imperfecta, type IK	620104	AD	3	Sp6
17q21.32	17:47941571-47949308	PNPO	Pyridoxamine 5'-phosphate oxidase	603287	PNPO	55163	ENSG00000108439,ENST00000642017;;;ENST00000642017		Pyridoxamine 5'-phosphate oxidase deficiency	610090	AR	3	Pnpo
17q21.32	17:48528526-48531011	HOXB1, HOX2I, HCFP3	Homeobox-B1	142968	HOXB1	3211	ENSG00000120094,ENST00000239174;;;ENST00000239174		Facial paresis, hereditary congenital, 3	614744	AR	3	Hoxb1
17q21.32	17:48724763-48728750	HOXB13, HPC9	Homeobox B13	604607	HOXB13	10481	ENSG00000159184,ENST00000290295;;;ENST00000290295		{Prostate cancer, hereditary, 9}	610997		3	Hoxb13
17q21.32	17:48929316-48944842	SNF8, VPS22, EAP30, DEE115, NEDOA	SNF8 subunit of ESCRIT-II	610904	SNF8	11267	ENSG00000159210,ENST00000502492;;;ENST00000502492		Developmental and epileptic encephalopathy 115	620783	AR	3	Snf8
17q21.32	17:48929316-48944842	SNF8, VPS22, EAP30, DEE115, NEDOA	SNF8 subunit of ESCRIT-II	610904	SNF8	11267	ENSG00000159210,ENST00000502492;;;ENST00000502492		Neurodevelopmental disorder plus optic atrophy	620784	AR	3	Snf8
17q21.32	17:49120344-49176840	B4GALNT2, GALGT2, SD, SDA	Beta-1,4-N-acetyl-galactosaminyl transferase 2	111730	B4GALNT2	124872	ENSG00000167080,ENST00000393354;;;ENST00000393354		[Blood group, Sid system]	615018		3	B4galnt2
17q21.32	17:49120344-49176840	B4GALNT2, GALGT2, SD, SDA	Beta-1,4-N-acetyl-galactosaminyl transferase 2	111730	B4GALNT2	124872	ENSG00000167080,ENST00000393354;;;ENST00000393354		Sd(a) polyagglutination syndrome	615018		3	B4galnt2
17q21.33	17:49404052-49414882	PHB1	Prohibitin 1	176705	PHB1	5245	ENSG00000167085,ENST00000300408;;;ENST00000300408		{Breast cancer, susceptibility to}	114480	AD, SMu	3	Phb1
17q21.33	17:49598884-49678163	SPOP, NSDVS1, NSDVS2	Speckle-type POZ protein	602650	SPOP	8405	ENSG00000121067,ENST00000504102;;;ENST00000504102		Nabais Sa-de Vries syndrome, type 1	618828	AD	3	Spop,Spopfm2,Spopfm3,Tdpoz1,Tdpoz2,Tdpoz3,Tdpoz4,Tdpoz5,Tdpoz6,Tdpoz8,Tdpoz9
17q21.33	17:49598884-49678163	SPOP, NSDVS1, NSDVS2	Speckle-type POZ protein	602650	SPOP	8405	ENSG00000121067,ENST00000504102;;;ENST00000504102		Nabais Sa-de Vries syndrome, type 2	618829	AD	3	Spop,Spopfm2,Spopfm3,Tdpoz1,Tdpoz2,Tdpoz3,Tdpoz4,Tdpoz5,Tdpoz6,Tdpoz8,Tdpoz9
17q21.33	17:49968572-49974959	DLX4, DLX7, DLX8, OFC15	Distal-less homeobox 4	601911	DLX4	1748	ENSG00000108813,ENST00000240306;;;ENST00000240306	mutation identified in 1 OFC15 family	?Orofacial cleft 15	616788	AD	3	Dlx4
17q21.33	17:49990005-49995224	DLX3, TDO, AI4	Distal-less homeobox 3	600525	DLX3	1747	ENSG00000064195,ENST00000434704;;;ENST00000434704		Amelogenesis imperfecta, type IV	104510	AD	3	Dlx3
17q21.33	17:49990005-49995224	DLX3, TDO, AI4	Distal-less homeobox 3	600525	DLX3	1747	ENSG00000064195,ENST00000434704;;;ENST00000434704		Trichodontoosseous syndrome	190320	AD	3	Dlx3
17q21.33	17:50056110-50090481	ITGA3, CD49C, GAPB3, JEB7	Integrin, alpha-3	605025	ITGA3	3675	ENSG00000005884,ENST00000320031;;;ENST00000320031		Epidermolysis bullosa, junctional 7, with interstitial lung disease and nephrotic syndrome	614748	AR	3	Itga3
17q21.33	17:50166005-50175928	SGCA, ADL, DAG2, LGMDR3	Sarcoglycan, alpha (50kD dystrophin-associated glycoprotein; adhalin)	600119	SGCA	6442	ENSG00000108823,ENST00000262018;;;ENST00000262018		Muscular dystrophy, limb-girdle, autosomal recessive 3	608099	AR	3	Sgca
17q21.33	17:50184101-50201631	COL1A1, OI1, OI2, OI3, OI4, EDSARTH1, CAFYD	Collagen I, alpha-1 polypeptide	120150	COL1A1	1277	ENSG00000108821,ENST00000225964;;;ENST00000225964	fused with PDGFB in DFPB	{Bone mineral density variation QTL, osteoporosis}	166710	AD	3	Col1a1
17q21.33	17:50184101-50201631	COL1A1, OI1, OI2, OI3, OI4, EDSARTH1, CAFYD	Collagen I, alpha-1 polypeptide	120150	COL1A1	1277	ENSG00000108821,ENST00000225964;;;ENST00000225964	fused with PDGFB in DFPB	Caffey disease	114000	AD	3	Col1a1
17q21.33	17:50184101-50201631	COL1A1, OI1, OI2, OI3, OI4, EDSARTH1, CAFYD	Collagen I, alpha-1 polypeptide	120150	COL1A1	1277	ENSG00000108821,ENST00000225964;;;ENST00000225964	fused with PDGFB in DFPB	Combined osteogenesis imperfecta and Ehlers-Danlos syndrome 1	619115	AD	3	Col1a1
17q21.33	17:50184101-50201631	COL1A1, OI1, OI2, OI3, OI4, EDSARTH1, CAFYD	Collagen I, alpha-1 polypeptide	120150	COL1A1	1277	ENSG00000108821,ENST00000225964;;;ENST00000225964	fused with PDGFB in DFPB	Ehlers-Danlos syndrome, arthrochalasia type, 1	130060	AD	3	Col1a1
17q21.33	17:50184101-50201631	COL1A1, OI1, OI2, OI3, OI4, EDSARTH1, CAFYD	Collagen I, alpha-1 polypeptide	120150	COL1A1	1277	ENSG00000108821,ENST00000225964;;;ENST00000225964	fused with PDGFB in DFPB	Osteogenesis imperfecta, type I	166200	AD	3	Col1a1
17q21.33	17:50184101-50201631	COL1A1, OI1, OI2, OI3, OI4, EDSARTH1, CAFYD	Collagen I, alpha-1 polypeptide	120150	COL1A1	1277	ENSG00000108821,ENST00000225964;;;ENST00000225964	fused with PDGFB in DFPB	Osteogenesis imperfecta, type II	166210	AD	3	Col1a1
17q21.33	17:50184101-50201631	COL1A1, OI1, OI2, OI3, OI4, EDSARTH1, CAFYD	Collagen I, alpha-1 polypeptide	120150	COL1A1	1277	ENSG00000108821,ENST00000225964;;;ENST00000225964	fused with PDGFB in DFPB	Osteogenesis imperfecta, type III	259420	AD	3	Col1a1
17q21.33	17:50184101-50201631	COL1A1, OI1, OI2, OI3, OI4, EDSARTH1, CAFYD	Collagen I, alpha-1 polypeptide	120150	COL1A1	1277	ENSG00000108821,ENST00000225964;;;ENST00000225964	fused with PDGFB in DFPB	Osteogenesis imperfecta, type IV	166220	AD	3	Col1a1
17q21.33	17:50346126-50361185	XYLT2, XT2, SOS	Xylosyltransferase 2	608125	XYLT2	64132	ENSG00000015532,ENST00000017003;;;ENST00000017003		{Pseudoxanthoma elasticum, modifier of severity of}	264800	AR	3	Xylt2
17q21.33	17:50346126-50361185	XYLT2, XT2, SOS	Xylosyltransferase 2	608125	XYLT2	64132	ENSG00000015532,ENST00000017003;;;ENST00000017003		Spondyloocular syndrome	605822	AR	3	Xylt2
17q21.33	17:50560715-50627474	CACNA1G, SCA42, SCA42ND	Calcium channel, voltage-dependent, T type, alpha-1G subunit	604065	CACNA1G	8913	ENSG00000006283,ENST00000359106;;;ENST00000359106		Spinocerebellar ataxia 42	616795	AD	3	Cacna1g
17q21.33	17:50560715-50627474	CACNA1G, SCA42, SCA42ND	Calcium channel, voltage-dependent, T type, alpha-1G subunit	604065	CACNA1G	8913	ENSG00000006283,ENST00000359106;;;ENST00000359106		Spinocerebellar ataxia 42, early-onset, severe, with neurodevelopmental deficits	618087	AD	3	Cacna1g
17q22	17:54951902-54968785	COX11, MC4DN23	Cytochrome c oxidase, subunit 11	603648	COX11	1353	ENSG00000166260,ENST00000299335;;;ENST00000299335	pseudogene on 6p23-p22	Mitochondrial complex IV deficiency, nuclear type 23	620275	AR	3	Cox11
17q22	17:56593699-56595611	NOG, SYM1, SYNS1A	Noggin	602991	NOG	9241	ENSG00000183691,ENST00000332822;;;ENST00000332822		Brachydactyly, type B2	611377	AD	3	Nog
17q22	17:56593699-56595611	NOG, SYM1, SYNS1A	Noggin	602991	NOG	9241	ENSG00000183691,ENST00000332822;;;ENST00000332822		Multiple synostoses syndrome 1	186500	AD	3	Nog
17q22	17:56593699-56595611	NOG, SYM1, SYNS1A	Noggin	602991	NOG	9241	ENSG00000183691,ENST00000332822;;;ENST00000332822		Stapes ankylosis with broad thumbs and toes	184460	AD	3	Nog
17q22	17:56593699-56595611	NOG, SYM1, SYNS1A	Noggin	602991	NOG	9241	ENSG00000183691,ENST00000332822;;;ENST00000332822		Symphalangism, proximal, 1A	185800	AD	3	Nog
17q22	17:56593699-56595611	NOG, SYM1, SYNS1A	Noggin	602991	NOG	9241	ENSG00000183691,ENST00000332822;;;ENST00000332822		Tarsal-carpal coalition syndrome	186570	AD	3	Nog
17q22	17:56834151-56869567	DGKE, NPHS7, AHUS7	Diacylglycerol kinase, epsilon, 64-kD	601440	DGKE	8526	ENSG00000153933,ENST00000284061;;;ENST00000284061		{Hemolytic uremic syndrome, atypical, susceptibility to, 7}	615008	AR	3	Dgke
17q22	17:56834151-56869567	DGKE, NPHS7, AHUS7	Diacylglycerol kinase, epsilon, 64-kD	601440	DGKE	8526	ENSG00000153933,ENST00000284061;;;ENST00000284061		Nephrotic syndrome, type 7	615008	AR	3	Dgke
17q22	17:57834781-57850044	MRPS23, COXPD46	Mitochondrial ribosomal protein S23	611985	MRPS23	51649	ENSG00000181610,ENST00000313608;;;ENST00000313608	mutation identified in 1 COXPD46 patient	?Combined oxidative phosphorylation deficiency 46	618952	AR	3	Mrps23
17q22	17:57971552-57988254	VEZF1, ZNF161, CMD1OO	Vascular endothelial zinc finger 1	606747	VEZF1	7716	ENSG00000136451,ENST00000581208;;;ENST00000581208	mutation identified in 1 CMD1OO family	?Cardiomyopathy, dilated, 1OO	620247	AD	3	Vezf1
17q22	17:57989038-58007246	SRSF1, SFRS1, ASF, SF2, SRp30a, NEDFBA	Splicing factor, arginine/serine-rich 1 (splicing factor 2, alternate splicing factor)	600812	SRSF1	6426	ENSG00000136450,ENST00000258962;;;ENST00000258962		Neurodevelopmental disorder with dysmorphic facies and behavioral abnormalities	620489	AD	3	Srsf1
17q22	17:58192726-58205174	EPX, EPXD	Eosinophil peroxidase	131399	EPX	8288	ENSG00000121053,ENST00000225371;;;ENST00000225371		[Eosinophil peroxidase deficiency]	261500	AR	3	Epx
17q22	17:58205441-58219255	MKS1, MKS, BBS13, JBTS28	MKS1 transition zone complex subunit 1	609883	MKS1	54903	ENSG00000011143,ENST00000393119;;;ENST00000393119	frequent in Finland	Bardet-Biedl syndrome 13	615990	AR	3	Mks1
17q22	17:58205441-58219255	MKS1, MKS, BBS13, JBTS28	MKS1 transition zone complex subunit 1	609883	MKS1	54903	ENSG00000011143,ENST00000393119;;;ENST00000393119	frequent in Finland	Joubert syndrome 28	617121	AR	3	Mks1
17q22	17:58205441-58219255	MKS1, MKS, BBS13, JBTS28	MKS1 transition zone complex subunit 1	609883	MKS1	54903	ENSG00000011143,ENST00000393119;;;ENST00000393119	frequent in Finland	Meckel syndrome 1	249000	AR	3	Mks1
17q22	17:58269855-58280935	MPO	Myeloperoxidase	606989	MPO	4353	ENSG00000005381,ENST00000225275;;;ENST00000225275	translocated in t(15;17)(q22;q11.2)	{Alzheimer disease, susceptibility to}	104300	AD	3	Mpo
17q22	17:58269855-58280935	MPO	Myeloperoxidase	606989	MPO	4353	ENSG00000005381,ENST00000225275;;;ENST00000225275	translocated in t(15;17)(q22;q11.2)	{Lung cancer, protection against, in smokers}			3	Mpo
17q22	17:58269855-58280935	MPO	Myeloperoxidase	606989	MPO	4353	ENSG00000005381,ENST00000225275;;;ENST00000225275	translocated in t(15;17)(q22;q11.2)	Myeloperoxidase deficiency	254600	AR	3	Mpo
17q22	17:58301231-58328795	TSPOAP1, RIMBP1, KIAA0612, BZRAP1, PRAX1, DYT22	TSPO associated protein 1	610764	TSPOAP1	9256	ENSG00000005379,ENST00000343736;;;ENST00000343736	mutation identified in 1 DYT22AO	?Dystonia 22, adult-onset	620456	AR	3	Tspoap1
17q22	17:58301231-58328795	TSPOAP1, RIMBP1, KIAA0612, BZRAP1, PRAX1, DYT22	TSPO associated protein 1	610764	TSPOAP1	9256	ENSG00000005379,ENST00000343736;;;ENST00000343736	mutation identified in 1 DYT22AO	Dystonia 22, juvenile-onset	620453	AR	3	Tspoap1
17q22	17:58352500-58417534	RNF43, RNF124, SSPCS	RING finger protein 43	612482	RNF43	54894	ENSG00000108375,ENST00000407977;;;ENST00000407977		Sessile serrated polyposis cancer syndrome	617108	AD	3	Rnf43
17q22	17:58520256-58544328	SEPTIN4, SEPT4, PNUTL2, SPGF99	Septin 4	603696	SEPTIN4	5414	ENSG00000108387,ENST00000672673;;;ENST00000672673		Spermatogenic failure 99	621194	AR	3	Septin4
17q22	17:58556678-58692045	TEX14, SPGF23	Testis-expressed gene 14	605792	TEX14	56155	ENSG00000121101,ENST00000349033;;;ENST00000349033		Spermatogenic failure 23	617707	AR	3	Tex14
17q22	17:58692573-58735611	RAD51C, FANCO, BROVCA3	RAD52 paralog C	602774	RAD51C	5889	ENSG00000108384,ENST00000337432;;;ENST00000337432		{Breast-ovarian cancer, familial, susceptibility to, 3}	613399		3	Rad51c
17q22	17:58692573-58735611	RAD51C, FANCO, BROVCA3	RAD52 paralog C	602774	RAD51C	5889	ENSG00000108384,ENST00000337432;;;ENST00000337432		Fanconi anemia, complementation group O	613390	AR	3	Rad51c
17q22	17:58967201-59106880	TRIM37, MUL, KIAA0898	Tripartite motif-containing 37	605073	TRIM37	4591	ENSG00000108395,ENST00000262294;;;ENST00000262294		Mulibrey nanism	253250	AR	3	Trim37
17q22	17:59210035-59215230	SMG8, C17orf71, ALKUS	SMG8 nonsense-mediated mRNA decay factor	613175	SMG8	55181	ENSG00000167447,ENST00000300917;;;ENST00000300917		Alzahrani-Kuwahara syndrome	619268	AR	3	Smg8
17q23	17:59500001-64600000	BSZQTL	Bone size quantitative trait locus 1	609656		100188793			{Bone size QTL}	609656		2	
17q23.1-q23.2	17:59500001-63100000	DEL17q23.1q23.2, C17DELq23.1q23.2	Chromosome 17q23.1-q23.2 deletion syndrome	613355					Chromosome 17q23.1-q23.2 deletion syndrome	613355	IC	4	
17q23.1-q23.2	17:59500001-63100000	DUP17q23.1q23.2, C17DUPq23.1q23.2	Chromosome 17q23.1-q23.2 duplication syndrome	613618				2.2 Mb contiguous gene duplication syndrome	Chromosome 17q23.1-q23.2 duplication syndrome	613618	AD	4	
17q23.1	17:59619895-59696956	CLTC, MRD56	Clathrin, heavy polypeptide (Hc)	118955	CLTC	1213	ENSG00000141367,ENST00000269122;;;ENST00000269122	fusion gene with TFE3 in renal adenocarcinoma	Intellectual developmental disorder, autosomal dominant 56	617854	AD	3	Cltc
17q23.1	17:59697308-59707430	PTRH2, BIT1, IMNEPD	Peptidyl-tRNA hydrolase 2	608625	PTRH2	51651	ENSG00000141378,ENST00000393038;;;ENST00000393038		Infantile-onset multisystem neurologic, endocrine, and pancreatic disease	616263	AR	3	Ptrh2
17q23.2-q25.1	17:60200001-76800000	BMIQ15	Body mass index quantitative trait locus 15	612967		100302719		associated with rs228883 and rs1005651	[Body mass index QTL 15]	612967		2	
17q23.2	17:60200001-63100000	RP17	Retinitis pigmentosa 17	600852					Retinitis pigmentosa 17	600852	AD	4	
17q23.2	17:60600193-60666280	PPM1D, WIP1, JDVS	Protein phosphatase, magnesium-dependent, 1, delta isoform	605100	PPM1D	8493	ENSG00000170836,ENST00000305921;;;ENST00000305921	amplified in breast cancer	Breast cancer, somatic	114480		3	Ppm1d
17q23.2	17:60600193-60666280	PPM1D, WIP1, JDVS	Protein phosphatase, magnesium-dependent, 1, delta isoform	605100	PPM1D	8493	ENSG00000170836,ENST00000305921;;;ENST00000305921	amplified in breast cancer	Jansen-de Vries syndrome	617450	AD	3	Ppm1d
17q23.2	17:60677851-61392831	BCAS3, HEMARS	BCAS3 microtubule associated cell migration factor	607470	BCAS3	54828	ENSG00000141376,ENST00000407086;;;ENST00000407086		Hengel-Maroofian-Schols syndrome	619641	AR	3	Bcas3
17q23.2	17:61399843-61409466	TBX2, VETD	T-box 2	600747	TBX2	6909	ENSG00000121068,ENST00000240328;;;ENST00000240328		Vertebral anomalies and variable endocrine and T-cell dysfunction	618223	AD	3	Tbx2
17q23.2	17:61452422-61485110	TBX4, ICPPS, PAPPAS	T-box 4	601719	TBX4	9496	ENSG00000121075,ENST00000644296;;;ENST00000644296		Amelia, posterior, with pelvic and pulmonary hypoplasia syndrome	601360	AR	3	Tbx4
17q23.2	17:61452422-61485110	TBX4, ICPPS, PAPPAS	T-box 4	601719	TBX4	9496	ENSG00000121075,ENST00000644296;;;ENST00000644296		Ischiocoxopodopatellar syndrome with or without pulmonary arterial hypertension	147891	AD	3	Tbx4
17q23.2	17:61679139-61863528	BRIP1, BACH1, FANCJ	BRCA1-associated C-terminal helicase 1	605882	BRIP1	83990	ENSG00000136492,ENST00000259008;;;ENST00000259008	?or 17q23	{Breast cancer, early-onset, susceptibility to}	114480	AD, SMu	3	Brip1
17q23.2	17:61679139-61863528	BRIP1, BACH1, FANCJ	BRCA1-associated C-terminal helicase 1	605882	BRIP1	83990	ENSG00000136492,ENST00000259008;;;ENST00000259008	?or 17q23	Fanconi anemia, complementation group J	609054		3	Brip1
17q23.2	17:61942605-62065278	MED13, THRAP1, TRAP240, MRD61	Mediator complex subunit 13	603808	MED13	9969	ENSG00000108510,ENST00000397786;;;ENST00000397786		Intellectual developmental disorder, autosomal dominant 61	618009	AD	3	Med13
17q23.2	17:62470914-62615481	TLK2, MRD57	Tousled-like kinase 2	608439	TLK2	11011	ENSG00000146872,ENST00000346027;;;ENST00000346027		Intellectual developmental disorder, autosomal dominant 57	618050	AD	3	Tlk2
17q23.2-q23.3	17:62966235-63427703	TANC2, KIAA1636, IDDALDS	Tetratricopeptide repeat-, ankyrin repeat-, and coiled-coil-containing protein 2	615047	TANC2	26115	ENSG00000170921,ENST00000689528;;;ENST00000689528		Intellectual developmental disorder with autistic features and language delay, with or without seizures	618906	AD	3	Tanc2
17q23.3	17:63432304-63446639	CYB561, ORTHYP2	Cytochrome b-561	600019	CYB561	1534	ENSG00000008283,ENST00000360793;;;ENST00000360793		Orthostatic hypotension 2	618182	AR	3	Cyb561
17q23.3	17:63477061-63498373	ACE, DCP1, ACE1, MVCD3, ICH	Angiotensin I converting enzyme (dipeptidyl carboxypeptidase-1)	106180	ACE	1636	ENSG00000159640,ENST00000290866;;;ENST00000290866		[Angiotensin I-converting enzyme, benign serum increase]			3	Ace
17q23.3	17:63477061-63498373	ACE, DCP1, ACE1, MVCD3, ICH	Angiotensin I converting enzyme (dipeptidyl carboxypeptidase-1)	106180	ACE	1636	ENSG00000159640,ENST00000290866;;;ENST00000290866		{Microvascular complications of diabetes 3}	612624		3	Ace
17q23.3	17:63477061-63498373	ACE, DCP1, ACE1, MVCD3, ICH	Angiotensin I converting enzyme (dipeptidyl carboxypeptidase-1)	106180	ACE	1636	ENSG00000159640,ENST00000290866;;;ENST00000290866		{Myocardial infarction, susceptibility to}			3	Ace
17q23.3	17:63477061-63498373	ACE, DCP1, ACE1, MVCD3, ICH	Angiotensin I converting enzyme (dipeptidyl carboxypeptidase-1)	106180	ACE	1636	ENSG00000159640,ENST00000290866;;;ENST00000290866		{SARS, progression of}			3	Ace
17q23.3	17:63477061-63498373	ACE, DCP1, ACE1, MVCD3, ICH	Angiotensin I converting enzyme (dipeptidyl carboxypeptidase-1)	106180	ACE	1636	ENSG00000159640,ENST00000290866;;;ENST00000290866		{Stroke, hemorrhagic}	614519		3	Ace
17q23.3	17:63477061-63498373	ACE, DCP1, ACE1, MVCD3, ICH	Angiotensin I converting enzyme (dipeptidyl carboxypeptidase-1)	106180	ACE	1636	ENSG00000159640,ENST00000290866;;;ENST00000290866		Renal tubular dysgenesis	267430	AR	3	Ace
17q23.3	17:63600895-63608365	TACO1, CCDC44, MC4DN8	Translational activator of mitochondrially encoded cytochrome c oxidase subunit I	612958	TACO1	51204	ENSG00000136463,ENST00000258975;;;ENST00000258975		Mitochondrial complex IV deficiency, nuclear type 8	619052	AR	3	Taco1
17q23.3	17:63622417-63696305	MAP3K3, MEKK3, MAPKKK3, CCM5	Mitogen-activated kinase kinase kinase 3	602539	MAP3K3	4215	ENSG00000198909,ENST00000361733;;;ENST00000361733		Cerebral cavernous malformations 5	621032	SMu	3	Map3k3
17q23.3	17:63702832-63741986	STRADA, STRAD, LYK5	STE20-related kinase adaptor alpha	608626	STRADA	92335	ENSG00000266173,ENST00000336174;;;ENST00000336174		Polyhydramnios, megalencephaly, and symptomatic epilepsy	611087	AR	3	Strada
17q23.3	17:63745255-63773597	CCDC47, THNS	Coiled-coil domain-containing protein 47	618260	CCDC47	57003	ENSG00000108588,ENST00000225726;;;ENST00000225726		Trichohepatoneurodevelopmental syndrome	618268	AR	3	Ccdc47
17q23.3	17:63832081-63842685	SMARCD2, BAF60B, SGD2	SWI/SNF-related, matrix-associated, actin-dependent regulator of chromatin, subfamily d, member 2	601736	SMARCD2	6603	ENSG00000108604,ENST00000448276;;;ENST00000448276		Specific granule deficiency 2	617475	AR	3	Smarcd2
17q23.3	17:63894918-63896574	CSH1, CSA, PL	Chorionic somatomammotropin hormone-1	150200	CSH1	1442	ENSG00000136488,ENST00000316193;;;ENST00000316193		[Placental lactogen deficiency]			1	Gh
17q23.3	17:63917203-63918839	GH1, GHN, IGHD1A, IGHD1B, IGHD2	Growth hormone-1	139250	GH1	2688	ENSG00000259384,ENST00000323322;;;ENST00000323322	5'-GH1-CSHP1-CSH1-GH2-CSH2-3'	Growth hormone deficiency, isolated, type IA	262400	AR	3	Gh
17q23.3	17:63917203-63918839	GH1, GHN, IGHD1A, IGHD1B, IGHD2	Growth hormone-1	139250	GH1	2688	ENSG00000259384,ENST00000323322;;;ENST00000323322	5'-GH1-CSHP1-CSH1-GH2-CSH2-3'	Growth hormone deficiency, isolated, type IB	612781		3	Gh
17q23.3	17:63917203-63918839	GH1, GHN, IGHD1A, IGHD1B, IGHD2	Growth hormone-1	139250	GH1	2688	ENSG00000259384,ENST00000323322;;;ENST00000323322	5'-GH1-CSHP1-CSH1-GH2-CSH2-3'	Growth hormone deficiency, isolated, type II	173100	AD	3	Gh
17q23.3	17:63917203-63918839	GH1, GHN, IGHD1A, IGHD1B, IGHD2	Growth hormone-1	139250	GH1	2688	ENSG00000259384,ENST00000323322;;;ENST00000323322	5'-GH1-CSHP1-CSH1-GH2-CSH2-3'	Kowarski syndrome	262650	AR	3	Gh
17q23.3	17:63928740-63932331	CD79B, IGB, B29, AGM6	CD79B antigen	147245	CD79B	974	ENSG00000007312,ENST00000006750;;;ENST00000006750		Agammaglobulinemia 6	612692	AR	3	Cd79b
17q23.3	17:63938554-63972918	SCN4A, HYPP, NAC1A, HOKPP2, CMS16, CMYO22A	Sodium voltage-gated channel, alpha subunit 4	603967	SCN4A	6329	ENSG00000007314,ENST00000435607;;;ENST00000435607	21.5kb from GH1	Congenital myopathy 22A, classic	620351	AR	3	Scn4a
17q23.3	17:63938554-63972918	SCN4A, HYPP, NAC1A, HOKPP2, CMS16, CMYO22A	Sodium voltage-gated channel, alpha subunit 4	603967	SCN4A	6329	ENSG00000007314,ENST00000435607;;;ENST00000435607	21.5kb from GH1	Congenital myopathy 22B, severe fetal	620369	AR	3	Scn4a
17q23.3	17:63938554-63972918	SCN4A, HYPP, NAC1A, HOKPP2, CMS16, CMYO22A	Sodium voltage-gated channel, alpha subunit 4	603967	SCN4A	6329	ENSG00000007314,ENST00000435607;;;ENST00000435607	21.5kb from GH1	Hyperkalemic periodic paralysis	170500	AD	3	Scn4a
17q23.3	17:63938554-63972918	SCN4A, HYPP, NAC1A, HOKPP2, CMS16, CMYO22A	Sodium voltage-gated channel, alpha subunit 4	603967	SCN4A	6329	ENSG00000007314,ENST00000435607;;;ENST00000435607	21.5kb from GH1	Hypokalemic periodic paralysis, type 2	613345	AD	3	Scn4a
17q23.3	17:63938554-63972918	SCN4A, HYPP, NAC1A, HOKPP2, CMS16, CMYO22A	Sodium voltage-gated channel, alpha subunit 4	603967	SCN4A	6329	ENSG00000007314,ENST00000435607;;;ENST00000435607	21.5kb from GH1	Myasthenic syndrome, congenital, 16	614198	AR	3	Scn4a
17q23.3	17:63938554-63972918	SCN4A, HYPP, NAC1A, HOKPP2, CMS16, CMYO22A	Sodium voltage-gated channel, alpha subunit 4	603967	SCN4A	6329	ENSG00000007314,ENST00000435607;;;ENST00000435607	21.5kb from GH1	Myotonia congenita, atypical, acetazolamide-responsive	608390	AD	3	Scn4a
17q23.3	17:63938554-63972918	SCN4A, HYPP, NAC1A, HOKPP2, CMS16, CMYO22A	Sodium voltage-gated channel, alpha subunit 4	603967	SCN4A	6329	ENSG00000007314,ENST00000435607;;;ENST00000435607	21.5kb from GH1	Paramyotonia congenita	168300	AD	3	Scn4a
17q23.3	17:64477785-64497054	POLG2, POLGB, PEOA4, MTDPS16A, MTDPS16B	Polymerase, DNA, gamma-2	604983	POLG2	11232	ENSG00000256525,ENST00000539111;;;ENST00000539111	mutation identified in 1 MTDPS16A patient and 1 MTDPS16B patient	?Mitochondrial DNA depletion syndrome 16 (hepatic type)	618528	AR	3	Polg2
17q23.3	17:64477785-64497054	POLG2, POLGB, PEOA4, MTDPS16A, MTDPS16B	Polymerase, DNA, gamma-2	604983	POLG2	11232	ENSG00000256525,ENST00000539111;;;ENST00000539111	mutation identified in 1 MTDPS16A patient and 1 MTDPS16B patient	?Mitochondrial DNA depletion syndrome 16B (neuroophthalmic type)	619425	AR	3	Polg2
17q23.3	17:64477785-64497054	POLG2, POLGB, PEOA4, MTDPS16A, MTDPS16B	Polymerase, DNA, gamma-2	604983	POLG2	11232	ENSG00000256525,ENST00000539111;;;ENST00000539111	mutation identified in 1 MTDPS16A patient and 1 MTDPS16B patient	Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 4	610131	AD	3	Polg2
17q24	17:64600001-72900000	CTRCT7, CCA1	Cataract 7	115660		878			Cataract 7	115660	AD	2	
17q24.1	17:65137370-65227703	RGS9, PERRS1	Regulator of G protein signaling 9	604067	RGS9	8787	ENSG00000108370,ENST00000262406;;;ENST00000262406		Prolonged electroretinal response suppression 1	608415	AR	3	Rgs9
17q24.1	17:65528563-65561648	AXIN2, ODCRCS	Axis inhibitor 2 (conductin, mouse, homolog of)	604025	AXIN2	8313	ENSG00000168646,ENST00000307078;;;ENST00000307078		Colorectal cancer, somatic	114500		3	Axin2
17q24.1	17:65528563-65561648	AXIN2, ODCRCS	Axis inhibitor 2 (conductin, mouse, homolog of)	604025	AXIN2	8313	ENSG00000168646,ENST00000307078;;;ENST00000307078		Oligodontia-colorectal cancer syndrome	608615	AD	3	Axin2
17q24.1	17:65635537-66192133	CEP112, CCDC46, MACOCO, SPGF44	Centrosomal protein, 112kD	618980	CEP112	201134	ENSG00000154240,ENST00000535342;;;ENST00000535342		Spermatogenic failure 44	619044	AR	3	Cep112
17q24.2-q24.3	17:66200001-72900000	HTGH, DEL17q24	Hypertrichosis terminalis, generalized, with or without gingival hyperplasia (chromosome 17q24 microdeletion syndrome)	135400					Hypertrichosis terminalis, generalized, with or without gingival hyperplasia	135400	AR	4	
17q24.2	17:66302613-66810743	PRKCA, PKCA	Protein kinase C, alpha polypeptide	176960	PRKCA	5578	ENSG00000154229,ENST00000413366;;;ENST00000413366	cen-COL1A1-PKCA-GH1	Pituitary tumor, invasive			3	Prkca
17q24.2	17:67337916-67366577	PSMD12, P55, STISS	Proteasome 26S subunit, non-ATPase, 12	604450	PSMD12	5718	ENSG00000197170,ENST00000356126;;;ENST00000356126		Stankiewicz-Isidor syndrome	617516	AD	3	Psmd12
17q24.2	17:67825503-67984378	BPTF, FALZ, FAC1, NURF301, NEDDFL	Bromodomain PHD finger transcription factor	601819	BPTF	2186	ENSG00000171634,ENST00000306378;;;ENST00000306378		{Kaposi sarcoma, susceptibility to}	148000	AD	3	Bptf
17q24.2	17:67825503-67984378	BPTF, FALZ, FAC1, NURF301, NEDDFL	Bromodomain PHD finger transcription factor	601819	BPTF	2186	ENSG00000171634,ENST00000306378;;;ENST00000306378		Neurodevelopmental disorder with dysmorphic facies and distal limb anomalies	617755	AD	3	Bptf
17q24.2	17:68259170-68452019	ARSG, KIAA1001, USH4	Arylsulfatase G	610008	ARSG	22901	ENSG00000141337,ENST00000621439;;;ENST00000621439		Usher syndrome, type IV	618144	AR	3	Arsg
17q24.2	17:68413623-68551316	PRKAR1A, TSE1, CNC1, CAR, PPNAD1, ACRDYS1	Protein kinase, cAMP-dependent, regulatory, type I, alpha	188830	PRKAR1A	5573	ENSG00000108946,ENST00000589228;;;ENST00000589228	fused with RET to form PTC2	Acrodysostosis 1, with or without hormone resistance	101800	AD	3	Prkar1a
17q24.2	17:68413623-68551316	PRKAR1A, TSE1, CNC1, CAR, PPNAD1, ACRDYS1	Protein kinase, cAMP-dependent, regulatory, type I, alpha	188830	PRKAR1A	5573	ENSG00000108946,ENST00000589228;;;ENST00000589228	fused with RET to form PTC2	Adrenocortical tumor, somatic			3	Prkar1a
17q24.2	17:68413623-68551316	PRKAR1A, TSE1, CNC1, CAR, PPNAD1, ACRDYS1	Protein kinase, cAMP-dependent, regulatory, type I, alpha	188830	PRKAR1A	5573	ENSG00000108946,ENST00000589228;;;ENST00000589228	fused with RET to form PTC2	Carney complex, type 1	160980	AD	3	Prkar1a
17q24.2	17:68413623-68551316	PRKAR1A, TSE1, CNC1, CAR, PPNAD1, ACRDYS1	Protein kinase, cAMP-dependent, regulatory, type I, alpha	188830	PRKAR1A	5573	ENSG00000108946,ENST00000589228;;;ENST00000589228	fused with RET to form PTC2	Myxoma, intracardiac	255960	AD	3	Prkar1a
17q24.2	17:68413623-68551316	PRKAR1A, TSE1, CNC1, CAR, PPNAD1, ACRDYS1	Protein kinase, cAMP-dependent, regulatory, type I, alpha	188830	PRKAR1A	5573	ENSG00000108946,ENST00000589228;;;ENST00000589228	fused with RET to form PTC2	Pigmented nodular adrenocortical disease, primary, 1	610489	AD	3	Prkar1a
17q24.2	17:68535116-68601367	FAM20A, AIGFS, AI1G	Family with sequence similarity 20, member A	611062	FAM20A	54757	ENSG00000108950,ENST00000592554;;;ENST00000592554		Amelogenesis imperfecta, type IG (enamel-renal syndrome)	204690	AR	3	Fam20a
17q24.3-q25.1	17:69100001-76800000	PRBNS	Pierre Robin syndrome	261800		100301572		between D17S795 and D17S929	Pierre Robin syndrome	261800	AR	2	
17q24.3	17:69100001-72900000	TTPP3	Thyrotoxic periodic paralysis, susceptibility to, 3	614834		112272595		associated with rs312691	{Thyrotoxic periodic paralysis, susceptibility to, 3}	614834		2	
17q24.3	17:69244311-69327133	ABCA5, KIAA1888, HTC3	ATP-binding cassette, subfamily A, member 5	612503	ABCA5	23461	ENSG00000154265,ENST00000392676;;;ENST00000392676	mutation identified in 1 HTC3 patient	?Hypertrichosis, congenital generalized, with gingival hyperplasia	135400	AR	3	Abca5
17q24.3	17:70075225-70135608	KCNJ16, KIR5.1, HKTD	Potassium channel, inwardly rectifying, subfamily J, member 16	605722	KCNJ16	3773	ENSG00000153822,ENST00000392671;;;ENST00000392671		Hypokalemic tubulopathy and deafness	619406	AR	3	Kcnj16
17q24.3	17:70169532-70180044	KCNJ2, HHIRK1, KIR2.1, IRK1, LQT7, SQT3, ATFB9	Potassium channel, inwardly rectifying, subfamily J, member 2	600681	KCNJ2	3759	ENSG00000123700,ENST00000243457;;;ENST00000243457		Andersen syndrome	170390	AD	3	Kcnj2
17q24.3	17:70169532-70180044	KCNJ2, HHIRK1, KIR2.1, IRK1, LQT7, SQT3, ATFB9	Potassium channel, inwardly rectifying, subfamily J, member 2	600681	KCNJ2	3759	ENSG00000123700,ENST00000243457;;;ENST00000243457		Atrial fibrillation, familial, 9	613980	AD	3	Kcnj2
17q24.3	17:70169532-70180044	KCNJ2, HHIRK1, KIR2.1, IRK1, LQT7, SQT3, ATFB9	Potassium channel, inwardly rectifying, subfamily J, member 2	600681	KCNJ2	3759	ENSG00000123700,ENST00000243457;;;ENST00000243457		Short QT syndrome 3	609622	AD	3	Kcnj2
17q24.3	17:72121020-72126416	SOX9, CMD1, SRA1, TES, TESCO, ENH13	SRY (sex-determining region Y)-box 9	608160	SOX9	6662	ENSG00000125398,ENST00000245479;;;ENST00000245479	SRXY10 due to deletion of upstream regulatory region; SRXX2 due to duplication of upstream regulatory region	46XX sex reversal 2	278850	AD	3	Sox9
17q24.3	17:72121020-72126416	SOX9, CMD1, SRA1, TES, TESCO, ENH13	SRY (sex-determining region Y)-box 9	608160	SOX9	6662	ENSG00000125398,ENST00000245479;;;ENST00000245479	SRXY10 due to deletion of upstream regulatory region; SRXX2 due to duplication of upstream regulatory region	46XY sex reversal 10	616425	AD	3	Sox9
17q24.3	17:72121020-72126416	SOX9, CMD1, SRA1, TES, TESCO, ENH13	SRY (sex-determining region Y)-box 9	608160	SOX9	6662	ENSG00000125398,ENST00000245479;;;ENST00000245479	SRXY10 due to deletion of upstream regulatory region; SRXX2 due to duplication of upstream regulatory region	Acampomelic campomelic dysplasia	114290	AD	3	Sox9
17q24.3	17:72121020-72126416	SOX9, CMD1, SRA1, TES, TESCO, ENH13	SRY (sex-determining region Y)-box 9	608160	SOX9	6662	ENSG00000125398,ENST00000245479;;;ENST00000245479	SRXY10 due to deletion of upstream regulatory region; SRXX2 due to duplication of upstream regulatory region	Campomelic dysplasia	114290	AD	3	Sox9
17q24.3	17:72121020-72126416	SOX9, CMD1, SRA1, TES, TESCO, ENH13	SRY (sex-determining region Y)-box 9	608160	SOX9	6662	ENSG00000125398,ENST00000245479;;;ENST00000245479	SRXY10 due to deletion of upstream regulatory region; SRXX2 due to duplication of upstream regulatory region	Campomelic dysplasia with autosomal sex reversal	114290	AD	3	Sox9
17q25.1-q25.3	17:72900001-83257441	NDNC9	Nail disorder, nonsyndromic congenital, 9 (anonychia-onycholysis)	614149		100682325		max lod at D17S1301	Nail disorder, nonsyndromic congenital, 9	614149	AR	2	
17q25.1	17:73193055-73208507	COG1, LDLB, KIAA1381, CDG2G	Component of oligomeric golgi complex 1	606973	COG1	9382	ENSG00000166685,ENST00000299886;;;ENST00000299886		Congenital disorder of glycosylation, type IIg	611209	AR	3	Cog1
17q25.1	17:74274234-74314884	DNAI2, CILD9	Dynein, axonemal, intermediate chain 2	605483	DNAI2	64446	ENSG00000171595,ENST00000311014;;;ENST00000311014		Ciliary dyskinesia, primary, 9, with or without situs inversus	612444	AR	3	Dnai2
17q25.1	17:74748628-74769353	SLC9A3R1, EBP50, NHERF1, NPHLOP2	Solute carrier family 9 (sodium/hydrogen exchanger), member 3 regulatory factor 1	604990	NHERF1	9368	ENSG00000109062,ENST00000262613;;;ENST00000262613		Nephrolithiasis/osteoporosis, hypophosphatemic, 2	612287	AD	3	Nherf1
17q25.1	17:74862497-74872994	FDXR, ADXR, ANOA, MMDS9B	Ferredoxin reductase (adrenodoxin reductase)	103270	FDXR	2232	ENSG00000161513,ENST00000293195;;;ENST00000293195		Auditory neuropathy and optic atrophy	617717	AR	3	Fdxr
17q25.1	17:74862497-74872994	FDXR, ADXR, ANOA, MMDS9B	Ferredoxin reductase (adrenodoxin reductase)	103270	FDXR	2232	ENSG00000161513,ENST00000293195;;;ENST00000293195		Multiple mitochondrial dysfunctions syndrome 9B	620887	AR	3	Fdxr
17q25.1	17:74916083-74923255	USH1G, SANS	USH1 protein network component SANS	607696	USH1G	124590	ENSG00000182040,ENST00000614341;;;ENST00000614341	?allelic to DFNA20	Usher syndrome, type 1G	606943	AR	3	Ush1g
17q25.1	17:74950742-74972759	HID1, 17orf28, DMC1, DEE105	HID1 domain-containing protein 1	605752	HID1	283987	ENSG00000167861,ENST00000425042;;;ENST00000425042		Developmental and epileptic encephalopathy 105 with hypopituitarism	619983	AR	3	Hid1
17q25.1	17:75205679-75235758	NUP85, PCNT1, PCNT, NPHS17	Nucleoporin 85kD	170285	NUP85	79902	ENSG00000125450,ENST00000245544;;;ENST00000245544		Nephrotic syndrome, type 17	618176	AR	3	Nup85
17q25.1	17:75261879-75266376	MRPS7, COXPD34	Mitochondrial ribosomal protein S7	611974	MRPS7	51081	ENSG00000125445,ENST00000245539;;;ENST00000245539	mutation identified in 1 COXPD34 family	?Combined oxidative phosphorylation deficiency 34	617872	AR	3	Mrps7
17q25.1	17:75272992-75289433	SLC25A19, DNC, MUP1, MCPHA, THMD3, THMD4	Solute carrier family 25 (mitochondrial deoxynucleotide carrier), member 19	606521	SLC25A19	60386	ENSG00000125454,ENST00000416858;;;ENST00000416858		Microcephaly, Amish type	607196	AR	3	Slc25a19
17q25.1	17:75272992-75289433	SLC25A19, DNC, MUP1, MCPHA, THMD3, THMD4	Solute carrier family 25 (mitochondrial deoxynucleotide carrier), member 19	606521	SLC25A19	60386	ENSG00000125454,ENST00000416858;;;ENST00000416858		Thiamine metabolism dysfunction syndrome 4 (progressive polyneuropathy type)	613710	AR	3	Slc25a19
17q25.1	17:75456635-75500452	TMEM94, KIAA0195, IDDCDF	Transmembrane protein 94	618163	TMEM94	9772	ENSG00000177728,ENST00000314256;;;ENST00000314256		Intellectual developmental disorder with cardiac defects and dysmorphic facies	618316	AR	3	Tmem94
17q25.1	17:75516528-75524735	TSEN54, SEN54, PCH2A, PCH4, PCH5	tRNA splicing endonuclease, subunit 54	608755	TSEN54	283989	ENSG00000182173,ENST00000333213;;;ENST00000333213	mutation identified in 1 PCH5 patient	?Pontocerebellar hypoplasia type 5	610204	AR	3	Tsen54
17q25.1	17:75516528-75524735	TSEN54, SEN54, PCH2A, PCH4, PCH5	tRNA splicing endonuclease, subunit 54	608755	TSEN54	283989	ENSG00000182173,ENST00000333213;;;ENST00000333213	mutation identified in 1 PCH5 patient	Pontocerebellar hypoplasia type 2A	277470	AR	3	Tsen54
17q25.1	17:75516528-75524735	TSEN54, SEN54, PCH2A, PCH4, PCH5	tRNA splicing endonuclease, subunit 54	608755	TSEN54	283989	ENSG00000182173,ENST00000333213;;;ENST00000333213	mutation identified in 1 PCH5 patient	Pontocerebellar hypoplasia type 4	225753	AR	3	Tsen54
17q25.1	17:75721459-75757818	ITGB4, JEB5B, JEB5A	Integrin, beta-4	147557	ITGB4	3691	ENSG00000132470,ENST00000200181;;;ENST00000200181		Epidermolysis bullosa, junctional 5A, intermediate	619816	AR	3	Itgb4
17q25.1	17:75721459-75757818	ITGB4, JEB5B, JEB5A	Integrin, beta-4	147557	ITGB4	3691	ENSG00000132470,ENST00000200181;;;ENST00000200181		Epidermolysis bullosa, junctional 5B, with pyloric atresia	226730	AR	3	Itgb4
17q25.1	17:75751469-75765192	GALK1	Galactokinase-1	604313	GALK1	2584	ENSG00000108479,ENST00000588479;;;ENST00000588479		Galactokinase deficiency with cataracts	230200	AR	3	Galk1
17q25.1	17:75776434-75779779	H3-3B, H3F3B, BRYLIB2	H3.3 histone B	601058	H3-3B	3021	ENSG00000132475,ENST00000254810;;;ENST00000254810		Bryant-Li-Bhoj neurodevelopmental syndrome 2	619721	AD	3	H3f3b
17q25.1	17:75827225-75844404	UNC13D, MUNC13-4, HPLH3, HLH3, FHL3	unc-13 homolog D	608897	UNC13D	201294	ENSG00000092929,ENST00000207549;;;ENST00000207549		Hemophagocytic lymphohistiocytosis, familial, 3	608898	AR	3	Unc13d
17q25.1	17:75845699-75856436	WBP2, DFNB107	WW domain-binding protein 2	606962	WBP2	23558	ENSG00000132471,ENST00000254806;;;ENST00000254806		Deafness, autosomal recessive 107	617639	AR	3	Wbp2
17q25.1	17:75941507-75979166	ACOX1, ACOX, SCOX, MITCH	Acyl-Coenzyme A oxidase 1, palmitoyl	609751	ACOX1	51	ENSG00000161533,ENST00000293217;;;ENST00000293217		Mitchell syndrome	618960	AD	3	Acox1
17q25.1	17:75941507-75979166	ACOX1, ACOX, SCOX, MITCH	Acyl-Coenzyme A oxidase 1, palmitoyl	609751	ACOX1	51	ENSG00000161533,ENST00000293217;;;ENST00000293217		Peroxisomal acyl-CoA oxidase deficiency	264470	AR	3	Acox1
17q25.1	17:76038785-76072517	SRP68, SCN10	Signal recognition particle, 68kD	604858	SRP68	6730	ENSG00000167881,ENST00000307877;;;ENST00000307877	mutation identified in 1 SCN10 patient	?Neutropenia, severe congenital, 10, autosomal recessive	620534	AR	3	Srp68
17q25.1	17:76081016-76103787	EXOC7, EX070, KIAA1067, NEDSEBA	Exocyst complex component 7	608163	EXOC7	23265	ENSG00000182473,ENST00000589210;;;ENST00000589210		Neurodevelopmental disorder with seizures and brain atrophy	619072	AR	3	Exoc7
17q25.1	17:76136333-76141245	FOXJ1, FKHL13, HFH4, CILD43	Forkhead box J1	602291	FOXJ1	2302	ENSG00000129654,ENST00000322957;;;ENST00000322957		Ciliary dyskinesia, primary, 43	618699	AD	3	Foxj1
17q25.1	17:76274049-76310964	QRICH2, SPGF35	Glutamine-rich protein 2	618304	QRICH2	84074	ENSG00000129646,ENST00000680821;;;ENST00000680821		Spermatogenic failure 35	618341	AR	3	Qrich2
17q25.1	17:76470893-76501427	RHBDF2, IRHOM2, TOC	Rhomboid 5, Drosophila, homolog of, 2	614404	RHBDF2	79651	ENSG00000129667,ENST00000675367;;;ENST00000675367		Tylosis with esophageal cancer	148500	AD	3	Rhbdf2
17q25.1	17:76527586-76553580	PRCD, RP36	Photoreceptor disc component	610598	PRCD	768206	ENSG00000214140,ENST00000592014;;;ENST00000592014		Retinitis pigmentosa 36	610599	AR	3	Prcd
17q25.1	17:76726041-76733881	METTL23, C17orf95, MRT44	Methyltransferase-like 23	615262	METTL23	124512	ENSG00000181038,ENST00000341249;;;ENST00000341249		Intellectual developmental disorder, autosomal recessive 44	615942	AR	3	Mettl23
17q25.3	17:77200001-83257441	ATOD4	Dermatitis, atopic, 4	605805				maximum lod at D17S1290	{Dermatitis, atopic, susceptibility to, 4}	605805		2	
17q25.3	17:77200001-83257441	IS5	Scoliosis, idiopathic, susceptibility to, 5	612239		100190985		between D17S1806 and 17qter	{Scoliosis, idiopathic, susceptibility to, 5}	612239		2	
17q25.3	17:77281499-77500596	SEPT9, MSF, MSF1, NAPB	Septin 9	604061	SEPTIN9	10801	ENSG00000184640,ENST00000427177;;;ENST00000427177		Amyotrophy, hereditary neuralgic	162100	AD	3	Septin9
17q25.3	17:78107397-78132427	TMC6, EVER1, EV1	Transmembrane channel-like 6	605828	TMC6	11322	ENSG00000141524,ENST00000590602;;;ENST00000590602		{Epidermodysplasia verruciformis, susceptibility to, 1}	226400	AR	3	Tmc6
17q25.3	17:78130771-78142968	TMC8, EVER2, EV2	Transmembrane channel-like 8	605829	TMC8	147138	ENSG00000167895,ENST00000318430;;;ENST00000318430		{Epidermodysplasia verruciformis, susceptibility to, 2}	618231	AR	3	Tmc8
17q25.3	17:78423697-78577396	DNAH17, DNEL2, SPGF39	Dynein, axonemal, heavy chain 17	610063	DNAH17	8632	ENSG00000187775,ENST00000389840;;;ENST00000389840		Spermatogenic failure 39	618643	AR	3	Dnah17
17q25.3	17:78991716-79009764	CANT1, SCAN1, DBQD1, EDM7	Calcium-activated nucleotidase 1	613165	CANT1	124583	ENSG00000171302,ENST00000392446;;;ENST00000392446		Desbuquois dysplasia 1	251450	AR	3	Cant1
17q25.3	17:78991716-79009764	CANT1, SCAN1, DBQD1, EDM7	Calcium-activated nucleotidase 1	613165	CANT1	124583	ENSG00000171302,ENST00000392446;;;ENST00000392446		Epiphyseal dysplasia, multiple, 7	617719	AR	3	Cant1
17q25.3	17:79777311-79787983	CBX2, M33, SRXY5	Chromobox 2	602770	CBX2	84733	ENSG00000173894,ENST00000310942;;;ENST00000310942	mutation identified in 1 SRXY5 patient	?46XY sex reversal 5	613080	AR	3	Cbx2
17q25.3	17:80036642-80100613	CCDC40, KIAA1640	Coiled-coil domain-containing protein 40	613799	CCDC40	55036	ENSG00000141519,ENST00000397545;;;ENST00000397545		Ciliary dyskinesia, primary, 15	613808	AR	3	Ccdc40
17q25.3	17:80101581-80119881	GAA, LOPD, IOPD	Glucosidase, acid alpha-	606800	GAA	2548	ENSG00000171298,ENST00000302262;;;ENST00000302262	distal to TK1	Pompe disease, infantile-onset	232300	AR	3	Gaa
17q25.3	17:80101581-80119881	GAA, LOPD, IOPD	Glucosidase, acid alpha-	606800	GAA	2548	ENSG00000171298,ENST00000302262;;;ENST00000302262	distal to TK1	Pompe disease, late-onset	621314	AR	3	Gaa
17q25.3	17:80134369-80147128	EIF4A3, DDX48, MUK34, NMP265, KIAA0111, RCPS	Eukaryotic translation initiation factor 4A3	608546	EIF4A3	9775	ENSG00000141543,ENST00000649764;;;ENST00000649764		Robin sequence with cleft mandible and limb anomalies	268305	AR	3	Eif4a3,Eif4a3l1,Eif4a3l2
17q25.3	17:80170030-80209331	CARD14, CARMA2, BIMP2, PSORS2, PSS1, PRP	Caspase recruitment domain-containing protein 14	607211	CARD14	79092	ENSG00000141527,ENST00000648509;;;ENST00000648509		Pityriasis rubra pilaris	173200	AD	3	Card14
17q25.3	17:80170030-80209331	CARD14, CARMA2, BIMP2, PSORS2, PSS1, PRP	Caspase recruitment domain-containing protein 14	607211	CARD14	79092	ENSG00000141527,ENST00000648509;;;ENST00000648509		Psoriasis 2	602723	AD	3	Card14
17q25.3	17:80200673-80220333	SGSH, MPS3A, SFMD	N-sulfoglucosamine sulfohydrolase (sulfamidase)	605270	SGSH	6448	ENSG00000181523,ENST00000326317;;;ENST00000326317		Mucopolysaccharidosis type IIIA (Sanfilippo A)	252900	AR	3	Sgsh
17q25.3	17:80260852-80398794	RNF213, ALO17, KIAA1618, MYMY2	RING finger protein 213	613768	RNF213	57674	ENSG00000173821,ENST00000582970;;;ENST00000582970		{Moyamoya disease 2, susceptibility to}	607151	AD, AR	3	Rnf213
17q25.3	17:80466834-80476607	NPTX1, NP1, SCA50	Neuronal pentraxin 1	602367	NPTX1	4884	ENSG00000171246,ENST00000306773;;;ENST00000306773		Spinocerebellar ataxia 50	620158	AD	3	Nptx1
17q25.3	17:81239311-81241310	NDUFAF8, C17orf89, MC1DN34	NADH dehydrogenase (ubiquinone) complex I, assembly factor 8	618461	NDUFAF8	284184	ENSG00000224877,ENST00000431388;;;ENST00000431388		Mitochondrial complex I deficiency, nuclear type 34	618776	AR	3	Ndufaf8
17q25.3	17:81509971-81512799	ACTG1, DFNA20, DFNA26, BRWS2	Actin, gamma-1	102560	ACTG1	71	ENSG00000184009,ENST00000573283;;;ENST00000573283		Baraitser-Winter syndrome 2	614583	AD	3	Actg1
17q25.3	17:81509971-81512799	ACTG1, DFNA20, DFNA26, BRWS2	Actin, gamma-1	102560	ACTG1	71	ENSG00000184009,ENST00000573283;;;ENST00000573283		Deafness, autosomal dominant 20/26	604717	AD	3	Actg1
17q25.3	17:81515062-81537130	FSCN2, RFSN, RP30	Fascin, sea urchin, homolog of, 2	607643	FSCN2	25794	ENSG00000186765,ENST00000417245;;;ENST00000417245	within 200kb of ACTG1	Retinitis pigmentosa 30	607921		3	Fscn2
17q25.3	17:81539891-81553133	FAAP100, C17orf70, FANCX	FA core complex associated protein 100	611301	FAAP100	80233	ENSG00000185504,ENST00000327787;;;ENST00000327787		Fanconi anemia, complementation group X	621258	AR	3	Faap100
17q25.3	17:81650459-81663127	PDE6G, PDEG, RP57	Phosphodiesterase 6G	180073	PDE6G	5148	ENSG00000185527,ENST00000331056;;;ENST00000331056		Retinitis pigmentosa 57	613582	AR	3	Pde6g
17q25.3	17:81703367-81707517	MRPL12, RPML12	Ribosomal protein, mitochondrial, L12	602375	MRPL12	6182	ENSG00000262814,ENST00000333676;;;ENST00000333676	mutation identified in 1 COXPD45 family	?Combined oxidative phosphorylation deficiency 45	618951	AR	3	Mrpl12
17q25.3	17:81712284-81721012	SLC25A10, DIC, MTDPS19	Solute carrier family 25 (mitochondrial carrier), member 10 (dicarboxylate ion carrier)	606794	SLC25A10	1468	ENSG00000183048,ENST00000350690;;;ENST00000350690	mutation identified in 1 MTDPS19 patient	?Mitochondrial DNA depletion syndrome 19	618972	AR	3	Slc25a10
17q25.3	17:81804150-81814008	GCGR, MVAH	Glucagon receptor	138033	GCGR	2642	ENSG00000215644,ENST00000400723;;;ENST00000400723		Mahvash disease	619290	AR	3	Gcgr
17q25.3	17:81843166-81860535	P4HB, PROHB, CLCRP1	Procollagen-proline, 2-oxoglutarate-4-dioxygenase, beta polypeptide	176790	P4HB	5034	ENSG00000185624,ENST00000331483;;;ENST00000331483		Cole-Carpenter syndrome 1	112240	AD	3	P4hb
17q25.3	17:81867721-81871337	ARHGDIA, GDIA1, NPHS8	Rho GDP dissociation inhibitor (GDI) alpha	601925	ARHGDIA	396	ENSG00000141522,ENST00000269321;;;ENST00000269321		Nephrotic syndrome, type 8	615244	AR	3	Arhgdia
17q25.3	17:81900958-81911399	PCYT2, ET, SPG82	Phosphate cytidylyltransferase 2, ethanolamine	602679	PCYT2	5833	ENSG00000185813,ENST00000538936;;;ENST00000538936		Spastic paraplegia 82, autosomal recessive	618770	AR	3	Pcyt2
17q25.3	17:81932391-81937300	PYCR1, PRO3, ARCL2B, ARCL3B	Pyrroline-5-carboxylate reductase-1	179035	PYCR1	5831	ENSG00000183010,ENST00000329875;;;ENST00000329875		Cutis laxa, autosomal recessive, type IIB	612940	AR	3	Pycr1
17q25.3	17:81932391-81937300	PYCR1, PRO3, ARCL2B, ARCL3B	Pyrroline-5-carboxylate reductase-1	179035	PYCR1	5831	ENSG00000183010,ENST00000329875;;;ENST00000329875		Cutis laxa, autosomal recessive, type IIIB	614438	AR	3	Pycr1
17q25.3	17:81977629-82017406	ASPSCR1, RCC17, ASPL, ASPS	Alveolar soft-part sarcoma chromosome region, candidate 1	606236	ASPSCR1	79058	ENSG00000169696,ENST00000306739;;;ENST00000306739	t(X;17)(p11.2;q25)	Alveolar soft-part sarcoma	606243		3	Aspscr1
17q25.3	17:82031678-82034204	RAC3	Rac family small GTPase 3	602050	RAC3	5881	ENSG00000169750,ENST00000306897;;;ENST00000306897		Neurodevelopmental disorder with structural brain anomalies and dysmorphic facies	618577	AD	3	Rac3
17q25.3	17:82035858-82037697	DCXR, P34H, PNTSU	Dicarbonyl/L-xylulose reductase	608347	DCXR	51181	ENSG00000169738,ENST00000306869;;;ENST00000306869		[Pentosuria]	260800	AR	3	Dcxr
17q25.3	17:82239019-82273750	CSNK1D, ASPS, FASPS2	Casein kinase-1, delta	600864	CSNK1D	1453	ENSG00000141551,ENST00000314028;;;ENST00000314028		Advanced sleep-phase syndrome, familial, 2	615224	AD	3	Csnk1d
17q25.3	17:82442586-82450752	CYBC1, EROS, C17orf62, CGD5	Cytochrome b(-254) chaperone 1	618334	CYBC1	79415	ENSG00000178927,ENST00000306645;;;ENST00000306645		Chronic granulomatous disease 5, autosomal recessive	618935	AR	3	Cybc1
17q25.3	17:82614562-82648444	WDR45B, WIPI3, WDR45L, NEDSBAS	WD repeat domain 45B	609226	WDR45B	56270	ENSG00000141580,ENST00000392325;;;ENST00000392325		Neurodevelopmental disorder with spastic quadriplegia and brain abnormalities with or without seizures	617977	AR	3	Wdr45b
17q25.3	17:82752065-82945914	TBCD, PEBAT	Tubulin folding cofactor D	604649	TBCD	6904	ENSG00000141556,ENST00000355528;;;ENST00000355528		Encephalopathy, progressive, early-onset, with brain atrophy and thin corpus callosum	617193	AR	3	Tbcd
17q25.3	17:82829434-82840022	ZNF750, FLJ13841, SLDPE	Zinc finger protein 750	610226	ZNF750	79755	ENSG00000141579,ENST00000269394;;;ENST00000269394	mutation identified in 1 SLDPE family	?Seborrhea-like dermatitis with psoriasiform elements	610227	AD	3	Zfp750
Chr.17	17:1-83257441	ODS1	Opioid dependence, susceptibility to, 1	610064		100188802			{Opioid dependence, susceptibility to, 1}	610064		2	
18p11.3-p11.2	18:1-15400000	AA1	Alopecia areata 1	104000		100034700		max lod at D18S967	Alopecia areata 1	104000	Mu	2	
18p	18:1-18500001	DEL18p, C18DELp	Chromosome 18p deletion syndrome	146390					Chromosome 18p deletion syndrome	146390	AD	4	
18p11.32-p11.31	18:1-7200000	DFNB46	Deafness, neurosensory, autosomal recessive 46	609647		449488		between D18S59 and D18S391	Deafness, autosomal recessive 46	609647	AR	2	
18p11	18:1-18500000	DYT15	Dystonia-15, myoclonic	607488		317714			Dystonia-15, myoclonic	607488	AD	2	
18p	18:1-18500001	DYT7	Dystonia-7 (torsion dystonia, adult-onset, focal)	602124		1866			Dystonia-7, torsion	602124	AD	2	
18p11	18:1-18500000	IBD21	Inflammatory bowel disease 21	612354		100192312		associated with rs2542151	{Inflammatory bowel disease 21}	612354	AD	2	
18p	18:1-18500001	MAFD1, BPAD, MD1	Major affective disorder 1	125480		4095		?also 18q	{Major affective disorder 1}	125480	AD	2	
18p11.3	18:1-7200000	MRT19	Intellectual developmental disorder, autosomal recessive 19	614343		100852395		between rs4606805 and rs1787846	Intellectual developmental disorder, autosomal recessive 19	614343	AR	2	
18p11.3	18:1-7200000	POROK6, DSAP4	Porokeratosis 6	612353		100196911		between telomere and D18S391	Porokeratosis 6, multiple types	612353	AD	2	
18p	18:1-18500001	SCZD8	Schizophrenia susceptibility locus, chromosome 18-related	603206		8806			{Schizophrenia}	181500	AD	2	
18p	18:1-18500001	TET18P	Tetrasomy 18p	614290					Tetrasomy 18p	614290		4	
18p11.32	18:214520-268047	THOC1, HPR1, DFNA86	THO complex 1 (nuclear matrix protein p84)	606930	THOC1	9984	ENSG00000079134,ENST00000261600;;;ENST00000261600	mutation identified in 1 DFNA86 family	?Deafness, autosomal dominant 86	620280	AD	3	Thoc1
18p11.32	18:657653-673578	TYMS, TS, TMS, DKCD	Thymidylate synthase	188350	TYMS	7298	ENSG00000176890,ENST00000323274;;;ENST00000323274	DKCD is digenic with C-A-ins haplotype	Dyskeratosis congenita, digenic	620040	DD	3	Tyms
18p11.32	18:2655726-2805017	SMCHD1, KIAA0650, BAMS	Structural maintenance of chromosomes flexible hinge domain-containing protein 1	614982	SMCHD1	23347	ENSG00000101596,ENST00000320876;;;ENST00000320876		Bosma arhinia microphthalmia syndrome	603457	AD	3	Smchd1
18p11.32	18:2655726-2805017	SMCHD1, KIAA0650, BAMS	Structural maintenance of chromosomes flexible hinge domain-containing protein 1	614982	SMCHD1	23347	ENSG00000101596,ENST00000320876;;;ENST00000320876		Facioscapulohumeral muscular dystrophy 2, digenic	158901	DD	3	Smchd1
18p11.31	18:2900001-7200000	MYP2	Myopia, high grade, autosomal dominant 1	160700		4658			Myopia 2	160700	AD	2	
18p11.31	18:2916994-3013144	LPIN2, MJDS, CRMO1	Lipin 2	605519	LPIN2	9663	ENSG00000101577,ENST00000677752;;;ENST00000677752		Majeed syndrome	609628		3	Lpin2
18p11.31	18:3412009-3459978	TGIF1, HPE4	TG-interacting factor 1	602630	TGIF1	7050	ENSG00000177426,ENST00000343820;;;ENST00000343820		Holoprosencephaly 4	142946	AD	3	Tgif1
18p11.31	18:6941742-7117797	LAMA1, PTBHS	Laminin, alpha-1	150320	LAMA1	284217	ENSG00000101680,ENST00000389658;;;ENST00000389658		Poretti-Boltshauser syndrome	615960	AR	3	Lama1
18p11.23-q12.2	18:7200001-39500000	ANIC	Anosmia, isolated congenital	107200		550625		max lod at D18S1108	Anosmia, isolated congenital	107200	AD	2	
18p11.2	18:7200001-15400000	DYX6, DYXQTL18	Dyslexia, susceptibility to, 6	606616		266691			{Dyslexia, susceptibility to, 6}	606616		2	
18p11.2	18:7200001-15400000	FEB6	Febrile seizures, familial, 6	609253		619397		max lod at D18S1158	Febrile seizures, familial, 6	609253	AD	2	
18p11.23	18:7200001-8500000	PSORS10	Psoriasis susceptibility 10	612410		503613		between D18S63 and D18S967	{Psoriasis susceptibility 10}	612410		2	
18p11.22	18:9102699-9134341	NDUFV2, MC1DN7	NADH-ubiquinone oxidoreductase core subunit V2	600532	NDUFV2	4729	ENSG00000178127,ENST00000318388;;;ENST00000318388	pseudogene on 19q13.3-qter	Mitochondrial complex I deficiency, nuclear type 7	618229	AR	3	Ndufv2
18p11.22	18:10454635-10489949	APCDD1, HHS, HYPT1, HTS	Adenomatosis polyposis coli down-regulated 1	607479	APCDD1	147495	ENSG00000154856,ENST00000355285;;;ENST00000355285		Hypotrichosis 1	605389	AD	3	Apcdd1
18p11.22-p11.21	18:10670247-11149569	PIEZO2, FAM38B, DA5, DA3, MWKS, DAIPT	PIEZO-type mechanosensitive ion channel component 2	613629	PIEZO2	63895	ENSG00000154864,ENST00000674853;;;ENST00000674853	mutation identified in 1 MWKS patient	?Marden-Walker syndrome	248700	AD	3	Piezo2
18p11.22-p11.21	18:10670247-11149569	PIEZO2, FAM38B, DA5, DA3, MWKS, DAIPT	PIEZO-type mechanosensitive ion channel component 2	613629	PIEZO2	63895	ENSG00000154864,ENST00000674853;;;ENST00000674853	mutation identified in 1 MWKS patient	Arthrogryposis, distal, type 3	114300	AD	3	Piezo2
18p11.22-p11.21	18:10670247-11149569	PIEZO2, FAM38B, DA5, DA3, MWKS, DAIPT	PIEZO-type mechanosensitive ion channel component 2	613629	PIEZO2	63895	ENSG00000154864,ENST00000674853;;;ENST00000674853	mutation identified in 1 MWKS patient	Arthrogryposis, distal, type 5	108145	AD	3	Piezo2
18p11.22-p11.21	18:10670247-11149569	PIEZO2, FAM38B, DA5, DA3, MWKS, DAIPT	PIEZO-type mechanosensitive ion channel component 2	613629	PIEZO2	63895	ENSG00000154864,ENST00000674853;;;ENST00000674853	mutation identified in 1 MWKS patient	Arthrogryposis, distal, with impaired proprioception and touch	617146	AR	3	Piezo2
18p11.21	18:11689264-11885685	GNAL, DYT25	Guanine nucleotide-binding protein, alpha-subunit, olfactory type	139312	GNAL	2774	ENSG00000141404,ENST00000334049;;;ENST00000334049		Dystonia 25	615073	AD	3	Gnal
18p11.21	18:12307669-12329826	TUBB6, FPVEPD	Tubulin, beta-6	615103	TUBB6	84617	ENSG00000176014,ENST00000317702;;;ENST00000317702	mutation identified in 1 FPVEPD family	?Facial palsy, congenital, with ptosis and velopharyngeal dysfunction	617732	AD	3	Tubb6
18p11.21	18:12328944-12377227	AFG3L2, SCA28, SPAX5, OPA12	AFG3-like matrix AAA peptidase, subunit 2	604581	AFG3L2	10939	ENSG00000141385,ENST00000269143;;;ENST00000269143		Optic atrophy 12	618977	AD	3	Afg3l2
18p11.21	18:12328944-12377227	AFG3L2, SCA28, SPAX5, OPA12	AFG3-like matrix AAA peptidase, subunit 2	604581	AFG3L2	10939	ENSG00000141385,ENST00000269143;;;ENST00000269143		Spastic ataxia 5, autosomal recessive	614487	AR	3	Afg3l2
18p11.21	18:12328944-12377227	AFG3L2, SCA28, SPAX5, OPA12	AFG3-like matrix AAA peptidase, subunit 2	604581	AFG3L2	10939	ENSG00000141385,ENST00000269143;;;ENST00000269143		Spinocerebellar ataxia 28	610246	AD	3	Afg3l2
18p11.21	18:12658738-12725740	PSMG2, TNFSF5IP1, HCCA3, CLAST3, PAC2, PRAAS4	Proteasome (prosome, macropain) assembly chaperone 1	609702	PSMG2	56984	ENSG00000128789,ENST00000317615;;;ENST00000317615	mutation identified in 1 PRAAS4 patient	?Proteasome-associated autoinflammatory syndrome 4	619183	AR	3	Psmg2
18p11.21	18:13882044-13915707	MC2R	Melanocortin-2 receptor (ACTH receptor)	607397	MC2R	4158	ENSG00000185231,ENST00000327606;;;ENST00000327606		Glucocorticoid deficiency, due to ACTH unresponsiveness	202200	AR	3	Mc2r
18q	18:18500001-80373285	DEL18q	Chromosome 18q deletion syndrome	601808					Chromosome 18q deletion syndrome	601808	AD	4	
18q	18:18500001-80373285	OHDS	Orthostatic hypotensive disorder of Streeten	143850		50948			Orthostatic hypotensive disorder of Streeten	143850	AD	2	
18q11.1-q11.2	18:21242232-21526112	GREB1L, C18orf6, KIAA1772, RHDA3, DFNA80	GREB1-like retinoic acid receptor coactivator	617782	GREB1L	80000	ENSG00000141449,ENST00000424526;;;ENST00000424526		Deafness, autosomal dominant 80	619274	AD	3	Greb1l
18q11.1-q11.2	18:21242232-21526112	GREB1L, C18orf6, KIAA1772, RHDA3, DFNA80	GREB1-like retinoic acid receptor coactivator	617782	GREB1L	80000	ENSG00000141449,ENST00000424526;;;ENST00000424526		Renal hypodysplasia/aplasia 3	617805	AD	3	Greb1l
18q11.2-q12.2	18:21500001-39500000	APMR3	Alopecia-intellectual disability syndrome 3	613930		100653369		between D18S866 and D18S811	Alopecia-intellectual disability syndrome 3	613930	AR	2	
18q11.2	18:21704916-21870953	MIB1, MIB, DIP1, KIAA1323, LVNC7	Mindbomb E3 ubiquitin protein ligase 1	608677	MIB1	57534	ENSG00000101752,ENST00000261537;;;ENST00000261537		Left ventricular noncompaction 7	615092	AD	3	Mib1
18q11.2	18:22169589-22202528	GATA6, AVSD5, ASD9, PACHD	GATA-binding protein-6	601656	GATA6	2627	ENSG00000141448,ENST00000269216;;;ENST00000269216		Atrial septal defect 9	614475	AD	3	Gata6
18q11.2	18:22169589-22202528	GATA6, AVSD5, ASD9, PACHD	GATA-binding protein-6	601656	GATA6	2627	ENSG00000141448,ENST00000269216;;;ENST00000269216		Atrioventricular septal defect 5	614474	AD	3	Gata6
18q11.2	18:22169589-22202528	GATA6, AVSD5, ASD9, PACHD	GATA-binding protein-6	601656	GATA6	2627	ENSG00000141448,ENST00000269216;;;ENST00000269216		Pancreatic agenesis and congenital heart defects	600001	AD	3	Gata6
18q11.2	18:22169589-22202528	GATA6, AVSD5, ASD9, PACHD	GATA-binding protein-6	601656	GATA6	2627	ENSG00000141448,ENST00000269216;;;ENST00000269216		Persistent truncus arteriosus	217095		3	Gata6
18q11.2	18:22169589-22202528	GATA6, AVSD5, ASD9, PACHD	GATA-binding protein-6	601656	GATA6	2627	ENSG00000141448,ENST00000269216;;;ENST00000269216		Tetralogy of Fallot	187500	AD	3	Gata6
18q11.2	18:22914139-23026486	RBBP8, RIM, SCKL2, JWDS	Retinoblastoma-binding protein 8	604124	RBBP8	5932	ENSG00000101773,ENST00000327155;;;ENST00000327155		Jawad syndrome	251255	AR	3	Rbbp8
18q11.2	18:22914139-23026486	RBBP8, RIM, SCKL2, JWDS	Retinoblastoma-binding protein 8	604124	RBBP8	5932	ENSG00000101773,ENST00000327155;;;ENST00000327155		Pancreatic carcinoma, somatic			3	Rbbp8
18q11.2	18:22914139-23026486	RBBP8, RIM, SCKL2, JWDS	Retinoblastoma-binding protein 8	604124	RBBP8	5932	ENSG00000101773,ENST00000327155;;;ENST00000327155		Seckel syndrome 2	606744	AR	3	Rbbp8
18q11.2	18:23506184-23586506	NPC1, NPC	NPC intracellular cholesterol transporter 1	607623	NPC1	4864	ENSG00000141458,ENST00000269228;;;ENST00000269228	some families not linked to 18; type D prob. allelic	Niemann-Pick disease, type C1	257220	AR	3	Npc1
18q11.2	18:23506184-23586506	NPC1, NPC	NPC intracellular cholesterol transporter 1	607623	NPC1	4864	ENSG00000141458,ENST00000269228;;;ENST00000269228	some families not linked to 18; type D prob. allelic	Niemann-Pick disease, type D	257220	AR	3	Npc1
18q11.2	18:23689453-23955066	LAMA3, LOCS, JEB2A, JEB2B, JEB2C	Laminin, alpha-3 (nicein, 150kD; kalinin, 165kD; BM600, 150kD; epiligrin)	600805	LAMA3	3909	ENSG00000053747,ENST00000313654;;;ENST00000313654		Epidermolysis bullosa, junctional 2A, intermediate	619783	AR	3	Lama3
18q11.2	18:23689453-23955066	LAMA3, LOCS, JEB2A, JEB2B, JEB2C	Laminin, alpha-3 (nicein, 150kD; kalinin, 165kD; BM600, 150kD; epiligrin)	600805	LAMA3	3909	ENSG00000053747,ENST00000313654;;;ENST00000313654		Epidermolysis bullosa, junctional 2B, severe	619784	AR	3	Lama3
18q11.2	18:23689453-23955066	LAMA3, LOCS, JEB2A, JEB2B, JEB2C	Laminin, alpha-3 (nicein, 150kD; kalinin, 165kD; BM600, 150kD; epiligrin)	600805	LAMA3	3909	ENSG00000053747,ENST00000313654;;;ENST00000313654		Epidermolysis bullosa, junctional 2C, laryngoonychocutaneous	245660	AR	3	Lama3
18q11.2	18:26016253-26091219	SS18, SSXT, SYT	Synovial sarcoma translocation, chromosome 18	600192	SS18	6760	ENSG00000141380,ENST00000415083;;;ENST00000415083	5' SYST/3' SSRC in t(X;18)	Sarcoma, synovial			1	Ss18
18q11.2	18:26226445-26391685	TAF4B, TAF2C2, TAFII105, SPGF13	TAF4b RNA polymerase II, TATA box-binding protein-associated factor, 105kD	601689	TAF4B	6875	ENSG00000141384,ENST00000269142;;;ENST00000269142	mutation identified in 1 SPGF13 family	?Spermatogenic failure 13	615841	AR	3	Taf4b
18q11.2	18:26454910-26657473	KCTD1, SENS	Potassium channel tetramerization domain-containing 1	613420	KCTD1	284252	ENSG00000134504,ENST00000580059;;;ENST00000580059		Scalp-ear-nipple syndrome	181270	AD	3	Kctd1
18q11.2	18:26852038-26865803	AQP4, MIWC, MLC4	Aquaporin-4	600308	AQP4	361	ENSG00000171885,ENST00000383168;;;ENST00000383168	mutation identified in 1 MLC4 family	?Megalencephalic leukoencephalopathy with subcortical cysts 4, remitting	620448	AR	3	Aqp4
18q12.1	18:27500001-35100000	MGR11	Migraine with or without aura, susceptibility to, 11	610209		117204003			{Migraine with or without aura, susceptibility to, 11}	610209	AD	2	
18q12.1	18:27932879-28177130	CDH2, NCAD, ARVD14, ACOGS, ADHD8	Cadherin 2 (cadherin, neuronal type; N-cadherin)	114020	CDH2	1000	ENSG00000170558,ENST00000269141;;;ENST00000269141	mutation identified in 1 ADHD8 family	?Attention deficit-hyperactivity disorder 8	619957	AR	3	Cdh2
18q12.1	18:27932879-28177130	CDH2, NCAD, ARVD14, ACOGS, ADHD8	Cadherin 2 (cadherin, neuronal type; N-cadherin)	114020	CDH2	1000	ENSG00000170558,ENST00000269141;;;ENST00000269141	mutation identified in 1 ADHD8 family	Agenesis of corpus callosum, cardiac, ocular, and genital syndrome	618929	AD	3	Cdh2
18q12.1	18:27932879-28177130	CDH2, NCAD, ARVD14, ACOGS, ADHD8	Cadherin 2 (cadherin, neuronal type; N-cadherin)	114020	CDH2	1000	ENSG00000170558,ENST00000269141;;;ENST00000269141	mutation identified in 1 ADHD8 family	Arrhythmogenic right ventricular dysplasia 14	618920	AD	3	Cdh2
18q12.1	18:30989365-31042742	DSC3, DSC4	Desmocollin-3	600271	DSC3	1825	ENSG00000134762,ENST00000360428;;;ENST00000360428		Hypotrichosis and recurrent skin vesicles	613102	AR	3	Dsc3
18q12.1	18:31058840-31102421	DSC2, DSC3, ARVD11	Desmocollin-2	125645	DSC2	1824	ENSG00000134755,ENST00000280904;;;ENST00000280904		Arrhythmogenic right ventricular dysplasia 11	610476	AD, AR	3	Dsc2
18q12.1	18:31058840-31102421	DSC2, DSC3, ARVD11	Desmocollin-2	125645	DSC2	1824	ENSG00000134755,ENST00000280904;;;ENST00000280904		Arrhythmogenic right ventricular dysplasia 11 with mild palmoplantar keratoderma and woolly hair	610476	AD, AR	3	Dsc2
18q12.1	18:31318160-31359246	DSG1, PPKS1, SPPK1, EPKHE	Desmoglein-1	125670	DSG1	1828	ENSG00000134760,ENST00000257192;;;ENST00000257192	pemphigus foliaceous antigen	Erythroderma, congenital, with palmoplantar keratoderma, hypotrichosis, and hyper IgE	615508	AR	3	Dsg1a,Dsg1b,Dsg1c
18q12.1	18:31318160-31359246	DSG1, PPKS1, SPPK1, EPKHE	Desmoglein-1	125670	DSG1	1828	ENSG00000134760,ENST00000257192;;;ENST00000257192	pemphigus foliaceous antigen	Keratosis palmoplantaris striata I, AD	148700	AD	3	Dsg1a,Dsg1b,Dsg1c
18q12.1	18:31376777-31414909	DSG4, LAH, HYPT6	Desmoglein 4	607892	DSG4	147409	ENSG00000175065,ENST00000308128;;;ENST00000308128		Hypotrichosis 6	607903	AR	3	Dsg4
18q12.1	18:31447741-31478702	DSG3, ABOLM	Desmoglein-3 (pemphigus vulgaris antigen)	169615	DSG3	1830	ENSG00000134757,ENST00000257189;;;ENST00000257189		Blistering, acantholytic, of oral and laryngeal mucosa	619226	AR	3	Dsg3
18q12.1	18:31498177-31549008	DSG2, ARVD10, ARVC10, CMD1BB	Desmoglein-2	125671	DSG2	1829	ENSG00000046604,ENST00000261590;;;ENST00000261590		Arrhythmogenic right ventricular dysplasia 10	610193	AD	3	Dsg2
18q12.1	18:31498177-31549008	DSG2, ARVD10, ARVC10, CMD1BB	Desmoglein-2	125671	DSG2	1829	ENSG00000046604,ENST00000261590;;;ENST00000261590		Cardiomyopathy, dilated, 1BB	612877	AR	3	Dsg2
18q12.1	18:31591877-31598821	TTR, PALB, AMYLD1	Transthyretin (prealbumin)	176300	TTR	7276	ENSG00000118271,ENST00000237014;;;ENST00000237014		[Dystransthyretinemic hyperthyroxinemia]	145680	AD	3	Ttr
18q12.1	18:31591877-31598821	TTR, PALB, AMYLD1	Transthyretin (prealbumin)	176300	TTR	7276	ENSG00000118271,ENST00000237014;;;ENST00000237014		Amyloidosis, hereditary systemic 1	105210	AD	3	Ttr
18q12.1	18:31591877-31598821	TTR, PALB, AMYLD1	Transthyretin (prealbumin)	176300	TTR	7276	ENSG00000118271,ENST00000237014;;;ENST00000237014		Carpal tunnel syndrome, familial	115430	AD	3	Ttr
18q12.1	18:32018825-32090806	RNF125, TRAC1, TNORS	RING finger protein 125	610432	RNF125	54941	ENSG00000101695,ENST00000217740;;;ENST00000217740		Tenorio syndrome	616260	AD	3	Rnf125
18q12.1	18:33578219-33751195	ASXL3, KIAA1713, BRPS	ASXL transcriptional regulator 3	615115	ASXL3	80816	ENSG00000141431,ENST00000269197;;;ENST00000269197		Bainbridge-Ropers syndrome	615485	AD	3	Asxl3
18q12.1	18:34493312-34891844	DTNA, D18S892E, DRP3, LVNC1, MMCKR2	Dystobrevin, alpha (dystrophin-related protein 3)	601239	DTNA	1837	ENSG00000134769,ENST00000444659;;;ENST00000444659		Left ventricular noncompaction 1, with or without congenital heart defects	604169	AD	3	Dtna
18q12.1	18:34493312-34891844	DTNA, D18S892E, DRP3, LVNC1, MMCKR2	Dystobrevin, alpha (dystrophin-related protein 3)	601239	DTNA	1837	ENSG00000134769,ENST00000444659;;;ENST00000444659		Myopathy with myalgia, increased serum creatine kinase, and with or without episodic rhabdomyolysis 2	620971	AD	3	Dtna
18q12.1-q12.2	18:34977027-35143470	MAPRE2, EB2, RP1, CSCSC2	Microtubule-associated protein, RP/EB family, member 2	605789	MAPRE2	10982	ENSG00000166974,ENST00000300249;;;ENST00000300249		Symmetric circumferential skin creases, congenital, 2	616734	AD	3	Mapre2
18q12.2-q12.3	18:35100001-45900000	OPA4	Optic atrophy 4	605293		58156			Optic atrophy 4	605293		2	
18q12.2	18:36129899-36180557	ELP2, STATIP1, MRT58	Elongator acetyltransferase complex, subunit 2	616054	ELP2	55250	ENSG00000134759,ENST00000358232;;;ENST00000358232		Intellectual developmental disorder, autosomal recessive 58	617270	AR	3	Elp2
18q12.2	18:36187497-36272157	MOCOS, MCS, XAN2	Molybdenum cofactor sulfurase	613274	MOCOS	55034	ENSG00000075643,ENST00000261326;;;ENST00000261326		Xanthinuria, type II	603592	AR	3	Mocos
18q12.2	18:36297713-36780220	FHOD3, FHOS2, KIAA1695, CMH28	Formin homology-2 domain-containing protein 3	609691	FHOD3	80206	ENSG00000134775,ENST00000590592;;;ENST00000590592		Cardiomyopathy, familial hypertrophic, 28	619402	AD	3	Fhod3
18q12.3	18:39500001-45900000	VUR6	Vesicoureteral reflux 6	614319		100820763		closest marker rs1054986	Vesicoureteral reflux 6	614319		2	
18q12.3	18:44680073-45068510	SETBP1, KIAA0437, SEB, MRD29	SET-binding protein 1	611060	SETBP1	26040	ENSG00000152217,ENST00000649279;;;ENST00000649279	fused with NUP98 in ALL	Intellectual developmental disorder, autosomal dominant 29	616078	AD	3	Setbp1
18q12.3	18:44680073-45068510	SETBP1, KIAA0437, SEB, MRD29	SET-binding protein 1	611060	SETBP1	26040	ENSG00000152217,ENST00000649279;;;ENST00000649279	fused with NUP98 in ALL	Schinzel-Giedion midface retraction syndrome	269150	AD	3	Setbp1
18q12.3	18:45724181-45752520	SLC14A1, JK, UTE, UT1	Solute carrier family 14 (urea transporter), member 1 (Kidd blood group)	613868	SLC14A1	6563	ENSG00000141469,ENST00000321925;;;ENST00000321925	previous suggestion of chr.7 or chr.2	[Blood group, Kidd]	111000		3	Slc14a1
18q12.3-q21.1	18:45800581-45967329	EPG5, KIAA1632, HEEW1, VICIS	Ectopic P-granules autophagy protein 5 homolog	615068	EPG5	57724	ENSG00000152223,ENST00000282041;;;ENST00000282041		Vici syndrome	242840	AR	3	Epg5
18q21	18:45900001-63900000	ALS3	Amyotrophic lateral sclerosis 3	606640		253			Amyotrophic lateral sclerosis 3	606640	AD	2	
18q21.1-q21.3	18:45900001-63900000	CORD1, CRD1	Cone rod dystrophy 1, autosomal dominant	600624		1319			Cone-rod retinal dystrophy-1	600624	AD	2	
18q21	18:45900001-63900000	IDDM6	Insulin-dependent diabetes mellitus-6	601941		3405			{Diabetes mellitus, insulin-dependent, 6}	601941		2	
18q21.1	18:46080248-46104227	ATP5F1A, ATP5A1, ATPM, ATP5A, ORM, MC5DN4B, COXPD22, MC5DN4A	ATP synthase F1, alpha subunit	164360	ATP5F1A	498	ENSG00000152234,ENST00000398752;;;ENST00000398752	pseudogenes on chr. 2, chr. 9, and chr.16; mutation identified in 1 MC5DN4 family and 1 COXPD22 family	?Combined oxidative phosphorylation deficiency 22	616045	AR	3	Atp5f1a
18q21.1	18:46080248-46104227	ATP5F1A, ATP5A1, ATPM, ATP5A, ORM, MC5DN4B, COXPD22, MC5DN4A	ATP synthase F1, alpha subunit	164360	ATP5F1A	498	ENSG00000152234,ENST00000398752;;;ENST00000398752	pseudogenes on chr. 2, chr. 9, and chr.16; mutation identified in 1 MC5DN4 family and 1 COXPD22 family	?Mitochondrial complex V (ATP synthase) deficiency, nuclear type 4B, encephalopathic type	615228	AR	3	Atp5f1a
18q21.1	18:46080248-46104227	ATP5F1A, ATP5A1, ATPM, ATP5A, ORM, MC5DN4B, COXPD22, MC5DN4A	ATP synthase F1, alpha subunit	164360	ATP5F1A	498	ENSG00000152234,ENST00000398752;;;ENST00000398752	pseudogenes on chr. 2, chr. 9, and chr.16; mutation identified in 1 MC5DN4 family and 1 COXPD22 family	Mitochondrial complex V (ATP synthase) deficiency, nuclear type 4A	620358	AD	3	Atp5f1a
18q21.1	18:46476961-46657220	LOXHD1, DFNB77	Lipoxygenase homology domains-containing 1	613072	LOXHD1	125336	ENSG00000167210,ENST00000642948;;;ENST00000642948		Deafness, autosomal recessive 77	613079	AR	3	Loxhd1
18q21.1	18:47152834-47176364	IER3IP1, MEDS	Immediate-early response 3-interacting protein 1	609382	IER3IP1	51124	ENSG00000134049,ENST00000256433;;;ENST00000256433		Microcephaly, epilepsy, and diabetes syndrome	614231	AR	3	Ier3ip1
18q21.1	18:47206169-47251660	SKOR2, FUSSEL18, CORL2, VAFCAS	SKI family transcriptional corepressor 2	617138	SKOR2	652991	ENSG00000215474,ENST00000425639;;;ENST00000425639		Valence-Farazi cerebellar ataxia syndrome	621386	AR	3	Skor2
18q21.1	18:47808957-47930872	SMAD2, MADH2, JV18, LDS6, CHTD8	SMAD family member 2	601366	SMAD2	4087	ENSG00000175387,ENST00000262160;;;ENST00000262160		Congenital heart defects, multiple types, 8, with or without heterotaxy	619657	AD	3	Smad2
18q21.1	18:47808957-47930872	SMAD2, MADH2, JV18, LDS6, CHTD8	SMAD family member 2	601366	SMAD2	4087	ENSG00000175387,ENST00000262160;;;ENST00000262160		Loeys-Dietz syndrome 6	619656	AD	3	Smad2
18q21.1	18:48919853-48950965	SMAD7, MADH7, CRCS3	SMAD family member 7	602932	SMAD7	4092	ENSG00000101665,ENST00000262158;;;ENST00000262158		{Colorectal cancer, susceptibility to, 3}	612229		3	Smad7
18q21.1	18:49036387-49460645	DYM, FLJ90130, DMC, SMC	Dymeclin	607461	DYM	54808	ENSG00000141627,ENST00000675505;;;ENST00000675505		Dyggve-Melchior-Clausen disease	223800	AR	3	Dym
18q21.1	18:49036387-49460645	DYM, FLJ90130, DMC, SMC	Dymeclin	607461	DYM	54808	ENSG00000141627,ENST00000675505;;;ENST00000675505		Smith-McCort dysplasia	607326	AR	3	Dym
18q21.1	18:49477243-49487234	C18orf32, GPIBD25	Chromosome 18 open reading frame 32	619979	C18orf32	497661	ENSG00000177576,ENST00000318240;;;ENST00000318240	mutation identified in 1 GPIBD25 patient	?Glycosylphosphatidylinositol biosynthesis defect 25	619985	AR	3	BC031181
18q21.1	18:49488481-49492465	RPL17, DBA22	Ribosomal protein L17	603661	RPL17	6139	ENSG00000265681,ENST00000580261;;;ENST00000580261		Diamond-Blackfan anemia 22	621262	AD	3	Gm6133,Rpl17
18q21.1	18:49822789-50195147	MYO5B, KIAA1119, DIAR2, MVID1, PFIC10	Myosin VB	606540	MYO5B	4645	ENSG00000167306,ENST00000285039;;;ENST00000285039		Cholestasis, progressive familial intrahepatic, 10	619868	AR	3	Myo5b
18q21.1	18:49822789-50195147	MYO5B, KIAA1119, DIAR2, MVID1, PFIC10	Myosin VB	606540	MYO5B	4645	ENSG00000167306,ENST00000285039;;;ENST00000285039		Diarrhea 2, with microvillus atrophy, with or without cholestasis	251850	AR	3	Myo5b
18q21.1	18:50227193-50266495	CFAP53, CCDC11, HTX6	Cilia- and flagella-associated protein 53	614759	CFAP53	220136	ENSG00000172361,ENST00000398545;;;ENST00000398545		Heterotaxy, visceral, 6, autosomal recessive	614779	AR	3	Cfap53
18q21.2	18:50700001-56200000	HYT8	Hypertension, essential, susceptibility to, 8	611014		100188321		associated with rs1941958 and rs1893379	{Hypertension, essential, susceptibility to, 8}	611014		2	
18q21.2	18:51030213-51085042	SMAD4, MADH4, DPC4, JIP, MYHRS	SMAD family member 4	600993	SMAD4	4089	ENSG00000141646,ENST00000342988;;;ENST00000342988		Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome	175050	AD	3	Smad4
18q21.2	18:51030213-51085042	SMAD4, MADH4, DPC4, JIP, MYHRS	SMAD family member 4	600993	SMAD4	4089	ENSG00000141646,ENST00000342988;;;ENST00000342988		Myhre syndrome	139210	AD	3	Smad4
18q21.2	18:51030213-51085042	SMAD4, MADH4, DPC4, JIP, MYHRS	SMAD family member 4	600993	SMAD4	4089	ENSG00000141646,ENST00000342988;;;ENST00000342988		Pancreatic cancer, somatic	260350		3	Smad4
18q21.2	18:51030213-51085042	SMAD4, MADH4, DPC4, JIP, MYHRS	SMAD family member 4	600993	SMAD4	4089	ENSG00000141646,ENST00000342988;;;ENST00000342988		Polyposis, juvenile intestinal	174900	AD	3	Smad4
18q21.2	18:52340197-53535899	DCC, MRMV1, HGPPS2	Deleted in colorectal carcinoma	120470	DCC	1630	ENSG00000187323,ENST00000442544;;;ENST00000442544		Colorectal cancer, somatic	114500		3	Dcc
18q21.2	18:52340197-53535899	DCC, MRMV1, HGPPS2	Deleted in colorectal carcinoma	120470	DCC	1630	ENSG00000187323,ENST00000442544;;;ENST00000442544		Esophageal carcinoma, somatic	133239		3	Dcc
18q21.2	18:52340197-53535899	DCC, MRMV1, HGPPS2	Deleted in colorectal carcinoma	120470	DCC	1630	ENSG00000187323,ENST00000442544;;;ENST00000442544		Gaze palsy, familial horizontal, with progressive scoliosis, 2	617542	AR	3	Dcc
18q21.2	18:52340197-53535899	DCC, MRMV1, HGPPS2	Deleted in colorectal carcinoma	120470	DCC	1630	ENSG00000187323,ENST00000442544;;;ENST00000442544		Mirror movements 1 and/or agenesis of the corpus callosum	157600	AD	3	Dcc
18q21.2	18:55222185-55635957	TCF4, SEF2, ITF2, PTHS, FECD3	Transcription factor-4 (immunoglobulin transcription factor-2)	602272	TCF4	6925	ENSG00000196628,ENST00000354452;;;ENST00000354452		Corneal dystrophy, Fuchs endothelial, 3	613267	AD	3	Tcf4
18q21.2	18:55222185-55635957	TCF4, SEF2, ITF2, PTHS, FECD3	Transcription factor-4 (immunoglobulin transcription factor-2)	602272	TCF4	6925	ENSG00000196628,ENST00000354452;;;ENST00000354452		Pitt-Hopkins syndrome	610954	AD	3	Tcf4
18q21.3	18:56200001-63900000	CNSN	Carnosinemia (carnosinase)	212200		8173			Carnosinemia	212200	AR	2	
18q21.31	18:57544377-57586702	FECH, FCE, EPP1	Ferrochelatase	612386	FECH	2235	ENSG00000066926,ENST00000262093;;;ENST00000262093		Protoporphyria, erythropoietic, 1	177000	AR	3	Fech
18q21.31	18:57600656-57621836	NARS1, NARS, ASNRS, NEDMILG, NEDMILEG	Asparaginyl-tRNA synthetase 1	108410	NARS1	4677	ENSG00000134440,ENST00000256854;;;ENST00000256854		Neurodevelopmental disorder with microcephaly, impaired language, and gait abnormalities, autosomal recessive	619091	AR	3	Nars1
18q21.31	18:57600656-57621836	NARS1, NARS, ASNRS, NEDMILG, NEDMILEG	Asparaginyl-tRNA synthetase 1	108410	NARS1	4677	ENSG00000134440,ENST00000256854;;;ENST00000256854		Neurodevelopmental disorder with microcephaly, impaired language, epilepsy, and gait abnormalities, autosomal dominant	619092	AD	3	Nars1
18q21.31	18:57646426-57803315	ATP8B1, FIC1, BRIC, PFIC1, ICP1	ATPase, class I, type 8B, member 1	602397	ATP8B1	5205	ENSG00000081923,ENST00000648908;;;ENST00000648908		Cholestasis, benign recurrent intrahepatic	243300	AR	3	Atp8b1
18q21.31	18:57646426-57803315	ATP8B1, FIC1, BRIC, PFIC1, ICP1	ATPase, class I, type 8B, member 1	602397	ATP8B1	5205	ENSG00000081923,ENST00000648908;;;ENST00000648908		Cholestasis, intrahepatic, of pregnancy, 1	147480	AD	3	Atp8b1
18q21.31	18:57646426-57803315	ATP8B1, FIC1, BRIC, PFIC1, ICP1	ATPase, class I, type 8B, member 1	602397	ATP8B1	5205	ENSG00000081923,ENST00000648908;;;ENST00000648908		Cholestasis, progressive familial intrahepatic 1	211600	AR	3	Atp8b1
18q21.31	18:58044226-58401540	NEDD4L, KIAA0439, RSP5, PVNH7	Ubiquitin protein ligase NEDD4-like	606384	NEDD4L	23327	ENSG00000049759,ENST00000400345;;;ENST00000400345		Periventricular nodular heterotopia 7	617201	AD	3	Nedd4l
18q21.32	18:58671465-58754477	MALT1, MLT, IMD12	MALT1 paracaspase	604860	MALT1	10892	ENSG00000172175,ENST00000649217;;;ENST00000649217	fused with API2 in MALT lymphoma	Immunodeficiency 12	615468	AR	3	Malt1
18q21.32	18:59267038-59273454	RAX, RX, MCOPS16	Retina and anterior neural fold homeobox gene	601881	RAX	30062	ENSG00000134438,ENST00000334889;;;ENST00000334889		Microphthalmia, syndromic 16	611038	AR	3	Rax
18q21.32	18:59327823-59359265	LMAN1, ERGIC53, F5F8D, MCFD1	Lectin, mannose-binding 1	601567	LMAN1	3998	ENSG00000074695,ENST00000251047;;;ENST00000251047		Combined factor V and VIII deficiency	227300	AR	3	Lman1
18q21.32	18:59430939-59697721	CCBE1, KIAA1983, HKLLS1	Collagen and calcium-binding EGF domain-containing protein 1	612753	CCBE1	147372	ENSG00000183287,ENST00000439986;;;ENST00000439986		Hennekam lymphangiectasia-lymphedema syndrome 1	235510	AR	3	Ccbe1
18q21.32	18:60371062-60372775	MC4R, BMIQ20	Melanocortin-4 receptor	155541	MC4R	4160	ENSG00000166603,ENST00000299766;;;ENST00000299766		{Obesity, resistance to (BMIQ20)}	618406	AD, AR	3	Mc4r
18q21.32	18:60371062-60372775	MC4R, BMIQ20	Melanocortin-4 receptor	155541	MC4R	4160	ENSG00000166603,ENST00000299766;;;ENST00000299766		Obesity (BMIQ20)	618406	AD, AR	3	Mc4r
18q21.33	18:62017615-62187056	PIGN, MCAHS1	Phosphatidylinositol glycan, class N	606097	PIGN	23556	ENSG00000197563,ENST00000640252;;;ENST00000640252		Multiple congenital anomalies-hypotonia-seizures syndrome 1	614080	AR	3	Pign
18q21.33	18:62325310-62391288	TNFRSF11A, RANK, ODFR, FEO, OPTB7, PDB2	Tumor necrosis factor receptor superfamily, member 11A	603499	TNFRSF11A	8792	ENSG00000141655,ENST00000586569;;;ENST00000586569		{Paget disease of bone 2, early-onset}	602080	AD	3	Tnfrsf11a
18q21.33	18:62325310-62391288	TNFRSF11A, RANK, ODFR, FEO, OPTB7, PDB2	Tumor necrosis factor receptor superfamily, member 11A	603499	TNFRSF11A	8792	ENSG00000141655,ENST00000586569;;;ENST00000586569		Osteolysis, familial expansile	174810	AD	3	Tnfrsf11a
18q21.33	18:62325310-62391288	TNFRSF11A, RANK, ODFR, FEO, OPTB7, PDB2	Tumor necrosis factor receptor superfamily, member 11A	603499	TNFRSF11A	8792	ENSG00000141655,ENST00000586569;;;ENST00000586569		Osteopetrosis, autosomal recessive 7	612301	AR	3	Tnfrsf11a
18q21.33	18:63123346-63320090	BCL2	BCL2 apoptosis regulator	151430	BCL2	596	ENSG00000171791,ENST00000333681;;;ENST00000333681	most frequent hematologic malignancy t(14;18)(q32;q21)	Leukemia/lymphoma, B-cell, 2			3	Bcl2
18q21.33	18:63327726-63367206	KDSR, FVT1, EKVP4	3-ketodihydrosphingosine reductase	136440	KDSR	2531	ENSG00000119537,ENST00000645214;;;ENST00000645214	~10kb 5' to BCL2	Erythrokeratodermia variabilis et progressiva 4	617526	AR	3	Kdsr
18q21.33	18:63753057-63805370	SERPINB7, MEGSIN, PPKN	Serpin peptidase inhibitor, clade B (ovalbumin), member 7	603357	SERPINB7	8710	ENSG00000166396,ENST00000398019;;;ENST00000398019		Palmoplantar keratoderma, Nagashima type	615598	AR	3	Serpinb7
18q22	18:63900001-75400000	DUP18pDEL18q, DUP18qDEL18p	Chromosome 18 pericentric inversion	609334					Chromosome 18 pericentric inversion	609334		4	
18q22.1-q22.3	18:63900001-75400000	ECTD8	Ectodermal dysplasia 8, hair/tooth/nail type	602401		101101768		between D18S857 and D18S815	Ectodermal dysplasia 8, hair/tooth/nail type	602401	AR	2	
18q22.1	18:63970081-64019779	SERPINB8, PI8, CAP2, PSS5	Serpin family B, member 8	601697	SERPINB8	5271	ENSG00000166401,ENST00000397985;;;ENST00000397985		Peeling skin syndrome 5	617115	AR	3	Serpinb8
18q22.2	18:70003031-70205687	RTTN, MSSP	Rotatin	610436	RTTN	25914	ENSG00000176225,ENST00000640769;;;ENST00000640769		Microcephaly, short stature, and polymicrogyria with seizures	614833	AR	3	Rttn
18q22.3	18:74250846-74291963	CYB5A, MCB5, METAG	Cytochrome b5	613218	CYB5A	1528	ENSG00000166347,ENST00000340533;;;ENST00000340533	pseudogenes on X, 14q, 20p; mutation identified in 1 MET5 patient	Methemoglobinemia and ambiguous genitalia	250790	AR	3	Cyb5a
18q22.3	18:74597870-75065671	ZNF407, SIMHA	Zinc finger protein 407	615894	ZNF407	55628	ENSG00000215421,ENST00000299687;;;ENST00000299687		SIMHA syndrome	619557	AR	3	Zfp407
18q22.3	18:75210797-75289944	TSHZ1, TSH1, CAA	Teashirt zinc finger homeobox 1	614427	TSHZ1	10194	ENSG00000179981,ENST00000580243;;;ENST00000580243		Aural atresia, congenital	607842	AD	3	Tshz1
18q23	18:79676768-79756625	CTDP1, FCP1, CCFDN	C-terminal domain of RNA polymerase II subunit A, phosphatase of, subunit 1	604927	CTDP1	9150	ENSG00000060069,ENST00000613122;;;ENST00000613122		Congenital cataracts, facial dysmorphism, and neuropathy	604168	AR	3	Ctdp1
18q23	18:79970813-80033936	TXNL4A, DIM1, BMKS	Thioredoxin-like 4A	611595	TXNL4A	10907	ENSG00000141759,ENST00000269601;;;ENST00000269601		Burn-McKeown syndrome	608572	AR	3	Txnl4a
19p13.3-p13.2	19:1-12600000	ATHS, ALP	Atherosclerosis susceptibility (lipoprotein associated)	108725		470		closely linked to LDLR; may be LDLR	{Atherosclerosis, susceptibility to}	108725	AD	2	
19p	19:1-26200001	EXT3	Exostoses, multiple, 3	600209		2133			Exostoses, multiple, type 3	600209	AD	2	
19pter-p13.1	19:1-19900000	FPH1, MUH, HPP	Hyperpigmentation, familial progressive, 1	614233					Hyperpigmentation, familial progressive, 1	614233		2	
19p13	19:1-19900000	IBD6	Inflammatory bowel disease 6	606674		50942			{Inflammatory bowel disease 6}	606674		2	
19p13.3	19:1-6900000	IS1, AIS	Adolescent idiopathic scoliosis	181800		260402			Scoliosis, idiopathic 1	181800	AD	2	
19p13	19:1-19900000	MGR5	Migraine with or without aura, susceptibility to, 5	607508		387576			{Migraine with or without aura, susceptibility to, 5}	607508	AD	2	
19p13	19:1-19900000	PPNAD4	Pigmented nodular adrenocortical disease, primary, 4	615830				duplication of 294kb to 2.7Mb on 19p13	Pigmented nodular adrenocortical disease, primary, 4	615830	AD	4	
19p13	19:1-19900000	PSORS6	Psoriasis susceptibility 6	605364		63869			{Psoriasis susceptibility 6}	605364		2	
19p13.3	19:571283-583493	BSG	Basigin (blood group OK)	109480	BSG	682	ENSG00000172270,ENST00000333511;;;ENST00000333511		[Blood group, OK]	111380		3	Bsg
19p13.3	19:589881-617159	HCN2, BCNG2, GEFSP11, FEB2, EIG17	Hyperpolarization-activated cyclic nucleotide-gated potassium channel 2	602781	HCN2	610	ENSG00000099822,ENST00000251287;;;ENST00000251287		{Epilepsy, idiopathic generalized, susceptibility to, 17}	602477	AD	3	Hcn2
19p13.3	19:589881-617159	HCN2, BCNG2, GEFSP11, FEB2, EIG17	Hyperpolarization-activated cyclic nucleotide-gated potassium channel 2	602781	HCN2	610	ENSG00000099822,ENST00000251287;;;ENST00000251287		Febrile seizures, familial, 2	602477	AD	3	Hcn2
19p13.3	19:589881-617159	HCN2, BCNG2, GEFSP11, FEB2, EIG17	Hyperpolarization-activated cyclic nucleotide-gated potassium channel 2	602781	HCN2	610	ENSG00000099822,ENST00000251287;;;ENST00000251287		Generalized epilepsy with febrile seizures plus, type 11	602477	AD	3	Hcn2
19p13.3	19:617221-633537	POLRMT, APOLMT, COXPD55	Polymerase (RNA) mitochondrial (DNA directed)	601778	POLRMT	5442	ENSG00000099821,ENST00000588649;;;ENST00000588649		Combined oxidative phosphorylation deficiency 55	619743	AD, AR	3	Polrmt
19p13.3	19:852303-856243	ELANE, ELA2, SCN1	Elastase, neutrophil-expressed	130130	ELANE	1991	ENSG00000197561,ENST00000263621;;;ENST00000263621		Neutropenia, cyclic	162800	AD	3	Elane
19p13.3	19:852303-856243	ELANE, ELA2, SCN1	Elastase, neutrophil-expressed	130130	ELANE	1991	ENSG00000197561,ENST00000263621;;;ENST00000263621		Neutropenia, severe congenital 1, autosomal dominant	202700	AD	3	Elane
19p13.3	19:859664-863641	CFD, ADN	Complement factor D	134350	CFD	1675	ENSG00000197766,ENST00000327726;;;ENST00000327726		Complement factor D deficiency	613912	AR	3	Cfd
19p13.3	19:867963-893187	MED16, THRAP5, DRIP92, TRAP95, GGNS	Mediator complex subunit 16	604062	MED16	10025	ENSG00000175221,ENST00000325464;;;ENST00000325464		Guillouet-Gordon syndrome	621220	AR	3	Med16
19p13.3	19:917333-921005	KISS1R, GPR54, HH8, CPPB1	KISS1 receptor	604161	KISS1R	84634	ENSG00000116014,ENST00000234371;;;ENST00000234371	mutation identified in 1 CPPB1 patient	?Precocious puberty, central, 1	176400	AD	3	Kiss1r
19p13.3	19:917333-921005	KISS1R, GPR54, HH8, CPPB1	KISS1 receptor	604161	KISS1R	84634	ENSG00000116014,ENST00000234371;;;ENST00000234371	mutation identified in 1 CPPB1 patient	Hypogonadotropic hypogonadism 8 with or without anosmia	614837	AR	3	Kiss1r
19p13.3	19:1040107-1065572	ABCA7, ABCX, AD9	ATP-binding cassette, subfamily A, member 7	605414	ABCA7	10347	ENSG00000064687,ENST00000263094;;;ENST00000263094		{Alzheimer disease 9, susceptibility to}	608907	AD	3	Abca7
19p13.3	19:1103994-1106779	GPX4, SMDS	Glutathione peroxidase-4 (phospholipid hydroperoxidase)	138322	GPX4	2879	ENSG00000167468,ENST00000354171;;;ENST00000354171		Spondylometaphyseal dysplasia, Sedaghatian type	250220	AR	3	Gpx4
19p13.3	19:1205778-1228431	STK11, PJS, LKB1	Serine/threonine protein kinase-11	602216	STK11	6794	ENSG00000118046,ENST00000326873;;;ENST00000326873		Melanoma, malignant, somatic	155600		3	Stk11
19p13.3	19:1205778-1228431	STK11, PJS, LKB1	Serine/threonine protein kinase-11	602216	STK11	6794	ENSG00000118046,ENST00000326873;;;ENST00000326873		Pancreatic cancer, somatic	260350		3	Stk11
19p13.3	19:1205778-1228431	STK11, PJS, LKB1	Serine/threonine protein kinase-11	602216	STK11	6794	ENSG00000118046,ENST00000326873;;;ENST00000326873		Peutz-Jeghers syndrome	175200	AD	3	Stk11
19p13.3	19:1205778-1228431	STK11, PJS, LKB1	Serine/threonine protein kinase-11	602216	STK11	6794	ENSG00000118046,ENST00000326873;;;ENST00000326873		Testicular tumor, somatic	273300		3	Stk11
19p13.3	19:1241751-1244825	ATP5F1D, ATP5D, MC5DN5	ATP synthase F1 subunit delta	603150	ATP5F1D	513	ENSG00000099624,ENST00000215375;;;ENST00000215375		Mitochondrial complex V (ATP synthase) deficiency	618120	AR	3	Atp5f1d
19p13.3	19:1383907-1395584	NDUFS7, PSST, MC1DN3	NADH-ubiquinone oxidoreductase core subunit S7	601825	NDUFS7	374291	ENSG00000115286,ENST00000233627;;;ENST00000233627		Mitochondrial complex I deficiency, nuclear type 3	618224	AR	3	Ndufs7
19p13.3	19:1397026-1401542	GAMT, CCDS2	Guanidinoacetate methyltransferase	601240	GAMT	2593	ENSG00000130005,ENST00000252288;;;ENST00000252288		Cerebral creatine deficiency syndrome 2	612736	AR	3	Gamt
19p13.3	19:1446230-1473244	APC2, APCL, MRT74	APC regulator of WNT signaling pathway 2	612034	APC2	10297	ENSG00000115266,ENST00000590469;;;ENST00000590469	mutation identified in 1 MRT74 family	Cortical dysplasia, complex, with other brain malformations 10	618677	AR	3	Apc2
19p13.3	19:1446230-1473244	APC2, APCL, MRT74	APC regulator of WNT signaling pathway 2	612034	APC2	10297	ENSG00000115266,ENST00000590469;;;ENST00000590469	mutation identified in 1 MRT74 family	Intellectual developmental disorder, autosomal recessive 74	617169	AR	3	Apc2
19p13.3	19:1491181-1497927	REEP6, DP1L1, TB2L1, C19orf32, RP77	Receptor expression-enhancing protein 6	609346	REEP6	92840	ENSG00000115255,ENST00000233596;;;ENST00000233596		Retinitis pigmentosa 77	617304	AR	3	Reep6
19p13.3	19:1609292-1652615	TCF3, E2A, AGM8A, AGM8B	Transcription factor-3 (E2A immunoglobulin enhancer-binding factors E12/E47)	147141	TCF3	6929	ENSG00000071564,ENST00000262965;;;ENST00000262965		Agammaglobulinemia 8A, autosomal dominant	616941	AD	3	Tcf3
19p13.3	19:1609292-1652615	TCF3, E2A, AGM8A, AGM8B	Transcription factor-3 (E2A immunoglobulin enhancer-binding factors E12/E47)	147141	TCF3	6929	ENSG00000071564,ENST00000262965;;;ENST00000262965		Agammaglobulinemia 8B, autosomal recessive	619824	AR	3	Tcf3
19p13.3	19:1905399-1913447	ADAT3, TAD3, NEDBGF	Adenosine deaminase, tRNA-specific, 3	615302	ADAT3	113179	ENSG00000213638,ENST00000329478;;;ENST00000329478		Neurodevelopmental disorder with brain abnormalities, poor growth, and dysmorphic facies	615286	AR	3	Adat3
19p13.3	19:2100988-2164616	AP3D1, HPS10	Adaptor-related protein complex 3, delta-1 subunit	607246	AP3D1	8943	ENSG00000065000,ENST00000643116;;;ENST00000643116	mutation identified in 1 HPS10 patient	?Hermansky-Pudlak syndrome 10	617050	AR	3	Ap3d1
19p13.3	19:2163933-2232578	DOT1L, DOT1, KIAA1814, NDNS	DOT1-like	607375	DOT1L	84444	ENSG00000104885,ENST00000398665;;;ENST00000398665		Nil-Deshwar neurodevelopmental syndrome	621265	AD	3	Dot1l
19p13.3	19:2249323-2252073	AMH, MIF	Anti-Mullerian hormone	600957	AMH	268	ENSG00000104899,ENST00000221496;;;ENST00000221496		Persistent Mullerian duct syndrome, type I	261550	AR	3	Amh
19p13.3	19:2321521-2328586	LSM7, LDCA	LSM7 protein	607287	LSM7	51690	ENSG00000130332,ENST00000252622;;;ENST00000252622		Leukodystrophy and cerebellar atrophy	621191	AR	3	Lsm7
19p13.3	19:2428166-2456959	LMNB2, LMN2, EPM9, MCPH27	Lamin B2	150341	LMNB2	84823	ENSG00000176619,ENST00000325327;;;ENST00000325327	mutation identified in 1 EPM9 family	?Epilepsy, progressive myoclonic, 9	616540	AR	3	Lmnb2
19p13.3	19:2428166-2456959	LMNB2, LMN2, EPM9, MCPH27	Lamin B2	150341	LMNB2	84823	ENSG00000176619,ENST00000325327;;;ENST00000325327	mutation identified in 1 EPM9 family	{Lipodystrophy, partial, acquired, susceptibility to}	608709	AD	3	Lmnb2
19p13.3	19:2428166-2456959	LMNB2, LMN2, EPM9, MCPH27	Lamin B2	150341	LMNB2	84823	ENSG00000176619,ENST00000325327;;;ENST00000325327	mutation identified in 1 EPM9 family	Microcephaly 27, primary, autosomal dominant	619180	AD	3	Lmnb2
19p13.3	19:2977401-2995179	TLE6, GRG6, OZEMA15	TLE family member 6, subcortical maternal complex member	612399	TLE6	79816	ENSG00000104953,ENST00000246112;;;ENST00000246112		Oocyte/zygote/embryo maturation arrest 15	616814	AR	3	Tle6
19p13.3	19:3094362-3123999	GNA11, HHC2, HYPOC2	Guanine nucleotide-binding protein (G protein), alpha-11	139313	GNA11	2767	ENSG00000088256,ENST00000078429;;;ENST00000078429		Hypocalcemia, autosomal dominant 2	615361	AD	3	Gna11
19p13.3	19:3094362-3123999	GNA11, HHC2, HYPOC2	Guanine nucleotide-binding protein (G protein), alpha-11	139313	GNA11	2767	ENSG00000088256,ENST00000078429;;;ENST00000078429		Hypocalciuric hypercalcemia, type II	145981	AD	3	Gna11
19p13.3	19:3490824-3500674	DOHH, HLRC1, NEDMVIC	Deoxyhypusine hydroxylase	611262	DOHH	83475	ENSG00000129932,ENST00000427575;;;ENST00000427575		Neurodevelopmental disorder with microcephaly, cerebral atrophy, and visual impairment	620066	AR	3	Dohh
19p13.3	19:3506311-3538334	FZR1, HCDH1, KIAA1242, DEE109	Fizzy and cell division cycle 20-related protein 1	603619	FZR1	51343	ENSG00000105325,ENST00000441788;;;ENST00000441788		Developmental and epileptic encephalopathy 109	620145	AD	3	Fzr1
19p13.3	19:3585478-3593541	GIPC3, DFNB15, DFNB72, DFNB95	GAIP C-terminus-interacting protein 3	608792	GIPC3	126326	ENSG00000179855,ENST00000644452;;;ENST00000644452		Deafness, autosomal recessive 15	601869	AR	3	Gipc3
19p13.3	19:3594507-3606875	TBXA2R, BDPLT13	Thromboxane A2 receptor	188070	TBXA2R	6915	ENSG00000006638,ENST00000375190;;;ENST00000375190		{Bleeding disorder, platelet-type, 13, susceptibility to}	614009	AD	3	Tbxa2r
19p13.3	19:3630183-3700468	PIP5K1C, LCCS3	Phosphatidylinositol-4-phosphate 5-kinase, type I, gamma	606102	PIP5K1C	23396	ENSG00000186111,ENST00000335312;;;ENST00000335312		Lethal congenital contractural syndrome 3	611369	AR	3	Pip5k1c
19p13.3	19:3769089-3772228	RAX2, RAXL1, QRX, CORD11, ARMD6, RP95	Retina and anterior neural fold homeobox 2	610362	RAX2	84839	ENSG00000173976,ENST00000555633;;;ENST00000555633	mutation identified in 1 ARMD6 patient	?Macular degeneration, age-related, 6	613757		3	
19p13.3	19:3769089-3772228	RAX2, RAXL1, QRX, CORD11, ARMD6, RP95	Retina and anterior neural fold homeobox 2	610362	RAX2	84839	ENSG00000173976,ENST00000555633;;;ENST00000555633	mutation identified in 1 ARMD6 patient	Cone-rod dystrophy 11	610381	AD	3	
19p13.3	19:3769089-3772228	RAX2, RAXL1, QRX, CORD11, ARMD6, RP95	Retina and anterior neural fold homeobox 2	610362	RAX2	84839	ENSG00000173976,ENST00000555633;;;ENST00000555633	mutation identified in 1 ARMD6 patient	Retinitis pigmentosa 95	620102	AR	3	
19p13.3	19:3880685-3928082	ATCAY, CLAC, KIAA1872	Caytaxin	608179	ATCAY	85300	ENSG00000167654,ENST00000450849;;;ENST00000450849		Ataxia, cerebellar, Cayman type	601238	AR	3	Atcay
19p13.3	19:3976056-3985463	EEF2, EF2, SCA26	Eukaryotic translation elongation factor-2	130610	EEF2	1938	ENSG00000167658,ENST00000309311;;;ENST00000309311	mutation identified in 1 family	?Spinocerebellar ataxia 26	609306	AD	3	Eef2
19p13.3	19:4043303-4066899	ZBTB7A, FBI1, LRF, MNDLFH	Zinc finger and BTB domain containing 7A	605878	ZBTB7A	51341	ENSG00000178951,ENST00000322357;;;ENST00000322357		Macrocephaly, neurodevelopmental delay, lymphoid hyperplasia, and persistent fetal hemoglobin	619769	AD	3	Zbtb7a
19p13.3	19:4090321-4124122	MAP2K2, PRKMK2, MEK2, MKK2, CFC4	Mitogen-activated protein kinase kinase 2	601263	MAP2K2	5605	ENSG00000126934,ENST00000262948;;;ENST00000262948	previously assigned to 7q32	Cardiofaciocutaneous syndrome 4	615280	AD	3	Map2k2
19p13.3	19:4153631-4173054	CREB3L3, CREBH, HYTG2	cAMP responsive element-binding protein 3-like 3	611998	CREB3L3	84699	ENSG00000060566,ENST00000078445;;;ENST00000078445		Hypertriglyceridemia 2	619324	AD	3	Creb3l3
19p13.3	19:4360370-4400547	SH3GL1, EEN	SH3 domain GRB2-like 1 (Extra 11-19 leukemia fusion gene)	601768	SH3GL1	6455	ENSG00000141985,ENST00000269886;;;ENST00000269886		Leukemia, acute myeloid	601626	AD, SMu	1	Sh3gl1
19p13.3	19:4502192-4518486	PLIN4, KIAA1881, MRUPAV	Perilipin 4	613247	PLIN4	729359	ENSG00000167676,ENST00000301286;;;ENST00000301286		Myopathy with rimmed ubiquitin-positive autophagic vacuolation, autosomal dominant	601846	AD	3	Plin4
19p13.3	19:4542593-4559684	SEMA6B, EPM11	Semaphorin 6B	608873	SEMA6B	10501	ENSG00000167680,ENST00000586582;;;ENST00000586582		Epilepsy, progressive myoclonic, 11	618876	AD	3	Sema6b
19p13.3	19:4675227-4723842	DPP9, DPRP2, HATIS, IMD111	Dipeptidyl peptidase IX	608258	DPP9	91039	ENSG00000142002,ENST00000262960;;;ENST00000262960		Hatipoglu immunodeficiency syndrome	620331	AR	3	Dpp9
19p13.3	19:4815932-4831712	TICAM1, TRIF, IIAE6	TIR domain-containing adaptor molecule 1	607601	TICAM1	148022	ENSG00000127666,ENST00000248244;;;ENST00000248244		{Encephalopathy, acute, infection-induced (herpes-specific), susceptibility to, 6}	614850	AD, AR	3	Ticam1
19p13.3	19:4969113-5153598	KDM4B, JMJD2B, KIAA0876, MRD65	Lysine demethylase 4B	609765	KDM4B	23030	ENSG00000127663,ENST00000159111;;;ENST00000159111		Intellectual developmental disorder, autosomal dominant 65	619320	AD	3	Kdm4b
19p13.3	19:5678422-5680516	MICOS13, C19orf70, MIC13, QIL1	Mitochondrial contact site and cristae organizing system subunit 13	616658	MICOS13	125988	ENSG00000174917,ENST00000309324;;;ENST00000309324		Combined oxidative phosphorylation deficiency 37	618329	AR	3	Micos13
19p13.3	19:5691834-5720452	LONP1, PRSS15, LON, CODASS	lon peptidase 1, mitochondrial	605490	LONP1	9361	ENSG00000196365,ENST00000360614;;;ENST00000360614		CODAS syndrome	600373	AR	3	Lonp1
19p13.3	19:5830408-5839702	FUT6	Fucosyltransferase 6 (alpha (1,3) fucosyltransferase)	136836	FUT6	2528	ENSG00000156413,ENST00000318336;;;ENST00000318336	in cluster with FUT3, FUT5	[Fucosyltransferase 6 deficiency]	613852		3	
19p13.3	19:5842888-5857122	FUT3, LE	Fucosyltransferase 3	111100	FUT3	2525	ENSG00000171124,ENST00000303225	cen-FUT5-23kb-FUT3-14kb-FUT6-ter	[Blood group, Lewis]	618983		3	
19p13.3	19:5891229-5903790	NDUFA11, MC1DN14	NADH-ubiquinone oxidoreductase subunit A11	612638	NDUFA11	126328	ENSG00000174886,ENST00000308961;;;ENST00000308961		Mitochondrial complex I deficiency, nuclear type 14	618236	AR	3	Ndufa11
19p13.3	19:6361531-6370242	CLPP, PRLTS3, DFNB81	ATP-dependent protease ClpAP, E. coli, proteolytic subunit, homolog of	601119	CLPP	8192	ENSG00000125656,ENST00000245816;;;ENST00000245816		Perrault syndrome 3	614129	AR	3	Clpp
19p13.3	19:6494319-6502848	TUBB4A, DYT4, HLD6	Tubulin, beta-4A	602662	TUBB4A	10382	ENSG00000104833,ENST00000264071;;;ENST00000264071		Dystonia 4, torsion, autosomal dominant	128101	AD	3	Tubb4a
19p13.3	19:6494319-6502848	TUBB4A, DYT4, HLD6	Tubulin, beta-4A	602662	TUBB4A	10382	ENSG00000104833,ENST00000264071;;;ENST00000264071		Leukodystrophy, hypomyelinating, 6	612438	AD	3	Tubb4a
19p13.3	19:6581648-6591150	CD70, TNFSF7, CD27L, LPFS3	CD70 molecule	602840	CD70	970	ENSG00000125726,ENST00000245903;;;ENST00000245903		Lymphoproliferative syndrome 3	618261	AR	3	Cd70
19p13.3	19:6677704-6720650	C3, ARMD9, AHUS5	Complement component-3	120700	C3	718	ENSG00000125730,ENST00000245907;;;ENST00000245907	LE ~7cM in males vs. C3 RFLP	{Hemolytic uremic syndrome, atypical, susceptibility to, 5}	612925	AD	3	C3
19p13.3	19:6677704-6720650	C3, ARMD9, AHUS5	Complement component-3	120700	C3	718	ENSG00000125730,ENST00000245907;;;ENST00000245907	LE ~7cM in males vs. C3 RFLP	{Macular degeneration, age-related, 9}	611378		3	C3
19p13.3	19:6677704-6720650	C3, ARMD9, AHUS5	Complement component-3	120700	C3	718	ENSG00000125730,ENST00000245907;;;ENST00000245907	LE ~7cM in males vs. C3 RFLP	C3 deficiency	613779	AR	3	C3
19p13.2-q13.3	19:6900001-50900000	LPSA, D19S381E	Oncogene liposarcoma (DNA segment, single copy, expressed, probes MC15, MC6)	164953		8177			Liposarcoma			1	
19p13.2	19:6900001-12600000	NRCLP6	Narcolepsy 6	614223		100689216		associated with rs2305795	Narcolepsy 6	614223		2	
19p13.2-p13.1	19:6900001-19900000	PAPA3	Polydactyly, postaxial, type A3	607324		338333		between D19S1165 and D19S929	Polydactyly, postaxial, type A3	607324		2	
19p13.2	19:6900001-12600000	PCOS1, PCO1, PCO	Polycystic ovary syndrome 1	184700		5120		max lod at D19S884	Polycystic ovary syndrome 1	184700	AD	2	
19p13.2	19:6900001-12600000	TCO	Thyroid carcinoma, nonmedullary, with cell oxyphilia	603386		50975			Thyroid carcinoma, nonmedullary, with cell oxyphilia	603386		2	
19p13.2	19:7112265-7294414	INSR, HHF5	Insulin receptor	147670	INSR	3643	ENSG00000171105,ENST00000302850;;;ENST00000302850	1 gene for alpha and beta subunits	Diabetes mellitus, insulin-resistant, with acanthosis nigricans	610549		3	Insr
19p13.2	19:7112265-7294414	INSR, HHF5	Insulin receptor	147670	INSR	3643	ENSG00000171105,ENST00000302850;;;ENST00000302850	1 gene for alpha and beta subunits	Donohue syndrome	246200	AR	3	Insr
19p13.2	19:7112265-7294414	INSR, HHF5	Insulin receptor	147670	INSR	3643	ENSG00000171105,ENST00000302850;;;ENST00000302850	1 gene for alpha and beta subunits	Hyperinsulinemic hypoglycemia, familial, 5	609968	AD	3	Insr
19p13.2	19:7112265-7294414	INSR, HHF5	Insulin receptor	147670	INSR	3643	ENSG00000171105,ENST00000302850;;;ENST00000302850	1 gene for alpha and beta subunits	Rabson-Mendenhall syndrome	262190	AR	3	Insr
19p13.2	19:7348937-7479989	ARHGEF18, KIAA0521, RP78	Rho guanine nucleotide exchange factor 18	616432	ARHGEF18	23370	ENSG00000104880,ENST00000668164;;;ENST00000668164		Retinitis pigmentosa 78	617433	AR	3	Arhgef18
19p13.2	19:7522624-7534009	MCOLN1, ML4, LECD	Mucolipin 1	605248	MCOLN1	57192	ENSG00000090674,ENST00000264079;;;ENST00000264079		Lisch epithelial corneal dystrophy	620763	AD	3	Mcoln1
19p13.2	19:7522624-7534009	MCOLN1, ML4, LECD	Mucolipin 1	605248	MCOLN1	57192	ENSG00000090674,ENST00000264079;;;ENST00000264079		Mucolipidosis IV	252650	AR	3	Mcoln1
19p13.2	19:7534164-7561767	PNPLA6, NTE, SPG39, NTEMND, BNHS, LNMS, OMCS	Patatin-like phospholipase domain-containing protein 6	603197	PNPLA6	10908	ENSG00000032444,ENST00000600737;;;ENST00000600737	mutation identified in 1 LMNS family	?Laurence-Moon syndrome	245800	AR	3	Pnpla6
19p13.2	19:7534164-7561767	PNPLA6, NTE, SPG39, NTEMND, BNHS, LNMS, OMCS	Patatin-like phospholipase domain-containing protein 6	603197	PNPLA6	10908	ENSG00000032444,ENST00000600737;;;ENST00000600737	mutation identified in 1 LMNS family	Boucher-Neuhauser syndrome	215470	AR	3	Pnpla6
19p13.2	19:7534164-7561767	PNPLA6, NTE, SPG39, NTEMND, BNHS, LNMS, OMCS	Patatin-like phospholipase domain-containing protein 6	603197	PNPLA6	10908	ENSG00000032444,ENST00000600737;;;ENST00000600737	mutation identified in 1 LMNS family	Oliver-McFarlane syndrome	275400	AR	3	Pnpla6
19p13.2	19:7534164-7561767	PNPLA6, NTE, SPG39, NTEMND, BNHS, LNMS, OMCS	Patatin-like phospholipase domain-containing protein 6	603197	PNPLA6	10908	ENSG00000032444,ENST00000600737;;;ENST00000600737	mutation identified in 1 LMNS family	Spastic paraplegia 39, autosomal recessive	612020	AR	3	Pnpla6
19p13.2	19:7629793-7631956	PET100, C19orf79, MC4DN12	PET100 cytochrome c oxidase chaperone	614770	PET100	100131801	ENSG00000229833,ENST00000594797;;;ENST00000594797		Mitochondrial complex IV deficiency, nuclear type 12	619055	AR	3	Pet100
19p13.2	19:7629793-7647873	STXBP2, UNC18B, FHL5	Syntaxin binding protein 2	601717	STXBP2	6813	ENSG00000076944,ENST00000221283;;;ENST00000221283		Hemophagocytic lymphohistiocytosis, familial, 5, with or without microvillus inclusion disease	613101	AR	3	Stxbp2
19p13.2	19:7669049-7670455	RETN, RSTN, FIZZ3	Resistin	605565	RETN	56729	ENSG00000104918,ENST00000221515;;;ENST00000221515		{Diabetes mellitus, noninsulin-dependent, susceptibility to}	125853	AD	3	Retn
19p13.2	19:7669049-7670455	RETN, RSTN, FIZZ3	Resistin	605565	RETN	56729	ENSG00000104918,ENST00000221515;;;ENST00000221515		{Hypertension, insulin resistance-related, susceptibility to}	125853	AD	3	Retn
19p13.2	19:7739993-7747534	CD209, CDSIGN	CD209 antigen	604672	CD209	30835	ENSG00000090659,ENST00000315599;;;ENST00000315599		{Dengue fever, protection against}	614371		3	Cd209a,Cd209b,Cd209c,Cd209d,Cd209e
19p13.2	19:7739993-7747534	CD209, CDSIGN	CD209 antigen	604672	CD209	30835	ENSG00000090659,ENST00000315599;;;ENST00000315599		{HIV type 1, susceptibility to}	609423		3	Cd209a,Cd209b,Cd209c,Cd209d,Cd209e
19p13.2	19:7739993-7747534	CD209, CDSIGN	CD209 antigen	604672	CD209	30835	ENSG00000090659,ENST00000315599;;;ENST00000315599		{Mycobacterium tuberculosis, susceptibility to}	607948		3	Cd209a,Cd209b,Cd209c,Cd209d,Cd209e
19p13.2	19:8302127-8308358	CD320, 8D6, 8D6A, TCBLR	CD320 molecule	606475	CD320	51293	ENSG00000167775,ENST00000301458;;;ENST00000301458		Methylmalonic aciduria, transient, due to transcobalamin receptor defect	613646	AR	3	Cd320
19p13.2	19:8321496-8323340	RPS28, DBA15	Ribosomal protein S28	603685	RPS28	6234	ENSG00000233927,ENST00000600659;;;ENST00000600659		Diamond Blackfan anemia 15 with mandibulofacial dysostosis	606164	AD	3	Rps28
19p13.2	19:8364155-8374370	ANGPTL4, PGAR, HFARP, FIAF, TGQTL	Angiopoietin-like 4	605910	ANGPTL4	51129	ENSG00000167772,ENST00000301455;;;ENST00000301455		Plasma triglyceride level QTL, low	615881	AD	3	Angptl4
19p13.2	19:8390360-8404434	RAB11B, NDAGSCW	Ras-associated protein RAB11B	604198	RAB11B	9230	ENSG00000185236,ENST00000328024;;;ENST00000328024		Neurodevelopmental disorder with ataxic gait, absent speech, and decreased cortical white matter	617807	AD	3	Rab11b
19p13.2	19:8580240-8610715	ADAMTS10, WMS1	ADAM metallopeptidase domain with thrombospondin type 1 motif, 10	608990	ADAMTS10	81794	ENSG00000142303,ENST00000597188;;;ENST00000597188		Weill-Marchesani syndrome 1, recessive	277600	AR	3	Adamts10
19p13.2	19:8697400-8698795	ACTL9, SPGF53	Actin-like 9	619251	ACTL9	284382	ENSG00000181786,ENST00000324436;;;ENST00000324436		Spermatogenic failure 53	619258	AR	3	Actl9
19p13.2	19:9291140-9309838	ZNF699, FLJ38144, DEGCAGS	Zinc finger protein 699	609571	ZNF699	374879	ENSG00000196110,ENST00000591998;;;ENST00000591998		DEGCAGS syndrome	619488	AR	3	
19p13.2	19:10013483-10022279	RDH8, PRRDH, STGD5	Retinol dehydrogenase 8	608575	RDH8	50700	ENSG00000080511,ENST00000591589;;;ENST00000591589		Stargardt disease 5	621259	AR	3	Rdh8
19p13.2	19:10133346-10194953	DNMT1, MCMT, HSN1E, ADCADN	DNA methyltransferase 1	126375	DNMT1	1786	ENSG00000130816,ENST00000359526;;;ENST00000359526		Cerebellar ataxia, deafness, and narcolepsy, autosomal dominant	604121	AD	3	Dnmt1
19p13.2	19:10133346-10194953	DNMT1, MCMT, HSN1E, ADCADN	DNA methyltransferase 1	126375	DNMT1	1786	ENSG00000130816,ENST00000359526;;;ENST00000359526		Neuropathy, hereditary sensory, type IE	614116	AD	3	Dnmt1
19p13.2	19:10221433-10231331	S1PR2, EDG5, DFNB68	Sphingosine-1-phosphate receptor 2	605111	S1PR2	9294	ENSG00000267534,ENST00000646641;;;ENST00000646641		Deafness, autosomal recessive 68	610419	AR	3	S1pr2
19p13.2	19:10271120-10286615	ICAM1	Intercellular adhesion molecule-1	147840	ICAM1	3383	ENSG00000090339,ENST00000264832;;;ENST00000264832	close to Ldlr in mouse	{Malaria, cerebral, susceptibility to}	611162		3	Icam1
19p13.2	19:10286955-10288520	ICAM4, CD242, LW	Intracellular adhesion molecule 4	614088	ICAM4	3386	ENSG00000105371,ENST00000380770;;;ENST00000380770	close to C3, LU	[Blood group, Landsteiner-Wiener]	111250		3	Icam4
19p13.2	19:10310045-10316015	FDX2, FDX1L, MEOAL	Ferredoxin 2	614585	FDX2	112812	ENSG00000267673,ENST00000393708;;;ENST00000393708		Mitochondrial myopathy, episodic, with optic atrophy and reversible leukoencephalopathy	251900	AR	3	Fdx2
19p13.2	19:10350533-10380572	TYK2, IMD35	Tyrosine kinase 2	176941	TYK2	7297	ENSG00000105397,ENST00000525621;;;ENST00000525621		Immunodeficiency 35	611521	AR	3	Tyk2
19p13.2	19:10543904-10553418	ATG4D, APG4D, AUTL4, SPGF101	Autophagy related 4D cysteine peptidase	611340	ATG4D	84971	ENSG00000130734,ENST00000309469;;;ENST00000309469		Spermatogenic failure 101	621269	AR	3	Atg4d
19p13.2	19:10718079-10831903	DNM2, CMTDIB, CMTDI1, CMT2M, LCCS5	Dynamin-2	602378	DNM2	1785	ENSG00000079805,ENST00000389253;;;ENST00000389253	1 LCCS5 family identified with mutation	Centronuclear myopathy 1	160150	AD	3	Dnm2
19p13.2	19:10718079-10831903	DNM2, CMTDIB, CMTDI1, CMT2M, LCCS5	Dynamin-2	602378	DNM2	1785	ENSG00000079805,ENST00000389253;;;ENST00000389253	1 LCCS5 family identified with mutation	Charcot-Marie-Tooth disease, axonal type 2M	606482	AD	3	Dnm2
19p13.2	19:10718079-10831903	DNM2, CMTDIB, CMTDI1, CMT2M, LCCS5	Dynamin-2	602378	DNM2	1785	ENSG00000079805,ENST00000389253;;;ENST00000389253	1 LCCS5 family identified with mutation	Charcot-Marie-Tooth disease, dominant intermediate B	606482	AD	3	Dnm2
19p13.2	19:10718079-10831903	DNM2, CMTDIB, CMTDI1, CMT2M, LCCS5	Dynamin-2	602378	DNM2	1785	ENSG00000079805,ENST00000389253;;;ENST00000389253	1 LCCS5 family identified with mutation	Lethal congenital contracture syndrome 5	615368	AR	3	Dnm2
19p13.2	19:10961030-11062273	SMARCA4, BRG1, RTPS2, MRD16, CSS4, OTSC12	SWI/SNF-related, matrix-associated, actin-dependent regulator of chromatin, subfamily A, member 4	603254	SMARCA4	6597	ENSG00000127616,ENST00000344626;;;ENST00000344626	mutation identified in 1 OTSC12 family	?Otosclerosis 12	620792	AD	3	Smarca4
19p13.2	19:10961030-11062273	SMARCA4, BRG1, RTPS2, MRD16, CSS4, OTSC12	SWI/SNF-related, matrix-associated, actin-dependent regulator of chromatin, subfamily A, member 4	603254	SMARCA4	6597	ENSG00000127616,ENST00000344626;;;ENST00000344626	mutation identified in 1 OTSC12 family	{Rhabdoid tumor predisposition syndrome 2}	613325	AD	3	Smarca4
19p13.2	19:10961030-11062273	SMARCA4, BRG1, RTPS2, MRD16, CSS4, OTSC12	SWI/SNF-related, matrix-associated, actin-dependent regulator of chromatin, subfamily A, member 4	603254	SMARCA4	6597	ENSG00000127616,ENST00000344626;;;ENST00000344626	mutation identified in 1 OTSC12 family	Coffin-Siris syndrome 4	614609	AD	3	Smarca4
19p13.2	19:11089463-11133820	LDLR, FHCL1, FHC, FH, LDLCQ2	Low density lipoprotein receptor	606945	LDLR	3949	ENSG00000130164,ENST00000558518;;;ENST00000558518	~20cM distal to C3	Hypercholesterolemia, familial, 1	143890	AD, AR	3	Ldlr
19p13.2	19:11089463-11133820	LDLR, FHCL1, FHC, FH, LDLCQ2	Low density lipoprotein receptor	606945	LDLR	3949	ENSG00000130164,ENST00000558518;;;ENST00000558518	~20cM distal to C3	LDL cholesterol level QTL2	143890	AD, AR	3	Ldlr
19p13.2	19:11164270-11197865	KANK2, ANKRD25, KIAA1518, PPKWH, NPHS16	KN motif- and ankyrin repeat domain-containing protein 2	614610	KANK2	25959	ENSG00000197256,ENST00000586659;;;ENST00000586659		Nephrotic syndrome, type 16	617783	AR	3	Kank2
19p13.2	19:11164270-11197865	KANK2, ANKRD25, KIAA1518, PPKWH, NPHS16	KN motif- and ankyrin repeat domain-containing protein 2	614610	KANK2	25959	ENSG00000197256,ENST00000586659;;;ENST00000586659		Palmoplantar keratoderma and woolly hair	616099	AR	3	Kank2
19p13.2	19:11199295-11262524	DOCK6, KIAA1395, AOS2	Dedicator of cytokinesis 6	614194	DOCK6	57572	ENSG00000130158,ENST00000294618;;;ENST00000294618		Adams-Oliver syndrome 2	614219	AR	3	Dock6
19p13.2	19:11377207-11384314	EPOR	Erythropoietin receptor	133171	EPOR	2057	ENSG00000187266,ENST00000222139;;;ENST00000222139		[Erythrocytosis, familial, 1]	133100	AD	3	Epor
19p13.2	19:11420605-11435782	ODAD3, CCDC151, CILD30	Outer dynein arm docking complex subunit 3	615956	ODAD3	115948	ENSG00000198003,ENST00000356392;;;ENST00000356392		Ciliary dyskinesia, primary, 30	616037	AR	3	Odad3
19p13.2	19:11435635-11450968	PRKCSH, G19P1, PCLD1	Protein kinase C substrate 80K-H	177060	PRKCSH	5589	ENSG00000130175,ENST00000677123;;;ENST00000677123		Polycystic liver disease 1	174050	AD	3	Prkcsh
19p13.2	19:11574660-11578975	ACP5, SPENCDI	Acid phosphatase 5, tartrate resistant	171640	ACP5	54	ENSG00000102575,ENST00000648477;;;ENST00000648477	incorrectly assigned to 15 by A	Spondyloenchondrodysplasia with immune dysregulation	607944	AR	3	Acp5
19p13.1	19:12600001-19900000	CELIAC4	Celiac disease, susceptibility to, 4	609753				associated with rs2305764	{Celiac disease, susceptibility to, 4}	609753	Mu	3	
19p13.13	19:12600001-13800000	DEL19p13.13, C19DELp13.13, DUP19p13.13, C19DUPp13.13	Chromosome 19p13.13 deletion syndrome (Chromosome 19p13.13 duplication syndrome)	613638				contiguous gene syndrome	Chromosome 19p13.13 deletion syndrome	613638	IC	4	
19p13.13	19:12600001-13800000	DEL19p13.13, C19DELp13.13, DUP19p13.13, C19DUPp13.13	Chromosome 19p13.13 deletion syndrome (Chromosome 19p13.13 duplication syndrome)	613638				contiguous gene syndrome	Chromosome 19p13.13 duplication syndrome	613638	IC	4	
19p13.13	19:12646512-12666742	MAN2B1, MANB	Mannosidase, alpha, class 2B, member 1	609458	MAN2B1	4125	ENSG00000104774,ENST00000456935;;;ENST00000456935		Mannosidosis, alpha-, types I and II	248500	AR	3	Man2b1
19p13.13	19:12668073-12669415	WDR83OS, C19orf56, ASTERIX, NEDFHCA	WDR83 opposite strand	618474	WDR83OS	51398	ENSG00000105583,ENST00000596731;;;ENST00000596731		Neurodevelopmental disorder with variable familial hypercholanemia	621016	AR	3	Wdr83os
19p13.13	19:12672470-12681880	DHPS, NEDSSWI	Deoxyhypusine synthase	600944	DHPS	1725	ENSG00000095059,ENST00000210060;;;ENST00000210060		Neurodevelopmental disorder with seizures and speech and walking impairment	618480	AR	3	Dhps
19p13.13	19:12699201-12723932	TNPO2, TRN2, KPNB2B, IDDHISD	Transportin 2	603002	TNPO2	30000	ENSG00000105576,ENST00000425528;;;ENST00000425528		Intellectual developmental disorder with hypotonia, impaired speech, and dysmorphic facies	619556	AD	3	Tnpo2
19p13.13	19:12737106-12748323	GET3, ASNA1, ARSA1, CMD2H	Guided entry of tail-anchored proteins factor 3, ATPase	601913	GET3	439	ENSG00000198356,ENST00000357332;;;ENST00000357332	mutation identified in 1 CMD2H family	?Cardiomyopathy, dilated, 2H	620203	AR	3	Get3
19p13.13	19:12806584-12813640	RNASEH2A, RNHIA, AGS4	Ribonuclease H2, large subunit	606034	RNASEH2A	10535	ENSG00000104889,ENST00000221486;;;ENST00000221486		Aicardi-Goutieres syndrome 4	610333	AR	3	Rnaseh2a
19p13.13	19:12838515-12874952	MAST1, SAST, KIAA0973, MCCCHCM	Microtubule-associated serine/threonine kinase 1	612256	MAST1	22983	ENSG00000105613,ENST00000251472;;;ENST00000251472		Mega-corpus-callosum syndrome with cerebellar hypoplasia and cortical malformations	618273	AD	3	Mast1
19p13.13	19:12875209-12881449	DNASE2, DNL, AIPCS	Deoxyribonuclease II, lysosomal	126350	DNASE2	1777	ENSG00000105612,ENST00000222219;;;ENST00000222219		Autoinflammatory-pancytopenia syndrome	619858	AR	3	Dnase2a
19p13.13	19:12884422-12887201	KLF1, EKLF, INLU, HBFQTL6, CDAN4A, CDAN4B	Kruppel-like factor 1, erythroid	600599	KLF1	10661	ENSG00000105610,ENST00000264834;;;ENST00000264834		[Hereditary persistence of fetal hemoglobin]	613566	AD	3	Klf1
19p13.13	19:12884422-12887201	KLF1, EKLF, INLU, HBFQTL6, CDAN4A, CDAN4B	Kruppel-like factor 1, erythroid	600599	KLF1	10661	ENSG00000105610,ENST00000264834;;;ENST00000264834		Anemia, congenital dyserythropoietic, type IVb	620969	AR	3	Klf1
19p13.13	19:12884422-12887201	KLF1, EKLF, INLU, HBFQTL6, CDAN4A, CDAN4B	Kruppel-like factor 1, erythroid	600599	KLF1	10661	ENSG00000105610,ENST00000264834;;;ENST00000264834		Anemia, dyserythropoietic congenital, type IVa	613673	AD	3	Klf1
19p13.13	19:12884422-12887201	KLF1, EKLF, INLU, HBFQTL6, CDAN4A, CDAN4B	Kruppel-like factor 1, erythroid	600599	KLF1	10661	ENSG00000105610,ENST00000264834;;;ENST00000264834		Blood group--Lutheran inhibitor	111150	AD	3	Klf1
19p13.13	19:12891129-12899999	GCDH	Glutaryl-Coenzyme A dehydrogenase	608801	GCDH	2639	ENSG00000105607,ENST00000222214;;;ENST00000222214		Glutaricaciduria, type I	231670	AR	3	Gcdh
19p13.13	19:12922479-12933711	FARSA, CML33, RILDBC2	Phenylalanine-tRNA synthetase, alpha subunit	602918	FARSA	2193	ENSG00000179115,ENST00000314606;;;ENST00000314606	mutation identified in 1 RILDBC2	?Rajab interstitial lung disease with brain calcifications 2	619013	AR	3	Farsa
19p13.13	19:12938609-12944489	CALR, SSA	Sicca syndrome antigen A (autoantigen Ro; calreticulin)	109091	CALR	811	ENSG00000179218,ENST00000316448;;;ENST00000316448	distal to C3, near LDLR	Myelofibrosis, somatic	254450		3	Calr
19p13.13	19:12938609-12944489	CALR, SSA	Sicca syndrome antigen A (autoantigen Ro; calreticulin)	109091	CALR	811	ENSG00000179218,ENST00000316448;;;ENST00000316448	distal to C3, near LDLR	Thrombocythemia, somatic	187950		3	Calr
19p13.13	19:12969576-12974760	DAND5, CER2, CERL2, DANTE, COCO, HTX13	DAN domain family, member 5	609068	DAND5	199699	ENSG00000179284,ENST00000317060;;;ENST00000317060		Heterotaxy, visceral, 13, autosomal	621079	AR	3	Dand5
19p13.13	19:12995475-13098796	NFIX, NF1A, MALNS, MRSHSS	Nuclear factor I/X (CCAAT-binding transcription factor)	164005	NFIX	4784	ENSG00000008441,ENST00000592199;;;ENST00000592199		Malan syndrome	614753	AD	3	Nfix
19p13.13	19:12995475-13098796	NFIX, NF1A, MALNS, MRSHSS	Nuclear factor I/X (CCAAT-binding transcription factor)	164005	NFIX	4784	ENSG00000008441,ENST00000592199;;;ENST00000592199		Marshall-Smith syndrome	602535	AD	3	Nfix
19p13.13	19:13099033-13102858	LYL1	Lymphoblastic leukemia derived sequence-1	151440	LYL1	4066	ENSG00000104903,ENST00000264824;;;ENST00000264824		Leukemia, T-cell acute lymphoblastoid	151440		2	Lyl1
19p13.13	19:13104907-13116740	TRMT1, TRM1, MRT68	tRNA methyltransferase 1	611669	TRMT1	55621	ENSG00000104907,ENST00000357720;;;ENST00000357720		Intellectual developmental disorder, autosomal recessive 68	618302	AR	3	Trmt1
19p13.13	19:13116852-13141147	NACC1, BTBD14B, NECFM	Nucleus accumbens-associated protein 1, BEN and BTB/POZ domains-containing	610672	NACC1	112939	ENSG00000160877,ENST00000292431;;;ENST00000292431		Neurodevelopmental disorder with epilepsy, cataracts, feeding difficulties, and delayed brain myelination	617393	AD	3	Nacc1
19p13.13	19:13206442-13506479	CACNA1A, CACNL1A4, SCA6, DEE42	Calcium channel, voltage-dependent, P/Q type, alpha 1A subunit	601011	CACNA1A	773	ENSG00000141837,ENST00000360228;;;ENST00000360228		Developmental and epileptic encephalopathy 42	617106	AD	3	Cacna1a
19p13.13	19:13206442-13506479	CACNA1A, CACNL1A4, SCA6, DEE42	Calcium channel, voltage-dependent, P/Q type, alpha 1A subunit	601011	CACNA1A	773	ENSG00000141837,ENST00000360228;;;ENST00000360228		Episodic ataxia, type 2	108500	AD	3	Cacna1a
19p13.13	19:13206442-13506479	CACNA1A, CACNL1A4, SCA6, DEE42	Calcium channel, voltage-dependent, P/Q type, alpha 1A subunit	601011	CACNA1A	773	ENSG00000141837,ENST00000360228;;;ENST00000360228		Migraine, familial hemiplegic, 1	141500	AD	3	Cacna1a
19p13.13	19:13206442-13506479	CACNA1A, CACNL1A4, SCA6, DEE42	Calcium channel, voltage-dependent, P/Q type, alpha 1A subunit	601011	CACNA1A	773	ENSG00000141837,ENST00000360228;;;ENST00000360228		Migraine, familial hemiplegic, 1, with progressive cerebellar ataxia	141500	AD	3	Cacna1a
19p13.13	19:13206442-13506479	CACNA1A, CACNL1A4, SCA6, DEE42	Calcium channel, voltage-dependent, P/Q type, alpha 1A subunit	601011	CACNA1A	773	ENSG00000141837,ENST00000360228;;;ENST00000360228		Spinocerebellar ataxia 6	183086	AD	3	Cacna1a
19p13.12	19:13906201-13930879	CC2D1A, MRT3	Coiled-coil and C2 domain-containing 1A	610055	CC2D1A	54862	ENSG00000132024,ENST00000318003;;;ENST00000318003		Intellectual developmental disorder, autosomal recessive 3	608443	AR	3	Cc2d1a
19p13.12	19:14091688-14117762	PRKACA, CAFD1	Protein kinase, cAMP-dependent, catalytic, alpha	601639	PRKACA	5566	ENSG00000072062,ENST00000308677;;;ENST00000308677		Cardioacrofacial dysplasia 1	619142	AD	3	Prkaca
19p13.12	19:14091688-14117762	PRKACA, CAFD1	Protein kinase, cAMP-dependent, catalytic, alpha	601639	PRKACA	5566	ENSG00000072062,ENST00000308677;;;ENST00000308677		Cushing syndrome, ACTH-independent adrenal, somatic	615830		3	Prkaca
19p13.12	19:14147743-14206169	ADGRL1, LPHN1, CIRL1, CL1, LEC2, KIAA0821, DEDBANP	Adhesion G protein-coupled receptor L1	616416	ADGRL1	22859	ENSG00000072071,ENST00000361434;;;ENST00000361434		Developmental delay, behavioral abnormalities, and neuropsychiatric disorders	620065	AD	3	Adgrl1
19p13.12	19:14477762-14496127	GIPC1, RGS19IP1, C19orf3, OPDM2	GIPC PDZ domain-containing family member 1	605072	GIPC1	10755	ENSG00000123159,ENST00000393033;;;ENST00000393033		Oculopharyngodistal myopathy 2	618940	AD	3	Gipc1
19p13.12	19:14527726-14565980	TECR, GPSN2, TER, SC2, MRT14	Trans-2,3-enoyl-CoA reductase	610057	TECR	9524	ENSG00000099797,ENST00000215567;;;ENST00000215567		Intellectual developmental disorder, autosomal recessive 14	614020	AR	3	Tecr
19p13.12	19:14566078-14572066	NDUFB7, MC1DN39	NADH-ubiquinone oxidoreductase subunit B7	603842	NDUFB7	4713	ENSG00000099795,ENST00000215565;;;ENST00000215565	mutation identified in 1 MC1DN39 family	?Mitochondrial complex I deficiency, nuclear type 39	620135	AR	3	Ndufb7
19p13.12	19:14724171-14778560	ADGRE2, EMR2, VBU	Adhesion G protein-coupled receptor E2	606100	ADGRE2	30817	ENSG00000127507,ENST00000315576;;;ENST00000315576		Vibratory urticaria	125630	AD	3	Adgre5
19p13.12	19:15049480-15058293	CASP14, ARCI12	Caspase 14, apoptosis-related cysteine protease	605848	CASP14	23581	ENSG00000105141,ENST00000427043;;;ENST00000427043		Ichthyosis, congenital, autosomal recessive 12	617320	AR	3	Casp14
19p13.12	19:15159038-15200995	NOTCH3, CADASIL1, CASIL, IMF2, LMNS, CARASIL1, FPLD1	Notch, Drosophila, homolog of, 3	600276	NOTCH3	4854	ENSG00000074181,ENST00000263388;;;ENST00000263388	mutation identified in 1 IMF2 family	?Myofibromatosis, infantile 2	615293	AD	3	Notch3
19p13.12	19:15159038-15200995	NOTCH3, CADASIL1, CASIL, IMF2, LMNS, CARASIL1, FPLD1	Notch, Drosophila, homolog of, 3	600276	NOTCH3	4854	ENSG00000074181,ENST00000263388;;;ENST00000263388	mutation identified in 1 IMF2 family	Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy 1	125310	AD, AR	3	Notch3
19p13.12	19:15159038-15200995	NOTCH3, CADASIL1, CASIL, IMF2, LMNS, CARASIL1, FPLD1	Notch, Drosophila, homolog of, 3	600276	NOTCH3	4854	ENSG00000074181,ENST00000263388;;;ENST00000263388	mutation identified in 1 IMF2 family	Cerebral arteriopathy, autosomal recessive, with subcortical infarcts and leukoencephalopathy 1	621295	AR	3	Notch3
19p13.12	19:15159038-15200995	NOTCH3, CADASIL1, CASIL, IMF2, LMNS, CARASIL1, FPLD1	Notch, Drosophila, homolog of, 3	600276	NOTCH3	4854	ENSG00000074181,ENST00000263388;;;ENST00000263388	mutation identified in 1 IMF2 family	Lateral meningocele syndrome	130720	AD	3	Notch3
19p13.12	19:15159038-15200995	NOTCH3, CADASIL1, CASIL, IMF2, LMNS, CARASIL1, FPLD1	Notch, Drosophila, homolog of, 3	600276	NOTCH3	4854	ENSG00000074181,ENST00000263388;;;ENST00000263388	mutation identified in 1 IMF2 family	Lipodystrophy, familial partial, type 1	608600	AD	3	Notch3
19p13.12	19:15235519-15332539	BRD4, CAP, HUNK1, CDLS6	Bromodomain-containing protein 4	608749	BRD4	23476	ENSG00000141867,ENST00000679869;;;ENST00000679869	fused with NUT	Cornelia de Lange syndrome 6	620568	AD	3	Brd4
19p13.12	19:15508525-15552317	CYP4F22, ARCI5, LI3	Cytochrome P450, family 4, subfamily F, polypeptide 22	611495	CYP4F22	126410	ENSG00000171954,ENST00000269703;;;ENST00000269703		Ichthyosis, congenital, autosomal recessive 5	604777	AR	3	Cyp4f39
19p13.12-p13.11	19:16067538-16103002	TPM4, BDPLT25	Tropomyosin 4	600317	TPM4	7171	ENSG00000167460,ENST00000643579;;;ENST00000643579		Bleeding disorder, platelet-type, 25	620486	AD	3	Tpm4
19p13.11	19:16892951-17026810	CPAMD8, KIAA1283, ASGD8	Complement component 3- and pregnancy zone protein-like alpha-2-macroglobin domain-containing protein 8	608841	CPAMD8	27151	ENSG00000160111,ENST00000443236;;;ENST00000443236		Anterior segment dysgenesis 8	617319	AR	3	
19p13.11	19:17334982-17342731	GTPBP3, MSS1, COXPD23	GTP-binding protein 3	608536	GTPBP3	84705	ENSG00000130299,ENST00000324894;;;ENST00000324894		Combined oxidative phosphorylation deficiency 23	616198	AR	3	Gtpbp3
19p13.11	19:17351455-17377342	PLVAP, PV1, DIAR10	Plasmalemma vesicle-associated protein	607647	PLVAP	83483	ENSG00000130300,ENST00000252590;;;ENST00000252590		Diarrhea 10, protein-losing enteropathy type	618183	AR	3	Plvap
19p13.11	19:17555649-17583157	COLGALT1, GLT25D1, BSVD3	Collagen beta(1-0)galactosyltransferase 1	617531	COLGALT1	79709	ENSG00000130309,ENST00000252599;;;ENST00000252599		Brain small vessel disease 3	618360	AR	3	Colgalt1
19p13.11	19:17747744-17788561	FCHO1, IMD76	FCH domain-only protein 1	613437	FCHO1	23149	ENSG00000130475,ENST00000596536;;;ENST00000596536		Immunodeficiency 76	619164	AR	3	Fcho1
19p13.11	19:17816512-17821519	INSL3	Insulin-like 3, Leydig cell	146738	INSL3	3640	ENSG00000248099,ENST00000317306;;;ENST00000317306		Cryptorchidism	219050	AD	3	Insl3
19p13.11	19:17824782-17847982	JAK3, JAKL	Janus kinase 3 (Janus kinase, leukocyte)	600173	JAK3	3718	ENSG00000105639,ENST00000458235;;;ENST00000458235		Severe combined immunodeficiency, autosomal recessive, T-negative/B-positive type	600802	AR	3	Jak3
19p13.11	19:17871945-17895174	SLC5A5, NIS, TDH1	Solute carrier family 5 (sodium iodide symporter), member-5	601843	SLC5A5	6528	ENSG00000105641,ENST00000222248;;;ENST00000222248		Thyroid dyshormonogenesis 1	274400	AR	3	Slc5a5
19p13.11	19:18058995-18098927	IL12RB1, IMD30	Interleukin-12 receptor, beta-1	601604	IL12RB1	3594	ENSG00000096996,ENST00000593993;;;ENST00000593993		Immunodeficiency 30	614891	AR	3	Il12rb1
19p13.11	19:18097778-18151687	MAST3, KIAA0561, DEE108	Microtubule-associated serine/threonine kinase 3	612258	MAST3	23031	ENSG00000099308,ENST00000687212;;;ENST00000687212		Developmental and epileptic encephalopathy 108	620115	AD	3	Mast3
19p13.11	19:18153163-18170532	PIK3R2, MPPH1	Phosphatidylinositol 3-kinase, regulatory subunit 2	603157	PIK3R2	5296	ENSG00000105647,ENST00000222254;;;ENST00000222254		Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 1	603387	AD	3	Pik3r2
19p13.11	19:18257098-18274452	IQCN, SPGF78	IQ motif-containing protein N	620160	IQCN	80726	ENSG00000130518,ENST00000392413;;;ENST00000392413		Spermatogenic failure 78	620170	AR	3	Iqcn
19p13.11	19:18386158-18389176	GDF15, PLAB, PDF, MIC1, HG	Growth/differentiation factor-15 (bone morphogenetic protein, placental)	605312	GDF15	9518	ENSG00000130513,ENST00000252809;;;ENST00000252809		{Hyperemesis gravidarum, susceptibility to}	620730	AD	3	Gdf15
19p13.11	19:18593237-18606799	CRLF1, CISS1	Cytokine-like factor 1	604237	CRLF1	9244	ENSG00000006016,ENST00000392386;;;ENST00000392386		Cold-induced sweating syndrome 1	272430	AR	3	Crlf1
19p13.11	19:18683680-18782333	CRTC1, MECT1, KIAA0616, FLJ14027	CREB-regulated transcription coactivator 1	607536	CRTC1	23373	ENSG00000105662,ENST00000321949;;;ENST00000321949	t(11;19)	Mucoepidermoid salivary gland carcinoma			3	Crtc1
19p13.11	19:18782773-18791305	COMP, EDM1, MED, PSACH, CTS2	Cartilage oligomeric matrix protein	600310	COMP	1311	ENSG00000105664,ENST00000222271;;;ENST00000222271		Carpal tunnel syndrome 2	619161	AD	3	Comp
19p13.11	19:18782773-18791305	COMP, EDM1, MED, PSACH, CTS2	Cartilage oligomeric matrix protein	600310	COMP	1311	ENSG00000105664,ENST00000222271;;;ENST00000222271		Epiphyseal dysplasia, multiple, 1	132400	AD	3	Comp
19p13.11	19:18782773-18791305	COMP, EDM1, MED, PSACH, CTS2	Cartilage oligomeric matrix protein	600310	COMP	1311	ENSG00000105664,ENST00000222271;;;ENST00000222271		Pseudoachondroplasia	177170	AD	3	Comp
19p13.11	19:18868545-18896982	CERS1, LASS1, UOG1, EPM8	Ceramide synthase 1	606919	CERS1	10715	ENSG00000223802,ENST00000623882;;;ENST00000623882		Epilepsy, progressive myoclonic, 8	616230	AR	3	Cers1
19p13.11	19:18868545-18896158	GDF1, DTGA3, DORV, RAI, CHTD6	Growth/differentiation factor 1	602880	GDF1	2657	ENSG00000130283,ENST00000247005;;;ENST00000247005		Congenital heart defects, multiple types, 6	613854	AD	3	Gdf1
19p13.11	19:18868545-18896158	GDF1, DTGA3, DORV, RAI, CHTD6	Growth/differentiation factor 1	602880	GDF1	2657	ENSG00000130283,ENST00000247005;;;ENST00000247005		Right atrial isomerism (Ivemark)	208530	AR	3	Gdf1
19p13.11	19:19063994-19113030	SLC25A42, MECREN	Solute carrier family 25, member 42	610823	SLC25A42	284439	ENSG00000181035,ENST00000318596;;;ENST00000318596		Metabolic crises, recurrent, with variable encephalomyopathic features and neurologic regression	618416	AR	3	Slc25a42
19p13.11	19:19176906-19192152	BORCS8, MEF2BNB, NDOABA	BLOC1-related complex, subunit 8	616601	BORCS8	729991	ENSG00000254901,ENST00000462790;;;ENST00000462790		Neurodegeneration, infantile-onset, with optic atrophy and brain abnormalities	620987	AR	3	Borcs8
19p13.11	19:19192258-19201866	RFXANK, MHC2D2	Regulatory factor X, ankyrin repeat-containing	603200	RFXANK	8625	ENSG00000064490,ENST00000303088;;;ENST00000303088		MHC class II deficiency 2	620815	AR	3	Rfxank
19p13.11	19:19516225-19528198	NDUFA13, GRIM19, MC1DN28	NADH-ubiquinone oxidoreductase subunit A13	609435	NDUFA13	51079	ENSG00000186010,ENST00000507754;;;ENST00000507754		{Thyroid carcinoma, Hurthle cell}	607464		3	Ndufa13
19p13.11	19:19516225-19528198	NDUFA13, GRIM19, MC1DN28	NADH-ubiquinone oxidoreductase subunit A13	609435	NDUFA13	51079	ENSG00000186010,ENST00000507754;;;ENST00000507754		Mitochondrial complex I deficiency, nuclear type 28	618249	AR	3	Ndufa13
19q	19:26200001-58617616	BFIS1, BFIC1	Benign familial infantile seizures	601764		8181			Seizures, benign familial infantile, 1	601764	AD	2	
19q	19:26200001-58617616	HPCQTL19	Prostate cancer aggressiveness quantitative trait locus on chromosome 19	607592		347747		D19S902	{Prostate cancer aggressiveness QTL}	607592		2	
19q	19:26200001-58617616	SLI2	Specific language impairment QTL, 2	606712		171014			Specific language impairment QTL, 2	606712	Mu	2	
19q12	19:28100001-31900000	HSCR7	Hirschsprung disease, susceptibility to, 7	606875		246322			{Hirschsprung disease, susceptibility to, 7}	606875		2	
19q12	19:29205320-29213151	UQCRFS1, MC3DN10	Ubiquinol-cytochrome c reductase, Rieske iron-sulfur polypeptide 1	191327	UQCRFS1	7386	ENSG00000169021,ENST00000304863;;;ENST00000304863		Mitochondrial complex III deficiency, nuclear type 10	618775	AR	3	Uqcrfs1
19q12	19:29698886-29715789	C19orf12, NBIA4, SPG43	Chromosome 19 open reading frame 12	614297	C19orf12	83636	ENSG00000131943,ENST00000323670;;;ENST00000323670	mutation identified in 1 SPG43 family	?Spastic paraplegia 43, autosomal recessive	615043	AR	3	1600014C10Rik
19q12	19:29698886-29715789	C19orf12, NBIA4, SPG43	Chromosome 19 open reading frame 12	614297	C19orf12	83636	ENSG00000131943,ENST00000323670;;;ENST00000323670	mutation identified in 1 SPG43 family	Neurodegeneration with brain iron accumulation 4	614298	AD, AR	3	1600014C10Rik
19q13	19:31900001-58617616	AAA1, AAA	Aortic aneurysm, familial abdominal 1	100070		100329167		near D19S416	Aortic aneurysm, familial abdominal 1	100070	AD	2	
19q13	19:31900001-58617616	ANIB2	Aneurysm, intracranial berry, 2	608542		449013		between D19S245 and D19S246	Aneurysm, intracranial berry, 2	608542		2	
19q13	19:31900001-58617616	CTRCT35, CATCN1	Cataract 35	609376		619404		max lod at D19S416	Cataract 35, congenital nuclear	609376	AR	2	
19q13.11	19:31900001-35100000	DEL19q13.11d, C19DELq13.11d	Chromosome 19q13.11 deletion syndrome, distal	613026				contiguous gene syndrome	Chromosome 19q13.11 deletion syndrome, distal	613026	AD	4	
19q13.11	19:31900001-35100000	DEL19q13.11p, C19DELq13.11p	Chromosome 19q13.11 deletion syndrome, proximal	617219					Chromosome 19q13.11 deletion syndrome, proximal	617219	AD	4	
19q13	19:31900001-58617616	EA7	Episodic ataxia, type 7	611907		100188859		between rs1366444 and rs952108	Episodic ataxia, type 7	611907	AD	2	
19q13	19:31900001-58617616	OFC3	Orofacial cleft 3	600757		4965		?role of BCL3	Orofacial cleft 3	600757	?AD	2	
19q13	19:31900001-58617616	PSS3	Peeling skin syndrome 3	616265		134198642		between D19S414 and D19S412	Peeling skin syndrome 3	616265	AR	2	
19q13	19:31900001-58617616	UAQTL5	Uric acid concentration, serum, quantitative trait locus 5	614746		100996934		associated with rs150414818	[Uric acid concentration, serum, QTL5]	614746		2	
19q13.11	19:32675848-32678300	RGS9BP, R9AP, RGS9, PERRS2	Regulator of G protein signaling 9-binding protein	607814	RGS9BP	388531	ENSG00000186326,ENST00000334176;;;ENST00000334176		Prolonged electroretinal response suppression 2	620344	AR	3	Rgs9bp
19q13.11	19:32830511-32869767	SLC7A9, CSNU3	Solute carrier family 7 (cationic amino acid transporter, y+ system), member 9	604144	SLC7A9	11136	ENSG00000021488,ENST00000023064;;;ENST00000023064		Cystinuria	220100	AD, AR	3	Slc7a9
19q13.11	19:33299934-33302534	CEBPA, CEBP	CCAAT/enhancer-binding protein (C/EBP), alpha	116897	CEBPA	1050	ENSG00000245848,ENST00000498907;;;ENST00000498907	germline mutation identified in 1 AML family	?Leukemia, acute myeloid	601626	AD, SMu	3	Cebpa
19q13.11	19:33299934-33302534	CEBPA, CEBP	CCAAT/enhancer-binding protein (C/EBP), alpha	116897	CEBPA	1050	ENSG00000245848,ENST00000498907;;;ENST00000498907	germline mutation identified in 1 AML family	Leukemia, acute myeloid, somatic	601626		3	Cebpa
19q13.11	19:33386950-33521791	PEPD	Peptidase D (prolidase)	613230	PEPD	5184	ENSG00000124299,ENST00000244137;;;ENST00000244137	closely linked to APOC2	Prolidase deficiency	170100	AR	3	Pepd
19q13.11	19:34359718-34402413	GPI, CNSHA4	Glucose phosphate isomerase; neuroleukin	172400	GPI	2821	ENSG00000105220,ENST00000356487;;;ENST00000356487		Anemia, congenital, nonspherocytic hemolytic, 4, glucose phosphate isomerase deficient	613470	AR	3	Gpi1
19q13.11	19:34428381-34471251	UBA2, SAE2, ACCES	Ubiquitin-like modifier-activating enzyme 2	613295	UBA2	10054	ENSG00000126261,ENST00000246548;;;ENST00000246548		ACCES syndrome	619959	AD	3	Uba2
19q13.11	19:35030470-35040449	SCN1B, GEFSP1, BRGDA5, ATFB13, DEE52	Sodium voltage-gated channel, beta subunit 1	600235	SCN1B	6324	ENSG00000105711,ENST00000262631;;;ENST00000262631		Atrial fibrillation, familial, 13	615377	AD	3	Scn1b
19q13.11	19:35030470-35040449	SCN1B, GEFSP1, BRGDA5, ATFB13, DEE52	Sodium voltage-gated channel, beta subunit 1	600235	SCN1B	6324	ENSG00000105711,ENST00000262631;;;ENST00000262631		Brugada syndrome 5	612838		3	Scn1b
19q13.11	19:35030470-35040449	SCN1B, GEFSP1, BRGDA5, ATFB13, DEE52	Sodium voltage-gated channel, beta subunit 1	600235	SCN1B	6324	ENSG00000105711,ENST00000262631;;;ENST00000262631		Cardiac conduction defect, nonspecific	612838		3	Scn1b
19q13.11	19:35030470-35040449	SCN1B, GEFSP1, BRGDA5, ATFB13, DEE52	Sodium voltage-gated channel, beta subunit 1	600235	SCN1B	6324	ENSG00000105711,ENST00000262631;;;ENST00000262631		Developmental and epileptic encephalopathy 52	617350	AR	3	Scn1b
19q13.11	19:35030470-35040449	SCN1B, GEFSP1, BRGDA5, ATFB13, DEE52	Sodium voltage-gated channel, beta subunit 1	600235	SCN1B	6324	ENSG00000105711,ENST00000262631;;;ENST00000262631		Generalized epilepsy with febrile seizures plus, type 1	604233	AD	3	Scn1b
19q13.12	19:35124513-35135059	LGI4, AMC1	Leucine-rich gene, glioma-inactivated, 4	608303	LGI4	163175	ENSG00000153902,ENST00000310123;;;ENST00000310123		Arthrogryposis multiplex congenita 1, neurogenic, with myelin defect	617468	AR	3	Lgi4
19q13.12	19:35282528-35285143	HAMP, LEAP1, HEPC, HFE2B	Hepcidin antimicrobial peptide	606464	HAMP	57817	ENSG00000105697,ENST00000222304;;;ENST00000222304	digenic form with HAMP and HFE mutations	Hemochromatosis, type 2B	613313	AR	3	Hamp,Hamp2
19q13.12	19:35292161-35313807	MAG, GMA, SPG75	Myelin-associated glycoprotein	159460	MAG	4099	ENSG00000105695,ENST00000392213;;;ENST00000392213		Spastic paraplegia 75, autosomal recessive	616680	AR	3	Mag
19q13.12	19:35545626-35547526	TMEM147, NEDFLPH	Transmembrane protein 147	613585	TMEM147	10430	ENSG00000105677,ENST00000222284;;;ENST00000222284		Neurodevelopmental disorder with facial dysmorphism, absent language, and pseudo-Pelger-Huet anomaly	620075	AR	3	Tmem147
19q13.12	19:35648323-35658782	COX6B1, MC4DN7	Cytochrome c oxidase, subunit VIb polypeptide 1 (ubiquitous)	124089	COX6B1	1340	ENSG00000126267,ENST00000649813;;;ENST00000649813		Mitochondrial complex IV deficiency, nuclear type 7	619051	AR	3	Cox6b1
19q13.12	19:35718003-35738878	KMT2B, MLL4, KIAA0304, DYT28, MRD68	Lysine-specific methyltransferase 2B	606834	KMT2B	9757	ENSG00000272333,ENST00000420124;;;ENST00000420124		Dystonia 28, childhood-onset	617284	AD	3	Kmt2b
19q13.12	19:35718003-35738878	KMT2B, MLL4, KIAA0304, DYT28, MRD68	Lysine-specific methyltransferase 2B	606834	KMT2B	9757	ENSG00000272333,ENST00000420124;;;ENST00000420124		Intellectual developmental disorder, autosomal dominant 68	619934	AD	3	Kmt2b
19q13.12	19:35745651-35747519	PSENEN, PEN2, ACNINV2	Presenilin enhancer, gamma-secretase subunit	607632	PSENEN	55851	ENSG00000205155,ENST00000587708;;;ENST00000587708		Acne inversa, familial, 2, with or without Dowling-Degos disease	613736	AD	3	Psenen
19q13.12	19:35825372-35852504	NPHS1, NPHN	Nephrin	602716	NPHS1	4868	ENSG00000161270,ENST00000378910;;;ENST00000378910		Nephrotic syndrome, type 1	256300	AR	3	Nphs1
19q13.12	19:35904403-35908295	TYROBP, DAP12, PLOSL1	TYRO protein tyrosine kinase-binding protein	604142	TYROBP	7305	ENSG00000011600,ENST00000262629;;;ENST00000262629		Polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy 1	221770	AR	3	Tyrobp
19q13.12	19:35995188-35996312	SDHAF1, MC2DN2	Succinate dehydrogenase complex assembly factor 1	612848	SDHAF1	644096	ENSG00000205138,ENST00000378887;;;ENST00000378887		Mitochondrial complex II deficiency, nuclear type 2	619166	AR	3	Sdhaf1
19q13.12	19:36003307-36008813	SYNE4, NESP4, C19orf46, DFNB76	Spectrin repeat-containing nuclear envelope protein 4	615535	SYNE4	163183	ENSG00000181392,ENST00000324444;;;ENST00000324444		Deafness, autosomal recessive 76	615540	AR	3	Syne4
19q13.12	19:36054897-36111145	WDR62, C19orf14, MCPH2	WD repeat-containing protein 62	613583	WDR62	284403	ENSG00000075702,ENST00000401500;;;ENST00000401500		Microcephaly 2, primary, autosomal recessive, with or without cortical malformations	604317	AR	3	Wdr62
19q13.12	19:36114967-36125941	TBCB, CKAP1	Tubulin folding cofactor B	601303	TBCB	1155	ENSG00000105254,ENST00000221855;;;ENST00000221855		Neurodevelopmental disorder with behavioral abnormalities and childhood onset spastic paraplegia	621382	AR	3	Tbcb
19q13.12	19:36140066-36150353	CAPNS1, CAPN4, PPH6	Calpain, small subunit 1	114170	CAPNS1	826	ENSG00000126247,ENST00000246533;;;ENST00000246533		Pulmonary hypertension, primary, 6	620777	AR	3	Capns1
19q13.13-q13.2	19:37907208-38208369	SIPA1L3, SPAL3, SPAR3, KIAA0545, CTRCT45	SIPA1-like protein 3	616655	SIPA1L3	23094	ENSG00000105738,ENST00000222345;;;ENST00000222345	mutation identified in 1 CTRCT45 family	?Cataract 45	616851	AR	3	Sipa1l3
19q13.2-q13.4	19:38200001-58617616	CFM1	Cystic fibrosis modifier-1	603855		10167			{Meconium ileus in cystic fibrosis, susceptibility to}	603855		2	
19q13.2-q13.3	19:38200001-50900000	MRT11	Intellectual developmental disorder, autosomal recessive 11	611097		100101426		between rs2109075 and rs8101149	Intellectual developmental disorder, autosomal recessive 11	611097	AR	2	
19q13.2	19:38200001-42900000	TEC	Transient erythroblastopenia of childhood	227050		100124696			Transient erythroblastopenia of childhood	227050	AR	2	
19q13.2	19:38264573-38292615	SPINT2, HAI2, DIAR3	Serine protease inhibitor, Kunitz-type, 2	605124	SPINT2	10653	ENSG00000167642,ENST00000301244;;;ENST00000301244		Diarrhea 3, secretory sodium, congenital, syndromic	270420	AR	3	Spint2
19q13.2	19:38303558-38321887	YIF1B, KABAMAS	YIP1-interacting factor homolog B, membrane-trafficking protein	619109	YIF1B	90522	ENSG00000167645,ENST00000339413;;;ENST00000339413		Kaya-Barakat-Masson syndrome	619125	AR	3	Yif1b
19q13.2	19:38384267-38388384	GGN	Gametogenetin, mouse, homolog of	609966	GGN	199720	ENSG00000179168,ENST00000334928;;;ENST00000334928		Spermatogenic failure 69	619826	AR	3	Ggn
19q13.2	19:38433691-38587564	RYR1, MHS, KDS, CMYO1A, CMYO1B	Ryanodine receptor-1, skeletal	180901	RYR1	6261	ENSG00000196218,ENST00000359596;;;ENST00000359596		{Malignant hyperthermia susceptibility 1}	145600	AD	3	Ryr1
19q13.2	19:38433691-38587564	RYR1, MHS, KDS, CMYO1A, CMYO1B	Ryanodine receptor-1, skeletal	180901	RYR1	6261	ENSG00000196218,ENST00000359596;;;ENST00000359596		Congenital myopathy 1A, autosomal dominant, with susceptibility to malignant hyperthermia	117000	AD	3	Ryr1
19q13.2	19:38433691-38587564	RYR1, MHS, KDS, CMYO1A, CMYO1B	Ryanodine receptor-1, skeletal	180901	RYR1	6261	ENSG00000196218,ENST00000359596;;;ENST00000359596		Congenital myopathy 1B, autosomal recessive	255320	AR	3	Ryr1
19q13.2	19:38433691-38587564	RYR1, MHS, KDS, CMYO1A, CMYO1B	Ryanodine receptor-1, skeletal	180901	RYR1	6261	ENSG00000196218,ENST00000359596;;;ENST00000359596		King-Denborough syndrome	619542	AD	3	Ryr1
19q13.2	19:38647649-38731589	ACTN4, FSGS1, FSGS	Actinin, alpha-4	604638	ACTN4	81	ENSG00000130402,ENST00000252699;;;ENST00000252699		Glomerulosclerosis, focal segmental, 1	603278	AD	3	Actn4
19q13.2	19:38915266-38930763	SARS2	Seryl-tRNA synthetase 2	612804	SARS2	54938	ENSG00000104835,ENST00000221431;;;ENST00000221431		Hyperuricemia, pulmonary hypertension, renal failure, and alkalosis	613845	AR	3	Sars2
19q13.2	19:39243455-39245250	IFNL3, IL28B	Interferon, lambda 3	607402	IFNL3	282617	ENSG00000197110,ENST00000413851;;;ENST00000413851		{Hepatitis C virus infection, response to therapy of}	609532		3	Ifnl2,Ifnl3
19q13.2	19:39412669-39428415	PLEKHG2, CLG, LDAMD	Pleckstrin homology domain- and RhoGEF domain-containing protein G2	611893	PLEKHG2	64857	ENSG00000090924,ENST00000425673;;;ENST00000425673		Leukodystrophy and acquired microcephaly with or without dystonia	616763	AR	3	Plekhg2
19q13.2	19:39480838-39493779	TIMM50, TIM50, MGCA9	Translocase of inner mitochondrial membrane 50	607381	TIMM50	92609	ENSG00000105197,ENST00000607714;;;ENST00000607714		3-methylglutaconic aciduria, type IX	617698	AR	3	Timm50
19q13.2	19:39498947-39508469	DLL3, SCDO1	Delta-like canonical Notch ligand 3	602768	DLL3	10683	ENSG00000090932,ENST00000356433;;;ENST00000356433		Spondylocostal dysostosis 1, autosomal recessive	277300	AR	3	Dll3
19q13.2	19:39825350-39834162	DYRK1B, MIRK, AOMS3	Dual-specificity tyrosine phosphorylation-regulated kinase 1B	604556	DYRK1B	9149	ENSG00000105204,ENST00000323039;;;ENST00000323039		Abdominal obesity-metabolic syndrome 3	615812	AD	3	Dyrk1b
19q13.2	19:40230317-40285345	AKT2, HIHGHH	AKT serine/threonine kinase 2	164731	AKT2	208	ENSG00000105221,ENST00000392038;;;ENST00000392038		Diabetes mellitus, type II	125853	AD	3	Akt2
19q13.2	19:40230317-40285345	AKT2, HIHGHH	AKT serine/threonine kinase 2	164731	AKT2	208	ENSG00000105221,ENST00000392038;;;ENST00000392038		Hypoinsulinemic hypoglycemia with hemihypertrophy	240900	AD	3	Akt2
19q13.2	19:40348695-40378485	PLD3, HUK4, SCA46	Phospholipase D family, member 3	615698	PLD3	23646	ENSG00000105223,ENST00000409735;;;ENST00000409735	mutation identified in 1 SCA46 family	?Spinocerebellar ataxia 46	617770	AD	3	Pld3
19q13.2	19:40393764-40414789	PRX, CMT4F	Periaxin	605725	PRX	57716	ENSG00000105227,ENST00000324001;;;ENST00000324001		Charcot-Marie-Tooth disease, type 4F	614895	AR	3	Prx
19q13.2	19:40393764-40414789	PRX, CMT4F	Periaxin	605725	PRX	57716	ENSG00000105227,ENST00000324001;;;ENST00000324001		Dejerine-Sottas disease	145900	AD, AR	3	Prx
19q13.2	19:40467001-40576464	SPTBN4, QV, NEDHND, CMND	Spectrin, beta, nonerythrocytic, 4 (quivering, mouse, homolog of)	606214	SPTBN4	57731	ENSG00000160460,ENST00000598249;;;ENST00000598249		Neurodevelopmental disorder with hypotonia, neuropathy, and deafness	617519	AR	3	Sptbn4
19q13.2	19:40593166-40629820	LTBP4, LTBP4S, LTBP4L, ARCL1C	Latent transforming growth factor-beta-binding protein 4	604710	LTBP4	8425	ENSG00000090006,ENST00000396819;;;ENST00000396819		Cutis laxa, autosomal recessive, type IC	613177	AR	3	Ltbp4
19q13.2	19:40691530-40716886	COQ8B, ADCK4, NPHS9	Coenzyme Q8B	615567	COQ8B	79934	ENSG00000123815,ENST00000324464;;;ENST00000324464		Nephrotic syndrome, type 9	615573	AR	3	Coq8b
19q13.2	19:40843541-40850447	CYP2A6, CYP2A3, CYP2A, P450C2A	Cytochrome P450, subfamily IIA, phenobarbital-inducible, polypeptide 6	122720	CYP2A6	1548	ENSG00000255974,ENST00000301141;;;ENST00000301141		{Lung cancer, resistance to}	211980	AD, SMu	3	Cyp2a12,Cyp2a22,Cyp2a4,Cyp2a5
19q13.2	19:40843541-40850447	CYP2A6, CYP2A3, CYP2A, P450C2A	Cytochrome P450, subfamily IIA, phenobarbital-inducible, polypeptide 6	122720	CYP2A6	1548	ENSG00000255974,ENST00000301141;;;ENST00000301141		{Nicotine addiction, protection from}	188890		3	Cyp2a12,Cyp2a22,Cyp2a4,Cyp2a5
19q13.2	19:40843541-40850447	CYP2A6, CYP2A3, CYP2A, P450C2A	Cytochrome P450, subfamily IIA, phenobarbital-inducible, polypeptide 6	122720	CYP2A6	1548	ENSG00000255974,ENST00000301141;;;ENST00000301141		Coumarin resistance	122700	AD	3	Cyp2a12,Cyp2a22,Cyp2a4,Cyp2a5
19q13.2	19:40991282-41018398	CYP2B6, CYP2B, EFVM	Cytochrome P450, family 2, subfamily B, polypeptide 6	123930	CYP2B6	1555	ENSG00000197408,ENST00000324071;;;ENST00000324071	same NotI fragment as CYP2A	{Efavirenz central nervous system toxicity, susceptibility to}	614546		3	Cyp2b10,Cyp2b13,Cyp2b19,Cyp2b23,Cyp2b9
19q13.2	19:40991282-41018398	CYP2B6, CYP2B, EFVM	Cytochrome P450, family 2, subfamily B, polypeptide 6	123930	CYP2B6	1555	ENSG00000197408,ENST00000324071;;;ENST00000324071	same NotI fragment as CYP2A	Efavirenz, poor metabolism of	614546		3	Cyp2b10,Cyp2b13,Cyp2b19,Cyp2b23,Cyp2b9
19q13.2	19:41330323-41353922	TGFB1, DPD1, CED, IBDIMDE	Transforming growth factor, beta-1	190180	TGFB1	7040	ENSG00000105329,ENST00000221930;;;ENST00000221930		{Cystic fibrosis lung disease, modifier of}	219700	AR	3	Tgfb1
19q13.2	19:41330323-41353922	TGFB1, DPD1, CED, IBDIMDE	Transforming growth factor, beta-1	190180	TGFB1	7040	ENSG00000105329,ENST00000221930;;;ENST00000221930		Camurati-Engelmann disease	131300	AD	3	Tgfb1
19q13.2	19:41330323-41353922	TGFB1, DPD1, CED, IBDIMDE	Transforming growth factor, beta-1	190180	TGFB1	7040	ENSG00000105329,ENST00000221930;;;ENST00000221930		Inflammatory bowel disease, immunodeficiency, and encephalopathy	618213	AR	3	Tgfb1
19q13.2	19:41354417-41364149	B9D2, MKS10, JBTS34	B9 domain-containing protein 2	611951	B9D2	80776	ENSG00000123810,ENST00000243578;;;ENST00000243578	mutation identified in 1 MKS10 family	?Meckel syndrome 10	614175	AR	3	B9d2
19q13.2	19:41354417-41364149	B9D2, MKS10, JBTS34	B9 domain-containing protein 2	611951	B9D2	80776	ENSG00000123810,ENST00000243578;;;ENST00000243578	mutation identified in 1 MKS10 family	Joubert syndrome 34	614175	AR	3	B9d2
19q13.2	19:41386374-41397359	EXOSC5, RRP46, CABAC	Exosome component 5	606492	EXOSC5	56915	ENSG00000077348,ENST00000221233;;;ENST00000221233		Cerebellar ataxia, brain abnormalities, and cardiac conduction defects	619576	AR	3	Exosc5
19q13.2	19:41397818-41425002	BCKDHA, MSUD1A	Branched chain keto acid dehydrogenase E1, alpha polypeptide	608348	BCKDHA	593	ENSG00000248098,ENST00000269980;;;ENST00000269980		Maple syrup urine disease, type Ia	248600	AR	3	Bckdha
19q13.2	19:41860255-41872925	RPS19, DBA, DBA1	Ribosomal protein S19	603474	RPS19	6223	ENSG00000105372,ENST00000598742;;;ENST00000598742		Diamond-Blackfan anemia 1	105650	AD	3	Rps19
19q13.2	19:41877279-41881372	CD79A, IGA	CD79A antigen (immunoglobulin-associated alpha)	112205	CD79A	973	ENSG00000105369,ENST00000221972;;;ENST00000221972		Agammaglobulinemia 3	613501	AR	3	Cd79a
19q13.2	19:41883184-41930141	ARHGEF1, LBCL2, IMD62	Rho guanine nucleotide exchange factor, 115-kD	601855	ARHGEF1	9138	ENSG00000076928,ENST00000354532;;;ENST00000354532	mutation identified in 1 IMD62 family	?Immunodeficiency 62	618459	AR	3	Arhgef1
19q13.2	19:41966582-41994230	ATP1A3, DYT12, RDP, AHC2, CAPOS, DEE99	ATPase, Na+K+ transporting, alpha-3 polypeptide	182350	ATP1A3	478	ENSG00000105409,ENST00000648268;;;ENST00000648268		Alternating hemiplegia of childhood 2	614820	AD	3	Atp1a3
19q13.2	19:41966582-41994230	ATP1A3, DYT12, RDP, AHC2, CAPOS, DEE99	ATPase, Na+K+ transporting, alpha-3 polypeptide	182350	ATP1A3	478	ENSG00000105409,ENST00000648268;;;ENST00000648268		CAPOS syndrome	601338	AD	3	Atp1a3
19q13.2	19:41966582-41994230	ATP1A3, DYT12, RDP, AHC2, CAPOS, DEE99	ATPase, Na+K+ transporting, alpha-3 polypeptide	182350	ATP1A3	478	ENSG00000105409,ENST00000648268;;;ENST00000648268		Developmental and epileptic encephalopathy 99	619606	AD	3	Atp1a3
19q13.2	19:41966582-41994230	ATP1A3, DYT12, RDP, AHC2, CAPOS, DEE99	ATPase, Na+K+ transporting, alpha-3 polypeptide	182350	ATP1A3	478	ENSG00000105409,ENST00000648268;;;ENST00000648268		Dystonia-12	128235	AD	3	Atp1a3
19q13.2	19:42220312-42228201	ZNF526, KIAA1951, DENNED	Zinc finger protein 526	614387	ZNF526	116115	ENSG00000167625,ENST00000301215;;;ENST00000301215		Dentici-Novelli neurodevelopmental syndrome	619877	AR	3	Zfp526
19q13.2	19:42247569-42255128	ERF, PE2, CRS4, CHYTS	ETS2 repressor factor	611888	ERF	2077	ENSG00000105722,ENST00000222329;;;ENST00000222329		Chitayat syndrome	617180	AD	3	Erf
19q13.2	19:42247569-42255128	ERF, PE2, CRS4, CHYTS	ETS2 repressor factor	611888	ERF	2077	ENSG00000105722,ENST00000222329;;;ENST00000222329		Craniosynostosis 4	600775	AD	3	Erf
19q13.2	19:42268530-42295796	CIC, KIAA0306, MRD45	Capicua transcriptional repressor	612082	CIC	23152	ENSG00000079432,ENST00000681038;;;ENST00000681038		Intellectual developmental disorder, autosomal dominant 45	617600	AD	3	Cic
19q13.2	19:42325635-42378765	MEGF8, EGFL4, CRPT2	Multiple epidermal growth factor-like domains 8	604267	MEGF8	1954	ENSG00000105429,ENST00000251268;;;ENST00000251268		Carpenter syndrome 2	614976	AR	3	Megf8
19q13.2	19:42401514-42427388	LIPE, LHS, FPLD6	Lipase E, hormone-sensitive	151750	LIPE	3991	ENSG00000079435,ENST00000244289;;;ENST00000244289		Lipodystrophy, familial partial, type 6	615980	AR	3	Lipe
19q13.31	19:43506719-43527201	ETHE1, HSCO, D83198	ETHE1 persulfide dioxygenase	608451	ETHE1	23474	ENSG00000105755,ENST00000292147;;;ENST00000292147		Ethylmalonic encephalopathy	602473	AR	3	Ethe1
19q13.31	19:43543311-43575527	XRCC1, SCAR26	X-ray repair cross complementing 1	194360	XRCC1	7515	ENSG00000073050,ENST00000262887;;;ENST00000262887	mutation identified in 1 SCAR26 patient	?Spinocerebellar ataxia, autosomal recessive 26	617633	AR	3	Xrcc1
19q13.31	19:43727983-43754962	SMG9, C19orf61, HBMS, NEDITPO	SMG9 nonsense mediated mRNA decay factor	613176	SMG9	56006	ENSG00000105771,ENST00000270066;;;ENST00000270066		Heart and brain malformation syndrome	616920	AR	3	Smg9
19q13.31	19:43727983-43754962	SMG9, C19orf61, HBMS, NEDITPO	SMG9 nonsense mediated mRNA decay factor	613176	SMG9	56006	ENSG00000105771,ENST00000270066;;;ENST00000270066		Neurodevelopmental disorder with intention tremor, pyramidal signs, dyspraxia, and ocular anomalies	619995	AR	3	Smg9
19q13.31	19:43766533-43780973	KCNN4, KCA4, SK4, DHS2	Potassium intermediate/small conductance calcium-activated channel, subfamily N, member 4	602754	KCNN4	3783	ENSG00000104783,ENST00000648319;;;ENST00000648319		Dehydrated hereditary stomatocytosis 2	616689	AD	3	Kcnn4
19q13.31-q13.32	19:44699151-44710718	CEACAM16, CEAL2, DFNA4B, DFNB113	CEA cell adhesion molecule 16	614591	CEACAM16	388551	ENSG00000213892,ENST00000587331;;;ENST00000587331		Deafness, autosomal dominant 4B	614614	AD	3	Ceacam16
19q13.31-q13.32	19:44699151-44710718	CEACAM16, CEAL2, DFNA4B, DFNB113	CEA cell adhesion molecule 16	614591	CEACAM16	388551	ENSG00000213892,ENST00000587331;;;ENST00000587331		Deafness, autosomal recessive 113	618410	AR	3	Ceacam16
19q13.32	19:44809059-44821421	LU, AU, BCAM	B-cell adhesion molecule	612773	BCAM	4059	ENSG00000187244,ENST00000270233;;;ENST00000270233	linked to SE	[Blood group, Auberger system]	111200		3	Bcam
19q13.32	19:44809059-44821421	LU, AU, BCAM	B-cell adhesion molecule	612773	BCAM	4059	ENSG00000187244,ENST00000270233;;;ENST00000270233	linked to SE	[Blood group, Lutheran null]	247420	AR	3	Bcam
19q13.32	19:44809059-44821421	LU, AU, BCAM	B-cell adhesion molecule	612773	BCAM	4059	ENSG00000187244,ENST00000270233;;;ENST00000270233	linked to SE	[Blood group, Lutheran system]	111200		3	Bcam
19q13.32	19:44905796-44909393	APOE, AD2, LPG, LDLCQ5	Apolipoprotein E	107741	APOE	348	ENSG00000130203,ENST00000252486;;;ENST00000252486	mutation identified in 1 APOE3-Christchurch patient	{?Alzheimer disease, protection against, due to APOE3-Christchurch}	607822	AD	3	Apoe
19q13.32	19:44905796-44909393	APOE, AD2, LPG, LDLCQ5	Apolipoprotein E	107741	APOE	348	ENSG00000130203,ENST00000252486;;;ENST00000252486	mutation identified in 1 APOE3-Christchurch patient	{?Macular degeneration, age-related}	603075	AD	3	Apoe
19q13.32	19:44905796-44909393	APOE, AD2, LPG, LDLCQ5	Apolipoprotein E	107741	APOE	348	ENSG00000130203,ENST00000252486;;;ENST00000252486	mutation identified in 1 APOE3-Christchurch patient	{Coronary artery disease, severe, susceptibility to}	617347		3	Apoe
19q13.32	19:44905796-44909393	APOE, AD2, LPG, LDLCQ5	Apolipoprotein E	107741	APOE	348	ENSG00000130203,ENST00000252486;;;ENST00000252486	mutation identified in 1 APOE3-Christchurch patient	Alzheimer disease 2	104310	AD	3	Apoe
19q13.32	19:44905796-44909393	APOE, AD2, LPG, LDLCQ5	Apolipoprotein E	107741	APOE	348	ENSG00000130203,ENST00000252486;;;ENST00000252486	mutation identified in 1 APOE3-Christchurch patient	Hyperlipoproteinemia, type III	617347		3	Apoe
19q13.32	19:44905796-44909393	APOE, AD2, LPG, LDLCQ5	Apolipoprotein E	107741	APOE	348	ENSG00000130203,ENST00000252486;;;ENST00000252486	mutation identified in 1 APOE3-Christchurch patient	Lipoprotein glomerulopathy	611771		3	Apoe
19q13.32	19:44905796-44909393	APOE, AD2, LPG, LDLCQ5	Apolipoprotein E	107741	APOE	348	ENSG00000130203,ENST00000252486;;;ENST00000252486	mutation identified in 1 APOE3-Christchurch patient	Sea-blue histiocyte disease	269600	AR	3	Apoe
19q13.32	19:44946051-44949565	APOC2	Apolipoprotein C-II	608083	APOC2	344	ENSG00000234906,ENST00000252490;;;ENST00000252490		Hyperlipoproteinemia, type Ib	207750	AR	3	Apoc2,Apoc2l
19q13.32	19:45001464-45038192	RELB, IREL, IMD53	v-rel avian reticuloendotheliosis viral oncogene homolog B	604758	RELB	5971	ENSG00000104856,ENST00000221452;;;ENST00000221452		Immunodeficiency 53	617585	AR	3	Relb
19q13.32	19:45178784-45217083	BLOC1S3, BLOS3, HPS8	Biogenesis of lysosome-related organelles complex 1, subunit 3	609762	BLOC1S3	388552	ENSG00000189114,ENST00000433642;;;ENST00000433642		Hermansky-Pudlak syndrome 8	614077	AR	3	Bloc1s3
19q13.32	19:45212370-45245407	EXOC3L2, XTP7, BMRS	Exocyst complex component 3-like 2	616927	EXOC3L2	90332	ENSG00000283632,ENST00000413988;;;ENST00000413988		Brain malformation renal syndrome	620943	AR	3	Exoc3l2
19q13.32	19:45349837-45370573	ERCC2, EM9, XPD, COFS2, TTD1	ERCC excision repair 2, TFIIH core complex helicase subunit	126340	ERCC2	2068	ENSG00000104884,ENST00000391945;;;ENST00000391945	< 250kb from ERCC1; mutation identified in 1 COFS2 patient	?Cerebrooculofacioskeletal syndrome 2	610756	AR	3	Ercc2
19q13.32	19:45349837-45370573	ERCC2, EM9, XPD, COFS2, TTD1	ERCC excision repair 2, TFIIH core complex helicase subunit	126340	ERCC2	2068	ENSG00000104884,ENST00000391945;;;ENST00000391945	< 250kb from ERCC1; mutation identified in 1 COFS2 patient	Trichothiodystrophy 1, photosensitive	601675	AR	3	Ercc2
19q13.32	19:45349837-45370573	ERCC2, EM9, XPD, COFS2, TTD1	ERCC excision repair 2, TFIIH core complex helicase subunit	126340	ERCC2	2068	ENSG00000104884,ENST00000391945;;;ENST00000391945	< 250kb from ERCC1; mutation identified in 1 COFS2 patient	Xeroderma pigmentosum, group D	278730	AR	3	Ercc2
19q13.32	19:45379638-45406361	PPP1R13L, RAI, IASPP, NKIP1, ARCME	Protein phosphatase 1, regulatory subunit 13-like	607463	PPP1R13L	10848	ENSG00000104881,ENST00000360957;;;ENST00000360957		Arrhythmogenic cardiomyopathy with variable ectodermal abnormalities	620519	AR	3	Ppp1r13l
19q13.32	19:45407334-45451547	ERCC1, UV20, COFS4	ERCC excision repair 1, endonuclease non-catalytic subunit	126380	ERCC1	2067	ENSG00000012061,ENST00000300853;;;ENST00000300853	distal to CKM	Cerebrooculofacioskeletal syndrome 4	610758	AR	3	Ercc1
19q13.32	19:45478601-45478687	TRU-TCA1-1, TRNAU1, TRSP, THMA3	tRNA selenocysteine (anticodon TCA) 1-1	165060	TRU-TCA1-1	7234		pseudogene on 22	Thyroid hormone metabolism, abnormal, 3	620198	AR	3	
19q13.32	19:45485294-45497047	RTN2, NSPL1, SPG12, HMNR11	Reticulon-2	603183	RTN2	6253	ENSG00000125744,ENST00000245923;;;ENST00000245923		Neuronopathy, distal hereditary motor, autosomal recessive 11, with spasticity	620854	AR	3	Rtn2
19q13.32	19:45485294-45497047	RTN2, NSPL1, SPG12, HMNR11	Reticulon-2	603183	RTN2	6253	ENSG00000125744,ENST00000245923;;;ENST00000245923		Spastic paraplegia 12, autosomal dominant	604805	AD	3	Rtn2
19q13.32	19:45527427-45584802	OPA3, MGA3	Outer mitochondrial membrane lipid metabolism regulator OPA3	606580	OPA3	80207	ENSG00000125741,ENST00000263275;;;ENST00000263275		3-methylglutaconic aciduria, type III	258501	AR	3	Opa3
19q13.32	19:45527427-45584802	OPA3, MGA3	Outer mitochondrial membrane lipid metabolism regulator OPA3	606580	OPA3	80207	ENSG00000125741,ENST00000263275;;;ENST00000263275		Optic atrophy 3 with cataract	165300	AD	3	Opa3
19q13.32	19:45764785-45769252	SIX5, DMAHP, BOR2	SIX homeobox 5	600963	SIX5	147912	ENSG00000177045,ENST00000317578;;;ENST00000317578		Branchiootorenal syndrome 2	610896		3	Six5
19q13.32	19:45769717-45782490	DMPK, DM, DMK	Dystrophia myotonica-protein kinase	605377	DMPK	1760	ENSG00000104936,ENST00000291270;;;ENST00000291270	distal to APOLP2; distal to CKM	Myotonic dystrophy 1	160900	AD	3	Dmpk
19q13.32	19:45933734-45973865	NOVA2, ANOVA, NEDASB	NOVA alternative splicing regulator 2	601991	NOVA2	4858	ENSG00000104967,ENST00000263257;;;ENST00000263257		Neurodevelopmental disorder with or without autistic features and/or structural brain abnormalities	618859	AD	3	Nova2
19q13.32	19:46410329-46413564	CCDC8, 3M3	Coiled-coil domain-containing protein 8	614145	CCDC8	83987	ENSG00000169515,ENST00000307522;;;ENST00000307522		3-M syndrome 3	614205	AR	3	Ccdc8
19q13.32	19:46601074-46610782	CALM3, LQT16, CPVT6	Calmodulin-3	114183	CALM3	808	ENSG00000160014,ENST00000291295;;;ENST00000291295	mutation identified in 1 CPVT6 family	?Ventricular tachycardia, catecholaminergic polymorphic 6	618782	AD	3	Calm3
19q13.32	19:46601074-46610782	CALM3, LQT16, CPVT6	Calmodulin-3	114183	CALM3	808	ENSG00000160014,ENST00000291295;;;ENST00000291295	mutation identified in 1 CPVT6 family	Long QT syndrome 16	618782	AD	3	Calm3
19q13.32	19:46744760-46758575	FKRP, MDC1C, LGMDR9, MDDGA5, MDDGB5, MDDGC5	Fukutin-related protein	606596	FKRP	79147	ENSG00000181027,ENST00000318584;;;ENST00000318584		Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 5	613153	AR	3	Fkrp
19q13.32	19:46744760-46758575	FKRP, MDC1C, LGMDR9, MDDGA5, MDDGB5, MDDGC5	Fukutin-related protein	606596	FKRP	79147	ENSG00000181027,ENST00000318584;;;ENST00000318584		Muscular dystrophy-dystroglycanopathy (congenital with or without impaired intellectual development), type B, 5	606612	AR	3	Fkrp
19q13.32	19:46744760-46758575	FKRP, MDC1C, LGMDR9, MDDGA5, MDDGB5, MDDGC5	Fukutin-related protein	606596	FKRP	79147	ENSG00000181027,ENST00000318584;;;ENST00000318584		Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 5	607155	AR	3	Fkrp
19q13.32	19:46838167-46850846	AP2S1, CLAPS2, AP17, HHC3	Adaptor-related protein complex 2, sigma 1 subunit	602242	AP2S1	1175	ENSG00000042753,ENST00000263270;;;ENST00000263270		Hypocalciuric hypercalcemia, type III	600740	AD	3	Ap2s1
19q13.32	19:47475150-47485839	KPTN, 2E4, MRT41	Kaptin	615620	KPTN	11133	ENSG00000118162,ENST00000338134;;;ENST00000338134		Intellectual developmental disorder, autosomal recessive 41	615637	AR	3	Kptn
19q13.33	19:47608196-47703277	BICRA, GLTSCR1, CSS12	BRD4-interacting chromatin remodeling complex-associated protein	605690	BICRA	29998	ENSG00000063169,ENST00000594866;;;ENST00000594866		Coffin-Siris syndrome 12	619325	AD	3	Bicra
19q13.33	19:47821937-47843324	CRX, CORD2, CRD, LCA7	Cone-rod homeobox-containing gene	602225	CRX	1406	ENSG00000105392,ENST00000221996;;;ENST00000221996		Cone-rod retinal dystrophy-2	120970	AD	3	Crx
19q13.33	19:47821937-47843324	CRX, CORD2, CRD, LCA7	Cone-rod homeobox-containing gene	602225	CRX	1406	ENSG00000105392,ENST00000221996;;;ENST00000221996		Leber congenital amaurosis 7	613829		3	Crx
19q13.33	19:48115445-48170344	LIG1, IMD96	Ligase I, DNA, ATP-dependent	126391	LIG1	3978	ENSG00000105486,ENST00000263274;;;ENST00000263274		Immunodeficiency 96	619774	AR	3	Lig1
19q13.33	19:48203148-48255946	CARD8, TUCAN, KIAA0955, NDPP1, IBD30	Caspase recruitment domain-containing protein 8	609051	CARD8	22900	ENSG00000105483,ENST00000651546;;;ENST00000651546	mutation identified in 1 IBD30 family	?Inflammatory bowel disease (Crohn disease) 30	619079	AD	3	
19q13.33	19:48296452-48321971	ODAD1, CCDC114, CILD20	Outer dynein arm docking complex subunit 1	615038	ODAD1	93233	ENSG00000105479,ENST00000674294;;;ENST00000674294		Ciliary dyskinesia, primary, 20	615067	AR	3	Odad1
19q13.33	19:48393668-48444931	GRIN2D, NMDAR2D, DEE46	Glutamate receptor, ionotropic, N-methyl-D-aspartate 2D	602717	GRIN2D	2906	ENSG00000105464,ENST00000263269;;;ENST00000263269		Developmental and epileptic encephalopathy 46	617162	AD	3	Grin2d
19q13.33	19:48445983-48457022	GRWD1, GRWD, KIAA1942, DIAR14	Glutamate-rich WD repeat-containing protein 1	610597	GRWD1	83743	ENSG00000105447,ENST00000253237;;;ENST00000253237	mutation identified in 1 DIAR14 family	?Diarrhea 14, congenital	621160	AR	3	Grwd1
19q13.33	19:48552172-48599427	SULT2B1, ARCI14	Sulfotransferase family 2B, member 1	604125	SULT2B1	6820	ENSG00000088002,ENST00000201586;;;ENST00000201586		Ichthyosis, congenital, autosomal recessive 14	617571	AR	3	Sult2b1
19q13.33	19:48615331-48619178	RPL18, DBA18	Ribosomal protein L18	604179	RPL18	6141	ENSG00000063177,ENST00000549920;;;ENST00000549920	mutation identified in 1 DBA18 family	?Diamond-Blackfan anemia 18	618310	AD	3	Rpl18
19q13.33	19:48695971-48705951	FUT2, SE, B12QTL1	Fucosyltransferase-2 (secretor)	182100	FUT2	2524	ENSG00000176920,ENST00000425340;;;ENST00000425340	H, SE = alpha-L-fucosyltransferases; from common ancestral genes; tightly linked to FUT1	[Bombay phenotype, digenic]	616754	AR	3	Fut2,Sec1
19q13.33	19:48695971-48705951	FUT2, SE, B12QTL1	Fucosyltransferase-2 (secretor)	182100	FUT2	2524	ENSG00000176920,ENST00000425340;;;ENST00000425340	H, SE = alpha-L-fucosyltransferases; from common ancestral genes; tightly linked to FUT1	{Norwalk virus infection, resistance to}			3	Fut2,Sec1
19q13.33	19:48695971-48705951	FUT2, SE, B12QTL1	Fucosyltransferase-2 (secretor)	182100	FUT2	2524	ENSG00000176920,ENST00000425340;;;ENST00000425340	H, SE = alpha-L-fucosyltransferases; from common ancestral genes; tightly linked to FUT1	{Vitamin B12 plasma level QTL1}	612542		3	Fut2,Sec1
19q13.33	19:48748011-48755358	FUT1, H, HH	Fucosyltransferase-1 (Bombay phenotype)	211100	FUT1	2523	ENSG00000174951,ENST00000645652;;;ENST00000645652	SE tightly linked	[Bombay phenotype]	616754	AR	3	Fut1
19q13.33	19:48795064-48811029	BCAT2, BCT2, HVLI, BCAT2	Branched chain aminotransferase-2, mitochondrial	113530	BCAT2	587	ENSG00000105552,ENST00000316273;;;ENST00000316273		Hypervalinemia and hyperleucine-isoleucinemia	618850	AR	3	Bcat2
19q13.33	19:48954875-48961798	BAX	BCL2-associated X protein	600040	BAX	581	ENSG00000087088,ENST00000345358;;;ENST00000345358		Colorectal cancer, somatic	114500		3	Bax
19q13.33	19:48954875-48961798	BAX	BCL2-associated X protein	600040	BAX	581	ENSG00000087088,ENST00000345358;;;ENST00000345358		T-cell acute lymphoblastic leukemia, somatic	613065		3	Bax
19q13.33	19:48965309-48966879	FTL, NBIA3, LFTD	Ferritin, light chain	134790	FTL	2512	ENSG00000087086,ENST00000331825;;;ENST00000331825		Hyperferritinemia-cataract syndrome	600886	AD	3	Ftl1,Ftl2-ps
19q13.33	19:48965309-48966879	FTL, NBIA3, LFTD	Ferritin, light chain	134790	FTL	2512	ENSG00000087086,ENST00000331825;;;ENST00000331825		L-ferritin deficiency, dominant and recessive	615604	AD, AR	3	Ftl1,Ftl2-ps
19q13.33	19:48965309-48966879	FTL, NBIA3, LFTD	Ferritin, light chain	134790	FTL	2512	ENSG00000087086,ENST00000331825;;;ENST00000331825		Neurodegeneration with brain iron accumulation 3	606159	AD	3	Ftl1,Ftl2-ps
19q13.33	19:48968130-48993309	GYS1, GYS	Glycogen synthase	138570	GYS1	2997	ENSG00000104812,ENST00000323798;;;ENST00000323798		Glycogen storage disease 0, muscle	611556	AR	3	Gys1
19q13.33	19:49015980-49019498	LHB, HH23	Luteinizing hormone, beta polypeptide	152780	LHB	3972	ENSG00000104826,ENST00000649238;;;ENST00000649238	beta chains of FSH, TSH on 11p, 1p, respectively	Hypogonadotropic hypogonadism 23 with or without anosmia	228300	AR	3	Lhb
19q13.33	19:49058284-49065035	NTF4 , NTF5, NT5, NT4, GLC1O	Neurotrophin-4 (neurotrophin-4/5)	162662	NTF4	4909	ENSG00000225950,ENST00000593537;;;ENST00000593537	3 genes, ? functional, also on 19	Glaucoma 1, open angle, 1O	613100		3	Ntf5
19q13.33	19:49119544-49151026	PPFIA3, LPNA3, NEDPACH	PTPRF-interacting protein alpha-3	603144	PPFIA3	8541	ENSG00000177380,ENST00000334186;;;ENST00000334186		Paul-Chao neurodevelopmental syndrome	621122	AD	3	Ppfia3
19q13.33	19:49157792-49211836	TRPM4, PFHB1B, EKVP6	Transient receptor potential cation channel, subfamily M, member 4	606936	TRPM4	54795	ENSG00000130529,ENST00000252826;;;ENST00000252826		Erythrokeratodermia variabilis et progressiva 6	618531	AD	3	Trpm4
19q13.33	19:49157792-49211836	TRPM4, PFHB1B, EKVP6	Transient receptor potential cation channel, subfamily M, member 4	606936	TRPM4	54795	ENSG00000130529,ENST00000252826;;;ENST00000252826		Progressive familial heart block, type IB	604559	AD	3	Trpm4
19q13.33	19:49388249-49417990	KASH5, CCDC155, SPGF88, POF22	KASH domain-containing protein 5	618125	KASH5	147872	ENSG00000161609,ENST00000447857;;;ENST00000447857		Premature ovarian failure 22	620548	AR	3	Kash5
19q13.33	19:49388249-49417990	KASH5, CCDC155, SPGF88, POF22	KASH domain-containing protein 5	618125	KASH5	147872	ENSG00000161609,ENST00000447857;;;ENST00000447857		Spermatogenic failure 88	620547	AR	3	Kash5
19q13.33	19:49474215-49486231	FLT3LG, FLG3L, IMD125	FMS-related tyrosine kinase 3 ligand	600007	FLT3LG	2323	ENSG00000090554,ENST00000597551;;;ENST00000597551	mutation identified in 1 IMD125 family	?Immunodeficiency 125	620926	AR	3	Flt3l
19q13.33	19:49591182-49626439	PRR12, KIAA1205, NOC	Proline-rich protein 12	616633	PRR12	57479	ENSG00000126464,ENST00000418929;;;ENST00000418929		Neuroocular syndrome	619539	AD	3	Prr12
19q13.33	19:49659572-49665857	IRF3, IIAE7	Interferon regulatory factor 3	603734	IRF3	3661	ENSG00000126456,ENST00000377139;;;ENST00000377139		{Encephalopathy, acute, infection-induced (herpes-specific), susceptibility to, 7}	616532	AD	3	Irf3
19q13.33	19:49690662-49713731	CPT1C, SPG73	Carnitine palmitoyltransferase IC	608846	CPT1C	126129	ENSG00000169169,ENST00000598293;;;ENST00000598293	mutation identified in 1 SPG73 family	?Spastic paraplegia 73, autosomal dominant	616282	AD	3	Cpt1c
19q13.33	19:49806866-49813553	FUZ, NTD	Fuzzy planar cell polarity protein	610622	FUZ	80199	ENSG00000010361,ENST00000313777;;;ENST00000313777		{Neural tube defects, susceptibility to}	182940	AD	3	Fuz
19q13.33	19:49818289-49840384	MED25, PTOV2, ARC92, BVSYS	Mediator of RNA polymerase II transcription, subunit 25, S. cerevisiae, homolog of	610197	MED25	81857	ENSG00000104973,ENST00000312865;;;ENST00000312865		Basel-Vanagaite-Smirin-Yosef syndrome	616449	AR	3	Med25
19q13.33	19:49861204-49867576	PNKP, PNK, MCSZ, AOA4, CMT2B2	Polynucleotide kinase 3' phosphatase	605610	PNKP	11284	ENSG00000039650,ENST00000322344;;;ENST00000322344	mutation identified in 1 CMT2B2 family	?Charcot-Marie-Tooth disease, type 2B2	605589	AR	3	Pnkp
19q13.33	19:49861204-49867576	PNKP, PNK, MCSZ, AOA4, CMT2B2	Polynucleotide kinase 3' phosphatase	605610	PNKP	11284	ENSG00000039650,ENST00000322344;;;ENST00000322344	mutation identified in 1 CMT2B2 family	Ataxia-oculomotor apraxia 4	616267	AR	3	Pnkp
19q13.33	19:49861204-49867576	PNKP, PNK, MCSZ, AOA4, CMT2B2	Polynucleotide kinase 3' phosphatase	605610	PNKP	11284	ENSG00000039650,ENST00000322344;;;ENST00000322344	mutation identified in 1 CMT2B2 family	Microcephaly, seizures, and developmental delay	613402	AR	3	Pnkp
19q13.33	19:49906825-49929504	NUP62, SNDI, IBSN	Nucleoporin, 62-kD	605815	NUP62	23636	ENSG00000213024,ENST00000352066;;;ENST00000352066		Striatonigral degeneration, infantile	271930	AR	3	Nup62
19q13.33	19:50203622-50310540	MYH14, KIAA2034, DFNA4A, PNMHH	Myosin, heavy chain 14, nonmuscle	608568	MYH14	79784	ENSG00000105357,ENST00000642316;;;ENST00000642316	mutation identified in 1 PNMHH family	?Peripheral neuropathy, myopathy, hoarseness, and hearing loss	614369	AD	3	Myh14
19q13.33	19:50203622-50310540	MYH14, KIAA2034, DFNA4A, PNMHH	Myosin, heavy chain 14, nonmuscle	608568	MYH14	79784	ENSG00000105357,ENST00000642316;;;ENST00000642316	mutation identified in 1 PNMHH family	Deafness, autosomal dominant 4A	600652	AD	3	Myh14
19q13.33	19:50311937-50333536	KCNC3, SCA13	Potassium voltage-gated channel, Shaw-related subfamily, member 3	176264	KCNC3	3748	ENSG00000131398,ENST00000477616;;;ENST00000477616		Spinocerebellar ataxia 13	605259	AD	3	Kcnc3
19q13.33	19:50384323-50418018	POLD1, CRCS10, MDPL, IMD120	Polymerase (DNA directed), delta 1, catalytic subunit	174761	POLD1	5424	ENSG00000062822,ENST00000440232;;;ENST00000440232		{Colorectal cancer, susceptibility to, 10}	612591	AD	3	Pold1
19q13.33	19:50384323-50418018	POLD1, CRCS10, MDPL, IMD120	Polymerase (DNA directed), delta 1, catalytic subunit	174761	POLD1	5424	ENSG00000062822,ENST00000440232;;;ENST00000440232		Immunodeficiency 120	620836	AR	3	Pold1
19q13.33	19:50384323-50418018	POLD1, CRCS10, MDPL, IMD120	Polymerase (DNA directed), delta 1, catalytic subunit	174761	POLD1	5424	ENSG00000062822,ENST00000440232;;;ENST00000440232		Mandibular hypoplasia, deafness, progeroid features, and lipodystrophy syndrome	615381	AD	3	Pold1
19q13.33	19:50476507-50490871	EMC10, C19orf63, HSS1, HSM1, NEDDFAS	ER membrane protein complex subunit 10	614545	EMC10	284361	ENSG00000161671,ENST00000334976;;;ENST00000334976		Neurodevelopmental disorder with dysmorphic facies and variable seizures	619264	AR	3	Emc10
19q13.33	19:50790415-50795219	ACP4, ACPT, AI1J	Acid phosphatase 4	606362	ACP4	93650	ENSG00000142513,ENST00000270593;;;ENST00000270593		Amelogenesis imperfecta, type IJ	617297	AR	3	Acp4
19q13.33	19:50819146-50823787	KLK1, KLKR	Kallikrein 1	147910	KLK1	3816	ENSG00000167748,ENST00000301420;;;ENST00000301420	~10cM distal to APOC2	[Kallikrein, decreased urinary activity of]	615953		3	Egfbp2,Klk1,Klk1b1,Klk1b11,Klk1b16,Klk1b21,Klk1b22,Klk1b24,Klk1b26,Klk1b27,Klk1b3,Klk1b4,Klk1b5,Klk1b8,Klk1b9
19q13.4	19:50900001-58617616	HPC15	Prostate cancer, hereditary, 15	611959		100188868		associated with rs2735839	{Prostate cancer, hereditary, 15}	611959		2	
19q13.4	19:50900001-58617616	MENOQ2	Menopause, natural, age at, QTL2	612884		100302517		associated with rs1172822, rs2384687, rs1551562, rs897798	{Menopause, natural, age at, QTL2}	612884		2	
19q13.41	19:50906351-50911395	KLK4, EMSP1, PRSS17, AI2A1	Kallikrein-related peptidase 4	603767	KLK4	9622	ENSG00000167749,ENST00000324041;;;ENST00000324041		Amelogenesis imperfecta, type IIA1	204700	AR	3	Klk4
19q13.41	19:51022236-51027991	KLK11, PRSS20, TLSP, IEKD	Kallikrein-related peptidase 11	604434	KLK11	11012	ENSG00000167757,ENST00000453757;;;ENST00000453757		Ichthyosis with erythrokeratoderma	620507	AD	3	Klk11
19q13.41	19:51345155-51366388	ETFB, MADD	Electron transfer flavoprotein, beta polypeptide	130410	ETFB	2109	ENSG00000105379,ENST00000309244;;;ENST00000309244		Glutaric acidemia IIB	231680	AR	3	Etfb
19q13.41	19:51379909-51387974	LIM2, MP19, CTRCT19	Lens intrinsic protein 2, 19kD	154045	LIM2	3982	ENSG00000105370,ENST00000596399;;;ENST00000596399	same cosmid as ETFB	Cataract 19, multiple types	615277	AD, AR	3	Lim2
19q13.41	19:52190052-52229518	PPP2R1A, MRD36, HJS2	Protein phosphatase 2, structural/regulatory subunit A, alpha	605983	PPP2R1A	5518	ENSG00000105568,ENST00000322088;;;ENST00000322088		Houge-Janssens syndrome 2	616362	AD	3	Ppp2r1a
19q13.41	19:52527668-52568753	ZNF808, PAGEN3	Zinc finger protein 808	620970	ZNF808	388558	ENSG00000198482,ENST00000359798;;;ENST00000359798		Pancreatic agenesis 3	620991	AR	3	
19q13.42	19:53793584-53824403	NLRP12, NALP12, PYPAF7, RNO, FCAS2	NLR family, pyrin domain containing 12	609648	NLRP12	91662	ENSG00000142405,ENST00000324134;;;ENST00000324134		Familial cold autoinflammatory syndrome 2	611762	AD	3	Nlrp12
19q13.42	19:53881094-53907652	PRKCG, PKCC, PKCG, SCA14	Protein kinase C, gamma polypeptide	176980	PRKCG	5582	ENSG00000126583,ENST00000263431;;;ENST00000263431		Spinocerebellar ataxia 14	605361	AD	3	Prkcg
19q13.42	19:54115754-54131713	PRPF31, PRP31, RP11	Pre-mRNA processing factor 11	606419	PRPF31	26121	ENSG00000105618,ENST00000321030;;;ENST00000321030		Retinitis pigmentosa 11	600138	AD	3	Prpf31
19q13.42	19:54137762-54155681	CNOT3, NOT3, IDDSADF	CCR4-NOT transcription complex, subunit 3	604910	CNOT3	4849	ENSG00000088038,ENST00000221232;;;ENST00000221232		Intellectual developmental disorder with speech delay, autism, and dysmorphic facies	618672	AD	3	Cnot3
19q13.42	19:54173415-54189580	MBOAT7, BB1, LENG4, MRT57	Membrane bound O-acyltransferase domain containing 7	606048	MBOAT7	79143	ENSG00000125505,ENST00000245615;;;ENST00000245615		Intellectual developmental disorder, autosomal recessive 57	617188	AR	3	Mboat7
19q13.42	19:54189441-54194532	TSEN34, PCH2C, LENG5, SEN34	tRNA splicing endonuclease, subunit 34	608754	TSEN34	79042	ENSG00000170892,ENST00000396388;;;ENST00000396388	mutation identified in 1 PCH2C patient	?Pontocerebellar hypoplasia type 2C	612390	AR	3	Tsen34
19q13.42	19:54923515-54966243	NLRP7, NALP7, NOD12, PYPAF3, HYDM	NLR family pyrin-domain containing 7	609661	NLRP7	199713	ENSG00000167634,ENST00000592784;;;ENST00000592784		Hydatidiform mole, recurrent, 1	231090	AR	3	Nlrp2
19q13.42	19:54965284-55001138	NLRP2, NALP2, PAN1, PYPAF2, OZEMA18	NLR family pyrin-domain containing 2	609364	NLRP2	55655	ENSG00000022556,ENST00000448584;;;ENST00000448584		Oocyte/zygote/embryo maturation arrest 18	620332	AR	3	Nlrp2
19q13.42	19:55013705-55038264	GP6, GPIV, BDPLT11	Glycoprotein VI, platelet	605546	GP6	51206	ENSG00000088053,ENST00000417454;;;ENST00000417454		Bleeding disorder, platelet-type, 11	614201	AR	3	Gp6
19q13.42	19:55132698-55149206	TNNT1, ANM, NEM5	Troponin-T1, skeletal, slow	191041	TNNT1	7138	ENSG00000105048,ENST00000588981;;;ENST00000588981		Nemaline myopathy 5A, autosomal recessive, severe infantile	605355	AR	3	Tnnt1
19q13.42	19:55132698-55149206	TNNT1, ANM, NEM5	Troponin-T1, skeletal, slow	191041	TNNT1	7138	ENSG00000105048,ENST00000588981;;;ENST00000588981		Nemaline myopathy 5B, autosomal recessive, childhood-onset	620386	AR	3	Tnnt1
19q13.42	19:55132698-55149206	TNNT1, ANM, NEM5	Troponin-T1, skeletal, slow	191041	TNNT1	7138	ENSG00000105048,ENST00000588981;;;ENST00000588981		Nemaline myopathy 5C, autosomal dominant	620389	AD	3	Tnnt1
19q13.42	19:55151767-55157732	TNNI3, CMH7, CMD2A, RCM1, CMD1FF	Troponin-I, cardiac	191044	TNNI3	7137	ENSG00000129991,ENST00000344887;;;ENST00000344887	mutation identified in 1 CMD2A family	?Cardiomyopathy, dilated, 2A	611880	AR	3	Tnni3
19q13.42	19:55151767-55157732	TNNI3, CMH7, CMD2A, RCM1, CMD1FF	Troponin-I, cardiac	191044	TNNI3	7137	ENSG00000129991,ENST00000344887;;;ENST00000344887	mutation identified in 1 CMD2A family	Cardiomyopathy, dilated, 1FF	613286		3	Tnni3
19q13.42	19:55151767-55157732	TNNI3, CMH7, CMD2A, RCM1, CMD1FF	Troponin-I, cardiac	191044	TNNI3	7137	ENSG00000129991,ENST00000344887;;;ENST00000344887	mutation identified in 1 CMD2A family	Cardiomyopathy, familial restrictive, 1	115210	AD	3	Tnni3
19q13.42	19:55151767-55157732	TNNI3, CMH7, CMD2A, RCM1, CMD1FF	Troponin-I, cardiac	191044	TNNI3	7137	ENSG00000129991,ENST00000344887;;;ENST00000344887	mutation identified in 1 CMD2A family	Cardiomyopathy, hypertrophic, 7	613690	AD	3	Tnni3
19q13.42	19:55158661-55166722	DNAAF3, PF22, DAB1, CILD2	Dynein, axonemal, assembly factor 3	614566	DNAAF3	352909	ENSG00000167646,ENST00000524407;;;ENST00000524407		Ciliary dyskinesia, primary, 2	606763	AR	3	Dnaaf3
19q13.42	19:55655035-55674716	U2AF2, U2AF65, DEVDFB	U2 small nuclear RNA auxiliary factor 2	191318	U2AF2	11338	ENSG00000063244,ENST00000308924;;;ENST00000308924		Developmental delay, dysmorphic facies, and brain anomalies	620535	AD	3	U2af2
19q13.43	19:55986775-56061810	NLRP5, NALP5, MATER, OZEMA19	NLR family pyrin-domain containing 5	609658	NLRP5	126206	ENSG00000171487,ENST00000850973		Oocyte/zygote/embryo maturation arrest 19	620333	AR	3	Nlrp5
19q13.43	19:57231023-57235548	AURKC, STK13, AIE2, SPGF5	Aurora kinase C	603495	AURKC	6795	ENSG00000105146,ENST00000302804;;;ENST00000302804		Spermatogenic failure 5	243060	AR	3	Aurkc
19q13.43	19:58544064-58550715	TRIM28, KAP1, TIF1B, WT7	Tripartite motif-containing protein 28	601742	TRIM28	10155	ENSG00000130726,ENST00000253024;;;ENST00000253024		Wilms tumor 7	621332	AD	3	Trim28
20p	20:1-28100001	AD8	Alzheimer disease 8	607116		353128		?related to CST3	Alzheimer disease 8	607116		2	
20p13	20:1-5100000	ALS7	Amyotrophic lateral sclerosis 7	608031		406238		max lod at D20S103	Amyotrophic lateral sclerosis 7	608031		2	
20p	20:1-28100001	ATOD3	Dermatitis, atopic, 3	605804		117187		max lod at D20S115	{Dermatitis, atopic, susceptibility to, 3}	605804		2	
20pter-p11.2	20:1-25700000	BMIQ6	Body mass index quantitative trait locus 6	608559		449017		near D20S482 and D20S851	[Body mass index QTL6]	608559		2	
20p13	20:1-5100000	RLS5	Restless legs syndrome, susceptibility to, 5	611242		100188839		max lod at D20S849	{Restless legs syndrome 5}	611242		2	
20p13	20:408299-432139	RBCK1, HOIL1, PGBM1, PBMEI, C20orf18	RANBP-type and C3HC4-type zinc finger-containing 1	610924	RBCK1	10616	ENSG00000125826,ENST00000356286;;;ENST00000356286		Polyglucosan body myopathy 1 with or without immunodeficiency	615895	AR	3	Rbck1
20p13	20:435480-462533	TBC1D20, C20orf140, WARBM4	TBC1 domain family, member 20	611663	TBC1D20	128637	ENSG00000125875,ENST00000354200;;;ENST00000354200		Warburg micro syndrome 4	615663	AR	3	Tbc1d20
20p13	20:472498-543790	CSNK2A1, CK2A1, OCNDS	Casein kinase-2, alpha-1 polypeptide	115440	CSNK2A1	1457	ENSG00000101266,ENST00000217244;;;ENST00000217244	pseudogene on 11p15	Okur-Chung neurodevelopmental syndrome	617062	AD	3	Csnk2a1
20p13	20:760080-780033	SLC52A3, C20orf54, RFT2, BVVLS1	Solute carrier family 52, riboflavin transporter, member 3	613350	SLC52A3	113278	ENSG00000101276,ENST00000645534;;;ENST00000645534	mutation identified in 1 FZLD family	?Fazio-Londe disease	211500	AR	3	Slc52a3
20p13	20:760080-780033	SLC52A3, C20orf54, RFT2, BVVLS1	Solute carrier family 52, riboflavin transporter, member 3	613350	SLC52A3	113278	ENSG00000101276,ENST00000645534;;;ENST00000645534	mutation identified in 1 FZLD family	Brown-Vialetto-Van Laere syndrome 1	211530	AR	3	Slc52a3
20p13	20:958452-1002311	RSPO4, CRISTIN4	R-spondin member 4	610573	RSPO4	343637	ENSG00000101282,ENST00000217260;;;ENST00000217260		Anonychia congenita	206800	AR	3	Rspo4
20p13	20:1978756-1994285	PDYN, SCA23	Prodynorphin	131340	PDYN	5173	ENSG00000101327,ENST00000217305;;;ENST00000217305		Spinocerebellar ataxia 23	610245	AD	3	Pdyn
20p13	20:2296001-2341079	TGM3, UHS2	Transglutaminase-3 (E polypeptide, protein-glutamine-gamma-glutamyl transferase)	600238	TGM3	7053	ENSG00000125780,ENST00000381458;;;ENST00000381458	mutation identified in 1 UHS2 patient	?Uncombable hair syndrome 2	617251	AR	3	Tgm3
20p13	20:2380901-2432753	TGM6, TG6, TGY, SCA35	Transglutaminase 6	613900	TGM6	343641	ENSG00000166948,ENST00000202625;;;ENST00000202625		Spinocerebellar ataxia 35	613908	AD	3	Tgm6
20p13	20:2461642-2470789	SNRPB, CCMS	Small nuclear ribonucleoprotein polypeptides B and B1	182282	SNRPB	6628	ENSG00000125835,ENST00000381342;;;ENST00000381342		Cerebrocostomandibular syndrome	117650	AD	3	Snrpb
20p13	20:2652632-2658393	NOP56, SCA36	Nop56, S. cerevisiae, homolog of	614154	NOP56	10528	ENSG00000101361,ENST00000329276;;;ENST00000329276		Spinocerebellar ataxia 36	614153	AD	3	Nop56
20p13	20:2658395-2664216	IDH3B, RP46	Isocitrate dehydrogenase (NAD+) 3, noncatalytic, beta subunit	604526	IDH3B	3420	ENSG00000101365,ENST00000380843;;;ENST00000380843		Retinitis pigmentosa 46	612572	AR	3	Idh3b
20p13	20:2840745-2866732	VPS16, DYT30	VPS16 core subunit of CORVET and HOPS complexes	608550	VPS16	64601	ENSG00000215305,ENST00000380445;;;ENST00000380445		Dystonia 30	619291	AD	3	Vps16
20p13	20:3082556-3084724	AVP, AVRP, VP	Arginine vasopressin (neurophysin II, antidiuretic hormone)	192340	AVP	551	ENSG00000101200,ENST00000380293;;;ENST00000380293	distal 20p	Diabetes insipidus, neurohypophyseal	125700	AD	3	Avp
20p13	20:3190350-3204682	DDRGK1, UFBP1, C20orf116, SEMDSH	DDRGK domain-containing protein 1	616177	DDRGK1	65992	ENSG00000198171,ENST00000354488;;;ENST00000354488		Spondyloepimetaphyseal dysplasia, Shohat type	602557	AR	3	Ddrgk1
20p13	20:3204065-3227449	ITPA, DEE35	Inosine triphosphatase-A	147520	ITPA	3704	ENSG00000125877,ENST00000380113;;;ENST00000380113		[Inosine triphosphatase deficiency]	613850		3	Itpa
20p13	20:3204065-3227449	ITPA, DEE35	Inosine triphosphatase-A	147520	ITPA	3704	ENSG00000125877,ENST00000380113;;;ENST00000380113		Developmental and epileptic encephalopathy 35	616647	AR	3	Itpa
20p13	20:3227417-3239559	SLC4A11, BTR1, NABC1, CHED, CDPD, FECD4	Solute carrier family 4 (sodium borate cotransporter), member 11	610206	SLC4A11	83959	ENSG00000088836,ENST00000642402;;;ENST00000642402		Corneal dystrophy, Fuchs endothelial, 4	613268		3	Slc4a11
20p13	20:3227417-3239559	SLC4A11, BTR1, NABC1, CHED, CDPD, FECD4	Solute carrier family 4 (sodium borate cotransporter), member 11	610206	SLC4A11	83959	ENSG00000088836,ENST00000642402;;;ENST00000642402		Corneal endothelial dystrophy and perceptive deafness	217400	AR	3	Slc4a11
20p13	20:3227417-3239559	SLC4A11, BTR1, NABC1, CHED, CDPD, FECD4	Solute carrier family 4 (sodium borate cotransporter), member 11	610206	SLC4A11	83959	ENSG00000088836,ENST00000642402;;;ENST00000642402		Corneal endothelial dystrophy, autosomal recessive	217700	AR	3	Slc4a11
20p13	20:3888781-3929887	PANK2, NBIA1, PKAN	Pantothenate kinase 2	606157	PANK2	80025	ENSG00000125779,ENST00000610179;;;ENST00000610179		Neurodegeneration with brain iron accumulation 1	234200	AR	3	Pank2
20p13	20:4686456-4701588	PRNP, PRIP, KURU, CJD	Prion protein	176640	PRNP	5621	ENSG00000171867,ENST00000379440;;;ENST00000379440	pter-PRNP-SCG1-BMP2A-PAX1-cen	{Kuru, susceptibility to}	245300		3	Prnp
20p13	20:4686456-4701588	PRNP, PRIP, KURU, CJD	Prion protein	176640	PRNP	5621	ENSG00000171867,ENST00000379440;;;ENST00000379440	pter-PRNP-SCG1-BMP2A-PAX1-cen	Cerebral amyloid angiopathy, PRNP-related	137440	AD	3	Prnp
20p13	20:4686456-4701588	PRNP, PRIP, KURU, CJD	Prion protein	176640	PRNP	5621	ENSG00000171867,ENST00000379440;;;ENST00000379440	pter-PRNP-SCG1-BMP2A-PAX1-cen	Creutzfeldt-Jakob disease	123400	AD	3	Prnp
20p13	20:4686456-4701588	PRNP, PRIP, KURU, CJD	Prion protein	176640	PRNP	5621	ENSG00000171867,ENST00000379440;;;ENST00000379440	pter-PRNP-SCG1-BMP2A-PAX1-cen	Gerstmann-Straussler disease	137440	AD	3	Prnp
20p13	20:4686456-4701588	PRNP, PRIP, KURU, CJD	Prion protein	176640	PRNP	5621	ENSG00000171867,ENST00000379440;;;ENST00000379440	pter-PRNP-SCG1-BMP2A-PAX1-cen	Huntington disease-like 1	603218	AD	3	Prnp
20p13	20:4686456-4701588	PRNP, PRIP, KURU, CJD	Prion protein	176640	PRNP	5621	ENSG00000171867,ENST00000379440;;;ENST00000379440	pter-PRNP-SCG1-BMP2A-PAX1-cen	Insomnia, fatal familial	600072	AD	3	Prnp
20p13	20:4686456-4701588	PRNP, PRIP, KURU, CJD	Prion protein	176640	PRNP	5621	ENSG00000171867,ENST00000379440;;;ENST00000379440	pter-PRNP-SCG1-BMP2A-PAX1-cen	Spongiform encephalopathy with neuropsychiatric features	606688	AD	3	Prnp
20p12.3	20:5100001-9200000	BMND7	Bone mineral density QTL 7	611738		100188853		most significant association with haplotype C	{Osteoporosis}	166710	AD	2	
20p12.3	20:5100001-9200000	CRCS11	Colorectal cancer, susceptibility to, 11	612592		100271692		associated with rs961253	{Colorectal cancer, susceptibility to, 11}	612592		2	
20p12	20:5100001-17900000	GLC1K, JOAG3	Glaucoma 1K, primary open angle, juvenile-onset	608696		574077		between D20S189 and D20S104	Glaucoma 1K, primary open angle, juvenile-onset	608696		2	
20p12	20:5100001-17900000	SLEB7	Systemic lupus erythematosus, susceptibility to, 7	610065		100188803			{Systemic lupus erythematosus, susceptibility to, 7}	610065	AD	2	
20p12.3	20:5114953-5126622	PCNA, ATLD2	Proliferating cell nuclear antigen	176740	PCNA	5111	ENSG00000132646,ENST00000379143;;;ENST00000379143	pseudogenes on X and 6; mutation identified in one ATLD2 family	?Ataxia-telangiectasia-like disorder 2	615919	AR	3	Pcna
20p12.3	20:5299218-5316954	PROKR2, PKR2, GPR73L1, HH3	Prokineticin receptor 2	607123	PROKR2	128674	ENSG00000101292,ENST00000678254;;;ENST00000678254		Hypogonadotropic hypogonadism 3 with or without anosmia	244200	AD	3	Prokr2
20p12.3	20:5950652-5998977	MCM8, POF10	Minichromosome maintenance complement component 8	608187	MCM8	84515	ENSG00000125885,ENST00000610722;;;ENST00000610722	mutation identified in 1 POF10 family	?Premature ovarian failure 10	612885	AR	3	Mcm8
20p12.3	20:6005938-6040053	CRLS1, GCD10, C20orf155, COSPD57	Cardiolipin synthase 1	608188	CRLS1	54675	ENSG00000088766,ENST00000378863;;;ENST00000378863		Combined oxidative phosphorylation deficiency 57	620167	AR	3	Crls1
20p12.3	20:6074845-6123030	FERMT1, KIND1, URP1, C20orf42	FERM domain-containing kindlin 1	607900	FERMT1	55612	ENSG00000101311,ENST00000217289;;;ENST00000217289		Kindler syndrome	173650	AR	3	Fermt1
20p12.3	20:6767686-6780246	BMP2, BMP2A, BDA2, SSFSC1	Bone morphogenetic protein-2	112261	BMP2	650	ENSG00000125845,ENST00000378827;;;ENST00000378827		{HFE hemochromatosis, modifier of}	235200	AR	3	Bmp2
20p12.3	20:6767686-6780246	BMP2, BMP2A, BDA2, SSFSC1	Bone morphogenetic protein-2	112261	BMP2	650	ENSG00000125845,ENST00000378827;;;ENST00000378827		Brachydactyly, type A2	112600	AD	3	Bmp2
20p12.3	20:6767686-6780246	BMP2, BMP2A, BDA2, SSFSC1	Bone morphogenetic protein-2	112261	BMP2	650	ENSG00000125845,ENST00000378827;;;ENST00000378827		Short stature, facial dysmorphism, and skeletal anomalies with or without cardiac anomalies 1	617877	AD	3	Bmp2
20p12.3	20:8132266-8884900	PLCB1, KIAA0581, PLCB1A, PLCB1B, DEE12	Phospholipase C, beta-1	607120	PLCB1	23236	ENSG00000182621,ENST00000338037;;;ENST00000338037		Developmental and epileptic encephalopathy 12	613722	AR	3	Plcb1
20p12.3-p12.2	20:9068678-9480808	PLCB4, ARCND2A, ARCND2B	Phospholipase C, beta 4	600810	PLCB4	5332	ENSG00000101333,ENST00000378473;;;ENST00000378473		Auriculocondylar syndrome 2A	614669	AD	3	Plcb4
20p12.3-p12.2	20:9068678-9480808	PLCB4, ARCND2A, ARCND2B	Phospholipase C, beta 4	600810	PLCB4	5332	ENSG00000101333,ENST00000378473;;;ENST00000378473		Auriculocondylar syndrome 2B	620458	AR	3	Plcb4
20p12.2	20:10218830-10307418	SNAP25, DEE117	Synaptosomal-associated protein, 25kD	600322	SNAP25	6616	ENSG00000132639,ENST00000254976;;;ENST00000254976		Developmental and epileptic encephalopathy 117	616330	AD	3	Snap25
20p12.2	20:10401009-10434222	MKKS, HMCS, KMS, MKS, BBS6	McKusick-Kaufman syndrome gene	604896	MKKS	8195	ENSG00000125863,ENST00000347364;;;ENST00000347364		Bardet-Biedl syndrome 6	605231	AR	3	Mkks
20p12.2	20:10401009-10434222	MKKS, HMCS, KMS, MKS, BBS6	McKusick-Kaufman syndrome gene	604896	MKKS	8195	ENSG00000125863,ENST00000347364;;;ENST00000347364		McKusick-Kaufman syndrome	236700	AR	3	Mkks
20p12.2	20:10637684-10673999	JAG1, AGS1, AHD, DCHE, CMT2HH	Jagged 1	601920	JAG1	182	ENSG00000101384,ENST00000254958;;;ENST00000254958	mutation identified in 1 DCHE family	?Deafness, congenital heart defects, and posterior embryotoxon	617992	AD	3	Jag1
20p12.2	20:10637684-10673999	JAG1, AGS1, AHD, DCHE, CMT2HH	Jagged 1	601920	JAG1	182	ENSG00000101384,ENST00000254958;;;ENST00000254958	mutation identified in 1 DCHE family	Alagille syndrome 1	118450	AD	3	Jag1
20p12.2	20:10637684-10673999	JAG1, AGS1, AHD, DCHE, CMT2HH	Jagged 1	601920	JAG1	182	ENSG00000101384,ENST00000254958;;;ENST00000254958	mutation identified in 1 DCHE family	Charcot-Marie-Tooth disease, axonal, type 2HH	619574	AD	3	Jag1
20p12.2	20:10637684-10673999	JAG1, AGS1, AHD, DCHE, CMT2HH	Jagged 1	601920	JAG1	182	ENSG00000101384,ENST00000254958;;;ENST00000254958	mutation identified in 1 DCHE family	Tetralogy of Fallot	187500	AD	3	Jag1
20p12.1	20:13104772-13638932	TASP1, C20orf13, SULEHS	Threonine aspartase 1	608270	TASP1	55617	ENSG00000089123,ENST00000337743;;;ENST00000337743		Suleiman-El-Hattab syndrome	618950	AR	3	Tasp1
20p12.1	20:13785028-13821580	NDUFAF5, C20orf7, MC1DN16	NADH-ubiquinone oxidoreductase complex assembly factor 5	612360	NDUFAF5	79133	ENSG00000101247,ENST00000378106;;;ENST00000378106		Mitochondrial complex I deficiency, nuclear type 16	618238	AR	3	Ndufaf5
20p12.1	20:14322985-14337612	FLRT3, HH21	Fibronectin-like domain-containing leucine-rich transmembrane protein-3	604808	FLRT3	23767	ENSG00000125848,ENST00000341420;;;ENST00000341420		Hypogonadotropic hypogonadism 21 with anosmia	615271	AD	3	Flrt3
20p12.1	20:17493905-17569220	BFSP1, CP115, CTRCT33	Beaded filament structural protein-1 (filensin)	603307	BFSP1	631	ENSG00000125864,ENST00000377873;;;ENST00000377873		Cataract 33, multiple types	611391	AD, AR	3	Bfsp1
20p11.2-q13.12	20:17900001-47800000	DYT17	Dystonia-17, primary torsion	612406		100216344		between D20S472 and D20S911	Dystonia-17, primary torsion	612406	AR	2	
20p11.23	20:17968590-17991122	MGME1, C20orf72, MTDPS11	Mitochondrial genome maintenance exonuclease 1	615076	MGME1	92667	ENSG00000125871,ENST00000377710;;;ENST00000377710		Mitochondrial DNA depletion syndrome 11	615084	AR	3	Mgme1
20p11.23	20:18024152-18059188	OVOL2, ZNF339, PPCD1	ovo-like 2	616441	OVOL2	58495	ENSG00000125850,ENST00000278780;;;ENST00000278780		Corneal dystrophy, posterior polymorphous, 1	122000	AD	3	Ovol2
20p11.23	20:18137863-18143169	PET117, MC4DN19	PET117 cytochrome c oxidase chaperone	614771	PET117	100303755	ENSG00000232838,ENST00000432901;;;ENST00000432901	mutation identified in 1 MC4DN19 family	?Mitochondrial complex IV deficiency, nuclear type 19	619063	AR	3	Pet117
20p11.23	20:18467390-18484646	POLR3F, RPC39, RPC6, IMD101	Polymerase III, RNA, subunit F	617455	POLR3F	10621	ENSG00000132664,ENST00000377603;;;ENST00000377603	mutation identified in 1 IMD101 family	?Immunodeficiency 101 (varicella zoster virus-specific)	619872	AD	3	Polr3f
20p11.23	20:18507548-18561415	SEC23B, CDAN2, HEMPAS, CWS7	SEC23 homolog B, coat complex II component	610512	SEC23B	10483	ENSG00000101310,ENST00000650089;;;ENST00000650089	mutation identified in 1 CWS7 family	?Cowden syndrome 7	616858	AD	3	Sec23b
20p11.23	20:18507548-18561415	SEC23B, CDAN2, HEMPAS, CWS7	SEC23 homolog B, coat complex II component	610512	SEC23B	10483	ENSG00000101310,ENST00000650089;;;ENST00000650089	mutation identified in 1 CWS7 family	Dyserythropoietic anemia, congenital, type II	224100	AR	3	Sec23b
20p11.23	20:19757599-20002456	RIN2, MACS	RAS and RAB interactor 2	610222	RIN2	54453	ENSG00000132669,ENST00000255006;;;ENST00000255006		Macrocephaly, alopecia, cutis laxa, and scoliosis	613075	AR	3	Rin2
20p11.23	20:20017290-20033655	NAA20, NAT5, NAT3, MRT73	N-alpha-acetyltransferase 20, NatB catalytic subunit	610833	NAA20	51126	ENSG00000173418,ENST00000334982;;;ENST00000334982		Intellectual developmental disorder, autosomal recessive 73	619717	AR	3	Naa20
20p11.23	20:20052532-20360698	CFAP61, SPGF84	Cilia- and flagella-associated protein 61	620381	CFAP61	26074	ENSG00000089101,ENST00000245957;;;ENST00000245957		Spermatogenic failure 84	620409	AR	3	Cfap61
20p11.23	20:21125975-21246622	KIZ, KIZUNA, C20orf19, RP69	Kizuna centrosomal protein	615757	KIZ	55857	ENSG00000088970,ENST00000619189;;;ENST00000619189		Retinitis pigmentosa 69	615780	AR	3	Kiz
20p11.22	20:21300001-22300000	AGA3	Alopecia, androgenetic, 3	612421		100217387		associated with rs1160312	Alopecia, androgenetic, 3	612421		2	
20p11.22	20:21705664-21718481	PAX1, OTFCS2	Paired box homeotic gene-1	167411	PAX1	5075	ENSG00000125813,ENST00000613128;;;ENST00000613128		Otofaciocervical syndrome 2 with T-cell deficiency	615560	AR	3	Pax1
20p11.21	20:23045633-23049672	THBD, THRM, AHUS6, THPH12	Thrombomodulin	188040	THBD	7056	ENSG00000178726,ENST00000377103;;;ENST00000377103		{Hemolytic uremic syndrome, atypical, susceptibility to, 6}	612926	AD	3	Thbd
20p11.21	20:23045633-23049672	THBD, THRM, AHUS6, THPH12	Thrombomodulin	188040	THBD	7056	ENSG00000178726,ENST00000377103;;;ENST00000377103		Thrombophilia 12 due to thrombomodulin defect	614486	AD	3	Thbd
20p11.21	20:23361127-23373062	GZF1, ZNF336, JLSM	GDNF-inducible zinc finger protein 1	613842	GZF1	64412	ENSG00000125812,ENST00000338121;;;ENST00000338121		Joint laxity, short stature, and myopia	617662	AR	3	Gzf1
20p11.21	20:23374522-23421488	NAPB, SNAPB, DEE107	NSF attachment protein, beta	611270	NAPB	63908	ENSG00000125814,ENST00000377026;;;ENST00000377026		Developmental and epileptic encephalopathy 107	620033	AR	3	Napb
20p11.21	20:23626706-23637955	CST3, ARMD11, ADLDWA	Cystatin C	604312	CST3	1471	ENSG00000101439,ENST00000376925;;;ENST00000376925	proximal to 20p11.2	{Macular degeneration, age-related, 11}	611953		3	Cst3
20p11.21	20:23626706-23637955	CST3, ARMD11, ADLDWA	Cystatin C	604312	CST3	1471	ENSG00000101439,ENST00000376925;;;ENST00000376925	proximal to 20p11.2	Cerebral amyloid angiopathy	105150	AD	3	Cst3
20p11.21	20:23626706-23637955	CST3, ARMD11, ADLDWA	Cystatin C	604312	CST3	1471	ENSG00000101439,ENST00000376925;;;ENST00000376925	proximal to 20p11.2	Leukodystrophy, adult-onset, autosomal dominant, without amyloid angiopathy	621214	AD	3	Cst3
20p11.21	20:25070880-25082141	VSX1, RINX, KTCN1, CAASDS	Visual system homeobox 1	605020	VSX1	30813	ENSG00000100987,ENST00000376709;;;ENST00000376709	mutation identified in 1 CAASDS family	?Craniofacial anomalies and anterior segment dysgenesis syndrome	614195	AD	3	Vsx1
20p11.21	20:25070880-25082141	VSX1, RINX, KTCN1, CAASDS	Visual system homeobox 1	605020	VSX1	30813	ENSG00000100987,ENST00000376709;;;ENST00000376709	mutation identified in 1 CAASDS family	Keratoconus 1	148300	AD	3	Vsx1
20p11.21	20:25294743-25390835	ABHD12, PHARC	Abhydrolase domain-containing protein 12, lysophospholipase	613599	ABHD12	26090	ENSG00000100997,ENST00000339157;;;ENST00000339157		Polyneuropathy, hearing loss, ataxia, retinitis pigmentosa, and cataract	612674	AR	3	Abhd12
20p11.21	20:25407673-25448563	GINS1, PSF1, KIAA0186, IMD55	GINS complex subunit 1	610608	GINS1	9837	ENSG00000101003,ENST00000262460;;;ENST00000262460		Immunodeficiency 55	617827	AR	3	Gins1
20q11-q13	20:28100001-64444167	HYT5	Hypertension, essential, susceptibility to, 5	610261		100188807			{Hypertension, essential, susceptibility to, 5}	145500	Mu	2	
20q11-q13	20:28100001-64444167	MBCS	Mulchandani-Bhoj-Conlin syndrome	617352				maternal uniparental disomy of imprinted region	Mulchandani-Bhoj-Conlin syndrome	617352	AD	4	
20q11	20:28100001-39000000	OBHP	Obesity and hypopigmentation	620195				rearrangement disrupts normal expression of ASIP	Obesity and hypopigmentation	620195	AD	4	
20q11-q13	20:28100001-64444167	SCAR6, CLA3	Spinocerebellar ataxia, autosomal recessive 6	608029		1167		between D20S471 and D20S119	Spinocerebellar ataxia, autosomal recessive 6	608029	AR	2	
20q11.2	20:30400001-39000000	CMM7	Melanoma, cutaneous malignant, susceptibility to, 7	612263		100190932		between rs910873 and rs1885120	{Melanoma, cutaneous malignant, 7}	612263		2	
20q11.21	20:31637912-31645006	COX4I2	Cytochrome c oxidase, subunit IV, isoform 2	607976	COX4I2	84701	ENSG00000131055,ENST00000376075;;;ENST00000376075		Exocrine pancreatic insufficiency, dyserythropoietic anemia, and calvarial hyperostosis	612714	AR	3	Cox4i2
20q11.21	20:31819356-31834684	MYLK2, MLCK	Myosin light chain kinase 2	606566	MYLK2	85366	ENSG00000101306,ENST00000375985;;;ENST00000375985		Cardiomyopathy, hypertrophic, 1, digenic	192600	AD, DD	3	Mylk2
20q11.21	20:32052242-32101856	HCK, AIPCV	HCK protooncogene, Src family tyrosine kinase	142370	HCK	3055	ENSG00000101336,ENST00000375852;;;ENST00000375852		Autoinflammation with pulmonary and cutaneous vasculitis	620296	AD	3	Hck
20q11.21	20:32207880-32238658	POFUT1, OFUCT1, KIAA0180, DDD2	Protein O-fucosyltransferase 1	607491	POFUT1	23509	ENSG00000101346,ENST00000375749;;;ENST00000375749		Dowling-Degos disease 2	615327	AD	3	Pofut1
20q11.21	20:32277651-32335011	KIF3B, KIAA0359, RP89	Kinesin family member 3B	603754	KIF3B	9371	ENSG00000101350,ENST00000375712;;;ENST00000375712		Retinitis pigmentosa 89	618955	AD	3	Kif3b
20q11.21	20:32358331-32439319	ASXL1, KIAA0978, BOPS, MDS	ASXL transcriptional regulator 1	612990	ASXL1	171023	ENSG00000171456,ENST00000375687;;;ENST00000375687		Bohring-Opitz syndrome	605039	AD	3	Asxl1
20q11.21	20:32358331-32439319	ASXL1, KIAA0978, BOPS, MDS	ASXL transcriptional regulator 1	612990	ASXL1	171023	ENSG00000171456,ENST00000375687;;;ENST00000375687		Myelodysplastic syndrome, somatic	614286		3	Asxl1
20q11.21	20:32762385-32809356	DNMT3B, ICF1, FSHD4	DNA methyltransferase 3B	602900	DNMT3B	1789	ENSG00000088305,ENST00000328111;;;ENST00000328111		Facioscapulohumeral muscular dystrophy 4, digenic	619478	DD	3	Dnmt3b
20q11.21	20:32762385-32809356	DNMT3B, ICF1, FSHD4	DNA methyltransferase 3B	602900	DNMT3B	1789	ENSG00000088305,ENST00000328111;;;ENST00000328111		Immunodeficiency-centromeric instability-facial anomalies syndrome 1	242860	AR	3	Dnmt3b
20q11.21	20:32983775-33004433	SUN5, TSARG4, SPAG4L, SPGF16	Sad1 and Unc84 domain-containing protein 5	613942	SUN5	140732	ENSG00000167098,ENST00000356173;;;ENST00000356173		Spermatogenic failure 16	617187	AR	3	Sun5
20q11.21	20:33407957-33443763	SNTA1, SNT1, TACIP1, LQT12	Syntrophin, alpha-1	601017	SNTA1	6640	ENSG00000101400,ENST00000217381;;;ENST00000217381		Long QT syndrome 12	612955	AD	3	Snta1
20q11.22	20:33500001-35800000	STQTL14	Stature quantitative trait locus 14	612228		100270797		associated with rs6060373	{Stature QTL 14}	612228		2	
20q11.22	20:33731996-33792269	ZNF341, HIES3	Zinc finger protein 341	618269	ZNF341	84905	ENSG00000131061,ENST00000375200;;;ENST00000375200		Hyper-IgE syndrome 3, autosomal recessive, with recurrent infections	618282	AR	3	Zfp341
20q11.22	20:33811348-33854366	CHMP4B, SNF7, CTPP3, CTRCT31	Charged multivesicular body protein 4B	610897	CHMP4B	128866	ENSG00000101421,ENST00000217402;;;ENST00000217402		Cataract 31, multiple types	605387	AD	3	Chmp4b
20q11.22	20:34186493-34269344	ASIP, AGTIL, SHEP9	Agouti, mouse, signaling protein	600201	ASIP	434	ENSG00000101440,ENST00000374954;;;ENST00000374954		[Skin/hair/eye pigmentation 9, brown/nonbrown eyes]	611742		3	a
20q11.22	20:34186493-34269344	ASIP, AGTIL, SHEP9	Agouti, mouse, signaling protein	600201	ASIP	434	ENSG00000101440,ENST00000374954;;;ENST00000374954		[Skin/hair/eye pigmentation 9, dark/light hair]	611742		3	a
20q11.22	20:34231981-34311836	AHCY, SAHH	S-adenosylhomocysteine hydrolase	180960	AHCY	191	ENSG00000101444,ENST00000217426;;;ENST00000217426		Hypermethioninemia with deficiency of S-adenosylhomocysteine hydrolase	613752	AR	3	Ahcy,Ahcyl
20q11.22	20:34363273-34511773	ITCH, AIP4, NAPP1, ADMFD	Itchy, mouse, homolog of	606409	ITCH	83737	ENSG00000078747,ENST00000374864;;;ENST00000374864		Autoimmune disease, multisystem, with facial dysmorphism	613385	AR	3	Itch
20q11.22	20:34560542-34677092	PIGU, CDC91L1, GPIBD21, NEDBSS	Phosphatidylinositol glycan anchor biosynthesis class U protein	608528	PIGU	128869	ENSG00000101464,ENST00000217446;;;ENST00000217446		Neurodevelopmental disorder with brain anomalies, seizures, and scoliosis	618590	AR	3	Pigu
20q11.22	20:34928432-34956027	GSS, GSHS, CNSHA6	Glutathione synthetase	601002	GSS	2937	ENSG00000100983,ENST00000651619;;;ENST00000651619		Anemia, congenital, nonspherocytic hemolytic, 6, glutatione synthetase deficient	231900	AR	3	Gss
20q11.22	20:34928432-34956027	GSS, GSHS, CNSHA6	Glutathione synthetase	601002	GSS	2937	ENSG00000100983,ENST00000651619;;;ENST00000651619		Glutathione synthetase deficiency	266130	AR	3	Gss
20q11.22	20:35433347-35454749	GDF5, CDMP1, SYNS2, OS5, BDA1C, SYM1B, DUPANS	Growth/differentiation factor-5 (cartilage-derived morphogenetic protein-1)	601146	GDF5	8200	ENSG00000125965,ENST00000374369;;;ENST00000374369	mutation identified in 1 AMD2C family	?Acromesomelic dysplasia 2C, Hunter-Thompson type	201250	AR	3	Gdf5
20q11.22	20:35433347-35454749	GDF5, CDMP1, SYNS2, OS5, BDA1C, SYM1B, DUPANS	Growth/differentiation factor-5 (cartilage-derived morphogenetic protein-1)	601146	GDF5	8200	ENSG00000125965,ENST00000374369;;;ENST00000374369	mutation identified in 1 AMD2C family	{Osteoarthritis-5}	612400		3	Gdf5
20q11.22	20:35433347-35454749	GDF5, CDMP1, SYNS2, OS5, BDA1C, SYM1B, DUPANS	Growth/differentiation factor-5 (cartilage-derived morphogenetic protein-1)	601146	GDF5	8200	ENSG00000125965,ENST00000374369;;;ENST00000374369	mutation identified in 1 AMD2C family	Acromesomelic dysplasia 2A	200700	AR	3	Gdf5
20q11.22	20:35433347-35454749	GDF5, CDMP1, SYNS2, OS5, BDA1C, SYM1B, DUPANS	Growth/differentiation factor-5 (cartilage-derived morphogenetic protein-1)	601146	GDF5	8200	ENSG00000125965,ENST00000374369;;;ENST00000374369	mutation identified in 1 AMD2C family	Acromesomelic dysplasia 2B	228900	AR	3	Gdf5
20q11.22	20:35433347-35454749	GDF5, CDMP1, SYNS2, OS5, BDA1C, SYM1B, DUPANS	Growth/differentiation factor-5 (cartilage-derived morphogenetic protein-1)	601146	GDF5	8200	ENSG00000125965,ENST00000374369;;;ENST00000374369	mutation identified in 1 AMD2C family	Brachydactyly, type A1, C	615072	AD, AR	3	Gdf5
20q11.22	20:35433347-35454749	GDF5, CDMP1, SYNS2, OS5, BDA1C, SYM1B, DUPANS	Growth/differentiation factor-5 (cartilage-derived morphogenetic protein-1)	601146	GDF5	8200	ENSG00000125965,ENST00000374369;;;ENST00000374369	mutation identified in 1 AMD2C family	Brachydactyly, type A2	112600	AD	3	Gdf5
20q11.22	20:35433347-35454749	GDF5, CDMP1, SYNS2, OS5, BDA1C, SYM1B, DUPANS	Growth/differentiation factor-5 (cartilage-derived morphogenetic protein-1)	601146	GDF5	8200	ENSG00000125965,ENST00000374369;;;ENST00000374369	mutation identified in 1 AMD2C family	Brachydactyly, type C	113100	AD	3	Gdf5
20q11.22	20:35433347-35454749	GDF5, CDMP1, SYNS2, OS5, BDA1C, SYM1B, DUPANS	Growth/differentiation factor-5 (cartilage-derived morphogenetic protein-1)	601146	GDF5	8200	ENSG00000125965,ENST00000374369;;;ENST00000374369	mutation identified in 1 AMD2C family	Multiple synostoses syndrome 2	610017	AD	3	Gdf5
20q11.22	20:35433347-35454749	GDF5, CDMP1, SYNS2, OS5, BDA1C, SYM1B, DUPANS	Growth/differentiation factor-5 (cartilage-derived morphogenetic protein-1)	601146	GDF5	8200	ENSG00000125965,ENST00000374369;;;ENST00000374369	mutation identified in 1 AMD2C family	Symphalangism, proximal, 1B	615298	AD	3	Gdf5
20q11.22	20:35455165-35519280	CEP250, CEP2, CNAP1, CRDHL2	Centrosomal protein, 250kD	609689	CEP250	11190	ENSG00000126001,ENST00000397527;;;ENST00000397527		Cone-rod dystrophy and hearing loss 2	618358	AR	3	Cep250
20q11.22	20:35648925-35664900	RBM12, KIAA0765, SCZD19	RNA-binding motif protein 12	607179	RBM12	10137	ENSG00000244462,ENST00000374114;;;ENST00000374114		{Schizophrenia 19, susceptibility to}	617629	AD	3	Rbm12
20q11.22	20:35668052-35699352	NFS1, NIFS, COXPD52	NFS1 cysteine desulfurase 1	603485	NFS1	9054	ENSG00000244005,ENST00000374092;;;ENST00000374092		Combined oxidative phosphorylation deficiency 52	619386	AR	3	Nfs1
20q11.23	20:36091414-36232799	EPB41L1, MRD11	Erythrocyte membrane protein band 4.1-like 1	602879	EPB41L1	2036	ENSG00000088367,ENST00000338074;;;ENST00000338074	mutation identified in 1 MRD11 patient	?Intellectual developmental disorder, autosomal dominant 11	614257	AD	3	Epb41l1
20q11.23	20:36541519-36551447	MYL9, MLC2, MMIHS4	Myosin light chain 9, regulatory	609905	MYL9	10398	ENSG00000101335,ENST00000279022;;;ENST00000279022	mutation identified in 1 MMIHS4 patient	?Megacystis-microcolon-intestinal hypoperistalsis syndrome 4	619365	AR	3	Myl9
20q11.23	20:36605779-36612557	RAB5IF, C20orf24, CFSMR2	RAB5-interacting factor	619960	RAB5IF	55969	ENSG00000101084,ENST00000344795;;;ENST00000344795	mutation identified in 1 CFSMR2 patient	?Craniofacial dysmorphism, skeletal anomalies, and impaired intellectual development syndrome 2	616994	AR	3	Rab5if
20q11.23	20:36889773-36951708	SAMHD1, AGS5, DCIP, CHBL2	SAM domain- and HD domain-containing protein 1	606754	SAMHD1	25939	ENSG00000101347,ENST00000646673;;;ENST00000646673	mutation identified in 1 CHBL2 family	?Chilblain lupus 2	614415	AD	3	Samhd1
20q11.23	20:36889773-36951708	SAMHD1, AGS5, DCIP, CHBL2	SAM domain- and HD domain-containing protein 1	606754	SAMHD1	25939	ENSG00000101347,ENST00000646673;;;ENST00000646673	mutation identified in 1 CHBL2 family	Aicardi-Goutieres syndrome 5	612952	AR	3	Samhd1
20q11.23	20:37251086-37261814	GHRH, GHRF	Growth hormone releasing hormone (somatocrinin)	139190	GHRH	2691	ENSG00000118702,ENST00000373614;;;ENST00000373614		?Isolated growth hormone deficiency due to defect in GHRF			1	Ghrh
20q11.23	20:37251086-37261814	GHRH, GHRF	Growth hormone releasing hormone (somatocrinin)	139190	GHRH	2691	ENSG00000118702,ENST00000373614;;;ENST00000373614		Gigantism due to GHRF hypersecretion			1	Ghrh
20q11.23	20:37344699-37406050	SRC, ASV, SRC1, THC6	Protooncogene SRC, Rous sarcoma	190090	SRC	6714	ENSG00000197122,ENST00000373578;;;ENST00000373578	mutation identified in 1 THC6 family	?Thrombocytopenia 6	616937	AD	3	Src
20q11.23	20:37344699-37406050	SRC, ASV, SRC1, THC6	Protooncogene SRC, Rous sarcoma	190090	SRC	6714	ENSG00000197122,ENST00000373578;;;ENST00000373578	mutation identified in 1 THC6 family	Colon cancer, advanced, somatic	114500		3	Src
20q11.23	20:37694030-37872118	CTNNBL1, NAP, IMD99	Catenin, beta-like, 1	611537	CTNNBL1	56259	ENSG00000132792,ENST00000361383;;;ENST00000361383	mutation identified in 1 IMD99 patient	?Immunodeficiency 99 with hypogammaglobulinemia and autoimmune cytopenias	619846	AR	3	Ctnnbl1
20q11.23	20:37983021-38033456	TTI1, KIAA0406, NEDMIM	TELO2-interacting protein 1	614425	TTI1	9675	ENSG00000101407,ENST00000373447;;;ENST00000373447		Neurodevelopmental disorder with microcephaly and movement abnormalities	620445	AR	3	Tti1
20q11.23	20:38724486-38729372	SLC32A1, VGAT, VIAAT, GEFSP12, DEE114	Solute carrier family 32 (GABA vesicular transporter), member 1	616440	SLC32A1	140679	ENSG00000101438,ENST00000217420;;;ENST00000217420		Developmental and epileptic encephalopathy 114	620774	AD	3	Slc32a1
20q11.23	20:38724486-38729372	SLC32A1, VGAT, VIAAT, GEFSP12, DEE114	Solute carrier family 32 (GABA vesicular transporter), member 1	616440	SLC32A1	140679	ENSG00000101438,ENST00000217420;;;ENST00000217420		Generalized epilepsy with febrile seizures plus, type 12	620755	AD	3	Slc32a1
20q12-q13.12	20:39000001-47800000	PSMNSW	Parasomnia, sleepwalking type	613938		100653383		between 55.6 and 61.4 cM	Parasomnia, sleepwalking type	613938	AD, Mu	2	
20q12-q13.1	20:39000001-51200000	T2D3	Type 2 diabetes mellitus 3	603694		50982			{Type 2 diabetes mellitus 3}	603694		2	
20q12	20:40685848-40689236	MAFB, KRML, MCTO, DURS3	MAF bZIP transcription factor B	608968	MAFB	9935	ENSG00000204103,ENST00000373313;;;ENST00000373313		Duane retraction syndrome 3	617041	AD	3	Mafb
20q12	20:40685848-40689236	MAFB, KRML, MCTO, DURS3	MAF bZIP transcription factor B	608968	MAFB	9935	ENSG00000204103,ENST00000373313;;;ENST00000373313		Multicentric carpotarsal osteolysis syndrome	166300	AD	3	Mafb
20q12	20:41028822-41124487	TOP1	Topoisomerase (DNA) I	126420	TOP1	7150	ENSG00000198900,ENST00000361337;;;ENST00000361337	pseudogenes on chr.1 and 22	DNA topoisomerase I, camptothecin-resistant			3	Top1
20q12	20:41137543-41177626	PLCG1, PLC1, IDAA	Phospholipase C, gamma 1 (formerly subtype 148)	172420	PLCG1	5335	ENSG00000124181,ENST00000685551;;;ENST00000685551	mutation identified in 1 IDAA patient	?Immune dysregulation, autoimmunity, and autoinflammation	620514	AD	3	Plcg1
20q13	20:43100001-64444167	GEVQ2	Gene expression, variation in, quantitative trait locus on chromosome 20	608878		474333			{Gene expression, variation in, QTL}	608878		2	
20q13.11	20:43100001-43500000	GRD2	Graves disease, susceptibility to, 2	603388		50976			{Graves disease, susceptibility to, 2}	603388		2	
20q13	20:43100001-64444167	HPC3	Prostate cancer, hereditary, 3	608656		408259			{Prostate cancer, susceptibility to, 3}	608656		2	
20q13	20:43100001-64444167	IBD24	Inflammatory bowel disease 24	612566		100270798		associated with rs2315008 and rs4809330	{Inflammatory bowel disease 24}	612566		2	
20q13	20:43100001-64444167	PSORS12	Psoriasis susceptibility 12	612950				associated with rs495337	{Psoriasis susceptibility 12}	612950		2	
20q13	20:43100001-64444167	SLEB8	Systemic lupus erythematosus, susceptibility to, 8	610066		100188804			{Systemic lupus erythematosus, susceptibility to, 8}	610066	AD	2	
20q13.12	20:43590937-43647299	IFT52	Intraflagellar transport 52	617094	IFT52	51098	ENSG00000101052,ENST00000373030;;;ENST00000373030		Short-rib thoracic dysplasia 16 with or without polydactyly	617102	AR	3	Ift52
20q13.12	20:44106590-44187188	JPH2, JP2, CMH17, CMD2E	Junctophilin 2	605267	JPH2	57158	ENSG00000149596,ENST00000372980;;;ENST00000372980		Cardiomyopathy, dilated, 2E	619492	AR	3	Jph2
20q13.12	20:44106590-44187188	JPH2, JP2, CMH17, CMD2E	Junctophilin 2	605267	JPH2	57158	ENSG00000149596,ENST00000372980;;;ENST00000372980		Cardiomyopathy, hypertrophic, 17	613873	AD	3	Jph2
20q13.12	20:44302840-44311202	FITM2, FIT2, C20orf142, SIDDIS	Fat storage-inducing transmembrane protein 2	612029	FITM2	128486	ENSG00000197296,ENST00000396825;;;ENST00000396825		Siddiqi syndrome	618635	AR	3	Fitm2
20q13.12	20:44355699-44434596	HNF4A, TCF14, MODY1, FRTS4	Hepatocyte nuclear factor 4, alpha (transcription factor-14)	600281	HNF4A	3172	ENSG00000101076,ENST00000316673;;;ENST00000316673		{Diabetes mellitus, noninsulin-dependent}	125853	AD	3	Hnf4a
20q13.12	20:44355699-44434596	HNF4A, TCF14, MODY1, FRTS4	Hepatocyte nuclear factor 4, alpha (transcription factor-14)	600281	HNF4A	3172	ENSG00000101076,ENST00000316673;;;ENST00000316673		Fanconi renotubular syndrome 4, with maturity-onset diabetes of the young	616026	AD	3	Hnf4a
20q13.12	20:44355699-44434596	HNF4A, TCF14, MODY1, FRTS4	Hepatocyte nuclear factor 4, alpha (transcription factor-14)	600281	HNF4A	3172	ENSG00000101076,ENST00000316673;;;ENST00000316673		MODY, type I	125850	AD	3	Hnf4a
20q13.12	20:44619522-44651699	ADA	Adenosine deaminase	608958	ADA	100	ENSG00000196839,ENST00000372874;;;ENST00000372874		Adenosine deaminase deficiency, partial	102700	AR, SMo	3	Ada
20q13.12	20:44619522-44651699	ADA	Adenosine deaminase	608958	ADA	100	ENSG00000196839,ENST00000372874;;;ENST00000372874		Severe combined immunodeficiency due to ADA deficiency	102700	AR, SMo	3	Ada
20q13.12	20:44910060-44939316	PABPC1L, EPAB, OZEMA22	Polyadenylate-binding protein, cytoplasmic, 1-like	621055	PABPC1L	80336	ENSG00000101104,ENST00000217073;;;ENST00000217073		Oocyte/zygote/embryo maturation arrest 22	621093	AR	3	Pabpc1l
20q13.12	20:44966512-45080021	STK4, MST1, KRS2, TIIAC	Serine/threonine protein kinase 4	604965	STK4	6789	ENSG00000101109,ENST00000372806;;;ENST00000372806		T-cell immunodeficiency, recurrent infections, autoimmunity, and cardiac malformations	614868	AR	3	Stk4
20q13.12	20:45416141-45426241	PIGT, NDAP, PNH2, MCAHS3	Phosphatidylinositol glycan, class T	610272	PIGT	51604	ENSG00000124155,ENST00000279036;;;ENST00000279036	mutation identified in 1 PNH2 family	?Paroxysmal nocturnal hemoglobinuria 2	615399	AD, SMu	3	Pigt
20q13.12	20:45416141-45426241	PIGT, NDAP, PNH2, MCAHS3	Phosphatidylinositol glycan, class T	610272	PIGT	51604	ENSG00000124155,ENST00000279036;;;ENST00000279036	mutation identified in 1 PNH2 family	Multiple congenital anomalies-hypotonia-seizures syndrome 3	615398	AR	3	Pigt
20q13.12	20:45469753-45481532	WFDC2, HE4, WAP5, BENP	WAP 4-disulfide core domain 2	617548	WFDC2	10406	ENSG00000101443,ENST00000372676;;;ENST00000372676		Bronchiectasis and nasal polyposis	620984	AR	3	Wfdc2
20q13.12	20:45823214-45833306	TNNC2, CMYO15	Troponin C2, fast	191039	TNNC2	7125	ENSG00000101470,ENST00000372555;;;ENST00000372555		Congenital myopathy 15	620161	AD	3	Tnnc2
20q13.12	20:45891335-45898820	CTSA, PPGB, GSL, NGBE, GLB2, BSVD6	Cathepsin A (protective protein for beta-galactosidase)	613111	CTSA	5476	ENSG00000064601,ENST00000646241;;;ENST00000646241		Brain small vessel disease 6 with leukoencephalopathy	621394		3	Ctsa
20q13.12	20:45891335-45898820	CTSA, PPGB, GSL, NGBE, GLB2, BSVD6	Cathepsin A (protective protein for beta-galactosidase)	613111	CTSA	5476	ENSG00000064601,ENST00000646241;;;ENST00000646241		Galactosialidosis	256540	AR	3	Ctsa
20q13.12	20:45948660-45972203	ZNF335, NIF1, NIF2, MCPH10	Zinc finger protein 335	610827	ZNF335	63925	ENSG00000198026,ENST00000322927;;;ENST00000322927		Microcephaly 10, primary, autosomal recessive	615095	AR	3	Zfp335
20q13.12	20:46008908-46016561	MMP9, CLG4B, MANDP2	Matrix metalloproteinase 9 (gelatinase B, 92kD type IV collagenase)	120361	MMP9	4318	ENSG00000100985,ENST00000372330;;;ENST00000372330		Metaphyseal anadysplasia 2	613073	AR	3	Mmp9
20q13.12	20:46021686-46060150	SLC12A5, KCC2, KIAA1176, DEE34, EIG14	Solute carrier family 12, (potassium-chloride transporter) member 5	606726	SLC12A5	57468	ENSG00000124140,ENST00000243964;;;ENST00000243964		{Epilepsy, idiopathic generalized, susceptibility to, 14}	616685	AD	3	Slc12a5
20q13.12	20:46021686-46060150	SLC12A5, KCC2, KIAA1176, DEE34, EIG14	Solute carrier family 12, (potassium-chloride transporter) member 5	606726	SLC12A5	57468	ENSG00000124140,ENST00000243964;;;ENST00000243964		Developmental and epileptic encephalopathy 34	616645	AR	3	Slc12a5
20q13.12	20:46118314-46129858	CD40, TNFRSF5	CD40 antigen	109535	CD40	958	ENSG00000101017,ENST00000372285;;;ENST00000372285		Immunodeficiency with hyper-IgM, type 3	606843	AR	3	Cd40
20q13.12	20:46366050-46406615	ELMO2, CED12, VMPI	Engulfment and cell motility gene 2	606421	ELMO2	63916	ENSG00000062598,ENST00000290246;;;ENST00000290246		Vascular malformation, primary intraosseous	606893	AR	3	Elmo2
20q13.12	20:46557828-46684485	SLC13A3, NADC3, ARLIAK	Solute carrier family 13 (sodium-dependent dicarboxylate transporter), member 3	606411	SLC13A3	64849	ENSG00000158296,ENST00000279027;;;ENST00000279027		Leukoencephalopathy, acute reversible, with increased urinary alpha-ketoglutarate	618384	AR	3	Slc13a3
20q13.12	20:46684365-46689444	TP53RK, PRPK, GAMOS4	TP53-regulating kinase	608679	TP53RK	112858	ENSG00000172315,ENST00000372114;;;ENST00000372114		Galloway-Mowat syndrome 4	617730	AR	3	Trp53rka,Trp53rkb
20q13.12	20:46708320-46736347	SLC2A10, GLUT10, ATORS	Solute carrier family 2 (facilitated glucose transporter), member 10	606145	SLC2A10	81031	ENSG00000197496,ENST00000359271;;;ENST00000359271		Arterial tortuosity syndrome	208050	AR	3	Slc2a10
20q13.13	20:48921711-49036693	ARFGEF2, BIG2, PVNH2	ADP-ribosylation factor guanine nucleotide-exchange factor 2, brefeldin A-inhibited	605371	ARFGEF2	10564	ENSG00000124198,ENST00000371917;;;ENST00000371917		Periventricular heterotopia with microcephaly	608097	AR	3	Arfgef2
20q13.13	20:49245900-49278057	ZNFX1, IMD91	Zincfinger NFX1-type domain-containing protein 1	618931	ZNFX1	57169	ENSG00000124201,ENST00000396105;;;ENST00000396105		Immunodeficiency 91 and hyperinflammation	619644	AR	3	Znfx1
20q13.13	20:49363877-49483362	KCNB1, DEE26	Potassium voltage-gated channel, Shab-related subfamily, member 1	600397	KCNB1	3745	ENSG00000158445,ENST00000371741;;;ENST00000371741		Developmental and epileptic encephalopathy 26	616056	AD	3	Kcnb1
20q13.13	20:49503874-49568137	PTGIS, CYP8A1, PGIS, CYP8	Prostaglandin I2 synthase	601699	PTGIS	5740	ENSG00000124212,ENST00000244043;;;ENST00000244043		Hypertension, essential	145500	Mu	3	Ptgis
20q13.13	20:50510383-50585241	PTPN1, PTP1B	Protein tyrosine phosphatase, nonreceptor-type, 1	176885	PTPN1	5770	ENSG00000196396,ENST00000371621;;;ENST00000371621	20pter-q12 by REa	{Insulin resistance, susceptibility to}	125853	AD	3	Ptpn1
20q13.13	20:50888918-50931437	ADNP, ADNP1, KIAA0784, HVDAS, MRD28	Activity-dependent neuroprotector homeobox	611386	ADNP	23394	ENSG00000101126,ENST00000621696;;;ENST00000621696		Helsmoortel-van der Aa syndrome	615873	AD	3	Adnp
20q13.13	20:50934855-50958564	DPM1, MPDS, CDGIE	Dolichyl-phosphate mannosyltransferase 1, catalytic subunit	603503	DPM1	8813	ENSG00000000419,ENST00000371588;;;ENST00000371588		Congenital disorder of glycosylation, type Ie	608799	AR	3	Dpm1
20q13.13	20:50958818-50963929	MOCS3, MOCODB2	Molybdenum cofactor synthesis 3	609277	MOCS3	27304	ENSG00000124217,ENST00000244051;;;ENST00000244051		Molybdenum cofactor deficiency, type B2	621373	AR	3	Mocs3
20q13.2-q13.3	20:51200001-64444167	DFNB65	Deafness, autosomal recessive 65	610248		692219		max lod at D20S840	Deafness, autosomal recessive 65	610248	AR	2	
20q13.2-q13.3	20:51200001-64444167	EEGV1, EEGL	Electroencephalographic variant pattern 1	130180		1940			Electroencephalographic variant pattern 1	130180	AD	2	
20q13.2	20:51386963-51562839	NFATC2, NFATP, JCOSL	Nuclear factor of activated T cells, cytoplasmic, calcineurin-dependent 2	600490	NFATC2	4773	ENSG00000101096,ENST00000371564;;;ENST00000371564	mutation identified in 1 JCOSL patient	?Joint contracture, osteochondromas, and B-cell lymphoma	620232	AR	3	Nfatc2
20q13.2	20:51596514-51768390	ATP9A, KIAA0611, NEDGBA	ATPase, class II, type 9A	609126	ATP9A	10079	ENSG00000054793,ENST00000338821;;;ENST00000338821		Neurodevelopmental disorder with poor growth and behavioral abnormalities	620242	AR	3	Atp9a
20q13.2	20:51782331-51802521	SALL4, HSAL4, DRRS, IVIC	sal-like 4	607343	SALL4	57167	ENSG00000101115,ENST00000217086;;;ENST00000217086	mutation identified in 1 IVIC family	?IVIC syndrome	147750	AD	3	Sall4
20q13.2	20:51782331-51802521	SALL4, HSAL4, DRRS, IVIC	sal-like 4	607343	SALL4	57167	ENSG00000101115,ENST00000217086;;;ENST00000217086	mutation identified in 1 IVIC family	Duane-radial ray syndrome	607323	AD	3	Sall4
20q13.2	20:54143538-54173986	CYP24A1, CYP24, HCINF1	Cytochrome P450, family 24, subfamily A, polypeptide 1 (vitamin D 24-hydroxylase)	126065	CYP24A1	1591	ENSG00000019186,ENST00000216862;;;ENST00000216862		Hypercalcemia, infantile, 1	143880	AR	3	Cyp24a1
20q13.2	20:56248732-56249815	MC3R, BMIQ9	Melanocortin-3 receptor	155540	MC3R	4159	ENSG00000124089,ENST00000243911;;;ENST00000243911		{Obesity, severe, susceptibility to, BMIQ9}	602025		3	Mc3r
20q13.2	20:56369390-56392215	AURKA, STK15, AURORA2, BTAK, ARK1, STK6, AIK	Aurora kinase A	603072	AURKA	6790	ENSG00000087586,ENST00000395915;;;ENST00000395915		{Colon cancer, susceptibility to}	114500	AD, SMu	3	Aurka
20q13.31-q13.33	20:56400001-64444167	MTBS3	Mycobacterium tuberculosis, susceptibility to, 3	612929		100302686		associated with rs3827103	{Mycobacterium tuberculosis, susceptibility to, 3}	612929		2	
20q13.31	20:57561110-57568121	PCK1, PCKDC	Phosphoenolpyruvate carboxykinase-1 (soluble)	614168	PCK1	5105	ENSG00000124253,ENST00000319441;;;ENST00000319441		Phosphoenolpyruvate carboxykinase deficiency, cytosolic	261680	AR	3	Pck1
20q13.32	20:58389229-58451101	VAPBC, VAPB, VAPC, ALS8	VAMP-associated protein B and C	605704	VAPB	9217	ENSG00000124164,ENST00000475243;;;ENST00000475243		Amyotrophic lateral sclerosis 8	608627	AD	3	Vapb
20q13.32	20:58389229-58451101	VAPBC, VAPB, VAPC, ALS8	VAMP-associated protein B and C	605704	VAPB	9217	ENSG00000124164,ENST00000475243;;;ENST00000475243		Spinal muscular atrophy, late-onset, Finkel type	182980	AD	3	Vapb
20q13.32	20:58651283-58679526	STX16, SYN16	Syntaxin 16	603666	STX16	8675	ENSG00000124222,ENST00000371141;;;ENST00000371141		Pseudohypoparathyroidism Ib	603233	AD	3	Stx16
20q13.32	20:58818918-58850902	GNASAS1, GNASAS, SANG, NESPAS	GNAS antisense RNA 1	610540	GNAS-AS1	149775	ENSG00000235590,ENST00000718285;;;ENST00000718285		Pseudohypoparathyroidism Ib	603233	AD	3	Gnasas1
20q13.32	20:58839748-58911192	GNAS, GNAS1, GPSA, POH, PHP1B, PHP1A, AHO, PHP1C, PITA3, AIMAH1	GNAS complex locus (guanine nucleotide binding protein (G protein), alpha stimulating activity polypeptide 1)	139320	GNAS	2778	ENSG00000087460,ENST00000371085;;;ENST00000371085		ACTH-independent macronodular adrenal hyperplasia 1, somatic	219080		3	Gnas
20q13.32	20:58839748-58911192	GNAS, GNAS1, GPSA, POH, PHP1B, PHP1A, AHO, PHP1C, PITA3, AIMAH1	GNAS complex locus (guanine nucleotide binding protein (G protein), alpha stimulating activity polypeptide 1)	139320	GNAS	2778	ENSG00000087460,ENST00000371085;;;ENST00000371085		McCune-Albright syndrome, somatic mosaic	174800		3	Gnas
20q13.32	20:58839748-58911192	GNAS, GNAS1, GPSA, POH, PHP1B, PHP1A, AHO, PHP1C, PITA3, AIMAH1	GNAS complex locus (guanine nucleotide binding protein (G protein), alpha stimulating activity polypeptide 1)	139320	GNAS	2778	ENSG00000087460,ENST00000371085;;;ENST00000371085		Osseous heteroplasia, progressive	166350	AD	3	Gnas
20q13.32	20:58839748-58911192	GNAS, GNAS1, GPSA, POH, PHP1B, PHP1A, AHO, PHP1C, PITA3, AIMAH1	GNAS complex locus (guanine nucleotide binding protein (G protein), alpha stimulating activity polypeptide 1)	139320	GNAS	2778	ENSG00000087460,ENST00000371085;;;ENST00000371085		Pituitary adenoma 3, multiple types, somatic	617686		3	Gnas
20q13.32	20:58839748-58911192	GNAS, GNAS1, GPSA, POH, PHP1B, PHP1A, AHO, PHP1C, PITA3, AIMAH1	GNAS complex locus (guanine nucleotide binding protein (G protein), alpha stimulating activity polypeptide 1)	139320	GNAS	2778	ENSG00000087460,ENST00000371085;;;ENST00000371085		Pseudohypoparathyroidism Ia	103580	AD	3	Gnas
20q13.32	20:58839748-58911192	GNAS, GNAS1, GPSA, POH, PHP1B, PHP1A, AHO, PHP1C, PITA3, AIMAH1	GNAS complex locus (guanine nucleotide binding protein (G protein), alpha stimulating activity polypeptide 1)	139320	GNAS	2778	ENSG00000087460,ENST00000371085;;;ENST00000371085		Pseudohypoparathyroidism Ib	603233	AD	3	Gnas
20q13.32	20:58839748-58911192	GNAS, GNAS1, GPSA, POH, PHP1B, PHP1A, AHO, PHP1C, PITA3, AIMAH1	GNAS complex locus (guanine nucleotide binding protein (G protein), alpha stimulating activity polypeptide 1)	139320	GNAS	2778	ENSG00000087460,ENST00000371085;;;ENST00000371085		Pseudohypoparathyroidism Ic	612462	AD	3	Gnas
20q13.32	20:58839748-58911192	GNAS, GNAS1, GPSA, POH, PHP1B, PHP1A, AHO, PHP1C, PITA3, AIMAH1	GNAS complex locus (guanine nucleotide binding protein (G protein), alpha stimulating activity polypeptide 1)	139320	GNAS	2778	ENSG00000087460,ENST00000371085;;;ENST00000371085		Pseudopseudohypoparathyroidism	612463	AD	3	Gnas
20q13.32	20:59016438-59026654	TUBB1, MACTHC1	Tubulin, beta-1	612901	TUBB1	81027	ENSG00000101162,ENST00000217133;;;ENST00000217133		Macrothrombocytopenia, isolated, 1, autosomal dominant	613112	AD	3	Tubb1
20q13.32	20:59025475-59032335	ATP5F1E, ATP5E, MC5DN3	ATP synthase F1, subunit episilon	606153	ATP5F1E	514	ENSG00000124172,ENST00000243997;;;ENST00000243997	pseudogene on 4q25	Mitochondrial complex V (ATP synthase) deficiency, nuclear type 3	614053	AR	3	Atp5f1e
20q13.32	20:59300611-59325992	EDN3, WS4B, HSCR4	Endothelin-3	131242	EDN3	1908	ENSG00000124205,ENST00000337938;;;ENST00000337938		{Hirschsprung disease, susceptibility to, 4}	613712	AD	3	Edn3
20q13.32	20:59300611-59325992	EDN3, WS4B, HSCR4	Endothelin-3	131242	EDN3	1908	ENSG00000124205,ENST00000337938;;;ENST00000337938		Waardenburg syndrome, type 4B	613265	AD, AR	3	Edn3
20q13.33	20:59700001-64444167	GLM6	Glioma susceptibility 6	613031		100415895		associated with rs6010620	{Glioma susceptibility 6}	613031		2	
20q13.33	20:59863571-59933637	SYCP2, SCP2, SPGF1	Synaptonemal complex protein 2	604105	SYCP2	10388	ENSG00000196074,ENST00000357552;;;ENST00000357552		Spermatogenic failure 1	258150	AD	3	Sycp2
20q13.33	20:61974798-62065881	TAF4, TAF2C1, TAFII130, TAF2C, MRD73	TAF4 RNA polymerase II, TATA box-binding protein-associated factor, 135kD	601796	TAF4	6874	ENSG00000130699,ENST00000252996;;;ENST00000252996		Intellectual developmental disorder, autosomal dominant 73	620450	AD	3	Taf4
20q13.33	20:62238521-62296183	OSBPL2, ORP2, KIAA0772, DNFA67, DIDA	Oxysterol-binding protein-like protein 2	606731	OSBPL2	9885	ENSG00000130703,ENST00000313733;;;ENST00000313733		Deafness, autosomal dominant 67	616340	AD	3	Osbpl2
20q13.33	20:62238521-62296183	OSBPL2, ORP2, KIAA0772, DNFA67, DIDA	Oxysterol-binding protein-like protein 2	606731	OSBPL2	9885	ENSG00000130703,ENST00000313733;;;ENST00000313733		Dyschromatosis, ichthyosis, deafness, and atopic disease	621400		3	Osbpl2
20q13.33	20:62309065-62367312	LAMA5, NPHS26, BBDS2	Laminin, alpha-5	601033	LAMA5	3911	ENSG00000130702,ENST00000252999;;;ENST00000252999	mutation identified in 1 BBDS2 family	?Bent bone dysplasia syndrome 2	620076	AR	3	Lama5
20q13.33	20:62309065-62367312	LAMA5, NPHS26, BBDS2	Laminin, alpha-5	601033	LAMA5	3911	ENSG00000130702,ENST00000252999;;;ENST00000252999	mutation identified in 1 BBDS2 family	Nephrotic syndrome, type 26	620049	AR	3	Lama5
20q13.33	20:62463497-62475995	GATA5, CHTD5	GATA-binding protein 5	611496	GATA5	140628	ENSG00000130700,ENST00000252997;;;ENST00000252997		Congenital heart defects, multiple types, 5	617912	AD, AR	3	Gata5
20q13.33	20:62816213-62841159	COL9A3, EDM3, IDD, STL6	Collagen IX, alpha-3 polypeptide	120270	COL9A3	1299	ENSG00000092758,ENST00000649368;;;ENST00000649368		{Intervertebral disc disease, susceptibility to}	603932		3	Col9a3
20q13.33	20:62816213-62841159	COL9A3, EDM3, IDD, STL6	Collagen IX, alpha-3 polypeptide	120270	COL9A3	1299	ENSG00000092758,ENST00000649368;;;ENST00000649368		Epiphyseal dysplasia, multiple, 3, with or without myopathy	600969	AD	3	Col9a3
20q13.33	20:62816213-62841159	COL9A3, EDM3, IDD, STL6	Collagen IX, alpha-3 polypeptide	120270	COL9A3	1299	ENSG00000092758,ENST00000649368;;;ENST00000649368		Stickler syndrome, type VI	620022	AR	3	Col9a3
20q13.33	20:62952709-62969585	SLC17A9, C20orf59, POROK8	Solute carrier family 17, member 9	612107	SLC17A9	63910	ENSG00000101194,ENST00000370351;;;ENST00000370351		Porokeratosis 8, disseminated superficial actinic type	616063	AD	3	Slc17a9
20q13.33	20:63343223-63361349	CHRNA4, ENFL1	Cholinergic receptor, nicotinic, alpha polypeptide-4	118504	CHRNA4	1137	ENSG00000101204,ENST00000370263;;;ENST00000370263		{Nicotine addiction, susceptibility to}	188890		3	Chrna4
20q13.33	20:63343223-63361349	CHRNA4, ENFL1	Cholinergic receptor, nicotinic, alpha polypeptide-4	118504	CHRNA4	1137	ENSG00000101204,ENST00000370263;;;ENST00000370263		Epilepsy, nocturnal frontal lobe, 1	600513	AD	3	Chrna4
20q13.33	20:63400208-63472655	KCNQ2, EBN1, DEE7, BFNS1	Potassium voltage-gated channel, KQT-like subfamily, member 2	602235	KCNQ2	3785	ENSG00000075043,ENST00000359125;;;ENST00000359125		Developmental and epileptic encephalopathy 7	613720	AD	3	Kcnq2
20q13.33	20:63400208-63472655	KCNQ2, EBN1, DEE7, BFNS1	Potassium voltage-gated channel, KQT-like subfamily, member 2	602235	KCNQ2	3785	ENSG00000075043,ENST00000359125;;;ENST00000359125		Myokymia	121200	AD	3	Kcnq2
20q13.33	20:63400208-63472655	KCNQ2, EBN1, DEE7, BFNS1	Potassium voltage-gated channel, KQT-like subfamily, member 2	602235	KCNQ2	3785	ENSG00000075043,ENST00000359125;;;ENST00000359125		Seizures, benign neonatal, 1	121200	AD	3	Kcnq2
20q13.33	20:63488014-63499083	EEF1A2, DEE33, MRD38	Eukaryotic translation elongation factor-1, alpha-2	602959	EEF1A2	1917	ENSG00000101210,ENST00000217182;;;ENST00000217182		Developmental and epileptic encephalopathy 33	616409	AD	3	Eef1a2
20q13.33	20:63488014-63499083	EEF1A2, DEE33, MRD38	Eukaryotic translation elongation factor-1, alpha-2	602959	EEF1A2	1917	ENSG00000101210,ENST00000217182;;;ENST00000217182		Intellectual developmental disorder, autosomal dominant 38	616393	AD	3	Eef1a2
20q13.33	20:63657810-63696253	RTEL1, C20orf41, NHL, KIAA1088, DKCB5, DKCA4, PFBMFT3	Regulator of telomere elongation helicase 1	608833	RTEL1	51750	ENSG00000258366,ENST00000360203;;;ENST00000360203		Dyskeratosis congenita, autosomal dominant 4	615190	AD, AR	3	Rtel1
20q13.33	20:63657810-63696253	RTEL1, C20orf41, NHL, KIAA1088, DKCB5, DKCA4, PFBMFT3	Regulator of telomere elongation helicase 1	608833	RTEL1	51750	ENSG00000258366,ENST00000360203;;;ENST00000360203		Dyskeratosis congenita, autosomal recessive 5	615190	AD, AR	3	Rtel1
20q13.33	20:63657810-63696253	RTEL1, C20orf41, NHL, KIAA1088, DKCB5, DKCA4, PFBMFT3	Regulator of telomere elongation helicase 1	608833	RTEL1	51750	ENSG00000258366,ENST00000360203;;;ENST00000360203		Pulmonary fibrosis and/or bone marrow failure syndrome, telomere-related, 3	616373	AD	3	Rtel1
20q13.33	20:63895126-63936011	DNAJC5, DNAJC5A, CSP, CLN4	DNAJ/HSP40 homolog, subfamily C, member 5	611203	DNAJC5	80331	ENSG00000101152,ENST00000360864;;;ENST00000360864		Ceroid lipofuscinosis, neuronal, 4 (Kufs type), autosomal dominant	162350	AD	3	Dnajc5
20q13.33	20:63981132-64033100	PRPF6, PRP6, ANT1, TOM, C20orf14	Pre-mRNA processing factor 6	613979	PRPF6	24148	ENSG00000101161,ENST00000266079;;;ENST00000266079		Retinitis pigmentosa 60	613983	AD	3	Prpf6
20q13.33	20:64047582-64049639	SOX18, HLTS, HLTRS	SOX18, mouse, homolog of	601618	SOX18	54345	ENSG00000203883,ENST00000340356;;;ENST00000340356		Hypotrichosis-lymphedema-telangiectasia syndrome	607823	AR	3	Sox18
20q13.33	20:64047582-64049639	SOX18, HLTS, HLTRS	SOX18, mouse, homolog of	601618	SOX18	54345	ENSG00000203883,ENST00000340356;;;ENST00000340356		Hypotrichosis-lymphedema-telangiectasia-renal defect syndrome	137940	AD	3	Sox18
21p13-q11	21:1-15000000	AUTS12	Autism, susceptibility to, 12	610838		100188314		max lod at D21S1437	{Autism susceptibility 12}	610838		2	
21q11.2	21:13000001-15000000	NRCLP3	Narcolepsy 3	609039		494446		max lod at D21S1245	Narcolepsy 3	609039	AD	2	
21q11.2	21:13000001-15000000	TAM, MST	Myeloproliferative syndrome, transient (transient abnormal myelopoiesis)	159595		8205			Leukemia, transient, of Down syndrome	159595		2	
21q11.2-q21.1	21:14961235-15065936	NRIP1, RIP140, CAKUT3	Nuclear receptor interacting protein 1 (receptor interacting protein 140)	602490	NRIP1	8204	ENSG00000180530,ENST00000318948;;;ENST00000318948	mutation identified in 1 CAKUT3 family	?Congenital anomalies of kidney and urinary tract 3	618270	AD	3	Nrip1
21q21	21:15000001-30200000	USH1E	Usher syndrome-1E, autosomal recessive, severe	602097		7396			Usher syndrome, type 1E	602097	AR	2	
21q21.1	21:15729982-15880064	USP25, USP21, EIG19	Ubiquitin-specific protease 25	604736	USP25	29761	ENSG00000155313,ENST00000400183;;;ENST00000400183		{Epilepsy, idiopathic generalized, susceptibility to, 19}	621064	AD	3	Usp25
21q21.1	21:18269116-18485884	TMPRSS15, PRSS7, ENTK	Transmembrane protease, serine 15	606635	TMPRSS15	5651	ENSG00000154646,ENST00000284885;;;ENST00000284885		Enterokinase deficiency	226200	AR	3	Tmprss15
21q21.3	21:25585656-25607859	MRPL39, MRPL5, COXPD59	Mitochondrial ribosomal protein L39	611845	MRPL39	54148	ENSG00000154719,ENST00000352957;;;ENST00000352957		Combined oxidative phosphorylation deficiency 59	620646	AR	3	Mrpl39
21q21.3	21:25639258-25717562	JAM2, VEJAM, IBGC8	Junctional adhesion molecule 2	606870	JAM2	58494	ENSG00000154721,ENST00000480456;;;ENST00000480456		Basal ganglia calcification, idiopathic, 8, autosomal recessive	618824	AR	3	Jam2
21q21.3	21:25880550-26171128	APP, AAA, CVAP, AD1	Amyloid beta (A4) precursor protein	104760	APP	351	ENSG00000142192,ENST00000346798;;;ENST00000346798	proximal to SOD; very distal q21 or boundary with q22	Alzheimer disease 1, familial	104300	AD	3	App
21q21.3	21:25880550-26171128	APP, AAA, CVAP, AD1	Amyloid beta (A4) precursor protein	104760	APP	351	ENSG00000142192,ENST00000346798;;;ENST00000346798	proximal to SOD; very distal q21 or boundary with q22	Cerebral amyloid angiopathy, Dutch, Italian, Iowa, Flemish, Arctic variants	605714	AD	3	App
21q22	21:30200001-46709983	BRDCS1, DEL21q22, C21DELq22	Braddock-Carey syndrome 1	619980				7.7 - 9.2 Mb deletion	Braddock-Carey syndrome 1	619980	AD	4	
21q22	21:30200001-46709983	FEB7	Febrile seizures, familial, 7	611515		100049160		max lod at D21S1910	Febrile seizures, familial, 7	611515		2	
21q22	21:30200001-46709983	TUKLS	Tukel syndrome	609428		574049		max lod at D21S1259	Tukel syndrome	609428	AR	2	
21q22.11	21:31118418-31559087	TIAM1, NEDLDS	T-cell lymphoma invasion and metastasis 1	600687	TIAM1	7074	ENSG00000156299,ENST00000541036;;;ENST00000541036		Neurodevelopmental disorder with language delay and seizures	619908	AR	3	Tiam1
21q22.11	21:31659693-31668931	SOD1, ALS1, STAHP	Superoxide dismutase-1, soluble	147450	SOD1	6647	ENSG00000142168,ENST00000270142;;;ENST00000270142	mid q22.1	Amyotrophic lateral sclerosis 1	105400	AD, AR	3	Sod1
21q22.11	21:31659693-31668931	SOD1, ALS1, STAHP	Superoxide dismutase-1, soluble	147450	SOD1	6647	ENSG00000142168,ENST00000270142;;;ENST00000270142	mid q22.1	Spastic tetraplegia and axial hypotonia, progressive	618598	AR	3	Sod1
21q22.11	21:31671000-31732118	SCAF4, KIAA1172, FZS	SR-related C-terminal domain-associated factor 4	616023	SCAF4	57466	ENSG00000156304,ENST00000286835;;;ENST00000286835		Fliedner-Zweier syndrome	620511	AD	3	Scaf4
21q22.11	21:32291813-32314784	MRAP, FALP, C21orf61, GCCD2, FGD2	Melanocortin 2 receptor accessory protein	609196	MRAP	56246	ENSG00000170262,ENST00000303645;;;ENST00000303645		Glucocorticoid deficiency 2	607398	AR	3	Mrap
21q22.11	21:32599354-32612377	CFAP298, C21orf59, CILD26	Cilia- and flagella-associated protein 298	615494	CFAP298	56683	ENSG00000159079,ENST00000290155;;;ENST00000290155		Ciliary dyskinesia, primary, 26	615500	AR	3	Cfap298
21q22.11	21:32628759-32728394	SYNJ1, PARK20, DEE53	Synaptojanin 1	604297	SYNJ1	8867	ENSG00000159082,ENST00000674351;;;ENST00000674351		Developmental and epileptic encephalopathy 53	617389	AR	3	Synj1
21q22.11	21:32628759-32728394	SYNJ1, PARK20, DEE53	Synaptojanin 1	604297	SYNJ1	8867	ENSG00000159082,ENST00000674351;;;ENST00000674351		Parkinson disease 20, early-onset	615530	AR	3	Synj1
21q22.11	21:33229938-33265664	IFNAR2, IMD45	Interferon, alpha, beta, and omega, receptor 2	602376	IFNAR2	3455	ENSG00000159110,ENST00000342136;;;ENST00000342136		{Hepatitis B virus, susceptibility to}	610424		3	Ifnar2
21q22.11	21:33229938-33265664	IFNAR2, IMD45	Interferon, alpha, beta, and omega, receptor 2	602376	IFNAR2	3455	ENSG00000159110,ENST00000342136;;;ENST00000342136		Immunodeficiency 45	616669	AR	3	Ifnar2
21q22.11	21:33266367-33310182	IL10RB, CRFB4, IBD25	Interleukin 10 receptor, beta	123889	IL10RB	3588	ENSG00000243646,ENST00000290200;;;ENST00000290200	35kb distal to IFNAR; D21S58	{Hepatitis B virus, susceptibility to}	610424		3	Il10rb
21q22.11	21:33266367-33310182	IL10RB, CRFB4, IBD25	Interleukin 10 receptor, beta	123889	IL10RB	3588	ENSG00000243646,ENST00000290200;;;ENST00000290200	35kb distal to IFNAR; D21S58	Inflammatory bowel disease 25, early onset, autosomal recessive	612567	AR	3	Il10rb
21q22.11	21:33324395-33359864	IFNAR1, IMD106	Interferon, alpha, beta and omega, receptor 1	107450	IFNAR1	3454	ENSG00000142166,ENST00000270139;;;ENST00000270139		Immunodeficiency 106, susceptibility to viral infections	619935	AR	3	Ifnar1
21q22.11	21:33402882-33437516	IFNGR2, IFNGT1, IFGR2, IMD28	Interferon gamma receptor-2 (interferon gamma transducer 1)	147569	IFNGR2	3460	ENSG00000159128,ENST00000290219;;;ENST00000290219		Immunodeficiency 28, mycobacteriosis	614889	AR	3	Ifngr2
21q22.11	21:33543038-33577481	SON, TOKIMS	SON DNA-binding protein	182465	SON	6651	ENSG00000159140,ENST00000356577;;;ENST00000356577		ZTTK syndrome	617140	AD	3	Son
21q22.11	21:33577551-33588684	DONSON, C21orf60, MISSLA, MIMIS	Downstream neighbor of SON	611428	DONSON	29980	ENSG00000159147,ENST00000303071;;;ENST00000303071		Microcephaly-micromelia syndrome	251230	AR	3	Donson
21q22.11	21:33577551-33588684	DONSON, C21orf60, MISSLA, MIMIS	Downstream neighbor of SON	611428	DONSON	29980	ENSG00000159147,ENST00000303071;;;ENST00000303071		Microcephaly, short stature, and limb abnormalities	617604	AR	3	Donson
21q22.11	21:33903453-33915804	ATP5PO, ATP5O, MC5DN7	ATP synthase, H+ transporting, mitochondrial F1 complex, O subunit (oligomycin sensitivity conferring protein)	600828	ATP5PO	539	ENSG00000241837,ENST00000290299;;;ENST00000290299		Mitochondrial complex V (ATP synthase) deficiency, nuclear type 7	620359	AR	3	Atp5po
21q22.11	21:34364006-34371381	KCNE2, MIRP1, LQT6, ATFB4	Potassium voltage-gated channel, Isk-related family, member 2	603796	KCNE2	9992	ENSG00000159197,ENST00000290310;;;ENST00000290310		Atrial fibrillation, familial, 4	611493		3	Kcne2
21q22.11	21:34364006-34371381	KCNE2, MIRP1, LQT6, ATFB4	Potassium voltage-gated channel, Isk-related family, member 2	603796	KCNE2	9992	ENSG00000159197,ENST00000290310;;;ENST00000290310		Long QT syndrome 6	613693	AD	3	Kcne2
21q22.12	21:34446688-34512210	KCNE1, JLNS, LQT5, JLNS2	Potassium voltage-gated channel, Isk-related subfamily, member 1	176261	KCNE1	3753	ENSG00000180509,ENST00000399286;;;ENST00000399286		Jervell and Lange-Nielsen syndrome 2	612347	AR	3	Kcne1
21q22.12	21:34446688-34512210	KCNE1, JLNS, LQT5, JLNS2	Potassium voltage-gated channel, Isk-related subfamily, member 1	176261	KCNE1	3753	ENSG00000180509,ENST00000399286;;;ENST00000399286		Long QT syndrome 5	613695	AD	3	Kcne1
21q22.12	21:34787801-35049302	RUNX1, CBFA2, AML1	Runt-related transcription factor 1 (aml1 oncogene)	151385	RUNX1	861	ENSG00000159216,ENST00000675419;;;ENST00000675419		Leukemia, acute myeloid	601626	AD, SMu	3	Runx1
21q22.12	21:34787801-35049302	RUNX1, CBFA2, AML1	Runt-related transcription factor 1 (aml1 oncogene)	151385	RUNX1	861	ENSG00000159216,ENST00000675419;;;ENST00000675419		Platelet disorder, familial, with associated myeloid malignancy	601399	AD	3	Runx1
21q22.13-qter	21:36400001-46709983	BMND6	Bone mineral density QTL 6	609876		100188797		max lod at D21S1446	[Bone mineral density QTL 6]	609876		2	
21q22.13	21:36400001-38300000	MAFD3, BPEO	Major affective disorder 3	609633		100188792		max lod at D21S1252	{Major affective disorder 3, early onset}	609633		2	
21q22.13	21:36460621-36576569	CLDN14, DFNB29	Claudin 14	605608	CLDN14	23562	ENSG00000159261,ENST00000399135;;;ENST00000399135		Deafness, autosomal recessive 29	614035	AR	3	Cldn14
21q22.13	21:36748625-36990211	HLCS, HCS	Holocarboxylase synthetase	609018	HLCS	3141	ENSG00000159267,ENST00000674895;;;ENST00000674895		Holocarboxylase synthetase deficiency	253270	AR	3	Hlcs
21q22.13	21:37065364-37073071	PIGP, DSCR5, DEE55	Phosphatidylinositol glycan, class P	605938	PIGP	51227	ENSG00000185808,ENST00000360525;;;ENST00000360525		Developmental and epileptic encephalopathy 55	617599	AR	3	Pigp
21q22.13	21:37365573-37526358	DYRK1A, MNBH, MNB, MRD7	Dual-specificity tyrosine phosphorylation-regulated kinase 1A	600855	DYRK1A	1859	ENSG00000157540,ENST00000647188;;;ENST00000647188	?triplicate state responsible for mental defect in Down syndrome	Intellectual developmental disorder, autosomal dominant 7	614104	AD	3	Dyrk1a
21q22.13	21:37607373-37916457	KCNJ6, GIRK2, KCNJ7, KPLBS	Potassium inwardly-rectifying channel, subfamily J, member 6	600877	KCNJ6	3763	ENSG00000157542,ENST00000609713;;;ENST00000609713		Keppen-Lubinsky syndrome	614098	AD	3	Kcnj6
21q22.2	21:38367261-38661783	ERG, LMPHM14	ETS transcription factor ERG	165080	ERG	2078	ENSG00000157554,ENST00000288319;;;ENST00000288319	fused with EWS in Ewing sarcoma, with FUS in leukemia	Lymphatic malformation 14	620602	AD	3	Erg
21q22.2	21:39184176-39321212	BRWD1, WRD9, C21orf107, CILD51	Bromodomain and WD repeat domain-containing protein 1	617824	BRWD1	54014	ENSG00000185658,ENST00000342449;;;ENST00000342449		Ciliary dyskinesia, primary, 51	620438	AR	3	Brwd1
21q22.3	21:41200001-46709983	DCR, DSCR	Down syndrome chromosome region	190685				many genes are involved in this phenotype	Down syndrome	190685	IC	4	
21q22.3	21:41200001-46709983	HPE1	Holoprosencephaly-1, alobar	236100		3244			Holoprosencephaly 1	236100	AD, IC	2	
21q22.3	21:41739373-41767052	RIPK4, NKRD3, DIK, PPS2, CHANDS	Receptor-interacting serine-threonine kinase 4	605706	RIPK4	54101	ENSG00000183421,ENST00000332512;;;ENST00000332512		CHAND syndrome	214350	AR	3	Ripk4
21q22.3	21:41739373-41767052	RIPK4, NKRD3, DIK, PPS2, CHANDS	Receptor-interacting serine-threonine kinase 4	605706	RIPK4	54101	ENSG00000183421,ENST00000332512;;;ENST00000332512		Popliteal pterygium syndrome, Bartsocas-Papas type 1	263650	AR	3	Ripk4
21q22.3	21:42371890-42396052	TMPRSS3, ECHOS1, DFNB8, DFNB10	Transmembrane protease, serine 3	605511	TMPRSS3	64699	ENSG00000160183,ENST00000644384;;;ENST00000644384		Deafness, autosomal recessive 8/10	601072	AR	3	Tmprss3
21q22.3	21:42472486-42496224	RSPH1, TSGA2, TSA2, CILD24	Radial spoke head component 1	609314	RSPH1	89765	ENSG00000160188,ENST00000291536;;;ENST00000291536		Ciliary dyskinesia, primary, 24	615481	AR	3	Rsph1
21q22.3	21:42843094-42892998	WDR4, MIGSB, GAMOS6	WD repeat-containing protein 4	605924	WDR4	10785	ENSG00000160193,ENST00000398208;;;ENST00000398208		Galloway-Mowat syndrome 6	618347	AR	3	Wdr4
21q22.3	21:42843094-42892998	WDR4, MIGSB, GAMOS6	WD repeat-containing protein 4	605924	WDR4	10785	ENSG00000160193,ENST00000398208;;;ENST00000398208		Microcephaly, growth deficiency, seizures, and brain malformations	618346	AR	3	Wdr4
21q22.3	21:43053191-43076873	CBS	Cystathionine beta-synthase	613381	CBS	875	ENSG00000160200,ENST00000398165;;;ENST00000398165	subtelomeric	Homocystinuria, B6-responsive and nonresponsive types	236200	AR	3	Cbs
21q22.3	21:43053191-43076873	CBS	Cystathionine beta-synthase	613381	CBS	875	ENSG00000160200,ENST00000398165;;;ENST00000398165	subtelomeric	Thrombosis, hyperhomocysteinemic	236200	AR	3	Cbs
21q22.3	21:43169008-43172810	CRYAA, CRYA1, CTRCT9	Crystallin, alpha A	123580	CRYAA	1409	ENSG00000160202,ENST00000291554;;;ENST00000291554		Cataract 9, multiple types	604219	AD, AR	3	Cryaa
21q22.3	21:43414483-43427131	SIK1, SNF1LK, MSK, DEE30	Salt-inducible kinase 1	605705	SIK1	150094	ENSG00000142178,ENST00000270162;;;ENST00000270162		Developmental and epileptic encephalopathy 30	616341	AD	3	Sik1
21q22.3	21:43444972-43659488	HSF2BP, POF19	Heat-shock transcription factor 2-binding protein	604554	HSF2BP	11077	ENSG00000160207,ENST00000291560;;;ENST00000291560		Premature ovarian failure 19	619245	AR	3	Hsf2bp
21q22.3	21:43719129-43762299	PDXK, PNK, PKH, HMSN6C	Pyridoxal kinase	179020	PDXK	8566	ENSG00000160209,ENST00000291565;;;ENST00000291565		Neuropathy, hereditary motor and sensory, type VIC, with optic atrophy	618511	AR	3	Pdxk
21q22.3	21:43773950-43776308	CSTB, STFB, EPM1, PME, EPM1A, ULD	Cystatin B (stefin B)	601145	CSTB	1476	ENSG00000160213,ENST00000291568;;;ENST00000291568		Epilepsy, progressive myoclonic 1A (Unverricht and Lundborg)	254800	AR	3	Cstb
21q22.3	21:44012309-44106552	TRAPPC10, TMEM1, EHOC1, NEDMISS	Trafficking protein particle complex, subunit 10	602103	TRAPPC10	7109	ENSG00000160218,ENST00000291574;;;ENST00000291574	near PWP2H	Neurodevelopmental disorder with microcephaly, short stature, and speech delay	620027	AR	3	Trappc10
21q22.3	21:44216981-44240943	ICOSLG, B7H2, GL50, B7RP1, IMD119	Inducible T-cell co-stimulator ligand	605717	ICOSLG	23308	ENSG00000160223,ENST00000407780;;;ENST00000407780	mutation identified in 1 IMD119 patient	?Immunodeficiency 119	620825	AR	3	Icosl
21q22.3	21:44285876-44298648	AIRE, APECED, APS1	Autoimmune regulator	607358	AIRE	326	ENSG00000160224,ENST00000291582;;;ENST00000291582		Autoimmune polyendocrinopathy syndrome , type I, with or without reversible metaphyseal dysplasia	240300	AD, AR	3	Aire
21q22.3	21:44300053-44327373	PFKL	Phosphofructokinase, liver type	171860	PFKL	5211	ENSG00000141959,ENST00000349048;;;ENST00000349048		Hemolytic anemia due to phosphofructokinase deficiency			1	Pfkl
21q22.3	21:44328944-44339390	CFAP410, C21orf2, SMDAX, RDMS	Cilia and flagella-associated protein 410	603191	CFAP410	755	ENSG00000160226,ENST00000339818;;;ENST00000339818		Retinal dystrophy with macular staphyloma	617547	AR	3	Cfap410
21q22.3	21:44328944-44339390	CFAP410, C21orf2, SMDAX, RDMS	Cilia and flagella-associated protein 410	603191	CFAP410	755	ENSG00000160226,ENST00000339818;;;ENST00000339818		Spondylometaphyseal dysplasia, axial	602271	AR	3	Cfap410
21q22.3	21:44497893-44711572	TSPEAR, C21orf29, DFNB98, ECTD14, STHAG10	Thrombospondin-type laminin G domain and EAR repeats	612920	TSPEAR	54084	ENSG00000175894,ENST00000323084;;;ENST00000323084	mutation identified in 1 DFNB98 family	?Deafness, autosomal recessive 98	614861	AR	3	Tspear
21q22.3	21:44497893-44711572	TSPEAR, C21orf29, DFNB98, ECTD14, STHAG10	Thrombospondin-type laminin G domain and EAR repeats	612920	TSPEAR	54084	ENSG00000175894,ENST00000323084;;;ENST00000323084	mutation identified in 1 DFNB98 family	Ectodermal dysplasia 14, hypohidrotic/hair/tooth/nail type	618180	AR	3	Tspear
21q22.3	21:44497893-44711572	TSPEAR, C21orf29, DFNB98, ECTD14, STHAG10	Thrombospondin-type laminin G domain and EAR repeats	612920	TSPEAR	54084	ENSG00000175894,ENST00000323084;;;ENST00000323084	mutation identified in 1 DFNB98 family	Tooth agenesis, selective, 10	620173	AR	3	Tspear
21q22.3	21:44885953-44928815	ITGB2, CD18, LCAMB, LAD	Integrin, beta-2 (antigen CD18 (p95), lymphocyte function-associated antigen-1; macrophage antigen, beta polypeptide)	600065	ITGB2	3689	ENSG00000160255,ENST00000652462;;;ENST00000652462	common subunit for CR3, LFA1, and P150,95	Leukocyte adhesion deficiency	116920	AR	3	Itgb2,Itgb2l
21q22.3	21:45074578-45226563	ADARB1, RED1, NEDHYMS	Adenosine deaminase, RNA-specific, B1 (RED1, rat, homolog of)	601218	ADARB1	104	ENSG00000197381,ENST00000348831;;;ENST00000348831		Neurodevelopmental disorder with hypotonia, microcephaly, and seizures	618862	AR	3	Adarb1
21q22.3	21:45405165-45513720	COL18A1, KNO1, GLCC	Collagen XVIII, alpha-1 polypeptide	120328	COL18A1	80781	ENSG00000182871,ENST00000651438;;;ENST00000651438		Glaucoma, primary closed-angle	618880	AD	3	Col18a1
21q22.3	21:45405165-45513720	COL18A1, KNO1, GLCC	Collagen XVIII, alpha-1 polypeptide	120328	COL18A1	80781	ENSG00000182871,ENST00000651438;;;ENST00000651438		Knobloch syndrome, type 1	267750	AR	3	Col18a1
21q22.3	21:45502517-45563025	SLC19A1, FOLT, MEGAF, IMD114	Solute carrier family 19 (folate transporter), member 1	600424	SLC19A1	6573	ENSG00000173638,ENST00000311124;;;ENST00000311124	mutation identified in 1 MEGAF patient	?Megaloblastic anemia, folate-responsive	601775	AR	3	Slc19a1
21q22.3	21:45502517-45563025	SLC19A1, FOLT, MEGAF, IMD114	Solute carrier family 19 (folate transporter), member 1	600424	SLC19A1	6573	ENSG00000173638,ENST00000311124;;;ENST00000311124	mutation identified in 1 MEGAF patient	Immunodeficiency 114, folate-responsive	620603	AR	3	Slc19a1
21q22.3	21:45981770-46005048	COL6A1, BTHLM1A, UCHMD1A	Collagen VI, alpha-1 polypeptide	120220	COL6A1	1291	ENSG00000142156,ENST00000361866;;;ENST00000361866		Bethlem myopathy 1A	158810	AD	3	Col6a1
21q22.3	21:45981770-46005048	COL6A1, BTHLM1A, UCHMD1A	Collagen VI, alpha-1 polypeptide	120220	COL6A1	1291	ENSG00000142156,ENST00000361866;;;ENST00000361866		Ullrich congenital muscular dystrophy 1A	254090	AD, AR	3	Col6a1
21q22.3	21:46098112-46132848	COL6A2, BTHLM1B, UCMD1B	Collagen VI, alpha-2 polypeptide	120240	COL6A2	1292	ENSG00000142173,ENST00000300527;;;ENST00000300527	mutation identified in 1 MYSCL family	?Myosclerosis, congenital	255600	AR	3	Col6a2
21q22.3	21:46098112-46132848	COL6A2, BTHLM1B, UCMD1B	Collagen VI, alpha-2 polypeptide	120240	COL6A2	1292	ENSG00000142173,ENST00000300527;;;ENST00000300527	mutation identified in 1 MYSCL family	Bethlem myopathy 1B	620725	AD, AR	3	Col6a2
21q22.3	21:46098112-46132848	COL6A2, BTHLM1B, UCMD1B	Collagen VI, alpha-2 polypeptide	120240	COL6A2	1292	ENSG00000142173,ENST00000300527;;;ENST00000300527	mutation identified in 1 MYSCL family	Ullrich congenital muscular dystrophy 1B	620727	AD, AR	3	Col6a2
21q22.3	21:46136262-46155579	FTCD	Formiminotransferase cyclodeminase	606806	FTCD	10841	ENSG00000160282,ENST00000397746;;;ENST00000397746		Glutamate formiminotransferase deficiency	229100	AR	3	Ftcd
21q22.3	21:46188446-46228774	LSS, OSC, CTRCT44, HYPT14, APMR4	Lanosterol synthase	600909	LSS	4047	ENSG00000160285,ENST00000397728;;;ENST00000397728		Alopecia-intellectual disability syndrome 4	618840	AR	3	Lss
21q22.3	21:46188446-46228774	LSS, OSC, CTRCT44, HYPT14, APMR4	Lanosterol synthase	600909	LSS	4047	ENSG00000160285,ENST00000397728;;;ENST00000397728		Cataract 44	616509	AR	3	Lss
21q22.3	21:46188446-46228774	LSS, OSC, CTRCT44, HYPT14, APMR4	Lanosterol synthase	600909	LSS	4047	ENSG00000160285,ENST00000397728;;;ENST00000397728		Hypotrichosis 14	618275	AR	3	Lss
21q22.3	21:46235133-46286265	MCM3AP, MAP80, GANP, PNRIID	Minichromosome maintenance 3-associated protein, 80-kD	603294	MCM3AP	8888	ENSG00000160294,ENST00000291688;;;ENST00000291688		Peripheral neuropathy, autosomal recessive, with or without impaired intellectual development	618124	AR	3	Mcm3ap
21q22.3	21:46324156-46445769	PCNT, PCNT2, KEN, SCKL4, MOPD2	Pericentrin	605925	PCNT	5116	ENSG00000160299,ENST00000359568;;;ENST00000359568		Microcephalic osteodysplastic primordial dwarfism, type II	210720	AR	3	Pcnt
22q11	22:15000001-25500000	ACF	Asymmetric crying facies (Cayler cardiofacial syndrome)	125520		387569			Cayler cardiofacial syndrome	125520	AD	2	
22q11	22:15000001-25500000	CECR, CES	Cat eye syndrome	115470				partial tetrasomy of 22q11	Cat eye syndrome	115470	AD	4	
22q11.1	22:17085000-17115693	IL17RA, IL17R, IMD51	Interleukin 17 receptor A	605461	IL17RA	23765	ENSG00000177663,ENST00000319363;;;ENST00000319363		Immunodeficiency 51	613953	AR	3	Il17ra
22q11.1	22:17178790-17221848	ADA2, CECR1, VAIHS, SNEDS	Adenosine deaminase 2	607575	ADA2	51816	ENSG00000093072,ENST00000399837;;;ENST00000399837		Sneddon syndrome	182410	AR	3	
22q11.1	22:17178790-17221848	ADA2, CECR1, VAIHS, SNEDS	Adenosine deaminase 2	607575	ADA2	51816	ENSG00000093072,ENST00000399837;;;ENST00000399837		Vasculitis, autoinflammation, immunodeficiency, and hematologic defects syndrome	615688	AR	3	
22q11.2	22:17400001-25500000	DEL22q11.2, C22DELq11.2	Chromosome 22q11.2 deletion syndrome, distal	611867					Chromosome 22q11.2 deletion syndrome, distal	611867	AD	4	
22q11.2	22:17400001-25500000	DER22t11-22	Emanuel syndrome (supernumerary der(22)t(11;22) syndrome)	609029					Emanuel syndrome	609029	ICB	4	
22q11.2	22:17400001-25500000	DER22t8-22	Supernumerary der(22)t(8;22) syndrome	613700					Supernumerary der(22)t(8-22) syndrome	613700		4	
22q11.21-q12.1	22:17400001-29200000	DFNB40	Deafness, autosomal recessive 40	608264		379003			Deafness, autosomal recessive 40	608264	AR	2	
22q11.2	22:17400001-25500000	DUP22q11.2	Chromosome 22q11.2 microduplication syndrome	608363				contiguous gene microduplication syndrome	Chromosome 22q11.2 microduplication syndrome	608363	AD, IC	4	
22q11.21	22:17592136-17628822	ATP6V1E1, ATP6E, ARCL2C	ATPase, H+ transporting, V1 subunit E1	108746	ATP6V1E1	529	ENSG00000131100,ENST00000253413;;;ENST00000253413		Cutis laxa, autosomal recessive, type IIC	617402	AR	3	Atp6v1e1
22q11.21	22:18077990-18105396	PEX26, PBD7A, PBD7B	Peroxisome biogenesis factor 26	608666	PEX26	55670	ENSG00000215193,ENST00000399744;;;ENST00000399744		Peroxisome biogenesis disorder 7A (Zellweger)	614872	AR	3	Pex26
22q11.21	22:18077990-18105396	PEX26, PBD7A, PBD7B	Peroxisome biogenesis factor 26	608666	PEX26	55670	ENSG00000215193,ENST00000399744;;;ENST00000399744		Peroxisome biogenesis disorder 7B	614873	AR	3	Pex26
22q11.21	22:18110809-18131732	TUBA8, TUBAL2, MACTHC2	Tubulin, alpha 8	605742	TUBA8	51807	ENSG00000183785,ENST00000330423;;;ENST00000330423		Macrothrombocytopenia, isolated, 2, autosomal dominant	619840	AD	3	Tuba8
22q11.21	22:18150170-18177397	USP18, UBP43, ISG43, PTORCH2	Ubiquitin-specific protease 18	607057	USP18	11274	ENSG00000184979,ENST00000215794;;;ENST00000215794		Pseudo-TORCH syndrome 2	617397	AR	3	Usp18
22q11.21	22:18912781-18936553	PRODH, PRODH2, SCZD4	Proline dehydrogenase (proline oxidase)	606810	PRODH	5625	ENSG00000100033,ENST00000357068;;;ENST00000357068		{Schizophrenia, susceptibility to, 4}	600850	AD	3	Prodh
22q11.21	22:18912781-18936553	PRODH, PRODH2, SCZD4	Proline dehydrogenase (proline oxidase)	606810	PRODH	5625	ENSG00000100033,ENST00000357068;;;ENST00000357068		Hyperprolinemia, type I	239500	AR	3	Prodh
22q11.21	22:19175581-19178736	SLC25A1, SLC20A3, CTP, D2L2AD, CMS23	Solute carrier family 25 (mitochondrial citrate transporter), member 1	190315	SLC25A1	6576	ENSG00000100075,ENST00000215882;;;ENST00000215882		Combined D-2- and L-2-hydroxyglutaric aciduria	615182	AR	3	Slc25a1
22q11.21	22:19175581-19178736	SLC25A1, SLC20A3, CTP, D2L2AD, CMS23	Solute carrier family 25 (mitochondrial citrate transporter), member 1	190315	SLC25A1	6576	ENSG00000100075,ENST00000215882;;;ENST00000215882		Myasthenic syndrome, congenital, 23, presynaptic	618197	AR	3	Slc25a1
22q11.21	22:19479466-19520612	CDC45, CDC45L, CDC45L2, MGORS7	Cell division cycle 45	603465	CDC45	8318	ENSG00000093009,ENST00000263201;;;ENST00000263201		Meier-Gorlin syndrome 7	617063	AR	3	Cdc45
22q11.21	22:19723539-19724771	GP1BB, BS, BDPLT1	Glycoprotein Ib, platelet, beta polypeptide	138720	GP1BB	2812	ENSG00000203618,ENST00000366425;;;ENST00000366425		Bernard-Soulier syndrome, type B	231200	AR	3	Gp1bb
22q11.21	22:19723539-19724771	GP1BB, BS, BDPLT1	Glycoprotein Ib, platelet, beta polypeptide	138720	GP1BB	2812	ENSG00000203618,ENST00000366425;;;ENST00000366425		Giant platelet disorder, isolated	231200	AR	3	Gp1bb
22q11.21	22:19756703-19783593	TBX1, DGS, CTHM, CAFS, TGA, DORV, VCFS, DGCR	T-box 1	602054	TBX1	6899	ENSG00000184058,ENST00000649276;;;ENST00000649276		Conotruncal anomaly face syndrome	217095		3	Tbx1
22q11.21	22:19756703-19783593	TBX1, DGS, CTHM, CAFS, TGA, DORV, VCFS, DGCR	T-box 1	602054	TBX1	6899	ENSG00000184058,ENST00000649276;;;ENST00000649276		DiGeorge syndrome	188400	AD	3	Tbx1
22q11.21	22:19756703-19783593	TBX1, DGS, CTHM, CAFS, TGA, DORV, VCFS, DGCR	T-box 1	602054	TBX1	6899	ENSG00000184058,ENST00000649276;;;ENST00000649276		Tetralogy of Fallot	187500	AD	3	Tbx1
22q11.21	22:19756703-19783593	TBX1, DGS, CTHM, CAFS, TGA, DORV, VCFS, DGCR	T-box 1	602054	TBX1	6899	ENSG00000184058,ENST00000649276;;;ENST00000649276		Velocardiofacial syndrome	192430	AD	3	Tbx1
22q11.21	22:19875522-19941818	TXNRD2, TRXR2, SELZ, GCCD5	Thioredoxin reductase 2	606448	TXNRD2	10587	ENSG00000184470,ENST00000400521;;;ENST00000400521	mutation identified in 1 GCCD5 family	?Glucocorticoid deficiency 5	617825	AR	3	Txnrd2
22q11.21	22:19941772-19969975	COMT	Catechol-O-methyltransferase	116790	COMT	1312	ENSG00000093010,ENST00000361682;;;ENST00000361682		[Catechol-O-methyltransferase activity, variation in]	621296		3	Comt
22q11.21	22:20017023-20067164	TANGO2, C22orf25, MECRCN	Transport and golgi organization 2 homolog	616830	TANGO2	128989	ENSG00000183597,ENST00000327374;;;ENST00000327374		Metabolic encephalomyopathic crises, recurrent, with rhabdomyolysis, cardiac arrhythmias, and neurodegeneration	616878	AR	3	Tango2
22q11.21	22:20241415-20268318	RTN4R, NOGOR	NOGO receptor (reticulon 4 receptor)	605566	RTN4R	65078	ENSG00000040608,ENST00000043402;;;ENST00000043402		{Schizophrenia, susceptibility to}	181500	AD	3	Rtn4r
22q11.21	22:20424584-20437825	SCARF2, SREC2, VDEGS	Scavenger receptor class F, member 2	613619	SCARF2	91179	ENSG00000244486,ENST00000622235;;;ENST00000622235		Van den Ende-Gupta syndrome	600920	AR	3	Scarf2
22q11.21	22:20707691-20858811	PI4KA, PIK4CA, PMGYCHA, SPG84, GIDID2	Phosphatidylinositol 4-kinase, alpha	600286	PI4KA	5297	ENSG00000241973,ENST00000255882;;;ENST00000255882		Gastrointestinal defects and immunodeficiency syndrome 2	619708	AR	3	Pi4ka
22q11.21	22:20707691-20858811	PI4KA, PIK4CA, PMGYCHA, SPG84, GIDID2	Phosphatidylinositol 4-kinase, alpha	600286	PI4KA	5297	ENSG00000241973,ENST00000255882;;;ENST00000255882		Polymicrogyria, perisylvian, with cerebellar hypoplasia and arthrogryposis	616531	AR	3	Pi4ka
22q11.21	22:20707691-20858811	PI4KA, PIK4CA, PMGYCHA, SPG84, GIDID2	Phosphatidylinositol 4-kinase, alpha	600286	PI4KA	5297	ENSG00000241973,ENST00000255882;;;ENST00000255882		Spastic paraplegia 84, autosomal recessive	619621	AR	3	Pi4ka
22q11.21	22:20774113-20787720	HCF2, HC2, SERPIND1, THPH10	Heparin cofactor II	142360	SERPIND1	3053	ENSG00000099937,ENST00000215727;;;ENST00000215727	proximal to BCR	Thrombophilia 10 due to heparin cofactor II deficiency	612356	AD	3	Serpind1
22q11.21	22:20859007-20891214	SNAP29, CEDNIK	Synaptosomal-associated protein, 29kD	604202	SNAP29	9342	ENSG00000099940,ENST00000215730;;;ENST00000215730		Cerebral dysgenesis, neuropathy, ichthyosis, and palmoplantar keratoderma syndrome	609528	AR	3	Snap29
22q11.21	22:20982297-20999032	LZTR1, SWNTS2, NS10, NS2	Leucine-zipper-like regulator-1	600574	LZTR1	8216	ENSG00000099949,ENST00000646124;;;ENST00000646124		{Schwannomatosis-2, susceptibility to}	615670	AD	3	Lztr1
22q11.21	22:20982297-20999032	LZTR1, SWNTS2, NS10, NS2	Leucine-zipper-like regulator-1	600574	LZTR1	8216	ENSG00000099949,ENST00000646124;;;ENST00000646124		Noonan syndrome 10	616564	AD	3	Lztr1
22q11.21	22:20982297-20999032	LZTR1, SWNTS2, NS10, NS2	Leucine-zipper-like regulator-1	600574	LZTR1	8216	ENSG00000099949,ENST00000646124;;;ENST00000646124		Noonan syndrome 2	605275	AR	3	Lztr1
22q11.21	22:21207976-21259684	GGT2	Gamma-glutamyltransferase-2	137181	GGT2P	728441			[Gamma-glutamyltransferase, familial high serum]	137181		2	Ggt1
22q11.22	22:21759657-21867680	MAPK1, PRKM1, ERK2, NS13	Mitogen-activated protein kinase 1	176948	MAPK1	5594	ENSG00000100030,ENST00000215832;;;ENST00000215832		Noonan syndrome 13	619087	AD	3	Mapk1
22q11.23	22:23180509-23318037	BCR, CML, PHL, ALL	BCR activator of RhoGEF and GTPase	151410	BCR	613	ENSG00000186716,ENST00000305877;;;ENST00000305877	Ph1=t(9;22) (q34.1;q11.21); fused with ABL in CML	Leukemia, acute lymphocytic, Philadelphia chromosome positive, somatic	613065		4	Bcr
22q11.23	22:23180509-23318037	BCR, CML, PHL, ALL	BCR activator of RhoGEF and GTPase	151410	BCR	613	ENSG00000186716,ENST00000305877;;;ENST00000305877	Ph1=t(9;22) (q34.1;q11.21); fused with ABL in CML	Leukemia, chronic myeloid, Philadelphia chromosome positive, somatic	608232		4	Bcr
22q11.23	22:23573125-23580290	IGLL1, IGO, IGL5, VPREB2, AGM2	Immunoglobulin lambda-like polypeptide 1 (immunoglobulin omega peptide)	146770	IGLL1	3543	ENSG00000128322,ENST00000330377;;;ENST00000330377	between BCR2 and BCR4; distal to IGLC	Agammaglobulinemia 2	613500	AR	3	Igll1
22q11.23	22:23765834-23767972	CHCHD10, FTDALS2, SMAJ, IMMD	Coiled-coil-helix-coiled-coil-helix domain-containing protein 10	615903	CHCHD10	400916	ENSG00000250479,ENST00000484558;;;ENST00000484558	mutation identified in 1 IMMD family	?Myopathy, isolated mitochondrial, autosomal dominant	616209	AD	3	Chchd10
22q11.23	22:23765834-23767972	CHCHD10, FTDALS2, SMAJ, IMMD	Coiled-coil-helix-coiled-coil-helix domain-containing protein 10	615903	CHCHD10	400916	ENSG00000250479,ENST00000484558;;;ENST00000484558	mutation identified in 1 IMMD family	Frontotemporal dementia and/or amyotrophic lateral sclerosis 2	615911	AD	3	Chchd10
22q11.23	22:23765834-23767972	CHCHD10, FTDALS2, SMAJ, IMMD	Coiled-coil-helix-coiled-coil-helix domain-containing protein 10	615903	CHCHD10	400916	ENSG00000250479,ENST00000484558;;;ENST00000484558	mutation identified in 1 IMMD family	Spinal muscular atrophy, Jokela type	615048	AD	3	Chchd10
22q11.23	22:23786966-23838009	SMARCB1, SNF5, INI1, RDT, RTPS1, MRD15, SWNTS1, CSS3	SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily b, member 1	601607	SMARCB1	6598	ENSG00000099956,ENST00000644036;;;ENST00000644036		{Rhabdoid tumor predisposition syndrome 1}	609322	AD	3	Smarcb1
22q11.23	22:23786966-23838009	SMARCB1, SNF5, INI1, RDT, RTPS1, MRD15, SWNTS1, CSS3	SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily b, member 1	601607	SMARCB1	6598	ENSG00000099956,ENST00000644036;;;ENST00000644036		{Schwannomatosis-1, susceptibility to}	162091	AD	3	Smarcb1
22q11.23	22:23786966-23838009	SMARCB1, SNF5, INI1, RDT, RTPS1, MRD15, SWNTS1, CSS3	SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily b, member 1	601607	SMARCB1	6598	ENSG00000099956,ENST00000644036;;;ENST00000644036		Coffin-Siris syndrome 3	614608	AD	3	Smarcb1
22q11.23	22:23786966-23838009	SMARCB1, SNF5, INI1, RDT, RTPS1, MRD15, SWNTS1, CSS3	SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily b, member 1	601607	SMARCB1	6598	ENSG00000099956,ENST00000644036;;;ENST00000644036		Rhabdoid tumors, somatic	609322		3	Smarcb1
22q11.23	22:23894383-23895223	MIF	Macrophage migration inhibitory factor	153620	MIF	4282	ENSG00000240972,ENST00000215754;;;ENST00000215754	previously assigned to chr.19	{Rheumatoid arthritis, systemic juvenile, susceptibility to}	604302		3	Mif
22q11.23	22:24270831-24417738	SPECC1L, KIAA0376, OBLFC1, TBHS1	Sperm antigen with calponin homology and coiled-coil domains 1-like	614140	SPECC1L	23384	ENSG00000100014,ENST00000314328;;;ENST00000314328	mutation identified in 1 OBLFC1 patient	?Facial clefting, oblique, 1	600251	AD	3	Specc1l
22q11.23	22:24270831-24417738	SPECC1L, KIAA0376, OBLFC1, TBHS1	Sperm antigen with calponin homology and coiled-coil domains 1-like	614140	SPECC1L	23384	ENSG00000100014,ENST00000314328;;;ENST00000314328	mutation identified in 1 OBLFC1 patient	Teebi hypertelorism syndrome 1	145420	AD	3	Specc1l
22q11.23	22:24495332-24528390	UPB1, BUP1	Beta-ureidopropionase	606673	UPB1	51733	ENSG00000100024,ENST00000326010;;;ENST00000326010		Beta-ureidopropionase deficiency	613161	AR	3	Upb1
22q11.23	22:24583750-24628996	GGT1, GGT, GGTD	Gamma-glutamyltransferase 1	612346	GGT1	2678	ENSG00000100031,ENST00000400382;;;ENST00000400382	mutation identified in 1 GGTD family	?Glutathioninuria	231950	AR	3	Ggt1
22q11.23	22:25199858-25207359	CRYBB3, CRYB3, CATCN2, CTRCT22	Crystallin, beta-B3	123630	CRYBB3	1417	ENSG00000100053,ENST00000215855;;;ENST00000215855		Cataract 22	609741	AD, AR	3	Crybb3
22q11.23	22:25211661-25231869	CRYBB2, CRYB2, CTRCT3, CCA2	Crystallin, beta-B2	123620	CRYBB2	1415	ENSG00000244752,ENST00000398215;;;ENST00000398215	2nd CRYB2 gene in same region	Cataract 3, multiple types	601547	AD	3	Crybb2
22q12	22:25500001-37200000	BRV2	Vertigo, benign recurrent, 2	613106		100313948			Vertigo, benign recurrent, 2	613106		2	
22q12-q13	22:25500001-50818468	HCHGQ3	Hematocrit/hemoglobin quantitative trait locus 3	613284		100381206		associated with rs855791	[Hematocrit/hemoglobin quantitative trait locus 3]	613284		2	
22q12.1-q12.2	22:25500001-31800000	ITS	Insulinoma tumor suppressor gene locus	606960		282551			Insulinoma			1	
22q12	22:25500001-37200000	KAZA1	Kala-azar (visceral leishmaniasis), susceptibility to, 1	608207		387582			{Kala-azar, susceptibility to, 1}	608207		2	
22q12	22:25500001-37200000	SQTL2	Smoking as a quantitative trait locus 2	611004		100188828		max lod at D22S315	{Smoking as a quantitative trait locus 2}	611004		2	
22q12.1	22:25742188-26063847	MYO18B, KFS4	Myosin XVIIIB	607295	MYO18B	84700	ENSG00000133454,ENST00000335473;;;ENST00000335473		Klippel-Feil syndrome 4, autosomal recessive, with myopathy and facial dysmorphism	616549	AR	3	Myo18b
22q12.1	22:26443109-26483863	HPS4	HPS4 biogenesis of lysosomal organelles complex 3 subunit 2	606682	HPS4	89781	ENSG00000100099,ENST00000398145;;;ENST00000398145		Hermansky-Pudlak syndrome 4	614073	AR	3	Hps4
22q12.1	22:26590220-26630669	CRYBA4, CTRCT23	Crystallin, beta polypeptide A4	123631	CRYBA4	1413	ENSG00000196431,ENST00000354760;;;ENST00000354760		Cataract 23	610425	AD	3	Cryba4
22q12.1	22:26599278-26618027	CRYBB1, CATCN3, CTRCT17	Crystallin, beta B1	600929	CRYBB1	1414	ENSG00000100122,ENST00000647684;;;ENST00000647684		Cataract 17, multiple types	611544	AD, AR	3	Crybb1
22q12.1	22:26646429-26676478	MIAT, C22orf35	MIAT gene	611082	MIAT	440823	ENSG00000225783,ENST00000620145;;;ENST00000620145		{Myocardial infarction, susceptibility to}	608446		3	Miat
22q12.1	22:27748277-27801756	MN1, MGCR, CEBALID	MN1 protooncogene, transcriptional regulator	156100	MN1	4330	ENSG00000169184,ENST00000302326;;;ENST00000302326	fused with TEL in AML	CEBALID syndrome	618774	AD	3	Mn1
22q12.1	22:27748277-27801756	MN1, MGCR, CEBALID	MN1 protooncogene, transcriptional regulator	156100	MN1	4330	ENSG00000169184,ENST00000302326;;;ENST00000302326	fused with TEL in AML	Meningioma	607174	AD	3	Mn1
22q12.1	22:28687742-28741834	CHEK2, RAD53, CHK2, CDS1, TPDS4	Checkpoint kinase 2	604373	CHEK2	11200	ENSG00000183765,ENST00000404276;;;ENST00000404276		Osteosarcoma, somatic	259500		3	Chek2
22q12.1	22:28687742-28741834	CHEK2, RAD53, CHK2, CDS1, TPDS4	Checkpoint kinase 2	604373	CHEK2	11200	ENSG00000183765,ENST00000404276;;;ENST00000404276		Prostate cancer, somatic	176807		3	Chek2
22q12.1	22:28687742-28741834	CHEK2, RAD53, CHK2, CDS1, TPDS4	Checkpoint kinase 2	604373	CHEK2	11200	ENSG00000183765,ENST00000404276;;;ENST00000404276		Tumor predisposition syndrome 4, breast/prostate/colorectal	609265		3	Chek2
22q12.1	22:28742032-28757510	HSC20, HSCB, JAC1, SIDBA5	HSCB mitochondrial iron-sulfur cluster cochaperone	608142	HSCB	150274	ENSG00000100209,ENST00000216027;;;ENST00000216027	mutation identified in 1 patient	?Anemia, sideroblastic, 5	619523	AR	3	Hscb
22q12.1	22:28794560-28800569	XBP1, XBP2	X-box-binding protein-1	194355	XBP1	7494	ENSG00000100219,ENST00000344347;;;ENST00000344347	pseudogene on chr.5	{Major affective disorder-7, susceptibility to}	612371		3	Xbp1
22q12.1	22:29073035-29168333	KREMEN1, KRM1, ECTD13	Kringle domain-containing transmembrane protein 1	609898	KREMEN1	83999	ENSG00000183762,ENST00000400335;;;ENST00000400335		Ectodermal dysplasia 13, hair/tooth type	617392	AR	3	Kremen1
22q12.2	22:29268268-29300521	EWSR1, EWS	EWS RNA-binding protein 1	133450	EWSR1	2130	ENSG00000182944,ENST00000397938;;;ENST00000397938	t(11;22)(q24;q12); t(21;22)(q22;q12)	Ewing sarcoma	612219		3	Ewsr1
22q12.2	22:29268268-29300521	EWSR1, EWS	EWS RNA-binding protein 1	133450	EWSR1	2130	ENSG00000182944,ENST00000397938;;;ENST00000397938	t(11;22)(q24;q12); t(21;22)(q22;q12)	Neuroepithelioma	612219		3	Ewsr1
22q12.2	22:29327680-29388570	AP1B1, ADTB1, BAM22, CLAPB2, KIDAR	Adaptor-related protein complex 1, beta 1 subunit (adaptin, beta)	600157	AP1B1	162	ENSG00000100280,ENST00000357586;;;ENST00000357586		Keratitis-ichthyosis-deafness syndrome, autosomal recessive	242150	AR	3	Ap1b1
22q12.2	22:29480218-29491390	NEFH, CMT2CC	Neurofilament, heavy polypeptide	162230	NEFH	4744	ENSG00000100285,ENST00000310624;;;ENST00000310624	mutation identified in 1 family with ALS susceptibility	{?Amyotrophic lateral sclerosis, susceptibility to}	105400	AD, AR	3	Nefh
22q12.2	22:29480218-29491390	NEFH, CMT2CC	Neurofilament, heavy polypeptide	162230	NEFH	4744	ENSG00000100285,ENST00000310624;;;ENST00000310624	mutation identified in 1 family with ALS susceptibility	Charcot-Marie-Tooth disease, axonal, type 2CC	616924	AD	3	Nefh
22q12.2	22:29603556-29698600	NF2, SWNV	Neurofibromin 2	607379	NF2	4771	ENSG00000186575,ENST00000338641;;;ENST00000338641		Meningioma, NF2-related, somatic	607174		3	Nf2
22q12.2	22:29603556-29698600	NF2, SWNV	Neurofibromin 2	607379	NF2	4771	ENSG00000186575,ENST00000338641;;;ENST00000338641		Schwannomatosis, somatic	101000		3	Nf2
22q12.2	22:29603556-29698600	NF2, SWNV	Neurofibromin 2	607379	NF2	4771	ENSG00000186575,ENST00000338641;;;ENST00000338641		Schwannomatosis, vestibular	101000	AD	3	Nf2
22q12.2	22:30607174-30627271	TCN2, TC2	Transcobalamin II	613441	TCN2	6948	ENSG00000185339,ENST00000215838;;;ENST00000215838	linked to P1	Transcobalamin II deficiency	275350	AR	3	Tcn2
22q12.2	22:30925130-30968774	MORC2, ZCW3, ZCWCC1, KIAA0852, CMT2Z, DIGFAN	MORC family CW-type zinc finger protein 2	616661	MORC2	22880	ENSG00000133422,ENST00000397641;;;ENST00000397641		Charcot-Marie-Tooth disease, axonal, type 2Z	616688	AD	3	Morc2a,Morc2b
22q12.2	22:30925130-30968774	MORC2, ZCW3, ZCWCC1, KIAA0852, CMT2Z, DIGFAN	MORC family CW-type zinc finger protein 2	616661	MORC2	22880	ENSG00000133422,ENST00000397641;;;ENST00000397641		Developmental delay, impaired growth, dysmorphic facies, and axonal neuropathy	619090	AD	3	Morc2a,Morc2b
22q12.2	22:31399604-31434452	DRG1, NEDD3, TANALS	Developmentally regulated GTP-binding protein 1	603952	DRG1	4733	ENSG00000185721,ENST00000331457;;;ENST00000331457		Tan-Almurshedi syndrome	620641	AR	3	Drg1
22q12.2	22:31618491-31662564	PISD, PSD, PSSC, LIBF	Phosphatidylserine decarboxylase	612770	PISD	23761	ENSG00000241878,ENST00000439502;;;ENST00000439502		Liberfarb syndrome	618889	AR	3	Pisd
22q12.2-q12.3	22:31753968-31908033	DEPDC5, KIAA0645, FFEVF1, DEE111	DEP domain-containing protein 5	614191	DEPDC5	9681	ENSG00000100150,ENST00000651528;;;ENST00000651528		Developmental and epileptic encephalopathy 111	620504	AR	3	Depdc5
22q12.2-q12.3	22:31753968-31908033	DEPDC5, KIAA0645, FFEVF1, DEE111	DEP domain-containing protein 5	614191	DEPDC5	9681	ENSG00000100150,ENST00000651528;;;ENST00000651528		Epilepsy, familial focal, with variable foci 1	604364	AD	3	Depdc5
22q12.3-q13.1	22:31800001-40600000	DFSP	Dermatofibrosarcoma protuberans	607907				caused by fusion of COL1A1 (exons 25, 31, 46) and PDGFB (exon 2)	Dermatofibrosarcoma protuberans	607907	IC	4	
22q12.3	22:31800001-37200000	HPC6	Prostate cancer, hereditary, 6	609558		100188789		between D22S1265 and D22S277	{Prostate cancer, susceptibility to}	609558		2	
22q12.3-q13.1	22:31800001-40600000	MDNS	Mammary-digital-nail syndrome	613689		100529148		max lod at D22S277, D22S1142, D22S683, D22S283	Mammary-digital-nail syndrome	613689	AD	2	
22q12.3	22:32043261-32113029	SLC5A1, SGLT1	Solute carrier family 5 (sodium/glucose transporter), member 1	182380	SLC5A1	6523	ENSG00000100170,ENST00000266088;;;ENST00000266088		Glucose/galactose malabsorption	606824	AR	3	Slc5a1
22q12.3	22:32474811-32498829	FBXO7, FBX7, FBX, PKPS, PARK15	F-box only protein 7	605648	FBXO7	25793	ENSG00000100225,ENST00000266087;;;ENST00000266087		Parkinson disease 15, autosomal recessive	260300	AR	3	Fbxo7
22q12.3	22:32801705-32863041	TIMP3, SFD	Tissue inhibitor of metalloproteinase-3	188826	TIMP3	7078	ENSG00000100234,ENST00000266085;;;ENST00000266085		Sorsby fundus dystrophy	136900	AD	3	Timp3
22q12.3	22:33066663-33922824	LARGE1, KIAA0609, MDC1D, MDDGA6, MDDGB6	Acetylglucosaminyltransferase-like protein	603590	LARGE1	9215	ENSG00000133424,ENST00000397394;;;ENST00000397394		Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 6	613154	AR	3	Large1
22q12.3	22:33066663-33922824	LARGE1, KIAA0609, MDC1D, MDDGA6, MDDGB6	Acetylglucosaminyltransferase-like protein	603590	LARGE1	9215	ENSG00000133424,ENST00000397394;;;ENST00000397394		Muscular dystrophy-dystroglycanopathy (congenital with impaired intellectual development), type B, 6	608840	AR	3	Large1
22q12.3	22:35299275-35347973	TOM1, IMD85	Target of MYB1 membrane trafficking protein	604700	TOM1	10043	ENSG00000100284,ENST00000449058;;;ENST00000449058	mutation identified in 1 IMD85 family	?Immunodeficiency 85 and autoimmunity	619510	AD	3	Tom1
22q12.3	22:35381096-35394207	HMOX1, HMOX1D	Heme oxygenase 1	141250	HMOX1	3162	ENSG00000100292,ENST00000216117;;;ENST00000216117		{Pulmonary disease, chronic obstructive, susceptibility to}	606963		3	Hmox1
22q12.3	22:35381096-35394207	HMOX1, HMOX1D	Heme oxygenase 1	141250	HMOX1	3162	ENSG00000100292,ENST00000216117;;;ENST00000216117		Heme oxygenase-1 deficiency	614034	AR	3	Hmox1
22q12.3	22:35400140-35455031	MCM5, CDC46, MGORS8	Minichromosome maintenance complex component 5	602696	MCM5	4174	ENSG00000100297,ENST00000216122;;;ENST00000216122	mutation identified in 1 MGORS8 patient	?Meier-Gorlin syndrome 8	617564	AR	3	Mcm5
22q12.3	22:35606764-35623354	MB, MYOSB	Myoglobin	160000	MB	4151	ENSG00000198125,ENST00000397326;;;ENST00000397326		Myopathy, sarcoplasmic body	620286	AD	3	Mb
22q12.3	22:36189128-36204833	APOL4	Apolipoprotein L4	607254	APOL4	80832	ENSG00000100336,ENST00000683024;;;ENST00000683024		{Schizophrenia}	181500	AD	1	Apol7a,Apol7b,Apol7c,Apol7e,Apol8
22q12.3	22:36226209-36239954	APOL2	Apolipoprotein L2	607252	APOL2	23780	ENSG00000128335,ENST00000358502;;;ENST00000358502		{Schizophrenia}	181500	AD	1	Apol10b,Apol11b,Apol7a,Apol7b,Apol7c,Apol7e,Apol8,Apol9a
22q12.3	22:36253133-36267525	APOL1, FSGS4	Apolipoprotein L1	603743	APOL1	8542	ENSG00000100342,ENST00000397278;;;ENST00000397278		{Glomerulosclerosis, focal segmental, 4, susceptibility to}	612551	AD	3	Apol10a,Apol10b,Apol11a,Apol11b,Apol7a,Apol7b,Apol7c,Apol7e,Apol8,Apol9a,Apol9b
22q12.3	22:36281280-36387967	MYH9, MHA, FTNS, DFNA17, BDPLT6, MATINS	Myosin, heavy polypeptide-9, nonmuscle	160775	MYH9	4627	ENSG00000100345,ENST00000216181;;;ENST00000216181		Deafness, autosomal dominant 17	603622	AD	3	Myh9
22q12.3	22:36281280-36387967	MYH9, MHA, FTNS, DFNA17, BDPLT6, MATINS	Myosin, heavy polypeptide-9, nonmuscle	160775	MYH9	4627	ENSG00000100345,ENST00000216181;;;ENST00000216181		Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss	155100	AD	3	Myh9
22q12.3	22:36467046-36481640	TXN2, TRX2, MTRX, COXPD29	Thioredoxin 2	609063	TXN2	25828	ENSG00000100348,ENST00000216185;;;ENST00000216185	mutation identified in 1 COXPD29 patient	?Combined oxidative phosphorylation deficiency 29	616811	AR	3	Txn2
22q12.3	22:36560857-36703752	CACNG2, MRD10	Calcium channel, voltage-dependent, gamma-2 subunit (stargazin)	602911	CACNG2	10369	ENSG00000166862,ENST00000300105;;;ENST00000300105	mutation identified one MRD10 patient	?Intellectual developmental disorder, autosomal dominant 10	614256	AD	3	Cacng2
22q12.3	22:36758211-36776119	IFT27, RABL4, BBS19	Intraflagellar transport 27	615870	IFT27	11020	ENSG00000100360,ENST00000433985;;;ENST00000433985		Bardet-Biedl syndrome 19	615996	AR	3	Ift27
22q12.3	22:36861006-36878015	NCF4, P40PHOX, CGD3	Neutrophil cytosolic factor-4	601488	NCF4	4689	ENSG00000100365,ENST00000248899;;;ENST00000248899		Chronic granulomatous disease 3, autosomal recessive	613960	AR	3	Ncf4
22q12.3	22:36913628-36940439	CSF2RB, SMDP5	Colony-stimulating factor-2 receptor, beta, low-affinity	138981	CSF2RB	1439	ENSG00000100368,ENST00000403662;;;ENST00000403662		Surfactant metabolism dysfunction, pulmonary, 5	614370	AR	3	Csf2rb,Csf2rb2
22q12.3	22:37051742-37063390	KCTD17	Potassium channel tetramerization domain-containing protein 17	616386	KCTD17	79734	ENSG00000100379,ENST00000403888;;;ENST00000403888		Dystonia 26, myoclonic	616398	AD	3	Kctd17
22q12.3	22:37065436-37110536	TMPRSS6, IRIDA	Transmembrane protease, serine 6 (matriptase 2)	609862	TMPRSS6	164656	ENSG00000187045,ENST00000676104;;;ENST00000676104		Iron-refractory iron deficiency anemia	206200	AR	3	Tmprss6
22q12.3	22:37125838-37175118	IL2RB, IMD63	Interleukin-2 receptor, beta polypeptide	146710	IL2RB	3560	ENSG00000100385,ENST00000216223;;;ENST00000216223		Immunodeficiency 63 with lymphoproliferation and autoimmunity	618495	AR	3	Il2rb
22q13	22:37200001-50818468	DUP22q13, C22DUPq13	Chromosome 22q13 duplication syndrome	615538					Chromosome 22q13 duplication syndrome	615538	IC	4	
22q13	22:37200001-50818468	FLD1, NAFLD1	Fatty liver disease, susceptibility to, 1	613282		100380876		associated with rs738409	{Fatty liver disease, susceptibility to, 1}	613282	Mu	2	
22q13	22:37200001-50818468	MENAQ1	Menarche, age at, QTL 1	610873		100188822		max lod at UT7136	{Menarche, age at, QTL}	610873		2	
22q13	22:37200001-50818468	NRCLP4	Narcolepsy 4	612417		100216484		associated with rs5770917	{Narcolepsy 4}	612417		2	
22q13.1	22:37225270-37244269	RAC2, IMD73A, IMD73B, IMD73C	Rac family small GTPase 2	602049	RAC2	5880	ENSG00000128340,ENST00000249071;;;ENST00000249071	mutation identified in 1 IMD73C family	?Immunodeficiency 73C with defective neutrophil chemotaxis and hypogammaglobulinemia	618987	AR	3	Rac2
22q13.1	22:37225270-37244269	RAC2, IMD73A, IMD73B, IMD73C	Rac family small GTPase 2	602049	RAC2	5880	ENSG00000128340,ENST00000249071;;;ENST00000249071	mutation identified in 1 IMD73C family	Immunodeficiency 73A with defective neutrophil chemotaxix and leukocytosis	608203	AD	3	Rac2
22q13.1	22:37225270-37244269	RAC2, IMD73A, IMD73B, IMD73C	Rac family small GTPase 2	602049	RAC2	5880	ENSG00000128340,ENST00000249071;;;ENST00000249071	mutation identified in 1 IMD73C family	Immunodeficiency 73B with defective neutrophil chemotaxis and lymphopenia	618986	AD	3	Rac2
22q13.1	22:37490362-37519415	CARD10, CARMA3, BIMP1, IMD89	Caspase recruitment domain-containing protein 10	607209	CARD10	29775	ENSG00000100065,ENST00000251973;;;ENST00000251973	mutation identifed in 1 IMD89 family	?Immunodeficiency 89 and autoimmunity	619632	AR	3	Card10
22q13.1	22:37570248-37580087	LGALS2	Lectin, galactoside-binding, soluble, 2	150571	LGALS2	3957	ENSG00000100079,ENST00000215886;;;ENST00000215886		{Myocardial infarction, susceptibility to}	608446		3	Lgals2
22q13.1	22:37697048-37776556	TRIOBP, KIAA1662	Trio- and F-actin-binding protein	609761	TRIOBP	11078	ENSG00000100106,ENST00000644935;;;ENST00000644935		Deafness, autosomal recessive 28	609823	AR	3	Triobp
22q13.1	22:37972312-37984555	SOX10, WS4, WS4C, PCWH	SRY (sex-determining region Y)-box-10	602229	SOX10	6663	ENSG00000100146,ENST00000396884;;;ENST00000396884	megacolon and spotting in mice	PCWH syndrome	609136	AD	3	Sox10
22q13.1	22:37972312-37984555	SOX10, WS4, WS4C, PCWH	SRY (sex-determining region Y)-box-10	602229	SOX10	6663	ENSG00000100146,ENST00000396884;;;ENST00000396884	megacolon and spotting in mice	Waardenburg syndrome, type 2E, with or without neurologic involvement	611584	AD	3	Sox10
22q13.1	22:37972312-37984555	SOX10, WS4, WS4C, PCWH	SRY (sex-determining region Y)-box-10	602229	SOX10	6663	ENSG00000100146,ENST00000396884;;;ENST00000396884	megacolon and spotting in mice	Waardenburg syndrome, type 4C	613266	AD	3	Sox10
22q13.1	22:38111495-38181830	PLA2G6, IPLA2, INAD1, NBIA2B, NBIA2A, PARK14	Phospholipase A2, group VI	603604	PLA2G6	8398	ENSG00000184381,ENST00000332509;;;ENST00000332509		Infantile neuroaxonal dystrophy 1	256600	AR	3	Pla2g6
22q13.1	22:38111495-38181830	PLA2G6, IPLA2, INAD1, NBIA2B, NBIA2A, PARK14	Phospholipase A2, group VI	603604	PLA2G6	8398	ENSG00000184381,ENST00000332509;;;ENST00000332509		Neurodegeneration with brain iron accumulation 2B	610217	AR	3	Pla2g6
22q13.1	22:38111495-38181830	PLA2G6, IPLA2, INAD1, NBIA2B, NBIA2A, PARK14	Phospholipase A2, group VI	603604	PLA2G6	8398	ENSG00000184381,ENST00000332509;;;ENST00000332509		Parkinson disease 14, autosomal recessive	612953	AR	3	Pla2g6
22q13.1	22:38705944-38743115	GTPBP1, GP1, NEDFET1	GTP-binding protein 1	602245	GTPBP1	9567	ENSG00000100226,ENST00000216044;;;ENST00000216044		Neurodevelopmental disorder with characteristic facial and ectodermal features and tetraparesis 1	620888	AR	3	Gtpbp1
22q13.1	22:38778508-38794143	DNAL4, MRMV3	Dynein, axonemal, light chain 4	610565	DNAL4	10126	ENSG00000100246,ENST00000216068;;;ENST00000216068	mutation identified in 1 MRMV3 family	?Mirror movements 3	616059	AR	3	Dnal4
22q13.1	22:39223359-39244982	PDGFB, SIS, IBGC5	Platelet-derived growth factor, beta polypeptide (oncogene SIS)	190040	PDGFB	5155	ENSG00000100311,ENST00000331163;;;ENST00000331163	fused with COL1A1 in DFSP	Basal ganglia calcification, idiopathic, 5	615483	AD	3	Pdgfb
22q13.1	22:39223359-39244982	PDGFB, SIS, IBGC5	Platelet-derived growth factor, beta polypeptide (oncogene SIS)	190040	PDGFB	5155	ENSG00000100311,ENST00000331163;;;ENST00000331163	fused with COL1A1 in DFSP	Meningioma, SIS-related	607174	AD	3	Pdgfb
22q13.1	22:39500100-39518132	MIEF1, SMCR7L, MID51, OPA14	Mitochondrial elongation factor 1	615497	MIEF1	54471	ENSG00000100335,ENST00000325301;;;ENST00000325301		Optic atrophy 14	620550	AD	3	Mief1
22q13.1	22:39570753-39689735	CACNA1I, KIAA1120, NEDSIS	Calcium channel, voltage-dependent, T type, alpha-1I subunit	608230	CACNA1I	8911	ENSG00000100346,ENST00000402142;;;ENST00000402142		Neurodevelopmental disorder with speech impairment and with or without seizures	620114	AD	3	Cacna1i
22q13.1	22:40044834-40335808	TNRC6B, KIAA1093, GDSBA	Trinucleotide repeat-containing gene 6B	610740	TNRC6B	23112	ENSG00000100354,ENST00000454349;;;ENST00000454349		Global developmental delay with speech and behavioral abnormalities	619243	AD	3	Tnrc6b
22q13.1	22:40346500-40387527	ADSL	Adenylosuccinate lyase	608222	ADSL	158	ENSG00000239900,ENST00000623063;;;ENST00000623063	ade(-)I; bifunctional	Adenylosuccinase deficiency	103050	AR	3	Adsl
22q13.1-q13.2	22:40410289-40636719	MKL1, AMKL, MAL	Megakaryoblastic leukemia 1 gene	606078	MRTFA	57591	ENSG00000196588,ENST00000355630;;;ENST00000355630	mutation identified in 1 IMD66 patient	?Immunodeficiency 66	618847	AR	3	Mrtfa
22q13.2	22:40857148-40932815	XPNPEP3, APP3, NPHPL1	X-prolyl aminopeptidase 3	613553	XPNPEP3	63929	ENSG00000196236,ENST00000357137;;;ENST00000357137		Nephronophthisis-like nephropathy 1	613159	AR	3	Xpnpep3
22q13.2	22:41092592-41180077	EP300, RSTS2, MKHK2	E1A-binding protein, 300kD	602700	EP300	2033	ENSG00000100393,ENST00000263253;;;ENST00000263253		Colorectal cancer, somatic	114500		3	Ep300
22q13.2	22:41092592-41180077	EP300, RSTS2, MKHK2	E1A-binding protein, 300kD	602700	EP300	2033	ENSG00000100393,ENST00000263253;;;ENST00000263253		Menke-Hennekam syndrome 2	618333	AD	3	Ep300
22q13.2	22:41092592-41180077	EP300, RSTS2, MKHK2	E1A-binding protein, 300kD	602700	EP300	2033	ENSG00000100393,ENST00000263253;;;ENST00000263253		Rubinstein-Taybi syndrome 2	613684	AD	3	Ep300
22q13.2	22:41469117-41528974	ACO2, ICRD, OPA9	Aconitase 2	100850	ACO2	50	ENSG00000100412,ENST00000216254;;;ENST00000216254	distal to Ph1 break	Infantile cerebellar-retinal degeneration	614559	AR	3	Aco2
22q13.2	22:41469117-41528974	ACO2, ICRD, OPA9	Aconitase 2	100850	ACO2	50	ENSG00000100412,ENST00000216254;;;ENST00000216254	distal to Ph1 break	Optic atrophy 9	616289	AD, AR	3	Aco2
22q13.2	22:41699503-41799454	MEI1, SPATA38, HYDM3	Meiotic double-stranded break formation protein 1	608797	MEI1	150365	ENSG00000167077,ENST00000401548;;;ENST00000401548		Hydatidiform mole, recurrent, 3	618431	AR	3	Mei1
22q13.2	22:41800679-41832164	CCDC134, OI22	Coiled-coil domain-containing protein 134	618788	CCDC134	79879	ENSG00000100147,ENST00000255784;;;ENST00000255784		Osteogenesis imperfecta, type XXII	619795	AR	3	Ccdc134
22q13.2	22:41922032-41926806	TNFRSF13C, BAFFR, CVID4	Tumor necrosis factor receptor superfamily, member 13C	606269	TNFRSF13C	115650	ENSG00000159958,ENST00000291232;;;ENST00000291232		Immunodeficiency, common variable, 4	613494	AR	3	Tnfrsf13c
22q13.2	22:42058334-42070842	NAGA	Acetylgalactosaminidase, alpha-N- (alpha-galactosidase B)	104170	NAGA	4668	ENSG00000198951,ENST00000396398;;;ENST00000396398	proximal to Ph1 break	Kanzaki disease	609242	AR	3	Naga
22q13.2	22:42058334-42070842	NAGA	Acetylgalactosaminidase, alpha-N- (alpha-galactosidase B)	104170	NAGA	4668	ENSG00000198951,ENST00000396398;;;ENST00000396398	proximal to Ph1 break	Schindler disease, type I	609241	AR	3	Naga
22q13.2	22:42058334-42070842	NAGA	Acetylgalactosaminidase, alpha-N- (alpha-galactosidase B)	104170	NAGA	4668	ENSG00000198951,ENST00000396398;;;ENST00000396398	proximal to Ph1 break	Schindler disease, type III	609241	AR	3	Naga
22q13.2	22:42085526-42090772	NDUFA6, MC1DN33	NADH-ubiquinone oxidoreductase subunit A6	602138	NDUFA6	4700	ENSG00000184983,ENST00000498737;;;ENST00000498737		Mitochondrial complex I deficiency, nuclear type 33	618253	AR	3	Ndufa6
22q13.2	22:42126499-42130810	CYP2D6, CPD6, P450DB1	Cytochrome P450, subfamily IID, polypeptide 6	124030	CYP2D6	1565	ENSG00000100197,ENST00000645361;;;ENST00000645361		{Codeine sensitivity}	608902	AR	3	Cyp2d10,Cyp2d11,Cyp2d12,Cyp2d22,Cyp2d26,Cyp2d34,Cyp2d40,Cyp2d9
22q13.2	22:42126499-42130810	CYP2D6, CPD6, P450DB1	Cytochrome P450, subfamily IID, polypeptide 6	124030	CYP2D6	1565	ENSG00000100197,ENST00000645361;;;ENST00000645361		{Debrisoquine sensitivity}	608902	AR	3	Cyp2d10,Cyp2d11,Cyp2d12,Cyp2d22,Cyp2d26,Cyp2d34,Cyp2d40,Cyp2d9
22q13.2	22:42160013-42343537	TCF20, SPBP, AR1, DDVIBA	Transcription factor 20	603107	TCF20	6942	ENSG00000100207,ENST00000677622;;;ENST00000677622		Developmental delay with variable intellectual impairment and behavioral abnormalities	618430	AD	3	Tcf20
22q13.2	22:42508344-42519796	RRP7A, MCPH28	Ribosomal RNA processing 7 homolog A	619449	RRP7A	27341	ENSG00000189306,ENST00000323013;;;ENST00000323013	mutation identified in 1 MCPH28 family	?Microcephaly 28, primary, autosomal recessive	619453	AR	3	Rrp7a
22q13.2	22:42615244-42615393	RNU12, SCAR33, CDAGS	RNA, U12 small nuclear	620204	RNU12	267010	ENSG00000276027,ENST00000362512;;;ENST00000362512	mutation identified in 1 SCAR33 family	?Spinocerebellar ataxia, autosomal recessive 33	620208	AR	3	
22q13.2	22:42615244-42615393	RNU12, SCAR33, CDAGS	RNA, U12 small nuclear	620204	RNU12	267010	ENSG00000276027,ENST00000362512;;;ENST00000362512	mutation identified in 1 SCAR33 family	CDAGS syndrome	603116	AR	3	
22q13.2	22:42617840-42649392	CYB5R3, DIA1, B5R	Cytochrome b5 reductase 3	613213	CYB5R3	1727	ENSG00000100243,ENST00000352397;;;ENST00000352397		Methemoglobinemia, type I	250800	AR	3	Cyb5r3
22q13.2	22:42617840-42649392	CYB5R3, DIA1, B5R	Cytochrome b5 reductase 3	613213	CYB5R3	1727	ENSG00000100243,ENST00000352397;;;ENST00000352397		Methemoglobinemia, type II	250800	AR	3	Cyb5r3
22q13.2	22:42692121-42721301	A4GALT, P1PK	Alpha 1,4-galactosyltransferase	607922	A4GALT	53947	ENSG00000128274,ENST00000642412;;;ENST00000642412		[Blood group, P1Pk system, p phenotype]	111400		3	A4galt
22q13.2	22:42692121-42721301	A4GALT, P1PK	Alpha 1,4-galactosyltransferase	607922	A4GALT	53947	ENSG00000128274,ENST00000642412;;;ENST00000642412		[Blood group, P1Pk system, P(2) phenotype]	111400		3	A4galt
22q13.2	22:42692121-42721301	A4GALT, P1PK	Alpha 1,4-galactosyltransferase	607922	A4GALT	53947	ENSG00000128274,ENST00000642412;;;ENST00000642412		NOR polyagglutination syndrome	111400		3	A4galt
22q13.2	22:43132206-43143398	MCAT, OPA15	Malonyl CoA:ACP acyltransferase, mitochondrial	614479	MCAT	27349	ENSG00000100294,ENST00000290429;;;ENST00000290429		Optic atrophy 15	620583	AR	3	Mcat
22q13.3	22:43800001-50818468	SPD2	Synpolydactyly 2	608180					Synpolydactyly, 3/3'/4, associated with metacarpal and metatarsal synostoses	608180	AD	4	
22q13.31	22:45671834-45845307	ATXN10, SCA10	Ataxin 10	611150	ATXN10	25814	ENSG00000130638,ENST00000252934;;;ENST00000252934	ATTCTn repeat in intron 9	Spinocerebellar ataxia 10	603516	AD	3	Atxn10
22q13.31	22:46335714-46357340	TRMU, MTO2	tRNA 5-methylaminomethyl-2-thiouridylate methyltransferase	610230	TRMU	55687	ENSG00000100416,ENST00000645190;;;ENST00000645190		{Deafness, mitochondrial, modifier of}	580000	Mi	3	Trmu
22q13.31	22:46335714-46357340	TRMU, MTO2	tRNA 5-methylaminomethyl-2-thiouridylate methyltransferase	610230	TRMU	55687	ENSG00000100416,ENST00000645190;;;ENST00000645190		Liver failure, transient infantile	613070	AR	3	Trmu
22q13.31	22:46361174-46537620	CELSR1, LMPHM9, YNS	Cadherin EGF LAG seven-pass G-type receptor 1	604523	CELSR1	9620	ENSG00000075275,ENST00000674500;;;ENST00000674500		Lymphatic malformation 9	619319	AD	3	Celsr1
22q13.31	22:46361174-46537620	CELSR1, LMPHM9, YNS	Cadherin EGF LAG seven-pass G-type receptor 1	604523	CELSR1	9620	ENSG00000075275,ENST00000674500;;;ENST00000674500		Yellow nail syndrome	153300	AR	3	Celsr1
22q13.33	22:49859311-49918438	ALG12, CDG1G	ALG12 alpha-1,6-mannosyltransferase	607144	ALG12	79087	ENSG00000182858,ENST00000330817;;;ENST00000330817		Congenital disorder of glycosylation, type Ig	607143	AR	3	Alg12
22q13.33	22:50059391-50085875	MLC1, LVM, VL, MLC1	Modulator of VRAC current 1	605908	MLC1	23209	ENSG00000100427,ENST00000311597;;;ENST00000311597		Megalencephalic leukoencephalopathy with subcortical cysts 1	604004	AR	3	Mlc1
22q13.33	22:50090006-50161687	MOV10L1, SPGF73	MOV10-like RISC complex RNA helicase 1	605794	MOV10L1	54456	ENSG00000073146,ENST00000262794;;;ENST00000262794	mutation identified in 1 SPGF73 family	?Spermatogenic failure 73	619878	AR	3	Mov10l1
22q13.33	22:50217694-50245023	TUBGCP6, GCP6, KIAA1669, MCCRP1	Tubulin-gamma complex-associated protein 6	610053	TUBGCP6	85378	ENSG00000128159,ENST00000248846;;;ENST00000248846		Microcephaly and chorioretinopathy, autosomal recessive, 1	251270	AR	3	Tubgcp6
22q13.33	22:50445000-50475035	SBF1, MTMR5, CMT4B3	SET-binding factor 1 (myotubularin-related protein 5)	603560	SBF1	6305	ENSG00000100241,ENST00000380817;;;ENST00000380817		Charcot-Marie-Tooth disease, type 4B3	615284	AR	3	Sbf1
22q13.33	22:50523568-50526442	SCO2, MC4DN2, MYP6	SCO2 cytochrome c oxidase assembly protein	604272	SCO2	9997	ENSG00000284194,ENST00000395693;;;ENST00000395693		Mitochondrial complex IV deficiency, nuclear type 2	604377	AR	3	Sco2
22q13.33	22:50523568-50526442	SCO2, MC4DN2, MYP6	SCO2 cytochrome c oxidase assembly protein	604272	SCO2	9997	ENSG00000284194,ENST00000395693;;;ENST00000395693		Myopia 6	608908	AD	3	Sco2
22q13.33	22:50525752-50530085	TYMP, ECGF1, MNGIE, PDECGF, MEDPS1, MTDPS1	Thymidine phosphorylase	131222	TYMP	1890	ENSG00000025708,ENST00000252029;;;ENST00000252029		Mitochondrial DNA depletion syndrome 1 (MNGIE type)	603041	AR	3	Tymp
22q13.33	22:50578963-50582849	CHKB, CHKL, CKEKB, EKB, MDCMC	Choline kinase, beta	612395	CHKB	1120	ENSG00000100288,ENST00000406938;;;ENST00000406938		Muscular dystrophy, congenital, megaconial type	602541	AR	3	Chkb
22q13.33	22:50622754-50628152	ARSA	Arylsulfatase A	607574	ARSA	410	ENSG00000100299,ENST00000216124;;;ENST00000216124		Metachromatic leukodystrophy	250100	AR	3	Arsa
22q13.33	22:50672823-50733212	SHANK3, PSAP2, PROSAP2, KIAA1650, DEL22q13.3, SCZD15	SH3 and multiple ankyrin repeat domains 3	606230	SHANK3	85358	ENSG00000251322,ENST00000692848		{Schizophrenia 15}	613950	AD	3	Shank3
22q13.33	22:50672823-50733212	SHANK3, PSAP2, PROSAP2, KIAA1650, DEL22q13.3, SCZD15	SH3 and multiple ankyrin repeat domains 3	606230	SHANK3	85358	ENSG00000251322,ENST00000692848		Phelan-McDermid syndrome	606232	AD	3	Shank3
22q13.33	22:50738204-50745339	ACR, SPGF87	Acrosin	102480	ACR	49	ENSG00000100312,ENST00000216139;;;ENST00000216139	mutation identified in 1 SPGF87 family	?Spermatogenic failure 87	620500	AR	3	Acr
Xp22	X:1-24900000	AIC	Aicardi syndrome	304050		192		?in p22.31 with FDH as contiguous gene syndrome	Aicardi syndrome	304050	XLD	2	
Xp22	X:1-24900000	ANIB5	Aneurysm, intracranial berry, 5	300870		137587484			Aneurysm, intracranial berry, 5	300870		2	
Xp22.3	X:1-9600000	EMWX	Episodic muscle weakness, X-linked	300211		10118			Episodic muscle weakness, X-linked	300211		2	
Xp22.3	X:1-9600000	FGS3	FG syndrome 3	300406		93985			FG syndrome 3	300406	XL	2	
Xpter-p22.32	X:1-6100000	HDPA	Hodgkin disease, susceptibility, pseudoautosomal	300221		50829			{Hodgkin disease susceptibility, pseudoautosomal}	300221		2	
Xp22	X:1-24900000	MNG2	Multinodular goiter-2	300273		59081			Goiter, multinodular, 2	300273	XLD	2	
Xp22.3	X:1-9600000	OASD	Ocular albinism and sensorineural deafness	300650		4941		?allelic to OA1	Ocular albinism with sensorineural deafness	300650	XL	2	
Xp22.33	X:1-4400000	VSPA	Visuospatial/perceptual abilities	313000		59332			[Visuospatial/perceptual abilities]	313000	?XLR	2	
Xp22.33	X:1-4400000	VSPA	Visuospatial/perceptual abilities	313000		59332			Turner syndrome-associated neurocognitive phenotype	313000	?XLR	2	
Xp22.3	X:1-9600000	XLID2, MRX2	Intellectual developmental disorder, X-linked 2	300428					Intellectual developmental disorder, X-linked 2	300428	XL	2	
Xp22.33	X:624344-659411	SHOX, GCFX, SS, PHOG	Short stature homeobox	312865	SHOX	6473	ENSG00000185960,ENST00000686671;;;ENST00000686671	pseudoautosomal; ?gene causing short stature in Turner syndrome	Langer mesomelic dysplasia	249700	PR	3	
Xp22.33	X:624344-659411	SHOX, GCFX, SS, PHOG	Short stature homeobox	312865	SHOX	6473	ENSG00000185960,ENST00000686671;;;ENST00000686671	pseudoautosomal; ?gene causing short stature in Turner syndrome	Leri-Weill dyschondrosteosis	127300	PD	3	
Xp22.33	X:624344-659411	SHOX, GCFX, SS, PHOG	Short stature homeobox	312865	SHOX	6473	ENSG00000185960,ENST00000686671;;;ENST00000686671	pseudoautosomal; ?gene causing short stature in Turner syndrome	Short stature, idiopathic familial	300582		3	
Xp22.33	X:1268814-1325218	CSF2RA, SMDP4	Colony-stimulating factor-2 receptor, alpha, low-affinity, granulocyte-macrophage	306250	CSF2RA	1438	ENSG00000198223,ENST00000381529;;;ENST00000381529	order in PAR: pter-CSF2RA-IL3RA-ANT3-ASMT-MIC2-cen	Surfactant metabolism dysfunction, pulmonary, 4	300770	PR	3	
Xp22.33	X:2219506-2500976	DHRSX, CDG1DD	Dehydrogenase/reductase, X-linked	301034	DHRSX	207063	ENSG00000169084,ENST00000334651;;;ENST00000334651	in pseudoautosomal region	Congenital disorder of glycosylation, type 1DD	301133	PR	3	Dhrsx
Xp22.33	X:2934521-2968245	ARSL, CDPX1, CDPXR	Arylsulfatase L	300180	ARSL	415	ENSG00000157399,ENST00000381134;;;ENST00000381134	CDPX1 in contiguous gene syndrome with STS	Chondrodysplasia punctata, X-linked recessive	302950	XLR	3	
Xp22.32	X:4400001-6100000	XGR, XG	XG/MIC2 regulator	314705					[XG blood group system, Xg(a-) phenotype]	314700		3	
Xp22.32-p22.31	X:5890042-6228867	NLGN4X, NLGN4, KIAA1260, AUTSX2	Neuroligin 4, X-linked	300427	NLGN4X	57502	ENSG00000146938,ENST00000381095;;;ENST00000381095		{Autism susceptibility, X-linked 2}	300495	XL	3	Nlgn4l
Xp22.32-p22.31	X:5890042-6228867	NLGN4X, NLGN4, KIAA1260, AUTSX2	Neuroligin 4, X-linked	300427	NLGN4X	57502	ENSG00000146938,ENST00000381095;;;ENST00000381095		Intellectual developmental disorder, X-linked	300495	XL	3	Nlgn4l
Xp22.31	X:7147290-7354641	STS, ARSC1, ARSC, SSDD, XLI	Steroid sulfatase, microsomal (arylsulfatase C, isozyme S)	300747	STS	412	ENSG00000101846,ENST00000674429;;;ENST00000674429	nonlyonizing	Ichthyosis, X-linked	308100	XLR	3	Sts
Xp22.31	X:8528874-8732137	ANOS1, KAL1, KMS, ADMLX, HH1	Anosmin 1	300836	ANOS1	3730	ENSG00000011201,ENST00000262648;;;ENST00000262648	with ichthyosis in probable microdeletion syndrome	Hypogonadotropic hypogonadism 1 with or without anosmia (Kallmann syndrome 1)	308700	XLR	3	
Xp22.31-p22.2	X:9463295-9719740	TBL1X, TBL1, CHNG8	Transducin-beta-like 1, X-linked	300196	TBL1X	6907	ENSG00000101849,ENST00000645353;;;ENST00000645353		Hypothyroidism, congenital, nongoitrous, 8	301033	XL	3	Tbl1x
Xp22.2	X:9600001-17400000	CMTX2	Charcot-Marie-Tooth disease, X-linked recessive, 2	302801		1253			Charcot-Marie-Tooth neuropathy, X-linked recessive, 2	302801	XLR	2	
Xp22.2	X:9600001-17400000	HBFQTL3, FCP1, FCPX, FCP	Fetal hemoglobin quantitative trait locus 3	305435		2221			Fetal hemoglobin quantitative trait locus 3	305435	XL	2	
Xp22.2	X:9600001-17400000	XLID73, MRX73	Intellectual developmental disorder, X-linked 73	300355		23694		between DXS8019 and DXS365	Intellectual developmental disorder, X-linked 73	300355	XLR	2	
Xp22.2	X:9725346-9778602	GPR143, OA1, NYS6	G protein-coupled receptor 143	300808	GPR143	4935	ENSG00000101850,ENST00000467482;;;ENST00000467482	linked to XG	Nystagmus 6, congenital, X-linked	300814	XLR	3	Gpr143
Xp22.2	X:9725346-9778602	GPR143, OA1, NYS6	G protein-coupled receptor 143	300808	GPR143	4935	ENSG00000101850,ENST00000467482;;;ENST00000467482	linked to XG	Ocular albinism, type I, Nettleship-Falls type	300500	XL	3	Gpr143
Xp22.2	X:10156975-10237660	CLCN4, MRX49, MRX15, MRXSRC	Chloride channel-4	302910	CLCN4	1183	ENSG00000073464,ENST00000380833;;;ENST00000380833		Raynaud-Claes syndrome	300114	XLD	3	Clcn4
Xp22.2	X:10445310-10833683	MID1, OGS1, GBBB, FXY, OSX	Midline-1	300552	MID1	4281	ENSG00000101871,ENST00000317552;;;ENST00000317552	type II defect on chr.22	Opitz GBBB syndrome	300000	XLR	3	Mid1
Xp22.2	X:11111332-11123086	HCCS, MCOPS7, LSDMCA1	Holocytochrome c synthase (cytochrome c heme-lyase)	300056	HCCS	3052	ENSG00000004961,ENST00000380762;;;ENST00000380762		Linear skin defects with multiple congenital anomalies 1	309801	XLD	3	Hccs
Xp22.2	X:11293413-11309588	AMELX, AMG, AIH1, AMGX, AI1E	Amelogenin	300391	AMELX	265	ENSG00000125363,ENST00000380714;;;ENST00000380714	also Y	Amelogenesis imperfecta, type 1E	301200	XLD	3	Amelx
Xp22.2	X:11758159-11775772	MSL3, MSL3L1, MRXSBA	MSL complex subunit 3	300609	MSL3	10943	ENSG00000005302,ENST00000312196;;;ENST00000312196		Basilicata-Akhtar syndrome	301032	XLD	3	Msl3,Msl3l2
Xp22.2	X:11822439-12724523	FRMPD4, PRESO, KIAA0316, XLID104	FERM and PDZ domains-containing protein 4	300838	FRMPD4	9758	ENSG00000169933,ENST00000675598;;;ENST00000675598		Intellectual developmental disorder, X-linked 104	300983	XL	3	Frmpd4
Xp22.2	X:12867072-12890361	TLR7, IMD74, SLEB17	Toll-like receptor 7	300365	TLR7	51284	ENSG00000196664,ENST00000380659;;;ENST00000380659	centromeric to TLR8	Immunodeficiency 74, COVID19-related, X-linked	301051	XLR	3	Tlr7
Xp22.2	X:12867072-12890361	TLR7, IMD74, SLEB17	Toll-like receptor 7	300365	TLR7	51284	ENSG00000196664,ENST00000380659;;;ENST00000380659	centromeric to TLR8	Systemic lupus erythematosus 17	301080	XLD	3	Tlr7
Xp22.2	X:12906620-12923169	TLR8, IMD98	Toll-like receptor 8	300366	TLR8	51311	ENSG00000101916,ENST00000218032;;;ENST00000218032	16kb telomeric to TLR7	Immunodeficiency 98 with autoinflammation, X-linked	301078	SMo, XL	3	Tlr8
Xp22.2	X:13712245-13734620	TRAPPC2, SEDL, SEDT	Trafficking protein particle complex 2 (sedlin)	300202	TRAPPC2	6399	ENSG00000196459,ENST00000380579;;;ENST00000380579		Spondyloepiphyseal dysplasia tarda	313400	XLR	3	Trappc2,Trappc2b
Xp22.2	X:13714505-13773738	OFD1, CXorf5, SGBS2, JBTS10, RP23	OFD1 centriole and centriolar satellite protein	300170	OFD1	8481	ENSG00000046651,ENST00000340096;;;ENST00000340096	mutation identified in 1 RP23 family	?Retinitis pigmentosa 23	300424	XLR	3	Ofd1
Xp22.2	X:13714505-13773738	OFD1, CXorf5, SGBS2, JBTS10, RP23	OFD1 centriole and centriolar satellite protein	300170	OFD1	8481	ENSG00000046651,ENST00000340096;;;ENST00000340096	mutation identified in 1 RP23 family	Joubert syndrome 10	300804	XLR	3	Ofd1
Xp22.2	X:13714505-13773738	OFD1, CXorf5, SGBS2, JBTS10, RP23	OFD1 centriole and centriolar satellite protein	300170	OFD1	8481	ENSG00000046651,ENST00000340096;;;ENST00000340096	mutation identified in 1 RP23 family	Orofaciodigital syndrome I	311200	XLD	3	Ofd1
Xp22.2	X:13714505-13773738	OFD1, CXorf5, SGBS2, JBTS10, RP23	OFD1 centriole and centriolar satellite protein	300170	OFD1	8481	ENSG00000046651,ENST00000340096;;;ENST00000340096	mutation identified in 1 RP23 family	Simpson-Golabi-Behmel syndrome, type 2	300209	XLR	3	Ofd1
Xp22.2	X:14448779-14731812	GLRA2, MRXSP	Glycine receptor, alpha-2 polypeptide	305990	GLRA2	2742	ENSG00000101958,ENST00000218075;;;ENST00000218075		Intellectual developmental disorder, X-linked syndromic, Pilorge type	301076	XL	3	Glra2
Xp22.2	X:14689524-14873069	FANCB, FAAP95, FAAP90, FLJ34064	Fanconi anemia, complementation group B gene	300515	FANCB	2187	ENSG00000181544,ENST00000650831;;;ENST00000650831		Fanconi anemia, complementation group B	300514	XLR	3	Fancb
Xp22.2	X:15319451-15335554	PIGA, PNH1, MCAHS2, NEDEPH	Phosphatidylinositol glycan, class A	311770	PIGA	5277	ENSG00000165195,ENST00000333590;;;ENST00000333590	pseudogene on chr.12	Multiple congenital anomalies-hypotonia-seizures syndrome 2	300868	XLR	3	Piga
Xp22.2	X:15319451-15335554	PIGA, PNH1, MCAHS2, NEDEPH	Phosphatidylinositol glycan, class A	311770	PIGA	5277	ENSG00000165195,ENST00000333590;;;ENST00000333590	pseudogene on chr.12	Neurodevelopmental disorder with epilepsy and hemochromatosis	301072	XLR	3	Piga
Xp22.2	X:15319451-15335554	PIGA, PNH1, MCAHS2, NEDEPH	Phosphatidylinositol glycan, class A	311770	PIGA	5277	ENSG00000165195,ENST00000333590;;;ENST00000333590	pseudogene on chr.12	Paroxysmal nocturnal hemoglobinuria, somatic	300818		3	Piga
Xp22.2	X:15790484-15823260	ZRSR2, U2AF1RS2, OFD21	Zinc finger-, CCCH domain-, and RNA-binding motif-containing serine/arginine-rich protein 2	300028	ZRSR2	8233	ENSG00000169249,ENST00000307771;;;ENST00000307771		Orofaciodigital syndrome XXI	301132	XLR	3	Zrsr2,Zrsr2-ps1
Xp22.2	X:15825806-15854813	AP1S2, MRX59, MRXSF, MRXS21, MRXS5, PGS	Adaptor-related protein complex 1, sigma-2 subunit	300629	AP1S2	8905	ENSG00000182287,ENST00000672987;;;ENST00000672987		Pettigrew syndrome	304340	XLR	3	Ap1s2
Xp22.2	X:16844341-16870362	RBBP7, SPGFX9	Retinoblastoma-binding protein 7	300825	RBBP7	5931	ENSG00000102054,ENST00000380087;;;ENST00000380087		Spermatogenic failure, X-linked, 9	301137	XL	3	Rbbp7
Xp22.2-p22.13	X:17375200-17735994	NHS, CXN, CTRCT40	NHS actin remodeling regulator	300457	NHS	4810	ENSG00000188158,ENST00000676302;;;ENST00000676302		Cataract 40, X-linked	302200	XL	3	Nhs
Xp22.2-p22.13	X:17375200-17735994	NHS, CXN, CTRCT40	NHS actin remodeling regulator	300457	NHS	4810	ENSG00000188158,ENST00000676302;;;ENST00000676302		Nance-Horan syndrome	302350	XLD	3	Nhs
Xp22.13	X:18425608-18653629	CDKL5, STK9, ISSX, DEE2	Cyclin-dependent kinase-like 5 (serine/threonine protein kinase 9)	300203	CDKL5	6792	ENSG00000008086,ENST00000623535;;;ENST00000623535		Developmental and epileptic encephalopathy 2	300672	XLD	3	Cdkl5
Xp22.13	X:18639688-18672108	RS1, XLRS1	Retinoschisin	300839	RS1	6247	ENSG00000102104,ENST00000379984;;;ENST00000379984	25cM from XG	Retinoschisis	312700	XLR	3	Rs1
Xp22.13	X:18892298-18984114	PHKA2, PHK, XLG, PYKL, GSD9A	Phosphorylase kinase, liver, alpha-2 subunit	300798	PHKA2	5256	ENSG00000044446,ENST00000379942;;;ENST00000379942		Glycogen storage disease, type IXa1	306000	XLR	3	Phka2
Xp22.13	X:18892298-18984114	PHKA2, PHK, XLG, PYKL, GSD9A	Phosphorylase kinase, liver, alpha-2 subunit	300798	PHKA2	5256	ENSG00000044446,ENST00000379942;;;ENST00000379942		Glycogen storage disease, type IXa2	306000	XLR	3	Phka2
Xp22.13	X:18989307-19122956	ADGRG2, GPR64, HE6, CBAVDX	Adhesion G protein-coupled receptor G2	300572	ADGRG2	10149	ENSG00000173698,ENST00000379869;;;ENST00000379869		Congenital bilateral absence of vas deferens, X-linked	300985	XL	3	Adgrg2
Xp22.12	X:19343927-19361718	PDHA1, PHE1A, PDHAD	Pyruvate dehydrogenase E1, subunit alpha-1	300502	PDHA1	5160	ENSG00000131828,ENST00000422285;;;ENST00000422285		Pyruvate dehydrogenase E1-alpha deficiency	312170	XLD	3	Pdha1
Xp22.12	X:19533977-19887600	SH3KBP1, CIN85, IMD61, AGMX2	SH3-domain kinase-binding protein 1	300374	SH3KBP1	30011	ENSG00000147010,ENST00000397821;;;ENST00000397821	mutation identified in 1 IMD61 family	?Immunodeficiency 61	300310	XLR	3	Sh3kbp1
Xp22.12	X:20149911-20267097	RPS6KA3, RSK2, XLID19	Ribosomal protein S6 kinase A3	300075	RPS6KA3	6197	ENSG00000177189,ENST00000379565;;;ENST00000379565		Coffin-Lowry syndrome	303600	XLD	3	Rps6ka3
Xp22.12	X:20149911-20267097	RPS6KA3, RSK2, XLID19	Ribosomal protein S6 kinase A3	300075	RPS6KA3	6197	ENSG00000177189,ENST00000379565;;;ENST00000379565		Intellectual developmental disorder, X-linked 19	300844	XLD	3	Rps6ka3
Xp22.12	X:21374418-21654689	CNKSR2, CNK2, KIAA0902, MRXSHG	connector enhancer of KSR 2	300724	CNKSR2	22866	ENSG00000149970,ENST00000379510;;;ENST00000379510		Intellectual developmental disorder, X-linked syndromic, Houge type	301008	XL	3	Cnksr2
Xp22.12	X:21705978-21758116	SMPX, DFNX4, MPD7	Small muscle protein, X-linked	300226	SMPX	23676	ENSG00000091482,ENST00000379494;;;ENST00000379494		Deafness, X-linked 4	300066	XLD	3	Smpx
Xp22.12	X:21705978-21758116	SMPX, DFNX4, MPD7	Small muscle protein, X-linked	300226	SMPX	23676	ENSG00000091482,ENST00000379494;;;ENST00000379494		Myopathy, distal, 7, adult-onset, X-linked	301075	XLR	3	Smpx
Xp22.12	X:21839617-21885423	MBTPS2, S2P, IFAP, KFSDX, OLMSX, OI19	Membrane-bound transcription factor protease, site 2	300294	MBTPS2	51360	ENSG00000012174,ENST00000379484;;;ENST00000379484	mutation identified in 1 OLMSX family	?Olmsted syndrome, X-linked	300918	XLR	3	Mbtps2
Xp22.12	X:21839617-21885423	MBTPS2, S2P, IFAP, KFSDX, OLMSX, OI19	Membrane-bound transcription factor protease, site 2	300294	MBTPS2	51360	ENSG00000012174,ENST00000379484;;;ENST00000379484	mutation identified in 1 OLMSX family	IFAP syndrome with or without BRESHECK syndrome	308205	XLR	3	Mbtps2
Xp22.12	X:21839617-21885423	MBTPS2, S2P, IFAP, KFSDX, OLMSX, OI19	Membrane-bound transcription factor protease, site 2	300294	MBTPS2	51360	ENSG00000012174,ENST00000379484;;;ENST00000379484	mutation identified in 1 OLMSX family	Keratosis follicularis spinulosa decalvans, X-linked	308800	XLR	3	Mbtps2
Xp22.12	X:21839617-21885423	MBTPS2, S2P, IFAP, KFSDX, OLMSX, OI19	Membrane-bound transcription factor protease, site 2	300294	MBTPS2	51360	ENSG00000012174,ENST00000379484;;;ENST00000379484	mutation identified in 1 OLMSX family	Osteogenesis imperfecta, type XIX	301014	XLR	3	Mbtps2
Xp22.11	X:21940709-21994837	SMS, SRS, MRXSSR	Spermine synthase	300105	SMS	6611	ENSG00000102172,ENST00000404933;;;ENST00000404933		Intellectual developmental disorder, X-linked syndromic, Snyder-Robinson type	309583	XLR	3	Sms
Xp22.11	X:22032325-22251310	PHEX, HYP, HPDR1, LXHR	Phosphate regulating endopeptidase homolog, X-linked	300550	PHEX	5251	ENSG00000102174,ENST00000379374;;;ENST00000379374		Hypophosphatemic rickets, X-linked dominant	307800	XLD	3	Phex
Xp22.11	X:23334396-23404374	PTCHD1, AUTSX4	Patched domain-containing protein 1	300828	PTCHD1	139411	ENSG00000165186,ENST00000379361;;;ENST00000379361		{Autism, susceptibility to, X-linked 4}	300830	XLR	3	Ptchd1
Xp22.11	X:23983720-24027186	KLHL15, KIAA1677, XLID103	Kelch-like 15	300980	KLHL15	80311	ENSG00000174010,ENST00000328046;;;ENST00000328046		Intellectual developmental disorder, X-linked 103	300982	XLR	3	Klhl15
Xp22.11	X:24054956-24078810	EIF2S3, EIF2G, MEHMO, MRXSBRK	Eukaryotic translation initiation factor 2, subunit 3	300161	EIF2S3	1968	ENSG00000130741,ENST00000253039;;;ENST00000253039		MEHMO syndrome	300148	XLR	3	Eif2s3x,Eif2s3y
Xp22.11	X:24148982-24216255	ZFX, MRXS37	Zinc finger protein, X-linked	314980	ZFX	7543	ENSG00000005889,ENST00000304543;;;ENST00000304543	nonlyonizing	Intellectual developmental disorder, X-linked syndromic 37	301118	XL	3	Zfx
Xp22.11	X:24465286-24550466	PDK3, CMTX6	Pyruvate dehydrogenase kinase, isoenzyme 3	300906	PDK3	5165	ENSG00000067992,ENST00000379162;;;ENST00000379162	1 family identified with mutation	?Charcot-Marie-Tooth disease, X-linked dominant, 6	300905	XLD	3	Pdk3
Xp22.11-p21.3	X:24693918-24996986	POLA1, VEODS	Polymerase, DNA, alpha-1	312040	POLA1	5422	ENSG00000101868,ENST00000379068;;;ENST00000379068		Pigmentary disorder, reticulate, with systemic manifestations, X-linked	301220	XLR	3	Pola1
Xp22.11-p21.3	X:24693918-24996986	POLA1, VEODS	Polymerase, DNA, alpha-1	312040	POLA1	5422	ENSG00000101868,ENST00000379068;;;ENST00000379068		Van Esch-O'Driscoll syndrome	301030	XLR	3	Pola1
Xp21	X:24900001-37800000	DELXp21, CXDELp21	Chromosome Xp21 deletion syndrome	300679				contiguous gene deletion syndrome	Chromosome Xp21 deletion syndrome	300679		4	
Xp21.3	X:24900001-29300000	MENOQ1	Menopause, natural, age at, QTL 1	300488		494029			{Menopause, natural, age at, QTL1}	300488	XLD	2	
Xp21.3-p21.2	X:24900001-31500000	RP6	Retinitis pigmentosa-6, X-linked recessive	312612		6104			?Retinitis pigmentosa, X-linked recessive, 6	312612	XL	2	
Xp21.3	X:25003694-25015965	ARX, ISSX, PRTS, MRXS1, MRX36, MRX54, MRX43, MRX87, MRX29, MRX32	Aristaless-related homeobox, X-linked	300382	ARX	170302	ENSG00000004848,ENST00000379044;;;ENST00000379044		Developmental and epileptic encephalopathy 1	308350	XLR	3	Arx
Xp21.3	X:25003694-25015965	ARX, ISSX, PRTS, MRXS1, MRX36, MRX54, MRX43, MRX87, MRX29, MRX32	Aristaless-related homeobox, X-linked	300382	ARX	170302	ENSG00000004848,ENST00000379044;;;ENST00000379044		Hydranencephaly with abnormal genitalia	300215	XL	3	Arx
Xp21.3	X:25003694-25015965	ARX, ISSX, PRTS, MRXS1, MRX36, MRX54, MRX43, MRX87, MRX29, MRX32	Aristaless-related homeobox, X-linked	300382	ARX	170302	ENSG00000004848,ENST00000379044;;;ENST00000379044		Intellectual developmental disorder, X-linked 29	300419	XLR	3	Arx
Xp21.3	X:25003694-25015965	ARX, ISSX, PRTS, MRXS1, MRX36, MRX54, MRX43, MRX87, MRX29, MRX32	Aristaless-related homeobox, X-linked	300382	ARX	170302	ENSG00000004848,ENST00000379044;;;ENST00000379044		Lissencephaly, X-linked 2	300215	XL	3	Arx
Xp21.3	X:25003694-25015965	ARX, ISSX, PRTS, MRXS1, MRX36, MRX54, MRX43, MRX87, MRX29, MRX32	Aristaless-related homeobox, X-linked	300382	ARX	170302	ENSG00000004848,ENST00000379044;;;ENST00000379044		Partington syndrome	309510	XLR	3	Arx
Xp21.3	X:25003694-25015965	ARX, ISSX, PRTS, MRXS1, MRX36, MRX54, MRX43, MRX87, MRX29, MRX32	Aristaless-related homeobox, X-linked	300382	ARX	170302	ENSG00000004848,ENST00000379044;;;ENST00000379044		Proud syndrome	300004	XL	3	Arx
Xp21.3-p21.2	X:28587446-29956718	IL1RAPL1, IL1R8, MRX21, MRX34	Il-1 receptor accessory protein-like 1	300206	IL1RAPL1	11141	ENSG00000169306,ENST00000378993;;;ENST00000378993		Intellectual developmental disorder, X-linked 21	300143	XLR	3	Il1rapl1
Xp21.2	X:29300001-31500000	DFNX3, DFN4	Deafness, X-linked 3	300030		1680		?same as DMD	Deafness, X-linked 3	300030	XL	2	
Xp21.2	X:30304206-30309390	NR0B1, DAX1, AHC, AHX, SRXY2	Nuclear receptor subfamily 0, group B, member 1	300473	NR0B1	190	ENSG00000169297,ENST00000378970;;;ENST00000378970	distal to GK	46XY sex reversal 2, dosage-sensitive	300018	XL	3	Nr0b1
Xp21.2	X:30304206-30309390	NR0B1, DAX1, AHC, AHX, SRXY2	Nuclear receptor subfamily 0, group B, member 1	300473	NR0B1	190	ENSG00000169297,ENST00000378970;;;ENST00000378970	distal to GK	Adrenal hypoplasia, congenital	300200	XLR	3	Nr0b1
Xp21.2	X:30653423-30731462	GK	Glycerol kinase	300474	GK	2710	ENSG00000198814,ENST00000427190;;;ENST00000427190	2Mb distal to DMD; pseudogene on 4q32	Glycerol kinase deficiency	307030	XLR	3	Gk
Xp21.2-p21.1	X:31119222-33339388	DMD, BMD, CMD3B	Dystrophin	300377	DMD	1756	ENSG00000198947,ENST00000357033;;;ENST00000357033	dystrophin gene; cen-5'-3'-pter; 2Mb; ?Xp21.13	Becker muscular dystrophy	300376	XLR	3	Dmd
Xp21.2-p21.1	X:31119222-33339388	DMD, BMD, CMD3B	Dystrophin	300377	DMD	1756	ENSG00000198947,ENST00000357033;;;ENST00000357033	dystrophin gene; cen-5'-3'-pter; 2Mb; ?Xp21.13	Cardiomyopathy, dilated, 3B	302045	XL	3	Dmd
Xp21.2-p21.1	X:31119222-33339388	DMD, BMD, CMD3B	Dystrophin	300377	DMD	1756	ENSG00000198947,ENST00000357033;;;ENST00000357033	dystrophin gene; cen-5'-3'-pter; 2Mb; ?Xp21.13	Duchenne muscular dystrophy	310200	XLR	3	Dmd
Xp21.1-p11.23	X:31500001-50100000	MRXS17	Intellectual developmental disorder, X-linked, syndromic 17	300858		100739996		between rs2748314 and rs5906782	Intellectual developmental disorder, X-linked syndromic 17	300858	XLR	2	
Xp21.1	X:35919734-36385317	CFAP47, CXorf22, SPGFX3	Cilia- and flagella-associated protein 47	301057	CFAP47	286464	ENSG00000165164,ENST00000378653;;;ENST00000378653		Spermatogenic failure, X-linked 3	301059	XLR	3	Cfap47
Xp21.1	X:37685791-37732130	XK, MCLDS	Kell blood group precursor	314850	XK	7504	ENSG00000047597,ENST00000378616;;;ENST00000378616	~500kb distal to CGD	McLeod syndrome	300842	XL	3	Xk
Xp21.1-p11.4	X:37780059-37813461	CYBB, CGDX, AMCBX2, IMD34	Cytochrome b-245, beta polypeptide	300481	CYBB	1536	ENSG00000165168,ENST00000378588;;;ENST00000378588	proximal to DMD	Chronic granulomatous disease, X-linked	306400	XLR	3	Cybb
Xp21.1-p11.4	X:37780059-37813461	CYBB, CGDX, AMCBX2, IMD34	Cytochrome b-245, beta polypeptide	300481	CYBB	1536	ENSG00000165168,ENST00000378588;;;ENST00000378588	proximal to DMD	Immunodeficiency 34, mycobacteriosis, X-linked	300645	XLR	3	Cybb
Xp11	X:37800001-61000000	GRDX, GD3	Graves disease, susceptibility to, X-linked	300351		117189			{Graves disease, susceptibility to, X-linked}	300351		2	
Xp11	X:37800001-61000000	IDDMX	Diabetes mellitus, insulin-dependent, X-linked, susceptibility to	300136		8245		only with DR3	{Diabetes mellitus, insulin-dependent, X-linked}	300136		2	
Xp11	X:37800001-61000000	MRXS12	Intellectual developmental disorder, X-linked, syndromic 12	309545		8246			?Intellectual developmental disorder, X-linked syndromic 12	309545	XL	2	
Xp11.4	X:37800001-42500000	NYS5	Nystagmus 5, congenital, X-linked	300589		780901		max lod at DXS993	Nystagmus 5, congenital, X-linked	300589	XLD	2	
Xp11.4-p11.21	X:37800001-58100000	OPA2	Optic atrophy, X-linked	311050		4977			Optic atrophy 2, X-linked	311050	XL	2	
Xp11-q21	X:37800001-99100000	XLID20, MRX20	Intellectual developmental disorder, X-linked 20	300047		4384			Intellectual developmental disorder, X-linked 20	300047	XL	2	
Xp11.4	X:38269163-38327509	RPGR, RP3, CRD, RP15, COD1, CORDX1	Retinitis pigmentosa GTPase regulator	312610	RPGR	6103	ENSG00000156313,ENST00000645032;;;ENST00000645032		Cone-rod dystrophy, X-linked, 1	304020	XLR	3	Rpgr
Xp11.4	X:38269163-38327509	RPGR, RP3, CRD, RP15, COD1, CORDX1	Retinitis pigmentosa GTPase regulator	312610	RPGR	6103	ENSG00000156313,ENST00000645032;;;ENST00000645032		Macular degeneration, X-linked atrophic	300834	XLR	3	Rpgr
Xp11.4	X:38269163-38327509	RPGR, RP3, CRD, RP15, COD1, CORDX1	Retinitis pigmentosa GTPase regulator	312610	RPGR	6103	ENSG00000156313,ENST00000645032;;;ENST00000645032		Retinitis pigmentosa 3	300029	XL	3	Rpgr
Xp11.4	X:38269163-38327509	RPGR, RP3, CRD, RP15, COD1, CORDX1	Retinitis pigmentosa GTPase regulator	312610	RPGR	6103	ENSG00000156313,ENST00000645032;;;ENST00000645032		Retinitis pigmentosa, X-linked, and sinorespiratory infections, with or without deafness	300455	XL	3	Rpgr
Xp11.4	X:38327684-38422928	OTC	Ornithine transcarbamylase	300461	OTC	5009	ENSG00000036473,ENST00000039007;;;ENST00000039007	proximal to DMD, CGD	Ornithine transcarbamylase deficiency	311250	XL	3	Otc
Xp11.4	X:38561542-38688918	TSPAN7, TM4SF2, MXS1, A15, XLID58	Tetraspanin 7	300096	TSPAN7	7102	ENSG00000156298,ENST00000378482;;;ENST00000378482		Intellectual developmental disorder, X-linked 58	300210	XLR	3	Tspan7
Xp11.4	X:40051246-40177277	BCOR, KIAA1575, MCOPS2, MAA2, ANOP2	BCL6 corepressor	300485	BCOR	54880	ENSG00000183337,ENST00000378444;;;ENST00000378444		Microphthalmia, syndromic 2	300166	XLD	3	Bcor
Xp11.4	X:40580970-40606848	ATP6AP2, ATP6M8-9, XMRE, MRXSH, XPDS, CDG2R	ATPase, H+ transporting, lysosomal, accessory protein 2	300556	ATP6AP2	10159	ENSG00000182220,ENST00000636580;;;ENST00000636580	mutation identified in 1 XPDS family	?Parkinsonism with spasticity, X-linked	300911	XLR	3	Atp6ap2
Xp11.4	X:40580970-40606848	ATP6AP2, ATP6M8-9, XMRE, MRXSH, XPDS, CDG2R	ATPase, H+ transporting, lysosomal, accessory protein 2	300556	ATP6AP2	10159	ENSG00000182220,ENST00000636580;;;ENST00000636580	mutation identified in 1 XPDS family	Congenital disorder of glycosylation, type IIr	301045	XLR	3	Atp6ap2
Xp11.4	X:40580970-40606848	ATP6AP2, ATP6M8-9, XMRE, MRXSH, XPDS, CDG2R	ATPase, H+ transporting, lysosomal, accessory protein 2	300556	ATP6AP2	10159	ENSG00000182220,ENST00000636580;;;ENST00000636580	mutation identified in 1 XPDS family	Intellectual developmental disorder, X-linked syndromic, Hedera type	300423	XLR	3	Atp6ap2
Xp11.4	X:41085445-41236579	USP9X, DFFRX, XLID99, MRXS99F	Ubiquitin-specific protease-9, X chromosome (Drosophila fat facets related, X-linked)	300072	USP9X	8239	ENSG00000124486,ENST00000378308;;;ENST00000378308		Intellectual developmental disorder, X-linked 99	300919	XLR	3	Usp9x
Xp11.4	X:41085445-41236579	USP9X, DFFRX, XLID99, MRXS99F	Ubiquitin-specific protease-9, X chromosome (Drosophila fat facets related, X-linked)	300072	USP9X	8239	ENSG00000124486,ENST00000378308;;;ENST00000378308		Intellectual developmental disorder, X-linked 99, syndromic, female-restricted	300968	XLD	3	Usp9x
Xp11.4	X:41333308-41364472	DDX3X, DDX3, DBX, MRX102, MRXSSB	DEAD-box helicase 3, X-linked	300160	DDX3X	1654	ENSG00000215301,ENST00000644876;;;ENST00000644876		Intellectual developmental disorder, X-linked syndromic, Snijders Blok type	300958	XLD, XLR	3	Ddx3x
Xp11.4	X:41447343-41475652	NYX, CSNB1A, NBM1	Nyctalopin	300278	NYX	60506	ENSG00000188937,ENST00000378220;;;ENST00000378220		Night blindness, congenital stationary (complete), 1A, X-linked	310500	XLR	3	Nyx
Xp11.4	X:41514934-41923554	CASK, MICPCH, FGS4, CMG, MRXSNA	Calcium/calmodulin-dependent serine protein kinase	300172	CASK	8573	ENSG00000147044,ENST00000378163;;;ENST00000378163		FG syndrome 4	300422	XLR	3	Cask
Xp11.4	X:41514934-41923554	CASK, MICPCH, FGS4, CMG, MRXSNA	Calcium/calmodulin-dependent serine protein kinase	300172	CASK	8573	ENSG00000147044,ENST00000378163;;;ENST00000378163		Intellectual developmental disorder and microcephaly with pontine and cerebellar hypoplasia	300749	XL	3	Cask
Xp11.4	X:41514934-41923554	CASK, MICPCH, FGS4, CMG, MRXSNA	Calcium/calmodulin-dependent serine protein kinase	300172	CASK	8573	ENSG00000147044,ENST00000378163;;;ENST00000378163		Intellectual developmental disorder, with or without nystagmus	300422	XLR	3	Cask
Xp11.3-q12	X:42500001-68500000	AGSPX	Angioma serptiginosum, X-linked	300652		100188767		between DXS8026 and DXS106	Angio serpiginosum	300652	XLD	2	
Xp11.3	X:42500001-47600000	DELXp11.3, CXDELp11.3	Chromosome Xp11.3 deletion syndrome	300578					Chromosome Xp11.3 deletion syndrome	300578	XLR	4	
Xp11.3-q22	X:42500001-109400000	MRXS7	Intellectual developmental disorder, X-linked, syndromic 7	300218		4429			Intellectual developmental disorder, X-linked syndromic 7	300218	XL	2	
Xp11.3-q13.3	X:42500001-76800000	XLID14, MRX14	Intellectual developmental disorder, X-linked 14	300062		4378			Intellectual developmental disorder, X-linked 14	300062	XL	2	
Xp11.3-p11.21	X:42500001-58100000	XLID45, MRX45	Intellectual developmental disorder, X-linked 45	300498					Intellectual developmental disorder, X-linked 45	300498	XL	2	
Xp11.3-q22.3	X:42500001-109400000	XLID84, MRX84	Intellectual developmental disorder, X-linked 84	300505		378882		29 other MRX loci in same region	Intellectual developmental disorder, X-linked 84	300505	XLR	2	
Xp11.3	X:42500001-47600000	XLID89, MRX89	Intellectual developmental disorder, X-linked 89	300848				t(X;7)(p11.3;q11.21)	Intellectual developmental disorder, X-linked 89	300848	XLD	2	
Xp11.3	X:42500001-47600000	XLID92, MRX92	Intellectual developmental disorder, X-linked 92	300851		102775565		previously associated with ZNF674	Intellectual developmental disorder, X-linked 92	300851	XLR	2	
Xp11.3	X:43655006-43746817	MAOA, BRNRS	Monoamine oxidase A	309850	MAOA	4128	ENSG00000189221,ENST00000338702;;;ENST00000338702	NDP, MAOA, MAOB closely linked	Brunner syndrome	300615	XLR	3	Maoa
Xp11.3	X:43948776-43973390	NDP, ND, EVR2	Norrin cystine knot growth factor	300658	NDP	4693	ENSG00000124479,ENST00000642620;;;ENST00000642620		Exudative vitreoretinopathy 2, X-linked	305390	XLD, XLR	3	Ndp
Xp11.3	X:43948776-43973390	NDP, ND, EVR2	Norrin cystine knot growth factor	300658	NDP	4693	ENSG00000124479,ENST00000642620;;;ENST00000642620		Norrie disease	310600	XLR	3	Ndp
Xp11.3	X:44873188-45112779	KDM6A, UTX, KABUK2	Lysine demethylase 6A	300128	KDM6A	7403	ENSG00000147050,ENST00000611820;;;ENST00000611820	UTY also in mouse and man; escapes inactivation	Kabuki syndrome 2	300867	XLD	3	Kdm6a
Xp11.3	X:46599251-46759118	SLC9A7, NHE7, MRX108	Solute carrier family 9 (sodium/hydrogen exchanger), member 7	300368	SLC9A7	84679	ENSG00000065923,ENST00000616978;;;ENST00000616978		Intellectual developmental disorder, X-linked 108	301024	XLR	3	Slc9a7
Xp11.3	X:46837043-46882358	RP2	RP2 activator of ARL3 GTPase	300757	RP2	6102	ENSG00000102218,ENST00000218340;;;ENST00000218340		Retinitis pigmentosa 2	312600	XL	3	Rp2
Xp11.3	X:47142216-47145491	NDUFB11, LSDMCA3, MC1DN30	NADH-ubiquinone oxidoreductase subunit B11	300403	NDUFB11	54539	ENSG00000147123,ENST00000377811;;;ENST00000377811	mutation identified in 1 MC1DN30 patient	?Mitochondrial complex I deficiency, nuclear type 30	301021	XL	3	Ndufb11,Ndufb11b
Xp11.3	X:47142216-47145491	NDUFB11, LSDMCA3, MC1DN30	NADH-ubiquinone oxidoreductase subunit B11	300403	NDUFB11	54539	ENSG00000147123,ENST00000377811;;;ENST00000377811	mutation identified in 1 MC1DN30 patient	Linear skin defects with multiple congenital anomalies 3	300952	XLD	3	Ndufb11,Ndufb11b
Xp11.3	X:47145221-47186813	RBM10, DXS8237E, KIAA0122, TARPS	RNA-binding motif protein 10	300080	RBM10	8241	ENSG00000182872,ENST00000377604;;;ENST00000377604		TARP syndrome	311900	XLR	3	Rbm10
Xp11.3	X:47190847-47215128	UBA1, UBE1, GXP1, A1ST, SMAX2, AMCX1, VEXAS	Ubiquitin-like modifier activating enzyme 1	314370	UBA1	7317	ENSG00000130985,ENST00000335972;;;ENST00000335972	escapes inactivation	Spinal muscular atrophy, X-linked 2, infantile	301830	XLR	3	Uba1
Xp11.3	X:47190847-47215128	UBA1, UBE1, GXP1, A1ST, SMAX2, AMCX1, VEXAS	Ubiquitin-like modifier activating enzyme 1	314370	UBA1	7317	ENSG00000130985,ENST00000335972;;;ENST00000335972	escapes inactivation	VEXAS syndrome, somatic	301054		3	Uba1
Xp11.3-p11.23	X:47571901-47619857	SYN1, EPILX1, MRX50	Synapsin I	313440	SYN1	6853	ENSG00000008056,ENST00000295987;;;ENST00000295987		Epilepsy, X-linked 1, with variable learning disabilities and behavior disorders	300491	XL	3	Syn1
Xp11.3-p11.23	X:47571901-47619857	SYN1, EPILX1, MRX50	Synapsin I	313440	SYN1	6853	ENSG00000008056,ENST00000295987;;;ENST00000295987		Intellectual developmental disorder, X-linked 50	300115	XL	3	Syn1
Xp11.23-p11.22	X:47600001-54800000	DUPXp11.23p11.22, CXDUPp11.23p11.22	Chromosome Xp11.23-p11.22 duplication syndrome	300801					Chromosome Xp11.23-p11.22 duplication syndrome	300801	XLD	4	
Xp11.2	X:47600001-58100000	SDSX, MRXSDS	Intellectual developmental disorder, X-linked, syndromic, Stocco dos Santos type	300434					Intellectual developmental disorder, X-linked, syndromic, Stocco dos Santos type	300434	XL	2	
Xp11.2-q12	X:47600001-68500000	XLID81, MRX81	Intellectual developmental disorder, X-linked 81	300433		266678		between DXS1039 and DXS1216	Intellectual developmental disorder, X-linked 81	300433	XLR	2	
Xp11.23	X:47623282-47630305	CFP, PFC, PFD	Complement factor properdin	300383	CFP	5199	ENSG00000126759,ENST00000396992;;;ENST00000396992		Properdin deficiency, X-linked	312060	XLR	3	Cfp
Xp11.23	X:48255392-48267444	SSX1, SSRC, SPGFX5	Synovial sarcoma, X breakpoint 1	312820	SSX1	6756	ENSG00000126752,ENST00000376919;;;ENST00000376919		Spermatogenic failure, X-linked, 5	301099	XL	3	Ssxa1,Ssxb1,Ssxb10,Ssxb13,Ssxb14,Ssxb15,Ssxb16,Ssxb3,Ssxb5,Ssxb6,Ssxb8,Ssxb9
Xp11.23	X:48476199-48486364	FTSJ1, JM23, SPB1, MRX44, MRX9, XLID9	FTSJ RNA 2-prime-O-methyltransferase 1	300499	FTSJ1	24140	ENSG00000068438,ENST00000348411;;;ENST00000348411		Intellectual developmental disorder, X-linked 9	309549	XLR	3	Ftsj1
Xp11.23	X:48508992-48520814	PORCN, PORC, DHOF, FODH	Porcupine O-acyltransferase	300651	PORCN	64840	ENSG00000102312,ENST00000326194;;;ENST00000326194		Focal dermal hypoplasia	305600	XLD	3	Porcn
Xp11.23	X:48521808-48528716	EBP, CDPX2, CPXD, CPX, MEND	Emopamil-binding protein	300205	EBP	10682	ENSG00000147155,ENST00000495186;;;ENST00000495186		Chondrodysplasia punctata, X-linked dominant	302960	XLD	3	Ebp
Xp11.23	X:48521808-48528716	EBP, CDPX2, CPXD, CPX, MEND	Emopamil-binding protein	300205	EBP	10682	ENSG00000147155,ENST00000495186;;;ENST00000495186		MEND syndrome	300960	XLR	3	Ebp
Xp11.23	X:48676636-48691427	WAS, IMD2, THC1, SCNX	WASP actin nucleation promoting factor	300392	WAS	7454	ENSG00000015285,ENST00000376701;;;ENST00000376701	t(18;X)(q11.2;p11.2); distal to TIMP	Neutropenia, severe congenital, X-linked	300299	XLR	3	Was
Xp11.23	X:48676636-48691427	WAS, IMD2, THC1, SCNX	WASP actin nucleation promoting factor	300392	WAS	7454	ENSG00000015285,ENST00000376701;;;ENST00000376701	t(18;X)(q11.2;p11.2); distal to TIMP	Thrombocytopenia, X-linked	313900	XLR	3	Was
Xp11.23	X:48676636-48691427	WAS, IMD2, THC1, SCNX	WASP actin nucleation promoting factor	300392	WAS	7454	ENSG00000015285,ENST00000376701;;;ENST00000376701	t(18;X)(q11.2;p11.2); distal to TIMP	Thrombocytopenia, X-linked, intermittent	313900	XLR	3	Was
Xp11.23	X:48676636-48691427	WAS, IMD2, THC1, SCNX	WASP actin nucleation promoting factor	300392	WAS	7454	ENSG00000015285,ENST00000376701;;;ENST00000376701	t(18;X)(q11.2;p11.2); distal to TIMP	Wiskott-Aldrich syndrome	301000	XLR	3	Was
Xp11.23	X:48786590-48794311	GATA1, GF1, ERYF1, NFE1, XLTDA, XLTT, XLANP, CNSHA9	GATA-binding protein-1 (globin transcription factor-1)	305371	GATA1	2623	ENSG00000102145,ENST00000376670;;;ENST00000376670		Anemia, congenital, nonspherocytic hemolytic, 9	301083	XLR	3	Gata1
Xp11.23	X:48786590-48794311	GATA1, GF1, ERYF1, NFE1, XLTDA, XLTT, XLANP, CNSHA9	GATA-binding protein-1 (globin transcription factor-1)	305371	GATA1	2623	ENSG00000102145,ENST00000376670;;;ENST00000376670		Anemia, X-linked, with/without neutropenia and/or platelet abnormalities	300835	XLR	3	Gata1
Xp11.23	X:48786590-48794311	GATA1, GF1, ERYF1, NFE1, XLTDA, XLTT, XLANP, CNSHA9	GATA-binding protein-1 (globin transcription factor-1)	305371	GATA1	2623	ENSG00000102145,ENST00000376670;;;ENST00000376670		Leukemia, megakaryoblastic, with or without Down syndrome, somatic	159595		3	Gata1
Xp11.23	X:48786590-48794311	GATA1, GF1, ERYF1, NFE1, XLTDA, XLTT, XLANP, CNSHA9	GATA-binding protein-1 (globin transcription factor-1)	305371	GATA1	2623	ENSG00000102145,ENST00000376670;;;ENST00000376670		Thrombocytopenia with beta-thalassemia, X-linked	314050	XLR	3	Gata1
Xp11.23	X:48786590-48794311	GATA1, GF1, ERYF1, NFE1, XLTDA, XLTT, XLANP, CNSHA9	GATA-binding protein-1 (globin transcription factor-1)	305371	GATA1	2623	ENSG00000102145,ENST00000376670;;;ENST00000376670		Thrombocytopenia, X-linked, with or without dyserythropoietic anemia	300367	XLR	3	Gata1
Xp11.23	X:48801398-48824982	HDAC6, CPBHM	Histone deacetylase 6	300272	HDAC6	10013	ENSG00000094631,ENST00000334136;;;ENST00000334136	mutation identified in 1 CPBHM family	?Chondrodysplasia with platyspondyly, distinctive brachydactyly, hydrocephaly, and microphthalmia	300863	XLD	3	Hdac6
Xp11.23	X:48897930-48903143	PQBP1, NPW38, SHS, MRX55, MRXS3, RENS1, MRXS8	Polyglutamine-binding protein 1	300463	PQBP1	10084	ENSG00000102103,ENST00000447146;;;ENST00000447146		Renpenning syndrome	309500	XLR	3	Pqbp1
Xp11.23	X:48903183-48911958	SLC35A2, UGALT, UGTL, UGT2, CDGX, CDG2M	Solute carrier family 35 (UDP-galactose transporter), member 2	314375	SLC35A2	7355	ENSG00000102100,ENST00000247138;;;ENST00000247138		Congenital disorder of glycosylation, type IIm	300896	SMo, XLD	3	Slc35a2
Xp11.23	X:48922024-48958381	OTUD5, DUBA, MCAND	OTU domain-containing protein 5	300713	OTUD5	55593	ENSG00000068308,ENST00000376488;;;ENST00000376488		Multiple congenital anomalies-neurodevelopmental syndrome, X-linked	301056	XLR	3	Otud5
Xp11.23	X:49028726-49043357	TFE3, RCCX1, MRXSPF	Transcription factor for IgH enhancer	314310	TFE3	7030	ENSG00000068323,ENST00000315869;;;ENST00000315869	fuses with PRCC in RCCP	Intellectual developmental disorder, X-linked syndromic, with pigmentary mosaicism and coarse facies	301066	XL	3	Tfe3
Xp11.23	X:49028726-49043357	TFE3, RCCX1, MRXSPF	Transcription factor for IgH enhancer	314310	TFE3	7030	ENSG00000068323,ENST00000315869;;;ENST00000315869	fuses with PRCC in RCCP	Renal cell carcinoma, papillary, 1	300854		3	Tfe3
Xp11.23	X:49074442-49101178	WDR45, WIPI4, NBIA5	WD repeat-containing protein 45	300526	WDR45	11152	ENSG00000196998,ENST00000376372;;;ENST00000376372	?pseudogene on 4q31.3	Neurodegeneration with brain iron accumulation 5	300894	XLD	3	Wdr45
Xp11.23	X:49174802-49186373	PRICKLE3, LMO6, LOAM	Prickle, Drosophila, homolog of, 3	300111	PRICKLE3	4007	ENSG00000012211,ENST00000599218;;;ENST00000599218		{Leber hereditary optic neuropathy, modifier of}	308905	XLD	3	Prickle3
Xp11.23	X:49187815-49200193	SYP, XLID96	Synaptophysin	313475	SYP	6855	ENSG00000102003,ENST00000263233;;;ENST00000263233		Intellectual developmental disorder, X-linked 96	300802	XLR	3	Syp
Xp11.23	X:49205063-49233340	CACNA1F, CSNB2, CORDX3, CSNB2A, AIED, OA2	Calcium channel, voltage-dependent, alpha-1F subunit	300110	CACNA1F	778	ENSG00000102001,ENST00000323022;;;ENST00000323022		Aland Island eye disease	300600	XL	3	Cacna1f
Xp11.23	X:49205063-49233340	CACNA1F, CSNB2, CORDX3, CSNB2A, AIED, OA2	Calcium channel, voltage-dependent, alpha-1F subunit	300110	CACNA1F	778	ENSG00000102001,ENST00000323022;;;ENST00000323022		Cone-rod dystrophy, X-linked, 3	300476	XLR	3	Cacna1f
Xp11.23	X:49205063-49233340	CACNA1F, CSNB2, CORDX3, CSNB2A, AIED, OA2	Calcium channel, voltage-dependent, alpha-1F subunit	300110	CACNA1F	778	ENSG00000102001,ENST00000323022;;;ENST00000323022		Night blindness, congenital stationary (incomplete), 2A, X-linked	300071	XL	3	Cacna1f
Xp11.23	X:49235470-49250520	CCDC22, RTSC2	Coiled-coil domain-containing protein 22	300859	CCDC22	28952	ENSG00000101997,ENST00000376227;;;ENST00000376227		Ritscher-Schinzel syndrome 2	300963	XLR	3	Ccdc22
Xp11.23	X:49250438-49264710	FOXP3, IPEX, AIID, XPID, PIDX	Forkhead box P3 (scurfin)	300292	FOXP3	50943	ENSG00000049768,ENST00000376207;;;ENST00000376207		Immunodysregulation, polyendocrinopathy, and enteropathy, X-linked	304790	XLR	3	Foxp3
Xp11.23	X:49879484-49882558	USP27X, USP22L, XLID105	Ubiquitin-specific protease 27, X-linked	300975	USP27X	389856	ENSG00000273820,ENST00000621775;;;ENST00000621775		Intellectual developmental disorder, X-linked 105	300984	XLR	3	Usp27x
Xp11.23	X:49922596-50099230	CLCN5, CLCK2, NPHL2, DENT1, NPHL1	Chloride channel-5	300008	CLCN5	1184	ENSG00000171365,ENST00000376091;;;ENST00000376091		Dent disease 1	300009	XLR	3	Clcn5
Xp11.23	X:49922596-50099230	CLCN5, CLCK2, NPHL2, DENT1, NPHL1	Chloride channel-5	300008	CLCN5	1184	ENSG00000171365,ENST00000376091;;;ENST00000376091		Hypophosphatemic rickets	300554	XLR	3	Clcn5
Xp11.23	X:49922596-50099230	CLCN5, CLCK2, NPHL2, DENT1, NPHL1	Chloride channel-5	300008	CLCN5	1184	ENSG00000171365,ENST00000376091;;;ENST00000376091		Nephrolithiasis, type I	310468	XLR	3	Clcn5
Xp11.23	X:49922596-50099230	CLCN5, CLCK2, NPHL2, DENT1, NPHL1	Chloride channel-5	300008	CLCN5	1184	ENSG00000171365,ENST00000376091;;;ENST00000376091		Proteinuria, low molecular weight, with hypercalciuric nephrocalcinosis	308990	XLR	3	Clcn5
Xp11.22	X:50100001-54800000	DUPXp11.22, MRX17, MRX31	Xp11.22 microduplication syndrome	300705				minimal duplicated region 228 kb overlapping HUWE1 and HSD17B10	Xp11.22 microduplication syndrome	300705		4	
Xp11.22	X:50100001-54800000	HPCX2	Prostate cancer, hereditary, X-linked 2	300704		100188769		associated with rs5945572	{Prostate cancer, hereditary, X-linked 2}	300704		2	
Xp11.22	X:50100001-54800000	HYSP4	Hypospadias 4, X-linked, susceptibility to	300856		100689214		associated with rs1934179 and rs7063116	{Hypospadias 4, X-linked, susceptibility to}	300856		2	
Xp11.22	X:50910735-50916641	BMP15, GDF9B, ODG2, POF4	Bone morphogenetic protein 15	300247	BMP15	9210	ENSG00000130385,ENST00000252677;;;ENST00000252677		Ovarian dysgenesis 2	300510	XL	3	Bmp15
Xp11.22	X:50910735-50916641	BMP15, GDF9B, ODG2, POF4	Bone morphogenetic protein 15	300247	BMP15	9210	ENSG00000130385,ENST00000252677;;;ENST00000252677		Premature ovarian failure 4	300510	XL	3	Bmp15
Xp11.22	X:53176277-53225207	KDM5C, JARID1C, SMCX, DXS1272E, XE169, MRXSCJ, MRXS16	Lysine demethylase 5C	314690	KDM5C	8242	ENSG00000126012,ENST00000375401;;;ENST00000375401	escapes inactivation	Intellectual developmental disorder, X-linked syndromic, Claes-Jensen type	300534	XLR	3	Kdm5c
Xp11.22	X:53225813-53321350	IQSEC2, KIAA0522, MRX1, MRX78, XLID1	IQ motif- and Sec7 domain-containing protein 2	300522	IQSEC2	23096	ENSG00000124313,ENST00000642864;;;ENST00000642864		Intellectual developmental disorder, X-linked 1	309530	XLD	3	Iqsec2
Xp11.22	X:53374149-53422728	SMC1A, SMC1L1, SMC1, DXS423E, KIAA0178, CDLS2, DEE85	Segregation of mitotic chromosomes 1 (SMC1, yeast, homolog of; DXS423E; SB1.8)	300040	SMC1A	8243	ENSG00000072501,ENST00000322213;;;ENST00000322213	escapes lyonization	Cornelia de Lange syndrome 2	300590	XLD	3	Smc1a
Xp11.22	X:53374149-53422728	SMC1A, SMC1L1, SMC1, DXS423E, KIAA0178, CDLS2, DEE85	Segregation of mitotic chromosomes 1 (SMC1, yeast, homolog of; DXS423E; SB1.8)	300040	SMC1A	8243	ENSG00000072501,ENST00000322213;;;ENST00000322213	escapes lyonization	Developmental and epileptic encephalopathy 85, with or without midline brain defects	301044	XLD	3	Smc1a
Xp11.22	X:53431258-53434376	HSD17B10, HADH2, ERAB, MRXS10, HSD10MD	17-beta-hydroxysteroid dehydrogenase X	300256	HSD17B10	3028	ENSG00000072506,ENST00000168216;;;ENST00000168216		HSD10 mitochondrial disease	300438	XLD	3	Hsd17b10
Xp11.22	X:53532096-53686719	HUWE1, UREB1, KIAA0312, LASU1, MRXST	HECT, UBA, and WWE domains-containing protein 1	300697	HUWE1	10075	ENSG00000086758,ENST00000262854;;;ENST00000262854		Intellectual developmental disorder, X-linked syndromic, Turner type	309590	XL	3	Huwe1
Xp11.22	X:53936680-54048936	PHF8, ZNF422, KIAA1111, MRXSSD	PHD finger protein 8	300560	PHF8	23133	ENSG00000172943,ENST00000338154;;;ENST00000338154		Intellectual developmental disorder, X-linked syndromic, Siderius type	300263	XLR	3	Phf8
Xp11.22	X:54192823-54358900	WNK3, PRKWNK3, KIAA1566, PRS	WNK lysine deficient protein kinase 3	300358	WNK3	65267	ENSG00000196632,ENST00000354646;;;ENST00000354646		Prieto syndrome	309610	XLR	3	Wnk3
Xp11.22	X:54440404-54448032	TSR2, WGG1, DBA14	TSR2, 20S rRNA accumulation, S. cerevisiae, homolog of	300945	TSR2	90121	ENSG00000158526,ENST00000375151;;;ENST00000375151	mutation identified in 1 DBA14 family	?Diamond-Blackfan anemia 14 with mandibulofacial dysostosis	300946	XLR	3	Tsr2
Xp11.22	X:54445454-54496234	FGD1, FGDY, AAS	FYVE, RhoGEF, and PH domain-containing protein 1	300546	FGD1	2245	ENSG00000102302,ENST00000375135;;;ENST00000375135		Aarskog-Scott syndrome	305400	XLR	3	Fgd1
Xp11.21	X:54807745-54816015	MAGED2, MAGED, BARTS5	Melanoma antigen, family D, 2	300470	MAGED2	10916	ENSG00000102316,ENST00000375068;;;ENST00000375068		Bartter syndrome, type 5, antenatal, transient	300971	XLR	3	Maged2
Xp11.21	X:55009055-55030977	ALAS2, ANH1, ASB, XLEPP, XLSA, SIDBA1	Aminolevulinate, delta-, synthase-2	301300	ALAS2	212	ENSG00000158578,ENST00000650242;;;ENST00000650242		Anemia, sideroblastic, 1	300751	XLR	3	Alas2
Xp11.21	X:55009055-55030977	ALAS2, ANH1, ASB, XLEPP, XLSA, SIDBA1	Aminolevulinate, delta-, synthase-2	301300	ALAS2	212	ENSG00000158578,ENST00000650242;;;ENST00000650242		Protoporphyria, erythropoietic, X-linked	300752	XL	3	Alas2
Xp11.21	X:56563627-56567868	UBQLN2, PLIC2, CHAP1, ALS15	Ubiquilin 2	300264	UBQLN2	29978	ENSG00000188021,ENST00000338222;;;ENST00000338222		Amyotrophic lateral sclerosis 15, with or without frontotemporal dementia	300857	XLD	3	Ubqln2
Xq11-q12	X:61000001-68500000	AGA2	Alopecia, androgenetic, 2	300710		100188771		associated with rs6152	Alopecia, androgenetic, 2	300710		2	
Xq	X:61000001-156040895	CGF1	Cognitive function-1, social	300082		1083		imprinted locus	[Social cognition]	300082	XL	2	
Xq	X:61000001-156040895	MGR2	Migraine, familial typical, susceptibility to, 2	300125		8249			{Migraine, familial typical, susceptibility to, 2}	300125	XL	2	
Xq	X:61000001-156040895	MTBSX	Mycobacterium tuberculosis, susceptibility to, X-linked	300259		57789			{Mycobacterium tuberculosis, susceptibility, X-linked}	300259		2	
Xq11.1	X:63347228-63351332	SPIN4, LJBS	Spindlin family, member 4	301113	SPIN4	139886	ENSG00000186767,ENST00000374884;;;ENST00000374884	mutation identified in 1 LJBS family	?Lui-Jee-Baron syndrome	301114	XL	3	Spin4
Xq11.1	X:63634967-63785214	ARHGEF9, PEM2, KIAA0424, DEE8	Rho guanine nucleotide exchange factor 9	300429	ARHGEF9	23229	ENSG00000131089,ENST00000671741;;;ENST00000671741		Developmental and epileptic encephalopathy 8	300607	XL	3	Arhgef9
Xq11.2	X:63800001-65400000	SPG16	Spastic paraplegia 16, X-linked, complicated	300266		57760			Spastic paraplegia 16, X-linked, complicated	300266	XLR	2	
Xq11.2	X:64185117-64205708	AMER1, FAM123B, WTX, OSCS	APC membrane recruitment protein 1	300647	AMER1	139285	ENSG00000184675,ENST00000374869;;;ENST00000374869		Osteopathia striata with cranial sclerosis	300373	XLD	3	Amer1
Xq11.2	X:64915807-65034741	ZC4H2, KIAA1166, WRWF, MRXS4, WRWFFR	Zinc finger C4H2 domain-containing protein	300897	ZC4H2	55906	ENSG00000126970,ENST00000374839;;;ENST00000374839		Wieacker-Wolff syndrome	314580	XLR	3	Zc4h2
Xq11.2	X:64915807-65034741	ZC4H2, KIAA1166, WRWF, MRXS4, WRWFFR	Zinc finger C4H2 domain-containing protein	300897	ZC4H2	55906	ENSG00000126970,ENST00000374839;;;ENST00000374839		Wieacker-Wolff syndrome, female-restricted	301041	XLD	3	Zc4h2
Xq12-q21.31	X:65400001-92700000	MRXS9	Intellectual developmental disorder, X-linked, syndromic 9	300709				between DXS1111 and DXS1197	Intellectual developmental disorder, X-linked syndromic 9	300709		2	
Xq12-q21.3	X:65400001-99100000	XLID77, MRX77	Intellectual developmental disorder, X-linked 77	300454		93991			Intellectual developmental disorder, X-linked 77	300454	XLR	2	
Xq12	X:65512582-65534787	LAS1L, MRXSWTS	Las1-like ribosome biogenesis factor	300964	LAS1L	81887	ENSG00000001497,ENST00000374811;;;ENST00000374811		Wilson-Turner syndrome	309585	XLR	3	Las1l
Xq12	X:65588377-65741931	MSN, IMD50	Moesin	309845	MSN	4478	ENSG00000147065,ENST00000360270;;;ENST00000360270		Immunodeficiency 50	300988	XLR	3	Msn
Xq12	X:67544021-67730619	AR, DHTR, TFM, SBMA, KD, SMAX1, HYSP1	Androgen receptor (dihydrotestosterone receptor)	313700	AR	367	ENSG00000169083,ENST00000374690;;;ENST00000374690		{Prostate cancer, susceptibility to}	301120	XL	3	Ar
Xq12	X:67544021-67730619	AR, DHTR, TFM, SBMA, KD, SMAX1, HYSP1	Androgen receptor (dihydrotestosterone receptor)	313700	AR	367	ENSG00000169083,ENST00000374690;;;ENST00000374690		Androgen insensitivity	300068	XLR	3	Ar
Xq12	X:67544021-67730619	AR, DHTR, TFM, SBMA, KD, SMAX1, HYSP1	Androgen receptor (dihydrotestosterone receptor)	313700	AR	367	ENSG00000169083,ENST00000374690;;;ENST00000374690		Androgen insensitivity, partial, with or without breast cancer	312300	XLR	3	Ar
Xq12	X:67544021-67730619	AR, DHTR, TFM, SBMA, KD, SMAX1, HYSP1	Androgen receptor (dihydrotestosterone receptor)	313700	AR	367	ENSG00000169083,ENST00000374690;;;ENST00000374690		Hypospadias 1, X-linked	300633	XLR	3	Ar
Xq12	X:67544021-67730619	AR, DHTR, TFM, SBMA, KD, SMAX1, HYSP1	Androgen receptor (dihydrotestosterone receptor)	313700	AR	367	ENSG00000169083,ENST00000374690;;;ENST00000374690		Spinal and bulbar muscular atrophy, X-linked 1	313200	XLR	3	Ar
Xq12	X:68042344-68433841	OPHN1, MRXSBL	Oligophrenin-1	300127	OPHN1	4983	ENSG00000079482,ENST00000355520;;;ENST00000355520		Intellectual developmental disorder, X-linked syndromic, Billuart type	300486	XLR	3	Ophn1
Xq13.1-q22.1	X:68500001-103300000	CFTDX	Myopathy, congenital, with fiber-type disproportion, X-linked	300580		100188765		between DXS8019 and DXS99	Myopathy, congenital, with fiber-type disproportion, X-linked	300580	XLD	2	
Xq13-q21	X:68500001-99100000	MRXSMP	Martin-Probst syndrome	300519		574047			Martin-Probst syndrome	300519	XLR	2	
Xq13.1	X:68829021-68842160	EFNB1, EPLG2, CFNS, CFND	eph-related receptor tyrosine kinase ligand 2 (ephrin B1)	300035	EFNB1	1947	ENSG00000090776,ENST00000204961;;;ENST00000204961	?CFNS also on Xp22	Craniofrontonasal dysplasia	304110	XLD	3	Efnb1
Xq13.1	X:69616113-70039472	EDA, ED1, ECTD1, HED1, STHAGX1	Ectodysplasin A	300451	EDA	1896	ENSG00000158813,ENST00000374552;;;ENST00000374552		Ectodermal dysplasia 1, hypohidrotic, X-linked	305100	XLR	3	Eda
Xq13.1	X:69616113-70039472	EDA, ED1, ECTD1, HED1, STHAGX1	Ectodysplasin A	300451	EDA	1896	ENSG00000158813,ENST00000374552;;;ENST00000374552		Tooth agenesis, selective, X-linked 1	313500	XLD	3	Eda
Xq13.1	X:70133447-70166324	IGBP1, MRXS28	Immunoglobulin-binding protein 1	300139	IGBP1	3476	ENSG00000089289,ENST00000356413;;;ENST00000356413	mutation identified in 1 MRXS28 family	?Corpus callosum, agenesis of, with impaired intellectual development, ocular coloboma and micrognathia	300472	XLR	3	Igbp1
Xq13.1	X:70268334-70281883	ARR3, MYP26	Arrestin 3, retinal	301770	ARR3	407	ENSG00000120500,ENST00000307959;;;ENST00000307959		Myopia 26, X-linked, female-limited	301010	XL	3	Arr3
Xq13.1	X:70290104-70420886	KIF4A, KIF4, XLID100, TMDI	Kinesin family member 4A	300521	KIF4A	24137	ENSG00000090889,ENST00000374403;;;ENST00000374403		Intellectual developmental disorder, X-linked 100	300923	XLR	3	Kif4
Xq13.1	X:70290104-70420886	KIF4A, KIF4, XLID100, TMDI	Kinesin family member 4A	300521	KIF4A	24137	ENSG00000090889,ENST00000374403;;;ENST00000374403		Taurodontism, microdontia, and dens invaginatus	313490	XLR	3	Kif4
Xq13.1	X:70444835-70505490	DLG3, NEDLG, SAP102, XLID90	Discs large MAGUK scaffold protein 3	300189	DLG3	1741	ENSG00000082458,ENST00000374360;;;ENST00000374360		Intellectual developmental disorder, X-linked 90	300850	XLR	3	Dlg3
Xq13.1	X:70511227-70908711	TEX11, SPGFX2	Testis-expressed gene 11	300311	TEX11	56159	ENSG00000120498,ENST00000374333;;;ENST00000374333		Spermatogenic failure, X-linked 2	309120	XLR	3	Tex11
Xq13.1	X:71107404-71111577	IL2RG, SCIDX1, SCIDX, IMD4	Interleukin-2 receptor, gamma	308380	IL2RG	3561	ENSG00000147168,ENST00000374202;;;ENST00000374202	linked to DXS159	Combined immunodeficiency, X-linked, moderate	312863	XLR	3	Il2rg
Xq13.1	X:71107404-71111577	IL2RG, SCIDX1, SCIDX, IMD4	Interleukin-2 receptor, gamma	308380	IL2RG	3561	ENSG00000147168,ENST00000374202;;;ENST00000374202	linked to DXS159	Severe combined immunodeficiency, X-linked	300400	XLR	3	Il2rg
Xq13.1	X:71118596-71142450	MED12, TNRC11, TRAP230, HOPA, KIAA0192, OKS, FGS1, OHDOX, HDKR	Mediator complex subunit 12	300188	MED12	9968	ENSG00000184634,ENST00000374080;;;ENST00000374080		Hardikar syndrome	301068	XLD	3	Med12
Xq13.1	X:71118596-71142450	MED12, TNRC11, TRAP230, HOPA, KIAA0192, OKS, FGS1, OHDOX, HDKR	Mediator complex subunit 12	300188	MED12	9968	ENSG00000184634,ENST00000374080;;;ENST00000374080		Lujan-Fryns syndrome	309520	XLR	3	Med12
Xq13.1	X:71118596-71142450	MED12, TNRC11, TRAP230, HOPA, KIAA0192, OKS, FGS1, OHDOX, HDKR	Mediator complex subunit 12	300188	MED12	9968	ENSG00000184634,ENST00000374080;;;ENST00000374080		Ohdo syndrome, X-linked	300895	XLR	3	Med12
Xq13.1	X:71118596-71142450	MED12, TNRC11, TRAP230, HOPA, KIAA0192, OKS, FGS1, OHDOX, HDKR	Mediator complex subunit 12	300188	MED12	9968	ENSG00000184634,ENST00000374080;;;ENST00000374080		Opitz-Kaveggia syndrome	305450	XLR	3	Med12
Xq13.1	X:71144841-71175307	NLGN3, AUTSX1	Neuroligin 3	300336	NLGN3	54413	ENSG00000196338,ENST00000358741;;;ENST00000358741		{Autism susceptibility, X-linked 1}	300425	XL	3	Nlgn3
Xq13.1	X:71215239-71225516	GJB1, CX32, CMTX1	Gap junction protein, beta-1, 32kD (connexin 32)	304040	GJB1	2705	ENSG00000169562,ENST00000361726;;;ENST00000361726		Charcot-Marie-Tooth neuropathy, X-linked dominant, 1	302800	XLD	3	Gjb1
Xq13.1	X:71239624-71255290	ZMYM3, ZNF261, DXS6673E, XLID112	Zinc finger, MYM-type 3	300061	ZMYM3	9203	ENSG00000147130,ENST00000314425;;;ENST00000314425		Intellectual developmental disorder, X-linked 112	301111	XLR	3	Zmym3
Xq13.1	X:71283635-71301168	NONO, NRB54, MRXS34	Non-Pou domain-containing octamer (ATGCAAAT) binding protein (nuclear RNA-binding protein, 54-kD)	300084	NONO	4841	ENSG00000147140,ENST00000276079;;;ENST00000276079	2Mb proximal to PHKA1	Intellectual developmental disorder, X-linked syndromic 34	300967	XL	3	Nono
Xq13.1	X:71366357-71530525	TAF1, TAF2A, CCG1, BA2R, DYT3, MRXS33	TATA-box binding protein-associated factor 1	313650	TAF1	6872	ENSG00000147133,ENST00000423759;;;ENST00000423759	SVA retrotransposon insertion	Dystonia-Parkinsonism, X-linked	314250	XLR	3	Taf1
Xq13.1	X:71366357-71530525	TAF1, TAF2A, CCG1, BA2R, DYT3, MRXS33	TATA-box binding protein-associated factor 1	313650	TAF1	6872	ENSG00000147133,ENST00000423759;;;ENST00000423759	SVA retrotransposon insertion	Intellectual developmental disorder, X-linked syndromic 33	300966	XLR	3	Taf1
Xq13.1	X:71533104-71575892	OGT, XLID106	O-linked N-acetylglucosamine transferase	300255	OGT	8473	ENSG00000147162,ENST00000373719;;;ENST00000373719		Intellectual developmental disorder, X-linked 106	300997	XLR	3	Ogt
Xq13.1	X:71578437-71613583	GCNA, ACRC, SPGFX4	Germ cell nuclear acidic peptidase	300369	GCNA	93953	ENSG00000147174,ENST00000373696;;;ENST00000373696		Spermatogenic failure, X-linked, 4	301077	XL	3	
Xq13.1	X:72329516-72572843	HDAC8, MRXS6, CDLS5	Histone deacetylase 8	300269	HDAC8	55869	ENSG00000147099,ENST00000373573;;;ENST00000373573		Cornelia de Lange syndrome 5	300882	XLD	3	Hdac8
Xq13.1	X:72578814-72714306	PHKA1	Phosphorylase kinase, muscle, alpha polypeptide	311870	PHKA1	5255	ENSG00000067177,ENST00000373542;;;ENST00000373542	?proximal and close to PGKA;	Muscle glycogenosis	300559	XLR	3	Phka1
Xq13.2-q13.3	X:73000001-76800000	DUPXq13	Chromosome Xq13 duplication syndrome	301069					Chromosome Xq13 duplication syndrome	301069	XL	4	
Xq13.2	X:73000001-74700000	MRXSAB	Intellectual developmental disorder, X-linked, Abidi type	300262		57792			Intellectual developmental disorder, X-linked syndromic, Abidi type	300262	XL	2	
Xq13.2	X:73820656-73852714	XIC, XCE, XIST, SXI1	X chromosome controlling element (X-inactivation center)	314670	XIST	7503	ENSG00000229807,ENST00000429829;;;ENST00000429829	q13-q21; metaphase bend, or fold, at q13.3-q21.1	X-inactivation, familial skewed	300087	XL	3	Xist
Xq13.2	X:74421493-74533916	SLC16A2, DXS128, XPCT	Solute carrier family 16 (monocarboxylic acid transporters), member 2	300095	SLC16A2	6567	ENSG00000147100,ENST00000587091;;;ENST00000587091		Allan-Herndon-Dudley syndrome	300523	XL	3	Slc16a2
Xq13.2	X:74582976-74614624	RLIM, RNF12, TOKAS	RING finger protein, LIM domain-interacting	300379	RLIM	51132	ENSG00000131263,ENST00000332687;;;ENST00000332687		Tonne-Kalscheuer syndrome	300978	XL	3	Rlim
Xq13.3	X:74700001-76800000	XLID91, MRX91	Intellectual developmental disorder, X-linked 91	300577				t(X;15)(q13.3;cen)	Intellectual developmental disorder, X-linked 91	300577	XLD	4	
Xq13.3	X:74732856-74925452	NEXMIF, KIAA2022, XLID98	Neurite extension and migration factor	300524	NEXMIF	340533	ENSG00000050030,ENST00000055682;;;ENST00000055682	inv(X)(q13;p22)	Intellectual developmental disorder, X-linked 98	300912	XLD	3	Nexmif
Xq13.3	X:75051048-75156283	ABCB7, ABC7, ASAT	ATP-binding cassette-7	300135	ABCB7	22	ENSG00000131269,ENST00000373394;;;ENST00000373394		Anemia, sideroblastic, with ataxia	301310	XL	3	Abcb7
Xq21	X:76800001-99100000	DELXq21, CXDELq21	Chromosome Xq21 deletion syndrome	303110				at least CHM and POU3F4 deleted	Xq21 deletion syndrome	303110	XLR	4	
Xq21-q25	X:76800001-129500000	PARK12	Parkinson disease-12	300557		677662		max lod with DXS1106, DXS8055, DXS1001	{Parkinson disease 12}	300557		2	
Xq21.1	X:77447389-77457278	FGF16, MF4	Fibroblast growth factor 16	300827	FGF16	8823	ENSG00000196468,ENST00000439435;;;ENST00000439435	previously mapped to 8q21.3	Metacarpal 4-5 fusion	309630	XLR	3	Fgf16
Xq21.1	X:77504880-77786216	ATRX, XH2, XNP, SHS, SFM1, MRXHF1	ATRX chromatin remodeler	300032	ATRX	546	ENSG00000085224,ENST00000373344;;;ENST00000373344		Alpha-thalassemia myelodysplasia syndrome, somatic	300448		3	Atrx
Xq21.1	X:77504880-77786216	ATRX, XH2, XNP, SHS, SFM1, MRXHF1	ATRX chromatin remodeler	300032	ATRX	546	ENSG00000085224,ENST00000373344;;;ENST00000373344		Alpha-thalassemia/impaired intellectual development syndrome	301040	XLD	3	Atrx
Xq21.1	X:77504880-77786216	ATRX, XH2, XNP, SHS, SFM1, MRXHF1	ATRX chromatin remodeler	300032	ATRX	546	ENSG00000085224,ENST00000373344;;;ENST00000373344		Intellectual disability-hypotonic facies syndrome, X-linked	309580	XLR	3	Atrx
Xq21.1	X:77825747-77895568	MAGT1, IAP, XMEN, CDG1CC	Magnesium transporter 1	300715	MAGT1	84061	ENSG00000102158,ENST00000618282;;;ENST00000618282		Congenital disorder of glycosylation, type Icc	301031	XLR	3	Magt1
Xq21.1	X:77825747-77895568	MAGT1, IAP, XMEN, CDG1CC	Magnesium transporter 1	300715	MAGT1	84061	ENSG00000102158,ENST00000618282;;;ENST00000618282		Immunodeficiency, X-linked, with magnesium defect, Epstein-Barr virus infection and neoplasia	300853	XLR	3	Magt1
Xq21.1	X:77899468-77907376	COX7B, LSDMCA2	Cytochrome c oxidase, subunit VIIb	300885	COX7B	1349	ENSG00000131174,ENST00000650309;;;ENST00000650309		Linear skin defects with multiple congenital anomalies 2	300887	XLD	3	Cox7b
Xq21.1	X:77910693-78050395	ATP7A, MNK, MK, OHS, HMNX	ATPase, Cu++ transporting, alpha polypeptide	300011	ATP7A	538	ENSG00000165240,ENST00000341514;;;ENST00000341514	probably Xq13.2-q13.3, ~150kb prox. to PGK1	Menkes disease	309400	XLR	3	Atp7a
Xq21.1	X:77910693-78050395	ATP7A, MNK, MK, OHS, HMNX	ATPase, Cu++ transporting, alpha polypeptide	300011	ATP7A	538	ENSG00000165240,ENST00000341514;;;ENST00000341514	probably Xq13.2-q13.3, ~150kb prox. to PGK1	Neuronopathy, distal hereditary motor, X-linked	300489	XLR	3	Atp7a
Xq21.1	X:77910693-78050395	ATP7A, MNK, MK, OHS, HMNX	ATPase, Cu++ transporting, alpha polypeptide	300011	ATP7A	538	ENSG00000165240,ENST00000341514;;;ENST00000341514	probably Xq13.2-q13.3, ~150kb prox. to PGK1	Occipital horn syndrome	304150	XLR	3	Atp7a
Xq21.1	X:78104248-78129295	PGK1, PGKA	Phosphoglycerate kinase-1	311800	PGK1	5230	ENSG00000102144,ENST00000373316;;;ENST00000373316	?Xq13.3; pseudogenes PGK1P1 on Xq, PGK1P2 on chr. 6	Phosphoglycerate kinase 1 deficiency	300653	XLR	3	Pgk1
Xq21.1	X:80014753-80031774	TBX22, CPX, ABERS	T-box 22	300307	TBX22	50945	ENSG00000122145,ENST00000373296;;;ENST00000373296	1 ABERS family identified with mutation	?Abruzzo-Erickson syndrome	302905	XL	3	Tbx22
Xq21.1	X:80014753-80031774	TBX22, CPX, ABERS	T-box 22	300307	TBX22	50945	ENSG00000122145,ENST00000373296;;;ENST00000373296	1 ABERS family identified with mutation	Cleft palate with ankyloglossia	303400	XL	3	Tbx22
Xq21.1	X:80669503-80809877	BRWD3, MRX93, XLID93	Bromodomain-and WD repeat-containing protein 3	300553	BRWD3	254065	ENSG00000165288,ENST00000373275;;;ENST00000373275		Intellectual developmental disorder, X-linked 93	300659	XLR	3	Brwd3
Xq21.1	X:83508290-83512127	POU3F4, DFN3, DFNX2	POU domain, class 3, transcription factor 4	300039	POU3F4	5456	ENSG00000196767,ENST00000644024;;;ENST00000644024		Deafness, X-linked 2	304400	XLR	3	Pou3f4
Xq21.1	X:83861146-83886698	CYLC1, SPGFX8	Cylicin 1	300768	CYLC1	1538	ENSG00000183035,ENST00000329312;;;ENST00000329312		{Spermatogenic failure, X-linked, 8, susceptibility to}	301119	XL	3	Cylc1
Xq21.1	X:85243991-85273357	ZNF711, ZNF6, CMPX1, XLID97	Zinc finger protein-711	314990	ZNF711	7552	ENSG00000147180,ENST00000674551;;;ENST00000674551		Intellectual developmental disorder, X-linked 97	300803	XL	3	Zfp711
Xq21.1	X:85277396-85379665	FLJ22792, POF1B, POF2B	FLJ22792 gene	300603	POF1B	79983	ENSG00000124429,ENST00000262753;;;ENST00000262753	mutation identified in 1 POF2B family	?Premature ovarian failure 2B	300604	XLR	3	Pof1b
Xq21.2	X:85861180-86047558	CHM, TCD	CHM Rab escort protein	300390	CHM	1121	ENSG00000188419,ENST00000357749;;;ENST00000357749		Choroideremia	303100	XL	3	Chm
Xq21.3	X:87000001-99100000	AD16	Alzheimer disease 16	300756		100271718		associated with rs5984894	{Alzheimer disease 16}	300756		2	
Xq21.33-q23	X:94300001-117400000	MRXSCS	Intellectual developmental disorder, X-linked, syndromic, Chudley-Schwartz type (2)	300861		100820761		max lod at DXS1120	Intellectual developmental disorder, X-linked syndromic, Chudley-Schwartz type	300861	XLR	2	
Xq21.33	X:96684842-97604997	DIAPH2, DIA, POF2A	diaphanous-related formin 2	300108	DIAPH2	1730	ENSG00000147202,ENST00000324765;;;ENST00000324765	mutation identified in 1 POF2A family	?Premature ovarian failure 2A	300511	XLD	3	Diaph2
Xq22-q28	X:99100001-156040895	AI1E2, AIH3	Amelogenesis imperfecta, hypomaturation or hypoplastic type, X-linked 2	301201		201			?Amelogenesis imperfecta, type IE, X-linked 2	301201	XL	2	
Xq22.1	X:100291644-100410273	PCDH19, KIAA1313, EFMR, DEE9	Protocadherin 19	300460	PCDH19	57526	ENSG00000165194,ENST00000373034;;;ENST00000373034		Developmental and epileptic encephalopathy 9	300088	XL	3	Pcdh19
Xq22.1	X:100644199-100675788	SRPX2, SRPUL, RESDX	SUSHI repeat-containing protein, X-linked, 2	300642	SRPX2	27286	ENSG00000102359,ENST00000373004;;;ENST00000373004	mutation identified in 1 RESDX family	?Rolandic epilepsy, impaired intellectual development, and speech dyspraxia	300643		3	Srpx2
Xq22.1	X:100820391-100841520	CSTF2, CSTF64, XLID113	Cleavage stimulation factor, 3-prime pre-RNA, subunit 2, 64kD	300907	CSTF2	1478	ENSG00000101811,ENST00000372972;;;ENST00000372972	mutation identified in 1 XLID113 family	?Intellectual developmental disorder, X-linked 113	301116	XLR	3	Cstf2
Xq22.1	X:101345661-101348742	TIMM8A, DFN1, DDP, MTS, DDP1	Translocase of inner mitochondrial membrane 8A	300356	TIMM8A	1678	ENSG00000126953,ENST00000372902;;;ENST00000372902		Mohr-Tranebjaerg syndrome	304700	XLR	3	Timm8a1
Xq22.1	X:101349450-101390796	BTK, AGMX1, IMD1, XLA, AT, IGHD3	Bruton agammaglobulinemia tyrosine kinase	300300	BTK	695	ENSG00000010671,ENST00000308731;;;ENST00000308731		Agammaglobulinemia, X-linked 1	300755	XLR	3	Btk
Xq22.1	X:101349450-101390796	BTK, AGMX1, IMD1, XLA, AT, IGHD3	Bruton agammaglobulinemia tyrosine kinase	300300	BTK	695	ENSG00000010671,ENST00000308731;;;ENST00000308731		Isolated growth hormone deficiency, type III, with agammaglobulinemia	307200	XLR	3	Btk
Xq22.1	X:101397803-101407925	GLA	Galactosidase, alpha	300644	GLA	2717	ENSG00000102393,ENST00000218516;;;ENST00000218516		Fabry disease	301500	XL	3	Gla
Xq22.1	X:101397803-101407925	GLA	Galactosidase, alpha	300644	GLA	2717	ENSG00000102393,ENST00000218516;;;ENST00000218516		Fabry disease, cardiac variant	301500	XL	3	Gla
Xq22.1	X:101408222-101414133	HNRNPH2, NRPH2, MRXSB	Heterogeneous nuclear ribonucleoprotein H2	300610	HNRNPH2	3188	ENSG00000126945,ENST00000316594;;;ENST00000316594		Intellectual developmental disorder, X-linked syndromic, Bain type	300986	XLD	3	Hnrnph2
Xq22.1	X:102712448-102717733	GPRASP2, GASP2, DFNX7	G protein-coupled receptor-associated sorting protein 2	300969	GPRASP2	114928	ENSG00000158301,ENST00000483720;;;ENST00000483720	mutation identified in 1 DFNX7 family	?Deafness, X-linked 7	301018	XLR	3	Gprasp2
Xq22.2-q26	X:103300001-138900000	XLID53, MRX53	Intellectual developmental disorder, X-linked 53	300324		4416			Intellectual developmental disorder, X-linked 53	300324	XLR	2	
Xq22.2	X:103628716-103630953	TCEAL1, P21, SIIR, HIJRS	Transcription elongation factor A-like 1	300237	TCEAL1	9338	ENSG00000172465,ENST00000372625;;;ENST00000372625		Hijazi-Reis syndrome	301094	XLD	3	Tceal1
Xq22.2	X:103776506-103792619	PLP1, PMD, HLD1, SPG2	Proteolipid protein 1	300401	PLP1	5354	ENSG00000123560,ENST00000621218;;;ENST00000621218		Pelizaeus-Merzbacher disease	312080	XLR	3	Plp1
Xq22.2	X:103776506-103792619	PLP1, PMD, HLD1, SPG2	Proteolipid protein 1	300401	PLP1	5354	ENSG00000123560,ENST00000621218;;;ENST00000621218		Spastic paraplegia 2, X-linked	312920	XLR	3	Plp1
Xq22.3	X:104500001-109400000	AMMEC, DELXq22.3, CXDELq22.3	Alport syndrome, impaired intellectual development, midface hypoplasia, and elliptocytosis complex	300194				contiguous gene deletion syndrome	AMME complex	300194		4	
Xq22.3	X:104500001-109400000	FGS5	FG syndrome 5	300581		780900			FG syndrome 5	300581	XL	2	
Xq22.3	X:106032435-106038727	TBG, TBGQTL	Thyroxine-binding globulin	314200	SERPINA7	6906	ENSG00000123561,ENST00000372563;;;ENST00000372563		[Thyroxine-binding globulin QTL]	300932	XL	3	Serpina7
Xq22.3	X:106802673-106876150	TBC1D8B, NPHS20	TBC1 domain family, member 8B	301027	TBC1D8B	54885	ENSG00000133138,ENST00000357242;;;ENST00000357242		Nephrotic syndrome, type 20	301028	XL	3	Tbc1d8b
Xq22.3	X:106900164-106930861	CLDN2, OAZON	Claudin 2	300520	CLDN2	9075	ENSG00000165376,ENST00000336803;;;ENST00000336803	mutation identified in 1 OAZON family	?Azoospermia, obstructive, with nephrolithiasis	301060	XLR	3	Cldn2
Xq22.3	X:107206611-107244247	DNAAF6, PIH1D3, CILD36	Dynein, axonemal, assembly factor 6	300933	DNAAF6	139212	ENSG00000080572,ENST00000372453;;;ENST00000372453		Ciliary dyskinesia, primary, 36, X-linked	300991	XLR	3	Dnaaf6,Dnaaf6rt
Xq22.3	X:107628510-107651026	PRPS1, CMTX5, DFNX1, DFN2	Phosphoribosyl pyrophosphate synthetase-1	311850	PRPS1	5631	ENSG00000147224,ENST00000372435;;;ENST00000372435		Arts syndrome	301835	XLR	3	Prps1,Prps1l3
Xq22.3	X:107628510-107651026	PRPS1, CMTX5, DFNX1, DFN2	Phosphoribosyl pyrophosphate synthetase-1	311850	PRPS1	5631	ENSG00000147224,ENST00000372435;;;ENST00000372435		Charcot-Marie-Tooth disease, X-linked recessive, 5	311070	XLR	3	Prps1,Prps1l3
Xq22.3	X:107628510-107651026	PRPS1, CMTX5, DFNX1, DFN2	Phosphoribosyl pyrophosphate synthetase-1	311850	PRPS1	5631	ENSG00000147224,ENST00000372435;;;ENST00000372435		Deafness, X-linked 1	304500	XL	3	Prps1,Prps1l3
Xq22.3	X:107628510-107651026	PRPS1, CMTX5, DFNX1, DFN2	Phosphoribosyl pyrophosphate synthetase-1	311850	PRPS1	5631	ENSG00000147224,ENST00000372435;;;ENST00000372435		Gout, PRPS-related	300661	XLR	3	Prps1,Prps1l3
Xq22.3	X:107628510-107651026	PRPS1, CMTX5, DFNX1, DFN2	Phosphoribosyl pyrophosphate synthetase-1	311850	PRPS1	5631	ENSG00000147224,ENST00000372435;;;ENST00000372435		Phosphoribosylpyrophosphate synthetase superactivity	300661	XLR	3	Prps1,Prps1l3
Xq22.3	X:107825735-107931637	MID2, XLID101	Midline 2	300204	MID2	11043	ENSG00000080561,ENST00000262843;;;ENST00000262843	mutation identified in 1 XLID101 family	?Intellectual developmental disorder, X-linked 101	300928	XLR	3	Mid2
Xq22.3	X:108155614-108439458	COL4A6, DELXq22.3, CXDELq22.3, DFNX6	Collagen IV, alpha-6 polypeptide	303631	COL4A6	1288	ENSG00000197565,ENST00000334504;;;ENST00000334504	mutation identified in 1 DFNX6 family	?Deafness, X-linked 6	300914	XLR	3	Col4a6
Xq22.3	X:108439838-108697545	COL4A5, ATS1	Collagen IV, alpha-5 polypeptide	303630	COL4A5	1287	ENSG00000188153,ENST00000328300;;;ENST00000328300	diffuse leiomyomatosis with Alport syndrome = contiguous gene syndrome with COL4A6	Alport syndrome 1, X-linked	301050	XLD	3	Col4a5
Xq22.3	X:108719946-108736563	IRS4, CHNG9	Insulin receptor substrate 4	300904	IRS4	8471	ENSG00000133124,ENST00000372129;;;ENST00000372129		Hypothyroidism, congenital, nongoitrous, 9	301035	XLR	3	Irs4
Xq23-q26	X:109400001-138900000	CHDS3	Coronary heart disease, susceptibility to, 3	300464		387573			{Coronary heart disease, susceptibility to, 3}	300464		2	
Xq23	X:109400001-117400000	IHPS4	Pyloric stenosis, infantile hypertrophic, 4	300711		100188772		max lod at rs3027802	Pyloric stenosis, infantile hypertrophic, 4	300711		2	
Xq23-q27.2	X:109400001-143000000	MYP13	Myopia 13	300613		677764		between DXS1210 and DXS1227	Myopia 13	300613		2	
Xq23-q24	X:109400001-121800000	XLID23, MRX23	Intellectual developmental disorder, X-linked 23	300046		4387		other MRX in same region MRX27, MRX30, MRX35, MRX47, MRX80	Intellectual developmental disorder, X-linked 23	300046	XL	2	
Xq23	X:109641335-109733257	ACSL4, FACL4, ACS4, XLID63	Acyl-CoA synthetase long-chain family member 4	300157	ACSL4	2182	ENSG00000068366,ENST00000672401;;;ENST00000672401		Intellectual developmental disorder, X-linked 63	300387	XLD	3	Acsl4
Xq23	X:110194186-110440233	AMMECR1, MFHIEN	AMMECR nuclear protein 1	300195	AMMECR1	9949	ENSG00000101935,ENST00000262844;;;ENST00000262844		Midface hypoplasia, hearing impairment, elliptocytosis, and nephrocalcinosis	300990	XLR	3	Ammecr1
Xq23	X:110673856-110795817	CHRDL1, VOPT, MGC1	Chordin-like 1	300350	CHRDL1	91851	ENSG00000101938,ENST00000372042;;;ENST00000372042		Megalocornea 1, X-linked	309300	XLR	3	Chrdl1
Xq23	X:110944397-111227361	PAK3, MRX30, MRX47, XLID30	p21-activated kinase-3	300142	PAK3	5063	ENSG00000077264,ENST00000372007;;;ENST00000372007		Intellectual developmental disorder, X-linked 30	300558	XLR	3	Pak3
Xq23	X:111293779-111412192	DCX, DBCN, LISX	Doublecortin	300121	DCX	1641	ENSG00000077279,ENST00000636035;;;ENST00000636035		Lissencephaly, X-linked	300067	XL	3	Dcx
Xq23	X:111293779-111412192	DCX, DBCN, LISX	Doublecortin	300121	DCX	1641	ENSG00000077279,ENST00000636035;;;ENST00000636035		Subcortical laminal heterotopia, X-linked	300067	XL	3	Dcx
Xq23	X:111681170-111760649	ALG13, GLT28D1, CDG1S, DEE36	ALG13 UDP-N-acetylglucosaminyltransferase subunit	300776	ALG13	79868	ENSG00000101901,ENST00000394780;;;ENST00000394780		Developmental and epileptic encephalopathy 36	300884	XL	3	Alg13
Xq23	X:115561174-115650861	PLS3, BMND18, DIH5	Plastin 3	300131	PLS3	5358	ENSG00000102024,ENST00000355899;;;ENST00000355899		Bone mineral density QTL18, osteoporosis	300910	XLD	3	Pls3
Xq23	X:115561174-115650861	PLS3, BMND18, DIH5	Plastin 3	300131	PLS3	5358	ENSG00000102024,ENST00000355899;;;ENST00000355899		Diaphragmatic hernia 5, X-linked	306950	XL	3	Pls3
Xq24-q26	X:117400001-138900000	ADFN, ALDS	Albinism-deafness syndrome	300700		122		~8cM proximal to F9	Albinism-deafness syndrome	300700	XL	2	
Xq24	X:117400001-121800000	BMIQ11	Body Mass Index quantitative trait locus 11	300306					{Obesity, susceptibility to, BMIQ11}	300306		2	
Xq24-qter	X:117400001-156040895	CND	Corneal dermoids	304730		8231			Dermoids of cornea	304730	XL	2	
Xq24-q27.1	X:117400001-141200000	PTOS2, PTOSX	Ptosis, hereditary congenital 2	300245		54115			Ptosis, hereditary congenital 2	300245	XLD	2	
Xq24-q25	X:117400001-129500000	RRDX	Radial ray deficiency	300378		266719			Radial ray deficiency	300378		2	
Xq24-q25	X:117400001-129500000	SPG34	Spastic paraplegia 34, X-linked	300750		724110		max lod at DXS8057	Spastic paraplegia 34, X-linked	300750	XLR	2	
Xq24-q25	X:117400001-129500000	STQTL6	Stature quantitative trait locus 6	300591		100037264		max lod at DXS8067	{Stature QTL 6}	300591		2	
Xq24-q25	X:117400001-129500000	XLID82, MRX82	Intellectual developmental disorder, X-linked 82	300518		378484		between DXS6805 and DXS7346	Intellectual developmental disorder, X-linked 82	300518	XLR	2	
Xq24	X:117400001-121800000	XLID88, MRX88	Intellectual developmental disorder, X-linked 88	300852		105463129			Intellectual developmental disorder, X-linked 88	300852	XL	2	
Xq24	X:118495815-118686147	DOCK11, ACG, ZIZ2, ADMIDX	Dedicator of cytokinesis 11	300681	DOCK11	139818	ENSG00000147251,ENST00000276202;;;ENST00000276202		Autoinflammatory disease, multisystem, with immune dysregulation, X-linked	301109	XLR	3	Dock11
Xq24	X:119538149-119565409	STEEP1, CXorf56, XLID107	STING1 ER exit protein 1	301012	STEEP1	63932	ENSG00000018610,ENST00000644802;;;ENST00000644802	mutation identified in 1 XLID107 family	?Intellectual developmental disorder, X-linked 107	301013	XL	3	Steep1
Xq24	X:119574563-119584423	UBE2A, RAD6A, MRXSN, MRXS30	Ubiquitin-conjugating enzyme E2 A	312180	UBE2A	7319	ENSG00000077721,ENST00000371558;;;ENST00000371558		Intellectual developmental disorder, X-linked syndromic, Nascimento type	300860	XLR	3	Ube2a
Xq24	X:119805311-119852963	UPF3B, RENT3B, MRXS14	UPF3B regulator of nonsense-mediated mRNA decay	300298	UPF3B	65109	ENSG00000125351,ENST00000276201;;;ENST00000276201		Intellectual developmental disorder, X-linked syndromic 14	300676	XLR	3	Upf3b
Xq24	X:119870475-119871733	RNF113A, ZNF183, TTD5	RING finger protein 113A	300951	RNF113A	7737	ENSG00000125352,ENST00000371442;;;ENST00000371442		Trichothiodystrophy 5, nonphotosensitive	300953	XL	3	Rnf113a1,Rnf113a2
Xq24	X:119871832-119876662	NDUFA1, MWFE, MC1DN12	NADH-ubiquinone oxidoreductase subunit A1	300078	NDUFA1	4694	ENSG00000125356,ENST00000371437;;;ENST00000371437		Mitochondrial complex I deficiency, nuclear type 12	301020	XLR	3	Ndufa1
Xq24	X:119920672-119943751	NKAP, MRXSHD	NFKB-activating protein	300766	NKAP	79576	ENSG00000101882,ENST00000371410;;;ENST00000371410		Intellectual developmental disorder, X-linked syndromic, Hackman-Di Donato type	301039	XLR	3	Nkap
Xq24	X:120426148-120469349	LAMP2, LAMPB, LGP110, DND	Lysosome-associated membrane protein-2	309060	LAMP2	3920	ENSG00000005893,ENST00000200639;;;ENST00000200639		Danon disease	300257	XLD	3	Lamp2
Xq24	X:120523858-120575532	CUL4B, MRXSC, MRXHF2, SFM2, MRXS15	Cullin-4B	300304	CUL4B	8450	ENSG00000158290,ENST00000371322;;;ENST00000371322		Intellectual developmental disorder, X-linked syndromic, Cabezas type	300354	XLR	3	Cul4b
Xq24	X:120604101-120621159	MCTS1, MCT1, IMD118	Malignant T-cell amplified sequence 1	300587	MCTS1	28985	ENSG00000232119,ENST00000371317;;;ENST00000371317		Immunodeficiency 118, mycobacteriosis	301115	XLR	3	Mcts1
Xq24	X:120625674-120630054	C1GALT1C1, COSMC, C1GALT2, TNPS, AHUS8	C1GALT1-specific chaperone 1	300611	C1GALT1C1	29071	ENSG00000171155,ENST00000304661;;;ENST00000304661		Hemolytic uremic syndrome, atypical, 8, with rhizomelic short stature	301110	XLR	3	C1galt1c1
Xq24	X:120625674-120630054	C1GALT1C1, COSMC, C1GALT2, TNPS, AHUS8	C1GALT1-specific chaperone 1	300611	C1GALT1C1	29071	ENSG00000171155,ENST00000304661;;;ENST00000304661		Tn polyagglutination syndrome, somatic	300622		3	C1galt1c1
Xq25	X:121800001-129500000	DUPXq25	Xq25 duplication syndrome	300979					Xq25 duplication syndrome	300979	XL	4	
Xq25-q27.1	X:121800001-141200000	SCAX5	Spinocerebellar ataxia, X-linked 5	300703		100188768		between DXS1047 and DXS1227	Spinocerebellar ataxia, X-linked 5	300703	XLR	2	
Xq25-q26	X:121800001-138900000	SXI2	X inactivation, familial skewed, 2	300179		117237			X inactivation, familial skewed, 2	300179		2	
Xq25-q26.1	X:121800001-131300000	THAS, TAS	Thoracoabdominal syndrome	313850		7055			Thoracoabdominal syndrome	313850	XL	2	
Xq25	X:121800001-129500000	XECD	Corneal dystrophy, endothelial, X-linked	300779		100302510		between DXS8057 and DXS1047	Corneal dystrophy, endothelial, X-linked	300779	XLD	2	
Xq25-q26	X:121800001-138900000	XLID46, MRX46	Intellectual developmental disorder, X-linked 56	300436				between DXS8072 and DXS294	Intellectual developmental disorder, X-linked 46	300436	XLR	2	
Xq25	X:123184278-123490915	GRIA3, GLUR3, MRXSW	Glutamate receptor, ionotropic, AMPA 3	305915	GRIA3	2892	ENSG00000125675,ENST00000620443;;;ENST00000620443		Intellectual developmental disorder, X-linked syndromic, Wu type	300699	XLR	3	Gria3
Xq25	X:123600569-123733052	THOC2, THO2, XLID12, AMC7	THO complex 2	300395	THOC2	57187	ENSG00000125676,ENST00000245838;;;ENST00000245838		Arthrogryposis multiplex congenita 7, X-linked	301127	XL	3	Thoc2,Thoc2l
Xq25	X:123600569-123733052	THOC2, THO2, XLID12, AMC7	THO complex 2	300395	THOC2	57187	ENSG00000125676,ENST00000245838;;;ENST00000245838		Intellectual developmental disorder, X-linked syndromic, Kumar type	300957	XL	3	Thoc2,Thoc2l
Xq25	X:123859708-123913972	XIAP, BIRC4, API3, XLP2	Inhibitor of apoptosis, X-linked	300079	XIAP	331	ENSG00000101966,ENST00000371199;;;ENST00000371199		Lymphoproliferative syndrome, X-linked, 2	300635	XLR	3	Xiap
Xq25	X:123960560-124102656	STAG2, SA2, MKMS, HPE13	Stromal antigen 2	300826	STAG2	10735	ENSG00000101972,ENST00000371145;;;ENST00000371145		Holoprosencephaly 13, X-linked	301043	XLD, XLR	3	Stag2
Xq25	X:123960560-124102656	STAG2, SA2, MKMS, HPE13	Stromal antigen 2	300826	STAG2	10735	ENSG00000101972,ENST00000371145;;;ENST00000371145		Mullegama-Klein-Martinez syndrome	301022	XL	3	Stag2
Xq25	X:124346563-124373160	SH2D1A, LYP, IMD5, XLP, XLPD1	SH2 domain protein 1A	300490	SH2D1A	4068	ENSG00000183918,ENST00000371139;;;ENST00000371139	1cM from DXS42; no recombination with DXS37	Lymphoproliferative syndrome, X-linked, 1	308240	XLR	3	Sh2d1a
Xq26	X:129500001-138900000	BZX, BDCS	Bazex-Dupre-Christol syndrome	301845				caused by microduplication in intergenic region	Bazex-Dupre-Christol syndrome	301845	XLD	4	
Xq26-q27	X:129500001-148000000	CFSS	Craniofacioskeletal syndrome	300712		100188773			?Craniofacioskeletal syndrome	300712	XLD, XLR	2	
Xq26	X:129500001-138900000	CMTX3	Charcot-Marie-Tooth neuropathy, X-linked recessive, 3	302802				genomic rearrangement between 8q24.3 and Xq27.1	Charcot-Marie-Tooth neuropathy, X-linked recessive, 3	302802	XLR	4	
Xq26-qter	X:129500001-156040895	INDX	Immunoneurologic syndrome X-linked, of Woods, Black, and Norbury	300076		8259			Woods-Black-Norbury syndrome	300076	XLD	2	
Xq26-q27	X:129500001-148000000	RP24	Retinitis pigmentosa-24	300155		6116			Retinitis pigmentosa 24	300155		2	
Xq26	X:129500001-138900000	SHFM2, SHFD2	Split hand/foot malformation, type (ectrodactyly) 2	313350		6463			Split hand/foot malformation 2	313350	XL	2	
Xq26	X:129500001-138900000	XLID42, MRX42	Intellectual developmental disorder, X-linked 42	300372		4406		?pericentromeric region	Intellectual developmental disorder, X-linked 42	300372		2	
Xq26.1	X:129540259-129592556	OCRL, LOCR, OCRL1, NPHL2, DENT2	OCRL inositol polyphosphate-5-phosphatase	300535	OCRL	4952	ENSG00000122126,ENST00000371113;;;ENST00000371113		Dent disease 2	300555	XLR	3	Ocrl
Xq26.1	X:129540259-129592556	OCRL, LOCR, OCRL1, NPHL2, DENT2	OCRL inositol polyphosphate-5-phosphatase	300535	OCRL	4952	ENSG00000122126,ENST00000371113;;;ENST00000371113		Lowe syndrome	309000	XLR	3	Ocrl
Xq26.1	X:129738979-129769536	XPNPEP2, AEACEI	X-prolyl aminopeptidase 2 (aminopeptidase P)	300145	XPNPEP2	7512	ENSG00000122121,ENST00000371106;;;ENST00000371106		{Angioedema induced by ACE inhibitors, susceptibility to}	300909		3	Xpnpep2
Xq26.1	X:129779949-129795201	SASH3, HACS2, CXorf9, SLY, IMD102	SAM and SH3 domain containing 3	300441	SASH3	54440	ENSG00000122122,ENST00000356892;;;ENST00000356892		Immunodeficiency 102	301082	XLR	3	Sash3
Xq26.1	X:129803288-129843886	ZDHHC9, DHHC9, MRXSR	Zinc finger DHHC domain-containing protein 9	300646	ZDHHC9	51114	ENSG00000188706,ENST00000357166;;;ENST00000357166		Intellectual developmental disorder, X-linked syndromic, Raymond type	300799	XL	3	Zdhhc9
Xq26.1	X:129980313-130058071	BCORL1, SHUVER	BCL6 corepressor-like 1	300688	BCORL1	63035	ENSG00000085185,ENST00000540052;;;ENST00000540052		Shukla-Vernon syndrome	301029	XLR	3	Bcorl1
Xq26.1	X:130063955-130111858	ELF4, MEF, AIFBL2	E74-like ETS transcription factor 4	300775	ELF4	2000	ENSG00000102034,ENST00000308167;;;ENST00000308167		Autoinflammatory syndrome, familial, X-linked, Behcet-like 2	301074	XLR	3	Elf4
Xq26.1	X:130129362-130165841	AIFM1, PDCD8, AIF, COXPD6, COWCK, CMTX4, DFNX5, SEMDHL	Apoptosis-inducing factor, mitochondrion-associated, 1	300169	AIFM1	9131	ENSG00000156709,ENST00000287295;;;ENST00000287295		Combined oxidative phosphorylation deficiency 6	300816	XLR	3	Aifm1
Xq26.1	X:130129362-130165841	AIFM1, PDCD8, AIF, COXPD6, COWCK, CMTX4, DFNX5, SEMDHL	Apoptosis-inducing factor, mitochondrion-associated, 1	300169	AIFM1	9131	ENSG00000156709,ENST00000287295;;;ENST00000287295		Cowchock syndrome	310490	XLR	3	Aifm1
Xq26.1	X:130129362-130165841	AIFM1, PDCD8, AIF, COXPD6, COWCK, CMTX4, DFNX5, SEMDHL	Apoptosis-inducing factor, mitochondrion-associated, 1	300169	AIFM1	9131	ENSG00000156709,ENST00000287295;;;ENST00000287295		Deafness, X-linked 5	300614	XLR	3	Aifm1
Xq26.1	X:130129362-130165841	AIFM1, PDCD8, AIF, COXPD6, COWCK, CMTX4, DFNX5, SEMDHL	Apoptosis-inducing factor, mitochondrion-associated, 1	300169	AIFM1	9131	ENSG00000156709,ENST00000287295;;;ENST00000287295		Spondyloepimetaphyseal dysplasia, X-linked, with hypomyelinating leukodystrophy	300232	XLR	3	Aifm1
Xq26.1	X:131273506-131289457	IGSF1, IGDC1, CHTE	Immunoglobulin superfamily, member 1	300137	IGSF1	3547	ENSG00000147255,ENST00000361420;;;ENST00000361420		Hypothyroidism, central, and testicular enlargement	300888	XLR	3	Igsf1
Xq26.2	X:132076990-132128020	FRMD7, NYS1, XIPAN	FERM domain-containing 7	300628	FRMD7	90167	ENSG00000165694,ENST00000298542;;;ENST00000298542		Nystagmus 1, congenital, X-linked	310700	XL	3	Frmd7
Xq26.2	X:132076990-132128020	FRMD7, NYS1, XIPAN	FERM domain-containing 7	300628	FRMD7	90167	ENSG00000165694,ENST00000298542;;;ENST00000298542		Nystagmus, infantile periodic alternating, X-linked	310700	XL	3	Frmd7
Xq26.2	X:132626015-132961370	HS6ST2, MRXSPM	Heparan sulfate 6-O-sulfotransferase 2	300545	HS6ST2	90161	ENSG00000171004,ENST00000370833;;;ENST00000370833	mutation identified in 1 MRXSPM family	?Paganini-Miozzo syndrome	301025	XLR	3	Hs6st2
Xq26.2	X:133023168-133097109	USP26, SPGFX6	Ubiquitin-specific protease 26	300309	USP26	83844	ENSG00000134588,ENST00000511190;;;ENST00000511190		Spermatogenic failure, X-linked, 6	301101	XL	3	Usp26
Xq26.2	X:133300103-133415489	GPC4, KPTS	Glypican 4	300168	GPC4	2239	ENSG00000076716,ENST00000370828;;;ENST00000370828	centromeric to GPC3	Keipert syndrome	301026	XLR	3	Gpc4
Xq26.2	X:133535745-133985594	GPC3, SDYS, SGBS1	Glypican 3	300037	GPC3	2719	ENSG00000147257,ENST00000370818;;;ENST00000370818		Simpson-Golabi-Behmel syndrome, type 1	312870	XLR	3	Gpc3
Xq26.2	X:133535745-133985594	GPC3, SDYS, SGBS1	Glypican 3	300037	GPC3	2719	ENSG00000147257,ENST00000370818;;;ENST00000370818		Wilms tumor, somatic	194070		3	Gpc3
Xq26.2	X:134373312-134428790	PHF6, BFLS	PHD finger protein 6	300414	PHF6	84295	ENSG00000156531,ENST00000370803;;;ENST00000370803		Borjeson-Forssman-Lehmann syndrome	301900	XLR	3	Phf6
Xq26.2-q26.3	X:134460165-134500668	HPRT1, HPRT	Hypoxanthine phosphoribosyltransferase 1	308000	HPRT1	3251	ENSG00000165704,ENST00000298556;;;ENST00000298556		Hyperuricemia, HRPT-related	300323	XLR	3	Hprt1
Xq26.2-q26.3	X:134460165-134500668	HPRT1, HPRT	Hypoxanthine phosphoribosyltransferase 1	308000	HPRT1	3251	ENSG00000165704,ENST00000298556;;;ENST00000298556		Lesch-Nyhan syndrome	300322	XLR	3	Hprt1
Xq26.3	X:134500001-138900000	CXDUPq26.3, DUPXq26.3, XLAG	Chromosome Xq26.3 duplication syndrome	300942					Chromosome Xq26.3 duplication syndrome	300942	XLD	4	
Xq26.3	X:134500001-138900000	SRXX3	46XX sex reversal 3	300833				due to deletion/duplication/rearrangement upstream of SOX3	46XX sex reversal 3	300833	XLD	4	
Xq26.3	X:135156536-135171827	CT55, SPGFX7	Cancer/Testis antigen 55	301105	CT55	54967	ENSG00000169551,ENST00000276241;;;ENST00000276241	mutation identified in 1 SPGFX7 family	?Spermatogenic failure, X-linked, 7	301106	XLR	3	Ct55
Xq26.3	X:135973837-136047269	SLC9A6, NHE6, MRXSCH, NDPACX	Solute carrier family 9 (sodium/hydrogen exchanger), member 6	300231	SLC9A6	10479	ENSG00000198689,ENST00000630721;;;ENST00000630721		Intellectual developmental disorder, X-linked syndromic, Christianson type	300243	XL	3	Slc9a6
Xq26.3	X:135973837-136047269	SLC9A6, NHE6, MRXSCH, NDPACX	Solute carrier family 9 (sodium/hydrogen exchanger), member 6	300231	SLC9A6	10479	ENSG00000198689,ENST00000630721;;;ENST00000630721		Neurodegenerative disorder, X-linked, female-restricted, with parkinsonism and cognitive impairment	301142	XLD	3	Slc9a6
Xq26.3	X:136146702-136211359	FHL1, SLIM1, XMPMA, KYOT, FHL1A, FHL1B, RBMX1A, RBMX1B, FCMSU	Four-and-a-half LIM domains 1	300163	FHL1	2273	ENSG00000022267,ENST00000370683;;;ENST00000370683	mutation identified in 1 FCMSU family	?Uruguay faciocardiomusculoskeletal syndrome	300280	XLR	3	Fhl1
Xq26.3	X:136146702-136211359	FHL1, SLIM1, XMPMA, KYOT, FHL1A, FHL1B, RBMX1A, RBMX1B, FCMSU	Four-and-a-half LIM domains 1	300163	FHL1	2273	ENSG00000022267,ENST00000370683;;;ENST00000370683	mutation identified in 1 FCMSU family	Emery-Dreifuss muscular dystrophy 6, X-linked	300696	XLR	3	Fhl1
Xq26.3	X:136146702-136211359	FHL1, SLIM1, XMPMA, KYOT, FHL1A, FHL1B, RBMX1A, RBMX1B, FCMSU	Four-and-a-half LIM domains 1	300163	FHL1	2273	ENSG00000022267,ENST00000370683;;;ENST00000370683	mutation identified in 1 FCMSU family	Myopathy, X-linked, with postural muscle atrophy	300696	XLR	3	Fhl1
Xq26.3	X:136146702-136211359	FHL1, SLIM1, XMPMA, KYOT, FHL1A, FHL1B, RBMX1A, RBMX1B, FCMSU	Four-and-a-half LIM domains 1	300163	FHL1	2273	ENSG00000022267,ENST00000370683;;;ENST00000370683	mutation identified in 1 FCMSU family	Reducing body myopathy, X-linked 1a, severe, infantile or early childhood onset	300717	XLD	3	Fhl1
Xq26.3	X:136146702-136211359	FHL1, SLIM1, XMPMA, KYOT, FHL1A, FHL1B, RBMX1A, RBMX1B, FCMSU	Four-and-a-half LIM domains 1	300163	FHL1	2273	ENSG00000022267,ENST00000370683;;;ENST00000370683	mutation identified in 1 FCMSU family	Reducing body myopathy, X-linked 1b, with late childhood or adult onset	300718	XL	3	Fhl1
Xq26.3	X:136146702-136211359	FHL1, SLIM1, XMPMA, KYOT, FHL1A, FHL1B, RBMX1A, RBMX1B, FCMSU	Four-and-a-half LIM domains 1	300163	FHL1	2273	ENSG00000022267,ENST00000370683;;;ENST00000370683	mutation identified in 1 FCMSU family	Scapuloperoneal myopathy, X-linked dominant	300695	XLD	3	Fhl1
Xq26.3	X:136648158-136660390	TNFSF5, CD40LG, HIGM1, IGM	Tumor necrosis factor ligand superfamily, member 5	300386	CD40LG	959	ENSG00000102245,ENST00000370629;;;ENST00000370629	Between DSX144E and DSX300	Immunodeficiency, X-linked, with hyper-IgM	308230	XLR	3	Cd40lg
Xq26.3	X:136869192-136880725	RBMX, MRXS11, MRXSH, MRXSG	RNA-binding motif protein, X chromosome	300199	RBMX	27316	ENSG00000147274,ENST00000320676;;;ENST00000320676	mutation identified in 1 MRXSSH family and 1 MRXSG family	?Intellectual developmental disorder, X-linked syndromic, Gustavson type	309555	XLR	3	Gm7324,Rbmx,Rbmxl1
Xq26.3	X:136869192-136880725	RBMX, MRXS11, MRXSH, MRXSG	RNA-binding motif protein, X chromosome	300199	RBMX	27316	ENSG00000147274,ENST00000320676;;;ENST00000320676	mutation identified in 1 MRXSSH family and 1 MRXSG family	?Intellectual developmental disorder, X-linked syndromic, Shashi type	300238	XLR	3	Gm7324,Rbmx,Rbmxl1
Xq26.3	X:137023929-137033995	GPR101, PAGH2, PITA2	G protein-coupled receptor 101	300393	GPR101	83550	ENSG00000165370,ENST00000651716;;;ENST00000651716		Pituitary adenoma 2, GH-secreting	300943	XL	3	Gpr101
Xq26.3	X:137566127-137577691	ZIC3, HTX1, HTX, VACTERLX	Zic family, member 3	300265	ZIC3	7547	ENSG00000156925,ENST00000287538;;;ENST00000287538		Congenital heart defects, nonsyndromic, multiple types, 1, X-linked	306955	XLR	3	Zic3
Xq26.3	X:137566127-137577691	ZIC3, HTX1, HTX, VACTERLX	Zic family, member 3	300265	ZIC3	7547	ENSG00000156925,ENST00000287538;;;ENST00000287538		Heterotaxy, visceral, 1, X-linked	306955	XLR	3	Zic3
Xq26.3	X:137566127-137577691	ZIC3, HTX1, HTX, VACTERLX	Zic family, member 3	300265	ZIC3	7547	ENSG00000156925,ENST00000287538;;;ENST00000287538		VACTERL association, X-linked	314390	XLR	3	Zic3
Xq26.3-q27.1	X:138614727-139205023	FGF13, FGF2, DEE90, XLID110	Fibroblast growth factor-13	300070	FGF13	2258	ENSG00000129682,ENST00000315930;;;ENST00000315930		Developmental and epileptic encephalopathy 90	301058	XL	3	Fgf13
Xq26.3-q27.1	X:138614727-139205023	FGF13, FGF2, DEE90, XLID110	Fibroblast growth factor-13	300070	FGF13	2258	ENSG00000129682,ENST00000315930;;;ENST00000315930		Intellectual developmental disorder, X-linked 110	301095	XLR	3	Fgf13
Xq27	X:138900001-148000000	BMND4	Bone mineral density QTL 4	300536		554316			[Bone mineral density QTL 4]	300536		2	
Xq27	X:138900001-148000000	COD2	Cone dystrophy-2, X-linked	300085		1275			Cone dystrophy, progressive X-linked, 2	300085	XL	2	
Xq27-q28	X:138900001-156040895	HPCX1	Prostate cancer, hereditary, X-linked 1	300147		9566		between D3S2390 and bG82i1.0	{Prostate cancer, hereditary, X-linked 1}	300147		2	
Xq27.1	X:138900001-141200000	HPT, HPTX, HYPX	Hypoparathyroidism	307700				interstitial deletion/insertion on Xq27.1	Hypoparathyroidism, X-linked	307700	XL	4	
Xq27.1	X:138900001-141200000	HTC2, HCG, CGH, CXINSq27.1	Hypertrichosis, congenital generalized	307150				palindrome-mediated interchromosomal insertion at Xq27.1	Hypertrichosis, congenital generalized	307150	XLD	4	
Xq27	X:138900001-148000000	RDXGH	Retinal dystrophy, X-linked, Gardner-Hardcastle type	301149				interchromosomal insertion at Xq27	Retinal dystrophy, X-linked, Gardner-Hardcastle type	301149	XLR	4	
Xq27	X:138900001-148000000	TGCT1	Testicular germ cell tumor 1	300228		50830			Testicular germ cell tumor	300228		2	
Xq27.1	X:139530739-139563459	F9, HEMB, THPH8	Coagulation factor IX (plasma thromboplastic component)	300746	F9	2158	ENSG00000101981,ENST00000218099;;;ENST00000218099	distal to HPRT; proximal part of Xq27	{Deep venous thrombosis, protection against}	300807	XLR	3	F9
Xq27.1	X:139530739-139563459	F9, HEMB, THPH8	Coagulation factor IX (plasma thromboplastic component)	300746	F9	2158	ENSG00000101981,ENST00000218099;;;ENST00000218099	distal to HPRT; proximal part of Xq27	{Warfarin sensitivity}	301052	XL	3	F9
Xq27.1	X:139530739-139563459	F9, HEMB, THPH8	Coagulation factor IX (plasma thromboplastic component)	300746	F9	2158	ENSG00000101981,ENST00000218099;;;ENST00000218099	distal to HPRT; proximal part of Xq27	Hemophilia B	306900	XLR	3	F9
Xq27.1	X:139530739-139563459	F9, HEMB, THPH8	Coagulation factor IX (plasma thromboplastic component)	300746	F9	2158	ENSG00000101981,ENST00000218099;;;ENST00000218099	distal to HPRT; proximal part of Xq27	Thrombophilia 8, X-linked, due to factor IX defect	300807	XLR	3	F9
Xq27.1	X:139726348-139936903	ATP11C, ATPIQ, ATPIG, HACXL	ATPase, class VI, type 11C	300516	ATP11C	286410	ENSG00000101974,ENST00000682941;;;ENST00000682941	mutation identified in 1 HACXL patient	?Hemolytic anemia, congenital, X-linked	301015	XLR	3	Atp11c
Xq27.1	X:140502985-140505069	SOX3, MRGH	SRY (sex determining region Y)-box 3	313430	SOX3	6658	ENSG00000134595,ENST00000370536;;;ENST00000370536	P mutant in BFLS	Intellectual developmental disorder, X-linked, with isolated growth hormone deficiency	300123		3	Sox3
Xq27.1	X:140502985-140505069	SOX3, MRGH	SRY (sex determining region Y)-box 3	313430	SOX3	6658	ENSG00000134595,ENST00000370536;;;ENST00000370536	P mutant in BFLS	Panhypopituitarism, X-linked	312000	XL	3	Sox3
Xq27.2-q28	X:141200001-156040895	BPP, PMGX, CBPS	Polymicrogyria, bilateral perisylvian	300388				possible genetic heterogeneity	Polymicrogyria, bilateral perisylvian	300388	XLD	2	
Xq27.3-q28	X:143000001-156040895	DUPXq27.3q28, CXDUPq27.3q28	Chromosome Xq27.3-q28 duplication syndrome	300869					Chromosome Xq27.3-q28 duplication syndrome	300869	XLR	4	
Xq27.3	X:143000001-148000000	DYX9	Dyslexia, susceptibility to, 9	300509		474159		max lod at DXS8043	{Dyslexia, susceptibility to, 9}	300509		2	
Xq27.3	X:145817829-145829856	SLITRK2, KIAA1854, CXorf1, CXorf2, XLID111	SLIT- and NTRK-like family, member 2	300561	SLITRK2	84631	ENSG00000185985,ENST00000335565;;;ENST00000335565		Intellectual developmental disorder, X-linked 111	301107	XL	3	Slitrk2
Xq27.3	X:147911919-147951125	FMR1, FRAXA, POF1	Fragile X messenger ribonucleoprotein 1	309550	FMR1	2332	ENSG00000102081,ENST00000370475;;;ENST00000370475	8-8.7Mb from telomere	Fragile X syndrome	300624	XLD	3	Fmr1
Xq27.3	X:147911919-147951125	FMR1, FRAXA, POF1	Fragile X messenger ribonucleoprotein 1	309550	FMR1	2332	ENSG00000102081,ENST00000370475;;;ENST00000370475	8-8.7Mb from telomere	Fragile X tremor/ataxia syndrome	300623	XLD	3	Fmr1
Xq27.3	X:147911919-147951125	FMR1, FRAXA, POF1	Fragile X messenger ribonucleoprotein 1	309550	FMR1	2332	ENSG00000102081,ENST00000370475;;;ENST00000370475	8-8.7Mb from telomere	Premature ovarian failure 1	311360	XL	3	Fmr1
Xq28	X:148000001-156040895	BED	Bornholm eye disease	300843		100653365		linked to F8	Bornholm eye disease	300843	XLR	2	
Xq28	X:148000001-156040895	DUPXq28, CXq28	Chromosome Xq28 duplication syndrome	300815					Chromosome Xq28 duplication syndrome	300815		4	
Xq28	X:148000001-156040895	HMS1, GAY1	Homosexuality, male	306995					[?Homosexuality, male]	306995	XL	2	
Xq28	X:148000001-156040895	MAFD2, MDX	Major affective disorder 2	309200		4096		linkage to G6PD,CB in non-Ashkenazi Jews	{?Major affective disorder 2}	309200	XLD	2	
Xq28	X:148000001-156040895	MRXSCH, CHRS, MRSD	Christian syndrome	309620		4364			Intellectual developmental disorder, X-linked, syndromic, Christian type	309620	XL	2	
Xq28	X:148000001-156040895	MYMY4, CXDELq38	Moyamoya disease 4 with short stature, hypergonadotropic hypogonadism and facial dysmorphism	300845				contiguous gene deletion syndrome (3.4kb)	Moyamoya disease 4	300845	XLR	4	
Xq28	X:148000001-156040895	MYP1	Myopia 1, X-linked	310460		4657			Myopia-1	310460	XLR	2	
Xq28	X:148000001-156040895	RP34	Retinitis pigmentosa 34	300605		777642			Retinitis pigmentosa 34	300605		2	
Xq28	X:148000001-156040895	SLEB15	Systemic lupus erythematosus, susceptibility to, 15	300809		100379200		associated with rs17435	{Systemic lupus erythematosus, susceptibility to, 15}	300809	XL	2	
Xq28	X:148000001-156040895	TKCR, TKC	Torticollis, keloids, cryptorchidism and renal dysplasia	314300		7085		distal to G6PD	Goeminne TKCR syndrome	314300	XL	2	
Xq28	X:148500617-149000663	AFF2, FMR2, FRAXE, XLID109	AF4/FMR2 family, member 2 (fragile site, X-linked, E)	300806	AFF2	2334	ENSG00000155966,ENST00000370460;;;ENST00000370460		Intellectual developmental disorder, X-linked 109	309548	XLR	3	Aff2
Xq28	X:149476988-149505306	IDS, MPS2, SIDS	Iduronate 2-sulfatase (Hunter syndrome)	300823	IDS	3423	ENSG00000010404,ENST00000340855;;;ENST00000340855	telomeric IDS2 source of inversion in IDS	Mucopolysaccharidosis II	309900	XLR	3	Ids
Xq28	X:150361572-150514173	MAMLD1, CXorf6, F18, HYSP2	Mastermind-like domain containing 1	300120	MAMLD1	10046	ENSG00000013619,ENST00000370401;;;ENST00000370401	near MTM1 in microdeletion	Hypospadias 2, X-linked	300758	XLR	3	Mamld1
Xq28	X:150562653-150673143	MTM1, MTMX, CNMX	Myotubularin	300415	MTM1	4534	ENSG00000171100,ENST00000370396;;;ENST00000370396	close to F8	Myopathy, centronuclear, X-linked	310400	XLR	3	Mtm1
Xq28	X:150980507-150990771	HMGB3, HMG4, HMG2A, MCOPS13	High-mobility group box 3 (high mobility group protein 4)	300193	HMGB3	3149	ENSG00000029993,ENST00000325307;;;ENST00000325307	mutation identified in 1 MCOPS13 family	?Microphthalmia, syndromic 13	300915	XL	3	Hmgb3
Xq28	X:151396595-151409364	VMA21, XMEA	Vma21, S. cerevisiae, homolog of	300913	VMA21	203547	ENSG00000160131,ENST00000330374;;;ENST00000330374		Myopathy, X-linked, with excessive autophagy	310440	XLR	3	Vma21
Xq28	X:152166234-152451315	GABRA3, EPILX2	Gamma-aminobutyric acid (GABA) A receptor, alpha-3	305660	GABRA3	2556	ENSG00000011677,ENST00000370314;;;ENST00000370314	4Mb from telomere	Epilepsy, X-linked 2, with or without impaired intellectual development and dysmorphic features	301091	XL	3	Gabra3
Xq28	X:152831063-152869729	NSDHL	NAD(P)H steroid dehydrogenase-like protein	300275	NSDHL	50814	ENSG00000147383,ENST00000370274;;;ENST00000370274		CHILD syndrome	308050	XLD	3	Nsdhl
Xq28	X:152831063-152869729	NSDHL	NAD(P)H steroid dehydrogenase-like protein	300275	NSDHL	50814	ENSG00000147383,ENST00000370274;;;ENST00000370274		CK syndrome	300831	XLR	3	Nsdhl
Xq28	X:153494980-153509546	BGN, SEMDX, MRLS	Biglycan	301870	BGN	633	ENSG00000182492,ENST00000331595;;;ENST00000331595	proximal Xq28	Meester-Loeys syndrome	300989	XL	3	Bgn
Xq28	X:153494980-153509546	BGN, SEMDX, MRLS	Biglycan	301870	BGN	633	ENSG00000182492,ENST00000331595;;;ENST00000331595	proximal Xq28	Spondyloepimetaphyseal dysplasia, X-linked	300106	XLR	3	Bgn
Xq28	X:153517642-153582929	ATP2B3, PMCA3, SCAX1	ATPase, Ca++ transporting, plasma membrane, 3	300014	ATP2B3	492	ENSG00000067842,ENST00000263519;;;ENST00000263519	mutation identified in 1 family	?Spinocerebellar ataxia, X-linked 1	302500	XLR	3	Atp2b3
Xq28	X:153587925-153599139	CCNQ, FAM58A, STAR	Cyclin Q	300708	CCNQ	92002	ENSG00000262919,ENST00000576892;;;ENST00000576892		STAR syndrome	300707	XLD	3	Ccnq
Xq28	X:153687926-153696593	SLC6A8, CRTR, CCDS1	Solute carrier family 6 (neurotransmitter transporter, creatine), member 8	300036	SLC6A8	6535	ENSG00000130821,ENST00000253122;;;ENST00000253122	distal to G6PD	Cerebral creatine deficiency syndrome 1	300352	XLR	3	Slc6a8
Xq28	X:153700492-153724387	BCAP31, BAP31, DXS1357E, DDCH	B-cell receptor-associated protein 31	300398	BCAP31	10134	ENSG00000185825,ENST00000345046;;;ENST00000345046		Deafness, dystonia, and cerebral hypomyelination	300475	XLR	3	Bcap31
Xq28	X:153724856-153744755	ABCD1, ALD, AMN	ATP-binding cassette, subfamily D, member 1	300371	ABCD1	215	ENSG00000101986,ENST00000218104;;;ENST00000218104	about 650kb from GCP/RCP	Adrenoleukodystrophy	300100	XLR	3	Abcd1
Xq28	X:153724856-153744755	ABCD1, ALD, AMN	ATP-binding cassette, subfamily D, member 1	300371	ABCD1	215	ENSG00000101986,ENST00000218104;;;ENST00000218104	about 650kb from GCP/RCP	Adrenomyeloneuropathy, adult	300100	XLR	3	Abcd1
Xq28	X:153781041-153785730	SRPK3, STK23, MSSK1, XLID114	SRSF protein kinase 3	301002	SRPK3	26576	ENSG00000184343,ENST00000370101;;;ENST00000370101		Intellectual developmental disorder, X-linked 114	301134	XL	3	Srpk3
Xq28	X:153785768-153794375	IDH3G, RP99	Isocitrate dehydrogenase (NAD+) 3, noncatalytic, gamma subunit	300089	IDH3G	3421	ENSG00000067829,ENST00000217901;;;ENST00000217901		Retinitis pigmentosa 99	301148	XLR	3	Idh3g
Xq28	X:153794159-153798499	SSR4, TRAPD, CDG1Y	Signal sequence receptor, delta	300090	SSR4	6748	ENSG00000180879,ENST00000370086;;;ENST00000370086		Congenital disorder of glycosylation, type Iy	300934	XLR	3	Ssr4
Xq28	X:153861514-153886173	L1CAM, CAML1, HYCX, MASA, SPG1	L1 cell adhesion molecule	308840	L1CAM	3897	ENSG00000198910,ENST00000370060;;;ENST00000370060	mutation identified in 1 PACCX family	?Corpus callosum, partial agenesis of	304100	XLR	3	L1cam
Xq28	X:153861514-153886173	L1CAM, CAML1, HYCX, MASA, SPG1	L1 cell adhesion molecule	308840	L1CAM	3897	ENSG00000198910,ENST00000370060;;;ENST00000370060	mutation identified in 1 PACCX family	Hydrocephalus, congenital, X-linked	307000	XLR	3	L1cam
Xq28	X:153861514-153886173	L1CAM, CAML1, HYCX, MASA, SPG1	L1 cell adhesion molecule	308840	L1CAM	3897	ENSG00000198910,ENST00000370060;;;ENST00000370060	mutation identified in 1 PACCX family	MASA syndrome	303350	XLR	3	L1cam
Xq28	X:153902625-153907166	AVPR2, DIR, DI1, ADHR, NDI1	Arginine vasopressin receptor-2	300538	AVPR2	554	ENSG00000126895,ENST00000646375;;;ENST00000646375		Diabetes insipidus, nephrogenic, 1	304800	XLR	3	Avpr2
Xq28	X:153902625-153907166	AVPR2, DIR, DI1, ADHR, NDI1	Arginine vasopressin receptor-2	300538	AVPR2	554	ENSG00000126895,ENST00000646375;;;ENST00000646375		Nephrogenic syndrome of inappropriate antidiuresis	300539	XLR	3	Avpr2
Xq28	X:153929225-153935037	NAA10, ARD1A, ARD1, TE2, NATD, OGDNS, MCOPS1	N-alpha-acetyltransferase 10, NatA catalytic subunit	300013	NAA10	8260	ENSG00000102030,ENST00000464845;;;ENST00000464845		Microphthalmia, syndromic 1	309800	XL	3	Naa10
Xq28	X:153929225-153935037	NAA10, ARD1A, ARD1, TE2, NATD, OGDNS, MCOPS1	N-alpha-acetyltransferase 10, NatA catalytic subunit	300013	NAA10	8260	ENSG00000102030,ENST00000464845;;;ENST00000464845		Ogden syndrome	300855	XLD, XLR	3	Naa10
Xq28	X:153947557-153971818	HCFC1, HCF1, MAHCX, XLID3	Host cell factor C1 (VP16-accessory protein)	300019	HCFC1	3054	ENSG00000172534,ENST00000310441;;;ENST00000310441	50kb distal to V2R	Methylmalonic aciduria and homocysteinemia, cblX type	309541	XLR	3	Hcfc1
Xq28	X:154021573-154097717	MECP2, RTT, PPMX, AUTSX3, MRXSL, MRXS13	Methyl-CpG-binding protein-2	300005	MECP2	4204	ENSG00000169057,ENST00000453960;;;ENST00000453960	70kb centromeric of RCP/GCP	{Autism susceptibility, X-linked 3}	300496	XL	3	Mecp2
Xq28	X:154021573-154097717	MECP2, RTT, PPMX, AUTSX3, MRXSL, MRXS13	Methyl-CpG-binding protein-2	300005	MECP2	4204	ENSG00000169057,ENST00000453960;;;ENST00000453960	70kb centromeric of RCP/GCP	Encephalopathy, neonatal severe	300673	XLR	3	Mecp2
Xq28	X:154021573-154097717	MECP2, RTT, PPMX, AUTSX3, MRXSL, MRXS13	Methyl-CpG-binding protein-2	300005	MECP2	4204	ENSG00000169057,ENST00000453960;;;ENST00000453960	70kb centromeric of RCP/GCP	Intellectual developmental disorder, X-linked syndromic 13	300055	XLR	3	Mecp2
Xq28	X:154021573-154097717	MECP2, RTT, PPMX, AUTSX3, MRXSL, MRXS13	Methyl-CpG-binding protein-2	300005	MECP2	4204	ENSG00000169057,ENST00000453960;;;ENST00000453960	70kb centromeric of RCP/GCP	Intellectual developmental disorder, X-linked syndromic, Lubs type	300260	XLR	3	Mecp2
Xq28	X:154021573-154097717	MECP2, RTT, PPMX, AUTSX3, MRXSL, MRXS13	Methyl-CpG-binding protein-2	300005	MECP2	4204	ENSG00000169057,ENST00000453960;;;ENST00000453960	70kb centromeric of RCP/GCP	Rett syndrome	312750	XLD	3	Mecp2
Xq28	X:154021573-154097717	MECP2, RTT, PPMX, AUTSX3, MRXSL, MRXS13	Methyl-CpG-binding protein-2	300005	MECP2	4204	ENSG00000169057,ENST00000453960;;;ENST00000453960	70kb centromeric of RCP/GCP	Rett syndrome, atypical	312750	XLD	3	Mecp2
Xq28	X:154021573-154097717	MECP2, RTT, PPMX, AUTSX3, MRXSL, MRXS13	Methyl-CpG-binding protein-2	300005	MECP2	4204	ENSG00000169057,ENST00000453960;;;ENST00000453960	70kb centromeric of RCP/GCP	Rett syndrome, preserved speech variant	312750	XLD	3	Mecp2
Xq28	X:154144243-154159032	OPN1LW, RCP, CBP, CBBM	Red cone pigment (opsin 1, long-wave-sensitive)	300822	OPN1LW	5956	ENSG00000102076,ENST00000369951;;;ENST00000369951	5' to CBD	Blue cone monochromacy	303700	XLR	3	Opn1mw
Xq28	X:154144243-154159032	OPN1LW, RCP, CBP, CBBM	Red cone pigment (opsin 1, long-wave-sensitive)	300822	OPN1LW	5956	ENSG00000102076,ENST00000369951;;;ENST00000369951	5' to CBD	Colorblindness, protan	303900	XL	3	Opn1mw
Xq28	X:154182596-154196861	OPN1MW, GCP, CBD, CBBM	Green cone pigment (opsin 1, medium-wave-sensitive)	300821	OPN1MW	2652	ENSG00000268221,ENST00000595290;;;ENST00000595290	linked to G6PD; multiple genes	Blue cone monochromacy	303700	XLR	3	Opn1mw
Xq28	X:154182596-154196861	OPN1MW, GCP, CBD, CBBM	Green cone pigment (opsin 1, medium-wave-sensitive)	300821	OPN1MW	2652	ENSG00000268221,ENST00000595290;;;ENST00000595290	linked to G6PD; multiple genes	Colorblindness, deutan	303800	XL	3	Opn1mw
Xq28	X:154348531-154374634	FLNA, FLN1, NHBP, OPD1, OPD2, FMD, MNS, CVD1, CSBS, FGS2	Filamin A, alpha (actin-binding protein-280)	300017	FLNA	2316	ENSG00000196924,ENST00000369850;;;ENST00000369850	mutation identified in 1 FGS2 patient	?FG syndrome 2	300321	XL	3	Flna
Xq28	X:154348531-154374634	FLNA, FLN1, NHBP, OPD1, OPD2, FMD, MNS, CVD1, CSBS, FGS2	Filamin A, alpha (actin-binding protein-280)	300017	FLNA	2316	ENSG00000196924,ENST00000369850;;;ENST00000369850	mutation identified in 1 FGS2 patient	Cardiac valvular dysplasia, X-linked	314400	XL	3	Flna
Xq28	X:154348531-154374634	FLNA, FLN1, NHBP, OPD1, OPD2, FMD, MNS, CVD1, CSBS, FGS2	Filamin A, alpha (actin-binding protein-280)	300017	FLNA	2316	ENSG00000196924,ENST00000369850;;;ENST00000369850	mutation identified in 1 FGS2 patient	Congenital short bowel syndrome	300048	XLR	3	Flna
Xq28	X:154348531-154374634	FLNA, FLN1, NHBP, OPD1, OPD2, FMD, MNS, CVD1, CSBS, FGS2	Filamin A, alpha (actin-binding protein-280)	300017	FLNA	2316	ENSG00000196924,ENST00000369850;;;ENST00000369850	mutation identified in 1 FGS2 patient	Frontometaphyseal dysplasia 1	305620	XLR	3	Flna
Xq28	X:154348531-154374634	FLNA, FLN1, NHBP, OPD1, OPD2, FMD, MNS, CVD1, CSBS, FGS2	Filamin A, alpha (actin-binding protein-280)	300017	FLNA	2316	ENSG00000196924,ENST00000369850;;;ENST00000369850	mutation identified in 1 FGS2 patient	Heterotopia, periventricular, 1	300049	XLD	3	Flna
Xq28	X:154348531-154374634	FLNA, FLN1, NHBP, OPD1, OPD2, FMD, MNS, CVD1, CSBS, FGS2	Filamin A, alpha (actin-binding protein-280)	300017	FLNA	2316	ENSG00000196924,ENST00000369850;;;ENST00000369850	mutation identified in 1 FGS2 patient	Intestinal pseudoobstruction, neuronal	300048	XLR	3	Flna
Xq28	X:154348531-154374634	FLNA, FLN1, NHBP, OPD1, OPD2, FMD, MNS, CVD1, CSBS, FGS2	Filamin A, alpha (actin-binding protein-280)	300017	FLNA	2316	ENSG00000196924,ENST00000369850;;;ENST00000369850	mutation identified in 1 FGS2 patient	Melnick-Needles syndrome	309350	XLD	3	Flna
Xq28	X:154348531-154374634	FLNA, FLN1, NHBP, OPD1, OPD2, FMD, MNS, CVD1, CSBS, FGS2	Filamin A, alpha (actin-binding protein-280)	300017	FLNA	2316	ENSG00000196924,ENST00000369850;;;ENST00000369850	mutation identified in 1 FGS2 patient	Otopalatodigital syndrome, type I	311300	XLD	3	Flna
Xq28	X:154348531-154374634	FLNA, FLN1, NHBP, OPD1, OPD2, FMD, MNS, CVD1, CSBS, FGS2	Filamin A, alpha (actin-binding protein-280)	300017	FLNA	2316	ENSG00000196924,ENST00000369850;;;ENST00000369850	mutation identified in 1 FGS2 patient	Otopalatodigital syndrome, type II	304120	XLD	3	Flna
Xq28	X:154348531-154374634	FLNA, FLN1, NHBP, OPD1, OPD2, FMD, MNS, CVD1, CSBS, FGS2	Filamin A, alpha (actin-binding protein-280)	300017	FLNA	2316	ENSG00000196924,ENST00000369850;;;ENST00000369850	mutation identified in 1 FGS2 patient	Terminal osseous dysplasia	300244	XLD	3	Flna
Xq28	X:154379295-154381523	EMD, EDMD, STA	Emerin	300384	EMD	2010	ENSG00000102119,ENST00000369842;;;ENST00000369842	in distal Xq28	Emery-Dreifuss muscular dystrophy 1, X-linked	310300	XLR	3	Emd
Xq28	X:154398065-154402339	RPL10, DXS648, QM, AUTSX5, MRXS35	Ribosomal protein L10	312173	RPL10	6134	ENSG00000147403,ENST00000369817;;;ENST00000369817		{Autism, susceptibility to, X-linked 5}	300847		3	Rpl10
Xq28	X:154398065-154402339	RPL10, DXS648, QM, AUTSX5, MRXS35	Ribosomal protein L10	312173	RPL10	6134	ENSG00000147403,ENST00000369817;;;ENST00000369817		Intellectual developmental disorder, X-linked syndromic 35	300998	XLR	3	Rpl10
Xq28	X:154411539-154421726	TAFAZZIN, TAZ, EFE2, BTHS, CMD3A, LVNCX	Tafazzin	300394	TAFAZZIN	6901	ENSG00000102125,ENST00000601016;;;ENST00000601016		Barth syndrome	302060	XLR	3	Tafazzin
Xq28	X:154428677-154436516	ATP6AP1, ATP6IP1, ATP6S1, VATPS1	ATPase, H+ transporting, lysosomal, accessory protein 1	300197	ATP6AP1	537	ENSG00000071553,ENST00000369762;;;ENST00000369762		Immunodeficiency 47	300972	XLR	3	Atp6ap1
Xq28	X:154437154-154443467	GDI1, RABGD1A, MRX41, MRX48, XLID41	GDP dissociation inhibitor 1	300104	GDI1	2664	ENSG00000203879,ENST00000447750;;;ENST00000447750		Intellectual developmental disorder, X-linked 41	300849	XLD	3	Gdi1
Xq28	X:154444141-154450654	FAM50A, DXS9928E, HXC26, MRXSA	Family with sequence similarity 50, member A	300453	FAM50A	9130	ENSG00000071859,ENST00000393600;;;ENST00000393600		Intellectual developmental disorder, X-linked syndromic, Armfield type	300261	XLR	3	Fam50a
Xq28	X:154477775-154479281	LAGE3, ITBA2, GAMOS2	L antigen family member 3	300060	LAGE3	8270	ENSG00000196976,ENST00000357360;;;ENST00000357360		Galloway-Mowat syndrome 2, X-linked	301006	XLR	3	Lage3
Xq28	X:154531390-154547569	G6PD, G6PD1, CNSHA1	Glucose-6-phosphate dehydrogenase	305900	G6PD	2539	ENSG00000160211,ENST00000393562;;;ENST00000393562		{Resistance to malaria due to G6PD deficiency}	611162		3	G6pd2,G6pdx
Xq28	X:154531390-154547569	G6PD, G6PD1, CNSHA1	Glucose-6-phosphate dehydrogenase	305900	G6PD	2539	ENSG00000160211,ENST00000393562;;;ENST00000393562		Anemia, congenital, nonspherocytic hemolytic, 1, G6PD deficient	300908	XL	3	G6pd2,G6pdx
Xq28	X:154541238-154565046	IKBKG, NEMO, FIP3, IP, EDAID1, IMD33, SAIDX	Inhibitor of nuclear factor kappa B kinase, regulatory subunit gamma	300248	IKBKG	8517	ENSG00000269335,ENST00000594239;;;ENST00000594239		Autoinflammatory disease, systemic, X-linked	301081	XL	3	Ikbkg
Xq28	X:154541238-154565046	IKBKG, NEMO, FIP3, IP, EDAID1, IMD33, SAIDX	Inhibitor of nuclear factor kappa B kinase, regulatory subunit gamma	300248	IKBKG	8517	ENSG00000269335,ENST00000594239;;;ENST00000594239		Ectodermal dysplasia and immunodeficiency 1	300291	XLR	3	Ikbkg
Xq28	X:154541238-154565046	IKBKG, NEMO, FIP3, IP, EDAID1, IMD33, SAIDX	Inhibitor of nuclear factor kappa B kinase, regulatory subunit gamma	300248	IKBKG	8517	ENSG00000269335,ENST00000594239;;;ENST00000594239		Immunodeficiency 33	300636	XLR	3	Ikbkg
Xq28	X:154541238-154565046	IKBKG, NEMO, FIP3, IP, EDAID1, IMD33, SAIDX	Inhibitor of nuclear factor kappa B kinase, regulatory subunit gamma	300248	IKBKG	8517	ENSG00000269335,ENST00000594239;;;ENST00000594239		Incontinentia pigmenti	308300	XLD	3	Ikbkg
Xq28	X:154762864-154777689	DKC1, DKCX, CHINE1	Dyskerin	300126	DKC1	1736	ENSG00000130826,ENST00000369550;;;ENST00000369550	mutation identified in 1 CHINE1 family	?Cataracts, hearing impairment, nephrotic syndrome, and enterocolitis 1	301108	XLD	3	Dkc1
Xq28	X:154762864-154777689	DKC1, DKCX, CHINE1	Dyskerin	300126	DKC1	1736	ENSG00000130826,ENST00000369550;;;ENST00000369550	mutation identified in 1 CHINE1 family	Dyskeratosis congenita, X-linked	305000	XLR	3	Dkc1
Xq28	X:154835792-155022723	F8, F8C, HEMA, THPH13	Coagulation factor VIII, procoagulant component	300841	F8	2157	ENSG00000185010,ENST00000360256;;;ENST00000360256	cen-G6PD-3' end of F8C-5'-ter; 1.1Mb from telomere	Hemophilia A	306700	XLR	3	F8
Xq28	X:154835792-155022723	F8, F8C, HEMA, THPH13	Coagulation factor VIII, procoagulant component	300841	F8	2157	ENSG00000185010,ENST00000360256;;;ENST00000360256	cen-G6PD-3' end of F8C-5'-ter; 1.1Mb from telomere	Thrombophilia 13, X-linked, due to factor VIII defect	301071	XL	3	F8
Xq28	X:155258235-155264491	RAB39B, XLID72, WSMN, MRX72	RAB39B, member Ras oncogene family	300774	RAB39B	116442	ENSG00000155961,ENST00000369454;;;ENST00000369454		Intellectual developmental disorder, X-linked 72	300271	XLR	3	Rab39b
Xq28	X:155258235-155264491	RAB39B, XLID72, WSMN, MRX72	RAB39B, member Ras oncogene family	300774	RAB39B	116442	ENSG00000155961,ENST00000369454;;;ENST00000369454		Waisman syndrome	311510	XLR	3	Rab39b
Xq28	X:155489011-155612952	TMLHE, BBOX2, TMLH, TMLHED, AUTSX6	Epsilon-trimethyllysine hydroxylase	300777	TMLHE	55217	ENSG00000185973,ENST00000334398;;;ENST00000334398		{Autism, susceptibility to, X-linked 6}	300872	XLR	3	Tmlhe
Chr.X	X:1-156040895	CCCSX	Cerebral-cerebellar-coloboma syndrome, X-linked	300864		100820758			Cerebral-cerebellar-coloboma syndrome, X-linked	300864	XLR	2	
Chr.X	X:1-156040895	CVMRF	Cubitus valgus with impaired intellectual development and unusual facies	300471		494028			Cubitus valgus with impaired intellectual development and unusual facies	300471	XLR	2	
Chr.X	X:1-156040895	DFCTRPS	Deafness, cataract, retinitis pigmentosa, and sperm abnormalities	300719		100188774			Deafness, cataract, retinitis pigmentosa, and sperm abnormalities	300719	XLR	2	
Chr.X	X:1-156040895	MCOPCB1	Microphthalmia, isolated, with coloboma 1	300345		85503			Microphthalmia with coloboma 1	300345		2	
Chr.X	X:1-156040895	MRXS32	Intellectual developmental disorder, X-linked, syndromic 32	300886		135933881			Intellectual developmental disorder, X-linked, syndromic 32	300886	XLR	2	
Chr.X	X:1-156040895	OFD8	Orofaciodigital syndrome VIII	300484					Orofaciodigital syndrome VIII	300484	XLR	2	
Chr.X	X:1-156040895	XLID95, MRX95	Intellectual developmental disorder, X-linked 95	300716		102775568			Intellectual developmental disorder, X-linked 95	300716	XLD	2	
Yp11.2	Y:600001-10300000	DHRSY, CDG1DD	Dehydrogenase/reductase, Y-linked	400049		138637319		in pseudoautosomal region	Congenital disorder of glycosylation, type 1DD	301133	PR	3	
Yp11.2	Y:624344-659411	SHOXY	Short stature homeobox, Y-linked	400020	SHOX	6473	ENSG00000185960,ENST00000686671;;;ENST00000686671	pseudoautosomal	Langer mesomelic dysplasia	249700	PR	3	
Yp11.2	Y:624344-659411	SHOXY	Short stature homeobox, Y-linked	400020	SHOX	6473	ENSG00000185960,ENST00000686671;;;ENST00000686671	pseudoautosomal	Leri-Weill dyschondrosteosis	127300	PD	3	
Yp11.2	Y:624344-659411	SHOXY	Short stature homeobox, Y-linked	400020	SHOX	6473	ENSG00000185960,ENST00000686671;;;ENST00000686671	pseudoautosomal	Short stature, idiopathic familial	300582		3	
Yp11.2	Y:2786855-2787682	SRY, TDF, TDY, SRXX1, SRXY1	Sex-determining region Y (testis determining factor)	480000	SRY	6736	ENSG00000184895,ENST00000383070;;;ENST00000383070		46XX sex reversal 1	400045	XLD	4	Sry
Yp11.2	Y:2786855-2787682	SRY, TDF, TDY, SRXX1, SRXY1	Sex-determining region Y (testis determining factor)	480000	SRY	6736	ENSG00000184895,ENST00000383070;;;ENST00000383070		46XY sex reversal 1	400044	YL	3	Sry
Yp11.2	Y:6910697-7091683	TBL1Y, DFNY2	Transducin-beta-like 1, Y-linked	400033	TBL1Y	90665	ENSG00000092377,ENST00000383032;;;ENST00000383032	mutation identified in 1 DFNY2 family	?Deafness, Y-linked 2	400047	YL	3	Tbl1x
Yq11	Y:10400001-26600000	DELYq11, CYDELq11, SPGFY1	Chromosome Yq11 interstitial deletion syndrome	400042				contiguous gene deletion syndrome	Spermatogenic failure, Y-linked, 1	400042	YL	4	
Yq	Y:10400001-57227415	HEY	Hairy ears, Y-linked	425500		100188776			?Hairy ears, Y-linked	425500	YL	2	
Yq11.221	Y:12701231-12860839	USP9Y, DFFRY, SPGFY2	Ubiquitin-specific protease-9, Y chromosome (Drosophila fat facets related, Y-linked)	400005	USP9Y	8287	ENSG00000114374,ENST00000338981;;;ENST00000338981		Spermatogenic failure, Y-linked, 2	415000	YL	3	Usp9y
Chr.Y	Y:1-57227415	DFNY1	Deafness, Y-linked 1	400043		724074			Deafness, Y-linked 1	400043	YL	2	
Chr.Y	Y:1-57227415	RPY	Retinitis pigmentosa, Y-linked	400004		79051			Retinitis pigmentosa, Y-linked	400004	YL	2	
